Morphological	O
characterization	O
of	O
the	O
AlphaA	O
-	O
and	O
AlphaB	O
-	O
crystallin	O
double	O
knockout	O
mouse	O
lens	O

Abstract	O

Background	O

One	O
approach	O
to	O
resolving	O
some	O
of	O
the	O
in	O
vivo	O
functions	O
of	O
alpha	O
-	O
crystallin	O
is	O
to	O
generate	O
animal	O
models	O
where	O
one	O
or	O
both	O
of	O
the	O
alpha	O
-	O
crystallin	O
gene	O
products	O
have	O
been	O
eliminated	O
.	O

In	O
the	O
single	O
alpha	O
-	O
crystallin	O
knockout	O
mice	O
,	O
the	O
remaining	O
alpha	O
-	O
crystallin	O
may	O
fully	O
or	O
partially	O
compensate	O
for	O
some	O
of	O
the	O
functions	O
of	O
the	O
missing	O
protein	O
,	O
especially	O
in	O
the	O
lens	O
,	O
where	O
both	O
alphaA	O
and	O
alphaB	O
are	O
normally	O
expressed	O
at	O
high	O
levels	O
.	O

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
characterize	O
gross	O
lenticular	O
morphology	O
in	O
normal	O
mice	O
and	O
mice	O
with	O
the	O
targeted	O
disruption	O
of	O
alphaA	O
-	O
and	O
alphaB	O
-	O
crystallin	O
genes	O
(	O
alphaA	O
/	O
BKO	O
)	O
.	O

Methods	O

Lenses	O
from	O
129SvEvTac	O
mice	O
and	O
alphaA	O
/	O
BKO	O
mice	O
were	O
examined	O
by	O
standard	O
scanning	O
electron	O
microscopy	O
and	O
confocal	O
microscopy	O
methodologies	O
.	O

Results	O

Equatorial	O
and	O
axial	O
(	O
sagittal	O
)	O
dimensions	O
of	O
lenses	O
for	O
alphaA	O
/	O
BKO	O
mice	O
were	O
significantly	O
smaller	O
than	O
age	O
-	O
matched	O
wild	O
type	O
lenses	O
.	O

No	O
posterior	O
sutures	O
or	O
fiber	O
cells	O
extending	O
to	O
the	O
posterior	O
capsule	O
of	O
the	O
lens	O
were	O
found	O
in	O
alphaA	O
/	O
BKO	O
lenses	O
.	O

Ectopical	O
nucleic	O
acid	O
staining	O
was	O
observed	O
in	O
the	O
posterior	O
subcapsular	O
region	O
of	O
5	O
wk	O
and	O
anterior	O
subcapsular	O
cortex	O
of	O
54	O
wk	O
alphaA	O
/	O
BKO	O
lenses	O
.	O

Gross	O
morphological	O
differences	O
were	O
also	O
observed	O
in	O
the	O
equatorial	O
/	O
bow	O
,	O
posterior	O
and	O
anterior	O
regions	O
of	O
lenses	O
from	O
alphaA	O
/	O
BKO	O
mice	O
as	O
compared	O
to	O
wild	O
mice	O
.	O

Conclusion	O

These	O
results	O
indicated	O
that	O
both	O
alphaA	O
-	O
and	O
alphaB	O
-	O
crystallin	O
are	O
necessary	O
for	O
proper	O
fiber	O
cell	O
formation	O
,	O
and	O
that	O
the	O
absence	O
of	O
alpha	O
-	O
crystallin	O
can	O
lead	O
to	O
cataract	O
formation	O
.	O

Background	O

Alpha	O
-	O
Crystallin	O
is	O
comprised	O
of	O
two	O
polypeptides	O
,	O
alphaA	O
-	O
crystallin	O
(	O
alphaA	O
)	O
and	O
alphaB	O
-	O
crystallin	O
(	O
alphaB	O
)	O
,	O
which	O
share	O
55	O
%	O
amino	O
acid	O
sequence	O
homology	O
[	O
1	O
]	O
.	O

They	O
are	O
the	O
most	O
abundant	O
proteins	O
in	O
lens	O
fiber	O
cells	O
[	O
2	O
,	O
3	O
]	O
and	O
exist	O
as	O
heteroaggregates	O
of	O
approximately	O
800	O
kDa	O
that	O
can	O
undergo	O
inter	O
-	O
aggregate	O
subunit	O
exchange	O
[	O
4	O
]	O
.	O

The	O
expression	O
of	O
these	O
two	O
proteins	O
in	O
the	O
lens	O
epithelium	O
,	O
however	O
,	O
is	O
not	O
uniform	O
throughout	O
different	O
regions	O
of	O
the	O
anterior	O
epithelium	O
.	O

AlphaB	O
expression	O
is	O
detected	O
in	O
central	O
epithelium	O
and	O
increases	O
from	O
the	O
central	O
to	O
elongation	O
zones	O
,	O
where	O
epithelial	O
cells	O
differentiate	O
into	O
fiber	O
cells	O
.	O

AlphaA	O
,	O
however	O
,	O
is	O
not	O
detected	O
in	O
the	O
central	O
epithelium	O
.	O

The	O
relative	O
proportion	O
of	O
alphaA	O
and	O
alphaB	O
changes	O
from	O
a	O
molar	O
ratio	O
of	O
1	O
:	O
3	O
in	O
the	O
pericentral	O
and	O
germative	O
zones	O
to	O
a	O
molar	O
ratio	O
of	O
3	O
:	O
1	O
in	O
the	O
elongation	O
zone	O
and	O
fiber	O
cells	O
[	O
2	O
,	O
3	O
]	O
.	O

These	O
differences	O
in	O
the	O
relative	O
proportions	O
of	O
alphaA	O
and	O
alphaB	O
within	O
the	O
lens	O
suggest	O
different	O
functions	O
for	O
the	O
two	O
subunits	O
in	O
the	O
developing	O
lens	O
.	O

Prior	O
to	O
the	O
1990	O
'	O
s	O
,	O
alpha	O
-	O
crystallin	O
was	O
thought	O
to	O
be	O
a	O
structural	O
protein	O
whose	O
major	O
cellular	O
function	O
was	O
to	O
produce	O
a	O
dense	O
solution	O
necessary	O
for	O
the	O
refraction	O
of	O
light	O
in	O
the	O
lens	O
.	O

During	O
the	O
early	O
1990	O
'	O
s	O
,	O
alpha	O
-	O
crystallin	O
was	O
shown	O
to	O
act	O
as	O
a	O
molecular	O
chaperone	O
,	O
binding	O
to	O
partially	O
denatured	O
proteins	O
,	O
both	O
in	O
vitro	O
[	O
5	O
]	O
and	O
probably	O
in	O
vivo	O
[	O
6	O
]	O
,	O
to	O
inhibit	O
further	O
denaturation	O
and	O
aggregation	O
of	O
lens	O
proteins	O
.	O

AlphaA	O
and	O
alphaB	O
were	O
also	O
shown	O
to	O
have	O
sequence	O
homology	O
with	O
several	O
other	O
proteins	O
that	O
are	O
members	O
of	O
the	O
small	O
heat	O
shock	O
protein	O
(	O
hsp	O
)	O
family	O
[	O
7	O
]	O
.	O

Moreover	O
,	O
expression	O
of	O
alpha	O
-	O
crystallin	O
,	O
particularly	O
alphaB	O
,	O
was	O
shown	O
to	O
not	O
be	O
restricted	O
to	O
the	O
lens	O
.	O

AlphaB	O
was	O
found	O
to	O
be	O
expressed	O
at	O
significant	O
levels	O
in	O
a	O
variety	O
of	O
nonlenticular	O
tissues	O
,	O
while	O
alphaA	O
has	O
only	O
been	O
detected	O
in	O
small	O
amounts	O
in	O
a	O
few	O
other	O
tissues	O
such	O
as	O
retina	O
,	O
spleen	O
and	O
thymus	O
[	O
8	O
-	O
12	O
]	O
.	O

Collectively	O
,	O
these	O
findings	O
have	O
challenged	O
the	O
dogma	O
that	O
alpha	O
-	O
crystallin	O
is	O
purely	O
a	O
structural	O
protein	O
necessary	O
for	O
light	O
refraction	O
,	O
and	O
have	O
led	O
to	O
the	O
realization	O
that	O
alpha	O
-	O
crystallin	O
may	O
have	O
a	O
variety	O
of	O
biological	O
functions	O
in	O
the	O
lens	O
.	O

A	O
much	O
broader	O
scope	O
of	O
cellular	O
functions	O
of	O
alpha	O
-	O
crystallin	O
in	O
lens	O
is	O
inferred	O
from	O
in	O
vitro	O
observations	O
.	O

Both	O
alphaA	O
and	O
alphaB	O
can	O
bind	O
specifically	O
to	O
actin	O
,	O
in	O
vitro	O
[	O
13	O
]	O
and	O
in	O
vivo	O
[	O
14	O
]	O
.	O

Although	O
actin	B-GO
filament	E-GO
formation	O
has	O
been	O
shown	O
to	O
be	O
necessary	O
for	O
differentiation	O
of	O
lens	O
epithelial	O
cells	O
[	O
15	O
]	O
,	O
the	O
significance	O
of	O
alpha	O
-	O
crystallin	O
'	O
s	O
interaction	O
with	O
actin	O
in	O
differentiation	O
is	O
not	O
known	O
.	O

In	O
the	O
lens	O
,	O
alpha	O
-	O
crystallin	O
also	O
associates	O
with	O
type	B-GO
III	I-GO
intermediate	I-GO
filament	E-GO
proteins	O
and	O
the	O
beaded	O
filament	O
proteins	O
CP49	O
and	O
CP115	O
,	O
and	O
correct	O
beaded	O
filament	O
assembly	O
has	O
been	O
shown	O
depend	O
on	O
the	O
presence	O
of	O
alpha	O
-	O
crystallin	O
[	O
16	O
]	O
.	O

Beaded	O
filament	O
mRNA	O
levels	O
are	O
greatly	O
increased	O
in	O
differentiating	O
lens	O
epithelium	O
and	O
have	O
been	O
suggested	O
as	O
a	O
pan	O
-	O
specific	O
marker	O
for	O
lens	O
fiber	O
development	O
[	O
17	O
]	O
.	O

Alpha	O
-	O
crystallin	O
has	O
also	O
been	O
shown	O
to	O
interact	O
directly	O
with	O
DNA	O
[	O
18	O
]	O
.	O

In	O
transfected	O
CHO	O
cells	O
,	O
alphaB	O
has	O
also	O
been	O
shown	O
to	O
ectopically	O
localize	O
to	O
interphase	O
nuclei	S-GO
,	O
suggesting	O
a	O
role	O
for	O
this	O
protein	O
in	O
the	O
nucleus	S-GO
[	O
19	O
]	O
.	O

A	O
nuclear	S-GO
role	O
for	O
alphaB	O
in	O
the	O
lens	O
was	O
supported	O
by	O
the	O
findings	O
that	O
a	O
subset	O
of	O
lens	O
epithelial	O
cells	O
derived	O
from	O
alphaB	O
knockout	O
mice	O
demonstrated	O
hyperproliferation	O
and	O
genomic	O
instability	O
[	O
20	O
]	O
.	O

In	O
addition	O
,	O
the	O
administration	O
of	O
exogenous	O
alpha	O
-	O
crystallin	O
to	O
primary	O
bovine	O
lens	O
epithelial	O
cell	O
cultures	O
resulted	O
in	O
the	O
formation	O
of	O
lentoid	O
bodies	O
,	O
consistent	O
with	O
a	O
role	O
for	O
these	O
proteins	O
in	O
lens	O
differentiation	O
[	O
21	O
]	O
.	O

These	O
findings	O
indicate	O
that	O
alpha	O
-	O
crystallin	O
may	O
have	O
a	O
multitude	O
of	O
in	O
vivo	O
functions	O
.	O

One	O
approach	O
to	O
resolving	O
some	O
of	O
the	O
in	O
vivo	O
functions	O
of	O
alpha	O
-	O
crystallin	O
is	O
to	O
generate	O
animal	O
models	O
where	O
one	O
or	O
both	O
of	O
the	O
alpha	O
-	O
crystallin	O
gene	O
products	O
have	O
been	O
eliminated	O
.	O

Brady	O
et	O
al	O
.	O

[	O
22	O
]	O
demonstrated	O
,	O
by	O
targeted	O
disruption	O
of	O
the	O
mouse	O
alphaA	O
gene	O
,	O
that	O
this	O
protein	O
was	O
essential	O
for	O
the	O
maintenance	O
of	O
lens	O
transparency	O
,	O
possibly	O
by	O
maintaining	O
the	O
solubility	O
of	O
alphaB	O
,	O
or	O
associated	O
proteins	O
,	O
in	O
the	O
lens	O
.	O

These	O
lenses	O
were	O
also	O
reported	O
to	O
be	O
smaller	O
in	O
equatorial	O
and	O
light	O
axial	O
dimensions	O
than	O
age	O
matched	O
wild	O
type	O
lens	O
.	O

It	O
was	O
not	O
possible	O
using	O
the	O
techniques	O
employed	O
in	O
the	O
study	O
to	O
determine	O
if	O
the	O
smaller	O
lenses	O
were	O
due	O
to	O
reduced	O
volume	O
or	O
number	O
of	O
fiber	O
cells	O
.	O

Targeted	O
disruption	O
of	O
the	O
mouse	O
alphaB	O
gene	O
resulted	O
in	O
lenses	O
similar	O
in	O
size	O
to	O
aged	O
-	O
matched	O
wild	O
type	O
lens	O
.	O

Moreover	O
,	O
no	O
cataract	O
formation	O
was	O
observed	O
in	O
the	O
alphaB	O
knockout	O
lenses	O
.	O

These	O
animals	O
have	O
muscle	O
cell	O
abnormalities	O
,	O
severe	O
postural	O
anomalies	O
,	O
selective	O
muscle	O
degeneration	O
,	O
and	O
shorter	O
life	O
spans	O
compared	O
to	O
normal	O
controls	O
[	O
23	O
]	O
.	O

In	O
the	O
single	O
alpha	O
-	O
crystallin	O
knockout	O
mice	O
,	O
the	O
remaining	O
alpha	O
-	O
crystallin	O
may	O
fully	O
or	O
partially	O
compensate	O
for	O
some	O
of	O
the	O
functions	O
of	O
the	O
missing	O
protein	O
,	O
especially	O
in	O
the	O
lens	O
,	O
where	O
both	O
alphaA	O
and	O
alphaB	O
are	O
normally	O
expressed	O
at	O
high	O
levels	O
.	O

The	O
objectives	O
of	O
the	O
current	O
report	O
were	O
to	O
characterize	O
gross	O
morphology	O
of	O
young	O
(	O
5	O
wk	O
)	O
and	O
old	O
(	O
54	O
wk	O
)	O
mouse	O
lenses	O
with	O
targeted	O
disruption	O
of	O
both	O
the	O
alphaA	O
and	O
alphaB	O
genes	O
,	O
in	O
comparison	O
to	O
age	O
matched	O
wild	O
type	O
lenses	O
,	O
using	O
scanning	O
electron	O
microscopy	O
(	O
SEM	O
)	O
and	O
confocal	O
microscopy	O
,	O
to	O
elucidate	O
the	O
possible	O
functions	O
of	O
alpha	O
-	O
crystallin	O
in	O
the	O
lens	O
.	O

The	O
results	O
indicate	O
that	O
alpha	O
-	O
crystallin	O
is	O
necessary	O
for	O
proper	O
fiber	O
cell	O
formation	O
and	O
resulting	O
lens	O
transparency	O
.	O

Methods	O

Lenses	O

The	O
wild	O
type	O
mouse	O
strain	O
used	O
in	O
this	O
study	O
was	O
the	O
129SvEvTac	O
mouse	O
.	O

Lenses	O
examined	O
were	O
from	O
5	O
(	O
8	O
lenses	O
)	O
,	O
46	O
(	O
8	O
lenses	O
)	O
and	O
72	O
(	O
6	O
lenses	O
)	O
wk	O
old	O
mice	O
.	O

AlphaA	O
/	O
BKO	O
was	O
generated	O
by	O
cross	O
breeding	O
alphaAKO	O
-	O
127	O
[	O
22	O
]	O
and	O
alphaBKO	O
-	O
168	O
mice	O
[	O
23	O
]	O
,	O
also	O
in	O
a	O
129Sv	O
background	O
.	O

These	O
mice	O
also	O
lack	O
the	O
HSPB2	O
gene	O
product	O
[	O
23	O
]	O
.	O

Lenses	O
examined	O
were	O
from	O
5	O
wk	O
(	O
6	O
lenses	O
)	O
and	O
54	O
wk	O
(	O
16	O
lenses	O
)	O
old	O
mice	O
.	O

All	O
animals	O
were	O
treated	O
in	O
accordance	O
with	O
the	O
Association	O
for	O
Research	O
in	O
Vision	O
and	O
Ophthalmology	O
Statement	O
for	O
the	O
Use	O
of	O
Animals	O
in	O
Ophthalmic	O
and	O
Vision	O
Research	O
.	O

Immediately	O
after	O
euthanizing	O
animals	O
,	O
eyes	O
were	O
enucleated	O
.	O

A	O
scalpel	O
blade	O
was	O
then	O
used	O
to	O
make	O
a	O
small	O
incision	O
into	O
the	O
anterior	O
chamber	O
near	O
the	O
equator	O
and	O
then	O
both	O
eyes	O
from	O
individual	O
animals	O
were	O
immersed	O
in	O
5	O
ml	O
fixative	O
(	O
2	O
%	O
(	O
w	O
/	O
v	O
)	O
paraformaldehyde	O
and	O
2	O
%	O
glutaraldehyde	O
(	O
v	O
/	O
v	O
)	O
in	O
0	O
.	O
1	O
M	O
sodium	O
cacodylate	O
buffer	O
,	O
pH	O
7	O
.	O
2	O
)	O
.	O

Eyes	O
were	O
fixed	O
for	O
at	O
least	O
24	O
hr	O
at	O
room	O
temperature	O
(	O
RT	O
)	O
prior	O
to	O
dissection	O
of	O
the	O
lenses	O
.	O

At	O
this	O
time	O
,	O
equatorial	O
and	O
axial	O
dimensions	O
of	O
lenses	O
and	O
gross	O
lenticular	O
appearance	O
were	O
recorded	O
.	O

Statistical	O
analyses	O
on	O
data	O
consisted	O
of	O
Student	O
'	O
s	O
t	O
-	O
test	O
,	O
means	O
and	O
standard	O
deviation	O
,	O
using	O
the	O
statistical	O
software	O
package	O
StatMost	O
(	O
Dataxiom	O
Software	O
Inc	O
.	O
,	O
Los	O
Angeles	O
,	O
CA	O
)	O
.	O

Confocal	O
microscopy	O

Lenses	O
were	O
vibratome	O
sectioned	O
into	O
100	O
-	O
200	O
mu	O
m	O
thick	O
sections	O
along	O
the	O
optical	O
(	O
anterior	O
to	O
posterior	O
)	O
or	O
equatorial	O
axes	O
.	O

Thick	O
sections	O
were	O
fixed	O
in	O
2	O
%	O
(	O
w	O
/	O
v	O
)	O
paraformaldehyde	O
and	O
2	O
%	O
glutaraldehyde	O
(	O
v	O
/	O
v	O
)	O
in	O
0	O
.	O
1	O
M	O
sodium	O
cacodylate	O
buffer	O
pH	O
7	O
.	O
2	O
at	O
RT	O
for	O
24	O
hrs	O
then	O
washed	O
several	O
times	O
in	O
Tris	O
buffered	O
saline	O
(	O
0	O
.	O
5	O
M	O
Tris	O
,	O
150	O
mM	O
NaCl	O
,	O
pH	O
7	O
.	O
4	O
)	O
.	O

To	O
visualize	O
lipid	O
membranes	S-GO
,	O
sections	O
were	O
stained	O
with	O
1	O
,	O
1	O
'	O
-	O
dioctadecyl	O
-	O
3	O
,	O
3	O
,	O
3	O
'	O
,	O
3	O
'	O
-	O
tetramethylindocarbocyanine	O
perchlorate	O
(	O
'	O
DiI	O
'	O
;	O
DiIC18	O
;	O
Molecular	O
Probes	O
)	O
as	O
previously	O
described	O
[	O
24	O
]	O
.	O

Sections	O
were	O
then	O
washed	O
several	O
times	O
with	O
Tris	O
buffered	O
saline	O
,	O
and	O
nucleic	O
acids	O
were	O
stained	O
by	O
incubating	O
sections	O
in	O
TBS	O
containing	O
1	O
mu	O
M	O
SYTOX	O
Green	O
(	O
Molecular	O
Probes	O
)	O
for	O
10	O
min	O
at	O
RT	O
followed	O
by	O
several	O
washes	O
with	O
TBS	O
prior	O
to	O
confocal	O
imaging	O
.	O

Lens	O
sections	O
were	O
viewed	O
on	O
a	O
Zeiss	O
laser	O
scanning	O
confocal	O
microscope	O
model	O
LSM	O
410	O
equipped	O
with	O
an	O
Axiovert	O
100	O
inverted	O
microscope	O
,	O
an	O
Argon	O
-	O
Krypton	O
488	O
/	O
568	O
/	O
647	O
laser	O
,	O
a	O
KP	O
line	O
selection	O
filter	O
,	O
a	O
FT	O
488	O
/	O
568	O
Dichroic	O
beam	O
splitter	O
,	O
a	O
FT	O
560	O
Dichroic	O
beam	O
splitter	O
,	O
a	O
LP	O
590	O
emission	O
filter	O
for	O
viewing	O
DiI	O
,	O
a	O
BP	O
515	O
-	O
540	O
emission	O
filter	O
for	O
viewing	O
SYTOX	O
green	O
,	O
and	O
the	O
software	O
package	O
LSM	O
3	O
.	O
993	O
.	O

Scanning	O
electron	O
microscopy	O

Lenses	O
bisected	O
along	O
the	O
optical	O
axes	O
were	O
immersion	O
fixed	O
in	O
2	O
%	O
(	O
w	O
/	O
v	O
)	O
paraformaldehyde	O
and	O
2	O
%	O
glutaraldehyde	O
(	O
v	O
/	O
v	O
)	O
in	O
0	O
.	O
1	O
M	O
sodium	O
cacodylate	O
buffer	O
pH	O
7	O
.	O
2	O
at	O
RT	O
for	O
24	O
hrs	O
.	O

Samples	O
were	O
then	O
washed	O
several	O
times	O
with	O
distilled	O
water	O
and	O
postfixed	O
in	O
1	O
%	O
(	O
v	O
/	O
v	O
)	O
aqueous	O
osmium	O
tetroxide	O
at	O
RT	O
for	O
1	O
hr	O
.	O

Lens	O
halves	O
were	O
dehydrated	O
in	O
an	O
ascending	O
ethanol	O
series	O
from	O
50	O
-	O
100	O
%	O
.	O

Once	O
lens	O
halves	O
were	O
in	O
100	O
%	O
ethanol	O
,	O
they	O
were	O
critical	O
point	O
dried	O
in	O
carbon	O
dioxide	O
in	O
a	O
Samdri	O
-	O
790B	O
(	O
Tousimis	O
Research	O
Corp	O
.	O
,	O
Rockville	O
,	O
MD	O
)	O
.	O

Critical	O
point	O
dried	O
lens	O
halves	O
were	O
secured	O
on	O
aluminum	O
stubs	O
with	O
double	O
sided	O
tape	O
.	O

Mounted	O
specimens	O
were	O
then	O
sputter	O
coated	O
with	O
gold	O
and	O
viewed	O
on	O
a	O
Hitachi	O
S	O
-	O
3500N	O
scanning	O
electron	O
microscope	O
(	O
Tokyo	O
,	O
Japan	O
)	O
at	O
1	O
-	O
5	O
kV	O
.	O

This	O
microscope	O
is	O
equipped	O
with	O
Hitachi	O
'	O
s	O
patented	O
"	O
Dual	O
-	O
Bias	O
"	O
which	O
allows	O
extremely	O
high	O
emission	O
currents	O
at	O
acceleration	O
voltages	O
of	O
5	O
kV	O
and	O
lower	O
.	O

Results	O

Equatorial	O
and	O
axial	O
(	O
sagittal	O
)	O
dimensions	O
of	O
lenses	O
,	O
and	O
gross	O
lenticular	O
appearance	O
,	O
were	O
recorded	O
(	O
Table	O
1	O
)	O
.	O

AlphaA	O
/	O
BKO	O
lenses	O
at	O
5	O
wks	O
of	O
age	O
were	O
significantly	O
smaller	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
,	O
both	O
equatorially	O
and	O
axially	O
,	O
than	O
5	O
wk	O
old	O
wild	O
type	O
lenses	O
and	O
remain	O
smaller	O
throughout	O
life	O
.	O

Fifty	O
-	O
four	O
wk	O
old	O
alphaA	O
/	O
BKO	O
lenses	O
were	O
much	O
smaller	O
than	O
similarly	O
aged	O
normal	O
lenses	O
,	O
and	O
were	O
similar	O
in	O
size	O
to	O
5	O
wk	O
old	O
wild	O
type	O
lenses	O
.	O

Both	O
the	O
5	O
wk	O
old	O
wild	O
type	O
lenses	O
and	O
the	O
54	O
wk	O
old	O
alphaA	O
/	O
BKO	O
lenses	O
were	O
significantly	O
smaller	O
(	O
p	O
<	O
0	O
.	O
01	O
)	O
than	O
the	O
46	O
or	O
72	O
wk	O
old	O
wild	O
type	O
lenses	O
.	O

AlphaA	O
/	O
BKO	O
lenses	O
at	O
5	O
wks	O
of	O
age	O
exhibited	O
vacuoles	S-GO
at	O
the	O
equatorial	O
region	O
(	O
Figure	O
1A	O
see	O
arrows	O
)	O
and	O
an	O
area	O
of	O
slight	O
light	O
scatter	O
at	O
the	O
posterior	O
subcapsular	O
regions	O
(	O
Figure	O
1B	O
see	O
arrowheads	O
)	O
.	O

By	O
54	O
wks	O
of	O
age	O
,	O
alphaA	O
/	O
BKO	O
lenses	O
exhibited	O
dense	O
cortical	O
and	O
nuclear	O
cataracts	O
(	O
Figure	O
1C	O
)	O
.	O

No	O
posterior	O
sutures	O
were	O
observed	O
in	O
any	O
of	O
the	O
alphaA	O
/	O
BKO	O
lenses	O
examined	O
.	O

All	O
wild	O
type	O
lenses	O
were	O
transparent	O
upon	O
removal	O
from	O
the	O
eye	O
(	O
Figure	O
1D	O
,	O
1E	O
and	O
1F	O
)	O
and	O
had	O
well	O
defined	O
posterior	O
sutures	O
.	O

Figure	O
1	O

Light	O
micrographs	O
of	O
lenses	O
dissected	O
from	O
fixed	O
eyes	O
of	O
alphaA	O
/	O
BKO	O
(	O
A	O
-	O
C	O
)	O
and	O
wild	O
type	O
(	O
D	O
-	O
F	O
)	O
mice	O
.	O

All	O
micrographs	O
were	O
generated	O
using	O
a	O
4	O
x	O
/	O
0	O
.	O
10	O
objective	O
on	O
a	O
Zeiss	O
LSM	O
410	O
using	O
transmitted	O
light	O
mode	O
.	O

Images	O
in	O
(	O
A	O
&	O
B	O
)	O
were	O
enlarged	O
compared	O
to	O
images	O
(	O
C	O
-	O
F	O
)	O
(	O
see	O
scale	O
bars	O
)	O
.	O

For	O
all	O
micrographs	O
except	O
(	O
B	O
)	O
the	O
objective	O
focal	O
point	O
was	O
set	O
at	O
the	O
equatorial	O
plane	O
of	O
the	O
lens	O
,	O
while	O
(	O
B	O
)	O
was	O
set	O
at	O
the	O
posterior	O
pole	O
of	O
the	O
lens	O
.	O

(	O
A	O
&	O
B	O
)	O
Representative	O
micrographs	O
of	O
lenses	O
from	O
5	O
wk	O
alphaA	O
/	O
BKO	O
mice	O
,	O
showing	O
changes	O
in	O
the	O
equatorial	O
(	O
A	O
)	O
and	O
posterior	O
sub	O
capsular	O
(	O
B	O
)	O
regions	O
.	O

(	O
C	O
)	O
Representative	O
micrograph	O
of	O
54	O
wk	O
alphaA	O
/	O
BKO	O
mouse	O
lens	O
showing	O
dense	O
whole	O
lens	O
cataract	O
.	O

(	O
D	O
-	O
F	O
)	O
Representative	O
clear	O
lenses	O
from	O
5	O
wk	O
(	O
D	O
)	O
,	O
46	O
wk	O
(	O
E	O
)	O
,	O
and	O
wk	O
72	O
(	O
F	O
)	O
wild	O
type	O
mice	O
.	O

Arrows	O
(	O
A	O
)	O
indicate	O
vacuoles	S-GO
in	O
the	O
equatorial	O
region	O
of	O
a	O
representative	O
5	O
wk	O
alphaA	O
/	O
BKO	O
lens	O
.	O

The	O
arrowheads	O
(	O
B	O
)	O
indicate	O
an	O
area	O
of	O
minor	O
light	O
scattering	O
deep	O
to	O
the	O
posterior	O
capsule	O
in	O
a	O
representative	O
5	O
wk	O
alphaA	O
/	O
BKO	O
lens	O
.	O

Table	O
1	O

Dimensions	O
and	O
gross	O
lenticular	O
appearance	O
of	O
lenses	O
.	O

Examination	O
of	O
mid	O
-	O
axial	O
sections	O
stained	O
with	O
DiI	O
and	O
SYTOX	O
green	O
revealed	O
unique	O
differences	O
in	O
gross	O
morphology	O
and	O
nucleic	O
acid	O
staining	O
between	O
alphaA	O
/	O
BKO	O
lenses	O
and	O
wild	O
type	O
lenses	O
(	O
Figure	O
2	O
)	O
.	O

In	O
five	O
week	O
old	O
alphaA	O
/	O
BKO	O
lenses	O
,	O
Sytox	O
green	O
stained	O
nuclei	S-GO
(	O
green	O
)	O
in	O
the	O
anterior	O
epithelium	O
,	O
equatorial	O
/	O
bow	O
,	O
and	O
posterior	O
subcapsular	O
regions	O
(	O
Figure	O
2A	O
)	O
.	O

Cell	O
nuclei	S-GO
localized	O
to	O
the	O
equatorial	O
/	O
bow	O
region	O
were	O
disorganized	O
as	O
compared	O
to	O
wild	O
type	O
.	O

There	O
were	O
enlarged	O
extracellular	B-GO
spaces	E-GO
between	O
cells	O
in	O
the	O
equatorial	O
/	O
bow	O
region	O
in	O
5	O
wk	O
old	O
alphaA	O
/	O
BKO	O
lenses	O
.	O

Fifty	O
-	O
four	O
wk	O
old	O
alphaA	O
/	O
BKO	O
lenses	O
(	O
Figure	O
2B	O
)	O
did	O
not	O
stain	O
for	O
nucleic	O
acid	O
in	O
the	O
posterior	O
subcapsular	O
region	O
,	O
however	O
,	O
the	O
entire	O
anterior	O
subcapsular	O
lens	O
region	O
stained	O
for	O
nucleic	O
acid	O
(	O
refer	O
to	O
Figure	O
3I	O
for	O
high	O
magnification	O
/	O
resolution	O
image	O
of	O
this	O
area	O
)	O
.	O

A	O
defined	O
equatorial	O
/	O
bow	O
region	O
was	O
not	O
observed	O
in	O
these	O
older	O
lenses	O
,	O
and	O
fiber	O
cells	O
extending	O
to	O
the	O
posterior	O
capsule	O
of	O
the	O
lens	O
were	O
not	O
found	O
.	O

Disorganized	O
cellular	O
material	O
capped	O
the	O
anterior	O
region	O
of	O
the	O
embryonic	O
/	O
fetal	O
nucleus	O
,	O
and	O
a	O
distinctive	O
indentation	O
of	O
the	O
lens	O
mass	O
at	O
the	O
equatorial	O
region	O
was	O
apparent	O
in	O
mid	O
-	O
axial	O
sections	O
as	O
well	O
as	O
whole	O
lenses	O
.	O

In	O
alphaA	O
/	O
BKO	O
lenses	O
the	O
embryonic	O
/	O
fetal	O
nucleus	O
(	O
primary	O
lens	O
fibers	O
)	O
had	O
migrated	O
posteriorly	O
and	O
appeared	O
to	O
be	O
in	O
contact	O
with	O
the	O
posterior	O
capsule	O
.	O

In	O
5	O
wk	O
,	O
46	O
wk	O
or	O
72	O
wk	O
old	O
wild	O
type	O
lenses	O
(	O
Figure	O
2C	O
,	O
2D	O
and	O
2E	O
)	O
,	O
however	O
,	O
there	O
was	O
no	O
posterior	O
or	O
anterior	O
subcapsular	O
nucleic	O
acid	O
staining	O
and	O
the	O
embryonic	O
-	O
fetal	O
nucleus	O
was	O
centrally	O
located	O
,	O
not	O
in	O
contact	O
with	O
the	O
posterior	O
capsule	O
.	O

Figure	O
2	O

Representative	O
confocal	O
optical	O
sections	O
taken	O
from	O
mid	O
-	O
axial	O
vibratome	O
sections	O
of	O
alphaA	O
/	O
BKO	O
(	O
A	O
&	O
B	O
)	O
and	O
wild	O
type	O
(	O
C	O
-	O
E	O
)	O
lenses	O
.	O

All	O
optical	O
sections	O
were	O
generated	O
using	O
a	O
4	O
x	O
/	O
0	O
.	O
10	O
objective	O
on	O
a	O
Zeiss	O
LSM	O
410	O
.	O

The	O
red	O
color	O
represents	O
DiI	O
staining	O
(	O
membrane	S-GO
)	O
,	O
while	O
the	O
green	O
color	O
represents	O
SYTOX	O
green	O
staining	O
(	O
DNA	O
)	O
.	O

(	O
A	O
&	O
B	O
)	O
were	O
taken	O
from	O
5	O
wk	O
and	O
54	O
wk	O
alphaA	O
/	O
BKO	O
lenses	O
,	O
respectively	O
.	O

(	O
C	O
-	O
E	O
)	O
were	O
taken	O
from	O
5	O
wk	O
,	O
46	O
wk	O
,	O
and	O
72	O
wk	O
wild	O
type	O
lenses	O
,	O
respectively	O
.	O

The	O
arrowheads	O
indicate	O
representative	O
anterior	O
epithelial	O
nuclei	S-GO
stained	O
with	O
SYTOX	O
green	O
.	O

Figure	O
3	O

Representative	O
confocal	O
optical	O
sections	O
from	O
alphaA	O
/	O
BKO	O
(	O
A	O
-	O
J	O
)	O
and	O
wild	O
type	O
(	O
K	O
-	O
T	O
)	O
lenses	O
.	O

All	O
optical	O
sections	O
were	O
generated	O
using	O
a	O
63	O
x	O
/	O
1	O
.	O
4	O
objective	O
on	O
a	O
Zeiss	O
LSM	O
410	O
.	O

The	O
red	O
color	O
represents	O
DiI	O
staining	O
(	O
membrane	S-GO
)	O
,	O
while	O
the	O
green	O
color	O
represents	O
SYTOX	O
green	O
staining	O
(	O
DNA	O
)	O
.	O

(	O
A	O
-	O
E	O
)	O
are	O
from	O
5	O
wk	O
alphaA	O
/	O
BKO	O
lenses	O
.	O

(	O
F	O
-	O
J	O
)	O
are	O
from	O
54	O
wk	O
alphaA	O
/	O
BKO	O
lenses	O
.	O

(	O
K	O
-	O
O	O
)	O
are	O
from	O
5	O
wk	O
wild	O
type	O
lenses	O
.	O

(	O
P	O
-	O
T	O
)	O
are	O
from	O
46	O
wk	O
wild	O
type	O
lenses	O
.	O

(	O
A	O
,	O
F	O
,	O
K	O
,	O
and	O
P	O
)	O
are	O
anterior	O
central	O
cortex	O
and	O
epithelium	O
.	O

(	O
B	O
,	O
G	O
,	O
L	O
,	O
and	O
Q	O
)	O
are	O
equatorial	O
bow	O
region	O
.	O

(	O
C	O
,	O
H	O
,	O
M	O
,	O
and	O
R	O
)	O
are	O
embryonic	O
/	O
fetal	O
nucleus	O
.	O

(	O
D	O
,	O
I	O
,	O
N	O
,	O
and	O
S	O
)	O
are	O
deep	O
anterior	O
cortex	O
.	O

(	O
E	O
,	O
J	O
,	O
O	O
,	O
and	O
T	O
)	O
are	O
posterior	O
subcapsular	O
region	O
.	O

(	O
*	O
)	O
indicates	O
areas	O
devoid	O
of	O
cellular	O
material	O
(	O
B	O
and	O
G	O
)	O
.	O

Arrow	O
indicates	O
posterior	O
suture	O
(	O
O	O
)	O
.	O

Arrowheads	O
indicate	O
representative	O
nuclei	S-GO
stained	O
with	O
SYTOX	O
green	O
(	O
A	O
,	O
B	O
,	O
E	O
,	O
F	O
,	O
G	O
,	O
I	O
,	O
K	O
,	O
L	O
,	O
P	O
,	O
and	O
Q	O
)	O
.	O

At	O
higher	O
magnification	O
,	O
examination	O
of	O
sections	O
stained	O
with	O
DiI	O
and	O
SYTOX	O
green	O
revealed	O
ultrastructural	O
differences	O
between	O
alphaA	O
/	O
BKO	O
lenses	O
and	O
wild	O
type	O
lenses	O
(	O
Figure	O
3	O
)	O
.	O

Anterior	O
epithelial	O
staining	O
in	O
5	O
wk	O
old	O
alphaA	O
/	O
BKO	O
(	O
Figure	O
3A	O
)	O
and	O
5	O
wk	O
old	O
wild	O
type	O
lenses	O
were	O
similar	O
(	O
Figure	O
3K	O
)	O
with	O
respect	O
to	O
nuclear	S-GO
staining	O
with	O
SYTOX	O
green	O
.	O

However	O
,	O
some	O
differences	O
in	O
54	O
wk	O
old	O
alphaA	O
/	O
BKO	O
lenses	O
(	O
Figure	O
3F	O
)	O
were	O
observed	O
in	O
the	O
central	O
anterior	O
epithelium	O
compared	O
to	O
5	O
wk	O
(	O
Figure	O
3K	O
)	O
,	O
46	O
wk	O
(	O
Figure	O
3P	O
)	O
,	O
and	O
72	O
wk	O
(	O
data	O
not	O
shown	O
)	O
wild	O
type	O
lenses	O
.	O

These	O
differences	O
included	O
changes	O
in	O
central	O
epithelial	O
nuclear	S-GO
staining	O
,	O
nuclear	S-GO
shape	O
and	O
epithelial	O
thickness	O
and	O
continuity	O
.	O

Superficial	O
and	O
deep	O
anterior	O
cortical	O
staining	O
was	O
grossly	O
different	O
between	O
alphaA	O
/	O
BKO	O
(	O
Figure	O
3A	O
,	O
3D	O
,	O
3F	O
and	O
3I	O
)	O
and	O
wild	O
type	O
lenses	O
(	O
Figure	O
3K	O
,	O
3N	O
,	O
3P	O
and	O
3S	O
)	O
.	O

In	O
5	O
and	O
54	O
wk	O
old	O
alphaA	O
/	O
BKO	O
lenses	O
,	O
superficial	O
and	O
deep	O
anterior	O
cortical	O
regions	O
,	O
stained	O
for	O
lipid	O
membranes	S-GO
,	O
did	O
not	O
reveal	O
any	O
patterns	O
typical	O
of	O
fiber	O
cells	O
cut	O
in	O
cross	O
-	O
section	O
or	O
longitudinal	O
section	O
.	O

In	O
5	O
wk	O
alphaA	O
/	O
BKO	O
lenses	O
there	O
was	O
a	O
high	O
density	O
of	O
stained	O
membranes	S-GO
per	O
unit	O
area	O
throughout	O
the	O
cortex	O
,	O
with	O
no	O
nucleic	O
acid	O
staining	O
in	O
these	O
regions	O
.	O

In	O
54	O
wk	O
alphaA	O
/	O
BKO	O
lenses	O
,	O
large	O
,	O
irregularly	O
shaped	O
cells	O
were	O
observed	O
,	O
interspersed	O
among	O
regions	O
of	O
high	O
membrane	S-GO
staining	O
density	O
per	O
unit	O
area	O
.	O

These	O
large	O
objects	O
were	O
not	O
vacuoles	S-GO
,	O
because	O
examination	O
of	O
the	O
interior	O
of	O
these	O
structures	O
by	O
transmitted	O
and	O
reflected	O
light	O
microscopy	O
showed	O
that	O
the	O
membranes	S-GO
encompassed	O
cellular	O
material	O
(	O
data	O
not	O
shown	O
)	O
.	O

In	O
addition	O
,	O
nucleic	O
acid	O
staining	O
was	O
observed	O
(	O
Figure	O
3F	O
and	O
3I	O
)	O
within	O
many	O
of	O
these	O
cells	O
exhibiting	O
large	O
cross	O
-	O
sectional	O
profiles	O
.	O

In	O
the	O
wild	O
type	O
lenses	O
,	O
typical	O
cross	O
-	O
sectional	O
patterns	O
of	O
fiber	O
cells	O
organized	O
in	O
radial	O
columns	O
were	O
observed	O
(	O
Figure	O
3K	O
,	O
3N	O
,	O
3P	O
and	O
3S	O
)	O
.	O

Ultrastructural	O
differences	O
at	O
the	O
equatorial	O
/	O
bow	O
region	O
were	O
also	O
observed	O
between	O
alphaA	O
/	O
BKO	O
lenses	O
(	O
Figure	O
3B	O
and	O
3G	O
)	O
and	O
wild	O
type	O
lenses	O
(	O
Figure	O
3L	O
and	O
3Q	O
)	O
.	O

In	O
contrast	O
to	O
wild	O
type	O
lenses	O
(	O
Figure	O
3L	O
and	O
3Q	O
)	O
,	O
the	O
alphaA	O
/	O
BKO	O
lenses	O
(	O
Figure	O
3B	O
and	O
3G	O
)	O
contained	O
large	O
areas	O
devoid	O
of	O
cellular	O
material	O
,	O
their	O
nuclei	S-GO
were	O
not	O
limited	O
to	O
a	O
well	O
defined	O
equatorial	O
/	O
bow	O
region	O
,	O
and	O
ordered	O
radial	O
columns	O
of	O
elongating	O
fiber	O
cells	O
extending	O
from	O
the	O
posterior	O
capsule	O
to	O
the	O
anterior	O
epithelium	O
were	O
not	O
observed	O
.	O

In	O
addition	O
to	O
the	O
equatorial	O
region	O
,	O
ultrastructural	O
differences	O
between	O
alphaA	O
/	O
BKO	O
lenses	O
(	O
Figure	O
3C	O
and	O
3H	O
)	O
and	O
wild	O
type	O
lenses	O
(	O
Figure	O
3M	O
and	O
3R	O
)	O
were	O
observed	O
in	O
fiber	O
cells	O
of	O
the	O
embryonic	O
and	O
fetal	O
nucleus	O
.	O

In	O
5	O
wk	O
alphaA	O
/	O
BKO	O
lenses	O
(	O
Figure	O
3C	O
)	O
,	O
a	O
greater	O
variation	O
in	O
cross	O
sectional	O
diameter	O
was	O
observed	O
,	O
with	O
cell	O
diameters	O
ranging	O
from	O
less	O
than	O
2	O
microns	O
up	O
to	O
approximately	O
25	O
microns	O
,	O
compared	O
to	O
the	O
5	O
wk	O
and	O
46	O
wk	O
wild	O
type	O
lenses	O
,	O
whose	O
diameters	O
ranged	O
from	O
less	O
than	O
2	O
microns	O
up	O
to	O
approximately	O
10	O
microns	O
(	O
Figure	O
3M	O
and	O
3R	O
)	O
.	O

At	O
54	O
wk	O
,	O
these	O
cells	O
in	O
the	O
alphaA	O
/	O
BKO	O
lenses	O
were	O
larger	O
in	O
cross	O
sectional	O
diameter	O
than	O
wild	O
type	O
,	O
and	O
exhibited	O
a	O
much	O
greater	O
variation	O
in	O
the	O
cross	O
sectional	O
size	O
and	O
cell	O
shape	O
.	O

Cells	O
adjacent	O
to	O
the	O
posterior	O
capsule	O
of	O
5	O
wk	O
alphaA	O
/	O
BKO	O
lenses	O
(	O
Figure	O
3E	O
)	O
exhibited	O
nucleic	O
acid	O
staining	O
,	O
were	O
small	O
and	O
non	O
-	O
elongated	O
,	O
with	O
numerous	O
membrane	B-GO
projections	E-GO
.	O
,	O
These	O
were	O
,	O
however	O
,	O
not	O
observed	O
in	O
54	O
wk	O
alphaA	O
/	O
BKO	O
lenses	O
.	O

In	O
5	O
wk	O
alphaA	O
/	O
BKO	O
lenses	O
,	O
deep	O
to	O
the	O
posterior	O
capsule	O
,	O
larger	O
diameter	O
cells	O
,	O
similar	O
to	O
those	O
observed	O
in	O
the	O
embryonic	O
/	O
fetal	O
nucleus	O
were	O
observed	O
(	O
data	O
not	O
shown	O
)	O
.	O

Fiber	O
cells	O
of	O
similar	O
dimension	O
and	O
appearance	O
to	O
embryonic	O
/	O
fetal	O
nuclear	O
fibers	O
were	O
seen	O
at	O
the	O
posterior	O
capsule	O
in	O
54	O
wk	O
alphaA	O
/	O
BKO	O
lenses	O
(	O
Figure	O
3J	O
)	O
.	O

In	O
both	O
5	O
and	O
54	O
wk	O
alphaA	O
/	O
BKO	O
lenses	O
,	O
no	O
posterior	O
sutures	O
could	O
be	O
found	O
in	O
any	O
axial	O
or	O
equatorial	O
vibratome	O
sections	O
examined	O
.	O

Posterior	O
sutures	O
were	O
readily	O
found	O
in	O
vibratome	O
sections	O
of	O
wild	O
type	O
lenses	O
(	O
Figure	O
3O	O
,	O
arrow	O
)	O
.	O

Fiber	O
cells	O
attached	O
to	O
the	O
posterior	O
capsule	O
and	O
extending	O
anteriorly	O
were	O
observed	O
in	O
5	O
wk	O
(	O
Figure	O
3O	O
)	O
,	O
46	O
wk	O
(	O
Figure	O
3T	O
)	O
and	O
72	O
wk	O
(	O
data	O
not	O
shown	O
)	O
wild	O
type	O
lenses	O
.	O

SEM	O
confirmed	O
many	O
of	O
the	O
observations	O
made	O
by	O
confocal	O
microscopy	O
.	O

In	O
the	O
equatorial	O
/	O
bow	O
region	O
,	O
a	O
disorganized	O
array	O
of	O
relatively	O
small	O
irregular	O
shaped	O
cells	O
were	O
observed	O
in	O
5	O
wk	O
(	O
Figure	O
4A	O
)	O
and	O
54	O
wk	O
(	O
Figure	O
4D	O
)	O
alphaA	O
/	O
BKO	O
lenses	O
,	O
while	O
elongated	O
fiber	O
cells	O
organized	O
into	O
radial	O
columns	O
,	O
with	O
ball	O
and	O
socket	O
interdigitations	O
,	O
were	O
observed	O
in	O
5	O
wk	O
(	O
Figure	O
4G	O
)	O
,	O
46	O
wk	O
(	O
Figure	O
4J	O
)	O
and	O
72	O
wk	O
(	O
data	O
not	O
shown	O
)	O
wild	O
type	O
lenses	O
.	O

In	O
the	O
anterior	O
cortical	O
region	O
of	O
5	O
wk	O
alphaA	O
/	O
BKO	O
lenses	O
,	O
radial	O
columns	O
of	O
cells	O
with	O
numerous	O
cell	B-GO
surface	I-GO
projections	E-GO
were	O
observed	O
(	O
Figure	O
4B	O
)	O
,	O
but	O
these	O
radial	O
columns	O
were	O
no	O
longer	O
present	O
at	O
54	O
weeks	O
of	O
age	O
(	O
Figure	O
4E	O
)	O
.	O

In	O
these	O
older	O
lenses	O
,	O
irregularly	O
shaped	O
,	O
convoluted	O
cells	O
,	O
with	O
no	O
recognizable	O
pattern	O
of	O
organization	O
,	O
were	O
present	O
.	O

In	O
contrast	O
,	O
radial	O
columns	O
of	O
elongated	O
fiber	O
cells	O
of	O
uniform	O
size	O
and	O
shape	O
,	O
with	O
ball	O
and	O
socket	O
interdigitations	O
,	O
were	O
present	O
in	O
the	O
anterior	O
cortical	O
region	O
of	O
5	O
wk	O
(	O
Figure	O
4H	O
)	O
,	O
46	O
wk	O
(	O
Figure	O
4K	O
)	O
and	O
72	O
week	O
(	O
data	O
not	O
shown	O
)	O
wild	O
type	O
lenses	O
.	O

The	O
posterior	O
subcapsular	O
regions	O
of	O
5	O
wk	O
(	O
Figure	O
4C	O
)	O
and	O
54	O
wk	O
(	O
Figure	O
4F	O
)	O
alphaA	O
/	O
BKO	O
lenses	O
were	O
filled	O
with	O
irregularly	O
shaped	O
cells	O
with	O
numerous	O
cell	B-GO
surface	I-GO
projections	E-GO
.	O

In	O
the	O
fetal	O
/	O
embryonic	O
nucleus	O
,	O
elongated	O
fiber	O
cells	O
with	O
numerous	O
long	O
,	O
finger	O
-	O
like	O
projections	O
and	O
furrowed	O
membranes	S-GO
were	O
evident	O
(	O
not	O
shown	O
)	O
.	O

No	O
elongated	O
cells	O
extending	O
from	O
the	O
bow	O
region	O
to	O
the	O
posterior	O
capsule	O
of	O
alphaA	O
/	O
BKO	O
lenses	O
were	O
observed	O
.	O

In	O
contrast	O
,	O
radial	O
columns	O
of	O
elongated	O
fiber	O
cells	O
of	O
uniform	O
size	O
and	O
shape	O
containing	O
ball	O
and	O
socket	O
interdigitations	O
were	O
observed	O
in	O
the	O
posterior	O
subcapsular	O
region	O
in	O
5	O
wk	O
(	O
Figure	O
4I	O
)	O
,	O
46	O
wk	O
(	O
Figure	O
4L	O
)	O
and	O
72	O
wk	O
(	O
data	O
not	O
shown	O
)	O
wild	O
type	O
lenses	O
,	O
and	O
fiber	O
cells	O
in	O
contact	O
with	O
the	O
posterior	O
capsule	O
could	O
be	O
traced	O
back	O
to	O
the	O
equatorial	O
bow	O
region	O
and	O
anterior	O
epithelium	O
.	O

Figure	O
4	O

Representative	O
scanning	O
electron	O
micrographs	O
of	O
alphaA	O
/	O
BKO	O
(	O
A	O
-	O
F	O
)	O
and	O
wild	O
type	O
(	O
G	O
-	O
L	O
)	O
lenses	O
.	O

(	O
A	O
-	O
C	O
)	O
Representative	O
images	O
from	O
5	O
wk	O
alphaA	O
/	O
BKO	O
lenses	O
.	O

(	O
D	O
-	O
F	O
)	O
Representative	O
images	O
from	O
54	O
wk	O
alphaA	O
/	O
BKO	O
lenses	O
.	O

(	O
G	O
-	O
I	O
)	O
Representative	O
images	O
from	O
5	O
wk	O
wild	O
type	O
lenses	O
.	O

(	O
J	O
-	O
L	O
)	O
Representative	O
images	O
from	O
46	O
wk	O
wild	O
type	O
lenses	O
.	O

(	O
A	O
,	O
D	O
,	O
G	O
,	O
and	O
J	O
)	O
Equatorial	O
/	O
bow	O
region	O
.	O

(	O
B	O
,	O
E	O
,	O
H	O
,	O
and	O
K	O
)	O
Anterior	O
cortex	O
.	O

C	O
,	O
(	O
F	O
,	O
I	O
,	O
and	O
L	O
)	O
Posterior	O
subcapsular	O
region	O
.	O

Discussion	O

One	O
approach	O
to	O
resolving	O
some	O
of	O
the	O
in	O
vivo	O
functions	O
of	O
alpha	O
-	O
crystallin	O
is	O
to	O
generate	O
animal	O
models	O
where	O
one	O
or	O
both	O
of	O
the	O
alpha	O
-	O
crystallin	O
gene	O
products	O
have	O
been	O
eliminated	O
.	O

Brady	O
et	O
al	O
.	O

[	O
22	O
]	O
demonstrated	O
,	O
by	O
targeted	O
disruption	O
of	O
the	O
mouse	O
alphaA	O
gene	O
,	O
that	O
this	O
protein	O
was	O
essential	O
for	O
the	O
maintenance	O
of	O
lens	O
transparency	O
,	O
possibly	O
by	O
maintaining	O
the	O
solubility	O
of	O
alphaB	O
,	O
or	O
associated	O
proteins	O
,	O
in	O
the	O
lens	O
.	O

These	O
lenses	O
were	O
also	O
reported	O
to	O
be	O
smaller	O
in	O
equatorial	O
and	O
axial	O
dimensions	O
than	O
age	O
matched	O
wild	O
type	O
lens	O
,	O
which	O
was	O
very	O
similar	O
to	O
that	O
which	O
was	O
observed	O
with	O
the	O
double	O
knockout	O
lens	O
.	O

Targeted	O
disruption	O
of	O
the	O
mouse	O
alphaB	O
gene	O
,	O
however	O
,	O
resulted	O
in	O
lenses	O
similar	O
in	O
size	O
to	O
aged	O
-	O
matched	O
wild	O
type	O
lens	O
with	O
no	O
cataracts	O
reported	O
[	O
23	O
]	O
.	O

This	O
indicates	O
that	O
alphaA	O
may	O
play	O
a	O
greater	O
role	O
in	O
maintaining	O
the	O
transparency	O
of	O
the	O
lens	O
then	O
alphaB	O
.	O

In	O
the	O
single	O
alpha	O
-	O
crystallin	O
knockout	O
mice	O
,	O
the	O
remaining	O
alpha	O
-	O
crystallin	O
may	O
fully	O
or	O
partially	O
compensate	O
for	O
some	O
of	O
the	O
functions	O
of	O
the	O
missing	O
protein	O
,	O
especially	O
in	O
the	O
lens	O
,	O
where	O
both	O
alphaA	O
and	O
alphaB	O
are	O
normally	O
expressed	O
at	O
high	O
levels	O
.	O

This	O
was	O
supported	O
by	O
the	O
morphological	O
observation	O
made	O
in	O
this	O
study	O
of	O
no	O
posterior	O
sutures	O
or	O
fiber	O
cells	O
extending	O
to	O
the	O
posterior	O
capsule	O
of	O
the	O
lens	O
,	O
ectopically	O
staining	O
nucleic	O
acids	O
in	O
the	O
posterior	O
subcapsular	O
region	O
of	O
5	O
wk	O
and	O
anterior	O
subcapsular	O
cortex	O
of	O
54	O
wk	O
,	O
gross	O
morphological	O
differences	O
in	O
the	O
equatorial	O
/	O
bow	O
,	O
posterior	O
and	O
anterior	O
regions	O
of	O
lenses	O
from	O
alphaA	O
/	O
BKO	O
mice	O
as	O
compared	O
to	O
wild	O
mice	O
.	O

None	O
of	O
these	O
morphological	O
differences	O
have	O
been	O
reported	O
in	O
the	O
single	O
alphaA	O
or	O
alphaB	O
knockout	O
mice	O
.	O

It	O
must	O
be	O
noted	O
,	O
however	O
,	O
that	O
the	O
alphaA	O
/	O
BKO	O
mice	O
also	O
lack	O
the	O
HSPB2	O
gene	O
product	O
[	O
23	O
]	O
and	O
the	O
contribution	O
of	O
this	O
protein	O
to	O
normal	O
lens	O
morphology	O
and	O
functions	O
should	O
not	O
be	O
overlooked	O
.	O

Future	O
studies	O
should	O
address	O
the	O
possible	O
functions	O
of	O
HSPB2	O
in	O
normal	O
lens	O
.	O

The	O
results	O
of	O
the	O
current	O
study	O
support	O
the	O
hypothesis	O
that	O
alpha	O
-	O
crystallin	O
plays	O
an	O
active	O
role	O
in	O
the	O
differentiation	O
and	O
growth	O
of	O
lens	O
fiber	O
cells	O
.	O

Normal	O
differentiation	O
of	O
lens	O
fiber	O
cells	O
consists	O
of	O
a	O
progression	O
from	O
a	O
simple	O
cuboidal	O
epithelial	O
cell	O
,	O
containing	O
a	O
nucleus	S-GO
and	O
a	O
minimal	O
numbers	O
of	O
organelles	S-GO
,	O
to	O
a	O
stratified	O
layer	O
of	O
elongated	O
fiber	O
-	O
like	O
cells	O
,	O
devoid	O
of	O
nuclei	S-GO
and	O
organelles	S-GO
.	O

Differentiation	O
of	O
epithelial	O
cells	O
occurs	O
in	O
the	O
equatorial	O
/	O
bow	O
region	O
of	O
the	O
lens	O
,	O
where	O
epithelial	O
cells	O
begin	O
to	O
elongate	O
and	O
differentiate	O
into	O
fiber	O
cells	O
of	O
uniform	O
cellular	O
shape	O
,	O
arranged	O
in	O
radial	O
columns	O
of	O
cells	O
extending	O
from	O
the	O
anterior	O
epithelium	O
to	O
the	O
posterior	O
capsule	O
.	O

This	O
process	O
did	O
not	O
appear	O
to	O
have	O
proceeded	O
normally	O
in	O
lenses	O
lacking	O
alphaA	O
and	O
alphaB	O
.	O

The	O
morphological	O
observations	O
presented	O
in	O
this	O
study	O
demonstrate	O
that	O
fiber	O
cells	O
in	O
lenses	O
lacking	O
alphaA	O
and	O
alphaB	O
fail	O
to	O
elongate	O
symmetrically	O
from	O
the	O
bow	O
region	O
and	O
therefore	O
do	O
not	O
establish	O
the	O
typical	O
"	O
onion	O
skin	O
"	O
conformation	O
in	O
which	O
cells	O
extend	O
from	O
the	O
anterior	O
epithelium	O
to	O
the	O
posterior	O
capsule	O
.	O

Additionally	O
,	O
in	O
lenses	O
from	O
54	O
wk	O
alphaA	O
/	O
BKO	O
lenses	O
,	O
there	O
was	O
a	O
persistence	O
of	O
cell	O
nuclei	S-GO
in	O
deeper	O
cortical	O
regions	O
,	O
and	O
ectopic	O
cell	O
nuclei	S-GO
were	O
present	O
in	O
large	O
numbers	O
in	O
the	O
anterior	O
central	O
cortex	O
.	O

At	O
5	O
wks	O
of	O
age	O
cell	O
nuclei	S-GO
were	O
present	O
,	O
adjacent	O
to	O
the	O
posterior	O
capsule	O
.	O

These	O
morphological	O
observations	O
are	O
consistent	O
with	O
a	O
defect	O
in	O
the	O
normal	O
differentiation	O
pathway	O
of	O
lens	O
epithelial	O
cells	O
into	O
fiber	O
cells	O
.	O

It	O
is	O
unlikely	O
that	O
these	O
alterations	O
in	O
alphaA	O
/	O
BKO	O
mouse	O
lenses	O
result	O
from	O
increased	O
susceptibility	O
of	O
these	O
lenses	O
to	O
light	O
-	O
induced	O
damage	O
in	O
the	O
absence	O
of	O
the	O
molecular	O
chaperone	O
protection	O
afforded	O
by	O
alphaA	O
and	O
alphaB	O
in	O
normal	O
lenses	O
.	O

With	O
the	O
normal	O
time	O
of	O
eye	O
opening	O
at	O
approximately	O
14	O
days	O
after	O
birth	O
,	O
the	O
5	O
wk	O
old	O
mice	O
had	O
their	O
eyes	O
open	O
and	O
lenses	O
exposed	O
to	O
light	O
for	O
only	O
about	O
3	O
weeks	O
prior	O
to	O
morphological	O
analysis	O
.	O

Moreover	O
,	O
these	O
animals	O
had	O
been	O
exposed	O
to	O
only	O
animal	O
facility	O
fluorescent	O
lighting	O
and	O
were	O
protected	O
from	O
UV	O
light	O
by	O
plastic	O
cages	O
.	O

If	O
lack	O
of	O
protection	O
from	O
light	O
-	O
induced	O
damage	O
was	O
the	O
major	O
factor	O
affecting	O
the	O
changes	O
in	O
these	O
lenses	O
,	O
then	O
the	O
bulk	O
of	O
the	O
damage	O
should	O
have	O
resided	O
along	O
the	O
visual	O
axis	O
,	O
particularly	O
in	O
the	O
central	O
anterior	O
epithelium	O
and	O
subcapsular	O
cortex	O
in	O
the	O
5	O
wk	O
lenses	O
,	O
but	O
this	O
was	O
not	O
the	O
case	O
.	O

In	O
these	O
lenses	O
,	O
gross	O
morphological	O
changes	O
were	O
apparent	O
in	O
the	O
equatorial	O
and	O
posterior	O
subcapsular	O
regions	O
.	O

These	O
changes	O
included	O
posterior	O
subcapsular	O
nucleic	O
acid	O
staining	O
,	O
absence	O
of	O
posterior	O
sutures	O
,	O
and	O
small	O
irregularly	O
shaped	O
cells	O
,	O
not	O
arranged	O
in	O
any	O
discernable	O
pattern	O
,	O
in	O
the	O
equatorial	O
/	O
bow	O
region	O
.	O

Systemic	O
stress	O
factors	O
crossing	O
the	O
blood	O
/	O
aqueous	O
barrier	O
might	O
explain	O
some	O
morphological	O
changes	O
at	O
the	O
equatorial	O
region	O
,	O
but	O
this	O
would	O
not	O
explain	O
nucleic	O
acid	O
staining	O
in	O
the	O
posterior	O
subcapsular	O
region	O
.	O

In	O
the	O
5	O
wk	O
alphaA	O
/	O
BKO	O
lenses	O
,	O
nucleic	O
acid	O
staining	O
in	O
the	O
posterior	O
subcapsular	O
region	O
is	O
consistent	O
with	O
either	O
anterior	O
epithelial	O
cells	O
migrating	O
aberrantly	O
to	O
the	O
posterior	O
pole	O
,	O
or	O
primary	O
fiber	O
cells	O
failing	O
to	O
fully	O
differentiate	O
by	O
5	O
wks	O
of	O
age	O
.	O

These	O
two	O
possibilities	O
could	O
not	O
be	O
differentiated	O
in	O
the	O
methods	O
employed	O
,	O
and	O
were	O
beyond	O
the	O
objectives	O
of	O
the	O
current	O
study	O
.	O

Future	O
studies	O
are	O
being	O
designed	O
to	O
address	O
which	O
of	O
these	O
two	O
processes	O
might	O
explain	O
nucleic	O
acid	O
staining	O
in	O
the	O
posterior	O
subcapsular	O
region	O
.	O

Staining	O
in	O
this	O
region	O
was	O
not	O
observed	O
in	O
older	O
alphaA	O
/	O
BKO	O
lenses	O
,	O
suggesting	O
that	O
this	O
pattern	O
was	O
transient	O
.	O

The	O
fate	O
of	O
the	O
nucleic	O
acid	O
-	O
containing	O
cells	O
in	O
the	O
posterior	O
capsular	O
region	O
of	O
younger	O
lenses	O
is	O
not	O
known	O
at	O
this	O
time	O
,	O
nor	O
is	O
the	O
morphology	O
of	O
earlier	O
stage	O
lenses	O
.	O

Future	O
studies	O
with	O
defined	O
objectives	O
to	O
address	O
the	O
development	O
and	O
progression	O
of	O
morphological	O
changes	O
seen	O
in	O
this	O
study	O
are	O
being	O
designed	O
.	O

The	O
morphological	O
differences	O
in	O
alphaA	O
/	O
BKO	O
lenses	O
,	O
compared	O
to	O
age	O
matched	O
wild	O
type	O
lenses	O
,	O
were	O
consistent	O
with	O
the	O
hypothesis	O
that	O
alpha	O
-	O
crystallin	O
plays	O
an	O
active	O
role	O
in	O
the	O
differentiation	O
and	O
growth	O
of	O
lens	O
fiber	O
cells	O
.	O

In	O
addition	O
,	O
it	O
was	O
clearly	O
evident	O
that	O
alpha	O
-	O
crystallin	O
is	O
necessary	O
for	O
lens	O
transparency	O
.	O

The	O
final	O
biological	O
event	O
in	O
a	O
lens	O
epithelial	O
cell	O
'	O
s	O
life	O
is	O
the	O
transformation	O
from	O
an	O
epithelial	O
cell	O
into	O
a	O
fiber	O
cell	O
,	O
which	O
occurs	O
at	O
the	O
equatorial	O
/	O
bow	O
region	O
of	O
the	O
lens	O
.	O

The	O
newly	O
forming	O
fiber	O
cell	O
continues	O
to	O
differentiate	O
in	O
the	O
cortex	O
until	O
a	O
mature	O
fiber	O
cell	O
devoid	O
of	O
organelles	S-GO
with	O
suture	O
formation	O
at	O
the	O
ends	O
of	O
the	O
cell	O
is	O
formed	O
.	O

This	O
entire	O
process	O
from	O
epithelial	O
cell	O
to	O
mature	O
fiber	O
cell	O
is	O
defined	O
as	O
lens	O
differentiation	O
.	O

The	O
precise	O
spatial	O
and	O
temporal	O
expression	O
of	O
the	O
crystallin	O
proteins	O
in	O
the	O
developing	O
lens	O
may	O
not	O
be	O
simply	O
a	O
consequence	O
of	O
the	O
differentiation	O
process	O
,	O
but	O
instead	O
may	O
play	O
an	O
important	O
,	O
if	O
not	O
essential	O
,	O
role	O
in	O
the	O
differentiation	O
process	O
itself	O
.	O

The	O
results	O
of	O
the	O
current	O
study	O
support	O
this	O
hypothesis	O
.	O

The	O
exact	O
in	O
vivo	O
molecular	O
mechanisms	O
,	O
by	O
which	O
alpha	O
-	O
crystallin	O
might	O
influence	O
lens	O
epithelial	O
cell	O
differentiation	O
,	O
and	O
maintenance	O
of	O
lens	O
transparency	O
,	O
remain	O
to	O
be	O
determined	O
.	O

AlphaA	O
and	O
alphaB	O
are	O
members	O
of	O
the	O
shsp	O
family	O
[	O
7	O
]	O
.	O

Previous	O
studies	O
have	O
shown	O
that	O
the	O
alpha	O
-	O
crystallin	O
possesses	O
molecular	O
chaperone	O
activity	O
,	O
binding	O
to	O
partially	O
denatured	O
proteins	O
,	O
both	O
in	O
vitro	O
[	O
5	O
]	O
and	O
probably	O
in	O
vivo	O
[	O
6	O
]	O
,	O
to	O
inhibit	O
further	O
denaturation	O
.	O

Although	O
this	O
property	O
may	O
be	O
a	O
major	O
contributor	O
to	O
the	O
maintenance	O
of	O
lens	O
clarity	O
,	O
the	O
early	O
changes	O
in	O
the	O
alphaA	O
/	O
BKO	O
lenses	O
indicate	O
a	O
much	O
broader	O
cellular	O
function	O
for	O
alpha	O
-	O
crystallin	O
.	O

Stress	O
proteins	O
have	O
been	O
shown	O
to	O
be	O
expressed	O
in	O
non	O
-	O
stressed	O
cells	O
during	O
development	O
and	O
differentiation	O
[	O
25	O
]	O
.	O

Hsps	O
were	O
shown	O
to	O
be	O
expressed	O
during	O
the	O
differentiation	O
of	O
mammalian	O
osteoblasts	O
and	O
promelocytic	O
leukemia	O
cells	O
[	O
26	O
]	O
.	O

In	O
addition	O
,	O
hsp	O
expression	O
has	O
been	O
shown	O
to	O
accompany	O
growth	O
arrest	O
in	O
human	O
B	O
lymphocytes	O
[	O
27	O
]	O
and	O
macrophage	O
differentiation	O
of	O
HL	O
60	O
cells	O
[	O
28	O
]	O
.	O

During	O
myogenic	O
differentiation	O
,	O
mRNA	O
for	O
alphaB	O
increases	O
in	O
conjunction	O
with	O
the	O
induction	O
of	O
mRNA	O
for	O
myogenin	O
,	O
the	O
earliest	O
known	O
event	O
in	O
myogenesis	O
[	O
29	O
]	O
.	O

The	O
addition	O
of	O
exogenous	O
alpha	O
-	O
crystallin	O
to	O
primary	O
bovine	O
lens	O
epithelium	O
was	O
shown	O
to	O
induce	O
rapid	O
changes	O
in	O
cell	O
shape	O
,	O
leading	O
to	O
the	O
formation	O
of	O
lentoid	O
bodies	O
[	O
21	O
]	O
.	O

These	O
studies	O
strongly	O
suggest	O
that	O
the	O
hsp	O
family	O
of	O
proteins	O
has	O
other	O
functions	O
in	O
addition	O
to	O
protecting	O
proteins	O
and	O
cells	O
during	O
stress	O
.	O

Alpha	O
-	O
crystallin	O
may	O
play	O
a	O
functional	O
role	O
in	O
the	O
cell	O
nucleus	S-GO
and	O
may	O
have	O
a	O
role	O
in	O
regulating	O
the	O
cell	O
cycle	O
.	O

Several	O
heat	O
shock	O
proteins	O
have	O
been	O
found	O
in	O
cell	O
nuclei	S-GO
in	O
the	O
absence	O
of	O
stress	O
[	O
30	O
]	O
,	O
and	O
alpha	O
-	O
crystallin	O
has	O
been	O
shown	O
to	O
interact	O
directly	O
with	O
DNA	O
[	O
18	O
]	O
.	O

AlphaB	O
,	O
expressed	O
in	O
transfected	O
CHO	O
cells	O
,	O
has	O
been	O
shown	O
to	O
ectopically	O
localize	O
to	O
interphase	O
nuclei	S-GO
,	O
suggesting	O
a	O
regulatory	O
role	O
for	O
this	O
protein	O
in	O
the	O
nucleus	S-GO
[	O
19	O
]	O
.	O

A	O
subset	O
of	O
immortalized	O
lens	O
epithelial	O
cells	O
from	O
alphaBKO	O
mice	O
have	O
been	O
shown	O
to	O
hyperproliferate	O
[	O
20	O
]	O
suggesting	O
that	O
alphaB	O
may	O
be	O
important	O
in	O
maintaining	O
genomic	O
stability	O
.	O

In	O
lens	O
epithelium	O
derived	O
from	O
alphaAKO	O
lenses	O
,	O
cell	O
growth	O
rates	O
were	O
reported	O
to	O
be	O
50	O
%	O
lower	O
compared	O
to	O
wild	O
type	O
[	O
31	O
]	O
,	O
suggesting	O
a	O
role	O
for	O
alphaA	O
in	O
regulating	O
the	O
cell	O
cycle	O
.	O

All	O
of	O
these	O
findings	O
raise	O
many	O
questions	O
as	O
to	O
the	O
possible	O
role	O
(	O
s	O
)	O
of	O
alpha	O
-	O
crystallin	O
in	O
the	O
nucleus	S-GO
and	O
in	O
cell	O
cycle	O
regulation	O
during	O
differentiation	O
.	O

In	O
the	O
current	O
study	O
,	O
the	O
observation	O
of	O
a	O
disorganized	O
pattern	O
of	O
nuclei	S-GO
localized	O
to	O
the	O
equatorial	O
bow	O
region	O
of	O
alphaA	O
/	O
BKO	O
lenses	O
,	O
and	O
nucleic	O
acid	O
staining	O
of	O
structures	O
throughout	O
the	O
anterior	O
cortex	O
of	O
54	O
wk	O
alphaA	O
/	O
BKO	O
lenses	O
,	O
is	O
consistent	O
with	O
a	O
role	O
for	O
alpha	O
-	O
crystallin	O
in	O
the	O
nucleus	S-GO
.	O

There	O
is	O
extensive	O
evidence	O
from	O
previous	O
studies	O
demonstrating	O
that	O
alpha	O
-	O
crystallin	O
plays	O
a	O
role	O
in	O
the	O
cytoskeletal	S-GO
organization	O
.	O

Both	O
alphaA	O
and	O
alphaB	O
can	O
bind	O
specifically	O
to	O
actin	O
,	O
both	O
in	O
vitro	O
[	O
13	O
]	O
and	O
in	O
vivo	O
[	O
14	O
]	O
.	O

Actin	B-GO
filament	E-GO
formation	O
has	O
been	O
shown	O
to	O
be	O
necessary	O
for	O
the	O
differentiation	O
of	O
lens	O
epithelial	O
cells	O
[	O
15	O
]	O
,	O
however	O
,	O
the	O
significance	O
of	O
alpha	O
-	O
crystallin	O
interaction	O
with	O
actin	O
in	O
differentiation	O
is	O
not	O
known	O
.	O

In	O
the	O
lens	O
,	O
alpha	O
-	O
crystallin	O
also	O
forms	O
a	O
complex	O
with	O
type	B-GO
III	I-GO
intermediate	I-GO
filament	E-GO
proteins	O
and	O
the	O
lens	O
-	O
specific	O
beaded	O
filament	O
proteins	O
CP49	O
and	O
CP115	O
,	O
which	O
may	O
be	O
critical	O
for	O
proper	O
filament	O
assembly	O
[	O
16	O
]	O
.	O

Beaded	O
filament	O
mRNA	O
levels	O
increase	O
greatly	O
in	O
differentiating	O
lens	O
epithelial	O
cells	O
,	O
and	O
have	O
been	O
suggested	O
as	O
a	O
pan	O
-	O
specific	O
marker	O
for	O
lens	O
fiber	O
cells	O
[	O
17	O
]	O
.	O

It	O
is	O
therefore	O
possible	O
that	O
increased	O
synthesis	O
of	O
alpha	O
-	O
crystallin	O
in	O
epithelial	O
cells	O
early	O
in	O
the	O
differentiation	O
process	O
may	O
have	O
profound	O
effects	O
upon	O
the	O
cytoskeleton	S-GO
,	O
which	O
in	O
turn	O
may	O
profoundly	O
affect	O
cell	O
shape	O
and	O
migration	O
.	O

The	O
lack	O
of	O
cellar	O
organization	O
and	O
uniform	O
cell	O
shape	O
at	O
the	O
equatorial	O
region	O
observed	O
in	O
alphaA	O
/	O
BKO	O
lenses	O
supports	O
this	O
hypothesis	O
.	O

Studies	O
are	O
currently	O
underway	O
to	O
characterize	O
cytoskeletal	S-GO
organization	O
in	O
the	O
alphaA	O
/	O
BKO	O
lens	O
.	O

Competing	O
interests	O

None	O
declared	O

Authors	O
'	O
contributions	O

DLB	O
conceived	O
and	O
designed	O
the	O
study	O
,	O
carried	O
out	O
sample	O
preparation	O
,	O
confocal	O
microscopy	O
,	O
scanning	O
electron	O
microscopy	O
,	O
statistical	O
analysis	O
,	O
and	O
drafted	O
the	O
manuscript	O
.	O

JPB	O
assisted	O
in	O
the	O
production	O
of	O
the	O
Alpha	O
/	O
BKO	O
mice	O
.	O

EFW	O
assisted	O
in	O
the	O
production	O
of	O
the	O
AlphaA	O
/	O
BKO	O
mice	O
,	O
experimental	O
design	O
,	O
and	O
initial	O
fixation	O
of	O
samples	O
.	O

All	O
authors	O
read	O
and	O
approved	O
the	O
final	O
manuscript	O
.	O

Pre	O
-	O
publication	O
history	O

The	O
pre	O
-	O
publication	O
history	O
for	O
this	O
paper	O
can	O
be	O
accessed	O
here	O
:	O

Acknowledgements	O

This	O
research	O
was	O
supported	O
in	O
part	O
by	O
a	O
NIH	O
Grant	O
for	O
Vision	O
Research	O
EY02932	O
awarded	O
to	O
LT	O
.	O

A	O
model	O
of	O
tripeptidyl	O
-	O
peptidase	O
I	O
(	O
CLN2	O
)	O
,	O
a	O
ubiquitous	O
and	O
highly	O
conserved	O
member	O
of	O
the	O
sedolisin	O
family	O
of	O
serine	O
-	O
carboxyl	O
peptidases	O

Abstract	O

Background	O

Tripeptidyl	O
-	O
peptidase	O
I	O
,	O
also	O
known	O
as	O
CLN2	O
,	O
is	O
a	O
member	O
of	O
the	O
family	O
of	O
sedolisins	O
(	O
serine	O
-	O
carboxyl	O
peptidases	O
)	O
.	O

In	O
humans	O
,	O
defects	O
in	O
expression	O
of	O
this	O
enzyme	O
lead	O
to	O
a	O
fatal	O
neurodegenerative	O
disease	O
,	O
classical	O
late	O
-	O
infantile	O
neuronal	O
ceroid	O
lipofuscinosis	O
.	O

Similar	O
enzymes	O
have	O
been	O
found	O
in	O
the	O
genomic	O
sequences	O
of	O
several	O
species	O
,	O
but	O
neither	O
systematic	O
analyses	O
of	O
their	O
distribution	O
nor	O
modeling	O
of	O
their	O
structures	O
have	O
been	O
previously	O
attempted	O
.	O

Results	O

We	O
have	O
analyzed	O
the	O
presence	O
of	O
orthologs	O
of	O
human	O
CLN2	O
in	O
the	O
genomic	O
sequences	O
of	O
a	O
number	O
of	O
eukaryotic	O
species	O
.	O

Enzymes	O
with	O
sequences	O
sharing	O
over	O
80	O
%	O
identity	O
have	O
been	O
found	O
in	O
the	O
genomes	O
of	O
macaque	O
,	O
mouse	O
,	O
rat	O
,	O
dog	O
,	O
and	O
cow	O
.	O

Closely	O
related	O
,	O
although	O
clearly	O
distinct	O
,	O
enzymes	O
are	O
present	O
in	O
fish	O
(	O
fugu	O
and	O
zebra	O
)	O
,	O
as	O
well	O
as	O
in	O
frogs	O
(	O
Xenopus	O
tropicalis	O
)	O
.	O

A	O
three	O
-	O
dimensional	O
model	O
of	O
human	O
CLN2	O
was	O
built	O
based	O
mainly	O
on	O
the	O
homology	O
with	O
Pseudomonas	O
sp	O
.	O

101	O
sedolisin	O
.	O

Conclusion	O

CLN2	O
is	O
very	O
highly	O
conserved	O
and	O
widely	O
distributed	O
among	O
higher	O
organisms	O
and	O
may	O
play	O
an	O
important	O
role	O
in	O
their	O
life	O
cycles	O
.	O

The	O
model	O
presented	O
here	O
indicates	O
a	O
very	O
open	O
and	O
accessible	O
active	O
site	O
that	O
is	O
almost	O
completely	O
conserved	O
among	O
all	O
known	O
CLN2	O
enzymes	O
.	O

This	O
result	O
is	O
somehow	O
surprising	O
for	O
a	O
tripeptidase	O
where	O
the	O
presence	O
of	O
a	O
more	O
constrained	O
binding	O
pocket	O
was	O
anticipated	O
.	O

This	O
structural	O
model	O
should	O
be	O
useful	O
in	O
the	O
search	O
for	O
the	O
physiological	O
substrates	O
of	O
these	O
enzymes	O
and	O
in	O
the	O
design	O
of	O
more	O
specific	O
inhibitors	O
of	O
CLN2	O
.	O

Background	O

Although	O
the	O
existence	O
of	O
tripeptidyl	O
-	O
peptidase	O
I	O
(	O
TPP	O
-	O
I	O
)	O
was	O
first	O
noted	O
over	O
40	O
years	O
ago	O
[	O
1	O
]	O
,	O
the	O
structural	O
and	O
mechanistic	O
basis	O
of	O
its	O
activity	O
has	O
been	O
largely	O
misunderstood	O
until	O
quite	O
recently	O
.	O

The	O
situation	O
changed	O
after	O
it	O
was	O
shown	O
that	O
TPP	O
-	O
I	O
is	O
identical	O
to	O
an	O
independently	O
characterized	O
enzyme	O
named	O
CLN2	O
.	O

It	O
was	O
also	O
demonstrated	O
that	O
mutations	O
leading	O
to	O
abolishment	O
of	O
the	O
enzymatic	O
activity	O
of	O
CLN2	O
were	O
the	O
direct	O
cause	O
of	O
a	O
fatal	O
inherited	O
neurodegenerative	O
disease	O
,	O
classical	O
late	O
-	O
infantile	O
neuronal	O
ceroid	O
lipofuscinosis	O
[	O
2	O
]	O
.	O

This	O
important	O
observation	O
was	O
followed	O
by	O
the	O
identification	O
of	O
CLN2	O
as	O
a	O
serine	O
peptidase	O
[	O
3	O
,	O
4	O
]	O
,	O
without	O
,	O
however	O
,	O
specifying	O
its	O
structural	O
fold	O
and	O
the	O
details	O
of	O
the	O
catalytic	O
site	O
.	O

More	O
accurate	O
placement	O
of	O
CLN2	O
within	O
the	O
context	O
of	O
a	O
family	O
of	O
related	O
enzymes	O
became	O
possible	O
only	O
after	O
high	O
-	O
resolution	O
crystal	O
structures	O
of	O
two	O
bacterial	O
enzymes	O
with	O
a	O
limited	O
sequence	O
similarity	O
to	O
CLN2	O
,	O
sedolisin	O
and	O
kumamolisin	O
,	O
became	O
available	O
[	O
5	O
-	O
7	O
]	O
.	O

These	O
structures	O
defined	O
a	O
novel	O
family	O
of	O
enzymes	O
,	O
now	O
called	O
sedolisins	O
or	O
serine	O
-	O
carboxyl	O
peptidases	O
,	O
that	O
is	O
characterized	O
by	O
the	O
utilization	O
of	O
a	O
fully	O
conserved	O
catalytic	O
triad	O
(	O
Ser	O
,	O
Glu	O
,	O
Asp	O
)	O
and	O
by	O
the	O
presence	O
of	O
an	O
Asp	O
in	O
the	O
oxyanion	O
hole	O
[	O
8	O
]	O
.	O

Sedolisin	O
and	O
its	O
several	O
variants	O
(	O
e	O
.	O
g	O
.	O
,	O
kumamolisin	O
,	O
aorsin	O
[	O
9	O
]	O
,	O
and	O
physarolisin	O
[	O
10	O
]	O
)	O
have	O
now	O
been	O
found	O
in	O
archaea	O
,	O
bacteria	O
,	O
fungi	O
and	O
amoebae	O
,	O
whereas	O
the	O
higher	O
organisms	O
seem	O
to	O
contain	O
only	O
variants	O
of	O
CLN2	O
[	O
8	O
]	O
.	O

The	O
physiological	O
role	O
of	O
sedolisins	O
in	O
the	O
lower	O
organisms	O
has	O
not	O
yet	O
been	O
elucidated	O
.	O

Despite	O
the	O
potential	O
medical	O
importance	O
of	O
CLN2	O
and	O
related	O
enzymes	O
,	O
no	O
systematic	O
studies	O
of	O
their	O
genomic	O
distribution	O
have	O
been	O
published	O
to	O
date	O
.	O

There	O
are	O
also	O
no	O
published	O
reports	O
of	O
the	O
crystallization	O
of	O
this	O
enzyme	O
.	O

In	O
the	O
absence	O
of	O
an	O
experimental	O
structure	O
obtained	O
by	O
crystallography	O
or	O
NMR	O
it	O
is	O
sometimes	O
necessary	O
to	O
resort	O
to	O
molecular	O
modeling	O
in	O
order	O
to	O
provide	O
a	O
structural	O
basis	O
for	O
the	O
explanation	O
of	O
the	O
biological	O
properties	O
of	O
an	O
enzyme	O
,	O
and	O
,	O
in	O
particular	O
,	O
to	O
initiate	O
design	O
of	O
its	O
inhibitors	O
.	O

Examples	O
of	O
such	O
very	O
successful	O
and	O
useful	O
modeling	O
efforts	O
are	O
provided	O
by	O
HIV	O
protease	O
[	O
11	O
]	O
,	O
or	O
very	O
recently	O
by	O
the	O
peptidase	O
from	O
a	O
coronavirus	O
involved	O
in	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
[	O
12	O
]	O
,	O
among	O
others	O
.	O

We	O
have	O
now	O
applied	O
the	O
tools	O
of	O
molecular	O
homology	O
modeling	O
to	O
predicting	O
a	O
structure	O
of	O
CLN2	O
that	O
could	O
be	O
used	O
as	O
a	O
basis	O
for	O
a	O
search	O
for	O
the	O
biological	O
substrates	O
of	O
this	O
family	O
of	O
enzymes	O
and	O
for	O
the	O
design	O
of	O
specific	O
inhibitors	O
.	O

Results	O
and	O
discussion	O

Sequence	O
comparisons	O
of	O
the	O
CLN2	O
-	O
like	O
enzymes	O

Mammalian	O
enzymes	O
homologous	O
to	O
human	O
CLN2	O
[	O
2	O
,	O
4	O
]	O
form	O
a	O
subfamily	O
of	O
sedolisins	O
with	O
highly	O
conserved	O
sequences	O
(	O
Figure	O
1	O
)	O
.	O

These	O
enzymes	O
are	O
expressed	O
with	O
a	O
prosegment	O
consisting	O
of	O
195	O
residues	O
that	O
is	O
cleaved	O
off	O
during	O
maturation	O
,	O
yielding	O
the	O
active	O
catalytic	O
domain	O
.	O

Complete	O
sequences	O
are	O
available	O
for	O
CLN2	O
from	O
six	O
species	O
in	O
which	O
it	O
has	O
been	O
found	O
so	O
far	O
(	O
human	O
,	O
macaque	O
,	O
dog	O
,	O
mouse	O
,	O
rat	O
,	O
and	O
cow	O
)	O
.	O

The	O
full	O
-	O
length	O
enzymes	O
consist	O
of	O
563	O
amino	O
acids	O
arranged	O
in	O
a	O
single	O
polypeptide	O
chain	O
containing	O
both	O
the	O
prosegment	O
and	O
the	O
catalytic	O
domain	O
,	O
with	O
the	O
exception	O
of	O
mouse	O
CLN2	O
that	O
has	O
a	O
single	O
deletion	O
in	O
the	O
prosegment	O
.	O

The	O
overall	O
sequence	O
identity	O
for	O
these	O
enzymes	O
is	O
81	O
%	O
,	O
whereas	O
the	O
similarity	O
is	O
92	O
%	O
.	O

A	O
pairwise	O
comparison	O
of	O
the	O
human	O
and	O
mouse	O
enzymes	O
yields	O
88	O
%	O
identity	O
and	O
94	O
%	O
similarity	O
,	O
considerably	O
higher	O
than	O
the	O
median	O
78	O
.	O
5	O
%	O
identity	O
reported	O
for	O
all	O
identified	O
mouse	O
-	O
human	O
orthologs	O
[	O
13	O
]	O
.	O

Thus	O
,	O
mammalian	O
CLN2	O
appears	O
to	O
be	O
a	O
highly	O
conserved	O
enzyme	O
.	O

Figure	O
1	O

Sequence	O
comparisons	O
of	O
mammalian	O
CLN2	O
-	O
like	O
enzymes	O
.	O
These	O
sequences	O
correspond	O
to	O
the	O
complete	O
enzymes	O
,	O
including	O
the	O
prosegment	O
.	O

Residues	O
forming	O
the	O
active	O
site	O
are	O
shown	O
in	O
yellow	O
on	O
red	O
background	O
,	O
other	O
conserved	O
residues	O
identified	O
as	O
important	O
for	O
the	O
stability	O
of	O
the	O
enzyme	O
are	O
marked	O
with	O
yellow	O
background	O
,	O
residues	O
identical	O
in	O
at	O
least	O
5	O
of	O
the	O
structures	O
are	O
green	O
,	O
and	O
residues	O
similar	O
in	O
their	O
character	O
are	O
shown	O
in	O
magenta	O
.	O

The	O
maturation	O
cleavage	O
point	O
generating	O
the	O
N	O
terminus	O
of	O
the	O
active	O
enzyme	O
is	O
marked	O
with	O
black	O
triangles	O
.	O

In	O
addition	O
to	O
the	O
mammals	O
,	O
CLN2	O
-	O
like	O
enzymes	O
are	O
also	O
found	O
in	O
fugu	O
(	O
puffer	O
fish	O
-	O
unannotated	O
record	O
SINFRUP00000077297	O
in	O
the	O
NCBI	O
fugu	O
sequence	O
database	O
,	O
)	O
and	O
zebrafish	O
(	O
contig	O
wz4596	O
.	O
2	O
in	O
the	O
zebrafish	O
EST	O
database	O
,	O
)	O
.	O

Only	O
a	O
fragment	O
of	O
the	O
sequence	O
of	O
the	O
latter	O
enzyme	O
agreed	O
with	O
the	O
former	O
.	O

However	O
,	O
a	O
few	O
comparatively	O
minor	O
modifications	O
can	O
bring	O
the	O
zebrafish	O
sequence	O
into	O
good	O
agreement	O
with	O
that	O
of	O
the	O
fugu	O
CLN2	O
.	O

These	O
modifications	O
include	O
a	O
deletion	O
of	O
a	O
single	O
nucleotide	O
from	O
a	O
run	O
of	O
three	O
,	O
as	O
well	O
as	O
three	O
insertions	O
of	O
repeated	O
nucleotide	O
pairs	O
(	O
Figure	O
2	O
)	O
.	O

It	O
must	O
be	O
stressed	O
that	O
these	O
modifications	O
are	O
speculative	O
and	O
may	O
lead	O
to	O
prediction	O
of	O
several	O
incorrect	O
amino	O
acids	O
;	O
however	O
,	O
they	O
bring	O
the	O
two	O
sequences	O
into	O
good	O
global	O
agreement	O
(	O
69	O
%	O
identities	O
and	O
83	O
%	O
similarities	O
)	O
.	O

Figure	O
2	O

Corrected	O
gene	O
sequence	O
of	O
the	O
zebrafish	O
CLN2	O
.	O
This	O
putative	O
sequence	O
shows	O
the	O
manual	O
corrections	O
that	O
bring	O
it	O
into	O
alignment	O
with	O
the	O
sequence	O
of	O
the	O
fugu	O
enzyme	O
.	O

Inserted	O
nucleotides	O
are	O
marked	O
in	O
green	O
and	O
a	O
deleted	O
one	O
in	O
red	O
.	O

The	O
available	O
amino	O
acid	O
sequence	O
of	O
the	O
fugu	O
CLN2	O
analog	O
,	O
named	O
by	O
us	O
sedolisin	O
-	O
TPP	O
[	O
8	O
]	O
,	O
is	O
also	O
in	O
good	O
agreement	O
with	O
the	O
sequences	O
of	O
the	O
mammalian	O
orthologs	O
(	O
Figure	O
3	O
)	O
.	O

The	O
only	O
major	O
difference	O
in	O
the	O
translated	O
amino	O
acid	O
sequence	O
compared	O
to	O
the	O
mammalian	O
and	O
zebrafish	O
enzymes	O
is	O
in	O
the	O
amino	O
terminus	O
of	O
the	O
propeptide	O
region	O
that	O
is	O
shorter	O
by	O
30	O
amino	O
acids	O
(	O
not	O
shown	O
)	O
.	O

It	O
is	O
very	O
likely	O
that	O
this	O
represents	O
a	O
fault	O
in	O
the	O
assembled	O
sequence	O
rather	O
than	O
a	O
real	O
variation	O
,	O
since	O
the	O
current	O
coding	O
frame	O
is	O
not	O
initiated	O
with	O
a	O
methionine	O
,	O
and	O
a	O
few	O
extra	O
residues	O
are	O
present	O
in	O
the	O
full	O
genomic	O
sequence	O
available	O
from	O
the	O
fugu	O
sequencing	O
consortium	O
.	O

Figure	O
3	O

Sequences	O
of	O
the	O
catalytic	O
domains	O
of	O
CLN2	O
.	O

Complete	O
sequences	O
are	O
shown	O
for	O
CLN2	O
from	O
human	O
,	O
fugu	O
,	O
and	O
zebrafish	O
,	O
together	O
with	O
the	O
partial	O
sequence	O
of	O
putative	O
CLN2	O
in	O
Xenopus	O
tropicalis	O
.	O

Residues	O
identical	O
in	O
all	O
four	O
enzymes	O
are	O
colored	O
green	O
and	O
those	O
similar	O
are	O
colored	O
magenta	O
.	O

Active	O
site	O
residues	O
are	O
marked	O
as	O
in	O
Figure	O
1	O
.	O

CLN2	O
is	O
present	O
not	O
only	O
in	O
fish	O
,	O
but	O
also	O
in	O
amphibians	O
,	O
in	O
particular	O
in	O
Xenopus	O
tropicalis	O
(	O
a	O
species	O
of	O
frog	O
)	O
.	O

A	O
partial	O
sequence	O
of	O
its	O
sedolisin	O
-	O
TPP	O
(	O
AL594774	O
)	O
found	O
in	O
the	O
EST	O
database	O
spans	O
the	O
middle	O
part	O
of	O
the	O
catalytic	O
domain	O
,	O
without	O
reaching	O
the	O
part	O
of	O
the	O
active	O
site	O
closer	O
to	O
the	O
N	O
terminus	O
that	O
contains	O
the	O
aspartic	O
and	O
glutamic	O
acids	O
that	O
belong	O
to	O
the	O
catalytic	O
triad	O
.	O

However	O
,	O
the	O
sequenced	O
part	O
of	O
the	O
enzyme	O
shows	O
75	O
%	O
identity	O
with	O
the	O
fugu	O
sedolisin	O
-	O
TPP	O
,	O
and	O
69	O
%	O
identity	O
with	O
human	O
CLN2	O
(	O
Figure	O
3	O
)	O
.	O

Sequence	O
similarity	O
to	O
bacterial	O
or	O
fungal	O
sedolisins	O
is	O
much	O
lower	O
,	O
indicating	O
that	O
the	O
enzyme	O
found	O
in	O
frogs	O
might	O
also	O
share	O
the	O
functional	O
properties	O
of	O
the	O
CLN2	O
subfamily	O
.	O

The	O
discovery	O
of	O
highly	O
conserved	O
CLN2	O
-	O
like	O
enzymes	O
not	O
only	O
in	O
mammals	O
but	O
also	O
in	O
two	O
fish	O
species	O
and	O
one	O
of	O
frogs	O
may	O
indicate	O
that	O
these	O
peptidases	O
are	O
universally	O
present	O
in	O
the	O
vertebrates	O
,	O
and	O
that	O
their	O
important	O
role	O
identified	O
in	O
humans	O
[	O
2	O
]	O
and	O
mice	O
[	O
14	O
]	O
might	O
be	O
a	O
more	O
general	O
feature	O
.	O

Modeling	O
of	O
the	O
structure	O
of	O
human	O
CLN2	O

The	O
medical	O
importance	O
of	O
CLN2	O
and	O
the	O
lack	O
of	O
a	O
crystal	O
structure	O
inspired	O
attempts	O
at	O
protein	O
modeling	O
.	O

The	O
first	O
such	O
model	O
assumed	O
that	O
this	O
enzyme	O
is	O
membrane	S-GO
-	O
bound	O
,	O
with	O
the	O
sequence	O
271	O
-	O
294	O
(	O
numbering	O
corresponding	O
to	O
the	O
mature	O
enzyme	O
,	O
Figure	O
1	O
)	O
forming	O
the	O
putative	O
transmembrane	S-GO
anchor	O
[	O
15	O
]	O
.	O

However	O
,	O
in	O
view	O
of	O
the	O
subsequently	O
obtained	O
structures	O
of	O
the	O
fully	O
water	O
-	O
soluble	O
sedolisins	O
,	O
this	O
model	O
was	O
clearly	O
incorrect	O
.	O

Exploiting	O
the	O
sequence	O
similarity	O
between	O
CLN2	O
,	O
sedolisin	O
,	O
and	O
kumamolisin	O
(	O
Figure	O
4	O
)	O
,	O
we	O
have	O
now	O
used	O
the	O
experimentally	O
obtained	O
structures	O
of	O
the	O
latter	O
two	O
enzymes	O
to	O
form	O
a	O
new	O
,	O
homology	O
-	O
derived	O
model	O
of	O
human	O
CLN2	O
.	O

The	O
primary	O
basis	O
of	O
the	O
homology	O
model	O
was	O
the	O
structure	O
of	O
a	O
complex	O
of	O
sedolisin	O
with	O
a	O
covalently	O
-	O
bound	O
inhibitor	O
,	O
pseudo	O
-	O
iodotyrostatin	O
.	O

Although	O
it	O
has	O
not	O
been	O
directly	O
shown	O
that	O
this	O
compound	O
can	O
inhibit	O
human	O
CLN2	O
,	O
other	O
similar	O
peptides	O
with	O
an	O
aldehyde	O
functionality	O
on	O
their	O
"	O
C	O
-	O
termini	O
"	O
are	O
weak	O
,	O
but	O
detectable	O
,	O
inhibitors	O
of	O
this	O
enzyme	O
(	O
Oda	O
,	O
unpublished	O
)	O
.	O

It	O
is	O
thus	O
likely	O
that	O
pseudo	O
-	O
iodotyrostatin	O
or	O
a	O
similar	O
inhibitor	O
might	O
work	O
for	O
CLN2	O
as	O
well	O
,	O
although	O
the	O
actual	O
contacts	O
between	O
the	O
inhibitor	O
and	O
the	O
enzyme	O
that	O
are	O
seen	O
in	O
the	O
model	O
have	O
to	O
be	O
treated	O
with	O
caution	O
.	O

Another	O
reason	O
for	O
the	O
modeling	O
of	O
a	O
pseudo	O
-	O
iodotyrostatin	O
complex	O
is	O
that	O
CLN2	O
is	O
a	O
tripeptidase	O
,	O
and	O
that	O
this	O
inhibitor	O
it	O
represents	O
the	O
only	O
experimental	O
structure	O
of	O
a	O
tripeptide	O
analog	O
bound	O
to	O
sedolisin	O
.	O

Figure	O
4	O

Sequence	O
alignment	O
of	O
bacterial	O
and	O
mammalian	O
enzymes	O
.	O

Alignment	O
of	O
the	O
sequences	O
of	O
sedolisin	O
,	O
kumamolisin	O
,	O
and	O
human	O
CLN2	O
used	O
in	O
the	O
construction	O
of	O
the	O
model	O
of	O
the	O
latter	O
enzyme	O
.	O

The	O
colors	O
scheme	O
is	O
the	O
same	O
as	O
in	O
Figure	O
2	O
.	O

The	O
r	O
.	O
m	O
.	O
s	O
.	O
deviation	O
between	O
the	O
corresponding	O
C	O
alpha	O
coordinates	O
of	O
the	O
model	O
of	O
CLN2	O
(	O
Figure	O
5	O
)	O
and	O
the	O
experimental	O
structure	O
of	O
sedolisin	O
is	O
about	O
1	O
.	O
75	O
A	O
,	O
not	O
much	O
larger	O
than	O
the	O
experimental	O
difference	O
between	O
sedolisin	O
and	O
kumamolisin	O
.	O

Interestingly	O
,	O
the	O
Cys327	O
and	O
Cys342	O
residues	O
in	O
the	O
model	O
were	O
found	O
to	O
be	O
ideally	O
positioned	O
to	O
form	O
a	O
disulfide	O
bond	O
even	O
though	O
this	O
was	O
not	O
part	O
of	O
the	O
design	O
strategy	O
.	O

That	O
this	O
bond	O
likely	O
occurs	O
in	O
the	O
real	O
protein	O
is	O
suggested	O
by	O
the	O
fact	O
that	O
these	O
two	O
cysteines	O
are	O
strictly	O
conserved	O
in	O
all	O
known	O
animal	O
species	O
of	O
CLN2	O
(	O
Figures	O
1	O
and	O
3	O
)	O
,	O
although	O
they	O
are	O
absent	O
in	O
all	O
known	O
sequences	O
of	O
bacterial	O
sedolisins	O
.	O

Thus	O
,	O
if	O
this	O
disulfide	O
were	O
experimentally	O
found	O
to	O
exist	O
in	O
CLN2	O
it	O
would	O
provide	O
support	O
for	O
the	O
correctness	O
of	O
the	O
model	O
.	O

Figure	O
5	O

A	O
homology	O
-	O
derived	O
model	O
of	O
human	O
CLN2	O
.	O

Ribbon	O
diagram	O
of	O
the	O
C	O
alpha	O
trace	O
of	O
CLN2	O
,	O
with	O
the	O
segments	O
that	O
were	O
modeled	O
based	O
on	O
the	O
highly	O
conserved	O
core	O
of	O
sedolisin	O
and	O
kumamolisin	O
(	O
r	O
.	O
m	O
.	O
s	O
.	O
deviation	O
of	O
1	O
A	O
)	O
colored	O
in	O
red	O
.	O

Side	O
chains	O
of	O
the	O
residues	O
that	O
were	O
found	O
to	O
be	O
mutated	O
in	O
the	O
genes	O
of	O
families	O
of	O
patients	O
with	O
late	O
-	O
infantile	O
neuronal	O
ceroid	O
lipofuscinosis	O
[	O
17	O
]	O
are	O
marked	O
in	O
ball	O
-	O
and	O
-	O
stick	O
.	O

Comparisons	O
of	O
the	O
substrate	O
binding	O
pockets	O
of	O
CLN2	O
and	O
sedolisin	O

Since	O
the	O
principal	O
known	O
activity	O
of	O
CLN2	O
is	O
that	O
of	O
a	O
tripeptidase	O
,	O
it	O
is	O
expected	O
that	O
three	O
substrate	O
-	O
binding	O
pockets	O
,	O
S1	O
through	O
S3	O
(	O
using	O
the	O
nomenclature	O
of	O
Schechter	O
and	O
Berger	O
[	O
16	O
]	O
)	O
,	O
should	O
be	O
discernible	O
.	O

Residues	O
P1	O
-	O
P3	O
of	O
the	O
inhibitor	O
that	O
should	O
occupy	O
these	O
pockets	O
are	O
shown	O
in	O
Figure	O
6	O
.	O

All	O
the	O
available	O
structures	O
of	O
the	O
complexes	O
of	O
either	O
sedolisin	O
or	O
kumamolisin	O
with	O
inhibitors	O
contain	O
either	O
a	O
tyrosine	O
or	O
a	O
phenylalanine	O
occupying	O
the	O
S1	O
pocket	O
.	O

Parts	O
of	O
this	O
pocket	O
are	O
fully	O
conserved	O
among	O
different	O
sedolisins	O
,	O
whereas	O
other	O
parts	O
of	O
it	O
differ	O
.	O

The	O
right	O
-	O
hand	O
side	O
of	O
the	O
pocket	O
(	O
in	O
the	O
view	O
used	O
in	O
Figure	O
6	O
)	O
is	O
made	O
of	O
the	O
main	O
chain	O
including	O
residues	O
164	O
-	O
165	O
(	O
unless	O
otherwise	O
indicated	O
,	O
the	O
numbering	O
refers	O
to	O
the	O
sequence	O
of	O
the	O
mature	O
human	O
CLN2	O
)	O
.	O

This	O
part	O
of	O
the	O
main	O
chain	O
is	O
held	O
in	O
place	O
through	O
a	O
hydrogen	O
-	O
bonded	O
interaction	O
with	O
the	O
side	O
chain	O
of	O
Thr279	O
,	O
part	O
of	O
the	O
signature	O
sequence	O
SGTSAS	O
surrounding	O
the	O
catalytic	O
Ser280	O
and	O
its	O
equivalents	O
in	O
the	O
other	O
enzymes	O
.	O

Asp165	O
itself	O
is	O
also	O
conserved	O
since	O
that	O
residue	O
provides	O
the	O
lining	O
of	O
the	O
oxyanion	O
hole	O
,	O
so	O
it	O
can	O
be	O
safely	O
assumed	O
that	O
this	O
part	O
of	O
the	O
S1	O
pocket	O
is	O
virtually	O
identical	O
.	O

No	O
side	O
chains	O
point	O
into	O
the	O
pocket	O
from	O
there	O
,	O
though	O
,	O
so	O
its	O
importance	O
is	O
limited	O
to	O
providing	O
a	O
steric	O
barrier	O
and	O
excluding	O
solvent	O
.	O

Another	O
wall	O
of	O
the	O
pocket	O
is	O
made	O
up	O
of	O
the	O
main	O
chain	O
of	O
residues	O
130	O
-	O
132	O
that	O
flank	O
the	O
conserved	O
Gly131	O
.	O

Again	O
,	O
this	O
part	O
of	O
the	O
chain	O
does	O
not	O
provide	O
any	O
specific	O
interactions	O
with	O
the	O
P1	O
residue	O
of	O
the	O
substrate	O
.	O

Figure	O
6	O

A	O
model	O
of	O
the	O
active	O
site	O
of	O
human	O
CLN2	O
.	O

The	O
enzyme	O
is	O
shown	O
in	O
complex	O
with	O
pseudo	O
-	O
iodotyrostatin	O
,	O
a	O
good	O
inhibitor	O
of	O
the	O
sedolisin	O
family	O
of	O
peptidases	O
.	O

Only	O
selected	O
residues	O
of	O
the	O
enzyme	O
are	O
explicitly	O
shown	O
on	O
the	O
background	O
consisting	O
of	O
the	O
molecular	O
surface	O
.	O

The	O
stick	O
model	O
of	O
the	O
inhibitor	O
is	O
colored	O
gold	O
and	O
the	O
P1	O
-	O
P3	O
residues	O
are	O
labeled	O
in	O
black	O
.	O

Similar	O
views	O
have	O
been	O
previously	O
published	O
for	O
the	O
experimentally	O
-	O
determined	O
structures	O
of	O
sedolisin	O
and	O
kumamolisin	O
[	O
8	O
]	O
.	O

The	O
figure	O
was	O
prepared	O
using	O
the	O
program	O
DINO	O
.	O

Considerable	O
differences	O
are	O
seen	O
,	O
however	O
,	O
at	O
the	O
bottom	O
of	O
the	O
pocket	O
,	O
where	O
the	O
side	O
chains	O
of	O
Asp179	O
in	O
kumamolisin	O
and	O
the	O
equivalent	O
Ser190	O
in	O
sedolisin	O
make	O
hydrogen	O
bonds	O
to	O
the	O
P1	O
tyrosine	O
of	O
the	O
inhibitor	O
(	O
if	O
present	O
)	O
.	O

The	O
equivalent	O
residue	O
in	O
CLN2	O
is	O
Thr182	O
,	O
but	O
it	O
is	O
very	O
unlikely	O
that	O
it	O
can	O
assume	O
an	O
orientation	O
that	O
would	O
allow	O
it	O
to	O
make	O
a	O
hydrogen	O
bond	O
to	O
a	O
P1	O
tyrosine	O
.	O

Other	O
polar	O
residues	O
in	O
the	O
vicinity	O
are	O
Glu175	O
in	O
sedolisin	O
and	O
the	O
corresponding	O
Asp169	O
in	O
kumamolisin	O
.	O

However	O
,	O
the	O
residue	O
found	O
here	O
in	O
CLN2	O
is	O
Cys170	O
,	O
much	O
less	O
polar	O
than	O
its	O
counterparts	O
.	O

There	O
is	O
also	O
no	O
equivalent	O
to	O
the	O
polar	O
interaction	O
between	O
Glu175	O
and	O
Glu171	O
in	O
sedolisin	O
,	O
since	O
the	O
equivalent	O
of	O
the	O
latter	O
residue	O
in	O
CLN2	O
is	O
Ser166	O
,	O
much	O
smaller	O
and	O
pointing	O
away	O
.	O

The	O
side	O
of	O
the	O
S1	O
pocket	O
that	O
is	O
created	O
by	O
the	O
very	O
flexible	O
side	O
chain	O
of	O
Arg179	O
in	O
sedolisin	O
contains	O
only	O
a	O
much	O
smaller	O
Ser174	O
in	O
CLN2	O
,	O
and	O
thus	O
is	O
much	O
more	O
open	O
in	O
the	O
latter	O
protein	O
.	O

This	O
part	O
of	O
the	O
pocket	O
,	O
with	O
the	O
main	O
chain	O
of	O
the	O
protein	O
quite	O
distant	O
from	O
the	O
substrate	O
,	O
is	O
indeed	O
not	O
well	O
conserved	O
in	O
these	O
proteins	O
,	O
with	O
kumamolisin	O
missing	O
it	O
entirely	O
due	O
to	O
a	O
deletion	O
in	O
the	O
corresponding	O
sequence	O
position	O
.	O

In	O
summary	O
,	O
the	O
S1	O
pocket	O
in	O
CLN2	O
has	O
less	O
polar	O
character	O
than	O
the	O
equivalent	O
pocket	O
in	O
the	O
related	O
proteins	O
,	O
and	O
is	O
lacking	O
direct	O
polar	O
anchors	O
for	O
any	O
side	O
chains	O
that	O
might	O
be	O
present	O
in	O
the	O
substrate	O
.	O

The	O
S2	O
pocket	O
in	O
CLN2	O
is	O
also	O
quite	O
open	O
and	O
accessible	O
to	O
solvent	O
.	O

It	O
is	O
most	O
likely	O
larger	O
than	O
the	O
equivalent	O
pockets	O
in	O
either	O
sedolisin	O
or	O
kumamolisin	O
,	O
since	O
these	O
are	O
limited	O
by	O
Trp81	O
in	O
the	O
former	O
and	O
Trp129	O
in	O
the	O
latter	O
(	O
these	O
residues	O
originate	O
from	O
different	O
parts	O
of	O
the	O
backbone	O
in	O
the	O
two	O
enzymes	O
and	O
are	O
not	O
topologically	O
related	O
)	O
.	O

Tyr130	O
,	O
an	O
equivalent	O
of	O
the	O
latter	O
residue	O
in	O
CLN2	O
,	O
is	O
unlikely	O
to	O
come	O
into	O
direct	O
contact	O
with	O
the	O
P2	O
residue	O
of	O
the	O
substrate	O
due	O
to	O
its	O
greater	O
distance	O
(	O
almost	O
4	O
A	O
for	O
the	O
closest	O
atoms	O
)	O
.	O

An	O
important	O
remaining	O
puzzle	O
is	O
that	O
the	O
predicted	O
structure	O
of	O
CLN2	O
does	O
not	O
show	O
any	O
clear	O
limitations	O
of	O
the	O
S3	O
pocket	O
that	O
could	O
explain	O
the	O
tripeptidase	O
activity	O
of	O
this	O
enzyme	O
.	O

The	O
location	O
of	O
the	O
P3	O
side	O
chain	O
of	O
the	O
substrate	O
is	O
ambiguous	O
,	O
since	O
it	O
could	O
point	O
in	O
either	O
one	O
of	O
two	O
directions	O
by	O
exchange	O
with	O
the	O
N	O
-	O
terminal	O
amine	O
.	O

The	O
only	O
negatively	O
charged	O
residue	O
of	O
CLN2	O
that	O
is	O
found	O
in	O
this	O
vicinity	O
is	O
Asp132	O
.	O

Although	O
in	O
the	O
current	O
model	O
the	O
distance	O
between	O
its	O
carboxylate	O
and	O
the	O
nitrogen	O
of	O
the	O
N	O
-	O
terminus	O
of	O
the	O
modeled	O
substrate	O
is	O
about	O
6	O
A	O
,	O
these	O
two	O
groups	O
could	O
be	O
brought	O
into	O
hydrogen	O
-	O
bonding	O
range	O
by	O
some	O
allowed	O
changes	O
in	O
the	O
torsion	O
angles	O
of	O
the	O
protein	O
.	O

Such	O
a	O
conformational	O
change	O
would	O
involve	O
breaking	O
of	O
the	O
hydrogen	O
bond	O
between	O
Asp132	O
and	O
Ser139	O
.	O

However	O
,	O
this	O
latter	O
interaction	O
is	O
not	O
likely	O
to	O
be	O
structurally	O
crucial	O
since	O
the	O
serine	O
is	O
not	O
absolutely	O
conserved	O
in	O
all	O
CLN2	O
-	O
like	O
enzymes	O
.	O

Location	O
of	O
mutations	O
implicated	O
in	O
disease	O

Location	O
of	O
mutations	O
found	O
through	O
a	O
genetic	O
survey	O
of	O
families	O
of	O
classic	O
late	O
-	O
infantile	O
neuronal	O
ceroid	O
lipofuscinosis	O
patients	O
has	O
been	O
described	O
previously	O
[	O
17	O
]	O
.	O

Most	O
such	O
mutations	O
result	O
in	O
expression	O
of	O
either	O
truncated	O
enzyme	O
or	O
in	O
incorrect	O
intron	O
-	O
exon	O
splices	O
.	O

However	O
,	O
some	O
of	O
the	O
mutations	O
lead	O
to	O
single	O
amino	O
acid	O
substitutions	O
in	O
the	O
mature	O
enzyme	O
.	O

Such	O
mutations	O
include	O
I92N	O
,	O
E148K	O
,	O
C170R	O
and	O
C170Y	O
,	O
V190D	O
,	O
G194E	O
,	O
Q227H	O
,	O
R252H	O
,	O
A259E	O
,	O
and	O
S280L	O
(	O
Figure	O
5	O
)	O
.	O

Only	O
the	O
role	O
of	O
the	O
latter	O
mutation	O
is	O
completely	O
clear	O
,	O
since	O
it	O
replaces	O
the	O
catalytic	O
serine	O
of	O
CLN2	O
with	O
a	O
side	O
chain	O
that	O
cannot	O
support	O
its	O
enzymatic	O
activity	O
.	O

No	O
other	O
residues	O
appear	O
to	O
be	O
located	O
in	O
the	O
immediate	O
vicinity	O
of	O
the	O
substrate	O
.	O

Residues	O
Val190	O
,	O
Gly194	O
,	O
and	O
Arg252	O
are	O
very	O
highly	O
conserved	O
not	O
only	O
in	O
CLN2	O
but	O
also	O
in	O
other	O
sedolisins	O
and	O
must	O
play	O
an	O
important	O
structural	O
role	O
.	O

The	O
reasons	O
why	O
the	O
remaining	O
mutations	O
would	O
lead	O
to	O
the	O
loss	O
of	O
enzymatic	O
activity	O
are	O
much	O
less	O
clear	O
,	O
but	O
the	O
wide	O
distribution	O
of	O
these	O
mutations	O
in	O
the	O
structure	O
supports	O
the	O
conclusion	O
that	O
any	O
modifications	O
to	O
CLN2	O
that	O
would	O
abolish	O
or	O
impair	O
its	O
function	O
could	O
lead	O
to	O
the	O
development	O
of	O
the	O
disease	O
.	O

Substrates	O
and	O
inhibitors	O
of	O
CLN2	O

Little	O
is	O
known	O
at	O
this	O
time	O
about	O
biologically	O
-	O
relevant	O
substrates	O
of	O
CLN2	O
.	O

Various	O
defects	O
that	O
include	O
truncations	O
and	O
single	O
-	O
site	O
mutations	O
in	O
CLN2	O
have	O
been	O
found	O
in	O
the	O
genes	O
of	O
patients	O
that	O
display	O
symptoms	O
of	O
late	O
-	O
infantile	O
neuronal	O
ceroid	O
lipofuscinosis	O
[	O
17	O
]	O
.	O

One	O
of	O
the	O
symptoms	O
of	O
the	O
disease	O
is	O
the	O
accumulation	O
of	O
an	O
autofluorescent	O
material	O
,	O
ceroid	O
-	O
lipofuscin	O
,	O
in	O
lysosomal	S-GO
storage	B-GO
bodies	E-GO
in	O
various	O
cell	O
types	O
,	O
primarily	O
in	O
the	O
nervous	O
system	O
.	O

Since	O
a	O
major	O
component	O
of	O
such	O
bodies	O
appears	O
to	O
be	O
intact	O
subunit	O
c	O
of	O
mitochondrial	O
ATP	O
synthase	O
,	O
this	O
protein	O
has	O
been	O
implicated	O
as	O
a	O
potential	O
biological	O
target	O
of	O
the	O
protease	O
.	O

It	O
has	O
been	O
shown	O
recently	O
that	O
CLN2	O
can	O
indeed	O
degrade	O
this	O
subunit	O
on	O
its	O
N	O
terminus	O
[	O
18	O
]	O
,	O
but	O
the	O
unambiguous	O
proof	O
that	O
this	O
is	O
indeed	O
the	O
most	O
important	O
target	O
is	O
still	O
lacking	O
.	O

CLN2	O
is	O
capable	O
of	O
processing	O
a	O
number	O
of	O
different	O
angiotensin	O
-	O
derived	O
peptides	O
[	O
19	O
]	O
,	O
with	O
the	O
efficiency	O
of	O
cleavage	O
dependent	O
on	O
the	O
length	O
of	O
such	O
peptides	O
.	O

The	O
most	O
efficiently	O
processed	O
peptide	O
consisted	O
of	O
14	O
amino	O
acids	O
,	O
with	O
the	O
tripeptide	O
Asp	O
-	O
Arg	O
-	O
Val	O
removed	O
from	O
its	O
N	O
terminus	O
.	O

The	O
model	O
of	O
CLN2	O
presented	O
here	O
can	O
easily	O
accommodate	O
this	O
peptide	O
on	O
the	O
P	O
side	O
of	O
the	O
substrate	O
-	O
binding	O
site	O
,	O
although	O
the	O
exact	O
mode	O
of	O
binding	O
of	O
the	O
long	O
P	O
'	O
portion	O
of	O
the	O
substrate	O
remains	O
obscure	O
.	O

The	O
observation	O
that	O
an	O
analogous	O
peptide	O
acetylated	O
on	O
its	O
N	O
terminus	O
cannot	O
be	O
processed	O
supports	O
the	O
postulate	O
that	O
the	O
interactions	O
of	O
the	O
N	O
-	O
terminal	O
amino	O
group	O
with	O
the	O
side	O
chain	O
of	O
Asp132	O
may	O
be	O
the	O
most	O
important	O
feature	O
defining	O
the	O
tripeptidase	O
specificity	O
of	O
CLN2	O
.	O

A	O
number	O
of	O
different	O
tripeptides	O
can	O
be	O
serially	O
processed	O
from	O
glucagon	O
,	O
with	O
their	O
sequences	O
varying	O
widely	O
[	O
20	O
]	O
.	O

Again	O
,	O
however	O
,	O
all	O
of	O
these	O
tripeptides	O
can	O
be	O
easily	O
accommodated	O
in	O
the	O
substrate	O
-	O
binding	O
site	O
of	O
the	O
CLN2	O
model	O
.	O

Other	O
potentially	O
biologically	O
relevant	O
substrates	O
include	O
cholecystokinin	O
and	O
possibly	O
other	O
neuropeptides	O
[	O
21	O
]	O
.	O

An	O
intriguing	O
property	O
of	O
CLN2	O
is	O
its	O
reported	O
ability	O
to	O
cleave	O
collagen	O
-	O
related	O
peptides	O
[	O
22	O
]	O
.	O

The	O
tripeptides	O
resulting	O
from	O
such	O
processing	O
include	O
Gly	O
-	O
Pro	O
-	O
Met	O
,	O
Gly	O
-	O
Pro	O
-	O
Arg	O
,	O
and	O
Gly	O
-	O
Pro	O
-	O
Ala	O
.	O

It	O
has	O
been	O
recently	O
reported	O
that	O
kumamolisin	O
,	O
and	O
particularly	O
a	O
closely	O
related	O
protein	O
from	O
Alicyclobacillus	O
sendaiensis	O
(	O
kumamolisin	O
-	O
As	O
)	O
can	O
efficiently	O
cleave	O
not	O
only	O
collagen	O
-	O
related	O
peptides	O
,	O
but	O
also	O
native	O
type	O
I	O
collagen	O
[	O
23	O
]	O
.	O

With	O
the	O
substrate	O
-	O
binding	O
site	O
of	O
CLN2	O
resembling	O
that	O
of	O
kumamolisin	O
more	O
than	O
sedolisin	O
(	O
the	O
latter	O
enzyme	O
has	O
low	O
,	O
if	O
any	O
,	O
collagenase	O
activity	O
)	O
,	O
the	O
potential	O
collagen	O
-	O
processing	O
role	O
of	O
CLN2	O
might	O
warrant	O
further	O
investigation	O
.	O

Conclusions	O

Since	O
the	O
catalytic	O
machinery	O
of	O
CLN2	O
matches	O
closely	O
that	O
of	O
sedolisin	O
,	O
kumamolisin	O
,	O
and	O
other	O
members	O
of	O
the	O
family	O
of	O
serine	O
-	O
carboxyl	O
peptidases	O
,	O
the	O
enzymatic	O
mechanism	O
of	O
all	O
these	O
enzymes	O
is	O
most	O
likely	O
the	O
same	O
.	O

Design	O
of	O
inhibitors	O
specific	O
for	O
CLN2	O
should	O
incorporate	O
the	O
features	O
that	O
have	O
been	O
proven	O
to	O
be	O
important	O
for	O
the	O
related	O
enzymes	O
,	O
such	O
as	O
the	O
placement	O
of	O
an	O
aldehyde	O
functionality	O
capable	O
of	O
making	O
covalent	O
interactions	O
with	O
the	O
catalytic	O
serine	O
,	O
or	O
the	O
utilization	O
of	O
chloromethyl	O
ketone	O
for	O
the	O
same	O
purpose	O
.	O

Since	O
the	O
few	O
inhibitors	O
that	O
have	O
been	O
successfully	O
used	O
in	O
the	O
studies	O
of	O
sedolisins	O
are	O
either	O
longer	O
than	O
tripeptides	O
or	O
contain	O
blocking	O
groups	O
on	O
their	O
N	O
termini	O
,	O
new	O
tripeptide	O
-	O
based	O
inhibitors	O
with	O
free	O
N	O
termini	O
are	O
now	O
being	O
synthesized	O
(	O
Oda	O
,	O
unpublished	O
)	O
.	O

It	O
will	O
be	O
necessary	O
to	O
test	O
the	O
binding	O
properties	O
of	O
different	O
substrates	O
in	O
order	O
to	O
determine	O
the	O
most	O
promising	O
peptide	O
sequences	O
.	O

Analysis	O
of	O
the	O
model	O
of	O
CLN2	O
suggests	O
that	O
the	O
size	O
of	O
the	O
S1	O
subsite	O
is	O
much	O
larger	O
than	O
in	O
either	O
sedolisin	O
or	O
kumamolisin	O
,	O
and	O
thus	O
the	O
use	O
of	O
a	O
large	O
P1	O
group	O
might	O
be	O
indicated	O
.	O

Of	O
course	O
,	O
the	O
availability	O
of	O
an	O
experimental	O
crystal	O
structure	O
will	O
make	O
the	O
design	O
of	O
inhibitors	O
easier	O
and	O
we	O
are	O
continuing	O
our	O
efforts	O
to	O
crystallize	O
CLN2	O
from	O
different	O
sources	O
.	O

Methods	O

Homology	O
modeling	O

Three	O
-	O
dimensional	O
,	O
atomic	O
-	O
scale	O
models	O
of	O
CLN2	O
were	O
developed	O
by	O
exploiting	O
the	O
sequence	O
similarity	O
to	O
the	O
sedolisin	O
and	O
kumamolisin	O
proteins	O
(	O
r	O
.	O
m	O
.	O
s	O
.	O
deviation	O
of	O
1	O
.	O
0	O
A	O
for	O
273	O
pairs	O
of	O
C	O
alpha	O
atoms	O
in	O
the	O
core	O
of	O
the	O
enzymes	O
)	O
.	O

Presently	O
,	O
these	O
two	O
enzymes	O
are	O
the	O
only	O
members	O
of	O
the	O
newly	O
-	O
defined	O
sedolisin	O
/	O
serine	O
-	O
carboxyl	O
peptidase	O
family	O
[	O
8	O
]	O
for	O
which	O
the	O
crystal	O
structures	O
have	O
been	O
published	O
[	O
5	O
-	O
7	O
]	O
.	O

The	O
actual	O
Protein	O
Data	O
Bank	O
[	O
24	O
]	O
:	O
)	O
entries	O
used	O
in	O
the	O
modeling	O
were	O
1GA4	O
.	O
pdb	O
and	O
1GT9	O
.	O
pdb	O
for	O
sedolisin	O
and	O
kumamolisin	O
,	O
respectively	O
.	O

The	O
first	O
step	O
was	O
to	O
form	O
a	O
global	O
,	O
multiple	O
sequence	O
alignment	O
between	O
all	O
known	O
members	O
of	O
the	O
sedolisin	O
family	O
.	O

Studies	O
have	O
shown	O
that	O
incorporating	O
the	O
specific	O
patterns	O
of	O
amino	O
acid	O
residue	O
-	O
type	O
variation	O
and	O
conservation	O
among	O
a	O
family	O
of	O
homologous	O
proteins	O
provides	O
superior	O
results	O
over	O
simple	O
,	O
pair	O
-	O
wise	O
sequence	O
alignment	O
[	O
25	O
]	O
.	O

Sequence	O
files	O
representing	O
the	O
different	O
subfamilies	O
were	O
extracted	O
from	O
the	O
non	O
-	O
redundant	O
GenBank	O
database	O
[	O
26	O
]	O
using	O
sedolisin	O
,	O
kumamolisin	O
,	O
and	O
the	O
human	O
CLN2	O
sequences	O
as	O
queries	O
to	O
the	O
web	O
-	O
based	O
version	O
of	O
the	O
BLAST	O
program	O
[	O
27	O
]	O
:	O
.	O

Initial	O
multiple	O
sequence	O
alignments	O
were	O
formed	O
with	O
the	O
ClustalX	O
computer	O
program	O
[	O
28	O
]	O
.	O

As	O
is	O
expected	O
for	O
a	O
family	O
of	O
proteins	O
,	O
highly	O
-	O
conserved	O
segments	O
were	O
found	O
aligned	O
to	O
the	O
crystal	O
structure	O
-	O
identified	O
core	O
regions	O
of	O
the	O
sedolisin	O
and	O
kumamolisin	O
sequences	O
.	O

Subsequently	O
,	O
the	O
sequences	O
were	O
divided	O
into	O
two	O
groups	O
:	O
those	O
closer	O
to	O
sedolisin	O
than	O
kumamolisin	O
and	O
vise	O
-	O
a	O
-	O
versa	O
.	O

The	O
alignment	O
of	O
these	O
two	O
groups	O
was	O
then	O
manually	O
set	O
by	O
the	O
observed	O
structural	O
alignment	O
of	O
the	O
sedolisin	O
and	O
kumamolisin	O
proteins	O
.	O

Finally	O
,	O
some	O
additional	O
adjustment	O
was	O
required	O
to	O
correct	O
the	O
few	O
places	O
where	O
highly	O
conserved	O
residues	O
of	O
the	O
core	O
regions	O
were	O
slightly	O
out	O
of	O
alignment	O
among	O
different	O
subfamilies	O
of	O
sequences	O
.	O

The	O
model	O
of	O
human	O
CLN2	O
was	O
built	O
using	O
the	O
structure	O
of	O
sedolisin	O
complexed	O
with	O
the	O
inhibitor	O
pseudo	O
-	O
tyrostatin	O
[	O
5	O
,	O
6	O
]	O
as	O
a	O
template	O
.	O

The	O
reason	O
for	O
this	O
choice	O
is	O
that	O
while	O
different	O
protein	O
models	O
were	O
generally	O
comparable	O
,	O
the	O
chosen	O
inhibitor	O
was	O
most	O
compatible	O
with	O
the	O
tripeptidase	O
character	O
of	O
CLN2	O
.	O

With	O
the	O
correspondence	O
of	O
residues	O
specified	O
in	O
the	O
alignments	O
,	O
atomic	O
coordinates	O
were	O
transferred	O
to	O
the	O
target	O
sequence	O
by	O
a	O
variety	O
of	O
methods	O
,	O
including	O
the	O
homology	O
modeling	O
modules	O
of	O
the	O
Look	O
/	O
GeneMine	O
[	O
29	O
]	O
and	O
DeepView	O
[	O
30	O
]	O
computer	O
program	O
packages	O
.	O

For	O
the	O
core	O
and	O
active	O
site	O
of	O
the	O
protein	O
,	O
coordinates	O
for	O
identical	O
residues	O
were	O
simply	O
transferred	O
unchanged	O
;	O
whereas	O
,	O
special	O
care	O
was	O
required	O
to	O
position	O
the	O
side	O
chains	O
of	O
residues	O
differing	O
from	O
the	O
template	O
.	O

This	O
was	O
first	O
accomplished	O
automatically	O
by	O
the	O
two	O
computer	O
packages	O
,	O
then	O
manually	O
adjusted	O
in	O
the	O
Quanta	O
molecular	O
modeling	O
package	O
(	O
Accelrys	O
,	O
Inc	O
.	O
)	O
to	O
better	O
mimic	O
the	O
templates	O
and	O
optimize	O
the	O
interactions	O
with	O
surrounding	O
residues	O
.	O

A	O
similar	O
two	O
-	O
step	O
approach	O
was	O
used	O
to	O
manifest	O
the	O
insertions	O
and	O
deletions	O
in	O
the	O
variable	O
,	O
loop	O
regions	O
of	O
the	O
protein	O
,	O
where	O
it	O
was	O
necessary	O
to	O
create	O
new	O
backbone	O
as	O
well	O
as	O
side	O
chain	O
coordinates	O
for	O
the	O
models	O
.	O

It	O
should	O
be	O
noted	O
that	O
,	O
for	O
obvious	O
reasons	O
,	O
the	O
conformation	O
of	O
poorly	O
conserved	O
loop	O
regions	O
is	O
generally	O
the	O
least	O
accurate	O
aspect	O
of	O
a	O
homology	O
model	O
.	O

Fortunately	O
,	O
these	O
problematic	O
loops	O
will	O
not	O
significantly	O
affect	O
the	O
active	O
site	O
of	O
the	O
model	O
,	O
since	O
only	O
two	O
of	O
them	O
impinge	O
on	O
the	O
boundary	O
of	O
this	O
highly	O
conserved	O
,	O
functional	O
region	O
.	O

Refinement	O
and	O
analysis	O
of	O
the	O
model	O

The	O
model	O
was	O
finished	O
by	O
performing	O
energy	O
minimization	O
in	O
vacuo	O
with	O
the	O
computer	O
program	O
CHARMM	O
[	O
31	O
]	O
.	O

This	O
refined	O
the	O
structure	O
by	O
bringing	O
the	O
covalent	O
geometry	O
and	O
non	O
-	O
bonded	O
interactions	O
into	O
agreement	O
with	O
experimentally	O
observed	O
and	O
calculated	O
values	O
.	O

Such	O
optimizations	O
included	O
adjusting	O
bond	O
lengths	O
,	O
3	O
-	O
point	O
angles	O
and	O
4	O
-	O
point	O
dihedral	O
angles	O
,	O
as	O
well	O
as	O
eliminating	O
atomic	O
overlap	O
and	O
forming	O
salt	O
-	O
bridges	O
and	O
hydrogen	O
bonds	O
.	O

Since	O
presently	O
the	O
potential	O
energy	O
functions	O
used	O
to	O
describe	O
the	O
atomic	O
-	O
scale	O
models	O
are	O
not	O
sufficiently	O
comprehensive	O
and	O
accurate	O
,	O
the	O
final	O
energy	O
of	O
the	O
model	O
was	O
not	O
used	O
as	O
an	O
indicator	O
of	O
the	O
realistic	O
quality	O
of	O
the	O
structure	O
.	O

The	O
final	O
quality	O
of	O
the	O
structure	O
was	O
analyzed	O
with	O
the	O
computer	O
program	O
PROCHECK	O
[	O
32	O
]	O
.	O

The	O
structure	O
was	O
deposited	O
at	O
the	O
PDB	O
under	O
accession	O
code	O
1R60	O
.	O

Authors	O
'	O
contributions	O

AW	O
initiated	O
this	O
project	O
and	O
analyzed	O
the	O
genomic	O
distribution	O
of	O
this	O
family	O
of	O
enzymes	O
.	O

SRD	O
contributed	O
the	O
modeling	O
of	O
the	O
three	O
-	O
dimensional	O
structure	O
of	O
CLN2	O
.	O

ML	O
analyzed	O
the	O
model	O
and	O
compared	O
it	O
to	O
the	O
crystal	O
structures	O
of	O
sedolisins	O
.	O

HO	O
,	O
KO	O
and	O
BMD	O
contributed	O
their	O
experience	O
gained	O
from	O
studies	O
of	O
serine	O
-	O
carboxyl	O
peptidases	O
and	O
the	O
design	O
of	O
their	O
inhibitors	O
,	O
aimed	O
at	O
analysis	O
of	O
substrate	O
-	O
enzyme	O
interactions	O
and	O
enzyme	O
specificity	O
.	O

All	O
authors	O
read	O
and	O
approved	O
the	O
final	O
manuscript	O
.	O

Acknowledgements	O

Extensive	O
discussions	O
with	O
Dr	O
.	O
A	O
.	O

Barrett	O
(	O
Wellcome	O
Trust	O
Sanger	O
Institute	O
,	O
Hinxton	O
,	O
UK	O
)	O
are	O
gratefully	O
acknowledged	O
.	O

Modeling	O
efforts	O
were	O
facilitated	O
by	O
Dr	O
.	O
Robert	O
Jernigan	O
(	O
Iowa	O
State	O
University	O
)	O
.	O

This	O
work	O
was	O
supported	O
in	O
part	O
by	O
a	O
Grant	O
-	O
in	O
-	O
Aid	O
for	O
Scientific	O
Research	O
(	O
B	O
)	O
,	O
15380072	O
,	O
from	O
the	O
Ministry	O
of	O
Education	O
,	O
Culture	O
,	O
Sports	O
,	O
Science	O
and	O
Technology	O
of	O
Japan	O
(	O
to	O
K	O
.	O
O	O
.	O
)	O
;	O
by	O
NIH	O
grants	O
DK18865	O
and	O
AI39211	O
(	O
to	O
B	O
.	O
M	O
.	O
D	O
.	O
)	O
;	O
and	O
in	O
part	O
with	O
Federal	O
funds	O
from	O
the	O
National	O
Cancer	O
Institute	O
,	O
National	O
Institutes	O
of	O
Health	O
,	O
under	O
contract	O
No	O
.	O

NO1	O
-	O
CO	O
-	O
12400	O
.	O

The	O
content	O
of	O
this	O
publication	O
does	O
not	O
necessarily	O
reflect	O
the	O
views	O
or	O
policies	O
of	O
the	O
Department	O
of	O
Health	O
and	O
Human	O
Services	O
,	O
nor	O
does	O
the	O
mention	O
of	O
trade	O
names	O
,	O
commercial	O
products	O
or	O
organizations	O
imply	O
endorsement	O
by	O
the	O
U	O
.	O

S	O
.	O

Government	O
.	O

The	O
Zebrafish	O
moonshine	O
Gene	O
Encodes	O
Transcriptional	O
Intermediary	O
Factor	O
1	O
gamma	O
,	O
an	O
Essential	O
Regulator	O
of	O
Hematopoiesis	O

Abstract	O

Hematopoiesis	O
is	O
precisely	O
orchestrated	O
by	O
lineage	O
-	O
specific	O
DNA	O
-	O
binding	O
proteins	O
that	O
regulate	O
transcription	O
in	O
concert	O
with	O
coactivators	O
and	O
corepressors	O
.	O

Mutations	O
in	O
the	O
zebrafish	O
moonshine	O
(	O
mon	O
)	O
gene	O
specifically	O
disrupt	O
both	O
embryonic	O
and	O
adult	O
hematopoiesis	O
,	O
resulting	O
in	O
severe	O
red	O
blood	O
cell	O
aplasia	O
.	O

We	O
report	O
that	O
mon	O
encodes	O
the	O
zebrafish	O
ortholog	O
of	O
mammalian	O
transcriptional	O
intermediary	O
factor	O
1	O
gamma	O
(	O
TIF1	O
gamma	O
)	O
(	O
or	O
TRIM33	O
)	O
,	O
a	O
member	O
of	O
the	O
TIF1	O
family	O
of	O
coactivators	O
and	O
corepressors	O
.	O

During	O
development	O
,	O
hematopoietic	O
progenitor	O
cells	O
in	O
mon	O
mutants	O
fail	O
to	O
express	O
normal	O
levels	O
of	O
hematopoietic	O
transcription	O
factors	O
,	O
including	O
gata1	O
,	O
and	O
undergo	O
apoptosis	O
.	O

Three	O
different	O
mon	O
mutant	O
alleles	O
each	O
encode	O
premature	O
stop	O
codons	O
,	O
and	O
enforced	O
expression	O
of	O
wild	O
-	O
type	O
tif1	O
gamma	O
mRNA	O
rescues	O
embryonic	O
hematopoiesis	O
in	O
homozygous	O
mon	O
mutants	O
.	O

Surprisingly	O
,	O
a	O
high	O
level	O
of	O
zygotic	O
tif1	O
gamma	O
mRNA	O
expression	O
delineates	O
ventral	O
mesoderm	O
during	O
hematopoietic	O
stem	O
cell	O
and	O
progenitor	O
formation	O
prior	O
to	O
gata1	O
expression	O
.	O

Transplantation	O
studies	O
reveal	O
that	O
tif1	O
gamma	O
functions	O
in	O
a	O
cell	O
-	O
autonomous	O
manner	O
during	O
the	O
differentiation	O
of	O
erythroid	O
precursors	O
.	O

Studies	O
in	O
murine	O
erythroid	O
cell	O
lines	O
demonstrate	O
that	O
Tif1	O
gamma	O
protein	O
is	O
localized	O
within	O
novel	O
nuclear	S-GO
foci	O
,	O
and	O
expression	O
decreases	O
during	O
erythroid	O
cell	O
maturation	O
.	O

Our	O
results	O
establish	O
a	O
major	O
role	O
for	O
this	O
transcriptional	O
intermediary	O
factor	O
in	O
the	O
differentiation	O
of	O
hematopoietic	O
cells	O
in	O
vertebrates	O
.	O

Introduction	O

Hematopoiesis	O
involves	O
the	O
coordinated	O
processes	O
of	O
cell	O
proliferation	O
and	O
differentiation	O
of	O
a	O
relatively	O
small	O
number	O
of	O
progenitor	O
cells	O
into	O
billions	O
of	O
circulating	O
red	O
and	O
white	O
blood	O
cells	O
(	O
Thisse	O
and	O
Zon	O
2002	O
)	O
.	O

Hematopoiesis	O
in	O
vertebrates	O
,	O
from	O
zebrafish	O
to	O
humans	O
,	O
is	O
an	O
evolutionarily	O
conserved	O
program	O
that	O
produces	O
two	O
waves	O
of	O
stem	O
or	O
progenitor	O
cells	O
that	O
differ	O
both	O
in	O
their	O
embryonic	O
origins	O
and	O
in	O
the	O
lineages	O
of	O
differentiated	O
blood	O
cells	O
produced	O
(	O
Palis	O
and	O
Yoder	O
2001	O
;	O
Orkin	O
and	O
Zon	O
2002	O
;	O
Galloway	O
and	O
Zon	O
2003	O
)	O
.	O

The	O
first	O
,	O
or	O
primitive	O
,	O
wave	O
of	O
hematopoiesis	O
originates	O
from	O
ventral	O
mesoderm	O
and	O
gives	O
rise	O
to	O
progenitor	O
cells	O
that	O
differentiate	O
in	O
embryonic	O
blood	O
islands	O
.	O

The	O
primitive	O
wave	O
of	O
hematopoiesis	O
produces	O
a	O
burst	O
of	O
embryonic	O
erythrocytes	O
and	O
macrophages	O
.	O

The	O
second	O
,	O
or	O
definitive	O
,	O
wave	O
of	O
hematopoiesis	O
arises	O
from	O
self	O
-	O
renewing	O
stem	O
cells	O
that	O
develop	O
primarily	O
in	O
the	O
intraembryonic	O
aorta	O
-	O
gonad	O
-	O
mesonephros	O
region	O
.	O

These	O
definitive	O
hematopoietic	O
stem	O
cells	O
seed	O
the	O
later	O
developing	O
marrow	O
spaces	O
,	O
to	O
produce	O
all	O
lineages	O
of	O
adult	O
blood	O
cells	O
,	O
including	O
definitive	O
erythrocytes	O
,	O
myeloid	O
cells	O
,	O
and	O
lymphocytes	O
.	O

We	O
have	O
undertaken	O
a	O
genetic	O
approach	O
to	O
characterize	O
genes	O
that	O
control	O
hematopoiesis	O
using	O
the	O
zebrafish	O
as	O
a	O
model	O
system	O
(	O
Thisse	O
and	O
Zon	O
2002	O
)	O
.	O

As	O
part	O
of	O
a	O
large	O
-	O
scale	O
forward	O
genetic	O
screen	O
,	O
we	O
previously	O
identified	O
bloodless	O
zebrafish	O
mutants	O
that	O
failed	O
to	O
express	O
the	O
erythroid	O
transcription	O
factor	O
gata1	O
normally	O
in	O
embryonic	O
hematopoietic	O
precursors	O
(	O
Ransom	O
et	O
al	O
.	O
1996	O
)	O
.	O

We	O
named	O
one	O
of	O
these	O
zebrafish	O
genes	O
moonshine	O
(	O
mon	O
)	O
,	O
and	O
another	O
group	O
named	O
a	O
noncomplementing	O
allele	O
vampire	O
(	O
Weinstein	O
et	O
al	O
.	O
1996	O
)	O
.	O

Here	O
,	O
we	O
have	O
determined	O
that	O
mutations	O
in	O
the	O
mon	O
gene	O
cause	O
a	O
disruption	O
in	O
both	O
primitive	O
embryonic	O
and	O
definitive	O
adult	O
hematopoiesis	O
,	O
resulting	O
in	O
a	O
severe	O
loss	O
of	O
erythroid	O
cells	O
.	O

Erythroid	O
progenitor	O
cells	O
in	O
mon	O
mutants	O
are	O
initially	O
present	O
,	O
but	O
fail	O
to	O
express	O
normal	O
levels	O
of	O
hematopoietic	O
transcription	O
factors	O
and	O
undergo	O
apoptosis	O
.	O

Positional	O
cloning	O
identifies	O
the	O
mon	O
gene	O
as	O
the	O
zebrafish	O
ortholog	O
of	O
mammalian	O
transcriptional	O
intermediary	O
factor	O
1	O
gamma	O
(	O
TIF1	O
gamma	O
)	O
,	O
a	O
member	O
of	O
the	O
TIF1	O
family	O
of	O
transcriptional	O
coactivators	O
and	O
corepressors	O
(	O
Le	O
Douarin	O
et	O
al	O
.	O
1995	O
;	O
Friedman	O
et	O
al	O
.	O
1996	O
;	O
Kim	O
et	O
al	O
.	O
1996	O
;	O
Venturini	O
et	O
al	O
.	O
1999	O
;	O
Peng	O
et	O
al	O
.	O
2002	O
)	O
.	O

The	O
three	O
members	O
of	O
the	O
vertebrate	O
TIF1	O
family	O
(	O
alpha	O
,	O
beta	O
,	O
and	O
gamma	O
)	O
are	O
large	O
nuclear	S-GO
proteins	O
that	O
each	O
contain	O
an	O
N	O
-	O
terminal	O
RBCC	O
or	O
TRIM	O
domain	O
(	O
Reymond	O
et	O
al	O
.	O
2001	O
)	O
composed	O
of	O
a	O
RING	O
finger	O
,	O
two	O
B	O
-	O
boxes	O
,	O
and	O
a	O
coiled	O
-	O
coil	O
domain	O
.	O

TIF1	O
family	O
members	O
also	O
contain	O
a	O
C	O
-	O
terminal	O
plant	O
homeodomain	O
finger	O
and	O
bromodomain	O
that	O
are	O
characteristic	O
of	O
chromatin	S-GO
remodeling	O
factors	O
.	O

TIF1	O
alpha	O
has	O
been	O
shown	O
to	O
associate	O
with	O
a	O
variety	O
of	O
ligand	O
-	O
bound	O
nuclear	S-GO
hormone	O
receptors	O
(	O
Le	O
Douarin	O
et	O
al	O
.	O
1995	O
)	O
and	O
function	O
as	O
a	O
coactivator	O
for	O
retinoic	O
acid	O
receptors	O
(	O
Zhong	O
et	O
al	O
.	O
1999	O
)	O
.	O

TIF1	O
beta	O
has	O
been	O
shown	O
to	O
act	O
as	O
a	O
corepressor	O
for	O
the	O
large	O
family	O
of	O
Kr	O
u	O
ppel	O
-	O
associated	O
box	O
(	O
KRAB	O
)	O
domain	O
zinc	O
-	O
finger	O
transcription	O
factors	O
(	O
Friedman	O
et	O
al	O
.	O
1996	O
;	O
Abrink	O
et	O
al	O
.	O
2001	O
)	O
.	O

In	O
contrast	O
,	O
TIF1	O
gamma	O
does	O
not	O
associate	O
directly	O
with	O
either	O
nuclear	S-GO
receptors	O
or	O
KRAB	O
domains	O
that	O
bind	O
to	O
the	O
other	O
TIF1	O
family	O
members	O
(	O
Venturini	O
et	O
al	O
.	O
1999	O
;	O
Abrink	O
et	O
al	O
.	O
2001	O
)	O
.	O

Biochemical	O
studies	O
also	O
demonstrate	O
that	O
TIF1	O
gamma	O
forms	O
both	O
homo	O
-	O
oligomers	O
and	O
hetero	O
-	O
oligomers	O
with	O
TIF1	O
alpha	O
but	O
not	O
with	O
TIF1	O
beta	O
(	O
Peng	O
et	O
al	O
.	O
2002	O
)	O
.	O

The	O
murine	O
Tif1	O
alpha	O
and	O
Tif1	O
gamma	O
genes	O
have	O
not	O
yet	O
been	O
subjected	O
to	O
gene	O
targeting	O
experiments	O
,	O
whereas	O
analysis	O
of	O
mouse	O
mutants	O
demonstrates	O
that	O
Tif1	O
beta	O
is	O
required	O
for	O
postimplantation	O
embryogenesis	O
and	O
mesoderm	O
induction	O
in	O
particular	O
(	O
Cammas	O
et	O
al	O
.	O
2000	O
)	O
.	O

Taken	O
together	O
,	O
these	O
studies	O
suggest	O
that	O
a	O
major	O
function	O
of	O
TIF1	O
family	O
members	O
is	O
to	O
link	O
DNA	O
-	O
binding	O
proteins	O
with	O
other	O
coactivators	O
or	O
corepressors	O
during	O
development	O
.	O

Our	O
studies	O
establish	O
that	O
tif1	O
gamma	O
functions	O
as	O
an	O
essential	O
regulator	O
of	O
embryonic	O
and	O
adult	O
hematopoiesis	O
in	O
vertebrates	O
.	O

Cell	O
transplantation	O
studies	O
demonstrate	O
that	O
tif1	O
gamma	O
acts	O
in	O
a	O
cell	O
-	O
autonomous	O
manner	O
during	O
embryonic	O
hematopoiesis	O
.	O

The	O
tif1	O
gamma	O
gene	O
is	O
expressed	O
specifically	O
in	O
ventral	O
mesoderm	O
and	O
hematopoietic	O
progenitors	O
,	O
then	O
downregulated	O
as	O
erythroid	O
maturation	O
occurs	O
.	O

Tif1	O
gamma	O
protein	O
localizes	O
to	O
a	O
novel	O
class	O
of	O
nuclear	B-GO
bodies	E-GO
in	O
both	O
primary	O
mouse	O
embryo	O
fibroblasts	O
and	O
erythroleukemia	O
cell	O
lines	O
.	O

Taken	O
together	O
,	O
our	O
studies	O
demonstrate	O
that	O
Tif1	O
gamma	O
is	O
required	O
for	O
normal	O
erythroid	O
cell	O
development	O
and	O
survival	O
.	O

Results	O

The	O
Zebrafish	O
mon	O
Gene	O
Is	O
Essential	O
for	O
Both	O
Primitive	O
and	O
Definitive	O
Erythropoiesis	O

In	O
order	O
to	O
determine	O
when	O
the	O
mon	O
gene	O
is	O
required	O
in	O
development	O
,	O
we	O
first	O
examined	O
hematopoietic	O
gene	O
expression	O
and	O
apoptosis	O
in	O
zebrafish	O
homozygous	O
mon	O
mutant	O
embryos	O
.	O

During	O
embryogenesis	O
,	O
homozygous	O
zebrafish	O
mon	O
mutants	O
have	O
no	O
red	O
blood	O
cells	O
(	O
RBCs	O
)	O
visible	O
in	O
circulation	O
(	O
Ransom	O
et	O
al	O
.	O
1996	O
;	O
Weinstein	O
et	O
al	O
.	O
1996	O
)	O
.	O

The	O
mon	O
mutants	O
initiate	O
expression	O
of	O
gata1	O
in	O
hematopoietic	O
cells	O
around	O
the	O
five	O
-	O
somite	O
stage	O
,	O
similar	O
to	O
wild	O
-	O
type	O
embryos	O
(	O
data	O
not	O
shown	O
)	O
;	O
however	O
,	O
based	O
on	O
TUNEL	O
staining	O
,	O
the	O
differentiating	O
erythroid	O
cells	O
undergo	O
programmed	O
cell	O
death	O
from	O
the	O
12	O
-	O
somite	O
stage	O
to	O
22	O
h	O
postfertilization	O
(	O
hpf	O
)	O
(	O
Figure	O
1A	O
and	O
1B	O
,	O
arrows	O
)	O
.	O

At	O
12	O
somites	O
,	O
gata1	O
expression	O
is	O
only	O
slightly	O
reduced	O
.	O

By	O
18	O
-	O
22	O
hpf	O
,	O
hematopoietic	O
-	O
specific	O
markers	O
such	O
as	O
gata1	O
,	O
scl	O
,	O
gata2	O
,	O
and	O
ikaros	O
are	O
not	O
detected	O
in	O
the	O
embryonic	O
blood	O
island	O
(	O
Figure	O
1A	O
and	O
1B	O
;	O
unpublished	O
data	O
)	O
.	O

The	O
hematopoietic	O
cells	O
are	O
thus	O
correctly	O
specified	O
early	O
during	O
the	O
development	O
of	O
mon	O
mutant	O
embryos	O
,	O
but	O
these	O
precursors	O
undergo	O
cell	O
death	O
.	O

Based	O
on	O
expression	O
of	O
c	O
-	O
myb	O
and	O
rag1	O
(	O
Figure	O
1B	O
,	O
arrows	O
)	O
,	O
mon	O
mutants	O
have	O
normal	O
myeloid	O
and	O
lymphoid	O
development	O
,	O
respectively	O
.	O

In	O
addition	O
to	O
the	O
deficit	O
of	O
RBCs	O
in	O
mon	O
mutants	O
,	O
there	O
is	O
a	O
prominent	O
loss	O
of	O
fin	O
-	O
fold	O
and	O
tail	O
mesenchyme	O
(	O
Ransom	O
et	O
al	O
.	O
1996	O
)	O
.	O

TUNEL	O
staining	O
of	O
mon	O
mutants	O
demonstrates	O
extensive	O
apoptosis	O
of	O
mesenchymal	O
cells	O
in	O
the	O
trunk	O
and	O
tail	O
bud	O
regions	O
(	O
Figure	O
1A	O
and	O
1B	O
,	O
arrows	O
)	O
.	O

The	O
mon	O
gene	O
is	O
thus	O
required	O
for	O
normal	O
development	O
and	O
survival	O
of	O
both	O
committed	O
erythroid	O
progenitor	O
cells	O
and	O
posterior	O
mesenchymal	O
cells	O
.	O

We	O
next	O
examined	O
definitive	O
hematopoiesis	O
in	O
rare	O
surviving	O
homozygous	O
adult	O
zebrafish	O
mon	O
mutants	O
.	O

Mutations	O
in	O
mon	O
are	O
generally	O
lethal	O
by	O
10	O
to	O
14	O
d	O
of	O
development	O
(	O
Ransom	O
et	O
al	O
.	O
1996	O
)	O
,	O
although	O
rare	O
mon	O
homozygous	O
mutants	O
(	O
approximately	O
1	O
in	O
500	O
bloodless	O
embryos	O
)	O
of	O
all	O
tested	O
alleles	O
survive	O
to	O
adulthood	O
.	O

Adult	O
mon	O
mutants	O
show	O
cardiac	O
hypertrophy	O
,	O
presumably	O
due	O
to	O
the	O
severe	O
anemia	O
leading	O
to	O
a	O
high	O
output	O
state	O
(	O
Figure	O
2	O
)	O
.	O

In	O
wild	O
-	O
type	O
zebrafish	O
,	O
the	O
adult	O
site	O
of	O
hematopoiesis	O
is	O
the	O
kidney	O
(	O
Al	O
Adhami	O
and	O
Kunz	O
1977	O
)	O
,	O
which	O
contains	O
erythroid	O
,	O
lymphoid	O
,	O
and	O
myeloid	O
populations	O
at	O
various	O
stages	O
of	O
differentiation	O
(	O
Bennett	O
et	O
al	O
.	O
2001	O
)	O
.	O

In	O
mon	O
homozygous	O
mutants	O
,	O
there	O
is	O
a	O
severe	O
block	O
in	O
maturation	O
at	O
the	O
proerythroblast	O
stage	O
(	O
Figure	O
2	O
)	O
,	O
whereas	O
the	O
differentiation	O
of	O
myeloid	O
cells	O
is	O
normal	O
(	O
unpublished	O
data	O
)	O
.	O

This	O
demonstrates	O
that	O
the	O
mon	O
gene	O
product	O
acts	O
during	O
both	O
primitive	O
and	O
definitive	O
erythropoiesis	O
.	O

Positional	O
Cloning	O
Identifies	O
mon	O
as	O
the	O
Zebrafish	O
Ortholog	O
of	O
Mammalian	O
TIF1	O
gamma	O

We	O
identified	O
the	O
mon	O
gene	O
by	O
positional	O
cloning	O
using	O
a	O
panel	O
of	O
2	O
,	O
200	O
diploid	O
mutants	O
collected	O
from	O
T	O
u	O
bingen	O
background	O
(	O
TU	O
)	O
/	O
WIK	O
strain	O
hybrid	O
parents	O
carrying	O
the	O
montg234	O
allele	O
.	O

The	O
mon	O
mutant	O
gene	O
was	O
positioned	O
on	O
Chromosome	S-GO
8	O
between	O
microsatellite	O
markers	O
z987	O
and	O
z11001	O
(	O
Figure	O
3A	O
)	O
(	O
Knapik	O
et	O
al	O
.	O
1998	O
)	O
.	O

For	O
positional	O
cloning	O
purposes	O
,	O
over	O
12	O
,	O
000	O
polymorphic	O
markers	O
were	O
screened	O
using	O
amplified	O
fragment	O
length	O
polymorphism	O
(	O
AFLP	O
)	O
(	O
Ransom	O
and	O
Zon	O
1999	O
)	O
,	O
and	O
36	O
markers	O
within	O
the	O
interval	O
were	O
isolated	O
.	O

One	O
of	O
these	O
,	O
MA3	O
,	O
was	O
found	O
to	O
be	O
0	O
.	O
3	O
cM	O
from	O
the	O
gene	O
(	O
Figure	O
3A	O
)	O
and	O
was	O
utilized	O
as	O
the	O
starting	O
point	O
of	O
a	O
chromosomal	S-GO
walk	O
.	O

A	O
critical	O
P1	O
bacterial	O
artificial	O
chromosome	O
clone	O
(	O
PAC	O
)	O
,	O
107N19	O
,	O
was	O
obtained	O
that	O
spanned	O
the	O
genetic	O
interval	O
.	O

Two	O
simple	O
sequence	O
conformation	O
polymorphism	O
(	O
SSCP	O
)	O
markers	O
found	O
on	O
this	O
PAC	O
clone	O
flank	O
the	O
critical	O
genetic	O
interval	O
.	O

The	O
marker	O
80M12	O
-	O
T7	O
maps	O
two	O
recombinants	O
out	O
of	O
4	O
,	O
400	O
meioses	O
telomeric	O
of	O
the	O
mutation	O
,	O
and	O
the	O
marker	O
157J23	O
-	O
T7	O
maps	O
one	O
recombinant	O
centromic	O
of	O
the	O
mutation	O
(	O
Figure	O
3A	O
)	O
.	O

The	O
end	O
sequences	O
and	O
SSCP	O
markers	O
of	O
PAC	O
107N19	O
are	O
found	O
in	O
the	O
zebrafish	O
genomic	O
sequence	O
contig	O
ctg23107	O
(	O
http	O
:	O
/	O
/	O
www	O
.	O
ensembl	O
.	O
org	O
/	O
Danio	O
_	O
rerio	O
/	O
)	O
containing	O
a	O
predicted	O
zebrafish	O
TIF1	O
family	O
gene	O
.	O

This	O
PAC	O
was	O
hybridized	O
to	O
a	O
kidney	O
cDNA	O
library	O
,	O
resulting	O
in	O
the	O
isolation	O
of	O
four	O
clones	O
that	O
represented	O
the	O
same	O
gene	O
.	O

The	O
mon	O
gene	O
encodes	O
a	O
member	O
of	O
the	O
TIF1	O
family	O
of	O
transcriptional	O
cofactors	O
(	O
Figure	O
3B	O
and	O
3C	O
)	O
.	O

The	O
coding	O
sequence	O
of	O
mon	O
is	O
most	O
similar	O
to	O
human	O
TIF	O
gamma	O
(	O
Le	O
Douarin	O
et	O
al	O
.	O
1995	O
;	O
Friedman	O
et	O
al	O
.	O
1996	O
;	O
Venturini	O
et	O
al	O
.	O
1999	O
)	O
,	O
and	O
the	O
locations	O
of	O
exon	O
boundaries	O
are	O
conserved	O
between	O
the	O
zebrafish	O
and	O
human	O
genes	O
(	O
unpublished	O
data	O
)	O
.	O

The	O
mon	O
locus	O
on	O
zebrafish	O
Chromosome	O
8	O
is	O
also	O
predicted	O
to	O
be	O
syntenic	O
to	O
the	O
region	O
of	O
human	O
Chromosome	O
1p	O
that	O
contains	O
the	O
TIF1	O
gamma	O
gene	O
based	O
on	O
the	O
conserved	O
locations	O
of	O
12	O
other	O
orthologous	O
gene	O
pairs	O
,	O
including	O
NRAS	O
,	O
mapped	O
to	O
these	O
regions	O
in	O
human	O
and	O
zebrafish	O
(	O
Barbazuk	O
et	O
al	O
.	O
2000	O
)	O
.	O

Therefore	O
,	O
based	O
on	O
sequence	O
similarity	O
and	O
chromosomal	O
location	O
,	O
the	O
zebrafish	O
mon	O
gene	O
is	O
the	O
likely	O
ortholog	O
of	O
the	O
human	O
TIF1	O
gamma	O
gene	O
.	O

We	O
have	O
identified	O
ethyl	O
-	O
nitrosourea	O
(	O
ENU	O
)	O
-	O
induced	O
point	O
mutations	O
in	O
three	O
alleles	O
of	O
mon	O
(	O
Figure	O
3C	O
and	O
3D	O
)	O
,	O
each	O
of	O
which	O
generates	O
a	O
premature	O
stop	O
codon	O
.	O

The	O
montb222b	O
and	O
montg234	O
alleles	O
have	O
a	O
severe	O
phenotype	O
with	O
no	O
circulating	O
blood	O
cells	O
.	O

In	O
contrast	O
,	O
the	O
monm262	O
allele	O
has	O
10	O
-	O
100	O
circulating	O
blood	O
cells	O
by	O
48	O
hpf	O
,	O
in	O
comparison	O
to	O
the	O
approximately	O
3	O
,	O
000	O
RBCs	O
in	O
the	O
circulation	O
of	O
wild	O
-	O
type	O
or	O
heterozygous	O
embryos	O
at	O
the	O
same	O
time	O
point	O
.	O

The	O
monm262	O
allele	O
was	O
found	O
to	O
encode	O
a	O
premature	O
stop	O
codon	O
at	O
position	O
E40	O
,	O
which	O
would	O
encode	O
a	O
putative	O
protein	O
of	O
only	O
40	O
amino	O
acids	O
.	O

Although	O
this	O
mutation	O
would	O
be	O
expected	O
to	O
lead	O
to	O
a	O
complete	O
loss	O
of	O
mon	O
gene	O
product	O
,	O
another	O
methionine	O
is	O
found	O
downstream	O
at	O
amino	O
acid	O
position	O
104	O
.	O

In	O
vitro	O
translation	O
experiments	O
in	O
reticulocyte	O
lysates	O
demonstrate	O
reinitiation	O
of	O
translation	O
from	O
this	O
methionine	O
(	O
unpublished	O
data	O
)	O
.	O

Therefore	O
,	O
the	O
hypomorphic	O
larval	O
phenotype	O
of	O
the	O
monm262	O
allele	O
is	O
likely	O
due	O
to	O
partial	O
loss	O
of	O
mon	O
function	O
or	O
expression	O
.	O

The	O
presence	O
of	O
mutations	O
in	O
each	O
of	O
the	O
mon	O
alleles	O
indicates	O
that	O
defective	O
Tif1	O
gamma	O
function	O
is	O
the	O
cause	O
of	O
the	O
mon	O
phenotype	O
.	O

In	O
order	O
to	O
determine	O
whether	O
tif1	O
gamma	O
is	O
expressed	O
in	O
hematopoietic	O
mesoderm	O
,	O
we	O
next	O
examined	O
zebrafish	O
embryos	O
by	O
whole	O
-	O
mount	O
in	O
situ	O
hybridization	O
(	O
Figure	O
4A	O
)	O
.	O

tif1	O
gamma	O
mRNA	O
is	O
expressed	O
maternally	O
and	O
is	O
found	O
throughout	O
the	O
embryo	O
during	O
blastula	O
stages	O
.	O

During	O
gastrulation	O
and	O
epiboly	O
stages	O
,	O
zygotic	O
expression	O
of	O
mon	O
is	O
highest	O
in	O
the	O
mesendoderm	O
of	O
the	O
germ	O
ring	O
.	O

At	O
tail	O
bud	O
and	O
early	O
somite	O
stages	O
a	O
high	O
level	O
of	O
tif1	O
gamma	O
expression	O
delineates	O
a	O
horseshoe	O
-	O
shaped	O
population	O
of	O
ventral	O
/	O
lateral	O
mesoderm	O
that	O
will	O
give	O
rise	O
to	O
blood	O
and	O
also	O
expresses	O
stem	O
cell	O
leukemiahematopoietic	O
transcription	O
factor	O
(	O
scl	O
)	O
(	O
Liao	O
et	O
al	O
.	O
1997	O
)	O
.	O

This	O
group	O
of	O
cells	O
continues	O
to	O
express	O
tif1	O
gamma	O
and	O
scl	O
while	O
it	O
converges	O
and	O
forms	O
the	O
embryonic	O
blood	O
island	O
(	O
Detrich	O
et	O
al	O
.	O
1995	O
)	O
.	O

The	O
tif1	O
gamma	O
gene	O
is	O
also	O
highly	O
expressed	O
in	O
the	O
central	O
nervous	O
system	O
as	O
well	O
as	O
the	O
mesenchyme	O
of	O
the	O
trunk	O
and	O
tail	O
.	O

Homozygous	O
montg234	O
mutants	O
have	O
a	O
greatly	O
reduced	O
amount	O
of	O
tif1	O
gamma	O
mRNA	O
in	O
all	O
tissues	O
consistent	O
with	O
nonsense	O
-	O
mediated	O
message	O
decay	O
.	O

Thus	O
,	O
zebrafish	O
tif1	O
gamma	O
is	O
specifically	O
expressed	O
in	O
ventral	O
mesoderm	O
and	O
putative	O
hemangioblasts	O
prior	O
to	O
and	O
during	O
the	O
embryonic	O
stages	O
when	O
hematopoietic	O
progenitors	O
are	O
undergoing	O
apoptosis	O
in	O
mon	O
mutants	O
.	O

We	O
also	O
compared	O
the	O
expression	O
of	O
zebrafish	O
mon	O
to	O
mouse	O
Tif1	O
gamma	O
(	O
Figure	O
4A	O
and	O
4B	O
)	O
.	O

Mouse	O
Tif1	O
gamma	O
is	O
highly	O
expressed	O
in	O
erythroid	O
blood	O
islands	O
of	O
the	O
yolk	O
sac	O
,	O
and	O
it	O
is	O
subsequently	O
expressed	O
in	O
the	O
fetal	O
liver	O
at	O
a	O
high	O
level	O
,	O
and	O
in	O
other	O
tissues	O
,	O
including	O
the	O
central	O
nervous	O
system	O
.	O

Taken	O
together	O
these	O
results	O
strongly	O
suggest	O
that	O
zebrafish	O
mon	O
and	O
mouse	O
Tif1	O
gamma	O
are	O
orthologs	O
that	O
function	O
during	O
hematopoiesis	O
.	O

Given	O
that	O
mammalian	O
TIF1	O
gamma	O
has	O
been	O
shown	O
to	O
form	O
hetero	O
-	O
oligomers	O
with	O
Tif1	O
alpha	O
(	O
Peng	O
et	O
al	O
.	O
2002	O
)	O
,	O
we	O
searched	O
for	O
additional	O
TIF1	O
family	O
members	O
in	O
zebrafish	O
to	O
compare	O
with	O
tif1	O
gamma	O
.	O

Using	O
zebrafish	O
expressed	O
sequence	O
tag	O
(	O
EST	O
)	O
sequences	O
,	O
we	O
designed	O
primers	O
to	O
RT	O
-	O
PCR	O
amplify	O
a	O
TIF1	O
-	O
related	O
cDNA	O
from	O
embryonic	O
10	O
-	O
hpf	O
and	O
24	O
-	O
hpf	O
RNA	O
.	O

This	O
cDNA	O
encodes	O
a	O
predicted	O
zebrafish	O
ortholog	O
of	O
human	O
TIF1	O
alpha	O
based	O
on	O
predicted	O
amino	O
acid	O
sequences	O
(	O
see	O
Figure	O
3B	O
)	O
.	O

In	O
addition	O
,	O
zebrafish	O
tif1	O
alpha	O
ESTs	O
map	O
to	O
LG4	O
in	O
a	O
region	O
predicted	O
to	O
be	O
syntenic	O
to	O
the	O
region	O
of	O
human	O
Chromosome	O
7	O
that	O
contains	O
the	O
TIF1	O
alpha	O
gene	O
based	O
on	O
the	O
conserved	O
locations	O
of	O
eight	O
other	O
orthologous	O
gene	O
pairs	O
,	O
including	O
SEMA3A	O
,	O
mapped	O
to	O
these	O
regions	O
in	O
human	O
and	O
zebrafish	O
(	O
Barbazuk	O
et	O
al	O
.	O
2000	O
)	O
.	O

We	O
next	O
compared	O
the	O
embryonic	O
expression	O
pattern	O
of	O
tif1	O
alpha	O
mRNA	O
to	O
tif1	O
gamma	O
by	O
in	O
situ	O
hybridization	O
.	O

Like	O
mammalian	O
TIF1	O
alpha	O
(	O
Le	O
Douarin	O
et	O
al	O
.	O
1995	O
;	O
Niederreither	O
et	O
al	O
.	O
1999	O
)	O
,	O
the	O
predicted	O
zebrafish	O
tif1	O
gamma	O
gene	O
is	O
broadly	O
expressed	O
(	O
see	O
Figure	O
4A	O
)	O
.	O

At	O
five	O
somites	O
,	O
zebrafish	O
tif1	O
alpha	O
does	O
not	O
display	O
the	O
relatively	O
high	O
expression	O
in	O
the	O
horseshoe	O
-	O
shaped	O
region	O
of	O
hematopoietic	O
mesoderm	O
seen	O
with	O
tif1	O
gamma	O
.	O

At	O
later	O
stages	O
,	O
tif1	O
alpha	O
is	O
evenly	O
expressed	O
throughout	O
most	O
of	O
the	O
embryo	O
,	O
including	O
the	O
developing	O
blood	O
islands	O
.	O

Therefore	O
,	O
tif1	O
alpha	O
is	O
coexpressed	O
in	O
the	O
same	O
cells	O
with	O
tif1	O
gamma	O
and	O
may	O
therefore	O
be	O
available	O
to	O
form	O
hetero	O
-	O
oligomers	O
in	O
vivo	O
.	O

Forced	O
Expression	O
of	O
tif1	O
gamma	O
Rescues	O
Hematopoiesis	O
in	O
mon	O
Mutants	O

To	O
further	O
confirm	O
that	O
a	O
mutation	O
in	O
the	O
zebrafish	O
tif1	O
gamma	O
gene	O
is	O
responsible	O
for	O
the	O
mon	O
mutant	O
phenotype	O
we	O
performed	O
embryo	O
rescue	O
experiments	O
(	O
Figure	O
5A	O
;	O
Table	O
1	O
)	O
.	O

Microinjection	O
of	O
synthetic	O
wild	O
-	O
type	O
mon	O
mRNA	O
at	O
the	O
one	O
-	O
cell	O
stage	O
rescues	O
the	O
formation	O
of	O
embryonic	O
erythrocytes	O
in	O
genotyped	O
mutant	O
embryos	O
without	O
causing	O
obvious	O
defects	O
in	O
embryonic	O
patterning	O
or	O
organogenesis	O
.	O

At	O
4	O
d	O
of	O
development	O
,	O
70	O
%	O
(	O
n	O
=	O
10	O
)	O
of	O
montg234	O
mutants	O
show	O
significant	O
(	O
greater	O
than	O
200	O
cells	O
in	O
comparison	O
to	O
a	O
wild	O
-	O
type	O
estimate	O
of	O
3	O
,	O
000	O
cells	O
)	O
rescue	O
of	O
circulating	O
hemoglobinized	O
RBCs	O
in	O
comparison	O
to	O
control	O
sibling	O
mutants	O
(	O
n	O
=	O
75	O
)	O
.	O

Based	O
on	O
the	O
correction	O
of	O
the	O
jagged	O
fin	O
-	O
fold	O
phenotype	O
(	O
Ransom	O
et	O
al	O
.	O
1996	O
)	O
,	O
the	O
mesenchymal	O
cells	O
are	O
rescued	O
to	O
a	O
similar	O
extent	O
as	O
the	O
anemia	O
(	O
unpublished	O
data	O
)	O
.	O

Overexpression	O
of	O
mon	O
did	O
not	O
result	O
in	O
expanded	O
blood	O
cell	O
numbers	O
in	O
wild	O
-	O
type	O
embryos	O
and	O
was	O
not	O
toxic	O
at	O
doses	O
that	O
rescue	O
the	O
phenotype	O
of	O
mon	O
mutants	O
(	O
unpublished	O
data	O
)	O
.	O

Since	O
there	O
were	O
no	O
expanded	O
or	O
ectopic	O
blood	O
populations	O
in	O
the	O
embryos	O
,	O
these	O
rescue	O
experiments	O
suggest	O
that	O
mon	O
functions	O
as	O
a	O
permissive	O
factor	O
required	O
for	O
hematopoiesis	O
.	O

Marrow	O
Transplantation	O
Rescues	O
Erythropoiesis	O
in	O
mon	O
Mutants	O

The	O
high	O
levels	O
of	O
tif1	O
gamma	O
expression	O
in	O
erythroid	O
cells	O
suggest	O
that	O
it	O
functions	O
as	O
a	O
cell	O
-	O
autonomous	O
regulator	O
of	O
gene	O
expression	O
in	O
hematopoietic	O
cells	O
.	O

In	O
order	O
to	O
test	O
this	O
hypothesis	O
,	O
we	O
transplanted	O
wild	O
-	O
type	O
adult	O
zebrafish	O
kidney	O
marrow	O
cells	O
carrying	O
a	O
gata1	O
:	O
green	O
fluorescent	O
protein	O
(	O
GFP	O
)	O
transgene	O
into	O
48	O
-	O
hpf	O
mon	O
mutant	O
embryos	O
(	O
Figure	O
5B	O
;	O
Table	O
2	O
)	O
.	O

The	O
gata1	O
:	O
GFP	O
transgene	O
makes	O
use	O
of	O
the	O
gata1	O
promoter	O
to	O
drive	O
GFP	O
expression	O
and	O
can	O
thus	O
be	O
used	O
to	O
mark	O
donor	O
-	O
derived	O
erythroid	O
cells	O
(	O
Long	O
et	O
al	O
.	O
1997	O
)	O
.	O

Untransplanted	O
mutant	O
embryos	O
have	O
no	O
embryonic	O
blood	O
cells	O
in	O
circulation	O
.	O

Following	O
transplantation	O
,	O
mutant	O
host	O
embryos	O
were	O
observed	O
daily	O
for	O
2	O
wk	O
.	O

Of	O
191	O
mutant	O
embryos	O
injected	O
,	O
129	O
(	O
68	O
%	O
)	O
showed	O
GFP	O
+	O
cells	O
in	O
circulation	O
2	O
d	O
later	O
.	O

Many	O
recipients	O
showed	O
robust	O
increases	O
in	O
donor	O
-	O
derived	O
cells	O
over	O
the	O
observation	O
period	O
.	O

Of	O
81	O
recipients	O
initially	O
scored	O
as	O
having	O
less	O
than	O
ten	O
GFP	O
+	O
cells	O
at	O
day	O
2	O
posttransplant	O
,	O
13	O
(	O
16	O
%	O
)	O
of	O
these	O
demonstrated	O
a	O
marked	O
increase	O
in	O
erythroid	O
cells	O
with	O
100	O
-	O
1	O
,	O
000	O
GFP	O
+	O
cells	O
in	O
circulation	O
6	O
d	O
later	O
.	O

By	O
day	O
10	O
,	O
these	O
transplanted	O
embryos	O
showed	O
approximately	O
3	O
,	O
000	O
cells	O
in	O
circulation	O
,	O
similar	O
to	O
the	O
number	O
of	O
blood	O
cells	O
in	O
normal	O
embryos	O
.	O

Despite	O
robust	O
reconstitution	O
of	O
blood	O
cells	O
,	O
mutant	O
recipients	O
did	O
not	O
inflate	O
their	O
swim	O
bladders	O
and	O
thus	O
failed	O
to	O
survive	O
longer	O
than	O
nontransplanted	O
sibling	O
controls	O
,	O
all	O
dying	O
by	O
3	O
wk	O
of	O
age	O
.	O

In	O
contrast	O
,	O
13	O
/	O
35	O
(	O
37	O
%	O
)	O
heterozygous	O
montg234	O
transplants	O
survived	O
to	O
early	O
adulthood	O
.	O

Similar	O
transplants	O
of	O
wild	O
-	O
type	O
cells	O
can	O
fully	O
rescue	O
vlad	O
tepes	O
(	O
gata1	O
)	O
mutants	O
(	O
Traver	O
et	O
al	O
.	O
2003	O
)	O
.	O

Therefore	O
,	O
the	O
results	O
of	O
cell	O
transplantations	O
suggests	O
that	O
tif1	O
gamma	O
plays	O
a	O
cell	O
-	O
autonomous	O
role	O
in	O
erythroid	O
cells	O
,	O
and	O
its	O
role	O
in	O
nonhematopoietic	O
tissues	O
,	O
such	O
as	O
trunk	O
mesenchyme	O
or	O
the	O
nervous	O
system	O
,	O
is	O
also	O
required	O
for	O
embryo	O
survival	O
.	O

Tif1	O
gamma	O
in	O
Punctate	O
Nuclear	S-GO
Foci	O
Is	O
Developmentally	O
Regulated	O

In	O
order	O
to	O
examine	O
the	O
subcellular	O
distribution	O
of	O
Tif1	O
gamma	O
protein	O
,	O
we	O
generated	O
an	O
affinity	O
-	O
purified	O
rabbit	O
polyclonal	O
antiserum	O
directed	O
against	O
the	O
C	O
-	O
terminal	O
15	O
amino	O
acids	O
conserved	O
in	O
human	O
TIF1	O
gamma	O
and	O
mouse	O
Tif1	O
gamma	O
.	O

Immunofluorescence	O
of	O
mouse	O
embryo	O
fibroblast	O
nuclei	S-GO
with	O
the	O
anti	O
-	O
Tif1	O
gamma	O
antiserum	O
demonstrates	O
that	O
Tif1	O
gamma	O
is	O
localized	O
in	O
small	O
nuclear	S-GO
foci	O
(	O
Figure	O
6A	O
)	O
.	O

The	O
localization	O
of	O
Tif1	O
gamma	O
protein	O
appears	O
different	O
from	O
the	O
more	O
diffuse	O
nuclear	S-GO
patterns	O
typically	O
seen	O
in	O
studies	O
of	O
Tif1	O
alpha	O
(	O
Remboutsika	O
et	O
al	O
.	O
2002	O
)	O
or	O
TIF1	O
beta	O
(	O
Cammas	O
et	O
al	O
.	O
2002	O
)	O
.	O

A	O
recent	O
report	O
demonstrates	O
that	O
TIF1	O
beta	O
associates	O
with	O
heterochromatin	S-GO
-	O
containing	O
foci	O
after	O
retinoic	O
acid	O
treatment	O
or	O
serum	O
starvation	O
(	O
Cammas	O
et	O
al	O
.	O
2002	O
)	O
.	O

Thus	O
,	O
localization	O
or	O
expression	O
of	O
the	O
TIF1	O
proteins	O
may	O
be	O
regulated	O
during	O
distinct	O
developmental	O
processes	O
or	O
by	O
environmental	O
cues	O
.	O

The	O
nuclear	S-GO
foci	O
that	O
contain	O
Tif1	O
gamma	O
do	O
not	O
colocalize	O
with	O
two	O
markers	O
of	O
heterochromatin	S-GO
,	O
HP1	O
alpha	O
protein	O
and	O
DAPI	O
staining	O
of	O
DNA	O
(	O
Figure	O
6A	O
)	O
.	O

Furthermore	O
,	O
Tif1	O
gamma	O
does	O
not	O
colocalize	O
with	O
promyelocytic	B-GO
leukemia	I-GO
gene	I-GO
product	I-GO
(	I-GO
PML	I-GO
)	I-GO
nuclear	I-GO
bodies	E-GO
,	O
DNA	O
repair	O
complexes	S-GO
that	O
contain	O
Mre11	O
,	O
or	O
transcriptional	B-GO
complexes	E-GO
containing	O
TFII	O
-	O
B	O
(	O
unpublished	O
data	O
)	O
.	O

We	O
next	O
examined	O
the	O
expression	O
of	O
Tif1	O
gamma	O
protein	O
during	O
the	O
differentiation	O
of	O
G1E	O
cells	O
,	O
a	O
murine	O
erythroleukemia	O
cell	O
line	O
that	O
can	O
terminally	O
differentiate	O
into	O
erythrocytes	O
when	O
a	O
Gata1	O
:	O
estrogen	O
receptor	O
fusion	O
protein	O
is	O
stabilized	O
in	O
response	O
to	O
estrogen	O
exposure	O
(	O
Weiss	O
et	O
al	O
.	O
1997	O
)	O
.	O

Western	O
blot	O
analysis	O
demonstrated	O
that	O
Tif1	O
gamma	O
protein	O
expression	O
decreases	O
with	O
terminal	O
erythroid	O
differentiation	O
(	O
Figure	O
6B	O
)	O
.	O

Consistent	O
with	O
this	O
finding	O
,	O
after	O
24	O
hpf	O
,	O
zebrafish	O
mon	O
mRNA	O
expression	O
falls	O
during	O
the	O
terminal	O
maturation	O
of	O
the	O
primitive	O
erythroid	O
cells	O
(	O
unpublished	O
data	O
)	O
.	O

In	O
two	O
different	O
murine	O
erythroleukemia	O
cell	O
lines	O
(	O
MEL	O
and	O
G1E	O
)	O
,	O
Tif1	O
gamma	O
is	O
also	O
expressed	O
in	O
nuclear	S-GO
foci	O
,	O
and	O
even	O
though	O
the	O
overall	O
Tif1	O
gamma	O
protein	O
level	O
is	O
reduced	O
,	O
this	O
nuclear	S-GO
foci	O
localization	O
does	O
not	O
change	O
with	O
differentiation	O
(	O
unpublished	O
data	O
)	O
.	O

This	O
provides	O
further	O
support	O
for	O
the	O
hypothesis	O
that	O
Tif1	O
gamma	O
acts	O
within	O
novel	O
nuclear	S-GO
foci	O
,	O
during	O
erythroid	O
differentiation	O
.	O

Discussion	O

The	O
zebrafish	O
is	O
an	O
excellent	O
model	O
system	O
to	O
elucidate	O
the	O
molecular	O
machinery	O
controlling	O
gene	O
expression	O
during	O
hematopoiesis	O
(	O
Thisse	O
and	O
Zon	O
2002	O
;	O
Galloway	O
and	O
Zon	O
2003	O
)	O
.	O

As	O
part	O
of	O
a	O
large	O
-	O
scale	O
forward	O
genetic	O
screen	O
,	O
we	O
originally	O
identified	O
a	O
complementation	O
group	O
of	O
independent	O
mutant	O
alleles	O
in	O
the	O
zebrafish	O
gene	O
that	O
we	O
named	O
moonshine	O
(	O
Ransom	O
et	O
al	O
.	O
1996	O
)	O
.	O

Positional	O
cloning	O
was	O
used	O
to	O
identify	O
the	O
mon	O
gene	O
,	O
establishing	O
a	O
critical	O
role	O
for	O
a	O
transcriptional	O
intermediary	O
factor	O
,	O
Tif1	O
gamma	O
,	O
during	O
hematopoietic	O
development	O
.	O

The	O
mon	O
Gene	O
Encodes	O
the	O
Zebrafish	O
Ortholog	O
of	O
Mammalian	O
TIF1	O
gamma	O

Our	O
results	O
strongly	O
support	O
the	O
conclusion	O
that	O
we	O
have	O
positionally	O
cloned	O
the	O
zebrafish	O
mon	O
gene	O
correctly	O
,	O
and	O
it	O
is	O
the	O
ortholog	O
of	O
mammalian	O
Tif1	O
gamma	O
.	O

Tif1	O
gamma	O
is	O
present	O
in	O
the	O
critical	O
genetic	O
interval	O
encompassing	O
a	O
single	O
approximately	O
50	O
-	O
kb	O
PAC	O
clone	O
defined	O
by	O
linkage	O
analysis	O
(	O
see	O
Figure	O
3	O
)	O
.	O

Sequence	O
analysis	O
indicates	O
that	O
zebrafish	O
tif1	O
gamma	O
is	O
most	O
similar	O
in	O
predicted	O
amino	O
acid	O
sequence	O
and	O
intron	O
/	O
exon	O
structure	O
compared	O
to	O
the	O
predicted	O
orthologous	O
human	O
and	O
mouse	O
genes	O
.	O

Zebrafish	O
tif1	O
gamma	O
is	O
located	O
in	O
a	O
region	O
of	O
zebrafish	O
Chromosome	O
8	O
syntenic	O
to	O
the	O
region	O
of	O
human	O
Chromosome	O
1	O
containing	O
TIF1	O
gamma	O
.	O

We	O
identified	O
point	O
mutations	O
in	O
tif1	O
gamma	O
from	O
three	O
different	O
alleles	O
of	O
mon	O
that	O
each	O
result	O
in	O
premature	O
stop	O
codons	O
and	O
mRNA	O
decay	O
.	O

In	O
addition	O
,	O
tif1	O
gamma	O
/	O
Tif1	O
gamma	O
is	O
highly	O
expressed	O
in	O
hematopoietic	O
cells	O
throughout	O
embryogenesis	O
in	O
both	O
zebrafish	O
and	O
mouse	O
(	O
see	O
Figure	O
4	O
)	O
.	O

And	O
as	O
predicted	O
,	O
forced	O
expression	O
of	O
wild	O
-	O
type	O
tif1	O
gamma	O
mRNA	O
efficiently	O
rescues	O
hematopoiesis	O
in	O
mon	O
mutants	O
and	O
does	O
not	O
perturb	O
hematopoiesis	O
in	O
wild	O
-	O
type	O
embryos	O
(	O
see	O
Figure	O
5	O
)	O
.	O

We	O
have	O
also	O
cloned	O
the	O
predicted	O
zebrafish	O
ortholog	O
of	O
tif1	O
alpha	O
,	O
which	O
is	O
more	O
uniformly	O
expressed	O
in	O
zebrafish	O
embryos	O
like	O
mammalian	O
TIF1	O
alpha	O
(	O
Le	O
Douarin	O
et	O
al	O
.	O
1995	O
;	O
Niederreither	O
et	O
al	O
.	O
1999	O
)	O
(	O
see	O
Figures	O
3A	O
and	O
4A	O
)	O
and	O
may	O
therefore	O
be	O
available	O
to	O
form	O
hetero	O
-	O
oligomers	O
with	O
Tif1	O
gamma	O
protein	O
in	O
developing	O
hematopoietic	O
cells	O
.	O

Comparing	O
available	O
zebrafish	O
and	O
mammalian	O
TIF1	O
-	O
predicted	O
amino	O
acid	O
sequences	O
,	O
it	O
appears	O
that	O
the	O
Tif1	O
gamma	O
orthologs	O
are	O
the	O
most	O
highly	O
conserved	O
family	O
members	O
while	O
the	O
Tif1	O
alpha	O
sequences	O
are	O
relatively	O
more	O
divergent	O
.	O

We	O
have	O
not	O
found	O
a	O
Tif1	O
beta	O
ortholog	O
,	O
thus	O
far	O
,	O
in	O
the	O
zebrafish	O
or	O
fugu	O
genome	O
or	O
EST	O
sequences	O
.	O

It	O
is	O
possible	O
that	O
Tif1	O
beta	O
,	O
like	O
the	O
KRAB	O
domain	O
transcription	O
factors	O
it	O
binds	O
to	O
,	O
may	O
be	O
present	O
only	O
in	O
tetrapods	O
(	O
Urrutia	O
2003	O
)	O
.	O

However	O
,	O
more	O
complete	O
genome	O
sequences	O
will	O
be	O
needed	O
to	O
confirm	O
this	O
hypothesis	O
.	O

Based	O
on	O
our	O
analysis	O
of	O
zebrafish	O
mon	O
mutants	O
,	O
it	O
is	O
reasonable	O
to	O
predict	O
that	O
Tif1	O
gamma	O
,	O
the	O
most	O
evolutionarily	O
conserved	O
TIF1	O
family	O
member	O
,	O
plays	O
a	O
similarly	O
essential	O
role	O
in	O
human	O
and	O
mouse	O
hematopoiesis	O
.	O

Mutations	O
in	O
tif1	O
gamma	O
Cause	O
Apoptosis	O
of	O
Erythroid	O
Progenitors	O

Our	O
examination	O
of	O
hematopoietic	O
gene	O
expression	O
,	O
apoptosis	O
,	O
and	O
marrow	O
histology	O
in	O
mon	O
mutants	O
demonstrates	O
that	O
early	O
erythroid	O
progenitors	O
are	O
formed	O
in	O
homozygous	O
mutants	O
,	O
but	O
they	O
fail	O
to	O
properly	O
differentiate	O
and	O
instead	O
undergo	O
programmed	O
cell	O
death	O
(	O
see	O
Figure	O
1	O
)	O
.	O

The	O
expression	O
of	O
gata1	O
appears	O
to	O
initiate	O
normally	O
in	O
the	O
committed	O
erythroid	O
cells	O
of	O
mon	O
mutants	O
.	O

However	O
,	O
the	O
cells	O
are	O
abnormal	O
prior	O
to	O
the	O
complete	O
loss	O
of	O
gata1	O
expression	O
.	O

TUNEL	O
-	O
positive	O
apoptotic	O
cells	O
are	O
abundant	O
by	O
the	O
12	O
-	O
somite	O
stage	O
of	O
development	O
,	O
and	O
by	O
22	O
hpf	O
all	O
hematopoietic	O
gene	O
expression	O
is	O
extinguished	O
.	O

The	O
expression	O
of	O
marker	O
genes	O
,	O
including	O
scl	O
and	O
gata2	O
,	O
characteristic	O
of	O
hematopoietic	O
stem	O
cells	O
and	O
primitive	O
hematopoietic	O
progenitors	O
,	O
are	O
also	O
not	O
detected	O
in	O
the	O
embryonic	O
blood	O
islands	O
of	O
mutants	O
at	O
22	O
hpf	O
.	O

This	O
indicates	O
that	O
the	O
mutant	O
hematopoietic	O
cells	O
are	O
not	O
blocked	O
prior	O
to	O
commitment	O
to	O
the	O
erythroid	O
lineage	O
,	O
but	O
instead	O
develop	O
as	O
abnormal	O
erythroid	O
cells	O
and	O
undergo	O
apoptosis	O
,	O
similar	O
to	O
gata1	O
-	O
deficient	O
erythroid	O
cells	O
(	O
Fujiwara	O
et	O
al	O
.	O
1996	O
;	O
Lyons	O
et	O
al	O
.	O
2002	O
)	O
.	O

Defective	O
erythropoiesis	O
and	O
severe	O
anemia	O
were	O
also	O
observed	O
in	O
rare	O
surviving	O
homozygous	O
mutant	O
mon	O
adults	O
,	O
demonstrating	O
that	O
tif1	O
gamma	O
is	O
also	O
required	O
in	O
definitive	O
hematopoiesis	O
(	O
see	O
Figure	O
2	O
)	O
.	O

The	O
zygotic	O
phenotypes	O
of	O
mon	O
mutants	O
may	O
not	O
reveal	O
the	O
function	O
of	O
maternally	O
inherited	O
Tif1	O
gamma	O
.	O

Maternally	O
expressed	O
zebrafish	O
Tif1	O
gamma	O
may	O
play	O
roles	O
in	O
hematopoiesis	O
or	O
other	O
aspects	O
of	O
organogenesis	O
that	O
are	O
not	O
detectable	O
due	O
to	O
the	O
presence	O
of	O
wild	O
-	O
type	O
mRNA	O
in	O
eggs	O
laid	O
by	O
heterozygous	O
mothers	O
.	O

Analysis	O
of	O
the	O
offspring	O
of	O
homozygous	O
mon	O
mutant	O
female	O
zebrafish	O
will	O
aid	O
in	O
defining	O
the	O
function	O
of	O
this	O
maternal	O
mRNA	O
.	O

The	O
present	O
analysis	O
of	O
zygotic	O
mon	O
mutants	O
provides	O
data	O
that	O
are	O
consistent	O
with	O
the	O
conclusion	O
that	O
tif1	O
gamma	O
is	O
essential	O
for	O
erythropoiesis	O
but	O
do	O
not	O
rule	O
out	O
essential	O
functions	O
in	O
other	O
hematopoietic	O
lineages	O
.	O

The	O
hematopoietic	O
phenotype	O
of	O
mon	O
mutants	O
resembles	O
the	O
loss	O
of	O
erythroid	O
cells	O
seen	O
in	O
both	O
mouse	O
Gata1	O
knockout	O
embryos	O
and	O
zebrafish	O
vlad	O
tepes	O
(	O
gata1	O
)	O
mutant	O
embryos	O
(	O
Fujiwara	O
et	O
al	O
.	O
1996	O
;	O
Lyons	O
et	O
al	O
.	O
2002	O
)	O
.	O

In	O
an	O
effort	O
to	O
determine	O
if	O
there	O
is	O
a	O
genetic	O
relationship	O
between	O
mon	O
and	O
gata1	O
,	O
we	O
tested	O
their	O
ability	O
to	O
rescue	O
erythropoiesis	O
.	O

Both	O
injection	O
of	O
gata1	O
mRNA	O
into	O
mon	O
homozygous	O
mutant	O
embryos	O
and	O
injection	O
of	O
tif1	O
gamma	O
mRNA	O
into	O
gata1	O
knock	O
-	O
down	O
embryos	O
failed	O
to	O
rescue	O
hematopoiesis	O
(	O
unpublished	O
data	O
)	O
.	O

We	O
also	O
tested	O
for	O
a	O
direct	O
interaction	O
between	O
Tif1	O
gamma	O
and	O
Gata1	O
proteins	O
by	O
coimmunoprecipitation	O
and	O
yeast	O
two	O
-	O
hybrid	O
assays	O
and	O
found	O
no	O
association	O
(	O
unpublished	O
data	O
)	O
.	O

Although	O
the	O
mutations	O
in	O
each	O
of	O
these	O
genes	O
arrest	O
cells	O
at	O
a	O
similar	O
stage	O
of	O
development	O
,	O
our	O
results	O
suggest	O
that	O
gata1	O
and	O
tif1	O
gamma	O
act	O
independently	O
.	O

This	O
does	O
not	O
rule	O
out	O
the	O
possibility	O
that	O
parallel	O
genetic	O
pathways	O
involving	O
gata1	O
and	O
tif1	O
gamma	O
,	O
operating	O
together	O
,	O
regulate	O
gene	O
transcription	O
within	O
blood	O
cells	O
.	O

The	O
Role	O
of	O
Tif1	O
gamma	O
in	O
Primitive	O
and	O
Definitive	O
Erythropoiesis	O

Taken	O
together	O
,	O
our	O
data	O
suggest	O
that	O
tif1	O
gamma	O
is	O
required	O
as	O
a	O
permissive	O
cofactor	O
for	O
the	O
erythroid	O
lineage	O
-	O
specific	O
control	O
of	O
hematopoietic	O
gene	O
expression	O
.	O

We	O
reasonably	O
predict	O
that	O
Tif1	O
gamma	O
protein	O
functions	O
as	O
a	O
transcriptional	O
intermediary	O
factor	O
in	O
hematopoietic	O
progenitor	O
cells	O
given	O
that	O
both	O
TIF1	O
alpha	O
(	O
Zhong	O
et	O
al	O
.	O
1999	O
)	O
and	O
TIF1	O
beta	O
(	O
Friedman	O
et	O
al	O
.	O
1996	O
;	O
Abrink	O
et	O
al	O
.	O
2001	O
)	O
have	O
been	O
shown	O
to	O
act	O
as	O
intermediary	O
factors	O
that	O
positively	O
or	O
negatively	O
regulate	O
gene	O
transcription	O
.	O

These	O
studies	O
indicate	O
that	O
TIF1	O
alpha	O
and	O
TIF1	O
beta	O
act	O
as	O
scaffolds	O
that	O
link	O
different	O
classes	O
of	O
DNA	O
-	O
binding	O
proteins	O
and	O
chromatin	S-GO
-	O
associated	O
proteins	O
into	O
larger	O
regulatory	O
complexes	S-GO
.	O

Tif1	O
gamma	O
is	O
detected	O
within	O
nuclear	S-GO
foci	O
(	O
see	O
Figure	O
6	O
)	O
,	O
which	O
,	O
based	O
on	O
our	O
analysis	O
,	O
do	O
not	O
appear	O
to	O
correspond	O
to	O
several	O
types	O
of	O
previously	O
described	O
nuclear	B-GO
bodies	E-GO
,	O
including	O
PML	B-GO
bodies	E-GO
.	O

Localization	O
of	O
Tif1	O
gamma	O
to	O
these	O
nuclear	B-GO
bodies	E-GO
may	O
be	O
regulated	O
by	O
posttranslational	O
modification	O
such	O
as	O
SUMO	O
modification	O
that	O
is	O
required	O
for	O
PML	O
to	O
form	O
PML	B-GO
nuclear	I-GO
domains	E-GO
(	O
Zhong	O
et	O
al	O
.	O
2000a	O
,	O
2000b	O
;	O
Best	O
et	O
al	O
.	O
2002	O
)	O
.	O

These	O
foci	O
may	O
serve	O
as	O
assembly	O
points	O
where	O
Tif1	O
gamma	O
forms	O
multisubunit	O
complexes	S-GO
with	O
DNA	O
-	O
binding	O
transcription	O
factors	O
and	O
their	O
other	O
essential	O
coactivators	O
or	O
corepressors	O
,	O
during	O
the	O
early	O
stages	O
of	O
erythroid	O
differentiation	O
.	O

It	O
will	O
be	O
important	O
to	O
determine	O
the	O
identity	O
of	O
Tif1	O
gamma	O
-	O
interacting	O
proteins	O
in	O
nuclear	S-GO
foci	O
and	O
establish	O
how	O
they	O
function	O
with	O
Tif1	O
gamma	O
to	O
regulate	O
blood	O
cell	O
development	O
.	O

Materials	O
and	O
Methods	O

Zebrafish	O
and	O
mouse	O
strains	O
and	O
studies	O

Zebrafish	O
were	O
maintained	O
and	O
staged	O
as	O
described	O
(	O
Westerfield	O
1998	O
)	O
.	O

The	O
alleles	O
montb222b	O
and	O
montg234	O
were	O
generated	O
in	O
a	O
large	O
-	O
scale	O
screen	O
for	O
ENU	O
-	O
induced	O
mutations	O
(	O
Ransom	O
et	O
al	O
.	O
1996	O
)	O
on	O
the	O
TU	O
,	O
whereas	O
the	O
monm262	O
allele	O
was	O
derived	O
on	O
the	O
AB	O
strain	O
and	O
was	O
originally	O
called	O
vampire	O
(	O
Weinstein	O
et	O
al	O
.	O
1996	O
)	O
.	O

Mapping	O
strains	O
were	O
constructed	O
by	O
mating	O
to	O
WIK	O
or	O
SJD	O
polymorphic	O
strains	O
.	O

Linkage	O
analysis	O
was	O
performed	O
on	O
haploid	O
or	O
diploid	O
embryos	O
obtained	O
from	O
TU	O
/	O
SJD	O
or	O
TU	O
/	O
WIK	O
hybrids	O
.	O

In	O
situ	O
hybridization	O
and	O
stainings	O
of	O
embryos	O
were	O
done	O
as	O
described	O
(	O
Thompson	O
et	O
al	O
.	O
1998	O
;	O
Liao	O
et	O
al	O
.	O
2002	O
)	O
.	O

In	O
situ	O
hybridization	O
of	O
mouse	O
embryos	O
was	O
performed	O
as	O
described	O
(	O
Kingsley	O
et	O
al	O
.	O
2001	O
)	O
.	O

Genomic	O
DNA	O
isolation	O
,	O
genotyping	O
,	O
AFLP	O
analysis	O
,	O
and	O
chromosomal	S-GO
walking	O
were	O
each	O
performed	O
as	O
previously	O
described	O
(	O
Brownlie	O
et	O
al	O
.	O
1998	O
;	O
Ransom	O
and	O
Zon	O
1999	O
)	O
.	O

A	O
complete	O
list	O
of	O
primers	O
for	O
genetic	O
mapping	O
,	O
RT	O
-	O
PCR	O
,	O
and	O
sequencing	O
of	O
mon	O
are	O
available	O
on	O
request	O
.	O

mRNA	O
expression	O
constructs	O
,	O
morpholinos	O
,	O
and	O
microinjection	O

The	O
full	O
-	O
length	O
mon	O
cDNA	O
was	O
subcloned	O
into	O
EcoRI	O
and	O
XhoI	O
sites	O
in	O
the	O
pCS2	O
+	O
vector	O
.	O

Synthetic	O
mRNA	O
was	O
transcribed	O
in	O
vitro	O
,	O
and	O
microinjection	O
was	O
performed	O
essentially	O
as	O
described	O
(	O
Liao	O
et	O
al	O
.	O
2002	O
)	O
.	O

Cell	O
transplantation	O

Whole	O
kidney	O
marrow	O
cells	O
were	O
isolated	O
from	O
adult	O
gata1	O
:	O
EGFP	O
transgenic	O
donors	O
,	O
resuspended	O
in	O
0	O
.	O
9X	O
phosphate	O
-	O
buffered	O
saline	O
+	O
5	O
%	O
fetal	O
bovine	O
serum	O
,	O
and	O
injected	O
into	O
the	O
sinus	O
venosus	O
of	O
2	O
-	O
d	O
-	O
old	O
montg234	O
-	O
/	O
-	O
and	O
control	O
embryos	O
.	O

Between	O
102	O
and	O
103	O
kidney	O
marrow	O
cells	O
were	O
injected	O
per	O
embryo	O
.	O

Individual	O
transplanted	O
embryos	O
were	O
anesthetized	O
and	O
visualized	O
daily	O
under	O
an	O
inverted	O
fluorescent	O
microscope	O
(	O
DM	O
-	O
IRE2	O
;	O
Leica	O
,	O
Wetzlar	O
,	O
Germany	O
)	O
for	O
GFP	O
+	O
cells	O
over	O
a	O
span	O
of	O
12	O
d	O
.	O

On	O
day	O
13	O
posttransplant	O
,	O
all	O
surviving	O
larvae	O
(	O
12	O
/	O
129	O
;	O
9	O
%	O
)	O
were	O
placed	O
in	O
tanks	O
and	O
monitored	O
for	O
survival	O
.	O

Antibodies	S-GO
,	O
immunostaining	O
,	O
and	O
immunoblots	O

Antisera	O
against	O
the	O
human	O
C	O
-	O
terminal	O
TIF1	O
gamma	O
sequence	O
RRKRLKSDERPVHIK	O
was	O
generated	O
in	O
rabbits	O
(	O
Genemed	O
Synthesis	O
,	O
South	O
San	O
Francisco	O
,	O
California	O
,	O
United	O
States	O
)	O
and	O
affinity	O
purified	O
.	O

Mouse	O
embryonic	O
fibroblasts	O
grown	O
on	O
coverslips	O
were	O
immunostained	O
with	O
HP1	O
alpha	O
(	O
Chemicon	O
,	O
Temecula	O
,	O
California	O
,	O
United	O
States	O
)	O
and	O
Tif1	O
gamma	O
antisera	O
simultaneously	O
.	O

In	O
brief	O
,	O
cells	O
were	O
fixed	O
in	O
4	O
%	O
paraformaldehyde	O
for	O
5	O
min	O
,	O
washed	O
with	O
phosphate	O
-	O
buffered	O
saline	O
,	O
and	O
blocked	O
with	O
5	O
%	O
serum	O
(	O
PBST	O
)	O
for	O
30	O
min	O
.	O

After	O
incubation	O
with	O
the	O
primary	O
antibodies	S-GO
(	O
PBST	O
,	O
60	O
min	O
)	O
cells	O
were	O
washed	O
three	O
times	O
with	O
PBST	O
and	O
incubated	O
with	O
secondary	O
antibodies	S-GO
(	O
Jackson	O
Laboratory	O
,	O
Bar	O
Harbor	O
,	O
Maine	O
,	O
United	O
States	O
)	O
followed	O
by	O
three	O
washes	O
in	O
PBST	O
.	O

Cells	O
were	O
embedded	O
with	O
Vectashield	O
/	O
DAPI	O
and	O
analyzed	O
using	O
an	O
Axioplan	O
2	O
microscope	O
(	O
Zeiss	O
,	O
Jena	O
,	O
Germany	O
)	O
.	O

Digital	O
images	O
were	O
processed	O
using	O
the	O
Volocity	O
1	O
.	O
0	O
software	O
(	O
Improvision	O
,	O
Lexington	O
,	O
Massachusetts	O
,	O
United	O
States	O
)	O
.	O

G1E	O
cell	O
differentiation	O
experiments	O
were	O
performed	O
essentially	O
as	O
described	O
(	O
Weiss	O
et	O
al	O
.	O
1997	O
)	O
.	O

Supporting	O
Information	O

Transplantation	O
of	O
wild	O
-	O
type	O
zebrafish	O
marrow	O
cells	O
carrying	O
a	O
gata1	O
:	O
GFP	O
transgene	O
into	O
2	O
-	O
d	O
-	O
old	O
embryos	O
reconstitutes	O
erythropoiesis	O
,	O
but	O
not	O
viability	O
,	O
in	O
montg234	O
homozygous	O
mutants	O
.	O

Movies	O
of	O
live	O
embryos	O
at	O
day	O
3	O
posttransplant	O
highlight	O
less	O
than	O
100	O
GFP	O
+	O
RBCs	O
in	O
circulation	O
.	O

Transplanted	O
cells	O
were	O
observed	O
to	O
proliferate	O
,	O
resulting	O
in	O
thousands	O
of	O
donor	O
-	O
derived	O
erythrocytes	O
7	O
d	O
later	O
.	O

Movies	O
present	O
GFP	O
-	O
fluorescent	O
images	O
of	O
live	O
zebrafish	O
larvae	O
.	O

Video	O
S1	O

Untransplanted	O
Control	O
montg234	O
Homozygous	O
Mutants	O
Had	O
No	O
Fluorescent	O
Cells	O
in	O
Circulation	O
at	O
3	O
Days	O
of	O
Development	O

(	O
13	O
.	O
7	O
MB	O
MOV	O
)	O
.	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Video	O
S2	O

One	O
Day	O
after	O
Transplantation	O
,	O
Less	O
Than	O
100	O
GFP	O
+	O
Erythrocytes	O
Were	O
Visible	O
in	O
the	O
Circulation	O
of	O
Three	O
montg234	O
Homozygous	O
Mutants	O

(	O
11	O
.	O
3	O
MB	O
MOV	O
)	O
.	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Video	O
S3	O

Untransplanted	O
Control	O
montg234	O
Homozygous	O
Mutants	O
Had	O
No	O
Fluorescent	O
Cells	O
in	O
Circulation	O
at	O
9	O
Days	O
of	O
Development	O

(	O
7	O
.	O
9	O
MB	O
MOV	O
)	O
.	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Video	O
S4	O

Seven	O
Days	O
after	O
Transplantation	O
,	O
Thousands	O
of	O
Donor	O
-	O
Derived	O
Erythrocytes	O
Were	O
Visible	O
in	O
the	O
Circulation	O
of	O
a	O
Representative	O
montg234	O
Homozygous	O
Mutant	O

(	O
11	O
.	O
2	O
MB	O
MOV	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Accession	O
Numbers	O

The	O
GenBank	O
(	O
http	O
:	O
/	O
/	O
www	O
.	O
ncbi	O
.	O
nlm	O
.	O
nih	O
.	O
gov	O
/	O
Genbank	O
)	O
accession	O
numbers	O
for	O
the	O
genes	O
and	O
gene	O
products	O
discussed	O
in	O
this	O
paper	O
are	O
fly	O
bonus	O
(	O
AAF19646	O
)	O
,	O
human	O
TIF1	O
alpha	O
(	O
015164	O
)	O
,	O
human	O
TIF1	O
beta	O
(	O
Q13263	O
)	O
,	O
human	O
TIF	O
gamma	O
(	O
Q9UPN9	O
)	O
,	O
human	O
TIF1	O
gamma	O
(	O
Q9UPN9	O
)	O
,	O
mon	O
(	O
AY59853	O
)	O
,	O
mouse	O
Tif1	O
alpha	O
(	O
Q64127	O
)	O
,	O
mouse	O
Tif1	O
beta	O
(	O
AAH58391	O
)	O
,	O
and	O
mouse	O
Tif1	O
gamma	O
(	O
NP444400	O
)	O
.	O

The	O
cDNA	O
sequences	O
of	O
zebrafish	O
mon	O
/	O
tif1	O
gamma	O
and	O
tif1	O
alpha	O
have	O
been	O
deposited	O
in	O
GenBank	O
under	O
the	O
accession	O
numbers	O
AY598453	O
and	O
AY598454	O
,	O
respectively	O
.	O

Acknowledgements	O

We	O
thank	O
A	O
.	O

Davidson	O
,	O
J	O
.	O

Amatruda	O
,	O
and	O
J	O
.	O

Christian	O
for	O
critical	O
review	O
of	O
this	O
manuscript	O
;	O
J	O
.	O

Postlethwait	O
and	O
W	O
.	O

Talbot	O
for	O
helpful	O
discussions	O
and	O
experimental	O
advice	O
;	O
B	O
.	O

Weinstein	O
for	O
the	O
gift	O
of	O
the	O
m262	O
allele	O
of	O
mon	O
;	O
and	O
D	O
.	O

Giarla	O
for	O
administrative	O
assistance	O
.	O

DGR	O
was	O
funded	O
by	O
the	O
American	O
Cancer	O
Society	O
and	O
an	O
award	O
to	O
Oregon	O
Health	O
and	O
Science	O
University	O
by	O
the	O
Howard	O
Hughes	O
Medical	O
Institute	O
(	O
HHMI	O
)	O
Biomedical	O
Research	O
Support	O
Program	O
for	O
Medical	O
Schools	O
.	O

LIZ	O
and	O
SHO	O
are	O
investigators	O
of	O
the	O
HHMI	O
.	O

This	O
work	O
was	O
supported	O
by	O
grants	O
from	O
the	O
National	O
Institutes	O
of	O
Health	O
.	O

Abbreviations	O

AFLP	O
-	O
amplified	O
fragment	O
length	O
polymorphism	O

ENU	O
-	O
ethyl	O
-	O
nitrosourea	O

EST	O
-	O
expressed	O
sequence	O
tag	O

GFP	O
-	O
green	O
fluorescent	O
protein	O

hpf	O
-	O
hours	O
postfertilization	O

KRAB	O
-	O
Kr	O
u	O
ppel	O
-	O
associated	O
box	O

mon	O
-	O
moonshine	O
;	O
PAC	O

PML	O
-	O
promyelocytic	O
leukemia	O
gene	O
product	O

RBCs	O
-	O
red	O
blood	O
cells	O

scl	O
-	O
stem	O
cell	O
leukemia	O
;	O
SSCP	O

TIF	O
-	O
transcriptional	O
intermediary	O
factor	O

TU	O
-	O
T	O
u	O
bingen	O
background	O

Figures	O
and	O
Tables	O

Figure	O
1	O

Zebrafish	O
mon	O
Mutants	O
Have	O
Severe	O
Defects	O
in	O
Primitive	O
Hematopoiesis	O

(	O
A	O
)	O
Whole	O
-	O
mount	O
TUNEL	O
assays	O
reveal	O
that	O
ventral	O
-	O
posterior	O
mesodermal	O
cells	O
undergo	O
apoptosis	O
in	O
homozygous	O
montg234	O
mutant	O
embryos	O
.	O

Whole	O
-	O
mount	O
in	O
situ	O
hybridization	O
of	O
gata1	O
detected	O
at	O
the	O
12	O
-	O
and	O
18	O
-	O
somite	O
stage	O
in	O
genotyped	O
embryos	O
.	O

Posterior	O
views	O
,	O
anterior	O
to	O
the	O
left	O
.	O

(	O
B	O
)	O
Extensive	O
apoptosis	O
is	O
visible	O
in	O
the	O
trunk	O
and	O
tail	O
(	O
arrowhead	O
)	O
and	O
also	O
in	O
hematopoietic	O
cells	O
of	O
the	O
embryonic	O
blood	O
island	O
at	O
22	O
h	O
of	O
development	O
(	O
arrow	O
)	O
.	O

Whole	O
-	O
mount	O
in	O
situ	O
hybridization	O
at	O
22	O
hpf	O
including	O
scl	O
,	O
gata2	O
,	O
gata1	O
,	O
ikaros	O
,	O
and	O
myb	O
in	O
montg234	O
mutants	O
.	O

Expression	O
of	O
myb	O
is	O
greatly	O
reduced	O
in	O
the	O
blood	O
islands	O
because	O
of	O
a	O
loss	O
of	O
erythroid	O
cells	O
,	O
but	O
embryonic	O
macrophages	O
are	O
still	O
present	O
(	O
arrows	O
)	O
.	O

The	O
expression	O
of	O
rag1	O
in	O
thymic	O
T	O
-	O
cells	O
appears	O
normal	O
in	O
mon	O
mutants	O
at	O
5	O
d	O
postfertilization	O
(	O
arrow	O
heads	O
)	O
.	O

Lateral	O
views	O
of	O
22	O
hpf	O
and	O
5	O
-	O
d	O
-	O
old	O
embryos	O
.	O

Figure	O
2	O

Zebrafish	O
mon	O
Mutants	O
Also	O
Have	O
Severe	O
Defects	O
in	O
Definitive	O
Hematopoiesis	O

Adult	O
phenotype	O
of	O
wild	O
-	O
type	O
and	O
mon	O
mutants	O
.	O

A	O
rare	O
surviving	O
montb222	O
homozygous	O
adult	O
shows	O
significant	O
cardiomegaly	O
in	O
comparison	O
to	O
a	O
wild	O
-	O
type	O
age	O
-	O
matched	O
control	O
.	O

Wright	O
-	O
Giemsa	O
stained	O
marrow	O
of	O
wild	O
-	O
type	O
adult	O
in	O
comparison	O
to	O
a	O
homozygous	O
mutant	O
.	O

Note	O
the	O
dramatic	O
reduction	O
of	O
terminally	O
differentiated	O
erythroid	O
cells	O
and	O
the	O
presence	O
of	O
abnormally	O
large	O
megaloblastic	O
proerythroblasts	O
in	O
the	O
montb222	O
mutant	O
marrow	O
.	O

Figure	O
3	O

Positional	O
Cloning	O
Identifies	O
the	O
mon	O
Gene	O
as	O
Zebrafish	O
tif1	O
gamma	O

(	O
A	O
)	O
Physical	O
map	O
of	O
the	O
mon	O
locus	O
on	O
zebrafish	O
Chromosome	O
8	O
.	O

Microsatellite	O
markers	O
z987	O
and	O
z11001	O
were	O
used	O
to	O
initially	O
identify	O
recombinants	O
in	O
a	O
panel	O
of	O
2	O
,	O
200	O
diploid	O
montg234	O
homozygous	O
mutants	O
.	O

The	O
AFLP	O
marker	O
MA3	O
was	O
used	O
to	O
initiate	O
a	O
chromosomal	S-GO
walk	O
in	O
PAC	O
libraries	O
.	O

The	O
critical	O
PACS	O
that	O
were	O
isolated	O
to	O
encompass	O
the	O
mon	O
locus	O
are	O
indicated	O
by	O
numbers	O
above	O
bar	O
.	O

The	O
PAC	O
107N19	O
defines	O
the	O
critical	O
interval	O
for	O
the	O
mon	O
gene	O
.	O

This	O
PAC	O
was	O
used	O
as	O
a	O
probe	O
to	O
screen	O
cDNA	O
libraries	O
and	O
to	O
identify	O
zebrafish	O
tif1	O
gamma	O
cDNAs	O
.	O

Numbers	O
below	O
the	O
bar	O
indicate	O
the	O
number	O
of	O
recombinants	O
identified	O
by	O
SSCP	O
analysis	O
.	O

(	O
B	O
)	O
Clustal	O
-	O
W	O
-	O
generated	O
phylogentic	O
tree	O
of	O
zebrafish	O
(	O
Danio	O
rerio	O
[	O
Dr	O
]	O
)	O
Tif1	O
gamma	O
and	O
Tif1	O
alpha	O
peptide	O
sequences	O
in	O
comparison	O
to	O
TIF1	O
family	O
members	O
:	O
human	O
(	O
Hs	O
)	O
TIF1	O
alpha	O
,	O
TIF1	O
beta	O
,	O
and	O
TIF1	O
gamma	O
;	O
mouse	O
(	O
Mm	O
)	O
Tif1	O
alpha	O
,	O
Tif1	O
beta	O
,	O
and	O
Tif1	O
gamma	O
;	O
;	O
and	O
fly	O
(	O
Dm	O
)	O
bonus	O
.	O

(	O
C	O
)	O
Diagrams	O
illustrating	O
the	O
structure	O
of	O
the	O
Tif1	O
gamma	O
-	O
predicted	O
peptide	O
and	O
the	O
three	O
identified	O
point	O
mutants	O
.	O

RING	O
finger	O
(	O
RING	O
)	O
,	O
B	O
-	O
boxes	O
(	O
B1	O
and	O
B2	O
)	O
,	O
plant	O
homeodomain	O
finger	O
(	O
PHD	O
)	O
and	O
bromodomain	O
(	O
BROMO	O
)	O
.	O

Numbers	O
below	O
the	O
first	O
diagram	O
indicate	O
the	O
percent	O
identity	O
shared	O
between	O
each	O
of	O
these	O
domains	O
in	O
zebrafish	O
and	O
human	O
TIF1	O
gamma	O
.	O

The	O
predicted	O
truncated	O
proteins	O
are	O
indicated	O
.	O

(	O
D	O
)	O
DNA	O
sequence	O
chromatograms	O
showing	O
the	O
three	O
ENU	O
-	O
induced	O
point	O
mutants	O
in	O
comparison	O
to	O
wild	O
-	O
type	O
control	O
sequences	O

Figure	O
4	O

The	O
mon	O
/	O
tif1	O
gamma	O
Gene	O
Is	O
Highly	O
Expressed	O
in	O
Hematopoietic	O
Mesoderm	O

(	O
A	O
)	O
In	O
situ	O
hybridization	O
of	O
zebrafish	O
embryos	O
demonstrating	O
the	O
embryonic	O
expression	O
of	O
tif1	O
gamma	O
.	O

tif1	O
gamma	O
is	O
initially	O
expressed	O
as	O
a	O
maternal	O
mRNA	O
.	O

Increased	O
expression	O
of	O
tif1	O
gamma	O
in	O
ventral	O
-	O
lateral	O
mesoderm	O
begins	O
between	O
the	O
one	O
-	O
to	O
three	O
-	O
somite	O
stages	O
and	O
increases	O
through	O
early	O
development	O
.	O

By	O
five	O
somites	O
,	O
tif1	O
gamma	O
is	O
strongly	O
expressed	O
in	O
lateral	O
stripes	O
of	O
mesoderm	O
that	O
also	O
express	O
scl	O
.	O

At	O
22	O
hpf	O
tif1	O
gamma	O
is	O
expressed	O
broadly	O
in	O
the	O
brain	O
,	O
spinal	O
cord	O
,	O
trunk	O
,	O
and	O
tail	O
mesenchyme	O
,	O
but	O
is	O
at	O
much	O
higher	O
levels	O
in	O
hematopoietic	O
cells	O
of	O
the	O
blood	O
island	O
.	O

Zebrafish	O
tif1	O
alpha	O
is	O
also	O
broadly	O
expressed	O
but	O
relatively	O
more	O
uniform	O
in	O
most	O
tissues	O
,	O
in	O
comparison	O
to	O
tif1	O
gamma	O
.	O

Tif1	O
alpha	O
is	O
weakly	O
expressed	O
at	O
early	O
somite	O
stages	O
in	O
hematopoietic	O
mesoderm	O
and	O
uniformly	O
expressed	O
at	O
22	O
hpf	O
,	O
including	O
expression	O
in	O
the	O
blood	O
islands	O
.	O

Expression	O
of	O
scl	O
at	O
five	O
somites	O
and	O
22	O
hpf	O
highlights	O
the	O
embryonic	O
blood	O
island	O
in	O
comparison	O
to	O
tif1	O
gamma	O
expression	O
.	O

(	O
B	O
)	O
In	O
situ	O
hybridization	O
of	O
mouse	O
embryos	O
detects	O
broad	O
expression	O
of	O
Tif1	O
gamma	O
at	O
embryonic	O
day	O
8	O
.	O
5	O
including	O
the	O
yolk	O
sac	O
blood	O
islands	O
(	O
arrow	O
)	O
.	O

AT	O
embryonic	O
day	O
12	O
.	O
5	O
,	O
there	O
is	O
high	O
level	O
expression	O
in	O
the	O
fetal	O
liver	O
(	O
arrow	O
)	O
and	O
broad	O
expression	O
in	O
the	O
embryonic	O
brain	O
,	O
spinal	O
chord	O
,	O
gut	O
,	O
and	O
muscle	O
.	O

Figure	O
5	O

Overexpression	O
of	O
Wild	O
-	O
Type	O
tif1	O
gamma	O
mRNA	O
or	O
Marrow	O
Transplantation	O
Rescues	O
Embryonic	O
Hematopoiesis	O
in	O
mon	O
Mutants	O

(	O
A	O
)	O
montg234	O
mutants	O
are	O
rescued	O
by	O
injection	O
of	O
mRNA	O
-	O
encoding	O
wild	O
-	O
type	O
Tif1	O
gamma	O
protein	O
.	O

At	O
4	O
d	O
of	O
development	O
,	O
large	O
numbers	O
of	O
RBCs	O
are	O
visible	O
in	O
the	O
circulation	O
of	O
wild	O
-	O
type	O
zebrafish	O
,	O
shown	O
here	O
by	O
o	O
-	O
dianisidine	O
staining	O
of	O
hemoglobin	S-GO
.	O

Uninjected	O
monttg234	O
homozygous	O
mutants	O
are	O
completely	O
bloodless	O
.	O

Injection	O
of	O
100	O
pg	O
of	O
wild	O
-	O
type	O
tif1	O
gamma	O
mRNA	O
rescues	O
erythropoiesis	O
in	O
mutant	O
embryos	O
.	O

o	O
-	O
dianisidine	O
-	O
stained	O
larvae	O
are	O
shown	O
in	O
ventral	O
views	O
to	O
highlight	O
blood	O
in	O
vessels	O
.	O

(	O
B	O
)	O
Transplantation	O
of	O
wild	O
-	O
type	O
zebrafish	O
marrow	O
cells	O
carrying	O
a	O
gata1	O
:	O
GFP	O
transgene	O
into	O
2	O
-	O
d	O
-	O
old	O
embryos	O
reconstitutes	O
erythropoiesis	O
,	O
but	O
not	O
viability	O
,	O
in	O
montg234	O
homozygous	O
mutants	O
.	O

Still	O
frames	O
from	O
movies	O
of	O
live	O
embryos	O
at	O
day	O
3	O
posttransplant	O
highlight	O
less	O
than	O
100	O
GFP	O
+	O
RBCs	O
in	O
circulation	O
(	O
top	O
)	O
.	O

Transplanted	O
cells	O
were	O
observed	O
to	O
proliferate	O
resulting	O
in	O
thousands	O
of	O
donor	O
-	O
derived	O
erythrocytes	O
7	O
d	O
later	O
(	O
bottom	O
)	O
.	O

Arrows	O
indicate	O
the	O
hearts	O
of	O
control	O
and	O
transplanted	O
zebrafish	O
.	O

See	O
Videos	O
S1	O
-	O
S4	O
.	O

Figure	O
6	O

Mammalian	O
Tif1	O
gamma	O
Protein	O
Localizes	O
to	O
Nuclear	B-GO
Bodies	E-GO
Distinct	O
from	O
Heterochromatin	S-GO

(	O
A	O
)	O
Deconvolved	O
immunofluorescence	O
images	O
of	O
a	O
mouse	O
embryonic	O
fibroblast	O
cell	O
nucleus	S-GO
stained	O
with	O
an	O
anti	O
-	O
Tif1	O
gamma	O
antibody	S-GO
and	O
stained	O
with	O
a	O
monoclonal	O
antibody	S-GO
directed	O
against	O
HP1	O
alpha	O
.	O

This	O
is	O
also	O
compared	O
to	O
DAPI	O
staining	O
.	O

The	O
merged	O
images	O
of	O
the	O
nucleus	S-GO
show	O
that	O
Tif1	O
gamma	O
does	O
not	O
colocalize	O
with	O
the	O
HP1	O
alpha	O
or	O
DAPI	O
staining	O
of	O
heterochromatin	S-GO
while	O
HP1	O
alpha	O
and	O
DAPI	O
staining	O
overlap	O
.	O

(	O
B	O
)	O
G1ER	O
mouse	O
erythroleukemia	O
cells	O
express	O
high	O
levels	O
of	O
Tif1	O
gamma	O
protein	O
as	O
detected	O
by	O
Western	O
blot	O
analysis	O
.	O

Expression	O
of	O
Tif1	O
gamma	O
decreases	O
during	O
Gata1	O
-	O
dependent	O
erythroid	O
maturation	O
induced	O
by	O
beta	O
-	O
estradiol	O
treatment	O
to	O
induce	O
a	O
Gata1	O
-	O
ER	O
fusion	O
protein	O
.	O

Table	O
1	O

Overexpression	O
of	O
tif1	O
gamma	O
mRNA	O
Rescues	O
mon	O
Mutants	O
:	O
Hematopoietic	O
Phenotypes	O

Synthetic	O
tif1	O
gamma	O
mRNA	O
(	O
100	O
pg	O
)	O
was	O
injected	O
at	O
the	O
one	O
-	O
cell	O
stage	O
into	O
embryos	O
of	O
the	O
indicated	O
genotypes	O
.	O

For	O
the	O
mon	O
embryos	O
,	O
circulating	O
cells	O
where	O
counted	O
each	O
day	O
through	O
4	O
d	O
,	O
when	O
the	O
embryos	O
were	O
fixed	O
and	O
stained	O
with	O
o	O
-	O
dianisidine	O
to	O
detect	O
hemoglobin	O
in	O
mature	O
RBCs	O
.	O

Normal	O
embryos	O
contain	O
approximately	O
3	O
,	O
000	O
circulating	O
cells	O
at	O
these	O
time	O
points	O
.	O

Results	O
are	O
given	O
as	O
number	O
of	O
embryos	O
with	O
the	O
indicated	O
phenotype	O
.	O

Numbers	O
in	O
parentheses	O
represent	O
percentage	O
of	O
total	O
embryos	O
analyzed	O

Table	O
2	O

Marrow	O
Transplantation	O
Rescues	O
Hematopoiesis	O
But	O
Not	O
Survival	O
in	O
mon	O
Mutants	O
:	O
Embryos	O
with	O
Transplanted	O
Erythroid	O
Cells	O

Between	O
100	O
and	O
1	O
,	O
000	O
kidney	O
marrow	O
cells	O
from	O
adult	O
gata1	O
:	O
EGFP	O
transgenic	O
donors	O
were	O
injected	O
per	O
zebrafish	O
embryo	O
at	O
48	O
hpf	O
.	O

Individual	O
transplanted	O
embryos	O
were	O
anesthetized	O
and	O
visualized	O
for	O
GFP	O
+	O
erythroid	O
cells	O
.	O

By	O
10	O
d	O
posttransplantation	O
the	O
indicated	O
number	O
of	O
embryos	O
had	O
an	O
estimated	O
100	O
to	O
3	O
,	O
000	O
GFP	O
+	O
cells	O
in	O
circulation	O
.	O

At	O
3	O
mo	O
the	O
indicated	O
number	O
of	O
fish	O
were	O
alive	O
.	O

The	O
relative	O
percentage	O
of	O
embryos	O
is	O
shown	O
in	O
parentheses	O

Footnotes	O

Conflicts	O
of	O
interest	O
.	O

The	O
authors	O
have	O
declared	O
that	O
no	O
conflicts	O
of	O
interest	O
exist	O
.	O

Author	O
contributions	O
.	O

DGR	O
,	O
NB	O
,	O
KN	O
,	O
DT	O
,	O
CB	O
,	O
NST	O
,	O
YZ	O
,	O
JP	O
,	O
SHO	O
,	O
and	O
LIZ	O
conceived	O
and	O
designed	O
the	O
experiments	O
.	O

DGR	O
,	O
NB	O
,	O
KN	O
,	O
DT	O
,	O
CB	O
,	O
NST	O
,	O
NPL	O
,	O
WJS	O
,	O
CAL	O
,	O
CH	O
,	O
BAB	O
,	O
and	O
PDK	O
performed	O
the	O
experiments	O
.	O

DGR	O
,	O
NB	O
,	O
KN	O
,	O
DT	O
,	O
CB	O
,	O
NST	O
,	O
NPL	O
,	O
YZ	O
,	O
JP	O
,	O
SHO	O
,	O
and	O
LIZ	O
analyzed	O
the	O
data	O
.	O

DGR	O
,	O
NB	O
,	O
KN	O
,	O
DT	O
,	O
NST	O
,	O
YZ	O
,	O
BAB	O
,	O
SL	O
,	O
and	O
JP	O
contributed	O
reagents	O
/	O
materials	O
/	O
analysis	O
tools	O
.	O

DGR	O
,	O
NB	O
,	O
KN	O
,	O
DT	O
,	O
and	O
LIZ	O
wrote	O
the	O
paper	O
.	O

Academic	O
Editor	O
:	O
William	O
Talbot	O
,	O
Stanford	O
University	O

currency	O
Current	O
address	O
:	O
Department	O
of	O
Cell	O
and	O
Developmental	O
Biology	O
,	O
Oregon	O
Health	O
and	O
Science	O
University	O
,	O
Portland	O
,	O
Oregon	O
,	O
United	O
States	O
of	O
America	O

Citation	O
:	O
Ransom	O
DG	O
,	O
Bahary	O
N	O
,	O
Niss	O
K	O
,	O
Traver	O
D	O
,	O
Burns	O
C	O
,	O
et	O
al	O
.	O

(	O
2004	O
)	O
The	O
zebrafish	O
moonshine	O
gene	O
encodes	O
transcriptional	O
intermediary	O
factor	O
1	O
gamma	O
,	O
an	O
essential	O
regulator	O
of	O
hematopoiesis	O
.	O

PLoS	O
Biol	O
2	O
(	O
8	O
)	O
:	O
e237	O
.	O

Spontaneous	O
Autoimmunity	O
in	O
129	O
and	O
C57BL	O
/	O
6	O
Mice	O
--	O
Implications	O
for	O
Autoimmunity	O
Described	O
in	O
Gene	O
-	O
Targeted	O
Mice	O

Abstract	O

Systemic	O
lupus	O
erythematosus	O
(	O
SLE	O
)	O
is	O
a	O
multisystem	O
autoimmune	O
disorder	O
in	O
which	O
complex	O
genetic	O
factors	O
play	O
an	O
important	O
role	O
.	O

Several	O
strains	O
of	O
gene	O
-	O
targeted	O
mice	O
have	O
been	O
reported	O
to	O
develop	O
SLE	O
,	O
implicating	O
the	O
null	O
genes	O
in	O
the	O
causation	O
of	O
disease	O
.	O

However	O
,	O
hybrid	O
strains	O
between	O
129	O
and	O
C57BL	O
/	O
6	O
mice	O
,	O
widely	O
used	O
in	O
the	O
generation	O
of	O
gene	O
-	O
targeted	O
mice	O
,	O
develop	O
spontaneous	O
autoimmunity	O
.	O

Furthermore	O
,	O
the	O
genetic	O
background	O
markedly	O
influences	O
the	O
autoimmune	O
phenotype	O
of	O
SLE	O
in	O
gene	O
-	O
targeted	O
mice	O
.	O

This	O
suggests	O
an	O
important	O
role	O
in	O
the	O
expression	O
of	O
autoimmunity	O
of	O
as	O
-	O
yet	O
-	O
uncharacterised	O
background	O
genes	O
originating	O
from	O
these	O
parental	O
mouse	O
strains	O
.	O

Using	O
genome	O
-	O
wide	O
linkage	O
analysis	O
,	O
we	O
identified	O
several	O
susceptibility	O
loci	O
,	O
derived	O
from	O
129	O
and	O
C57BL	O
/	O
6	O
mice	O
,	O
mapped	O
in	O
the	O
lupus	O
-	O
prone	O
hybrid	O
(	O
129	O
x	O
C57BL	O
/	O
6	O
)	O
model	O
.	O

By	O
creating	O
a	O
C57BL	O
/	O
6	O
congenic	O
strain	O
carrying	O
a	O
129	O
-	O
derived	O
Chromosome	O
1	O
segment	O
,	O
we	O
found	O
that	O
this	O
129	O
interval	O
was	O
sufficient	O
to	O
mediate	O
the	O
loss	O
of	O
tolerance	O
to	O
nuclear	S-GO
antigens	O
,	O
which	O
had	O
previously	O
been	O
attributed	O
to	O
a	O
disrupted	O
gene	O
.	O

These	O
results	O
demonstrate	O
important	O
epistatic	O
modifiers	O
of	O
autoimmunity	O
in	O
129	O
and	O
C57BL	O
/	O
6	O
mouse	O
strains	O
,	O
widely	O
used	O
in	O
gene	O
targeting	O
.	O

These	O
background	O
gene	O
influences	O
may	O
account	O
for	O
some	O
,	O
or	O
even	O
all	O
,	O
of	O
the	O
autoimmune	O
traits	O
described	O
in	O
some	O
gene	O
-	O
targeted	O
models	O
of	O
SLE	O
.	O

Introduction	O

Systemic	O
lupus	O
erythematosus	O
(	O
SLE	O
)	O
is	O
a	O
chronic	O
autoimmune	O
disease	O
characterised	O
by	O
the	O
production	O
of	O
autoantibodies	O
(	O
auto	O
-	O
Abs	S-GO
)	O
against	O
a	O
wide	O
spectrum	O
of	O
self	O
-	O
antigens	O
,	O
mainly	O
from	O
subcellular	O
compartments	O
,	O
especially	O
the	O
cell	O
nucleus	S-GO
.	O

Genetic	O
predisposition	O
is	O
an	O
important	O
contributor	O
to	O
susceptibility	O
to	O
SLE	O
in	O
both	O
humans	O
and	O
animals	O
(	O
Vyse	O
and	O
Todd	O
1996	O
;	O
Harley	O
et	O
al	O
.	O
1998	O
;	O
Theofilopoulos	O
and	O
Kono	O
1999	O
;	O
Wakeland	O
et	O
al	O
.	O
2001	O
)	O
.	O

Genes	O
in	O
multiple	O
pathways	O
participate	O
in	O
mediating	O
disease	O
pathogenesis	O
,	O
and	O
epistatic	O
interactions	O
amongst	O
these	O
genes	O
influence	O
the	O
expression	O
of	O
disease	O
.	O

In	O
this	O
context	O
,	O
both	O
genetic	O
linkage	O
studies	O
in	O
spontaneous	O
lupus	O
-	O
prone	O
models	O
and	O
synthetic	O
murine	O
models	O
of	O
autoimmunity	O
generated	O
by	O
targeted	O
disruption	O
of	O
specific	O
genes	O
modulating	O
the	O
immune	O
system	O
have	O
widely	O
been	O
used	O
to	O
investigate	O
the	O
complexity	O
of	O
SLE	O
.	O

The	O
best	O
-	O
studied	O
strains	O
of	O
mice	O
that	O
spontaneously	O
develop	O
a	O
lupus	O
-	O
like	O
pathology	O
are	O
the	O
New	O
Zealand	O
Black	O
/	O
New	O
Zealand	O
White	O
hybrid	O
strain	O
(	O
NZB	O
/	O
WF1	O
)	O
;	O
the	O
MRL	O
/	O
Mp	O
lpr	O
/	O
lpr	O
strain	O
,	O
which	O
carries	O
the	O
lpr	O
mutation	O
of	O
the	O
FAS	O
receptor	O
gene	O
;	O
and	O
the	O
BXSB	O
strain	O
,	O
which	O
carries	O
the	O
Y	O
chromosome	O
autoimmune	O
accelerator	O
(	O
Yaa	O
)	O
gene	O
(	O
Theofilopoulos	O
and	O
Dixon	O
1985	O
)	O
.	O

Extensive	O
genetic	O
mapping	O
studies	O
in	O
all	O
three	O
strains	O
have	O
identified	O
multiple	O
intervals	O
associated	O
with	O
disease	O
susceptibility	O
.	O

Interestingly	O
,	O
the	O
majority	O
of	O
the	O
intervals	O
detected	O
are	O
strain	O
-	O
specific	O
,	O
confirming	O
the	O
genetic	O
complexity	O
of	O
the	O
disease	O
and	O
indicating	O
the	O
presence	O
of	O
extensive	O
heterogeneity	O
in	O
the	O
genes	O
contributing	O
to	O
the	O
pathogenesis	O
of	O
the	O
disease	O
.	O

However	O
,	O
some	O
susceptibility	O
loci	O
have	O
been	O
mapped	O
to	O
similar	O
chromosome	O
locations	O
in	O
different	O
strains	O
,	O
suggesting	O
that	O
at	O
least	O
some	O
susceptibility	O
may	O
be	O
shared	O
amongst	O
lupus	O
-	O
prone	O
strains	O
.	O

Amongst	O
these	O
shared	O
susceptibility	O
loci	O
,	O
the	O
most	O
striking	O
are	O
loci	O
on	O
distal	O
Chromosome	O
1	O
,	O
for	O
which	O
important	O
contributing	O
genes	O
have	O
been	O
found	O
in	O
New	O
Zealand	O
and	O
BXSB	O
models	O
(	O
Theofilopoulos	O
and	O
Kono	O
1999	O
;	O
Wakeland	O
et	O
al	O
.	O
2001	O
)	O
.	O

Although	O
considerable	O
efforts	O
have	O
been	O
made	O
to	O
identify	O
the	O
genes	O
responsible	O
for	O
the	O
development	O
of	O
the	O
disease	O
,	O
with	O
the	O
exception	O
of	O
the	O
lpr	O
mutation	O
,	O
none	O
of	O
the	O
genetic	O
contributions	O
to	O
disease	O
in	O
the	O
three	O
well	O
-	O
documented	O
murine	O
SLE	O
strains	O
have	O
yet	O
been	O
fully	O
resolved	O
at	O
the	O
molecular	O
or	O
protein	O
level	O
.	O

Thus	O
,	O
targeted	O
genetic	O
disruption	O
of	O
candidate	O
genes	O
encoding	O
proteins	O
of	O
the	O
immune	O
system	O
has	O
been	O
extensively	O
used	O
to	O
examine	O
their	O
role	O
in	O
immune	O
regulation	O
.	O

However	O
,	O
the	O
most	O
surprising	O
result	O
of	O
this	O
powerful	O
approach	O
has	O
been	O
the	O
high	O
frequency	O
with	O
which	O
such	O
mutations	O
have	O
been	O
associated	O
with	O
an	O
autoimmune	O
phenotype	O
.	O

In	O
this	O
regard	O
,	O
it	O
is	O
of	O
note	O
that	O
hybrid	O
strains	O
between	O
129	O
and	O
C57BL	O
/	O
6	O
mice	O
,	O
widely	O
used	O
in	O
the	O
generation	O
of	O
gene	O
-	O
targeted	O
mice	O
,	O
are	O
spontaneously	O
predisposed	O
to	O
development	O
of	O
humoral	O
autoimmunity	O
with	O
low	O
levels	O
of	O
glomerulonephritis	O
(	O
Obata	O
et	O
al	O
.	O
1979	O
;	O
Botto	O
et	O
al	O
.	O
1998	O
;	O
Bickerstaff	O
et	O
al	O
.	O
1999	O
;	O
Santiago	O
-	O
Raber	O
et	O
al	O
.	O
2001	O
)	O
.	O

Furthermore	O
,	O
the	O
genetic	O
background	O
markedly	O
influences	O
the	O
autoimmune	O
phenotype	O
in	O
gene	O
-	O
targeted	O
mice	O
(	O
Bolland	O
and	O
Ravetch	O
2000	O
;	O
Santiago	O
-	O
Raber	O
et	O
al	O
.	O
2001	O
;	O
Mitchell	O
et	O
al	O
.	O
2002	O
)	O
.	O

These	O
observations	O
led	O
to	O
the	O
hypothesis	O
that	O
the	O
autoimmune	O
phenotype	O
described	O
in	O
some	O
gene	O
-	O
targeted	O
mice	O
might	O
be	O
due	O
primarily	O
to	O
combinations	O
of	O
as	O
-	O
yet	O
-	O
uncharacterised	O
background	O
genes	O
,	O
originating	O
from	O
129	O
and	O
C57BL	O
/	O
6	O
mice	O
strains	O
,	O
interacting	O
or	O
not	O
with	O
the	O
mutated	O
allele	O
.	O

To	O
test	O
this	O
,	O
we	O
conducted	O
a	O
genome	O
-	O
wide	O
scan	O
analysis	O
of	O
two	O
large	O
cohorts	O
of	O
(	O
129	O
x	O
C57BL	O
/	O
6	O
)	O
F2	O
mice	O
,	O
one	O
of	O
which	O
carried	O
a	O
mutation	O
in	O
the	O
serum	O
amyloid	O
P	O
component	O
gene	O
(	O
Apcs	O
)	O
.	O

The	O
Apcs	O
-	O
deficient	O
mice	O
(	O
Apcs	O
-	O
/	O
-	O
)	O
were	O
chosen	O
as	O
an	O
example	O
of	O
a	O
gene	O
-	O
targeted	O
strain	O
previously	O
reported	O
to	O
develop	O
a	O
lupus	O
-	O
like	O
disease	O
on	O
the	O
hybrid	O
genetic	O
background	O
(	O
129	O
x	O
C57BL	O
/	O
6	O
)	O
;	O
autoimmunity	O
in	O
Apcs	O
-	O
/	O
-	O
mice	O
persists	O
even	O
after	O
backcrossing	O
the	O
mutated	O
gene	O
onto	O
C57BL	O
/	O
6	O
(	O
Bickerstaff	O
et	O
al	O
.	O
1999	O
)	O
.	O

We	O
chose	O
this	O
targeted	O
gene	O
in	O
particular	O
to	O
study	O
since	O
the	O
Apcs	O
gene	O
is	O
located	O
on	O
Chromosome	S-GO
1	O
,	O
approximately	O
94	O
cM	O
from	O
the	O
centromere	O
,	O
within	O
a	O
region	O
where	O
several	O
lupus	O
-	O
susceptibility	O
loci	O
,	O
designated	O
Sle1	O
(	O
Morel	O
et	O
al	O
.	O
2001	O
)	O
,	O
Nba2	O
(	O
Drake	O
et	O
al	O
.	O
1995	O
;	O
Vyse	O
et	O
al	O
.	O
1997	O
)	O
,	O
and	O
Bxs3	O
(	O
Hogarth	O
et	O
al	O
.	O
1998	O
;	O
Haywood	O
et	O
al	O
.	O
2000	O
)	O
,	O
have	O
been	O
mapped	O
in	O
NZW	O
,	O
NZB	O
,	O
and	O
BXSB	O
lupus	O
-	O
prone	O
strains	O
,	O
respectively	O
.	O

This	O
region	O
contains	O
several	O
genes	O
,	O
including	O
those	O
encoding	O
Fc	O
gamma	O
RII	O
,	O
the	O
complement	O
receptor	O
CR1	O
/	O
2	O
(	O
CD35	O
/	O
CD21	O
)	O
,	O
and	O
the	O
decay	O
-	O
accelerating	O
factor	O
CD55	O
(	O
Prodeus	O
et	O
al	O
.	O
1998	O
;	O
Bolland	O
and	O
Ravetch	O
2000	O
;	O
Miwa	O
et	O
al	O
.	O
2002	O
;	O
Wu	O
et	O
al	O
.	O
2002	O
)	O
,	O
which	O
have	O
each	O
been	O
implicated	O
in	O
the	O
causation	O
of	O
SLE	O
when	O
inactivated	O
by	O
gene	O
-	O
targeting	O
in	O
129	O
embryonic	O
stem	O
cells	O
.	O

Here	O
we	O
show	O
that	O
there	O
are	O
multiple	O
genetic	O
loci	O
,	O
derived	O
from	O
both	O
129	O
and	O
C57BL	O
/	O
6	O
mice	O
,	O
contributing	O
to	O
autoimmunity	O
.	O

Furthermore	O
,	O
a	O
129	O
-	O
derived	O
interval	O
on	O
distal	O
Chromosome	O
1	O
,	O
when	O
transferred	O
onto	O
the	O
C57BL	O
/	O
6	O
genome	O
,	O
a	O
combination	O
commonly	O
created	O
by	O
backcrossing	O
onto	O
C57BL	O
/	O
6	O
a	O
gene	O
that	O
has	O
been	O
inactivated	O
in	O
129	O
embryonic	O
stem	O
cells	O
,	O
was	O
sufficient	O
to	O
cause	O
humoral	O
autoimmunity	O
in	O
its	O
own	O
right	O
,	O
irrespective	O
of	O
the	O
presence	O
of	O
the	O
mutated	O
Apcs	O
gene	O
.	O

These	O
results	O
demonstrate	O
important	O
epistatic	O
interactions	O
between	O
genes	O
from	O
129	O
and	O
C57BL	O
/	O
6	O
genomes	O
on	O
the	O
development	O
of	O
autoimmunity	O
and	O
illustrate	O
the	O
important	O
effects	O
of	O
background	O
genes	O
in	O
the	O
analysis	O
and	O
interpretation	O
of	O
autoimmune	O
phenotypes	O
associated	O
with	O
targeted	O
genetic	O
disruptions	O
.	O

Results	O

Disease	O
Traits	O
in	O
(	O
129	O
x	O
C57BL	O
/	O
6	O
)	O
F2	O
and	O
(	O
129	O
x	O
C57BL	O
/	O
6	O
)	O
F2	O
.	O
Apcs	O
-	O
/	O
-	O
Mice	O

To	O
investigate	O
the	O
genetic	O
basis	O
of	O
the	O
lupus	O
-	O
like	O
disease	O
observed	O
in	O
the	O
(	O
129	O
x	O
C57BL	O
/	O
6	O
)	O
hybrid	O
mice	O
,	O
we	O
generated	O
two	O
large	O
cohorts	O
of	O
(	O
129	O
x	O
C57BL	O
/	O
6	O
)	O
F2	O
animals	O
,	O
one	O
carrying	O
a	O
mutation	O
in	O
the	O
Apcs	O
gene	O
,	O
and	O
monitored	O
them	O
for	O
1	O
y	O
under	O
identical	O
environmental	O
conditions	O
.	O

Since	O
female	O
mice	O
in	O
the	O
original	O
reports	O
showed	O
a	O
higher	O
penetrance	O
of	O
disease	O
,	O
the	O
present	O
study	O
was	O
conducted	O
only	O
on	O
female	O
mice	O
.	O

The	O
results	O
of	O
the	O
phenotypic	O
analysis	O
at	O
1	O
y	O
of	O
age	O
are	O
summarised	O
in	O
Tables	O
1	O
and	O
2	O
.	O

As	O
previously	O
reported	O
(	O
Botto	O
et	O
al	O
.	O
1998	O
)	O
,	O
the	O
wild	O
-	O
type	O
(	O
129	O
x	O
C57BL	O
/	O
6	O
)	O
F2	O
mice	O
developed	O
lupus	O
traits	O
with	O
elevated	O
levels	O
of	O
auto	O
-	O
Abs	S-GO
,	O
starting	O
from	O
6	O
mo	O
of	O
age	O
(	O
data	O
not	O
shown	O
)	O
,	O
and	O
histological	O
evidence	O
of	O
proliferative	O
glomerulonephritis	O
.	O

In	O
agreement	O
with	O
our	O
previous	O
observations	O
(	O
Bickerstaff	O
et	O
al	O
.	O
1999	O
)	O
,	O
the	O
titres	O
of	O
anti	O
-	O
nuclear	S-GO
Abs	S-GO
(	O
ANAs	O
)	O
and	O
anti	O
-	O
chromatin	S-GO
Ab	S-GO
were	O
considerably	O
greater	O
in	O
the	O
(	O
129	O
x	O
C57BL	O
/	O
6	O
)	O
F2	O
.	O
Apcs	O
-	O
/	O
-	O
mice	O
compared	O
with	O
the	O
strain	O
-	O
matched	O
controls	O
.	O

However	O
,	O
in	O
contrast	O
to	O
our	O
original	O
findings	O
,	O
the	O
levels	O
of	O
the	O
other	O
two	O
disease	O
serological	O
markers	O
analysed	O
(	O
anti	O
-	O
single	O
-	O
stranded	O
DNA	O
[	O
ssDNA	O
]	O
and	O
anti	O
-	O
double	O
-	O
stranded	O
DNA	O
[	O
dsDNA	O
]	O
Abs	S-GO
)	O
and	O
the	O
severity	O
of	O
the	O
renal	O
pathology	O
were	O
not	O
different	O
between	O
the	O
two	O
experimental	O
groups	O
.	O

In	O
view	O
of	O
the	O
possibility	O
of	O
an	O
association	O
between	O
the	O
fixed	O
129	O
-	O
derived	O
segment	O
flanking	O
the	O
mutated	O
Apcs	O
gene	O
and	O
the	O
autoimmune	O
traits	O
observed	O
,	O
the	O
genome	O
-	O
wide	O
linkage	O
analysis	O
of	O
the	O
two	O
experimental	O
cohorts	O
was	O
carried	O
out	O
separately	O
.	O

Mapping	O
of	O
Loci	O
Predisposing	O
to	O
Lupus	O
in	O
the	O
Hybrid	O
Strain	O
(	O
129	O
x	O
C57BL	O
/	O
6	O
)	O

Mice	O
were	O
genotyped	O
with	O
143	O
microsatellite	O
markers	O
distributed	O
throughout	O
the	O
autosomes	S-GO
such	O
that	O
98	O
%	O
of	O
the	O
genes	O
were	O
within	O
20	O
cM	O
of	O
an	O
informative	O
marker	O
.	O

A	O
summary	O
of	O
the	O
genome	O
-	O
wide	O
linkage	O
analysis	O
for	O
each	O
of	O
the	O
disease	O
traits	O
measured	O
is	O
shown	O
in	O
Table	O
3	O
.	O

The	O
areas	O
of	O
linkage	O
were	O
defined	O
according	O
to	O
the	O
parental	O
origin	O
,	O
129	O
or	O
C57BL	O
/	O
6	O
.	O

Only	O
linkages	O
identified	O
in	O
both	O
experimental	O
groups	O
are	O
reported	O
in	O
Table	O
3	O
,	O
with	O
the	O
exception	O
of	O
the	O
Chromosome	O
1	O
distal	O
segment	O
,	O
where	O
the	O
linkage	O
analysis	O
could	O
not	O
be	O
applied	O
to	O
the	O
(	O
129	O
x	O
C57BL	O
/	O
6	O
)	O
F2	O
.	O
Apcs	O
-	O
/	O
-	O
mice	O
as	O
this	O
region	O
was	O
of	O
fixed	O
129	O
origin	O
.	O

Chromosomes	S-GO
where	O
linkages	O
were	O
present	O
only	O
in	O
one	O
of	O
the	O
two	O
cohorts	O
are	O
shown	O
in	O
Figures	O
1	O
-	O
3	O
.	O

The	O
quantitative	O
trait	O
linkage	O
(	O
QTL	O
)	O
analysis	O
identified	O
several	O
intervals	O
on	O
Chromosome	O
1	O
with	O
linkage	O
to	O
disease	O
serological	O
markers	O
,	O
and	O
these	O
regions	O
were	O
all	O
derived	O
from	O
the	O
129	O
mouse	O
strain	O
(	O
see	O
Table	O
3	O
;	O
Figures	O
4	O
and	O
5	O
)	O
.	O

Interestingly	O
,	O
whilst	O
ANA	O
and	O
anti	O
-	O
chromatin	S-GO
Ab	S-GO
levels	O
showed	O
suggestive	O
or	O
significant	O
linkages	O
only	O
to	O
the	O
telomeric	B-GO
region	I-GO
of	I-GO
Chromosome	E-GO
1	O
,	O
with	O
an	O
estimated	O
peak	O
occurring	O
at	O
a	O
position	O
approximately	O
90	O
cM	O
near	O
the	O
Apcs	O
gene	O
,	O
anti	O
-	O
dsDNA	O
or	O
anti	O
-	O
ssDNA	O
Ab	S-GO
production	O
was	O
also	O
linked	O
to	O
other	O
segments	O
on	O
Chromosome	O
1	O
,	O
indicating	O
a	O
more	O
complex	O
genetic	O
contribution	O
from	O
the	O
129	O
mouse	O
strain	O
.	O

Guided	O
by	O
these	O
observations	O
,	O
we	O
investigated	O
whether	O
the	O
increased	O
levels	O
of	O
ANA	O
and	O
anti	O
-	O
chromatin	S-GO
Ab	S-GO
observed	O
in	O
the	O
Apcs	O
-	O
/	O
-	O
mice	O
were	O
caused	O
by	O
a	O
gene	O
(	O
s	O
)	O
within	O
the	O
fixed	O
129	O
region	O
surrounding	O
the	O
mutated	O
Apcs	O
gene	O
,	O
rather	O
than	O
caused	O
by	O
the	O
mutated	O
Apcs	O
gene	O
itself	O
.	O

We	O
compared	O
the	O
levels	O
of	O
these	O
auto	O
-	O
Abs	S-GO
between	O
all	O
(	O
129	O
x	O
C57BL	O
/	O
6	O
)	O
F2	O
.	O
Apcs	O
-	O
/	O
-	O
mice	O
and	O
a	O
group	O
of	O
33	O
wild	O
-	O
type	O
mice	O
that	O
were	O
selected	O
for	O
being	O
homozygous	O
129	O
in	O
the	O
region	O
of	O
Chromosome	O
1	O
between	O
microsatellites	O
D1Mit105	O
and	O
D1Mit	O
223	O
(	O
80	O
-	O
106	O
cM	O
)	O
(	O
Figure	O
6A	O
-	O
6D	O
)	O
.	O

In	O
contrast	O
to	O
the	O
results	O
reported	O
in	O
Table	O
1	O
,	O
this	O
comparison	O
showed	O
no	O
significant	O
differences	O
between	O
the	O
two	O
experimental	O
groups	O
.	O

This	O
result	O
demonstrates	O
that	O
,	O
most	O
likely	O
,	O
the	O
129	O
-	O
derived	O
region	O
and	O
not	O
the	O
lack	O
of	O
Apcs	O
was	O
mediating	O
the	O
production	O
of	O
ANA	O
and	O
anti	O
-	O
chromatin	S-GO
Ab	S-GO
.	O

Consistent	O
with	O
this	O
explanation	O
,	O
we	O
found	O
that	O
the	O
129	O
mice	O
have	O
significantly	O
higher	O
levels	O
of	O
Apcs	O
in	O
circulation	O
compared	O
with	O
the	O
C57BL	O
/	O
6	O
mice	O
(	O
median	O
,	O
83	O
mg	O
/	O
l	O
;	O
range	O
,	O
25	O
-	O
208	O
;	O
n	O
=	O
16	O
versus	O
median	O
,	O
5	O
mg	O
/	O
l	O
;	O
range	O
,	O
4	O
-	O
9	O
;	O
n	O
=	O
10	O
,	O
respectively	O
;	O
p	O
<	O
0	O
.	O
0001	O
)	O
.	O

The	O
C57BL	O
/	O
6	O
strain	O
has	O
previously	O
been	O
reported	O
to	O
be	O
one	O
of	O
the	O
murine	O
strains	O
defined	O
as	O
low	O
Apcs	O
producers	O
(	O
Pepys	O
et	O
al	O
.	O
1979	O
;	O
Baltz	O
et	O
al	O
.	O
1980	O
)	O
.	O

In	O
addition	O
,	O
sequence	O
analysis	O
of	O
the	O
entire	O
Apcs	O
coding	O
region	O
in	O
both	O
strains	O
failed	O
to	O
identify	O
any	O
coding	O
sequence	O
polymorphisms	O
in	O
the	O
Apcs	O
gene	O
(	O
data	O
not	O
shown	O
)	O
,	O
indicating	O
that	O
a	O
structural	O
variant	O
of	O
the	O
protein	O
is	O
unlikely	O
to	O
be	O
the	O
explanation	O
for	O
our	O
findings	O
.	O

This	O
is	O
consistent	O
with	O
a	O
previous	O
report	O
by	O
Drake	O
et	O
al	O
.	O

(	O
1996	O
)	O
that	O
showed	O
no	O
Apcs	O
coding	O
sequence	O
differences	O
amongst	O
several	O
autoimmune	O
and	O
nonautoimmune	O
murine	O
strains	O
.	O

In	O
addition	O
to	O
the	O
129	O
-	O
derived	O
segments	O
,	O
in	O
both	O
cohorts	O
the	O
C57BL	O
/	O
6	O
strain	O
contributed	O
to	O
the	O
autoimmune	O
traits	O
with	O
one	O
major	O
susceptibility	O
locus	O
on	O
Chromosome	O
3	O
.	O

A	O
genomic	O
region	O
between	O
D3Mit40	O
and	O
D3Mit13	O
,	O
with	O
an	O
estimated	O
peak	O
at	O
position	O
approximately	O
51	O
cM	O
,	O
showed	O
a	O
significant	O
linkage	O
to	O
ANA	O
production	O
and	O
weaker	O
linkages	O
to	O
anti	O
-	O
ssDNA	O
and	O
anti	O
-	O
chromatin	S-GO
production	O
(	O
see	O
Table	O
3	O
;	O
Figure	O
7	O
)	O
.	O

The	O
high	O
frequency	O
of	O
autoimmune	O
phenotype	O
in	O
the	O
(	O
129	O
x	O
C57BL	O
/	O
6	O
)	O
hybrid	O
genetic	O
background	O
and	O
its	O
absence	O
in	O
either	O
of	O
the	O
inbred	O
parental	O
strains	O
imply	O
that	O
there	O
are	O
essential	O
interactions	O
between	O
129	O
-	O
and	O
C57BL	O
/	O
6	O
-	O
derived	O
alleles	O
for	O
the	O
expression	O
of	O
autoimmunity	O
.	O

We	O
investigated	O
further	O
the	O
effects	O
of	O
genes	O
from	O
the	O
C57BL	O
/	O
6	O
background	O
by	O
repeating	O
the	O
linkage	O
analysis	O
in	O
(	O
129	O
x	O
C57BL	O
/	O
6	O
)	O
F2	O
mice	O
,	O
whilst	O
controlling	O
for	O
the	O
very	O
strong	O
129	O
effect	O
on	O
distal	O
Chromosome	S-GO
1	O
,	O
as	O
previously	O
described	O
(	O
Zeng	O
1994	O
)	O
.	O

The	O
results	O
of	O
this	O
analysis	O
showed	O
that	O
the	O
statistical	O
support	O
for	O
the	O
linkage	O
of	O
the	O
C57BL	O
/	O
6	O
locus	O
on	O
Chromosome	O
3	O
for	O
ANA	O
increased	O
from	O
logarithm	O
of	O
odds	O
(	O
LOD	O
)	O
5	O
.	O
4	O
to	O
LOD	O
6	O
.	O
4	O
.	O

In	O
contrast	O
to	O
these	O
strong	O
associations	O
with	O
disease	O
serological	O
markers	O
,	O
the	O
QTL	O
analysis	O
identified	O
only	O
two	O
potential	O
linkages	O
to	O
glomerulonephritis	O
:	O
one	O
in	O
the	O
wild	O
-	O
type	O
mice	O
on	O
Chromosome	S-GO
7	O
across	O
a	O
10	O
cM	O
region	O
between	O
D7Mit246	O
(	O
15	O
cM	O
)	O
and	O
D7Mit145	O
(	O
26	O
.	O
5	O
cM	O
)	O
of	O
129	O
origin	O
(	O
LOD	O
2	O
.	O
86	O
,	O
p	O
=	O
0	O
.	O
0013	O
)	O
,	O
and	O
one	O
on	O
Chromosome	S-GO
17	O
between	O
D17Mit100	O
(	O
11	O
.	O
7	O
cM	O
)	O
and	O
D17Mit216	O
(	O
29	O
.	O
4	O
cM	O
)	O
from	O
the	O
C57BL	O
/	O
6	O
strain	O
(	O
LOD	O
1	O
.	O
3	O
,	O
p	O
=	O
0	O
.	O
049	O
and	O
LOD	O
1	O
.	O
67	O
,	O
p	O
=	O
0	O
.	O
021	O
in	O
the	O
wild	O
-	O
type	O
and	O
Apcs	O
-	O
/	O
-	O
mice	O
,	O
respectively	O
)	O
.	O

Histological	O
evidence	O
of	O
glomerulonephritis	O
was	O
only	O
found	O
in	O
approximately	O
20	O
%	O
of	O
the	O
mice	O
in	O
each	O
cohort	O
,	O
which	O
reduces	O
the	O
power	O
of	O
the	O
QTL	O
analysis	O
for	O
this	O
disease	O
trait	O
.	O

Production	O
of	O
a	O
C57BL	O
/	O
6	O
.	O
129	O
Chromosome	S-GO
1	O
Congenic	O
Line	O
and	O
Its	O
Phenotypic	O
Analysis	O

We	O
generated	O
a	O
C57BL	O
/	O
6	O
congenic	O
line	O
carrying	O
the	O
telomeric	B-GO
region	I-GO
of	I-GO
Chromosome	E-GO
1	O
from	O
the	O
129	O
mouse	O
strain	O
,	O
in	O
order	O
to	O
dissect	O
the	O
complex	O
polygenic	O
disease	O
phenotype	O
of	O
the	O
(	O
C57BL	O
/	O
6	O
x	O
129	O
/	O
Sv	O
)	O
F2	O
hybrid	O
strain	O
into	O
its	O
individual	O
genetic	O
components	O
.	O

The	O
129	O
interval	O
was	O
backcrossed	O
seven	O
times	O
onto	O
C57BL	O
/	O
6	O
,	O
and	O
at	O
each	O
generation	O
the	O
presence	O
or	O
absence	O
of	O
the	O
Chromosome	O
1	O
interval	O
was	O
determined	O
with	O
several	O
microsatellite	O
markers	O
.	O

Each	O
backcrossed	O
generation	O
was	O
screened	O
with	O
more	O
than	O
three	O
markers	O
per	O
chromosome	S-GO
to	O
facilitate	O
the	O
removal	O
of	O
unselected	O
129	O
genomic	O
regions	O
.	O

At	O
the	O
end	O
of	O
the	O
backcrossing	O
,	O
the	O
129	O
-	O
derived	O
Chromosome	O
1	O
interval	O
in	O
the	O
congenic	O
mice	O
extended	O
from	O
microsatellite	O
marker	O
D1Mit105	O
to	O
D1Mit223	O
(	O
80	O
-	O
106	O
cM	O
)	O
,	O
which	O
encompasses	O
the	O
most	O
important	O
129	O
interval	O
identified	O
by	O
the	O
linkage	O
studies	O
in	O
the	O
(	O
C57BL	O
/	O
6	O
x	O
129	O
/	O
Sv	O
)	O
F2	O
mice	O
.	O

Female	O
Chromosome	S-GO
1	O
congenic	O
mice	O
(	O
C57BL	O
/	O
6	O
.	O
129	O
[	O
D1Mit105	O
-	O
223	O
]	O
)	O
,	O
together	O
with	O
sex	O
-	O
matched	O
Apcs	O
-	O
/	O
-	O
mice	O
backcrossed	O
onto	O
C57BL	O
/	O
6	O
for	O
ten	O
generations	O
(	O
C57BL	O
/	O
6	O
.	O
Apcs	O
-	O
/	O
-	O
)	O
and	O
C57BL	O
/	O
6	O
controls	O
,	O
were	O
monitored	O
for	O
the	O
presence	O
of	O
lupus	O
.	O

In	O
the	O
C57BL	O
/	O
6	O
.	O
Apcs	O
-	O
/	O
-	O
mice	O
,	O
the	O
129	O
genome	O
around	O
the	O
Apcs	O
locus	O
was	O
mapped	O
as	O
a	O
stretch	O
of	O
approximately	O
17	O
cM	O
,	O
positioned	O
from	O
87	O
.	O
9	O
cM	O
(	O
D1Mit15	O
)	O
to	O
105	O
cM	O
(	O
D1Mit17	O
)	O
.	O

Thus	O
,	O
the	O
congenic	O
line	O
carried	O
a	O
similar	O
129	O
region	O
(	O
80	O
-	O
106	O
cM	O
)	O
to	O
the	O
one	O
present	O
in	O
the	O
C57BL	O
/	O
6	O
.	O
Apcs	O
-	O
/	O
-	O
mice	O
(	O
87	O
.	O
9	O
-	O
105	O
cM	O
)	O
.	O

At	O
1	O
y	O
of	O
age	O
,	O
all	O
animals	O
were	O
sacrificed	O
,	O
the	O
auto	O
-	O
Abs	S-GO
assessed	O
,	O
and	O
the	O
renal	O
histology	O
examined	O
.	O

The	O
results	O
of	O
this	O
analysis	O
are	O
shown	O
in	O
Figure	O
8	O
.	O

As	O
previously	O
reported	O
(	O
Bickerstaff	O
et	O
al	O
.	O
1999	O
)	O
,	O
the	O
levels	O
of	O
auto	O
-	O
Abs	S-GO
were	O
markedly	O
increased	O
in	O
the	O
C57BL	O
/	O
6	O
.	O
Apcs	O
-	O
/	O
-	O
compared	O
to	O
the	O
wild	O
-	O
type	O
C57BL	O
/	O
6	O
controls	O
.	O

However	O
,	O
the	O
C57BL	O
/	O
6	O
.	O
129	O
(	O
D1Mit105	O
-	O
223	O
)	O
animals	O
also	O
expressed	O
high	O
levels	O
of	O
auto	O
-	O
Abs	S-GO
,	O
and	O
these	O
titres	O
were	O
not	O
different	O
from	O
those	O
detected	O
in	O
the	O
matched	O
congenic	O
mice	O
containing	O
a	O
null	O
mutation	O
of	O
the	O
Apcs	O
gene	O
.	O

These	O
results	O
clearly	O
demonstrated	O
that	O
epistatic	O
interactions	O
between	O
129	O
loci	O
on	O
Chromosome	O
1	O
and	O
C57BL	O
/	O
6	O
genes	O
were	O
sufficient	O
to	O
mediate	O
the	O
loss	O
of	O
tolerance	O
to	O
nuclear	S-GO
autoantigens	O
.	O

However	O
,	O
in	O
contrast	O
to	O
the	O
serological	O
data	O
,	O
the	O
histological	O
assessment	O
of	O
the	O
kidneys	O
showed	O
evidence	O
of	O
markedly	O
increased	O
glomerulonephritis	O
in	O
the	O
C57BL	O
/	O
6	O
.	O
Apcs	O
-	O
/	O
-	O
compared	O
to	O
both	O
control	O
groups	O
(	O
Figure	O
9	O
)	O
,	O
suggesting	O
that	O
the	O
lack	O
of	O
Apcs	O
,	O
when	O
combined	O
with	O
other	O
C57BL	O
/	O
6	O
susceptibility	O
alleles	O
,	O
can	O
induce	O
the	O
development	O
of	O
severe	O
renal	O
damage	O
.	O

Discussion	O

There	O
is	O
accumulating	O
evidence	O
that	O
background	O
genes	O
may	O
influence	O
the	O
expression	O
of	O
autoimmunity	O
in	O
gene	O
-	O
targeted	O
mice	O
.	O

Here	O
we	O
report	O
what	O
is	O
to	O
our	O
knowledge	O
the	O
first	O
systematic	O
study	O
that	O
has	O
examined	O
this	O
in	O
the	O
129	O
and	O
C57BL	O
/	O
6	O
mouse	O
strains	O
,	O
widely	O
used	O
for	O
gene	O
targeting	O
.	O

Our	O
results	O
demonstrate	O
interacting	O
loci	O
between	O
129	O
and	O
C57BL	O
/	O
6	O
mice	O
that	O
can	O
cause	O
the	O
expression	O
of	O
a	O
powerful	O
autoimmune	O
phenotype	O
in	O
these	O
animals	O
,	O
in	O
the	O
absence	O
of	O
any	O
gene	O
-	O
targeted	O
mutations	O
.	O

We	O
also	O
developed	O
a	O
congenic	O
mouse	O
strain	O
bearing	O
a	O
portion	O
of	O
129	O
Chromosome	O
1	O
on	O
a	O
C57BL	O
/	O
6	O
background	O
and	O
showed	O
that	O
this	O
wild	O
-	O
type	O
congenic	O
line	O
expressed	O
striking	O
anti	O
-	O
nuclear	S-GO
autoimmunity	O
.	O

By	O
comparing	O
this	O
Chromosome	S-GO
1	O
congenic	O
strain	O
with	O
matched	O
congenic	O
mice	O
lacking	O
the	O
Apcs	O
gene	O
,	O
we	O
demonstrated	O
that	O
serum	O
amyloid	O
P	O
component	O
deficiency	O
influences	O
the	O
severity	O
of	O
glomerulonephritis	O
,	O
but	O
is	O
not	O
the	O
prime	O
mover	O
in	O
the	O
induction	O
of	O
anti	O
-	O
nuclear	S-GO
autoimmunity	O
,	O
contrary	O
to	O
our	O
own	O
original	O
interpretation	O
of	O
our	O
data	O
(	O
Bickerstaff	O
et	O
al	O
.	O
1999	O
)	O
.	O

The	O
same	O
consideration	O
applies	O
to	O
other	O
genes	O
located	O
in	O
the	O
same	O
Chromosome	O
1	O
region	O
that	O
have	O
been	O
implicated	O
in	O
the	O
development	O
of	O
SLE	O
when	O
inactivated	O
by	O
gene	O
-	O
targeting	O
in	O
129	O
embryonic	O
stem	O
cells	O
and	O
then	O
backcrossed	O
onto	O
a	O
pure	O
genetic	O
background	O
(	O
Bolland	O
and	O
Ravetch	O
2000	O
;	O
Miwa	O
et	O
al	O
.	O
2002	O
;	O
Wu	O
et	O
al	O
.	O
2002	O
)	O
.	O

For	O
each	O
,	O
there	O
has	O
to	O
be	O
a	O
question	O
as	O
to	O
whether	O
the	O
anti	O
-	O
nuclear	S-GO
autoimmunity	O
is	O
due	O
to	O
the	O
gene	O
-	O
targeted	O
mutant	O
gene	O
or	O
to	O
the	O
normal	O
129	O
genes	O
expressed	O
in	O
the	O
same	O
region	O
as	O
the	O
targeted	O
gene	O
.	O

The	O
influence	O
of	O
background	O
genes	O
on	O
the	O
development	O
of	O
spontaneous	O
autoimmune	O
disease	O
is	O
well	O
known	O
,	O
especially	O
with	O
respect	O
to	O
the	O
lpr	O
and	O
Yaa	O
disease	O
-	O
susceptibility	O
genes	O
.	O

In	O
MRL	O
/	O
Mp	O
mice	O
,	O
the	O
presence	O
of	O
the	O
lpr	O
gene	O
accelerates	O
the	O
development	O
of	O
high	O
level	O
and	O
broad	O
-	O
spectrum	O
auto	O
-	O
Ab	S-GO
production	O
and	O
lethal	O
glomerulonephritis	O
,	O
in	O
addition	O
to	O
marked	O
lymphoproliferative	O
disease	O
.	O

In	O
contrast	O
,	O
homozygosity	O
of	O
the	O
lpr	O
gene	O
in	O
other	O
strains	O
such	O
as	O
C57BL	O
/	O
6	O
,	O
AKR	O
,	O
LG	O
/	O
J	O
,	O
and	O
C3H	O
leads	O
only	O
to	O
auto	O
-	O
Ab	S-GO
production	O
(	O
Izui	O
et	O
al	O
.	O
1984	O
)	O
.	O

Similarly	O
,	O
the	O
Y	B-GO
-	I-GO
chromosome	E-GO
-	O
linked	O
Yaa	O
gene	O
in	O
BXSB	O
and	O
MRL	O
/	O
Mp	O
males	O
enhances	O
the	O
rapid	O
development	O
of	O
auto	O
-	O
Abs	S-GO
and	O
glomerulonephritis	O
(	O
Izui	O
et	O
al	O
.	O
1988	O
;	O
Merino	O
et	O
al	O
.	O
1989	O
)	O
.	O

However	O
,	O
in	O
the	O
C57BL	O
/	O
6	O
background	O
,	O
the	O
Yaa	O
gene	O
does	O
not	O
lead	O
to	O
an	O
autoimmune	O
phenotype	O
(	O
Izui	O
et	O
al	O
.	O
1988	O
)	O
.	O

Not	O
surprisingly	O
,	O
important	O
effects	O
of	O
the	O
genetic	O
background	O
on	O
the	O
expression	O
of	O
autoimmunity	O
have	O
also	O
been	O
reported	O
in	O
gene	O
-	O
targeted	O
mice	O
(	O
Bolland	O
and	O
Ravetch	O
2000	O
;	O
Santiago	O
-	O
Raber	O
et	O
al	O
.	O
2001	O
;	O
Mitchell	O
et	O
al	O
.	O
2002	O
)	O
.	O

Thus	O
,	O
SLE	O
exists	O
as	O
a	O
complex	O
-	O
trait	O
disorder	O
in	O
which	O
specific	O
combinations	O
of	O
susceptibility	O
alleles	O
are	O
required	O
for	O
the	O
expression	O
of	O
the	O
full	O
phenotype	O
.	O

Through	O
the	O
use	O
of	O
microsatellite	O
marker	O
maps	O
,	O
the	O
identification	O
of	O
murine	O
SLE	O
susceptibility	O
intervals	O
in	O
experimental	O
crosses	O
has	O
been	O
made	O
possible	O
.	O

These	O
mapping	O
studies	O
have	O
shown	O
that	O
the	O
disease	O
expression	O
in	O
relation	O
to	O
the	O
inheritance	O
of	O
the	O
different	O
alleles	O
followed	O
a	O
threshold	O
liability	O
pattern	O
in	O
which	O
a	O
positive	O
phenotype	O
depended	O
upon	O
the	O
presence	O
of	O
multiple	O
discrete	O
susceptibility	O
loci	O
with	O
no	O
single	O
locus	O
being	O
a	O
prerequisite	O
factor	O
.	O

We	O
have	O
employed	O
the	O
same	O
approach	O
to	O
analyse	O
the	O
genetic	O
basis	O
of	O
disease	O
inheritance	O
in	O
the	O
(	O
129	O
x	O
C57BL	O
/	O
6	O
)	O
hybrid	O
strain	O
,	O
the	O
most	O
common	O
genetic	O
background	O
in	O
gene	O
-	O
targeted	O
mice	O
.	O

Although	O
spontaneous	O
autoimmunity	O
has	O
not	O
been	O
documented	O
in	O
either	O
of	O
the	O
pure	O
129	O
or	O
C57BL	O
/	O
6	O
strains	O
,	O
a	O
spontaneous	O
lupus	O
-	O
like	O
phenotype	O
has	O
been	O
described	O
in	O
(	O
129	O
x	O
C57BL	O
/	O
6	O
)	O
hybrid	O
strains	O
(	O
Obata	O
et	O
al	O
.	O
1979	O
;	O
Botto	O
et	O
al	O
.	O
1998	O
;	O
Bickerstaff	O
et	O
al	O
.	O
1999	O
;	O
Santiago	O
-	O
Raber	O
et	O
al	O
.	O
2001	O
)	O
,	O
suggesting	O
that	O
the	O
predisposition	O
in	O
these	O
hybrid	O
mice	O
may	O
arise	O
as	O
a	O
result	O
of	O
the	O
interaction	O
between	O
specific	O
combinations	O
of	O
alleles	O
inherited	O
from	O
both	O
the	O
129	O
and	O
C57BL	O
/	O
6	O
parental	O
strains	O
.	O

This	O
was	O
confirmed	O
by	O
the	O
mapping	O
study	O
reported	O
here	O
.	O

We	O
showed	O
that	O
there	O
are	O
multiple	O
genetic	O
loci	O
contributing	O
to	O
the	O
disease	O
and	O
these	O
are	O
derived	O
from	O
both	O
129	O
and	O
C57BL	O
/	O
6	O
mice	O
.	O

We	O
demonstrated	O
that	O
a	O
129	O
-	O
derived	O
segment	O
of	O
Chromosome	O
1	O
was	O
strongly	O
linked	O
to	O
the	O
expression	O
of	O
auto	O
-	O
Abs	S-GO
.	O

This	O
region	O
is	O
probably	O
capable	O
of	O
causing	O
the	O
initiation	O
of	O
a	O
humoral	O
autoimmune	O
response	O
to	O
nuclear	S-GO
antigens	O
;	O
however	O
,	O
this	O
response	O
does	O
not	O
occur	O
in	O
the	O
absence	O
of	O
C57BL	O
/	O
6	O
genes	O
.	O

In	O
support	O
of	O
this	O
,	O
we	O
identified	O
a	O
C57BL	O
/	O
6	O
segment	O
on	O
Chromosome	O
3	O
,	O
which	O
may	O
interact	O
with	O
the	O
129	O
genes	O
on	O
Chromosome	S-GO
1	O
to	O
mediate	O
the	O
loss	O
of	O
tolerance	O
.	O

Interestingly	O
,	O
although	O
the	O
C57BL	O
/	O
6	O
SLE	O
-	O
susceptibility	O
region	O
on	O
Chromosome	O
3	O
is	O
novel	O
,	O
disease	O
-	O
modifying	O
alleles	O
derived	O
from	O
C57BL	O
/	O
10	O
and	O
C57BL	O
/	O
6	O
strains	O
have	O
been	O
mapped	O
to	O
a	O
portion	O
of	O
Chromosome	O
3	O
close	O
to	O
the	O
region	O
identified	O
in	O
this	O
study	O
(	O
Morel	O
et	O
al	O
.	O
1999	O
;	O
Haywood	O
et	O
al	O
.	O
2000	O
)	O
.	O

Furthermore	O
,	O
the	O
region	O
on	O
Chromosome	O
7	O
associated	O
with	O
the	O
development	O
of	O
lupus	O
nephritis	O
has	O
been	O
linked	O
to	O
the	O
same	O
trait	O
in	O
other	O
murine	O
models	O
of	O
SLE	O
(	O
Santiago	O
et	O
al	O
.	O
1998	O
;	O
Morel	O
et	O
al	O
.	O
1999	O
;	O
Xie	O
et	O
al	O
.	O
2002	O
)	O
,	O
suggesting	O
the	O
possibility	O
of	O
shared	O
susceptibility	O
loci	O
.	O

Taken	O
together	O
our	O
results	O
suggest	O
a	O
complex	O
genetic	O
contribution	O
from	O
the	O
(	O
129	O
x	O
C57BL	O
/	O
6	O
)	O
hybrid	O
background	O
genome	O
,	O
with	O
both	O
enhancing	O
as	O
well	O
as	O
inhibitory	O
loci	O
from	O
the	O
129	O
mouse	O
,	O
in	O
addition	O
to	O
genes	O
promoting	O
autoimmunity	O
from	O
the	O
C57BL	O
/	O
6	O
mice	O
.	O

The	O
impact	O
that	O
these	O
interacting	O
loci	O
may	O
have	O
on	O
the	O
lupus	O
-	O
like	O
disease	O
present	O
in	O
several	O
gene	O
-	O
targeted	O
animals	O
was	O
further	O
assessed	O
by	O
comparing	O
Apcs	O
-	O
/	O
-	O
mice	O
with	O
Chromosome	S-GO
1	O
genetically	O
matched	O
controls	O
.	O

In	O
the	O
context	O
of	O
SLE	O
susceptibility	O
,	O
one	O
of	O
the	O
most	O
consistently	O
mapped	O
non	O
-	O
MHC	S-GO
regions	O
of	O
the	O
mouse	O
genome	O
is	O
the	O
telomeric	B-GO
Chromosome	I-GO
1	I-GO
segment	E-GO
,	O
where	O
several	O
disease	O
loci	O
,	O
designated	O
Sle1	O
(	O
Morel	O
et	O
al	O
.	O
2001	O
)	O
,	O
Nba2	O
(	O
Drake	O
et	O
al	O
.	O
1995	O
;	O
Rozzo	O
et	O
al	O
.	O
1996	O
;	O
Vyse	O
et	O
al	O
.	O
1997	O
)	O
,	O
and	O
Bxs3	O
(	O
Hogarth	O
et	O
al	O
.	O
1998	O
)	O
,	O
have	O
been	O
mapped	O
in	O
lupus	O
-	O
prone	O
strains	O
.	O

Moreover	O
,	O
this	O
region	O
of	O
mouse	O
Chromosome	O
1	O
is	O
orthologous	O
to	O
a	O
region	O
on	O
human	O
Chromosome	O
1q22	O
-	O
1q25	O
,	O
which	O
has	O
also	O
been	O
linked	O
with	O
human	O
SLE	O
(	O
Moser	O
et	O
al	O
.	O
1998	O
)	O
.	O

The	O
Apcs	O
gene	O
is	O
one	O
of	O
the	O
candidate	O
genes	O
known	O
to	O
lie	O
within	O
this	O
region	O
.	O

The	O
human	O
serum	O
amyloid	O
P	O
component	O
binds	O
avidly	O
to	O
DNA	O
,	O
chromatin	S-GO
,	O
and	O
apoptotic	O
cells	O
in	O
physiological	O
conditions	O
in	O
vitro	O
(	O
Pepys	O
1974	O
;	O
Pepys	O
and	O
Butler	O
1987	O
;	O
Butler	O
et	O
al	O
.	O
1990	O
)	O
and	O
also	O
to	O
exposed	O
chromatin	S-GO
and	O
apoptotic	O
cells	O
in	O
vivo	O
(	O
Hintner	O
et	O
al	O
.	O
1988	O
;	O
Breathnach	O
et	O
al	O
.	O
1989	O
;	O
Familian	O
et	O
al	O
.	O
2001	O
)	O
.	O

We	O
have	O
previously	O
reported	O
that	O
(	O
129	O
x	O
C57BL	O
/	O
6	O
)	O
.	O
Apcs	O
-	O
/	O
-	O
mice	O
spontaneously	O
produce	O
a	O
wide	O
range	O
of	O
ANAs	O
and	O
develop	O
significant	O
immune	B-GO
complex	E-GO
glomerulonephritis	O
(	O
Bickerstaff	O
et	O
al	O
.	O
1999	O
)	O
.	O

On	O
the	O
basis	O
of	O
these	O
observations	O
,	O
it	O
was	O
postulated	O
that	O
Apcs	O
,	O
by	O
altering	O
the	O
clearance	O
of	O
chromatin	S-GO
,	O
contributes	O
to	O
the	O
pathogenesis	O
of	O
SLE	O
.	O

However	O
,	O
in	O
this	O
study	O
we	O
found	O
that	O
only	O
ANA	O
and	O
anti	O
-	O
chromatin	S-GO
Ab	S-GO
levels	O
were	O
significantly	O
increased	O
in	O
the	O
(	O
129	O
x	O
C57BL	O
/	O
6	O
)	O
F2	O
.	O
Apcs	O
-	O
/	O
-	O
mice	O
.	O

A	O
possible	O
explanation	O
for	O
this	O
discrepancy	O
may	O
lie	O
in	O
the	O
fact	O
that	O
the	O
Apcs	O
-	O
/	O
-	O
mice	O
analysed	O
in	O
the	O
original	O
study	O
were	O
generated	O
from	O
a	O
limited	O
number	O
of	O
founders	O
and	O
that	O
this	O
may	O
have	O
caused	O
a	O
nonrandom	O
inheritance	O
of	O
the	O
loci	O
from	O
the	O
parental	O
strains	O
.	O

Furthermore	O
,	O
the	O
whole	O
-	O
genome	O
analysis	O
identified	O
the	O
129	O
region	O
surrounding	O
the	O
Apcs	O
gene	O
as	O
the	O
main	O
locus	O
contributing	O
to	O
the	O
development	O
of	O
ANA	O
and	O
anti	O
-	O
chromatin	S-GO
Ab	S-GO
.	O

In	O
agreement	O
with	O
this	O
,	O
when	O
we	O
carried	O
out	O
a	O
selective	O
comparison	O
between	O
the	O
(	O
129	O
x	O
C57BL	O
/	O
6	O
)	O
F2	O
.	O
Apcs	O
-	O
/	O
-	O
mice	O
and	O
Chromosome	S-GO
1	O
genetically	O
matched	O
controls	O
,	O
we	O
failed	O
to	O
detect	O
any	O
significant	O
difference	O
in	O
the	O
levels	O
of	O
these	O
two	O
auto	O
-	O
Abs	S-GO
.	O

These	O
findings	O
,	O
taken	O
together	O
,	O
indicated	O
that	O
the	O
phenotype	O
associated	O
with	O
Apcs	O
deficiency	O
was	O
caused	O
by	O
the	O
presence	O
of	O
unaltered	O
129	O
genes	O
from	O
the	O
telomeric	B-GO
region	I-GO
of	I-GO
Chromosome	E-GO
1	O
operating	O
in	O
the	O
C57BL	O
/	O
6	O
genomic	O
background	O
.	O

Strong	O
supportive	O
evidence	O
for	O
this	O
was	O
provided	O
by	O
the	O
analysis	O
of	O
the	O
C57BL	O
/	O
6	O
mice	O
congenic	O
for	O
this	O
129	O
region	O
.	O

The	O
generation	O
and	O
analysis	O
of	O
congenic	O
strains	O
have	O
successfully	O
been	O
used	O
to	O
dissect	O
the	O
contribution	O
of	O
individual	O
susceptibility	O
alleles	O
to	O
a	O
multigenic	O
trait	O
such	O
as	O
SLE	O
.	O

We	O
adopted	O
the	O
same	O
strategy	O
to	O
investigate	O
the	O
relative	O
contribution	O
of	O
the	O
129	O
Chromosome	O
1	O
segment	O
and	O
the	O
Apcs	O
gene	O
to	O
each	O
disease	O
trait	O
.	O

Using	O
this	O
approach	O
,	O
we	O
demonstrated	O
that	O
the	O
129	O
interval	O
on	O
distal	O
Chromosome	O
1	O
,	O
when	O
transferred	O
onto	O
the	O
C57BL	O
/	O
6	O
genome	O
,	O
a	O
combination	O
commonly	O
created	O
by	O
backcrossing	O
onto	O
C57BL	O
/	O
6	O
a	O
mutated	O
gene	O
located	O
in	O
that	O
chromosomal	O
region	O
,	O
was	O
sufficient	O
to	O
mediate	O
the	O
production	O
of	O
auto	O
-	O
Abs	S-GO
.	O

In	O
this	O
context	O
,	O
it	O
is	O
of	O
note	O
that	O
several	O
strains	O
of	O
mice	O
with	O
targeted	O
mutations	O
of	O
genes	O
encoded	O
in	O
this	O
region	O
have	O
been	O
reported	O
to	O
express	O
a	O
lupus	O
-	O
like	O
illness	O
,	O
including	O
mice	O
lacking	O
Fc	O
gamma	O
RIIB	O
(	O
Bolland	O
and	O
Ravetch	O
2000	O
)	O
,	O
complement	O
receptors	O
(	O
CR1	O
/	O
2	O
)	O
(	O
Prodeus	O
et	O
al	O
.	O
1998	O
;	O
Wu	O
et	O
al	O
.	O
2002	O
)	O
,	O
and	O
decay	O
-	O
accelerating	O
factor	O
(	O
CD55	O
)	O
(	O
Miwa	O
et	O
al	O
.	O
2002	O
)	O
.	O

In	O
each	O
case	O
,	O
the	O
autoimmune	O
phenotype	O
was	O
described	O
in	O
mice	O
in	O
which	O
the	O
null	O
mutation	O
was	O
generated	O
in	O
129	O
embryonic	O
stem	O
cells	O
and	O
then	O
backcrossed	O
to	O
the	O
C57BL	O
/	O
6	O
or	O
another	O
genetic	O
background	O
.	O

Thus	O
,	O
in	O
view	O
of	O
our	O
findings	O
,	O
one	O
may	O
postulate	O
that	O
in	O
each	O
of	O
these	O
murine	O
models	O
of	O
SLE	O
,	O
the	O
effects	O
of	O
the	O
targeted	O
null	O
gene	O
were	O
irrelevant	O
.	O

Similar	O
conclusions	O
may	O
apply	O
to	O
other	O
gene	O
-	O
targeted	O
animals	O
carrying	O
mutations	O
of	O
genes	O
mapped	O
in	O
the	O
129	O
-	O
derived	O
susceptibility	O
allele	O
on	O
Chromosome	S-GO
7	O
(	O
O	O
'	O
Keefe	O
et	O
al	O
.	O
1996	O
,	O
1999	O
)	O
.	O

The	O
expression	O
of	O
anti	O
-	O
nuclear	S-GO
autoimmunity	O
was	O
identical	O
comparing	O
the	O
congenic	O
with	O
the	O
Apcs	O
-	O
/	O
-	O
mice	O
.	O

The	O
only	O
difference	O
in	O
phenotype	O
between	O
these	O
mice	O
was	O
in	O
the	O
expression	O
of	O
glomerulonephritis	O
,	O
which	O
was	O
more	O
pronounced	O
in	O
the	O
Apcs	O
-	O
/	O
-	O
mice	O
compared	O
with	O
the	O
congenic	O
mice	O
.	O

Although	O
these	O
findings	O
demonstrate	O
that	O
Apcs	O
is	O
not	O
implicated	O
in	O
the	O
processing	O
of	O
autoantigens	O
,	O
as	O
it	O
had	O
previously	O
been	O
suggested	O
,	O
they	O
indicate	O
that	O
Apcs	O
might	O
still	O
play	O
an	O
important	O
protective	O
role	O
in	O
lupus	O
nephritis	O
.	O

In	O
support	O
of	O
this	O
,	O
the	O
expression	O
of	O
the	O
human	O
C	O
-	O
reactive	O
protein	O
,	O
an	O
acute	O
-	O
phase	O
protein	O
closely	O
related	O
to	O
Apcs	O
,	O
has	O
been	O
shown	O
to	O
delay	O
the	O
onset	O
and	O
severity	O
of	O
lupus	O
nephritis	O
in	O
the	O
NZB	O
/	O
W	O
strain	O
by	O
preventing	O
the	O
deposition	O
of	O
immune	B-GO
complexes	E-GO
in	O
the	O
renal	O
cortex	O
(	O
Szalai	O
et	O
al	O
.	O
2003	O
)	O
.	O

Consistent	O
with	O
this	O
,	O
a	O
polymorphism	O
associated	O
with	O
reduced	O
basal	O
level	O
of	O
C	O
-	O
reactive	O
protein	O
has	O
been	O
reported	O
to	O
be	O
linked	O
to	O
SLE	O
in	O
humans	O
(	O
Russell	O
et	O
al	O
.	O
2004	O
)	O
.	O

However	O
,	O
as	O
the	O
congenic	O
mice	O
and	O
the	O
Apcs	O
-	O
/	O
-	O
mice	O
carried	O
similar	O
but	O
not	O
identical	O
129	O
regions	O
on	O
Chromosome	O
1	O
,	O
an	O
alternative	O
explanation	O
for	O
our	O
findings	O
may	O
still	O
lay	O
in	O
the	O
numerous	O
and	O
complex	O
synergistic	O
and	O
counteractive	O
interactions	O
between	O
129	O
and	O
C57BL	O
/	O
6	O
genes	O
involved	O
in	O
self	O
-	O
tolerance	O
and	O
end	O
organ	O
damage	O
.	O

Thus	O
,	O
whilst	O
the	O
lack	O
of	O
lupus	O
nephritis	O
in	O
the	O
congenic	O
mice	O
is	O
consistent	O
with	O
the	O
need	O
for	O
multiple	O
susceptibility	O
genes	O
for	O
the	O
full	O
expression	O
of	O
lupus	O
,	O
further	O
studies	O
will	O
be	O
required	O
to	O
fully	O
elucidate	O
the	O
role	O
of	O
Apcs	O
in	O
the	O
pathogenesis	O
of	O
renal	O
damage	O
.	O

In	O
summary	O
,	O
our	O
findings	O
demonstrate	O
the	O
impact	O
of	O
epistatic	O
interactions	O
between	O
129	O
and	O
C57BL	O
/	O
6	O
genomes	O
on	O
the	O
development	O
of	O
SLE	O
and	O
illustrate	O
how	O
these	O
background	O
gene	O
effects	O
may	O
lead	O
to	O
incorrect	O
interpretations	O
when	O
analysing	O
the	O
autoimmune	O
phenotype	O
of	O
specific	O
genetic	O
disruptions	O
.	O

Materials	O
and	O
Methods	O

Mice	O
.	O

All	O
the	O
mice	O
were	O
females	O
.	O

Wild	O
-	O
type	O
C57BL	O
/	O
6	O
and	O
129	O
/	O
Sv	O
(	O
129S6	O
,	O
according	O
to	O
the	O
revised	O
nomenclature	O
)	O
were	O
bred	O
and	O
maintained	O
in	O
the	O
animal	O
care	O
facility	O
at	O
Imperial	O
College	O
,	O
London	O
,	O
United	O
Kingdom	O
.	O

(	O
129	O
x	O
C57BL	O
/	O
6	O
)	O
F1	O
mice	O
were	O
generated	O
by	O
intercrossing	O
the	O
two	O
wild	O
-	O
type	O
strains	O
and	O
(	O
129	O
x	O
C57BL	O
/	O
6	O
)	O
F2	O
mice	O
by	O
interbreeding	O
the	O
(	O
129	O
x	O
C57BL	O
/	O
6	O
)	O
F1	O
mice	O
.	O

The	O
Apcs	O
-	O
/	O
-	O
mice	O
were	O
generated	O
as	O
previously	O
reported	O
(	O
Botto	O
et	O
al	O
.	O
1997	O
)	O
,	O
and	O
the	O
(	O
129	O
x	O
C57BL	O
/	O
6	O
)	O
F2	O
.	O
Apcs	O
-	O
/	O
-	O
mice	O
were	O
generated	O
by	O
intercrossing	O
Apcs	O
-	O
/	O
-	O
mice	O
on	O
the	O
129	O
genetic	O
background	O
with	O
Apcs	O
-	O
/	O
-	O
animals	O
backcrossed	O
onto	O
C57BL	O
/	O
6	O
for	O
ten	O
generations	O
.	O

A	O
total	O
of	O
141	O
(	O
129	O
x	O
C57BL	O
/	O
6	O
)	O
F2	O
and	O
158	O
(	O
129	O
x	O
C57BL	O
/	O
6	O
)	O
F2	O
.	O
Apcs	O
-	O
/	O
-	O
female	O
mice	O
were	O
produced	O
and	O
monitored	O
for	O
1	O
y	O
.	O

Wild	O
-	O
type	O
congenic	O
C57BL	O
/	O
6	O
.	O
129	O
(	O
D1Mit105	O
-	O
223	O
)	O
mice	O
were	O
generated	O
by	O
backcrossing	O
the	O
129	O
interval	O
between	O
microsatellites	O
D1Mit105	O
and	O
D1Mit223	O
(	O
80	O
cM	O
to	O
106	O
cM	O
)	O
onto	O
the	O
C57BL	O
/	O
6	O
strain	O
.	O

Inherited	O
129	O
regions	O
were	O
mapped	O
with	O
microsatellite	O
markers	O
polymorphic	O
between	O
129	O
and	O
C57BL	O
/	O
6	O
mice	O
(	O
see	O
below	O
)	O
.	O

After	O
seven	O
generations	O
of	O
backcrossing	O
,	O
siblings	O
were	O
intercrossed	O
to	O
generate	O
C57BL	O
/	O
6	O
.	O
129	O
(	O
D1Mit105	O
-	O
223	O
)	O
congenic	O
mice	O
homozygous	O
for	O
the	O
129	O
Chromosome	O
1	O
interval	O
.	O

Inside	O
129	O
markers	O
at	O
positions	O
81	O
.	O
6	O
cM	O
(	O
D1Mit159	O
)	O
and	O
105	O
cM	O
(	O
D1Mit17	O
)	O
,	O
respectively	O
,	O
and	O
an	O
outside	O
C57BL	O
/	O
6	O
marker	O
at	O
position	O
74	O
.	O
3cM	O
(	O
D1Mit159	O
)	O
were	O
used	O
to	O
further	O
define	O
the	O
interval	O
.	O

In	O
the	O
C57BL	O
/	O
6	O
.	O
Apcs	O
-	O
/	O
-	O
mice	O
(	O
backcrossed	O
onto	O
C57BL	O
/	O
6	O
for	O
ten	O
generations	O
)	O
,	O
the	O
129	O
genome	O
around	O
the	O
Apcs	O
locus	O
was	O
mapped	O
as	O
a	O
segment	O
from	O
87	O
.	O
9	O
cM	O
(	O
D1Mit15	O
)	O
to	O
105	O
cM	O
(	O
D1Mit17	O
)	O
.	O

In	O
this	O
analysis	O
,	O
the	O
inside	O
129	O
markers	O
were	O
at	O
positions	O
93	O
cM	O
(	O
D1Mit36	O
)	O
and	O
99	O
.	O
7	O
cM	O
(	O
D1Mit115	O
)	O
and	O
the	O
outside	O
C57BL	O
/	O
6	O
markers	O
at	O
positions	O
81	O
.	O
6	O
cM	O
(	O
D1Mit159	O
)	O
and	O
106	O
cM	O
(	O
D1Mit223	O
)	O
.	O

Along	O
with	O
28	O
C57BL	O
/	O
6	O
.	O
Apcs	O
-	O
/	O
-	O
mice	O
and	O
30	O
C57BL	O
/	O
6	O
wild	O
-	O
type	O
animals	O
,	O
26	O
C57BL	O
/	O
6	O
.	O
129	O
(	O
D1Mit105	O
-	O
223	O
)	O
female	O
mice	O
-	O
/	O
-	O
were	O
followed	O
up	O
to	O
1	O
y	O
of	O
age	O
.	O

Animals	O
were	O
maintained	O
in	O
specific	O
pathogen	O
-	O
free	O
conditions	O
.	O

All	O
animal	O
procedures	O
were	O
in	O
accordance	O
with	O
institutional	O
guidelines	O
.	O

Serological	O
analyses	O
.	O

Sera	O
,	O
collected	O
at	O
6	O
and	O
12	O
mo	O
of	O
age	O
,	O
were	O
assayed	O
for	O
the	O
presence	O
of	O
auto	O
-	O
Abs	S-GO
.	O

Levels	O
of	O
IgG	O
ANA	O
were	O
sought	O
by	O
indirect	O
immunofluorescence	O
using	O
Hep	O
-	O
2	O
cells	O
,	O
and	O
anti	O
-	O
dsDNA	O
Abs	S-GO
were	O
detected	O
by	O
indirect	O
immunofluorescence	O
on	O
Crithidia	O
luciliae	O
as	O
previously	O
described	O
(	O
Mitchell	O
et	O
al	O
.	O
2002	O
)	O
.	O

Serum	O
samples	O
were	O
screened	O
at	O
a	O
1	O
:	O
80	O
(	O
ANA	O
)	O
or	O
1	O
:	O
20	O
(	O
anti	O
-	O
dsDNA	O
)	O
dilution	O
and	O
the	O
positive	O
samples	O
titrated	O
to	O
endpoint	O
.	O

Abs	S-GO
to	O
ssDNA	O
and	O
anti	O
-	O
chromatin	S-GO
were	O
measured	O
by	O
ELISA	O
,	O
as	O
previously	O
described	O
(	O
Mitchell	O
et	O
al	O
.	O
2002	O
)	O
.	O

Samples	O
were	O
screened	O
at	O
a	O
1	O
:	O
100	O
dilution	O
,	O
and	O
the	O
results	O
were	O
expressed	O
in	O
arbitrary	O
ELISA	O
units	O
(	O
AEUs	O
)	O
relative	O
to	O
a	O
standard	O
positive	O
sample	O
(	O
derived	O
from	O
an	O
MRL	O
/	O
Mp	O
.	O
lpr	O
/	O
lpr	O
mouse	O
)	O
,	O
which	O
was	O
assigned	O
a	O
value	O
of	O
100	O
.	O

For	O
interplate	O
comparison	O
,	O
serial	O
dilutions	O
of	O
a	O
positive	O
control	O
serum	O
sample	O
were	O
included	O
on	O
each	O
plate	O
.	O

Apcs	O
levels	O
were	O
assessed	O
by	O
ELISA	O
using	O
sheep	O
anti	O
-	O
mouse	O
Apcs	O
and	O
rabbit	O
anti	O
-	O
mouse	O
Apcs	O
Abs	S-GO
(	O
Calbiochem	O
,	O
Nottigham	O
,	O
United	O
Kingdom	O
)	O
.	O

Samples	O
were	O
screened	O
at	O
a	O
1	O
:	O
3	O
,	O
000	O
dilution	O
,	O
and	O
the	O
results	O
were	O
expressed	O
in	O
milligrams	O
per	O
liters	O
,	O
referring	O
to	O
a	O
standard	O
curve	O
derived	O
from	O
an	O
acute	O
-	O
phase	O
serum	O
with	O
a	O
known	O
concentration	O
of	O
Apcs	O
(	O
Calbiochem	O
)	O
.	O

Apcs	O
-	O
/	O
-	O
mouse	O
serum	O
was	O
included	O
as	O
a	O
negative	O
control	O
.	O

Histological	O
analysis	O
.	O

All	O
the	O
mice	O
,	O
except	O
the	O
few	O
that	O
died	O
before	O
the	O
end	O
of	O
the	O
experiment	O
,	O
were	O
sacrificed	O
at	O
1	O
y	O
of	O
age	O
,	O
and	O
kidney	O
portions	O
were	O
fixed	O
in	O
Bouin	O
'	O
s	O
solution	O
and	O
paraffin	O
embedded	O
,	O
and	O
sections	O
were	O
stained	O
with	O
periodic	O
acid	O
-	O
Schiff	O
reagent	O
.	O

Glomerular	O
histology	O
was	O
graded	O
in	O
a	O
blinded	O
fashion	O
as	O
follows	O
:	O
grade	O
0	O
,	O
normal	O
;	O
grade	O
1	O
,	O
hypercellularity	O
involving	O
greater	O
than	O
50	O
%	O
of	O
the	O
glomerular	O
tuft	O
in	O
25	O
%	O
-	O
50	O
%	O
of	O
glomeruli	O
;	O
grade	O
2	O
,	O
hypercellularity	O
involving	O
greater	O
than	O
50	O
%	O
of	O
the	O
glomerular	O
tuft	O
in	O
50	O
%	O
-	O
75	O
%	O
of	O
glomeruli	O
;	O
grade	O
3	O
,	O
glomerular	O
hypercellularity	O
in	O
greater	O
than	O
75	O
%	O
of	O
glomeruli	O
or	O
crescents	O
in	O
greater	O
than	O
25	O
%	O
of	O
glomeruli	O
.	O

Statistical	O
analysis	O

Non	O
-	O
parametric	O
data	O
are	O
expressed	O
as	O
median	O
with	O
range	O
of	O
values	O
in	O
parentheses	O
.	O

All	O
statistics	O
were	O
calculated	O
using	O
GraphPad	O
PrismTM	O
version	O
3	O
.	O
0	O
for	O
Windows	O
(	O
GraphPad	O
Software	O
,	O
San	O
Diego	O
,	O
California	O
,	O
United	O
States	O
)	O
.	O

Non	O
-	O
parametric	O
tests	O
were	O
applied	O
throughout	O
,	O
with	O
differences	O
being	O
considered	O
significant	O
for	O
p	O
values	O
<	O
0	O
.	O
05	O
.	O

The	O
Mann	O
-	O
Whitney	O
test	O
was	O
used	O
for	O
comparison	O
of	O
two	O
groups	O
,	O
whilst	O
for	O
analysis	O
of	O
three	O
groups	O
the	O
Kruskal	O
-	O
Wallis	O
test	O
with	O
Dunn	O
'	O
s	O
multiple	O
comparison	O
test	O
was	O
used	O
.	O

Genotypic	O
analysis	O

Genotyping	O
was	O
carried	O
out	O
by	O
PCR	O
of	O
genomic	O
DNA	O
using	O
143	O
polymorphic	O
markers	O
(	O
list	O
available	O
on	O
request	O
)	O
distributed	O
throughout	O
all	O
19	O
autosomes	S-GO
.	O

PCRs	O
were	O
performed	O
using	O
standard	O
reagents	O
containing	O
1	O
.	O
5	O
mM	O
MgCl2	O
and	O
0	O
.	O
4	O
mu	O
M	O
primers	O
.	O

Microsatellite	O
markers	O
were	O
screened	O
for	O
size	O
polymorphisms	O
between	O
129	O
and	O
C57BL	O
/	O
6	O
mice	O
.	O

Only	O
primers	O
with	O
differences	O
detectable	O
on	O
ethidium	O
bromide	O
-	O
stained	O
agarose	O
gels	O
or	O
on	O
SDS	O
-	O
polyacrylamide	O
gels	O
were	O
used	O
.	O

Linkage	O
analysis	O

The	O
QTL	O
program	O
MAPMANAGER	O
.	O
QTL	O
(	O
ftp	O
:	O
/	O
/	O
mcbio	O
.	O
med	O
.	O
buffalo	O
.	O
edu	O
/	O
pub	O
/	O
MapMgr	O
/	O
)	O
was	O
used	O
,	O
and	O
the	O
two	O
experimental	O
groups	O
were	O
examined	O
independently	O
.	O

Only	O
data	O
from	O
mice	O
at	O
12	O
mo	O
of	O
age	O
were	O
analysed	O
.	O

Log	O
transformations	O
of	O
auto	O
-	O
Abs	S-GO
levels	O
resulted	O
in	O
more	O
normalised	O
distribution	O
and	O
were	O
used	O
in	O
QTL	O
mapping	O
.	O

LOD	O
thresholds	O
for	O
suggestive	O
and	O
significant	O
linkages	O
were	O
determined	O
by	O
using	O
a	O
cohort	O
-	O
and	O
trait	O
-	O
specific	O
permutation	O
test	O
(	O
1	O
,	O
000	O
permutations	O
)	O
.	O

The	O
average	O
threshold	O
for	O
suggestive	O
,	O
significant	O
,	O
and	O
highly	O
significant	O
linkages	O
were	O
LOD	O
>=	O
2	O
.	O
1	O
(	O
p	O
<=	O
7	O
.	O
8	O
x	O
10	O
-	O
3	O
)	O
,	O
LOD	O
>=	O
3	O
.	O
6	O
(	O
p	O
<=	O
2	O
.	O
4	O
x	O
10	O
-	O
4	O
)	O
,	O
and	O
LOD	O
>=	O
5	O
(	O
p	O
<=	O
1	O
x	O
10	O
-	O
5	O
)	O
,	O
respectively	O
(	O
Manly	O
and	O
Olson	O
1999	O
)	O
.	O

Supporting	O
Information	O

Accession	O
Numbers	O

The	O
LocusLink	O
(	O
http	O
:	O
/	O
/	O
www	O
.	O
ncbi	O
.	O
nlm	O
.	O
nih	O
.	O
gov	O
/	O
LocusLink	O
/	O
)	O
ID	O
numbers	O
for	O
the	O
genes	O
and	O
gene	O
products	O
discussed	O
in	O
this	O
paper	O
are	O
Apcs	O
(	O
LocusLink	O
ID	O
20219	O
)	O
,	O
CD35	O
/	O
CD21	O
(	O
LocusLink	O
ID	O
12902	O
)	O
,	O
CD55	O
(	O
LocusLink	O
ID	O
13136	O
)	O
,	O
the	O
FAS	O
receptor	O
gene	O
(	O
LocusLink	O
ID	O
14102	O
)	O
,	O
and	O
Fc	O
gamma	O
RII	O
(	O
LocusLink	O
ID	O
14130	O
)	O
.	O

Acknowledgements	O

We	O
are	O
grateful	O
to	O
M	O
.	O

Lewis	O
for	O
the	O
processing	O
of	O
the	O
samples	O
for	O
histology	O
and	O
to	O
F	O
.	O

Reid	O
and	O
D	O
.	O

Mitchell	O
for	O
their	O
help	O
.	O

We	O
thank	O
all	O
of	O
the	O
staff	O
in	O
the	O
animal	O
facility	O
for	O
their	O
technical	O
assistance	O
.	O

This	O
work	O
was	O
supported	O
by	O
the	O
Wellcome	O
Trust	O
(	O
grant	O
number	O
061438	O
)	O
.	O

JCH	O
was	O
a	O
recipient	O
of	O
a	O
fellowship	O
from	O
the	O
National	O
Institute	O
of	O
Health	O
,	O
Spain	O
(	O
BEFI	O
99	O
/	O
9212	O
)	O
.	O

Abbreviations	O

Ab	S-GO
-	O
antibody	S-GO

ANA	O
-	O
anti	O
-	O
nuclear	O
antibody	S-GO

AEU	O
-	O
arbitrary	O
ELISA	O
unit	O

Apcs	O
-	O
/	O
-	O
-	O
Apcs	O
-	O
deficient	O
mice	O

Apcs	O
-	O
serum	O
amyloid	O
P	O
component	O
gene	O

dsDNA	O
-	O
double	O
-	O
stranded	O
DNA	O

LOD	O
-	O
logarithm	O
of	O
odds	O

QTL	O
-	O
quantitative	O
trait	O
linkage	O

SLE	O
-	O
systemic	O
lupus	O
erythematosus	O

ssDNA	O
-	O
anti	O
-	O
single	O
-	O
stranded	O
DNA	O

Figures	O
and	O
Tables	O

Figure	O
1	O

Linkage	O
of	O
Chromosome	S-GO
2	O
with	O
ANA	O
and	O
Anti	O
-	O
Chromatin	S-GO
Abs	S-GO
in	O
(	O
129	O
x	O
C57BL	O
/	O
6	O
)	O
F2	O
.	O
Apcs	O
-	O
/	O
-	O
Mice	O

These	O
associations	O
were	O
not	O
detected	O
in	O
(	O
129	O
x	O
C57BL	O
/	O
6	O
)	O
F2	O
animals	O
.	O

Centimorgan	O
positions	O
were	O
deduced	O
by	O
interval	O
mapping	O
,	O
anchoring	O
marker	O
locations	O
to	O
data	O
from	O
http	O
:	O
/	O
/	O
www	O
.	O
informatics	O
.	O
jax	O
.	O
org	O
.	O

Dotted	O
lines	O
and	O
the	O
dashed	O
line	O
indicate	O
the	O
threshold	O
over	O
which	O
linkages	O
were	O
considered	O
suggestive	O
or	O
significant	O
,	O
respectively	O
,	O
as	O
defined	O
in	O
Materials	O
and	O
Methods	O
.	O

Figure	O
3	O

Linkage	O
of	O
Chromosome	S-GO
4	O
with	O
Anti	O
-	O
dsDNA	O
Abs	S-GO

The	O
estimated	O
peak	O
in	O
(	O
129	O
x	O
C57BL	O
/	O
6	O
)	O
F2	O
mice	O
was	O
at	O
position	O
51	O
.	O
3	O
cM	O
,	O
whilst	O
in	O
the	O
(	O
129	O
x	O
C57BL	O
/	O
6	O
)	O
F2	O
.	O
Apcs	O
-	O
/	O
-	O
animals	O
it	O
was	O
was	O
at	O
position	O
71	O
cM	O
,	O
indicating	O
that	O
most	O
likely	O
these	O
were	O
two	O
independent	O
loci	O
.	O

Centimorgan	O
positions	O
were	O
deduced	O
by	O
interval	O
mapping	O
,	O
anchoring	O
marker	O
locations	O
to	O
data	O
from	O
http	O
:	O
/	O
/	O
www	O
.	O
informatics	O
.	O
jax	O
.	O
org	O
.	O

Dotted	O
lines	O
the	O
indicate	O
threshold	O
over	O
which	O
linkage	O
was	O
considered	O
suggestive	O
,	O
as	O
defined	O
in	O
Materials	O
and	O
Methods	O
.	O

Figure	O
4	O

Interval	O
Mapping	O
Scans	O
Showing	O
QTL	O
on	O
Chromosome	S-GO
1	O
with	O
Anti	O
-	O
dsDNA	O
and	O
Anti	O
-	O
ssDNA	O
Abs	S-GO

Centimorgan	O
positions	O
were	O
deduced	O
by	O
interval	O
mapping	O
,	O
anchoring	O
marker	O
locations	O
to	O
data	O
from	O
http	O
:	O
/	O
/	O
www	O
.	O
informatics	O
.	O
jax	O
.	O
org	O
.	O

Dotted	O
lines	O
indicate	O
the	O
threshold	O
over	O
which	O
linkage	O
was	O
considered	O
suggestive	O
,	O
dashed	O
lines	O
indicate	O
the	O
threshold	O
over	O
which	O
linkage	O
was	O
considered	O
significant	O
,	O
and	O
dotted	O
/	O
dashed	O
lines	O
indicate	O
highly	O
significant	O
linkage	O
,	O
as	O
defined	O
in	O
Materials	O
and	O
Methods	O
.	O

See	O
Table	O
3	O
for	O
additional	O
details	O
.	O

Figure	O
5	O

Interval	O
Mapping	O
Scans	O
Showing	O
QTL	O
on	O
Chromosome	S-GO
1	O
with	O
ANA	O
and	O
Anti	O
-	O
Chromatin	S-GO
Abs	S-GO

Centimorgan	O
positions	O
were	O
deduced	O
by	O
interval	O
mapping	O
,	O
anchoring	O
marker	O
locations	O
to	O
data	O
from	O
http	O
:	O
/	O
/	O
www	O
.	O
informatics	O
.	O
jax	O
.	O
org	O
.	O

Dotted	O
lines	O
indicate	O
the	O
threshold	O
over	O
which	O
linkage	O
was	O
considered	O
suggestive	O
,	O
and	O
dashed	O
lines	O
indicate	O
the	O
threshold	O
over	O
which	O
linkage	O
was	O
considered	O
significant	O
,	O
as	O
defined	O
in	O
Materials	O
and	O
Methods	O
.	O

See	O
Table	O
3	O
for	O
additional	O
details	O
.	O

Figure	O
6	O

Auto	O
-	O
Ab	S-GO
Profiles	O

(	O
A	O
)	O
ANA	O
titres	O
in	O
the	O
(	O
129	O
x	O
C57BL	O
/	O
6	O
)	O
F2	O
.	O
Apcs	O
-	O
/	O
-	O
mice	O
and	O
(	O
129	O
x	O
C57BL	O
/	O
6	O
)	O
F2	O
at	O
1	O
y	O
of	O
age	O
.	O

A	O
small	O
circle	O
represents	O
one	O
mouse	O
;	O
a	O
large	O
circle	O
,	O
a	O
variable	O
number	O
of	O
animals	O
,	O
as	O
indicated	O
in	O
parentheses	O
.	O

Serum	O
samples	O
were	O
titrated	O
to	O
endpoint	O
.	O

(	O
B	O
)	O
ANA	O
titres	O
in	O
the	O
(	O
129	O
x	O
C57BL	O
/	O
6	O
)	O
F2	O
.	O
Apcs	O
-	O
/	O
-	O
mice	O
and	O
a	O
selected	O
number	O
of	O
wild	O
-	O
type	O
(	O
129	O
x	O
C57BL	O
/	O
6	O
)	O
F2	O
animals	O
carrying	O
the	O
Chromosome	O
1	O
region	O
between	O
D1Mit105	O
and	O
D1Mit223	O
(	O
80	O
-	O
106	O
cM	O
)	O
of	O
129	O
origin	O
.	O

The	O
symbols	O
are	O
as	O
in	O
(	O
A	O
)	O
.	O

(	O
C	O
and	O
D	O
)	O
Anti	O
-	O
chromatin	S-GO
Ab	S-GO
levels	O
expressed	O
in	O
AEUs	O
related	O
to	O
a	O
standard	O
positive	O
sample	O
,	O
which	O
was	O
assigned	O
a	O
value	O
of	O
100	O
AEU	O
.	O

The	O
comparison	O
is	O
between	O
the	O
same	O
groups	O
of	O
mice	O
as	O
in	O
(	O
A	O
)	O
and	O
(	O
B	O
)	O
,	O
respectively	O
.	O

The	O
symbols	O
are	O
as	O
in	O
(	O
A	O
)	O
.	O

Figure	O
7	O

Interval	O
Mapping	O
Scans	O
Showing	O
QTL	O
on	O
Chromosome	S-GO
3	O
with	O
ANA	O
,	O
Anti	O
-	O
Chromatin	S-GO
,	O
and	O
Anti	O
-	O
ssDNA	O
Abs	S-GO

See	O
Table	O
3	O
for	O
additional	O
details	O
.	O

Centimorgan	O
positions	O
were	O
deduced	O
by	O
interval	O
mapping	O
,	O
anchoring	O
marker	O
locations	O
to	O
data	O
from	O
http	O
:	O
/	O
/	O
www	O
.	O
informatics	O
.	O
jax	O
.	O
org	O
.	O

Dotted	O
lines	O
indicate	O
the	O
threshold	O
over	O
which	O
linkage	O
was	O
considered	O
suggestive	O
,	O
the	O
dashed	O
line	O
indicate	O
the	O
threshold	O
over	O
which	O
linkage	O
was	O
considered	O
significant	O
,	O
and	O
dotted	O
/	O
dashed	O
lines	O
indicate	O
highly	O
significant	O
linkage	O
,	O
as	O
defined	O
in	O
Materials	O
and	O
Methods	O
.	O

Figure	O
8	O

Auto	O
-	O
Ab	S-GO
Profiles	O

(	O
A	O
)	O
ANA	O
titres	O
in	O
C57BL	O
/	O
6	O
mice	O
,	O
C57BL	O
/	O
6	O
.	O
Apcs	O
-	O
/	O
-	O
mice	O
,	O
and	O
C57BL	O
/	O
6	O
.	O
129	O
(	O
D1Mit105	O
-	O
223	O
)	O
congenic	O
mice	O
at	O
1	O
y	O
of	O
age	O
.	O

Small	O
symbols	O
represent	O
one	O
mouse	O
;	O
large	O
symbols	O
,	O
a	O
variable	O
number	O
of	O
animals	O
as	O
indicated	O
in	O
parentheses	O
.	O

Serum	O
sample	O
were	O
titrated	O
to	O
endpoint	O
.	O

(	O
B	O
and	O
C	O
)	O
Anti	O
-	O
ssDNA	O
(	O
B	O
)	O
and	O
anti	O
-	O
chromatin	S-GO
(	O
C	O
)	O
Ab	S-GO
levels	O
in	O
the	O
same	O
cohorts	O
of	O
mice	O
as	O
in	O
(	O
A	O
)	O
.	O

The	O
Ab	S-GO
levels	O
are	O
expressed	O
in	O
AEUs	O
related	O
to	O
a	O
standard	O
positive	O
sample	O
,	O
which	O
was	O
assigned	O
a	O
value	O
of	O
100	O
AEU	O
.	O

(	O
D	O
)	O
Anti	O
-	O
dsDNA	O
Ab	S-GO
levels	O
.	O

Serum	O
samples	O
were	O
screened	O
at	O
1	O
:	O
20	O
.	O

Samples	O
that	O
were	O
positive	O
were	O
titrated	O
to	O
endpoint	O
.	O

The	O
symbols	O
are	O
as	O
in	O
(	O
A	O
)	O
.	O

Figure	O
9	O

Renal	O
Histological	O
Assessment	O

C57BL	O
/	O
6	O
mice	O
,	O
C57BL	O
/	O
6	O
.	O
Apcs	O
-	O
/	O
-	O
mice	O
,	O
and	O
C57BL	O
/	O
6	O
.	O
129	O
(	O
D1Mit105	O
-	O
223	O
)	O
congenic	O
mice	O
were	O
sacrificed	O
at	O
1	O
y	O
of	O
age	O
to	O
obtain	O
age	O
-	O
matched	O
autopsy	O
specimens	O
.	O

Bouin	O
'	O
s	O
fixed	O
kidney	O
sections	O
were	O
scored	O
blinded	O
for	O
glomerulonephritis	O
.	O

Glomerulonephritis	O
was	O
graded	O
on	O
a	O
0	O
-	O
3	O
scale	O
(	O
see	O
Materials	O
and	O
Methods	O
for	O
details	O
)	O
.	O

Figure	O
2	O

Linkage	O
of	O
Chromosome	S-GO
8	O
with	O
Anti	O
-	O
Chromatin	S-GO
and	O
Anti	O
-	O
dsDNA	O
Abs	S-GO
in	O
(	O
129	O
x	O
C57BL	O
/	O
6	O
)	O
F2	O
Mice	O

These	O
linkages	O
were	O
not	O
detected	O
in	O
(	O
129	O
x	O
C57BL	O
/	O
6	O
)	O
F2	O
.	O
Apcs	O
-	O
/	O
-	O
animals	O
.	O

Centimorgan	O
positions	O
were	O
deduced	O
by	O
interval	O
mapping	O
,	O
anchoring	O
marker	O
locations	O
to	O
data	O
from	O
http	O
:	O
/	O
/	O
www	O
.	O
informatics	O
.	O
jax	O
.	O
org	O
.	O

Dotted	O
lines	O
indicate	O
the	O
threshold	O
over	O
which	O
linkage	O
was	O
considered	O
suggestive	O
,	O
as	O
defined	O
in	O
Materials	O
and	O
Methods	O
.	O

Table	O
1	O

Spontaneous	O
Auto	O
-	O
Abs	S-GO
in	O
Apcs	O
-	O
/	O
-	O
and	O
Wild	O
-	O
Type	O
(	O
129	O
x	O
C57BL	O
/	O
6	O
)	O
F2	O
Female	O
Mice	O

Significant	O
differences	O
between	O
Apcs	O
-	O
/	O
-	O
and	O
wild	O
-	O
type	O
controls	O
by	O
Mann	O
-	O
Whitney	O
U	O
test	O
.	O

The	O
numbers	O
tested	O
for	O
different	O
phenotypes	O
are	O
not	O
equal	O
due	O
to	O
the	O
limited	O
amount	O
of	O
serum	O
or	O
death	O
of	O
the	O
mice	O
before	O
the	O
end	O
of	O
the	O
experiment	O
.	O

NS	O
,	O
not	O
significant	O

Table	O
2	O

Histological	O
Assessment	O
of	O
Kidney	O
Sections	O
in	O
Apcs	O
-	O
/	O
-	O
and	O
Wild	O
-	O
Type	O
(	O
129	O
x	O
C57BL	O
/	O
6	O
)	O
F2	O
Female	O
Mice	O

The	O
renal	O
sections	O
were	O
scored	O
on	O
a	O
0	O
-	O
3	O
scale	O
on	O
the	O
intensity	O
and	O
extent	O
of	O
the	O
histopathological	O
changes	O
as	O
described	O
in	O
Materials	O
and	O
Methods	O
.	O

The	O
difference	O
between	O
the	O
two	O
experimental	O
groups	O
was	O
not	O
significant	O

Table	O
3	O

Summary	O
of	O
Genome	O
-	O
Wide	O
Linkage	O
Analysis	O
in	O
Apcs	O
-	O
/	O
-	O
and	O
Wild	O
-	O
Type	O
(	O
129	O
x	O
C57BL	O
/	O
6	O
)	O
F2	O
Female	O
Mice	O

a	O
Suggestive	O
linkage	O

b	O
Significant	O
linkage	O

c	O
Highly	O
significant	O
linkage	O
as	O
defined	O
in	O
the	O
material	O
and	O
method	O
section	O

Chr	S-GO
,	O
Chromosome	S-GO
;	O
Est	O
.	O

Peak	O
,	O
Estimated	O
Peak	O
;	O
LOD	O
,	O
logarithm	O
of	O
odds	O
;	O
N	O
/	O
A	O
,	O
not	O
applicable	O

Chromosomes	S-GO
where	O
linkages	O
were	O
not	O
present	O
in	O
both	O
experimental	O
groups	O
are	O
not	O
illustrated	O
.	O

See	O
Materials	O
and	O
Methods	O
for	O
details	O
.	O

The	O
oligonucleotide	O
sequences	O
and	O
approximate	O
positions	O
of	O
the	O
microsatellite	O
markers	O
used	O
were	O
taken	O
from	O
the	O
Mouse	O
Genome	O
Database	O
,	O
Mouse	O
Genome	O
Informatics	O
,	O
Jackson	O
Laboratory	O
,	O
Bar	O
Harbor	O
,	O
Maine	O
,	O
United	O
States	O
(	O
http	O
:	O
/	O
/	O
www	O
.	O
informatics	O
.	O
jax	O
.	O
org	O
)	O

Footnotes	O

Conflicts	O
of	O
interest	O
.	O

The	O
authors	O
have	O
declared	O
that	O
no	O
conflicts	O
of	O
interest	O
exist	O
.	O

Author	O
contributions	O
.	O

MJW	O
,	O
TJV	O
,	O
and	O
MB	O
conceived	O
and	O
designed	O
the	O
experiments	O
.	O

AEB	O
,	O
KLR	O
,	O
JW	O
,	O
JC	O
-	O
H	O
,	O
and	O
RJR	O
performed	O
the	O
experiments	O
.	O

AEB	O
,	O
KLR	O
,	O
RJR	O
,	O
and	O
HTC	O
analyzed	O
the	O
data	O
.	O

MB	O
wrote	O
the	O
paper	O
.	O

Academic	O
Editor	O
:	O
David	O
Nemazee	O
,	O
Scripps	O
Research	O
Institute	O

currency	O
Current	O
address	O
:	O
The	O
Wellcome	O
Trust	O
,	O
London	O
,	O
United	O
Kingdom	O

Citation	O
:	O
Bygrave	O
AE	O
,	O
Rose	O
KL	O
,	O
Cortes	O
-	O
Hernandez	O
J	O
,	O
Warren	O
J	O
,	O
Rigby	O
RJ	O
,	O
et	O
al	O
.	O

(	O
2004	O
)	O
Spontaneous	O
autoimmunity	O
in	O
129	O
and	O
C57BL	O
/	O
6	O
mice	O
--	O
Implications	O
for	O
autoimmunity	O
described	O
in	O
gene	O
-	O
targeted	O
mice	O
.	O

PLoS	O
Biol	O
2	O
(	O
8	O
)	O
:	O
e243	O
.	O

The	O
phosphatidylserine	O
receptor	O
has	O
essential	O
functions	O
during	O
embryogenesis	O
but	O
not	O
in	O
apoptotic	O
cell	O
removal	O

Abstract	O

Background	O

Phagocytosis	O
of	O
apoptotic	O
cells	O
is	O
fundamental	O
to	O
animal	O
development	O
,	O
immune	O
function	O
and	O
cellular	O
homeostasis	O
.	O

The	O
phosphatidylserine	O
receptor	O
(	O
Ptdsr	O
)	O
on	O
phagocytes	O
has	O
been	O
implicated	O
in	O
the	O
recognition	O
and	O
engulfment	O
of	O
apoptotic	O
cells	O
and	O
in	O
anti	O
-	O
inflammatory	O
signaling	O
.	O

To	O
determine	O
the	O
biological	O
function	O
of	O
the	O
phosphatidylserine	O
receptor	O
in	O
vivo	O
,	O
we	O
inactivated	O
the	O
Ptdsr	O
gene	O
in	O
the	O
mouse	O
.	O

Results	O

Ablation	O
of	O
Ptdsr	O
function	O
in	O
mice	O
causes	O
perinatal	O
lethality	O
,	O
growth	O
retardation	O
and	O
a	O
delay	O
in	O
terminal	O
differentiation	O
of	O
the	O
kidney	O
,	O
intestine	O
,	O
liver	O
and	O
lungs	O
during	O
embryogenesis	O
.	O

Moreover	O
,	O
eye	O
development	O
can	O
be	O
severely	O
disturbed	O
,	O
ranging	O
from	O
defects	O
in	O
retinal	O
differentiation	O
to	O
complete	O
unilateral	O
or	O
bilateral	O
absence	O
of	O
eyes	O
.	O

Ptdsr	O
-	O
/	O
-	O
mice	O
with	O
anophthalmia	O
develop	O
novel	O
lesions	O
,	O
with	O
induction	O
of	O
ectopic	O
retinal	O
-	O
pigmented	O
epithelium	O
in	O
nasal	O
cavities	O
.	O

A	O
comprehensive	O
investigation	O
of	O
apoptotic	O
cell	O
clearance	O
in	O
vivo	O
and	O
in	O
vitro	O
demonstrated	O
that	O
engulfment	O
of	O
apoptotic	O
cells	O
was	O
normal	O
in	O
Ptdsr	O
knockout	O
mice	O
,	O
but	O
Ptdsr	O
-	O
deficient	O
macrophages	O
were	O
impaired	O
in	O
pro	O
-	O
and	O
anti	O
-	O
inflammatory	O
cytokine	O
signaling	O
after	O
stimulation	O
with	O
apoptotic	O
cells	O
or	O
with	O
lipopolysaccharide	O
.	O

Conclusion	O

Ptdsr	O
is	O
essential	O
for	O
the	O
development	O
and	O
differentiation	O
of	O
multiple	O
organs	O
during	O
embryogenesis	O
but	O
not	O
for	O
apoptotic	O
cell	O
removal	O
.	O

Ptdsr	O
may	O
thus	O
have	O
a	O
novel	O
,	O
unexpected	O
developmental	O
function	O
as	O
an	O
important	O
differentiation	O
-	O
promoting	O
gene	O
.	O

Moreover	O
,	O
Ptdsr	O
is	O
not	O
required	O
for	O
apoptotic	O
cell	O
clearance	O
by	O
macrophages	O
but	O
seems	O
to	O
be	O
necessary	O
for	O
the	O
regulation	O
of	O
macrophage	O
cytokine	O
responses	O
.	O

These	O
results	O
clearly	O
contradict	O
the	O
current	O
view	O
that	O
the	O
phosphatidylserine	O
receptor	O
primarily	O
functions	O
in	O
apoptotic	O
cell	O
clearance	O
.	O

Background	O

Programmed	O
cell	O
death	O
,	O
or	O
apoptosis	O
,	O
is	O
required	O
for	O
the	O
normal	O
development	O
of	O
almost	O
all	O
multicellular	O
organisms	O
and	O
is	O
a	O
physiological	O
mechanism	O
for	O
controlling	O
cell	O
number	O
;	O
as	O
a	O
result	O
,	O
structures	O
that	O
are	O
no	O
longer	O
needed	O
are	O
deleted	O
during	O
development	O
and	O
abnormal	O
cells	O
are	O
eliminated	O
[	O
1	O
,	O
2	O
]	O
.	O

Most	O
of	O
the	O
cells	O
produced	O
during	O
mammalian	O
embryonic	O
development	O
undergo	O
physiological	O
cell	O
death	O
before	O
the	O
end	O
of	O
the	O
perinatal	O
period	O
[	O
3	O
]	O
.	O

Apoptotic	O
cells	O
are	O
removed	O
rapidly	O
and	O
efficiently	O
as	O
intact	O
cells	O
or	O
apoptotic	O
bodies	O
by	O
professional	O
phagocytes	O
or	O
by	O
neighboring	O
cells	O
.	O

This	O
highly	O
regulated	O
process	O
prevents	O
the	O
release	O
of	O
potentially	O
noxious	O
or	O
immunogenic	O
intracellular	S-GO
materials	O
and	O
constitutes	O
the	O
fate	O
of	O
most	O
dying	O
cells	O
throughout	O
the	O
lifespan	O
of	O
an	O
organism	O
[	O
4	O
,	O
5	O
]	O
.	O

Phagocytosis	O
of	O
apoptotic	O
cells	O
is	O
very	O
distinct	O
from	O
other	O
engulfment	O
processes	O
that	O
result	O
,	O
for	O
example	O
,	O
in	O
the	O
clearance	O
of	O
microorganisms	O
,	O
because	O
engulfment	O
of	O
apoptotic	O
cells	O
triggers	O
the	O
secretion	O
of	O
potent	O
anti	O
-	O
inflammatory	O
and	O
immunosuppressive	O
mediators	O
,	O
whereas	O
pathogen	O
recognition	O
causes	O
the	O
release	O
of	O
pro	O
-	O
inflammatory	O
signals	O
[	O
6	O
]	O
.	O

Almost	O
all	O
cell	O
types	O
can	O
recognize	O
,	O
respond	O
to	O
,	O
and	O
ingest	O
apoptotic	O
cells	O
by	O
using	O
specific	O
sets	O
of	O
phagocytic	O
receptors	O
that	O
bind	O
to	O
specific	O
ligands	O
on	O
apoptotic	O
cells	O
.	O

Detailed	O
genetic	O
studies	O
in	O
Drosophila	O
and	O
Caenorhabditis	O
elegans	O
have	O
recently	O
yielded	O
evidence	O
that	O
basic	O
phagocytic	O
mechanisms	O
and	O
pathways	O
for	O
the	O
recognition	O
and	O
engulfment	O
of	O
apoptotic	O
cells	O
are	O
highly	O
conserved	O
throughout	O
phylogeny	O
[	O
7	O
,	O
8	O
]	O
.	O

In	O
vertebrates	O
,	O
a	O
number	O
of	O
receptors	O
have	O
been	O
identified	O
that	O
can	O
mediate	O
phagocytosis	O
of	O
apoptotic	O
cells	O
.	O

These	O
include	O
,	O
for	O
example	O
,	O
scavenger	O
receptors	O
and	O
pattern	O
recognition	O
receptors	O
such	O
as	O
CD36	O
,	O
SR	O
-	O
A	O
and	O
CD14	O
,	O
integrins	S-GO
such	O
as	O
the	O
vitronectin	O
receptor	O
alpha	O
v	O
beta	O
3	O
,	O
and	O
members	O
of	O
the	O
collectin	O
family	O
and	O
their	O
receptors	O
CD91	O
and	O
calreticulin	O
[	O
9	O
-	O
13	O
]	O
.	O

The	O
individual	O
roles	O
of	O
these	O
molecules	O
in	O
binding	O
,	O
phagocytosis	O
or	O
transduction	O
of	O
anti	O
-	O
inflammatory	O
signals	O
upon	O
apoptotic	O
cell	O
recognition	O
have	O
not	O
been	O
well	O
defined	O
,	O
however	O
[	O
5	O
,	O
6	O
,	O
14	O
]	O
.	O

The	O
importance	O
of	O
efficient	O
mechanisms	O
for	O
apoptotic	O
cell	O
clearance	O
in	O
vivo	O
is	O
supported	O
by	O
the	O
observation	O
that	O
autoimmune	O
responses	O
can	O
be	O
provoked	O
in	O
mice	O
when	O
key	O
molecules	O
for	O
apoptotic	O
cell	O
recognition	O
and	O
uptake	O
are	O
missing	O
.	O

This	O
has	O
been	O
reported	O
for	O
knockout	O
mice	O
lacking	O
the	O
complement	O
protein	O
C1q	O
[	O
15	O
]	O
,	O
for	O
mice	O
with	O
a	O
mutation	O
in	O
the	O
tyrosine	O
kinase	O
receptor	O
gene	O
Mer	O
[	O
16	O
]	O
and	O
,	O
more	O
recently	O
,	O
in	O
mice	O
lacking	O
transglutaminase	O
2	O
or	O
milk	O
fat	O
globule	O
epidermal	O
growth	O
factor	O
8	O
(	O
MFG	O
-	O
E8	O
)	O
[	O
17	O
,	O
18	O
]	O
.	O

The	O
exposure	O
of	O
the	O
phospholipid	O
phosphatidylserine	O
(	O
PS	O
)	O
in	O
the	O
outer	O
leaflet	O
of	O
the	O
plasma	B-GO
membrane	E-GO
of	O
apoptotic	O
cells	O
has	O
been	O
described	O
as	O
one	O
of	O
the	O
hallmarks	O
of	O
the	O
induction	O
of	O
apoptosis	O
and	O
is	O
considered	O
to	O
be	O
one	O
of	O
the	O
most	O
important	O
signals	O
required	O
for	O
apoptotic	O
cell	O
recognition	O
and	O
removal	O
[	O
19	O
]	O
.	O

A	O
number	O
of	O
cell	B-GO
-	I-GO
surface	E-GO
and	O
bridging	O
molecules	O
can	O
interact	O
with	O
exposed	O
PS	O
on	O
apoptotic	O
cells	O
.	O

These	O
include	O
the	O
serum	O
proteins	O
beta	O
2	O
-	O
glycoprotein	O
1	O
and	O
protein	O
S	O
[	O
20	O
,	O
21	O
]	O
,	O
the	O
growth	O
-	O
arrest	O
-	O
specific	O
gene	O
product	O
GAS	O
-	O
6	O
[	O
22	O
]	O
,	O
complement	O
activation	O
products	O
[	O
23	O
]	O
,	O
the	O
milk	O
fat	O
globule	O
protein	O
MFG	O
-	O
E8	O
[	O
24	O
]	O
,	O
and	O
annexin	O
I	O
[	O
25	O
]	O
.	O

In	O
most	O
cases	O
the	O
receptors	O
on	O
phagocytes	O
that	O
recognize	O
these	O
PS	O
-	O
bridging	O
molecules	O
have	O
not	O
been	O
defined	O
,	O
but	O
it	O
has	O
been	O
reported	O
that	O
GAS	O
-	O
6	O
is	O
a	O
ligand	O
for	O
the	O
tyrosine	O
kinase	O
receptor	O
Mer	O
and	O
that	O
MFG	O
-	O
E8	O
can	O
bind	O
to	O
the	O
vitronectin	O
receptor	O
alpha	O
v	O
beta	O
3	O
[	O
16	O
,	O
24	O
]	O
.	O

Other	O
molecules	O
that	O
bind	O
PS	O
with	O
varying	O
specificity	O
are	O
the	O
lectin	O
-	O
like	O
oxidized	O
low	O
-	O
density	O
lipoprotein	O
receptor	O
-	O
1	O
(	O
LOX	O
-	O
1	O
)	O
and	O
the	O
scavenger	O
receptors	O
CD36	O
and	O
CD68	O
(	O
for	O
review	O
see	O
[	O
5	O
]	O
and	O
references	O
therein	O
)	O
.	O

The	O
best	O
-	O
characterized	O
molecule	O
so	O
far	O
that	O
binds	O
PS	O
in	O
a	O
stereo	O
-	O
specific	O
manner	O
is	O
the	O
phosphatidylserine	O
receptor	O
(	O
Ptdsr	O
)	O
[	O
26	O
]	O
.	O

In	O
vitro	O
,	O
it	O
has	O
been	O
shown	O
that	O
the	O
Ptdsr	O
can	O
mediate	O
the	O
uptake	O
of	O
apoptotic	O
cells	O
and	O
that	O
such	O
Ptdsr	O
-	O
mediated	O
phagocytosis	O
can	O
be	O
inhibited	O
through	O
addition	O
of	O
PS	O
liposomes	O
,	O
the	O
PS	O
-	O
binding	O
molecule	O
annexin	O
V	O
or	O
an	O
anti	O
-	O
Ptdsr	O
antibody	S-GO
[	O
26	O
]	O
.	O

Moreover	O
,	O
the	O
binding	O
of	O
Ptdsr	O
to	O
PS	O
on	O
apoptotic	O
cells	O
has	O
been	O
reported	O
to	O
be	O
important	O
for	O
the	O
release	O
of	O
anti	O
-	O
inflammatory	O
mediators	O
,	O
including	O
transforming	O
growth	O
factor	O
-	O
beta	O
1	O
(	O
TGF	O
-	O
beta	O
1	O
)	O
,	O
platelet	O
-	O
activating	O
factor	O
(	O
PAF	O
)	O
,	O
and	O
prostaglandin	O
E2	O
[	O
26	O
,	O
27	O
]	O
.	O

These	O
data	O
supported	O
the	O
hypothesis	O
that	O
Ptdsr	O
fulfils	O
a	O
role	O
as	O
a	O
crucial	O
signaling	O
switch	O
after	O
the	O
engagement	O
of	O
macrophages	O
with	O
apoptotic	O
cells	O
and	O
is	O
thereby	O
fundamental	O
for	O
preventing	O
local	O
immune	O
responses	O
to	O
apoptotic	O
cells	O
before	O
their	O
clearance	O
[	O
28	O
]	O
.	O

Very	O
recently	O
,	O
Ptdsr	O
has	O
been	O
found	O
in	O
the	O
cell	O
nucleus	S-GO
.	O

Its	O
nuclear	S-GO
localization	O
is	O
mediated	O
by	O
five	O
independent	O
nuclear	S-GO
localization	O
signals	O
,	O
each	O
of	O
which	O
alone	O
is	O
capable	O
of	O
targeting	O
Ptdsr	O
to	O
the	O
cell	O
nucleus	S-GO
[	O
29	O
]	O
.	O

Moreover	O
,	O
an	O
additional	O
study	O
performed	O
recently	O
in	O
Hydra	O
showed	O
an	O
exclusively	O
nuclear	S-GO
localization	O
for	O
the	O
Ptdsr	O
protein	O
[	O
30	O
]	O
.	O

Most	O
interestingly	O
,	O
the	O
nuclear	S-GO
localization	O
of	O
Ptdsr	O
in	O
Hydra	O
epithelial	O
cells	O
did	O
not	O
change	O
upon	O
phagocytosis	O
of	O
apoptotic	O
cells	O
.	O

These	O
reports	O
challenge	O
the	O
original	O
hypothesis	O
,	O
according	O
to	O
which	O
Ptdsr	O
is	O
an	O
exclusively	O
transmembrane	S-GO
receptor	O
for	O
apoptotic	O
cell	O
recognition	O
and	O
anti	O
-	O
inflammatory	O
signaling	O
.	O

To	O
examine	O
further	O
the	O
role	O
of	O
Ptdsr	O
in	O
vivo	O
,	O
we	O
performed	O
gene	O
-	O
expression	O
and	O
gene	O
-	O
targeting	O
studies	O
in	O
mice	O
.	O

A	O
perinatally	O
lethal	O
phenotype	O
was	O
observed	O
in	O
Ptdsr	O
-	O
knockout	O
mice	O
,	O
and	O
Ptdsr	O
-	O
deficient	O
embryos	O
displayed	O
multiple	O
defects	O
in	O
tissue	O
and	O
organ	O
differentiation	O
.	O

While	O
this	O
work	O
was	O
in	O
progress	O
,	O
both	O
Li	O
et	O
al	O
.	O

[	O
31	O
]	O
and	O
Kunisaki	O
et	O
al	O
.	O

[	O
32	O
]	O
also	O
reported	O
the	O
generation	O
and	O
phenotypic	O
characterization	O
of	O
Ptdsr	O
-	O
knockout	O
mice	O
.	O

Of	O
note	O
,	O
although	O
some	O
of	O
their	O
results	O
were	O
confirmed	O
in	O
our	O
study	O
,	O
we	O
found	O
a	O
fundamentally	O
different	O
phenotype	O
with	O
regard	O
to	O
clearance	O
of	O
apoptotic	O
cells	O
.	O

Moreover	O
,	O
our	O
study	O
revealed	O
marked	O
and	O
unexpected	O
findings	O
in	O
Ptdsr	O
-	O
deficient	O
mice	O
that	O
are	O
not	O
related	O
to	O
apoptosis	O
.	O

Results	O

Generation	O
of	O
Ptdsr	O
-	O
deficient	O
mice	O

To	O
investigate	O
in	O
vivo	O
the	O
functions	O
of	O
the	O
phosphatidylserine	O
receptor	O
Ptdsr	O
,	O
we	O
generated	O
a	O
null	O
allele	O
in	O
the	O
mouse	O
by	O
gene	O
targeting	O
(	O
Figure	O
1a	O
,	O
1b	O
,	O
1c	O
)	O
.	O

In	O
contrast	O
to	O
previously	O
described	O
Ptdsr	O
-	O
knockout	O
mice	O
[	O
31	O
,	O
32	O
]	O
,	O
we	O
used	O
Bruce4	O
embryonic	O
stem	O
(	O
ES	O
)	O
cells	O
for	O
gene	O
targeting	O
[	O
33	O
]	O
,	O
thus	O
generating	O
a	O
Ptdsr	O
-	O
null	O
allele	O
in	O
a	O
pure	O
,	O
isogenic	O
C57BL	O
/	O
6J	O
genetic	O
background	O
.	O

The	O
newly	O
established	O
knockout	O
mouse	O
line	O
was	O
named	O
Ptdsrtm1Gbf	O
(	O
hereafter	O
referred	O
to	O
as	O
Ptdsr	O
-	O
/	O
-	O
)	O
.	O

Heterozygous	O
Ptdsr	O
+	O
/	O
-	O
mice	O
were	O
viable	O
and	O
fertile	O
and	O
showed	O
no	O
obvious	O
abnormalities	O
.	O

Ptdsr	O
+	O
/	O
-	O
mice	O
were	O
intercrossed	O
to	O
generate	O
homozygous	O
Ptdsr	O
-	O
deficient	O
mice	O
.	O

The	O
absence	O
of	O
Ptdsr	O
expression	O
in	O
Ptdsr	O
-	O
/	O
-	O
embryos	O
was	O
confirmed	O
by	O
RT	O
-	O
PCR	O
(	O
data	O
not	O
shown	O
)	O
,	O
and	O
by	O
northern	O
and	O
western	O
blotting	O
analyses	O
(	O
Figure	O
1d	O
,	O
e	O
)	O
.	O

Interbreeding	O
of	O
heterozygous	O
mice	O
showed	O
that	O
the	O
mutation	O
was	O
lethal	O
,	O
since	O
homozygous	O
mutants	O
were	O
not	O
detected	O
in	O
over	O
100	O
analyzed	O
litters	O
at	O
weaning	O
.	O

To	O
determine	O
the	O
stages	O
of	O
embryonic	O
development	O
affected	O
by	O
the	O
Ptdsrtm1Gbf	O
mutation	O
,	O
timed	O
breedings	O
were	O
followed	O
by	O
PCR	O
genotyping	O
(	O
Figure	O
1c	O
)	O
of	O
embryos	O
.	O

We	O
recovered	O
fewer	O
than	O
the	O
expected	O
number	O
of	O
homozygous	O
embryos	O
from	O
intercrosses	O
of	O
Ptdsr	O
+	O
/	O
-	O
mice	O
.	O

From	O
a	O
total	O
of	O
1	O
,	O
031	O
embryos	O
analyzed	O
between	O
gestational	O
day	O
(	O
E	O
)	O
9	O
.	O
5	O
and	O
E18	O
.	O
5	O
,	O
198	O
(	O
19	O
.	O
2	O
%	O
)	O
Ptdsr	O
-	O
deficient	O
homozygous	O
embryos	O
were	O
harvested	O
,	O
indicating	O
that	O
the	O
introduced	O
mutation	O
is	O
associated	O
with	O
a	O
low	O
rate	O
of	O
embryonic	O
lethality	O
in	O
utero	O
.	O

From	O
E9	O
.	O
5	O
to	O
E12	O
.	O
5	O
,	O
Ptdsr	O
-	O
/	O
-	O
embryos	O
were	O
viable	O
and	O
of	O
normal	O
size	O
.	O

At	O
E13	O
.	O
5	O
and	O
thereafter	O
,	O
however	O
,	O
most	O
Ptdsr	O
-	O
/	O
-	O
embryos	O
showed	O
morphological	O
abnormalities	O
(	O
Table	O
1	O
)	O
.	O

All	O
homozygous	O
embryos	O
harvested	O
were	O
growth	O
-	O
retarded	O
from	O
E13	O
.	O
5	O
onwards	O
,	O
had	O
a	O
pale	O
appearance	O
,	O
and	O
displayed	O
multiple	O
developmental	O
dysmorphologies	O
.	O

These	O
included	O
various	O
head	O
and	O
craniofacial	O
malformations	O
,	O
such	O
as	O
exencephaly	O
,	O
cleft	O
palate	O
and	O
abnormal	O
head	O
shape	O
(	O
Figure	O
1f	O
,	O
g	O
)	O
.	O

Gross	O
inspection	O
revealed	O
that	O
eye	O
development	O
was	O
severely	O
affected	O
in	O
14	O
.	O
1	O
%	O
of	O
homozygous	O
embryos	O
.	O

The	O
affected	O
animals	O
displayed	O
a	O
complete	O
unilateral	O
or	O
bilateral	O
absence	O
of	O
the	O
eyes	O
(	O
Table	O
1	O
)	O
that	O
was	O
never	O
detected	O
in	O
Ptdsr	O
+	O
/	O
+	O
or	O
Ptdsr	O
+	O
/	O
-	O
littermates	O
.	O

Furthermore	O
,	O
homozygous	O
embryos	O
harvested	O
between	O
E12	O
.	O
5	O
and	O
E15	O
.	O
5	O
had	O
subcutaneous	O
edema	O
(	O
Figure	O
1f	O
,	O
g	O
)	O
.	O

Because	O
we	O
were	O
able	O
to	O
recover	O
Ptdsr	O
-	O
/	O
-	O
embryos	O
until	O
E18	O
.	O
5	O
,	O
we	O
investigated	O
whether	O
Ptdsr	O
-	O
knockout	O
mice	O
could	O
be	O
born	O
alive	O
.	O

Careful	O
observation	O
of	O
timed	O
matings	O
allowed	O
us	O
to	O
recover	O
Ptdsr	O
-	O
/	O
-	O
neonates	O
,	O
but	O
homozygous	O
pups	O
died	O
during	O
delivery	O
or	O
within	O
minutes	O
after	O
birth	O
.	O

Ptdsr	O
-	O
deficient	O
neonates	O
were	O
also	O
growth	O
-	O
retarded	O
,	O
had	O
a	O
pale	O
appearance	O
and	O
displayed	O
various	O
malformations	O
.	O

These	O
included	O
cleft	O
palate	O
,	O
abnormal	O
head	O
shape	O
,	O
absence	O
of	O
eyes	O
and	O
edematous	O
skin	O
(	O
Figure	O
1h	O
)	O
.	O

Thus	O
,	O
deletion	O
of	O
the	O
Ptdsr	O
gene	O
resulted	O
in	O
perinatal	O
lethality	O
with	O
variable	O
severity	O
and	O
penetrance	O
of	O
phenotypes	O
.	O

Expression	O
of	O
Ptdsr	O
during	O
embryogenesis	O
and	O
in	O
adult	O
tissues	O

The	O
observed	O
perinatal	O
lethality	O
indicates	O
that	O
Ptdsr	O
plays	O
an	O
important	O
role	O
during	O
development	O
.	O

Analysis	O
by	O
RT	O
-	O
PCR	O
(	O
data	O
not	O
shown	O
)	O
showed	O
that	O
Ptdsr	O
is	O
expressed	O
early	O
in	O
development	O
,	O
because	O
we	O
were	O
able	O
to	O
detect	O
Ptdsr	O
transcripts	O
in	O
ES	O
cells	O
and	O
embryos	O
at	O
all	O
developmental	O
stages	O
.	O

To	O
analyze	O
in	O
more	O
detail	O
the	O
temporal	O
and	O
spatial	O
expression	O
patterns	O
of	O
Ptdsr	O
,	O
and	O
to	O
correlate	O
expression	O
patterns	O
with	O
observed	O
pathological	O
malformations	O
,	O
we	O
made	O
use	O
of	O
a	O
Ptdsr	O
-	O
beta	O
-	O
geo	O
gene	O
-	O
trap	O
reporter	O
mouse	O
line	O
generated	O
from	O
a	O
Ptdsr	O
gene	O
-	O
trap	O
ES	O
cell	O
clone	O
.	O

This	O
line	O
has	O
an	O
insertion	O
of	O
beta	O
-	O
galactosidase	O
in	O
the	O
3	O
'	O
region	O
of	O
the	O
gene	O
(	O
Figure	O
2a	O
)	O
.	O

We	O
first	O
examined	O
Ptdsr	O
expression	O
by	O
X	O
-	O
Gal	O
staining	O
in	O
heterozygous	O
embryos	O
staged	O
from	O
E9	O
.	O
5	O
to	O
E12	O
.	O
5	O
.	O

These	O
developmental	O
stages	O
were	O
chosen	O
so	O
as	O
to	O
investigate	O
Ptdsr	O
expression	O
in	O
affected	O
organs	O
prior	O
to	O
the	O
onset	O
of	O
pathological	O
malformations	O
in	O
Ptdsr	O
-	O
/	O
-	O
embryos	O
.	O

At	O
E9	O
.	O
5	O
we	O
found	O
Ptdsr	O
expression	O
in	O
the	O
developing	O
neural	O
tube	O
,	O
somites	O
,	O
heart	O
,	O
gut	O
and	O
branchial	O
arches	O
(	O
Figure	O
2b	O
)	O
.	O

At	O
E10	O
.	O
5	O
,	O
Ptdsr	O
expression	O
remained	O
high	O
in	O
the	O
developing	O
nervous	O
system	O
,	O
with	O
most	O
intense	O
staining	O
in	O
the	O
forebrain	O
,	O
hindbrain	O
and	O
neural	O
tube	O
.	O

At	O
this	O
stage	O
of	O
embryogenesis	O
,	O
high	O
levels	O
of	O
Ptdsr	O
expression	O
could	O
also	O
be	O
detected	O
in	O
the	O
developing	O
limb	O
buds	O
and	O
eyes	O
(	O
Figure	O
2b	O
)	O
.	O

Ptdsr	O
expression	O
was	O
altered	O
at	O
E12	O
.	O
5	O
,	O
with	O
most	O
intensive	O
beta	O
-	O
galactosidase	O
staining	O
in	O
the	O
eyes	O
,	O
developing	O
condensations	O
of	O
the	O
limb	O
buds	O
,	O
neural	O
tube	O
and	O
brain	O
(	O
Figure	O
2b	O
)	O
.	O

Transverse	O
sections	O
of	O
X	O
-	O
Gal	O
-	O
stained	O
embryos	O
at	O
E12	O
.	O
5	O
showed	O
an	O
asymmetric	O
expression	O
pattern	O
in	O
the	O
neural	O
tube	O
with	O
intense	O
staining	O
of	O
the	O
central	O
mantle	O
layer	O
but	O
no	O
expression	O
in	O
the	O
dorsal	O
part	O
of	O
the	O
neural	O
tube	O
(	O
for	O
example	O
,	O
the	O
roof	O
plate	O
;	O
Figure	O
2c	O
)	O
.	O

Expression	O
in	O
dorsal	O
root	O
ganglia	O
lateral	O
to	O
the	O
neural	O
tube	O
and	O
in	O
the	O
somites	O
was	O
observed	O
;	O
Ptdsr	O
was	O
expressed	O
throughout	O
the	O
somite	O
structure	O
(	O
myotome	O
,	O
dermatome	O
and	O
sclerotome	O
;	O
Figure	O
2d	O
)	O
.	O

Expression	O
boundaries	O
between	O
somites	O
were	O
evident	O
,	O
with	O
no	O
expression	O
in	O
the	O
segmental	O
interzones	O
,	O
which	O
correspond	O
to	O
the	O
prospective	O
intervertebral	O
discs	O
(	O
Figure	O
2d	O
)	O
.	O

Transverse	O
sections	O
of	O
the	O
developing	O
eye	O
at	O
E12	O
.	O
5	O
revealed	O
strong	O
Ptdsr	O
expression	O
in	O
the	O
inner	O
layer	O
of	O
the	O
neural	O
cup	O
,	O
which	O
will	O
later	O
develop	O
into	O
the	O
neural	O
retina	O
.	O

Furthermore	O
,	O
Ptdsr	O
expression	O
was	O
detected	O
in	O
the	O
primary	O
lens	O
fiber	O
cells	O
of	O
the	O
developing	O
lens	O
(	O
Figure	O
2e	O
)	O
.	O

We	O
carefully	O
investigated	O
whether	O
Ptdsr	O
is	O
expressed	O
from	O
E10	O
.	O
5	O
to	O
E12	O
.	O
5	O
in	O
the	O
developing	O
kidney	O
and	O
lungs	O
,	O
but	O
no	O
expression	O
could	O
be	O
detected	O
indicating	O
that	O
Ptdsr	O
expression	O
is	O
required	O
only	O
at	O
later	O
stages	O
in	O
the	O
development	O
of	O
these	O
organs	O
(	O
see	O
below	O
)	O
.	O

Hybridization	O
of	O
a	O
multiple	O
-	O
tissue	O
northern	O
blot	O
revealed	O
a	O
single	O
transcript	O
of	O
about	O
1	O
.	O
8	O
kb	O
in	O
almost	O
every	O
tissue	O
analyzed	O
in	O
adult	O
mice	O
(	O
Figure	O
2f	O
)	O
.	O

The	O
most	O
prominent	O
expression	O
was	O
observed	O
in	O
testis	O
,	O
thymus	O
,	O
kidney	O
,	O
liver	O
and	O
skin	O
,	O
with	O
moderate	O
to	O
low	O
expression	O
in	O
lung	O
,	O
small	O
intestine	O
,	O
spleen	O
,	O
stomach	O
and	O
skeletal	O
muscle	O
.	O

Thus	O
,	O
Ptdsr	O
is	O
ubiquitously	O
expressed	O
throughout	O
embryogenesis	O
and	O
in	O
adult	O
tissues	O
,	O
although	O
at	O
different	O
levels	O
.	O

Ptdsr	O
is	O
required	O
for	O
normal	O
tissue	O
and	O
organ	O
differentiation	O

We	O
next	O
examined	O
the	O
role	O
of	O
Ptdsr	O
in	O
organ	O
development	O
.	O

Serial	O
histological	O
sections	O
of	O
Ptdsr	O
-	O
/	O
-	O
and	O
control	O
embryos	O
were	O
taken	O
to	O
perform	O
a	O
detailed	O
morphological	O
analysis	O
of	O
all	O
organ	O
systems	O
during	O
development	O
.	O

A	O
significant	O
delay	O
in	O
organ	O
and	O
tissue	O
differentiation	O
was	O
observed	O
at	O
E16	O
.	O
5	O
in	O
lungs	O
,	O
kidneys	O
and	O
intestine	O
.	O

Lungs	O
of	O
control	O
littermates	O
were	O
properly	O
developed	O
with	O
expanding	O
alveoli	O
(	O
Figure	O
3a	O
)	O
.	O

Terminal	O
bronchi	O
and	O
bronchioles	O
were	O
already	O
well	O
developed	O
,	O
and	O
terminally	O
differentiated	O
epithelial	O
cells	O
with	O
cilia	S-GO
on	O
the	O
luminal	O
cell	B-GO
surface	E-GO
were	O
present	O
.	O

In	O
contrast	O
,	O
almost	O
no	O
alveoli	O
or	O
bronchioles	O
were	O
present	O
in	O
Ptdsr	O
-	O
/	O
-	O
lungs	O
,	O
indicating	O
a	O
delay	O
or	O
arrest	O
in	O
lung	O
sacculation	O
and	O
expansion	O
.	O

Instead	O
,	O
we	O
observed	O
an	O
abundance	O
of	O
mesenchyme	O
that	O
appeared	O
highly	O
immature	O
(	O
Figure	O
3g	O
)	O
.	O

A	O
similar	O
delay	O
in	O
tissue	O
differentiation	O
of	O
Ptdsr	O
-	O
/	O
-	O
embryos	O
was	O
found	O
in	O
the	O
kidneys	O
(	O
Figure	O
3h	O
)	O
.	O

Kidneys	O
from	O
Ptdsr	O
+	O
/	O
+	O
embryos	O
were	O
well	O
developed	O
at	O
E16	O
.	O
5	O
,	O
showing	O
terminally	O
differentiated	O
glomeruli	O
with	O
Bowman	O
'	O
s	O
capsule	O
and	O
collecting	O
tubules	O
lined	O
with	O
cuboidal	O
epithelial	O
cells	O
(	O
Figure	O
3b	O
)	O
.	O

In	O
contrast	O
,	O
Ptdsr	O
-	O
deficient	O
kidneys	O
had	O
only	O
primitive	O
glomeruli	O
at	O
E16	O
.	O
5	O
,	O
and	O
collecting	O
tubules	O
were	O
less	O
well	O
-	O
developed	O
.	O

Instead	O
,	O
a	O
large	O
amount	O
of	O
undifferentiated	O
mesenchyme	O
was	O
present	O
in	O
Ptdsr	O
-	O
/	O
-	O
kidneys	O
(	O
Figure	O
3h	O
)	O
.	O

A	O
delay	O
in	O
tissue	O
differentiation	O
was	O
also	O
found	O
in	O
the	O
intestine	O
at	O
this	O
stage	O
of	O
development	O
.	O

Ptdsr	O
-	O
/	O
-	O
embryos	O
displayed	O
improperly	O
developed	O
villi	O
and	O
an	O
underdeveloped	O
or	O
absent	O
submucosa	O
(	O
Figure	O
3i	O
)	O
.	O

In	O
wild	O
-	O
type	O
embryos	O
(	O
Figure	O
3c	O
)	O
,	O
intestinal	O
cellular	O
differentiation	O
was	O
already	O
highly	O
organized	O
,	O
with	O
intramural	O
ganglion	O
cells	O
between	O
the	O
external	O
and	O
internal	O
muscular	O
layers	O
.	O

Such	O
neuronal	O
cells	O
were	O
absent	O
from	O
the	O
intestine	O
of	O
Ptdsr	O
-	O
/	O
-	O
embryos	O
(	O
Figure	O
3i	O
)	O
,	O
however	O
.	O

Some	O
Ptdsr	O
-	O
/	O
-	O
mice	O
(	O
4	O
.	O
5	O
%	O
)	O
also	O
displayed	O
extensive	O
brain	O
malformations	O
that	O
resulted	O
in	O
externally	O
visible	O
head	O
abnormalities	O
,	O
with	O
occasional	O
ectopic	O
tissue	O
outside	O
the	O
skull	O
or	O
exencephaly	O
(	O
Figure	O
1f	O
,	O
h	O
)	O
.	O

Histological	O
analysis	O
revealed	O
an	O
extensive	O
hyperplasia	O
of	O
brain	O
tissue	O
with	O
herniation	O
of	O
brain	O
tissue	O
either	O
through	O
the	O
skull	O
-	O
cap	O
or	O
through	O
the	O
ventral	O
skull	O
(	O
Figure	O
3d	O
,	O
j	O
)	O
.	O

In	O
the	O
most	O
severe	O
cases	O
,	O
expansion	O
of	O
brain	O
tissue	O
in	O
mutant	O
mice	O
resulted	O
in	O
further	O
perturbations	O
of	O
cortical	O
structures	O
(	O
Figure	O
3d	O
,	O
j	O
)	O
.	O

Of	O
note	O
,	O
a	O
similar	O
brain	O
phenotype	O
was	O
observed	O
in	O
the	O
Ptdsr	O
-	O
deficient	O
mouse	O
line	O
generated	O
by	O
Li	O
and	O
colleagues	O
[	O
31	O
]	O
.	O

In	O
contrast	O
to	O
the	O
study	O
of	O
Li	O
et	O
al	O
.	O

[	O
31	O
]	O
,	O
however	O
,	O
we	O
found	O
almost	O
normally	O
developed	O
lungs	O
at	O
birth	O
.	O

Ptdsr	O
-	O
/	O
-	O
lungs	O
showed	O
,	O
in	O
comparison	O
to	O
wild	O
-	O
type	O
,	O
only	O
a	O
slight	O
delay	O
in	O
maturation	O
and	O
were	O
fully	O
ventilated	O
in	O
neonates	O
in	O
most	O
cases	O
(	O
Figure	O
3e	O
,	O
k	O
)	O
.	O

This	O
demonstrates	O
that	O
Ptdsr	O
-	O
deficient	O
mice	O
can	O
overcome	O
the	O
delay	O
in	O
embryonic	O
lung	O
differentiation	O
and	O
display	O
normal	O
lung	O
morphology	O
at	O
birth	O
.	O

Thus	O
,	O
it	O
would	O
appear	O
highly	O
unlikely	O
that	O
Ptdsr	O
-	O
/	O
-	O
mice	O
die	O
from	O
respiratory	O
failure	O
.	O

Consistent	O
with	O
the	O
observations	O
of	O
Kunisaki	O
and	O
colleagues	O
[	O
32	O
]	O
,	O
we	O
found	O
severely	O
blocked	O
erythropoietic	O
differentiation	O
at	O
an	O
early	O
erythroblast	O
stage	O
in	O
the	O
liver	O
(	O
Figure	O
3f	O
,	O
3l	O
)	O
,	O
suggesting	O
an	O
explanation	O
for	O
the	O
grossly	O
anemic	O
appearance	O
that	O
we	O
observed	O
in	O
our	O
Ptdsr	O
-	O
/	O
-	O
mice	O
.	O

Loss	O
of	O
Ptdsr	O
activity	O
is	O
associated	O
with	O
defects	O
in	O
ocular	O
development	O
and	O
can	O
lead	O
to	O
formation	O
of	O
ectopic	O
eye	O
structures	O

By	O
gross	O
morphology	O
we	O
could	O
differentiate	O
two	O
classes	O
of	O
Ptdsr	O
mutants	O
:	O
those	O
that	O
appeared	O
normal	O
with	O
both	O
eyes	O
present	O
(	O
Figure	O
4	O
)	O
and	O
those	O
that	O
were	O
severely	O
affected	O
and	O
displayed	O
uni	O
-	O
or	O
bilateral	O
anophthalmia	O
(	O
Figure	O
5	O
)	O
.	O

Analysis	O
of	O
normal	O
or	O
mildly	O
affected	O
embryos	O
revealed	O
no	O
differences	O
between	O
mutant	O
and	O
wild	O
-	O
type	O
embryos	O
in	O
the	O
differentiation	O
of	O
the	O
developing	O
eye	O
until	O
E16	O
.	O
5	O
.	O

In	O
both	O
genotypes	O
,	O
inner	O
and	O
outer	O
layers	O
of	O
the	O
retina	O
displayed	O
a	O
comparable	O
differentiation	O
status	O
,	O
as	O
shown	O
,	O
for	O
example	O
,	O
at	O
E12	O
.	O
5	O
(	O
Figure	O
4a	O
,	O
e	O
)	O
.	O

At	O
day	O
E16	O
.	O
5	O
,	O
however	O
,	O
retinal	O
layers	O
in	O
Ptdsr	O
-	O
/	O
-	O
embryos	O
were	O
much	O
thinner	O
than	O
in	O
wild	O
-	O
type	O
embryos	O
,	O
contained	O
fewer	O
cells	O
and	O
were	O
greatly	O
reduced	O
in	O
size	O
(	O
Figure	O
4b	O
,	O
f	O
)	O
.	O

Comparison	O
of	O
the	O
retinal	O
structures	O
of	O
Ptdsr	O
+	O
/	O
+	O
and	O
Ptdsr	O
-	O
/	O
-	O
embryos	O
revealed	O
that	O
all	O
four	O
retinal	O
layers	O
were	O
present	O
in	O
Ptdsr	O
-	O
knockout	O
mice	O
at	O
E16	O
.	O
5	O
(	O
Figure	O
4b	O
,	O
f	O
)	O
.	O

At	O
E18	O
.	O
5	O
(	O
Figure	O
4c	O
,	O
g	O
)	O
and	O
in	O
neonatal	O
animals	O
(	O
postnatal	O
day	O
P0	O
;	O
Figure	O
4d	O
,	O
h	O
)	O
,	O
the	O
differences	O
in	O
retinal	O
differentiation	O
between	O
Ptdsr	O
+	O
/	O
+	O
and	O
Ptdsr	O
-	O
/	O
-	O
mice	O
were	O
still	O
evident	O
,	O
but	O
the	O
size	O
reduction	O
of	O
the	O
retinal	O
layers	O
was	O
less	O
pronounced	O
in	O
the	O
knockout	O
mice	O
.	O

Ptdsr	O
-	O
deficient	O
animals	O
seem	O
to	O
have	O
compensated	O
for	O
the	O
marked	O
delay	O
in	O
cellular	O
differentiation	O
and	O
expansion	O
of	O
retinal	O
layers	O
.	O

Close	O
examination	O
of	O
retinal	O
structures	O
revealed	O
that	O
the	O
inner	O
granular	O
layer	O
was	O
still	O
less	O
expanded	O
in	O
Ptdsr	O
-	O
deficient	O
animals	O
,	O
however	O
,	O
and	O
that	O
it	O
contained	O
fewer	O
cells	O
and	O
was	O
still	O
severely	O
underdeveloped	O
in	O
comparison	O
with	O
the	O
corresponding	O
retinal	O
layer	O
in	O
control	O
animals	O
(	O
Figure	O
4c	O
,	O
4g	O
and	O
4d	O
,	O
4h	O
)	O
.	O

Thus	O
,	O
even	O
mildly	O
affected	O
Ptdsr	O
-	O
/	O
-	O
mutants	O
had	O
ocular	O
malformations	O
with	O
defects	O
in	O
differentiation	O
of	O
retinal	O
structures	O
.	O

We	O
next	O
examined	O
Ptdsr	O
-	O
/	O
-	O
embryos	O
that	O
displayed	O
unilateral	O
or	O
bilateral	O
absence	O
of	O
eyes	O
(	O
Figure	O
5a	O
)	O
by	O
serial	O
sectioning	O
of	O
whole	O
embryos	O
.	O

These	O
embryos	O
showed	O
complex	O
malformations	O
of	O
the	O
optical	O
cup	O
,	O
including	O
absence	O
of	O
the	O
lens	O
(	O
Figure	O
5b	O
)	O
.	O

Most	O
surprisingly	O
,	O
we	O
found	O
pigmented	O
epithelial	O
cells	O
in	O
the	O
nasal	O
cavity	O
of	O
all	O
Ptdsr	O
-	O
knockout	O
mice	O
with	O
anophthalmia	O
that	O
were	O
analyzed	O
histopathologically	O
.	O

We	O
could	O
identify	O
black	O
-	O
colored	O
pigmented	O
cells	O
embedded	O
in	O
the	O
epithelium	O
of	O
the	O
maxillary	O
sinus	O
that	O
resembled	O
presumptive	O
retinal	O
-	O
pigmented	O
epithelium	O
(	O
Figure	O
5b	O
,	O
c	O
)	O
.	O

Examination	O
of	O
consecutive	O
serial	O
sections	O
revealed	O
the	O
formation	O
of	O
a	O
primitive	O
eye	O
structure	O
,	O
with	O
induction	O
and	O
subsequent	O
proliferation	O
of	O
ectopic	O
mesenchymal	O
tissue	O
immediately	O
adjacent	O
to	O
the	O
displaced	O
pigmented	O
epithelium	O
(	O
Figure	O
5d	O
)	O
.	O

This	O
structure	O
was	O
clearly	O
induced	O
ectopically	O
,	O
and	O
we	O
failed	O
to	O
identify	O
similar	O
changes	O
in	O
any	O
of	O
the	O
wild	O
-	O
type	O
embryos	O
.	O

In	O
summary	O
,	O
we	O
observed	O
a	O
wide	O
range	O
of	O
ocular	O
malformations	O
in	O
Ptdsr	O
-	O
deficient	O
mice	O
that	O
ranged	O
from	O
differentiation	O
defects	O
in	O
retinal	O
cell	O
layers	O
(	O
for	O
example	O
,	O
the	O
inner	O
granular	O
layer	O
)	O
in	O
mildly	O
affected	O
homozygotes	O
to	O
anophthalmia	O
in	O
severely	O
affected	O
Ptdsr	O
-	O
/	O
-	O
mice	O
that	O
was	O
associated	O
with	O
induction	O
of	O
ectopic	O
eye	O
structures	O
in	O
nasal	O
cavities	O
.	O

Phagocytosis	O
and	O
clearance	O
of	O
apoptotic	O
cells	O
is	O
normal	O
in	O
Ptdsr	O
-	O
deficient	O
mice	O

We	O
next	O
tested	O
whether	O
Ptdsr	O
is	O
functionally	O
required	O
for	O
the	O
clearance	O
of	O
apoptotic	O
cells	O
.	O

We	O
started	O
with	O
an	O
investigation	O
of	O
cell	O
death	O
in	O
vivo	O
in	O
the	O
interdigital	O
areas	O
of	O
the	O
developing	O
limbs	O
.	O

Apoptosis	O
of	O
interdigital	O
cells	O
in	O
the	O
distal	O
mesenchyme	O
of	O
limb	O
buds	O
occurs	O
most	O
prominently	O
from	O
developmental	O
stages	O
E12	O
.	O
0	O
to	O
E13	O
.	O
5	O
and	O
can	O
be	O
easily	O
examined	O
in	O
situ	O
by	O
whole	O
-	O
mount	O
terminal	O
deoxynucleotide	O
transferase	O
-	O
mediated	O
UTP	O
end	O
-	O
labeling	O
(	O
TUNEL	O
)	O
.	O

We	O
compared	O
the	O
pattern	O
of	O
interdigital	O
cell	O
death	O
in	O
fore	O
and	O
hind	O
limb	O
buds	O
from	O
Ptdsr	O
-	O
/	O
-	O
(	O
n	O
=	O
3	O
)	O
and	O
Ptdsr	O
+	O
/	O
+	O
(	O
n	O
=	O
3	O
)	O
mice	O
at	O
E12	O
.	O
5	O
and	O
E13	O
.	O
5	O
.	O

No	O
differences	O
in	O
accumulation	O
of	O
TUNEL	O
-	O
positive	O
cell	O
corpses	O
were	O
observed	O
between	O
the	O
two	O
genotypes	O
(	O
Figure	O
6a	O
)	O
.	O

The	O
kinetics	O
of	O
cell	O
death	O
occurrence	O
and	O
regression	O
of	O
the	O
interdigital	O
web	O
was	O
similar	O
in	O
wild	O
-	O
type	O
and	O
mutant	O
littermates	O
,	O
providing	O
no	O
evidence	O
that	O
Ptdsr	O
-	O
deficiency	O
is	O
associated	O
with	O
impaired	O
clearance	O
of	O
apoptotic	O
interdigital	O
cells	O
during	O
limb	O
development	O
.	O

To	O
investigate	O
further	O
whether	O
removal	O
of	O
apoptotic	O
cells	O
is	O
impaired	O
in	O
Ptdsr	O
-	O
/	O
-	O
mice	O
,	O
we	O
stained	O
immunohistochemically	O
for	O
activated	O
caspase	O
3	O
(	O
aCasp3	O
)	O
and	O
analyzed	O
additional	O
organs	O
and	O
tissues	O
where	O
apoptosis	O
plays	O
a	O
crucial	O
role	O
in	O
tissue	O
remodeling	O
during	O
development	O
.	O

Starting	O
at	O
E12	O
.	O
5	O
,	O
we	O
analyzed	O
and	O
compared	O
the	O
number	O
and	O
distribution	O
of	O
aCasp3	O
-	O
positive	O
cells	O
in	O
over	O
140	O
serial	O
sections	O
of	O
three	O
wild	O
-	O
type	O
and	O
six	O
Ptdsr	O
-	O
/	O
-	O
embryos	O
in	O
consecutive	O
and	O
corresponding	O
sections	O
.	O

The	O
sagittal	O
sections	O
were	O
separated	O
by	O
5	O
mu	O
m	O
,	O
allowing	O
a	O
detailed	O
analysis	O
of	O
apoptosis	O
in	O
several	O
organs	O
and	O
tissues	O
.	O

Tissue	O
restructuring	O
by	O
programmed	O
cell	O
death	O
occurred	O
most	O
notably	O
within	O
the	O
ventral	O
part	O
of	O
the	O
neural	O
tube	O
(	O
Figure	O
6b	O
,	O
f	O
)	O
and	O
in	O
the	O
developing	O
paravertebral	O
ganglia	O
(	O
Figure	O
6d	O
,	O
h	O
)	O
with	O
many	O
apoptotic	O
cells	O
being	O
present	O
.	O

In	O
these	O
tissues	O
Ptdsr	O
is	O
highly	O
expressed	O
at	O
E12	O
.	O
5	O
(	O
Figure	O
2c	O
)	O
but	O
we	O
observed	O
no	O
difference	O
in	O
the	O
number	O
or	O
distribution	O
of	O
apoptotic	O
cells	O
in	O
Ptdsr	O
+	O
/	O
+	O
and	O
Ptdsr	O
-	O
/	O
-	O
embryos	O
.	O

The	O
same	O
was	O
true	O
for	O
the	O
developing	O
kidney	O
:	O
apoptotic	O
cells	O
were	O
present	O
in	O
Ptdsr	O
+	O
/	O
+	O
and	O
Ptdsr	O
-	O
/	O
-	O
embryos	O
,	O
in	O
limited	O
numbers	O
,	O
but	O
we	O
failed	O
to	O
detect	O
any	O
differences	O
in	O
the	O
number	O
of	O
apoptotic	O
cells	O
between	O
the	O
genotypes	O
(	O
Figure	O
6c	O
,	O
6g	O
)	O
.	O

Furthermore	O
,	O
when	O
we	O
continued	O
our	O
analysis	O
of	O
apoptotic	O
cell	O
clearance	O
in	O
vivo	O
at	O
E16	O
.	O
5	O
,	O
E17	O
.	O
5	O
and	O
E18	O
.	O
5	O
of	O
embryonic	O
development	O
as	O
well	O
as	O
in	O
neonatal	O
mice	O
,	O
the	O
number	O
and	O
distribution	O
of	O
apoptotic	O
cells	O
was	O
similar	O
in	O
both	O
genotypes	O
.	O

As	O
already	O
observed	O
at	O
E12	O
.	O
5	O
,	O
analysis	O
of	O
aCasp3	O
-	O
stained	O
sections	O
of	O
the	O
developing	O
thymus	O
,	O
heart	O
,	O
diaphragm	O
,	O
genital	O
ridge	O
,	O
eyes	O
and	O
retina	O
convincingly	O
showed	O
that	O
there	O
was	O
no	O
impairment	O
in	O
apoptotic	O
cell	O
removal	O
in	O
Ptdsr	O
-	O
/	O
-	O
mice	O
.	O

Moreover	O
,	O
because	O
Li	O
and	O
colleagues	O
[	O
31	O
]	O
reported	O
impaired	O
clearance	O
of	O
dead	O
cells	O
during	O
lung	O
development	O
in	O
Ptdsr	O
-	O
deficient	O
mice	O
,	O
we	O
examined	O
the	O
rate	O
of	O
apoptosis	O
induction	O
and	O
cell	O
clearance	O
in	O
our	O
Ptdsr	O
-	O
knockout	O
mice	O
in	O
the	O
lung	O
.	O

Analysis	O
of	O
aCasp3	O
-	O
stained	O
lung	O
tissue	O
from	O
Ptdsr	O
+	O
/	O
+	O
and	O
Ptdsr	O
-	O
/	O
-	O
mice	O
at	O
E17	O
.	O
5	O
and	O
P0	O
demonstrated	O
that	O
apoptosis	O
was	O
an	O
extremely	O
rare	O
event	O
during	O
lung	O
morphogenesis	O
at	O
this	O
stage	O
.	O

In	O
addition	O
,	O
there	O
were	O
no	O
differences	O
in	O
the	O
number	O
or	O
distribution	O
of	O
apoptotic	O
cells	O
in	O
Ptdsr	O
-	O
/	O
-	O
and	O
Ptdsr	O
+	O
/	O
+	O
mice	O
.	O

Furthermore	O
,	O
we	O
were	O
unable	O
to	O
detect	O
any	O
evidence	O
of	O
tissue	O
necrosis	O
in	O
lungs	O
from	O
Ptdsr	O
-	O
deficient	O
mice	O
.	O

In	O
contrast	O
to	O
the	O
report	O
of	O
Li	O
et	O
al	O
.	O

[	O
31	O
]	O
,	O
we	O
never	O
observed	O
recruitment	O
of	O
neutrophils	O
or	O
other	O
signs	O
of	O
pulmonary	O
inflammation	O
at	O
any	O
stage	O
of	O
development	O
in	O
our	O
Ptdsr	O
-	O
deficient	O
mice	O
.	O

To	O
analyze	O
whether	O
macrophages	O
are	O
recruited	O
into	O
areas	O
where	O
apoptosis	O
is	O
prominent	O
during	O
embryogenesis	O
,	O
we	O
stained	O
consecutive	O
serial	O
sections	O
either	O
with	O
the	O
macrophage	O
surface	S-GO
marker	O
F4	O
/	O
80	O
or	O
with	O
aCasp3	O
.	O

Surprisingly	O
,	O
there	O
was	O
no	O
co	O
-	O
localization	O
of	O
macrophages	O
with	O
apoptotic	O
cells	O
.	O

In	O
virtually	O
all	O
embryonic	O
tissues	O
,	O
apoptotic	O
cells	O
and	O
macrophages	O
were	O
localized	O
in	O
different	O
compartments	O
(	O
Figure	O
6e	O
,	O
6i	O
;	O
and	O
see	O
also	O
Additional	O
data	O
file	O
1	O
,	O
Figure	O
S1	O
)	O
.	O

This	O
suggests	O
that	O
at	O
this	O
stage	O
of	O
development	O
it	O
is	O
mainly	O
neighboring	O
cells	O
that	O
are	O
involved	O
in	O
removal	O
of	O
apoptotic	O
cells	O
,	O
rather	O
than	O
professional	O
macrophages	O
.	O

In	O
summary	O
,	O
our	O
analysis	O
in	O
vivo	O
did	O
not	O
reveal	O
any	O
impairment	O
in	O
apoptotic	O
cell	O
clearance	O
in	O
Ptdsr	O
-	O
deficient	O
embryos	O
during	O
development	O
and	O
further	O
suggests	O
that	O
phagocytosis	O
of	O
apoptotic	O
cells	O
is	O
mainly	O
mediated	O
by	O
non	O
-	O
professional	O
'	O
bystander	O
'	O
cells	O
.	O

To	O
determine	O
whether	O
macrophages	O
from	O
Ptdsr	O
-	O
knockout	O
mice	O
were	O
impaired	O
in	O
the	O
efficacy	O
of	O
apoptotic	O
cell	O
uptake	O
in	O
vitro	O
,	O
we	O
performed	O
phagocytosis	O
assays	O
with	O
fetal	O
-	O
liver	O
-	O
derived	O
macrophages	O
(	O
FLDMs	O
)	O
and	O
quantified	O
their	O
phagocytosis	O
rates	O
.	O

Phagocytosis	O
of	O
apoptotic	O
thymocytes	O
was	O
investigated	O
at	O
60	O
,	O
90	O
and	O
120	O
minutes	O
after	O
addition	O
of	O
target	O
cells	O
in	O
the	O
absence	O
of	O
serum	O
.	O

Analysis	O
of	O
phagocytosis	O
rates	O
by	O
flow	O
cytometric	O
analysis	O
(	O
FACS	O
)	O
revealed	O
no	O
differences	O
in	O
the	O
efficacy	O
of	O
apoptotic	O
cell	O
uptake	O
between	O
Ptdsr	O
-	O
/	O
-	O
and	O
Ptdsr	O
+	O
/	O
+	O
macrophages	O
and	O
demonstrated	O
no	O
differences	O
in	O
apoptotic	O
cell	O
engulfment	O
between	O
selected	O
time	O
points	O
(	O
data	O
not	O
shown	O
)	O
.	O

To	O
re	O
-	O
examine	O
and	O
further	O
independently	O
validate	O
the	O
result	O
of	O
normal	O
apoptotic	O
cell	O
uptake	O
by	O
Ptdsr	O
-	O
/	O
-	O
macrophages	O
,	O
we	O
performed	O
phagocytosis	O
assays	O
for	O
60	O
min	O
and	O
determined	O
the	O
percentage	O
of	O
macrophages	O
that	O
had	O
engulfed	O
apoptotic	O
cells	O
,	O
in	O
a	O
total	O
of	O
at	O
least	O
300	O
macrophages	O
counted	O
by	O
fluorescence	O
microscopy	O
.	O

Phagocytosed	O
,	O
5	O
-	O
carboxytetramethylrhodamine	O
-	O
(	O
TAMRA	O
-	O
)	O
labeled	O
apoptotic	O
cells	O
were	O
identified	O
as	O
being	O
engulfed	O
by	O
inclusion	O
in	O
F4	O
/	O
80	O
-	O
labeled	O
macrophages	O
.	O

Analysis	O
was	O
done	O
independently	O
by	O
three	O
investigators	O
who	O
were	O
not	O
aware	O
of	O
macrophage	O
genotypes	O
(	O
Ptdsr	O
-	O
/	O
-	O
or	O
Ptdsr	O
+	O
/	O
+	O
)	O
.	O

Again	O
,	O
no	O
differences	O
were	O
found	O
in	O
the	O
percentage	O
of	O
macrophages	O
that	O
had	O
engulfed	O
apoptotic	O
cells	O
(	O
Figure	O
7a	O
,	O
c	O
,	O
e	O
)	O
or	O
in	O
the	O
relative	O
number	O
of	O
phagocytosed	O
apoptotic	O
cells	O
per	O
macrophage	O
(	O
phagocytotic	O
index	O
;	O
Figure	O
7f	O
)	O
.	O

Moreover	O
,	O
single	O
Ptdsr	O
-	O
/	O
-	O
macrophages	O
could	O
be	O
identified	O
that	O
had	O
engulfed	O
even	O
more	O
apoptotic	O
target	O
cells	O
than	O
had	O
wild	O
-	O
type	O
macrophages	O
(	O
Figure	O
7b	O
,	O
d	O
)	O
.	O

Thus	O
,	O
Ptdsr	O
-	O
deficient	O
macrophages	O
had	O
a	O
normal	O
ability	O
to	O
ingest	O
apoptotic	O
cells	O
and	O
were	O
not	O
impaired	O
in	O
recognition	O
or	O
phagocytosis	O
of	O
cells	O
that	O
had	O
undergone	O
programmed	O
cell	O
death	O
.	O

Ptdsr	O
-	O
deficiency	O
results	O
in	O
reduced	O
production	O
of	O
pro	O
-	O
and	O
anti	O
-	O
inflammatory	O
cytokines	O
after	O
macrophage	O
stimulation	O

In	O
addition	O
to	O
its	O
suggested	O
importance	O
for	O
phagocytosis	O
of	O
apoptotic	O
cells	O
,	O
it	O
has	O
been	O
proposed	O
that	O
Ptdsr	O
fulfils	O
a	O
second	O
crucial	O
role	O
in	O
regulating	O
and	O
maintaining	O
a	O
non	O
-	O
inflammatory	O
environment	O
upon	O
the	O
recognition	O
of	O
apoptotic	O
cells	O
by	O
macrophages	O
[	O
26	O
]	O
.	O

We	O
therefore	O
tested	O
whether	O
Ptdsr	O
-	O
/	O
-	O
macrophages	O
were	O
able	O
to	O
release	O
anti	O
-	O
inflammatory	O
cytokines	O
after	O
ingestion	O
of	O
apoptotic	O
cells	O
.	O

We	O
examined	O
levels	O
of	O
TGF	O
-	O
beta	O
1	O
and	O
interleukin	O
-	O
10	O
(	O
IL	O
-	O
10	O
)	O
after	O
stimulation	O
of	O
FLDMs	O
with	O
lipopolysaccharide	O
(	O
LPS	O
)	O
,	O
with	O
and	O
without	O
co	O
-	O
culture	O
of	O
apoptotic	O
cells	O
.	O

Quantification	O
of	O
TGF	O
-	O
beta	O
1	O
and	O
IL	O
-	O
10	O
levels	O
after	O
22	O
hours	O
of	O
culture	O
demonstrated	O
that	O
Ptdsr	O
-	O
/	O
-	O
macrophages	O
were	O
able	O
to	O
secrete	O
these	O
anti	O
-	O
inflammatory	O
cytokines	O
upon	O
ingestion	O
of	O
apoptotic	O
cells	O
,	O
although	O
at	O
a	O
slightly	O
lower	O
level	O
than	O
wild	O
-	O
type	O
(	O
Figure	O
8a	O
,	O
b	O
)	O
.	O

This	O
indicates	O
that	O
ablation	O
of	O
Ptdsr	O
function	O
does	O
not	O
compromise	O
in	O
general	O
the	O
ability	O
of	O
macrophages	O
to	O
release	O
immune	O
-	O
suppressive	O
cytokines	O
after	O
recognition	O
and	O
engulfment	O
of	O
apoptotic	O
cells	O
.	O

To	O
analyze	O
whether	O
pro	O
-	O
inflammatory	O
signaling	O
is	O
affected	O
in	O
Ptdsr	O
-	O
/	O
-	O
macrophages	O
,	O
we	O
stimulated	O
FLDMs	O
from	O
Ptdsr	O
+	O
/	O
+	O
and	O
Ptdsr	O
-	O
/	O
-	O
mice	O
with	O
LPS	O
and	O
measured	O
levels	O
of	O
tumor	O
necrosis	O
factor	O
-	O
alpha	O
(	O
TNF	O
-	O
alpha	O
)	O
at	O
different	O
time	O
points	O
after	O
stimulation	O
(	O
Figure	O
8c	O
)	O
.	O

Ptdsr	O
-	O
/	O
-	O
macrophages	O
produced	O
significantly	O
less	O
TNF	O
-	O
alpha	O
than	O
did	O
wild	O
-	O
type	O
macrophages	O
.	O

The	O
difference	O
in	O
TNF	O
-	O
alpha	O
secretion	O
was	O
first	O
visible	O
after	O
3	O
h	O
of	O
LPS	O
stimulation	O
and	O
became	O
more	O
prominent	O
during	O
the	O
course	O
of	O
the	O
experiment	O
(	O
for	O
example	O
,	O
after	O
9	O
h	O
and	O
12	O
h	O
of	O
LPS	O
stimulation	O
;	O
Figure	O
8c	O
)	O
.	O

To	O
analyze	O
whether	O
TNF	O
-	O
alpha	O
release	O
by	O
Ptdsr	O
-	O
/	O
-	O
macrophages	O
can	O
be	O
affected	O
by	O
engulfment	O
of	O
apoptotic	O
cells	O
,	O
we	O
stimulated	O
FLDMs	O
with	O
LPS	O
,	O
apoptotic	O
cells	O
or	O
both	O
.	O

Quantification	O
of	O
TNF	O
-	O
alpha	O
levels	O
by	O
ELISA	O
after	O
22	O
h	O
showed	O
that	O
Ptdsr	O
-	O
deficient	O
macrophages	O
release	O
less	O
TNF	O
-	O
alpha	O
after	O
stimulation	O
with	O
LPS	O
alone	O
,	O
and	O
also	O
after	O
double	O
stimulation	O
of	O
macrophages	O
with	O
LPS	O
and	O
apoptotic	O
cells	O
(	O
Figure	O
8d	O
)	O
.	O

Moreover	O
,	O
the	O
double	O
stimulation	O
demonstrated	O
that	O
the	O
LPS	O
-	O
induced	O
TNF	O
-	O
alpha	O
release	O
by	O
Ptdsr	O
-	O
/	O
-	O
macrophages	O
could	O
be	O
inhibited	O
by	O
co	O
-	O
administration	O
of	O
apoptotic	O
cells	O
to	O
an	O
extent	O
comparable	O
to	O
that	O
seen	O
in	O
wild	O
-	O
type	O
macrophages	O
.	O

Similar	O
results	O
were	O
obtained	O
when	O
other	O
pro	O
-	O
inflammatory	O
cytokines	O
,	O
such	O
as	O
interleukin	O
-	O
6	O
and	O
monocyte	O
chemoattractant	O
protein	O
-	O
1	O
,	O
were	O
analyzed	O
(	O
data	O
not	O
shown	O
)	O
.	O

These	O
results	O
indicate	O
that	O
Ptdsr	O
is	O
not	O
required	O
in	O
macrophages	O
for	O
the	O
inhibition	O
of	O
pro	O
-	O
inflammatory	O
signaling	O
after	O
recognition	O
and	O
engulfment	O
of	O
apoptotic	O
cells	O
.	O

Ptdsr	O
-	O
deficiency	O
does	O
,	O
however	O
,	O
affect	O
the	O
overall	O
release	O
of	O
pro	O
-	O
and	O
anti	O
-	O
inflammatory	O
cytokines	O
after	O
stimulation	O
with	O
LPS	O
and	O
after	O
double	O
treatment	O
with	O
LPS	O
and	O
apoptotic	O
cells	O
,	O
indicating	O
that	O
Ptdsr	O
-	O
deficient	O
macrophages	O
have	O
a	O
reduced	O
capacity	O
to	O
produce	O
or	O
secrete	O
pro	O
-	O
and	O
anti	O
-	O
inflammatory	O
cytokines	O
.	O

Discussion	O

Ptdsr	O
is	O
required	O
for	O
the	O
differentiation	O
of	O
multiple	O
organ	O
systems	O
during	O
development	O

In	O
this	O
study	O
,	O
we	O
have	O
generated	O
a	O
null	O
mutation	O
in	O
the	O
phosphatidylserine	O
receptor	O
(	O
Ptdsr	O
)	O
gene	O
in	O
C57BL	O
/	O
6J	O
mice	O
.	O

We	O
show	O
that	O
ablation	O
of	O
Ptdsr	O
results	O
in	O
profound	O
differentiation	O
defects	O
in	O
multiple	O
organs	O
and	O
tissues	O
during	O
embryogenesis	O
,	O
although	O
with	O
variable	O
penetrance	O
.	O

While	O
this	O
work	O
was	O
in	O
progress	O
,	O
two	O
other	O
groups	O
reported	O
the	O
generation	O
of	O
Ptdsr	O
-	O
deficient	O
mice	O
[	O
31	O
,	O
32	O
]	O
.	O

In	O
all	O
three	O
knockout	O
mouse	O
lines	O
,	O
the	O
first	O
two	O
exons	O
(	O
[	O
31	O
]	O
and	O
this	O
study	O
)	O
or	O
exons	O
one	O
to	O
three	O
[	O
32	O
]	O
were	O
deleted	O
by	O
replacement	O
with	O
a	O
neomycin	O
-	O
selection	O
cassette	O
.	O

The	O
Ptdsr	O
-	O
knockout	O
mouse	O
lines	O
differ	O
in	O
the	O
genetic	O
background	O
in	O
which	O
the	O
mutation	O
was	O
generated	O
and	O
maintained	O
,	O
however	O
.	O

In	O
our	O
case	O
,	O
the	O
Ptdsr	O
-	O
null	O
allele	O
was	O
generated	O
in	O
an	O
isogenic	O
C57BL	O
/	O
6J	O
background	O
,	O
whereas	O
Li	O
et	O
al	O
.	O

[	O
31	O
]	O
and	O
Kunisaki	O
et	O
al	O
.	O

[	O
32	O
]	O
investigated	O
the	O
phenotype	O
of	O
their	O
Ptdsr	O
-	O
knockout	O
mice	O
in	O
a	O
mixed	O
129	O
x	O
C57BL	O
/	O
6	O
background	O
.	O

The	O
ablation	O
of	O
Ptdsr	O
function	O
results	O
in	O
perinatal	O
lethality	O
in	O
all	O
cases	O
,	O
but	O
there	O
are	O
interesting	O
differences	O
in	O
severity	O
or	O
expressivities	O
of	O
phenotypes	O
among	O
the	O
different	O
Ptdsr	O
-	O
deficient	O
mouse	O
lines	O
.	O

This	O
might	O
be	O
due	O
either	O
to	O
differences	O
in	O
genetic	O
background	O
or	O
because	O
the	O
phenotypes	O
that	O
have	O
been	O
investigated	O
in	O
this	O
study	O
have	O
not	O
been	O
analyzed	O
in	O
such	O
detail	O
before	O
.	O

In	O
the	O
Ptdsr	O
-	O
knockout	O
mouse	O
line	O
reported	O
here	O
,	O
growth	O
retardation	O
started	O
from	O
E12	O
.	O
5	O
onwards	O
and	O
was	O
associated	O
with	O
delayed	O
differentiation	O
in	O
several	O
organs	O
in	O
which	O
Ptdsr	O
is	O
expressed	O
either	O
during	O
embryogenesis	O
or	O
later	O
in	O
adulthood	O
.	O

At	O
E16	O
.	O
5	O
almost	O
no	O
branching	O
morphogenesis	O
of	O
the	O
lung	O
epithelium	O
was	O
observed	O
in	O
Ptdsr	O
-	O
/	O
-	O
lungs	O
.	O

Similarly	O
,	O
epithelial	O
structures	O
were	O
only	O
partially	O
developed	O
in	O
mutant	O
kidneys	O
,	O
without	O
terminal	O
differentiation	O
of	O
Bowman	O
'	O
s	O
capsule	O
and	O
with	O
a	O
severe	O
reduction	O
in	O
the	O
number	O
of	O
differentiated	O
collecting	O
tubules	O
.	O

Likewise	O
,	O
the	O
differentiation	O
of	O
the	O
intestine	O
was	O
also	O
severely	O
delayed	O
at	O
this	O
developmental	O
stage	O
.	O

When	O
compared	O
with	O
wild	O
-	O
type	O
controls	O
,	O
intestinal	O
tissues	O
of	O
Ptdsr	O
knockout	O
mice	O
appeared	O
unstructured	O
,	O
with	O
an	O
absence	O
of	O
enteric	O
ganglia	O
and	O
of	O
differentiated	O
smooth	O
muscle	O
tissue	O
.	O

Interestingly	O
,	O
defects	O
in	O
kidney	O
and	O
intestine	O
differentiation	O
were	O
not	O
described	O
in	O
the	O
Ptdsr	O
-	O
knockouts	O
generated	O
by	O
Li	O
et	O
al	O
.	O

[	O
31	O
]	O
and	O
Kunisaki	O
et	O
al	O
.	O

[	O
32	O
]	O
.	O

Surprisingly	O
,	O
when	O
we	O
examined	O
Ptdsr	O
-	O
/	O
-	O
embryos	O
shortly	O
before	O
birth	O
(	O
E18	O
.	O
5	O
)	O
or	O
neonatally	O
,	O
we	O
found	O
only	O
mild	O
differentiation	O
delays	O
in	O
organs	O
that	O
appeared	O
severely	O
affected	O
at	O
mid	O
-	O
gestation	O
.	O

This	O
'	O
recovery	O
'	O
was	O
most	O
visible	O
in	O
Ptdsr	O
-	O
/	O
-	O
lungs	O
:	O
at	O
P0	O
we	O
found	O
expanded	O
lungs	O
in	O
the	O
knockout	O
mice	O
that	O
showed	O
normal	O
branching	O
patterns	O
,	O
with	O
differentiated	O
alveoli	O
and	O
bronchioles	O
.	O

We	O
investigated	O
the	O
occurrence	O
of	O
programmed	O
cell	O
death	O
during	O
lung	O
development	O
in	O
wild	O
-	O
type	O
and	O
Ptdsr	O
-	O
knockout	O
mice	O
throughout	O
embryogenesis	O
(	O
E16	O
.	O
5	O
to	O
P0	O
)	O
.	O

Comparative	O
immunohistochemistry	O
for	O
aCasp3	O
revealed	O
that	O
apoptosis	O
is	O
a	O
rare	O
event	O
during	O
lung	O
morphogenesis	O
.	O

Furthermore	O
,	O
we	O
failed	O
to	O
detect	O
any	O
differences	O
in	O
the	O
number	O
of	O
apoptotic	O
cells	O
in	O
Ptdsr	O
-	O
knockout	O
and	O
wild	O
-	O
type	O
animals	O
in	O
the	O
rare	O
cases	O
where	O
we	O
could	O
detect	O
apoptotic	O
cells	O
within	O
lung	O
tissues	O
.	O

These	O
findings	O
are	O
contrary	O
to	O
the	O
results	O
reported	O
by	O
Li	O
et	O
al	O
.	O

[	O
31	O
]	O
,	O
who	O
suggested	O
that	O
impaired	O
clearance	O
of	O
apoptotic	O
mesenchymal	O
and	O
epithelial	O
cells	O
causes	O
a	O
failure	O
in	O
lung	O
morphogenesis	O
in	O
Ptdsr	O
-	O
deficient	O
mice	O
.	O

In	O
contrast	O
,	O
our	O
findings	O
are	O
in	O
line	O
with	O
the	O
current	O
view	O
on	O
lung	O
development	O
during	O
embryogenesis	O
.	O

Accordingly	O
,	O
formation	O
of	O
the	O
epithelial	O
lung	O
via	O
branching	O
morphogenesis	O
can	O
be	O
subdivided	O
into	O
a	O
series	O
of	O
sequential	O
steps	O
that	O
involve	O
:	O
first	O
,	O
formation	O
of	O
the	O
organ	O
anlage	O
in	O
the	O
form	O
of	O
a	O
placode	O
;	O
second	O
,	O
primary	O
bud	O
formation	O
by	O
placode	O
invagination	O
;	O
third	O
,	O
branch	O
initiation	O
and	O
branch	O
outgrowth	O
;	O
fourth	O
,	O
further	O
reiteration	O
of	O
the	O
branching	O
process	O
;	O
and	O
fifth	O
,	O
terminal	O
differentiation	O
of	O
organ	O
-	O
specific	O
proximal	O
and	O
distal	O
structures	O
[	O
34	O
,	O
35	O
]	O
.	O

In	O
contrast	O
to	O
other	O
invagination	O
processes	O
during	O
embryogenesis	O
,	O
such	O
as	O
mammary	O
gland	O
formation	O
,	O
the	O
lumen	O
of	O
the	O
lungs	O
is	O
expanded	O
by	O
successive	O
branching	O
events	O
,	O
branch	O
outgrowth	O
and	O
elongation	O
,	O
rather	O
than	O
by	O
apoptosis	O
[	O
34	O
,	O
36	O
]	O
.	O

Finally	O
,	O
because	O
the	O
lungs	O
of	O
Ptdsr	O
-	O
/	O
-	O
neonates	O
were	O
almost	O
fully	O
expanded	O
and	O
appeared	O
normal	O
in	O
structure	O
in	O
comparison	O
to	O
wild	O
-	O
type	O
littermates	O
,	O
it	O
is	O
highly	O
unlikely	O
that	O
Ptdsr	O
mutants	O
die	O
of	O
respiratory	O
lung	O
failure	O
.	O

In	O
addition	O
,	O
Li	O
and	O
colleagues	O
[	O
31	O
]	O
demonstrated	O
that	O
surfactant	O
expression	O
is	O
normal	O
in	O
Ptdsr	O
-	O
deficient	O
animals	O
,	O
supporting	O
the	O
idea	O
of	O
normal	O
maturation	O
of	O
surfactant	O
-	O
producing	O
type	O
II	O
alveolar	O
epithelial	O
cells	O
and	O
lung	O
function	O
.	O

Other	O
defects	O
must	O
therefore	O
be	O
responsible	O
for	O
the	O
death	O
of	O
Ptdsr	O
-	O
mutant	O
mice	O
.	O

The	O
frequently	O
observed	O
subcutaneous	O
edema	O
of	O
various	O
extents	O
in	O
Ptdsr	O
-	O
deficient	O
homozygotes	O
gave	O
us	O
a	O
hint	O
that	O
Ptdsr	O
-	O
deficiency	O
and	O
lethality	O
might	O
be	O
associated	O
with	O
cardiovascular	O
problems	O
.	O

Indeed	O
,	O
very	O
recently	O
we	O
have	O
obtained	O
strong	O
evidence	O
that	O
Ptdsr	O
-	O
knockout	O
mice	O
die	O
as	O
a	O
result	O
of	O
defects	O
in	O
heart	O
development	O
that	O
are	O
associated	O
with	O
specific	O
cardiopulmonary	O
malformations	O
;	O
(	O
J	O
.	O
E	O
.	O
Schneider	O
,	O
J	O
.	O
B	O
.	O
,	O
S	O
.	O
D	O
.	O
Bamfort	O
,	O
A	O
.	O
D	O
.	O
G	O
.	O
,	O
C	O
.	O
Broadbent	O
,	O
K	O
.	O
Clarke	O
,	O
S	O
.	O
Neubauer	O
,	O
A	O
.	O
L	O
.	O
and	O
S	O
.	O
Battacharya	O
,	O
unpublished	O
observations	O
)	O
.	O

In	O
addition	O
,	O
we	O
demonstrate	O
that	O
eye	O
development	O
requires	O
a	O
functional	O
Ptdsr	O
gene	O
.	O

Ptdsr	O
-	O
deficient	O
embryos	O
can	O
be	O
roughly	O
divided	O
into	O
two	O
categories	O
.	O

The	O
first	O
,	O
severely	O
affected	O
group	O
develops	O
anophthalmia	O
that	O
correlates	O
with	O
formation	O
of	O
ectopic	O
retinal	O
-	O
pigmented	O
epithelium	O
and	O
induction	O
of	O
proliferation	O
of	O
underlying	O
mesenchyme	O
in	O
the	O
nasal	O
cavity	O
.	O

This	O
phenotype	O
represents	O
a	O
completely	O
novel	O
lesion	O
that	O
to	O
our	O
knowledge	O
has	O
not	O
been	O
described	O
before	O
in	O
any	O
other	O
mouse	O
mutant	O
.	O

The	O
second	O
group	O
shows	O
normal	O
external	O
eye	O
structures	O
,	O
although	O
in	O
this	O
case	O
retinal	O
development	O
is	O
temporally	O
delayed	O
during	O
mid	O
-	O
gestation	O
,	O
with	O
persistent	O
,	O
abnormal	O
morphogenesis	O
of	O
the	O
inner	O
granular	O
retinal	O
layer	O
at	O
later	O
stages	O
of	O
embryogenesis	O
.	O

A	O
possible	O
explanation	O
for	O
these	O
two	O
phenotypes	O
can	O
be	O
found	O
in	O
the	O
expression	O
pattern	O
of	O
the	O
Ptdsr	O
gene	O
.	O

Initially	O
,	O
Ptdsr	O
is	O
expressed	O
throughout	O
the	O
whole	O
developing	O
nervous	O
system	O
,	O
with	O
exceptionally	O
high	O
levels	O
in	O
the	O
anterior	O
part	O
of	O
the	O
forebrain	O
.	O

Later	O
expression	O
becomes	O
more	O
restricted	O
to	O
the	O
developing	O
retina	O
and	O
lens	O
.	O

Thus	O
,	O
Ptdsr	O
might	O
play	O
an	O
important	O
role	O
in	O
early	O
events	O
of	O
ocular	O
morphogenesis	O
,	O
such	O
as	O
establishment	O
and	O
bisection	O
of	O
eye	O
fields	O
and	O
formation	O
of	O
optic	O
cups	O
.	O

These	O
early	O
eye	O
-	O
formation	O
steps	O
are	O
closely	O
interconnected	O
with	O
development	O
of	O
the	O
forebrain	O
[	O
37	O
,	O
38	O
]	O
and	O
the	O
nose	O
[	O
39	O
-	O
41	O
]	O
.	O

Interestingly	O
,	O
we	O
occasionally	O
observed	O
serious	O
malformations	O
of	O
forebrain	O
and	O
nasal	O
structures	O
in	O
Ptdsr	O
-	O
knockout	O
embryos	O
that	O
were	O
associated	O
with	O
bilateral	O
anophthalmia	O
(	O
see	O
for	O
example	O
the	O
mutant	O
embryo	O
in	O
Figure	O
1g	O
)	O
.	O

This	O
suggests	O
that	O
Ptdsr	O
is	O
involved	O
in	O
the	O
regulation	O
of	O
differentiation	O
processes	O
within	O
forebrain	O
regions	O
,	O
and	O
that	O
ablation	O
of	O
Ptdsr	O
function	O
might	O
secondarily	O
affect	O
early	O
eye	O
formation	O
.	O

Li	O
et	O
al	O
.	O

[	O
31	O
]	O
found	O
smaller	O
lenses	O
in	O
Ptdsr	O
-	O
knockout	O
mice	O
and	O
described	O
the	O
formation	O
of	O
retinal	O
protrusions	O
,	O
although	O
anophthalmia	O
and	O
specific	O
differentiation	O
defects	O
of	O
retinal	O
cell	O
layers	O
were	O
not	O
reported	O
in	O
their	O
study	O
.	O

Li	O
et	O
al	O
.	O
proposed	O
[	O
31	O
]	O
that	O
the	O
eye	O
phenotype	O
they	O
observed	O
could	O
be	O
explained	O
by	O
failed	O
removal	O
of	O
apoptotic	O
cells	O
during	O
eye	O
development	O
,	O
but	O
we	O
think	O
that	O
the	O
observed	O
defects	O
are	O
unrelated	O
to	O
a	O
failure	O
of	O
apoptotic	O
cell	O
clearance	O
.	O

A	O
recent	O
comprehensive	O
kinetic	O
analysis	O
of	O
apoptosis	O
induction	O
during	O
mouse	O
retinal	O
development	O
described	O
four	O
major	O
peaks	O
of	O
apoptotic	O
cell	O
death	O
[	O
42	O
]	O
.	O

This	O
study	O
demonstrated	O
that	O
there	O
is	O
an	O
initial	O
phase	O
of	O
cell	O
death	O
during	O
the	O
invagination	O
of	O
the	O
optic	O
cup	O
(	O
E10	O
.	O
5	O
)	O
,	O
followed	O
by	O
subsequent	O
waves	O
of	O
apoptosis	O
induction	O
immediately	O
before	O
and	O
after	O
birth	O
(	O
E18	O
.	O
5	O
to	O
postnatal	O
day	O
P2	O
)	O
,	O
and	O
from	O
postnatal	O
days	O
P9	O
to	O
P10	O
and	O
P14	O
to	O
P16	O
[	O
42	O
]	O
.	O

Thus	O
,	O
besides	O
the	O
formation	O
of	O
the	O
inner	O
and	O
outer	O
layers	O
of	O
the	O
optic	O
cup	O
in	O
early	O
eye	O
development	O
,	O
other	O
major	O
phases	O
of	O
retinal	O
cell	O
apoptosis	O
take	O
place	O
only	O
postnatally	O
and	O
correspond	O
to	O
important	O
periods	O
in	O
the	O
establishment	O
of	O
neuronal	O
connections	O
.	O

Furthermore	O
,	O
cell	O
death	O
during	O
normal	O
retinal	O
development	O
occurs	O
in	O
retinal	O
layers	O
distinct	O
from	O
the	O
inner	O
granular	O
layer	O
where	O
we	O
observed	O
the	O
most	O
pronounced	O
differentiation	O
defects	O
in	O
the	O
Ptdsr	O
-	O
/	O
-	O
mutants	O
described	O
here	O
.	O

Other	O
studies	O
that	O
connect	O
the	O
postnatal	O
elimination	O
of	O
apoptotic	O
photoreceptor	O
cells	O
to	O
Ptdsr	O
-	O
mediated	O
macrophage	O
engulfment	O
[	O
43	O
]	O
should	O
be	O
interpreted	O
with	O
extreme	O
caution	O
as	O
these	O
studies	O
were	O
based	O
on	O
the	O
monoclonal	O
anti	O
-	O
Ptdsr	O
antibody	S-GO
mAb	O
217G8E9	O
[	O
26	O
,	O
43	O
]	O
(	O
see	O
below	O
)	O
.	O

Consistent	O
with	O
the	O
results	O
of	O
Li	O
et	O
al	O
.	O

[	O
31	O
]	O
,	O
we	O
found	O
particular	O
brain	O
malformations	O
in	O
our	O
Ptdsr	O
-	O
/	O
-	O
mice	O
.	O

Exencephaly	O
and	O
hyperplastic	O
brain	O
phenotypes	O
were	O
observed	O
at	O
a	O
low	O
penetrance	O
in	O
Ptdsr	O
-	O
mutant	O
mice	O
(	O
less	O
then	O
4	O
.	O
5	O
%	O
of	O
homozygotes	O
)	O
,	O
but	O
these	O
do	O
not	O
resemble	O
to	O
any	O
extent	O
the	O
brain	O
-	O
overgrowth	O
phenotypes	O
of	O
caspase	O
-	O
or	O
Apaf1	O
-	O
knockout	O
mice	O
(	O
[	O
44	O
]	O
,	O
and	O
references	O
therein	O
)	O
in	O
that	O
we	O
failed	O
to	O
identify	O
any	O
differences	O
in	O
the	O
number	O
or	O
distribution	O
of	O
apoptotic	O
cells	O
or	O
pyknotic	O
cell	O
clusters	O
in	O
the	O
neuroepithelium	O
of	O
Ptdsr	O
-	O
/	O
-	O
and	O
Ptdsr	O
+	O
/	O
+	O
mice	O
.	O

Thus	O
,	O
reduced	O
cell	O
death	O
or	O
diminished	O
clearance	O
of	O
apoptotic	O
neural	O
progenitor	O
cells	O
is	O
unlikely	O
to	O
be	O
the	O
cause	O
of	O
the	O
brain	O
hyperplasia	O
.	O

In	O
summary	O
,	O
our	O
studies	O
demonstrate	O
that	O
Ptdsr	O
is	O
required	O
for	O
normal	O
tissue	O
differentiation	O
,	O
especially	O
during	O
the	O
mid	O
-	O
gestation	O
period	O
when	O
we	O
observed	O
the	O
most	O
severe	O
differentiation	O
delays	O
in	O
several	O
organs	O
of	O
Ptdsr	O
-	O
knockout	O
mice	O
.	O

The	O
multiple	O
defects	O
in	O
tissue	O
differentiation	O
cannot	O
be	O
explained	O
by	O
failure	O
of	O
apoptotic	O
cell	O
clearance	O
,	O
as	O
this	O
process	O
is	O
normal	O
in	O
our	O
Ptdsr	O
-	O
knockout	O
line	O
.	O

This	O
result	O
therefore	O
indicates	O
that	O
Ptdsr	O
has	O
a	O
novel	O
,	O
hitherto	O
unexpected	O
,	O
role	O
in	O
promoting	O
tissue	O
maturation	O
and	O
terminal	O
differentiation	O
.	O

Additional	O
studies	O
with	O
conditionally	O
targeted	O
Ptdsr	O
-	O
deficient	O
mice	O
are	O
required	O
to	O
investigate	O
the	O
role	O
of	O
spatial	O
and	O
temporal	O
Ptdsr	O
expression	O
and	O
function	O
during	O
tissue	O
differentiation	O
.	O

Ptdsr	O
is	O
not	O
essential	O
for	O
the	O
clearance	O
of	O
apoptotic	O
cells	O

Our	O
studies	O
demonstrate	O
that	O
Ptdsr	O
is	O
not	O
a	O
primary	O
receptor	O
for	O
the	O
uptake	O
of	O
apoptotic	O
cells	O
.	O

Investigation	O
of	O
apoptotic	O
cell	O
clearance	O
in	O
vivo	O
in	O
Ptdsr	O
-	O
/	O
-	O
embryos	O
conclusively	O
showed	O
that	O
removal	O
of	O
apoptotic	O
cells	O
is	O
not	O
compromised	O
by	O
ablation	O
of	O
Ptdsr	O
function	O
.	O

Comparative	O
analysis	O
of	O
ten	O
different	O
tissues	O
and	O
organs	O
in	O
Ptdsr	O
+	O
/	O
+	O
and	O
Ptdsr	O
-	O
/	O
-	O
animals	O
at	O
several	O
stages	O
of	O
embryonic	O
development	O
and	O
in	O
neonates	O
failed	O
to	O
identify	O
impaired	O
uptake	O
of	O
apoptotic	O
cells	O
at	O
any	O
time	O
during	O
development	O
.	O

Furthermore	O
,	O
phagocytosis	O
assays	O
in	O
vitro	O
demonstrated	O
a	O
completely	O
normal	O
uptake	O
of	O
apoptotic	O
cells	O
by	O
Ptdsr	O
-	O
/	O
-	O
macrophages	O
,	O
with	O
some	O
knockout	O
macrophages	O
showing	O
loads	O
even	O
higher	O
than	O
wild	O
-	O
type	O
of	O
engulfed	O
dead	O
cells	O
.	O

These	O
results	O
are	O
contrary	O
to	O
the	O
expected	O
role	O
of	O
Ptdsr	O
in	O
apoptotic	O
cell	O
clearance	O
and	O
to	O
the	O
reported	O
findings	O
of	O
Li	O
et	O
al	O
.	O

[	O
31	O
]	O
and	O
Kunisaki	O
et	O
al	O
.	O

[	O
32	O
]	O
,	O
as	O
well	O
as	O
to	O
a	O
study	O
done	O
with	O
a	O
phosphatidylserine	O
receptor	O
null	O
allele	O
in	O
C	O
.	O
elegans	O
[	O
45	O
]	O
.	O

In	O
previous	O
studies	O
in	O
the	O
mouse	O
,	O
the	O
distribution	O
and	O
amount	O
of	O
apoptotic	O
cells	O
in	O
Ptdsr	O
-	O
knockout	O
and	O
control	O
animals	O
were	O
investigated	O
in	O
only	O
a	O
few	O
tissues	O
and	O
at	O
one	O
[	O
31	O
]	O
or	O
two	O
[	O
32	O
]	O
developmental	O
stages	O
.	O

Li	O
et	O
al	O
.	O

[	O
31	O
]	O
examined	O
lung	O
,	O
midbrain	O
and	O
retina	O
at	O
day	O
E17	O
.	O
5	O
of	O
gestation	O
and	O
identified	O
apoptotic	O
cells	O
by	O
TUNEL	O
staining	O
.	O

Their	O
findings	O
must	O
be	O
interpreted	O
with	O
caution	O
because	O
remodeling	O
of	O
cellular	O
structures	O
by	O
apoptosis	O
in	O
specific	O
retina	O
layers	O
is	O
known	O
to	O
occur	O
mainly	O
postnatally	O
[	O
42	O
]	O
,	O
and	O
apoptosis	O
plays	O
an	O
important	O
physiological	O
role	O
in	O
the	O
maintenance	O
and	O
homeostasis	O
of	O
lung	O
epithelium	O
after	O
birth	O
or	O
in	O
pathological	O
conditions	O
involving	O
pulmonary	O
inflammation	O
and	O
not	O
during	O
lung	O
development	O
[	O
46	O
]	O
.	O

This	O
postnatal	O
role	O
for	O
apoptosis	O
is	O
in	O
accordance	O
with	O
our	O
data	O
,	O
as	O
we	O
rarely	O
observed	O
apoptotic	O
cells	O
in	O
retina	O
or	O
lung	O
tissue	O
throughout	O
embryogenesis	O
in	O
Ptdsr	O
+	O
/	O
+	O
and	O
Ptdsr	O
-	O
/	O
-	O
mice	O
.	O

Kunisaki	O
et	O
al	O
.	O

[	O
32	O
]	O
analyzed	O
TUNEL	O
-	O
stained	O
sections	O
of	O
liver	O
and	O
thymus	O
at	O
days	O
E13	O
.	O
5	O
and	O
E16	O
.	O
5	O
of	O
development	O
in	O
Ptdsr	O
+	O
/	O
-	O
and	O
Ptdsr	O
-	O
/	O
-	O
embryos	O
and	O
found	O
reduced	O
rather	O
than	O
increased	O
numbers	O
of	O
TUNEL	O
-	O
positive	O
cells	O
in	O
Ptdsr	O
-	O
deficient	O
embryos	O
.	O

Using	O
co	O
-	O
localization	O
of	O
TUNEL	O
-	O
positive	O
cells	O
with	O
F4	O
/	O
80	O
-	O
positive	O
macrophages	O
they	O
suggested	O
that	O
Ptdsr	O
-	O
/	O
-	O
embryos	O
exhibited	O
a	O
three	O
-	O
fold	O
increase	O
in	O
the	O
frequency	O
of	O
unphagocytosed	O
TUNEL	O
-	O
positive	O
cells	O
together	O
with	O
a	O
severely	O
reduced	O
number	O
of	O
F4	O
/	O
80	O
-	O
positive	O
cells	O
.	O

These	O
results	O
must	O
be	O
interpreted	O
very	O
carefully	O
,	O
however	O
,	O
as	O
it	O
is	O
technically	O
difficult	O
to	O
unambiguously	O
identify	O
engulfed	O
target	O
cells	O
in	O
individual	O
macrophages	O
in	O
solid	O
tissues	O
by	O
fluorescence	O
microscopy	O
.	O

In	O
addition	O
,	O
our	O
data	O
suggest	O
that	O
during	O
embryogenesis	O
,	O
macrophage	O
-	O
mediated	O
clearance	O
of	O
apoptotic	O
cells	O
is	O
not	O
the	O
only	O
-	O
or	O
even	O
the	O
primary	O
-	O
mechanism	O
for	O
the	O
removal	O
of	O
apoptotic	O
cells	O
.	O

In	O
many	O
tissues	O
where	O
programmed	O
cell	O
death	O
occurs	O
as	O
a	O
prominent	O
event	O
during	O
embryogenesis	O
,	O
such	O
as	O
remodeling	O
of	O
the	O
genital	O
ridge	O
during	O
gonad	O
morphogenesis	O
and	O
differentiation	O
of	O
the	O
neural	O
tube	O
,	O
we	O
found	O
almost	O
no	O
co	O
-	O
localization	O
of	O
apoptotic	O
cells	O
and	O
macrophages	O
.	O

This	O
indicates	O
that	O
in	O
these	O
cases	O
clearance	O
of	O
apoptotic	O
cells	O
is	O
directly	O
mediated	O
by	O
neighboring	O
'	O
bystander	O
'	O
cells	O
rather	O
than	O
by	O
macrophages	O
that	O
have	O
been	O
recruited	O
into	O
areas	O
where	O
apoptosis	O
occurs	O
.	O

Obviously	O
these	O
in	O
vivo	O
clearance	O
mechanisms	O
are	O
not	O
compromised	O
by	O
Ptdsr	O
-	O
deficiency	O
in	O
our	O
knockout	O
mutant	O
.	O

This	O
finding	O
is	O
in	O
line	O
with	O
studies	O
in	O
macrophageless	O
Sfpi1	O
-	O
knockout	O
embryos	O
that	O
are	O
deficient	O
for	O
the	O
hematopoietic	O
-	O
lineage	O
-	O
specific	O
transcription	O
factor	O
PU	O
.	O
1	O
.	O

Here	O
,	O
the	O
phagocytosis	O
of	O
apoptotic	O
cells	O
during	O
embryogenesis	O
is	O
taken	O
over	O
by	O
'	O
stand	O
-	O
in	O
'	O
mesenchymal	O
neighbors	O
[	O
47	O
]	O
.	O

As	O
recognition	O
of	O
phosphatidylserine	O
is	O
thought	O
to	O
be	O
a	O
universal	O
engulfment	O
mechanism	O
for	O
all	O
cells	O
that	O
are	O
able	O
to	O
phagocytose	O
apoptotic	O
cells	O
,	O
it	O
is	O
very	O
striking	O
that	O
apoptotic	O
cell	O
clearance	O
mediated	O
by	O
non	O
-	O
professional	O
bystander	O
cells	O
is	O
also	O
not	O
compromised	O
by	O
Ptdsr	O
-	O
deficiency	O
.	O

In	O
contrast	O
to	O
Li	O
et	O
al	O
.	O

[	O
31	O
]	O
,	O
we	O
did	O
not	O
observe	O
any	O
impairment	O
in	O
the	O
uptake	O
of	O
apoptotic	O
cells	O
by	O
Ptdsr	O
-	O
/	O
-	O
macrophages	O
in	O
vitro	O
.	O

We	O
performed	O
phagocytosis	O
assays	O
in	O
vitro	O
with	O
fetal	O
-	O
liver	O
-	O
derived	O
macrophages	O
,	O
while	O
in	O
their	O
assays	O
,	O
Li	O
and	O
colleagues	O
used	O
thioglycollate	O
-	O
elicited	O
peritoneal	O
macrophages	O
after	O
adoptive	O
transfer	O
of	O
Ptdsr	O
-	O
/	O
-	O
hematopoietic	O
stem	O
cells	O
.	O

The	O
different	O
results	O
obtained	O
in	O
the	O
two	O
studies	O
are	O
puzzling	O
;	O
they	O
might	O
be	O
due	O
to	O
the	O
use	O
of	O
different	O
macrophage	O
or	O
cell	O
populations	O
.	O

We	O
and	O
Kunisaki	O
et	O
al	O
.	O

[	O
32	O
]	O
found	O
that	O
Ptdsr	O
-	O
deficiency	O
is	O
to	O
some	O
extent	O
associated	O
with	O
defects	O
in	O
hematopoiesis	O
.	O

Thus	O
,	O
it	O
seems	O
possible	O
that	O
recruitment	O
and	O
activation	O
/	O
differentiation	O
of	O
macrophages	O
after	O
adoptive	O
transfer	O
and	O
thioglycollate	O
elicitation	O
are	O
affected	O
by	O
Ptdsr	O
-	O
deficiency	O
.	O

We	O
do	O
not	O
think	O
that	O
the	O
different	O
results	O
observed	O
in	O
Ptdsr	O
-	O
knockout	O
mice	O
in	O
a	O
mixed	O
C57BL	O
/	O
6	O
x	O
129	O
background	O
and	O
in	O
a	O
pure	O
C57BL	O
/	O
6J	O
background	O
can	O
be	O
attributed	O
to	O
genetic	O
background	O
effects	O
:	O
comparison	O
of	O
apoptotic	O
cell	O
engulfment	O
efficacies	O
of	O
thioglycollate	O
-	O
elicited	O
macrophages	O
from	O
129P2	O
/	O
OlaHsd	O
and	O
C57BL	O
/	O
6J	O
mice	O
did	O
not	O
show	O
any	O
differences	O
in	O
apoptotic	O
cell	O
uptake	O
(	O
J	O
.	O
B	O
.	O
and	O
A	O
.	O
L	O
.	O
,	O
unpublished	O
observations	O
)	O
.	O

Moreover	O
,	O
in	O
contrast	O
to	O
our	O
studies	O
,	O
neither	O
Li	O
et	O
al	O
.	O

[	O
31	O
]	O
nor	O
Kunisaki	O
et	O
al	O
.	O

[	O
32	O
]	O
determined	O
phagocytotic	O
engulfment	O
indexes	O
for	O
Ptdsr	O
-	O
deficient	O
macrophages	O
.	O

Interestingly	O
,	O
we	O
observed	O
differences	O
between	O
Ptdsr	O
+	O
/	O
+	O
and	O
Ptdsr	O
-	O
/	O
-	O
macrophages	O
in	O
the	O
secretion	O
of	O
pro	O
-	O
and	O
anti	O
-	O
inflammatory	O
cytokines	O
after	O
stimulation	O
with	O
LPS	O
and	O
apoptotic	O
cells	O
.	O

This	O
provides	O
evidence	O
that	O
cellular	O
activation	O
and	O
effector	O
mechanisms	O
are	O
impaired	O
in	O
Ptdsr	O
-	O
deleted	O
macrophages	O
.	O

It	O
remains	O
to	O
be	O
determined	O
which	O
classical	O
pathways	O
of	O
macrophage	O
activation	O
and	O
function	O
involve	O
Ptdsr	O
.	O

This	O
is	O
especially	O
important	O
in	O
light	O
of	O
recent	O
findings	O
that	O
demonstrated	O
nuclear	S-GO
localization	O
of	O
the	O
Ptdsr	O
protein	O
[	O
29	O
]	O
.	O

Most	O
strikingly	O
,	O
the	O
recently	O
published	O
data	O
regarding	O
the	O
genetic	O
ablation	O
or	O
perturbation	O
of	O
phosphatidylserine	O
receptor	O
function	O
in	O
C	O
.	O
elegans	O
are	O
also	O
contradictory	O
.	O

Wang	O
et	O
al	O
.	O

[	O
45	O
]	O
reported	O
that	O
psr	O
-	O
1	O
,	O
the	O
C	O
.	O
elegans	O
homolog	O
of	O
Ptdsr	O
,	O
is	O
important	O
for	O
cell	O
-	O
corpse	O
engulfment	O
,	O
whereas	O
psr	O
-	O
1	O
RNAi	O
studies	O
performed	O
by	O
Arur	O
et	O
al	O
.	O

[	O
25	O
]	O
yielded	O
,	O
in	O
this	O
respect	O
,	O
no	O
phenotype	O
.	O

Moreover	O
,	O
Wang	O
and	O
colleagues	O
hypothesized	O
on	O
the	O
basis	O
of	O
their	O
data	O
that	O
psr	O
-	O
1	O
might	O
act	O
to	O
transduce	O
an	O
engulfment	O
signal	O
upstream	O
of	O
Ced	O
-	O
2	O
(	O
Crk	O
II	O
)	O
,	O
Ced	O
-	O
5	O
(	O
Dock	O
180	O
)	O
,	O
Ced	O
-	O
10	O
(	O
Rac	O
1	O
)	O
and	O
Ced	O
-	O
12	O
(	O
Elmo	O
)	O
in	O
one	O
of	O
the	O
two	O
cell	O
-	O
corpse	O
engulfment	O
pathways	O
in	O
the	O
worm	O
[	O
45	O
]	O
.	O

But	O
the	O
loss	O
-	O
of	O
-	O
function	O
phenotype	O
of	O
psr	O
-	O
1	O
mutants	O
and	O
the	O
complementation	O
phenotypes	O
in	O
overexpressing	O
transgenic	O
worms	O
shown	O
by	O
Wang	O
et	O
al	O
.	O

[	O
45	O
]	O
are	O
rather	O
weak	O
as	O
compared	O
to	O
the	O
classical	O
C	O
.	O
elegans	O
engulfment	O
mutants	O
[	O
8	O
]	O
.	O

Many	O
previous	O
functional	O
studies	O
that	O
reported	O
a	O
requirement	O
for	O
Ptdsr	O
for	O
the	O
phagocytosis	O
of	O
apoptotic	O
cells	O
used	O
the	O
monoclonal	O
anti	O
-	O
Ptdsr	O
antibody	S-GO
mAb	O
217G8E9	O
[	O
26	O
]	O
.	O

This	O
antibody	S-GO
was	O
used	O
in	O
Ptdsr	O
binding	O
and	O
blocking	O
experiments	O
,	O
as	O
well	O
as	O
in	O
subcellular	O
localization	O
studies	O
,	O
which	O
led	O
to	O
the	O
conclusion	O
that	O
Ptdsr	O
is	O
a	O
transmembrane	S-GO
receptor	O
critical	O
for	O
signal	O
transduction	O
at	O
the	O
engulfment	O
interface	O
.	O

More	O
recently	O
it	O
was	O
used	O
in	O
binding	O
assays	O
to	O
show	O
that	O
the	O
human	O
and	O
worm	O
Ptdsr	O
molecules	O
can	O
recognize	O
phosphatidylserine	O
[	O
45	O
]	O
.	O

In	O
the	O
course	O
of	O
the	O
study	O
presented	O
here	O
,	O
we	O
stained	O
immunohistochemically	O
for	O
Ptdsr	O
with	O
mAb	O
217G8E9	O
on	O
wild	O
-	O
type	O
and	O
Ptdsr	O
-	O
deficient	O
macrophages	O
and	O
fibroblasts	O
(	O
see	O
Additional	O
data	O
file	O
1	O
,	O
Figure	O
S2	O
and	O
data	O
not	O
shown	O
)	O
.	O

To	O
our	O
surprise	O
,	O
we	O
observed	O
similar	O
staining	O
patterns	O
with	O
cells	O
of	O
both	O
genotypes	O
.	O

Furthermore	O
,	O
using	O
a	O
Ptdsr	O
-	O
peptide	O
array	O
we	O
found	O
that	O
mAb	O
217G8E9	O
can	O
bind	O
weakly	O
to	O
a	O
Ptdsr	O
peptide	O
,	O
explaining	O
the	O
original	O
isolation	O
of	O
Ptdsr	O
cDNA	O
clones	O
by	O
phage	O
display	O
[	O
26	O
]	O
;	O
but	O
the	O
antibody	S-GO
mainly	O
recognizes	O
additional	O
,	O
as	O
-	O
yet	O
unknown	O
,	O
membrane	S-GO
-	O
associated	O
protein	O
(	O
s	O
)	O
(	O
see	O
Additional	O
data	O
file	O
1	O
,	O
Figure	O
S2	O
)	O
.	O

Experiments	O
that	O
have	O
used	O
this	O
antibody	S-GO
should	O
therefore	O
be	O
interpreted	O
with	O
great	O
caution	O
as	O
they	O
might	O
come	O
to	O
be	O
viewed	O
in	O
a	O
different	O
light	O
.	O

Conclusion	O

Our	O
results	O
demonstrate	O
that	O
Ptdsr	O
is	O
essential	O
for	O
the	O
differentiation	O
and	O
maturation	O
of	O
multiple	O
tissues	O
during	O
embryogenesis	O
.	O

Ablation	O
of	O
Ptdsr	O
function	O
results	O
in	O
neonatal	O
lethality	O
and	O
severe	O
defects	O
in	O
the	O
morphogenesis	O
of	O
several	O
organs	O
.	O

The	O
developmental	O
malformations	O
cannot	O
be	O
explained	O
by	O
impaired	O
clearance	O
of	O
apoptotic	O
cells	O
,	O
a	O
process	O
that	O
proved	O
to	O
be	O
normal	O
in	O
Ptdsr	O
-	O
deficient	O
mice	O
.	O

This	O
opens	O
up	O
the	O
possibility	O
either	O
that	O
there	O
is	O
an	O
as	O
-	O
yet	O
unknown	O
Ptdsr	O
receptor	O
,	O
which	O
might	O
act	O
as	O
a	O
primary	O
phosphatidylserine	O
recognition	O
receptor	O
,	O
or	O
that	O
recognition	O
of	O
phosphatidylserine	O
and	O
subsequent	O
apoptotic	O
cell	O
engulfment	O
and	O
anti	O
-	O
inflammatory	O
signaling	O
are	O
mainly	O
mediated	O
through	O
phosphatidylserine	O
bridging	O
proteins	O
and	O
their	O
cognate	O
receptors	O
.	O

Although	O
Ptdsr	O
-	O
/	O
-	O
macrophages	O
were	O
not	O
impaired	O
in	O
their	O
ability	O
to	O
phagocytose	O
apoptotic	O
cells	O
,	O
they	O
showed	O
reduced	O
cytokine	O
responses	O
after	O
stimulation	O
.	O

Further	O
work	O
will	O
be	O
required	O
to	O
determine	O
the	O
molecular	O
mechanisms	O
of	O
these	O
newly	O
recognized	O
Ptdsr	O
functions	O
during	O
development	O
.	O

Materials	O
and	O
methods	O

Construction	O
of	O
the	O
targeting	O
vector	O
and	O
generation	O
of	O
Ptdsr	O
-	O
knockout	O
and	O
gene	O
-	O
trap	O
mice	O

Targeting	O
vector	O

A	O
Ptdsr	O
-	O
containing	O
bacterial	O
artificial	O
chromosome	O
(	O
BAC	O
)	O
clone	O
(	O
GenBank	O
accession	O
number	O
AC091694	O
;	O
RP	O
-	O
23	O
-	O
316F3	O
)	O
was	O
isolated	O
by	O
sequence	O
homology	O
from	O
a	O
C57BL	O
/	O
6J	O
genomic	O
BAC	O
library	O
(	O
RP	O
-	O
23	O
;	O
BACPAC	O
Resources	O
,	O
Oakland	O
,	O
USA	O
)	O
.	O

A	O
14	O
.	O
5	O
kb	O
KpnI	O
/	O
BamHI	O
fragment	O
containing	O
the	O
entire	O
Ptdsr	O
locus	O
and	O
5	O
'	O
and	O
3	O
'	O
flanking	O
regions	O
was	O
subcloned	O
from	O
this	O
BAC	O
clone	O
and	O
a	O
1	O
.	O
9	O
kb	O
RsrII	O
/	O
AatII	O
fragment	O
containing	O
exons	O
I	O
and	O
II	O
of	O
the	O
Ptdsr	O
gene	O
was	O
replaced	O
by	O
a	O
1	O
.	O
2	O
kb	O
loxP	O
-	O
flanked	O
neomycin	O
-	O
resistance	O
gene	O
cassette	O
(	O
neo	O
)	O
.	O

Homologous	O
recombination	O
in	O
ES	O
cells	O
and	O
generation	O
of	O
germ	O
-	O
line	O
chimeras	O

Bruce4	O
ES	O
cells	O
were	O
transfected	O
with	O
KpnI	O
-	O
linearized	O
targeting	O
vector	O
and	O
selected	O
with	O
G418	O
.	O

ES	O
-	O
cell	O
clones	O
resistant	O
to	O
G418	O
were	O
isolated	O
and	O
analyzed	O
by	O
Southern	O
blot	O
analysis	O
for	O
homologous	O
recombination	O
events	O
within	O
the	O
Ptdsr	O
locus	O
.	O

Chimeric	O
mice	O
were	O
produced	O
by	O
microinjection	O
of	O
two	O
independent	O
homologous	O
recombinant	O
(	O
Ptdsr	O
+	O
/	O
-	O
)	O
ES	O
cells	O
into	O
BALB	O
/	O
c	O
blastocysts	O
and	O
transfer	O
to	O
pseudopregnant	O
foster	O
mothers	O
followed	O
by	O
development	O
to	O
term	O
.	O

Chimeric	O
males	O
were	O
mated	O
with	O
C57BL	O
/	O
6J	O
females	O
.	O

From	O
the	O
two	O
selected	O
ES	O
-	O
cell	O
clones	O
,	O
one	O
successfully	O
contributed	O
to	O
the	O
germ	O
-	O
line	O
.	O

Germ	O
-	O
line	O
transmission	O
of	O
the	O
mutant	O
allele	O
was	O
verified	O
by	O
PCR	O
and	O
Southern	O
blot	O
of	O
genomic	O
DNA	O
from	O
black	O
coat	O
-	O
color	O
F1	O
offspring	O
.	O

Ptdsr	O
gene	O
-	O
trap	O
and	O
generation	O
of	O
germ	O
-	O
line	O
chimeras	O

An	O
ES	O
-	O
cell	O
line	O
carrying	O
a	O
beta	O
-	O
geo	O
gene	O
-	O
trap	O
vector	O
in	O
the	O
Ptdsr	O
locus	O
was	O
identified	O
by	O
searching	O
the	O
BayGenomics	O
database	O
(	O
BayGenomics	O
,	O
San	O
Francisco	O
,	O
USA	O
;	O
[	O
48	O
]	O
)	O
with	O
the	O
full	O
-	O
length	O
Ptdsr	O
cDNA	O
.	O

A	O
single	O
ES	O
-	O
cell	O
line	O
was	O
identified	O
carrying	O
the	O
gene	O
-	O
trap	O
in	O
intron	O
V	O
,	O
between	O
exons	O
V	O
and	O
VI	O
of	O
the	O
Ptdsr	O
gene	O
.	O

Chimeric	O
mice	O
were	O
generated	O
by	O
microinjection	O
into	O
CB20	O
blastocysts	O
and	O
transfer	O
to	O
pseudopregnant	O
foster	O
mothers	O
.	O

Chimeric	O
males	O
were	O
mated	O
with	O
129P2	O
/	O
OlaHsd	O
females	O
.	O

Germ	O
-	O
line	O
transmission	O
of	O
the	O
mutant	O
gene	O
-	O
trap	O
allele	O
was	O
verified	O
by	O
expression	O
analysis	O
using	O
beta	O
-	O
galactosidase	O
staining	O
and	O
RT	O
-	O
PCR	O
.	O

Genotype	O
analysis	O

The	O
genotypes	O
of	O
embryos	O
or	O
animals	O
were	O
determined	O
by	O
PCR	O
analysis	O
and	O
confirmed	O
by	O
Southern	O
blot	O
.	O

Genomic	O
DNA	O
for	O
PCR	O
was	O
prepared	O
from	O
extraembryonic	O
membranes	O
or	O
tail	O
clips	O
using	O
a	O
non	O
-	O
organic	O
tail	O
-	O
DNA	O
extraction	O
protocol	O
[	O
49	O
]	O
.	O

High	O
molecular	O
weight	O
genomic	O
DNA	O
for	O
Southern	O
blotting	O
was	O
prepared	O
according	O
to	O
standard	O
protocols	O
.	O

For	O
PCR	O
analysis	O
the	O
wild	O
-	O
type	O
Ptdsr	O
allele	O
was	O
detected	O
using	O
forward	O
primer	O
1	O
(	O
5	O
'	O
-	O
GACACTGTCCATGGCAAACAC	O
-	O
3	O
'	O
)	O
and	O
reverse	O
primer	O
2	O
(	O
5	O
'	O
-	O
TAAAGTCGCCTTCCAGAAGATT	O
-	O
3	O
'	O
)	O
.	O

The	O
primer	O
1	O
site	O
is	O
located	O
5	O
'	O
to	O
the	O
deletion	O
and	O
the	O
primer	O
2	O
site	O
within	O
the	O
deletion	O
.	O

This	O
primer	O
pair	O
amplified	O
a	O
fragment	O
of	O
approximately	O
300	O
bp	O
from	O
wild	O
-	O
type	O
and	O
Ptdsr	O
+	O
/	O
-	O
mice	O
but	O
not	O
from	O
Ptdsr	O
-	O
/	O
-	O
mutants	O
.	O

To	O
detect	O
the	O
mutant	O
Ptdsr	O
allele	O
,	O
genomic	O
DNA	O
was	O
also	O
amplified	O
using	O
primer	O
1	O
and	O
reverse	O
primer	O
3	O
(	O
5	O
'	O
-	O
CCACACGCGTCACCTTAATA	O
-	O
3	O
'	O
)	O
,	O
which	O
corresponds	O
to	O
a	O
sequence	O
in	O
the	O
neo	O
cassette	O
.	O

In	O
this	O
case	O
,	O
a	O
500	O
bp	O
fragment	O
was	O
detected	O
in	O
mice	O
heterozygous	O
or	O
homozygous	O
for	O
the	O
mutant	O
allele	O
,	O
while	O
no	O
signal	O
was	O
detected	O
in	O
wild	O
-	O
type	O
mice	O
.	O

For	O
Southern	O
blot	O
analysis	O
,	O
genomic	O
DNA	O
(	O
30	O
mu	O
g	O
)	O
was	O
digested	O
overnight	O
with	O
BamHI	O
(	O
30	O
U	O
;	O
Roche	O
Diagnostics	O
GmbH	O
,	O
Mannheim	O
,	O
Germany	O
)	O
and	O
ScaI	O
(	O
30	O
U	O
;	O
Roche	O
)	O
,	O
fractionated	O
on	O
a	O
0	O
.	O
8	O
%	O
agarose	O
gel	O
,	O
transferred	O
to	O
a	O
nylon	O
membrane	O
(	O
Hybond	O
N	O
;	O
Amersham	O
Biosciences	O
Europe	O
GmbH	O
,	O
Freiburg	O
,	O
Germany	O
)	O
and	O
hybridized	O
with	O
5	O
'	O
and	O
3	O
'	O
flanking	O
probes	O
.	O

The	O
BamHI	O
digest	O
was	O
hybridized	O
with	O
a	O
Ptdsr	O
-	O
specific	O
5	O
'	O
flanking	O
probe	O
,	O
and	O
Southern	O
blot	O
gave	O
a	O
single	O
17	O
.	O
2	O
kb	O
band	O
for	O
wild	O
-	O
type	O
(	O
+	O
/	O
+	O
)	O
,	O
an	O
11	O
.	O
6	O
kb	O
band	O
for	O
homozygous	O
(	O
-	O
/	O
-	O
)	O
and	O
both	O
bands	O
for	O
heterozygous	O
(	O
+	O
/	O
-	O
)	O
mice	O
.	O

The	O
ScaI	O
digest	O
was	O
hybridized	O
using	O
a	O
3	O
'	O
flanking	O
probe	O
,	O
and	O
Southern	O
blot	O
gave	O
a	O
single	O
12	O
.	O
4	O
kb	O
band	O
for	O
wild	O
-	O
type	O
,	O
a	O
17	O
.	O
2	O
kb	O
band	O
for	O
homozygous	O
and	O
both	O
bands	O
for	O
heterozygous	O
mice	O
.	O

Northern	O
blot	O
analysis	O

Total	O
RNA	O
was	O
isolated	O
from	O
homogenized	O
embryos	O
using	O
TRIZOL	O
reagent	O
(	O
Invitrogen	O
GmbH	O
,	O
Karlsruhe	O
,	O
Germany	O
)	O
.	O

For	O
northern	O
blots	O
,	O
either	O
total	O
RNA	O
(	O
30	O
mu	O
g	O
)	O
was	O
extracted	O
from	O
embryos	O
,	O
electrophoresed	O
and	O
transferred	O
to	O
a	O
nylon	O
membrane	O
(	O
Hybond	O
N	O
;	O
Amersham	O
)	O
or	O
a	O
polyA	O
+	O
RNA	O
northern	O
blot	O
(	O
OriGene	O
Technologies	O
Inc	O
.	O
,	O
Rockville	O
,	O
USA	O
)	O
was	O
hybridized	O
using	O
as	O
the	O
probe	O
a	O
Ptdsr	O
fragment	O
amplified	O
from	O
wild	O
-	O
type	O
cDNA	O
using	O
forward	O
primer	O
5	O
'	O
-	O
GTTCCAGCTCGTCAGACTCG	O
-	O
3	O
'	O
and	O
reverse	O
primer	O
5	O
'	O
-	O
TGCCCCTAAGACATGACCAC	O
-	O
3	O
'	O
.	O

In	O
all	O
experiments	O
the	O
same	O
membrane	O
was	O
re	O
-	O
hybridized	O
with	O
a	O
beta	O
-	O
actin	O
probe	O
(	O
OriGene	O
)	O
to	O
confirm	O
that	O
equivalent	O
RNA	O
levels	O
were	O
present	O
in	O
each	O
lane	O
.	O

Northern	O
blotting	O
indicated	O
that	O
homozygous	O
mutant	O
embryos	O
did	O
not	O
express	O
Ptdsr	O
mRNA	O
and	O
heterozygous	O
mutant	O
embryos	O
expressed	O
only	O
reduced	O
amounts	O
of	O
Ptdsr	O
mRNA	O
.	O

Western	O
blot	O
analysis	O

Embryos	O
(	O
E13	O
.	O
5	O
)	O
for	O
protein	O
isolation	O
were	O
homogenized	O
in	O
lysis	O
buffer	O
containing	O
1	O
x	O
PBS	O
,	O
1	O
%	O
Nonidet	O
P	O
-	O
40	O
,	O
0	O
.	O
5	O
%	O
sodium	O
deoxycholate	O
,	O
0	O
.	O
1	O
%	O
SDS	O
and	O
protease	O
inhibitor	O
cocktail	O
(	O
CompleteMini	O
;	O
Roche	O
)	O
.	O

Equal	O
amounts	O
(	O
25	O
mu	O
g	O
)	O
of	O
protein	O
lysate	O
were	O
separated	O
by	O
SDS	O
-	O
polyacrylamide	O
gel	O
electrophoresis	O
and	O
transferred	O
onto	O
a	O
PVDF	O
membrane	O
(	O
Millipore	O
,	O
Billerica	O
,	O
USA	O
)	O
according	O
to	O
standard	O
protocols	O
.	O

Western	O
blots	O
were	O
done	O
using	O
a	O
specific	O
antibody	S-GO
to	O
Ptdsr	O
(	O
PSR	O
N	O
-	O
20	O
,	O
sc	O
-	O
11632	O
;	O
Santa	O
Cruz	O
Biotechnology	O
Inc	O
.	O
,	O
Santa	O
Cruz	O
,	O
USA	O
)	O
and	O
beta	O
-	O
actin	O
(	O
ab	O
-	O
6276	O
;	O
Abcam	O
,	O
Cambridge	O
,	O
UK	O
)	O
as	O
described	O
by	O
the	O
supplier	O
.	O

Secondary	O
antibodies	S-GO
conjugated	O
to	O
horseradish	O
peroxidase	O
were	O
from	O
Santa	O
Cruz	O
and	O
Abcam	O
,	O
used	O
as	O
described	O
by	O
the	O
supplier	O
,	O
and	O
detection	O
was	O
performed	O
with	O
an	O
enhanced	O
chemiluminescence	O
system	O
(	O
ECLPlus	O
;	O
Amersham	O
)	O
.	O

Animal	O
experiments	O

Wild	O
-	O
type	O
C57BL	O
/	O
6J	O
and	O
129P2	O
/	O
OlaHsd	O
mice	O
were	O
obtained	O
from	O
Jackson	O
Laboratories	O
(	O
Bar	O
Harbor	O
,	O
USA	O
)	O
and	O
Harlan	O
UK	O
(	O
Bicester	O
,	O
UK	O
)	O
,	O
respectively	O
.	O

All	O
mice	O
were	O
housed	O
in	O
individually	O
ventilated	O
cages	O
in	O
a	O
specific	O
pathogen	O
-	O
free	O
environment	O
with	O
a	O
12	O
h	O
light	O
-	O
dark	O
cycle	O
and	O
were	O
fed	O
a	O
regular	O
unrestricted	O
diet	O
.	O

The	O
GBF	O
'	O
s	O
routine	O
surveillance	O
program	O
screened	O
for	O
selected	O
pathogens	O
.	O

The	O
Ptdsrtm1Gbf	O
mutant	O
was	O
crossed	O
to	O
C57BL	O
/	O
6J	O
mice	O
to	O
establish	O
the	O
co	O
-	O
isogenic	O
C57BL	O
/	O
6J	O
-	O
Ptdsrtm1Gbf	O
mouse	O
line	O
.	O

All	O
studies	O
were	O
approved	O
by	O
the	O
appropriate	O
authorities	O
.	O

Isolation	O
of	O
embryos	O

Heterozygous	O
male	O
and	O
female	O
mice	O
were	O
intercrossed	O
in	O
order	O
to	O
obtain	O
Ptdsr	O
-	O
deficient	O
progeny	O
.	O

Females	O
were	O
daily	O
monitored	O
for	O
vaginal	O
plugs	O
,	O
and	O
noon	O
of	O
the	O
day	O
of	O
plug	O
detection	O
was	O
defined	O
as	O
E0	O
.	O
5	O
.	O

Embryos	O
at	O
indicated	O
time	O
points	O
were	O
dissected	O
in	O
sterile	O
PBS	O
,	O
washed	O
in	O
ice	O
-	O
cold	O
PBS	O
and	O
transferred	O
to	O
cold	O
fixative	O
.	O

Extra	O
-	O
embryonic	O
membranes	O
were	O
kept	O
and	O
used	O
for	O
genotyping	O
.	O

Ptdsr	O
-	O
/	O
-	O
embryos	O
and	O
their	O
wild	O
-	O
type	O
littermates	O
were	O
used	O
for	O
experiments	O
.	O

Histology	O
,	O
TUNEL	O
staining	O
and	O
immunohistochemistry	O

Embryos	O
for	O
histology	O
and	O
immunohistochemistry	O
were	O
harvested	O
and	O
fixed	O
in	O
10	O
%	O
neutral	O
-	O
buffered	O
formalin	O
,	O
dehydrated	O
through	O
a	O
graded	O
series	O
of	O
alcohol	O
,	O
embedded	O
in	O
paraffin	O
,	O
sagittally	O
sectioned	O
at	O
5	O
mu	O
m	O
intervals	O
,	O
and	O
every	O
fifth	O
section	O
was	O
processed	O
for	O
hematoxylin	O
and	O
eosin	O
(	O
H	O
&	O
E	O
)	O
staining	O
according	O
to	O
standard	O
protocols	O
.	O

Remaining	O
sections	O
of	O
wild	O
-	O
type	O
and	O
Ptdsr	O
-	O
/	O
-	O
specimens	O
were	O
used	O
for	O
immunohistochemistry	O
.	O

For	O
detection	O
of	O
apoptotic	O
cells	O
and	O
macrophages	O
,	O
anti	O
-	O
aCasp3	O
(	O
an	O
antibody	S-GO
specific	O
for	O
activated	O
caspase	O
3	O
;	O
R	O
&	O
D	O
Systems	O
,	O
Minneapolis	O
,	O
USA	O
)	O
and	O
anti	O
-	O
F4	O
/	O
80	O
(	O
Serotec	O
GmBH	O
,	O
D	O
u	O
sseldorf	O
,	O
Germany	O
;	O
#	O
MCA	O
1957	O
)	O
antibodies	S-GO
were	O
used	O
as	O
described	O
by	O
the	O
supplier	O
.	O

Detection	O
was	O
performed	O
using	O
indirect	O
streptavidin	O
with	O
biotinylated	O
secondary	O
antibodies	S-GO
and	O
cobalt	O
-	O
enhanced	O
diaminobenzidine	O
(	O
brown	O
)	O
or	O
fast	O
-	O
red	O
(	O
red	O
)	O
as	O
chromogens	O
.	O

Sections	O
were	O
counterstained	O
with	O
hematoxylin	O
.	O

For	O
whole	O
-	O
mount	O
terminal	O
deoxynucleotidyl	O
transferase	O
-	O
mediated	O
UTP	O
end	O
labeling	O
(	O
TUNEL	O
)	O
,	O
limb	O
buds	O
were	O
dissected	O
from	O
E12	O
.	O
5	O
and	O
E13	O
.	O
5	O
embryos	O
,	O
fixed	O
in	O
4	O
%	O
paraformaldehyde	O
and	O
processed	O
for	O
analysis	O
as	O
previously	O
described	O
[	O
50	O
]	O
.	O

Preparation	O
of	O
fetal	O
liver	O
-	O
derived	O
macrophages	O
(	O
FLDMs	O
)	O

Fetal	O
livers	O
were	O
excised	O
from	O
embryos	O
at	O
E12	O
.	O
5	O
and	O
E13	O
.	O
5	O
,	O
respectively	O
,	O
washed	O
in	O
PBS	O
and	O
dissociated	O
enzymatically	O
for	O
60	O
min	O
at	O
37	O
degrees	O
C	O
.	O

The	O
digestion	O
buffer	O
(	O
150	O
mu	O
l	O
per	O
liver	O
)	O
comprised	O
0	O
.	O
6	O
U	O
/	O
ml	O
dispase	O
I	O
(	O
Roche	O
)	O
,	O
0	O
.	O
1	O
%	O
collagenase	O
D	O
(	O
Roche	O
)	O
,	O
10	O
U	O
DNase	O
(	O
Roche	O
)	O
,	O
and	O
20	O
%	O
FCS	O
in	O
PBS	O
.	O

X	O
-	O
Vivo	O
15	O
medium	O
(	O
Cambrex	O
,	O
East	O
Rutherford	O
,	O
USA	O
)	O
was	O
added	O
to	O
the	O
resulting	O
cell	O
suspension	O
,	O
and	O
after	O
centrifugation	O
(	O
200	O
x	O
g	O
;	O
3	O
min	O
)	O
cells	O
were	O
resuspended	O
in	O
X	O
-	O
Vivo	O
15	O
medium	O
supplemented	O
with	O
50	O
ng	O
/	O
ml	O
macrophage	O
colony	O
-	O
stimulating	O
factor	O
(	O
M	O
-	O
CSF	O
;	O
Sigma	O
-	O
Aldrich	O
,	O
St	O
.	O
Louis	O
,	O
USA	O
)	O
and	O
cultured	O
on	O
non	O
-	O
treated	O
tissue	O
-	O
culture	O
dishes	O
at	O
37	O
degrees	O
C	O
with	O
5	O
%	O
CO2	O
.	O

Every	O
second	O
or	O
third	O
day	O
the	O
medium	O
was	O
changed	O
by	O
centrifugation	O
.	O

Following	O
withdrawal	O
of	O
M	O
-	O
CSF	O
on	O
day	O
6	O
after	O
excision	O
,	O
adherent	O
cells	O
were	O
cultured	O
for	O
an	O
additional	O
24	O
-	O
48	O
h	O
in	O
X	O
-	O
Vivo	O
15	O
medium	O
.	O

Macrophage	O
phagocytosis	O
assays	O

For	O
preparation	O
of	O
monolayer	O
cultures	O
of	O
macrophages	O
,	O
FLDMs	O
were	O
plated	O
on	O
glass	O
coverslips	O
in	O
24	O
well	O
plates	O
(	O
2	O
x	O
105	O
cells	O
per	O
well	O
)	O
in	O
X	O
-	O
Vivo	O
15	O
medium	O
.	O

For	O
preparation	O
of	O
apoptotic	O
target	O
cells	O
,	O
primary	O
thymocytes	O
were	O
harvested	O
from	O
the	O
thymus	O
of	O
4	O
-	O
to	O
8	O
-	O
week	O
-	O
old	O
C57BL	O
/	O
6J	O
mice	O
,	O
stained	O
with	O
TAMRA	O
for	O
15	O
min	O
,	O
and	O
apoptosis	O
was	O
induced	O
either	O
by	O
treating	O
cells	O
with	O
5	O
mu	O
M	O
staurosporine	O
in	O
medium	O
for	O
4	O
h	O
at	O
37	O
degrees	O
C	O
or	O
by	O
culturing	O
cells	O
in	O
medium	O
overnight	O
.	O

The	O
efficacy	O
of	O
apoptosis	O
induction	O
was	O
compared	O
in	O
thymic	O
target	O
cells	O
and	O
controls	O
by	O
FACS	O
analysis	O
.	O

On	O
average	O
,	O
60	O
%	O
of	O
the	O
cells	O
of	O
the	O
resulting	O
population	O
were	O
apoptotic	O
,	O
with	O
exposed	O
PS	O
on	O
their	O
surface	S-GO
,	O
and	O
less	O
than	O
5	O
%	O
of	O
the	O
cells	O
were	O
necrotic	O
,	O
as	O
confirmed	O
by	O
FITC	O
-	O
annexin	O
V	O
and	O
propidium	O
iodide	O
staining	O
.	O

The	O
apoptotic	O
thymocytes	O
obtained	O
were	O
washed	O
with	O
PBS	O
and	O
added	O
to	O
the	O
prepared	O
FLDM	O
cultures	O
(	O
ratio	O
10	O
:	O
1	O
)	O
.	O

Phagocytosis	O
was	O
then	O
allowed	O
to	O
proceed	O
at	O
37	O
degrees	O
C	O
and	O
5	O
%	O
CO2	O
.	O

After	O
the	O
indicated	O
time	O
periods	O
,	O
the	O
uptake	O
of	O
apoptotic	O
cells	O
by	O
FLDMs	O
was	O
stopped	O
by	O
intensive	O
washing	O
of	O
co	O
-	O
cultures	O
with	O
cold	O
PBS	O
to	O
remove	O
unphagocytosed	O
cells	O
.	O

To	O
measure	O
phagocytosis	O
of	O
apoptotic	O
thymocytes	O
,	O
macrophages	O
were	O
further	O
processed	O
for	O
immunofluorescence	O
analysis	O
.	O

Cells	O
were	O
fixed	O
in	O
4	O
%	O
paraformaldehyde	O
,	O
blocked	O
in	O
0	O
.	O
5	O
%	O
BSA	O
/	O
PBS	O
and	O
stained	O
with	O
an	O
anti	O
-	O
F4	O
/	O
80	O
antibody	S-GO
(	O
Serotec	O
)	O
followed	O
by	O
a	O
secondary	O
antibody	S-GO
coupled	O
to	O
Alexa	O
488	O
(	O
Molecular	O
Probes	O
Inc	O
.	O
,	O
Eugene	O
,	O
USA	O
)	O
.	O

Coverslips	O
were	O
mounted	O
on	O
slides	O
and	O
engulfed	O
thymocytes	O
were	O
enumerated	O
by	O
fluorescence	O
microscopy	O
.	O

The	O
percentage	O
of	O
phagocytosis	O
was	O
calculated	O
by	O
counting	O
at	O
least	O
300	O
macrophages	O
and	O
determining	O
the	O
number	O
of	O
macrophages	O
that	O
had	O
engulfed	O
apoptotic	O
thymocytes	O
.	O

The	O
phagocytotic	O
index	O
was	O
calculated	O
according	O
to	O
the	O
following	O
formula	O
:	O
phagocytotic	O
index	O
=	O
(	O
total	O
number	O
of	O
engulfed	O
cells	O
/	O
total	O
number	O
of	O
counted	O
macrophages	O
)	O
x	O
(	O
number	O
of	O
macrophages	O
containing	O
engulfed	O
cells	O
/	O
total	O
number	O
of	O
counted	O
macrophages	O
)	O
x	O
100	O
.	O

The	O
experiments	O
were	O
performed	O
at	O
least	O
three	O
times	O
,	O
each	O
time	O
in	O
triplicate	O
,	O
and	O
the	O
counting	O
was	O
done	O
by	O
three	O
different	O
investigators	O
.	O

Measurement	O
of	O
macrophage	O
cytokine	O
production	O

Monolayer	O
cultures	O
of	O
FLDMs	O
and	O
apoptotic	O
thymocytes	O
were	O
prepared	O
as	O
described	O
above	O
.	O

FLDMs	O
were	O
incubated	O
with	O
medium	O
,	O
LPS	O
(	O
10	O
ng	O
/	O
ml	O
)	O
,	O
apoptotic	O
cells	O
(	O
ratio	O
1	O
:	O
10	O
)	O
or	O
both	O
for	O
the	O
determination	O
of	O
IL	O
-	O
10	O
,	O
TGF	O
-	O
beta	O
1	O
or	O
TNF	O
-	O
alpha	O
levels	O
after	O
co	O
-	O
culture	O
for	O
22	O
h	O
.	O

For	O
TNF	O
-	O
alpha	O
quantification	O
at	O
various	O
time	O
points	O
,	O
FLDMs	O
were	O
cultured	O
with	O
a	O
high	O
concentration	O
of	O
LPS	O
(	O
100	O
ng	O
/	O
ml	O
)	O
.	O

Culture	O
supernatants	O
were	O
harvested	O
and	O
TNF	O
-	O
alpha	O
(	O
Mouse	O
TNF	O
-	O
alpha	O
OptEIA	O
set	O
;	O
BD	O
Biosciences	O
,	O
Heidelberg	O
,	O
Germany	O
)	O
and	O
TGF	O
-	O
beta	O
1	O
(	O
Quantikine	O
,	O
TGF	O
-	O
beta	O
1	O
immunoassay	O
;	O
R	O
&	O
D	O
Systems	O
)	O
were	O
measured	O
by	O
ELISA	O
as	O
described	O
by	O
the	O
supplier	O
.	O

IL	O
-	O
10	O
in	O
culture	O
supernatants	O
was	O
determined	O
by	O
a	O
cytometric	O
bead	O
assay	O
(	O
Mouse	O
inflammation	O
CBA	O
;	O
BD	O
Biosciences	O
)	O
as	O
indicated	O
in	O
the	O
manual	O
.	O

Data	O
are	O
presented	O
as	O
mean	O
+/-	O
SEM	O
from	O
at	O
least	O
three	O
independent	O
experiments	O
,	O
each	O
carried	O
out	O
in	O
triplicate	O
.	O

Analysis	O
of	O
the	O
results	O
used	O
the	O
Wilcoxon	O
-	O
signed	O
rank	O
test	O
;	O
p	O
values	O
below	O
0	O
.	O
05	O
were	O
considered	O
significant	O
.	O

Additional	O
data	O
files	O

Additional	O
data	O
file	O
1	O
contains	O
:	O
Figure	O
S1	O
showing	O
the	O
localization	O
of	O
apoptotic	O
cells	O
and	O
macrophages	O
in	O
the	O
subcutis	O
of	O
developing	O
embryos	O
;	O
and	O
Figure	O
S2	O
showing	O
immunohistochemical	O
staining	O
of	O
the	O
Ptdsr	O
protein	O
in	O
macrophages	O
derived	O
from	O
wild	O
-	O
type	O
and	O
Ptdsr	O
-	O
knockout	O
mice	O
.	O

Supplementary	O
Material	O

Additional	O
data	O
file	O
1	O

Figure	O
S1	O
showing	O
the	O
localization	O
of	O
apoptotic	O
cells	O
and	O
macrophages	O
in	O
the	O
subcutis	O
of	O
developing	O
embryos	O
;	O
and	O
Figure	O
S2	O
showing	O
immunohistochemical	O
staining	O
of	O
the	O
Ptdsr	O
protein	O
in	O
macrophages	O
derived	O
from	O
wild	O
-	O
type	O
and	O
Ptdsr	O
-	O
knockout	O
mice	O

Click	O
here	O
for	O
additional	O
data	O
file	O

Acknowledgements	O

We	O
thank	O
Rudi	O
Balling	O
(	O
GBF	O
Research	O
Center	O
)	O
and	O
Shoumo	O
Bhattacharya	O
(	O
University	O
of	O
Oxford	O
)	O
for	O
many	O
helpful	O
and	O
stimulating	O
discussions	O
.	O

We	O
thank	O
Evi	O
Wollscheid	O
-	O
Lengeling	O
(	O
GBF	O
)	O
for	O
help	O
with	O
harvest	O
of	O
neonatal	O
mice	O
,	O
Ronald	O
Frank	O
(	O
GBF	O
)	O
for	O
providing	O
Ptdsr	O
peptide	O
arrays	O
,	O
Maria	O
Ebel	O
(	O
GBF	O
)	O
for	O
ES	O
cell	O
blastocyst	O
injections	O
,	O
Manfred	O
Rohde	O
(	O
GBF	O
)	O
for	O
electron	O
microscopy	O
,	O
Kurt	O
Dittmar	O
(	O
GBF	O
)	O
for	O
help	O
with	O
confocal	O
microscopy	O
and	O
Bastian	O
Pasche	O
(	O
GBF	O
)	O
for	O
critical	O
reading	O
of	O
the	O
manuscript	O
.	O

We	O
thank	O
BayGenomics	O
,	O
a	O
genomic	O
consortium	O
funded	O
by	O
the	O
US	O
National	O
Heart	O
,	O
Lung	O
,	O
and	O
Blood	O
Institute	O
,	O
for	O
providing	O
the	O
ES	O
cell	O
gene	O
-	O
trap	O
line	O
RRJ099	O
.	O

This	O
work	O
was	O
supported	O
in	O
part	O
by	O
the	O
EU	O
project	O
EUMORPHIA	O
,	O
"	O
Understanding	O
human	O
molecular	O
physiology	O
and	O
pathology	O
through	O
integrated	O
functional	O
genomics	O
in	O
the	O
mouse	O
model	O
"	O
(	O
QLG2	O
-	O
CT	O
-	O
2002	O
-	O
00930	O
)	O
.	O

Figures	O
and	O
Tables	O

Figure	O
1	O

Targeted	O
inactivation	O
of	O
the	O
phosphatidylserine	O
receptor	O
gene	O
.	O

(	O
a	O
)	O
Ptdsr	O
gene	O
-	O
targeting	O
strategy	O
.	O

Homologous	O
recombination	O
in	O
ES	O
cells	O
results	O
in	O
the	O
deletion	O
of	O
exons	O
I	O
and	O
II	O
of	O
the	O
murine	O
Ptdsr	O
gene	O
through	O
replacement	O
of	O
a	O
loxP	O
-	O
flanked	O
neomycin	O
phosphotransferase	O
gene	O
(	O
neo	O
)	O
,	O
thereby	O
ablating	O
the	O
reading	O
frame	O
of	O
the	O
encoded	O
protein	O
.	O

Coding	O
exons	O
I	O
-	O
VI	O
are	O
shown	O
as	O
filled	O
boxes	O
,	O
and	O
deleted	O
exons	O
are	O
colored	O
green	O
.	O

Restriction	O
sites	O
are	O
:	O
A	O
,	O
AatII	O
;	O
B	O
,	O
BamHI	O
;	O
EI	O
,	O
EcoRI	O
;	O
EV	O
,	O
EcoRV	O
;	O
K	O
,	O
KpnI	O
;	O
R	O
,	O
RsrII	O
;	O
S	O
,	O
SacII	O
;	O
Sc	O
,	O
ScaI	O
,	O
X	O
,	O
XhoI	O
.	O

The	O
probe	O
sites	O
are	O
red	O
boxes	O
labeled	O
:	O
C	O
,	O
5	O
'	O
outside	O
probe	O
;	O
D	O
,	O
3	O
'	O
outside	O
probe	O
.	O

(	O
b	O
)	O
Southern	O
blot	O
analysis	O
of	O
genomic	O
DNA	O
extracted	O
from	O
wild	O
-	O
type	O
(	O
+	O
/	O
+	O
)	O
and	O
Ptdsr	O
+	O
/	O
-	O
(	O
+	O
/	O
-	O
)	O
animals	O
,	O
digested	O
with	O
BamHI	O
and	O
hybridized	O
with	O
the	O
5	O
'	O
outside	O
probe	O
to	O
confirm	O
germ	O
-	O
line	O
transmission	O
of	O
the	O
mutant	O
Ptdsr	O
allele	O
.	O

'	O
Wild	O
-	O
type	O
'	O
indicates	O
the	O
BamHI	O
fragment	O
of	O
17	O
.	O
2	O
kb	O
from	O
the	O
wild	O
-	O
type	O
Ptdsr	O
allele	O
;	O
'	O
mutant	O
'	O
indicates	O
the	O
BamHI	O
fragment	O
of	O
11	O
.	O
6	O
kb	O
from	O
the	O
targeted	O
Ptdsr	O
allele	O
.	O

(	O
c	O
)	O
PCR	O
genotyping	O
of	O
embryos	O
and	O
animals	O
from	O
intercrosses	O
of	O
heterozygous	O
Ptdsr	O
+	O
/	O
-	O
using	O
a	O
wild	O
-	O
type	O
and	O
a	O
mutant	O
allele	O
-	O
specific	O
primer	O
combination	O
,	O
respectively	O
.	O

(	O
d	O
)	O
Northern	O
blot	O
analysis	O
of	O
total	O
RNA	O
isolated	O
from	O
E13	O
.	O
5	O
wild	O
-	O
type	O
,	O
Ptdsr	O
+	O
/	O
-	O
and	O
Ptdsr	O
-	O
/	O
-	O
embryos	O
.	O

(	O
e	O
)	O
Western	O
blot	O
analysis	O
of	O
protein	O
from	O
homogenates	O
of	O
E13	O
.	O
5	O
wild	O
-	O
type	O
,	O
Ptdsr	O
+	O
/	O
-	O
and	O
Ptdsr	O
-	O
/	O
-	O
embryos	O
using	O
a	O
Ptdsr	O
-	O
specific	O
antibody	S-GO
.	O

Developmental	O
abnormalities	O
at	O
(	O
f	O
,	O
g	O
)	O
E15	O
.	O
5	O
and	O
(	O
h	O
)	O
birth	O
;	O
in	O
this	O
and	O
all	O
subsequent	O
figures	O
wild	O
-	O
type	O
littermates	O
are	O
located	O
on	O
the	O
left	O
and	O
homozygous	O
mutant	O
mice	O
on	O
the	O
right	O
.	O

The	O
Ptdsr	O
-	O
/	O
-	O
embryos	O
show	O
exencephaly	O
(	O
f	O
)	O
or	O
prosencephalic	O
hernia	O
in	O
the	O
forebrain	O
region	O
(	O
arrowhead	O
,	O
neonate	O
2	O
;	O
h	O
)	O
,	O
uni	O
-	O
or	O
bilateral	O
absence	O
of	O
the	O
eyes	O
(	O
f	O
,	O
g	O
and	O
neonate	O
2	O
in	O
h	O
,	O
and	O
arrow	O
,	O
neonate	O
3	O
in	O
h	O
)	O
,	O
an	O
abnormal	O
head	O
shape	O
with	O
proboscis	O
(	O
g	O
)	O
,	O
edema	O
(	O
arrowheads	O
in	O
f	O
and	O
g	O
)	O
,	O
and	O
general	O
anemia	O
(	O
asterisk	O
,	O
neonate	O
3	O
in	O
h	O
)	O
.	O

Figure	O
2	O

Expression	O
analysis	O
of	O
Ptdsr	O
during	O
embryonic	O
development	O
.	O

(	O
a	O
)	O
Schematic	O
representation	O
of	O
the	O
construction	O
of	O
the	O
Ptdsr	O
gene	O
-	O
trap	O
mouse	O
line	O
used	O
for	O
expression	O
analysis	O
at	O
different	O
embryonic	O
stages	O
.	O

Gray	O
and	O
bright	O
blue	O
boxes	O
represent	O
regulatory	O
elements	O
of	O
the	O
gene	O
-	O
trap	O
,	O
and	O
beta	O
-	O
geo	O
,	O
the	O
beta	O
-	O
galactosidase	O
/	O
neomycin	O
phosphotransferase	O
fusion	O
protein	O
-	O
expression	O
cassette	O
[	O
48	O
,	O
51	O
]	O
.	O

Restriction	O
enzyme	O
nomenclature	O
is	O
as	O
in	O
Figure	O
1	O
(	O
b	O
)	O
Whole	O
-	O
mount	O
beta	O
-	O
galactosidase	O
staining	O
of	O
heterozygous	O
Ptdsr	O
gene	O
-	O
trap	O
embryos	O
at	O
mid	O
-	O
gestation	O
.	O

Expression	O
of	O
Ptdsr	O
is	O
highest	O
in	O
neural	O
tissues	O
and	O
somites	O
,	O
in	O
the	O
branchial	O
arches	O
,	O
the	O
developing	O
limbs	O
,	O
the	O
heart	O
,	O
the	O
primitive	O
gut	O
and	O
the	O
developing	O
eye	O
.	O

(	O
c	O
-	O
e	O
)	O
Sectioning	O
of	O
E12	O
.	O
5	O
beta	O
-	O
galactosidase	O
-	O
stained	O
embryos	O
confirms	O
expression	O
of	O
Ptdsr	O
in	O
(	O
c	O
)	O
the	O
neural	O
tube	O
;	O
(	O
inset	O
in	O
c	O
)	O
neural	O
epithelium	O
;	O
(	O
d	O
)	O
somites	O
;	O
and	O
(	O
e	O
)	O
eyes	O
.	O

Expression	O
in	O
the	O
eye	O
is	O
restricted	O
to	O
developing	O
neural	O
retinal	O
and	O
lens	O
cells	O
.	O

(	O
f	O
)	O
Expression	O
analysis	O
of	O
adult	O
tissues	O
by	O
northern	O
blot	O
.	O

Expression	O
of	O
Ptdsr	O
in	O
the	O
muscle	O
(	O
asterisk	O
)	O
was	O
detected	O
only	O
on	O
long	O
-	O
term	O
exposures	O
of	O
the	O
filter	O
(	O
>	O
48	O
h	O
)	O
.	O

A	O
beta	O
-	O
actin	O
hybridization	O
was	O
used	O
to	O
confirm	O
equal	O
loading	O
of	O
RNA	O
samples	O
.	O

Scale	O
bar	O
,	O
100	O
mu	O
m	O
.	O

Figure	O
3	O

Histological	O
analysis	O
of	O
wild	O
-	O
type	O
and	O
Ptdsr	O
-	O
/	O
-	O
organs	O
during	O
embryogenesis	O
.	O

(	O
a	O
-	O
f	O
)	O
Wild	O
-	O
type	O
embryos	O
and	O
(	O
g	O
-	O
l	O
)	O
Ptdsr	O
-	O
/	O
-	O
littermates	O
were	O
isolated	O
at	O
various	O
embryonic	O
stages	O
,	O
serially	O
sectioned	O
sagittally	O
and	O
analyzed	O
for	O
developmental	O
abnormalities	O
in	O
detail	O
after	O
H	O
&	O
E	O
staining	O
.	O

At	O
E16	O
.	O
5	O
,	O
the	O
lungs	O
of	O
(	O
g	O
)	O
Ptdsr	O
-	O
/	O
-	O
embryos	O
had	O
sacculation	O
just	O
starting	O
,	O
and	O
well	O
-	O
formed	O
alveoli	O
(	O
asterisks	O
)	O
or	O
epithelium	O
-	O
lined	O
bronchioles	O
(	O
arrows	O
)	O
were	O
scarce	O
compared	O
to	O
(	O
a	O
)	O
wild	O
-	O
type	O
lungs	O
.	O

At	O
E16	O
.	O
5	O
,	O
the	O
glomeruli	O
(	O
arrows	O
)	O
in	O
the	O
kidney	O
of	O
(	O
h	O
)	O
Ptdsr	O
-	O
/	O
-	O
embryos	O
were	O
underdeveloped	O
compared	O
to	O
(	O
b	O
)	O
wild	O
-	O
type	O
,	O
collecting	O
tubules	O
(	O
arrowheads	O
)	O
were	O
missing	O
and	O
undifferentiated	O
blastemas	O
(	O
asterisks	O
)	O
were	O
more	O
abundant	O
.	O

The	O
jejunum	O
had	O
no	O
intramural	O
ganglia	O
in	O
Ptdsr	O
-	O
/	O
-	O
embryos	O
(	O
i	O
;	O
and	O
arrows	O
in	O
c	O
)	O
;	O
and	O
a	O
well	O
-	O
developed	O
submucosa	O
(	O
asterisk	O
in	O
c	O
)	O
was	O
missing	O
.	O

Brain	O
sections	O
at	O
E18	O
.	O
5	O
show	O
that	O
(	O
j	O
)	O
Ptdsr	O
-	O
/	O
-	O
embryos	O
may	O
have	O
herniation	O
(	O
arrow	O
)	O
of	O
the	O
hypothalamus	O
through	O
the	O
ventral	O
skull	O
(	O
secondary	O
palate	O
)	O
,	O
most	O
likely	O
through	O
Rathke	O
'	O
s	O
pouch	O
,	O
and	O
a	O
severe	O
malformation	O
of	O
the	O
cortex	O
(	O
asterisks	O
)	O
compared	O
to	O
(	O
d	O
)	O
wild	O
-	O
type	O
embryos	O
.	O

At	O
E18	O
.	O
5	O
,	O
(	O
e	O
)	O
wild	O
-	O
type	O
and	O
(	O
k	O
)	O
Ptdsr	O
-	O
/	O
-	O
lungs	O
showed	O
normal	O
sacculation	O
and	O
formation	O
of	O
alveoli	O
(	O
asterisks	O
)	O
and	O
bronchioles	O
(	O
arrow	O
)	O
.	O

(	O
f	O
)	O
Wild	O
-	O
type	O
neonatal	O
liver	O
had	O
significant	O
numbers	O
of	O
megakaryocytes	O
(	O
arrows	O
)	O
,	O
compared	O
to	O
(	O
l	O
)	O
homozygous	O
mutant	O
littermates	O
,	O
and	O
higher	O
numbers	O
of	O
erythropoietic	O
islands	O
and	O
of	O
mature	O
erythrocytes	O
.	O

Hepatocellular	O
vacuoles	O
are	O
due	O
to	O
glycogen	O
stores	O
(	O
asterisks	O
)	O
that	O
were	O
not	O
metabolized	O
in	O
perinatally	O
dying	O
Ptdsr	O
-	O
/	O
-	O
animals	O
,	O
in	O
contrast	O
to	O
wild	O
-	O
type	O
newborns	O
.	O

Scale	O
bar	O
,	O
100	O
mu	O
m	O
,	O
except	O
for	O
(	O
d	O
)	O
and	O
(	O
j	O
)	O
,	O
1	O
mm	O
.	O

Figure	O
4	O

Morphology	O
of	O
wild	O
-	O
type	O
and	O
Ptdsr	O
-	O
/	O
-	O
retinas	O
.	O

Serial	O
sagittal	O
sections	O
of	O
(	O
a	O
-	O
d	O
)	O
wild	O
-	O
type	O
and	O
(	O
e	O
-	O
h	O
)	O
Ptdsr	O
-	O
/	O
-	O
retina	O
were	O
analyzed	O
for	O
developmental	O
abnormalities	O
at	O
(	O
a	O
,	O
e	O
)	O
E12	O
.	O
5	O
,	O
(	O
b	O
,	O
f	O
)	O
E16	O
.	O
5	O
,	O
(	O
c	O
,	O
g	O
)	O
E18	O
.	O
5	O
,	O
and	O
(	O
d	O
,	O
h	O
)	O
P0	O
.	O

Normal	O
patterning	O
of	O
the	O
retina	O
was	O
observed	O
in	O
Ptdsr	O
-	O
/	O
-	O
embryos	O
,	O
with	O
an	O
outer	O
granular	O
layer	O
(	O
OGL	O
)	O
,	O
outer	O
plexiform	O
layer	O
(	O
OPL	O
)	O
,	O
inner	O
granular	O
layer	O
(	O
IGL	O
)	O
and	O
inner	O
plexiform	O
layer	O
(	O
IPL	O
)	O
.	O

Note	O
that	O
the	O
IGL	O
in	O
Ptdsr	O
-	O
/	O
-	O
retinas	O
is	O
less	O
thick	O
than	O
that	O
in	O
wild	O
-	O
type	O
littermates	O
in	O
comparing	O
(	O
c	O
,	O
g	O
)	O
and	O
(	O
d	O
,	O
h	O
)	O
.	O

Morphometric	O
analysis	O
(	O
numbered	O
lines	O
)	O
of	O
wild	O
-	O
type	O
and	O
Ptdsr	O
-	O
/	O
-	O
retinas	O
confirmed	O
the	O
initial	O
finding	O
of	O
a	O
thinner	O
retina	O
in	O
Ptdsr	O
-	O
/	O
-	O
animals	O
than	O
in	O
wild	O
-	O
type	O
(	O
all	O
values	O
in	O
mu	O
m	O
)	O
.	O

Scale	O
bar	O
,	O
50	O
mu	O
m	O
.	O

Figure	O
5	O

Histological	O
analysis	O
of	O
eye	O
development	O
in	O
severely	O
affected	O
eyeless	O
Ptdsr	O
-	O
/	O
-	O
embryos	O
.	O

(	O
a	O
)	O
In	O
anophthalmic	O
Ptdsr	O
-	O
/	O
-	O
embryos	O
,	O
unilateral	O
or	O
bilateral	O
absence	O
of	O
the	O
eyes	O
could	O
be	O
detected	O
.	O

(	O
b	O
-	O
d	O
)	O
Serial	O
H	O
&	O
E	O
-	O
stained	O
sagittal	O
sections	O
of	O
homozygous	O
mutant	O
embryos	O
at	O
(	O
b	O
)	O
E17	O
.	O
5	O
and	O
(	O
c	O
,	O
d	O
)	O
E18	O
.	O
5	O
show	O
complex	O
malformation	O
of	O
the	O
optic	O
cup	O
and	O
lack	O
of	O
any	O
lens	O
structure	O
.	O

Careful	O
examination	O
of	O
adjacent	O
sections	O
(	O
b	O
-	O
d	O
)	O
reveals	O
an	O
ectopic	O
misplacement	O
of	O
retinal	O
-	O
pigmented	O
epithelium	O
in	O
the	O
maxillary	O
sinus	O
.	O

Not	O
only	O
is	O
the	O
deposition	O
of	O
pigment	O
clearly	O
visible	O
(	O
higher	O
magnification	O
insets	O
)	O
but	O
also	O
the	O
induction	O
of	O
proliferation	O
of	O
underlying	O
tissues	O
and	O
the	O
change	O
in	O
morphology	O
of	O
the	O
maxillary	O
sinus	O
(	O
d	O
)	O
.	O

Scale	O
bar	O
,	O
100	O
mu	O
m	O
in	O
(	O
b	O
-	O
d	O
)	O
.	O

Figure	O
6	O

Analysis	O
of	O
programmed	O
cell	O
death	O
and	O
involvement	O
of	O
macrophages	O
in	O
the	O
removal	O
of	O
apoptotic	O
cells	O
in	O
wild	O
-	O
type	O
and	O
Ptdsr	O
-	O
/	O
-	O
embryos	O
.	O

(	O
a	O
)	O
Whole	O
-	O
mount	O
TUNEL	O
staining	O
(	O
blue	O
)	O
of	O
limb	O
buds	O
from	O
wild	O
-	O
type	O
and	O
Ptdsr	O
-	O
/	O
-	O
embryos	O
at	O
E13	O
.	O
5	O
show	O
no	O
differences	O
in	O
the	O
amount	O
or	O
localization	O
of	O
apoptotic	O
cells	O
during	O
the	O
beginning	O
regression	O
of	O
the	O
interdigital	O
web	O
.	O

Serial	O
sagittal	O
sections	O
stained	O
for	O
activated	O
caspase	O
3	O
(	O
aCasp3	O
;	O
red	O
)	O
in	O
(	O
b	O
-	O
d	O
)	O
wild	O
-	O
type	O
and	O
(	O
f	O
-	O
h	O
)	O
Ptdsr	O
-	O
/	O
-	O
embryos	O
at	O
E12	O
.	O
5	O
show	O
apoptotic	O
cells	O
in	O
the	O
neural	O
tube	O
(	O
b	O
,	O
f	O
)	O
,	O
the	O
mesonephros	O
(	O
c	O
,	O
g	O
)	O
and	O
the	O
developing	O
paravertebral	O
ganglia	O
(	O
d	O
,	O
h	O
)	O
.	O

Tissue	O
distribution	O
and	O
total	O
number	O
of	O
apoptotic	O
cells	O
was	O
indistinguishable	O
between	O
genotypes	O
and	O
was	O
confirmed	O
by	O
the	O
comparison	O
of	O
consecutive	O
sections	O
of	O
wild	O
-	O
type	O
and	O
Ptdsr	O
-	O
/	O
-	O
embryos	O
from	O
different	O
developmental	O
stages	O
.	O

Analysis	O
of	O
macrophage	O
numbers	O
and	O
location	O
by	O
F4	O
/	O
80	O
staining	O
(	O
brown	O
)	O
of	O
consecutive	O
sections	O
in	O
paravertebral	O
ganglia	O
of	O
(	O
e	O
)	O
wild	O
-	O
type	O
and	O
(	O
i	O
)	O
homozygous	O
mutant	O
embryos	O
revealed	O
that	O
macrophages	O
(	O
arrows	O
)	O
are	O
not	O
located	O
close	O
to	O
apoptotic	O
cells	O
during	O
embryonic	O
development	O
.	O

(	O
For	O
comparison	O
,	O
see	O
also	O
Additional	O
data	O
file	O
1	O
,	O
Figure	O
S1	O
,	O
with	O
the	O
online	O
version	O
of	O
this	O
article	O
)	O
.	O

Scale	O
bar	O
,	O
100	O
mu	O
m	O
.	O

Figure	O
7	O

Phagocytosis	O
of	O
apoptotic	O
cells	O
by	O
fetal	O
liver	O
-	O
derived	O
macrophages	O
(	O
FLDMs	O
)	O
.	O

FLDMs	O
from	O
(	O
a	O
,	O
b	O
)	O
wild	O
-	O
type	O
and	O
(	O
c	O
,	O
d	O
)	O
Ptdsr	O
-	O
/	O
-	O
embryos	O
were	O
cultured	O
for	O
60	O
min	O
with	O
TAMRA	O
-	O
stained	O
(	O
red	O
)	O
apoptotic	O
thymocytes	O
(	O
treated	O
with	O
staurosporine	O
)	O
from	O
C57BL	O
/	O
6J	O
mice	O
and	O
then	O
stained	O
with	O
F4	O
/	O
80	O
(	O
green	O
)	O
.	O

Macrophages	O
of	O
both	O
genotypes	O
have	O
phagocytosed	O
apoptotic	O
cells	O
(	O
arrowheads	O
)	O
.	O

(	O
e	O
)	O
Quantification	O
of	O
phagocytosis	O
of	O
apoptotic	O
cells	O
by	O
wild	O
-	O
type	O
or	O
Ptdsr	O
-	O
/	O
-	O
macrophages	O
revealed	O
no	O
differences	O
in	O
the	O
percentage	O
of	O
macrophages	O
that	O
had	O
engulfed	O
apoptotic	O
cells	O
,	O
whether	O
or	O
not	O
apoptosis	O
had	O
been	O
induced	O
by	O
staurosporine	O
.	O

Microscopic	O
analysis	O
(	O
b	O
,	O
d	O
)	O
and	O
quantification	O
of	O
the	O
number	O
of	O
apoptotic	O
cells	O
phagocytosed	O
by	O
single	O
macrophages	O
and	O
(	O
f	O
)	O
calculation	O
of	O
the	O
average	O
number	O
of	O
cells	O
phagocytosed	O
per	O
macrophage	O
failed	O
to	O
reveal	O
differences	O
in	O
the	O
efficacy	O
of	O
removal	O
of	O
apoptotic	O
cells	O
between	O
wild	O
-	O
type	O
and	O
Ptdsr	O
-	O
/	O
-	O
FLDMs	O
.	O

Figure	O
8	O

Cytokine	O
production	O
by	O
FLDMs	O
upon	O
stimulation	O
with	O
lipopolysaccharide	O
(	O
LPS	O
)	O
and	O
apoptotic	O
cells	O
.	O

FLDMs	O
from	O
wild	O
-	O
type	O
and	O
Ptdsr	O
-	O
/	O
-	O
embryos	O
were	O
incubated	O
(	O
a	O
,	O
b	O
,	O
d	O
)	O
with	O
medium	O
(	O
0	O
)	O
,	O
LPS	O
(	O
10	O
ng	O
/	O
ml	O
)	O
,	O
apoptotic	O
cells	O
(	O
ratio	O
1	O
:	O
10	O
)	O
or	O
in	O
combination	O
with	O
LPS	O
and	O
apoptotic	O
cells	O
or	O
(	O
c	O
)	O
with	O
LPS	O
(	O
100	O
ng	O
/	O
ml	O
)	O
alone	O
.	O

Culture	O
supernatants	O
were	O
harvested	O
after	O
22	O
h	O
(	O
a	O
,	O
b	O
,	O
d	O
)	O
or	O
at	O
the	O
indicated	O
time	O
points	O
(	O
c	O
)	O
.	O

TNF	O
-	O
alpha	O
and	O
TGF	O
-	O
beta	O
1	O
were	O
quantified	O
by	O
ELISA	O
and	O
IL	O
-	O
10	O
by	O
cytometric	O
bead	O
array	O
(	O
CBA	O
)	O
assay	O
.	O

Data	O
are	O
presented	O
as	O
mean	O
+/-	O
SEM	O
from	O
at	O
least	O
three	O
independent	O
experiments	O
,	O
each	O
carried	O
out	O
in	O
triplicate	O
.	O

*	O
,	O
significant	O
difference	O
between	O
genotypes	O
,	O
p	O
<	O
0	O
.	O
05	O
;	O
*	O
*	O
,	O
significant	O
difference	O
between	O
genotypes	O
,	O
p	O
<	O
0	O
.	O
01	O
;	O
Wilcoxon	O
-	O
signed	O
rank	O
test	O
.	O

Table	O
1	O

Penetrance	O
of	O
phenotypes	O
in	O
Ptdsr	O
-	O
/	O
-	O
mice	O
from	O
E9	O
.	O
5	O
to	O
E18	O
.	O
5	O
,	O
as	O
detected	O
by	O
gross	O
morphology	O

Subsets	O
of	O
the	O
major	O
categories	O
of	O
malformation	O
are	O
indicated	O
by	O
indentation	O
.	O

BMP	O
Receptor	O
Signaling	O
Is	O
Required	O
for	O
Postnatal	O
Maintenance	O
of	O
Articular	O
Cartilage	O

Abstract	O

Articular	O
cartilage	O
plays	O
an	O
essential	O
role	O
in	O
health	O
and	O
mobility	O
,	O
but	O
is	O
frequently	O
damaged	O
or	O
lost	O
in	O
millions	O
of	O
people	O
that	O
develop	O
arthritis	O
.	O

The	O
molecular	O
mechanisms	O
that	O
create	O
and	O
maintain	O
this	O
thin	O
layer	O
of	O
cartilage	O
that	O
covers	O
the	O
surface	O
of	O
bones	O
in	O
joint	O
regions	O
are	O
poorly	O
understood	O
,	O
in	O
part	O
because	O
tools	O
to	O
manipulate	O
gene	O
expression	O
specifically	O
in	O
this	O
tissue	O
have	O
not	O
been	O
available	O
.	O

Here	O
we	O
use	O
regulatory	O
information	O
from	O
the	O
mouse	O
Gdf5	O
gene	O
(	O
a	O
bone	O
morphogenetic	O
protein	O
[	O
BMP	O
]	O
family	O
member	O
)	O
to	O
develop	O
new	O
mouse	O
lines	O
that	O
can	O
be	O
used	O
to	O
either	O
activate	O
or	O
inactivate	O
genes	O
specifically	O
in	O
developing	O
joints	O
.	O

Expression	O
of	O
Cre	O
recombinase	O
from	O
Gdf5	O
bacterial	O
artificial	O
chromosome	O
clones	O
leads	O
to	O
specific	O
activation	O
or	O
inactivation	O
of	O
floxed	O
target	O
genes	O
in	O
developing	O
joints	O
,	O
including	O
early	O
joint	O
interzones	O
,	O
adult	O
articular	O
cartilage	O
,	O
and	O
the	O
joint	O
capsule	O
.	O

We	O
have	O
used	O
this	O
system	O
to	O
test	O
the	O
role	O
of	O
BMP	O
receptor	O
signaling	O
in	O
joint	O
development	O
.	O

Mice	O
with	O
null	O
mutations	O
in	O
Bmpr1a	O
are	O
known	O
to	O
die	O
early	O
in	O
embryogenesis	O
with	O
multiple	O
defects	O
.	O

However	O
,	O
combining	O
a	O
floxed	O
Bmpr1a	O
allele	O
with	O
the	O
Gdf5	O
-	O
Cre	O
driver	O
bypasses	O
this	O
embryonic	O
lethality	O
,	O
and	O
leads	O
to	O
birth	O
and	O
postnatal	O
development	O
of	O
mice	O
missing	O
the	O
Bmpr1a	O
gene	O
in	O
articular	O
regions	O
.	O

Most	O
joints	O
in	O
the	O
body	O
form	O
normally	O
in	O
the	O
absence	O
of	O
Bmpr1a	O
receptor	O
function	O
.	O

However	O
,	O
articular	O
cartilage	O
within	O
the	O
joints	O
gradually	O
wears	O
away	O
in	O
receptor	O
-	O
deficient	O
mice	O
after	O
birth	O
in	O
a	O
process	O
resembling	O
human	O
osteoarthritis	O
.	O

Gdf5	O
-	O
Cre	O
mice	O
provide	O
a	O
general	O
system	O
that	O
can	O
be	O
used	O
to	O
test	O
the	O
role	O
of	O
genes	O
in	O
articular	O
regions	O
.	O

BMP	O
receptor	O
signaling	O
is	O
required	O
not	O
only	O
for	O
early	O
development	O
and	O
creation	O
of	O
multiple	O
tissues	O
,	O
but	O
also	O
for	O
ongoing	O
maintenance	O
of	O
articular	O
cartilage	O
after	O
birth	O
.	O

Genetic	O
variation	O
in	O
the	O
strength	O
of	O
BMP	O
receptor	O
signaling	O
may	O
be	O
an	O
important	O
risk	O
factor	O
in	O
human	O
osteoarthritis	O
,	O
and	O
treatments	O
that	O
mimic	O
or	O
augment	O
BMP	O
receptor	O
signaling	O
should	O
be	O
investigated	O
as	O
a	O
possible	O
therapeutic	O
strategy	O
for	O
maintaining	O
the	O
health	O
of	O
joint	O
linings	O
.	O

Introduction	O

Thin	O
layers	O
of	O
articular	O
cartilage	O
line	O
the	O
bones	O
of	O
synovial	O
joints	O
and	O
provide	O
a	O
smooth	O
,	O
wear	O
-	O
resistant	O
structure	O
that	O
reduces	O
friction	O
and	O
absorbs	O
impact	O
forces	O
(	O
Brandt	O
et	O
al	O
.	O
1998	O
)	O
.	O

Loss	O
or	O
damage	O
to	O
articular	O
cartilage	O
is	O
a	O
hallmark	O
of	O
arthritic	O
diseases	O
and	O
is	O
one	O
of	O
the	O
most	O
common	O
reasons	O
that	O
both	O
young	O
and	O
old	O
adults	O
seek	O
medical	O
care	O
.	O

Millions	O
of	O
people	O
are	O
afflicted	O
with	O
arthritis	O
,	O
and	O
it	O
ultimately	O
affects	O
more	O
than	O
half	O
of	O
people	O
over	O
the	O
age	O
of	O
65	O
(	O
Badley	O
1995	O
;	O
Yelin	O
and	O
Callahan	O
1995	O
)	O
.	O

A	O
better	O
understanding	O
of	O
the	O
molecular	O
mechanisms	O
that	O
create	O
and	O
maintain	O
articular	O
cartilage	O
is	O
crucial	O
for	O
discovering	O
the	O
causes	O
of	O
joint	O
disorders	O
and	O
providing	O
useful	O
medical	O
treatments	O
.	O

Joint	O
formation	O
begins	O
during	O
embryogenesis	O
,	O
when	O
stripes	O
of	O
high	O
cell	O
density	O
called	O
interzones	O
form	O
across	O
developing	O
skeletal	O
precursors	O
(	O
Haines	O
1947	O
)	O
.	O

Programmed	O
cell	O
death	O
occurs	O
within	O
the	O
interzone	O
,	O
and	O
a	O
three	O
-	O
layered	O
interzone	O
forms	O
that	O
has	O
two	O
layers	O
of	O
higher	O
cell	O
density	O
flanking	O
a	O
region	O
of	O
lower	O
cell	O
density	O
.	O

Non	O
-	O
joint	O
precursors	O
of	O
the	O
skeleton	O
typically	O
develop	O
into	O
cartilage	O
,	O
which	O
hypertrophies	O
and	O
is	O
replaced	O
by	O
bone	O
.	O

However	O
,	O
cells	O
within	O
the	O
high	O
-	O
density	O
layers	O
of	O
the	O
interzone	O
are	O
excluded	O
from	O
this	O
process	O
and	O
develop	O
into	O
the	O
permanent	O
layers	O
of	O
articular	O
cartilage	O
found	O
in	O
the	O
mature	O
joint	O
(	O
Mitrovic	O
1978	O
)	O
.	O

Studies	O
over	O
the	O
last	O
10	O
y	O
have	O
begun	O
to	O
elucidate	O
some	O
of	O
the	O
signaling	O
pathways	O
that	O
contribute	O
to	O
the	O
early	O
stages	O
of	O
joint	O
formation	O
.	O

Wnt14	O
is	O
expressed	O
in	O
stripes	O
at	O
the	O
sites	O
where	O
joints	O
will	O
form	O
,	O
and	O
it	O
is	O
capable	O
of	O
inducing	O
expression	O
of	O
other	O
joint	O
markers	O
when	O
misexpressed	O
at	O
new	O
locations	O
in	O
the	O
limb	O
(	O
Hartmann	O
and	O
Tabin	O
2001	O
)	O
.	O

Several	O
members	O
of	O
the	O
bone	O
morphogenetic	O
protein	O
(	O
BMP	O
)	O
family	O
of	O
secreted	O
signaling	O
molecules	O
are	O
also	O
expressed	O
in	O
stripes	O
at	O
sites	O
where	O
joints	O
will	O
form	O
,	O
including	O
those	O
encoded	O
by	O
the	O
genes	O
Gdf5	O
,	O
Gdf6	O
,	O
Gdf7	O
,	O
Bmp2	O
,	O
and	O
Bmp4	O
(	O
Storm	O
and	O
Kingsley	O
1996	O
;	O
Wolfman	O
et	O
al	O
.	O
1997	O
;	O
Francis	O
-	O
West	O
et	O
al	O
.	O
1999	O
;	O
Settle	O
et	O
al	O
.	O
2003	O
)	O
.	O

Of	O
these	O
,	O
Gdf5	O
expression	O
is	O
most	O
strikingly	O
limited	O
to	O
regions	O
where	O
joints	O
will	O
develop	O
and	O
is	O
one	O
of	O
the	O
earliest	O
known	O
markers	O
of	O
joint	O
formation	O
.	O

Mutations	O
in	O
either	O
Gdf5	O
or	O
the	O
closely	O
related	O
Gdf6	O
gene	O
also	O
block	O
formation	O
of	O
joints	O
at	O
specific	O
locations	O
,	O
providing	O
strong	O
evidence	O
that	O
these	O
molecules	O
are	O
essential	O
for	O
the	O
joint	O
formation	O
process	O
(	O
Storm	O
et	O
al	O
.	O
1994	O
;	O
Settle	O
et	O
al	O
.	O
2003	O
)	O
.	O

However	O
,	O
mutations	O
in	O
Bmp2	O
or	O
Bmp4	O
cause	O
early	O
embryonic	O
lethality	O
,	O
making	O
it	O
difficult	O
to	O
test	O
their	O
role	O
in	O
joint	O
formation	O
(	O
Winnier	O
et	O
al	O
.	O
1995	O
;	O
Zhang	O
and	O
Bradley	O
1996	O
)	O
.	O

Much	O
less	O
is	O
known	O
about	O
how	O
signaling	O
pathways	O
function	O
during	O
the	O
subsequent	O
maturation	O
and	O
maintenance	O
of	O
adult	O
joint	O
structures	O
.	O

Importantly	O
,	O
BMP	O
signaling	O
components	O
are	O
present	O
in	O
adult	O
articular	O
cartilage	O
,	O
suggesting	O
that	O
they	O
may	O
function	O
during	O
the	O
late	O
development	O
or	O
maintenance	O
of	O
this	O
critical	O
structure	O
(	O
Erlacher	O
et	O
al	O
.	O
1998	O
;	O
Chubinskaya	O
et	O
al	O
.	O
2000	O
;	O
Muehleman	O
et	O
al	O
.	O
2002	O
;	O
Bau	O
et	O
al	O
.	O
2002	O
;	O
Bobacz	O
et	O
al	O
.	O
2003	O
)	O
.	O

BMPs	O
bind	O
tetrameric	O
complexes	S-GO
of	O
two	O
type	O
I	O
and	O
two	O
type	O
II	O
transmembrane	S-GO
serine	O
-	O
threonine	O
kinase	O
receptors	O
.	O

Upon	O
BMP	O
binding	O
,	O
these	O
complexes	S-GO
transduce	O
a	O
signal	O
by	O
phosphorylating	O
members	O
of	O
the	O
Smad	O
family	O
of	O
transcription	O
factors	O
(	O
Massague	O
1996	O
)	O
.	O

Recent	O
experiments	O
have	O
implicated	O
two	O
different	O
BMP	O
type	O
I	O
receptors	O
in	O
skeletal	O
patterning	O
,	O
BMPR1A	O
and	O
BMPR1B	O
.	O

Both	O
receptors	O
can	O
bind	O
BMP2	O
,	O
BMP4	O
,	O
and	O
GDF5	O
,	O
although	O
GDF5	O
shows	O
higher	O
affinity	O
for	O
BMPR1B	O
(	O
Koenig	O
et	O
al	O
.	O
1994	O
;	O
ten	O
Dijke	O
et	O
al	O
.	O
1994	O
;	O
Yamaji	O
et	O
al	O
.	O
1994	O
;	O
Nishitoh	O
et	O
al	O
.	O
1996	O
;	O
Chalaux	O
et	O
al	O
.	O
1998	O
)	O
.	O

Both	O
receptors	O
are	O
also	O
expressed	O
in	O
dynamic	O
patterns	O
during	O
normal	O
development	O
.	O

In	O
limbs	O
,	O
Bmpr1a	O
expression	O
becomes	O
restricted	O
to	O
joint	O
interzones	O
,	O
perichondrium	O
,	O
periarticular	O
cartilage	O
,	O
hypertrophic	O
chondrocytes	O
,	O
and	O
interdigital	O
limb	O
mesenchyme	O
.	O

In	O
comparison	O
,	O
Bmpr1b	O
expression	O
is	O
seen	O
primarily	O
in	O
condensing	O
precartilaginous	O
mesenchymal	O
cells	O
,	O
regions	O
flanking	O
joint	O
interzones	O
,	O
perichondrium	O
,	O
and	O
periarticular	O
cartilage	O
(	O
Dewulf	O
et	O
al	O
.	O
1995	O
;	O
Mishina	O
et	O
al	O
.	O
1995	O
;	O
Zou	O
et	O
al	O
.	O
1997	O
;	O
Baur	O
et	O
al	O
.	O
2000	O
)	O
.	O

Null	O
mutations	O
in	O
the	O
Bmpr1b	O
gene	O
produce	O
viable	O
mice	O
with	O
defects	O
in	O
bone	O
and	O
joint	O
formation	O
that	O
closely	O
resemble	O
those	O
seen	O
in	O
mice	O
missing	O
Gdf5	O
(	O
Storm	O
and	O
Kingsley	O
1996	O
;	O
Baur	O
et	O
al	O
.	O
2000	O
;	O
Yi	O
et	O
al	O
.	O
2000	O
)	O
.	O

Null	O
mutations	O
in	O
Bmpr1a	O
cause	O
early	O
embryonic	O
lethality	O
,	O
with	O
defects	O
in	O
gastrulation	O
similar	O
to	O
those	O
seen	O
in	O
mice	O
with	O
mutations	O
in	O
Bmp4	O
(	O
Mishina	O
et	O
al	O
.	O
1995	O
;	O
Winnier	O
et	O
al	O
.	O
1995	O
)	O
.	O

Recent	O
studies	O
with	O
floxed	O
alleles	O
suggest	O
that	O
Bmpr1a	O
is	O
also	O
required	O
for	O
many	O
later	O
developmental	O
events	O
,	O
but	O
its	O
roles	O
in	O
bone	O
and	O
joint	O
formation	O
have	O
not	O
yet	O
been	O
tested	O
(	O
Mishina	O
2003	O
)	O
.	O

A	O
genetic	O
system	O
for	O
activating	O
or	O
inactivating	O
genes	O
specifically	O
in	O
joint	O
tissues	O
would	O
be	O
particularly	O
useful	O
for	O
further	O
studies	O
of	O
joint	O
formation	O
and	O
maintenance	O
.	O

Here	O
we	O
take	O
advantage	O
of	O
the	O
tissue	O
-	O
specific	O
expression	O
pattern	O
of	O
the	O
Gdf5	O
gene	O
to	O
engineer	O
a	O
Cre	O
/	O
loxP	O
system	O
(	O
Nagy	O
2000	O
)	O
,	O
Gdf5	O
-	O
Cre	O
,	O
that	O
can	O
be	O
used	O
to	O
remove	O
or	O
ectopically	O
express	O
genes	O
in	O
joints	O
.	O

Tests	O
with	O
reporter	O
mice	O
show	O
that	O
this	O
system	O
is	O
capable	O
of	O
modifying	O
genes	O
in	O
all	O
of	O
the	O
structures	O
of	O
the	O
mature	O
synovial	O
joint	O
,	O
including	O
the	O
ligaments	O
of	O
the	O
joint	O
capsule	O
,	O
the	O
synovial	O
membrane	O
,	O
and	O
the	O
articular	O
cartilage	O
.	O

Gdf5	O
-	O
Cre	O
recombination	O
bypasses	O
the	O
early	O
embryonic	O
lethality	O
of	O
null	O
mutations	O
in	O
Bmpr1a	O
,	O
and	O
shows	O
that	O
this	O
receptor	O
is	O
required	O
for	O
early	O
joint	O
formation	O
at	O
some	O
locations	O
and	O
for	O
initiation	O
of	O
programmed	O
cell	O
death	O
in	O
webbing	O
between	O
digits	O
.	O

Interestingly	O
,	O
Bmpr1a	O
is	O
also	O
required	O
for	O
postnatal	O
maintenance	O
of	O
articular	O
cartilage	O
throughout	O
most	O
of	O
the	O
skeleton	O
.	O

In	O
Gdf5	O
-	O
Cre	O
/	O
Bmpr1afloxP	O
mice	O
,	O
articular	O
cartilage	O
initially	O
forms	O
normally	O
,	O
but	O
subsequently	O
loses	O
expression	O
of	O
several	O
key	O
cartilage	O
markers	O
after	O
birth	O
.	O

It	O
ultimately	O
fibrillates	O
and	O
degenerates	O
,	O
resulting	O
in	O
severe	O
osteoarthritis	O
and	O
loss	O
of	O
mobility	O
.	O

These	O
experiments	O
suggest	O
that	O
BMP	O
signaling	O
is	O
required	O
for	O
normal	O
maintenance	O
of	O
postnatal	O
articular	O
cartilage	O
,	O
and	O
that	O
modulation	O
of	O
the	O
BMP	O
signaling	O
pathway	O
may	O
play	O
an	O
important	O
role	O
in	O
joint	O
disease	O
.	O

Results	O

Genetic	O
System	O
for	O
Testing	O
the	O
Function	O
of	O
Genes	O
in	O
Joint	O
Development	O

To	O
generate	O
a	O
general	O
system	O
capable	O
of	O
specifically	O
testing	O
genes	O
for	O
functions	O
in	O
skeletal	O
joint	O
development	O
,	O
we	O
engineered	O
transgenic	O
mice	O
to	O
express	O
Cre	O
recombinase	O
in	O
developing	O
joints	O
(	O
Figure	O
1	O
)	O
.	O

Gdf5	O
is	O
a	O
gene	O
strongly	O
expressed	O
in	O
stripes	O
across	O
developing	O
skeletal	O
elements	O
during	O
embryonic	O
joint	O
formation	O
.	O

A	O
bacterial	O
artificial	O
chromosome	O
(	O
BAC	O
)	O
containing	O
the	O
Gdf5	O
locus	O
was	O
modified	O
by	O
homologous	O
recombination	O
in	O
bacteria	O
to	O
insert	O
a	O
cassette	O
encoding	O
Cre	O
-	O
internal	O
ribosome	O
entry	O
site	O
(	O
IRES	O
)	O
-	O
human	O
placental	O
alkaline	O
phosphatase	O
(	O
hPLAP	O
)	O
into	O
the	O
translation	O
start	O
site	O
of	O
Gdf5	O
(	O
Figure	O
1A	O
)	O
.	O

This	O
modified	O
BAC	O
was	O
then	O
used	O
to	O
make	O
lines	O
of	O
transgenic	O
mice	O
.	O

The	O
resulting	O
Gdf5	O
-	O
Cre	O
transgenic	O
mice	O
were	O
tested	O
for	O
transgene	O
expression	O
and	O
Cre	O
recombinase	O
activity	O
by	O
crossing	O
them	O
to	O
R26R	O
reporter	O
mice	O
that	O
activate	O
the	O
expression	O
of	O
lacZ	O
after	O
Cre	O
-	O
mediated	O
removal	O
of	O
transcriptional	O
stop	O
sequences	O
(	O
Soriano	O
1999	O
)	O
.	O

The	O
resulting	O
progeny	O
were	O
analyzed	O
both	O
for	O
expression	O
of	O
the	O
transgene	O
by	O
assaying	O
HPLAP	O
activity	O
and	O
for	O
recombination	O
of	O
DNA	O
by	O
assaying	O
LACZ	O
activity	O
.	O

The	O
progeny	O
from	O
all	O
three	O
lines	O
showed	O
strong	O
LACZ	O
expression	O
primarily	O
in	O
joints	O
,	O
and	O
in	O
two	O
of	O
three	O
lines	O
HPLAP	O
expression	O
could	O
also	O
be	O
seen	O
in	O
joint	O
regions	O
.	O

Interestingly	O
,	O
HPLAP	O
expression	O
in	O
the	O
Gdf5	O
-	O
Cre	O
transgenic	O
GAC	O
(	O
A	O
)	O
line	O
used	O
for	O
all	O
subsequent	O
breeding	O
experiments	O
was	O
seen	O
to	O
precede	O
LACZ	O
expression	O
during	O
successive	O
development	O
of	O
joints	O
in	O
the	O
digits	O
(	O
Figure	O
1C	O
)	O
(	O
unpublished	O
data	O
)	O
.	O

These	O
experiments	O
clearly	O
demonstrate	O
that	O
the	O
Gdf5	O
-	O
Cre	O
transgene	O
expresses	O
Cre	O
recombinase	O
and	O
causes	O
DNA	O
recombination	O
in	O
developing	O
joint	O
regions	O
.	O

GAC	O
(	O
A	O
)	O
mice	O
were	O
crossed	O
with	O
lacZ	O
ROSA26	O
Cre	O
reporter	O
strain	O
(	O
R26R	O
)	O
mice	O
to	O
analyze	O
the	O
pattern	O
of	O
Cre	O
-	O
mediated	O
lacZ	O
recombination	O
throughout	O
development	O
.	O

Joints	O
in	O
developing	O
limbs	O
begin	O
forming	O
in	O
a	O
proximal	O
-	O
distal	O
pattern	O
such	O
that	O
the	O
shoulder	O
joint	O
forms	O
prior	O
to	O
the	O
elbow	O
joint	O
.	O

In	O
addition	O
,	O
three	O
major	O
stages	O
of	O
early	O
joint	O
development	O
have	O
been	O
defined	O
by	O
histology	O
as	O
(	O
1	O
)	O
interzone	O
formation	O
,	O
(	O
2	O
)	O
three	O
-	O
layer	O
interzone	O
formation	O
,	O
and	O
(	O
3	O
)	O
cavitation	O
(	O
Mitrovic	O
1978	O
)	O
.	O

Consistent	O
with	O
the	O
proximal	O
-	O
distal	O
pattern	O
of	O
joint	O
development	O
in	O
the	O
limbs	O
,	O
LACZ	O
activity	O
is	O
seen	O
at	O
embryonic	O
day	O
12	O
.	O
5	O
(	O
E12	O
.	O
5	O
)	O
in	O
the	O
more	O
proximal	O
joints	O
,	O
including	O
the	O
shoulder	O
and	O
knee	O
(	O
unpublished	O
data	O
)	O
.	O

By	O
E14	O
.	O
5	O
,	O
LACZ	O
expression	O
is	O
typically	O
seen	O
in	O
all	O
but	O
the	O
most	O
distal	O
joints	O
of	O
the	O
limbs	O
(	O
Figure	O
1B	O
and	O
1C	O
)	O
,	O
but	O
with	O
some	O
variability	O
in	O
both	O
strength	O
and	O
extent	O
of	O
expression	O
from	O
embryo	O
to	O
embryo	O
.	O

The	O
strongest	O
-	O
staining	O
embryos	O
often	O
have	O
additional	O
staining	O
in	O
fingertips	O
(	O
not	O
seen	O
in	O
the	O
E14	O
.	O
5	O
embryo	O
in	O
Figure	O
1C	O
,	O
but	O
clearly	O
detectable	O
in	O
the	O
E13	O
.	O
5	O
embryo	O
shown	O
in	O
Figure	O
2	O
)	O
.	O

Sections	O
through	O
developing	O
joints	O
show	O
that	O
LACZ	O
is	O
present	O
in	O
many	O
cells	O
at	O
the	O
interzone	O
stage	O
(	O
unpublished	O
data	O
)	O
.	O

However	O
,	O
expression	O
of	O
LACZ	O
in	O
nearly	O
100	O
%	O
of	O
joint	O
cells	O
is	O
not	O
achieved	O
until	O
the	O
three	O
-	O
layer	O
interzone	O
stage	O
(	O
for	O
example	O
,	O
in	O
the	O
knee	O
joint	O
at	O
E14	O
.	O
5	O
or	O
in	O
any	O
of	O
the	O
phalangeal	O
joints	O
at	O
E16	O
.	O
5	O
(	O
unpublished	O
data	O
)	O
.	O

Within	O
the	O
developing	O
skeleton	O
,	O
Cre	O
-	O
mediated	O
expression	O
of	O
LACZ	O
remains	O
strikingly	O
specific	O
to	O
joints	O
throughout	O
development	O
.	O

Furthermore	O
,	O
it	O
is	O
seen	O
in	O
all	O
the	O
structures	O
of	O
postnatal	O
synovial	O
joints	O
including	O
the	O
articular	O
cartilage	O
,	O
joint	O
capsule	O
,	O
and	O
synovial	O
membrane	O
(	O
Figure	O
1D	O
and	O
1E	O
)	O
(	O
unpublished	O
data	O
)	O
.	O

These	O
patterns	O
are	O
consistent	O
with	O
the	O
well	O
-	O
established	O
expression	O
of	O
Gdf5	O
in	O
interzone	O
regions	O
during	O
embryonic	O
development	O
(	O
Storm	O
and	O
Kingsley	O
1996	O
)	O
.	O

Adult	O
expression	O
patterns	O
of	O
the	O
Gdf5	O
gene	O
are	O
not	O
as	O
well	O
characterized	O
,	O
but	O
Gdf5	O
expression	O
has	O
previously	O
been	O
detected	O
in	O
adult	O
articular	O
cartilage	O
using	O
both	O
RT	O
-	O
PCR	O
and	O
immunocytochemistry	O
(	O
Chang	O
et	O
al	O
.	O
1994	O
;	O
Erlacher	O
et	O
al	O
.	O
1998	O
;	O
Bobacz	O
et	O
al	O
.	O
2002	O
)	O
.	O

Other	O
sites	O
besides	O
limb	O
joints	O
also	O
have	O
Cre	O
-	O
mediated	O
lacZ	O
expression	O
.	O

Starting	O
at	O
E13	O
.	O
5	O
,	O
LACZ	O
activity	O
is	O
detected	O
in	O
an	O
anterior	O
and	O
posterior	O
domain	O
of	O
the	O
limb	O
bud	O
(	O
Figure	O
2C	O
)	O
.	O

At	O
E14	O
.	O
5	O
,	O
LACZ	O
activity	O
is	O
detectable	O
in	O
the	O
developing	O
ear	O
pinnae	O
,	O
ribs	O
,	O
sternum	O
,	O
tissues	O
in	O
the	O
face	O
,	O
and	O
some	O
regions	O
of	O
the	O
brain	O
and	O
spinal	O
cord	O
(	O
Figure	O
1B	O
)	O
(	O
unpublished	O
data	O
)	O
.	O

At	O
birth	O
,	O
LACZ	O
is	O
also	O
expressed	O
in	O
tendons	O
running	O
along	O
the	O
vertebral	O
column	O
,	O
regions	O
of	O
tendons	O
in	O
the	O
wrist	O
and	O
ankle	O
,	O
and	O
some	O
tendon	O
insertions	O
(	O
Figure	O
1D	O
)	O
(	O
unpublished	O
data	O
)	O
.	O

By	O
5	O
wk	O
of	O
age	O
,	O
LACZ	O
is	O
also	O
expressed	O
in	O
the	O
hair	O
follicles	O
,	O
ear	O
cartilage	O
,	O
some	O
cells	O
in	O
the	O
growth	O
plate	O
of	O
the	O
long	O
bones	O
,	O
and	O
portions	O
of	O
the	O
brain	O
and	O
spinal	O
cord	O
(	O
unpublished	O
data	O
)	O
.	O

Surprisingly	O
,	O
23	O
of	O
63	O
,	O
or	O
37	O
%	O
of	O
transgenic	O
mice	O
analyzed	O
also	O
show	O
some	O
degree	O
of	O
wider	O
"	O
ectopic	O
"	O
LACZ	O
expression	O
,	O
which	O
can	O
extend	O
throughout	O
many	O
different	O
tissues	O
in	O
the	O
animal	O
.	O

However	O
,	O
sustained	O
expression	O
of	O
the	O
transgene	O
itself	O
,	O
as	O
assayed	O
by	O
HPLAP	O
activity	O
,	O
is	O
still	O
restricted	O
primarily	O
to	O
joints	O
in	O
animals	O
that	O
show	O
evidence	O
of	O
more	O
generalized	O
recombination	O
based	O
on	O
LACZ	O
expression	O
(	O
unpublished	O
data	O
)	O
.	O

This	O
suggests	O
that	O
in	O
a	O
fraction	O
of	O
animals	O
,	O
sporadic	O
expression	O
of	O
Cre	O
at	O
some	O
time	O
early	O
in	O
development	O
is	O
sufficient	O
to	O
lead	O
to	O
both	O
ectopic	O
recombination	O
and	O
LACZ	O
expression	O
.	O

While	O
the	O
fraction	O
of	O
animals	O
with	O
broader	O
recombination	O
patterns	O
must	O
be	O
tracked	O
and	O
accounted	O
for	O
during	O
experiments	O
,	O
these	O
animals	O
offer	O
the	O
potential	O
benefit	O
of	O
revealing	O
additional	O
new	O
functions	O
of	O
target	O
genes	O
that	O
could	O
be	O
subsequently	O
studied	O
with	O
additional	O
site	O
-	O
specific	O
Cre	O
drivers	O
.	O

Gdf5	O
-	O
Cre	O
/	O
Bmpr1afloxP	O
Animals	O
Survive	O
to	O
Adulthood	O
with	O
Ear	O
,	O
Webbing	O
,	O
and	O
Joint	O
Defects	O

We	O
next	O
used	O
the	O
Gdf5	O
-	O
Cre	O
system	O
to	O
test	O
the	O
role	O
of	O
BMP	O
signaling	O
during	O
normal	O
joint	O
development	O
.	O

Gdf5	O
-	O
Cre	O
transgenic	O
mice	O
were	O
bred	O
to	O
animals	O
carrying	O
a	O
conditional	O
floxed	O
allele	O
of	O
the	O
Bmpr1a	O
locus	O
(	O
Mishina	O
et	O
al	O
.	O
2002	O
)	O
,	O
usually	O
in	O
the	O
presence	O
of	O
the	O
R26R	O
reporter	O
allele	O
to	O
facilitate	O
simultaneous	O
visualization	O
of	O
Cre	O
-	O
mediated	O
recombination	O
patterns	O
(	O
see	O
typical	O
cross	O
in	O
Figure	O
3	O
)	O
.	O

PCR	O
amplification	O
confirmed	O
that	O
a	O
key	O
exon	O
of	O
the	O
Bmpr1a	O
gene	O
was	O
deleted	O
in	O
mice	O
that	O
also	O
carried	O
the	O
Gdf5	O
-	O
Cre	O
transgene	O
(	O
unpublished	O
data	O
)	O
.	O

Previous	O
studies	O
have	O
shown	O
that	O
the	O
recombined	O
Bmpr1afloxP	O
allele	O
mimics	O
a	O
null	O
allele	O
of	O
the	O
Bmpr1a	O
locus	O
when	O
transmitted	O
through	O
the	O
germline	O
(	O
Mishina	O
et	O
al	O
.	O
2002	O
)	O
.	O

The	O
Gdf5	O
-	O
Cre	O
/	O
Bmpr1afloxP	O
conditional	O
knockout	O
mice	O
were	O
viable	O
and	O
survived	O
to	O
adulthood	O
,	O
showing	O
that	O
the	O
Gdf5	O
-	O
Cre	O
driver	O
can	O
bypass	O
the	O
early	O
embryonic	O
lethality	O
previously	O
reported	O
in	O
animals	O
with	O
a	O
null	O
mutation	O
in	O
the	O
Bmpr1a	O
locus	O
(	O
Mishina	O
et	O
al	O
.	O
1995	O
)	O
.	O

The	O
viable	O
Gdf5	O
-	O
Cre	O
/	O
Bmpr1afloxP	O
mice	O
showed	O
several	O
phenotypes	O
.	O

First	O
,	O
the	O
conditional	O
knockout	O
mice	O
had	O
shorter	O
ears	O
that	O
often	O
lay	O
flatter	O
against	O
their	O
heads	O
than	O
controls	O
(	O
controls	O
13	O
.	O
1	O
+/-	O
0	O
.	O
1	O
mm	O
long	O
,	O
n	O
=	O
38	O
;	O
mutants	O
11	O
.	O
8	O
+/-	O
0	O
.	O
2	O
mm	O
,	O
n	O
=	O
11	O
;	O
p	O
<	O
0	O
.	O
0001	O
)	O
.	O

BMP	O
signaling	O
is	O
known	O
to	O
be	O
required	O
for	O
growth	O
of	O
the	O
external	O
ear	O
of	O
mice	O
(	O
Kingsley	O
et	O
al	O
.	O
1992	O
)	O
,	O
and	O
this	O
phenotype	O
likely	O
reflects	O
loss	O
of	O
Bmpr1a	O
function	O
in	O
the	O
fraction	O
of	O
ear	O
cells	O
that	O
express	O
the	O
Gdf5	O
-	O
Cre	O
transgene	O
.	O

Most	O
mutant	O
mice	O
also	O
showed	O
soft	O
tissue	O
syndactyly	O
or	O
retention	O
of	O
webbing	O
between	O
the	O
first	O
and	O
second	O
digits	O
of	O
their	O
feet	O
,	O
a	O
phenotype	O
that	O
was	O
more	O
frequent	O
and	O
more	O
severe	O
in	O
the	O
forelimbs	O
(	O
201	O
of	O
220	O
,	O
or	O
91	O
%	O
,	O
of	O
forefeet	O
and	O
109	O
of	O
220	O
,	O
or	O
50	O
%	O
,	O
of	O
hindfeet	O
)	O
.	O

Finally	O
,	O
mutant	O
animals	O
showed	O
obvious	O
skeletal	O
changes	O
in	O
whole	O
-	O
mount	O
skeletal	O
preparations	O
.	O

At	O
some	O
sites	O
in	O
the	O
ankles	O
,	O
joints	O
seemed	O
to	O
be	O
missing	O
entirely	O
,	O
with	O
fusion	O
of	O
bones	O
that	O
would	O
normally	O
be	O
separate	O
.	O

For	O
example	O
,	O
the	O
second	O
distal	O
tarsal	O
was	O
fused	O
to	O
the	O
central	O
tarsal	O
bone	O
in	O
every	O
conditional	O
knockout	O
animal	O
examined	O
(	O
18	O
of	O
18	O
)	O
,	O
a	O
phenotype	O
not	O
observed	O
in	O
controls	O
(	O
zero	O
of	O
18	O
)	O
(	O
Figure	O
3B	O
and	O
3C	O
)	O
.	O

At	O
other	O
locations	O
,	O
joints	O
had	O
clearly	O
formed	O
but	O
showed	O
dramatic	O
loss	O
of	O
staining	O
with	O
the	O
cartilage	O
matrix	S-GO
marker	O
Alcian	O
blue	O
(	O
Figure	O
3B	O
-	O
3E	O
)	O
(	O
unpublished	O
data	O
)	O
.	O

Normal	O
Alcian	O
blue	O
staining	O
was	O
seen	O
in	O
non	O
-	O
articular	O
regions	O
,	O
such	O
as	O
the	O
cartilaginous	O
growth	O
plate	O
(	O
Figure	O
3D	O
and	O
3E	O
,	O
asterisk	O
)	O
.	O

These	O
data	O
suggest	O
that	O
Bmpr1a	O
function	O
is	O
required	O
for	O
the	O
formation	O
of	O
specific	O
joints	O
in	O
the	O
ankle	O
region	O
and	O
for	O
either	O
generation	O
or	O
maintenance	O
of	O
articular	O
cartilage	O
in	O
most	O
other	O
joints	O
of	O
the	O
limb	O
.	O

Developmental	O
Origin	O
of	O
Webbing	O
Phenotype	O

Interdigital	O
mesenchyme	O
is	O
normally	O
eliminated	O
by	O
apoptosis	O
during	O
embryonic	O
development	O
,	O
a	O
process	O
that	O
can	O
be	O
stimulated	O
by	O
BMP	O
beads	O
,	O
inhibited	O
by	O
Noggin	O
,	O
or	O
blocked	O
by	O
overexpression	O
of	O
dominant	O
-	O
negative	O
BMP	O
receptors	O
(	O
Garcia	O
-	O
Martinez	O
et	O
al	O
.	O
1993	O
;	O
Yokouchi	O
et	O
al	O
.	O
1996	O
;	O
Zou	O
and	O
Niswander	O
1996	O
;	O
Guha	O
et	O
al	O
.	O
2002	O
)	O
.	O

Limbs	O
of	O
Gdf5	O
-	O
Cre	O
/	O
Bmpr1afloxP	O
mutant	O
embryos	O
showed	O
obvious	O
retention	O
of	O
interdigital	O
webbing	O
between	O
the	O
first	O
and	O
second	O
,	O
but	O
not	O
other	O
,	O
digits	O
of	O
E14	O
.	O
5	O
forelimbs	O
(	O
Figure	O
2A	O
and	O
2B	O
)	O
,	O
a	O
pattern	O
that	O
corresponds	O
to	O
the	O
presence	O
or	O
absence	O
of	O
webbing	O
seen	O
in	O
the	O
adult	O
limb	O
.	O

They	O
also	O
showed	O
excess	O
tissue	O
on	O
the	O
posterior	O
margin	O
of	O
the	O
fifth	O
digit	O
(	O
Figure	O
2B	O
,	O
arrow	O
)	O
.	O

Analysis	O
of	O
LACZ	O
expression	O
in	O
Gdf5	O
-	O
Cre	O
/	O
R26R	O
reporter	O
embryos	O
showed	O
that	O
Cre	O
-	O
mediated	O
recombination	O
has	O
occurred	O
by	O
E13	O
.	O
5	O
in	O
the	O
metacarpal	O
-	O
phalangeal	O
joints	O
,	O
and	O
in	O
the	O
interdigital	O
region	O
between	O
the	O
first	O
and	O
second	O
,	O
but	O
not	O
other	O
,	O
digits	O
.	O

In	O
addition	O
,	O
a	O
domain	O
of	O
recombination	O
and	O
expression	O
of	O
LACZ	O
is	O
also	O
reproducibly	O
seen	O
in	O
the	O
posterior	O
half	O
of	O
the	O
fifth	O
digit	O
(	O
Figure	O
2C	O
)	O
.	O

Terminal	O
deoxynucleotidyl	O
transferase	O
-	O
mediated	O
deoxyuridine	O
triphosphate	O
nick	O
end	O
labeling	O
(	O
TUNEL	O
)	O
staining	O
of	O
interdigital	O
mesenchyme	O
between	O
the	O
first	O
and	O
second	O
digits	O
(	O
Figure	O
2D	O
and	O
2E	O
)	O
and	O
the	O
fifth	O
digit	O
flanking	O
mesenchyme	O
showed	O
a	O
decreased	O
number	O
of	O
dying	O
cells	O
in	O
the	O
regions	O
where	O
excess	O
tissue	O
is	O
retained	O
in	O
the	O
mutant	O
limbs	O
.	O

Numbers	O
of	O
phosphorylated	O
histone	O
H3	O
-	O
labeled	O
proliferating	O
cells	O
were	O
also	O
elevated	O
in	O
these	O
regions	O
(	O
Figure	O
2F	O
)	O
.	O

Most	O
cells	O
found	O
in	O
the	O
webbed	O
region	O
between	O
the	O
first	O
and	O
second	O
digits	O
at	O
E15	O
.	O
5	O
strongly	O
expressed	O
LACZ	O
in	O
Gdf5	O
-	O
Cre	O
/	O
Bmpr1afloxP	O
mutant	O
embryos	O
(	O
Figure	O
2H	O
)	O
.	O

These	O
data	O
suggest	O
that	O
regional	O
loss	O
of	O
BMPR1A	O
receptor	O
signaling	O
blocks	O
programmed	O
cell	O
death	O
in	O
interdigital	O
mesenchyme	O
,	O
and	O
that	O
the	O
recombined	O
cells	O
survive	O
and	O
proliferate	O
in	O
the	O
absence	O
of	O
BMPR1A	O
signaling	O
.	O

Failure	O
of	O
Early	O
Joint	O
Formation	O
in	O
Ankle	O
Regions	O

The	O
Bmpr1a	O
gene	O
is	O
expressed	O
in	O
the	O
interzone	O
region	O
of	O
developing	O
joints	O
at	O
E13	O
.	O
5	O
(	O
Baur	O
et	O
al	O
.	O
2000	O
)	O
.	O

In	O
situ	O
hybridization	O
showed	O
that	O
the	O
gene	O
is	O
also	O
expressed	O
in	O
the	O
interzones	O
of	O
ankle	O
joints	O
and	O
prospective	O
articular	O
cartilage	O
regions	O
of	O
digit	O
joints	O
at	O
E15	O
.	O
5	O
(	O
Figure	O
4	O
)	O
.	O

LACZ	O
staining	O
indicated	O
that	O
Cre	O
-	O
mediated	O
recombination	O
begins	O
to	O
occur	O
in	O
ankle	O
joints	O
around	O
E14	O
.	O
5	O
,	O
and	O
is	O
extensive	O
by	O
E15	O
.	O
5	O
(	O
Figure	O
4G	O
and	O
4J	O
)	O
(	O
unpublished	O
data	O
)	O
.	O

In	O
the	O
ankle	O
joint	O
regions	O
that	O
were	O
obviously	O
fused	O
in	O
postnatal	O
mutant	O
animals	O
,	O
alterations	O
in	O
early	O
joint	O
marker	O
expression	O
could	O
also	O
be	O
seen	O
by	O
E15	O
.	O
5	O
.	O

At	O
this	O
stage	O
,	O
the	O
Gdf5	O
gene	O
is	O
normally	O
expressed	O
in	O
stripes	O
that	O
mark	O
the	O
sites	O
of	O
joint	O
formation	O
(	O
Figure	O
4F	O
)	O
,	O
and	O
the	O
gene	O
for	O
the	O
major	O
collagen	O
protein	O
of	O
cartilage	O
matrix	S-GO
(	O
Col2a1	O
)	O
is	O
down	O
-	O
regulated	O
in	O
the	O
interzone	O
region	O
(	O
Figure	O
4E	O
)	O
.	O

In	O
contrast	O
,	O
Col2a1	O
staining	O
extended	O
completely	O
through	O
the	O
joint	O
region	O
between	O
the	O
second	O
and	O
central	O
tarsal	O
of	O
Gdf5	O
-	O
Cre	O
/	O
Bmpr1afloxP	O
mutants	O
(	O
Figure	O
4H	O
,	O
black	O
arrow	O
)	O
,	O
and	O
Gdf5	O
expression	O
was	O
seen	O
only	O
as	O
a	O
small	O
notch	O
extending	O
into	O
where	O
the	O
joint	O
should	O
be	O
forming	O
(	O
Figure	O
4I	O
,	O
bracket	O
)	O
.	O

These	O
data	O
suggest	O
that	O
the	O
fusions	O
seen	O
between	O
ankle	O
bones	O
in	O
postnatal	O
mutant	O
skeletons	O
are	O
the	O
result	O
of	O
incomplete	O
segmentation	O
of	O
skeletal	O
precursors	O
during	O
embryonic	O
development	O
,	O
a	O
defect	O
confined	O
to	O
some	O
locations	O
in	O
the	O
ankle	O
.	O

Failure	O
to	O
Maintain	O
Articular	O
Cartilage	O
in	O
Other	O
Joints	O

In	O
most	O
joints	O
of	O
Bmpr1a	O
conditional	O
knockout	O
mice	O
,	O
embryonic	O
segmentation	O
of	O
skeletal	O
precursors	O
occurred	O
normally	O
.	O

Although	O
Gdf5	O
-	O
Cre	O
-	O
mediated	O
recombination	O
was	O
seen	O
as	O
early	O
as	O
E13	O
.	O
5	O
in	O
digit	O
interzone	O
regions	O
(	O
see	O
Figure	O
2C	O
)	O
,	O
no	O
changes	O
in	O
cell	O
death	O
or	O
cell	O
proliferation	O
could	O
be	O
seen	O
in	O
the	O
metacarpal	O
-	O
phalangeal	O
or	O
metatarsal	O
-	O
phalangeal	O
joints	O
at	O
E13	O
.	O
5	O
or	O
E14	O
.	O
5	O
(	O
unpublished	O
data	O
)	O
.	O

Similarly	O
,	O
although	O
clear	O
LACZ	O
expression	O
was	O
seen	O
by	O
E15	O
.	O
5	O
in	O
interphalangeal	O
joints	O
and	O
periarticular	O
regions	O
(	O
Figure	O
4D	O
)	O
,	O
no	O
difference	O
in	O
morphology	O
or	O
expression	O
of	O
Col2a1	O
,	O
Gdf5	O
,	O
or	O
Bmpr1b	O
was	O
seen	O
in	O
the	O
articular	O
regions	O
of	O
the	O
phalanges	O
at	O
these	O
stages	O
(	O
unpublished	O
data	O
)	O
.	O

At	O
birth	O
,	O
digit	O
joints	O
were	O
generally	O
indistinguishable	O
from	O
those	O
in	O
control	O
animals	O
;	O
chondrocytes	O
were	O
abundant	O
in	O
articular	O
regions	O
and	O
were	O
surrounded	O
by	O
typical	O
cartilage	O
matrix	S-GO
with	O
normal	O
staining	O
by	O
Safranin	O
O	O
,	O
a	O
histological	O
stain	O
for	O
proteoglycans	O
(	O
Figure	O
5	O
)	O
.	O

At	O
this	O
stage	O
,	O
both	O
wild	O
-	O
type	O
and	O
mutant	O
cells	O
in	O
articular	O
regions	O
also	O
expressed	O
high	O
levels	O
of	O
Col2a1	O
and	O
Aggrecan	O
(	O
Agg	O
)	O
,	O
the	O
genes	O
encoding	O
the	O
major	O
structural	O
proteins	O
of	O
cartilage	O
matrix	S-GO
(	O
Figure	O
5B	O
and	O
5G	O
)	O
(	O
unpublished	O
data	O
)	O
.	O

No	O
alterations	O
in	O
cellular	O
apoptosis	O
or	O
proliferation	O
were	O
observed	O
(	O
unpublished	O
data	O
)	O
.	O

To	O
determine	O
whether	O
articular	O
cells	O
were	O
properly	O
specified	O
in	O
mutants	O
,	O
we	O
also	O
analyzed	O
expression	O
of	O
Matrilin	O
-	O
4	O
(	O
Mat4	O
)	O
,	O
a	O
gene	O
expressed	O
specifically	O
in	O
the	O
periarticular	O
and	O
perichondral	O
regions	O
of	O
developing	O
joints	O
(	O
Klatt	O
et	O
al	O
.	O
2001	O
)	O
.	O

In	O
both	O
control	O
and	O
mutant	O
animals	O
,	O
transcription	O
of	O
Mat4	O
was	O
clearly	O
detectable	O
in	O
the	O
articular	O
cartilage	O
layers	O
of	O
newborn	O
joints	O
(	O
Figure	O
5D	O
and	O
5I	O
)	O
.	O

In	O
all	O
experiments	O
,	O
expression	O
of	O
LACZ	O
throughout	O
articular	O
regions	O
indicated	O
that	O
Cre	O
-	O
mediated	O
recombination	O
had	O
occurred	O
throughout	O
the	O
articular	O
regions	O
(	O
Figure	O
5C	O
,	O
5H	O
,	O
5E	O
,	O
and	O
5J	O
)	O
.	O

The	O
normal	O
histological	O
appearance	O
,	O
staining	O
properties	O
,	O
and	O
marker	O
gene	O
expression	O
patterns	O
suggest	O
that	O
Bmpr1a	O
is	O
not	O
required	O
for	O
the	O
initial	O
formation	O
or	O
specification	O
of	O
articular	O
cartilage	O
.	O

By	O
1	O
wk	O
after	O
birth	O
,	O
obvious	O
differences	O
began	O
to	O
be	O
detected	O
in	O
the	O
articular	O
regions	O
of	O
mutant	O
animals	O
.	O

The	O
expression	O
of	O
Col2a1	O
was	O
reduced	O
throughout	O
the	O
articular	O
surfaces	O
of	O
the	O
carpals	O
,	O
metacarpals	O
,	O
and	O
phalanges	O
of	O
the	O
forefeet	O
(	O
unpublished	O
data	O
)	O
.	O

Less	O
severe	O
reductions	O
were	O
also	O
seen	O
in	O
articular	O
cells	O
of	O
tarsals	O
and	O
metatarsals	O
in	O
the	O
hindfeet	O
(	O
unpublished	O
data	O
)	O
.	O

By	O
2	O
wk	O
of	O
age	O
,	O
Col2a1	O
expression	O
was	O
reduced	O
in	O
most	O
cells	O
of	O
the	O
articular	O
region	O
(	O
Figure	O
5L	O
and	O
5Q	O
)	O
,	O
accompanied	O
by	O
markedly	O
reduced	O
Safranin	O
O	O
staining	O
(	O
Figure	O
5K	O
and	O
5P	O
)	O
,	O
and	O
decreased	O
expression	O
of	O
Agg	O
and	O
two	O
genes	O
normally	O
expressed	O
in	O
more	O
mature	O
articular	O
cartilage	O
cells	O
,	O
Collagen	O
3	O
(	O
Col3a1	O
)	O
and	O
Collagen	O
10	O
(	O
Col10a1	O
)	O
(	O
Figure	O
5M	O
and	O
5R	O
)	O
(	O
unpublished	O
data	O
)	O
(	O
Eyre	O
2002	O
)	O
.	O

Inhibition	O
of	O
BMP	O
signaling	O
in	O
cultured	O
chondrocytes	O
has	O
previously	O
been	O
reported	O
to	O
induce	O
Collagen	O
1	O
(	O
Col1a1	O
)	O
expression	O
,	O
increase	O
proliferation	O
,	O
and	O
result	O
in	O
cells	O
with	O
flattened	O
,	O
fibroblast	O
-	O
like	O
morphology	O
(	O
Enomoto	O
-	O
Iwamoto	O
et	O
al	O
.	O
1998	O
)	O
.	O

However	O
,	O
we	O
saw	O
no	O
increase	O
in	O
the	O
expression	O
of	O
Col1a1	O
in	O
mutant	O
articular	O
cartilage	O
,	O
and	O
no	O
proliferation	O
was	O
detected	O
in	O
articular	O
cells	O
of	O
either	O
mutant	O
or	O
control	O
animals	O
(	O
unpublished	O
data	O
)	O
.	O

While	O
recombined	O
LACZ	O
marker	O
expression	O
was	O
detected	O
in	O
most	O
articular	O
cartilage	O
cells	O
,	O
it	O
was	O
also	O
observed	O
in	O
scattered	O
subarticular	O
chondrocytes	O
,	O
growth	O
plate	O
chondrocytes	O
,	O
and	O
osteoblasts	O
(	O
Figure	O
5O	O
and	O
5T	O
)	O
(	O
unpublished	O
data	O
)	O
.	O

Although	O
this	O
implies	O
that	O
BMP	O
signaling	O
was	O
defective	O
in	O
multiple	O
cell	O
types	O
,	O
the	O
observed	O
defects	O
were	O
confined	O
to	O
the	O
articular	O
cartilage	O
.	O

For	O
example	O
,	O
Osteocalcin	O
and	O
Col1a1	O
expression	O
appeared	O
normal	O
in	O
osteoblasts	O
(	O
unpublished	O
data	O
)	O
.	O

Together	O
,	O
these	O
data	O
suggest	O
that	O
BMPR1A	O
activity	O
is	O
required	O
in	O
postnatal	O
joint	O
articular	O
cartilage	O
to	O
maintain	O
expression	O
of	O
many	O
genes	O
encoding	O
structural	O
components	B-GO
of	I-GO
cartilage	I-GO
matrix	E-GO
.	O

Previous	O
studies	O
have	O
shown	O
that	O
Sox9	O
is	O
required	O
for	O
normal	O
cartilage	O
differentiation	O
,	O
for	O
expression	O
of	O
cartilage	O
extracellular	B-GO
matrix	E-GO
(	O
ECM	S-GO
)	O
genes	O
including	O
Agg	O
,	O
and	O
is	O
a	O
direct	O
transcriptional	O
regulator	O
of	O
the	O
key	O
cartilage	O
matrix	S-GO
gene	O
Col2a1	O
(	O
Bell	O
et	O
al	O
.	O
1997	O
;	O
Lefebvre	O
et	O
al	O
.	O
1997	O
;	O
Bi	O
et	O
al	O
.	O
1999	O
;	O
Sekiya	O
et	O
al	O
.	O
2000	O
)	O
.	O

Notably	O
,	O
despite	O
reduced	O
expression	O
of	O
many	O
cartilage	O
matrix	S-GO
marker	O
genes	O
in	O
Bmpr1a	O
mutant	O
mice	O
,	O
the	O
SOX9	O
protein	O
was	O
present	O
at	O
normal	O
levels	O
in	O
articular	O
regions	O
at	O
all	O
stages	O
examined	O
,	O
including	O
newborn	O
,	O
2	O
-	O
wk	O
-	O
old	O
,	O
7	O
-	O
wk	O
-	O
old	O
,	O
and	O
9	O
-	O
mo	O
-	O
old	O
mice	O
(	O
Figure	O
5N	O
and	O
5S	O
)	O
(	O
unpublished	O
data	O
)	O
.	O

Synovial	O
Hypertrophy	O
,	O
Cartilage	O
Erosion	O
,	O
and	O
Accelerated	O
Cartilage	O
Maturation	O

Conditional	O
loss	O
of	O
Bmpr1a	O
led	O
to	O
marked	O
hypertrophy	O
of	O
the	O
synovial	O
membrane	O
in	O
the	O
joint	O
capsule	O
of	O
some	O
joints	O
,	O
particularly	O
in	O
the	O
ankle	O
region	O
.	O

In	O
the	O
most	O
severely	O
affected	O
joints	O
,	O
the	O
expanded	O
synovial	O
membrane	O
grew	O
into	O
the	O
joint	O
space	O
and	O
was	O
associated	O
with	O
obvious	O
loss	O
or	O
erosion	O
of	O
the	O
articular	O
cartilage	O
(	O
Figure	O
6A	O
and	O
6B	O
,	O
asterisks	O
,	O
arrows	O
)	O
.	O

Accelerated	O
cartilage	O
maturation	O
and	O
increased	O
expression	O
of	O
Col10a1	O
was	O
frequently	O
seen	O
in	O
the	O
chondrocytes	O
underlying	O
the	O
articular	O
erosions	O
(	O
Figure	O
6C	O
and	O
6D	O
,	O
brackets	O
)	O
(	O
unpublished	O
data	O
)	O
.	O

Interestingly	O
,	O
the	O
regions	O
of	O
increased	O
Col10a1	O
expression	O
did	O
not	O
correspond	O
to	O
the	O
regions	O
that	O
had	O
undergone	O
Cre	O
-	O
mediated	O
recombination	O
.	O

Instead	O
,	O
increased	O
expression	O
of	O
Col10a1	O
was	O
seen	O
in	O
a	O
zone	O
of	O
largely	O
LACZ	O
-	O
negative	O
cells	O
stretching	O
from	O
the	O
cartilage	O
adjacent	O
to	O
the	O
ossification	O
front	O
(	O
where	O
Col10a1	O
is	O
normally	O
expressed	O
in	O
maturing	O
cartilage	O
cells	O
)	O
,	O
toward	O
the	O
regions	O
where	O
surface	O
articular	O
cartilage	O
was	O
severely	O
eroded	O
or	O
missing	O
(	O
Figure	O
6A	O
and	O
6B	O
,	O
arrowheads	O
)	O
.	O

Previous	O
studies	O
suggest	O
that	O
parathyroid	O
hormone	O
-	O
related	O
protein	O
,	O
a	O
diffusible	O
signal	O
made	O
in	O
the	O
articular	O
surface	O
,	O
may	O
normally	O
inhibit	O
maturation	O
of	O
underlying	O
cartilage	O
(	O
Vortkamp	O
et	O
al	O
.	O
1996	O
;	O
Weir	O
et	O
al	O
.	O
1996	O
)	O
.	O

Local	O
loss	O
of	O
the	O
articular	O
surface	O
could	O
remove	O
this	O
inhibition	O
and	O
lead	O
to	O
a	O
cell	O
-	O
nonautonomous	O
acceleration	O
of	O
maturation	O
in	O
chondrocytes	O
underlying	O
points	O
of	O
articular	O
erosion	O
.	O

This	O
synovial	O
hypertrophy	O
is	O
associated	O
with	O
increased	O
numbers	O
of	O
mononuclear	O
cells	O
resembling	O
synoviocytes	O
or	O
macrophages	O
,	O
cell	O
types	O
that	O
are	O
difficult	O
to	O
distinguish	O
even	O
with	O
surface	S-GO
markers	O
at	O
early	O
postnatal	O
stages	O
.	O

However	O
,	O
no	O
neutrophils	O
were	O
observed	O
,	O
suggesting	O
that	O
there	O
is	O
little	O
inflammation	O
.	O

At	O
later	O
stages	O
synovial	O
hypertrophy	O
is	O
reduced	O
.	O

Further	O
work	O
will	O
be	O
needed	O
to	O
determine	O
whether	O
synovial	O
development	O
is	O
regulated	O
by	O
BMP	O
signaling	O
,	O
or	O
whether	O
the	O
synovium	O
becomes	O
enlarged	O
as	O
a	O
response	O
to	O
nearby	O
skeletal	O
malformations	O
(	O
such	O
as	O
fusion	O
of	O
the	O
second	O
and	O
central	O
tarsals	O
or	O
defects	O
in	O
the	O
articular	O
cartilage	O
)	O
.	O

Noninflammatory	O
Degeneration	O
of	O
Articular	O
Cartilage	O
in	O
Digit	O
and	O
Knee	O
Joints	O

Outside	O
of	O
the	O
ankle	O
region	O
,	O
little	O
or	O
no	O
evidence	O
was	O
seen	O
for	O
expansion	O
of	O
the	O
synovial	O
membrane	O
.	O

Instead	O
,	O
mutant	O
mice	O
showed	O
histological	O
signs	O
of	O
osteoarthritis	O
,	O
such	O
as	O
fibrillation	O
of	O
the	O
articular	O
surface	O
(	O
Figure	O
7	O
)	O
.	O

As	O
previously	O
seen	O
in	O
1	O
-	O
and	O
2	O
-	O
wk	O
-	O
old	O
animals	O
,	O
Safranin	O
O	O
staining	O
and	O
Agg	O
and	O
Col10	O
expression	O
were	O
all	O
reduced	O
in	O
mutant	O
articular	O
regions	O
of	O
the	O
forefeet	O
and	O
hindfeet	O
by	O
7	O
wk	O
of	O
age	O
,	O
and	O
the	O
beginning	O
signs	O
of	O
cartilage	O
loss	O
were	O
observed	O
(	O
unpublished	O
data	O
)	O
.	O

By	O
9	O
mo	O
of	O
age	O
,	O
many	O
regions	O
of	O
articular	O
cartilage	O
were	O
completely	O
missing	O
or	O
extremely	O
fibrillated	O
,	O
leaving	O
regions	O
of	O
exposed	O
bone	O
on	O
the	O
surface	O
(	O
Figure	O
7A	O
-	O
7D	O
)	O
.	O

No	O
alterations	O
were	O
seen	O
in	O
the	O
expression	O
of	O
Osteocalcin	O
,	O
Col1a1	O
,	O
or	O
matrix	O
metalloprotease	O
-	O
13	O
at	O
either	O
7	O
wk	O
or	O
9	O
mo	O
.	O

The	O
major	O
weight	O
-	O
bearing	O
joint	O
of	O
the	O
hindlimb	O
,	O
the	O
knee	O
,	O
showed	O
changes	O
that	O
closely	O
paralleled	O
that	O
seen	O
in	O
the	O
foot	O
joints	O
.	O

All	O
markers	O
of	O
cartilage	O
matrix	S-GO
looked	O
similar	O
to	O
controls	O
at	O
E16	O
.	O
5	O
,	O
suggesting	O
that	O
early	O
stages	O
of	O
joint	O
formation	O
were	O
not	O
disrupted	O
(	O
unpublished	O
data	O
)	O
.	O

By	O
postnatal	O
day	O
7	O
,	O
Safranin	O
O	O
staining	O
and	O
Col2a1	O
and	O
Agg	O
expression	O
were	O
clearly	O
reduced	O
in	O
the	O
mutant	O
,	O
despite	O
continued	O
expression	O
of	O
Sox9	O
(	O
unpublished	O
data	O
)	O
.	O

The	O
overall	O
shape	O
of	O
mutant	O
knee	O
skeletal	O
elements	O
appeared	O
similar	O
to	O
controls	O
,	O
although	O
the	O
fibrocartilaginous	O
meniscus	O
that	O
resides	O
between	O
the	O
femur	O
and	O
tibia	O
appeared	O
much	O
less	O
dense	O
in	O
mutants	O
at	O
E16	O
.	O
5	O
.	O

Some	O
cartilage	O
formed	O
in	O
the	O
meniscus	O
region	O
,	O
but	O
the	O
size	O
of	O
these	O
elements	O
was	O
greatly	O
reduced	O
and	O
contained	O
abundant	O
cells	O
with	O
fibrous	O
,	O
noncartilaginous	O
appearance	O
(	O
unpublished	O
data	O
)	O
.	O

This	O
reduction	O
of	O
the	O
meniscus	O
can	O
also	O
be	O
seen	O
in	O
sections	O
from	O
7	O
-	O
wk	O
-	O
and	O
9	O
-	O
mo	O
-	O
old	O
animals	O
(	O
Figure	O
7E	O
,	O
7H	O
,	O
7K	O
,	O
and	O
7N	O
,	O
arrows	O
)	O
.	O

At	O
7	O
wk	O
of	O
age	O
the	O
normally	O
domed	O
tibial	O
epiphysis	O
was	O
flattened	O
and	O
depressed	O
in	O
the	O
knees	O
of	O
mutant	O
animals	O
,	O
markedly	O
reducing	O
the	O
distance	O
between	O
the	O
growth	O
plate	O
and	O
articular	O
surface	O
(	O
Figure	O
7E	O
and	O
7H	O
,	O
vertical	O
bar	O
)	O
.	O

Articular	O
cartilage	O
was	O
also	O
thinner	O
than	O
in	O
control	O
animals	O
,	O
showed	O
nearly	O
complete	O
absence	O
of	O
Safranin	O
O	O
staining	O
,	O
and	O
was	O
either	O
acellular	O
or	O
beginning	O
to	O
fibrillate	O
in	O
many	O
regions	O
(	O
Figure	O
7F	O
and	O
7I	O
)	O
.	O

The	O
few	O
large	O
Safranin	O
O	O
-	O
stained	O
cells	O
still	O
apparent	O
in	O
mutant	O
articular	O
regions	O
appeared	O
to	O
correspond	O
in	O
position	O
to	O
rare	O
LACZ	O
-	O
negative	O
cells	O
in	O
adjacent	O
sections	O
,	O
suggesting	O
that	O
Bmpr1a	O
is	O
required	O
cell	O
-	O
autonomously	O
in	O
articular	O
cartilage	O
(	O
Figure	O
7I	O
and	O
7J	O
,	O
white	O
arrowheads	O
)	O
.	O

By	O
9	O
mo	O
,	O
large	O
areas	O
of	O
mutant	O
knees	O
were	O
devoid	O
of	O
articular	O
cells	O
,	O
and	O
the	O
bones	O
of	O
the	O
femur	O
and	O
tibia	O
appeared	O
to	O
rub	O
directly	O
against	O
each	O
other	O
.	O

Furthermore	O
,	O
the	O
epiphysis	O
of	O
the	O
tibia	O
was	O
extremely	O
depressed	O
,	O
to	O
the	O
point	O
that	O
growth	O
plate	O
cartilage	O
was	O
almost	O
exposed	O
through	O
the	O
surface	O
of	O
the	O
bone	O
(	O
Figure	O
7K	O
,	O
7L	O
,	O
7N	O
,	O
and	O
7O	O
)	O
.	O

In	O
addition	O
,	O
mutants	O
at	O
7	O
wk	O
and	O
9	O
mo	O
showed	O
subchondral	O
sclerosis	O
,	O
especially	O
in	O
the	O
epiphysis	O
of	O
the	O
femur	O
(	O
Figure	O
7E	O
,	O
7H	O
,	O
7K	O
,	O
and	O
7N	O
,	O
asterisks	O
)	O
.	O

While	O
subchondral	O
sclerosis	O
is	O
commonly	O
seen	O
in	O
cases	O
of	O
osteoarthritis	O
,	O
it	O
is	O
unclear	O
in	O
this	O
case	O
whether	O
the	O
sclerosis	O
is	O
mainly	O
a	O
response	O
of	O
bone	O
formation	O
to	O
compensate	O
for	O
decreased	O
articular	O
cartilage	O
,	O
or	O
whether	O
it	O
is	O
the	O
effect	O
of	O
loss	O
of	O
Bmpr1a	O
signaling	O
in	O
some	O
LACZ	O
-	O
positive	O
cells	O
that	O
are	O
also	O
observed	O
in	O
these	O
regions	O
(	O
unpublished	O
data	O
)	O
.	O

The	O
histological	O
signs	O
of	O
joint	O
arthritis	O
were	O
accompanied	O
by	O
functional	O
impairments	O
in	O
both	O
grasping	O
ability	O
and	O
range	O
of	O
motion	O
in	O
mutant	O
animals	O
.	O

Gdf5	O
-	O
Cre	O
/	O
Bmpr1afloxP	O
mutant	O
animals	O
showed	O
a	O
highly	O
significantly	O
reduced	O
ability	O
to	O
grasp	O
and	O
remain	O
suspended	O
on	O
a	O
slender	O
rod	O
(	O
mean	O
suspension	O
time	O
:	O
controls	O
38	O
+/-	O
6	O
s	O
,	O
n	O
=	O
39	O
;	O
mutants	O
6	O
+/-	O
3	O
s	O
,	O
n	O
=	O
11	O
;	O
p	O
<	O
0	O
.	O
0001	O
)	O
.	O

Mutant	O
mice	O
also	O
showed	O
a	O
clear	O
decrease	O
in	O
the	O
maximum	O
range	O
of	O
mobility	O
of	O
two	O
different	O
joints	O
in	O
the	O
digits	O
,	O
as	O
assayed	O
by	O
passive	O
manipulation	O
(	O
MT	O
/	O
P1	O
joint	O
:	O
controls	O
100	O
+/-	O
0	O
degrees	O
,	O
n	O
=	O
26	O
;	O
mutants	O
82	O
+/-	O
3	O
degrees	O
,	O
n	O
=	O
8	O
;	O
p	O
<	O
0	O
.	O
0003	O
;	O
P1	O
/	O
P2	O
joint	O
:	O
controls	O
152	O
+/-	O
1	O
degrees	O
,	O
n	O
=	O
23	O
;	O
mutants	O
140	O
+/-	O
5	O
degrees	O
,	O
n	O
=	O
6	O
;	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O

The	O
structural	O
,	O
histological	O
,	O
marker	O
gene	O
expression	O
,	O
and	O
functional	O
changes	O
in	O
mutant	O
mice	O
demonstrate	O
that	O
BMPR1A	O
is	O
required	O
for	O
normal	O
postnatal	O
maintenance	O
of	O
articular	O
cartilage	O
.	O

Discussion	O

Previous	O
studies	O
suggest	O
that	O
BMP	O
signaling	O
is	O
involved	O
in	O
a	O
large	O
number	O
of	O
developmental	O
events	O
.	O

Many	O
of	O
these	O
events	O
occur	O
early	O
in	O
embryogenesis	O
,	O
and	O
complete	O
inactivation	O
of	O
BMP	O
receptors	O
causes	O
death	O
by	O
E9	O
.	O
5	O
(	O
Mishina	O
et	O
al	O
.	O
1995	O
)	O
.	O

The	O
Gdf5	O
-	O
Cre	O
recombination	O
system	O
bypasses	O
the	O
early	O
embryonic	O
lethality	O
of	O
Bmpr1a	O
mutations	O
,	O
and	O
provides	O
important	O
new	O
information	O
about	O
the	O
role	O
of	O
this	O
receptor	O
in	O
limb	O
and	O
skeletal	O
development	O
.	O

The	O
three	O
major	O
limb	O
phenotypes	O
revealed	O
by	O
eliminating	O
Bmpr1a	O
with	O
Gdf5	O
-	O
driven	O
Cre	O
include	O
webbing	O
between	O
digits	O
,	O
lack	O
of	O
joint	O
formation	O
at	O
specific	O
locations	O
in	O
the	O
ankle	O
,	O
and	O
failure	O
to	O
maintain	O
articular	O
cartilage	O
after	O
birth	O
,	O
resulting	O
in	O
severe	O
arthritis	O
.	O

Previous	O
studies	O
have	O
shown	O
that	O
manipulation	O
of	O
BMP	O
signaling	O
alters	O
interdigital	O
apoptosis	O
during	O
development	O
of	O
the	O
limb	O
,	O
but	O
no	O
experiment	O
has	O
identified	O
a	O
specific	O
member	O
of	O
the	O
BMP	O
signaling	O
pathway	O
that	O
is	O
required	O
for	O
this	O
process	O
(	O
Yokouchi	O
et	O
al	O
.	O
1996	O
;	O
Zou	O
and	O
Niswander	O
1996	O
;	O
Zou	O
et	O
al	O
.	O
1997	O
;	O
Guha	O
et	O
al	O
.	O
2002	O
)	O
.	O

Our	O
new	O
loss	O
-	O
of	O
-	O
function	O
data	O
confirm	O
that	O
BMP	O
signaling	O
is	O
required	O
for	O
interdigital	O
apoptosis	O
and	O
suggests	O
that	O
Bmpr1a	O
is	O
a	O
critical	O
component	O
for	O
mediating	O
this	O
signal	O
.	O

At	O
some	O
sites	O
,	O
loss	O
of	O
Bmpr1a	O
function	O
leads	O
to	O
a	O
defect	O
in	O
the	O
early	O
stages	O
of	O
joint	O
formation	O
,	O
resulting	O
in	O
a	O
complete	O
failure	O
to	O
form	O
a	O
joint	O
and	O
fusion	O
of	O
bones	O
in	O
the	O
ankle	O
.	O

Mutations	O
in	O
two	O
different	O
ligands	O
in	O
the	O
BMP	O
family	O
,	O
Gdf5	O
and	O
Gdf6	O
,	O
the	O
Bmpr1b	O
receptor	O
,	O
and	O
in	O
the	O
human	O
Noggin	O
locus	O
(	O
Storm	O
and	O
Kingsley	O
1996	O
;	O
Gong	O
et	O
al	O
.	O
1999	O
;	O
Baur	O
et	O
al	O
.	O
2000	O
;	O
Yi	O
et	O
al	O
.	O
2000	O
;	O
Settle	O
et	O
al	O
.	O
2003	O
)	O
also	O
produce	O
defects	O
in	O
joint	O
formation	O
at	O
specific	O
locations	O
in	O
the	O
limbs	O
.	O

The	O
joint	O
defects	O
associated	O
with	O
multiple	O
components	O
of	O
the	O
BMP	O
pathway	O
provide	O
strong	O
evidence	O
that	O
BMP	O
signaling	O
is	O
required	O
for	O
early	O
stages	O
of	O
joint	O
formation	O
at	O
some	O
anatomical	O
locations	O
.	O

Most	O
joints	O
still	O
form	O
normally	O
when	O
Bmpr1a	O
is	O
knocked	O
out	O
in	O
Gdf5	O
expression	O
domains	O
.	O

The	O
lack	O
of	O
joint	O
fusions	O
outside	O
the	O
ankle	O
region	O
could	O
be	O
due	O
to	O
differences	O
in	O
requirement	O
for	O
BMP	O
signaling	O
in	O
different	O
joints	O
,	O
to	O
compensating	O
expression	O
of	O
other	O
BMP	O
receptors	O
outside	O
the	O
ankles	O
,	O
or	O
to	O
differences	O
in	O
the	O
detailed	O
timing	O
of	O
Gdf5	O
-	O
Cre	O
stimulated	O
gene	O
inactivation	O
in	O
ankles	O
and	O
other	O
joint	O
regions	O
.	O

Comparison	O
of	O
the	O
expression	O
of	O
the	O
HPLAP	O
marker	O
(	O
driven	O
directly	O
by	O
Gdf5	O
control	O
elements	O
)	O
and	O
the	O
R26R	O
LACZ	O
marker	O
(	O
expressed	O
following	O
Gdf5	O
-	O
Cre	O
recombination	O
)	O
suggests	O
that	O
recombination	O
-	O
stimulated	O
changes	O
in	O
gene	O
expression	O
may	O
be	O
delayed	O
for	O
a	O
0	O
.	O
5	O
-	O
1	O
d	O
in	O
the	O
digit	O
region	O
(	O
see	O
Figure	O
1C	O
)	O
.	O

In	O
addition	O
,	O
levels	O
of	O
Bmpr1a	O
mRNA	O
and	O
protein	O
may	O
persist	O
for	O
some	O
time	O
following	O
Gdf5	O
-	O
Cre	O
stimulated	O
recombination	O
,	O
making	O
it	O
possible	O
to	O
bypass	O
an	O
early	O
requirement	O
for	O
Bmpr1a	O
in	O
joint	O
formation	O
at	O
some	O
locations	O
.	O

Following	O
the	O
decay	O
of	O
Bmpr1a	O
mRNA	O
and	O
protein	O
,	O
the	O
Gdf5	O
-	O
Cre	O
strategy	O
should	O
result	O
in	O
permanent	O
inactivation	O
of	O
Bmpr1a	O
function	O
in	O
recombined	O
cells	O
.	O

This	O
system	O
thus	O
provides	O
one	O
of	O
the	O
first	O
strong	O
genetic	O
tests	O
of	O
Bmpr1a	O
function	O
at	O
later	O
stages	O
of	O
joint	O
development	O
.	O

Despite	O
the	O
normal	O
appearance	O
of	O
articular	O
regions	O
and	O
gene	O
expression	O
immediately	O
after	O
birth	O
,	O
Bmpr1a	O
-	O
deficient	O
animals	O
are	O
unable	O
to	O
maintain	O
the	O
normal	O
differentiated	O
state	O
of	O
articular	O
cartilage	O
as	O
they	O
continue	O
to	O
develop	O
and	O
age	O
.	O

These	O
results	O
suggest	O
that	O
BMP	O
receptor	O
signaling	O
is	O
essential	O
for	O
continued	O
health	O
and	O
integrity	O
of	O
articular	O
cartilage	O
in	O
the	O
postnatal	O
period	O
.	O

Articular	O
cartilage	O
is	O
a	O
key	O
component	O
of	O
synovial	O
joints	O
and	O
is	O
one	O
of	O
the	O
few	O
regions	O
in	O
the	O
skeleton	O
where	O
cartilage	O
is	O
maintained	O
into	O
adulthood	O
.	O

Despite	O
the	O
importance	O
of	O
articular	O
cartilage	O
in	O
joint	O
health	O
and	O
mobility	O
,	O
little	O
is	O
known	O
about	O
the	O
factors	O
that	O
create	O
and	O
maintain	O
it	O
in	O
thin	O
layers	O
at	O
the	O
ends	O
of	O
long	O
bones	O
.	O

In	O
our	O
experiments	O
,	O
articular	O
cartilage	O
lacking	O
Bmpr1a	O
retains	O
some	O
normal	O
characteristics	O
,	O
in	O
that	O
it	O
maintains	O
a	O
very	O
low	O
proliferation	O
rate	O
,	O
does	O
not	O
express	O
Col1a1	O
,	O
and	O
continues	O
to	O
express	O
SOX9	O
,	O
a	O
major	O
transcription	O
factor	O
regulating	O
expression	O
of	O
structural	O
components	B-GO
of	I-GO
cartilage	I-GO
matrix	E-GO
.	O

However	O
,	O
several	O
of	O
the	O
most	O
prominent	O
structural	O
components	B-GO
of	I-GO
cartilage	I-GO
matrix	E-GO
fail	O
to	O
be	O
maintained	O
in	O
mutant	O
animals	O
,	O
resulting	O
in	O
decreased	O
synthesis	O
of	O
Col2a1	O
,	O
Agg	O
,	O
and	O
proteoglycans	O
.	O

Therefore	O
,	O
BMPR1A	O
appears	O
to	O
maintain	O
articular	O
cartilage	O
primarily	O
through	O
inducing	O
expression	O
of	O
key	O
ECM	B-GO
components	E-GO
.	O

It	O
is	O
interesting	O
that	O
the	O
SOX9	O
transcription	O
factor	O
continues	O
to	O
be	O
expressed	O
in	O
mutant	O
cartilage	O
despite	O
loss	O
of	O
Col2a1	O
,	O
a	O
direct	O
target	O
of	O
this	O
transcription	O
factor	O
(	O
Bell	O
et	O
al	O
.	O
1997	O
;	O
Lefebvre	O
et	O
al	O
.	O
1997	O
)	O
.	O

Previous	O
studies	O
suggest	O
that	O
SOX9	O
activity	O
can	O
be	O
modified	O
by	O
protein	O
kinase	O
A	O
(	O
PKA	O
)	O
-	O
dependent	O
protein	O
phosphorylation	O
,	O
or	O
by	O
coexpression	O
of	O
two	O
related	O
proteins	O
,	O
L	O
-	O
SOX5	O
and	O
SOX6	O
(	O
Lefebvre	O
et	O
al	O
.	O
1998	O
;	O
Huang	O
et	O
al	O
.	O
2000	O
)	O
.	O

In	O
addition	O
,	O
close	O
examination	O
of	O
the	O
order	O
of	O
genes	O
induced	O
during	O
chicken	O
digit	O
formation	O
reveals	O
that	O
Sox9	O
turns	O
on	O
first	O
,	O
followed	O
by	O
Bmpr1b	O
with	O
L	O
-	O
Sox5	O
,	O
and	O
then	O
Sox6	O
and	O
the	O
cartilage	O
matrix	B-GO
structural	I-GO
components	E-GO
Col2a1	O
and	O
Agg	O
(	O
Chimal	O
-	O
Monroy	O
et	O
al	O
.	O
2003	O
)	O
.	O

These	O
results	O
,	O
together	O
with	O
the	O
altered	O
pattern	O
of	O
gene	O
expression	O
seen	O
in	O
our	O
Bmpr1a	O
-	O
deficient	O
mice	O
,	O
suggest	O
that	O
BMPR1A	O
signaling	O
may	O
normally	O
act	O
to	O
stimulate	O
SOX9	O
by	O
post	O
-	O
translational	O
protein	O
modification	O
,	O
or	O
to	O
induce	O
L	O
-	O
Sox5	O
or	O
Sox6	O
in	O
cartilage	O
to	O
maintain	O
expression	O
of	O
ECM	B-GO
components	E-GO
.	O

These	O
models	O
are	O
consistent	O
with	O
the	O
ability	O
of	O
BMP2	O
to	O
both	O
increase	O
PKA	O
activity	O
and	O
induce	O
expression	O
of	O
Sox6	O
in	O
tissue	O
culture	O
cells	O
(	O
Lee	O
and	O
Chuong	O
1997	O
;	O
Fernandez	O
-	O
Lloris	O
et	O
al	O
.	O
2003	O
)	O
.	O

Although	O
we	O
have	O
tried	O
to	O
monitor	O
the	O
expression	O
of	O
L	O
-	O
Sox5	O
or	O
Sox6	O
in	O
postnatal	O
articular	O
cartilage	O
,	O
and	O
test	O
the	O
phosphorylation	O
state	O
of	O
SOX9	O
using	O
previously	O
described	O
reagents	O
(	O
Lefebvre	O
et	O
al	O
.	O
1998	O
;	O
Huang	O
et	O
al	O
.	O
2000	O
)	O
,	O
we	O
have	O
been	O
unable	O
to	O
obtain	O
specific	O
signal	O
at	O
the	O
late	O
postnatal	O
stages	O
required	O
(	O
unpublished	O
data	O
)	O
.	O

Furthermore	O
,	O
null	O
mutations	O
in	O
L	O
-	O
Sox5	O
or	O
Sox	O
-	O
6	O
cause	O
lethality	O
at	O
or	O
soon	O
after	O
birth	O
,	O
and	O
no	O
effect	O
on	O
cartilage	O
maintenance	O
has	O
been	O
reported	O
(	O
Smits	O
et	O
al	O
.	O
2001	O
)	O
.	O

However	O
,	O
it	O
seems	O
likely	O
that	O
these	O
or	O
other	O
processes	O
regulated	O
by	O
BMP	O
signaling	O
cooperate	O
with	O
SOX9	O
to	O
induce	O
target	O
genes	O
in	O
articular	O
cartilage	O
.	O

Mutation	O
of	O
Smad3	O
or	O
expression	O
of	O
dominant	O
negative	O
transforming	O
growth	O
factor	O
beta	O
(	O
TGF	O
-	O
beta	O
)	O
type	O
II	O
receptor	O
also	O
disrupts	O
normal	O
articular	O
cartilage	O
maintenance	O
(	O
Serra	O
et	O
al	O
.	O
1997	O
;	O
Yang	O
et	O
al	O
.	O
2001	O
)	O
.	O

Both	O
manipulations	O
should	O
disrupt	O
TGF	O
beta	O
rather	O
than	O
BMP	O
signaling	O
,	O
and	O
both	O
manipulations	O
cause	O
articular	O
cartilage	O
to	O
hypertrophy	O
and	O
be	O
replaced	O
by	O
bone	O
.	O

In	O
contrast	O
,	O
our	O
analysis	O
of	O
Bmpr1a	O
mutant	O
articular	O
cartilage	O
showed	O
a	O
loss	O
of	O
ECM	B-GO
components	E-GO
,	O
but	O
no	O
signs	O
of	O
hypertrophy	O
or	O
bone	O
replacement	O
.	O

Therefore	O
,	O
TGF	O
beta	O
and	O
BMP	O
signaling	O
are	O
playing	O
distinct	O
but	O
necessary	O
roles	O
to	O
maintain	O
articular	O
cartilage	O
.	O

Although	O
BMPs	O
were	O
originally	O
isolated	O
on	O
the	O
basis	O
of	O
their	O
ability	O
to	O
induce	O
ectopic	O
bone	O
formation	O
,	O
their	O
presence	O
in	O
articular	O
cartilage	O
and	O
strong	O
effect	O
on	O
cartilage	O
formation	O
has	O
stimulated	O
interest	O
in	O
using	O
them	O
to	O
repair	O
or	O
regenerate	O
cartilage	O
defects	O
in	O
adult	O
animals	O
(	O
Chang	O
et	O
al	O
.	O
1994	O
;	O
Erlacher	O
et	O
al	O
.	O
1998	O
;	O
Edwards	O
and	O
Francis	O
-	O
West	O
2001	O
;	O
Chubinskaya	O
and	O
Kuettner	O
2003	O
)	O
.	O

The	O
failure	O
to	O
maintain	O
articular	O
cartilage	O
in	O
the	O
absence	O
of	O
normal	O
BMPR1A	O
function	O
suggests	O
that	O
ligands	O
or	O
small	O
molecule	O
agonists	O
that	O
interact	O
specifically	O
with	O
this	O
receptor	O
subtype	O
may	O
be	O
particularly	O
good	O
candidates	O
for	O
designing	O
new	O
approaches	O
to	O
maintain	O
or	O
heal	O
articular	O
cartilage	O
at	O
postnatal	O
stages	O
.	O

Lack	O
of	O
Bmpr1a	O
function	O
in	O
articular	O
cartilage	O
results	O
in	O
severe	O
fibrillation	O
of	O
the	O
articular	O
surface	O
and	O
loss	O
of	O
joint	O
mobility	O
.	O

The	O
development	O
of	O
severe	O
arthritis	O
symptoms	O
in	O
Bmpr1a	O
-	O
deficient	O
mice	O
raises	O
the	O
possibility	O
that	O
defects	O
in	O
BMP	O
signaling	O
also	O
contribute	O
to	O
human	O
joint	O
disease	O
.	O

Osteoarthritis	O
is	O
known	O
to	O
have	O
a	O
significant	O
genetic	O
component	O
,	O
but	O
it	O
likely	O
involves	O
multiple	O
genetic	O
factors	O
that	O
have	O
been	O
difficult	O
to	O
identify	O
(	O
Spector	O
et	O
al	O
.	O
1996	O
;	O
Felson	O
et	O
al	O
.	O
1998	O
;	O
Hirsch	O
et	O
al	O
.	O
1998	O
)	O
.	O

Humans	O
that	O
are	O
heterozygous	O
for	O
loss	O
-	O
of	O
-	O
function	O
mutations	O
in	O
BMPR1A	O
are	O
known	O
to	O
be	O
at	O
risk	O
for	O
juvenile	O
polyposis	O
(	O
Howe	O
et	O
al	O
.	O
2001	O
;	O
Zhou	O
et	O
al	O
.	O
2001	O
)	O
,	O
but	O
the	O
risk	O
of	O
osteoarthritis	O
for	O
these	O
people	O
has	O
not	O
been	O
reported	O
.	O

However	O
,	O
the	O
control	O
mice	O
used	O
in	O
this	O
study	O
were	O
heterozygous	O
for	O
a	O
null	O
allele	O
of	O
Bmpr1a	O
,	O
and	O
they	O
showed	O
little	O
sign	O
of	O
osteoarthritis	O
even	O
late	O
in	O
life	O
.	O

Several	O
chromosome	O
regions	O
have	O
been	O
previously	O
linked	O
to	O
arthritis	O
phenotypes	O
in	O
humans	O
using	O
either	O
association	O
studies	O
in	O
populations	O
or	O
linkage	O
studies	O
in	O
families	O
.	O

It	O
is	O
interesting	O
to	O
note	O
that	O
several	O
of	O
these	O
chromosome	O
regions	O
contain	O
genes	O
encoding	O
different	O
members	O
of	O
the	O
BMP	O
signaling	O
pathway	O
,	O
including	O
the	O
BMP5	O
gene	O
on	O
human	O
chromosome	S-GO
6p12	O
(	O
Loughlin	O
et	O
al	O
.	O
2002	O
)	O
,	O
the	O
MADH1	O
gene	O
on	O
human	O
chromosome	S-GO
4q26	O
-	O
4q31	O
(	O
Leppavuori	O
et	O
al	O
.	O
1999	O
;	O
Kent	O
et	O
al	O
.	O
2002	O
)	O
,	O
and	O
the	O
BMPR2	O
receptor	O
on	O
human	O
chromosome	S-GO
2q33	O
(	O
Wright	O
et	O
al	O
.	O
1996	O
)	O
.	O

The	O
complex	O
nature	O
of	O
human	O
osteoarthritis	O
suggests	O
that	O
interactions	O
between	O
multiple	O
genes	O
may	O
be	O
involved	O
in	O
modifying	O
susceptibility	O
to	O
the	O
disease	O
.	O

The	O
inclusion	O
of	O
genetic	O
markers	O
near	O
BMP	O
signaling	O
components	O
may	O
help	O
identify	O
additional	O
osteoarthritis	O
susceptibility	O
loci	O
and	O
facilitate	O
the	O
search	O
for	O
causative	O
mutations	O
.	O

Development	O
and	O
disease	O
processes	O
in	O
synovial	O
joints	O
have	O
been	O
difficult	O
to	O
study	O
genetically	O
,	O
because	O
synovial	O
joints	O
are	O
generated	O
and	O
function	O
at	O
relatively	O
late	O
stages	O
of	O
vertebrate	O
development	O
.	O

The	O
Gdf5	O
-	O
Cre	O
system	O
provides	O
a	O
new	O
method	O
for	O
restricting	O
gene	O
expression	O
or	O
inactivation	O
primarily	O
to	O
articular	O
regions	O
,	O
thus	O
avoiding	O
the	O
pleiotropic	O
functions	O
of	O
many	O
genes	O
in	O
other	O
tissues	O
.	O

Depending	O
on	O
the	O
configuration	O
of	O
the	O
floxed	O
target	O
gene	O
,	O
this	O
system	O
can	O
be	O
used	O
to	O
either	O
activate	O
the	O
expression	O
of	O
a	O
gene	O
primarily	O
in	O
developing	O
joints	O
(	O
ssee	O
Figure	O
1B	O
-	O
1D	O
)	O
,	O
or	O
to	O
inactivate	O
gene	O
function	O
in	O
articular	O
regions	O
(	O
see	O
Figure	O
3	O
)	O
.	O

Additional	O
studies	O
with	O
this	O
system	O
should	O
greatly	O
enhance	O
our	O
knowledge	O
of	O
the	O
development	O
,	O
function	O
,	O
and	O
disease	O
mechanisms	O
of	O
joints	O
,	O
and	O
may	O
bring	O
us	O
closer	O
to	O
better	O
prevention	O
and	O
treatment	O
of	O
joint	O
diseases	O
.	O

Materials	O
and	O
Methods	O

Generation	O
of	O
Gdf5	O
-	O
Cre	O
transgenic	O
mice	O

A	O
mouse	O
129x1	O
/	O
SvJ	O
BAC	O
library	O
(	O
Invitrogen	O
)	O
was	O
screened	O
to	O
identify	O
a	O
140	O
-	O
kb	O
BAC	O
from	O
the	O
Gdf5	O
locus	O
.	O

This	O
BAC	O
was	O
modified	O
using	O
a	O
homologous	O
recombination	O
system	O
in	O
E	O
.	O
coli	O
(	O
Yang	O
et	O
al	O
.	O
1997	O
)	O
to	O
place	O
nuclear	S-GO
-	O
localized	O
Cre	O
recombinase	O
(	O
from	O
plasmid	O
pML78	O
,	O
gift	O
of	O
Gail	O
Martin	O
)	O
followed	O
by	O
IRES	O
-	O
hPLAP	O
(	O
from	O
plasmid	O
1726	O
,	O
gift	O
of	O
Oliver	O
Bogler	O
)	O
directly	O
behind	O
the	O
ATG	O
start	O
site	O
of	O
Gdf5	O
.	O

In	O
the	O
process	O
,	O
583	O
bp	O
of	O
the	O
first	O
exon	O
of	O
Gdf5	O
was	O
removed	O
and	O
no	O
functional	O
GDF5	O
protein	O
is	O
predicted	O
to	O
be	O
produced	O
.	O

The	O
5	O
'	O
homology	O
arm	O
was	O
subcloned	O
from	O
a	O
PCR	O
product	O
tailed	O
with	O
XhoI	O
and	O
Bsp120I	O
restriction	O
sites	O
that	O
contains	O
781	O
bp	O
of	O
5	O
'	O
genomic	O
Gdf5	O
sequence	O
ending	O
at	O
the	O
ATG	O
translation	O
start	O
site	O
(	O
forward	O
primer	O
5	O
'	O
-	O
CTGTCTCGAGATGAGGTGGAGGTGAAGACCCC	O
-	O
3	O
'	O
;	O
reverse	O
5	O
'	O
-	O
GTTTGGGCCCATCCTCTGGCCAGCCGCTG	O
-	O
3	O
'	O
)	O
.	O

Cre	O
was	O
subcloned	O
from	O
a	O
1	O
.	O
1	O
-	O
kb	O
Bsp120I	O
/	O
EcoRI	O
fragment	O
of	O
pML78	O
.	O

IRES	O
hPLAP	O
was	O
subcloned	O
from	O
a	O
2	O
.	O
1	O
-	O
kb	O
PCR	O
product	O
tailed	O
with	O
EcoRI	O
and	O
SpeI	O
sites	O
that	O
contains	O
the	O
hPLAP	O
translation	O
stop	O
site	O
(	O
forward	O
primer	O
5	O
'	O
-	O
ATCTCTCGAGGAATTCTCCACCATATTGCCGTCTTTTG	O
-	O
3	O
'	O
;	O
reverse	O
5	O
'	O
-	O
AGAACTCGAGACTAGTCGGGACACTCAGGGAGTAGTGG	O
-	O
3	O
'	O
)	O
.	O

The	O
3	O
'	O
homology	O
arm	O
was	O
subcloned	O
from	O
a	O
0	O
.	O
8	O
-	O
kb	O
PCR	O
product	O
amplified	O
from	O
a	O
0	O
.	O
9	O
-	O
kb	O
XhoI	O
Gdf5	O
genomic	O
subclone	O
containing	O
part	O
of	O
the	O
first	O
exon	O
and	O
downstream	O
intron	O
.	O

The	O
forward	O
primer	O
contains	O
the	O
3	O
'	O
end	O
of	O
the	O
first	O
exon	O
and	O
is	O
tailed	O
with	O
a	O
SpeI	O
site	O
;	O
the	O
reverse	O
primer	O
is	O
from	O
the	O
T7	O
promoter	O
of	O
the	O
vector	O
containing	O
the	O
0	O
.	O
9	O
-	O
kb	O
subclone	O
and	O
flanks	O
the	O
intronic	O
XhoI	O
site	O
(	O
forward	O
primer	O
5	O
'	O
-	O
CTAAACTAGTCACCAGCTTTATTGACAAAGG	O
-	O
3	O
'	O
;	O
reverse	O
5	O
'	O
-	O
GATTTCTAGAGTAATACGACTCACTATAGGGC	O
-	O
3	O
'	O
)	O
.	O

The	O
targeting	O
construct	O
was	O
built	O
and	O
verified	O
in	O
pBSSK	O
(	O
Stratagene	O
,	O
La	O
Jolla	O
,	O
California	O
,	O
United	O
States	O
)	O
,	O
then	O
digested	O
with	O
XhoI	O
and	O
subcloned	O
into	O
pSV1	O
,	O
the	O
vector	O
used	O
for	O
homologous	O
recombination	O
(	O
Yang	O
et	O
al	O
.	O
1997	O
)	O
.	O

Southern	O
blotting	O
,	O
PCR	O
,	O
and	O
DNA	O
sequence	O
analysis	O
confirmed	O
the	O
appropriate	O
targeting	O
construct	O
and	O
BAC	O
modifications	O
were	O
made	O
(	O
unpublished	O
data	O
)	O
.	O

Before	O
the	O
modified	O
BAC	O
was	O
injected	O
to	O
produce	O
transgenic	O
animals	O
,	O
a	O
loxP	O
site	O
present	O
in	O
the	O
BAC	O
vector	O
,	O
pBeloBAC11	O
,	O
was	O
removed	O
to	O
prevent	O
the	O
addition	O
of	O
undesired	O
Cre	O
target	O
sites	O
into	O
the	O
genome	O
.	O

To	O
do	O
this	O
,	O
BAC	O
DNA	O
was	O
prepared	O
by	O
CsCl	O
separation	O
,	O
digested	O
with	O
NotI	O
to	O
free	O
the	O
insert	O
from	O
the	O
vector	O
,	O
and	O
size	O
-	O
fractionated	O
over	O
a	O
sucrose	O
gradient	O
.	O

Aliquots	O
of	O
fractions	O
were	O
run	O
on	O
a	O
pulse	O
-	O
field	O
gel	O
and	O
Southern	O
blotted	O
using	O
vector	O
-	O
specific	O
DNA	O
as	O
a	O
probe	O
.	O

Fractions	O
containing	O
unsheared	O
insert	O
and	O
almost	O
no	O
detectable	O
vector	O
DNA	O
were	O
dialyzed	O
in	O
microinjection	O
buffer	O
(	O
10	O
mM	O
Tris	O
[	O
pH	O
7	O
.	O
4	O
]	O
with	O
0	O
.	O
15	O
mM	O
EDTA	O
[	O
pH	O
8	O
.	O
0	O
]	O
)	O
using	O
Centriprep	O
-	O
30	O
concentrators	O
(	O
Millipore	O
,	O
Billerica	O
,	O
Massachusetts	O
,	O
United	O
States	O
)	O
.	O

This	O
purified	O
insert	O
DNA	O
was	O
adjusted	O
to	O
1	O
ng	O
/	O
mu	O
l	O
and	O
injected	O
into	O
the	O
pronucleus	S-GO
of	O
fertilized	O
eggs	O
from	O
FVB	O
/	O
N	O
mice	O
by	O
the	O
Stanford	O
Transgenic	O
Facility	O
.	O

Transgenic	O
founder	O
mice	O
were	O
identified	O
by	O
PCR	O
using	O
Cre	O
-	O
specific	O
primers	O
5	O
'	O
-	O
GCCTGCATTACCGGTCGATGCAACGA	O
-	O
3	O
'	O
and	O
5	O
'	O
-	O
GTGGCAGATGGCGCGGCAACACCATT	O
-	O
3	O
'	O
,	O
which	O
amplify	O
a	O
725	O
-	O
bp	O
product	O
,	O
and	O
were	O
assessed	O
for	O
absence	O
of	O
BAC	O
vector	O
using	O
vector	O
-	O
specific	O
primers	O
5	O
'	O
-	O
CGGAGTCTGATGCGGTTGCGATG	O
-	O
3	O
'	O
and	O
5	O
'	O
-	O
AGTGCTGTTCCCTGGTGCTTCCTC	O
-	O
3	O
'	O
,	O
which	O
amplify	O
a	O
465	O
-	O
bp	O
product	O
.	O

Three	O
lines	O
of	O
Gdf5	O
-	O
Cre	O
mice	O
were	O
established	O
and	O
maintained	O
on	O
the	O
FVB	O
background	O
.	O

Matings	O
with	O
R26R	O
Cre	O
-	O
inducible	O
LACZ	O
reporter	O
mice	O
(	O
Soriano	O
1999	O
)	O
were	O
used	O
to	O
test	O
for	O
Cre	O
activity	O
.	O

Staining	O
for	O
LACZ	O
and	O
HPLAP	O
on	O
whole	O
embryos	O
or	O
sections	O
of	O
embryos	O
was	O
accomplished	O
following	O
established	O
protocols	O
(	O
Lobe	O
et	O
al	O
.	O
1999	O
)	O
.	O

The	O
red	O
LACZ	O
substrate	O
(	O
see	O
Figure	O
1E	O
)	O
is	O
6	O
-	O
chloro	O
-	O
3	O
-	O
indoxyl	O
-	O
beta	O
-	O
D	O
-	O
galactopyranoside	O
(	O
Biosynth	O
International	O
,	O
Naperville	O
,	O
Illinois	O
,	O
United	O
States	O
)	O
.	O

General	O
characterization	O
of	O
Bmpr1a	O
mutant	O
mice	O

Bmpr1a	O
null	O
and	O
floxed	O
alleles	O
(	O
Ahn	O
et	O
al	O
.	O
2001	O
;	O
Mishina	O
et	O
al	O
.	O
2002	O
)	O
were	O
obtained	O
on	O
a	O
mixed	O
129	O
and	O
C57BL	O
/	O
6	O
background	O
and	O
maintained	O
by	O
random	O
breeding	O
.	O

Mice	O
carrying	O
the	O
null	O
and	O
floxed	O
alleles	O
were	O
typically	O
mated	O
to	O
Gdf5	O
-	O
Cre	O
mice	O
as	O
shown	O
in	O
Figure	O
3	O
.	O

The	O
resulting	O
mice	O
are	O
on	O
a	O
mixed	O
129	O
;	O
C57Bl	O
/	O
6	O
;	O
FVB	O
/	O
N	O
background	O
,	O
with	O
both	O
controls	O
and	O
mutant	O
animals	O
generated	O
as	O
littermates	O
from	O
the	O
same	O
matings	O
.	O

Whole	O
-	O
mount	O
skeletal	O
preparations	O
were	O
made	O
from	O
34	O
-	O
to	O
36	O
-	O
d	O
-	O
old	O
mice	O
(	O
Lufkin	O
et	O
al	O
.	O
1992	O
)	O
.	O

Pairs	O
of	O
ears	O
from	O
euthanized	O
6	O
-	O
mo	O
-	O
old	O
animals	O
were	O
removed	O
,	O
pinned	O
,	O
photographed	O
,	O
projected	O
,	O
and	O
measured	O
from	O
the	O
base	O
of	O
the	O
curve	O
formed	O
between	O
the	O
tragus	O
and	O
antitragus	O
to	O
the	O
farthest	O
point	O
at	O
the	O
edge	O
of	O
the	O
pinnae	O
.	O

Grasping	O
ability	O
in	O
6	O
-	O
mo	O
-	O
old	O
mice	O
was	O
measured	O
by	O
placing	O
animals	O
on	O
a	O
slender	O
rod	O
and	O
timing	O
how	O
long	O
they	O
could	O
remain	O
suspended	O
on	O
the	O
rod	O
,	O
to	O
a	O
maximum	O
time	O
allowed	O
of	O
2	O
min	O
.	O

Data	O
from	O
five	O
consecutive	O
trials	O
for	O
each	O
mouse	O
were	O
averaged	O
.	O

Range	O
of	O
motion	O
assays	O
were	O
conducted	O
on	O
the	O
MT	O
/	O
P1	O
and	O
P1	O
/	O
P2	O
joints	O
of	O
the	O
second	O
hindlimb	O
digit	O
from	O
euthanized	O
18	O
-	O
wk	O
-	O
old	O
animals	O
.	O

Forceps	O
were	O
used	O
to	O
bend	O
the	O
joint	O
to	O
its	O
natural	O
stopping	O
position	O
,	O
and	O
the	O
resulting	O
angle	O
was	O
measured	O
to	O
the	O
nearest	O
10	O
degrees	O
under	O
12	O
.	O
5	O
x	O
magnification	O
using	O
a	O
360	O
degrees	O
reticule	O
.	O

Analysis	O
described	O
in	O
this	O
section	O
occurred	O
on	O
animals	O
lacking	O
R26R	O
.	O

Control	O
mice	O
included	O
all	O
nonmutant	O
genotypes	O
generated	O
by	O
Parent	O
1	O
being	O
heterozygous	O
for	O
Gdf5	O
-	O
Cre	O
and	O
Bmpr1anull	O
and	O
Parent	O
2	O
being	O
heterozygous	O
for	O
Bmpr1afloxP	O
(	O
see	O
Figure	O
3	O
)	O
.	O

All	O
statistical	O
analysis	O
used	O
the	O
Student	O
'	O
s	O
t	O
-	O
test	O
or	O
Welch	O
'	O
s	O
t	O
-	O
test	O
,	O
and	O
values	O
listed	O
are	O
mean	O
+/-	O
standard	O
error	O
of	O
the	O
mean	O
.	O

Cell	O
death	O
and	O
proliferation	O
assays	O

Limbs	O
from	O
mutant	O
and	O
control	O
animals	O
at	O
E13	O
.	O
5	O
and	O
E14	O
.	O
5	O
were	O
dissected	O
and	O
frozen	O
in	O
OCT	O
(	O
Sakura	O
Finetek	O
,	O
Torrence	O
,	O
CA	O
,	O
United	O
States	O
)	O
.	O

Cryosections	O
of	O
tissue	O
were	O
assayed	O
by	O
TUNEL	O
using	O
the	O
In	O
Situ	O
Cell	O
Death	O
Detection	O
Kit	O
,	O
Fluorescein	O
(	O
Roche	O
,	O
Basel	O
,	O
Switzerland	O
)	O
.	O

Following	O
TUNEL	O
,	O
slides	O
were	O
washed	O
in	O
PBS	O
,	O
blocked	O
with	O
PBS	O
+	O
0	O
.	O
05	O
%	O
Tween	O
-	O
20	O
+	O
5	O
%	O
goat	O
serum	O
,	O
washed	O
again	O
,	O
and	O
incubated	O
with	O
a	O
1	O
:	O
200	O
dilution	O
of	O
a	O
rabbit	O
anti	O
-	O
phospho	O
-	O
histone	O
-	O
H3	O
antibody	S-GO
called	O
Mitosis	O
Marker	O
(	O
Upstate	O
Biotechnology	O
,	O
Lake	O
Placid	O
,	O
New	O
York	O
,	O
United	O
States	O
)	O
to	O
identify	O
cells	O
in	O
mitosis	O
.	O

Cy3	O
-	O
labeled	O
anti	O
-	O
rabbit	O
secondary	O
antibody	S-GO
was	O
used	O
to	O
detect	O
the	O
antibody	S-GO
.	O

Cell	O
nuclei	S-GO
were	O
labeled	O
with	O
DAPI	O
,	O
and	O
slides	O
were	O
mounted	O
in	O
Vectamount	O
(	O
Vector	O
Laboratories	O
,	O
Burlingame	O
,	O
California	O
,	O
United	O
States	O
)	O
and	O
visualized	O
at	O
100	O
x	O
magnification	O
.	O

The	O
area	O
of	O
selected	O
anatomical	O
sites	O
were	O
measured	O
,	O
and	O
the	O
number	O
of	O
TUNEL	O
-	O
labeled	O
nuclear	B-GO
fragments	E-GO
and	O
the	O
number	O
of	O
Cy3	O
-	O
labeled	O
nuclei	S-GO
were	O
counted	O
from	O
three	O
10	O
-	O
mu	O
m	O
sections	O
spanning	O
50	O
mu	O
m	O
,	O
from	O
three	O
control	O
and	O
three	O
mutant	O
animals	O
.	O

The	O
number	O
of	O
labeled	O
cells	O
in	O
the	O
metacarpal	O
-	O
phalangeal	O
and	O
metatarsal	O
-	O
phalangeal	O
joints	O
was	O
counted	O
in	O
a	O
290	O
mu	O
m	O
x	O
365	O
mu	O
m	O
rectangle	O
placed	O
around	O
the	O
center	O
of	O
the	O
joint	O
.	O

The	O
posterior	O
region	O
of	O
the	O
fifth	O
digit	O
was	O
defined	O
by	O
drawing	O
a	O
line	O
from	O
the	O
tip	O
of	O
the	O
digit	O
down	O
2	O
.	O
15	O
mm	O
and	O
across	O
to	O
the	O
lateral	O
edge	O
of	O
the	O
tissue	O
.	O

For	O
this	O
analysis	O
,	O
the	O
R26R	O
Cre	O
reporter	O
was	O
not	O
present	O
.	O

Histology	O
and	O
histochemistry	O

Tissue	O
from	O
animals	O
ranging	O
from	O
stages	O
E14	O
.	O
5	O
to	O
P14	O
was	O
prepared	O
for	O
analysis	O
by	O
fixing	O
in	O
4	O
%	O
paraformaldehyde	O
(	O
PFA	O
)	O
in	O
PBS	O
for	O
45	O
min	O
to	O
4	O
h	O
depending	O
on	O
the	O
stage	O
;	O
washing	O
three	O
times	O
in	O
PBS	O
,	O
once	O
in	O
PBS	O
+	O
15	O
%	O
sucrose	O
for	O
1	O
h	O
,	O
and	O
once	O
in	O
PBS	O
+	O
30	O
%	O
sucrose	O
for	O
2	O
h	O
to	O
overnight	O
depending	O
on	O
the	O
stage	O
;	O
and	O
then	O
freezing	O
in	O
OCT	O
.	O

Tissue	O
from	O
animals	O
aged	O
7	O
wk	O
to	O
9	O
mo	O
was	O
processed	O
similarly	O
to	O
earlier	O
stages	O
except	O
that	O
it	O
was	O
decalcified	O
in	O
0	O
.	O
5	O
M	O
EDTA	O
(	O
pH	O
7	O
.	O
4	O
)	O
for	O
4	O
d	O
prior	O
to	O
incubating	O
in	O
sucrose	O
.	O

All	O
solutions	O
were	O
prechilled	O
and	O
used	O
at	O
4	O
degrees	O
C	O
with	O
agitation	O
,	O
and	O
skin	O
from	O
tissues	O
of	O
P0	O
or	O
older	O
mice	O
was	O
lacerated	O
or	O
removed	O
prior	O
to	O
processing	O
.	O

Tissue	O
was	O
then	O
cryosectioned	O
at	O
12	O
mu	O
m	O
and	O
processed	O
.	O

Staining	O
of	O
sections	O
with	O
Safranin	O
O	O
,	O
Fast	O
Green	O
,	O
and	O
Harris	O
'	O
hematoxylin	O
was	O
carried	O
out	O
using	O
standard	O
histological	O
procedures	O
.	O

Detection	O
of	O
LACZ	O
activity	O
with	O
X	O
-	O
Gal	O
was	O
performed	O
as	O
described	O
(	O
Lobe	O
et	O
al	O
.	O
1999	O
)	O
and	O
was	O
followed	O
by	O
refixing	O
in	O
4	O
%	O
PFA	O
,	O
rinsing	O
with	O
deionized	O
water	O
,	O
counterstaining	O
with	O
Nuclear	S-GO
Fast	O
Red	O
(	O
Vector	O
Labs	O
)	O
,	O
rinsing	O
with	O
water	O
again	O
,	O
and	O
then	O
mounting	O
in	O
Aquamount	O
(	O
Lerner	O
Labs	O
,	O
Pittsburgh	O
,	O
Pennsylvania	O
,	O
United	O
States	O
)	O
.	O

RNA	O
in	O
situ	O
hybridization	O
was	O
performed	O
as	O
described	O
(	O
Storm	O
and	O
Kingsley	O
1996	O
)	O
,	O
with	O
the	O
following	O
modifications	O
:	O
(	O
1	O
)	O
Prior	O
to	O
the	O
acetylation	O
step	O
,	O
sections	O
were	O
incubated	O
with	O
10	O
-	O
20	O
mu	O
g	O
/	O
ml	O
proteinase	O
K	O
for	O
30	O
s	O
to	O
7	O
min	O
at	O
room	O
temperature	O
(	O
depending	O
on	O
the	O
developmental	O
stage	O
)	O
,	O
followed	O
by	O
refixing	O
in	O
4	O
%	O
PFA	O
and	O
washing	O
three	O
times	O
in	O
PBS	O
;	O
(	O
2	O
)	O
prehybridization	O
step	O
was	O
skipped	O
,	O
and	O
(	O
3	O
)	O
embryonic	O
tissue	O
sections	O
used	O
a	O
different	O
color	O
development	O
mix	O
(	O
Thut	O
et	O
al	O
.	O
2001	O
)	O
.	O

Probes	O
for	O
the	O
following	O
genes	O
have	O
been	O
published	O
previously	O
:	O
Bmpr1a	O
(	O
Mishina	O
et	O
al	O
.	O
1995	O
)	O
,	O
Col2a1	O
(	O
Metsaranta	O
et	O
al	O
.	O
1991	O
)	O
,	O
Col10a1	O
(	O
Apte	O
et	O
al	O
.	O
1992	O
)	O
,	O
Gdf5	O
(	O
Storm	O
and	O
Kingsley	O
1996	O
)	O
,	O
Osteocalcin	O
(	O
Celeste	O
et	O
al	O
.	O
1986	O
)	O
,	O
and	O
Sox5	O
and	O
Sox6	O
(	O
Lefebvre	O
et	O
al	O
.	O
1998	O
)	O
.	O

The	O
following	O
probe	O
templates	O
were	O
gifts	O
:	O
Agg	O
,	O
Dr	O
.	O
Vicki	O
Rosen	O
,	O
Genetics	O
Institute	O
;	O
Bmp2	O
and	O
Bmp4	O
,	O
Arend	O
Sidow	O
,	O
Stanford	O
University	O
;	O
Col1a1	O
,	O
Bjorn	O
Olsen	O
,	O
Harvard	O
Medical	O
School	O
;	O
Bmpr1b	O
,	O
Col3a1	O
,	O
and	O
Mat4	O
probes	O
were	O
made	O
from	O
ESTs	O
with	O
IMAGE	O
clone	O
numbers	O
5056341	O
,	O
478480	O
,	O
and	O
406027	O
,	O
respectively	O
(	O
Invitrogen	O
,	O
Carlsbad	O
,	O
California	O
,	O
United	O
States	O
)	O
.	O

Sections	O
for	O
immunohistochemistry	O
were	O
fixed	O
in	O
4	O
%	O
PFA	O
,	O
then	O
digested	O
with	O
942	O
-	O
2	O
,	O
000	O
U	O
/	O
ml	O
type	O
IV	O
-	O
S	O
bovine	O
hyaluronindase	O
(	O
Sigma	O
,	O
St	O
.	O
Louis	O
,	O
Missouri	O
,	O
United	O
States	O
)	O
in	O
PBS	O
(	O
pH	O
5	O
)	O
at	O
37	O
degrees	O
C	O
for	O
30	O
min	O
to	O
2	O
h	O
depending	O
on	O
the	O
stage	O
.	O

Slides	O
were	O
then	O
washed	O
in	O
PBS	O
,	O
treated	O
with	O
0	O
.	O
3	O
%	O
hydrogen	O
peroxide	O
in	O
100	O
%	O
methanol	O
for	O
30	O
min	O
,	O
washed	O
,	O
blocked	O
with	O
PBS	O
+	O
0	O
.	O
05	O
%	O
Tween20	O
+	O
5	O
%	O
goat	O
or	O
fetal	O
bovine	O
serum	O
,	O
washed	O
again	O
,	O
and	O
incubated	O
with	O
primary	O
antibodies	S-GO
in	O
PBS	O
+	O
0	O
.	O
05	O
%	O
Tween	O
20	O
+	O
1	O
%	O
goat	O
or	O
fetal	O
bovine	O
serum	O
overnight	O
at	O
4	O
degrees	O
C	O
.	O

Biotin	O
-	O
labeled	O
secondary	O
antibodies	S-GO
(	O
Vector	O
Labs	O
)	O
were	O
tagged	O
with	O
HRP	O
using	O
the	O
Vectastain	O
Elite	O
ABC	O
kit	O
(	O
Vector	O
Labs	O
)	O
followed	O
by	O
detection	O
with	O
DAB	O
(	O
Vector	O
Labs	O
)	O
.	O

Primary	O
antibodies	S-GO
and	O
dilutions	O
used	O
were	O
:	O
goat	O
anti	O
-	O
mouse	O
MMP13	O
,	O
1	O
:	O
100	O
(	O
Chemicon	O
International	O
,	O
Temecula	O
,	O
California	O
,	O
United	O
States	O
)	O
;	O
rabbit	O
anti	O
-	O
human	O
SOX9	O
,	O
1	O
:	O
500	O
(	O
Morais	O
da	O
Silva	O
et	O
al	O
.	O
1996	O
)	O
;	O
rabbit	O
anti	O
-	O
phosphorylated	O
-	O
SOX9	O
(	O
SOX9	O
.	O
P	O
)	O
,	O
1	O
:	O
10	O
-	O
1	O
:	O
250	O
(	O
Huang	O
et	O
al	O
.	O
2000	O
)	O
.	O

Supporting	O
Information	O

Accession	O
Numbers	O

GenBank	O
(	O
http	O
:	O
/	O
/	O
www	O
.	O
ncbi	O
.	O
nih	O
.	O
gov	O
/	O
Genbank	O
/	O
)	O
accession	O
numbers	O
for	O
the	O
genes	O
discussed	O
in	O
this	O
paper	O
are	O
Gdf5	O
(	O
AC084323	O
)	O
and	O
Bmpr1a	O
(	O
NM	O
_	O
009758	O
)	O
.	O

Acknowledgements	O

We	O
thank	O
Gail	O
Martin	O
for	O
the	O
Cre	O
construct	O
(	O
plasmid	O
pML78	O
)	O
and	O
Oliver	O
Bogler	O
for	O
the	O
IRES	O
-	O
hPLAP	O
construct	O
(	O
plasmid	O
1726	O
)	O
;	O
Bjorn	O
Olsen	O
and	O
Benoit	O
de	O
Crombrugghe	O
for	O
antibodies	S-GO
;	O
the	O
following	O
individuals	O
for	O
in	O
situ	O
probe	O
templates	O
:	O
Sophie	O
Candille	O
,	O
Arend	O
Sidow	O
(	O
Bmp2	O
and	O
Bmp4	O
)	O
,	O
Vicki	O
Rosen	O
(	O
Agg	O
)	O
,	O
and	O
Bjorn	O
Olsen	O
(	O
Col1a1	O
)	O
;	O
V	O
e	O
ronique	O
Lefebvre	O
for	O
Sox5	O
and	O
Sox6	O
probe	O
templates	O
and	O
useful	O
discussions	O
;	O
Michelle	O
Johnson	O
for	O
help	O
with	O
phenotypic	O
assays	O
on	O
mice	O
;	O
Dr	O
.	O
Corrine	O
Davis	O
for	O
help	O
in	O
evaluating	O
synovial	O
sections	O
;	O
Rebecca	O
Rountree	O
for	O
Adobe	O
Photoshop	O
and	O
Illustrator	O
tips	O
;	O
and	O
members	O
of	O
the	O
Kingsley	O
lab	O
for	O
helpful	O
comments	O
on	O
the	O
manuscript	O
.	O

This	O
work	O
was	O
supported	O
by	O
an	O
NIH	O
predoctoral	O
training	O
grant	O
(	O
RR	O
)	O
,	O
a	O
postdoctoral	O
fellowship	O
from	O
the	O
Arthritis	O
Foundation	O
(	O
MS	O
)	O
,	O
and	O
grants	O
from	O
the	O
National	O
Institutes	O
of	O
Health	O
(	O
DK	O
)	O
.	O

Dr	O
.	O
Kingsley	O
is	O
an	O
associate	O
investigator	O
of	O
the	O
Howard	O
Hughes	O
Medical	O
Institute	O
.	O

Abbreviations	O

BAC	O
-	O
bacterial	O
artificial	O
chromosome	O

Bmpr1a	O
-	O
bone	O
morphogenetic	O
protein	O
receptor	O
1a	O

E	O
[	O
number	O
]	O
-	O
embyonic	O
day	O
[	O
number	O
]	O

ECM	S-GO
-	O
extracellular	B-GO
matrix	E-GO

GAC	O
-	O
transgenic	O
line	O
carrying	O
Gdf5	O
-	O
alkaline	O
phosphatase	O
-	O
Cre	O
construct	O

Gdf5	O
-	O
growth	O
differentiation	O
factor	O
5	O

hPLAP	O
-	O
human	O
placental	O
alkaline	O
phosphatase	O

IRES	O
-	O
internal	O
ribosome	O
entry	O
site	O

PFA	O
-	O
paraformaldehyde	O

R26R	O
-	O
lacZ	O
ROSA26	O
Cre	O
reporter	O
strain	O

TGF	O
-	O
beta	O
-	O
transforming	O
growth	O
factor	O
beta	O

TUNEL	O
-	O
terminal	O
deoxynucleotidyl	O
transferase	O
-	O
mediated	O
deoxyuridine	O
triphosphate	O
nick	O
end	O
labeling	O

Figures	O
and	O
Tables	O

Figure	O
1	O

A	O
Genetic	O
System	O
to	O
Drive	O
Gene	O
Recombination	O
in	O
Developing	O
Joints	O

(	O
A	O
)	O
A	O
140	O
-	O
kb	O
BAC	O
from	O
the	O
Gdf5	O
locus	O
was	O
modified	O
by	O
inserting	O
Cre	O
-	O
IRES	O
-	O
hPLAP	O
into	O
the	O
translation	O
start	O
site	O
of	O
Gdf5	O
and	O
used	O
to	O
make	O
transgenic	O
mice	O
.	O

Not	O
to	O
scale	O
.	O

See	O
Materials	O
and	O
Methods	O
for	O
details	O
.	O

(	O
B	O
-	O
E	O
)	O
Visualization	O
of	O
Gdf5	O
-	O
Cre	O
driven	O
recombination	O
patterns	O
based	O
on	O
activation	O
of	O
lacZ	O
expression	O
from	O
the	O
R26R	O
Cre	O
reporter	O
allele	O
.	O

(	O
B	O
)	O
LACZ	O
activity	O
is	O
visible	O
as	O
blue	O
staining	O
in	O
the	O
ear	O
(	O
ea	O
)	O
and	O
the	O
joints	O
of	O
the	O
shoulder	O
(	O
s	O
)	O
,	O
elbow	O
(	O
eb	O
)	O
,	O
wrist	O
(	O
w	O
)	O
,	O
knee	O
(	O
k	O
)	O
,	O
ankle	O
(	O
a	O
)	O
,	O
vertebra	O
(	O
vj	O
)	O
,	O
and	O
phalanges	O
(	O
black	O
arrowheads	O
)	O
of	O
an	O
E14	O
.	O
5	O
mouse	O
embryo	O
.	O

(	O
C	O
)	O
E14	O
.	O
5	O
hindlimb	O
double	O
-	O
stained	O
to	O
show	O
both	O
HPLAP	O
expression	O
from	O
the	O
transgene	O
(	O
grey	O
/	O
purple	O
staining	O
)	O
and	O
LACZ	O
expression	O
from	O
the	O
rearranged	O
R26R	O
allele	O
(	O
blue	O
staining	O
)	O
.	O

Note	O
that	O
both	O
markers	O
are	O
visible	O
in	O
the	O
oldest	O
,	O
proximal	O
interphalangeal	O
joint	O
(	O
black	O
arrowhead	O
)	O
,	O
only	O
HPLAP	O
activity	O
is	O
visible	O
in	O
the	O
more	O
recently	O
formed	O
medial	O
interphalangeal	O
joint	O
(	O
black	O
arrow	O
)	O
,	O
and	O
neither	O
HPLAP	O
nor	O
LACZ	O
expression	O
is	O
visible	O
in	O
the	O
youngest	O
,	O
most	O
distal	O
joint	O
of	O
the	O
digit	O
(	O
white	O
arrowhead	O
)	O
.	O

(	O
D	O
)	O
Newborn	O
(	O
P0	O
)	O
forelimb	O
with	O
skin	O
partially	O
removed	O
showing	O
LACZ	O
activity	O
expressed	O
in	O
all	O
phalangeal	O
joints	O
(	O
red	O
Salmon	O
gal	O
staining	O
,	O
black	O
arrowheads	O
)	O
and	O
regions	O
of	O
some	O
tendons	O
(	O
asterisk	O
)	O
.	O

(	O
E	O
)	O
Section	O
through	O
the	O
most	O
distal	O
phalangeal	O
joint	O
of	O
a	O
P0	O
hindlimb	O
stained	O
with	O
Alcian	O
blue	O
to	O
mark	O
cartilage	O
showing	O
LACZ	O
expression	O
(	O
stained	O
red	O
)	O
in	O
all	O
tissues	O
of	O
developing	O
joints	O
:	O
articular	O
cartilage	O
(	O
black	O
arrowhead	O
)	O
,	O
precursors	O
of	O
ligaments	O
and	O
synovial	O
membranes	O
(	O
black	O
arrow	O
)	O
,	O
and	O
cells	O
where	O
cavitation	O
is	O
occurring	O
(	O
asterisk	O
)	O
.	O

Figure	O
2	O

Bmpr1a	O
Is	O
Required	O
for	O
Webbing	O
Regression	O
and	O
Apoptosis	O
in	O
Specific	O
Regions	O
of	O
the	O
Limb	O

(	O
A	O
and	O
B	O
)	O
Control	O
E14	O
.	O
5	O
forelimb	O
(	O
A	O
)	O
compared	O
to	O
a	O
,	O
E14	O
.	O
5	O
mutant	O
forelimb	O
(	O
B	O
)	O
showing	O
webbing	O
between	O
digits	O
1	O
and	O
2	O
(	O
arrowheads	O
)	O
and	O
extra	O
tissue	O
at	O
the	O
posterior	O
of	O
digit	O
5	O
(	O
arrows	O
)	O
.	O

(	O
C	O
)	O
Gdf5	O
-	O
Cre	O
induced	O
lacZ	O
expression	O
from	O
R26R	O
in	O
an	O
E13	O
.	O
5	O
forelimb	O
showing	O
LACZ	O
staining	O
(	O
blue	O
)	O
in	O
metacarpal	O
-	O
phalangeal	O
joints	O
,	O
between	O
digits	O
1	O
and	O
2	O
(	O
arrowhead	O
)	O
,	O
and	O
in	O
a	O
region	O
posterior	O
to	O
digit	O
5	O
(	O
arrow	O
)	O
.	O

(	O
D	O
and	O
E	O
)	O
Sections	O
of	O
E14	O
.	O
5	O
hindlimbs	O
showing	O
apoptosis	O
visualized	O
by	O
TUNEL	O
staining	O
(	O
green	O
)	O
and	O
proliferation	O
visualized	O
by	O
staining	O
for	O
histone	O
H3	O
phosphorylation	O
(	O
red	O
)	O
.	O

Controls	O
show	O
strong	O
,	O
uniform	O
TUNEL	O
staining	O
between	O
digits	O
1	O
and	O
2	O
(	O
D	O
,	O
arrowhead	O
)	O
while	O
mutants	O
show	O
patchy	O
TUNEL	O
staining	O
interspersed	O
with	O
mitotic	O
cells	O
in	O
similar	O
regions	O
(	O
E	O
)	O
.	O

Scale	O
bar	O
=	O
200	O
mu	O
m	O
.	O

(	O
F	O
)	O
Quantitation	O
of	O
TUNEL	O
staining	O
and	O
mitotic	O
cells	O
in	O
the	O
posterior	O
region	O
of	O
the	O
fifth	O
digit	O
shows	O
apoptosis	O
is	O
reduced	O
30	O
%	O
while	O
proliferation	O
is	O
increased	O
20	O
%	O
(	O
asterisks	O
indicate	O
statistically	O
significant	O
difference	O
)	O
.	O

(	O
G	O
and	O
H	O
)	O
By	O
E15	O
.	O
5	O
,	O
interdigital	O
tissue	O
has	O
regressed	O
in	O
controls	O
(	O
G	O
,	O
arrowhead	O
)	O
.	O

In	O
contrast	O
,	O
tissue	O
remains	O
in	O
mutants	O
at	O
this	O
location	O
,	O
primarily	O
derived	O
from	O
cells	O
that	O
have	O
undergone	O
Gdf5	O
-	O
Cre	O
-	O
mediated	O
recombination	O
that	O
inactivates	O
Bmpr1a	O
function	O
and	O
activates	O
expression	O
of	O
LACZ	O
(	O
H	O
)	O
.	O

Scale	O
bar	O
=	O
75	O
mu	O
m	O
.	O

Figure	O
3	O

Gdf5	O
-	O
Cre	O
-	O
Mediated	O
Deletion	O
of	O
Bmpr1a	O

(	O
A	O
)	O
Breeding	O
strategy	O
simultaneously	O
deletes	O
Bmpr1afloxP	O
and	O
allows	O
visualization	O
of	O
Gdf5	O
-	O
Cre	O
-	O
mediated	O
recombination	O
by	O
lacZ	O
expression	O
from	O
R26R	O
.	O

(	O
B	O
-	O
E	O
)	O
5	O
-	O
week	O
-	O
old	O
mutant	O
and	O
control	O
mice	O
stained	O
with	O
Alcian	O
blue	O
to	O
mark	O
cartilage	O
and	O
alizarin	O
red	O
to	O
mark	O
bone	O
.	O

(	O
B	O
)	O
Ankle	O
of	O
control	O
with	O
strong	O
blue	O
staining	O
lining	O
each	O
joint	O
(	O
arrowheads	O
)	O
.	O

(	O
C	O
)	O
Ankle	O
of	O
mutant	O
showing	O
an	O
absence	O
of	O
blue	O
staining	O
in	O
most	O
regions	O
(	O
arrowheads	O
)	O
and	O
a	O
joint	O
fusion	O
between	O
the	O
central	O
(	O
c	O
)	O
and	O
second	O
(	O
2	O
)	O
tarsals	O
(	O
arrow	O
)	O
.	O

(	O
D	O
)	O
Control	O
and	O
(	O
E	O
)	O
mutant	O
metatarsal	O
/	O
phalangeal	O
joint	O
which	O
lacks	O
blue	O
staining	O
in	O
articular	O
regions	O
(	O
arrowheads	O
)	O
but	O
retains	O
staining	O
in	O
the	O
growth	O
plate	O
(	O
asterisks	O
)	O
.	O

(	O
F	O
)	O
Control	O
forelimb	O
.	O

(	O
G	O
)	O
Mutant	O
forelimb	O
with	O
webbing	O
between	O
the	O
first	O
and	O
second	O
digit	O
(	O
black	O
arrowhead	O
)	O
.	O

Figure	O
4	O

Bmpr1a	O
Is	O
Expressed	O
in	O
Joints	O
and	O
Is	O
Required	O
for	O
Continued	O
Joint	O
Formation	O
in	O
the	O
Ankle	O
Region	O

(	O
A	O
)	O
Diagram	O
of	O
ankle	O
bones	O
from	O
a	O
wild	O
-	O
type	O
mouse	O
;	O
bones	O
fusing	O
in	O
mutant	O
are	O
colored	O
red	O
.	O

Roman	O
numerals	O
II	O
-	O
IV	O
,	O
metatarsals	O
;	O
2	O
,	O
3	O
,	O
and	O
4	O
/	O
5	O
,	O
distal	O
row	O
of	O
tarsal	O
bones	O
;	O
c	O
,	O
central	O
tarsal	O
bone	O
;	O
ta	O
,	O
talus	O
;	O
ca	O
,	O
calcaneus	O
.	O

(	O
B	O
and	O
C	O
)	O
In	O
situ	O
hybridization	O
at	O
E15	O
.	O
5	O
showing	O
that	O
Bmpr1a	O
is	O
expressed	O
in	O
ankle	O
joint	O
interzones	O
(	O
B	O
,	O
arrowheads	O
)	O
and	O
in	O
the	O
forming	O
articular	O
regions	O
of	O
the	O
phalangeal	O
joints	O
(	O
C	O
,	O
arrowheads	O
)	O
.	O

(	O
D	O
)	O
Near	O
adjacent	O
section	O
to	O
(	O
C	O
)	O
showing	O
Gdf5	O
-	O
Cre	O
induced	O
LACZ	O
expression	O
from	O
R26R	O
in	O
the	O
forming	O
joints	O
of	O
the	O
digits	O
(	O
arrowheads	O
)	O
.	O

(	O
E	O
-	O
J	O
)	O
Marker	O
gene	O
expression	O
and	O
R26R	O
LACZ	O
staining	O
patterns	O
on	O
near	O
adjacent	O
sections	O
of	O
control	O
and	O
mutant	O
embryos	O
.	O

In	O
control	O
mice	O
at	O
E15	O
.	O
5	O
ankle	O
joints	O
are	O
clearly	O
delineated	O
as	O
regions	O
that	O
have	O
down	O
-	O
regulated	O
Col2	O
(	O
E	O
)	O
,	O
express	O
Gdf5	O
throughout	O
(	O
F	O
)	O
,	O
and	O
express	O
LACZ	O
in	O
most	O
cells	O
(	O
G	O
;	O
white	O
arrowheads	O
and	O
black	O
arrows	O
)	O
.	O

In	O
mutant	O
embryos	O
at	O
the	O
same	O
stage	O
,	O
joint	O
formation	O
is	O
incomplete	O
.	O

Faint	O
Col2	O
expression	O
can	O
be	O
seen	O
connecting	O
a	O
medial	O
region	O
of	O
tarsal	O
2	O
with	O
metatarsal	O
II	O
(	O
H	O
,	O
white	O
arrowhead	O
)	O
,	O
and	O
Gdf5	O
expression	O
does	O
not	O
extend	O
all	O
the	O
way	O
across	O
the	O
joint	O
at	O
this	O
location	O
(	O
I	O
,	O
white	O
arrowhead	O
)	O
.	O

Between	O
tarsals	O
c	O
and	O
2	O
,	O
mutants	O
express	O
Col2	O
across	O
the	O
normal	O
joint	O
-	O
forming	O
region	O
(	O
H	O
,	O
black	O
arrow	O
)	O
and	O
lack	O
expression	O
of	O
Gdf5	O
at	O
sites	O
where	O
skeletal	O
fusions	O
are	O
observed	O
(	O
I	O
,	O
black	O
arrow	O
and	O
bracket	O
)	O
.	O

(	O
J	O
)	O
Scale	O
bar	O
=	O
100	O
mu	O
m	O
.	O

Figure	O
5	O

Bmpr1a	O
Is	O
Required	O
to	O
Maintain	O
Expression	O
of	O
ECM	B-GO
Components	E-GO
in	O
Articular	O
Cartilage	O

In	O
situ	O
hybridization	O
or	O
LACZ	O
staining	O
on	O
near	O
adjacent	O
sections	O
of	O
metacarpal	O
-	O
phalangeal	O
joints	O
(	O
A	O
-	O
C	O
and	O
F	O
-	O
H	O
)	O
and	O
the	O
tarsal	O
2	O
-	O
metatarsal	O
II	O
joint	O
(	O
D	O
-	O
E	O
and	O
I	O
-	O
J	O
)	O
of	O
P0	O
mice	O
.	O

At	O
birth	O
,	O
articular	O
cartilage	O
of	O
controls	O
(	O
A	O
-	O
E	O
)	O
and	O
mutants	O
(	O
F	O
-	O
J	O
)	O
appears	O
similar	O
by	O
Safranin	O
O	O
staining	O
(	O
A	O
and	O
F	O
)	O
,	O
and	O
Col2	O
expression	O
(	O
B	O
,	O
G	O
)	O
.	O

Mat4	O
expression	O
confirms	O
that	O
articular	O
cartilage	O
is	O
initially	O
specified	O
in	O
mutants	O
(	O
D	O
andI	O
,	O
brackets	O
)	O
.	O

LACZ	O
expression	O
confirms	O
Cre	O
-	O
mediated	O
recombination	O
has	O
occurred	O
in	O
articular	O
cartilage	O
(	O
C	O
,	O
H	O
,	O
E	O
,	O
and	O
J	O
)	O
.	O

(	O
K	O
-	O
T	O
)	O
Near	O
adjacent	O
sections	O
of	O
the	O
metacarpal	O
-	O
phalangeal	O
joints	O
of	O
P14	O
mice	O
.	O

Two	O
weeks	O
after	O
birth	O
,	O
articular	O
cartilage	O
of	O
controls	O
stains	O
with	O
pericellular	O
Safranin	O
O	O
(	O
orange	O
staining	O
,	O
K	O
)	O
,	O
and	O
expresses	O
Col2	O
(	O
L	O
)	O
,	O
Agg	O
(	O
M	O
)	O
,	O
and	O
SOX9	O
(	O
N	O
)	O
.	O

In	O
contrast	O
,	O
mutant	O
articular	O
cells	O
are	O
smaller	O
and	O
more	O
densely	O
packed	O
,	O
lack	O
pericellular	O
Safranin	O
O	O
staining	O
(	O
P	O
)	O
,	O
have	O
reduced	O
expression	O
of	O
Col2	O
(	O
Q	O
)	O
and	O
Agg	O
(	O
R	O
)	O
,	O
but	O
retain	O
normal	O
levels	O
of	O
SOX9	O
protein	O
(	O
S	O
,	O
brackets	O
;	O
dashed	O
line	O
marks	O
faint	O
edges	O
of	O
articular	O
surfaces	O
)	O
.	O

LACZ	O
expression	O
confirms	O
Cre	O
-	O
mediated	O
recombination	O
has	O
occurred	O
in	O
articular	O
cells	O
(	O
O	O
ansd	O
T	O
,	O
brackets	O
)	O
.	O

(	O
A	O
and	O
K	O
)	O
Scale	O
bar	O
=	O
75	O
mu	O
m	O
.	O

Figure	O
6	O

Synovial	O
Membrane	O
Expansion	O
,	O
Articular	O
Surface	O
Erosion	O
,	O
and	O
Accelerated	O
Maturation	O
of	O
Underlying	O
Cartilage	O
in	O
Ankles	O
of	O
Bmpr1a	O
Mutant	O
Mice	O

Near	O
adjacent	O
sections	O
from	O
the	O
tarsal	O
2	O
-	O
metatarsal	O
II	O
joint	O
of	O
7	O
-	O
d	O
-	O
old	O
mice	O
.	O

(	O
A	O
and	O
B	O
)	O
LACZ	O
staining	O
(	O
blue	O
)	O
shows	O
Cre	O
-	O
mediated	O
recombination	O
is	O
largely	O
restricted	O
to	O
articular	O
(	O
arrowheads	O
)	O
and	O
synovial	O
cells	O
(	O
asterisks	O
)	O
in	O
both	O
controls	O
and	O
mutants	O
.	O

(	O
C	O
and	O
D	O
)	O
In	O
situ	O
hybridization	O
shows	O
Col10	O
expression	O
expands	O
in	O
mutants	O
toward	O
regions	O
of	O
synovial	O
membrane	O
expansion	O
and	O
articular	O
surface	O
erosion	O
(	O
brackets	O
and	O
arrows	O
)	O
.	O

This	O
may	O
be	O
a	O
cell	O
nonautonomous	O
effect	O
of	O
joint	O
damage	O
,	O
since	O
the	O
LACZ	O
expressing	O
cells	O
at	O
the	O
articular	O
surface	O
do	O
not	O
show	O
upregulation	O
of	O
Col10	O
(	O
arrowheads	O
)	O
and	O
the	O
region	O
of	O
expanded	O
Col10	O
expression	O
is	O
largely	O
made	O
up	O
of	O
cells	O
that	O
have	O
not	O
undergone	O
Cre	O
-	O
mediated	O
recombination	O
.	O

Note	O
the	O
formation	O
of	O
a	O
cartilaginous	O
bridge	O
along	O
the	O
joint	O
capsule	O
of	O
the	O
mutant	O
where	O
joint	O
formation	O
is	O
disrupted	O
at	O
earlier	O
stages	O
(	O
B	O
,	O
white	O
arrowhead	O
,	O
and	O
Figure	O
3	O
,	O
white	O
arrowheads	O
)	O
.	O

(	O
A	O
)	O
Scale	O
bar	O
=	O
75	O
mu	O
m	O
.	O

Figure	O
7	O

Loss	O
of	O
Bmpr1a	O
Signaling	O
Leads	O
to	O
Articular	O
Cartilage	O
Fibrillation	O
and	O
Degeneration	O
in	O
Digits	O
and	O
Knees	O
of	O
Aging	O
Mice	O

(	O
A	O
-	O
D	O
)	O
Near	O
adjacent	O
sections	O
of	O
metatarsal	O
-	O
phalangeal	O
joints	O
from	O
9	O
month	O
old	O
mice	O
.	O

Articular	O
cartilage	O
of	O
controls	O
is	O
complete	O
and	O
stains	O
strongly	O
with	O
Safranin	O
O	O
(	O
A	O
,	O
orange	O
stain	O
)	O
.	O

In	O
contrast	O
,	O
articular	O
cells	O
of	O
mutants	O
are	O
severely	O
fibrillated	O
or	O
absent	O
with	O
much	O
reduced	O
staining	O
of	O
Safranin	O
O	O
(	O
C	O
,	O
arrowheads	O
)	O
.	O

LACZ	O
expression	O
confirms	O
Cre	O
-	O
mediated	O
recombination	O
has	O
occurred	O
in	O
articular	O
cells	O
(	O
B	O
and	O
D	O
)	O
.	O

(	O
E	O
-	O
P	O
)	O
Sagittal	O
sections	O
through	O
knee	O
joints	O
of	O
7	O
-	O
wk	O
-	O
(	O
E	O
-	O
J	O
)	O
or	O
9	O
-	O
mo	O
-	O
old	O
animals	O
(	O
K	O
-	O
P	O
)	O
;	O
fe	O
,	O
femur	O
;	O
ti	O
,	O
tibia	O
;	O
gp	O
,	O
growth	O
plate	O
.	O

Seven	O
weeks	O
after	O
birth	O
,	O
the	O
height	O
of	O
the	O
tibial	O
epiphysis	O
is	O
reduced	O
in	O
mutants	O
(	O
E	O
and	O
H	O
,	O
bars	O
)	O
,	O
and	O
their	O
articular	O
layer	O
stains	O
poorly	O
with	O
Safranin	O
O	O
,	O
is	O
fibrillated	O
,	O
and	O
is	O
strikingly	O
thinner	O
(	O
F	O
and	O
I	O
,	O
black	O
arrowhead	O
,	O
and	O
brackets	O
)	O
.	O

Near	O
adjacent	O
sections	O
with	O
LACZ	O
staining	O
confirm	O
Cre	O
-	O
mediated	O
recombination	O
has	O
occurred	O
in	O
articular	O
cells	O
(	O
G	O
and	O
J	O
)	O
.	O

Note	O
that	O
in	O
mutants	O
,	O
LACZ	O
is	O
absent	O
in	O
cells	O
adjacent	O
to	O
those	O
that	O
do	O
stain	O
with	O
Safranin	O
O	O
,	O
suggesting	O
Bmpr1a	O
may	O
act	O
cell	O
autonomously	O
(	O
I	O
and	O
J	O
,	O
white	O
arrowheads	O
)	O
.	O

At	O
9	O
mo	O
old	O
,	O
the	O
mutant	O
tibial	O
epiphysis	O
is	O
extremely	O
thin	O
(	O
K	O
and	O
N	O
,	O
bars	O
)	O
,	O
and	O
the	O
articular	O
layer	O
is	O
completely	O
absent	O
,	O
leaving	O
bone	O
to	O
rub	O
directly	O
on	O
bone	O
(	O
L	O
and	O
O	O
,	O
bracket	O
)	O
.	O

LACZ	O
staining	O
shows	O
Cre	O
-	O
mediated	O
recombination	O
occurred	O
in	O
articular	O
cells	O
of	O
controls	O
(	O
M	O
)	O
and	O
in	O
some	O
remaining	O
skeletal	O
tissue	O
of	O
mutants	O
(	O
P	O
)	O
.	O

Also	O
note	O
aberrantly	O
formed	O
meniscal	O
cartilage	O
in	O
mutants	O
(	O
E	O
,	O
H	O
,	O
K	O
,	O
and	O
N	O
,	O
arrows	O
)	O
,	O
and	O
increased	O
sclerosis	O
in	O
mutant	O
epiphyses	O
(	O
E	O
,	O
H	O
,	O
K	O
,	O
and	O
N	O
,	O
asterisks	O
)	O
.	O

(	O
A	O
and	O
K	O
)	O
Scale	O
bar	O
=	O
50	O
mu	O
m	O
;	O
(	O
I	O
)	O
scale	O
bar	O
=	O
300	O
mu	O
m	O
.	O

Footnotes	O

Conflicts	O
of	O
interest	O
.	O

The	O
authors	O
have	O
declared	O
that	O
no	O
conflicts	O
of	O
interest	O
exist	O
.	O

Author	O
contributions	O
.	O

RBR	O
,	O
MS	O
,	O
and	O
DMK	O
conceived	O
and	O
designed	O
the	O
experiments	O
.	O

RBR	O
and	O
MEM	O
performed	O
the	O
experiments	O
.	O

RBR	O
,	O
HC	O
,	O
and	O
DMK	O
analyzed	O
the	O
data	O
.	O

MS	O
,	O
HC	O
,	O
VH	O
,	O
and	O
YM	O
contributed	O
reagents	O
/	O
materials	O
/	O
analysis	O
tools	O
.	O

RBR	O
and	O
DMK	O
wrote	O
the	O
paper	O
.	O

Academic	O
Editor	O
:	O
Lee	O
Niswander	O
,	O
University	O
of	O
Colorado	O
Health	O
Sciences	O
Center	O

currency	O
Current	O
address	O
:	O
ARTEMIS	O
Pharmaceuticals	O
,	O
an	O
Exelixis	O
Company	O
,	O
K	O
o	O
ln	O
,	O
Germany	O

Citation	O
:	O
Rountree	O
RB	O
,	O
Schoor	O
M	O
,	O
Chen	O
H	O
,	O
Marks	O
ME	O
,	O
Harley	O
V	O
,	O
et	O
al	O
.	O

(	O
2004	O
)	O
BMP	O
receptor	O
signaling	O
is	O
required	O
for	O
postnatal	O
maintenance	O
of	O
articular	O
cartilage	O
.	O

PLoS	O
Biol	O
2	O
(	O
11	O
)	O
:	O
e355	O
.	O

A	O
Chemoattractant	O
Role	O
for	O
NT	O
-	O
3	O
in	O
Proprioceptive	O
Axon	S-GO
Guidance	O

Abstract	O

Neurotrophin	O
-	O
3	O
(	O
NT	O
-	O
3	O
)	O
is	O
required	O
for	O
proprioceptive	O
neuron	O
survival	O
.	O

Deletion	O
of	O
the	O
proapoptotic	O
gene	O
Bax	O
in	O
NT	O
-	O
3	O
knockout	O
mice	O
rescues	O
these	O
neurons	O
and	O
allows	O
for	O
examination	O
of	O
their	O
axon	S-GO
growth	O
in	O
the	O
absence	O
of	O
NT	O
-	O
3	O
signaling	O
.	O

TrkC	O
-	O
positive	O
peripheral	O
and	O
central	O
axons	S-GO
from	O
dorsal	O
root	O
ganglia	O
follow	O
proper	O
trajectories	O
and	O
arrive	O
in	O
close	O
proximity	O
to	O
their	O
targets	O
but	O
fail	O
to	O
innervate	O
them	O
.	O

Peripherally	O
,	O
muscle	O
spindles	O
are	O
absent	O
and	O
TrkC	O
-	O
positive	O
axons	S-GO
do	O
not	O
enter	O
their	O
target	O
muscles	O
.	O

Centrally	O
,	O
proprioceptive	O
axons	S-GO
branch	O
in	O
ectopic	O
regions	O
of	O
the	O
spinal	O
cord	O
,	O
even	O
crossing	O
the	O
midline	O
.	O

In	O
vitro	O
assays	O
reveal	O
chemoattractant	O
effects	O
of	O
NT	O
-	O
3	O
on	O
dorsal	O
root	O
ganglion	O
axons	S-GO
.	O

Our	O
results	O
show	O
that	O
survival	O
factor	O
NT	O
-	O
3	O
acts	O
as	O
a	O
short	O
-	O
distance	O
axon	S-GO
guidance	O
molecule	O
for	O
muscle	O
sensory	O
afferents	O
as	O
they	O
approach	O
their	O
proper	O
targets	O
.	O

Introduction	O

Neurotrophin	O
-	O
3	O
(	O
NT	O
-	O
3	O
)	O
is	O
a	O
key	O
requirement	O
for	O
the	O
development	O
of	O
proprioceptive	O
inputs	O
to	O
motor	O
neurons	O
(	O
Chen	O
and	O
Frank	O
1999	O
;	O
Chen	O
et	O
al	O
.	O
2003	O
)	O
.	O

Mice	O
deficient	O
in	O
NT	O
-	O
3	O
,	O
its	O
tyrosine	O
kinase	O
receptor	O
,	O
TrkC	O
,	O
or	O
in	O
TrkC	O
-	O
positive	O
neuron	O
-	O
specific	O
transcription	O
factor	O
Runx3	O
display	O
severe	O
ataxia	O
associated	O
with	O
the	O
absence	O
of	O
muscle	O
spindles	O
,	O
and	O
loss	O
of	O
proprioceptive	O
neurons	O
in	O
dorsal	O
root	O
ganglia	O
(	O
DRGs	O
)	O
or	O
their	O
axons	S-GO
(	O
Ernfors	O
et	O
al	O
.	O
1994	O
;	O
Klein	O
et	O
al	O
.	O
1994	O
;	O
Tessarollo	O
et	O
al	O
.	O
1994	O
;	O
Fari	O
n	O
as	O
et	O
al	O
.	O
1996	O
;	O
Liebl	O
et	O
al	O
.	O
1997	O
;	O
Inoue	O
et	O
al	O
.	O
2002	O
;	O
Levanon	O
et	O
al	O
.	O
2002	O
)	O
.	O

NT	O
-	O
3	O
is	O
expressed	O
in	O
the	O
ventral	O
spinal	O
cord	O
,	O
in	O
the	O
developing	O
limb	O
buds	O
,	O
and	O
in	O
intrafusal	O
bag	O
fibers	O
of	O
muscle	O
spindles	O
later	O
in	O
development	O
(	O
Copray	O
and	O
Brouwer	O
1994	O
;	O
Fari	O
n	O
as	O
et	O
al	O
.	O
1996	O
;	O
Tojo	O
et	O
al	O
.	O
1996	O
)	O
.	O

When	O
sensory	O
axons	S-GO
contact	O
developing	O
myotubes	O
,	O
they	O
induce	O
muscle	O
spindle	O
differentiation	O
,	O
forming	O
ring	O
-	O
like	O
spiral	O
nerve	B-GO
endings	E-GO
around	O
them	O
.	O

In	O
the	O
chicken	O
embryo	O
,	O
limb	O
ablations	O
or	O
anti	O
-	O
NT	O
-	O
3	O
antibody	S-GO
injections	O
into	O
limb	O
buds	O
lead	O
to	O
elimination	O
of	O
TrkC	O
-	O
positive	O
neurons	O
and	O
decreased	O
innervation	O
of	O
motor	O
neurons	O
(	O
Oakley	O
et	O
al	O
.	O
1995	O
,	O
1997	O
)	O
.	O

Is	O
NT	O
-	O
3	O
only	O
a	O
chemotrophic	O
survival	O
factor	O
for	O
muscle	O
sensory	O
afferents	O
,	O
or	O
does	O
it	O
have	O
additional	O
roles	O
in	O
the	O
development	O
of	O
the	O
proprioceptors	O
and	O
the	O
establishment	O
of	O
the	O
monosynaptic	O
reflex	O
arc	O
?	O

Here	O
we	O
provide	O
evidence	O
that	O
NT	O
-	O
3	O
acts	O
as	O
a	O
chemoattractant	O
for	O
sensory	O
axons	S-GO
during	O
the	O
final	O
phase	O
of	O
their	O
target	O
-	O
directed	O
pathfinding	O
.	O

Results	O

TrkC	O
-	O
Positive	O
DRG	O
Neurons	O
Are	O
Rescued	O
in	O
Bax	O
/	O
NT	O
-	O
3	O
Double	O
Knockout	O
Mice	O

Mice	O
lacking	O
proapoptotic	O
protein	O
Bax	O
allow	O
for	O
distinguishing	O
survival	O
effects	O
of	O
neurotrophins	O
from	O
other	O
effects	O
.	O

Bax	O
-	O
deficient	O
sensory	O
neurons	O
no	O
longer	O
require	O
neurotrophins	O
for	O
survival	O
(	O
White	O
et	O
al	O
.	O
1998	O
;	O
Patel	O
et	O
al	O
.	O
2000	O
)	O
,	O
thus	O
they	O
can	O
be	O
used	O
to	O
examine	O
axonal	S-GO
effects	O
.	O

We	O
bred	O
NT	O
-	O
3	O
heterozygote	O
and	O
Bax	O
knockout	O
(	O
KO	O
)	O
mice	O
to	O
obtain	O
mice	O
with	O
double	O
KO	O
of	O
both	O
NT	O
-	O
3	O
and	O
Bax	O
genes	O
,	O
and	O
examined	O
proprioceptive	O
axonal	S-GO
projections	S-GO
.	O

All	O
NT	O
-	O
3	O
and	O
double	O
KOs	O
died	O
within	O
48	O
h	O
after	O
birth	O
(	O
Tessarollo	O
et	O
al	O
.	O
1994	O
)	O
.	O

We	O
performed	O
TrkA	O
/	O
TrkC	O
double	O
immunohistochemistry	O
(	O
Huang	O
et	O
al	O
.	O
1999	O
)	O
,	O
enabling	O
detection	O
of	O
both	O
proteins	O
in	O
the	O
same	O
sample	O
.	O

TrkC	O
-	O
positive	O
cells	O
(	O
Figure	O
1A	O
)	O
and	O
fibers	O
(	O
Figure	O
1E	O
)	O
were	O
absent	O
in	O
NT	O
-	O
3	O
KOs	O
at	O
embryonic	O
day	O
(	O
E	O
)	O
15	O
.	O

Two	O
subsets	O
of	O
DRG	O
cells	O
expressing	O
either	O
TrkA	O
or	O
TrkC	O
were	O
detected	O
in	O
double	O
KOs	O
,	O
similar	O
to	O
wild	O
-	O
type	O
(	O
WT	O
)	O
or	O
Bax	O
KO	O
animals	O
.	O

Surprisingly	O
,	O
at	O
postnatal	O
day	O
(	O
P	O
)	O
0	O
,	O
a	O
few	O
cells	O
expressed	O
TrkC	O
even	O
in	O
NT	O
-	O
3	O
KO	O
animals	O
in	O
the	O
Bax	O
+	O
/	O
+	O
genetic	O
background	O
,	O
and	O
some	O
cells	O
co	O
-	O
expressed	O
TrkA	O
and	O
TrkC	O
,	O
regardless	O
of	O
the	O
genotype	O
(	O
Figure	O
1B	O
)	O
.	O

In	O
order	O
to	O
quantify	O
our	O
results	O
,	O
we	O
analyzed	O
the	O
ratio	O
of	O
TrkA	O
and	O
TrkC	O
immunopositive	O
cells	O
from	O
four	O
different	O
DRGs	O
of	O
animals	O
of	O
different	O
genotypes	O
.	O

At	O
all	O
ages	O
studied	O
,	O
Bax	O
/	O
NT	O
-	O
3	O
double	O
null	O
DRGs	O
had	O
TrkA	O
/	O
TrkC	O
ratios	O
similar	O
to	O
those	O
of	O
Bax	O
null	O
DRGs	O
,	O
and	O
higher	O
than	O
those	O
of	O
NT	O
-	O
3	O
null	O
DRGs	O
(	O
Figure	O
1D	O
)	O
.	O

TrkC	O
-	O
positive	O
neurons	O
rescued	O
by	O
Bax	O
deletion	O
,	O
however	O
,	O
failed	O
to	O
differentiate	O
properly	O
,	O
as	O
evidenced	O
by	O
the	O
lack	O
of	O
expression	O
of	O
the	O
proprioceptive	O
molecular	O
marker	O
Parvalbumin	O
(	O
PV	O
)	O
(	O
Figure	O
1C	O
)	O
.	O

NT	O
-	O
3	O
Is	O
Necessary	O
for	O
Proper	O
Innervation	O
of	O
Motor	O
Neurons	O

TrkA	O
/	O
TrkC	O
-	O
positive	O
fibers	O
in	O
the	O
spinal	O
cord	O
could	O
be	O
detected	O
at	O
E15	O
(	O
Figure	O
1E	O
)	O
.	O

TrkA	O
-	O
positive	O
fibers	O
were	O
restricted	O
to	O
and	O
terminated	O
in	O
the	O
dorsolateral	O
spinal	O
cord	O
,	O
whereas	O
TrkC	O
-	O
positive	O
fibers	O
entered	O
the	O
cord	O
dorsomedially	O
,	O
and	O
descended	O
into	O
the	O
ventral	O
horns	O
in	O
WT	O
(	O
Ozaki	O
and	O
Snider	O
1997	O
)	O
and	O
Bax	O
KO	O
embryos	O
.	O

There	O
was	O
no	O
detectable	O
TrkC	O
expression	O
in	O
NT	O
-	O
3	O
KO	O
spinal	O
cord	O
,	O
indicating	O
complete	O
absence	O
of	O
proprioceptive	O
fibers	O
.	O

In	O
double	O
KO	O
spinal	O
cord	O
,	O
TrkC	O
-	O
positive	O
fibers	O
entered	O
the	O
dorsal	O
spinal	O
cord	O
and	O
descended	O
medially	O
in	O
a	O
manner	O
similar	O
to	O
that	O
seen	O
in	O
WT	O
or	O
Bax	O
KO	O
cases	O
.	O

However	O
,	O
it	O
was	O
not	O
possible	O
to	O
follow	O
TrkC	O
immunolabeled	O
fibers	O
all	O
the	O
way	O
to	O
their	O
terminal	O
zones	O
in	O
any	O
of	O
the	O
cases	O
.	O

Next	O
we	O
examined	O
the	O
central	O
projections	S-GO
of	O
DRG	O
axons	S-GO
with	O
the	O
lipophilic	O
tracer	O
DiI	O
at	O
P0	O
.	O

In	O
WT	O
and	O
Bax	O
KO	O
pups	O
,	O
proprioceptive	O
afferents	O
entered	O
the	O
dorsal	O
spinal	O
cord	O
and	O
followed	O
a	O
medial	O
course	O
towards	O
the	O
ventral	O
horn	O
.	O

They	O
then	O
turned	O
laterally	O
towards	O
motor	O
neurons	O
in	O
the	O
lateral	O
motor	O
column	O
,	O
where	O
they	O
branched	O
and	O
terminated	O
(	O
Figure	O
2A	O
)	O
.	O

DiI	O
labeling	O
was	O
confined	O
to	O
dorsal	O
spinal	O
cord	O
in	O
NT	O
-	O
3	O
KOs	O
(	O
Figure	O
2A	O
)	O
,	O
as	O
reported	O
earlier	O
,	O
consistent	O
with	O
a	O
complete	O
absence	O
of	O
proprioceptive	O
innervation	O
(	O
Ernfors	O
et	O
al	O
.	O
1994	O
;	O
Tessarollo	O
et	O
al	O
.	O
1994	O
)	O
.	O

In	O
double	O
KOs	O
,	O
proprioceptive	O
afferents	O
initially	O
followed	O
a	O
trajectory	O
similar	O
to	O
that	O
of	O
WT	O
counterparts	O
,	O
but	O
most	O
of	O
them	O
failed	O
to	O
project	O
all	O
the	O
way	O
to	O
the	O
ventral	O
cord	O
and	O
into	O
the	O
lateral	O
motor	O
column	O
.	O

Instead	O
,	O
they	O
arborized	O
near	O
the	O
ventral	O
midline	O
;	O
some	O
crossed	O
the	O
midline	O
and	O
extended	O
into	O
the	O
contralateral	O
ventral	O
cord	O
(	O
Figure	O
2A	O
and	O
2C	O
)	O
.	O

In	O
order	O
to	O
distinguish	O
between	O
a	O
role	O
for	O
NT	O
-	O
3	O
in	O
initiation	O
of	O
motor	O
neuron	O
innervation	O
and	O
a	O
role	O
for	O
maintenance	O
,	O
we	O
repeated	O
the	O
DiI	O
labeling	O
at	O
E17	O
.	O

Innervation	O
patterns	O
of	O
E17	O
spinal	O
cords	O
(	O
Figure	O
3	O
)	O
were	O
similar	O
to	O
those	O
at	O
P0	O
(	O
Figure	O
2	O
)	O
.	O

Dorsal	O
horns	O
of	O
all	O
genotypes	O
were	O
filled	O
with	O
DiI	O
-	O
labeled	O
fibers	O
corresponding	O
to	O
nerve	O
growth	O
factor	O
-	O
dependent	O
nociceptive	O
axons	S-GO
.	O

In	O
WT	O
and	O
Bax	O
KO	O
embryos	O
,	O
proprioceptive	O
fibers	O
extended	O
towards	O
ventral	O
horn	O
motor	O
neurons	O
(	O
Figure	O
3A	O
and	O
3B	O
)	O
,	O
whereas	O
the	O
ventral	O
horns	O
of	O
the	O
NT	O
-	O
3	O
KO	O
embryos	O
were	O
devoid	O
of	O
innervation	O
(	O
Figure	O
3C	O
)	O
.	O

In	O
the	O
Bax	O
/	O
NT	O
-	O
3	O
double	O
KOs	O
,	O
DiI	O
-	O
labeled	O
fibers	O
entered	O
the	O
ventral	O
spinal	O
cord	O
,	O
but	O
extended	O
towards	O
the	O
midline	O
instead	O
of	O
the	O
ventral	O
horn	O
(	O
Figure	O
3D	O
)	O
,	O
in	O
a	O
pattern	O
similar	O
to	O
that	O
observed	O
at	O
P0	O
.	O

Our	O
data	O
point	O
to	O
a	O
complete	O
absence	O
of	O
proprioceptive	O
innervation	O
of	O
the	O
ventral	O
horn	O
of	O
the	O
Bax	O
/	O
NT	O
-	O
3	O
null	O
spinal	O
cord	O
throughout	O
the	O
developmental	O
stages	O
investigated	O
.	O

As	O
the	O
sensory	O
axons	S-GO
never	O
reach	O
motor	O
neuron	O
dendrites	S-GO
in	O
the	O
ventral	O
horn	O
(	O
Figure	O
S1	O
)	O
,	O
the	O
stretch	O
reflex	O
arc	O
circuit	O
is	O
not	O
established	O
.	O

The	O
failure	O
to	O
initiate	O
contact	O
between	O
sensory	O
axons	S-GO
and	O
motor	O
neurons	O
in	O
the	O
absence	O
of	O
NT	O
-	O
3	O
suggests	O
a	O
requirement	O
for	O
NT	O
-	O
3	O
for	O
proper	O
axon	S-GO
targeting	O
in	O
addition	O
to	O
a	O
role	O
in	O
sensory	O
axon	S-GO
maintenance	O
.	O

NT	O
-	O
3	O
Is	O
Required	O
for	O
Proper	O
Peripheral	O
Innervation	O

In	O
order	O
to	O
study	O
peripheral	O
innervation	O
in	O
double	O
KO	O
animals	O
,	O
we	O
investigated	O
spindle	O
development	O
in	O
the	O
gastrocnemius	O
muscle	O
.	O

Muscle	O
spindles	O
could	O
be	O
identified	O
easily	O
in	O
P0	O
WT	O
and	O
Bax	O
KO	O
animals	O
by	O
their	O
characteristic	O
morphology	O
(	O
Figure	O
4A	O
and	O
4B	O
)	O
.	O

Proprioceptive	O
fibers	O
labeled	O
with	O
neurofilament	O
-	O
M	O
(	O
NF	O
-	O
M	O
)	O
antibody	S-GO
formed	O
ring	O
-	O
like	O
spiral	O
endings	O
wrapped	O
around	O
intrafusal	O
bag	O
fibers	O
labeled	O
with	O
S46	O
antibody	S-GO
,	O
specific	O
for	O
slow	O
developmental	O
myosin	S-GO
heavy	O
chain	O
protein	O
(	O
Miller	O
et	O
al	O
.	O
1985	O
)	O
.	O

As	O
reported	O
earlier	O
,	O
there	O
were	O
no	O
muscle	O
spindles	O
in	O
NT	O
-	O
3	O
KO	O
animals	O
(	O
Ernfors	O
et	O
al	O
.	O
1994	O
)	O
.	O

On	O
the	O
other	O
hand	O
,	O
Bax	O
KO	O
animals	O
had	O
more	O
spindles	O
than	O
WT	O
,	O
and	O
spindles	O
were	O
in	O
clusters	O
similar	O
to	O
animals	O
over	O
-	O
expressing	O
NT	O
-	O
3	O
in	O
the	O
muscle	O
(	O
Wright	O
et	O
al	O
.	O
1997	O
)	O
.	O

Although	O
NT	O
-	O
3	O
-	O
dependent	O
cells	O
were	O
rescued	O
,	O
no	O
muscle	O
spindles	O
were	O
detected	O
in	O
the	O
limbs	O
of	O
double	O
KOs	O
(	O
Figure	O
4A	O
and	O
4B	O
)	O
.	O

Muscle	O
spindles	O
could	O
be	O
observed	O
with	O
TrkC	O
antibody	S-GO
in	O
WT	O
and	O
Bax	O
KO	O
animals	O
,	O
but	O
not	O
in	O
NT	O
-	O
3	O
or	O
double	O
KOs	O
(	O
Figure	O
4E	O
)	O
.	O

In	O
both	O
NT	O
-	O
3	O
and	O
double	O
KO	O
animals	O
,	O
NF	O
-	O
M	O
-	O
labeled	O
fibers	O
could	O
be	O
detected	O
in	O
muscles	O
,	O
thus	O
the	O
muscles	O
of	O
these	O
animals	O
were	O
not	O
completely	O
devoid	O
of	O
nerve	O
fibers	O
.	O

Since	O
there	O
were	O
no	O
TrkC	O
-	O
positive	O
fibers	O
in	O
these	O
muscles	O
,	O
we	O
think	O
that	O
these	O
NF	O
-	O
M	O
-	O
labeled	O
fibers	O
correspond	O
to	O
motor	O
axons	S-GO
.	O

Absence	O
of	O
muscle	O
spindles	O
might	O
be	O
due	O
to	O
a	O
failure	O
in	O
initiation	O
of	O
differentiation	O
by	O
proprioceptive	O
axons	S-GO
,	O
or	O
a	O
failure	O
of	O
maturation	O
and	O
maintenance	O
in	O
the	O
absence	O
of	O
NT	O
-	O
3	O
.	O

To	O
distinguish	O
between	O
these	O
two	O
possibilities	O
,	O
we	O
investigated	O
muscle	O
spindle	O
development	O
at	O
E15	O
and	O
E17	O
with	O
S46	O
/	O
NF	O
-	O
M	O
immunostaining	O
as	O
well	O
as	O
DiI	O
labeling	O
.	O

No	O
structures	O
with	O
the	O
characteristic	O
muscle	O
spindle	O
shape	O
could	O
be	O
detected	O
in	O
any	O
of	O
the	O
genotypes	O
at	O
E15	O
(	O
Figure	O
S2	O
)	O
.	O

However	O
,	O
numerous	O
developing	O
spindles	O
could	O
be	O
identified	O
at	O
E17	O
in	O
WT	O
and	O
Bax	O
KOs	O
,	O
but	O
not	O
in	O
NT	O
-	O
3	O
KO	O
embryos	O
(	O
Figure	O
4C	O
)	O
.	O

Bax	O
/	O
NT	O
-	O
3	O
double	O
null	O
muscles	O
were	O
devoid	O
of	O
spindles	O
(	O
Figure	O
4C	O
)	O
,	O
except	O
for	O
one	O
spindle	O
-	O
like	O
structure	O
observed	O
in	O
one	O
leg	O
of	O
an	O
embryo	O
(	O
Figure	O
4C	O
,	O
inset	O
,	O
denoted	O
by	O
the	O
asterisk	O
)	O
.	O

DiI	O
labeling	O
through	O
the	O
DRGs	O
at	O
E17	O
yielded	O
similar	O
results	O
,	O
with	O
muscle	O
spindles	O
identified	O
in	O
parallel	O
sections	O
in	O
WT	O
and	O
Bax	O
null	O
muscles	O
(	O
Figure	O
4D	O
)	O
,	O
but	O
not	O
in	O
NT	O
-	O
3	O
or	O
double	O
KO	O
animals	O
.	O

Although	O
DiI	O
-	O
labeled	O
fibers	O
could	O
be	O
detected	O
in	O
double	O
null	O
muscles	O
,	O
they	O
never	O
formed	O
ring	O
-	O
like	O
structures	O
characteristic	O
of	O
muscle	O
spindles	O
.	O

We	O
also	O
examined	O
TrkA	O
/	O
TrkC	O
expression	O
at	O
P0	O
in	O
the	O
tibial	O
nerve	O
,	O
which	O
carries	O
sensory	O
fibers	O
to	O
the	O
gastrocnemius	O
muscle	O
as	O
well	O
as	O
the	O
skin	O
of	O
the	O
lower	O
leg	O
.	O

In	O
NT	O
-	O
3	O
KOs	O
,	O
TrkA	O
-	O
positive	O
axons	S-GO
could	O
be	O
seen	O
in	O
the	O
tibial	O
nerve	O
but	O
there	O
were	O
no	O
TrkC	O
-	O
positive	O
axons	S-GO
;	O
in	O
contrast	O
,	O
TrkA	O
-	O
and	O
TrkC	O
-	O
labeled	O
axons	S-GO
are	O
both	O
present	O
in	O
WT	O
,	O
Bax	O
KO	O
,	O
and	O
double	O
KO	O
animals	O
(	O
Figure	O
4F	O
)	O
.	O

These	O
results	O
suggest	O
that	O
although	O
proprioceptive	O
axons	S-GO
follow	O
proper	O
trajectories	O
in	O
distal	O
peripheral	O
nerves	O
,	O
they	O
fail	O
to	O
innervate	O
their	O
target	O
muscles	O
in	O
the	O
absence	O
of	O
NT	O
-	O
3	O
.	O

NT	O
-	O
3	O
Is	O
a	O
Chemoattractant	O
for	O
DRG	O
Axons	S-GO
In	O
Vitro	O

To	O
test	O
the	O
hypothesis	O
that	O
NT	O
-	O
3	O
acts	O
as	O
a	O
chemoattractant	O
for	O
sensory	O
axons	S-GO
,	O
we	O
performed	O
a	O
series	O
of	O
in	O
vitro	O
assays	O
.	O

Proprioceptive	O
axons	S-GO
in	O
mice	O
enter	O
the	O
gray	O
matter	O
in	O
the	O
spinal	O
cord	O
and	O
advance	O
ventrally	O
parallel	O
to	O
the	O
midline	O
by	O
E13	O
and	O
reach	O
the	O
motor	O
neurons	O
by	O
E15	O
(	O
Ozaki	O
and	O
Snider	O
1994	O
)	O
.	O

We	O
co	O
-	O
cultured	O
collagen	O
-	O
embedded	O
E13	O
WT	O
DRG	O
explants	O
with	O
NT	O
-	O
3	O
-	O
soaked	O
sepharose	O
beads	O
(	O
n	O
=	O
26	O
)	O
.	O

Control	O
cultures	O
were	O
set	O
up	O
using	O
bovine	O
serum	O
albumin	O
(	O
BSA	O
)	O
-	O
or	O
phosphate	O
buffer	O
saline	O
(	O
PBS	O
)	O
-	O
soaked	O
beads	O
(	O
n	O
=	O
12	O
)	O
.	O

DRG	O
axons	S-GO
began	O
extending	O
towards	O
the	O
localized	O
NT	O
-	O
3	O
source	O
by	O
the	O
end	O
of	O
the	O
first	O
day	O
and	O
consistently	O
displayed	O
a	O
strong	O
chemoattraction	O
by	O
3	O
d	O
in	O
vitro	O
,	O
whereas	O
they	O
did	O
not	O
show	O
such	O
preference	O
for	O
BSA	O
-	O
loaded	O
control	O
beads	O
(	O
Figure	O
5A	O
and	O
5B	O
)	O
.	O

This	O
attraction	O
was	O
not	O
due	O
to	O
survival	O
support	O
of	O
NT	O
-	O
3	O
because	O
Bax	O
null	O
ganglia	O
displayed	O
the	O
same	O
chemoattraction	O
(	O
Figure	O
5C	O
;	O
n	O
=	O
16	O
)	O
.	O

NT	O
-	O
3	O
may	O
act	O
through	O
either	O
TrkC	O
,	O
or	O
the	O
p75NTR	O
.	O

We	O
repeated	O
the	O
co	O
-	O
culture	O
experiments	O
with	O
DRG	O
explants	O
derived	O
from	O
p75NTR	O
KO	O
mice	O
(	O
n	O
=	O
18	O
)	O
.	O

Axons	S-GO
of	O
these	O
ganglia	O
also	O
showed	O
strong	O
chemoattraction	O
towards	O
the	O
NT	O
-	O
3	O
beads	O
(	O
Figure	O
5D	O
)	O
.	O

Finally	O
,	O
we	O
used	O
diffusible	O
TrkC	O
receptors	O
conjugated	O
to	O
IgG	O
constant	O
regions	O
(	O
TrkC	O
-	O
Fc	O
)	O
added	O
to	O
the	O
medium	O
(	O
n	O
=	O
6	O
)	O
to	O
deplete	O
soluble	O
NT	O
-	O
3	O
from	O
the	O
collagen	O
gels	O
(	O
Figure	O
5E	O
)	O
.	O

In	O
the	O
presence	O
of	O
TrkC	O
-	O
Fc	O
the	O
chemoattraction	O
was	O
completely	O
blocked	O
,	O
demonstrating	O
that	O
the	O
effect	O
we	O
see	O
is	O
specific	O
for	O
NT	O
-	O
3	O
.	O

In	O
order	O
to	O
investigate	O
the	O
active	O
range	O
of	O
our	O
beads	O
,	O
we	O
have	O
repeated	O
the	O
cultures	O
with	O
WT	O
E13	O
DRGs	O
by	O
placing	O
the	O
beads	O
at	O
increasing	O
distances	O
from	O
the	O
ganglia	O
(	O
n	O
=	O
4	O
each	O
)	O
(	O
Figure	O
5F	O
)	O
.	O

There	O
was	O
still	O
preferred	O
growth	O
towards	O
the	O
bead	O
at	O
1	O
,	O
200	O
mu	O
m	O
,	O
the	O
longest	O
distance	O
studied	O
,	O
although	O
the	O
number	O
of	O
axons	S-GO
and	O
the	O
extent	O
of	O
growth	O
were	O
not	O
as	O
robust	O
.	O

Next	O
,	O
we	O
set	O
up	O
E13	O
DRG	O
spinal	O
cord	O
explant	O
cultures	O
using	O
NT	O
-	O
3	O
-	O
loaded	O
beads	O
placed	O
at	O
the	O
midline	O
at	O
mid	O
-	O
spinal	O
cord	O
level	O
as	O
an	O
ectopic	O
NT	O
-	O
3	O
source	O
(	O
n	O
=	O
15	O
)	O
.	O

Control	O
cultures	O
were	O
set	O
using	O
PBS	O
-	O
loaded	O
beads	O
(	O
n	O
=	O
6	O
)	O
.	O

DiI	O
labeling	O
through	O
the	O
DRGs	O
revealed	O
numerous	O
fibers	O
entering	O
the	O
spinal	O
cord	O
at	O
ectopic	O
regions	O
and	O
growing	O
towards	O
the	O
NT	O
-	O
3	O
beads	O
(	O
Figure	O
6A	O
)	O
,	O
surrounding	O
the	O
beads	O
and	O
forming	O
bundles	O
around	O
them	O
(	O
Figure	O
6C	O
-	O
6E	O
)	O
.	O

In	O
control	O
cultures	O
,	O
all	O
labeled	O
fibers	O
were	O
directed	O
towards	O
the	O
dorsal	O
spinal	O
cord	O
and	O
terminated	O
there	O
,	O
where	O
they	O
normally	O
enter	O
the	O
gray	O
matter	O
at	O
E13	O
(	O
Figure	O
6B	O
)	O
.	O

No	O
axons	S-GO
were	O
observed	O
around	O
the	O
PBS	O
-	O
loaded	O
control	O
beads	O
(	O
Figure	O
6F	O
)	O
.	O

Axons	S-GO
that	O
normally	O
enter	O
the	O
gray	O
matter	O
through	O
dorsal	O
spinal	O
cord	O
grow	O
towards	O
the	O
midline	O
when	O
presented	O
with	O
a	O
localized	O
NT	O
-	O
3	O
source	O
,	O
and	O
new	O
axon	S-GO
growth	O
towards	O
the	O
NT	O
-	O
3	O
bead	O
is	O
initiated	O
from	O
DRGs	O
,	O
entering	O
the	O
spinal	O
cord	O
at	O
ectopic	O
loci	O
at	O
lateral	O
mid	O
-	O
spinal	O
cord	O
(	O
Figure	O
6G	O
)	O
.	O

NT	O
-	O
3	O
is	O
therefore	O
capable	O
of	O
acting	O
as	O
a	O
chemoattractant	O
for	O
DRG	O
axons	S-GO
.	O

Discussion	O

Relatively	O
few	O
studies	O
have	O
implicated	O
NT	O
-	O
3	O
as	O
a	O
chemoattractant	O
agent	O
for	O
sensory	O
and	O
motor	O
axons	S-GO
.	O

Previously	O
noted	O
chemoattractant	O
action	O
of	O
the	O
embryonic	O
mouse	O
maxillary	O
process	O
on	O
trigeminal	O
ganglion	O
neurons	O
(	O
Lumsden	O
and	O
Davies	O
1986	O
)	O
is	O
now	O
attributed	O
to	O
NT	O
-	O
3	O
and	O
brain	O
-	O
derived	O
neurotrophic	O
factor	O
(	O
BDNF	O
)	O
(	O
O	O
'	O
Connor	O
et	O
al	O
.	O
1999	O
)	O
.	O

Recently	O
,	O
Tucker	O
et	O
al	O
.	O

(	O
2001	O
)	O
showed	O
that	O
developing	O
sensory	O
and	O
motor	O
axons	S-GO
in	O
limb	O
slice	O
cultures	O
preferentially	O
grow	O
towards	O
neurotrophin	O
-	O
soaked	O
beads	O
instead	O
of	O
following	O
their	O
normal	O
trajectories	O
.	O

Conversely	O
,	O
beads	O
soaked	O
with	O
neurotrophin	O
function	O
-	O
blocking	O
antibodies	S-GO
led	O
to	O
reduction	O
of	O
sensory	O
and	O
motor	O
axon	S-GO
growth	O
towards	O
the	O
limb	O
.	O

In	O
transgenic	O
mice	O
,	O
which	O
over	O
-	O
express	O
NT	O
-	O
3	O
under	O
the	O
nestin	O
promoter	O
in	O
the	O
central	O
nervous	O
system	O
,	O
the	O
course	O
of	O
the	O
proprioceptive	O
afferents	O
are	O
altered	O
and	O
directed	O
towards	O
the	O
regions	O
with	O
high	O
levels	O
of	O
ectopic	O
NT	O
-	O
3	O
expression	O
in	O
the	O
spinal	O
cord	O
(	O
Ringstedt	O
et	O
al	O
.	O
1997	O
)	O
.	O

Ringstedt	O
et	O
al	O
.	O
considered	O
the	O
possibility	O
that	O
NT	O
-	O
3	O
may	O
play	O
a	O
chemoattractant	O
role	O
during	O
the	O
innervation	O
of	O
ventral	O
horns	O
by	O
proprioceptive	O
afferents	O
.	O

However	O
,	O
earlier	O
findings	O
of	O
normal	O
proprioceptive	O
afferent	O
trajectories	O
in	O
chicken	O
embryos	O
despite	O
injection	O
of	O
function	O
-	O
blocking	O
NT	O
-	O
3	O
antibody	S-GO
into	O
the	O
spinal	O
cord	O
(	O
Oakley	O
et	O
al	O
.	O
1995	O
)	O
led	O
them	O
to	O
discount	O
this	O
possibility	O
.	O

In	O
that	O
study	O
,	O
though	O
,	O
assays	O
on	O
the	O
effectiveness	O
of	O
antibody	S-GO
perturbation	O
on	O
NT	O
-	O
3	O
-	O
dependent	O
cell	O
survival	O
showed	O
that	O
effectiveness	O
was	O
significant	O
(	O
approximately	O
90	O
%	O
)	O
but	O
not	O
complete	O
(	O
Oakley	O
et	O
al	O
.	O
1995	O
)	O
.	O

Ringstedt	O
et	O
al	O
.	O

(	O
1997	O
)	O
argue	O
that	O
while	O
central	O
sensory	O
axons	S-GO
may	O
still	O
navigate	O
properly	O
in	O
the	O
absence	O
of	O
NT	O
-	O
3	O
,	O
ectopic	O
expression	O
of	O
NT	O
-	O
3	O
disrupts	O
their	O
targeting	O
.	O

Recently	O
,	O
another	O
member	O
of	O
the	O
neurotrophin	O
family	O
,	O
BDNF	O
,	O
has	O
been	O
suggested	O
to	O
act	O
as	O
a	O
chemoattractant	O
for	O
sensory	O
axons	S-GO
innervating	O
ear	O
(	O
Tessarollo	O
et	O
al	O
.	O
2004	O
)	O
.	O

In	O
a	O
gene	O
replacement	O
strategy	O
in	O
which	O
BDNF	O
expression	O
was	O
driven	O
by	O
the	O
NT	O
-	O
3	O
promoter	O
,	O
vestibular	O
axons	S-GO
rerouted	O
towards	O
ectopic	O
sources	O
of	O
BDNF	O
in	O
the	O
cochlea	O
that	O
normally	O
expressed	O
NT	O
-	O
3	O
and	O
were	O
not	O
innervated	O
by	O
these	O
axons	S-GO
.	O

Ectopic	O
NT	O
-	O
3	O
supplied	O
using	O
osmotic	O
pumps	O
and	O
adenovirus	O
-	O
mediated	O
expression	O
induce	O
sensory	O
axon	S-GO
growth	O
during	O
regeneration	O
(	O
Zhang	O
et	O
al	O
.	O
1998	O
,	O
Bradbury	O
et	O
al	O
.	O
1999	O
,	O
Oudega	O
et	O
al	O
.	O
1999	O
,	O
Ramer	O
et	O
al	O
.	O
2002	O
)	O
,	O
and	O
induce	O
axonal	S-GO
plasticity	O
of	O
corticospinal	O
axons	S-GO
in	O
injured	O
adult	O
spinal	O
cord	O
(	O
Zhou	O
et	O
al	O
.	O
2003	O
)	O
,	O
where	O
the	O
sprouting	O
axons	S-GO
from	O
the	O
intact	O
site	O
cross	O
the	O
midline	O
towards	O
the	O
NT	O
-	O
3	O
source	O
on	O
the	O
lesion	O
side	O
of	O
the	O
spinal	O
cord	O
.	O

Our	O
present	O
results	O
are	O
in	O
agreement	O
with	O
these	O
observations	O
,	O
and	O
provide	O
further	O
evidence	O
that	O
NT	O
-	O
3	O
acts	O
as	O
a	O
chemoattractant	O
for	O
sensory	O
afferents	O
.	O

Previously	O
,	O
normal	O
motor	O
neuron	O
innervation	O
was	O
rescued	O
in	O
NT	O
-	O
3	O
KO	O
animals	O
by	O
over	O
-	O
expressing	O
NT	O
-	O
3	O
selectively	O
in	O
their	O
muscles	O
(	O
Wright	O
et	O
al	O
.	O
1997	O
)	O
.	O

It	O
appears	O
that	O
peripheral	O
NT	O
-	O
3	O
alone	O
is	O
sufficient	O
for	O
rescuing	O
proprioceptive	O
neurons	O
in	O
NT	O
-	O
3	O
KO	O
animals	O
and	O
proper	O
axonal	S-GO
pathfinding	O
in	O
the	O
spinal	O
cord	O
.	O

However	O
,	O
it	O
is	O
unclear	O
whether	O
NT	O
-	O
3	O
is	O
absent	O
from	O
the	O
ventral	O
spinal	O
cords	O
of	O
these	O
animals	O
.	O

The	O
possibility	O
has	O
been	O
raised	O
that	O
motor	O
neurons	O
may	O
retrogradely	O
transport	O
NT	O
-	O
3	O
in	O
muscle	O
to	O
the	O
spinal	O
cord	O
(	O
Chen	O
and	O
Frank	O
1999	O
)	O
.	O

Assays	O
to	O
determine	O
whether	O
any	O
NT	O
-	O
3	O
is	O
present	O
in	O
the	O
ventral	O
horns	O
of	O
these	O
mice	O
would	O
be	O
informative	O
.	O

Recently	O
,	O
Patel	O
et	O
al	O
.	O

(	O
2003	O
)	O
reported	O
their	O
observations	O
on	O
Bax	O
/	O
NT	O
-	O
3	O
double	O
KO	O
mice	O
they	O
bred	O
.	O

Their	O
results	O
are	O
significantly	O
different	O
from	O
ours	O
.	O

They	O
see	O
no	O
proprioceptive	O
afferents	O
in	O
the	O
periphery	O
of	O
the	O
double	O
knockouts	O
and	O
note	O
that	O
central	O
proprioceptive	O
afferents	O
terminate	O
in	O
the	O
intermediate	O
spinal	O
cord	O
without	O
extending	O
ventrally	O
.	O

Their	O
observations	O
are	O
based	O
on	O
PV	O
immunostaining	O
and	O
DiI	O
labeling	O
of	O
the	O
peripheral	O
nerves	O
.	O

We	O
noted	O
that	O
PV	O
immunolabeling	O
is	O
diminished	O
in	O
our	O
Bax	O
/	O
NT	O
-	O
3	O
double	O
KOs	O
.	O

In	O
various	O
manipulations	O
of	O
the	O
neurotrophins	O
it	O
has	O
been	O
noted	O
that	O
molecular	O
markers	O
for	O
proprioceptive	O
axons	S-GO
such	O
as	O
PV	O
or	O
calcitonin	O
gene	O
-	O
related	O
peptide	O
for	O
nerve	O
growth	O
factor	O
-	O
responsive	O
axons	S-GO
are	O
compromised	O
(	O
Ringstedt	O
et	O
al	O
.	O
1997	O
;	O
Patel	O
et	O
al	O
.	O
2000	O
)	O
,	O
thus	O
PV	O
immunostaining	O
in	O
Bax	O
/	O
NT	O
-	O
3	O
double	O
KOs	O
cannot	O
reveal	O
the	O
extent	O
of	O
proprioceptive	O
axons	S-GO
in	O
the	O
periphery	O
.	O

Seventy	O
-	O
three	O
percent	O
of	O
retrogradely	O
labeled	O
gastrocnemius	O
muscle	O
afferents	O
were	O
reported	O
to	O
be	O
expressing	O
TrkC	O
RNA	O
in	O
the	O
adult	O
rat	O
DRG	O
,	O
although	O
some	O
of	O
these	O
(	O
about	O
10	O
%	O
)	O
may	O
represent	O
cutaneous	O
innervation	O
(	O
McMahon	O
et	O
al	O
.	O
1994	O
)	O
.	O

Presently	O
,	O
it	O
is	O
not	O
clear	O
whether	O
TrkC	O
protein	O
is	O
also	O
made	O
by	O
cutaneous	O
afferents	O
and	O
if	O
so	O
at	O
what	O
stage	O
in	O
development	O
this	O
receptor	O
is	O
expressed	O
by	O
cutaneous	O
axons	S-GO
.	O

Based	O
on	O
the	O
available	O
evidence	O
showing	O
that	O
all	O
proprioceptive	O
neurons	O
are	O
eliminated	O
in	O
NT	O
-	O
3	O
or	O
TrkC	O
null	O
mice	O
,	O
we	O
think	O
that	O
TrkC	O
staining	O
in	O
the	O
tibial	O
nerve	O
mostly	O
represents	O
proprioceptive	O
axons	S-GO
in	O
the	O
vicinity	O
of	O
their	O
peripheral	O
target	O
.	O

Altogether	O
,	O
our	O
findings	O
suggest	O
a	O
role	O
for	O
NT	O
-	O
3	O
in	O
initiation	O
of	O
muscle	O
innervation	O
and	O
spindle	O
differentiation	O
by	O
the	O
proprioceptive	O
axons	S-GO
.	O

Patel	O
et	O
al	O
.	O

(	O
2003	O
)	O
examined	O
DiI	O
-	O
labeled	O
central	O
DRG	O
axons	S-GO
in	O
the	O
spinal	O
cord	O
of	O
three	O
E17	O
and	O
two	O
P0	O
cases	O
,	O
and	O
report	O
that	O
central	O
proprioceptive	O
axons	S-GO
stop	O
in	O
the	O
intermediate	O
laminae	O
,	O
never	O
entering	O
the	O
ventral	O
cord	O
.	O

We	O
have	O
examined	O
nine	O
Bax	O
/	O
NT	O
-	O
3	O
double	O
KO	O
cases	O
,	O
and	O
often	O
incomplete	O
DiI	O
labeling	O
gives	O
the	O
impression	O
that	O
there	O
are	O
no	O
axons	S-GO
reaching	O
the	O
ventral	O
spinal	O
cord	O
.	O

We	O
have	O
also	O
seen	O
cases	O
similar	O
to	O
theirs	O
(	O
n	O
=	O
4	O
)	O
,	O
but	O
at	O
higher	O
magnification	O
these	O
axons	S-GO
did	O
not	O
have	O
terminal	B-GO
boutons	E-GO
and	O
were	O
not	O
completely	O
labeled	O
.	O

However	O
,	O
with	O
complete	O
fills	O
(	O
n	O
=	O
5	O
)	O
,	O
it	O
was	O
possible	O
to	O
trace	O
these	O
axons	S-GO
into	O
the	O
ventral	O
midline	O
and	O
across	O
to	O
the	O
contralateral	O
side	O
,	O
and	O
visualize	O
terminal	B-GO
boutons	E-GO
at	O
their	O
tips	O
(	O
see	O
Figure	O
3C	O
)	O
.	O

Previously	O
,	O
Arber	O
et	O
al	O
.	O

(	O
2000	O
)	O
reported	O
that	O
members	O
of	O
the	O
Ets	O
family	O
of	O
transcription	O
factors	O
,	O
Er81	O
and	O
Pea3	O
,	O
are	O
expressed	O
by	O
DRG	O
neurons	O
as	O
well	O
as	O
motor	O
neurons	O
and	O
their	O
target	O
muscle	O
fibers	O
.	O

They	O
found	O
that	O
in	O
the	O
spinal	O
cord	O
of	O
Er81	O
KO	O
mice	O
,	O
ventral	O
projections	S-GO
of	O
proprioceptive	O
axons	S-GO
were	O
mostly	O
absent	O
,	O
and	O
very	O
few	O
axons	S-GO
made	O
it	O
to	O
the	O
ventral	O
cord	O
.	O

Patel	O
et	O
al	O
.	O

(	O
2003	O
)	O
note	O
that	O
the	O
phenotype	O
they	O
observed	O
in	O
their	O
Bax	O
/	O
NT	O
-	O
3	O
double	O
KO	O
mice	O
is	O
quite	O
similar	O
to	O
that	O
of	O
Er81	O
KO	O
mice	O
.	O

They	O
provide	O
evidence	O
that	O
NT	O
-	O
3	O
induces	O
Er81	O
expression	O
in	O
DRG	O
explants	O
in	O
vitro	O
.	O

Patel	O
et	O
al	O
.	O

(	O
2003	O
)	O
report	O
that	O
Er81	O
mRNA	O
expression	O
is	O
diminished	O
(	O
but	O
not	O
abolished	O
)	O
in	O
both	O
NT	O
-	O
3	O
KO	O
and	O
Bax	O
/	O
NT	O
-	O
3	O
double	O
KO	O
mice	O
,	O
while	O
their	O
immunohistochemistry	O
shows	O
much	O
less	O
protein	O
expression	O
in	O
the	O
double	O
KO	O
mice	O
.	O

It	O
is	O
highly	O
possible	O
that	O
a	O
small	O
but	O
considerable	O
number	O
of	O
DRG	O
cells	O
express	O
the	O
transcription	O
factor	O
Er81	O
and	O
that	O
their	O
axons	S-GO
grow	O
beyond	O
the	O
intermediate	O
levels	O
of	O
the	O
spinal	O
cord	O
in	O
Bax	O
/	O
NT	O
-	O
3	O
double	O
KO	O
mice	O
.	O

While	O
the	O
phenotype	O
of	O
Er81	O
KO	O
mice	O
is	O
quite	O
dramatic	O
,	O
and	O
most	O
proprioceptive	O
axons	S-GO
stop	O
within	O
the	O
intermediate	O
spinal	O
cord	O
,	O
it	O
is	O
important	O
to	O
note	O
that	O
a	O
few	O
axons	S-GO
still	O
find	O
their	O
way	O
to	O
the	O
ventral	O
spinal	O
cord	O
and	O
target	O
properly	O
to	O
the	O
motor	O
neurons	O
(	O
Arber	O
et	O
al	O
.	O
2000	O
)	O
.	O

Patel	O
et	O
al	O
.	O

(	O
2003	O
)	O
also	O
present	O
observations	O
from	O
islet2DTA	O
mice	O
,	O
which	O
lack	O
a	O
significant	O
portion	O
of	O
the	O
motor	O
neurons	O
in	O
the	O
ventral	O
cord	O
.	O

In	O
these	O
mice	O
PV	O
immunostaining	O
shows	O
axons	S-GO
in	O
the	O
ventral	O
horns	O
.	O

Patel	O
et	O
al	O
.	O
argue	O
that	O
since	O
motor	O
neurons	O
are	O
absent	O
in	O
these	O
mice	O
,	O
NT	O
-	O
3	O
secreted	O
by	O
them	O
could	O
not	O
be	O
a	O
signal	O
for	O
proprioceptive	O
axons	S-GO
to	O
enter	O
the	O
lateral	O
motor	O
columns	O
.	O

However	O
,	O
there	O
is	O
no	O
evidence	O
showing	O
that	O
NT	O
-	O
3	O
mRNA	O
or	O
protein	O
expressed	O
in	O
the	O
ventral	O
spinal	O
cord	O
is	O
exclusively	O
from	O
motor	O
neurons	O
,	O
and	O
there	O
are	O
no	O
available	O
data	O
indicating	O
that	O
in	O
islet2DTA	O
mice	O
,	O
NT	O
-	O
3	O
expression	O
in	O
the	O
ventral	O
spinal	O
cord	O
is	O
abolished	O
(	O
Yang	O
et	O
al	O
.	O
2001	O
;	O
Pun	O
et	O
al	O
.	O
2002	O
)	O
.	O

Studies	O
in	O
embryonic	O
mice	O
reported	O
NT	O
-	O
3	O
mRNA	O
in	O
the	O
ventral	O
horns	O
of	O
the	O
spinal	O
cord	O
,	O
but	O
it	O
is	O
not	O
definitive	O
that	O
both	O
mRNA	O
and	O
protein	O
are	O
expressed	O
solely	O
by	O
motor	O
neurons	O
.	O

In	O
the	O
adult	O
spinal	O
cord	O
,	O
while	O
motor	O
neurons	O
express	O
high	O
levels	O
of	O
NT	O
-	O
3	O
,	O
other	O
cells	O
,	O
including	O
glia	O
,	O
also	O
express	O
it	O
(	O
Zhou	O
and	O
Rush	O
1994	O
;	O
Dreyfus	O
et	O
al	O
.	O
1999	O
;	O
Buck	O
et	O
al	O
.	O
2000	O
)	O
.	O

Our	O
present	O
results	O
,	O
along	O
with	O
those	O
from	O
transgenic	O
mice	O
with	O
NT	O
-	O
3	O
over	O
-	O
expression	O
in	O
ectopic	O
regions	O
of	O
the	O
spinal	O
cord	O
(	O
Ringstedt	O
et	O
al	O
.	O
1997	O
)	O
,	O
argue	O
for	O
a	O
role	O
of	O
NT	O
-	O
3	O
in	O
chemoattractant	O
axon	S-GO
guidance	O
of	O
proprioceptive	O
axons	S-GO
in	O
the	O
spinal	O
cord	O
.	O

Finally	O
,	O
in	O
culture	O
assays	O
,	O
we	O
see	O
a	O
strong	O
chemoattraction	O
of	O
DRG	O
neurons	O
to	O
localized	O
sources	O
of	O
NT	O
-	O
3	O
.	O

This	O
response	O
is	O
seen	O
in	O
WT	O
,	O
Bax	O
null	O
and	O
in	O
p75	O
null	O
DRG	O
explants	O
,	O
and	O
in	O
the	O
absence	O
of	O
any	O
other	O
neurotrophins	O
or	O
target	O
-	O
derived	O
axon	S-GO
guidance	O
molecules	O
.	O

Furthermore	O
,	O
in	O
vitro	O
,	O
sensory	O
axon	S-GO
response	O
to	O
NT	O
-	O
3	O
does	O
not	O
appear	O
to	O
be	O
dose	O
-	O
dependent	O
(	O
Ringstedt	O
et	O
al	O
.	O
1997	O
;	O
Tucker	O
et	O
al	O
.	O
2001	O
)	O
.	O

NT	O
-	O
3	O
is	O
capable	O
of	O
attracting	O
axons	S-GO
along	O
distances	O
of	O
up	O
to	O
1	O
mm	O
in	O
collagen	O
gel	O
matrix	O
,	O
covering	O
the	O
physiological	O
range	O
it	O
needs	O
to	O
attract	O
axons	S-GO
during	O
development	O
.	O

Previous	O
studies	O
with	O
exogenous	O
or	O
local	O
applications	O
of	O
NT	O
-	O
3	O
to	O
developing	O
primary	O
sensory	O
axons	S-GO
have	O
indicated	O
that	O
this	O
neurotrophin	O
can	O
attract	O
and	O
induce	O
axonal	S-GO
branching	O
(	O
Ulup	O
i	O
nar	O
et	O
al	O
.	O
2000	O
;	O
O	O
zdinler	O
and	O
Erzurumlu	O
2001	O
,	O
O	O
zdinler	O
et	O
al	O
.	O
2004	O
)	O
.	O

Along	O
the	O
monosynaptic	O
stretch	O
reflex	O
pathway	O
,	O
only	O
Wnt	O
-	O
3	O
has	O
been	O
implicated	O
as	O
an	O
axon	S-GO
arborization	O
factor	O
in	O
the	O
spinal	O
cord	O
(	O
Krylova	O
et	O
al	O
.	O
2002	O
)	O
.	O

Another	O
molecule	O
,	O
Slit2	O
,	O
expressed	O
in	O
the	O
midline	O
and	O
by	O
motor	O
neurons	O
(	O
Wang	O
et	O
al	O
.	O
1999	O
)	O
is	O
capable	O
of	O
inducing	O
axonal	S-GO
branching	O
(	O
Nguyen	O
Ba	O
-	O
Charvet	O
et	O
al	O
.	O
2001	O
;	O
O	O
zdinler	O
and	O
Erzurumlu	O
2002	O
)	O
.	O

DRG	O
neurons	O
express	O
Robo	O
receptors	O
,	O
which	O
bind	O
to	O
Slits	O
,	O
and	O
proprioceptive	O
axons	S-GO
are	O
therefore	O
capable	O
of	O
responding	O
to	O
Slit	O
signals	O
(	O
Wang	O
et	O
al	O
.	O
1999	O
)	O
.	O

Slit2	O
does	O
not	O
cause	O
repulsion	O
of	O
NT	O
-	O
3	O
-	O
responsive	O
DRG	O
axons	S-GO
in	O
vitro	O
(	O
Nguyen	O
Ba	O
-	O
Charvet	O
et	O
al	O
.	O
2001	O
)	O
,	O
but	O
causes	O
ectopic	O
branching	O
and	O
arborization	O
of	O
trigeminal	O
axons	S-GO
in	O
the	O
brainstem	O
(	O
O	O
zdinler	O
and	O
Erzurumlu	O
2002	O
)	O
.	O

Thus	O
,	O
Slit2	O
might	O
also	O
be	O
involved	O
in	O
terminal	O
branching	O
of	O
propioceptive	O
axons	S-GO
in	O
the	O
ventral	O
cord	O
and	O
in	O
the	O
midline	O
branching	O
observed	O
in	O
our	O
double	O
KOs	O
.	O

Lack	O
of	O
PV	O
expression	O
in	O
Bax	O
/	O
NT	O
-	O
3	O
KO	O
mice	O
suggests	O
that	O
PV	O
expression	O
might	O
be	O
responsible	O
for	O
proper	O
axon	S-GO
targeting	O
and	O
muscle	O
spindle	O
differentiation	O
.	O

Presently	O
we	O
cannot	O
completely	O
rule	O
out	O
this	O
possibility	O
.	O

However	O
,	O
no	O
defects	O
in	O
axon	S-GO
pathfinding	O
along	O
the	O
monosynaptic	O
reflex	O
arc	O
or	O
in	O
muscle	O
spindle	O
differentiation	O
have	O
been	O
noted	O
in	O
PV	O
KO	O
mice	O
,	O
which	O
develop	O
normally	O
and	O
show	O
no	O
apparent	O
changes	O
in	O
their	O
behavior	O
or	O
physical	O
activity	O
(	O
Schwaller	O
et	O
al	O
.	O
1999	O
)	O
.	O

These	O
observations	O
suggest	O
that	O
axonal	S-GO
targeting	O
defects	O
in	O
Bax	O
/	O
NT	O
-	O
3	O
double	O
KO	O
mice	O
cannot	O
be	O
simply	O
due	O
to	O
lack	O
of	O
PV	O
expression	O
in	O
proprioceptive	O
cells	O
.	O

Our	O
present	O
results	O
suggest	O
that	O
NT	O
-	O
3	O
acts	O
as	O
a	O
short	O
-	O
range	O
axon	S-GO
guidance	O
cue	O
for	O
proprioceptive	O
axons	S-GO
centrally	O
and	O
peripherally	O
,	O
as	O
they	O
navigate	O
to	O
their	O
targets	O
using	O
other	O
axon	S-GO
guidance	O
cues	O
.	O

In	O
its	O
absence	O
,	O
these	O
axons	S-GO
terminate	O
in	O
inappropriate	O
loci	O
.	O

However	O
,	O
NT	O
-	O
3	O
may	O
not	O
be	O
the	O
only	O
molecule	O
that	O
plays	O
a	O
role	O
in	O
targeting	O
and	O
terminal	O
branching	O
of	O
sensory	O
axons	S-GO
in	O
the	O
ventral	O
spinal	O
cord	O
.	O

NT	O
-	O
3	O
most	O
likely	O
acts	O
cooperatively	O
with	O
other	O
axon	S-GO
guidance	O
molecules	O
or	O
by	O
regulating	O
expression	O
of	O
yet	O
to	O
be	O
identified	O
proprioceptive	O
neuron	O
-	O
specific	O
receptors	O
/	O
ligands	O
for	O
numerous	O
axon	S-GO
guidance	O
cues	O
.	O

Materials	O
and	O
Methods	O

Generation	O
of	O
double	O
KOs	O
.	O

We	O
crossed	O
Bax	O
KO	O
females	O
on	O
a	O
C57BL	O
/	O
6	O
background	O
(	O
Jackson	O
Laboratory	O
,	O
Bar	O
Harbor	O
,	O
Maine	O
,	O
United	O
States	O
)	O
to	O
NT	O
-	O
3	O
heterozygote	O
males	O
on	O
a	O
129	O
Sv	O
background	O
to	O
generate	O
double	O
heterozygote	O
animals	O
.	O

Progeny	O
was	O
genotyped	O
with	O
PCR	O
,	O
and	O
animals	O
heterozygous	O
for	O
both	O
genes	O
were	O
bred	O
to	O
obtain	O
the	O
double	O
KOs	O
.	O

Primers	O
used	O
for	O
the	O
Bax	O
locus	O
were	O
R661	O
,	O
GTT	O
GAC	O
CAG	O
AGT	O
GGC	O
GTA	O
GG	O
;	O
R662	O
,	O
CCG	O
CTT	O
CCA	O
TTG	O
CTC	O
AGC	O
GG	O
;	O
and	O
R663	O
,	O
GAG	O
CTG	O
ATC	O
AGA	O
ACC	O
ATC	O
ATG	O
.	O

Primers	O
used	O
for	O
the	O
NT	O
-	O
3	O
locus	O
were	O
NT3A	O
,	O
CGT	O
GGT	O
GAG	O
GTT	O
CTA	O
TTG	O
GCT	O
AC	O
;	O
NT3B	O
,	O
CAG	O
AGC	O
ACC	O
CTG	O
CCC	O
AAA	O
GCA	O
GAG	O
;	O
NT3R	O
,	O
CCT	O
TGA	O
CAA	O
TAC	O
TGA	O
ATG	O
CC	O
;	O
and	O
NEOF	O
,	O
GGG	O
AAC	O
TTC	O
CTG	O
ACT	O
AGG	O
.	O

WT	O
,	O
Bax	O
KO	O
,	O
and	O
NT	O
-	O
3	O
KO	O
littermates	O
were	O
used	O
as	O
controls	O
.	O

A	O
total	O
of	O
11	O
Bax	O
/	O
NT	O
-	O
3	O
double	O
KO	O
mice	O
were	O
analyzed	O
,	O
of	O
these	O
nine	O
were	O
P0	O
pups	O
.	O

The	O
p75	O
colony	O
on	O
a	O
129	O
S1	O
background	O
was	O
received	O
from	O
Jackson	O
Laboratory	O
.	O

We	O
used	O
tail	O
DNA	O
to	O
genotype	O
animals	O
using	O
the	O
primers	O
IMR0013	O
,	O
CTT	O
GGG	O
TGG	O
AGA	O
GGC	O
TAT	O
TC	O
;	O
IMR0014	O
,	O
AGG	O
TGA	O
GAT	O
GAC	O
AGG	O
AGA	O
TC	O
(	O
generic	O
neo	O
primers	O
)	O
;	O
IMR0710	O
,	O
TGT	O
TAC	O
GTT	O
CTC	O
TGA	O
CGT	O
GGT	O
GAG	O
;	O
and	O
IMR0711	O
,	O
TCA	O
GCC	O
CAG	O
GGT	O
GTG	O
CAC	O
TC	O
(	O
p75	O
locus	O
)	O
.	O

For	O
embryonic	O
experiments	O
,	O
day	O
of	O
plug	O
positivity	O
was	O
considered	O
E0	O
.	O

All	O
of	O
the	O
protocols	O
used	O
in	O
this	O
study	O
were	O
approved	O
by	O
the	O
Louisiana	O
State	O
University	O
Health	O
Sciences	O
Center	O
Institutional	O
Animal	O
Care	O
and	O
Use	O
Committee	O
and	O
conformed	O
to	O
the	O
National	O
Institutes	O
of	O
Health	O
guidelines	O
for	O
use	O
of	O
experimental	O
animals	O
.	O

TrkA	O
/	O
TrkC	O
immunohistochemistry	O
.	O

Frozen	O
spinal	O
cord	O
sections	O
(	O
10	O
mu	O
m	O
thick	O
)	O
were	O
blocked	O
and	O
incubated	O
in	O
a	O
cocktail	O
of	O
rabbit	O
anti	O
-	O
TrkA	O
and	O
goat	O
anti	O
-	O
TrkC	O
antibodies	S-GO
(	O
gift	O
of	O
Dr	O
.	O
Reichardt	O
;	O
Huang	O
et	O
al	O
.	O
1999	O
)	O
,	O
followed	O
by	O
a	O
cocktail	O
of	O
CY3	O
conjugated	O
donkey	O
anti	O
-	O
rabbit	O
and	O
FITC	O
conjugated	O
donkey	O
anti	O
-	O
goat	O
antibodies	S-GO
(	O
Chemicon	O
,	O
Temecula	O
,	O
California	O
,	O
United	O
States	O
)	O
in	O
the	O
presence	O
of	O
0	O
.	O
3	O
%	O
TritonX	O
-	O
100	O
and	O
10	O
%	O
normal	O
donkey	O
serum	O
.	O

For	O
PV	O
immunohistochemistry	O
,	O
sections	O
were	O
reacted	O
with	O
monoclonal	O
mouse	O
anti	O
-	O
PV	O
antibody	S-GO
(	O
Sigma	O
,	O
St	O
.	O
Louis	O
,	O
Missouri	O
,	O
United	O
States	O
)	O
,	O
and	O
developed	O
by	O
Vector	O
fluorescein	O
mouse	O
on	O
mouse	O
kit	O
(	O
Vector	O
Laboratories	O
,	O
Burlingame	O
,	O
California	O
,	O
United	O
States	O
)	O
.	O

For	O
quantification	O
purposes	O
,	O
TrkA	O
-	O
and	O
TrkC	O
-	O
labeled	O
cells	O
from	O
four	O
different	O
DRGs	O
of	O
each	O
genotype	O
and	O
age	O
studied	O
were	O
counted	O
,	O
and	O
ratios	O
plotted	O
.	O

Muscle	O
spindle	O
detection	O
.	O

Gastrocnemius	O
muscle	O
was	O
dissected	O
out	O
in	O
P0	O
pups	O
and	O
sectioned	O
longitudinally	O
,	O
or	O
,	O
in	O
some	O
cases	O
,	O
the	O
whole	O
leg	O
at	O
the	O
level	O
of	O
gastrocnemius	O
muscle	O
with	O
tibial	O
nerve	O
was	O
sectioned	O
in	O
cross	O
section	O
.	O

Sections	O
were	O
incubated	O
with	O
monoclonal	O
S46	O
antibody	S-GO
(	O
gift	O
of	O
Dr	O
.	O
Stockdale	O
)	O
reactive	O
to	O
the	O
spindle	O
-	O
specific	O
slow	O
-	O
tonic	O
myosin	S-GO
heavy	O
chain	O
isoform	O
and	O
developed	O
by	O
Vector	O
mouse	O
on	O
mouse	O
kit	O
as	O
described	O
above	O
,	O
followed	O
by	O
rabbit	O
anti	O
-	O
NF	O
-	O
M	O
antibody	S-GO
(	O
Chemicon	O
)	O
and	O
CY3	O
conjugated	O
goat	O
anti	O
-	O
rabbit	O
antibody	S-GO
(	O
Chemicon	O
)	O
in	O
a	O
sequential	O
double	O
-	O
labeling	O
protocol	O
.	O

In	O
another	O
method	O
,	O
DiI	O
crystals	O
were	O
placed	O
in	O
DRGs	O
of	O
E17	O
embryos	O
from	O
different	O
genotypes	O
(	O
n	O
=	O
2	O
)	O
,	O
and	O
the	O
gastrocnemius	O
muscle	O
was	O
isolated	O
and	O
sectioned	O
into	O
40	O
-	O
mu	O
m	O
-	O
thick	O
slices	O
on	O
a	O
vibratome	O
.	O

DiI	O
labeling	O
.	O

Spinal	O
cords	O
were	O
dissected	O
out	O
with	O
the	O
DRGs	O
attached	O
,	O
motor	O
root	O
was	O
cut	O
to	O
prevent	O
backfilling	O
of	O
motor	O
neurons	O
,	O
and	O
crystals	O
of	O
1	O
,	O
1	O
'	O
-	O
dioctadecyl	O
-	O
3	O
,	O
3	O
,	O
3	O
'	O
,	O
3	O
'	O
-	O
tetramethylindocarbocyanine	O
perchlorate	O
(	O
DiI	O
;	O
Molecular	O
Probes	O
,	O
Eugene	O
,	O
Oregon	O
,	O
United	O
States	O
)	O
were	O
inserted	O
in	O
DRGs	O
.	O

Labeled	O
spinal	O
cords	O
were	O
incubated	O
at	O
37	O
degrees	O
C	O
for	O
8	O
d	O
and	O
sectioned	O
on	O
a	O
vibrotome	O
at	O
100	O
mu	O
m	O
.	O

Sections	O
were	O
observed	O
under	O
the	O
fluorescent	O
microscope	O
and	O
photographed	O
,	O
and	O
images	O
were	O
transferred	O
to	O
Adobe	O
Photoshop	O
,	O
inverted	O
,	O
and	O
adjusted	O
for	O
brightness	O
and	O
contrast	O
.	O

Photoconverted	O
in	O
0	O
.	O
15	O
%	O
DAB	O
(	O
3	O
,	O
3	O
'	O
-	O
diaminobenzidine	O
;	O
Sigma	O
)	O
in	O
0	O
.	O
1M	O
Tris	O
buffer	O
(	O
pH	O
8	O
.	O
2	O
)	O
.	O

In	O
vitro	O
co	O
-	O
culture	O
assay	O
.	O

DRG	O
explants	O
were	O
derived	O
from	O
Swiss	O
Webster	O
,	O
Bax	O
null	O
,	O
and	O
p75	O
null	O
mouse	O
embryos	O
(	O
E13	O
)	O
.	O

For	O
collagen	O
matrix	O
assays	O
,	O
DRGs	O
were	O
dissected	O
out	O
under	O
a	O
stereomicroscope	O
using	O
tungsten	O
needles	O
.	O

Collagen	O
matrix	O
was	O
prepared	O
with	O
430	O
mu	O
l	O
of	O
collagen	O
(	O
3	O
mg	O
/	O
ml	O
dissolved	O
in	O
0	O
.	O
1M	O
acetic	O
acid	O
,	O
Sigma	O
)	O
,	O
50	O
mu	O
l	O
of	O
10X	O
DMEM	O
medium	O
,	O
and	O
2	O
.	O
5	O
mu	O
l	O
of	O
0	O
.	O
8	O
M	O
NaCa2	O
,	O
and	O
the	O
pH	O
was	O
adjusted	O
to	O
7	O
.	O
5	O
.	O

Individual	O
ganglion	O
explants	O
were	O
placed	O
in	O
24	O
-	O
well	O
plates	O
and	O
covered	O
with	O
freshly	O
prepared	O
collagen	O
.	O

Sepharose	O
beads	O
with	O
an	O
average	O
diameter	O
of	O
150	O
mu	O
m	O
were	O
used	O
.	O

Beads	O
were	O
washed	O
twice	O
with	O
PBS	O
,	O
air	O
dried	O
,	O
and	O
loaded	O
with	O
10	O
,	O
20	O
,	O
50	O
,	O
or	O
100	O
ng	O
/	O
mu	O
l	O
NT	O
-	O
3	O
(	O
Collaborative	O
Research	O
,	O
Chemicon	O
)	O
at	O
4	O
degrees	O
C	O
overnight	O
with	O
constant	O
shaking	O
.	O

For	O
negative	O
control	O
,	O
beads	O
were	O
loaded	O
with	O
BSA	O
(	O
10	O
-	O
100	O
ng	O
/	O
mu	O
l	O
)	O
or	O
PBS	O
.	O

Either	O
a	O
single	O
neurotrophin	O
-	O
loaded	O
bead	O
or	O
a	O
single	O
BSA	O
(	O
or	O
PBS	O
)	O
-	O
loaded	O
bead	O
was	O
implanted	O
about	O
200	O
-	O
1	O
,	O
200	O
mu	O
m	O
away	O
from	O
the	O
ganglion	O
explant	O
.	O

Collagen	O
-	O
embedded	O
cultures	O
were	O
then	O
placed	O
at	O
33	O
degrees	O
C	O
for	O
15	O
min	O
for	O
the	O
matrix	O
to	O
harden	O
.	O

Serum	O
-	O
free	O
culture	O
medium	O
was	O
then	O
added	O
to	O
each	O
well	O
.	O

In	O
cultures	O
with	O
WT	O
DRG	O
and	O
control	O
beads	O
,	O
10	O
%	O
serum	O
was	O
added	O
to	O
ensure	O
viability	O
of	O
the	O
explants	O
.	O

TrkC	O
-	O
Fc	O
(	O
Regeneron	O
Pharmaceuticals	O
,	O
Tarrytown	O
,	O
New	O
York	O
,	O
United	O
States	O
)	O
was	O
added	O
(	O
20	O
mu	O
g	O
/	O
ml	O
)	O
into	O
the	O
culture	O
medium	O
.	O

Explant	O
co	O
-	O
cultures	O

Spinal	O
cords	O
with	O
attached	O
DRGs	O
were	O
dissected	O
out	O
from	O
Swiss	O
Webster	O
mouse	O
embryos	O
at	O
E13	O
,	O
and	O
sectioned	O
into	O
300	O
-	O
mu	O
m	O
-	O
thick	O
slices	O
.	O

Tissue	O
slices	O
were	O
placed	O
on	O
Millicell	O
Tissue	O
Culture	O
Inserts	O
(	O
Millipore	O
,	O
Billrica	O
,	O
Massachusetts	O
,	O
United	O
States	O
)	O
.	O

NT	O
-	O
3	O
-	O
loaded	O
(	O
n	O
=	O
15	O
)	O
or	O
PBS	O
-	O
loaded	O
(	O
n	O
=	O
6	O
)	O
sepharose	O
beads	O
were	O
prepared	O
as	O
described	O
above	O
,	O
and	O
placed	O
in	O
the	O
midline	O
at	O
mid	O
-	O
spinal	O
cord	O
level	O
.	O

Inserts	O
were	O
placed	O
in	O
six	O
-	O
well	O
plates	O
with	O
serum	O
-	O
free	O
medium	O
at	O
the	O
bottom	O
of	O
the	O
wells	O
,	O
and	O
kept	O
at	O
33	O
degrees	O
C	O
for	O
3	O
d	O
in	O
the	O
presence	O
of	O
5	O
%	O
CO2	O
.	O

Cultures	O
were	O
then	O
fixed	O
with	O
4	O
%	O
paraformaldehyde	O
in	O
PBS	O
,	O
and	O
small	O
crystals	O
of	O
DiI	O
were	O
placed	O
into	O
the	O
DRGs	O
.	O

Samples	O
were	O
incubated	O
in	O
a	O
37	O
-	O
degrees	O
C	O
incubator	O
,	O
allowing	O
the	O
dye	O
to	O
diffuse	O
,	O
and	O
photographed	O
under	O
a	O
Nikon	O
(	O
Tokyo	O
,	O
Japan	O
)	O
inverted	O
epifluoresence	O
microscope	O
.	O

Supporting	O
Information	O

Figure	O
S1	O

Motor	O
Neuron	O
Innervation	O
Initiated	O
in	O
WT	O
E17	O
Embryos	O
Cannot	O
Be	O
Detected	O
in	O
Bax	O
/	O
NT	O
-	O
3	O
Double	O
KOs	O

In	O
some	O
of	O
the	O
samples	O
,	O
motor	O
neurons	O
were	O
labeled	O
by	O
backfilling	O
through	O
the	O
ventral	O
root	O
in	O
addition	O
to	O
the	O
sensory	O
axons	S-GO
labeled	O
through	O
the	O
DRGs	O
.	O

(	O
A	O
)	O
WT	O
embryo	O
showing	O
proprioceptive	O
axons	S-GO
contacting	O
motor	O
neuron	O
dendrites	S-GO
in	O
the	O
ventral	O
horn	O
,	O
forming	O
synapses	S-GO
.	O

(	O
B	O
)	O
Bax	O
/	O
NT	O
-	O
3	O
double	O
null	O
spinal	O
cord	O
.	O

Although	O
labeled	O
fibers	O
enter	O
the	O
ventral	O
spinal	O
cord	O
,	O
they	O
extend	O
towards	O
the	O
midline	O
instead	O
of	O
the	O
ventral	O
horn	O
and	O
never	O
contact	O
the	O
motor	O
neuron	O
dendrites	S-GO
.	O

(	O
C	O
)	O
High	O
-	O
power	O
image	O
of	O
the	O
inset	O
in	O
(	O
A	O
)	O
.	O

Arrows	O
point	O
to	O
the	O
proprioceptive	O
fibers	O
contacting	O
motor	O
neurons	O
(	O
asterisk	O
)	O
.	O

(	O
D	O
)	O
High	O
-	O
power	O
image	O
of	O
the	O
inset	O
in	O
(	O
B	O
)	O
.	O

Notice	O
that	O
there	O
are	O
no	O
sensory	O
axons	S-GO
contacting	O
labeled	O
motor	O
neurons	O
(	O
asterisk	O
)	O
.	O

Scale	O
bar	O
:	O
100	O
mu	O
m	O
(	O
A	O
and	O
B	O
)	O
,	O
50	O
mu	O
m	O
(	O
C	O
and	O
D	O
)	O
.	O

(	O
24	O
MB	O
TIF	O
)	O
.	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Figure	O
S2	O

S46	O
/	O
NF	O
-	O
M	O
Immunohistochemistry	O
at	O
E15	O
Gastrocnemius	O
Muscle	O

Although	O
numerous	O
muscle	O
and	O
nerve	O
fibers	O
were	O
labeled	O
,	O
no	O
muscle	O
spindles	O
could	O
be	O
identified	O
because	O
the	O
characteristic	O
morphology	O
of	O
sensory	O
nerve	O
ending	O
wrapped	O
around	O
muscle	O
bag	O
fiber	O
had	O
not	O
begun	O
to	O
develop	O
in	O
any	O
of	O
the	O
genotypes	O
yet	O
.	O

Scale	O
bar	O
:	O
25	O
mu	O
m	O
.	O

(	O
13	O
MB	O
TIF	O
)	O
.	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Acknowledgements	O

We	O
thank	O
L	O
.	O

Tessarollo	O
for	O
providing	O
NT	O
-	O
3	O
KO	O
animals	O
,	O
L	O
.	O

Reichardt	O
for	O
TrkA	O
and	O
TrkC	O
antibodies	S-GO
,	O
F	O
.	O

Stockdale	O
for	O
the	O
S46	O
antibody	S-GO
,	O
K	O
.	O

Muneoka	O
for	O
sepharose	O
beads	O
,	O
and	O
B	O
.	O

King	O
for	O
maintenance	O
of	O
animals	O
used	O
in	O
this	O
study	O
.	O

We	O
particularly	O
thank	O
E	O
.	O

Frank	O
for	O
many	O
helpful	O
comments	O
and	O
discussions	O
about	O
this	O
study	O
and	O
for	O
sharing	O
unpublished	O
data	O
from	O
his	O
laboratory	O
.	O

Supported	O
by	O
National	O
Institutes	O
of	O
Health	O
/	O
National	O
Institute	O
of	O
Dental	O
and	O
Craniofacial	O
Research	O
grant	O
P01	O
DE07734	O
.	O

Abbreviations	O

BDNF	O
-	O
brain	O
-	O
derived	O
neurotrophic	O
factor	O

BSA	O
-	O
bovine	O
serum	O
albumin	O

DRG	O
-	O
dorsal	O
root	O
ganglion	O

E	O
-	O
embryonic	O
day	O

KO	O
-	O
knockout	O

NF	O
-	O
M	O
-	O
neurofilament	O
-	O
M	O

NT	O
-	O
3	O
-	O
neurotrophin	O
-	O
3	O

P	O
-	O
postnatal	O
day	O

PBS	O
-	O
phosphate	O
buffer	O
saline	O

PV	O
-	O
parvalbumin	O

TrkC	O
-	O
Fc	O
-	O
diffusible	O
TrkC	O
receptors	O
conjugated	O
to	O
IgG	O
constant	O
regions	O

WT	O
-	O
wild	O
-	O
type	O

Figures	O
and	O
Tables	O

Figure	O
1	O

TrkA	O
/	O
TrkC	O
and	O
PV	O
Immunohistochemistry	O
in	O
DRG	O
and	O
Spinal	O
Cord	O

Red	O
represents	O
TrkA	O
,	O
green	O
represents	O
TrkC	O
(	O
and	O
PV	O
in	O
[	O
C	O
]	O
)	O
,	O
and	O
yellow	O
represents	O
co	O
-	O
expression	O
.	O

(	O
A	O
)	O
TrkA	O
/	O
TrkC	O
immunostaining	O
in	O
E15	O
DRG	O
.	O

TrkC	O
-	O
positive	O
neurons	O
normally	O
eliminated	O
in	O
NT	O
-	O
3	O
KOs	O
are	O
rescued	O
in	O
double	O
KOs	O
.	O

(	O
B	O
)	O
TrkA	O
/	O
TrkC	O
immunostaining	O
at	O
P0	O
in	O
DRG	O
.	O

(	O
C	O
)	O
PV	O
immunostaining	O
in	O
P0	O
DRG	O
.	O

Rescued	O
TrkC	O
-	O
positive	O
cells	O
fail	O
to	O
express	O
PV	O
.	O

(	O
D	O
)	O
Ratio	O
of	O
TrkA	O
-	O
immunopositive	O
cells	O
to	O
TrkC	O
-	O
immunopositive	O
cells	O
in	O
E15	O
and	O
P0	O
DRGs	O
.	O

Data	O
are	O
presented	O
as	O
percentage	O
of	O
cells	O
with	O
standard	O
deviation	O
.	O

Double	O
KOs	O
always	O
had	O
similar	O
ratios	O
to	O
Bax	O
KOs	O
,	O
and	O
NT	O
-	O
3	O
KOs	O
had	O
the	O
least	O
amount	O
of	O
TrkC	O
-	O
positive	O
cells	O
,	O
if	O
any	O
.	O

(	O
E	O
)	O
TrkA	O
/	O
TrkC	O
immunostaining	O
in	O
E15	O
spinal	O
cord	O
.	O

Arrow	O
points	O
to	O
group	O
Ia	O
fibers	O
.	O

Dorsal	O
is	O
up	O
.	O

Scale	O
bar	O
:	O
50	O
mu	O
m	O
(	O
A	O
-	O
C	O
)	O
,	O
1	O
mm	O
(	O
E	O
)	O
.	O

Figure	O
2	O

Axonal	S-GO
Projections	S-GO
in	O
the	O
Spinal	O
Cord	O
after	O
DiI	O
Labeling	O
of	O
DRG	O
at	O
P0	O

(	O
A	O
)	O
Rescued	O
DRG	O
proprioceptive	O
neurons	O
fail	O
to	O
properly	O
innervate	O
motor	O
neurons	O
in	O
double	O
KOs	O
.	O

Instead	O
,	O
some	O
axons	S-GO
are	O
directed	O
towards	O
the	O
ventral	O
midline	O
;	O
they	O
cross	O
the	O
midline	O
and	O
branch	O
.	O

(	O
B	O
)	O
Schematic	O
drawing	O
of	O
the	O
monosynaptic	O
reflex	O
arc	O
as	O
it	O
normally	O
develops	O
.	O

Small	O
black	O
dots	O
represent	O
NT	O
-	O
3	O
released	O
centrally	O
by	O
the	O
motor	O
neurons	O
and	O
peripherally	O
by	O
the	O
muscle	O
spindles	O
.	O

(	O
C	O
)	O
High	O
-	O
power	O
magnification	O
of	O
the	O
inset	O
in	O
(	O
A	O
)	O
.	O

Arrow	O
points	O
to	O
the	O
midline	O
,	O
and	O
arrowheads	O
point	O
to	O
synaptic	B-GO
bouton	E-GO
-	O
like	O
structures	O
.	O

Scale	O
bar	O
:	O
1	O
mm	O
(	O
A	O
)	O
,	O
400	O
mu	O
m	O
(	O
C	O
)	O
.	O

Figure	O
3	O

Sensory	O
Axons	S-GO
Labeled	O
with	O
DiI	O
through	O
the	O
DRG	O
at	O
E17	O

(	O
A	O
)	O
DiI	O
-	O
labeled	O
fibers	O
in	O
WT	O
spinal	O
cord	O
.	O

Notice	O
proprioceptive	O
axons	S-GO
extending	O
towards	O
the	O
motor	O
neurons	O
located	O
in	O
the	O
ventral	O
horn	O
of	O
the	O
spinal	O
cord	O
in	O
cross	O
section	O
.	O

(	O
B	O
)	O
Bax	O
null	O
spinal	O
cord	O
.	O

(	O
C	O
)	O
NT	O
-	O
3	O
null	O
spinal	O
cord	O
.	O

Stained	O
fibers	O
are	O
restricted	O
to	O
the	O
nociceptive	O
axons	S-GO
in	O
the	O
dorsal	O
horn	O
,	O
as	O
evidenced	O
by	O
the	O
complete	O
absence	O
of	O
labeling	O
in	O
the	O
ventral	O
spinal	O
cord	O
.	O

(	O
D	O
)	O
Bax	O
/	O
NT	O
-	O
3	O
double	O
null	O
spinal	O
cord	O
.	O

Although	O
fibers	O
extend	O
into	O
the	O
ventral	O
spinal	O
cord	O
,	O
they	O
never	O
grow	O
towards	O
the	O
motor	O
neurons	O
,	O
but	O
are	O
directed	O
towards	O
the	O
midline	O
instead	O
.	O

Scale	O
bar	O
:	O
100	O
mu	O
m	O
.	O

Figure	O
4	O

Muscle	O
Spindles	O
in	O
Gastrocnemius	O
Muscle	O
and	O
TrkA	O
/	O
TrkC	O
Staining	O
in	O
the	O
Tibial	O
Nerve	O
at	O
P0	O

(	O
A	O
)	O
NF	O
-	O
M	O
(	O
red	O
)	O
and	O
S46	O
(	O
green	O
)	O
immunostaining	O
in	O
cross	O
section	O
of	O
gastrocnemius	O
muscle	O
at	O
P0	O
.	O

There	O
are	O
no	O
muscle	O
spindles	O
detected	O
in	O
double	O
KOs	O
.	O

(	O
B	O
)	O
NF	O
-	O
M	O
(	O
red	O
)	O
and	O
S46	O
(	O
green	O
)	O
immunostaining	O
in	O
parallel	O
sections	O
of	O
gastrocnemius	O
muscle	O
at	O
P0	O
.	O

(	O
C	O
)	O
NF	O
-	O
M	O
(	O
red	O
)	O
and	O
S46	O
(	O
green	O
)	O
immunostaining	O
in	O
parallel	O
sections	O
of	O
gastrocnemius	O
muscle	O
at	O
E17	O
.	O

Double	O
null	O
muscles	O
are	O
mostly	O
devoid	O
of	O
muscle	O
spindles	O
,	O
except	O
for	O
one	O
spindle	O
-	O
like	O
structure	O
detected	O
(	O
shown	O
in	O
inset	O
,	O
denoted	O
by	O
the	O
asterisk	O
)	O
.	O

(	O
D	O
)	O
Muscle	O
spindles	O
detected	O
by	O
DiI	O
labeling	O
through	O
the	O
DRG	O
.	O

Gastrocnemius	O
muscle	O
is	O
sectioned	O
at	O
40	O
mu	O
m	O
thickness	O
in	O
parallel	O
plane	O
to	O
the	O
muscle	O
fibers	O
.	O

(	O
E	O
)	O
Muscle	O
spindles	O
detected	O
by	O
TrkC	O
staining	O
in	O
cross	O
section	O
of	O
gastrocnemius	O
muscle	O
at	O
P0	O
.	O

(	O
F	O
)	O
TrkA	O
(	O
red	O
)	O
and	O
TrkC	O
(	O
green	O
)	O
immunostaining	O
in	O
the	O
tibial	O
nerve	O
cross	O
section	O
at	O
P0	O
.	O

TrkC	O
-	O
positive	O
fibers	O
are	O
missing	O
in	O
NT	O
-	O
3	O
KOs	O
.	O

Red	O
-	O
green	O
overlap	O
(	O
yellow	O
)	O
is	O
due	O
to	O
the	O
thickness	O
of	O
the	O
section	O
and	O
overlapping	O
of	O
red	O
-	O
and	O
green	O
-	O
labeled	O
(	O
TrkA	O
and	O
TrkC	O
)	O
fibers	O
present	O
at	O
different	O
focal	O
depths	O
,	O
rather	O
than	O
co	O
-	O
localization	O
.	O

Arrows	O
indicate	O
muscle	O
spindles	O
.	O

Scale	O
bar	O
:	O
50	O
mu	O
m	O
(	O
A	O
,	O
B	O
,	O
D	O
)	O
,	O
25	O
mu	O
m	O
(	O
C	O
,	O
E	O
)	O
,	O
75	O
mu	O
m	O
(	O
F	O
)	O
.	O

Figure	O
5	O

Chemoattraction	O
of	O
E13	O
DRG	O
Axons	S-GO
to	O
Local	O
NT	O
-	O
3	O
Observed	O
by	O
In	O
Vitro	O
Co	O
-	O
Culture	O
Assays	O

(	O
A	O
)	O
WT	O
DRG	O
with	O
NT	O
-	O
3	O
-	O
loaded	O
bead	O
.	O

(	O
B	O
)	O
WT	O
DRG	O
with	O
BSA	O
-	O
loaded	O
bead	O
.	O

(	O
C	O
)	O
Bax	O
null	O
DRG	O
with	O
NT	O
-	O
3	O
-	O
loaded	O
bead	O
.	O

(	O
D	O
)	O
p75	O
null	O
DRG	O
with	O
NT	O
-	O
3	O
-	O
loaded	O
bead	O
.	O

(	O
E	O
)	O
WT	O
DRG	O
with	O
NT	O
-	O
3	O
-	O
loaded	O
bead	O
and	O
TrkC	O
-	O
Fc	O
in	O
the	O
medium	O
.	O

(	O
F	O
)	O
WT	O
DRG	O
with	O
NT	O
-	O
3	O
loaded	O
beads	O
placed	O
at	O
increasing	O
distances	O
away	O
from	O
the	O
ganglia	O
(	O
range	O
,	O
500	O
-	O
1	O
,	O
200	O
mu	O
m	O
)	O
.	O

Scale	O
bar	O
:	O
150	O
mu	O
m	O
(	O
A	O
-	O
E	O
)	O
,	O
350	O
mu	O
m	O
(	O
F	O
)	O
.	O

Figure	O
6	O

Chemoattraction	O
Towards	O
NT	O
-	O
3	O
Beads	O
Placed	O
in	O
E13	O
Spinal	O
Cord	O
DRG	O
Explant	O
Co	O
-	O
Cultures	O

(	O
A	O
)	O
NT	O
-	O
3	O
bead	O
placed	O
in	O
the	O
midline	O
of	O
E13	O
WT	O
spinal	O
cord	O
.	O

Notice	O
axons	S-GO
labeled	O
through	O
the	O
DRGs	O
(	O
circled	O
with	O
black	O
dashed	O
lines	O
)	O
growing	O
towards	O
the	O
bead	O
(	O
circled	O
with	O
white	O
dashed	O
lines	O
)	O
enter	O
the	O
spinal	O
cord	O
at	O
ectopic	O
loci	O
instead	O
of	O
dorsal	O
spinal	O
cord	O
.	O

(	O
B	O
)	O
PBS	O
-	O
loaded	O
bead	O
in	O
E13	O
spinal	O
cord	O
.	O

All	O
labeled	O
axons	S-GO
extend	O
along	O
the	O
dorsal	O
spinal	O
cord	O
,	O
where	O
they	O
terminate	O
.	O

(	O
C	O
)	O
High	O
-	O
power	O
image	O
of	O
the	O
bead	O
in	O
(	O
A	O
)	O
.	O

Notice	O
labeled	O
axons	S-GO
surrounding	O
the	O
bead	O
.	O

(	O
D	O
)	O
High	O
-	O
power	O
image	O
of	O
an	O
NT	O
-	O
3	O
-	O
loaded	O
bead	O
.	O

Notice	O
axons	S-GO
bundled	O
around	O
the	O
bead	O
.	O

(	O
E	O
)	O
High	O
-	O
power	O
image	O
of	O
an	O
NT	O
-	O
3	O
-	O
loaded	O
bead	O
.	O

Notice	O
the	O
axons	S-GO
approaching	O
the	O
bead	O
via	O
the	O
dorsal	O
spinal	O
cord	O
.	O

(	O
F	O
)	O
High	O
-	O
power	O
image	O
of	O
a	O
PBS	O
-	O
loaded	O
bead	O
.	O

No	O
labeled	O
fibers	O
were	O
observed	O
around	O
control	O
beads	O
.	O

(	O
G	O
)	O
Summary	O
of	O
our	O
observations	O
from	O
E13	O
spinal	O
cord	O
DRG	O
organotypic	O
cultures	O
.	O

In	O
control	O
cultures	O
fibers	O
extend	O
along	O
the	O
dorsal	O
spinal	O
cord	O
,	O
where	O
they	O
normally	O
enter	O
the	O
gray	O
matter	O
at	O
E13	O
.	O

In	O
the	O
presence	O
of	O
an	O
ectopic	O
NT	O
-	O
3	O
source	O
localized	O
at	O
the	O
midline	O
,	O
these	O
axons	S-GO
grow	O
towards	O
the	O
NT	O
-	O
3	O
bead	O
.	O

NT	O
-	O
3	O
also	O
initiates	O
axon	O
growth	O
from	O
the	O
DRGs	O
,	O
entering	O
the	O
spinal	O
cord	O
at	O
ectopic	O
lateral	O
loci	O
,	O
growing	O
towards	O
the	O
bead	O
,	O
surrounding	O
the	O
bead	O
,	O
forming	O
nerve	O
bundles	O
,	O
and	O
branching	O
around	O
it	O
.	O

Scale	O
bar	O
,	O
175	O
mu	O
m	O
(	O
A	O
and	O
B	O
)	O
,	O
100	O
mu	O
m	O
(	O
C	O
-	O
F	O
)	O
.	O

Footnotes	O

Conflicts	O
of	O
interest	O
.	O

The	O
authors	O
have	O
declared	O
that	O
no	O
conflicts	O
of	O
interest	O
exist	O
.	O

Author	O
contributions	O
.	O

BG	O
and	O
RE	O
conceived	O
and	O
designed	O
the	O
experiments	O
.	O

BG	O
,	O
AEM	O
,	O
and	O
PHO	O
performed	O
the	O
experiments	O
.	O

BG	O
,	O
PHO	O
,	O
and	O
RE	O
analyzed	O
the	O
data	O
.	O

BG	O
and	O
RE	O
wrote	O
the	O
paper	O
.	O

Academic	O
Editor	O
:	O
Joshua	O
R	O
.	O
Sanes	O
,	O
Harvard	O
University	O

currency	O
Current	O
address	O
:	O
Massachusetts	O
General	O
Hospital	O
,	O
Harvard	O
Medical	O
School	O
Center	O
for	O
Nervous	O
System	O
Repair	O
,	O
Boston	O
,	O
Massachusetts	O
,	O
United	O
States	O
of	O
America	O

Citation	O
:	O
Gen	O
c	O
B	O
,	O
O	O
zdinler	O
PH	O
,	O
Mendoza	O
AE	O
,	O
Erzurumlu	O
RS	O
(	O
2004	O
)	O
A	O
chemoattractant	O
role	O
for	O
NT	O
-	O
3	O
in	O
proprioceptive	O
axon	S-GO
guidance	O
.	O

PLoS	O
Biol	O
2	O
(	O
12	O
)	O
:	O
e403	O
.	O

DNA	O
binding	O
and	O
helicase	O
actions	O
of	O
mouse	O
MCM4	O
/	O
6	O
/	O
7	O
helicase	O

Abstract	O

Helicases	O
play	O
central	O
roles	O
in	O
initiation	O
and	O
elongation	O
of	O
DNA	O
replication	O
.	O

We	O
previously	O
reported	O
that	O
helicase	O
and	O
ATPase	O
activities	O
of	O
the	O
mammalian	O
Mcm4	O
/	O
6	O
/	O
7	O
complex	S-GO
are	O
activated	O
specifically	O
by	O
thymine	O
-	O
rich	O
single	O
-	O
stranded	O
DNA	O
.	O

Here	O
,	O
we	O
examined	O
its	O
substrate	O
preference	O
and	O
helicase	O
actions	O
using	O
various	O
synthetic	O
DNAs	O
.	O

On	O
a	O
bubble	O
substrate	O
,	O
Mcm4	O
/	O
6	O
/	O
7	O
makes	O
symmetric	O
dual	O
contacts	O
with	O
the	O
5	O
'	O
-	O
proximal	O
25	O
nt	O
single	O
-	O
stranded	O
segments	O
adjacent	O
to	O
the	O
branch	O
points	O
,	O
presumably	O
generating	O
double	O
hexamers	O
.	O

Loss	O
of	O
thymine	O
residues	O
from	O
one	O
single	O
-	O
strand	O
results	O
in	O
significant	O
decrease	O
of	O
unwinding	O
efficacy	O
,	O
suggesting	O
that	O
concurrent	O
bidirectional	O
unwinding	O
by	O
a	O
single	O
double	O
hexameric	O
Mcm4	O
/	O
6	O
/	O
7	O
may	O
play	O
a	O
role	O
in	O
efficient	O
unwinding	O
of	O
the	O
bubble	O
.	O

Mcm4	O
/	O
6	O
/	O
7	O
binds	O
and	O
unwinds	O
various	O
fork	S-GO
and	O
extension	O
structures	O
carrying	O
a	O
single	O
-	O
stranded	O
3	O
'	O
-	O
tail	O
DNA	O
.	O

The	O
extent	O
of	O
helicase	O
activation	O
depends	O
on	O
the	O
sequence	O
context	O
of	O
the	O
3	O
'	O
-	O
tail	O
,	O
and	O
the	O
maximum	O
level	O
is	O
achieved	O
by	O
DNA	O
with	O
50	O
%	O
or	O
more	O
thymine	O
content	O
.	O

Strand	O
displacement	O
by	O
Mcm4	O
/	O
6	O
/	O
7	O
is	O
inhibited	O
,	O
as	O
the	O
GC	O
content	O
of	O
the	O
duplex	O
region	O
increases	O
.	O

Replacement	O
of	O
cytosine	O
-	O
guanine	O
pairs	O
with	O
cytosine	O
-	O
inosine	O
pairs	O
in	O
the	O
duplex	O
restored	O
unwinding	O
,	O
suggesting	O
that	O
mammalian	O
Mcm4	O
/	O
6	O
/	O
7	O
helicase	O
has	O
difficulties	O
in	O
unwinding	O
stably	O
base	O
-	O
paired	O
duplex	O
.	O

Taken	O
together	O
,	O
these	O
findings	O
reveal	O
important	O
features	O
on	O
activation	O
and	O
substrate	O
preference	O
of	O
the	O
eukaryotic	O
replicative	O
helicase	O
.	O

INTRODUCTION	O

DNA	O
helicases	O
couple	O
the	O
hydrolysis	O
of	O
nucleotide	O
or	O
deoxynucleotide	O
triphosphate	O
to	O
duplex	O
unwinding	O
(	O
1	O
)	O
.	O

Coordination	O
of	O
a	O
set	O
of	O
subactivities	O
including	O
nucleotide	O
binding	O
,	O
DNA	O
binding	O
and	O
ATP	O
hydrolysis	O
is	O
required	O
for	O
unwinding	O
of	O
duplex	O
DNA	O
(	O
1	O
,	O
2	O
)	O
.	O

The	O
hexameric	O
helicases	O
,	O
to	O
which	O
minichromosome	B-GO
maintenance	I-GO
(	I-GO
Mcm	I-GO
)	I-GO
helicase	E-GO
belongs	O
,	O
are	O
known	O
to	O
assemble	O
a	O
ring	O
-	O
like	O
structure	O
(	O
3	O
-	O
5	O
)	O
.	O

Whereas	O
most	O
of	O
DNA	O
helicases	O
of	O
this	O
group	O
,	O
including	O
simian	O
virus	O
40	O
large	O
T	O
-	O
antigen	O
(	O
6	O
)	O
,	O
Escherichia	O
coli	O
DnaB	O
(	O
7	O
)	O
and	O
Archaeal	O
Mcm	O
(	O
4	O
,	O
8	O
,	O
9	O
)	O
,	O
are	O
composed	O
of	O
a	O
single	O
subunit	O
,	O
the	O
active	O
eukaryotic	O
Mcm	B-GO
helicases	E-GO
are	O
composed	O
of	O
two	O
trimeric	O
Mcm4	O
/	O
6	O
/	O
7	O
proteins	O
(	O
10	O
-	O
14	O
)	O
.	O

All	O
the	O
six	O
Mcm	O
2	O
-	O
7	O
proteins	O
contain	O
highly	O
conserved	O
DNA	O
-	O
dependent	O
ATPase	O
motifs	O
in	O
their	O
central	O
regions	O
(	O
15	O
,	O
16	O
)	O
.	O

Among	O
the	O
several	O
stable	O
subcomplexes	O
which	O
MCM	S-GO
proteins	O
can	O
generate	O
,	O
only	O
the	O
Mcm4	O
/	O
6	O
/	O
7	O
complex	S-GO
has	O
been	O
shown	O
to	O
possess	O
an	O
intrinsic	O
DNA	O
helicase	O
activity	O
(	O
10	O
-	O
14	O
,	O
17	O
-	O
18	O
)	O
.	O

While	O
Mcm4	O
,	O
Mcm6	O
and	O
Mcm7	O
proteins	O
make	O
distinct	O
contribution	O
to	O
its	O
helicase	O
activity	O
(	O
11	O
-	O
13	O
)	O
,	O
Mcm2	O
or	O
Mcm3	O
/	O
5	O
inhibit	O
the	O
helicase	O
activity	O
of	O
the	O
Mcm4	O
/	O
6	O
/	O
7	O
complex	S-GO
by	O
converting	O
its	O
double	O
trimer	O
structure	O
into	O
a	O
heterotetramer	O
or	O
heteropentamer	O
,	O
respectively	O
(	O
3	O
,	O
11	O
)	O
.	O

Chromatin	S-GO
immunoprecipitation	O
assays	O
and	O
genetic	O
characterization	O
in	O
Saccharomyces	O
cerevisiae	O
strongly	O
suggested	O
that	O
Mcm	S-GO
is	O
involved	O
not	O
only	O
in	O
initiation	O
but	O
also	O
in	O
the	O
DNA	O
chain	O
elongation	O
stage	O
as	O
a	O
replicative	O
helicase	O
(	O
19	O
,	O
20	O
)	O
.	O

Consistent	O
with	O
this	O
notion	O
,	O
the	O
processivity	O
of	O
the	O
Schizosaccharomyces	O
pombe	O
and	O
mouse	O
Mcm4	O
/	O
6	O
/	O
7	O
complexes	S-GO
is	O
significantly	O
stimulated	O
on	O
forked	S-GO
DNA	O
structures	O
and	O
it	O
can	O
unwind	O
duplex	O
DNA	O
of	O
400	O
-	O
500	O
bp	O
(	O
13	O
,	O
14	O
)	O
.	O

Mcm4	O
/	O
6	O
/	O
7	O
binds	O
to	O
fork	B-GO
and	I-GO
bubble	I-GO
structures	E-GO
in	O
an	O
ATP	O
-	O
dependent	O
manner	O
,	O
and	O
generates	O
a	O
double	O
-	O
hexameric	O
complex	S-GO
,	O
as	O
was	O
shown	O
for	O
T	O
-	O
antigen	O
(	O
13	O
,	O
14	O
,	O
21	O
)	O
.	O

Recently	O
,	O
we	O
reported	O
that	O
the	O
helicase	O
and	O
ATP	O
hydrolysis	O
activities	O
of	O
mammalian	O
Mcm4	O
/	O
6	O
/	O
7	O
are	O
specifically	O
activated	O
by	O
single	O
-	O
stranded	O
DNA	O
containing	O
stretches	O
of	O
thymine	O
residues	O
and	O
proposed	O
a	O
novel	O
model	O
that	O
Mcm	S-GO
may	O
play	O
a	O
crucial	O
role	O
in	O
selection	O
of	O
replication	O
origins	O
in	O
higher	O
eukaryotes	O
(	O
13	O
)	O
.	O

In	O
this	O
report	O
,	O
in	O
order	O
to	O
clarify	O
the	O
mode	O
of	O
action	O
of	O
the	O
Mcm	B-GO
helicase	E-GO
and	O
obtain	O
insight	O
into	O
how	O
it	O
may	O
function	O
at	O
the	O
replication	B-GO
forks	E-GO
in	O
vivo	O
,	O
we	O
have	O
conducted	O
detailed	O
analyses	O
of	O
helicase	O
action	O
and	O
DNA	O
binding	O
of	O
mouse	O
Mcm4	O
/	O
6	O
/	O
7	O
helicase	O
using	O
various	O
forked	S-GO
and	O
bubble	O
substrate	O
DNAs	O
.	O

We	O
specifically	O
addressed	O
sequence	O
requirement	O
for	O
the	O
Mcm	B-GO
helicase	E-GO
activation	O
,	O
mode	O
of	O
interaction	O
with	O
DNA	O
substrates	O
and	O
whether	O
the	O
thymine	O
sequences	O
are	O
required	O
for	O
continuous	O
activation	O
of	O
Mcm	B-GO
helicase	E-GO
during	O
the	O
unwinding	O
process	O
.	O

The	O
results	O
indicate	O
that	O
mammalian	O
Mcm4	O
/	O
6	O
/	O
7	O
primarily	O
binds	O
to	O
single	O
-	O
stranded	O
DNA	O
region	O
,	O
and	O
that	O
the	O
extent	O
of	O
helicase	O
activation	O
is	O
related	O
to	O
the	O
thymine	O
content	O
of	O
the	O
single	O
-	O
stranded	O
segment	O
.	O

Unexpectedly	O
,	O
Mcm4	O
/	O
6	O
/	O
7	O
helicase	O
is	O
not	O
capable	O
of	O
efficiently	O
unwinding	O
the	O
GC	O
-	O
rich	O
duplex	O
segment	O
,	O
suggesting	O
that	O
some	O
other	O
mechanism	O
may	O
be	O
required	O
for	O
completion	O
of	O
replication	O
of	O
the	O
entire	O
genome	O
.	O

MATERIALS	O
AND	O
METHODS	O

Reagents	O

Labeled	O
and	O
unlabeled	O
dNTPs	O
/	O
rNTPs	O
and	O
Sequenase	O
were	O
purchased	O
from	O
Amersham	O
Pharmacia	O
.	O

M13mp18	O
and	O
M13mp19	O
single	O
-	O
stranded	O
circular	O
DNA	O
,	O
T4	O
polynucleotide	O
kinase	O
,	O
DNase	O
I	O
and	O
the	O
Klenow	O
fragment	O
were	O
from	O
TAKARA	O
,	O
Nuclease	O
P1	O
was	O
from	O
Roche	O
,	O
and	O
anti	O
-	O
FLAG	O
M2	O
Ab	S-GO
(	O
antibody	S-GO
)	O
-	O
agarose	O
and	O
FLAG	O
peptide	O
were	O
from	O
Sigma	O
.	O

SV40	O
T	O
-	O
antigen	O
was	O
purified	O
from	O
baculovirus	O
-	O
infected	O
insect	O
cells	O
as	O
reported	O
(	O
22	O
)	O
.	O

PriA	O
helicase	O
protein	O
was	O
provided	O
by	O
Dr	O
Taku	O
Tanaka	O
(	O
23	O
)	O
.	O

Oligonucleotides	O
were	O
purchased	O
from	O
Hokkaido	O
system	O
science	O
Co	O
.	O
,	O
Ltd	O
(	O
Hokkaido	O
,	O
Japan	O
)	O
,	O
and	O
were	O
purified	O
on	O
polyacrylamide	O
gel	O
,	O
followed	O
by	O
purification	O
by	O
Sep	O
-	O
Pak	O
Plus	O
C18	O
cartridge	O
column	O
(	O
Waters	O
)	O
.	O

Expression	O
and	O
purification	O
of	O
mouse	O
Mcm4	O
/	O
6	O
/	O
7	O
complex	S-GO

The	O
recombinant	O
baculoviruses	O
expressing	O
His6	O
-	O
Mcm4	O
/	O
Mcm6	O
or	O
Mcm7	O
-	O
FLAG	O
proteins	O
were	O
previously	O
described	O
(	O
11	O
)	O
.	O

Sf9	O
and	O
High	O
five	O
insect	O
cells	O
were	O
cultured	O
at	O
27	O
degrees	O
C	O
in	O
Sf	O
-	O
900	O
II	O
SFM	O
(	O
Life	O
Technologies	O
,	O
Inc	O
.	O
)	O
and	O
EX	O
-	O
CELL	O
405	O
medium	O
(	O
JRH	O
Biosciences	O
)	O
,	O
respectively	O
.	O

For	O
expression	O
of	O
the	O
Mcm4	O
/	O
6	O
/	O
7	O
proteins	O
,	O
High	O
five	O
cells	O
were	O
coinfected	O
with	O
recombinant	O
baculoviruses	O
expressing	O
the	O
His6	O
-	O
Mcm4	O
/	O
Mcm6	O
proteins	O
and	O
those	O
expressing	O
the	O
Mcm7	O
-	O
FLAG	O
,	O
and	O
were	O
collected	O
at	O
48	O
h	O
post	O
-	O
infection	O
.	O

The	O
recombinant	O
Mcm4	O
/	O
6	O
/	O
7	O
complexes	S-GO
were	O
purified	O
as	O
previously	O
described	O
(	O
12	O
)	O
.	O

DNA	O
substrates	O

The	O
sequences	O
for	O
all	O
the	O
oligonucleotides	O
used	O
for	O
constructions	O
of	O
DNA	O
substrates	O
are	O
listed	O
in	O
Tables	O
1	O
and	O
2	O
.	O

The	O
partial	O
heteroduplex	O
substrates	O
were	O
constructed	O
by	O
annealing	O
labeled	O
oligonucleotides	O
with	O
M13mp18	O
single	O
-	O
stranded	O
circular	O
DNA	O
or	O
its	O
derivative	O
.	O

The	O
labeled	O
substrates	O
were	O
purified	O
by	O
Sepharose	O
CL4B	O
column	O
chromatography	O
(	O
Amersham	O
Pharmacia	O
Biotech	O
)	O
.	O

The	O
DNA	O
bubble	O
substrates	O
were	O
assembled	O
from	O
two	O
partially	O
complementary	O
oligonucleotides	O
with	O
top	O
and	O
bottom	O
strand	O
sequences	O
(	O
Table	O
1	O
)	O
.	O

T	O
-	O
tailed	O
Y	O
-	O
fork	S-GO
substrates	O
were	O
prepared	O
by	O
annealing	O
two	O
oligonucleotides	O
(	O
dT30	O
and	O
dT60	O
series	O
)	O
.	O

To	O
construct	O
the	O
arrested	O
fork	S-GO
and	O
3	O
'	O
-	O
or	O
5	O
'	O
-	O
extension	O
substrates	O
,	O
various	O
combinations	O
of	O
oligonucleotides	O
shown	O
in	O
Table	O
1	O
were	O
annealed	O
.	O

Bub	O
-	O
82	O
/	O
lamin	O
B2	O
containing	O
the	O
T	O
-	O
rich	O
strand	O
of	O
the	O
lamin	O
B2	O
origin	O
region	O
was	O
constructed	O
as	O
previously	O
described	O
(	O
13	O
)	O
.	O

The	O
bubble	O
substrate	O
,	O
c	O
-	O
myc	O
/	O
DUE	O
or	O
c	O
-	O
myc	O
/	O
DUE	O
-	O
C	O
,	O
contains	O
sequences	O
(	O
GenBank	O
accession	O
number	O
K01908	O
)	O
from	O
nucleotides	O
722	O
to	O
853	O
or	O
those	O
from	O
828	O
to	O
747	O
(	O
complementary	O
strand	O
)	O
,	O
respectively	O
,	O
in	O
the	O
central	O
melted	O
region	O
.	O

For	O
each	O
substrate	O
,	O
labeled	O
oligonucleotide	O
(	O
3	O
pmol	O
)	O
was	O
annealed	O
with	O
the	O
unlabeled	O
oligonucleotide	O
(	O
6	O
pmol	O
)	O
in	O
a	O
reaction	O
mixture	O
(	O
50	O
mu	O
l	O
)	O
containing	O
20	O
mM	O
Tris	O
-	O
HCl	O
(	O
pH	O
7	O
.	O
5	O
)	O
,	O
10	O
mM	O
MgCl2	O
and	O
25	O
mM	O
NaCl	O
,	O
which	O
were	O
heated	O
to	O
95	O
degrees	O
C	O
,	O
kept	O
at	O
67	O
degrees	O
C	O
for	O
1	O
h	O
,	O
and	O
then	O
allowed	O
to	O
slowly	O
cool	O
down	O
to	O
37	O
degrees	O
C	O
.	O

The	O
assembled	O
substrates	O
were	O
purified	O
from	O
polyacrylamide	O
gel	O
by	O
elution	O
into	O
TE	O
buffer	O
(	O
24	O
)	O
.	O

The	O
partial	O
heteroduplex	O
substrates	O
on	O
a	O
single	O
-	O
stranded	O
circular	O
DNA	O
with	O
varied	O
lengths	O
of	O
duplex	O
regions	O
were	O
prepared	O
by	O
extending	O
DNA	O
chains	O
from	O
the	O
3	O
'	O
end	O
of	O
the	O
dT40	O
-	O
37mer	O
(	O
37mer	O
region	O
hybridizing	O
at	O
positions	O
6289	O
-	O
6326	O
of	O
M13mp18	O
vector	O
)	O
annealed	O
to	O
the	O
single	O
-	O
stranded	O
circular	O
DNA	O
.	O

DNA	O
chains	O
were	O
elongated	O
with	O
Sequenase	O
in	O
the	O
presence	O
of	O
[	O
alpha	O
-	O
32P	O
]	O
dGTP	O
,	O
followed	O
by	O
extension	O
after	O
addition	O
of	O
ddGTP	O
and	O
all	O
four	O
dNTPs	O
,	O
resulting	O
in	O
substrates	O
containing	O
labeled	O
duplex	O
regions	O
of	O
varied	O
lengths	O
(	O
13	O
)	O
.	O

The	O
substrate	O
(	O
5	O
fmol	O
)	O
was	O
first	O
incubated	O
with	O
indicated	O
amount	O
of	O
the	O
Mcm4	O
/	O
6	O
/	O
7	O
complex	S-GO
at	O
37	O
degrees	O
C	O
for	O
1	O
h	O
in	O
reaction	O
mixture	O
as	O
described	O
(	O
11	O
)	O
,	O
and	O
then	O
reactions	O
were	O
stopped	O
by	O
addition	O
of	O
EDTA	O
(	O
20	O
mM	O
)	O
,	O
SDS	O
(	O
0	O
.	O
1	O
%	O
)	O
and	O
2	O
mu	O
g	O
proteinase	O
K	O
,	O
followed	O
by	O
incubation	O
for	O
20	O
min	O
.	O

Aliquots	O
were	O
electrophoresed	O
on	O
a	O
6	O
.	O
5	O
%	O
polyacrylamide	O
gel	O
in	O
1	O
x	O
TBE	O
at	O
300	O
V	O
for	O
2	O
.	O
5	O
h	O
.	O

The	O
single	O
-	O
stranded	O
circular	O
DNAs	O
used	O
were	O
M13mp18	O
and	O
M13mp19	O
+	O
G	O
-	O
rich	O
.	O

The	O
latter	O
was	O
constructed	O
by	O
inserting	O
a	O
G	O
-	O
rich	O
repeat	O
sequence	O
(	O
GGGGCGTGGGC	O
)	O
6	O
,	O
prepared	O
by	O
annealing	O
of	O
two	O
oligonucleotides	O
(	O
5	O
'	O
-	O
GATCC	O
-	O
[	O
GGGGCGTGGGC	O
]	O
6	O
-	O
3	O
'	O
/	O
5	O
'	O
-	O
GATCC	O
-	O
[	O
GCCCACGCCCC	O
]	O
6	O
-	O
3	O
'	O
)	O
at	O
the	O
BamHI	O
site	O
of	O
M13mp19	O
and	O
the	O
sequences	O
of	O
the	O
insert	O
were	O
confirmed	O
.	O

DNA	O
helicase	O
and	O
gel	O
shift	O
assays	O

In	O
gel	O
shift	O
assays	O
,	O
Mcm4	O
/	O
6	O
/	O
7	O
proteins	O
were	O
incubated	O
at	O
30	O
degrees	O
C	O
for	O
30	O
min	O
in	O
reaction	O
mixtures	O
(	O
15	O
mu	O
l	O
)	O
containing	O
25	O
mM	O
HEPES	O
-	O
NaOH	O
(	O
pH	O
7	O
.	O
5	O
)	O
,	O
50	O
mM	O
sodium	O
acetate	O
,	O
10	O
mM	O
Mg	O
(	O
CH3COO	O
)	O
2	O
,	O
1	O
mM	O
DTT	O
,	O
0	O
.	O
25	O
mu	O
g	O
/	O
ml	O
BSA	O
,	O
0	O
.	O
5	O
mM	O
ATP	O
-	O
gamma	O
-	O
S	O
and	O
labeled	O
substrates	O
of	O
the	O
amount	O
indicated	O
.	O

After	O
addition	O
of	O
2	O
mu	O
l	O
of	O
50	O
%	O
glycerol	O
,	O
the	O
reaction	O
mixtures	O
were	O
directly	O
applied	O
on	O
a	O
polyacrylamide	O
gel	O
containing	O
6	O
mM	O
magnesium	O
acetate	O
and	O
5	O
%	O
glycerol	O
in	O
0	O
.	O
5	O
x	O
TBE	O
,	O
and	O
electrophoresis	O
was	O
conducted	O
at	O
room	O
temperature	O
.	O

For	O
DNA	O
helicase	O
assays	O
,	O
the	O
reaction	O
mixtures	O
of	O
the	O
gel	O
shift	O
assays	O
,	O
as	O
described	O
above	O
,	O
were	O
incubated	O
at	O
30	O
degrees	O
C	O
for	O
15	O
min	O
,	O
and	O
then	O
the	O
ATP	O
was	O
added	O
at	O
10	O
mM	O
,	O
followed	O
by	O
incubation	O
at	O
37	O
degrees	O
C	O
for	O
additional	O
30	O
min	O
.	O

The	O
reactions	O
were	O
terminated	O
by	O
addition	O
of	O
EDTA	O
(	O
20	O
mM	O
)	O
,	O
SDS	O
(	O
0	O
.	O
1	O
%	O
)	O
and	O
2	O
mu	O
g	O
proteinase	O
K	O
,	O
and	O
were	O
incubated	O
for	O
additional	O
15	O
min	O
.	O

The	O
samples	O
were	O
separated	O
by	O
electrophoresis	O
on	O
nondenaturing	O
polyacrylamide	O
gel	O
in	O
1	O
x	O
TBE	O
.	O

Nuclease	O
protection	O
assays	O

The	O
reaction	O
mixtures	O
(	O
25	O
mu	O
l	O
)	O
contained	O
25	O
mM	O
HEPES	O
-	O
NaOH	O
(	O
pH	O
7	O
.	O
5	O
)	O
,	O
50	O
mM	O
sodium	O
acetate	O
,	O
10	O
mM	O
Mg	O
(	O
CH3COO	O
)	O
2	O
,	O
1	O
mM	O
DTT	O
,	O
0	O
.	O
25	O
mg	O
/	O
ml	O
BSA	O
,	O
0	O
.	O
5	O
mM	O
ATP	O
-	O
gamma	O
-	O
S	O
,	O
0	O
.	O
5	O
mM	O
CaCl2	O
,	O
10	O
fmol	O
of	O
32P	O
-	O
labeled	O
bubble	O
substrate	O
,	O
and	O
the	O
indicated	O
amount	O
of	O
Mcm4	O
/	O
6	O
/	O
7	O
proteins	O
.	O

After	O
incubation	O
at	O
30	O
degrees	O
C	O
for	O
30	O
min	O
,	O
the	O
indicated	O
amount	O
of	O
DNase	O
I	O
(	O
TAKARA	O
Biomedical	O
,	O
Japan	O
)	O
was	O
added	O
,	O
and	O
the	O
mixtures	O
were	O
incubated	O
at	O
room	O
temperature	O
for	O
1	O
min	O
.	O

DNase	O
I	O
was	O
inactivated	O
by	O
the	O
addition	O
of	O
250	O
mu	O
l	O
of	O
stop	O
solution	O
(	O
20	O
mM	O
EDTA	O
,	O
0	O
.	O
2M	O
sodium	O
chloride	O
,	O
1	O
%	O
SDS	O
and	O
12	O
.	O
5	O
mu	O
g	O
/	O
ml	O
yeast	O
RNA	O
)	O
.	O

For	O
nuclease	O
P1	O
footprinting	O
assay	O
,	O
binding	O
reactions	O
were	O
carried	O
out	O
under	O
the	O
same	O
conditions	O
except	O
that	O
CaCl2	O
was	O
omitted	O
.	O

P1	O
nuclease	O
(	O
0	O
.	O
3	O
U	O
,	O
Roche	O
)	O
was	O
added	O
and	O
incubation	O
was	O
continued	O
at	O
37	O
degrees	O
C	O
for	O
1	O
min	O
.	O

Cleavage	O
was	O
stopped	O
by	O
addition	O
of	O
50	O
mu	O
l	O
of	O
25	O
mM	O
EDTA	O
and	O
0	O
.	O
4	O
M	O
NaOH	O
;	O
the	O
mixture	O
was	O
incubated	O
at	O
room	O
temperature	O
for	O
10	O
min	O
followed	O
by	O
the	O
addition	O
of	O
12	O
mu	O
l	O
of	O
3	O
M	O
sodium	O
acetate	O
(	O
pH	O
4	O
.	O
8	O
)	O
.	O

Proteins	O
were	O
removed	O
by	O
phenol	O
-	O
chloroform	O
extraction	O
,	O
and	O
DNAs	O
were	O
collected	O
by	O
ethanol	O
precipitation	O
followed	O
by	O
wash	O
with	O
70	O
%	O
ethanol	O
.	O

The	O
digested	O
DNA	O
was	O
subjected	O
to	O
electrophoresis	O
through	O
a	O
10	O
or	O
12	O
%	O
polyacrylamide	O
sequencing	O
gel	O
containing	O
7	O
M	O
urea	O
,	O
followed	O
by	O
autoradiography	O
.	O

RESULTS	O

Mcm4	O
/	O
6	O
/	O
7	O
complex	S-GO
primarily	O
interacts	O
with	O
the	O
single	O
-	O
stranded	O
DNA	O
segment	O

Mcm4	O
/	O
6	O
/	O
7	O
binds	O
to	O
'	O
bubble	O
'	O
DNA	O
substrates	O
and	O
unwinds	O
the	O
duplex	O
segments	O
when	O
the	O
central	O
single	O
-	O
stranded	O
segment	O
contains	O
thymine	O
stretches	O
(	O
13	O
)	O
.	O

In	O
order	O
to	O
examine	O
the	O
mode	O
of	O
binding	O
of	O
Mcm4	O
/	O
6	O
/	O
7	O
on	O
bubble	O
DNAs	O
,	O
we	O
conducted	O
nuclease	O
protection	O
assays	O
using	O
labeled	O
bubble	O
substrate	O
DNAs	O
and	O
Mcm4	O
/	O
6	O
/	O
7	O
in	O
the	O
presence	O
of	O
ATP	O
-	O
gamma	O
-	O
S	O
which	O
permits	O
binding	O
to	O
substrate	O
DNA	O
but	O
does	O
not	O
mobilize	O
the	O
helicase	O
.	O

At	O
an	O
optimum	O
concentration	O
of	O
DNase	O
I	O
,	O
strong	O
cleavages	O
were	O
detected	O
on	O
the	O
21	O
bp	O
duplex	O
regions	O
at	O
both	O
ends	O
of	O
the	O
substrates	O
,	O
whereas	O
weaker	O
cleavages	O
were	O
detected	O
on	O
the	O
central	O
single	O
-	O
stranded	O
region	O
,	O
consistent	O
with	O
preference	O
of	O
DNase	O
I	O
to	O
double	O
-	O
stranded	O
DNA	O
.	O

With	O
the	O
Bub66	O
/	O
T	O
-	O
rich	O
substrate	O
,	O
strong	O
protection	O
was	O
detected	O
on	O
the	O
entire	O
single	O
-	O
stranded	O
regions	O
of	O
both	O
top	O
and	O
bottom	O
strands	O
with	O
increasing	O
concentration	O
of	O
Mcm4	O
/	O
6	O
/	O
7	O
,	O
consistent	O
with	O
high	O
affinity	O
of	O
Mcm4	O
/	O
6	O
/	O
7	O
to	O
T	O
-	O
rich	O
bubble	O
sequences	O
(	O
Figure	O
1A	O
)	O
.	O

Similar	O
,	O
but	O
less	O
significant	O
protection	O
was	O
detected	O
on	O
the	O
single	O
-	O
stranded	O
DNA	O
segment	O
with	O
P1	O
nucleases	O
(	O
Figure	O
1A	O
)	O
,	O
which	O
is	O
specific	O
to	O
single	O
-	O
stranded	O
DNA	O
.	O

The	O
results	O
indicate	O
that	O
the	O
Mcm	B-GO
complex	E-GO
is	O
loaded	O
onto	O
bubble	O
DNA	O
through	O
binding	O
to	O
both	O
strands	O
of	O
the	O
single	O
-	O
stranded	O
region	O
.	O

Careful	O
examination	O
of	O
Mcm4	O
/	O
6	O
/	O
7	O
footprints	O
on	O
a	O
bubble	O
indicated	O
strong	O
protection	O
on	O
the	O
5	O
'	O
-	O
half	O
of	O
the	O
top	O
strand	O
and	O
moderate	O
protection	O
on	O
the	O
remaining	O
3	O
'	O
-	O
half	O
,	O
as	O
well	O
as	O
on	O
several	O
base	O
-	O
pair	O
duplex	O
segment	O
adjacent	O
to	O
the	O
branch	O
point	O
(	O
Figure	O
1A	O
and	O
data	O
not	O
shown	O
)	O
.	O

A	O
similar	O
pattern	O
of	O
protection	O
was	O
observed	O
also	O
on	O
the	O
bottom	O
strand	O
.	O

This	O
suggests	O
that	O
Mcm4	O
/	O
6	O
/	O
7	O
may	O
bind	O
to	O
a	O
replication	O
bubble	O
substrate	O
with	O
a	O
2	O
-	O
fold	O
symmetry	O
as	O
a	O
double	O
hexamer	O
(	O
Figure	O
1A	O
,	O
see	O
the	O
lower	O
scheme	O
)	O
,	O
in	O
a	O
manner	O
similar	O
to	O
SV40	O
T	O
-	O
antigen	O
(	O
21	O
)	O
.	O

Nuclease	O
protection	O
assays	O
were	O
conducted	O
also	O
on	O
a	O
T	O
-	O
tailed	O
Y	O
-	O
fork	O
structure	O
(	O
Figure	O
1B	O
)	O
.	O

Not	O
only	O
the	O
single	O
-	O
stranded	O
tail	O
region	O
but	O
also	O
the	O
7	O
bp	O
duplex	O
DNA	O
adjacent	O
to	O
the	O
duplex	O
-	O
to	O
-	O
single	O
-	O
strand	O
junction	O
were	O
protected	O
by	O
Mcm	S-GO
binding	O
from	O
DNaseI	O
digestion	O
.	O

These	O
results	O
indicate	O
that	O
Mcm4	O
/	O
6	O
/	O
7	O
protein	O
primarily	O
interacts	O
with	O
single	O
-	O
stranded	O
DNA	O
region	O
and	O
that	O
the	O
interaction	O
also	O
spans	O
the	O
duplex	O
segments	O
near	O
the	O
branchpoint	O
of	O
the	O
replication	B-GO
fork	E-GO
.	O

Formation	O
of	O
double	O
hexameric	O
Mcm4	O
/	O
6	O
/	O
7	O
complexes	S-GO
facilitates	O
helicase	O
actions	O
on	O
bubble	O
substrates	O

The	O
above	O
results	O
suggest	O
that	O
Mcm4	O
/	O
6	O
/	O
7	O
generates	O
a	O
double	O
hexameric	O
complex	S-GO
on	O
a	O
bubble	O
,	O
each	O
hexamer	O
of	O
which	O
makes	O
symmetric	O
contact	O
with	O
the	O
5	O
'	O
-	O
proximal	O
central	O
single	O
-	O
stranded	O
segment	O
.	O

This	O
predicts	O
that	O
the	O
single	O
-	O
stranded	O
segment	O
needs	O
to	O
be	O
of	O
a	O
sufficient	O
length	O
in	O
order	O
to	O
accommodate	O
the	O
Mcm	B-GO
complex	E-GO
.	O

In	O
fact	O
,	O
we	O
previously	O
showed	O
that	O
the	O
Mcm4	O
/	O
6	O
/	O
7	O
mainly	O
forms	O
a	O
single	O
hexameric	O
complex	S-GO
on	O
bubble	O
-	O
20	O
(	O
a	O
bubble	O
substrate	O
with	O
20	O
nt	O
long	O
central	O
single	O
-	O
stranded	O
segment	O
)	O
and	O
a	O
double	O
hexameric	O
complex	S-GO
on	O
bubble	O
-	O
60	O
DNA	O
(	O
13	O
)	O
.	O

In	O
order	O
to	O
determine	O
the	O
minimum	O
requirement	O
for	O
double	O
-	O
hexamer	O
formation	O
,	O
a	O
set	O
of	O
synthetic	O
bubble	O
-	O
like	O
substrates	O
(	O
Bub	O
-	O
T10	O
,	O
Bub	O
-	O
T20	O
,	O
Bub	O
-	O
T30	O
,	O
Bub	O
-	O
T40	O
and	O
Bub	O
-	O
T50	O
)	O
that	O
differed	O
in	O
the	O
length	O
of	O
the	O
central	O
unpaired	O
segment	O
were	O
constructed	O
,	O
and	O
the	O
binding	O
and	O
helicase	O
activities	O
of	O
Mcm4	O
/	O
6	O
/	O
7	O
on	O
these	O
substrates	O
were	O
examined	O
.	O

Mcm4	O
/	O
6	O
/	O
7	O
was	O
incubated	O
with	O
a	O
radiolabeled	O
synthetic	O
bubble	O
substrate	O
in	O
the	O
presence	O
of	O
0	O
.	O
5	O
mM	O
ATP	O
-	O
gamma	O
-	O
S	O
to	O
allow	O
complex	S-GO
formation	O
.	O

A	O
half	O
of	O
these	O
reaction	O
mixtures	O
were	O
analyzed	O
for	O
DNA	O
binding	O
in	O
gel	O
shift	O
assays	O
(	O
Figure	O
2A	O
)	O
,	O
and	O
the	O
remainder	O
was	O
further	O
incubated	O
in	O
the	O
presence	O
of	O
10	O
mM	O
ATP	O
to	O
measure	O
DNA	O
helicase	O
activity	O
(	O
Figure	O
2B	O
)	O
.	O

Bub	O
-	O
10	O
generated	O
only	O
a	O
low	O
level	O
of	O
complexes	S-GO
with	O
Mcm4	O
/	O
6	O
/	O
7	O
,	O
and	O
Bub	O
-	O
20	O
generated	O
primarily	O
a	O
single	O
mobility	O
-	O
shifted	O
form	O
,	O
which	O
may	O
contain	O
a	O
single	O
hexamer	O
of	O
Mcm4	O
/	O
6	O
/	O
7	O
.	O

On	O
Bub	O
-	O
30	O
,	O
significant	O
amount	O
of	O
complexes	S-GO
containing	O
a	O
double	O
hexamer	O
were	O
generated	O
in	O
addition	O
to	O
those	O
containing	O
a	O
single	O
hexamer	O
(	O
Figure	O
2A	O
)	O
(	O
13	O
,	O
21	O
)	O
.	O

The	O
amounts	O
of	O
double	O
hexamer	O
complexes	S-GO
increased	O
on	O
Bub	O
-	O
T40	O
and	O
Bub	O
-	O
T50	O
with	O
concomitant	O
decrease	O
of	O
single	O
hexamer	O
complexes	S-GO
(	O
Figure	O
2A	O
)	O
.	O

The	O
results	O
indicate	O
that	O
a	O
single	O
-	O
stranded	O
segment	O
of	O
at	O
least	O
40	O
nt	O
long	O
is	O
required	O
for	O
efficient	O
loading	O
of	O
the	O
double	O
-	O
hexameric	O
Mcm	B-GO
helicase	E-GO
on	O
a	O
bubble	O
substrate	O
.	O

In	O
DNA	O
helicase	O
assays	O
,	O
Mcm4	O
/	O
6	O
/	O
7	O
complex	S-GO
did	O
not	O
show	O
helicase	O
activity	O
on	O
either	O
Bub	O
-	O
10	O
or	O
Bub	O
-	O
20	O
substrate	O
.	O

The	O
efficiency	O
of	O
displacement	O
slightly	O
improved	O
as	O
the	O
length	O
of	O
the	O
single	O
-	O
stranded	O
segment	O
increased	O
up	O
to	O
30	O
nt	O
.	O

On	O
Bub	O
-	O
T40	O
and	O
Bub	O
-	O
T50	O
,	O
on	O
the	O
other	O
hand	O
,	O
significant	O
displacement	O
was	O
observed	O
,	O
indicating	O
that	O
a	O
single	O
-	O
stranded	O
segment	O
of	O
at	O
least	O
40	O
nt	O
long	O
is	O
required	O
for	O
efficient	O
helicase	O
actions	O
on	O
bubble	O
substrates	O
(	O
Figure	O
2B	O
)	O
.	O

Taken	O
together	O
,	O
the	O
above	O
results	O
are	O
consistent	O
with	O
the	O
notion	O
that	O
the	O
Mcm4	O
/	O
6	O
/	O
7	O
complex	S-GO
,	O
loaded	O
onto	O
DNA	O
as	O
a	O
double	O
hexameric	O
complex	S-GO
,	O
efficiently	O
unwinds	O
the	O
duplex	O
region	O
of	O
the	O
substrate	O
DNA	O
.	O

Both	O
strands	O
of	O
thymine	O
-	O
rich	O
single	O
-	O
stranded	O
segments	O
are	O
required	O
for	O
efficient	O
unwinding	O
of	O
bubble	O
DNA	O
by	O
Mcm4	O
/	O
6	O
/	O
7	O

Symmetric	O
binding	O
of	O
the	O
Mcm4	O
/	O
6	O
/	O
7	O
double	O
hexamer	O
to	O
bubble	O
suggests	O
that	O
each	O
hexamer	O
catalyzes	O
unwinding	O
of	O
one	O
of	O
the	O
two	O
duplex	O
segments	O
.	O

We	O
asked	O
whether	O
activation	O
of	O
both	O
hexamers	O
is	O
required	O
for	O
unwinding	O
of	O
the	O
bubble	O
substrate	O
.	O

The	O
preferred	O
bubble	O
substrate	O
which	O
is	O
efficiently	O
unwound	O
by	O
Mcm4	O
/	O
6	O
/	O
7	O
contains	O
thymine	O
stretches	O
on	O
both	O
strands	O
of	O
the	O
single	O
-	O
stranded	O
segment	O
.	O

We	O
constructed	O
a	O
hetero	O
-	O
bubble	O
(	O
Bub66	O
/	O
T	O
-	O
G	O
-	O
rich	O
)	O
in	O
which	O
one	O
strand	O
is	O
T	O
-	O
rich	O
(	O
same	O
as	O
Bub66	O
/	O
T	O
-	O
rich	O
)	O
and	O
the	O
other	O
strand	O
is	O
G	O
-	O
rich	O
(	O
same	O
as	O
Bub66	O
/	O
G	O
-	O
rich	O
)	O
(	O
13	O
)	O
,	O
and	O
helicase	O
assays	O
were	O
conducted	O
with	O
increasing	O
amount	O
of	O
Mcm4	O
/	O
6	O
/	O
7	O
.	O

Only	O
weak	O
unwinding	O
was	O
detected	O
on	O
this	O
substrate	O
compared	O
to	O
Bub66	O
/	O
T	O
-	O
rich	O
(	O
Figure	O
3A	O
)	O
.	O

Since	O
Mcm4	O
/	O
6	O
/	O
7	O
can	O
bind	O
to	O
Bub66	O
/	O
T	O
-	O
G	O
-	O
rich	O
and	O
forms	O
a	O
double	O
hexameric	O
complex	S-GO
(	O
data	O
not	O
shown	O
)	O
,	O
the	O
defective	O
unwinding	O
is	O
not	O
due	O
to	O
inefficient	O
loading	O
of	O
the	O
helicase	O
onto	O
the	O
substrate	O
.	O

If	O
one	O
hexamer	O
interacting	O
with	O
the	O
thymine	O
-	O
rich	O
strand	O
dissociates	O
from	O
the	O
other	O
hexamer	O
and	O
displaces	O
only	O
one	O
of	O
the	O
duplex	O
segments	O
,	O
then	O
it	O
would	O
result	O
in	O
generation	O
of	O
Y	O
-	O
fork	B-GO
structures	E-GO
which	O
could	O
not	O
be	O
further	O
displaced	O
due	O
to	O
the	O
presence	O
of	O
G	O
-	O
rich	O
3	O
'	O
-	O
tail	O
and	O
would	O
appear	O
on	O
the	O
gel	O
.	O

However	O
,	O
we	O
did	O
not	O
detect	O
such	O
intermediates	O
during	O
the	O
course	O
of	O
the	O
experiment	O
(	O
Figure	O
3B	O
)	O
,	O
suggesting	O
that	O
bubble	O
can	O
be	O
displaced	O
efficiently	O
only	O
when	O
two	O
molecules	O
of	O
the	O
Mcm4	O
/	O
6	O
/	O
7	O
hexamers	O
are	O
simultaneously	O
activated	O
.	O

Binding	O
and	O
helicase	O
actions	O
of	O
Mcm4	O
/	O
6	O
/	O
7	O
on	O
forked	S-GO
and	O
3	O
'	O
-	O
or	O
5	O
'	O
-	O
extension	O
substrates	O

In	O
order	O
to	O
examine	O
more	O
precisely	O
the	O
interaction	O
and	O
helicase	O
actions	O
with	O
forked	S-GO
substrates	O
,	O
Y	O
-	O
fork	S-GO
substrates	O
containing	O
a	O
nascent	O
leading	O
strand	O
(	O
A	O
-	O
fork	S-GO
[	O
3	O
'	O
]	O
)	O
,	O
nascent	O
lagging	O
strand	O
(	O
A	O
-	O
fork	S-GO
[	O
5	O
'	O
]	O
)	O
,	O
or	O
both	O
of	O
them	O
(	O
A	O
-	O
fork	S-GO
[	O
3	O
'	O
,	O
5	O
'	O
]	O
)	O
,	O
as	O
well	O
as	O
5	O
'	O
-	O
extension	O
or	O
3	O
'	O
-	O
extension	O
structures	O
were	O
constructed	O
.	O

Mcm4	O
/	O
6	O
/	O
7	O
bound	O
to	O
A	O
-	O
fork	S-GO
[	O
3	O
'	O
]	O
or	O
A	O
-	O
fork	S-GO
[	O
5	O
'	O
]	O
with	O
affinity	O
similar	O
to	O
that	O
of	O
a	O
simple	O
Y	O
-	O
fork	S-GO
(	O
Figure	O
4A	O
and	O
data	O
not	O
shown	O
)	O
.	O

In	O
contrast	O
,	O
PriA	O
helicase	O
,	O
used	O
as	O
a	O
control	O
,	O
bound	O
to	O
A	O
-	O
fork	S-GO
[	O
3	O
'	O
]	O
more	O
efficiently	O
than	O
to	O
A	O
-	O
fork	S-GO
[	O
5	O
'	O
]	O
,	O
as	O
reported	O
previously	O
(	O
23	O
,	O
25	O
)	O
.	O

Mcm4	O
/	O
6	O
/	O
7	O
bound	O
also	O
to	O
5	O
'	O
-	O
extension	O
and	O
3	O
'	O
-	O
extension	O
,	O
albeit	O
with	O
slightly	O
reduced	O
affinity	O
compared	O
to	O
A	O
-	O
fork	S-GO
[	O
3	O
'	O
]	O
and	O
A	O
-	O
fork	S-GO
[	O
5	O
'	O
]	O
(	O
Figure	O
4A	O
)	O
.	O

Mcm4	O
/	O
6	O
/	O
7	O
bound	O
to	O
A	O
-	O
fork	S-GO
[	O
3	O
'	O
,	O
5	O
'	O
]	O
with	O
much	O
lower	O
affinity	O
,	O
and	O
the	O
complex	S-GO
gave	O
rise	O
to	O
a	O
single	O
band	O
.	O

These	O
findings	O
indicate	O
that	O
the	O
Mcm4	O
/	O
6	O
/	O
7	O
complex	S-GO
is	O
loaded	O
onto	O
DNA	O
preferentially	O
and	O
efficiently	O
through	O
single	O
-	O
stranded	O
region	O
,	O
regardless	O
of	O
the	O
presence	O
of	O
3	O
'	O
-	O
or	O
5	O
'	O
-	O
terminus	O
.	O

In	O
contrast	O
,	O
only	O
the	O
substrate	O
containing	O
a	O
3	O
'	O
single	O
-	O
stranded	O
DNA	O
tail	O
(	O
A	O
-	O
fork	S-GO
[	O
5	O
'	O
]	O
)	O
was	O
efficiently	O
unwound	O
and	O
A	O
-	O
fork	S-GO
[	O
3	O
'	O
]	O
or	O
A	O
-	O
fork	S-GO
[	O
3	O
'	O
,	O
5	O
'	O
]	O
,	O
was	O
not	O
unwound	O
by	O
Mcm4	O
/	O
6	O
/	O
7	O
(	O
Figure	O
4B	O
)	O
.	O

Absence	O
of	O
helicase	O
actions	O
on	O
A	O
-	O
fork	S-GO
[	O
3	O
'	O
,	O
5	O
'	O
]	O
composed	O
only	O
of	O
duplex	O
regions	O
is	O
expected	O
since	O
double	O
-	O
stranded	O
DNA	O
is	O
not	O
able	O
to	O
activate	O
the	O
ATPase	O
activity	O
of	O
Mcm4	O
/	O
6	O
/	O
7	O
(	O
10	O
)	O
.	O

In	O
contrast	O
,	O
the	O
PriA	O
,	O
a	O
structure	O
-	O
specific	O
helicase	O
used	O
as	O
a	O
control	O
,	O
binds	O
at	O
the	O
fork	S-GO
junction	O
and	O
unwinds	O
the	O
fork	S-GO
and	O
the	O
nascent	O
lagging	O
strand	O
DNA	O
on	O
A	O
-	O
fork	S-GO
[	O
5	O
'	O
]	O
,	O
or	O
unwinds	O
the	O
nascent	O
lagging	O
strand	O
on	O
A	O
-	O
fork	S-GO
[	O
3	O
'	O
,	O
5	O
'	O
]	O
,	O
as	O
reported	O
before	O
(	O
25	O
)	O
.	O

These	O
results	O
indicate	O
that	O
the	O
Mcm4	O
/	O
6	O
/	O
7	O
complex	S-GO
binds	O
to	O
single	O
-	O
stranded	O
DNA	O
and	O
that	O
its	O
helicase	O
is	O
activated	O
only	O
in	O
the	O
presence	O
of	O
a	O
single	O
-	O
stranded	O
3	O
'	O
-	O
tail	O
.	O

3	O
'	O
-	O
extension	O
with	O
poly	O
(	O
dT	O
)	O
tail	O
is	O
displaced	O
by	O
Mcm4	O
/	O
6	O
/	O
7	O

It	O
has	O
been	O
reported	O
that	O
the	O
3	O
'	O
-	O
extension	O
can	O
be	O
unwound	O
by	O
the	O
archaeal	O
Mcm	S-GO
homohexamer	O
but	O
not	O
by	O
fission	O
and	O
budding	O
yeast	O
Mcm	B-GO
complexes	E-GO
(	O
14	O
,	O
26	O
,	O
27	O
)	O
.	O

We	O
have	O
constructed	O
3	O
'	O
-	O
extension	O
substrates	O
containing	O
poly	O
(	O
dT	O
)	O
,	O
poly	O
(	O
dA	O
)	O
,	O
poly	O
(	O
dC	O
)	O
and	O
poly	O
(	O
dG	O
)	O
3	O
'	O
-	O
tails	O
in	O
order	O
to	O
examine	O
whether	O
mouse	O
Mcm4	O
/	O
6	O
/	O
7	O
can	O
displace	O
these	O
substrates	O
.	O

We	O
first	O
found	O
that	O
Mcm4	O
/	O
6	O
/	O
7	O
binds	O
to	O
dT	O
-	O
,	O
dC	O
-	O
and	O
dG	O
-	O
3	O
'	O
-	O
extension	O
with	O
similar	O
affinity	O
,	O
and	O
to	O
dA	O
-	O
3	O
'	O
-	O
extension	O
with	O
much	O
lower	O
affinity	O
(	O
Figure	O
5A	O
)	O
.	O

This	O
is	O
consistent	O
with	O
the	O
previous	O
results	O
that	O
Mcm4	O
/	O
6	O
/	O
7	O
binds	O
to	O
50mer	O
oligo	O
-	O
dT	O
,	O
-	O
dC	O
and	O
-	O
dG	O
,	O
but	O
not	O
to	O
a	O
50mer	O
oligo	O
-	O
dA	O
(	O
13	O
)	O
.	O

We	O
found	O
that	O
dT	O
-	O
tailed	O
3	O
'	O
-	O
extension	O
was	O
displaced	O
efficiently	O
by	O
Mcm	O
4	O
/	O
6	O
/	O
7	O
while	O
almost	O
no	O
or	O
very	O
little	O
activity	O
was	O
detected	O
on	O
other	O
substrates	O
(	O
Figure	O
5B	O
and	O
C	O
)	O
.	O

This	O
is	O
in	O
sharp	O
contrast	O
to	O
yeast	O
Mcm4	O
/	O
6	O
/	O
7	O
helicases	O
which	O
are	O
not	O
capable	O
of	O
unwinding	O
3	O
'	O
-	O
extension	O
substrates	O
.	O

Furthermore	O
,	O
dT	O
-	O
tailed	O
5	O
'	O
-	O
extension	O
,	O
to	O
which	O
Mcm4	O
/	O
6	O
/	O
7	O
could	O
bind	O
,	O
was	O
not	O
displaced	O
by	O
the	O
Mcm	B-GO
helicase	E-GO
.	O

The	O
addition	O
of	O
the	O
5	O
'	O
-	O
tail	O
to	O
dT	O
-	O
tailed	O
3	O
'	O
-	O
extension	O
further	O
stimulated	O
the	O
displacement	O
(	O
Figure	O
5D	O
)	O
,	O
confirming	O
the	O
previous	O
report	O
that	O
the	O
fork	B-GO
structures	E-GO
facilitate	O
the	O
helicase	O
action	O
.	O

Thus	O
,	O
these	O
results	O
further	O
strengthen	O
our	O
conclusion	O
that	O
the	O
mammalian	O
Mcm	B-GO
helicase	E-GO
is	O
generally	O
activated	O
by	O
the	O
thymine	O
-	O
stretch	O
on	O
the	O
3	O
'	O
-	O
single	O
-	O
stranded	O
tail	O
.	O

The	O
effects	O
of	O
the	O
thymine	O
content	O
of	O
the	O
3	O
'	O
-	O
tail	O
on	O
Mcm	B-GO
helicase	E-GO
activity	O

We	O
next	O
examined	O
more	O
systematically	O
the	O
effect	O
of	O
the	O
compositions	O
of	O
the	O
thymine	O
residues	O
of	O
the	O
3	O
'	O
-	O
tail	O
on	O
the	O
Mcm	B-GO
helicase	E-GO
activity	O
.	O

A	O
partial	O
heteroduplex	O
M13	O
single	O
-	O
stranded	O
DNA	O
containing	O
a	O
37	O
bp	O
duplex	O
region	O
in	O
the	O
presence	O
or	O
absence	O
of	O
the	O
50	O
nt	O
long	O
3	O
'	O
-	O
tail	O
of	O
various	O
nucleotide	O
compositions	O
were	O
constructed	O
and	O
the	O
unwinding	O
by	O
mouse	O
Mcm4	O
/	O
6	O
/	O
7	O
was	O
examined	O
(	O
Figure	O
6A	O
)	O
.	O

Due	O
to	O
its	O
low	O
processivity	O
,	O
Mcm4	O
/	O
6	O
/	O
7	O
barely	O
displaced	O
the	O
annealed	O
37mer	O
oligonucleotide	O
without	O
a	O
3	O
'	O
-	O
tail	O
(	O
37mer	O
;	O
Figure	O
6A	O
)	O
.	O

Only	O
weak	O
helicase	O
activity	O
was	O
observed	O
on	O
the	O
substrate	O
carrying	O
the	O
3	O
'	O
-	O
tail	O
of	O
25	O
repeats	O
of	O
TA	O
dinucleotide	O
(	O
37	O
-	O
TA25	O
;	O
Figure	O
6A	O
)	O
,	O
whereas	O
strong	O
helicase	O
activity	O
was	O
observed	O
on	O
37	O
-	O
TTA17	O
.	O

Increase	O
of	O
thymine	O
content	O
on	O
the	O
3	O
'	O
-	O
tail	O
did	O
not	O
further	O
increase	O
the	O
extent	O
of	O
unwinding	O
(	O
37	O
-	O
TTTA13	O
,	O
37	O
-	O
TTTTA10	O
and	O
37	O
-	O
T50	O
;	O
Figure	O
6A	O
)	O
,	O
suggesting	O
that	O
17	O
repeats	O
of	O
TT	O
dinucleotides	O
(	O
67	O
%	O
thymine	O
)	O
may	O
be	O
sufficient	O
for	O
activation	O
of	O
Mcm	B-GO
helicase	E-GO
.	O

It	O
should	O
be	O
noted	O
that	O
the	O
TA25	O
tail	O
would	O
self	O
-	O
anneal	O
and	O
this	O
would	O
prevent	O
the	O
loading	O
of	O
Mcm	S-GO
,	O
since	O
the	O
3	O
'	O
-	O
tail	O
containing	O
TTAA13	O
or	O
TTTAAA8	O
did	O
not	O
enhance	O
the	O
unwinding	O
either	O
(	O
data	O
not	O
shown	O
)	O
.	O

Therefore	O
,	O
we	O
next	O
examined	O
the	O
effects	O
of	O
repeating	O
sequences	O
of	O
thymine	O
and	O
cytosine	O
(	O
Figure	O
6B	O
)	O
.	O

Partial	O
heteroduplex	O
substrates	O
containing	O
the	O
3	O
'	O
-	O
tail	O
of	O
TC25	O
,	O
TTCC13	O
,	O
TTTCCC8	O
,	O
TTTTCCCC6	O
,	O
TTCC17	O
were	O
displaced	O
by	O
the	O
Mcm4	O
/	O
6	O
/	O
7	O
complex	S-GO
to	O
the	O
extent	O
similar	O
to	O
that	O
achieved	O
by	O
TTA17	O
,	O
suggesting	O
that	O
50	O
%	O
thymine	O
content	O
is	O
sufficient	O
for	O
full	O
activation	O
of	O
Mcm	B-GO
helicase	E-GO
.	O

TTCC13	O
and	O
TTCC17	O
were	O
displaced	O
to	O
a	O
similar	O
extent	O
,	O
consistent	O
with	O
the	O
earlier	O
result	O
that	O
a	O
40	O
nt	O
tail	O
is	O
sufficient	O
for	O
activation	O
(	O
13	O
)	O
.	O

However	O
,	O
the	O
efficiency	O
of	O
the	O
displacement	O
significantly	O
decreased	O
as	O
the	O
thymine	O
content	O
of	O
the	O
3	O
'	O
-	O
tail	O
dropped	O
to	O
33	O
%	O
,	O
as	O
in	O
TAA17	O
or	O
TCC17	O
(	O
Figure	O
6B	O
and	O
C	O
)	O
.	O

Thus	O
,	O
the	O
minimal	O
thymine	O
content	O
required	O
for	O
activation	O
of	O
the	O
Mcm	B-GO
helicase	E-GO
may	O
be	O
somewhere	O
between	O
33	O
and	O
50	O
%	O
.	O

DUE	O
sequences	O
from	O
the	O
c	O
-	O
myc	O
origin	O
activate	O
Mcm	B-GO
helicase	E-GO

Our	O
previous	O
studies	O
have	O
shown	O
that	O
the	O
sequences	O
containing	O
periodic	O
(	O
dT	O
)	O
n	O
tracts	O
derived	O
from	O
the	O
human	O
lamin	O
B2	O
origin	O
(	O
48	O
%	O
thymine	O
content	O
)	O
can	O
serve	O
as	O
an	O
efficient	O
activator	O
for	O
the	O
Mcm	B-GO
helicase	E-GO
on	O
a	O
bubble	O
,	O
and	O
replacement	O
of	O
thymines	O
with	O
guanines	O
abolished	O
the	O
helicase	O
activation	O
(	O
13	O
,	O
28	O
)	O
.	O

In	O
order	O
to	O
examine	O
other	O
natural	O
replication	O
origins	O
with	O
different	O
thymine	O
contents	O
for	O
the	O
ability	O
to	O
activate	O
Mcm	B-GO
helicase	E-GO
on	O
a	O
bubble	O
substrate	O
,	O
we	O
constructed	O
new	O
bubble	O
substrates	O
,	O
Bub82	O
/	O
c	O
-	O
myc	O
,	O
containing	O
sequences	O
derived	O
from	O
the	O
DUE	O
(	O
DNA	O
unwinding	O
element	O
)	O
region	O
of	O
the	O
human	O
c	O
-	O
myc	O
origin	O
which	O
is	O
essential	O
for	O
c	O
-	O
myc	O
replicator	O
activity	O
(	O
29	O
,	O
30	O
)	O
.	O

The	O
unpaired	O
segment	O
in	O
Bub82	O
/	O
c	O
-	O
myc	O
/	O
DUE	O
contains	O
one	O
strand	O
of	O
DUE	O
and	O
that	O
in	O
Bub82	O
/	O
c	O
-	O
myc	O
/	O
DUE	O
-	O
C	O
contains	O
another	O
strand	O
.	O

This	O
DUE	O
is	O
believed	O
to	O
coincide	O
with	O
the	O
initially	O
unwound	O
region	O
of	O
the	O
c	O
-	O
myc	O
origin	O
(	O
29	O
)	O
,	O
and	O
its	O
deletion	O
substantially	O
reduced	O
the	O
replicator	O
activity	O
(	O
30	O
)	O
.	O

Mcm4	O
/	O
6	O
/	O
7	O
unwound	O
Bub82	O
/	O
lamin	O
B2	O
(	O
thymine	O
48	O
%	O
)	O
,	O
Bub82	O
/	O
c	O
-	O
myc	O
/	O
DUE	O
(	O
37	O
%	O
)	O
and	O
Bub82	O
/	O
c	O
-	O
myc	O
/	O
DUE	O
-	O
C	O
(	O
39	O
%	O
)	O
with	O
similar	O
efficiency	O
(	O
Figure	O
7A	O
)	O
,	O
indicating	O
that	O
the	O
sequences	O
from	O
the	O
c	O
-	O
myc	O
origin	O
also	O
can	O
serve	O
as	O
efficient	O
activators	O
of	O
the	O
Mcm	B-GO
helicase	E-GO
.	O

This	O
result	O
also	O
indicates	O
that	O
sequences	O
with	O
37	O
%	O
thymine	O
content	O
can	O
activate	O
Mcm4	O
/	O
6	O
/	O
7	O
to	O
displace	O
24	O
nt	O
duplex	O
on	O
both	O
sides	O
in	O
a	O
bubble	O
substrate	O
,	O
suggesting	O
that	O
the	O
not	O
only	O
thymine	O
content	O
but	O
also	O
the	O
sequence	O
context	O
may	O
affect	O
the	O
Mcm	B-GO
helicase	E-GO
activation	O
.	O

In	O
gel	O
shift	O
assays	O
,	O
MCM4	O
/	O
6	O
/	O
7	O
bound	O
to	O
all	O
the	O
three	O
bubbles	O
,	O
although	O
the	O
affinity	O
to	O
Bub82	O
/	O
c	O
-	O
myc	O
/	O
DUE	O
and	O
to	O
Bub82	O
/	O
c	O
-	O
myc	O
/	O
DUE	O
-	O
C	O
is	O
slightly	O
lower	O
than	O
that	O
to	O
Bub	O
-	O
82	O
/	O
lamin	O
B2	O
(	O
Figure	O
7B	O
)	O
.	O

Therefore	O
,	O
helicase	O
and	O
DNA	O
binding	O
activities	O
do	O
not	O
necessarily	O
correlate	O
with	O
each	O
other	O
.	O

This	O
was	O
also	O
indicated	O
by	O
our	O
previous	O
results	O
that	O
guanine	O
and	O
cytosine	O
stretches	O
can	O
bind	O
to	O
Mcm	S-GO
but	O
cannot	O
activate	O
the	O
helicase	O
(	O
13	O
)	O
.	O

DNA	O
unwinding	O
by	O
Mcm4	O
/	O
6	O
/	O
7	O
is	O
inhibited	O
by	O
the	O
GC	O
-	O
rich	O
sequences	O
on	O
the	O
duplex	O
segment	O

Our	O
results	O
indicate	O
that	O
thymine	O
-	O
rich	O
single	O
-	O
stranded	O
DNA	O
is	O
required	O
for	O
initial	O
loading	O
and	O
activation	O
of	O
the	O
Mcm	B-GO
helicase	E-GO
.	O

However	O
,	O
it	O
is	O
not	O
known	O
whether	O
thymine	O
sequences	O
are	O
required	O
for	O
processive	O
unwinding	O
of	O
duplex	O
DNA	O
.	O

Therefore	O
,	O
we	O
have	O
examined	O
whether	O
the	O
nucleotide	O
composition	O
of	O
the	O
duplex	O
region	O
affects	O
its	O
unwinding	O
activity	O
.	O

To	O
address	O
this	O
issue	O
,	O
we	O
constructed	O
a	O
series	O
of	O
T	O
-	O
tailed	O
Y	O
-	O
fork	B-GO
structures	E-GO
(	O
T	O
-	O
fork	S-GO
)	O
containing	O
various	O
sequences	O
in	O
the	O
duplex	O
segment	O
.	O

They	O
carried	O
varied	O
contents	O
of	O
cytosine	O
residues	O
on	O
the	O
3	O
'	O
-	O
tail	O
strand	O
.	O

In	O
gel	O
shift	O
assays	O
,	O
Mcm4	O
/	O
6	O
/	O
7	O
bound	O
to	O
these	O
Y	O
-	O
fork	S-GO
substrates	O
with	O
identical	O
affinity	O
(	O
Figure	O
8A	O
)	O
,	O
consistent	O
with	O
the	O
notion	O
that	O
the	O
Mcm4	O
/	O
6	O
/	O
7	O
binds	O
to	O
single	O
-	O
stranded	O
tails	O
.	O

However	O
,	O
in	O
DNA	O
helicase	O
assays	O
,	O
T	O
-	O
fork	S-GO
/	O
(	O
C	O
:	O
G	O
)	O
49	O
was	O
hardly	O
displaced	O
by	O
Mcm4	O
/	O
6	O
/	O
7	O
,	O
but	O
was	O
readily	O
displaced	O
by	O
SV40	O
T	O
-	O
antigen	O
DNA	O
helicase	O
(	O
Figure	O
8B	O
)	O
.	O

When	O
thymine	O
or	O
adenine	O
is	O
inserted	O
as	O
every	O
third	O
nucleotide	O
(	O
repeats	O
of	O
CCT	O
or	O
CCA	O
)	O
,	O
the	O
extent	O
of	O
unwinding	O
increased	O
(	O
T	O
-	O
fork	S-GO
/	O
(	O
CCT	O
:	O
GGA	O
)	O
16	O
and	O
T	O
-	O
fork	S-GO
/	O
(	O
CCA	O
:	O
GGT	O
)	O
16	O
)	O
.	O

The	O
efficiency	O
of	O
unwinding	O
is	O
roughly	O
correlated	O
with	O
the	O
content	O
of	O
GC	O
pairs	O
in	O
the	O
duplex	O
segment	O
[	O
T	O
-	O
fork	S-GO
/	O
(	O
CCAA	O
:	O
GGTT	O
)	O
12	O
,	O
T	O
-	O
fork	S-GO
/	O
(	O
CCTT	O
:	O
GGAA	O
)	O
12	O
,	O
T	O
-	O
fork	S-GO
/	O
(	O
CAAA	O
:	O
GTTT	O
)	O
12	O
and	O
T	O
-	O
fork	S-GO
/	O
(	O
CTTT	O
:	O
GAAA	O
)	O
12	O
;	O
Figure	O
8B	O
]	O
.	O

It	O
appears	O
that	O
the	O
duplex	O
segment	O
containing	O
<	O
50	O
%	O
GC	O
pairs	O
is	O
efficiently	O
unwound	O
(	O
Figure	O
8C	O
)	O
.	O

We	O
next	O
examined	O
the	O
effect	O
of	O
GC	O
-	O
rich	O
segments	O
on	O
a	O
partial	O
heteroduplex	O
DNA	O
on	O
a	O
single	O
-	O
stranded	O
circular	O
DNA	O
.	O

We	O
have	O
constructed	O
two	O
sets	O
of	O
5	O
'	O
-	O
tailed	O
partial	O
heteroduplex	O
DNA	O
substrates	O
containing	O
duplex	O
regions	O
of	O
variable	O
lengths	O
;	O
one	O
on	O
M13mp18	O
vector	O
and	O
the	O
other	O
on	O
M13mp19	O
containing	O
a	O
66	O
nt	O
long	O
G	O
-	O
rich	O
segment	O
downstream	O
of	O
the	O
hybridizing	O
oligonucleotide	O
.	O

We	O
found	O
that	O
the	O
Mcm4	O
/	O
6	O
/	O
7	O
helicase	O
can	O
displace	O
duplex	O
DNA	O
up	O
to	O
350	O
nt	O
long	O
on	O
its	O
own	O
on	O
the	O
former	O
substrate	O
(	O
Figure	O
8D	O
,	O
left	O
)	O
,	O
consistent	O
with	O
previous	O
results	O
(	O
13	O
)	O
.	O

In	O
contrast	O
,	O
displacement	O
was	O
inhibited	O
over	O
the	O
GC	O
-	O
rich	O
segments	O
on	O
the	O
latter	O
substrate	O
(	O
Figure	O
8D	O
,	O
right	O
panel	O
)	O
,	O
although	O
displacement	O
up	O
to	O
250	O
nt	O
in	O
length	O
,	O
albeit	O
at	O
a	O
reduced	O
level	O
,	O
was	O
observed	O
at	O
a	O
high	O
concentration	O
of	O
Mcm4	O
/	O
6	O
/	O
7	O
complex	S-GO
.	O

This	O
result	O
is	O
consistent	O
with	O
that	O
on	O
Y	O
-	O
fork	S-GO
and	O
indicates	O
that	O
GC	O
-	O
rich	O
duplex	O
segment	O
is	O
inhibitory	O
for	O
unwinding	O
by	O
the	O
Mcm	B-GO
helicase	E-GO
.	O

These	O
results	O
may	O
indicate	O
that	O
the	O
presence	O
of	O
thymine	O
-	O
adenine	O
pairs	O
with	O
a	O
certain	O
frequency	O
in	O
the	O
duplex	O
region	O
may	O
facilitate	O
continuous	O
unwinding	O
by	O
Mcm4	O
/	O
6	O
/	O
7	O
.	O

Alternatively	O
,	O
Mcm4	O
/	O
6	O
/	O
7	O
is	O
not	O
efficient	O
enough	O
to	O
displace	O
thermodynamically	O
stable	O
GC	O
-	O
base	O
-	O
paired	O
segment	O
.	O

In	O
order	O
to	O
distinguish	O
these	O
two	O
possibilities	O
,	O
we	O
designed	O
a	O
new	O
T	O
-	O
fork	S-GO
substrate	O
containing	O
inosine	O
(	O
I	O
)	O
residue	O
instead	O
of	O
guanosine	O
residue	O
.	O

The	O
thermal	O
stability	O
of	O
the	O
I	O
:	O
C	O
base	O
pair	O
is	O
lower	O
than	O
that	O
of	O
the	O
G	O
:	O
C	O
base	O
pair	O
in	O
duplex	O
DNA	O
due	O
to	O
loss	O
of	O
one	O
hydrogen	O
bond	O
and	O
is	O
even	O
lower	O
than	O
A	O
:	O
T	O
base	O
pair	O
(	O
31	O
)	O
.	O

We	O
constructed	O
the	O
T	O
-	O
tailed	O
fork	S-GO
substrates	O
containing	O
the	O
(	O
GCC	O
:	O
CGG	O
)	O
10	O
,	O
(	O
GCC	O
:	O
CIG	O
)	O
10	O
or	O
(	O
GAA	O
:	O
CTT	O
)	O
10	O
duplex	O
DNA	O
segment	O
(	O
Figure	O
8E	O
)	O
.	O

Mcm4	O
/	O
6	O
/	O
7	O
hardly	O
displaced	O
the	O
31	O
nt	O
long	O
duplex	O
of	O
GCC	O
:	O
CGG	O
repeats	O
,	O
whereas	O
the	O
T	O
-	O
fork	S-GO
/	O
(	O
GAA	O
:	O
CTT	O
)	O
10	O
was	O
displaced	O
efficiently	O
,	O
as	O
described	O
above	O
.	O

T	O
-	O
fork	S-GO
/	O
(	O
GCC	O
:	O
CIG	O
)	O
10	O
was	O
displaced	O
with	O
efficiency	O
much	O
greater	O
than	O
that	O
of	O
T	O
-	O
fork	S-GO
/	O
(	O
GCC	O
:	O
CGG	O
)	O
10	O
,	O
indicating	O
that	O
the	O
thermostability	O
of	O
the	O
duplex	O
segment	O
,	O
not	O
the	O
lack	O
of	O
AT	O
base	O
pair	O
,	O
is	O
responsible	O
for	O
inability	O
of	O
Mcm4	O
/	O
6	O
/	O
7	O
to	O
displace	O
the	O
duplex	O
.	O

DISCUSSION	O

DNA	O
helicase	O
is	O
a	O
central	O
factor	O
for	O
operation	O
of	O
replication	B-GO
forks	E-GO
.	O

It	O
also	O
plays	O
a	O
crucial	O
role	O
in	O
the	O
initiation	O
step	O
at	O
the	O
replication	O
origins	O
.	O

Therefore	O
,	O
the	O
elucidation	O
of	O
how	O
the	O
replicative	O
helicases	O
interact	O
with	O
DNA	O
substrate	O
and	O
how	O
they	O
are	O
activated	O
is	O
crucial	O
for	O
understanding	O
the	O
molecular	O
basis	O
of	O
initiation	O
of	O
DNA	O
replication	O
.	O

It	O
is	O
now	O
believed	O
that	O
Mcm	S-GO
is	O
a	O
major	O
component	O
of	O
the	O
eukaryotic	O
replicative	O
helicase	O
.	O

In	O
this	O
report	O
,	O
we	O
have	O
conducted	O
detailed	O
analyses	O
on	O
binding	O
and	O
helicase	O
actions	O
of	O
mouse	O
Mcm4	O
/	O
6	O
/	O
7	O
using	O
various	O
substrates	O
including	O
fork	B-GO
and	I-GO
bubble	I-GO
structures	E-GO
.	O

Modes	O
of	O
binding	O
and	O
activation	O
of	O
Mcm4	O
/	O
6	O
/	O
7	O
helicase	O
on	O
a	O
bubble	O
structure	O

Initiation	O
of	O
DNA	O
replication	O
is	O
associated	O
with	O
localized	O
melting	O
of	O
duplex	O
DNA	O
near	O
replication	O
origins	O
.	O

Helicases	O
are	O
loaded	O
onto	O
replication	B-GO
forks	E-GO
through	O
the	O
melted	O
region	O
,	O
induced	O
by	O
initiator	O
binding	O
,	O
in	O
bacteria	O
(	O
32	O
)	O
.	O

We	O
previously	O
reported	O
that	O
Mcm4	O
/	O
6	O
/	O
7	O
can	O
be	O
loaded	O
onto	O
a	O
bubble	O
-	O
like	O
structure	O
and	O
can	O
serve	O
as	O
a	O
DNA	O
helicase	O
at	O
the	O
forks	S-GO
(	O
13	O
)	O
.	O

The	O
ability	O
of	O
Mcm4	O
/	O
6	O
/	O
7	O
to	O
unwind	O
the	O
bubble	O
substrate	O
but	O
not	O
the	O
conventional	O
duplex	O
DNA	O
(	O
Figures	O
2	O
and	O
13	O
)	O
indicates	O
that	O
Mcm	S-GO
can	O
be	O
loaded	O
through	O
the	O
single	O
-	O
stranded	O
segment	O
of	O
the	O
bubble	O
.	O

Furthermore	O
,	O
the	O
Mcm4	O
/	O
6	O
/	O
7	O
complex	S-GO
displays	O
marked	O
preference	O
for	O
thymine	O
-	O
rich	O
sequences	O
within	O
the	O
single	O
-	O
stranded	O
segment	O
for	O
helicase	O
activation	O
(	O
13	O
)	O
.	O

The	O
results	O
in	O
this	O
report	O
indicate	O
that	O
helicase	O
action	O
of	O
Mcm4	O
/	O
6	O
/	O
7	O
on	O
synthetic	O
bubbles	O
may	O
depend	O
on	O
the	O
presence	O
of	O
an	O
unpaired	O
region	O
of	O
sufficient	O
length	O
(	O
at	O
least	O
40	O
nt	O
)	O
,	O
which	O
may	O
permit	O
assembly	O
of	O
a	O
double	O
-	O
hexameric	O
complex	S-GO
on	O
the	O
substrate	O
DNA	O
,	O
similar	O
to	O
SV40	O
T	O
-	O
antigen	O
protein	O
(	O
Figure	O
2A	O
)	O
(	O
21	O
)	O
.	O

When	O
one	O
strand	O
of	O
the	O
single	O
-	O
stranded	O
segment	O
in	O
T	O
-	O
rich	O
bubble	O
was	O
replaced	O
by	O
guanine	O
-	O
rich	O
sequences	O
,	O
the	O
efficiency	O
of	O
unwinding	O
was	O
significantly	O
reduced	O
.	O

Our	O
footprinting	O
analyses	O
showed	O
that	O
Mcm4	O
/	O
6	O
/	O
7	O
strongly	O
protects	O
25	O
nt	O
single	O
-	O
stranded	O
DNA	O
segment	O
adjacent	O
to	O
each	O
branch	O
point	O
and	O
proximal	O
to	O
5	O
'	O
ends	O
of	O
both	O
strands	O
of	O
the	O
bubble	O
.	O

At	O
each	O
fork	S-GO
,	O
one	O
Mcm4	O
/	O
6	O
/	O
7	O
complex	S-GO
is	O
likely	O
to	O
encircle	O
the	O
single	O
-	O
stranded	O
DNA	O
strand	O
and	O
two	O
hexamers	O
may	O
bind	O
symmetrically	O
to	O
the	O
bubble	O
substrate	O
,	O
forming	O
a	O
double	O
hexameric	O
structure	O
on	O
the	O
bubble	O
(	O
see	O
schematic	O
drawing	O
of	O
Figure	O
1A	O
)	O
.	O

Efficient	O
unwinding	O
into	O
both	O
directions	O
may	O
require	O
simultaneous	O
activation	O
of	O
both	O
hexamers	O
which	O
may	O
sit	O
at	O
the	O
center	O
while	O
extruding	O
the	O
unwound	O
single	O
-	O
stranded	O
DNA	O
through	O
the	O
rings	O
.	O

This	O
may	O
closely	O
resemble	O
the	O
proposed	O
modes	O
of	O
binding	O
and	O
helicase	O
actions	O
of	O
T	O
-	O
antigen	O
(	O
21	O
)	O
.	O

Although	O
we	O
cannot	O
totally	O
exclude	O
the	O
possibility	O
that	O
one	O
Mcm4	O
/	O
6	O
/	O
7	O
hexamer	O
at	O
each	O
fork	S-GO
unwinds	O
the	O
duplex	O
independently	O
,	O
ring	O
-	O
shaped	O
structures	O
of	O
mouse	O
and	O
archea	O
MCM	S-GO
,	O
as	O
revealed	O
by	O
electron	O
microscopy	O
,	O
bear	O
much	O
similarity	O
to	O
the	O
recently	O
solved	O
structure	O
of	O
the	O
SV40	O
large	O
T	O
-	O
antigen	O
(	O
4	O
,	O
6	O
)	O
,	O
and	O
are	O
in	O
favor	O
of	O
the	O
double	O
-	O
hexameric	O
structure	O
of	O
mouse	O
Mcm	S-GO
on	O
a	O
bubble	O
DNA	O
.	O

Substrate	O
and	O
sequence	O
requirement	O
for	O
Mcm4	O
/	O
6	O
/	O
7	O
helicase	O
activation	O

DNA	O
binding	O
assays	O
indicate	O
that	O
Mcm4	O
/	O
6	O
/	O
7	O
binds	O
to	O
those	O
substrates	O
containing	O
single	O
-	O
stranded	O
DNA	O
regions	O
regardless	O
of	O
the	O
presence	O
or	O
absence	O
of	O
single	O
-	O
stranded	O
3	O
'	O
or	O
5	O
'	O
end	O
.	O

Unwinding	O
of	O
the	O
duplex	O
DNA	O
depends	O
on	O
translocation	O
of	O
single	O
-	O
stranded	O
DNA	O
from	O
3	O
'	O
to	O
5	O
'	O
direction	O
.	O

This	O
is	O
most	O
clearly	O
shown	O
by	O
its	O
helicase	O
action	O
on	O
A	O
-	O
fork	S-GO
[	O
5	O
'	O
]	O
and	O
3	O
'	O
-	O
extension	O
but	O
not	O
on	O
A	O
-	O
fork	S-GO
[	O
3	O
'	O
]	O
,	O
A	O
-	O
fork	S-GO
[	O
3	O
'	O
,	O
5	O
'	O
]	O
nor	O
5	O
'	O
-	O
extension	O
.	O

However	O
,	O
it	O
does	O
not	O
necessarily	O
require	O
3	O
'	O
end	O
of	O
single	O
-	O
stranded	O
DNA	O
,	O
since	O
Mcm4	O
/	O
6	O
/	O
7	O
can	O
displace	O
annealing	O
oligonucleotide	O
on	O
a	O
circular	O
single	O
-	O
stranded	O
DNA	O
.	O

The	O
ability	O
of	O
the	O
mouse	O
Mcm4	O
/	O
6	O
/	O
7	O
to	O
unwind	O
3	O
'	O
-	O
extension	O
is	O
shared	O
by	O
the	O
archaeal	O
Mcm	B-GO
helicase	E-GO
but	O
not	O
by	O
Mcm4	O
/	O
6	O
/	O
7	O
from	O
S	O
.	O
pombe	O
and	O
S	O
.	O
cerevisiae	O
(	O
14	O
,	O
26	O
,	O
27	O
)	O
.	O

The	O
archaeal	O
Mcm	S-GO
can	O
unwind	O
A	O
-	O
fork	S-GO
[	O
3	O
'	O
]	O
but	O
eukaryotic	O
Mcm4	O
/	O
6	O
/	O
7	O
cannot	O
,	O
since	O
the	O
former	O
binds	O
to	O
double	O
-	O
stranded	O
DNA	O
but	O
the	O
latter	O
does	O
not	O
(	O
5	O
,	O
27	O
)	O
.	O

While	O
yeast	O
Mcm	B-GO
helicases	E-GO
can	O
translocate	O
on	O
duplex	O
DNA	O
,	O
such	O
activity	O
was	O
not	O
observed	O
with	O
mammalian	O
Mcm4	O
/	O
6	O
/	O
7	O
(	O
data	O
not	O
shown	O
)	O
.	O

Occurrence	O
of	O
AT	O
-	O
rich	O
sequences	O
,	O
with	O
asymmetric	O
distribution	O
of	O
adenine	O
and	O
thymine	O
,	O
near	O
the	O
replication	O
origins	O
,	O
lead	O
us	O
to	O
propose	O
that	O
Mcm	S-GO
may	O
play	O
a	O
role	O
in	O
selection	O
of	O
initiation	O
sites	O
of	O
mammalian	O
DNA	O
replication	O
,	O
and	O
prompted	O
us	O
to	O
examine	O
the	O
ability	O
of	O
sequences	O
from	O
human	O
replication	O
origins	O
to	O
activate	O
Mcm4	O
/	O
6	O
/	O
7	O
helicase	O
.	O

Both	O
lamin	O
-	O
B2	O
and	O
c	O
-	O
myc	O
origins	O
served	O
as	O
efficient	O
activator	O
for	O
Mcm	B-GO
helicase	E-GO
in	O
vitro	O
.	O

Consistent	O
with	O
it	O
,	O
site	O
-	O
specific	O
loading	O
of	O
Mcm	S-GO
in	O
the	O
DNA	O
replication	O
initiation	O
zone	O
of	O
the	O
c	O
-	O
myc	O
was	O
recently	O
reported	O
(	O
33	O
)	O
.	O

We	O
have	O
examined	O
in	O
detail	O
the	O
effect	O
of	O
sequence	O
context	O
of	O
the	O
single	O
-	O
stranded	O
DNA	O
on	O
the	O
helicase	O
activity	O
of	O
Mcm	S-GO
.	O

The	O
results	O
indicate	O
that	O
thymine	O
content	O
of	O
50	O
%	O
is	O
sufficient	O
for	O
the	O
maximum	O
helicase	O
activity	O
.	O

The	O
efficiency	O
of	O
displacement	O
decreased	O
as	O
the	O
thymine	O
content	O
of	O
the	O
3	O
'	O
-	O
tail	O
dropped	O
to	O
33	O
%	O
(	O
Figure	O
6	O
)	O
.	O

The	O
stretches	O
of	O
thymine	O
residues	O
may	O
not	O
be	O
necessarily	O
required	O
,	O
since	O
repeats	O
of	O
TC	O
dinucleotides	O
served	O
as	O
a	O
potent	O
activator	O
for	O
Mcm4	O
/	O
6	O
/	O
7	O
.	O

We	O
also	O
noticed	O
that	O
the	O
presence	O
of	O
a	O
secondary	O
structure	O
within	O
the	O
single	O
-	O
stranded	O
DNA	O
is	O
inhibitory	O
for	O
helicase	O
action	O
.	O

Nuclease	O
footprinting	O
assays	O
indicated	O
that	O
binding	O
was	O
interfered	O
by	O
the	O
secondary	O
structure	O
(	O
data	O
not	O
shown	O
)	O
.	O

Thus	O
,	O
we	O
have	O
concluded	O
that	O
Mcm4	O
/	O
6	O
/	O
7	O
helicase	O
is	O
most	O
efficiently	O
activated	O
by	O
non	O
-	O
structured	O
single	O
-	O
stranded	O
DNA	O
with	O
thymine	O
content	O
of	O
50	O
%	O
or	O
more	O
,	O
although	O
significant	O
stimulation	O
is	O
observed	O
also	O
by	O
DNA	O
with	O
less	O
thymine	O
content	O
(	O
Figure	O
7	O
)	O
,	O
suggesting	O
that	O
the	O
sequence	O
specificity	O
for	O
Mcm	B-GO
helicase	E-GO
activation	O
is	O
rather	O
relaxed	O
and	O
that	O
the	O
extent	O
of	O
the	O
activation	O
may	O
depend	O
on	O
the	O
sequence	O
context	O
.	O

This	O
would	O
be	O
reasonable	O
given	O
the	O
flexibility	O
and	O
differential	O
regulation	O
of	O
site	O
selection	O
for	O
initiation	O
of	O
DNA	O
replication	O
during	O
development	O
or	O
in	O
various	O
cell	O
types	O
,	O
as	O
well	O
as	O
the	O
variability	O
in	O
initiation	O
potential	O
of	O
each	O
replication	O
origin	O
on	O
the	O
genome	O
even	O
within	O
the	O
single	O
cell	O
type	O
.	O

Mcm4	O
/	O
6	O
/	O
7	O
helicase	O
during	O
processive	O
unwinding	O
at	O
the	O
fork	S-GO

The	O
specific	O
requirement	O
of	O
single	O
-	O
stranded	O
thymine	O
residues	O
for	O
activation	O
of	O
Mcm	B-GO
helicase	E-GO
prompted	O
us	O
to	O
examine	O
whether	O
they	O
are	O
required	O
also	O
for	O
processive	O
unwinding	O
of	O
duplex	O
DNA	O
.	O

Our	O
results	O
indicated	O
that	O
increase	O
of	O
GC	O
pair	O
in	O
the	O
duplex	O
segment	O
significantly	O
inhibited	O
the	O
Mcm	B-GO
helicase	E-GO
activity	O
.	O

Duplex	O
DNA	O
composed	O
only	O
of	O
GC	O
pairs	O
(	O
10	O
repeats	O
of	O
CGG	O
)	O
on	O
a	O
Y	O
-	O
fork	S-GO
was	O
not	O
displaced	O
at	O
all	O
,	O
while	O
the	O
same	O
template	O
was	O
readily	O
displaced	O
by	O
SV40	O
T	O
-	O
antigen	O
(	O
Figure	O
8B	O
)	O
.	O

Mcm	B-GO
helicase	E-GO
was	O
inhibited	O
by	O
the	O
presence	O
of	O
GC	O
-	O
rich	O
duplex	O
segment	O
also	O
on	O
a	O
circular	O
single	O
-	O
stranded	O
partial	O
heteroduplex	O
substrate	O
.	O

However	O
,	O
on	O
this	O
substrate	O
,	O
Mcm4	O
/	O
6	O
/	O
7	O
was	O
able	O
to	O
displace	O
DNA	O
past	O
the	O
GC	O
-	O
rich	O
region	O
,	O
albeit	O
to	O
a	O
limited	O
extent	O
,	O
when	O
it	O
was	O
added	O
at	O
a	O
high	O
concentration	O
.	O

On	O
the	O
partial	O
heteroduplex	O
template	O
,	O
Mcm	S-GO
is	O
loaded	O
onto	O
the	O
circular	O
single	O
-	O
stranded	O
DNA	O
of	O
6	O
.	O
4	O
kb	O
,	O
while	O
it	O
is	O
loaded	O
onto	O
the	O
50	O
nt	O
long	O
3	O
'	O
-	O
tail	O
DNA	O
on	O
the	O
Y	O
-	O
fork	S-GO
.	O

Thus	O
,	O
the	O
difference	O
of	O
helicase	O
actions	O
may	O
reflect	O
the	O
efficiency	O
of	O
Mcm	S-GO
loading	O
.	O

Alternatively	O
,	O
the	O
presence	O
of	O
'	O
random	O
'	O
sequence	O
at	O
the	O
initially	O
unwound	O
duplex	O
segment	O
in	O
the	O
former	O
template	O
may	O
engage	O
the	O
Mcm	B-GO
helicase	E-GO
in	O
a	O
more	O
active	O
conformation	O
which	O
can	O
displace	O
the	O
GC	O
-	O
rich	O
duplex	O
segment	O
.	O

On	O
Y	O
-	O
fork	S-GO
substrates	O
,	O
increase	O
of	O
AT	O
base	O
pairs	O
in	O
the	O
duplex	O
(	O
10	O
repeats	O
of	O
CTT	O
)	O
restored	O
the	O
unwinding	O
.	O

These	O
results	O
indicate	O
either	O
that	O
thymine	O
residues	O
are	O
required	O
on	O
the	O
duplex	O
DNA	O
for	O
continuous	O
unwinding	O
,	O
or	O
that	O
Mcm4	O
/	O
6	O
/	O
7	O
is	O
simply	O
not	O
efficient	O
enough	O
to	O
unwind	O
the	O
stable	O
GC	O
pairs	O
.	O

Replacement	O
of	O
the	O
central	O
guanosine	O
with	O
inosine	O
in	O
the	O
CGG	O
repeat	O
duplex	O
DNA	O
resulted	O
in	O
displacement	O
(	O
Figure	O
8E	O
)	O
(	O
31	O
)	O
,	O
suggesting	O
that	O
the	O
continuous	O
presence	O
of	O
AT	O
base	O
pair	O
may	O
not	O
be	O
essential	O
for	O
the	O
Mcm	B-GO
helicase	E-GO
function	O
and	O
that	O
the	O
thermostability	O
of	O
GC	O
base	O
pairs	O
is	O
inhibitory	O
for	O
helicase	O
action	O
of	O
Mcm4	O
/	O
6	O
/	O
7	O
.	O

The	O
results	O
described	O
in	O
this	O
manuscript	O
reveal	O
potentially	O
important	O
features	O
of	O
mammalian	O
Mcm4	O
/	O
6	O
/	O
7	O
helicase	O
,	O
which	O
is	O
likely	O
to	O
be	O
a	O
key	O
component	O
of	O
the	O
eukaryotic	O
replicative	O
helicase	O
.	O

Prior	O
to	O
initiation	O
of	O
DNA	O
replication	O
,	O
Mcm	B-GO
helicase	E-GO
may	O
adopt	O
a	O
double	O
hexameric	O
complex	S-GO
at	O
the	O
partially	O
melted	O
origin	O
region	O
,	O
and	O
may	O
catalyze	O
concurrent	O
unwinding	O
of	O
duplex	O
DNA	O
into	O
both	O
directions	O
,	O
while	O
stably	O
associated	O
with	O
the	O
origins	O
of	O
DNA	O
replication	O
.	O

This	O
is	O
similar	O
to	O
the	O
T	O
-	O
antigen	O
model	O
originally	O
proposed	O
by	O
Smelkova	O
and	O
Borowiec	O
(	O
21	O
)	O
.	O

We	O
propose	O
that	O
,	O
only	O
when	O
both	O
hexamers	O
are	O
activated	O
by	O
the	O
interacting	O
thymine	O
-	O
rich	O
sequences	O
present	O
within	O
the	O
melted	O
region	O
,	O
the	O
Mcm	B-GO
helicase	E-GO
is	O
mobilized	O
and	O
initiation	O
takes	O
place	O
.	O

A	O
crucial	O
question	O
is	O
how	O
these	O
double	O
hexameric	O
helicase	B-GO
complexes	E-GO
are	O
generated	O
and	O
turn	O
into	O
active	O
helicases	O
at	O
the	O
origins	O
.	O

This	O
process	O
would	O
involve	O
melting	O
of	O
duplex	O
DNA	O
,	O
which	O
may	O
be	O
facilitated	O
by	O
binding	O
of	O
preRC	S-GO
components	O
in	O
the	O
context	O
of	O
proper	O
chromatin	B-GO
structures	E-GO
,	O
or	O
by	O
other	O
unwinding	O
factors	O
including	O
a	O
topoisomerase	O
or	O
a	O
newly	O
identified	O
Mcm8	O
helicase	O
(	O
34	O
-	O
36	O
)	O
.	O

It	O
may	O
also	O
require	O
association	O
of	O
fork	S-GO
-	O
assisting	O
proteins	O
such	O
as	O
Cdc45	O
(	O
37	O
,	O
38	O
)	O
as	O
well	O
as	O
phosphorylation	O
events	O
by	O
Cdk	O
and	O
Cdc7	O
kinases	O
(	O
39	O
,	O
40	O
)	O
.	O

One	O
unexpected	O
finding	O
of	O
this	O
study	O
is	O
low	O
helicase	O
activity	O
of	O
Mcm4	O
/	O
6	O
/	O
7	O
on	O
GC	O
-	O
rich	O
duplex	O
DNA	O
.	O

This	O
,	O
in	O
conjunction	O
with	O
the	O
low	O
processivity	O
of	O
Mcm4	O
/	O
6	O
/	O
7	O
helicase	O
,	O
strongly	O
indicates	O
that	O
the	O
replicative	O
helicase	O
at	O
the	O
replication	B-GO
forks	E-GO
would	O
require	O
more	O
than	O
Mcm4	O
/	O
6	O
/	O
7	O
complex	S-GO
.	O

During	O
the	O
processive	O
unwinding	O
of	O
duplex	O
DNA	B-GO
replication	I-GO
forks	E-GO
,	O
Mcm4	O
/	O
6	O
/	O
7	O
may	O
be	O
further	O
stimulated	O
by	O
interaction	O
with	O
other	O
proteins	O
,	O
including	O
remaining	O
Mcm	S-GO
subunits	O
,	O
Cdc45	O
(	O
37	O
,	O
38	O
)	O
,	O
GINS	S-GO
(	O
41	O
,	O
42	O
)	O
,	O
DNA	B-GO
polymerase	E-GO
subunits	O
(	O
43	O
)	O
,	O
Mcm8	O
(	O
35	O
,	O
36	O
)	O
,	O
etc	O
.	O
to	O
become	O
a	O
truly	O
processive	O
and	O
potent	O
helicase	O
capable	O
of	O
replicating	O
the	O
entire	O
genome	O
.	O

Acknowledgements	O

We	O
thank	O
Dr	O
Taku	O
Tanaka	O
for	O
preparations	O
of	O
some	O
of	O
the	O
substrate	O
DNAs	O
used	O
in	O
this	O
study	O
and	O
for	O
useful	O
suggestions	O
,	O
and	O
also	O
the	O
members	O
of	O
our	O
laboratory	O
for	O
helpful	O
discussion	O
.	O

This	O
work	O
was	O
supported	O
in	O
part	O
by	O
grants	O
-	O
in	O
-	O
aid	O
for	O
scientific	O
research	O
from	O
the	O
Ministry	O
of	O
Education	O
,	O
Culture	O
,	O
Sports	O
,	O
Science	O
and	O
Technology	O
of	O
Japan	O
(	O
MEXT	O
)	O
awarded	O
to	O
Z	O
.	O
Y	O
.	O
and	O
H	O
.	O
M	O
.	O

Funding	O
to	O
pay	O
the	O
Open	O
Access	O
publication	O
charges	O
for	O
this	O
article	O
was	O
provided	O
by	O
MEXT	O
.	O

Conflict	O
of	O
interest	O
statement	O
.	O

None	O
declared	O
.	O

Figures	O
and	O
Tables	O

Figure	O
1	O

Nuclease	O
protection	O
analyses	O
of	O
binding	O
of	O
Mcm4	O
/	O
6	O
/	O
7	O
protein	O
to	O
synthetic	O
bubble	O
and	O
fork	S-GO
substrates	O
.	O

(	O
A	O
)	O
The	O
Bub66	O
/	O
T	O
-	O
rich	O
substrate	O
(	O
4	O
fmol	O
)	O
,	O
the	O
top	O
strand	O
or	O
bottom	O
strand	O
of	O
which	O
were	O
32P	O
-	O
labeled	O
at	O
the	O
5	O
'	O
end	O
,	O
were	O
incubated	O
with	O
0	O
(	O
lane	O
1	O
)	O
,	O
25	O
ng	O
(	O
lane	O
2	O
)	O
,	O
50	O
ng	O
(	O
lane	O
3	O
)	O
or	O
75	O
ng	O
(	O
lane	O
4	O
)	O
of	O
Mcm4	O
/	O
6	O
/	O
7	O
protein	O
.	O

Reaction	O
mixtures	O
were	O
then	O
treated	O
with	O
0	O
.	O
11	O
U	O
of	O
DNase	O
I	O
or	O
0	O
.	O
3	O
U	O
of	O
nuclease	O
P1	O
.	O

(	O
B	O
)	O
The	O
T	O
-	O
tailed	O
Y	O
-	O
fork	S-GO
/	O
random	O
substrate	O
(	O
4	O
fmol	O
)	O
was	O
incubated	O
with	O
0	O
(	O
lane	O
1	O
)	O
,	O
15	O
ng	O
(	O
lane	O
2	O
)	O
,	O
30	O
ng	O
(	O
lane	O
3	O
)	O
,	O
60	O
ng	O
(	O
lane	O
4	O
)	O
or	O
120	O
ng	O
(	O
lane	O
5	O
)	O
of	O
Mcm4	O
/	O
6	O
/	O
7	O
protein	O
,	O
and	O
then	O
treated	O
with	O
0	O
.	O
037	O
U	O
of	O
DNase	O
I	O
or	O
0	O
.	O
3	O
U	O
of	O
nuclease	O
P1	O
.	O

The	O
reaction	O
products	O
were	O
separated	O
on	O
denaturing	O
PAGE	O
.	O

Single	O
-	O
stranded	O
and	O
duplex	O
regions	O
of	O
the	O
substrates	O
used	O
in	O
the	O
assays	O
are	O
indicated	O
along	O
the	O
gel	O
.	O

In	O
(	O
A	O
)	O
,	O
top	O
and	O
bottom	O
strands	O
are	O
indicated	O
by	O
boldface	O
and	O
normal	O
lines	O
,	O
respectively	O
.	O

Regions	O
of	O
strong	O
and	O
moderate	O
protection	O
are	O
indicated	O
by	O
bold	O
and	O
normal	O
gray	O
lines	O
,	O
respectively	O
,	O
along	O
the	O
substrate	O
structure	O
.	O

The	O
drawing	O
at	O
the	O
bottom	O
of	O
(	O
A	O
)	O
shows	O
summary	O
of	O
the	O
protection	O
pattern	O
(	O
protected	O
regions	O
indicated	O
by	O
gray	O
bold	O
lines	O
)	O
and	O
predicted	O
binding	O
modes	O
of	O
the	O
double	O
hexameric	O
Mcm4	O
/	O
6	O
/	O
7	O
(	O
shown	O
by	O
pale	O
gray	O
ovals	O
)	O
on	O
the	O
bubble	O
substrate	O
.	O

The	O
star	O
marks	O
represent	O
the	O
radioactive	O
5	O
'	O
ends	O
of	O
the	O
annealed	O
oligonucleotides	O
.	O

M	O
,	O
radiolabeled	O
10	O
and	O
50	O
bp	O
ladder	O
.	O

Figure	O
2	O

Binding	O
and	O
helicase	O
actions	O
of	O
mouse	O
Mcm4	O
/	O
6	O
/	O
7	O
on	O
bubble	O
substrates	O
containing	O
single	O
-	O
stranded	O
segments	O
of	O
varied	O
lengths	O
.	O

Gel	O
shift	O
(	O
A	O
)	O
and	O
DNA	O
helicase	O
(	O
B	O
)	O
assays	O
were	O
performed	O
with	O
mouse	O
Mcm4	O
/	O
6	O
/	O
7	O
on	O
synthetic	O
bubble	O
DNAs	O
(	O
4	O
fmol	O
)	O
,	O
Bub	O
-	O
T10	O
,	O
Bub	O
-	O
T20	O
,	O
Bub	O
-	O
T30	O
,	O
Bub	O
-	O
T40	O
and	O
Bub	O
-	O
T50	O
(	O
Table	O
1	O
)	O
.	O

Lanes	O
1	O
-	O
4	O
contain	O
0	O
,	O
25	O
,	O
50	O
and	O
100	O
ng	O
of	O
Mcm4	O
/	O
6	O
/	O
7	O
protein	O
,	O
respectively	O
.	O

B	O
,	O
boiled	O
substrate	O
.	O

The	O
drawing	O
in	O
(	O
A	O
)	O
shows	O
a	O
schematic	O
representation	O
of	O
the	O
substrates	O
used	O
.	O

The	O
asterisk	O
indicates	O
32P	O
-	O
labeled	O
5	O
'	O
-	O
terminus	O
.	O

Figure	O
3	O

Effect	O
of	O
the	O
loss	O
of	O
thymine	O
-	O
rich	O
sequences	O
from	O
one	O
single	O
-	O
strand	O
of	O
the	O
T	O
-	O
rich	O
bubble	O
on	O
unwinding	O
by	O
Mcm4	O
/	O
6	O
/	O
7	O
.	O

(	O
A	O
)	O
The	O
Mcm4	O
/	O
6	O
/	O
7	O
helicase	O
activity	O
was	O
measured	O
by	O
using	O
bubble	O
DNA	O
substrate	O
(	O
4	O
fmol	O
)	O
containing	O
an	O
unpaired	O
segment	O
of	O
two	O
thymine	O
-	O
rich	O
sequences	O
(	O
Bub66	O
/	O
T	O
-	O
rich	O
)	O
or	O
that	O
containing	O
thymine	O
-	O
and	O
guanine	O
-	O
rich	O
sequence	O
on	O
each	O
strand	O
(	O
Bub66	O
/	O
T	O
-	O
G	O
-	O
rich	O
)	O
.	O

The	O
drawings	O
under	O
the	O
panels	O
show	O
schematic	O
representations	O
of	O
the	O
substrates	O
used	O
in	O
this	O
assay	O
.	O

B	O
,	O
boiled	O
substrate	O
;	O
lane	O
1	O
,	O
no	O
protein	O
;	O
lanes	O
2	O
-	O
4	O
contain	O
25	O
,	O
50	O
and	O
100	O
ng	O
of	O
the	O
Mcm4	O
/	O
6	O
/	O
7	O
complex	S-GO
,	O
respectively	O
.	O

(	O
B	O
)	O
Helicase	O
assays	O
were	O
conducted	O
with	O
Mcm4	O
/	O
6	O
/	O
7	O
(	O
50	O
ng	O
)	O
on	O
the	O
bubble	O
substrates	O
indicated	O
for	O
various	O
time	O
.	O

Quantification	O
of	O
displaced	O
substrates	O
is	O
presented	O
in	O
the	O
graphs	O
.	O

Figure	O
4	O

DNA	O
binding	O
and	O
helicase	O
actions	O
of	O
Mcm4	O
/	O
6	O
/	O
7	O
on	O
various	O
fork	S-GO
substrates	O
.	O

(	O
A	O
)	O
Gel	O
-	O
shift	O
assays	O
were	O
conducted	O
with	O
Mcm4	O
/	O
6	O
/	O
7	O
on	O
specific	O
fork	S-GO
and	O
extension	O
substrates	O
(	O
3	O
fmol	O
)	O
as	O
indicated	O
.	O

(	O
B	O
)	O
DNA	O
helicase	O
assays	O
were	O
conducted	O
on	O
various	O
substrates	O
(	O
3	O
fmol	O
)	O
used	O
in	O
(	O
A	O
)	O
.	O

The	O
amounts	O
of	O
Mcm4	O
/	O
6	O
/	O
7	O
added	O
were	O
0	O
(	O
lane	O
1	O
)	O
,	O
25	O
(	O
lane	O
2	O
)	O
,	O
50	O
(	O
lane	O
3	O
)	O
and	O
100	O
ng	O
(	O
lane	O
4	O
)	O
.	O

Lane	O
5	O
,	O
PriA	O
helicase	O
at	O
10	O
nM	O
.	O

B	O
,	O
boiled	O
substrate	O
.	O

The	O
drawings	O
show	O
schematic	O
representation	O
of	O
the	O
substrates	O
used	O
in	O
the	O
assays	O
.	O

Arrows	O
a	O
-	O
d	O
indicate	O
displaced	O
products	O
,	O
and	O
their	O
structures	O
are	O
indicated	O
below	O
the	O
panel	O
.	O

The	O
positions	O
of	O
the	O
complexes	S-GO
containing	O
a	O
single	O
hexamer	O
or	O
double	O
hexamer	O
are	O
indicated	O
.	O

In	O
the	O
schematic	O
drawings	O
of	O
the	O
substrates	O
,	O
the	O
labeled	O
oligonucleotides	O
are	O
shown	O
as	O
bold	O
lines	O
,	O
and	O
the	O
asterisks	O
indicate	O
32P	O
-	O
labeled	O
5	O
'	O
-	O
termini	O
.	O

Figure	O
5	O

DNA	O
binding	O
and	O
helicase	O
actions	O
of	O
Mcm4	O
/	O
6	O
/	O
7	O
on	O
5	O
'	O
-	O
and	O
3	O
'	O
-	O
extension	O
substrates	O
.	O

DNA	O
-	O
binding	O
(	O
A	O
)	O
and	O
helicase	O
(	O
B	O
)	O
activities	O
of	O
Mcm4	O
/	O
6	O
/	O
7	O
were	O
examined	O
on	O
various	O
3	O
'	O
-	O
extension	O
substrates	O
(	O
4	O
fmol	O
)	O
as	O
shown	O
.	O

(	O
C	O
)	O
Quantification	O
of	O
the	O
displaced	O
substrates	O
in	O
(	O
B	O
)	O
.	O

(	O
D	O
)	O
DNA	O
helicase	O
assays	O
on	O
5	O
'	O
-	O
extension	O
,	O
3	O
'	O
-	O
extension	O
and	O
Y	O
-	O
forked	S-GO
substrates	O
.	O

Lanes	O
1	O
-	O
4	O
are	O
reactions	O
with	O
0	O
,	O
25	O
,	O
50	O
and	O
100	O
ng	O
of	O
the	O
Mcm4	O
/	O
6	O
/	O
7	O
complex	S-GO
,	O
respectively	O
.	O

Schematic	O
drawings	O
of	O
the	O
substrates	O
used	O
in	O
the	O
assays	O
are	O
also	O
shown	O
.	O

The	O
star	O
marks	O
indicate	O
32P	O
-	O
labeled	O
5	O
'	O
-	O
termini	O
.	O

Figure	O
6	O

The	O
effects	O
of	O
the	O
nucleotide	O
compositions	O
of	O
the	O
3	O
'	O
-	O
tail	O
on	O
displacement	O
of	O
partial	O
heteroduplex	O
substrates	O
by	O
Mcm4	O
/	O
6	O
/	O
7	O
.	O

(	O
A	O
)	O
DNA	O
helicase	O
assays	O
were	O
performed	O
with	O
3	O
'	O
-	O
tailed	O
partial	O
heteroduplex	O
helicase	O
substrates	O
(	O
on	O
a	O
single	O
-	O
stranded	O
circular	O
DNA	O
;	O
4	O
fmol	O
)	O
carrying	O
various	O
nucleotide	O
sequences	O
in	O
the	O
3	O
'	O
-	O
tail	O
as	O
shown	O
.	O

The	O
asterisks	O
represent	O
the	O
32P	O
-	O
labeled	O
5	O
'	O
ends	O
of	O
the	O
annealed	O
oligonucleotides	O
.	O

(	O
B	O
)	O
DNA	O
helicase	O
assays	O
were	O
performed	O
with	O
similar	O
sets	O
of	O
partial	O
heteroduplex	O
helicase	O
substrates	O
carrying	O
the	O
3	O
'	O
-	O
tails	O
as	O
shown	O
.	O

(	O
C	O
)	O
Quantification	O
of	O
displaced	O
oligonucleotides	O
in	O
(	O
B	O
)	O
.	O

Lanes	O
1	O
-	O
4	O
contain	O
0	O
,	O
25	O
,	O
50	O
and	O
100	O
ng	O
of	O
the	O
Mcm4	O
/	O
6	O
/	O
7	O
complex	S-GO
,	O
respectively	O
.	O

B	O
,	O
boiled	O
substrate	O
.	O

Figure	O
7	O

Activation	O
of	O
Mcm4	O
/	O
6	O
/	O
7	O
DNA	O
helicase	O
by	O
sequences	O
derived	O
from	O
the	O
human	O
c	O
-	O
myc	O
origin	O
.	O

(	O
A	O
)	O
DNA	O
helicase	O
assays	O
of	O
Mcm4	O
/	O
6	O
/	O
7	O
were	O
conducted	O
using	O
Bub	O
-	O
82	O
bubble	O
substrates	O
(	O
6	O
fmol	O
)	O
containing	O
c	O
-	O
myc	O
/	O
DUE	O
,	O
Lamin	O
B2	O
and	O
c	O
-	O
myc	O
/	O
DUE	O
-	O
C	O
sequences	O
in	O
the	O
unpaired	O
segment	O
,	O
the	O
thymine	O
contents	O
of	O
which	O
are	O
48	O
,	O
37	O
and	O
39	O
%	O
,	O
respectively	O
.	O

Quantification	O
of	O
displaced	O
substrates	O
is	O
presented	O
in	O
the	O
graph	O
.	O

(	O
B	O
)	O
DNA	O
binding	O
of	O
Mcm4	O
/	O
6	O
/	O
7	O
was	O
examined	O
in	O
gel	O
shift	O
assays	O
using	O
the	O
same	O
set	O
of	O
substrates	O
.	O

Lanes	O
1	O
-	O
4	O
are	O
reactions	O
with	O
0	O
,	O
25	O
,	O
50	O
and	O
100	O
ng	O
of	O
the	O
Mcm4	O
/	O
6	O
/	O
7	O
complex	S-GO
,	O
respectively	O
.	O

B	O
,	O
boiled	O
substrate	O
.	O

Figure	O
8	O

Effect	O
of	O
nucleotide	O
compositions	O
of	O
the	O
duplex	O
segments	O
on	O
helicase	O
action	O
of	O
Mcm4	O
/	O
6	O
/	O
7	O
.	O

DNA	O
binding	O
(	O
A	O
)	O
and	O
helicase	O
(	O
B	O
,	O
D	O
and	O
E	O
)	O
activities	O
of	O
the	O
Mcm4	O
/	O
6	O
/	O
7	O
helicase	O
were	O
examined	O
on	O
various	O
Y	O
-	O
fork	S-GO
DNAs	O
(	O
3	O
fmol	O
)	O
carrying	O
different	O
nucleotides	O
in	O
the	O
duplex	O
region	O
as	O
shown	O
(	O
A	O
,	O
B	O
and	O
E	O
)	O
or	O
on	O
single	O
-	O
stranded	O
circular	O
partial	O
heteroduplex	O
DNA	O
substrates	O
(	O
5	O
fmol	O
)	O
(	O
D	O
)	O
.	O

(	O
A	O
,	O
B	O
and	O
E	O
)	O
Lane	O
1	O
,	O
no	O
protein	O
added	O
;	O
lanes	O
2	O
-	O
4	O
contain	O
25	O
,	O
50	O
and	O
100	O
ng	O
of	O
the	O
Mcm4	O
/	O
6	O
/	O
7	O
protein	O
,	O
respectively	O
;	O
lane	O
5	O
[	O
in	O
(	O
B	O
)	O
]	O
,	O
50	O
ng	O
of	O
SV40	O
T	O
-	O
antigen	O
.	O

(	O
C	O
)	O
Quantification	O
of	O
the	O
displaced	O
substrates	O
in	O
(	O
B	O
)	O
.	O

(	O
D	O
)	O
Helicase	O
assays	O
on	O
dT40	O
-	O
Nmer	O
/	O
M13mp18	O
and	O
dT40	O
-	O
Nmer	O
/	O
M13mp19	O
+	O
G	O
-	O
rich	O
carrying	O
the	O
labeled	O
duplex	O
regions	O
of	O
varied	O
lengths	O
.	O

Lane	O
1	O
,	O
no	O
protein	O
added	O
;	O
lanes	O
2	O
-	O
7	O
contain	O
25	O
,	O
50	O
,	O
75	O
,	O
125	O
,	O
200	O
and	O
300	O
ng	O
of	O
the	O
Mcm4	O
/	O
6	O
/	O
7	O
protein	O
,	O
respectively	O
.	O

Lanes	O
8	O
and	O
9	O
,	O
boiled	O
M13mp18	O
and	O
M13mp19	O
+	O
G	O
-	O
rich	O
substrates	O
,	O
respectively	O
.	O

The	O
drawings	O
show	O
schematic	O
representations	O
of	O
the	O
substrates	O
used	O
in	O
the	O
assays	O
.	O

The	O
red	O
segment	O
in	O
bold	O
face	O
in	O
(	O
D	O
)	O
indicates	O
the	O
66	O
nt	O
long	O
G	O
-	O
rich	O
segment	O
.	O

The	O
asterisks	O
represent	O
radiaoactive	O
[	O
alpha	O
-	O
32P	O
]	O
dGTP	O
incorporated	O
into	O
the	O
duplex	O
segment	O
or	O
32P	O
-	O
labeled	O
5	O
'	O
ends	O
of	O
the	O
annealed	O
oligonucleotides	O
.	O

M	O
[	O
in	O
(	O
D	O
)	O
]	O
,	O
denatured	O
50	O
bp	O
ladder	O
DNA	O
marker	O
;	O
and	O
I	O
[	O
in	O
(	O
E	O
)	O
]	O
,	O
inosine	O
.	O

B	O
,	O
boiled	O
substrate	O
.	O

Table	O
1	O

Constructions	O
of	O
helicase	O
substrates	O
used	O
in	O
this	O
study	O

The	O
numbers	O
with	O
'	O
#	O
'	O
refer	O
to	O
oligonucleotides	O
whose	O
sequences	O
are	O
given	O
in	O
Table	O
2	O
.	O

Table	O
2	O

List	O
of	O
oligonucleotides	O
used	O
in	O
this	O
study	O

Inactivation	O
of	O
the	O
Huntington	O
'	O
s	O
disease	O
gene	O
(	O
Hdh	O
)	O
impairs	O
anterior	O
streak	O
formation	O
and	O
early	O
patterning	O
of	O
the	O
mouse	O
embryo	O

Abstract	O

Background	O

Huntingtin	O
,	O
the	O
HD	O
gene	O
encoded	O
protein	O
mutated	O
by	O
polyglutamine	O
expansion	O
in	O
Huntington	O
'	O
s	O
disease	O
,	O
is	O
required	O
in	O
extraembryonic	O
tissues	O
for	O
proper	O
gastrulation	O
,	O
implicating	O
its	O
activities	O
in	O
nutrition	O
or	O
patterning	O
of	O
the	O
developing	O
embryo	O
.	O

To	O
test	O
these	O
possibilities	O
,	O
we	O
have	O
used	O
whole	O
mount	O
in	O
situ	O
hybridization	O
to	O
examine	O
embryonic	O
patterning	O
and	O
morphogenesis	O
in	O
homozygous	O
Hdhex4	O
/	O
5	O
huntingtin	O
deficient	O
embryos	O
.	O

Results	O

In	O
the	O
absence	O
of	O
huntingtin	O
,	O
expression	O
of	O
nutritive	O
genes	O
appears	O
normal	O
but	O
E7	O
.	O
0	O
-	O
7	O
.	O
5	O
embryos	O
exhibit	O
a	O
unique	O
combination	O
of	O
patterning	O
defects	O
.	O

Notable	O
are	O
a	O
shortened	O
primitive	O
streak	O
,	O
absence	O
of	O
a	O
proper	O
node	O
and	O
diminished	O
production	O
of	O
anterior	O
streak	O
derivatives	O
.	O

Reduced	O
Wnt3a	O
,	O
Tbx6	O
and	O
Dll1	O
expression	O
signify	O
decreased	O
paraxial	O
mesoderm	O
and	O
reduced	O
Otx2	O
expression	O
and	O
lack	O
of	O
headfolds	O
denote	O
a	O
failure	O
of	O
head	O
development	O
.	O

In	O
addition	O
,	O
genes	O
initially	O
broadly	O
expressed	O
are	O
not	O
properly	O
restricted	O
to	O
the	O
posterior	O
,	O
as	O
evidenced	O
by	O
the	O
ectopic	O
expression	O
of	O
Nodal	O
,	O
Fgf8	O
and	O
Gsc	O
in	O
the	O
epiblast	O
and	O
T	O
(	O
Brachyury	O
)	O
and	O
Evx1	O
in	O
proximal	O
mesoderm	O
derivatives	O
.	O

Despite	O
impaired	O
posterior	O
restriction	O
and	O
anterior	O
streak	O
deficits	O
,	O
overall	O
anterior	O
/	O
posterior	O
polarity	O
is	O
established	O
.	O

A	O
single	O
primitive	O
streak	O
forms	O
and	O
marker	O
expression	O
shows	O
that	O
the	O
anterior	O
epiblast	O
and	O
anterior	O
visceral	O
endoderm	O
(	O
AVE	O
)	O
are	O
specified	O
.	O

Conclusion	O

Huntingtin	O
is	O
essential	O
in	O
the	O
early	O
patterning	O
of	O
the	O
embryo	O
for	O
formation	O
of	O
the	O
anterior	O
region	O
of	O
the	O
primitive	O
streak	O
,	O
and	O
for	O
down	O
-	O
regulation	O
of	O
a	O
subset	O
of	O
dynamic	O
growth	O
and	O
transcription	O
factor	O
genes	O
.	O

These	O
findings	O
provide	O
fundamental	O
starting	O
points	O
for	O
identifying	O
the	O
novel	O
cellular	O
and	O
molecular	O
activities	O
of	O
huntingtin	O
in	O
the	O
extraembryonic	O
tissues	O
that	O
govern	O
normal	O
anterior	O
streak	O
development	O
.	O

This	O
knowledge	O
may	O
prove	O
to	O
be	O
important	O
for	O
understanding	O
the	O
mechanism	O
by	O
which	O
the	O
dominant	O
polyglutamine	O
expansion	O
in	O
huntingtin	O
determines	O
the	O
loss	O
of	O
neurons	O
in	O
Huntington	O
'	O
s	O
disease	O
.	O

Background	O

Huntington	O
'	O
s	O
disease	O
(	O
HD	O
)	O
is	O
a	O
dominantly	O
inherited	O
neurodegenerative	O
disorder	O
that	O
is	O
caused	O
by	O
CAG	O
repeats	O
in	O
the	O
HD	O
locus	O
that	O
extend	O
a	O
polyglutamine	O
tract	O
in	O
a	O
ubiquitous	O
HEAT	O
domain	O
protein	O
called	O
huntingtin	O
[	O
1	O
]	O
.	O

The	O
molecular	O
mechanism	O
by	O
which	O
the	O
new	O
property	O
that	O
is	O
conferred	O
on	O
huntingtin	O
by	O
the	O
polyglutamine	O
expansion	O
leads	O
to	O
the	O
hallmark	O
loss	O
of	O
striatal	O
neurons	O
in	O
HD	O
is	O
not	O
known	O
.	O

However	O
,	O
polyglutamine	O
expansions	O
in	O
unrelated	O
proteins	O
that	O
target	O
distinct	O
neuronal	O
cell	O
populations	O
cause	O
distinct	O
'	O
polyglutamine	O
'	O
neurodegenerative	O
disorders	O
.	O

This	O
observation	O
strongly	O
suggests	O
that	O
the	O
striatal	O
cell	O
specificity	O
of	O
the	O
polyglutamine	O
expansion	O
in	O
the	O
context	O
of	O
huntingtin	O
must	O
be	O
determined	O
by	O
some	O
aspect	O
of	O
huntingtin	O
'	O
s	O
structure	O
,	O
subcellular	O
location	O
or	O
activities	O
[	O
2	O
]	O
.	O

Huntingtin	O
is	O
postulated	O
to	O
function	O
as	O
a	O
flexible	O
~	O
350	O
kDa	O
HEAT	O
domain	O
scaffold	O
that	O
may	O
facilitate	O
the	O
assembly	O
and	O
possibly	O
the	O
subcellular	O
location	O
of	O
large	O
protein	B-GO
complexes	E-GO
[	O
3	O
-	O
7	O
]	O
.	O

Huntingtin	O
'	O
s	O
large	O
number	O
of	O
diverse	O
cytoplasmic	S-GO
and	O
nuclear	S-GO
protein	O
binding	O
partners	O
strongly	O
suggest	O
that	O
huntingtin	O
may	O
participate	O
in	O
a	O
variety	O
of	O
cellular	O
processes	O
that	O
range	O
from	O
trafficking	O
of	O
growth	O
factor	O
complexes	S-GO
to	O
gene	O
transcription	O
(	O
reviewed	O
in	O
[	O
5	O
,	O
8	O
,	O
9	O
]	O
.	O

However	O
,	O
despite	O
the	O
potential	O
importance	O
of	O
huntingtin	O
'	O
s	O
normal	O
function	O
to	O
our	O
understanding	O
of	O
how	O
the	O
dominant	O
polyglutamine	O
mutation	O
causes	O
HD	O
pathology	O
,	O
huntingtin	O
'	O
s	O
precise	O
molecular	O
and	O
cellular	O
activities	O
have	O
not	O
been	O
defined	O
.	O

Therefore	O
,	O
we	O
,	O
and	O
others	O
,	O
set	O
out	O
to	O
discover	O
huntingtin	O
'	O
s	O
essential	O
activities	O
by	O
studying	O
the	O
effects	O
of	O
huntingtin	O
deficiency	O
in	O
the	O
mouse	O
.	O

Inactivation	O
of	O
the	O
mouse	O
HD	O
gene	O
(	O
Hdh	O
)	O
has	O
shown	O
that	O
huntingtin	O
is	O
not	O
required	O
for	O
cell	O
viability	O
,	O
as	O
evidenced	O
by	O
the	O
survival	O
of	O
mouse	O
embryonic	O
stem	O
cells	O
and	O
neurons	O
that	O
lack	O
huntingtin	O
[	O
10	O
-	O
12	O
]	O
.	O

However	O
,	O
huntingtin	O
is	O
needed	O
at	O
the	O
level	O
of	O
the	O
organism	O
for	O
proper	O
mammalian	O
embryonic	O
development	O
[	O
10	O
,	O
13	O
,	O
14	O
]	O
.	O

Complete	O
lack	O
of	O
huntingtin	O
results	O
in	O
developmental	O
arrest	O
during	O
gastrulation	O
,	O
while	O
severe	O
reduction	O
of	O
huntingtin	O
levels	O
results	O
in	O
abnormal	O
neurogenesis	O
and	O
perinatal	O
lethality	O
[	O
15	O
]	O
.	O

Analysis	O
of	O
huntingtin	O
deficient	O
Hdhex4	O
/	O
5	O
/	O
Hdhex4	O
/	O
5	O
embryos	O
reveals	O
that	O
homozygous	O
inactivation	O
of	O
the	O
mouse	O
HD	O
gene	O
does	O
not	O
overtly	O
affect	O
development	O
until	O
E7	O
.	O
0	O
.	O

By	O
E7	O
.	O
5	O
,	O
mutant	O
embryos	O
exhibit	O
a	O
shortened	O
primitive	O
streak	O
,	O
reduced	O
size	O
and	O
,	O
by	O
morphology	O
,	O
lack	O
a	O
node	O
and	O
head	O
folds	O
.	O

Mutants	O
are	O
rapidly	O
resorbed	O
by	O
E8	O
.	O
0	O
[	O
10	O
]	O
.	O

Importantly	O
,	O
the	O
expression	O
of	O
huntingtin	O
only	O
in	O
extraembryonic	O
tissues	O
in	O
chimeras	O
rescues	O
this	O
gastrulation	O
phenotype	O
,	O
suggesting	O
that	O
huntingtin	O
is	O
required	O
only	O
in	O
cells	O
of	O
the	O
extraembryonic	O
lineage	O
and	O
acts	O
in	O
a	O
cell	O
non	O
-	O
autonomous	O
manner	O
at	O
this	O
stage	O
[	O
16	O
]	O
.	O

Extraembryonic	O
tissues	O
are	O
essential	O
for	O
supplying	O
nutrients	O
and	O
signals	O
that	O
direct	O
anterior	O
/	O
posterior	O
axis	O
formation	O
and	O
patterning	O
in	O
the	O
developing	O
embryo	O
(	O
reviewed	O
in	O
[	O
17	O
]	O
)	O
,	O
implicating	O
huntingtin	O
in	O
either	O
or	O
both	O
of	O
these	O
processes	O
.	O

Of	O
these	O
possibilities	O
,	O
the	O
nutritive	O
role	O
has	O
been	O
more	O
extensively	O
investigated	O
.	O

However	O
,	O
huntingtin	O
deficient	O
embryos	O
do	O
not	O
display	O
obvious	O
visceral	O
endoderm	O
defects	O
,	O
with	O
the	O
notable	O
exception	O
of	O
compromised	O
iron	O
transport	O
in	O
later	O
stage	O
mutants	O
,	O
although	O
iron	O
uptake	O
is	O
undisturbed	O
[	O
16	O
]	O
and	O
endocytosis	O
is	O
not	O
impaired	O
in	O
huntingtin	O
deficient	O
embryos	O
or	O
embryonic	O
stem	O
cells	O
[	O
16	O
,	O
18	O
]	O
.	O

By	O
the	O
same	O
token	O
,	O
huntingtin	O
shuttles	O
through	O
the	O
nucleus	S-GO
,	O
where	O
it	O
is	O
required	O
for	O
proper	O
nuclear	S-GO
localization	O
of	O
its	O
transcription	O
factor	O
partners	O
,	O
suggesting	O
that	O
huntingtin	O
may	O
play	O
a	O
role	O
in	O
transcription	O
cascades	O
in	O
extraembryonic	O
tissues	O
that	O
pattern	O
the	O
embryo	O
[	O
18	O
]	O
.	O

Therefore	O
,	O
we	O
have	O
examined	O
this	O
hypothesis	O
,	O
by	O
monitoring	O
the	O
expression	O
of	O
genes	O
that	O
determine	O
normal	O
embryonic	O
patterning	O
and	O
morphogenesis	O
in	O
Hdhex4	O
/	O
5	O
/	O
Hdhex4	O
/	O
5	O
huntingtin	O
deficient	O
embryos	O
.	O

Our	O
results	O
support	O
and	O
refine	O
the	O
hypothesis	O
,	O
indicating	O
that	O
huntingtin	O
is	O
required	O
for	O
proper	O
mesoderm	O
patterning	O
and	O
for	O
normal	O
regional	O
restriction	O
of	O
the	O
expression	O
of	O
a	O
subset	O
of	O
growth	O
and	O
transcription	O
factors	O
.	O

Results	O

Huntingtin	O
-	O
deficient	O
embryos	O
exhibit	O
abnormal	O
streak	O
progression	O
and	O
paraxial	O
mesoderm	O
production	O

Since	O
extraembryonic	O
tissues	O
supply	O
nutrients	O
to	O
the	O
developing	O
embryo	O
,	O
we	O
tested	O
the	O
possibility	O
that	O
huntingtin	O
deficiency	O
may	O
perturb	O
this	O
function	O
by	O
performing	O
RT	O
-	O
PCR	O
analysis	O
to	O
examine	O
the	O
expression	O
of	O
a	O
panel	O
of	O
'	O
nutritive	O
'	O
genes	O
in	O
E7	O
.	O
5	O
wild	O
-	O
type	O
and	O
Hdhex4	O
/	O
5	O
/	O
Hdhex4	O
/	O
5	O
huntingtin	O
deficient	O
embryos	O
.	O

Consistent	O
with	O
a	O
previous	O
report	O
[	O
16	O
]	O
,	O
no	O
obvious	O
differences	O
were	O
found	O
in	O
the	O
expression	O
of	O
"	O
nutritive	O
"	O
genes	O
(	O
Hnf4	O
,	O
Afp	O
,	O
Tfn	O
,	O
ApoAI	O
,	O
Apo	O
-	O
AIV	O
,	O
and	O
ApoB	O
)	O
or	O
genes	O
involved	O
in	O
yolk	O
sac	O
hematopoiesis	O
or	O
vasculogenesis	O
(	O
Ttr	O
,	O
Rbp	O
,	O
Flt1	O
,	O
Flk1	O
,	O
Tal1	O
,	O
Rbtn2	O
,	O
GATA1	O
)	O
(	O
data	O
not	O
shown	O
)	O
,	O
suggesting	O
that	O
huntingtin	O
is	O
not	O
essential	O
for	O
the	O
proper	O
expression	O
of	O
genes	O
required	O
for	O
the	O
nutritive	O
function	O
of	O
the	O
extraembryonic	O
tissues	O
.	O

To	O
investigate	O
huntingtin	O
'	O
s	O
developmental	O
activities	O
,	O
we	O
then	O
analyzed	O
the	O
expression	O
of	O
genes	O
which	O
pattern	O
the	O
early	O
embryo	O
or	O
mark	O
morphogenic	O
landmarks	O
in	O
wild	O
-	O
type	O
and	O
Hdhex4	O
/	O
5	O
/	O
Hdhex4	O
/	O
5	O
embryos	O
by	O
whole	O
mount	O
and	O
section	O
in	O
situ	O
hybridization	O
.	O

The	O
dissections	O
confirmed	O
previous	O
morphologic	O
data	O
at	O
E7	O
.	O
0	O
-	O
7	O
.	O
5	O
that	O
all	O
Hdhex4	O
/	O
5	O
/	O
Hdhex4	O
/	O
5	O
homozygotes	O
exhibit	O
abnormal	O
morphology	O
,	O
including	O
shortened	O
primitive	O
streak	O
and	O
a	O
lack	O
of	O
morphological	O
head	O
folds	O
or	O
node	O
[	O
10	O
,	O
13	O
]	O
.	O

The	O
results	O
of	O
in	O
situ	O
hybridization	O
analysis	O
also	O
confirmed	O
that	O
all	O
three	O
germ	O
layers	O
and	O
extraembryonic	O
tissue	O
are	O
formed	O
in	O
huntingtin	O
deficient	O
embryos	O
.	O

Otx2	O
,	O
normally	O
expressed	O
in	O
the	O
anterior	O
neuroectoderm	O
and	O
anterior	O
visceral	O
endoderm	O
[	O
19	O
]	O
,	O
is	O
expressed	O
in	O
mutant	O
embryos	O
at	O
E7	O
.	O
5	O
(	O
Fig	O
.	O
1A	O
,	O
B	O
)	O
although	O
the	O
expression	O
domain	O
appears	O
reduced	O
.	O

Similarly	O
,	O
Hesx1	O
expression	O
is	O
grossly	O
normal	O
in	O
mutant	O
embryos	O
,	O
with	O
expression	O
localized	O
to	O
the	O
AVE	O
and	O
neuroectoderm	O
(	O
Fig	O
.	O
1C	O
-	O
F	O
,	O
[	O
20	O
]	O
)	O
,	O
although	O
the	O
expression	O
domain	O
also	O
appears	O
reduced	O
.	O

These	O
results	O
indicate	O
appropriate	O
specification	O
and	O
movement	O
of	O
anterior	O
visceral	O
endoderm	O
(	O
AVE	O
)	O
cells	O
from	O
the	O
distal	O
tip	O
and	O
suggest	O
that	O
neuroectoderm	O
is	O
induced	O
in	O
the	O
mutant	O
embryos	O
.	O

Figure	O
1	O

AVE	O
displacement	O
and	O
anterior	O
neurectoderm	O
induction	O
occur	O
normally	O
in	O
the	O
absence	O
of	O
huntingtin	O
.	O

Whole	O
mount	O
in	O
situ	O
hybridization	O
analysis	O
of	O
Otx2	O
(	O
A	O
,	O
B	O
)	O
and	O
Hesx	O
(	O
C	O
-	O
F	O
)	O
in	O
E7	O
.	O
5	O
normal	O
(	O
A	O
,	O
C	O
,	O
E	O
)	O
and	O
mutant	O
(	O
B	O
,	O
D	O
,	O
F	O
)	O
embryos	O
reveals	O
that	O
neuroectoderm	O
and	O
anterior	O
visceral	O
endoderm	O
(	O
AVE	O
)	O
develop	O
normally	O
in	O
huntingtin	O
deficient	O
embryos	O
,	O
although	O
the	O
neuroectoderm	O
expression	O
domain	O
is	O
reduced	O
.	O

Asymmetrical	O
expression	O
of	O
Hesx	O
in	O
mutant	O
embryos	O
(	O
F	O
)	O
suggests	O
that	O
left	O
-	O
right	O
transcriptional	O
control	O
is	O
maintained	O
.	O

Hnf3	O
beta	O
expression	O
in	O
the	O
definitive	O
endoderm	O
extends	O
around	O
the	O
distal	O
tip	O
and	O
is	O
reduced	O
in	O
the	O
AVE	O
(	O
*	O
)	O
in	O
both	O
normal	O
(	O
G	O
,	O
I	O
)	O
and	O
mutant	O
embryos	O
(	O
H	O
,	O
J	O
)	O
.	O

Taken	O
together	O
,	O
these	O
results	O
suggest	O
normal	O
ectoderm	O
and	O
endoderm	O
induction	O
and	O
localization	O
in	O
Hdhex4	O
/	O
5	O
/	O
Hdhex4	O
/	O
5	O
embryos	O
.	O

Embryos	O
are	O
shown	O
in	O
lateral	O
views	O
,	O
with	O
anterior	O
to	O
the	O
left	O
in	O
all	O
pictures	O
with	O
the	O
exception	O
of	O
E	O
and	O
F	O
.	O

Embryos	O
are	O
viewed	O
from	O
the	O
anterior	O
aspect	O
in	O
E	O
and	O
F	O
.	O

To	O
examine	O
definitive	O
endoderm	O
formation	O
,	O
the	O
expression	O
of	O
Hnf3	O
beta	O
(	O
FoxA2	O
)	O
in	O
mutant	O
and	O
wild	O
-	O
type	O
embryos	O
was	O
analyzed	O
.	O

In	O
wild	O
-	O
type	O
embryos	O
,	O
Hnf3	O
beta	O
expression	O
is	O
confined	O
to	O
the	O
node	O
and	O
anterior	O
definitive	O
endoderm	O
(	O
Fig	O
.	O
1G	O
,	O
I	O
[	O
21	O
]	O
)	O
.	O

Mutant	O
embryos	O
exhibit	O
Hnf3	O
beta	O
-	O
reactive	O
definitive	O
endoderm	O
over	O
the	O
disorganized	O
anterior	O
streak	O
region	O
and	O
proceeding	O
rostrally	O
around	O
the	O
distal	O
tip	O
(	O
Fig	O
.	O
1H	O
,	O
J	O
)	O
.	O

In	O
both	O
normal	O
and	O
mutant	O
embryos	O
,	O
the	O
AVE	O
exhibits	O
little	O
Hnf3	O
beta	O
expression	O
.	O

Therefore	O
,	O
huntingtin	O
deficiency	O
does	O
not	O
greatly	O
affect	O
Hnf3	O
beta	O
regulation	O
or	O
the	O
reorganization	O
of	O
the	O
visceral	O
endoderm	O
.	O

The	O
lack	O
of	O
a	O
morphological	O
node	O
and	O
presence	O
of	O
a	O
shortened	O
streak	O
,	O
together	O
with	O
reduced	O
neuroectoderm	O
and	O
lack	O
of	O
headfolds	O
,	O
suggest	O
that	O
anterior	O
streak	O
formation	O
may	O
be	O
impaired	O
in	O
huntingtin	O
deficient	O
embryos	O
.	O

To	O
investigate	O
this	O
possibility	O
,	O
we	O
examined	O
mesoderm	O
formation	O
in	O
mutant	O
embryos	O
.	O

Mesoderm	O
is	O
specified	O
in	O
the	O
mutant	O
embryos	O
,	O
as	O
marked	O
by	O
the	O
expression	O
of	O
T	O
(	O
Brachyury	O
)	O
and	O
Evx1	O
(	O
Fig	O
.	O
2A	O
-	O
F	O
)	O
.	O

However	O
,	O
close	O
inspection	O
of	O
the	O
data	O
reveals	O
abnormal	O
patterning	O
within	O
this	O
tissue	O
and	O
its	O
derivatives	O
.	O
T	O
,	O
normally	O
expressed	O
in	O
the	O
primitive	O
streak	O
,	O
node	O
and	O
axial	O
head	O
process	O
/	O
notochord	O
mesoderm	O
[	O
22	O
]	O
,	O
is	O
detected	O
in	O
the	O
shortened	O
streak	O
and	O
axial	O
mesoderm	O
in	O
Hdhex4	O
/	O
5	O
/	O
Hdhex4	O
/	O
5	O
embryos	O
,	O
extending	O
rostrally	O
from	O
a	O
region	O
of	O
weakly	O
positive	O
cells	O
(	O
Fig	O
.	O
2A	O
,	O
B	O
)	O
.	O

T	O
expression	O
appears	O
weaker	O
,	O
however	O
,	O
in	O
the	O
anterior	O
streak	O
,	O
corresponding	O
to	O
cells	O
that	O
will	O
give	O
rise	O
to	O
axial	O
mesoderm	O
(	O
Fig	O
.	O
2D	O
)	O
.	O

T	O
is	O
also	O
ectopically	O
expressed	O
in	O
mutant	O
extraembryonic	O
mesoderm	O
at	O
the	O
anterior	O
embryonic	O
junction	O
and	O
along	O
the	O
chorion	O
(	O
Fig	O
.	O
2B	O
,	O
D	O
)	O
.	O

Similarly	O
,	O
Evx1	O
,	O
normally	O
expressed	O
in	O
primitive	O
streak	O
mesoderm	O
at	O
E7	O
.	O
5	O
with	O
highest	O
levels	O
in	O
proximal	O
cells	O
[	O
23	O
]	O
,	O
is	O
expressed	O
in	O
the	O
proximal	O
shortened	O
streak	O
but	O
is	O
also	O
aberrantly	O
expressed	O
throughout	O
the	O
extraembryonic	O
mesoderm	O
,	O
allantois	O
and	O
chorion	O
(	O
Fig	O
.	O
2E	O
,	O
F	O
)	O
.	O

Extraembryonic	O
mesoderm	O
,	O
derived	O
from	O
the	O
proximal	O
streak	O
,	O
does	O
not	O
normally	O
express	O
T	O
or	O
Evx1	O
in	O
wild	O
-	O
type	O
embryos	O
[	O
22	O
]	O
.	O

Therefore	O
,	O
the	O
inappropriate	O
expression	O
of	O
T	O
and	O
Evx1	O
,	O
the	O
shortened	O
primitive	O
streak	O
,	O
and	O
the	O
absence	O
of	O
a	O
morphological	O
node	O
,	O
all	O
suggest	O
that	O
the	O
anterior	O
primitive	O
streak	O
is	O
deficient	O
in	O
the	O
mutant	O
embryos	O
.	O

Figure	O
2	O

Huntingtin	O
is	O
required	O
for	O
formation	O
of	O
anterior	O
primitive	O
streak	O
and	O
paraxial	O
mesoderm	O
.	O

Whole	O
mount	O
and	O
section	O
insitu	O
hybridizations	O
of	O
E7	O
.	O
5	O
embryos	O
shows	O
T	O
(	O
Brachyury	O
)	O
(	O
A	O
-	O
D	O
)	O
is	O
expressed	O
in	O
the	O
primitive	O
streak	O
,	O
node	O
,	O
axial	O
mesoderm	O
and	O
Evx1	O
(	O
E	O
-	O
F	O
)	O
is	O
expressed	O
in	O
the	O
primitive	O
streak	O
,	O
most	O
strongly	O
in	O
the	O
proximal	O
streak	O
wild	O
-	O
type	O
embryos	O
.	O

However	O
,	O
in	O
mutant	O
embryos	O
,	O
both	O
T	O
(	O
B	O
,	O
D	O
)	O
and	O
Evx1	O
(	O
F	O
)	O
are	O
ectopically	O
expressed	O
in	O
the	O
extraembryonic	O
region	O
.	O

Wnt3A	O
expression	O
is	O
reduced	O
in	O
mutant	O
embryos	O
(	O
H	O
)	O
,	O
although	O
the	O
localization	O
of	O
its	O
expression	O
to	O
the	O
proximal	O
streak	O
is	O
the	O
same	O
as	O
in	O
wild	O
-	O
type	O
embryos	O
(	O
G	O
)	O
.	O

Analysis	O
of	O
paraxial	O
mesoderm	O
markers	O
Tbx6	O
(	O
I	O
,	O
J	O
)	O
and	O
Dll1	O
(	O
K	O
,	O
L	O
)	O
,	O
reveals	O
that	O
these	O
markers	O
are	O
reduced	O
in	O
mutant	O
embryos	O
(	O
J	O
,	O
L	O
)	O
,	O
suggesting	O
impaired	O
paraxial	O
mesoderm	O
production	O
in	O
the	O
absence	O
of	O
huntingtin	O
.	O

Embryos	O
in	O
A	O
-	O
H	O
are	O
shown	O
in	O
a	O
lateral	O
view	O
with	O
anterior	O
oriented	O
to	O
the	O
left	O
.	O

Embryos	O
in	O
I	O
-	O
L	O
are	O
shown	O
in	O
a	O
posterior	O
view	O
(	O
I	O
,	O
K	O
)	O
or	O
near	O
posterior	O
(	O
J	O
,	O
L	O
)	O
view	O
with	O
proximal	O
oriented	O
toward	O
the	O
top	O
.	O

In	O
(	O
C	O
,	O
D	O
)	O
,	O
al	O
=	O
allantois	O
,	O
a	O
=	O
amnion	O
,	O
ch	O
=	O
chorion	O
,	O
ee	O
=	O
embryonic	O
node	O
(	O
N	O
)	O
,	O
em	O
=	O
extraembryonic	O
mesoderm	O
,	O
n	O
=	O
node	O
,	O
ps	O
=	O
primitive	O
streak	O
.	O

Rather	O
than	O
a	O
node	O
,	O
mutant	O
embryos	O
exhibit	O
a	O
region	O
of	O
disorganized	O
cells	O
(	O
*	O
)	O
at	O
the	O
distal	O
extent	O
of	O
the	O
short	O
primitive	O
streak	O
.	O

The	O
anterior	O
streak	O
generates	O
paraxial	O
mesoderm	O
.	O

Therefore	O
we	O
examined	O
paraxial	O
mesoderm	O
formation	O
in	O
wild	O
-	O
type	O
and	O
mutant	O
embryos	O
,	O
revealing	O
deficits	O
in	O
mesoderm	O
patterning	O
.	O

Starting	O
at	O
E	O
.	O
7	O
.	O
5	O
,	O
Wnt3A	O
is	O
expressed	O
in	O
the	O
primitive	O
streak	O
in	O
cells	O
fated	O
to	O
become	O
paraxial	O
mesoderm	O
.	O

In	O
huntingtin	O
deficient	O
mutants	O
,	O
Wnt3a	O
is	O
induced	O
in	O
the	O
proximal	O
streak	O
(	O
Fig	O
.	O
2G	O
,	O
H	O
)	O
,	O
confirming	O
stage	O
appropriate	O
posterior	O
development	O
,	O
in	O
contrast	O
to	O
the	O
absence	O
of	O
anterior	O
head	O
folds	O
.	O

However	O
,	O
expression	O
of	O
Wnt3a	O
is	O
noticeably	O
reduced	O
in	O
Hdhex4	O
/	O
5	O
/	O
Hdhex4	O
/	O
5	O
embryos	O
,	O
suggesting	O
a	O
defect	O
in	O
paraxial	O
mesoderm	O
development	O
(	O
Fig	O
.	O
2H	O
)	O
.	O

Reduced	O
expression	O
of	O
Tbx6	O
in	O
the	O
mesoderm	O
lateral	O
to	O
the	O
primitive	O
streak	O
in	O
mutant	O
embryos	O
confirms	O
this	O
interpretation	O
(	O
Fig	O
.	O
2I	O
,	O
J	O
)	O
.	O

Furthermore	O
,	O
in	O
mutant	O
embryos	O
at	O
E7	O
.	O
5	O
,	O
the	O
expression	O
of	O
Dll1	O
in	O
the	O
distal	O
streak	O
region	O
and	O
in	O
only	O
a	O
narrow	O
swath	O
of	O
cells	O
located	O
laterally	O
confirms	O
the	O
paucity	O
of	O
paraxial	O
mesoderm	O
(	O
Fig	O
.	O
2K	O
,	O
L	O
,	O
[	O
24	O
]	O
)	O
.	O

These	O
results	O
strongly	O
suggest	O
that	O
anterior	O
primitive	O
streak	O
formation	O
is	O
impaired	O
,	O
resulting	O
in	O
reduced	O
axial	O
and	O
paraxial	O
mesoderm	O
formation	O
and	O
impaired	O
neural	O
development	O
.	O

Impaired	O
regional	O
restriction	O
of	O
growth	O
factor	O
expression	O
in	O
the	O
absence	O
of	O
huntingtin	O

To	O
elucidate	O
the	O
apparent	O
patterning	O
deficits	O
,	O
we	O
next	O
analyzed	O
signaling	O
molecules	O
that	O
are	O
required	O
for	O
early	O
patterning	O
.	O

Nodal	O
,	O
a	O
member	O
of	O
the	O
Tgf	O
beta	O
family	O
of	O
secreted	O
molecules	O
is	O
required	O
for	O
the	O
formation	O
and	O
maintenance	O
of	O
the	O
primitive	O
streak	O
and	O
induction	O
of	O
the	O
AVE	O
[	O
25	O
-	O
27	O
]	O
.	O

Nodal	O
is	O
normally	O
expressed	O
throughout	O
the	O
epiblast	O
and	O
overlying	O
visceral	O
endoderm	O
at	O
early	O
post	O
implantation	O
stages	O
[	O
28	O
]	O
,	O
but	O
later	O
becomes	O
restricted	O
to	O
the	O
posterior	O
of	O
the	O
embryo	O
to	O
the	O
site	O
of	O
primitive	O
streak	O
with	O
asymmetrical	O
visceral	O
endoderm	O
expression	O
marking	O
the	O
left	O
-	O
right	O
axis	O
.	O

By	O
E7	O
.	O
5	O
,	O
Nodal	O
expression	O
is	O
restricted	O
to	O
the	O
node	O
.	O

Nodal	O
expression	O
was	O
assessed	O
in	O
Hdhex4	O
/	O
5	O
/	O
Hdhex4	O
/	O
5	O
embryos	O
heterozygous	O
for	O
the	O
Ndl	O
lac	O
Z	O
allele	O
[	O
28	O
,	O
29	O
]	O
.	O

Notably	O
,	O
heterozygous	O
loss	O
of	O
nodal	O
does	O
not	O
alter	O
the	O
Hdhex4	O
/	O
5	O
/	O
Hdhex4	O
/	O
5	O
phenotype	O
,	O
as	O
determined	O
by	O
morphology	O
of	O
Hdhex4	O
/	O
5	O
/	O
Hdhex4	O
/	O
5	O
:	O
Ndllacz	O
/	O
Ndl	O
+	O
embryos	O
compared	O
with	O
Hdhex4	O
/	O
5	O
/	O
Hdhex4	O
/	O
5	O
embryos	O
(	O
data	O
not	O
shown	O
)	O
.	O

In	O
contrast	O
to	O
wild	O
-	O
type	O
embryos	O
,	O
which	O
exhibit	O
tight	O
restriction	O
of	O
Nodal	O
.	O
LacZ	O
expression	O
to	O
the	O
node	O
,	O
Hdhex4	O
/	O
5	O
/	O
Hdhex4	O
/	O
5	O
:	O
Ndllacz	O
/	O
Ndl	O
+	O
embryos	O
express	O
Nodal	O
.	O
LacZ	O
throughout	O
the	O
endoderm	O
overlying	O
the	O
epiblast	O
,	O
with	O
higher	O
levels	O
in	O
the	O
posterior	O
in	O
an	O
asymmetric	O
pattern	O
(	O
Fig	O
.	O
3A	O
-	O
D	O
)	O
.	O

The	O
lack	O
of	O
tight	O
restriction	O
of	O
nodal	O
signal	O
is	O
consistent	O
with	O
a	O
failure	O
to	O
form	O
an	O
organized	O
node	O
structure	O
.	O

Figure	O
3	O

Impaired	O
regional	O
restriction	O
of	O
gene	O
expression	O
in	O
huntingtin	O
deficient	O
embryos	O
.	O

X	O
-	O
gal	O
staining	O
of	O
Nodal	O
-	O
LacZ	O
embryos	O
shows	O
staining	O
in	O
endoderm	O
near	O
the	O
node	O
of	O
normal	O
embryos	O
(	O
A	O
,	O
C	O
)	O
but	O
broad	O
staining	O
in	O
mutant	O
embryos	O
(	O
B	O
,	O
D	O
)	O
,	O
although	O
expression	O
is	O
higher	O
in	O
the	O
posterior	O
.	O

The	O
tight	O
node	O
expression	O
of	O
Nodal	O
in	O
normal	O
embryos	O
(	O
C	O
)	O
is	O
lost	O
in	O
mutant	O
embryos	O
(	O
D	O
)	O
,	O
consistent	O
with	O
the	O
loss	O
of	O
a	O
morphological	O
node	O
in	O
the	O
absence	O
of	O
huntingtin	O
.	O

Whole	O
mount	O
and	O
in	O
situ	O
hybridization	O
of	O
E7	O
.	O
5	O
day	O
embryos	O
reveals	O
that	O
Fgf8	O
is	O
detected	O
in	O
the	O
proximal	O
streak	O
and	O
is	O
downregulated	O
in	O
cells	O
migrating	O
out	O
of	O
the	O
streak	O
in	O
normal	O
embryos	O
(	O
E	O
,	O
G	O
)	O
.	O

In	O
contrast	O
,	O
Fgf8	O
remains	O
highly	O
expressed	O
in	O
mutant	O
embryos	O
(	O
F	O
,	O
H	O
)	O
.	O

Transient	O
expression	O
of	O
Gsc	O
in	O
the	O
definitive	O
endoderm	O
overlying	O
the	O
prospective	O
head	O
region	O
in	O
normal	O
embryos	O
(	O
I	O
,	O
K	O
)	O
is	O
distinguished	O
in	O
other	O
cell	O
layers	O
in	O
normal	O
embryos	O
but	O
remains	O
unrestricted	O
in	O
mutant	O
embryos	O
(	O
J	O
,	O
L	O
)	O
.	O

Earlier	O
posterior	O
expression	O
of	O
Gsc	O
is	O
also	O
maintained	O
in	O
mutant	O
embryos	O
(	O
J	O
)	O
while	O
it	O
is	O
down	O
-	O
regulated	O
in	O
normal	O
embryos	O
(	O
I	O
)	O
.	O

Embryos	O
(	O
A	O
,	O
B	O
,	O
E	O
,	O
F	O
,	O
G	O
,	O
H	O
,	O
I	O
,	O
K	O
,	O
L	O
)	O
are	O
shown	O
in	O
a	O
lateral	O
view	O
with	O
anterior	O
oriented	O
to	O
the	O
left	O
.	O

Embryos	O
(	O
C	O
,	O
D	O
)	O
are	O
in	O
a	O
posterior	O
view	O
.	O

Fgf8	O
signaling	O
is	O
also	O
essential	O
for	O
normal	O
gastrulation	O
in	O
the	O
mouse	O
embryo	O
.	O

Fgf8	O
is	O
required	O
for	O
cell	O
migration	O
away	O
from	O
the	O
primitive	O
streak	O
[	O
30	O
]	O
.	O

Expressed	O
just	O
prior	O
to	O
streak	O
formation	O
in	O
the	O
posterior	O
epiblast	O
and	O
visceral	O
endoderm	O
,	O
Fgf8	O
is	O
restricted	O
to	O
the	O
streak	O
mesoderm	O
at	O
E7	O
.	O
5	O
in	O
a	O
decreasing	O
proximal	O
-	O
distal	O
gradient	O
and	O
is	O
downregulated	O
in	O
cells	O
shortly	O
after	O
they	O
exit	O
the	O
streak	O
(	O
Fig	O
.	O
3E	O
,	O
G	O
)	O
.	O

In	O
Hdhex4	O
/	O
5	O
/	O
Hdhex4	O
/	O
5	O
embryos	O
,	O
Fgf8	O
expression	O
is	O
strongly	O
expressed	O
in	O
the	O
posterior	O
region	O
in	O
the	O
primitive	O
streak	O
and	O
ectopically	O
in	O
the	O
endoderm	O
overlying	O
the	O
entire	O
epiblast	O
(	O
Fig	O
.	O
3F	O
,	O
H	O
)	O
.	O

However	O
,	O
streak	O
derivatives	O
appear	O
to	O
migrate	O
normally	O
as	O
evidenced	O
by	O
the	O
proper	O
anterior	O
expression	O
of	O
markers	O
such	O
as	O
Otx2	O
,	O
Hnf3	O
beta	O
and	O
Hesx1	O
anteriorly	O
(	O
Fig	O
.	O
1	O
)	O
.	O

Therefore	O
,	O
mutant	O
embryos	O
exhibit	O
normal	O
migration	O
of	O
streak	O
derivatives	O
but	O
display	O
impaired	O
Fgf8	O
repression	O
in	O
mutant	O
endoderm	O
.	O

Hdhex4	O
/	O
5	O
/	O
Hdhex4	O
/	O
5	O
embryos	O
also	O
fail	O
to	O
restrict	O
the	O
expression	O
of	O
goosecoid	O
(	O
Gsc	O
)	O
.	O

Normally	O
,	O
Gsc	O
is	O
initially	O
expressed	O
in	O
the	O
visceral	O
endoderm	O
and	O
proximal	O
,	O
posterior	O
streak	O
where	O
the	O
primitive	O
streak	O
will	O
form	O
prior	O
to	O
gastrulation	O
.	O

As	O
the	O
primitive	O
streak	O
forms	O
and	O
extends	O
,	O
Gsc	O
is	O
expressed	O
in	O
the	O
distal	O
streak	O
,	O
the	O
node	O
,	O
and	O
the	O
axial	O
mesoderm	O
extending	O
anteriorly	O
from	O
the	O
node	O
(	O
Fig	O
.	O
3I	O
,	O
K	O
,	O
[	O
31	O
,	O
32	O
]	O
)	O
.	O

However	O
,	O
in	O
the	O
mutant	O
Hdhex4	O
/	O
5	O
/	O
Hdhex4	O
/	O
5	O
embryos	O
,	O
high	O
levels	O
of	O
Gsc	O
expression	O
remain	O
unrestricted	O
in	O
the	O
endoderm	O
overlying	O
the	O
entire	O
embryo	O
and	O
ectopically	O
in	O
cells	O
adjacent	O
to	O
the	O
ectoplacental	O
cone	O
(	O
Fig	O
.	O
3J	O
,	O
L	O
)	O
.	O

These	O
results	O
suggest	O
that	O
,	O
in	O
contrast	O
to	O
proper	O
Hnf3	O
beta	O
regulation	O
,	O
Gsc	O
remains	O
inappropriately	O
activated	O
in	O
mutant	O
visceral	O
and	O
definitive	O
endoderm	O
,	O
implicating	O
huntingtin	O
in	O
the	O
proper	O
restriction	O
of	O
this	O
homeodomain	O
transcription	O
factor	O
.	O

Huntingtin	O
is	O
not	O
required	O
for	O
expression	O
of	O
extraembryonic	O
signaling	O
molecules	O

Previous	O
studies	O
of	O
chimeric	O
embryos	O
suggest	O
that	O
huntingtin	O
is	O
required	O
only	O
in	O
the	O
extraembryonic	O
tissue	O
for	O
proper	O
development	O
[	O
16	O
]	O
.	O

Signals	O
from	O
the	O
extraembryonic	O
tissue	O
are	O
critical	O
for	O
the	O
induction	O
of	O
embryonic	O
signals	O
and	O
for	O
patterning	O
the	O
epiblast	O
.	O

Consequently	O
,	O
we	O
examined	O
extraembryonic	O
development	O
in	O
huntingtin	O
deficient	O
embryos	O
.	O

Hnf4	O
is	O
a	O
transcription	O
factor	O
expressed	O
in	O
the	O
primitive	O
endoderm	O
as	O
soon	O
as	O
this	O
tissue	O
becomes	O
distinct	O
and	O
is	O
a	O
key	O
regulator	O
of	O
visceral	O
endoderm	O
secreted	O
factors	O
such	O
as	O
alphafetoprotein	O
,	O
apolipoproteins	O
,	O
and	O
transferrin	O
.	O

Inactivation	O
of	O
Hnf4	O
results	O
in	O
impaired	O
gastrulation	O
[	O
33	O
,	O
34	O
]	O
.	O

At	O
E7	O
.	O
5	O
,	O
Hnf4	O
is	O
expressed	O
in	O
the	O
columnar	O
visceral	O
endoderm	O
cells	O
at	O
the	O
extraembryonic	O
-	O
ectoderm	O
junction	O
(	O
Fig	O
.	O
4A	O
,	O
[	O
33	O
]	O
)	O
.	O

In	O
Hdhex4	O
/	O
5	O
/	O
Hdhex4	O
/	O
5	O
embryos	O
,	O
consistent	O
with	O
normal	O
primitive	O
and	O
visceral	O
endoderm	O
differentiation	O
,	O
Hnf4	O
expression	O
appears	O
normal	O
,	O
although	O
the	O
signal	O
is	O
stronger	O
in	O
mutant	O
embryos	O
compared	O
to	O
wild	O
-	O
type	O
embryos	O
(	O
Fig	O
.	O
4B	O
)	O
.	O

Similarly	O
,	O
Pem	O
,	O
a	O
transcription	O
factor	O
expressed	O
in	O
proximal	O
visceral	O
endoderm	O
and	O
ectoplacental	O
cone	O
in	O
wild	O
-	O
type	O
embryos	O
at	O
E7	O
.	O
5	O
,	O
also	O
is	O
expressed	O
in	O
these	O
tissues	O
in	O
the	O
mutant	O
embryos	O
(	O
Fig	O
.	O
4C	O
,	O
D	O
[	O
35	O
]	O
)	O
.	O

However	O
,	O
Pem	O
expressing	O
visceral	O
endoderm	O
hangs	O
over	O
the	O
anterior	O
of	O
the	O
mutant	O
embryos	O
,	O
revealing	O
abnormal	O
location	O
despite	O
grossly	O
normal	O
differentiation	O
.	O

Figure	O
4	O

Normal	O
expression	O
of	O
extraembryonic	O
markers	O
in	O
huntingtin	O
deficient	O
embryos	O
.	O

Whole	O
mount	O
in	O
situ	O
hybridization	O
analysis	O
at	O
E7	O
.	O
5	O
of	O
markers	O
of	O
the	O
extraembryonic	O
tissues	O
reveals	O
grossly	O
normal	O
expression	O
in	O
the	O
absence	O
of	O
huntingtin	O
.	O

Hnf4	O
,	O
expressed	O
in	O
the	O
visceral	O
endoderm	O
at	O
the	O
junction	O
of	O
embryonic	O
-	O
ectoderm	O
junction	O
(	O
A	O
)	O
,	O
is	O
normal	O
in	O
mutant	O
embryos	O
,	O
although	O
the	O
signal	O
is	O
slightly	O
higher	O
(	O
B	O
)	O
.	O

Similarly	O
,	O
the	O
expression	O
of	O
Pem	O
transcripts	O
is	O
maintained	O
in	O
mutant	O
embryos	O
(	O
D	O
)	O
similar	O
to	O
normal	O
embryos	O
(	O
C	O
)	O
,	O
although	O
Pem	O
is	O
expressed	O
in	O
the	O
abnormal	O
lopsided	O
overhang	O
of	O
visceral	O
endoderm	O
over	O
the	O
anterior	O
of	O
the	O
mutant	O
embryos	O
.	O

Expression	O
of	O
extraembryonic	O
signaling	O
molecules	O
is	O
unaffected	O
by	O
the	O
loss	O
of	O
huntingtin	O
,	O
as	O
evidenced	O
by	O
the	O
expression	O
of	O
Bmp4	O
(	O
E	O
,	O
F	O
)	O
in	O
the	O
extraembryonic	O
ectoderm	O
,	O
and	O
Lefty1	O
and	O
Dkk1	O
(	O
I	O
-	O
L	O
)	O
in	O
the	O
AVE	O
in	O
mutant	O
embryos	O
.	O

Bmp4	O
is	O
not	O
localized	O
,	O
however	O
,	O
to	O
a	O
ring	O
of	O
extraembryonic	O
ectoderm	O
in	O
mutant	O
embryos	O
(	O
F	O
)	O
as	O
in	O
normal	O
embryos	O
(	O
E	O
)	O
.	O

Primitive	O
germ	O
cells	O
(	O
PCGs	O
)	O
are	O
induced	O
normally	O
in	O
both	O
wild	O
-	O
type	O
(	O
G	O
)	O
and	O
mutant	O
embryos	O
(	O
H	O
)	O
,	O
suggesting	O
the	O
Bmp4	O
signaling	O
from	O
the	O
extraembryonic	O
ectoderm	O
to	O
the	O
epiblast	O
is	O
normal	O
.	O

Lefty1	O
expression	O
appears	O
disorganized	O
in	O
mutant	O
embryos	O
(	O
I	O
)	O
compared	O
to	O
wild	O
-	O
type	O
embryos	O
(	O
J	O
)	O
.	O

In	O
contrast	O
,	O
the	O
anterior	O
expression	O
of	O
Dkk1	O
in	O
the	O
AVE	O
in	O
mutant	O
embryos	O
(	O
L	O
)	O
matches	O
the	O
wild	O
-	O
type	O
expression	O
pattern	O
(	O
K	O
)	O
.	O

Despite	O
normal	O
AVE	O
formation	O
,	O
head	O
folds	O
fail	O
to	O
form	O
in	O
mutant	O
embryos	O
,	O
even	O
when	O
cultured	O
in	O
nutrient	O
rich	O
media	O
for	O
24	O
hours	O
.	O

Wild	O
-	O
type	O
E7	O
.	O
5	O
embryos	O
,	O
when	O
cultured	O
in	O
75	O
%	O
rat	O
serum	O
,	O
develop	O
somites	O
(	O
M	O
)	O
,	O
heart	O
(	O
white	O
arrow	O
,	O
N	O
)	O
and	O
head	O
folds	O
(	O
blue	O
arrow	O
head	O
,	O
N	O
)	O
in	O
culture	O
.	O

In	O
contrast	O
,	O
huntingtin	O
deficient	O
embryos	O
continue	O
to	O
live	O
in	O
culture	O
but	O
do	O
not	O
form	O
headfolds	O
,	O
heart	O
or	O
somites	O
(	O
O	O
)	O
.	O

Embryos	O
are	O
shown	O
in	O
a	O
lateral	O
view	O
(	O
A	O
-	O
F	O
,	O
I	O
-	O
J	O
)	O
with	O
anterior	O
oriented	O
to	O
the	O
left	O
.	O

Embryos	O
in	O
(	O
G	O
,	O
H	O
,	O
K	O
,	O
L	O
)	O
are	O
shown	O
in	O
an	O
anterior	O
view	O
with	O
proximal	O
oriented	O
up	O
.	O

Signals	O
from	O
the	O
extraembryonic	O
tissues	O
,	O
including	O
the	O
anterior	O
visceral	O
endoderm	O
and	O
extraembryonic	O
ectoderm	O
are	O
required	O
for	O
proper	O
formation	O
and	O
patterning	O
of	O
the	O
epiblast	O
[	O
17	O
]	O
.	O

Bmp4	O
is	O
a	O
signaling	O
molecule	O
that	O
is	O
first	O
expressed	O
uniformly	O
throughout	O
the	O
extraembryonic	O
ectoderm	O
and	O
subsequently	O
is	O
localized	O
to	O
a	O
ring	O
of	O
extraembryonic	O
ectoderm	O
adjacent	O
to	O
the	O
epiblast	O
(	O
Fig	O
.	O
4E	O
,	O
[	O
36	O
]	O
)	O
.	O

A	O
key	O
factor	O
in	O
regulating	O
the	O
formation	O
of	O
the	O
node	O
and	O
primitive	O
streak	O
,	O
Bmp4	O
is	O
required	O
for	O
patterning	O
the	O
embryo	O
along	O
the	O
proximodistal	O
axis	O
[	O
37	O
-	O
40	O
]	O
.	O

In	O
the	O
absence	O
of	O
huntingtin	O
,	O
Bmp4	O
expression	O
is	O
properly	O
maintained	O
in	O
the	O
Hdhex4	O
/	O
5	O
/	O
Hdhex4	O
/	O
5	O
extraembryonic	O
ectoderm	O
but	O
is	O
also	O
expressed	O
throughout	O
the	O
extraembryonic	O
ectoderm	O
(	O
Fig	O
.	O
4F	O
)	O
in	O
a	O
pattern	O
that	O
is	O
similar	O
to	O
early	O
Bmp4	O
expression	O
rather	O
than	O
being	O
restricted	O
to	O
a	O
ring	O
of	O
extraembryonic	O
ectoderm	O
as	O
seen	O
in	O
the	O
wild	O
-	O
type	O
embryos	O
To	O
assess	O
Bmp4	O
signaling	O
from	O
the	O
extraembryonic	O
ectoderm	O
,	O
we	O
evaluated	O
primordial	O
germ	O
cells	O
(	O
PGCs	O
)	O
,	O
which	O
require	O
Bmp4	O
for	O
their	O
induction	O
[	O
37	O
]	O
.	O

PGCs	O
can	O
first	O
be	O
detected	O
at	O
E7	O
.	O
0	O
and	O
subsequently	O
underlie	O
the	O
posterior	O
portion	O
of	O
the	O
primitive	O
streak	O
.	O

Whole	O
mount	O
staining	O
of	O
E7	O
.	O
5	O
mutant	O
and	O
wild	O
-	O
type	O
embryos	O
for	O
alkaline	O
phosphatase	O
activity	O
reveals	O
that	O
PCGs	O
form	O
in	O
Hdhex4	O
/	O
5	O
/	O
Hdhex4	O
/	O
5	O
embryos	O
,	O
suggesting	O
that	O
Bmp4	O
signaling	O
is	O
functional	O
in	O
the	O
absence	O
of	O
huntingtin	O
(	O
Fig	O
.	O
4G	O
,	O
H	O
)	O
.	O

The	O
anterior	O
visceral	O
endoderm	O
(	O
AVE	O
)	O
is	O
also	O
an	O
extraembryonic	O
source	O
of	O
signals	O
that	O
are	O
critical	O
for	O
early	O
patterning	O
.	O

Wnt	O
and	O
nodal	O
antagonists	O
,	O
Dkk1	O
(	O
mdkk	O
-	O
1	O
)	O
and	O
Lefty1	O
respectively	O
,	O
are	O
expressed	O
in	O
the	O
AVE	O
and	O
are	O
important	O
in	O
limiting	O
the	O
posteriorization	O
of	O
the	O
anterior	O
embryo	O
by	O
restricting	O
Nodal	O
and	O
Wnt	O
signaling	O
[	O
41	O
-	O
43	O
]	O
.	O

In	O
Hdhex4	O
/	O
5	O
/	O
Hdhex4	O
/	O
5	O
embryos	O
,	O
both	O
Dkk1	O
(	O
Fig	O
.	O
4I	O
,	O
J	O
)	O
and	O
Lefty1	O
(	O
Fig	O
.	O
4K	O
,	O
L	O
)	O
are	O
expressed	O
normally	O
in	O
the	O
AVE	O
as	O
compared	O
with	O
wild	O
-	O
type	O
embryos	O
.	O

However	O
,	O
Dkk	O
-	O
1	O
levels	O
appear	O
to	O
be	O
slightly	O
increased	O
in	O
Hdhex4	O
/	O
5	O
/	O
Hdhex4	O
/	O
5	O
embryos	O
,	O
although	O
the	O
pattern	O
of	O
Dkk	O
-	O
1	O
expression	O
remains	O
unchanged	O
and	O
this	O
increase	O
may	O
just	O
reflect	O
the	O
same	O
amount	O
of	O
expression	O
in	O
a	O
smaller	O
area	O
.	O

Therefore	O
,	O
the	O
ectopic	O
expression	O
of	O
Nodal	O
(	O
Fig	O
.	O
3A	O
-	O
D	O
)	O
and	O
the	O
decreased	O
Wnt3a	O
expression	O
(	O
Fig	O
.	O
2H	O
)	O
in	O
mutant	O
embryos	O
do	O
not	O
appear	O
to	O
be	O
result	O
of	O
changes	O
in	O
the	O
expression	O
pattern	O
of	O
Lefty1	O
or	O
Dkk1	O
.	O

Despite	O
normal	O
AVE	O
formation	O
and	O
neuroectoderm	O
induction	O
,	O
head	O
folds	O
do	O
not	O
form	O
in	O
Hdhex4	O
/	O
5	O
/	O
Hdhex4	O
/	O
5	O
embryos	O
.	O

Therefore	O
,	O
to	O
determine	O
whether	O
mutant	O
embryos	O
are	O
inherently	O
capable	O
of	O
forming	O
head	O
folds	O
,	O
embryos	O
harvested	O
at	O
stage	O
E7	O
.	O
5	O
were	O
allowed	O
to	O
progress	O
in	O
rich	O
culture	O
medium	O
in	O
vitro	O
for	O
24	O
hours	O
.	O

Wild	O
-	O
type	O
embryos	O
continued	O
to	O
develop	O
head	O
folds	O
,	O
somites	O
and	O
hearts	O
(	O
Fig	O
.	O
4M	O
,	O
N	O
)	O
.	O

In	O
contrast	O
,	O
mutant	O
stage	O
7	O
.	O
5	O
embryos	O
did	O
not	O
develop	O
headfolds	O
,	O
hearts	O
or	O
somites	O
,	O
although	O
these	O
embryos	O
continued	O
to	O
live	O
(	O
Fig	O
.	O
4O	O
)	O
.	O

These	O
results	O
strongly	O
suggest	O
that	O
in	O
the	O
absence	O
of	O
huntingtin	O
,	O
embryos	O
are	O
unable	O
to	O
undergo	O
organogenesis	O
,	O
even	O
if	O
they	O
continue	O
to	O
live	O
past	O
E7	O
.	O
5	O
in	O
a	O
nutrient	O
rich	O
environment	O
.	O

Discussion	O

We	O
have	O
investigated	O
the	O
embryonic	O
processes	O
that	O
require	O
huntingtin	O
in	O
order	O
to	O
more	O
precisely	O
delineate	O
huntingtin	O
'	O
s	O
essential	O
molecular	O
and	O
cellular	O
activities	O
and	O
to	O
provide	O
clues	O
to	O
the	O
mechanism	O
by	O
which	O
the	O
dominant	O
polyglutamine	O
expansion	O
mutation	O
in	O
huntingtin	O
leads	O
to	O
HD	O
pathogenesis	O
.	O

In	O
pursuing	O
the	O
finding	O
that	O
huntingtin	O
is	O
needed	O
only	O
in	O
extraembryonic	O
tissues	O
for	O
normal	O
gastrulation	O
,	O
our	O
data	O
fail	O
to	O
provide	O
evidence	O
of	O
abnormal	O
nutritive	O
gene	O
expression	O
in	O
Hdhex4	O
/	O
5	O
/	O
Hdhex4	O
/	O
5	O
embryos	O
.	O

Instead	O
,	O
our	O
results	O
reveal	O
that	O
huntingtin	O
is	O
required	O
for	O
normal	O
anterior	O
streak	O
formation	O
and	O
the	O
consequent	O
production	O
of	O
paraxial	O
mesoderm	O
,	O
with	O
a	O
previously	O
unrecognized	O
role	O
for	O
huntingtin	O
in	O
the	O
proper	O
extinction	O
of	O
transiently	O
and	O
/	O
or	O
dynamically	O
expressed	O
genes	O
.	O

Indeed	O
,	O
the	O
hallmark	O
of	O
the	O
huntingtin	O
deficient	O
molecular	O
phenotype	O
is	O
the	O
impaired	O
down	O
-	O
regulation	O
of	O
a	O
subset	O
of	O
dynamically	O
expressed	O
genes	O
,	O
after	O
the	O
proper	O
onset	O
of	O
expression	O
.	O

This	O
phenomenon	O
does	O
not	O
reflect	O
a	O
lack	O
of	O
anterior	O
/	O
posterior	O
axis	O
formation	O
,	O
as	O
evidenced	O
by	O
the	O
formation	O
of	O
the	O
AVE	O
anteriorly	O
and	O
the	O
primitive	O
streak	O
posteriorly	O
.	O

Nor	O
can	O
it	O
be	O
simply	O
explained	O
by	O
delayed	O
development	O
,	O
as	O
stage	O
-	O
specific	O
markers	O
,	O
such	O
as	O
Wnt3a	O
and	O
primordial	O
germ	O
cells	O
,	O
which	O
are	O
detectable	O
at	O
E7	O
.	O
0	O
in	O
wild	O
-	O
type	O
embryos	O
,	O
are	O
induced	O
appropriately	O
.	O

Furthermore	O
,	O
the	O
expression	O
of	O
T	O
and	O
Evx1	O
in	O
the	O
extraembryonic	O
mesoderm	O
of	O
mutant	O
embryos	O
is	O
not	O
a	O
feature	O
of	O
wild	O
-	O
type	O
embryos	O
,	O
even	O
at	O
earlier	O
stages	O
.	O

This	O
strongly	O
suggests	O
that	O
in	O
huntingtin	O
deficient	O
embryos	O
,	O
the	O
migration	O
of	O
the	O
distal	O
streak	O
derivatives	O
to	O
the	O
extraembryonic	O
mesoderm	O
occurs	O
normally	O
but	O
that	O
the	O
down	O
-	O
regulation	O
of	O
these	O
genes	O
is	O
impaired	O
.	O

This	O
impairment	O
may	O
also	O
explain	O
the	O
failure	O
of	O
huntingtin	O
deficient	O
embryos	O
to	O
properly	O
restrict	O
the	O
expression	O
of	O
Fgf8	O
,	O
Nodal	O
and	O
Gsc	O
.	O

Thus	O
,	O
huntingtin	O
may	O
play	O
a	O
direct	O
role	O
in	O
the	O
transcriptional	O
regulation	O
,	O
or	O
mRNA	O
stability	O
of	O
these	O
genes	O
or	O
it	O
may	O
act	O
indirectly	O
by	O
intersecting	O
with	O
other	O
pathways	O
that	O
regulate	O
the	O
expression	O
of	O
these	O
genes	O
.	O

The	O
requirement	O
for	O
huntingtin	O
in	O
the	O
extraembryonic	O
tissues	O
had	O
prompted	O
us	O
to	O
test	O
whether	O
impaired	O
extraembryonic	O
signals	O
might	O
be	O
responsible	O
for	O
the	O
dysregulation	O
of	O
gene	O
expression	O
within	O
the	O
epiblast	O
that	O
is	O
observed	O
in	O
Hdhex4	O
/	O
5	O
/	O
Hdhex4	O
/	O
5	O
embryos	O
.	O

Extraembryonic	O
development	O
in	O
Hdhex4	O
/	O
5	O
/	O
Hdhex4	O
/	O
5	O
embryos	O
is	O
associated	O
with	O
mildly	O
elevated	O
levels	O
expression	O
of	O
Hnf4	O
in	O
the	O
primitive	O
endoderm	O
and	O
Pem	O
in	O
the	O
lopsided	O
anterior	O
chorion	O
but	O
the	O
expression	O
of	O
other	O
known	O
signals	O
,	O
such	O
as	O
Bmp4	O
from	O
the	O
extraembryonic	O
ectoderm	O
,	O
and	O
Dkk1	O
and	O
Lefty1	O
from	O
the	O
AVE	O
,	O
appear	O
to	O
be	O
normal	O
,	O
although	O
the	O
slight	O
increase	O
in	O
Dkk	O
-	O
1	O
expression	O
in	O
Hdhex4	O
/	O
5	O
/	O
Hdhex4	O
/	O
5	O
embryos	O
suggests	O
that	O
further	O
investigation	O
into	O
Wnt	O
signaling	O
is	O
warranted	O
.	O

Moreover	O
,	O
extraembryonic	O
Bmp4	O
signaling	O
is	O
not	O
impaired	O
in	O
the	O
absence	O
of	O
huntingtin	O
,	O
as	O
the	O
induction	O
of	O
PCGs	O
in	O
mutant	O
embryos	O
is	O
normal	O
,	O
implying	O
proper	O
transport	O
and	O
secretion	O
of	O
the	O
appropriate	O
extraembryonic	O
signals	O
.	O

However	O
,	O
Nodal	O
,	O
Fgf8	O
and	O
Gsc	O
are	O
expressed	O
ectopically	O
in	O
the	O
visceral	O
endoderm	O
of	O
Hdhex4	O
/	O
5	O
/	O
Hdhex4	O
/	O
5	O
embryos	O
.	O

Both	O
Nodal	O
and	O
Fgf8	O
,	O
important	O
growth	O
factors	O
required	O
for	O
normal	O
development	O
of	O
the	O
epiblast	O
,	O
are	O
tightly	O
regulated	O
during	O
gastrulation	O
.	O

Therefore	O
,	O
misexpression	O
of	O
either	O
or	O
both	O
of	O
these	O
factors	O
,	O
or	O
of	O
goosecoid	O
,	O
in	O
the	O
visceral	O
endoderm	O
could	O
contribute	O
to	O
the	O
Hdhex4	O
/	O
5	O
/	O
Hdhex4	O
/	O
5	O
mutant	O
phenotype	O
.	O

In	O
addition	O
,	O
it	O
is	O
possible	O
that	O
other	O
extraembryonic	O
signal	O
(	O
s	O
)	O
that	O
we	O
have	O
not	O
analyzed	O
may	O
also	O
be	O
affected	O
by	O
the	O
lack	O
of	O
huntingtin	O
activity	O
in	O
extraembryonic	O
cells	O
in	O
mutant	O
embryos	O
.	O

Huntingtin	O
deficient	O
embryos	O
also	O
fail	O
to	O
form	O
headfolds	O
,	O
and	O
to	O
undergo	O
organogenesis	O
,	O
even	O
after	O
culturing	O
in	O
nutrient	O
rich	O
media	O
.	O

The	O
absence	O
of	O
headfold	O
formation	O
in	O
these	O
embryos	O
does	O
not	O
appear	O
to	O
be	O
a	O
result	O
of	O
a	O
failure	O
to	O
induce	O
neurectoderm	O
or	O
a	O
failure	O
to	O
form	O
the	O
AVE	O
,	O
since	O
mutant	O
embryos	O
express	O
markers	O
such	O
as	O
Otx2	O
,	O
Ddk1	O
,	O
Lefty1	O
and	O
Hesx1	O
.	O

In	O
addition	O
,	O
since	O
node	O
formation	O
is	O
not	O
required	O
for	O
neural	O
induction	O
[	O
44	O
-	O
46	O
]	O
,	O
the	O
failure	O
to	O
form	O
a	O
node	O
in	O
huntingtin	O
deficient	O
embryos	O
is	O
also	O
unlikely	O
to	O
explain	O
the	O
lack	O
of	O
headfolds	O
.	O

The	O
apparent	O
reduction	O
of	O
paraxial	O
mesoderm	O
in	O
Hdhex4	O
/	O
5	O
/	O
Hdhex4	O
/	O
5	O
embryos	O
could	O
explain	O
the	O
lack	O
of	O
headfolds	O
since	O
paraxial	O
mesoderm	O
is	O
important	O
for	O
the	O
full	O
development	O
of	O
neuroectoderm	O
,	O
and	O
consequently	O
,	O
headfolds	O
.	O

Alternatively	O
,	O
the	O
inability	O
to	O
manifest	O
headfolds	O
could	O
suggest	O
that	O
huntingtin	O
is	O
required	O
at	O
a	O
very	O
early	O
stage	O
for	O
normal	O
CNS	O
development	O
.	O

This	O
conclusion	O
is	O
consistent	O
with	O
the	O
finding	O
that	O
severely	O
reduced	O
levels	O
of	O
huntingtin	O
,	O
from	O
a	O
hypomorphic	O
Hdh	O
allele	O
,	O
lead	O
to	O
abnormal	O
brains	O
later	O
in	O
embryonic	O
development	O
[	O
15	O
]	O
.	O

The	O
cardinal	O
features	O
of	O
complete	O
Hdh	O
inactivation	O
that	O
we	O
observe	O
are	O
similar	O
to	O
the	O
phenotypes	O
that	O
stem	O
from	O
the	O
complete	O
inactivation	O
of	O
the	O
Polycomb	O
group	O
gene	O
(	O
Pc	O
-	O
g	O
)	O
Eed	O
(	O
embryonic	O
ectoderm	O
development	O
)	O
.	O

Indeed	O
,	O
complete	O
deficiency	O
for	O
either	O
huntingtin	O
or	O
the	O
eed	O
protein	O
leads	O
to	O
abnormal	O
streak	O
development	O
,	O
lack	O
of	O
headfold	O
formation	O
,	O
ectopic	O
T	O
,	O
Evx1	O
and	O
Nodal	O
expression	O
and	O
disruption	O
of	O
anterior	O
primitive	O
streak	O
mesoderm	O
production	O
[	O
47	O
]	O
.	O

Interestingly	O
,	O
Eed	O
protein	O
is	O
also	O
required	O
for	O
proper	O
trophoblast	O
development	O
and	O
normal	O
maintenance	O
of	O
imprinted	O
X	S-GO
-	O
inactivation	O
and	O
genomic	O
imprinting	O
[	O
47	O
-	O
49	O
]	O
,	O
suggesting	O
that	O
these	O
activities	O
warrant	O
investigation	O
in	O
huntingtin	O
deficient	O
embryos	O
.	O

Thus	O
,	O
our	O
observations	O
provide	O
unexpected	O
starting	O
-	O
points	O
in	O
the	O
search	O
for	O
huntingtin	O
'	O
s	O
precise	O
molecular	O
activities	O
,	O
which	O
began	O
with	O
the	O
discovery	O
that	O
this	O
HEAT	O
domain	O
protein	O
hosts	O
the	O
dominant	O
polyglutamine	O
property	O
that	O
is	O
the	O
fundamental	O
basis	O
of	O
HD	O
pathogenesis	O
.	O

In	O
HD	O
patients	O
and	O
in	O
accurate	O
genetic	O
replicas	O
,	O
HD	O
CAG	O
knock	O
-	O
in	O
mice	O
,	O
the	O
dominant	O
mutation	O
specifically	O
affects	O
the	O
major	O
population	O
of	O
neurons	O
in	O
the	O
striatum	O
,	O
without	O
impairing	O
huntingtin	O
'	O
s	O
essential	O
activities	O
in	O
embryonic	O
development	O
[	O
50	O
-	O
53	O
]	O
.	O

Indeed	O
,	O
homozygous	O
HD	O
patients	O
make	O
no	O
wild	O
-	O
type	O
huntingtin	O
,	O
and	O
,	O
in	O
the	O
mouse	O
,	O
a	O
single	O
mutant	O
Hdh	O
allele	O
'	O
s	O
worth	O
of	O
mutant	O
huntingtin	O
can	O
fully	O
rescue	O
huntingtin	O
deficiency	O
embryonic	O
phenotypes	O
[	O
15	O
,	O
51	O
]	O
.	O

The	O
quest	O
to	O
understand	O
the	O
HD	O
mechanism	O
,	O
therefore	O
,	O
is	O
aimed	O
at	O
delineating	O
the	O
huntingtin	O
activity	O
that	O
may	O
explain	O
the	O
striatal	O
cell	O
specificity	O
of	O
the	O
polyglutamine	O
mutant	O
version	O
of	O
huntingtin	O
.	O

One	O
hypothesis	O
is	O
that	O
huntingtin	O
is	O
normally	O
involved	O
in	O
gene	O
transcription	O
,	O
as	O
proposed	O
for	O
NRSF	O
/	O
REST	O
mediated	O
BDNF	O
expression	O
[	O
54	O
]	O
.	O

Now	O
,	O
our	O
finding	O
that	O
huntingtin	O
can	O
be	O
absolutely	O
necessary	O
for	O
the	O
appropriate	O
regulation	O
of	O
genes	O
with	O
dynamic	O
expression	O
patterns	O
in	O
vivo	O
,	O
provides	O
a	O
compelling	O
reason	O
to	O
elucidate	O
the	O
cellular	O
machinery	O
that	O
is	O
necessary	O
for	O
huntingtin	O
mediated	O
gene	O
regulation	O
.	O

Conclusion	O

Our	O
findings	O
indicate	O
that	O
huntingtin	O
is	O
required	O
for	O
proper	O
patterning	O
of	O
the	O
epiblast	O
during	O
early	O
embryogenesis	O
,	O
for	O
proper	O
anterior	O
streak	O
and	O
node	O
formation	O
,	O
primitive	O
streak	O
progression	O
,	O
paraxial	O
mesoderm	O
and	O
head	O
fold	O
formation	O
,	O
as	O
well	O
as	O
for	O
the	O
proper	O
restriction	O
of	O
transiently	O
expressed	O
growth	O
and	O
transcription	O
factor	O
genes	O
.	O

Knowledge	O
of	O
the	O
molecular	O
basis	O
of	O
these	O
changes	O
in	O
huntingtin	O
deficient	O
embryos	O
should	O
facilitate	O
the	O
identification	O
of	O
the	O
cellular	O
pathways	O
that	O
are	O
dependent	O
on	O
huntingtin	O
activities	O
.	O

These	O
will	O
be	O
important	O
for	O
implicating	O
candidates	O
to	O
be	O
assessed	O
in	O
the	O
extraembryonic	O
signals	O
that	O
determine	O
anterior	O
streak	O
progression	O
in	O
the	O
developing	O
embryo	O
and	O
in	O
delineating	O
the	O
dominant	O
activity	O
of	O
the	O
polyglutamine	O
tract	O
in	O
huntingtin	O
that	O
determines	O
the	O
striatal	O
specificity	O
of	O
HD	O
.	O

Methods	O

Mice	O
and	O
genotyping	O

The	O
Hdhex4	O
/	O
5	O
mice	O
carrying	O
a	O
pGKneo	O
insertion	O
/	O
replacement	O
inactivating	O
mutation	O
in	O
the	O
mouse	O
HD	O
gene	O
homologue	O
have	O
been	O
described	O
previously	O
[	O
10	O
]	O
.	O

The	O
experiments	O
were	O
conducted	O
in	O
accordance	O
with	O
an	O
IACUC	O
approved	O
protocol	O
,	O
through	O
the	O
MGH	O
Subcommittee	O
on	O
Animal	O
Research	O
.	O

Mutant	O
Hdhex4	O
/	O
5	O
/	O
Hdhex4	O
/	O
5	O
and	O
normal	O
littermates	O
were	O
obtained	O
in	O
timed	O
pregnancies	O
from	O
mating	O
of	O
Hdhex4	O
/	O
5	O
/	O
Hdh	O
+	O
heterozygotes	O
,	O
genotyped	O
by	O
PCR	O
assay	O
,	O
as	O
described	O
[	O
10	O
]	O
.	O

The	O
day	O
of	O
plug	O
was	O
taken	O
to	O
be	O
E0	O
.	O
5	O
.	O

Embryos	O
that	O
were	O
morphologically	O
normal	O
were	O
pooled	O
separately	O
from	O
morphologically	O
mutant	O
embryos	O
for	O
analysis	O
.	O

Nodal	O
expression	O
was	O
determined	O
in	O
embryos	O
from	O
matings	O
of	O
Hdhex4	O
/	O
5	O
/	O
Hdh	O
+	O
;	O
NdllacZ	O
/	O
Ndl	O
+	O
compound	O
heterozygotes	O
genotyped	O
by	O
PCR	O
assay	O
as	O
described	O
in	O
[	O
29	O
]	O
.	O

Whole	O
mount	O
and	O
section	O
in	O
situ	O
hybridization	O
and	O
beta	O
-	O
gal	O
staining	O

After	O
dissection	O
in	O
PBS	O
,	O
embryos	O
were	O
fixed	O
overnight	O
in	O
4	O
%	O
paraformaldehyde	O
at	O
4	O
degrees	O
C	O
.	O

For	O
sections	O
,	O
decidua	O
fixed	O
in	O
4	O
%	O
paraformaldehyde	O
,	O
were	O
embedded	O
in	O
paraffin	O
and	O
sectioned	O
at	O
7	O
microns	O
.	O

RNA	O
in	O
situ	O
hybridizations	O
were	O
performed	O
as	O
described	O
previously	O
[	O
55	O
]	O
.	O

Nodal	O
.	O
lacZ	O
expression	O
was	O
assessed	O
by	O
beta	O
-	O
galactosidase	O
staining	O
as	O
reported	O
[	O
29	O
]	O
,	O
on	O
embryos	O
post	O
fixed	O
in	O
4	O
%	O
paraformaldehyde	O
.	O

Embryos	O
were	O
mounted	O
in	O
80	O
%	O
glycerol	O
before	O
being	O
photographed	O
.	O

The	O
huntingtin	O
deficient	O
phenotype	O
is	O
fully	O
penetrant	O
at	O
each	O
of	O
the	O
stages	O
that	O
were	O
assessed	O
[	O
10	O
]	O
.	O

Three	O
to	O
six	O
embryos	O
were	O
evaluated	O
for	O
each	O
marker	O
,	O
with	O
every	O
embryo	O
exhibiting	O
the	O
same	O
mutant	O
phenotype	O
in	O
each	O
case	O
.	O

Alkaline	O
phosphatase	O
staining	O
of	O
Primordial	O
Germ	O
Cells	O
(	O
PCGs	O
)	O

After	O
dissections	O
,	O
embryos	O
were	O
fixed	O
in	O
4	O
%	O
paraformaldehyde	O
briefly	O
and	O
washed	O
and	O
stored	O
in	O
1	O
x	O
PBS	O
/	O
0	O
.	O
1	O
%	O
TX	O
-	O
100	O
at	O
4	O
degrees	O
C	O
.	O

Embryos	O
were	O
washed	O
once	O
with	O
Tris	O
-	O
Maleate	O
Buffer	O
(	O
25	O
mM	O
Tris	O
-	O
Maleate	O
,	O
pH	O
=	O
9	O
.	O
0	O
,	O
0	O
.	O
8	O
mM	O
MgCl2	O
)	O
and	O
were	O
subsequently	O
incubated	O
in	O
alkaline	O
phosphatase	O
staining	O
solution	O
(	O
25	O
mM	O
Tris	O
-	O
Maleate	O
,	O
pH	O
=	O
9	O
.	O
0	O
,	O
0	O
.	O
8	O
mM	O
MgCl2	O
,	O
0	O
.	O
4	O
mg	O
/	O
ml	O
alpha	O
-	O
naphthyl	O
phosphate	O
,	O
1	O
mg	O
/	O
ml	O
Fast	O
-	O
Red	O
)	O
.	O

Stained	O
embryos	O
were	O
washed	O
in	O
1	O
x	O
PBS	O
/	O
0	O
.	O
1	O
%	O
TX	O
-	O
100	O
.	O

Whole	O
embryo	O
culture	O

Embryos	O
were	O
dissected	O
at	O
E7	O
.	O
5	O
and	O
washed	O
in	O
DMEM	O
.	O

Embryos	O
were	O
then	O
cultured	O
individually	O
in	O
1	O
ml	O
of	O
culture	O
media	O
(	O
75	O
%	O
immediately	O
centrifuged	O
rat	O
serum	O
and	O
25	O
%	O
DMEM	O
[	O
56	O
]	O
)	O
for	O
24	O
hours	O
while	O
rotating	O
in	O
a	O
37	O
degrees	O
C	O
incubator	O
in	O
5	O
%	O
CO2	O
.	O

Embryos	O
were	O
then	O
fixed	O
in	O
4	O
%	O
paraformaldehyde	O
for	O
analysis	O
.	O

Abbreviations	O

AVE	O
,	O
anterior	O
visceral	O
endoderm	O
;	O
HD	O
,	O
Huntington	O
'	O
s	O
disease	O
gene	O
;	O
HD	O
,	O
Huntington	O
'	O
s	O
disease	O
;	O
Hdh	O
,	O
mouse	O
HD	O
gene	O
homologue	O
;	O
PCGs	O
,	O
primordial	O
germ	O
cells	O

Authors	O
'	O
contributions	O

JMW	O
,	O
TC	O
,	O
PH	O
-	O
M	O
and	O
MD	O
performed	O
whole	O
mount	O
and	O
in	O
situ	O
hybridization	O
assays	O
.	O

MEM	O
and	O
RC	O
contributed	O
to	O
the	O
conception	O
of	O
this	O
study	O
.	O

JMW	O
,	O
TC	O
,	O
PH	O
-	O
M	O
and	O
MEM	O
drafted	O
the	O
manuscript	O
and	O
RC	O
contributed	O
to	O
its	O
finalization	O
.	O

All	O
authors	O
read	O
and	O
approved	O
the	O
final	O
manuscript	O
.	O

Acknowledgements	O

We	O
are	O
grateful	O
to	O
Drs	O
.	O

A	O
.	O

Gossler	O
,	O
J	O
.	O

Darnell	O
,	O
Jr	O
.	O
,	O
J	O
Rossant	O
,	O
G	O
.	O

Keller	O
,	O
S	O
.	O

Orkin	O
,	O
G	O
.	O

Martin	O
,	O
T	O
.	O

Yamaguchi	O
,	O
A	O
.	O

McMahon	O
,	O
R	O
.	O

Maas	O
,	O
K	O
.	O
,	O
Muneoka	O
,	O
A	O
.	O

Simeone	O
,	O
Hamada	O
H	O
.	O
and	O
C	O
.	O

Niehrs	O
for	O
the	O
generous	O
gifts	O
of	O
clones	O
and	O
antibody	S-GO
reagents	O
and	O
Dr	O
.	O
E	O
.	O

Robertson	O
for	O
NdllacZ	O
mice	O
.	O

We	O
would	O
like	O
to	O
thank	O
Kathy	O
Molyneaux	O
for	O
her	O
helpful	O
suggestions	O
and	O
technical	O
assistance	O
.	O

We	O
also	O
thank	O
Vladimir	O
Vrbanac	O
,	O
Janice	O
Espinola	O
and	O
Edith	O
Toral	O
Lopez	O
for	O
assistance	O
with	O
animal	O
husbandry	O
.	O

We	O
also	O
thank	O
the	O
members	O
of	O
the	O
MacDonald	O
lab	O
for	O
helpful	O
discussions	O
during	O
the	O
completion	O
of	O
this	O
work	O
.	O

This	O
work	O
was	O
supported	O
by	O
the	O
NINDS	O
grants	O
NS32765	O
and	O
NS16367	O
,	O
and	O
grants	O
from	O
the	O
Foundation	O
for	O
the	O
Care	O
and	O
Cure	O
of	O
Huntington	O
'	O
s	O
disease	O
and	O
with	O
the	O
support	O
of	O
the	O
Huntington	O
'	O
s	O
Disease	O
Society	O
of	O
America	O
Coalition	O
for	O
the	O
Cure	O
and	O
the	O
Hereditary	O
Disease	O
Foundation	O
.	O

Juliana	O
M	O
.	O
Woda	O
is	O
the	O
recipient	O
of	O
the	O
Milton	O
Wexler	O
Postdoctoral	O
Fellowship	O
from	O
the	O
Hereditary	O
Disease	O
Foundation	O
.	O

Diabetes	O
Insipidus	O
in	O
Mice	O
with	O
a	O
Mutation	O
in	O
Aquaporin	O
-	O
2	O

Abstract	O

Congenital	O
nephrogenic	O
diabetes	O
insipidus	O
(	O
NDI	O
)	O
is	O
a	O
disease	O
characterized	O
by	O
failure	O
of	O
the	O
kidney	O
to	O
concentrate	O
urine	O
in	O
response	O
to	O
vasopressin	O
.	O

Human	O
kindreds	O
with	O
nephrogenic	O
diabetes	O
insipidus	O
have	O
been	O
found	O
to	O
harbor	O
mutations	O
in	O
the	O
vasopressin	O
receptor	O
2	O
(	O
Avpr2	O
)	O
gene	O
or	O
the	O
vasopressin	O
-	O
sensitive	O
water	O
channel	O
aquaporin	O
-	O
2	O
(	O
Aqp2	O
)	O
gene	O
.	O

Development	O
of	O
a	O
treatment	O
is	O
rendered	O
difficult	O
due	O
to	O
the	O
lack	O
of	O
a	O
viable	O
animal	O
model	O
.	O

Through	O
forward	O
genetic	O
screening	O
of	O
ethylnitrosourea	O
-	O
mutagenized	O
mice	O
,	O
we	O
report	O
the	O
identification	O
and	O
characterization	O
of	O
a	O
mouse	O
model	O
of	O
NDI	O
,	O
with	O
an	O
F204V	O
mutation	O
in	O
the	O
Aqp2	O
gene	O
.	O

Unlike	O
previously	O
attempted	O
murine	O
models	O
of	O
NDI	O
,	O
our	O
mice	O
survive	O
to	O
adulthood	O
and	O
more	O
exactly	O
recapitulate	O
the	O
human	O
disorder	O
.	O

Previous	O
in	O
vitro	O
experiments	O
using	O
renal	O
cell	O
lines	O
suggest	O
recessive	O
Aqp2	O
mutations	O
result	O
in	O
improper	O
trafficking	O
of	O
the	O
mutant	O
water	O
pore	O
.	O

Using	O
these	O
animals	O
,	O
we	O
have	O
directly	O
proven	O
this	O
hypothesis	O
of	O
improper	O
AQP2	O
translocation	O
as	O
the	O
molecular	O
defect	O
in	O
nephrogenic	O
diabetes	O
insipidus	O
in	O
the	O
intact	O
organism	O
.	O

Additionally	O
,	O
using	O
a	O
renal	O
cell	O
line	O
we	O
show	O
that	O
the	O
mutated	O
protein	O
,	O
AQP2	O
-	O
F204V	O
,	O
is	O
retained	O
in	O
the	O
endoplasmic	B-GO
reticulum	E-GO
and	O
that	O
this	O
abnormal	O
localization	O
can	O
be	O
rescued	O
by	O
wild	O
-	O
type	O
protein	O
.	O

This	O
novel	O
mouse	O
model	O
allows	O
for	O
further	O
mechanistic	O
studies	O
as	O
well	O
as	O
testing	O
of	O
pharmacological	O
and	O
gene	O
therapies	O
for	O
NDI	O
.	O

Synopsis	O

Nephrogenic	O
diabetes	O
insipidus	O
(	O
NDI	O
)	O
is	O
a	O
disease	O
marked	O
by	O
excessive	O
urination	O
and	O
thirst	O
.	O

Normally	O
,	O
the	O
hypothalamus	O
senses	O
situations	O
where	O
water	O
is	O
limited	O
and	O
signals	O
to	O
the	O
kidney	O
to	O
increase	O
water	O
reabsorption	O
from	O
urine	O
.	O

The	O
signaling	O
molecule	O
secreted	O
by	O
the	O
hypothalamus	O
is	O
arginine	O
vasopressin	O
(	O
AVP	O
)	O
,	O
which	O
binds	O
to	O
a	O
specific	O
protein	O
on	O
the	O
surface	B-GO
of	I-GO
kidney	I-GO
cells	E-GO
,	O
AVP	O
receptor	O
(	O
AVPR2	O
)	O
.	O

AVP	O
binding	O
to	O
its	O
receptor	O
on	O
kidney	O
cells	O
begins	O
a	O
series	O
of	O
biochemical	O
events	O
that	O
ultimately	O
results	O
in	O
the	O
insertion	O
of	O
a	O
protein	O
,	O
aquaporin	O
2	O
(	O
AQP2	O
)	O
,	O
into	O
the	O
outer	O
surface	B-GO
of	I-GO
the	I-GO
kidney	I-GO
cell	E-GO
.	O

As	O
its	O
name	O
suggests	O
,	O
AQP2	O
facilitates	O
the	O
reuptake	O
of	O
water	O
from	O
the	O
urinary	O
space	S-GO
into	O
the	O
cell	O
,	O
thus	O
concentrating	O
the	O
urine	O
and	O
conserving	O
water	O
.	O

Congenital	O
NDI	O
is	O
caused	O
by	O
mutations	O
in	O
either	O
the	O
water	O
channel	O
,	O
AQP2	O
,	O
or	O
in	O
the	O
receptor	O
,	O
AVPR2	O
.	O

While	O
these	O
mutations	O
have	O
been	O
studied	O
extensively	O
in	O
the	O
lab	O
,	O
work	O
in	O
live	O
animals	O
has	O
been	O
very	O
limited	O
.	O

This	O
report	O
describes	O
the	O
first	O
viable	O
mouse	O
model	O
of	O
NDI	O
.	O

Previous	O
models	O
have	O
been	O
attempted	O
by	O
targeted	O
mutation	O
,	O
i	O
.	O
e	O
.	O
,	O
genes	O
known	O
to	O
be	O
involved	O
in	O
the	O
disease	O
have	O
been	O
altered	O
in	O
the	O
mouse	O
,	O
a	O
so	O
-	O
called	O
reverse	O
genetic	O
approach	O
.	O

Reverse	O
genetic	O
approaches	O
have	O
so	O
far	O
failed	O
to	O
produce	O
a	O
viable	O
mouse	O
model	O
of	O
NDI	O
.	O

Here	O
the	O
authors	O
take	O
a	O
forward	O
genetic	O
approach	O
in	O
which	O
genes	O
are	O
mutated	O
at	O
random	O
and	O
animals	O
are	O
screened	O
for	O
disease	O
-	O
like	O
properties	O
.	O

As	O
well	O
as	O
proving	O
hypotheses	O
that	O
come	O
from	O
lab	O
studies	O
,	O
this	O
model	O
opens	O
the	O
door	O
to	O
the	O
testing	O
of	O
gene	O
therapy	O
or	O
other	O
therapies	O
for	O
treatment	O
of	O
NDI	O
.	O

Introduction	O

Nephrogenic	O
diabetes	O
insipidus	O
(	O
NDI	O
)	O
is	O
a	O
disease	O
characterized	O
by	O
excessive	O
urination	O
and	O
thirst	O
,	O
despite	O
normal	O
production	O
of	O
the	O
antidiuretic	O
hormone	O
arginine	O
vasopressin	O
(	O
AVP	O
)	O
[	O
1	O
]	O
.	O

The	O
inherited	O
forms	O
are	O
either	O
X	S-GO
-	O
linked	O
as	O
a	O
consequence	O
of	O
mutation	O
of	O
the	O
Avpr2	O
gene	O
[	O
2	O
]	O
,	O
or	O
autosomal	S-GO
due	O
to	O
mutation	O
of	O
the	O
Aqp2	O
gene	O
[	O
3	O
]	O
.	O

Aquaporin	O
-	O
2	O
(	O
AQP2	O
)	O
is	O
a	O
pore	O
-	O
forming	O
protein	O
belonging	O
to	O
a	O
family	O
of	O
water	O
channels	O
[	O
4	O
]	O
,	O
and	O
it	O
is	O
expressed	O
in	O
collecting	O
-	O
duct	O
principal	O
cells	O
in	O
the	O
kidney	O
[	O
5	O
]	O
.	O

Generally	O
these	O
proteins	O
permit	O
the	O
passage	O
of	O
water	O
through	O
the	O
plasma	B-GO
membrane	E-GO
(	O
PM	S-GO
)	O
of	O
cells	O
,	O
several	O
of	O
which	O
carry	O
out	O
this	O
role	O
specifically	O
in	O
the	O
process	O
of	O
water	O
reabsorption	O
from	O
urine	O
in	O
the	O
kidney	O
.	O

It	O
has	O
been	O
established	O
that	O
aquaporins	O
,	O
although	O
functional	O
as	O
a	O
monomer	O
,	O
tetramerize	O
before	O
their	O
insertion	O
into	O
the	O
plasma	B-GO
membrane	E-GO
[	O
4	O
,	O
6	O
]	O
.	O

Furthermore	O
these	O
proteins	O
can	O
also	O
be	O
differentially	O
targeted	O
to	O
distinct	O
regions	B-GO
of	I-GO
the	I-GO
PM	E-GO
;	O
for	O
example	O
,	O
AQP2	O
is	O
routed	O
to	O
the	O
apical	B-GO
membrane	I-GO
of	I-GO
cells	E-GO
surrounding	O
the	O
collecting	O
duct	O
,	O
whereas	O
other	O
aquaporins	O
(	O
AQP3	O
or	O
4	O
)	O
are	O
inserted	O
into	O
the	O
basolateral	O
face	O
.	O

Unlike	O
all	O
other	O
family	O
members	O
,	O
AQP2	O
is	O
not	O
constitutively	O
inserted	O
into	O
the	O
plasma	B-GO
membrane	E-GO
.	O

Under	O
basal	O
conditions	O
,	O
the	O
protein	O
resides	O
in	O
subapical	O
intracellular	S-GO
vesicles	S-GO
;	O
however	O
,	O
under	O
conditions	O
requiring	O
water	O
retention	O
AQP2	O
translocates	O
to	O
the	O
apical	B-GO
membrane	E-GO
,	O
permitting	O
water	O
reabsorption	O
[	O
7	O
,	O
8	O
]	O
.	O

For	O
this	O
process	O
to	O
occur	O
,	O
AVP	O
binds	O
its	O
receptor	O
,	O
AVPR2	O
,	O
on	O
the	O
basolateral	O
face	O
of	O
the	O
collecting	O
duct	O
cells	O
,	O
leading	O
to	O
a	O
rise	O
in	O
intracellular	S-GO
cAMP	O
,	O
ultimately	O
resulting	O
in	O
phosphorylation	O
of	O
AQP2	O
at	O
serine	O
256	O
by	O
cAMP	O
-	O
dependent	O
protein	O
kinase	O
[	O
9	O
]	O
and	O
its	O
redistribution	O
to	O
the	O
plasma	B-GO
membrane	E-GO
.	O

The	O
importance	O
of	O
AQP2	O
redistribution	O
has	O
been	O
highlighted	O
by	O
functional	O
characterization	O
of	O
Aqp2	O
mutations	O
resulting	O
in	O
severe	O
NDI	O
in	O
humans	O
[	O
3	O
,	O
10	O
]	O
.	O

Recessive	O
Aqp2	O
mutations	O
are	O
generally	O
thought	O
to	O
produce	O
an	O
abnormally	O
localized	O
and	O
,	O
in	O
most	O
instances	O
,	O
misfolded	O
water	O
pore	O
that	O
responds	O
abnormally	O
to	O
an	O
increase	O
in	O
cAMP	O
[	O
6	O
,	O
11	O
]	O
.	O

Furthermore	O
,	O
dominant	O
mutations	O
have	O
been	O
described	O
and	O
found	O
to	O
misroute	O
both	O
the	O
mutant	O
and	O
the	O
wild	O
-	O
type	O
protein	O
to	O
the	O
basolateral	B-GO
membrane	E-GO
[	O
6	O
,	O
12	O
]	O
.	O

Several	O
mouse	O
models	O
of	O
diabetes	O
insipidus	O
have	O
been	O
generated	O
[	O
13	O
-	O
17	O
]	O
.	O

In	O
an	O
attempt	O
to	O
recapitulate	O
human	O
NDI	O
,	O
mice	O
have	O
been	O
generated	O
with	O
mutations	O
in	O
Aqp2	O
and	O
Avpr2	O
[	O
15	O
,	O
18	O
]	O
.	O

Yang	O
and	O
colleagues	O
created	O
a	O
mouse	O
with	O
a	O
T126M	O
knock	O
-	O
in	O
mutation	O
in	O
the	O
Aqp2	O
gene	O
.	O

Unexpectedly	O
,	O
homozygous	O
mutant	O
mice	O
died	O
within	O
6	O
d	O
after	O
birth	O
.	O

Interestingly	O
,	O
AVPR2	O
-	O
deficient	O
male	O
pups	O
also	O
die	O
within	O
the	O
first	O
week	O
after	O
birth	O
.	O

Together	O
these	O
models	O
suggest	O
that	O
the	O
mouse	O
may	O
be	O
a	O
highly	O
sensitive	O
organism	O
with	O
regard	O
to	O
water	O
homeostasis	O
,	O
and	O
is	O
unable	O
to	O
survive	O
with	O
polyuria	O
.	O

In	O
a	O
forward	O
genetic	O
screen	O
,	O
a	O
mouse	O
with	O
an	O
Aqp2	O
mutation	O
was	O
identified	O
.	O

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
characterize	O
this	O
murine	O
model	O
of	O
recessive	O
nephrogenic	O
DI	O
.	O

We	O
now	O
report	O
a	O
novel	O
F204V	O
mutation	O
in	O
the	O
Aqp2	O
gene	O
.	O

This	O
allele	O
of	O
Aqp2	O
was	O
found	O
to	O
cause	O
the	O
first	O
mouse	O
model	O
of	O
NDI	O
to	O
survive	O
past	O
the	O
first	O
week	O
of	O
life	O
.	O

Molecular	O
analyses	O
concluded	O
that	O
mutant	O
AQP2	O
adopts	O
a	O
different	O
subcellular	O
localization	O
in	O
renal	O
collecting	O
-	O
duct	O
cells	O
,	O
and	O
was	O
resistant	O
to	O
translocation	O
induced	O
by	O
desmopressin	O
,	O
an	O
agonist	O
of	O
AVP	O
.	O

In	O
vitro	O
studies	O
using	O
the	O
Madin	O
-	O
Darby	O
canine	O
kidney	O
(	O
MDCK	O
)	O
cell	O
line	O
demonstrated	O
an	O
endoplasmic	B-GO
reticulum	E-GO
pattern	O
for	O
the	O
mutant	O
protein	O
,	O
and	O
apparent	O
resistance	O
to	O
translocation	O
.	O

These	O
data	O
conclusively	O
prove	O
that	O
autosomal	S-GO
recessive	O
NDI	O
is	O
a	O
consequence	O
of	O
improper	O
AQP2	O
routing	O
in	O
the	O
intact	O
mammal	O
.	O

Results	O

In	O
a	O
forward	O
genetic	O
screen	O
that	O
used	O
ethylnitrosourea	O
(	O
ENU	O
)	O
to	O
induce	O
mutations	O
in	O
a	O
founder	O
animal	O
whose	O
offspring	O
were	O
then	O
screened	O
for	O
abnormal	O
whole	O
body	O
metabolism	O
[	O
19	O
,	O
20	O
]	O
,	O
we	O
found	O
a	O
family	O
of	O
mice	O
that	O
urinated	O
and	O
drank	O
excessively	O
.	O

Serum	O
and	O
urine	O
analysis	O
showed	O
that	O
plasma	O
glucose	O
levels	O
were	O
normal	O
and	O
there	O
was	O
no	O
glucose	O
in	O
the	O
urine	O
(	O
unpublished	O
data	O
)	O
.	O

Hence	O
,	O
this	O
was	O
an	O
example	O
of	O
diabetes	O
insipidus	O
.	O

The	O
disorder	O
in	O
these	O
mice	O
segregated	O
in	O
a	O
monogenic	O
,	O
autosomal	S-GO
recessive	O
manner	O
,	O
making	O
Aqp2	O
a	O
candidate	O
gene	O
.	O

Sequencing	O
of	O
Aqp2	O
coding	O
region	O
of	O
affected	O
mice	O
identified	O
a	O
thymine	O
to	O
guanine	O
(	O
T	O
to	O
G	O
)	O
transversion	O
(	O
Figure	O
1A	O
)	O
,	O
which	O
is	O
predicted	O
to	O
lead	O
to	O
a	O
valine	O
for	O
phenylalanine	O
substitution	O
at	O
amino	O
acid	O
204	O
of	O
the	O
protein	O
(	O
F204V	O
)	O
.	O

AQP2	O
is	O
a	O
six	O
-	O
transmembrane	S-GO
water	O
channel	O
,	O
and	O
F204	O
lies	O
near	O
the	O
extracellular	S-GO
face	O
of	O
the	O
sixth	O
membrane	S-GO
spanning	O
domain	O
,	O
a	O
region	O
rich	O
in	O
hydrophobic	O
amino	O
acids	O
.	O

This	O
and	O
the	O
other	O
membrane	S-GO
-	O
spanning	O
domains	O
are	O
conserved	O
among	O
vertebrate	O
species	O
.	O

The	O
phenylalanine	O
at	O
position	O
204	O
is	O
particularly	O
well	O
conserved	O
(	O
Figure	O
1B	O
)	O
,	O
not	O
only	O
among	O
vertebrate	O
AQP2	O
proteins	O
,	O
but	O
also	O
among	O
others	O
members	O
of	O
this	O
family	O
.	O

Aqp2F204V	O
/	O
F204V	O
mice	O
have	O
dramatically	O
increased	O
urine	O
production	O
,	O
in	O
some	O
cases	O
producing	O
an	O
amount	O
of	O
urine	O
in	O
24	O
h	O
that	O
exceeds	O
their	O
body	O
weight	O
,	O
compared	O
to	O
their	O
heterozygous	O
or	O
wild	O
-	O
type	O
littermates	O
.	O

Such	O
loss	O
of	O
water	O
would	O
rapidly	O
lead	O
to	O
dehydration	O
were	O
it	O
not	O
compensated	O
by	O
increased	O
water	O
intake	O
.	O

Indeed	O
,	O
mutant	O
mice	O
also	O
dramatically	O
increase	O
their	O
water	O
intake	O
(	O
Figure	O
1C	O
)	O
compared	O
to	O
their	O
heterozygous	O
or	O
wild	O
-	O
type	O
littermates	O
.	O

This	O
phenotype	O
--	O
increased	O
urinary	O
output	O
and	O
water	O
intake	O
--	O
showed	O
complete	O
concordance	O
with	O
homozygosity	O
of	O
the	O
F204V	O
mutation	O
in	O
the	O
58	O
animals	O
tested	O
.	O

Diabetes	O
insipidus	O
can	O
be	O
defined	O
as	O
an	O
inability	O
to	O
concentrate	O
urine	O
where	O
appropriate	O
.	O

Compared	O
to	O
wild	O
-	O
type	O
or	O
heterozygous	O
littermates	O
,	O
Aqp2F204V	O
/	O
F204V	O
mice	O
produce	O
very	O
dilute	O
urine	O
(	O
Figure	O
1D	O
)	O
.	O

Basal	O
urine	O
concentration	O
in	O
mutant	O
mice	O
is	O
about	O
161	O
mOsm	O
,	O
compared	O
to	O
about	O
1	O
,	O
293	O
mOsm	O
in	O
wild	O
-	O
type	O
mice	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
.	O

Normally	O
,	O
urine	O
concentration	O
is	O
under	O
the	O
control	O
of	O
the	O
hypothalamus	O
,	O
which	O
,	O
in	O
response	O
to	O
hypovolemia	O
or	O
hypernatremia	O
[	O
21	O
]	O
,	O
secretes	O
AVP	O
.	O

The	O
synthetic	O
AVP	O
analog	O
,	O
1	O
-	O
deamino	O
-	O
8	O
-	O
D	O
-	O
arginine	O
vasopressin	O
(	O
dDAVP	O
;	O
also	O
called	O
desmopressin	O
)	O
,	O
is	O
a	O
potent	O
agonist	O
of	O
AVPR2	O
.	O

When	O
administered	O
to	O
wild	O
-	O
type	O
mice	O
,	O
dDAVP	O
leads	O
to	O
a	O
dramatic	O
increase	O
in	O
urine	O
concentration	O
,	O
from	O
1	O
,	O
293	O
to	O
5	O
,	O
885	O
mOsm	O
(	O
4	O
.	O
6	O
-	O
fold	O
;	O
Figure	O
1D	O
)	O
.	O

With	O
similar	O
treatment	O
,	O
mutant	O
mice	O
concentrate	O
their	O
urine	O
to	O
a	O
lesser	O
but	O
still	O
significant	O
extent	O
,	O
from	O
161	O
to	O
470	O
mOsm	O
(	O
2	O
.	O
9	O
-	O
fold	O
)	O
,	O
indicating	O
that	O
these	O
animals	O
are	O
not	O
only	O
unable	O
to	O
concentrate	O
their	O
urine	O
properly	O
but	O
are	O
also	O
defective	O
in	O
their	O
response	O
to	O
dDAVP	O
.	O

The	O
smaller	O
response	O
to	O
dDAVP	O
indicates	O
some	O
residual	O
activity	O
of	O
the	O
mutant	O
AQP2	O
channel	O
,	O
which	O
must	O
be	O
sufficient	O
to	O
allow	O
survival	O
of	O
the	O
individual	O
,	O
in	O
contrast	O
to	O
the	O
T126M	O
knock	O
-	O
in	O
mouse	O
[	O
18	O
]	O
.	O

Multiple	O
heterozygous	O
matings	O
yielded	O
101	O
animals	O
,	O
which	O
appeared	O
at	O
a	O
ratio	O
of	O
26	O
:	O
49	O
:	O
26	O
,	O
near	O
the	O
expected	O
Mendelian	O
wild	O
type	O
,	O
heterozygote	O
,	O
and	O
mutant	O
frequencies	O
,	O
respectively	O
,	O
indicating	O
that	O
there	O
is	O
no	O
reduced	O
viability	O
associated	O
with	O
this	O
mutation	O
.	O

Other	O
than	O
the	O
increased	O
urine	O
production	O
and	O
water	O
intake	O
,	O
there	O
was	O
no	O
overt	O
phenotype	O
in	O
mutant	O
mice	O
,	O
save	O
distended	O
kidneys	O
,	O
which	O
appeared	O
variably	O
in	O
adult	O
animals	O
(	O
Figure	O
2A	O
)	O
.	O

Although	O
not	O
specifically	O
measured	O
,	O
mutant	O
mice	O
seem	O
to	O
have	O
a	O
normal	O
lifespan	O
.	O

The	O
one	O
animal	O
that	O
was	O
followed	O
lived	O
to	O
18	O
mo	O
,	O
typical	O
for	O
animals	O
in	O
our	O
colony	O
.	O

Aqp2F204V	O
/	O
F204V	O
mice	O
suffer	O
from	O
severe	O
hydronephrosis	O
(	O
Figure	O
2A	O
and	O
2B	O
)	O
,	O
presumably	O
as	O
a	O
consequence	O
of	O
an	O
inability	O
to	O
cope	O
with	O
the	O
extreme	O
polyuria	O
.	O

We	O
found	O
distended	O
kidneys	O
in	O
all	O
Aqp2F204V	O
/	O
F204V	O
mice	O
;	O
however	O
,	O
the	O
degree	O
of	O
inflation	O
was	O
variable	O
in	O
affected	O
mice	O
and	O
worsened	O
with	O
age	O
.	O

Severe	O
hydronephrosis	O
has	O
previously	O
been	O
observed	O
in	O
double	O
Aqp1	O
/	O
Aqp3	O
knock	O
-	O
out	O
mice	O
[	O
17	O
]	O
,	O
and	O
appears	O
at	O
6	O
wk	O
.	O

Even	O
at	O
4	O
wk	O
,	O
Aqp2F204V	O
/	O
F204V	O
mice	O
had	O
hydronephrosis	O
.	O

Histologic	O
sections	O
from	O
Aqp2F204V	O
/	O
F204V	O
mice	O
demonstrated	O
marked	O
dilatation	O
of	O
the	O
renal	O
pelvis	O
yet	O
normal	O
morphology	O
of	O
the	O
ureter	O
(	O
Figure	O
2C	O
and	O
2D	O
)	O
.	O

In	O
particular	O
,	O
the	O
muscularis	O
propria	O
was	O
neither	O
hypertrophied	O
nor	O
thinned	O
.	O

There	O
was	O
the	O
normal	O
festooned	O
appearance	O
of	O
the	O
urothelium	O
,	O
and	O
this	O
transitional	O
epithelium	O
was	O
of	O
normal	O
thickness	O
.	O

There	O
was	O
thinning	O
of	O
the	O
kidney	O
as	O
measured	O
from	O
renal	O
capsule	O
to	O
renal	O
pelvis	O
.	O

However	O
,	O
the	O
morphologic	O
features	O
of	O
the	O
glomeruli	O
and	O
proximal	O
/	O
distal	O
tubules	O
were	O
unremarkable	O
(	O
Figure	O
2D	O
)	O
.	O

As	O
shown	O
previously	O
[	O
18	O
,	O
22	O
]	O
,	O
immunoblotting	O
revealed	O
three	O
different	O
forms	O
of	O
AQP2	O
,	O
due	O
to	O
different	O
degrees	O
and	O
forms	O
of	O
glycosylation	O
(	O
Figure	O
3A	O
)	O
.	O

Previous	O
reports	O
have	O
demonstrated	O
that	O
nonglycosylated	O
protein	O
appears	O
as	O
a	O
29	O
kDa	O
band	O
,	O
while	O
complex	O
glycosylated	O
protein	O
runs	O
as	O
a	O
smear	O
between	O
35	O
and	O
45	O
kDa	O
.	O

A	O
short	O
-	O
lived	O
intermediate	O
form	O
of	O
31	O
kDa	O
representing	O
core	O
,	O
high	O
-	O
mannose	O
glycosylation	O
of	O
AQP2	O
is	O
apparent	O
from	O
pulse	O
-	O
chase	O
labeling	O
experiments	O
[	O
22	O
]	O
.	O

Compared	O
to	O
that	O
from	O
the	O
kidneys	O
of	O
wild	O
-	O
type	O
animals	O
,	O
AQP2	O
from	O
mutant	O
animals	O
was	O
reduced	O
in	O
both	O
the	O
high	O
molecular	O
weight	O
,	O
diffuse	O
form	O
and	O
the	O
lowest	O
molecular	O
weight	O
form	O
,	O
but	O
enriched	O
in	O
the	O
intermediate	O
molecular	O
weight	O
form	O
(	O
Figure	O
3A	O
)	O
.	O

Heterozygous	O
animals	O
showed	O
intermediate	O
amounts	O
of	O
all	O
three	O
forms	O
.	O

The	O
nature	O
of	O
these	O
glycosylated	O
forms	O
was	O
revealed	O
by	O
digestion	O
with	O
endoglycosidase	O
H	O
,	O
which	O
specifically	O
cleaves	O
mannose	O
-	O
rich	O
carbohydrate	O
from	O
the	O
protein	O
backbone	O
.	O

Treatment	O
of	O
endogenous	O
AQP2	O
from	O
kidneys	O
of	O
wild	O
-	O
type	O
,	O
heterozygous	O
,	O
and	O
mutant	O
animals	O
specifically	O
affected	O
the	O
intermediate	O
molecular	O
weight	O
form	O
(	O
Figure	O
3B	O
)	O
.	O

The	O
presence	O
of	O
some	O
mature	O
glycosylated	O
proteins	O
(	O
35	O
-	O
45	O
kDa	O
)	O
in	O
Aqp2F204V	O
/	O
F204V	O
mice	O
presumably	O
permits	O
their	O
survival	O
compared	O
to	O
Aqp2T126M	O
/	O
T126M	O
mice	O
,	O
and	O
is	O
consistent	O
with	O
a	O
diminished	O
response	O
to	O
dDAVP	O
.	O

In	O
humans	O
,	O
recessive	O
alleles	O
of	O
Aqp2	O
are	O
postulated	O
to	O
cause	O
NDI	O
because	O
they	O
do	O
not	O
properly	O
translocate	O
to	O
the	O
apical	S-GO
cell	B-GO
surface	E-GO
in	O
response	O
to	O
AVP	O
.	O

This	O
postulate	O
comes	O
solely	O
from	O
in	O
vitro	O
studies	O
in	O
which	O
mutant	O
Aqp2	O
cDNAs	O
corresponding	O
to	O
human	O
disease	O
mutations	O
are	O
transfected	O
into	O
kidney	O
cell	O
lines	O
.	O

In	O
general	O
,	O
such	O
recessive	O
alleles	O
,	O
when	O
visualized	O
immunocytochemically	O
,	O
fail	O
to	O
localize	O
to	O
AVP	O
-	O
responsive	O
vesicles	S-GO
.	O

Rather	O
,	O
they	O
get	O
trapped	O
in	O
the	O
endoplasmic	B-GO
reticulum	E-GO
(	O
ER	S-GO
)	O
.	O

Our	O
mouse	O
model	O
of	O
NDI	O
affords	O
the	O
first	O
opportunity	O
to	O
test	O
this	O
hypothesis	O
in	O
a	O
mature	O
animal	O
.	O

As	O
shown	O
in	O
Figure	O
4A	O
(	O
top	O
row	O
of	O
photomicrographs	O
)	O
,	O
AQP2	O
(	O
stained	O
red	O
)	O
normally	O
localized	O
to	O
the	O
subapical	O
region	B-GO
of	I-GO
collecting	I-GO
duct	I-GO
cells	E-GO
in	O
kidneys	O
of	O
wild	O
-	O
type	O
mice	O
.	O

Upon	O
stimulation	O
with	O
dDAVP	O
,	O
AQP2	O
translocated	O
to	O
or	O
near	O
the	O
cell	B-GO
surface	E-GO
(	O
Figure	O
4A	O
,	O
second	O
row	O
)	O
.	O

In	O
kidneys	O
taken	O
from	O
mutant	O
animals	O
,	O
however	O
,	O
AQP2	O
was	O
distributed	O
randomly	O
throughout	O
the	O
cell	O
in	O
the	O
basal	O
state	O
(	O
Figure	O
4A	O
,	O
third	O
row	O
)	O
,	O
while	O
AQP3	O
(	O
green	O
)	O
appropriately	O
localized	O
to	O
the	O
basolateral	O
surface	S-GO
[	O
23	O
]	O
.	O

Furthermore	O
,	O
upon	O
dDAVP	O
stimulation	O
,	O
AQP2	O
-	O
F204V	O
failed	O
to	O
translocate	O
to	O
the	O
cell	B-GO
surface	E-GO
(	O
Figure	O
4A	O
,	O
bottom	O
row	O
)	O
.	O

To	O
confirm	O
these	O
findings	O
,	O
the	O
staining	O
was	O
repeated	O
in	O
kidneys	O
taken	O
from	O
two	O
further	O
mice	O
for	O
each	O
class	O
,	O
wild	O
-	O
type	O
or	O
mutant	O
,	O
with	O
or	O
without	O
dDAVP	O
treatment	O
,	O
with	O
identical	O
results	O
.	O

To	O
investigate	O
the	O
mechanism	O
of	O
defective	O
translocation	O
of	O
AQP2	O
-	O
F204V	O
,	O
we	O
turned	O
to	O
transfection	O
of	O
MDCK	O
cells	O
.	O

Stable	O
cell	O
lines	O
expressing	O
mouse	O
wild	O
-	O
type	O
AQP2	O
and	O
AQP2	O
-	O
F204V	O
were	O
established	O
.	O

Immunoblots	O
of	O
protein	O
extracts	O
from	O
stable	O
cell	O
lines	O
showed	O
that	O
MDCK	O
cells	O
recapitulate	O
the	O
glycosylation	O
defect	O
seen	O
in	O
mutant	O
mice	O
(	O
unpublished	O
data	O
)	O
.	O

The	O
wild	O
-	O
type	O
protein	O
was	O
again	O
present	O
in	O
three	O
different	O
forms	O
.	O

Cells	O
expressing	O
AQP2	O
-	O
F204V	O
lacked	O
the	O
35	O
-	O
45	O
kDa	O
form	O
and	O
were	O
enriched	O
in	O
the	O
core	O
-	O
glycosylated	O
31	O
kDa	O
form	O
.	O

In	O
transfected	O
,	O
unstimulated	O
MDCK	O
cells	O
,	O
wild	O
-	O
type	O
AQP2	O
(	O
stained	O
green	O
)	O
appeared	O
in	O
a	O
punctate	O
pattern	O
distributed	O
throughout	O
the	O
subapical	O
region	O
(	O
Figure	O
4B	O
,	O
left	O
column	O
photomicrographs	O
)	O
,	O
consistent	O
with	O
vesicular	S-GO
compartmentalization	O
.	O

AQP2	O
-	O
F204V	O
,	O
on	O
the	O
other	O
hand	O
,	O
appeared	O
in	O
a	O
punctate	O
but	O
perinuclear	S-GO
pattern	O
(	O
Figure	O
4B	O
,	O
third	O
column	O
)	O
.	O

Upon	O
stimulation	O
with	O
forskolin	O
,	O
a	O
cAMP	O
-	O
dependent	O
protein	O
kinase	O
activator	O
,	O
wild	O
-	O
type	O
AQP2	O
translocated	O
to	O
the	O
apical	S-GO
surface	B-GO
of	I-GO
polarized	I-GO
MDCK	I-GO
cells	E-GO
(	O
Figure	O
4B	O
,	O
second	O
column	O
)	O
.	O

Along	O
the	O
z	O
-	O
axis	O
,	O
the	O
perinuclear	S-GO
distribution	O
of	O
AQP2	O
-	O
F204V	O
was	O
clearly	O
seen	O
,	O
and	O
this	O
distribution	O
is	O
not	O
altered	O
by	O
forskolin	O
(	O
Figure	O
4B	O
,	O
bottom	O
row	O
,	O
two	O
right	O
columns	O
)	O
.	O

The	O
perinuclear	S-GO
distribution	O
of	O
AQP2	O
-	O
F204V	O
is	O
consistent	O
with	O
an	O
ER	S-GO
compartmentalization	O
.	O

To	O
test	O
the	O
idea	O
that	O
AQP2	O
-	O
F204V	O
localizes	O
to	O
the	O
ER	S-GO
,	O
we	O
co	O
-	O
stained	O
cells	O
transfected	O
with	O
Aqp2F204V	O
(	O
cDNA	O
)	O
for	O
AQP2	O
and	O
an	O
ER	S-GO
marker	O
,	O
calnexin	O
(	O
Figure	O
4C	O
)	O
.	O

Colocalization	O
of	O
calnexin	O
with	O
AQP2	O
was	O
investigated	O
directly	O
,	O
and	O
it	O
was	O
found	O
that	O
80	O
%	O
of	O
all	O
AQP2	O
-	O
F204V	O
protein	O
colocalized	O
with	O
calnexin	O
.	O

The	O
remaining	O
20	O
%	O
appeared	O
at	O
the	O
periphery	O
of	O
the	O
ER	S-GO
,	O
representing	O
AQP2	O
-	O
F204V	O
that	O
had	O
potentially	O
progressed	O
beyond	O
the	O
ER	S-GO
.	O

This	O
"	O
ER	S-GO
escape	O
"	O
was	O
consistent	O
with	O
the	O
small	O
proportion	O
of	O
mature	O
,	O
complex	O
glycosylated	O
,	O
AQP2	O
-	O
F204V	O
in	O
mutant	O
kidneys	O
(	O
see	O
Figure	O
3A	O
)	O
.	O

Animals	O
heterozygous	O
for	O
the	O
Aqp2F204V	O
mutation	O
were	O
not	O
affected	O
in	O
their	O
urine	O
production	O
or	O
urine	O
osmolality	O
(	O
see	O
Figure	O
1C	O
and	O
1D	O
)	O
.	O

It	O
has	O
also	O
been	O
shown	O
that	O
a	O
recessive	O
NDI	O
allele	O
,	O
AQP2	O
-	O
R187C	O
,	O
does	O
not	O
interact	O
with	O
wild	O
-	O
type	O
protein	O
in	O
oocytes	O
[	O
24	O
]	O
,	O
nor	O
does	O
it	O
homo	O
-	O
oligomerize	O
in	O
MDCK	O
cells	O
[	O
22	O
]	O
.	O

Therefore	O
,	O
kidneys	O
from	O
heterozygous	O
animals	O
were	O
examined	O
for	O
evidence	O
of	O
two	O
populations	O
of	O
AQP2	O
protein	O
.	O

Surprisingly	O
,	O
immunohistochemical	O
staining	O
of	O
kidney	O
collecting	O
ducts	O
from	O
Aqp2F204V	O
/	O
+	O
mice	O
revealed	O
a	O
pattern	O
remarkably	O
similar	O
to	O
wild	O
type	O
(	O
Figure	O
5A	O
)	O
.	O

AQP2	O
translocated	O
completely	O
to	O
the	O
apical	S-GO
cell	B-GO
surface	E-GO
upon	O
dDAVP	O
stimulation	O
.	O

This	O
wild	O
-	O
type	O
staining	O
pattern	O
may	O
simply	O
reflect	O
the	O
fact	O
that	O
decreasing	O
the	O
amount	O
of	O
mutant	O
protein	O
by	O
half	O
makes	O
it	O
undetectable	O
by	O
immunocytochemistry	O
.	O

Alternatively	O
,	O
the	O
presence	O
of	O
wild	O
-	O
type	O
protein	O
may	O
alter	O
the	O
localization	O
of	O
the	O
mutant	O
protein	O
.	O

Indeed	O
,	O
Hendriks	O
et	O
al	O
.	O
proposed	O
a	O
"	O
piggy	O
-	O
back	O
"	O
mechanism	O
to	O
explain	O
the	O
transport	O
of	O
nonglycosylated	O
subunits	O
of	O
AQP2	O
to	O
the	O
cell	B-GO
surface	E-GO
by	O
glycosylated	O
subunits	O
[	O
22	O
]	O
.	O

It	O
has	O
also	O
been	O
shown	O
that	O
wild	O
-	O
type	O
AQP2	O
protein	O
can	O
rescue	O
a	O
translocation	O
-	O
defective	O
mutant	O
protein	O
,	O
AQP2	O
-	O
P262L	O
,	O
when	O
the	O
two	O
are	O
coexpressed	O
in	O
MDCK	O
cells	O
[	O
25	O
]	O
.	O

In	O
the	O
collecting	O
ducts	O
from	O
Aqp2F204V	O
/	O
+	O
mice	O
,	O
the	O
wild	O
type	O
may	O
rescue	O
the	O
mutant	O
protein	O
as	O
suggested	O
by	O
the	O
subcellular	O
distribution	O
of	O
AQP2	O
protein	O
.	O

To	O
test	O
this	O
idea	O
,	O
we	O
first	O
looked	O
for	O
an	O
interaction	O
between	O
mutant	O
and	O
wild	O
-	O
type	O
proteins	O
in	O
transfected	O
MDCK	O
cells	O
(	O
Figure	O
5B	O
)	O
.	O

MDCK	O
cells	O
stably	O
expressing	O
wild	O
-	O
type	O
AQP2	O
were	O
transiently	O
transfected	O
with	O
GFP	O
expression	O
constructs	O
encoding	O
GFP	O
-	O
tagged	O
wild	O
-	O
type	O
AQP2	O
,	O
AQP2	O
-	O
F204V	O
,	O
or	O
GFP	O
alone	O
.	O

Antibodies	S-GO
against	O
GFP	O
coimmunoprecipitated	O
wild	O
-	O
type	O
AQP2	O
when	O
AQP2	O
-	O
GFP	O
or	O
AQP2	O
-	O
F204V	O
-	O
GFP	O
was	O
transiently	O
transfected	O
,	O
but	O
not	O
when	O
GFP	O
by	O
itself	O
was	O
transiently	O
transfected	O
into	O
MDCK	O
cells	O
stably	O
expressing	O
wild	O
-	O
type	O
AQP2	O
(	O
Figure	O
5B	O
,	O
upper	O
blots	O
)	O
.	O

Western	O
blot	O
of	O
total	O
membranes	S-GO
showed	O
that	O
wild	O
-	O
type	O
AQP2	O
is	O
equivalently	O
expressed	O
in	O
all	O
three	O
cases	O
(	O
Figure	O
5B	O
,	O
lower	O
blots	O
)	O
.	O

If	O
wild	O
-	O
type	O
and	O
mutant	O
proteins	O
are	O
indeed	O
interacting	O
in	O
the	O
cell	O
,	O
is	O
this	O
interaction	O
sufficient	O
to	O
rescue	O
the	O
localization	O
of	O
mutant	O
protein	O
?	O

To	O
answer	O
this	O
question	O
,	O
we	O
used	O
MDCK	O
cells	O
stably	O
transfected	O
with	O
wild	O
-	O
type	O
AQP2	O
expressing	O
vector	O
or	O
with	O
empty	O
vector	O
.	O

On	O
top	O
of	O
these	O
,	O
we	O
transiently	O
transfected	O
AQP2	O
-	O
GFP	O
or	O
AQP2	O
-	O
F204V	O
-	O
GFP	O
expression	O
constructs	O
.	O

AQP2	O
-	O
GFP	O
localized	O
to	O
the	O
apical	S-GO
surface	S-GO
upon	O
forskolin	O
stimulation	O
whether	O
it	O
was	O
transiently	O
transfected	O
into	O
vector	O
-	O
only	O
cells	O
(	O
Figure	O
5C	O
,	O
upper	O
left	O
images	O
)	O
or	O
into	O
wild	O
-	O
type	O
AQP2	O
cells	O
(	O
Figure	O
5C	O
,	O
upper	O
right	O
)	O
.	O

AQP2	O
-	O
F204V	O
-	O
GFP	O
,	O
when	O
expressed	O
by	O
transient	O
transfection	O
into	O
vector	O
only	O
cells	O
,	O
showed	O
a	O
diffuse	O
cytoplasmic	S-GO
distribution	O
pattern	O
(	O
Figure	O
5C	O
,	O
lower	O
left	O
)	O
.	O

When	O
expressed	O
in	O
wild	O
-	O
type	O
AQP2	O
cells	O
,	O
however	O
,	O
AQP2	O
-	O
F204V	O
-	O
GFP	O
localized	O
to	O
the	O
apical	S-GO
surface	S-GO
to	O
varying	O
degrees	O
(	O
Figure	O
5C	O
,	O
lower	O
right	O
images	O
[	O
i	O
-	O
iii	O
]	O
)	O
.	O

The	O
lower	O
right	O
images	O
of	O
Figure	O
5C	O
shows	O
three	O
cells	O
from	O
a	O
single	O
transfection	O
.	O

The	O
first	O
is	O
a	O
nontransfected	O
cell	O
that	O
shows	O
the	O
localization	O
of	O
the	O
stably	O
expressing	O
wild	O
-	O
type	O
AQP2	O
,	O
which	O
is	O
apical	S-GO
upon	O
forskolin	O
stimulation	O
.	O

The	O
next	O
two	O
show	O
expression	O
of	O
both	O
the	O
stable	O
wild	O
-	O
type	O
AQP2	O
and	O
the	O
transient	O
AQP2	O
-	O
F204V	O
-	O
GFP	O
.	O

In	O
cell	O
(	O
ii	O
)	O
,	O
localization	O
of	O
wild	O
-	O
type	O
AQP2	O
was	O
indistinguishable	O
from	O
AQP2	O
-	O
F204V	O
-	O
GFP	O
;	O
both	O
were	O
apical	S-GO
upon	O
forskolin	O
stimulation	O
.	O

Although	O
the	O
effect	O
was	O
subtle	O
in	O
cell	O
(	O
iii	O
)	O
,	O
AQP2	O
-	O
F204V	O
-	O
GFP	O
was	O
partly	O
localized	O
to	O
the	O
apical	S-GO
surface	S-GO
.	O

Generally	O
,	O
the	O
localization	O
of	O
AQP2	O
-	O
F204V	O
-	O
GFP	O
was	O
clearly	O
more	O
apical	S-GO
when	O
wild	O
-	O
type	O
AQP2	O
was	O
also	O
expressed	O
.	O

To	O
confirm	O
these	O
results	O
biochemically	O
,	O
we	O
transfected	O
the	O
same	O
cell	O
lines	O
(	O
wild	O
-	O
type	O
AQP2	O
or	O
vector	O
)	O
with	O
F204V	O
-	O
GFP	O
,	O
biotinylated	O
surface	S-GO
proteins	O
after	O
forskolin	O
stimulation	O
,	O
and	O
precipitated	O
the	O
biotinylated	O
proteins	O
(	O
Figure	O
5D	O
)	O
.	O

AQP2	O
-	O
F204V	O
-	O
GFP	O
is	O
expressed	O
approximately	O
equally	O
in	O
both	O
cell	O
lines	O
(	O
Figure	O
5D	O
,	O
total	O
cells	O
)	O
,	O
but	O
is	O
biotinylated	O
only	O
when	O
wild	O
-	O
type	O
AQP2	O
is	O
also	O
expressed	O
(	O
Figure	O
5D	O
,	O
surface	S-GO
biotinylated	O
)	O
.	O

Since	O
only	O
cell	B-GO
surface	E-GO
proteins	O
are	O
accessible	O
to	O
biotin	O
,	O
these	O
results	O
indicate	O
that	O
AQP2	O
-	O
F204V	O
is	O
transported	O
to	O
the	O
cell	B-GO
surface	E-GO
when	O
wild	O
-	O
type	O
AQP2	O
is	O
present	O
,	O
but	O
not	O
on	O
its	O
own	O
.	O

Discussion	O

Aqp2F204	O
/	O
F204V	O
mice	O
are	O
viable	O
and	O
grow	O
and	O
reproduce	O
normally	O
.	O

They	O
are	O
,	O
however	O
,	O
severely	O
defective	O
in	O
their	O
ability	O
to	O
concentrate	O
urine	O
,	O
leading	O
to	O
increased	O
urine	O
output	O
and	O
water	O
intake	O
,	O
thus	O
making	O
them	O
the	O
first	O
mouse	O
model	O
of	O
NDI	O
to	O
survive	O
to	O
maturity	O
.	O

In	O
humans	O
,	O
NDI	O
is	O
caused	O
by	O
mutations	O
in	O
Avpr2	O
or	O
Aqp2	O
.	O

Knockout	O
of	O
the	O
X	S-GO
-	O
linked	O
Avpr2	O
gene	O
in	O
mice	O
[	O
15	O
]	O
gave	O
an	O
NDI	O
-	O
like	O
phenotype	O
in	O
male	O
,	O
hemizygous	O
neonates	O
,	O
but	O
the	O
phenotype	O
could	O
not	O
be	O
assessed	O
in	O
adults	O
as	O
the	O
mice	O
died	O
within	O
1	O
wk	O
of	O
birth	O
.	O

The	O
adult	O
heterozygous	O
females	O
showed	O
a	O
mild	O
tendency	O
toward	O
increased	O
urinary	O
output	O
and	O
water	O
intake	O
and	O
decreased	O
urine	O
osmolality	O
.	O

Knockout	O
of	O
the	O
mouse	O
Aqp2	O
gene	O
has	O
not	O
been	O
reported	O
.	O

A	O
knock	O
-	O
in	O
of	O
a	O
human	O
disease	O
-	O
causing	O
mutation	O
(	O
T126M	O
)	O
,	O
however	O
,	O
has	O
been	O
made	O
[	O
18	O
]	O
.	O

These	O
mice	O
have	O
a	O
severe	O
urine	O
-	O
concentrating	O
defect	O
resulting	O
in	O
dehydration	O
and	O
death	O
within	O
1	O
wk	O
of	O
birth	O
.	O

Curiously	O
,	O
AQP2	O
-	O
T126M	O
does	O
localize	O
properly	O
in	O
at	O
least	O
a	O
subset	O
of	O
cells	O
.	O

The	O
grossly	O
abnormal	O
collecting	O
duct	O
morphology	O
makes	O
it	O
impossible	O
to	O
pinpoint	O
the	O
molecular	O
defect	O
in	O
these	O
knock	O
-	O
in	O
mice	O
.	O

The	O
T126M	O
knock	O
-	O
in	O
clearly	O
shows	O
that	O
Aqp2	O
is	O
an	O
essential	O
gene	O
[	O
18	O
]	O
.	O

The	O
fact	O
that	O
our	O
mice	O
survive	O
shows	O
either	O
that	O
AQP2	O
-	O
F204V	O
possesses	O
some	O
residual	O
water	O
transporting	O
ability	O
or	O
that	O
there	O
are	O
AVP	O
-	O
independent	O
pathways	O
for	O
water	O
reabsorption	O
.	O

Residual	O
activity	O
of	O
AQP2	O
-	O
F204V	O
is	O
likely	O
,	O
as	O
mutant	O
animals	O
show	O
some	O
small	O
response	O
to	O
dDAVP	O
,	O
although	O
dDAVP	O
-	O
stimulated	O
urine	O
osmolality	O
remains	O
quite	O
low	O
.	O

Immunostaining	O
of	O
kidney	O
shows	O
that	O
AQP2	O
-	O
F204V	O
does	O
not	O
efficiently	O
transport	O
water	O
,	O
because	O
it	O
fails	O
to	O
localize	O
to	O
the	O
apical	S-GO
cell	B-GO
surface	E-GO
after	O
dDAVP	O
treatment	O
.	O

Some	O
residual	O
activity	O
of	O
AQP2	O
would	O
imply	O
that	O
some	O
small	O
,	O
undetectable	O
portion	O
of	O
the	O
mutant	O
protein	O
is	O
getting	O
to	O
the	O
cell	B-GO
surface	E-GO
.	O

The	O
surface	S-GO
biotinylation	O
experiment	O
(	O
Figure	O
5D	O
)	O
suggests	O
that	O
no	O
mutant	O
protein	O
gets	O
to	O
the	O
surface	S-GO
,	O
but	O
this	O
does	O
not	O
necessarily	O
reflect	O
the	O
situation	O
in	O
vivo	O
.	O

While	O
this	O
small	O
fraction	O
of	O
protein	O
may	O
not	O
be	O
detectable	O
by	O
immunofluorescence	O
,	O
Western	O
blotting	O
shows	O
that	O
some	O
mutant	O
protein	O
does	O
progress	O
beyond	O
the	O
ER	S-GO
(	O
35	O
-	O
45	O
kDa	O
species	O
in	O
Figure	O
3A	O
)	O
.	O

Compared	O
to	O
wild	O
-	O
type	O
,	O
mutant	O
protein	O
is	O
enriched	O
in	O
the	O
high	O
-	O
mannose	O
,	O
core	O
-	O
glycosylated	O
form	O
(	O
31	O
kDa	O
)	O
and	O
deficient	O
in	O
nonglycosylated	O
(	O
29	O
kDa	O
)	O
and	O
complex	O
glycosylated	O
(	O
35	O
-	O
45	O
kDa	O
)	O
forms	O
.	O

The	O
presence	O
of	O
a	O
reduced	O
but	O
detectable	O
amount	O
of	O
protein	O
in	O
the	O
35	O
-	O
45	O
kDa	O
range	O
indicates	O
that	O
mutant	O
protein	O
is	O
transported	O
out	O
of	O
the	O
ER	S-GO
,	O
but	O
with	O
greatly	O
reduced	O
efficiency	O
.	O

Colocalization	O
of	O
AQP2	O
-	O
F204V	O
with	O
the	O
ER	S-GO
protein	O
calnexin	O
in	O
transfected	O
MDCK	O
cells	O
shows	O
that	O
,	O
while	O
most	O
of	O
the	O
mutant	O
protein	O
is	O
trapped	O
in	O
the	O
ER	S-GO
,	O
some	O
does	O
progress	O
beyond	O
the	O
ER	S-GO
.	O

Diminished	O
response	O
to	O
dDAVP	O
,	O
diminished	O
abundance	O
of	O
mature	O
glycosylated	O
protein	O
in	O
mutant	O
animals	O
,	O
and	O
the	O
transport	O
of	O
a	O
fraction	O
of	O
mutant	O
protein	O
beyond	O
the	O
ER	S-GO
in	O
MDCK	O
cells	O
are	O
all	O
consistent	O
with	O
the	O
notion	O
that	O
AQP2	O
-	O
F204V	O
misfolding	O
is	O
limited	O
and	O
that	O
it	O
may	O
retain	O
some	O
residual	O
water	O
transporting	O
activity	O
.	O

Evidently	O
this	O
residual	O
activity	O
is	O
sufficient	O
for	O
the	O
viability	O
and	O
growth	O
of	O
mutant	O
animals	O
.	O

Reduced	O
efficiency	O
in	O
exiting	O
the	O
ER	S-GO
may	O
explain	O
why	O
AQP2	O
-	O
F204V	O
is	O
enriched	O
in	O
the	O
31	O
kDa	O
high	O
-	O
mannose	O
glycosylated	O
form	O
.	O

The	O
high	O
-	O
mannose	O
core	O
oligosaccharide	O
is	O
added	O
in	O
the	O
ER	S-GO
and	O
is	O
later	O
modified	O
and	O
elaborated	O
in	O
the	O
Golgi	B-GO
apparatus	E-GO
[	O
26	O
]	O
.	O

The	O
increase	O
in	O
the	O
high	O
-	O
mannose	O
glycosylated	O
form	O
of	O
AQP2	O
-	O
F204V	O
may	O
simply	O
reflect	O
its	O
prolonged	O
presence	O
in	O
the	O
ER	S-GO
and	O
exposure	O
to	O
oligosaccharyl	O
transferase	O
.	O

While	O
improper	O
localization	O
of	O
AQP2	O
explains	O
the	O
phenotype	O
of	O
homozygous	O
mutant	O
mice	O
,	O
the	O
complete	O
lack	O
of	O
a	O
phenotype	O
in	O
heterozygous	O
mice	O
is	O
more	O
difficult	O
to	O
explain	O
.	O

Physiologically	O
,	O
heterozygous	O
mice	O
have	O
no	O
symptoms	O
(	O
see	O
Figure	O
1C	O
)	O
,	O
and	O
they	O
are	O
indistinguishable	O
from	O
wild	O
type	O
on	O
immunostaining	O
of	O
kidneys	O
(	O
Figure	O
5A	O
)	O
.	O

The	O
presence	O
of	O
50	O
%	O
of	O
the	O
normal	O
amount	O
of	O
wild	O
-	O
type	O
protein	O
may	O
explain	O
the	O
lack	O
of	O
symptoms	O
,	O
but	O
it	O
cannot	O
explain	O
the	O
lack	O
of	O
any	O
ER	S-GO
-	O
retained	O
mutant	O
protein	O
.	O

Rather	O
,	O
the	O
phenotype	O
of	O
the	O
Aqp2F204V	O
/	O
+	O
animals	O
suggests	O
that	O
the	O
mutant	O
protein	O
is	O
being	O
rescued	O
by	O
the	O
wild	O
-	O
type	O
protein	O
.	O

Indeed	O
,	O
de	O
Mattia	O
et	O
al	O
.	O

(	O
26	O
)	O
have	O
demonstrated	O
that	O
one	O
recessive	O
allele	O
of	O
Aqp2	O
,	O
P262L	O
,	O
does	O
not	O
properly	O
translocate	O
when	O
expressed	O
by	O
itself	O
in	O
MDCK	O
cells	O
,	O
but	O
that	O
in	O
the	O
presence	O
of	O
wild	O
-	O
type	O
protein	O
,	O
it	O
localizes	O
normally	O
.	O

The	O
same	O
mechanism	O
seems	O
to	O
apply	O
in	O
vivo	O
with	O
Aqp2F204V	O
/	O
+	O
mice	O
.	O

In	O
support	O
of	O
this	O
,	O
AQP2	O
-	O
F204V	O
can	O
interact	O
with	O
wild	O
-	O
type	O
AQP2	O
(	O
Figure	O
5B	O
)	O
,	O
and	O
when	O
coexpressed	O
with	O
wild	O
-	O
type	O
protein	O
,	O
AQP2	O
-	O
F204V	O
can	O
reach	O
the	O
cell	B-GO
surface	E-GO
(	O
Figure	O
5C	O
bottom	O
right	O
panel	O
and	O
5D	O
)	O
.	O

Although	O
it	O
has	O
been	O
demonstrated	O
that	O
a	O
recessive	O
allele	O
(	O
encoding	O
AQP2	O
-	O
R187C	O
)	O
of	O
NDI	O
fails	O
to	O
interact	O
with	O
wild	O
-	O
type	O
AQP2	O
[	O
6	O
]	O
,	O
here	O
we	O
show	O
that	O
AQP2	O
-	O
F204V	O
does	O
interact	O
with	O
the	O
wild	O
-	O
type	O
protein	O
,	O
presumably	O
as	O
part	O
of	O
heterotetramers	O
,	O
and	O
represents	O
a	O
rescuable	O
allele	O
,	O
both	O
in	O
vitro	O
and	O
in	O
vivo	O
.	O

Immunostaining	O
the	O
kidneys	O
of	O
homozygous	O
Aqp2F204V	O
/	O
F204V	O
mice	O
shows	O
that	O
the	O
mutant	O
-	O
expressing	O
collecting	O
duct	O
cells	O
can	O
not	O
mediate	O
water	O
reabsorption	O
,	O
because	O
it	O
fails	O
to	O
insert	O
into	O
the	O
apical	B-GO
plasma	I-GO
membrane	E-GO
in	O
response	O
to	O
dDAVP	O
.	O

This	O
is	O
this	O
first	O
in	O
vivo	O
proof	O
of	O
a	O
long	O
-	O
standing	O
hypothesis	O
that	O
comes	O
from	O
in	O
vitro	O
studies	O
with	O
recessive	O
Aqp2	O
mutations	O
.	O

Transfection	O
into	O
MDCK	O
cells	O
of	O
any	O
of	O
several	O
Aqp2	O
mutations	O
corresponding	O
to	O
recessive	O
human	O
alleles	O
shows	O
abnormal	O
subcellular	O
localization	O
[	O
25	O
]	O
,	O
[	O
27	O
]	O
and	O
failure	O
to	O
appropriately	O
translocate	O
to	O
the	O
plasma	B-GO
membrane	E-GO
.	O

Thus	O
,	O
misfolding	O
,	O
retention	O
in	O
the	O
ER	S-GO
,	O
and	O
failure	O
to	O
translocate	O
in	O
response	O
to	O
dDAVP	O
were	O
proposed	O
as	O
the	O
mechanism	O
for	O
autosomal	S-GO
recessive	O
NDI	O
.	O

Here	O
we	O
not	O
only	O
prove	O
this	O
hypothesis	O
but	O
also	O
establish	O
a	O
useful	O
model	O
for	O
human	O
NDI	O
.	O

This	O
mouse	O
model	O
of	O
NDI	O
based	O
on	O
an	O
Aqp2	O
allele	O
that	O
can	O
be	O
rescued	O
provides	O
the	O
opportunity	O
to	O
test	O
therapies	O
,	O
including	O
gene	O
therapy	O
,	O
that	O
may	O
promote	O
proper	O
subcellular	O
localization	O
.	O

Materials	O
and	O
Methods	O

Generation	O
of	O
ENU	O
mice	O
and	O
housing	O
.	O

ENU	O
mutagenized	O
C57BL	O
/	O
6	O
mice	O
were	O
generated	O
as	O
described	O
[	O
19	O
]	O
.	O

Mice	O
were	O
maintained	O
by	O
backcrossing	O
affected	O
animals	O
to	O
C57BL	O
/	O
6	O
and	O
housed	O
in	O
the	O
Genomics	O
Institute	O
of	O
the	O
Novartis	O
Research	O
Foundation	O
Specific	O
Pathogen	O
Free	O
animal	O
facility	O
(	O
La	O
Jolla	O
,	O
California	O
,	O
United	O
States	O
)	O
.	O

All	O
procedures	O
were	O
approved	O
by	O
the	O
Genomics	O
Institute	O
of	O
the	O
Novartis	O
Research	O
Foundation	O
Institutional	O
Animal	O
Care	O
and	O
Use	O
Committee	O
.	O

Constructs	O
.	O

The	O
complete	O
coding	O
sequence	O
of	O
mouse	O
AQP2	O
from	O
an	O
IMAGE	O
clone	O
was	O
digested	O
from	O
the	O
pCMV	O
.	O
SPORT6	O
plasmid	O
with	O
EcoRI	O
and	O
NotI	O
and	O
ligated	O
into	O
pcDNA3	O
.	O
1	O
(	O
Invitrogen	O
,	O
Carlsbad	O
,	O
California	O
,	O
United	O
States	O
)	O
.	O

The	O
F204V	O
mutation	O
was	O
introduced	O
by	O
site	O
-	O
directed	O
mutagenesis	O
(	O
Stratagene	O
,	O
La	O
Jolla	O
,	O
California	O
,	O
United	O
States	O
)	O
,	O
using	O
the	O
sense	O
oligonucleotide	O
5	O
'	O
-	O
GATGATCACTGGGTCGTCTGGATCGGACCCC	O
-	O
3	O
'	O
,	O
and	O
antisense	O
oligonucleotide	O
5	O
'	O
-	O
GGGGTCCGATCCAGACGACCCAGTGATCATC	O
-	O
3	O
'	O
.	O

To	O
generate	O
GFP	O
fusions	O
of	O
AQP2	O
,	O
the	O
pCMV	O
.	O
SPORT6	O
AQP2	O
construct	O
was	O
used	O
in	O
a	O
PCR	O
reaction	O
with	O
the	O
primers	O
Sp6	O
and	O
5	O
'	O
-	O
GACTGGATCCCGGCCTTGCTGCCGCGCGGCAG	O
-	O
3	O
'	O
to	O
remove	O
the	O
stop	O
codon	O
of	O
AQP2	O
.	O

The	O
product	O
was	O
digested	O
with	O
KpnI	O
and	O
BamHI	O
and	O
ligated	O
into	O
pEGFP	O
-	O
N2	O
(	O
BD	O
Biosciences	O
,	O
San	O
Diego	O
,	O
California	O
,	O
United	O
States	O
)	O
.	O

The	O
F204V	O
mutation	O
was	O
introduced	O
using	O
the	O
same	O
mutagenic	O
oligonucleotides	O
.	O

Cell	O
culture	O
and	O
generation	O
of	O
stable	O
cell	O
lines	O
.	O

MDCK	O
cells	O
(	O
CCL	O
-	O
34	O
;	O
ATCC	O
,	O
Manassas	O
,	O
Virginia	O
,	O
United	O
States	O
)	O
were	O
cultured	O
in	O
DMEM	O
(	O
Sigma	O
-	O
Aldrich	O
,	O
St	O
.	O
Louis	O
,	O
Missouri	O
,	O
United	O
States	O
)	O
supplemented	O
with	O
10	O
%	O
FBS	O
(	O
Sigma	O
-	O
Aldrich	O
)	O
,	O
100	O
U	O
/	O
ml	O
of	O
penicillin	O
,	O
and	O
100	O
mu	O
g	O
/	O
ml	O
of	O
streptomycin	O
at	O
37	O
degrees	O
C	O
in	O
5	O
%	O
CO2	O
.	O

To	O
generate	O
stable	O
MDCK	O
cell	O
lines	O
,	O
cells	O
were	O
transfected	O
using	O
Lipofectamine	O
2000	O
(	O
Invitrogen	O
)	O
and	O
the	O
pcDNA3	O
.	O
1	O
expression	O
constructs	O
(	O
containing	O
wild	O
-	O
type	O
AQP2	O
,	O
AQP2	O
-	O
F204V	O
,	O
or	O
no	O
insert	O
)	O
and	O
selected	O
with	O
900	O
mu	O
g	O
/	O
ml	O
G418	O
(	O
Sigma	O
-	O
Aldrich	O
)	O
.	O

Individual	O
colonies	O
were	O
expanded	O
14	O
d	O
later	O
.	O

For	O
the	O
duration	O
of	O
these	O
experiments	O
,	O
the	O
antibiotic	O
was	O
continually	O
added	O
to	O
the	O
media	O
.	O

Transient	O
GFP	O
transfections	O
were	O
carried	O
out	O
in	O
subconfluent	O
stable	O
cells	O
lines	O
also	O
using	O
Lipofectamine	O
2000	O
.	O

Sequencing	O
of	O
Aqp2	O
and	O
genotyping	O
of	O
mice	O
.	O

All	O
exons	O
of	O
Aqp2	O
were	O
amplified	O
from	O
mouse	O
genomic	O
DNA	O
and	O
sequenced	O
.	O

For	O
genotyping	O
,	O
exon	O
4	O
was	O
amplified	O
using	O
the	O
primers	O
5	O
'	O
-	O
TCAGAACTTGCCCACTAGCC	O
-	O
3	O
'	O
and	O
5	O
'	O
-	O
TGTAGAGGAGGGAACCGATG	O
-	O
3	O
'	O
.	O

Urine	O
measurements	O
.	O

Total	O
urine	O
output	O
was	O
measured	O
by	O
separately	O
housing	O
adult	O
mice	O
in	O
Nalgene	O
Metabolic	O
Cages	O
(	O
Minimitter	O
,	O
Bend	O
,	O
Oregon	O
,	O
United	O
States	O
)	O
for	O
2	O
-	O
3	O
d	O
and	O
collecting	O
urine	O
every	O
24	O
h	O
period	O
.	O

Urine	O
osmolalities	O
were	O
determined	O
using	O
an	O
Osmometer	O
(	O
Osmette	O
5004	O
;	O
Precision	O
Systems	O
,	O
Natick	O
,	O
Massachusetts	O
,	O
United	O
States	O
)	O
.	O

Urine	O
concentrating	O
experiments	O
were	O
carried	O
out	O
by	O
intraperitoneal	O
injection	O
of	O
dDAVP	O
(	O
0	O
.	O
4	O
mu	O
g	O
/	O
kg	O
)	O
.	O

Mice	O
were	O
injected	O
twice	O
with	O
dDAVP	O
,	O
once	O
at	O
time	O
0	O
and	O
again	O
at	O
30	O
min	O
.	O

Urine	O
was	O
collected	O
at	O
the	O
start	O
of	O
the	O
experiment	O
and	O
30	O
min	O
after	O
the	O
second	O
injection	O
.	O

Kidney	O
membrane	S-GO
preparation	O
.	O

Whole	O
mouse	O
kidneys	O
were	O
homogenized	O
in	O
10	O
mM	O
Tris	O
(	O
pH	O
7	O
.	O
4	O
)	O
,	O
350	O
mM	O
sucrose	O
,	O
and	O
5	O
mM	O
EDTA	O
containing	O
protease	O
inhibitors	O
(	O
Sigma	O
-	O
Aldrich	O
,	O
#	O
P	O
-	O
8340	O
)	O
in	O
a	O
Potter	O
-	O
Elvehjem	O
homogenizer	O
.	O

The	O
homogenate	O
was	O
centrifuged	O
at	O
2	O
,	O
000	O
g	O
for	O
10	O
min	O
and	O
the	O
supernatant	O
was	O
subjected	O
to	O
ultracentrifugation	O
at	O
100	O
,	O
000	O
g	O
for	O
1	O
h	O
at	O
4	O
degrees	O
C	O
.	O

Pelleted	O
membranes	S-GO
were	O
resuspended	O
in	O
the	O
same	O
buffer	O
,	O
and	O
protein	O
concentration	O
was	O
determined	O
by	O
Bradford	O
assay	O
.	O

Immunoblotting	O
.	O

Kidney	O
membrane	B-GO
fractions	E-GO
(	O
60	O
mu	O
g	O
)	O
were	O
resolved	O
on	O
a	O
12	O
%	O
SDS	O
-	O
polyacrylamide	O
gel	O
and	O
transferred	O
to	O
a	O
nitrocellulose	O
membrane	O
.	O

Membranes	O
were	O
blocked	O
in	O
5	O
%	O
nonfat	O
milk	O
in	O
Tris	O
-	O
buffered	O
saline	O
with	O
0	O
.	O
05	O
%	O
Tween	O
20	O
(	O
TBST	O
)	O
,	O
followed	O
by	O
an	O
overnight	O
incubation	O
(	O
at	O
4	O
degrees	O
C	O
)	O
with	O
AQP2	O
polyclonal	O
antibody	S-GO
(	O
Santa	O
Cruz	O
Biotechnology	O
,	O
Santa	O
Cruz	O
,	O
California	O
,	O
United	O
States	O
;	O
#	O
sc	O
-	O
9882	O
)	O
.	O

Membranes	O
were	O
washed	O
in	O
TBST	O
then	O
incubated	O
with	O
HRP	O
-	O
conjugated	O
donkey	O
anti	O
-	O
goat	O
antibody	S-GO
.	O

Membranes	O
were	O
washed	O
further	O
in	O
TBST	O
and	O
bands	O
were	O
visualized	O
using	O
ECL	O
reagent	O
(	O
Amersham	O
Biosciences	O
,	O
Little	O
Chalfont	O
,	O
United	O
Kingdom	O
)	O
.	O

Endoglycosidase	O
digestion	O
.	O

Kidney	O
membranes	S-GO
(	O
60	O
mu	O
g	O
)	O
were	O
incubated	O
in	O
50	O
mM	O
sodium	O
phosphate	O
(	O
pH	O
5	O
.	O
5	O
)	O
,	O
0	O
.	O
1	O
%	O
SDS	O
,	O
and	O
50	O
mM	O
beta	O
-	O
mercaptoethanol	O
,	O
heated	O
to	O
100	O
degrees	O
C	O
for	O
5	O
min	O
,	O
then	O
cooled	O
.	O

Endoglycosidase	O
H	O
(	O
0	O
.	O
01	O
units	O
;	O
Sigma	O
-	O
Aldrich	O
)	O
was	O
added	O
and	O
incubated	O
at	O
37	O
degrees	O
C	O
for	O
2	O
h	O
.	O

The	O
reaction	O
was	O
stopped	O
by	O
boiling	O
the	O
samples	O
in	O
Laemmli	O
buffer	O
.	O

Total	O
reactants	O
were	O
immunoblotted	O
as	O
described	O
above	O
.	O

Coimmunoprecipitation	O
and	O
biotinylation	O
in	O
MDCK	O
cells	O
.	O

MDCK	O
cells	O
stably	O
expressing	O
wild	O
-	O
type	O
AQP2	O
(	O
grown	O
on	O
10	O
-	O
cm	O
plates	O
)	O
were	O
transfected	O
with	O
pEGFP	O
-	O
wild	O
-	O
type	O
AQP2	O
,	O
pEGFP	O
-	O
AQP2	O
-	O
F204V	O
,	O
or	O
vector	O
alone	O
.	O

The	O
cells	O
were	O
homogenized	O
in	O
10	O
mM	O
Tris	O
(	O
pH	O
7	O
.	O
4	O
)	O
,	O
1	O
mM	O
EDTA	O
,	O
and	O
250	O
mM	O
sucrose	O
40	O
h	O
later	O
.	O

The	O
clarified	O
supernatant	O
was	O
centrifuged	O
at	O
200	O
,	O
000	O
g	O
for	O
30	O
min	O
.	O

Pelleted	O
membranes	S-GO
were	O
resuspended	O
in	O
the	O
same	O
buffer	O
but	O
containing	O
4	O
%	O
sodium	O
deoxycholate	O
and	O
incubated	O
at	O
37	O
degrees	O
C	O
for	O
1	O
h	O
.	O

From	O
the	O
dissolved	O
membranes	S-GO
,	O
a	O
30	O
mu	O
l	O
sample	O
was	O
removed	O
and	O
used	O
as	O
the	O
total	O
membrane	B-GO
fraction	E-GO
.	O

The	O
remaining	O
membranes	S-GO
were	O
diluted	O
with	O
600	O
mu	O
l	O
of	O
the	O
homogenization	O
buffer	O
,	O
and	O
incubated	O
with	O
1	O
mu	O
l	O
of	O
GFP	O
antisera	O
(	O
Invitrogen	O
,	O
#	O
46	O
-	O
0092	O
)	O
and	O
protein	O
A	O
/	O
G	O
sepharose	O
.	O

Following	O
overnight	O
incubation	O
,	O
the	O
precipitated	O
proteins	O
were	O
washed	O
in	O
RIPA	O
buffer	O
and	O
finally	O
boiled	O
in	O
50	O
mu	O
l	O
of	O
Laemmli	O
buffer	O
.	O

Half	O
of	O
the	O
total	O
membrane	B-GO
and	I-GO
the	I-GO
IP	I-GO
fractions	E-GO
were	O
processed	O
for	O
immunoblotting	O
.	O

Cell	B-GO
surface	E-GO
biotinylation	O
was	O
performed	O
in	O
a	O
similar	O
manner	O
.	O

However	O
,	O
pEGFP	O
-	O
AQP2	O
-	O
F204V	O
,	O
was	O
transfected	O
into	O
MDCK	O
cells	O
stably	O
expressing	O
wild	O
-	O
type	O
AQP2	O
and	O
cells	O
made	O
stable	O
with	O
vector	O
alone	O
.	O

Twenty	O
-	O
four	O
hours	O
post	O
-	O
transfection	O
,	O
cells	O
were	O
stimulated	O
with	O
forskolin	O
,	O
trypsinized	O
,	O
resuspended	O
in	O
1	O
ml	O
of	O
PBS	O
(	O
2	O
.	O
5	O
x	O
106	O
cells	O
/	O
ml	O
)	O
,	O
and	O
incubated	O
with	O
0	O
.	O
5	O
mg	O
of	O
NHS	O
-	O
PEO4	O
-	O
biotin	O
(	O
Pierce	O
Biotechnology	O
)	O
for	O
30	O
min	O
at	O
room	O
temperature	O
.	O

Cells	O
were	O
washed	O
once	O
in	O
10	O
mM	O
Tris	O
(	O
pH	O
8	O
)	O
and	O
three	O
times	O
in	O
PBS	O
,	O
after	O
which	O
membranes	S-GO
were	O
purified	O
and	O
solubilized	O
as	O
described	O
above	O
.	O

Solubilized	O
membranes	S-GO
were	O
incubated	O
with	O
20	O
mu	O
l	O
of	O
immobilized	O
streptavidin	O
(	O
Pierce	O
Biotechnology	O
)	O
for	O
2	O
h	O
at	O
4	O
degrees	O
C	O
.	O

Finally	O
the	O
precipitated	O
proteins	O
were	O
washed	O
in	O
RIPA	O
buffer	O
and	O
boiled	O
in	O
50	O
mu	O
l	O
of	O
Laemmli	O
buffer	O
.	O

Total	O
cells	O
and	O
the	O
biotinylated	O
precipitates	O
were	O
immunoblotting	O
using	O
an	O
antibody	S-GO
to	O
AQP2	O
.	O

Kidney	O
immunohistochemistry	O
.	O

Whole	O
mouse	O
kidneys	O
were	O
fixed	O
in	O
10	O
%	O
phosphate	O
-	O
buffered	O
formalin	O
for	O
24	O
h	O
.	O

Kidneys	O
were	O
embedded	O
in	O
paraffin	O
,	O
and	O
5	O
-	O
mu	O
m	O
sections	O
were	O
prepared	O
.	O

Following	O
antigen	O
retrieval	O
using	O
10	O
mM	O
sodium	O
citrate	O
(	O
pH	O
8	O
)	O
for	O
10	O
min	O
at	O
98	O
degrees	O
C	O
,	O
sections	O
were	O
sequentially	O
probed	O
,	O
first	O
for	O
AQP3	O
and	O
then	O
for	O
AQP2	O
.	O

Sections	O
were	O
incubated	O
in	O
5	O
%	O
donkey	O
serum	O
and	O
then	O
in	O
goat	O
anti	O
-	O
AQP3	O
antibody	S-GO
(	O
1	O
:	O
100	O
;	O
Santa	O
Cruz	O
Biotechnology	O
;	O
#	O
sc	O
-	O
9885	O
)	O
.	O

Slides	O
were	O
washed	O
with	O
PBS	O
and	O
incubated	O
with	O
AlexaFluor	O
488	O
-	O
conjugated	O
donkey	O
anti	O
-	O
goat	O
antibody	S-GO
(	O
Molecular	O
Probes	O
,	O
Eugene	O
,	O
Oregon	O
,	O
United	O
States	O
)	O
.	O

The	O
slides	O
were	O
subsequently	O
blocked	O
in	O
5	O
%	O
chicken	O
serum	O
,	O
incubated	O
with	O
a	O
rabbit	O
anti	O
-	O
AQP2	O
antibody	S-GO
(	O
1	O
:	O
250	O
;	O
USB	O
,	O
Cleveland	O
,	O
Ohio	O
,	O
United	O
States	O
;	O
#	O
A3000	O
-	O
06	O
)	O
,	O
which	O
was	O
detected	O
with	O
a	O
AlexaFluor	O
594	O
-	O
conjugated	O
chicken	O
anti	O
-	O
rabbit	O
antibody	S-GO
(	O
1	O
:	O
500	O
;	O
Molecular	O
Probes	O
)	O
.	O

The	O
sections	O
were	O
stained	O
with	O
DAPI	O
and	O
mounted	O
in	O
Vectashield	O
(	O
Vector	O
Labs	O
,	O
Burlingame	O
,	O
California	O
,	O
United	O
States	O
)	O
.	O

Immunocytochemistry	O
on	O
MDCK	O
cells	O
.	O

MDCK	O
stable	O
cell	O
lines	O
expressing	O
vector	O
alone	O
,	O
wild	O
-	O
type	O
AQP2	O
,	O
or	O
AQP2	O
-	O
F204V	O
(	O
and	O
in	O
some	O
cases	O
transiently	O
expressing	O
a	O
GFP	O
construct	O
)	O
were	O
grown	O
on	O
fibronectin	O
-	O
coated	O
coverslips	O
until	O
tight	B-GO
junctions	E-GO
formed	O
.	O

Cells	O
were	O
treated	O
with	O
or	O
without	O
150	O
mu	O
M	O
forskolin	O
for	O
90	O
min	O
,	O
and	O
fixed	O
in	O
methanol	O
at	O
-	O
20	O
degrees	O
C	O
.	O

Subsequently	O
,	O
cells	O
were	O
washed	O
and	O
permeabilized	O
in	O
0	O
.	O
2	O
%	O
Triton	O
X	O
-	O
100	O
for	O
5	O
min	O
,	O
and	O
sequentially	O
probed	O
for	O
AQP2	O
and	O
organelle	S-GO
markers	O
for	O
either	O
the	O
PM	S-GO
or	O
the	O
ER	S-GO
.	O

AQP2	O
was	O
detected	O
using	O
goat	O
anti	O
-	O
AQP2	O
(	O
1	O
:	O
100	O
;	O
Santa	O
Cruz	O
Biotechnology	O
;	O
#	O
sc	O
-	O
9882	O
)	O
and	O
a	O
1	O
:	O
200	O
dilution	O
of	O
AlexaFluor	O
488	O
-	O
conjugated	O
donkey	O
anti	O
-	O
goat	O
secondary	O
antibody	S-GO
.	O

The	O
PM	S-GO
and	O
ER	S-GO
were	O
probed	O
using	O
mouse	O
anti	O
-	O
Na	O
+	O
/	O
K	O
+	O
-	O
ATPase	O
(	O
Upstate	O
,	O
Waltham	O
,	O
Massachusetts	O
,	O
United	O
States	O
)	O
or	O
rabbit	O
anti	O
-	O
calnexin	O
(	O
Stressgen	O
Biotechnology	O
,	O
Victoria	O
,	O
British	O
Columbia	O
,	O
Canada	O
)	O
antibodies	S-GO
and	O
the	O
secondary	O
antibodies	S-GO
,	O
Cy3	O
-	O
conjugated	O
goat	O
anti	O
-	O
mouse	O
(	O
1	O
:	O
200	O
;	O
Jackson	O
ImmunoResearch	O
,	O
West	O
Grove	O
,	O
Pennsylvania	O
,	O
United	O
States	O
)	O
or	O
AlexaFluor	O
594	O
-	O
conjugated	O
chicken	O
anti	O
-	O
rabbit	O
(	O
1	O
:	O
200	O
)	O
respectively	O
.	O

Cells	O
were	O
washed	O
in	O
PBS	O
,	O
counterstained	O
with	O
DAPI	O
,	O
and	O
mounted	O
in	O
Vectashield	O
.	O

In	O
experiments	O
in	O
which	O
GFP	O
fusions	O
were	O
used	O
,	O
AQP2	O
was	O
probed	O
using	O
the	O
antibody	S-GO
combination	O
used	O
for	O
kidney	O
immunohistochemistry	O
in	O
order	O
to	O
detect	O
the	O
AQP2	O
at	O
594	O
nm	O
,	O
to	O
distinguish	O
between	O
the	O
GFP	O
fusion	O
proteins	O
.	O

Confocal	O
microscopy	O
.	O

Optical	O
z	O
-	O
section	O
images	O
were	O
collected	O
on	O
a	O
BioRad	O
(	O
Hercules	O
,	O
California	O
,	O
United	O
States	O
)	O
Rainbow	O
Radiance	O
2100	O
Laser	O
Scanning	O
Confocal	O
Microscope	O
.	O

Image	O
stacks	O
were	O
flattened	O
,	O
or	O
sectioned	O
along	O
the	O
z	O
-	O
axis	O
,	O
then	O
further	O
processed	O
using	O
BioRad	O
Laser	O
Sharp	O
2000	O
software	O
and	O
Image	O
J	O
software	O
(	O
v	O
.	O
1	O
.	O
32	O
;	O
National	O
Institutes	O
of	O
Health	O
)	O
.	O

Colocalization	O
was	O
performed	O
using	O
the	O
overlay	O
coefficient	O
of	O
Image	O
J	O
software	O
.	O

Supporting	O
Information	O

Accession	O
Numbers	O

The	O
GenBank	O
(	O
http	O
:	O
/	O
/	O
www	O
.	O
ncbi	O
.	O
nlm	O
.	O
nih	O
.	O
gov	O
/	O
)	O
accession	O
number	O
of	O
Aqp2	O
is	O
NM	O
_	O
009699	O
.	O

The	O
IMAGE	O
(	O
http	O
:	O
/	O
/	O
image	O
.	O
llnl	O
.	O
gov	O
)	O
accession	O
number	O
of	O
AQP2	O
is	O
4222942	O
.	O

Acknowledgements	O

We	O
thank	O
Debby	O
Stradley	O
for	O
all	O
genotyping	O
,	O
Lacey	O
Kischassey	O
for	O
breeding	O
and	O
care	O
of	O
mice	O
,	O
Karina	O
Ayala	O
and	O
Sandy	O
Bohan	O
for	O
phenotyping	O
the	O
study	O
mice	O
,	O
Miah	O
Gilmore	O
for	O
performing	O
endoglycosidase	O
H	O
experiments	O
,	O
James	O
Watson	O
for	O
sectioning	O
tissue	O
,	O
and	O
Dr	O
.	O
William	O
Kiossis	O
for	O
collecting	O
confocal	O
images	O
.	O

Abbreviations	O

AQP	O
[	O
number	O
]	O
-	O
aquaporin	O
-	O
[	O
number	O
]	O

AVPR2	O
-	O
AVP	O
type	O
2	O
receptor	O

AVP	O
-	O
arginine	O
vasopressin	O

dDAVP	O
-	O
1	O
-	O
deamino	O
-	O
8	O
-	O
D	O
-	O
arginine	O
vasopressin	O

ER	S-GO
-	O
endoplasmic	B-GO
reticulum	E-GO

MDCK	O
-	O
Madin	O
-	O
Darby	O
canine	O
kidney	O

NDI	O
-	O
nephrogenic	O
diabetes	O
insipidus	O

PM	S-GO
-	O
plasma	B-GO
membrane	E-GO

Figures	O

Figure	O
1	O

Analysis	O
of	O
Aqp2	O
Sequence	O
and	O
Phenotype	O
in	O
Mutant	O
Mice	O

(	O
A	O
)	O
Chromatographic	O
traces	O
of	O
Aqp2	O
F204V	O
mutation	O
.	O

The	O
box	O
shows	O
the	O
mutated	O
codon	O
,	O
TTC	O
(	O
Phe	O
)	O
to	O
GTC	O
(	O
Val	O
)	O
at	O
position	O
204	O
.	O

WT	O
,	O
wild	O
type	O
;	O
Mut	O
,	O
mutant	O
.	O

(	O
B	O
)	O
Amino	O
acid	O
conservation	O
of	O
mouse	O
AQP2	O
(	O
residues	O
194	O
-	O
214	O
)	O
.	O

The	O
boxed	O
residue	O
indicates	O
phenylalanine	O
at	O
position	O
204	O
.	O

hAQP2	O
,	O
human	O
AQP2	O
;	O
mAQP1	O
,	O
mouse	O
AQP1	O
;	O
mAQP2	O
,	O
mouse	O
AQP2	O
;	O
rAQP2	O
,	O
rat	O
AQP2	O
;	O
xAQP2	O
,	O
Xenopus	O
AQP2	O
.	O

(	O
C	O
)	O
Urine	O
production	O
(	O
ml	O
)	O
and	O
water	O
consumption	O
(	O
ml	O
)	O
of	O
58	O
F2	O
mice	O
over	O
a	O
24	O
-	O
h	O
period	O
(	O
both	O
sexes	O
,	O
aged	O
10	O
-	O
22	O
wk	O
)	O
.	O

Mutant	O
mice	O
(	O
black	O
squares	O
)	O
exhibit	O
overt	O
polyuria	O
and	O
polydipsia	O
compared	O
to	O
littermate	O
wild	O
-	O
type	O
(	O
white	O
triangles	O
)	O
and	O
heterozygous	O
(	O
grey	O
circles	O
)	O
mice	O
.	O

(	O
D	O
)	O
Urine	O
osmolality	O
and	O
concentrating	O
ability	O
in	O
Aqp2	O
mutant	O
and	O
their	O
littermates	O
(	O
10	O
-	O
22	O
wk	O
,	O
both	O
sexes	O
)	O
,	O
before	O
(	O
white	O
bars	O
)	O
and	O
after	O
(	O
black	O
bars	O
)	O
dDAVP	O
treatment	O
.	O

Wild	O
type	O
(	O
WT	O
;	O
n	O
=	O
12	O
)	O
;	O
heterozygote	O
(	O
Het	O
;	O
n	O
=	O
20	O
)	O
;	O
mutant	O
(	O
Mut	O
;	O
n	O
=	O
9	O
)	O
.	O

Data	O
represent	O
averages	O
+/-	O
standard	O
error	O
of	O
the	O
mean	O
,	O
*	O
*	O
p	O
<	O
0	O
.	O
01	O
;	O
*	O
*	O
*	O
p	O
<	O
0	O
.	O
001	O
.	O

Figure	O
2	O

Anatomy	O
and	O
Histology	O
of	O
Mouse	O
Kidneys	O

(	O
A	O
)	O
Gross	O
anatomy	O
of	O
an	O
affected	O
mouse	O
(	O
8	O
-	O
mo	O
-	O
old	O
male	O
)	O
.	O

This	O
shows	O
the	O
enlargement	O
and	O
cystic	O
dilatation	O
of	O
the	O
renal	O
pelvis	O
.	O

There	O
is	O
thinning	O
of	O
the	O
overlying	O
renal	O
parenchyma	O
imparting	O
a	O
translucent	O
appearance	O
to	O
portions	O
of	O
the	O
kidney	O
and	O
collecting	O
system	O
.	O

The	O
bladder	O
is	O
also	O
dilated	O
.	O

(	O
B	O
)	O
Left	O
kidney	O
from	O
mutant	O
mouse	O
(	O
right	O
)	O
shown	O
in	O
(	O
A	O
)	O
compared	O
to	O
a	O
kidney	O
from	O
an	O
age	O
-	O
sex	O
matched	O
unaffected	O
littermate	O
(	O
left	O
)	O
.	O

(	O
C	O
)	O
Hematoxylin	O
and	O
eosin	O
stained	O
section	O
of	O
ureter	O
from	O
a	O
mutant	O
mouse	O
,	O
showing	O
normal	O
histology	O
despite	O
bloating	O
of	O
the	O
kidney	O
.	O

(	O
D	O
)	O
Hematoxylin	O
and	O
eosin	O
stained	O
histologic	O
section	O
of	O
a	O
kidney	O
from	O
a	O
4	O
-	O
wk	O
-	O
old	O
female	O
mutant	O
mouse	O
.	O

The	O
mutant	O
kidney	O
shows	O
marked	O
dilatation	O
of	O
the	O
renal	O
pelvis	O
with	O
blunting	O
of	O
the	O
papilla	O
.	O

There	O
is	O
preservation	O
of	O
the	O
cortex	O
and	O
medulla	O
.	O

Figure	O
3	O

Immunoblot	O
Analyses	O
of	O
AQP2	O
from	O
Mouse	O
Kidneys	O

(	O
A	O
)	O
Western	O
blot	O
analyses	O
of	O
total	O
kidney	O
membranes	S-GO
from	O
littermate	O
mice	O
.	O

An	O
intermediate	O
form	O
of	O
AQP2	O
at	O
31	O
kDa	O
was	O
identified	O
in	O
kidney	O
membranes	S-GO
from	O
a	O
mutant	O
mouse	O
(	O
Mut	O
)	O
and	O
partially	O
in	O
a	O
heterozygous	O
mouse	O
(	O
Het	O
)	O
.	O

(	O
B	O
)	O
Total	O
kidney	O
membranes	S-GO
were	O
subjected	O
to	O
endoglycosidase	O
H	O
treatment	O
(	O
Endo	O
H	O
)	O
prior	O
to	O
Western	O
blotting	O
.	O

High	O
-	O
mannose	O
(	O
h	O
.	O
m	O
.	O
)	O
glycosylated	O
proteins	O
that	O
have	O
not	O
exited	O
the	O
ER	S-GO
are	O
sensitive	O
to	O
endoglycosidase	O
H	O
digestion	O
.	O

Figure	O
4	O

AQP2	O
Subcellular	O
Localization	O
and	O
Translocation	O
in	O
Mouse	O
Kidney	O
Collecting	O
Ducts	O
and	O
MDCK	O
Cell	O
Lines	O

(	O
A	O
)	O
Immunohistochemistry	O
on	O
collecting	O
ducts	O
in	O
kidney	O
sections	O
from	O
an	O
AQP2	O
-	O
F204V	O
mutant	O
(	O
Mut	O
)	O
mouse	O
and	O
an	O
age	O
-	O
sex	O
matched	O
wild	O
-	O
type	O
(	O
WT	O
)	O
littermate	O
.	O

Mice	O
were	O
injected	O
intraperitoneally	O
with	O
PBS	O
(	O
NT	O
)	O
or	O
dDAVP	O
before	O
sacrificing	O
and	O
fixation	O
of	O
the	O
kidneys	O
.	O

Kidneys	O
sections	O
were	O
immunostained	O
for	O
AQP2	O
(	O
red	O
)	O
and	O
the	O
basolateral	O
marker	O
AQP3	O
(	O
green	O
)	O
.	O

The	O
images	O
were	O
merged	O
and	O
an	O
area	B-GO
of	I-GO
the	I-GO
cytoplasm	E-GO
was	O
magnified	O
(	O
zoom	O
)	O
.	O

Note	O
that	O
mutant	O
AQP2	O
is	O
not	O
properly	O
localized	O
to	O
the	O
subapical	O
compartment	O
,	O
nor	O
does	O
it	O
respond	O
to	O
dDAVP	O
.	O

(	O
B	O
)	O
MDCK	O
cell	O
lines	O
,	O
stably	O
transfected	O
with	O
constructs	O
encoding	O
mouse	O
WT	O
or	O
AQP2	O
-	O
F204V	O
,	O
were	O
treated	O
with	O
and	O
without	O
150	O
mu	O
M	O
forskolin	O
for	O
90	O
min	O
,	O
after	O
which	O
cells	O
were	O
fixed	O
,	O
permeabilized	O
,	O
and	O
subjected	O
to	O
immunocytochemistry	O
.	O

AQP2	O
is	O
shown	O
in	O
green	O
,	O
and	O
the	O
basolateral	O
marker	O
Na	O
+	O
/	O
K	O
+	O
-	O
ATPase	O
is	O
shown	O
in	O
red	O
,	O
alongside	O
the	O
nuclear	S-GO
stain	O
DAPI	O
.	O

The	O
z	O
-	O
profile	O
images	O
were	O
reconstructed	O
from	O
multiple	O
z	O
-	O
sections	O
,	O
along	O
the	O
dotted	O
line	O
.	O

Mutant	O
AQP2	O
fails	O
to	O
localize	O
to	O
the	O
cell	B-GO
surface	E-GO
upon	O
forskolin	O
stimulation	O
.	O

Rather	O
,	O
the	O
perinuclear	S-GO
staining	O
is	O
consistent	O
with	O
an	O
ER	S-GO
localization	O
of	O
mutant	O
AQP2	O
.	O

(	O
C	O
)	O
The	O
MDCK	O
cell	O
line	O
expressing	O
AQP2	O
-	O
F204V	O
was	O
grown	O
on	O
fibronectin	O
-	O
coated	O
coverslips	O
until	O
tight	B-GO
junctions	E-GO
formed	O
,	O
at	O
which	O
point	O
the	O
cells	O
were	O
treated	O
with	O
150	O
mu	O
M	O
forskolin	O
for	O
90	O
min	O
.	O

Cells	O
were	O
fixed	O
,	O
permeabilized	O
,	O
and	O
sequentially	O
immunoblotted	O
for	O
AQP2	O
(	O
green	O
)	O
and	O
calnexin	O
(	O
red	O
)	O
,	O
an	O
ER	S-GO
marker	O
.	O

The	O
merged	O
image	O
shows	O
that	O
AQP2	O
-	O
F204V	O
colocalizes	O
with	O
the	O
endoplasmic	B-GO
reticulum	E-GO
marker	O
.	O

Scale	O
bar	O
refers	O
to	O
10	O
mu	O
m	O
.	O

Figure	O
5	O

AQP2	O
-	O
F204V	O
Rescue	O
in	O
Heterozygous	O
Mouse	O
Collecting	O
Ducts	O
and	O
in	O
Cotransfected	O
MDCK	O
Cells	O

(	O
A	O
)	O
In	O
heterozygous	O
animals	O
,	O
AQP2	O
localizes	O
and	O
responds	O
to	O
dDAVP	O
normally	O
.	O

Immunohistochemistry	O
was	O
carried	O
out	O
on	O
kidney	O
sections	O
from	O
an	O
Aqp2F204V	O
/	O
+	O
mouse	O
,	O
after	O
injection	O
with	O
dDAVP	O
.	O

Kidney	O
sections	O
were	O
sequentially	O
immunostained	O
for	O
AQP2	O
(	O
red	O
)	O
and	O
the	O
basolateral	O
marker	O
AQP3	O
(	O
green	O
)	O
.	O

(	O
B	O
)	O
Mutant	O
and	O
wild	O
-	O
type	O
AQP2	O
physically	O
interact	O
.	O

MDCK	O
cells	O
stably	O
expressing	O
wild	O
-	O
type	O
AQP2	O
were	O
transiently	O
transfected	O
with	O
GFP	O
tagged	O
wild	O
-	O
type	O
AQP2	O
,	O
AQP2	O
-	O
F204V	O
,	O
or	O
GFP	O
alone	O
.	O

Solubilized	O
membranes	S-GO
were	O
immunoprecipitated	O
with	O
a	O
GFP	O
antibody	S-GO
.	O

Total	O
membranes	S-GO
and	O
immunoprecipitates	O
(	O
GFP	O
-	O
IP	O
)	O
were	O
Western	O
blotted	O
using	O
an	O
antibody	S-GO
against	O
AQP2	O
(	O
arrow	O
)	O
or	O
AQP2	O
-	O
GFP	O
fusions	O
(	O
arrowhead	O
)	O
.	O

(	O
C	O
)	O
Wild	O
-	O
type	O
AQP2	O
rescues	O
the	O
localization	O
defect	O
of	O
mutant	O
AQP2	O
.	O

GFP	O
fusions	O
of	O
either	O
wild	O
-	O
type	O
AQP2	O
(	O
WT	O
-	O
GFP	O
,	O
top	O
photomicrographs	O
)	O
or	O
F204V	O
AQP2	O
(	O
F204V	O
-	O
GFP	O
,	O
bottom	O
photomicrographs	O
)	O
were	O
expressed	O
in	O
polarized	O
MDCK	O
stable	O
cell	O
lines	O
expressing	O
vector	O
alone	O
(	O
vector	O
,	O
left	O
photomicrographs	O
)	O
or	O
AQP2	O
-	O
WT	O
(	O
right	O
photomicrographs	O
)	O
.	O

Cells	O
were	O
stimulated	O
with	O
forskolin	O
,	O
processed	O
for	O
immunocytochemistry	O
,	O
and	O
used	O
to	O
generate	O
z	O
-	O
sectional	O
images	O
.	O

(	O
D	O
)	O
Mutant	O
AQP2	O
is	O
present	O
at	O
the	O
cell	B-GO
surface	E-GO
in	O
cells	O
coexpressing	O
wild	O
-	O
type	O
AQP2	O
(	O
AQP2	O
-	O
WT	O
)	O
.	O

GFP	O
fused	O
to	O
AQP2	O
-	O
F204V	O
was	O
expressed	O
in	O
MDCK	O
cells	O
expressing	O
wild	O
-	O
type	O
AQP2	O
or	O
vector	O
alone	O
.	O

Cells	O
were	O
stimulated	O
with	O
forskolin	O
,	O
and	O
cell	B-GO
surface	E-GO
biotinylated	O
proteins	O
were	O
precipitated	O
then	O
analyzed	O
for	O
the	O
presence	O
of	O
wild	O
-	O
type	O
AQP2	O
(	O
arrow	O
)	O
and	O
AQP2	O
-	O
F204V	O
(	O
arrowhead	O
)	O
by	O
Western	O
blot	O
.	O

Footnotes	O

Competing	O
interests	O
.	O

The	O
authors	O
have	O
declared	O
that	O
no	O
competing	O
interests	O
exist	O
.	O

Author	O
contributions	O
.	O

DJL	O
and	O
NG	O
conceived	O
and	O
designed	O
the	O
experiments	O
.	O

DJL	O
performed	O
the	O
experiments	O
.	O

DJL	O
,	O
FWH	O
,	O
and	O
NG	O
analyzed	O
the	O
data	O
.	O

DJL	O
and	O
LMT	O
contributed	O
reagents	O
/	O
materials	O
/	O
analysis	O
tools	O
.	O

DJL	O
and	O
NG	O
wrote	O
the	O
paper	O
.	O

Citation	O
:	O
Lloyd	O
DJ	O
,	O
Hall	O
FW	O
,	O
Tarantino	O
LM	O
,	O
Gekakis	O
N	O
(	O
2005	O
)	O
Diabetes	O
insipidus	O
in	O
mice	O
with	O
a	O
mutation	O
in	O
aquaporin	O
-	O
2	O
.	O

PLoS	O
Genet	O
1	O
(	O
2	O
)	O
:	O
e20	O
.	O

Enhanced	O
Odor	O
Discrimination	O
and	O
Impaired	O
Olfactory	O
Memory	O
by	O
Spatially	O
Controlled	O
Switch	O
of	O
AMPA	O
Receptors	O

Abstract	O

Genetic	O
perturbations	O
of	O
alpha	O
-	O
amino	O
-	O
3	O
-	O
hydroxy	O
-	O
5	O
-	O
methyl	O
-	O
4	O
-	O
isoxazolepropionate	O
receptors	O
(	O
AMPARs	O
)	O
are	O
widely	O
used	O
to	O
dissect	O
molecular	O
mechanisms	O
of	O
sensory	O
coding	O
,	O
learning	O
,	O
and	O
memory	O
.	O

In	O
this	O
study	O
,	O
we	O
investigated	O
the	O
role	O
of	O
Ca2	O
+	O
-	O
permeable	O
AMPARs	O
in	O
olfactory	O
behavior	O
.	O

AMPAR	O
modification	O
was	O
obtained	O
by	O
depletion	O
of	O
the	O
GluR	O
-	O
B	O
subunit	O
or	O
expression	O
of	O
unedited	O
GluR	O
-	O
B	O
(	O
Q	O
)	O
,	O
both	O
leading	O
to	O
increased	O
Ca2	O
+	O
permeability	O
of	O
AMPARs	O
.	O

Mice	O
with	O
this	O
functional	O
AMPAR	O
switch	O
,	O
specifically	O
in	O
forebrain	O
,	O
showed	O
enhanced	O
olfactory	O
discrimination	O
and	O
more	O
rapid	O
learning	O
in	O
a	O
go	O
/	O
no	O
-	O
go	O
operant	O
conditioning	O
task	O
.	O

Olfactory	O
memory	O
,	O
however	O
,	O
was	O
dramatically	O
impaired	O
.	O

GluR	O
-	O
B	O
depletion	O
in	O
forebrain	O
was	O
ectopically	O
variable	O
(	O
"	O
mosaic	O
"	O
)	O
among	O
individuals	O
and	O
strongly	O
correlated	O
with	O
decreased	O
olfactory	O
memory	O
in	O
hippocampus	O
and	O
cortex	O
.	O

Accordingly	O
,	O
memory	O
was	O
rescued	O
by	O
transgenic	O
GluR	O
-	O
B	O
expression	O
restricted	O
to	O
piriform	O
cortex	O
and	O
hippocampus	O
,	O
while	O
enhanced	O
odor	O
discrimination	O
was	O
independent	O
of	O
both	O
GluR	O
-	O
B	O
variability	O
and	O
transgenic	O
GluR	O
-	O
B	O
expression	O
.	O

Thus	O
,	O
correlated	O
differences	O
in	O
behavior	O
and	O
levels	O
of	O
GluR	O
-	O
B	O
expression	O
allowed	O
a	O
mechanistic	O
and	O
spatial	O
dissection	O
of	O
olfactory	O
learning	O
,	O
discrimination	O
,	O
and	O
memory	O
capabilities	O
.	O

Introduction	O

The	O
sense	O
of	O
smell	O
is	O
of	O
paramount	O
importance	O
for	O
rodents	O
[	O
1	O
]	O
,	O
for	O
which	O
rapid	O
odor	O
discrimination	O
and	O
long	O
-	O
lasting	O
olfactory	O
memory	O
permits	O
responses	O
to	O
predator	O
and	O
prey	O
critical	O
for	O
survival	O
.	O

Consequently	O
,	O
the	O
behavioral	O
analyses	O
of	O
olfactory	O
capabilities	O
in	O
rodents	O
are	O
efficient	O
,	O
quantitative	O
,	O
and	O
reproducible	O
[	O
2	O
-	O
4	O
]	O
.	O

While	O
in	O
the	O
formation	O
and	O
storage	O
of	O
olfactory	O
memory	O
piriform	O
cortex	O
[	O
5	O
-	O
7	O
]	O
,	O
hippocampus	O
[	O
8	O
,	O
9	O
]	O
,	O
and	O
olfactory	O
bulb	O
[	O
10	O
-	O
12	O
]	O
are	O
all	O
implicated	O
,	O
the	O
cellular	O
correlates	O
for	O
these	O
processes	O
have	O
not	O
been	O
clearly	O
delineated	O
.	O

The	O
contribution	O
of	O
the	O
hippocampus	O
to	O
olfactory	O
memory	O
is	O
presently	O
controversial	O
[	O
2	O
,	O
13	O
-	O
18	O
]	O
,	O
but	O
is	O
deemed	O
unlikely	O
for	O
simple	O
olfactory	O
discrimination	O
tasks	O
[	O
9	O
,	O
19	O
]	O
.	O

In	O
fact	O
,	O
the	O
most	O
likely	O
candidates	O
for	O
a	O
cellular	O
correlate	O
of	O
olfactory	O
memory	O
appear	O
to	O
be	O
the	O
neuronal	O
connections	O
in	O
the	O
piriform	O
cortex	O
due	O
to	O
the	O
associational	O
connectivity	O
[	O
5	O
]	O
and	O
the	O
expression	O
of	O
several	O
forms	O
of	O
cellular	O
and	O
synaptic	S-GO
plasticity	O
[	O
7	O
,	O
20	O
-	O
23	O
]	O
.	O

Concerning	O
odor	O
discrimination	O
itself	O
,	O
cellular	O
mechanisms	O
for	O
this	O
process	O
are	O
often	O
attributed	O
to	O
the	O
inhibitory	O
circuitry	O
of	O
the	O
olfactory	O
bulb	O
(	O
[	O
24	O
-	O
30	O
]	O
;	O
reviewed	O
in	O
[	O
31	O
-	O
33	O
]	O
)	O
.	O

Lateral	O
inhibitory	O
circuits	O
were	O
postulated	O
,	O
in	O
analogy	O
to	O
retina	O
[	O
34	O
,	O
35	O
]	O
,	O
to	O
mediate	O
contrast	O
enhancement	O
[	O
24	O
]	O
,	O
for	O
which	O
physiological	O
recordings	O
[	O
24	O
,	O
36	O
,	O
37	O
]	O
and	O
modeling	O
data	O
,	O
based	O
on	O
the	O
well	O
-	O
known	O
anatomy	O
[	O
29	O
]	O
,	O
provide	O
additional	O
support	O
.	O

Such	O
contrast	O
enhancement	O
may	O
rest	O
in	O
large	O
part	O
on	O
the	O
particular	O
properties	O
of	O
dendrodendritic	O
synapses	S-GO
between	O
the	O
principal	O
output	O
neurons	O
(	O
mitral	O
cells	O
)	O
and	O
local	O
inhibitory	O
neurons	O
(	O
granule	O
cells	O
)	O
of	O
the	O
olfactory	O
bulb	O
.	O

In	O
these	O
distinct	O
synapses	S-GO
,	O
lateral	O
and	O
recurrent	O
inhibition	O
mediated	O
by	O
the	O
gamma	O
-	O
aminobutyric	O
acid	O
-	O
A	O
system	O
may	O
be	O
controlled	O
by	O
the	O
activity	O
of	O
the	O
closely	O
appositioned	O
glutamatergic	O
part	O
,	O
perhaps	O
triggering	O
increased	O
gamma	O
-	O
aminobutyric	O
acid	O
release	O
by	O
Ca2	O
+	O
influx	O
through	O
glutamate	O
-	O
gated	O
receptor	O
channels	O
(	O
[	O
38	O
]	O
;	O
see	O
also	O
[	O
39	O
]	O
)	O
.	O

Given	O
that	O
neuronal	O
circuits	O
underlying	O
odor	O
discrimination	O
,	O
as	O
well	O
as	O
olfactory	O
memory	O
,	O
rely	O
on	O
properties	O
of	O
fast	O
excitatory	O
neurotransmission	O
mediated	O
by	O
alpha	O
-	O
amino	O
-	O
3	O
-	O
hydroxy	O
-	O
5	O
-	O
methyl	O
-	O
4	O
-	O
isoxazolepropionate	O
receptors	O
(	O
AMPARs	O
)	O
,	O
we	O
sought	O
to	O
alter	O
,	O
by	O
genetic	O
means	O
,	O
the	O
specific	O
functional	O
contribution	O
of	O
alpha	O
-	O
amino	O
-	O
3	O
-	O
hydroxy	O
-	O
5	O
-	O
methyl	O
-	O
4	O
-	O
isoxazolepropionate	O
(	O
AMPA	O
)	O
channels	O
containing	O
the	O
dominant	O
subunit	O
GluR	O
-	O
B	O
.	O

Of	O
the	O
four	O
AMPAR	O
constituents	O
,	O
GluR	O
-	O
A	O
to	O
D	O
(	O
GluR1	O
to	O
4	O
)	O
,	O
which	O
form	O
tetrameric	O
channels	O
with	O
different	O
binary	O
subunit	O
combinations	O
,	O
GluR	O
-	O
B	O
is	O
contained	O
in	O
the	O
majority	O
of	O
AMPARs	O
.	O

GluR	O
-	O
B	O
is	O
critically	O
involved	O
in	O
the	O
formation	O
and	O
trafficking	O
of	O
AMPARs	O
,	O
and	O
dominates	O
their	O
ion	O
conductance	O
and	O
gating	O
properties	O
[	O
40	O
-	O
46	O
]	O
.	O

Notably	O
,	O
the	O
normally	O
low	O
Ca2	O
+	O
permeability	O
of	O
AMPA	O
channels	O
in	O
principal	O
neurons	O
is	O
solely	O
mediated	O
by	O
GluR	O
-	O
B	O
,	O
due	O
to	O
a	O
unique	O
arginine	O
residue	O
(	O
R587	O
)	O
in	O
the	O
functionally	O
critical	O
glutamine	O
/	O
arginine	O
(	O
Q	O
/	O
R	O
)	O
site	O
of	O
the	O
pore	O
-	O
forming	O
segment	O
M2	O
[	O
44	O
,	O
47	O
,	O
48	O
]	O
,	O
resulting	O
from	O
RNA	O
editing	O
of	O
GluR	O
-	O
B	O
pre	O
-	O
mRNA	O
(	O
[	O
49	O
]	O
;	O
reviewed	O
in	O
[	O
50	O
]	O
)	O
.	O

Hence	O
,	O
either	O
GluR	O
-	O
B	O
deficiency	O
,	O
or	O
the	O
expression	O
of	O
Q	O
/	O
R	O
site	O
-	O
unedited	O
GluR	O
-	O
B	O
with	O
a	O
glutamine	O
residue	O
at	O
the	O
critical	O
channel	O
site	O
,	O
leads	O
to	O
increased	O
Ca2	O
+	O
permeability	O
of	O
AMPA	O
channels	O
,	O
as	O
amply	O
demonstrated	O
in	O
gene	O
-	O
targeted	O
mice	O
[	O
51	O
,	O
53	O
,	O
58	O
,	O
60	O
]	O
.	O

Thus	O
,	O
the	O
absence	O
of	O
GluR	O
-	O
B	O
,	O
or	O
the	O
expression	O
of	O
GluR	O
-	O
B	O
(	O
Q	O
)	O
in	O
the	O
olfactory	O
bulb	O
,	O
may	O
generate	O
increased	O
inhibition	O
in	O
mitral	O
cells	O
.	O

Moreover	O
,	O
the	O
ablation	O
of	O
GluR	O
-	O
B	O
,	O
but	O
also	O
changes	O
in	O
the	O
extent	O
of	O
Q	O
/	O
R	O
site	O
editing	O
of	O
GluR	O
-	O
B	O
,	O
can	O
alter	O
the	O
strength	O
of	O
excitatory	B-GO
synaptic	E-GO
transmission	O
in	O
the	O
genetically	O
addressed	O
neuronal	O
populations	O
[	O
51	O
,	O
58	O
,	O
60	O
]	O
,	O
thus	O
potentially	O
shifting	O
the	O
balance	O
of	O
excitatory	O
and	O
inhibitory	O
transmission	O
in	O
the	O
affected	O
circuits	O
.	O

Similarly	O
,	O
changes	O
in	O
synaptic	S-GO
plasticity	O
due	O
to	O
Ca2	O
+	O
-	O
permeable	O
AMPARs	O
[	O
51	O
,	O
52	O
,	O
60	O
]	O
,	O
e	O
.	O
g	O
.	O
,	O
in	O
piriform	O
cortex	O
,	O
might	O
alter	O
odor	O
memorization	O
processes	O
.	O

Thus	O
,	O
alterations	O
of	O
AMPAR	O
properties	O
in	O
these	O
brain	O
regions	O
will	O
allow	O
investigation	O
and	O
possibly	O
separation	O
of	O
mechanisms	O
underlying	O
these	O
behavioral	O
traits	O
.	O

Concerning	O
this	O
intended	O
switch	O
in	O
AMPAR	O
properties	O
,	O
mice	O
lacking	O
all	O
GluR	O
-	O
B	O
,	O
however	O
,	O
show	O
a	O
widespread	O
impairment	O
in	O
behavior	O
,	O
including	O
lethargy	O
,	O
motor	O
coordination	O
problems	O
,	O
and	O
deficits	O
in	O
exploratory	O
activity	O
[	O
51	O
]	O
,	O
which	O
preclude	O
detailed	O
behavioral	O
analyses	O
.	O

Similarly	O
,	O
mice	O
expressing	O
(	O
in	O
the	O
entire	O
brain	O
)	O
a	O
substantial	O
part	O
of	O
the	O
GluR	O
-	O
B	O
population	O
in	O
the	O
Q	O
/	O
R	O
site	O
-	O
unedited	O
form	O
become	O
seizure	O
-	O
prone	O
and	O
die	O
prematurely	O
[	O
53	O
]	O
.	O

Some	O
of	O
these	O
problems	O
can	O
be	O
partially	O
overcome	O
by	O
use	O
of	O
spatially	O
and	O
temporally	O
restricted	O
expression	O
systems	O
[	O
54	O
-	O
56	O
]	O
,	O
in	O
particular	O
the	O
Cre	O
-	O
lox	O
system	O
,	O
with	O
Cre	O
-	O
recombinase	O
expression	O
in	O
defined	O
brain	O
areas	O
of	O
gene	O
-	O
targeted	O
mice	O
carrying	O
GluR	O
-	O
B	O
alleles	O
marked	O
by	O
loxP	O
sites	O
for	O
Cre	O
-	O
mediated	O
recombination	O
[	O
55	O
,	O
57	O
]	O
.	O

Indeed	O
,	O
restricting	O
the	O
expression	O
of	O
Q	O
/	O
R	O
site	O
-	O
unedited	O
GluR	O
-	O
B	O
to	O
forebrain	O
resulted	O
in	O
almost	O
normal	O
lifespan	O
and	O
an	O
only	O
weakly	O
seizure	O
-	O
prone	O
phenotype	O
[	O
58	O
]	O
.	O

Mice	O
with	O
forebrain	O
-	O
specific	O
GluR	O
-	O
B	O
depletion	O
appeared	O
almost	O
completely	O
normal	O
throughout	O
life	O
with	O
no	O
developmental	O
abnormalities	O
,	O
thus	O
permitting	O
a	O
detailed	O
,	O
quantitative	O
investigation	O
of	O
olfactory	O
behavior	O
.	O

To	O
allow	O
for	O
the	O
mechanistic	O
separation	O
of	O
olfactory	O
learning	O
,	O
discrimination	O
,	O
and	O
memory	O
,	O
we	O
exploited	O
a	O
well	O
-	O
known	O
phenomenon	O
of	O
transgenes	O
,	O
which	O
concerns	O
heterogeneous	O
expression	O
among	O
different	O
founder	O
lines	O
and	O
even	O
among	O
genetically	O
identical	O
individuals	O
of	O
a	O
given	O
line	O
.	O

Although	O
such	O
"	O
mosaic	O
"	O
expression	O
is	O
usually	O
undesired	O
,	O
here	O
we	O
took	O
advantage	O
of	O
it	O
by	O
ablating	O
GluR	O
-	O
B	O
via	O
gene	O
-	O
targeted	O
,	O
floxed	O
GluR	O
-	O
B	O
alleles	O
with	O
the	O
help	O
of	O
a	O
transgenic	O
mouse	O
line	O
with	O
variegated	O
Cre	O
expression	O
in	O
forebrain	O
.	O

By	O
correlating	O
GluR	O
-	O
B	O
levels	O
in	O
olfaction	O
-	O
related	O
brain	O
regions	O
with	O
quantitative	O
behavioral	O
data	O
,	O
we	O
investigated	O
the	O
dependence	O
on	O
GluR	O
-	O
B	O
of	O
olfactory	O
discrimination	O
and	O
memory	O
.	O

Moreover	O
,	O
to	O
delineate	O
the	O
brain	O
areas	O
involved	O
in	O
these	O
distinctive	O
olfactory	O
processes	O
we	O
used	O
transgenic	O
"	O
rescue	O
"	O
of	O
GluR	O
-	O
B	O
ablation	O
,	O
specifically	O
in	O
piriform	O
cortex	O
and	O
hippocampus	O
.	O

These	O
efforts	O
allowed	O
us	O
to	O
dissect	O
,	O
both	O
spatially	O
and	O
mechanistically	O
,	O
the	O
role	O
of	O
GluR	O
-	O
B	O
-	O
mediated	O
AMPAR	O
properties	O
in	O
selected	O
brain	O
regions	O
in	O
odor	O
learning	O
,	O
discrimination	O
,	O
and	O
memory	O
.	O

Results	O

GluR	O
-	O
B	O
(	O
Q	O
)	O
Expression	O
in	O
the	O
Forebrain	O
Increases	O
Olfactory	O
Learning	O
and	O
Discrimination	O

To	O
explore	O
the	O
role	O
of	O
fast	O
excitatory	O
neurotransmission	O
carried	O
by	O
GluR	O
-	O
B	O
-	O
containing	O
AMPA	O
channels	O
in	O
olfactory	O
processes	O
,	O
we	O
first	O
analyzed	O
mice	O
that	O
express	O
part	O
of	O
the	O
GluR	O
-	O
B	O
population	O
in	O
a	O
Q	O
/	O
R	O
site	O
-	O
unedited	O
form	O
(	O
Figure	O
1A	O
;	O
termed	O
"	O
GluR	O
-	O
B	O
Delta	O
ECS	O
:	O
FB	O
"	O
;	O
see	O
also	O
[	O
58	O
]	O
)	O
.	O

These	O
mice	O
carry	O
,	O
in	O
addition	O
to	O
a	O
wild	O
-	O
type	O
GluR	O
-	O
B	O
allele	O
,	O
a	O
gene	O
-	O
targeted	O
GluR	O
-	O
Bneo	O
allele	O
in	O
which	O
the	O
intronic	O
sequence	O
critical	O
for	O
GluR	O
-	O
B	O
pre	O
-	O
mRNA	O
editing	O
at	O
the	O
Q	O
/	O
R	O
site	O
is	O
replaced	O
by	O
a	O
floxed	O
TK	O
-	O
neo	O
gene	O
,	O
which	O
severely	O
reduces	O
splicing	O
of	O
the	O
modified	O
intron	O
and	O
hence	O
attenuates	O
the	O
expression	O
of	O
the	O
GluR	O
-	O
Bneo	O
allele	O
[	O
60	O
]	O
.	O

To	O
unsilence	O
the	O
attenuated	O
GluR	O
-	O
Bneo	O
allele	O
,	O
specifically	O
in	O
the	O
postnatal	O
forebrain	O
,	O
we	O
crossed	O
in	O
the	O
TgCre4	O
transgene	O
,	O
which	O
encodes	O
Cre	O
-	O
recombinase	O
and	O
is	O
driven	O
by	O
the	O
alpha	O
CaMKII	O
promoter	O
(	O
[	O
59	O
]	O
;	O
"	O
Camkcre4	O
"	O
)	O
.	O

Thus	O
,	O
Cre	O
-	O
recombinase	O
removes	O
in	O
forebrain	O
neurons	O
the	O
intronic	O
TK	O
-	O
neo	O
gene	O
,	O
leading	O
to	O
the	O
active	O
GluR	O
-	O
B	O
Delta	O
ECS	O
allele	O
for	O
Q	O
/	O
R	O
site	O
-	O
unedited	O
GluR	O
-	O
B	O
(	O
Q	O
)	O
subunits	O
(	O
Figures	O
1	O
and	O
S1	O
)	O
.	O

As	O
expected	O
[	O
53	O
,	O
60	O
]	O
,	O
also	O
in	O
mice	O
expressing	O
postnatally	O
forebrain	O
-	O
specific	O
Q	O
/	O
R	O
site	O
-	O
unedited	O
GluR	O
-	O
B	O
(	O
Q	O
)	O
subunits	O
,	O
Ca2	O
+	O
permeability	O
through	O
AMPAR	O
was	O
increased	O
and	O
AMPAR	O
currents	O
showed	O
rectification	O
(	O
[	O
58	O
]	O
and	O
unpublished	O
data	O
)	O
.	O

GluR	O
-	O
B	O
Delta	O
ECS	O
:	O
FB	O
mice	O
had	O
,	O
in	O
contrast	O
to	O
mice	O
expressing	O
GluR	O
-	O
B	O
(	O
Q	O
)	O
globally	O
,	O
a	O
prolonged	O
lifespan	O
and	O
no	O
severe	O
developmental	O
alterations	O
.	O

They	O
were	O
however	O
,	O
still	O
seizure	O
-	O
prone	O
[	O
58	O
]	O
,	O
and	O
hence	O
behavioral	O
training	O
was	O
restricted	O
to	O
short	O
periods	O
of	O
time	O
.	O

We	O
trained	O
six	O
GluR	O
-	O
B	O
Delta	O
ECS	O
:	O
FB	O
mice	O
and	O
six	O
littermate	O
controls	O
on	O
one	O
odor	O
pair	O
in	O
an	O
automated	O
go	O
/	O
no	O
-	O
go	O
olfactory	O
conditioning	O
task	O
[	O
3	O
,	O
61	O
]	O
.	O

In	O
this	O
task	O
,	O
water	O
-	O
deprived	O
mice	O
are	O
trained	O
to	O
distinguish	O
a	O
water	O
-	O
rewarded	O
odor	O
(	O
S	O
+	O
)	O
and	O
an	O
unrewarded	O
odor	O
(	O
S	O
-	O
)	O
by	O
their	O
licking	O
response	O
(	O
Figure	O
1B	O
)	O
.	O

Both	O
GluR	O
-	O
B	O
Delta	O
ECS	O
:	O
FB	O
and	O
control	O
mice	O
acquired	O
the	O
"	O
simple	O
"	O
task	O
to	O
discriminate	O
between	O
the	O
monomolecular	O
odors	O
amylacetate	O
and	O
ethylbutyrate	O
(	O
percentage	O
correct	O
>	O
70	O
%	O
after	O
400	O
trials	O
)	O
.	O

Strikingly	O
,	O
GluR	O
-	O
B	O
Delta	O
ECS	O
:	O
FB	O
mice	O
showed	O
more	O
rapid	O
learning	O
and	O
enhanced	O
discrimination	O
capabilities	O
(	O
Figure	O
1C	O
,	O
group	O
effect	O
:	O
F	O
(	O
1	O
,	O
10	O
)	O
=	O
10	O
.	O
2	O
,	O
p	O
<	O
0	O
.	O
01	O
)	O
.	O

This	O
was	O
confirmed	O
by	O
fitting	O
linear	O
trend	O
lines	O
to	O
the	O
initial	O
part	O
of	O
the	O
learning	O
curve	O
(	O
slope	O
difference	O
:	O
p	O
<	O
0	O
.	O
05	O
;	O
see	O
Materials	O
and	O
Methods	O
)	O
.	O

The	O
training	O
system	O
employed	O
allows	O
for	O
careful	O
monitoring	O
of	O
head	O
positions	O
[	O
3	O
]	O
.	O

For	O
rewarded	O
trials	O
(	O
Figure	O
1D	O
,	O
green	O
)	O
,	O
already	O
weakly	O
trained	O
animals	O
kept	O
their	O
head	O
in	O
the	O
sampling	O
port	O
(	O
large	O
tube	O
in	O
Figure	O
1B	O
)	O
during	O
the	O
entire	O
2	O
-	O
s	O
trial	O
,	O
whereas	O
for	O
unrewarded	O
trials	O
the	O
head	O
is	O
retracted	O
quickly	O
(	O
Figure	O
1D	O
,	O
red	O
)	O
.	O

The	O
difference	O
of	O
these	O
two	O
curves	O
(	O
Figure	O
1E	O
,	O
black	O
)	O
is	O
a	O
very	O
sensitive	O
assay	O
for	O
discrimination	O
performance	O
;	O
the	O
fitted	O
maximum	O
of	O
this	O
curve	O
(	O
Figure	O
1E	O
,	O
blue	O
)	O
is	O
referred	O
to	O
as	O
the	O
"	O
discrimination	O
index	O
"	O
in	O
the	O
remainder	O
of	O
the	O
paper	O
and	O
is	O
again	O
strongly	O
improved	O
for	O
GluR	O
-	O
B	O
Delta	O
ECS	O
:	O
FB	O
mice	O
,	O
compared	O
with	O
controls	O
(	O
Figure	O
1F	O
;	O
group	O
effect	O
:	O
F	O
(	O
1	O
,	O
10	O
)	O
=	O
11	O
.	O
7	O
,	O
p	O
<	O
0	O
.	O
01	O
)	O
.	O

This	O
was	O
not	O
due	O
to	O
general	O
motor	O
performance	O
,	O
attention	O
,	O
or	O
motivation	O
changes	O
,	O
as	O
both	O
the	O
intertrial	O
interval	O
(	O
group	O
effect	O
:	O
F	O
(	O
1	O
,	O
10	O
)	O
=	O
0	O
.	O
56	O
,	O
p	O
>	O
0	O
.	O
4	O
)	O
and	O
the	O
overall	O
licking	O
frequency	O
(	O
group	O
effect	O
:	O
F	O
(	O
1	O
,	O
10	O
)	O
=	O
0	O
.	O
72	O
,	O
p	O
>	O
0	O
.	O
4	O
)	O
were	O
unaffected	O
.	O

Thus	O
,	O
expression	O
of	O
Ca2	O
+	O
-	O
permeable	O
AMPARs	O
in	O
forebrain	O
areas	O
,	O
including	O
the	O
olfactory	O
bulb	O
,	O
resulted	O
in	O
more	O
rapid	O
odor	O
learning	O
and	O
enhanced	O
olfactory	O
discrimination	O
.	O

GluR	O
-	O
B	O
Delta	O
FB	O
Mice	O
Exhibit	O
Increased	O
Olfactory	O
Discrimination	O
Performance	O

To	O
ascertain	O
if	O
enhanced	O
olfactory	O
learning	O
and	O
odor	O
discrimination	O
may	O
indeed	O
correlate	O
with	O
the	O
increased	O
Ca2	O
+	O
permeability	O
of	O
AMPA	O
channels	O
in	O
the	O
Q	O
/	O
R	O
site	O
-	O
unedited	O
form	O
,	O
we	O
next	O
analyzed	O
GluR	O
-	O
B	O
Delta	O
FB	O
mice	O
,	O
which	O
lack	O
GluR	O
-	O
B	O
in	O
forebrain	O
.	O

This	O
specific	O
ablation	O
was	O
generated	O
by	O
forebrain	O
-	O
selective	O
TgCre4	O
expression	O
(	O
[	O
59	O
]	O
"	O
Camkcre4	O
"	O
)	O
in	O
gene	O
-	O
targeted	O
GluR	O
-	O
B2lox	O
mice	O
carrying	O
,	O
in	O
both	O
GluR	O
-	O
B	O
alleles	O
,	O
a	O
floxed	O
exon	O
11	O
(	O
Figure	O
2A	O
)	O
.	O

The	O
specific	O
GluR	O
-	O
B	O
depletion	O
in	O
GluR	O
-	O
B	O
Delta	O
FB	O
mice	O
can	O
be	O
monitored	O
by	O
immunohistochemistry	O
(	O
see	O
below	O
)	O
and	O
immunoblotting	O
.	O

In	O
quantitative	O
immunoblot	O
analyses	O
,	O
we	O
found	O
GluR	O
-	O
B	O
levels	O
reduced	O
to	O
28	O
+/-	O
7	O
%	O
,	O
29	O
+/-	O
8	O
%	O
,	O
and	O
52	O
+/-	O
9	O
%	O
(	O
+/-	O
SEM	O
;	O
n	O
=	O
10	O
)	O
in	O
the	O
hippocampus	O
,	O
cortical	O
areas	O
,	O
and	O
olfactory	O
bulb	O
,	O
respectively	O
,	O
relative	O
to	O
GluR	O
-	O
B	O
levels	O
in	O
GluR	O
-	O
B2lox	O
littermate	O
controls	O
.	O

In	O
the	O
absence	O
of	O
GluR	O
-	O
B	O
,	O
the	O
electrophysiological	O
properties	O
of	O
AMPA	O
channels	O
become	O
similar	O
to	O
those	O
with	O
GluR	O
-	O
B	O
/	O
GluR	O
-	O
B	O
(	O
Q	O
)	O
switch	O
[	O
51	O
]	O
showing	O
strong	O
rectification	O
and	O
increased	O
Ca2	O
+	O
permeability	O
through	O
AMPA	O
channels	O
(	O
unpublished	O
data	O
)	O
.	O

However	O
,	O
GluR	O
-	O
B	O
depletion	O
is	O
not	O
lethal	O
and	O
does	O
not	O
produce	O
seizures	O
.	O

In	O
addition	O
,	O
in	O
contrast	O
to	O
the	O
complete	O
GluR	O
-	O
B	O
knockouts	O
,	O
mice	O
with	O
forebrain	O
-	O
specific	O
GluR	O
-	O
B	O
depletion	O
appeared	O
normal	O
throughout	O
life	O
with	O
no	O
developmental	O
abnormalities	O
,	O
or	O
difference	O
in	O
body	O
size	O
and	O
weight	O
in	O
adulthood	O
(	O
wild	O
-	O
type	O
:	O
31	O
.	O
0	O
g	O
+/-	O
1	O
.	O
2	O
;	O
GluR	O
-	O
B	O
Delta	O
FB	O
:	O
28	O
.	O
4	O
+/-	O
0	O
.	O
9	O
;	O
each	O
n	O
=	O
10	O
)	O
.	O

Exploratory	O
activity	O
in	O
an	O
open	O
field	O
task	O
was	O
slightly	O
increased	O
in	O
GluR	O
-	O
B	O
Delta	O
FB	O
mice	O
(	O
3	O
,	O
480	O
cm	O
+/-	O
180	O
,	O
n	O
=	O
11	O
)	O
,	O
compared	O
with	O
wild	O
-	O
type	O
littermates	O
(	O
2	O
,	O
512	O
cm	O
+/-	O
96	O
,	O
n	O
=	O
12	O
,	O
p	O
<	O
0	O
.	O
01	O
)	O
.	O

Motor	O
coordination	O
measured	O
in	O
an	O
accelerating	O
rotarod	O
was	O
somewhat	O
impaired	O
in	O
the	O
mutant	O
mice	O
(	O
wild	O
-	O
type	O
:	O
156	O
s	O
+/-	O
37	O
,	O
n	O
=	O
6	O
;	O
GluR	O
-	O
B	O
Delta	O
FB	O
:	O
37	O
s	O
+/-	O
10	O
,	O
n	O
=	O
6	O
;	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O

Tests	O
in	O
the	O
dark	O
/	O
light	O
box	O
revealed	O
increased	O
anxiety	O
of	O
GluR	O
-	O
B	O
Delta	O
FB	O
mice	O
(	O
latency	O
of	O
first	O
exit	O
:	O
wild	O
-	O
type	O
[	O
17	O
s	O
+/-	O
3	O
]	O
,	O
GluR	O
-	O
B	O
Delta	O
FB	O
[	O
97	O
s	O
+/-	O
42	O
]	O
,	O
p	O
=	O
0	O
.	O
047	O
;	O
compartment	O
changes	O
:	O
wild	O
-	O
type	O
[	O
17	O
s	O
+/-	O
3	O
]	O
,	O
GluR	O
-	O
B	O
Delta	O
FB	O
[	O
7	O
+/-	O
2	O
]	O
,	O
p	O
<	O
0	O
.	O
05	O
;	O
time	O
spent	O
in	O
lit	O
compartment	O
:	O
wild	O
-	O
type	O
[	O
103	O
s	O
+/-	O
10	O
]	O
,	O
GluR	O
-	O
B	O
Delta	O
FB	O
[	O
59	O
s	O
+/-	O
19	O
]	O
,	O
p	O
=	O
0	O
.	O
051	O
;	O
each	O
n	O
=	O
6	O
)	O
.	O

Hence	O
,	O
unlike	O
the	O
complete	O
GluR	O
-	O
B	O
knockouts	O
,	O
GluR	O
-	O
B	O
Delta	O
FB	O
mice	O
show	O
only	O
very	O
minor	O
changes	O
in	O
general	O
activity	O
and	O
no	O
sign	O
of	O
any	O
major	O
developmental	O
disturbance	O
,	O
thus	O
allowing	O
detailed	O
,	O
quantitative	O
behavioral	O
investigations	O
.	O

If	O
the	O
GluR	O
-	O
B	O
/	O
GluR	O
-	O
B	O
(	O
Q	O
)	O
switch	O
-	O
induced	O
alterations	O
in	O
the	O
Ca2	O
+	O
permeability	O
of	O
the	O
AMPA	O
channels	O
are	O
linked	O
to	O
enhanced	O
odor	O
discrimination	O
and	O
learning	O
,	O
the	O
depletion	O
of	O
the	O
GluR	O
-	O
B	O
subunit	O
should	O
lead	O
to	O
a	O
similar	O
phenotypic	O
readout	O
.	O

We	O
therefore	O
trained	O
nine	O
GluR	O
-	O
B	O
Delta	O
FB	O
mice	O
and	O
nine	O
littermate	O
controls	O
in	O
the	O
same	O
automated	O
associative	O
go	O
/	O
no	O
-	O
go	O
olfactory	O
conditioning	O
task	O
described	O
above	O
.	O

To	O
cover	O
even	O
small	O
phenotypic	O
changes	O
in	O
olfaction	O
,	O
we	O
tested	O
different	O
odor	O
pairs	O
,	O
"	O
simple	O
"	O
monomolecular	O
odors	O
and	O
"	O
difficult	O
"	O
binary	O
mixtures	O
[	O
3	O
]	O
.	O

After	O
habituation	O
,	O
GluR	O
-	O
B	O
Delta	O
FB	O
and	O
control	O
mice	O
were	O
trained	O
to	O
discriminate	O
between	O
the	O
"	O
simple	O
"	O
monomolecular	O
odors	O
amylacetate	O
and	O
ethylbutyrate	O
,	O
and	O
subsequently	O
additionally	O
on	O
a	O
"	O
difficult	O
"	O
discrimination	O
task	O
consisting	O
of	O
similar	O
binary	O
mixtures	O
of	O
cineol	O
and	O
eugenol	O
;	O
and	O
finally	O
again	O
on	O
a	O
"	O
simple	O
"	O
discrimination	O
task	O
with	O
the	O
monomolecular	O
odors	O
pelargonic	O
and	O
valeric	O
acid	O
.	O

Similar	O
to	O
GluR	O
-	O
B	O
Delta	O
ECS	O
:	O
FB	O
,	O
GluR	O
-	O
B	O
Delta	O
FB	O
mice	O
also	O
showed	O
enhanced	O
learning	O
and	O
discrimination	O
compared	O
with	O
controls	O
(	O
Figure	O
2B	O
;	O
group	O
effect	O
:	O
F	O
(	O
1	O
,	O
16	O
)	O
=	O
6	O
.	O
55	O
;	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O

Increased	O
discrimination	O
performance	O
is	O
expected	O
to	O
show	O
more	O
pronounced	O
effects	O
for	O
closely	O
related	O
odors	O
because	O
of	O
the	O
more	O
challenging	O
"	O
difficult	O
"	O
discrimination	O
task	O
that	O
is	O
closer	O
to	O
the	O
psychophysical	O
limits	O
of	O
the	O
system	O
[	O
3	O
,	O
4	O
]	O
.	O

Consistent	O
with	O
this	O
notion	O
,	O
differences	O
between	O
GluR	O
-	O
B	O
Delta	O
FB	O
and	O
control	O
mice	O
were	O
not	O
only	O
larger	O
if	O
the	O
detailed	O
sampling	O
pattern	O
and	O
discrimination	O
index	O
were	O
investigated	O
(	O
Figure	O
2C	O
and	O
2D	O
,	O
group	O
effect	O
:	O
F	O
(	O
1	O
,	O
16	O
)	O
=	O
29	O
.	O
5	O
;	O
p	O
<	O
10	O
-	O
4	O
)	O
,	O
but	O
in	O
particular	O
for	O
the	O
discrimination	O
of	O
binary	O
mixtures	O
with	O
similar	O
composition	O
(	O
group	O
effect	O
:	O
F	O
(	O
1	O
,	O
16	O
)	O
=	O
27	O
.	O
8	O
;	O
p	O
<	O
10	O
-	O
4	O
for	O
the	O
mixture	O
;	O
FAA	O
EB	O
(	O
1	O
,	O
16	O
)	O
=	O
7	O
.	O
0	O
;	O
p	O
=	O
0	O
.	O
02	O
,	O
and	O
FPel	O
Val	O
(	O
1	O
,	O
16	O
)	O
=	O
5	O
.	O
8	O
;	O
p	O
=	O
0	O
.	O
03	O
for	O
the	O
"	O
simple	O
"	O
discrimination	O
tasks	O
;	O
3	O
-	O
way	O
ANOVA	O
:	O
F	O
(	O
6	O
,	O
96	O
)	O
=	O
2	O
.	O
9	O
;	O
p	O
=	O
0	O
.	O
01	O
)	O
.	O

As	O
activity	O
,	O
measured	O
by	O
the	O
intertrial	O
interval	O
,	O
was	O
not	O
significantly	O
different	O
between	O
genotypes	O
(	O
F	O
(	O
1	O
,	O
16	O
)	O
=	O
3	O
.	O
1	O
;	O
p	O
=	O
0	O
.	O
1	O
)	O
,	O
and	O
analysis	O
of	O
the	O
lick	O
frequency	O
showed	O
a	O
tendency	O
to	O
reduced	O
motivation	O
of	O
GluR	O
-	O
B	O
Delta	O
FB	O
mice	O
in	O
this	O
particular	O
task	O
(	O
F	O
(	O
1	O
,	O
16	O
)	O
=	O
9	O
.	O
2	O
;	O
p	O
<	O
0	O
.	O
01	O
)	O
,	O
we	O
conclude	O
that	O
depletion	O
of	O
GluR	O
-	O
B	O
in	O
forebrain	O
areas	O
indeed	O
resulted	O
in	O
increased	O
olfactory	O
learning	O
and	O
discrimination	O
performances	O
,	O
rather	O
than	O
motivational	O
alterations	O
.	O

To	O
assess	O
olfaction	O
specificity	O
,	O
we	O
trained	O
ten	O
GluR	O
-	O
B	O
Delta	O
FB	O
mice	O
and	O
ten	O
controls	O
in	O
a	O
nonolfactory	O
hippocampus	O
-	O
dependent	O
spatial	O
learning	O
task	O
(	O
elevated	O
Y	O
-	O
maze	O
)	O
.	O

Performance	O
in	O
this	O
task	O
was	O
not	O
improved	O
compared	O
with	O
controls	O
(	O
Figure	O
S2	O
)	O
;	O
on	O
the	O
contrary	O
,	O
the	O
acquisition	O
of	O
this	O
task	O
was	O
slightly	O
impaired	O
,	O
allowing	O
the	O
conclusion	O
that	O
the	O
enhanced	O
olfactory	O
discrimination	O
performance	O
is	O
likely	O
to	O
be	O
specific	O
to	O
the	O
sense	O
of	O
smell	O
and	O
possibly	O
related	O
to	O
enhanced	O
discrimination	O
capability	O
,	O
rather	O
than	O
a	O
general	O
increase	O
in	O
alertness	O
.	O

Furthermore	O
,	O
enhancement	O
in	O
odor	O
discrimination	O
in	O
both	O
GluR	O
-	O
B	O
Delta	O
ECS	O
:	O
FB	O
and	O
GluR	O
-	O
B	O
Delta	O
FB	O
mice	O
makes	O
it	O
likely	O
that	O
improvement	O
in	O
this	O
task	O
results	O
from	O
the	O
common	O
AMPAR	O
property	O
change	O
mediated	O
by	O
the	O
depletion	O
of	O
GluR	O
-	O
B	O
and	O
the	O
lack	O
of	O
the	O
Q	O
/	O
R	O
site	O
-	O
edited	O
GluR	O
-	O
B	O
subunit	O
,	O
both	O
resulting	O
in	O
Ca2	O
+	O
-	O
permeable	O
AMPARs	O
.	O

Thus	O
,	O
this	O
suggests	O
that	O
increased	O
Ca2	O
+	O
influx	O
via	O
AMPARs	O
leads	O
to	O
enhanced	O
olfactory	O
learning	O
and	O
discrimination	O
.	O

Olfactory	O
Memory	O
Is	O
Significantly	O
Decreased	O
but	O
Highly	O
Variable	O
in	O
GluR	O
-	O
B	O
Delta	O
FB	O
Mice	O

To	O
capture	O
the	O
full	O
extent	O
of	O
the	O
role	O
of	O
Ca2	O
+	O
-	O
permeable	O
AMPARs	O
in	O
olfactory	O
behavior	O
,	O
we	O
next	O
assessed	O
the	O
effects	O
of	O
altered	O
AMPA	O
channels	O
on	O
olfactory	O
memory	O
.	O

To	O
probe	O
olfactory	O
memory	O
in	O
GluR	O
-	O
B	O
Delta	O
FB	O
mice	O
,	O
six	O
days	O
after	O
the	O
end	O
of	O
the	O
first	O
training	O
phase	O
for	O
odor	O
discrimination	O
(	O
amylacetate	O
versus	O
ethylbutyrate	O
)	O
,	O
the	O
training	O
trials	O
for	O
the	O
third	O
odor	O
pair	O
(	O
pelargonic	O
versus	O
valeric	O
acid	O
)	O
were	O
interleaved	O
with	O
unrewarded	O
trials	O
in	O
which	O
amylacetate	O
or	O
ethylbutyrate	O
were	O
again	O
presented	O
(	O
black	O
bar	O
in	O
Figure	O
2C	O
)	O
.	O

Whereas	O
control	O
mice	O
reliably	O
responded	O
only	O
to	O
the	O
previously	O
rewarded	O
odor	O
(	O
memory	O
of	O
86	O
+/-	O
8	O
%	O
,	O
mean	O
+/-	O
SD	O
,	O
n	O
=	O
9	O
,	O
Figure	O
2E	O
)	O
,	O
GluR	O
-	O
B	O
Delta	O
FB	O
mice	O
showed	O
reduced	O
olfactory	O
memory	O
(	O
69	O
+/-	O
16	O
%	O
,	O
n	O
=	O
9	O
,	O
p	O
<	O
0	O
.	O
05	O
,	O
Mann	O
-	O
Whitney	O
)	O
.	O

Due	O
to	O
the	O
more	O
rapid	O
learning	O
observed	O
in	O
GluR	O
-	O
B	O
Delta	O
FB	O
,	O
one	O
could	O
speculate	O
that	O
a	O
decrease	O
in	O
olfactory	O
memory	O
might	O
simply	O
reflect	O
increased	O
extinction	O
.	O

However	O
,	O
extinction	O
levels	O
were	O
low	O
in	O
general	O
,	O
no	O
significant	O
group	O
-	O
trial	O
interaction	O
could	O
be	O
found	O
for	O
the	O
memory	O
trials	O
(	O
2	O
-	O
way	O
ANOVA	O
,	O
F	O
(	O
6	O
,	O
90	O
)	O
=	O
1	O
.	O
5	O
,	O
p	O
>	O
0	O
.	O
1	O
)	O
,	O
and	O
a	O
restriction	O
of	O
the	O
analysis	O
to	O
early	O
memory	O
trials	O
displayed	O
essentially	O
the	O
same	O
pattern	O
(	O
Figure	O
S3A	O
)	O
.	O

Thus	O
,	O
reduced	O
performance	O
in	O
the	O
probe	O
trials	O
is	O
not	O
due	O
to	O
increased	O
extinction	O
but	O
reflects	O
genuine	O
memory	O
impairment	O
.	O

Moreover	O
,	O
because	O
the	O
hippocampus	O
-	O
dependent	O
spatial	O
memory	O
after	O
-	O
task	O
acquisition	O
in	O
the	O
Y	O
-	O
maze	O
was	O
not	O
affected	O
(	O
Figure	O
S2	O
)	O
,	O
we	O
conclude	O
that	O
the	O
observed	O
olfactory	O
memory	O
deficit	O
is	O
rather	O
specific	O
for	O
olfaction	O
and	O
does	O
not	O
readily	O
generalize	O
to	O
other	O
modalities	O
.	O

While	O
the	O
improved	O
odor	O
discrimination	O
and	O
learning	O
behavior	O
showed	O
only	O
little	O
variability	O
,	O
the	O
significantly	O
impaired	O
memory	O
performance	O
observed	O
in	O
GluR	O
-	O
B	O
Delta	O
FB	O
mice	O
was	O
highly	O
variable	O
among	O
individual	O
animals	O
compared	O
with	O
control	O
littermates	O
(	O
Figure	O
2E	O
)	O
.	O

This	O
variability	O
in	O
olfactory	O
memory	O
was	O
reflected	O
in	O
the	O
level	O
and	O
extent	O
of	O
Cre	O
-	O
recombinase	O
expression	O
in	O
forebrain	O
of	O
transgenic	O
TgCre4	O
mice	O
,	O
as	O
visualized	O
by	O
Cre	O
-	O
activity	O
in	O
the	O
Cre	O
-	O
indicator	O
mouse	O
line	O
R26R	O
.	O

We	O
observed	O
that	O
onset	O
and	O
extent	O
of	O
Cre	O
-	O
recombinase	O
expression	O
in	O
different	O
forebrain	O
regions	O
varied	O
among	O
individual	O
TgCre4	O
mice	O
(	O
Figure	O
3A	O
)	O
,	O
which	O
could	O
also	O
be	O
directly	O
visualized	O
by	O
immunohistochemistry	O
with	O
a	O
Cre	O
-	O
antibody	S-GO
(	O
unpublished	O
data	O
)	O
.	O

As	O
this	O
variability	O
persisted	O
after	O
several	O
backcrosses	O
,	O
and	O
Southern	O
blot	O
analysis	O
revealed	O
no	O
differences	O
of	O
transgene	O
integration	O
or	O
number	O
among	O
animals	O
(	O
Figure	O
3B	O
)	O
,	O
it	O
could	O
not	O
be	O
attributed	O
to	O
genetic	O
differences	O
but	O
rather	O
to	O
epigenetic	O
mechanisms	O
.	O

Hence	O
,	O
we	O
hypothesized	O
that	O
the	O
variability	O
in	O
olfactory	O
memory	O
reflected	O
the	O
mosaicism	O
observed	O
in	O
the	O
transgenic	O
TgCre4	O
line	O
.	O

The	O
evaluation	O
of	O
regional	O
differences	O
in	O
expression	O
pattern	O
of	O
animals	O
with	O
robust	O
and	O
poor	O
olfactory	O
memory	O
could	O
then	O
be	O
applied	O
to	O
identify	O
brain	O
areas	O
responsible	O
for	O
the	O
observed	O
phenotypes	O
.	O

Olfactory	O
Memory	O
Correlates	O
with	O
Residual	O
GluR	O
-	O
B	O
Protein	O
Expression	O
in	O
GluR	O
-	O
B	O
Delta	O
FB	O
Mice	O

Thus	O
,	O
to	O
examine	O
whether	O
the	O
pronounced	O
variability	O
of	O
olfactory	O
memory	O
in	O
GluR	O
-	O
B	O
Delta	O
FB	O
mice	O
(	O
Figure	O
2E	O
)	O
reflects	O
variability	O
of	O
GluR	O
-	O
B	O
levels	O
in	O
GluR	O
-	O
B	O
Delta	O
FB	O
mice	O
,	O
we	O
analyzed	O
the	O
residual	O
amount	O
of	O
GluR	O
-	O
B	O
protein	O
in	O
mice	O
with	O
disparate	O
memory	O
performances	O
(	O
Figure	O
4A	O
-	O
C	O
)	O
.	O

Notably	O
,	O
mice	O
with	O
pronounced	O
memory	O
deficits	O
(	O
memory	O
<	O
70	O
%	O
)	O
showed	O
essentially	O
no	O
detectable	O
GluR	O
-	O
B	O
protein	O
in	O
hippocampus	O
,	O
amygdala	O
,	O
olfactory	O
bulb	O
,	O
and	O
piriform	O
cortex	O
(	O
n	O
=	O
2	O
,	O
Figure	O
4B	O
,	O
and	O
unpublished	O
data	O
)	O
,	O
but	O
mice	O
with	O
almost	O
complete	O
memory	O
displayed	O
substantial	O
residual	O
GluR	O
-	O
B	O
levels	O
in	O
all	O
brain	O
areas	O
investigated	O
(	O
n	O
=	O
2	O
,	O
Figure	O
4B	O
,	O
and	O
unpublished	O
data	O
)	O
.	O

To	O
quantify	O
the	O
relation	O
between	O
residual	O
GluR	O
-	O
B	O
protein	O
and	O
olfactory	O
memory	O
,	O
the	O
memory	O
experiment	O
was	O
repeated	O
with	O
nine	O
additional	O
GluR	O
-	O
B	O
Delta	O
FB	O
mice	O
and	O
two	O
GluR	O
-	O
B2lox	O
control	O
animals	O
(	O
indicated	O
with	O
shaded	O
symbols	O
in	O
Figure	O
4A	O
)	O
,	O
resulting	O
in	O
the	O
same	O
mean	O
,	O
variability	O
,	O
and	O
range	O
of	O
memory	O
performance	O
(	O
control	O
:	O
89	O
+/-	O
10	O
%	O
;	O
GluR	O
-	O
B	O
Delta	O
FB	O
:	O
63	O
+/-	O
14	O
%	O
)	O
.	O

Subsequently	O
,	O
protein	O
was	O
extracted	O
from	O
olfactory	O
bulbs	O
,	O
cortical	O
areas	O
,	O
and	O
hippocampi	O
from	O
each	O
mouse	O
,	O
and	O
GluR	O
-	O
B	O
protein	O
was	O
quantified	O
(	O
Figure	O
4C	O
)	O
.	O

The	O
summarized	O
correlations	O
are	O
depicted	O
in	O
Figure	O
4D	O
(	O
two	O
animals	O
were	O
used	O
for	O
immunofluorescent	O
analysis	O
that	O
yielded	O
the	O
same	O
results	O
as	O
in	O
the	O
first	O
experiment	O
)	O
.	O

Whereas	O
no	O
learning	O
or	O
discrimination	O
-	O
related	O
parameter	O
correlated	O
with	O
residual	O
protein	O
levels	O
(	O
Figure	O
4D	O
,	O
R2	O
<	O
0	O
.	O
3	O
)	O
,	O
a	O
strong	O
correlation	O
between	O
memory	O
and	O
GluR	O
-	O
B	O
protein	O
was	O
observed	O
in	O
hippocampus	O
(	O
Figure	O
4D	O
,	O
R2	O
=	O
0	O
.	O
72	O
,	O
p	O
<	O
0	O
.	O
003	O
,	O
n	O
=	O
10	O
)	O
and	O
cortical	O
areas	O
(	O
Figure	O
4D	O
,	O
R2	O
=	O
0	O
.	O
62	O
,	O
p	O
<	O
0	O
.	O
006	O
,	O
n	O
=	O
10	O
)	O
.	O

Only	O
a	O
weakly	O
significant	O
correlation	O
was	O
found	O
in	O
the	O
olfactory	O
bulb	O
(	O
Figure	O
4D	O
,	O
R2	O
=	O
0	O
.	O
48	O
,	O
p	O
=	O
0	O
.	O
03	O
,	O
n	O
=	O
10	O
)	O
.	O

GluR	O
-	O
A	O
levels	O
were	O
unchanged	O
from	O
wild	O
-	O
type	O
,	O
indicating	O
that	O
compensatory	O
up	O
-	O
regulation	O
of	O
other	O
AMPAR	O
subunits	O
is	O
unlikely	O
(	O
GluR	O
-	O
A	O
levels	O
relative	O
to	O
control	O
:	O
1	O
.	O
02	O
+/-	O
0	O
.	O
05	O
,	O
mean	O
+/-	O
SEM	O
,	O
n	O
=	O
10	O
)	O
.	O

In	O
summary	O
,	O
mice	O
with	O
reduced	O
GluR	O
-	O
B	O
levels	O
in	O
forebrain	O
areas	O
showed	O
decreased	O
olfactory	O
memory	O
,	O
which	O
correlated	O
tightly	O
with	O
a	O
reduction	O
in	O
GluR	O
-	O
B	O
levels	O
in	O
the	O
hippocampus	O
and	O
cortical	O
areas	O
.	O

Enhanced	O
odor	O
learning	O
and	O
discrimination	O
,	O
on	O
the	O
other	O
hand	O
,	O
was	O
independent	O
of	O
residual	O
GluR	O
-	O
B	O
levels	O
in	O
the	O
olfactory	O
bulb	O
and	O
other	O
forebrain	O
areas	O
,	O
indicating	O
that	O
moderate	O
GluR	O
-	O
B	O
reductions	O
are	O
sufficient	O
to	O
saturate	O
enhanced	O
odor	O
learning	O
and	O
discrimination	O
.	O

Thus	O
,	O
although	O
both	O
are	O
mediated	O
by	O
alterations	O
in	O
the	O
AMPAR	O
subunit	O
GluR	O
-	O
B	O
,	O
due	O
to	O
the	O
qualitatively	O
different	O
dose	O
-	O
response	O
curves	O
,	O
the	O
phenotypes	O
regarding	O
olfactory	O
memory	O
,	O
and	O
olfactory	O
learning	O
/	O
discrimination	O
must	O
be	O
mechanistically	O
distinct	O
.	O

Partial	O
Rescue	O
of	O
Olfactory	O
Memory	O
Deficit	O
by	O
Selective	O
Transgenic	O
GluR	O
-	O
B	O
Expression	O
in	O
Hippocampus	O
and	O
Piriform	O
Cortex	O
in	O
GluR	O
-	O
B	O
Delta	O
FB	O
Mice	O

The	O
effect	O
of	O
selective	O
GluR	O
-	O
B	O
depletion	O
in	O
mice	O
indicated	O
that	O
GluR	O
-	O
B	O
-	O
containing	O
AMPARs	O
in	O
the	O
hippocampus	O
,	O
and	O
/	O
or	O
(	O
olfactory	O
)	O
cortex	O
are	O
likely	O
to	O
be	O
important	O
for	O
olfactory	O
memory	O
.	O

The	O
olfactory	O
memory	O
phenotype	O
could	O
be	O
due	O
to	O
depletion	O
of	O
GluR	O
-	O
B	O
in	O
olfactory	O
cortex	O
or	O
hippocampus	O
;	O
enhanced	O
learning	O
and	O
discrimination	O
capabilities	O
might	O
rather	O
be	O
evoked	O
by	O
AMPARs	O
lacking	O
GluR	O
-	O
B	O
in	O
the	O
olfactory	O
bulb	O
.	O

To	O
obtain	O
independent	O
evidence	O
for	O
this	O
spatial	O
and	O
mechanistic	O
dissection	O
of	O
the	O
roles	O
of	O
Ca2	O
+	O
-	O
permeable	O
AMPARs	O
,	O
we	O
expressed	O
by	O
transgenic	O
means	O
N	O
-	O
terminally	O
green	O
fluorescent	O
protein	O
(	O
GFP	O
)	O
-	O
tagged	O
GluR	O
-	O
B	O
specifically	O
in	O
hippocampus	O
and	O
piriform	O
cortex	O
of	O
GluR	O
-	O
B	O
Delta	O
FB	O
mice	O
(	O
Figure	O
5A	O
and	O
5B	O
)	O
.	O

In	O
accordance	O
with	O
the	O
proposed	O
region	O
-	O
dependence	O
,	O
we	O
expected	O
that	O
additional	O
GluR	O
-	O
B	O
subunits	O
in	O
hippocampus	O
and	O
/	O
or	O
piriform	O
cortex	O
improve	O
odor	O
memory	O
but	O
do	O
not	O
alter	O
odor	O
discrimination	O
performance	O
.	O

The	O
mouse	O
line	O
employed	O
for	O
this	O
purpose	O
,	O
termed	O
GluR	O
-	O
BRescue	O
,	O
had	O
the	O
genetic	O
background	O
of	O
GluR	O
-	O
B	O
Delta	O
FB	O
mice	O
but	O
additionally	O
carried	O
a	O
bidirectional	O
module	O
for	O
beta	O
-	O
galactosidase	O
and	O
GFPGluR	O
-	O
B	O
expression	O
,	O
responsive	O
to	O
the	O
tetracycline	O
-	O
controlled	O
transcriptional	O
transactivator	O
[	O
62	O
]	O
.	O

The	O
transactivator	O
was	O
under	O
the	O
control	O
of	O
a	O
modified	O
alpha	O
CaMKII	O
-	O
promoter	O
fragment	O
to	O
obtain	O
high	O
expression	O
selectivity	O
(	O
Figure	O
5A	O
;	O
see	O
also	O
Materials	O
and	O
Methods	O
)	O
.	O

The	O
transgenic	O
expression	O
level	O
of	O
GFPGluR	O
-	O
B	O
was	O
9	O
.	O
72	O
%	O
+/-	O
1	O
.	O
25	O
(	O
n	O
=	O
3	O
)	O
in	O
the	O
hippocampus	O
,	O
compared	O
with	O
endogenous	O
GluR	O
-	O
B	O
(	O
Figure	O
5C	O
and	O
5D	O
)	O
.	O

Analysis	O
of	O
beta	O
-	O
galactosidase	O
activity	O
and	O
GFPGluR	O
-	O
B	O
expression	O
in	O
brain	O
sections	O
of	O
GluR	O
-	O
BRescue	O
mice	O
revealed	O
expression	O
in	O
hippocampus	O
and	O
piriform	O
cortex	O
,	O
whereas	O
cortex	O
,	O
amygdala	O
,	O
and	O
striatum	O
only	O
rarely	O
showed	O
any	O
positive	O
cells	O
(	O
Figure	O
5B	O
)	O
.	O

Importantly	O
,	O
both	O
the	O
spatial	O
pattern	O
and	O
intensity	O
of	O
GFPGluR	O
-	O
B	O
expression	O
were	O
constant	O
among	O
all	O
GluR	O
-	O
BRescue	O
mice	O
analyzed	O
(	O
n	O
=	O
11	O
)	O
.	O

Olfactory	O
memory	O
experiments	O
with	O
GluR	O
-	O
BRescue	O
,	O
and	O
both	O
GluR	O
-	O
B	O
Delta	O
FB	O
and	O
GluR	O
-	O
B2lox	O
mice	O
as	O
controls	O
,	O
were	O
performed	O
as	O
described	O
above	O
(	O
indicated	O
with	O
shaded	O
symbols	O
in	O
Figure	O
6A	O
)	O
.	O

Memory	O
was	O
again	O
highly	O
reproducible	O
in	O
both	O
GluR	O
-	O
B	O
Delta	O
FB	O
(	O
66	O
+/-	O
12	O
%	O
;	O
n	O
=	O
4	O
)	O
and	O
GluR	O
-	O
B2lox	O
(	O
94	O
+/-	O
2	O
%	O
;	O
n	O
=	O
3	O
)	O
mice	O
,	O
compared	O
with	O
experiments	O
performed	O
earlier	O
(	O
Figures	O
2E	O
and	O
4A	O
)	O
.	O

Importantly	O
,	O
olfactory	O
memory	O
in	O
GluR	O
-	O
BRescue	O
mice	O
was	O
intermediate	O
(	O
75	O
+/-	O
15	O
%	O
,	O
n	O
=	O
8	O
)	O
,	O
below	O
GluR	O
-	O
B2lox	O
control	O
levels	O
,	O
but	O
better	O
than	O
in	O
GluR	O
-	O
B	O
Delta	O
FB	O
mice	O
.	O

Assessing	O
memory	O
under	O
extinction	O
-	O
free	O
condition	O
,	O
where	O
each	O
trial	O
was	O
rewarded	O
,	O
confirmed	O
again	O
that	O
the	O
memory	O
deficit	O
was	O
a	O
true	O
memory	O
deficit	O
and	O
not	O
due	O
to	O
increased	O
extinction	O
(	O
Figure	O
S3B	O
)	O
.	O

Data	O
from	O
the	O
experiments	O
described	O
in	O
Figures	O
2	O
and	O
4	O
were	O
combined	O
to	O
allow	O
statistical	O
comparison	O
(	O
Figure	O
6A	O
and	O
6B	O
)	O
.	O

In	O
summary	O
,	O
GluR	O
-	O
BRescue	O
mice	O
showed	O
both	O
enhanced	O
memory	O
performances	O
compared	O
with	O
GluR	O
-	O
B	O
Delta	O
FB	O
(	O
overall	O
ANOVA	O
:	O
F	O
(	O
2	O
,	O
41	O
)	O
=	O
13	O
.	O
6	O
,	O
p	O
<	O
10	O
-	O
4	O
;	O
memoryRescue	O
=	O
75	O
+/-	O
15	O
%	O
,	O
n	O
=	O
8	O
;	O
memory	O
Delta	O
FB	O
=	O
66	O
+/-	O
14	O
%	O
,	O
n	O
=	O
22	O
;	O
p	O
<	O
0	O
.	O
05	O
;	O
Figure	O
6A	O
)	O
,	O
but	O
were	O
still	O
impaired	O
relative	O
to	O
GluR	O
-	O
B2lox	O
controls	O
(	O
memory2lox	O
=	O
88	O
+/-	O
8	O
%	O
,	O
n	O
=	O
14	O
;	O
p	O
<	O
0	O
.	O
005	O
)	O
,	O
consistent	O
with	O
a	O
partial	O
rescue	O
of	O
the	O
memory	O
deficit	O
by	O
circumscribed	O
transgenic	O
GFPGluR	O
-	O
B	O
expression	O
in	O
hippocampus	O
and	O
piriform	O
cortex	O
.	O

Notably	O
,	O
the	O
partial	O
memory	O
is	O
in	O
numerical	O
agreement	O
with	O
the	O
predictions	O
from	O
the	O
protein	O
correlation	O
and	O
the	O
measurement	O
of	O
transgenic	O
protein	O
expression	O
(	O
see	O
predicted	O
memory	O
,	O
blue	O
line	O
,	O
in	O
Figure	O
6B	O
)	O
.	O

In	O
the	O
olfactory	O
memory	O
experiments	O
with	O
GluR	O
-	O
B	O
Delta	O
FB	O
animals	O
,	O
olfactory	O
memory	O
linearly	O
depended	O
on	O
GluR	O
-	O
B	O
expression	O
in	O
cortex	O
and	O
hippocampus	O
with	O
a	O
slope	O
of	O
9	O
.	O
1	O
+/-	O
2	O
.	O
5	O
%	O
(	O
cortex	O
)	O
and	O
8	O
.	O
9	O
+/-	O
2	O
.	O
0	O
%	O
(	O
hippocampus	O
)	O
increase	O
in	O
memory	O
per	O
10	O
%	O
increase	O
in	O
protein	O
(	O
Figure	O
4D	O
)	O
.	O

A	O
9	O
.	O
7	O
%	O
increase	O
in	O
GluR	O
-	O
B	O
in	O
these	O
brain	O
regions	O
,	O
as	O
achieved	O
by	O
GluR	O
-	O
BRescue	O
animals	O
(	O
Figure	O
5	O
)	O
,	O
is	O
thus	O
predicted	O
to	O
increase	O
olfactory	O
memory	O
by	O
approximately	O
9	O
%	O
throughout	O
the	O
heterogeneous	O
population	O
(	O
blue	O
line	O
in	O
Figure	O
6B	O
)	O
.	O

This	O
confirms	O
the	O
role	O
of	O
these	O
brain	O
areas	O
as	O
inferred	O
from	O
the	O
mosaic	O
expression	O
and	O
protein	O
correlation	O
analysis	O
described	O
above	O
(	O
Figure	O
4	O
)	O
.	O

However	O
,	O
odor	O
discrimination	O
(	O
measured	O
by	O
the	O
discrimination	O
index	O
as	O
in	O
Figures	O
1	O
,	O
2	O
,	O
and	O
4D	O
)	O
was	O
as	O
enhanced	O
as	O
in	O
GluR	O
-	O
B	O
Delta	O
FB	O
mice	O
(	O
0	O
.	O
79	O
+/-	O
0	O
.	O
05	O
,	O
mean	O
+/-	O
SEM	O
compared	O
with	O
0	O
.	O
76	O
+/-	O
0	O
.	O
02	O
,	O
p	O
>	O
0	O
.	O
7	O
,	O
Figure	O
6C	O
)	O
,	O
and	O
improved	O
relative	O
to	O
GluR	O
-	O
B2lox	O
controls	O
(	O
0	O
.	O
48	O
+/-	O
0	O
.	O
06	O
;	O
Figure	O
6C	O
;	O
overall	O
ANOVA	O
:	O
F	O
(	O
2	O
,	O
41	O
)	O
=	O
17	O
.	O
2	O
,	O
p	O
<	O
10	O
-	O
5	O
;	O
post	O
hoc	O
Newman	O
Keuls	O
:	O
p	O
<	O
10	O
-	O
3	O
)	O
,	O
as	O
expected	O
if	O
the	O
enhanced	O
discrimination	O
phenotype	O
is	O
due	O
to	O
Ca2	O
+	O
-	O
permeable	O
AMPARs	O
in	O
the	O
olfactory	O
bulb	O
and	O
unaffected	O
by	O
GluR	O
-	O
B	O
expression	O
in	O
piriform	O
cortex	O
or	O
hippocampus	O
.	O

Hence	O
,	O
transgenic	O
GluR	O
-	O
B	O
expression	O
,	O
specifically	O
in	O
the	O
piriform	O
cortex	O
and	O
hippocampus	O
in	O
the	O
GluR	O
-	O
B	O
knockout	O
background	O
,	O
rescues	O
the	O
odor	O
memory	O
deficit	O
but	O
leaves	O
enhanced	O
olfactory	O
discrimination	O
and	O
learning	O
unaltered	O
.	O

Discussion	O

Here	O
we	O
present	O
mechanistic	O
and	O
spatial	O
dissections	O
of	O
olfactory	O
discrimination	O
,	O
learning	O
,	O
and	O
memory	O
.	O

We	O
employed	O
gene	O
-	O
targeted	O
and	O
transgenic	O
mice	O
with	O
region	O
-	O
specific	O
expression	O
to	O
demonstrate	O
that	O
a	O
change	O
in	O
GluR	O
-	O
B	O
-	O
mediated	O
properties	O
of	O
AMPA	O
channels	O
in	O
alpha	O
CaMKII	O
-	O
expressing	O
neurons	O
of	O
mouse	O
forebrain	O
,	O
including	O
olfactory	O
bulb	O
mitral	O
and	O
granule	O
cells	O
,	O
enhances	O
olfactory	O
discrimination	O
and	O
learning	O
but	O
impairs	O
olfactory	O
memory	O
.	O

These	O
pertinent	O
olfactory	O
behaviors	O
were	O
assessed	O
in	O
a	O
go	O
/	O
no	O
-	O
go	O
operant	O
conditioning	O
task	O
,	O
which	O
provides	O
a	O
quantitative	O
,	O
robust	O
,	O
and	O
reproducible	O
behavioral	O
tool	O
[	O
3	O
]	O
.	O

We	O
observed	O
among	O
individual	O
mice	O
a	O
striking	O
variability	O
in	O
olfactory	O
memory	O
performance	O
but	O
not	O
in	O
odor	O
discrimination	O
.	O

This	O
variability	O
could	O
be	O
traced	O
to	O
epigenetic	O
variability	O
in	O
the	O
transgenic	O
expression	O
of	O
Cre	O
-	O
recombinase	O
,	O
which	O
mediated	O
recombination	O
within	O
loxP	O
-	O
flanked	O
segments	O
of	O
gene	O
-	O
targeted	O
alleles	O
for	O
the	O
dominant	O
AMPAR	O
subunit	O
GluR	O
-	O
B	O
,	O
and	O
hence	O
operated	O
the	O
switch	O
in	O
AMPAR	O
properties	O
toward	O
GluR	O
-	O
B	O
ablation	O
and	O
increased	O
Ca2	O
+	O
permeability	O
.	O

In	O
contrast	O
to	O
variable	O
memory	O
,	O
olfactory	O
discrimination	O
and	O
learning	O
performances	O
appeared	O
already	O
saturated	O
by	O
even	O
moderate	O
extents	O
of	O
Cre	O
expression	O
,	O
and	O
hence	O
moderate	O
changes	O
in	O
AMPAR	O
properties	O
.	O

The	O
subsequent	O
transgene	O
-	O
driven	O
re	O
-	O
introduction	O
of	O
GluR	O
-	O
B	O
,	O
specifically	O
in	O
piriform	O
cortex	O
and	O
hippocampus	O
,	O
reversed	O
the	O
Cre	O
-	O
induced	O
loss	O
of	O
GluR	O
-	O
B	O
and	O
partially	O
rescued	O
the	O
odor	O
memory	O
deficit	O
,	O
but	O
left	O
unaltered	O
the	O
enhanced	O
olfactory	O
discrimination	O
.	O

In	O
a	O
nutshell	O
,	O
we	O
conclude	O
that	O
olfactory	O
discrimination	O
is	O
enhanced	O
by	O
an	O
increase	O
in	O
AMPAR	O
-	O
mediated	O
Ca2	O
+	O
permeability	O
within	O
the	O
olfactory	O
bulb	O
,	O
whereas	O
olfactory	O
memory	O
becomes	O
impaired	O
upon	O
genetically	O
induced	O
GluR	O
-	O
B	O
ablation	O
in	O
higher	O
brain	O
centers	O
,	O
specifically	O
in	O
piriform	O
cortex	O
.	O

Olfactory	O
Discrimination	O
Is	O
Increased	O
in	O
Mice	O
with	O
Forebrain	O
-	O
Specific	O
GluR	O
-	O
B	O
Ablation	O
or	O
GluR	O
-	O
B	O
(	O
Q	O
)	O
Expression	O

Both	O
forebrain	O
-	O
specific	O
GluR	O
-	O
B	O
(	O
Q	O
)	O
expression	O
and	O
GluR	O
-	O
B	O
depletion	O
led	O
to	O
increased	O
olfactory	O
learning	O
and	O
discrimination	O
capabilities	O
.	O

This	O
was	O
rather	O
pronounced	O
for	O
GluR	O
-	O
B	O
(	O
Q	O
)	O
-	O
expressing	O
mice	O
,	O
consistent	O
with	O
the	O
overall	O
stronger	O
phenotypic	O
consequences	O
in	O
comparison	O
to	O
GluR	O
-	O
B	O
depletion	O
,	O
both	O
when	O
forebrain	O
-	O
selective	O
(	O
[	O
58	O
]	O
,	O
and	O
this	O
study	O
)	O
or	O
global	O
[	O
53	O
,	O
60	O
]	O
.	O

A	O
detailed	O
analysis	O
of	O
the	O
sampling	O
pattern	O
[	O
3	O
]	O
,	O
and	O
in	O
particular	O
the	O
analysis	O
of	O
discrimination	O
tasks	O
that	O
involved	O
"	O
simple	O
"	O
dissimilar	O
monomolecular	O
odor	O
pairs	O
and	O
"	O
difficult	O
"	O
binary	O
mixtures	O
,	O
were	O
necessary	O
to	O
fully	O
capture	O
the	O
characteristics	O
of	O
the	O
olfactory	O
discrimination	O
phenotype	O
for	O
forebrain	O
-	O
specific	O
GluR	O
-	O
B	O
-	O
depleted	O
mice	O
.	O

For	O
closely	O
related	O
binary	O
mixtures	O
,	O
discrimination	O
improvements	O
were	O
largest	O
,	O
consistent	O
with	O
a	O
specific	O
alteration	O
in	O
odor	O
discrimination	O
,	O
rather	O
than	O
a	O
general	O
enhancement	O
of	O
learning	O
capabilities	O
.	O

This	O
is	O
further	O
supported	O
by	O
the	O
notion	O
that	O
no	O
general	O
improvement	O
was	O
observed	O
in	O
other	O
nonolfactory	O
behavioral	O
tasks	O
,	O
e	O
.	O
g	O
.	O
,	O
hippocampus	O
-	O
dependent	O
spatial	O
learning	O
tasks	O
such	O
as	O
matching	O
-	O
to	O
-	O
place	O
spatial	O
reference	O
memory	O
tasks	O
(	O
Figure	O
S2	O
)	O
.	O

As	O
no	O
Cre	O
expression	O
and	O
activity	O
was	O
observed	O
in	O
the	O
main	O
olfactory	O
sensory	O
neurons	O
at	O
any	O
developmental	O
stage	O
(	O
Figure	O
S4	O
and	O
unpublished	O
data	O
)	O
,	O
olfactory	O
epithelial	O
function	O
was	O
unaltered	O
by	O
the	O
genetic	O
modification	O
.	O

The	O
vomeronasal	O
organ	O
showed	O
very	O
weak	O
Cre	O
expression	O
(	O
unpublished	O
data	O
)	O
,	O
but	O
a	O
role	O
of	O
this	O
structure	O
concerning	O
performance	O
in	O
the	O
olfactory	O
discrimination	O
task	O
is	O
unlikely	O
(	O
for	O
review	O
,	O
see	O
[	O
63	O
]	O
)	O
.	O

The	O
behavioral	O
phenotype	O
is	O
thus	O
likely	O
to	O
be	O
associated	O
with	O
the	O
processing	O
of	O
olfactory	O
information	O
rather	O
than	O
the	O
detection	O
of	O
odors	O
.	O

Furthermore	O
,	O
increased	O
performance	O
even	O
after	O
long	O
stretches	O
of	O
training	O
and	O
,	O
in	O
particular	O
,	O
increased	O
sampling	O
pattern	O
differences	O
(	O
TB	O
and	O
ATS	O
,	O
unpublished	O
data	O
)	O
supported	O
the	O
notion	O
that	O
GluR	O
-	O
B	O
depletion	O
resulted	O
in	O
enhanced	O
odor	O
discrimination	O
capability	O
.	O

The	O
learning	O
phenotype	O
might	O
thus	O
be	O
a	O
result	O
of	O
this	O
enhanced	O
discrimination	O
capability	O
or	O
reflect	O
additional	O
changes	O
in	O
circuits	O
underlying	O
task	O
acquisition	O
.	O

Putative	O
Cellular	O
Basis	O
of	O
Enhanced	O
Odor	O
Discrimination	O
and	O
Learning	O

AMPAR	O
properties	O
were	O
altered	O
specifically	O
in	O
neurons	O
of	O
forebrain	O
areas	O
,	O
most	O
notably	O
olfactory	O
bulb	O
,	O
olfactory	O
cortex	O
,	O
and	O
other	O
cortical	O
areas	O
and	O
hippocampus	O
,	O
leading	O
to	O
enhanced	O
odor	O
discrimination	O
and	O
learning	O
.	O

Interestingly	O
,	O
transgenic	O
expression	O
of	O
GFPGluR	O
-	O
B	O
in	O
GluR	O
-	O
B	O
Delta	O
FB	O
mice	O
(	O
genetic	O
"	O
rescue	O
"	O
)	O
,	O
specifically	O
in	O
piriform	O
cortex	O
and	O
hippocampus	O
with	O
no	O
detectable	O
expression	O
in	O
the	O
olfactory	O
bulb	O
,	O
did	O
not	O
alter	O
enhanced	O
discrimination	O
and	O
learning	O
capabilities	O
.	O

This	O
is	O
consistent	O
with	O
a	O
primary	O
role	O
of	O
the	O
olfactory	O
bulb	O
in	O
olfactory	O
discrimination	O
and	O
learning	O
.	O

Alternatively	O
,	O
transgenic	O
protein	O
levels	O
might	O
have	O
been	O
too	O
low	O
to	O
alter	O
discrimination	O
and	O
learning	O
capabilities	O
,	O
although	O
memory	O
was	O
clearly	O
affected	O
.	O

This	O
notion	O
will	O
be	O
further	O
tested	O
in	O
mice	O
with	O
piriform	O
cortex	O
-	O
specific	O
GluR	O
-	O
B	O
ablation	O
.	O

A	O
direct	O
contribution	O
to	O
the	O
phenotype	O
by	O
Ca2	O
+	O
influx	O
through	O
genetically	O
modified	O
AMPA	O
channels	O
seems	O
to	O
be	O
likely	O
,	O
since	O
mice	O
expressing	O
Q	O
/	O
R	O
site	O
-	O
unedited	O
GluR	O
-	O
B	O
showed	O
even	O
better	O
odor	O
learning	O
and	O
discrimination	O
performance	O
compared	O
with	O
mice	O
with	O
depleted	O
GluR	O
-	O
B	O
.	O

In	O
both	O
mouse	O
models	O
Ca2	O
+	O
influx	O
through	O
AMPA	O
channels	O
is	O
increased	O
,	O
whereas	O
the	O
effect	O
on	O
the	O
macroscopic	O
AMPA	O
conductance	O
differs	O
.	O

AMPAR	O
currents	O
are	O
reduced	O
in	O
mice	O
not	O
expressing	O
GluR	O
-	O
B	O
[	O
51	O
]	O
,	O
possibly	O
due	O
to	O
fewer	O
synaptic	S-GO
AMPA	O
channels	O
and	O
impaired	O
AMPAR	O
trafficking	O
and	O
recycling	O
.	O

In	O
mice	O
expressing	O
the	O
unedited	O
form	O
of	O
GluR	O
-	O
B	O
(	O
Q	O
)	O
,	O
macroscopic	O
conductance	O
in	O
whole	O
-	O
cell	O
patches	O
of	O
CA1	O
pyramidals	O
is	O
increased	O
[	O
60	O
]	O
,	O
but	O
excitatory	O
transmission	O
in	O
CA3	O
-	O
to	O
-	O
CA1	O
cell	O
synapses	S-GO
is	O
somewhat	O
reduced	O
,	O
in	O
spite	O
of	O
a	O
lower	O
threshold	O
for	O
generating	O
a	O
population	O
spike	O
[	O
58	O
]	O
,	O
indicating	O
increased	O
synaptic	S-GO
excitability	O
by	O
sustained	O
GluR	O
-	O
B	O
(	O
Q	O
)	O
expression	O
,	O
in	O
line	O
with	O
the	O
seizure	O
-	O
prone	O
phenotype	O
.	O

Yet	O
,	O
both	O
mouse	O
models	O
yield	O
enhanced	O
discrimination	O
and	O
learning	O
capability	O
.	O

The	O
milder	O
phenotype	O
upon	O
GluR	O
-	O
B	O
depletion	O
could	O
be	O
attributed	O
to	O
reduced	O
AMPAR	O
densities	O
at	O
synapses	S-GO
[	O
40	O
,	O
41	O
]	O
and	O
therefore	O
probably	O
to	O
a	O
lesser	O
extent	O
of	O
Ca2	O
+	O
influx	O
.	O

This	O
is	O
further	O
supported	O
by	O
kainate	O
-	O
induced	O
Co2	O
+	O
uptake	O
in	O
acute	O
brain	O
slices	O
,	O
revealing	O
considerably	O
higher	O
Co2	O
+	O
uptake	O
via	O
Ca2	O
+	O
-	O
permeable	O
AMPARs	O
in	O
hippocampal	O
pyramidal	O
neurons	O
of	O
mice	O
expressing	O
GluR	O
-	O
B	O
(	O
Q	O
)	O
,	O
than	O
those	O
lacking	O
GluR	O
-	O
B	O
(	O
DRS	O
,	O
RS	O
,	O
and	O
PHS	O
,	O
unpublished	O
data	O
)	O
.	O

Normally	O
,	O
GluR	O
-	O
B	O
-	O
containing	O
AMPARs	O
are	O
prominently	O
localized	O
at	O
the	O
dendrodendritic	O
synapse	S-GO
between	O
mitral	O
and	O
granule	O
cells	O
in	O
the	O
olfactory	O
bulb	O
[	O
64	O
,	O
65	O
]	O
.	O

As	O
Ca2	O
+	O
influx	O
through	O
glutamate	O
receptors	O
is	O
thought	O
to	O
contribute	O
to	O
lateral	O
and	O
recurrent	O
inhibition	O
(	O
[	O
38	O
]	O
see	O
also	O
[	O
39	O
]	O
)	O
,	O
the	O
absence	O
of	O
GluR	O
-	O
B	O
,	O
or	O
the	O
presence	O
of	O
GluR	O
-	O
B	O
(	O
Q	O
)	O
in	O
the	O
olfactory	O
bulb	O
,	O
is	O
likely	O
to	O
result	O
in	O
increased	O
inhibition	O
between	O
the	O
principal	O
neurons	O
in	O
this	O
structure	O
.	O

Notably	O
,	O
the	O
improved	O
olfactory	O
discrimination	O
capabilities	O
were	O
apparent	O
even	O
upon	O
relatively	O
small	O
reductions	O
in	O
GluR	O
-	O
B	O
levels	O
.	O

It	O
will	O
be	O
interesting	O
to	O
see	O
if	O
GluR	O
-	O
B	O
+	O
/	O
neo	O
mice	O
also	O
exhibit	O
enhanced	O
odor	O
discrimination	O
,	O
which	O
is	O
indeed	O
likely	O
given	O
that	O
low	O
levels	O
of	O
GluR	O
-	O
B	O
(	O
Q	O
)	O
,	O
and	O
hence	O
a	O
small	O
increase	O
in	O
Ca2	O
+	O
-	O
permeable	O
AMPARs	O
,	O
arise	O
from	O
the	O
attenuated	O
GluR	O
-	O
Bneo	O
allele	O
[	O
60	O
]	O
,	O
and	O
,	O
moreover	O
,	O
that	O
GluR	O
-	O
B	O
levels	O
are	O
decreased	O
in	O
these	O
mice	O
due	O
to	O
the	O
single	O
copy	O
of	O
the	O
GluR	O
-	O
B	O
+	O
allele	O
.	O

In	O
virtually	O
all	O
models	O
of	O
the	O
olfactory	O
bulb	O
,	O
lateral	O
(	O
and	O
,	O
in	O
fewer	O
models	O
,	O
also	O
recurrent	O
)	O
inhibition	O
plays	O
a	O
dominant	O
role	O
,	O
either	O
in	O
establishing	O
spatiotemporal	O
dynamics	O
[	O
32	O
,	O
66	O
-	O
69	O
]	O
,	O
or	O
in	O
directly	O
enhancing	O
contrast	O
and	O
therefore	O
simplifying	O
discrimination	O
and	O
learning	O
of	O
similar	O
odorants	O
[	O
24	O
,	O
28	O
,	O
29	O
,	O
36	O
]	O
.	O

Increased	O
inhibition	O
will	O
thus	O
in	O
general	O
improve	O
discriminability	O
,	O
consistent	O
with	O
the	O
behavioral	O
improvements	O
observed	O
with	O
GluR	O
-	O
B	O
(	O
Q	O
)	O
expression	O
,	O
the	O
GluR	O
-	O
B	O
knockout	O
,	O
and	O
the	O
"	O
rescue	O
"	O
mice	O
.	O

A	O
direct	O
test	O
of	O
this	O
link	O
would	O
require	O
the	O
quantitative	O
measurement	O
of	O
inhibition	O
in	O
the	O
intact	O
preparation	O
,	O
a	O
task	O
that	O
might	O
be	O
feasible	O
with	O
further	O
improved	O
in	O
vivo	O
electrophysiological	O
techniques	O
,	O
such	O
as	O
targeted	O
recordings	O
[	O
70	O
,	O
71	O
]	O
or	O
simultaneous	O
pre	O
-	O
and	O
postsynaptic	O
intracellular	S-GO
measurements	O
.	O

Olfactory	O
Memory	O
Is	O
Reduced	O
in	O
GluR	O
-	O
B	O
Knockout	O
Mice	O
and	O
Improved	O
by	O
GluR	O
-	O
B	O
Expression	O
in	O
Piriform	O
Cortex	O
and	O
Hippocampus	O

To	O
assess	O
olfactory	O
memory	O
of	O
GluR	O
-	O
B	O
Delta	O
FB	O
mice	O
,	O
after	O
six	O
days	O
the	O
mice	O
were	O
probed	O
with	O
unrewarded	O
odor	O
presentations	O
that	O
interleaved	O
a	O
simple	O
discrimination	O
task	O
.	O

Prolonged	O
behavioral	O
tasks	O
such	O
as	O
the	O
assessment	O
of	O
long	O
-	O
term	O
olfactory	O
memory	O
were	O
not	O
performed	O
with	O
the	O
seizure	O
-	O
prone	O
GluR	O
-	O
B	O
Delta	O
ECS	O
:	O
FB	O
mice	O
.	O

Memory	O
in	O
GluR	O
-	O
B	O
Delta	O
FB	O
mice	O
,	O
however	O
,	O
was	O
dramatically	O
impaired	O
.	O

This	O
cannot	O
be	O
attributed	O
to	O
a	O
general	O
,	O
unspecific	O
deficit	O
because	O
,	O
simultaneous	O
to	O
the	O
memory	O
trials	O
,	O
the	O
normal	O
,	O
rewarded	O
discrimination	O
task	O
was	O
performed	O
even	O
better	O
than	O
by	O
controls	O
.	O

Reduced	O
olfactory	O
memory	O
can	O
also	O
not	O
be	O
simply	O
attributed	O
to	O
increased	O
extinction	O
,	O
as	O
no	O
significant	O
trial	O
-	O
group	O
interactions	O
were	O
observed	O
and	O
also	O
,	O
when	O
restricted	O
to	O
the	O
first	O
unrewarded	O
memory	O
trials	O
,	O
a	O
significant	O
impairment	O
was	O
observed	O
(	O
Figure	O
S3A	O
)	O
.	O

Additionally	O
,	O
investigating	O
relearning	O
of	O
the	O
first	O
discrimination	O
task	O
revealed	O
a	O
significant	O
correlation	O
with	O
the	O
memory	O
performance	O
,	O
showing	O
a	O
"	O
memory	O
"	O
deficit	O
under	O
extinction	O
-	O
free	O
conditions	O
(	O
Figure	O
S3B	O
)	O
.	O

Finally	O
,	O
in	O
other	O
memory	O
-	O
related	O
tasks	O
,	O
such	O
as	O
a	O
hippocampus	O
-	O
dependent	O
spatial	O
reference	O
memory	O
task	O
(	O
Figure	O
S2	O
)	O
,	O
mice	O
with	O
GluR	O
-	O
B	O
depletion	O
were	O
not	O
impaired	O
after	O
task	O
acquisition	O
.	O

We	O
therefore	O
conclude	O
that	O
forebrain	O
-	O
specific	O
ablation	O
of	O
GluR	O
-	O
B	O
results	O
in	O
a	O
specific	O
loss	O
of	O
long	O
-	O
term	O
olfactory	O
memory	O
but	O
,	O
at	O
the	O
same	O
time	O
,	O
in	O
enhanced	O
odor	O
discrimination	O
and	O
learning	O
capabilities	O
.	O

To	O
dissect	O
the	O
discrimination	O
,	O
learning	O
,	O
and	O
memory	O
phenotypes	O
,	O
and	O
ultimately	O
identify	O
potential	O
cellular	O
correlates	O
,	O
we	O
made	O
use	O
of	O
the	O
variegated	O
Cre	O
expression	O
of	O
TgCre4	O
mice	O
.	O

Therefore	O
,	O
residual	O
GluR	O
-	O
B	O
levels	O
were	O
determined	O
from	O
each	O
mouse	O
that	O
had	O
been	O
tested	O
in	O
the	O
behavioral	O
experiments	O
,	O
and	O
levels	O
were	O
correlated	O
with	O
odor	O
learning	O
,	O
discrimination	O
,	O
and	O
olfactory	O
memory	O
.	O

The	O
significant	O
direct	O
correlation	O
between	O
residual	O
GluR	O
-	O
B	O
levels	O
in	O
hippocampus	O
and	O
cortical	O
areas	O
with	O
olfactory	O
memory	O
suggested	O
hippocampal	O
and	O
/	O
or	O
cortical	O
neurons	O
as	O
putative	O
mediators	O
for	O
odor	O
memorization	O
and	O
/	O
or	O
storage	O
.	O

No	O
measure	O
of	O
discrimination	O
and	O
learning	O
,	O
on	O
the	O
other	O
hand	O
,	O
correlated	O
with	O
residual	O
GluR	O
-	O
B	O
levels	O
;	O
even	O
the	O
smallest	O
reduction	O
in	O
GluR	O
-	O
B	O
levels	O
(	O
about	O
20	O
%	O
-	O
60	O
%	O
)	O
was	O
sufficient	O
to	O
establish	O
and	O
saturate	O
enhanced	O
odor	O
discrimination	O
capabilities	O
.	O

Together	O
,	O
this	O
allows	O
the	O
conclusion	O
that	O
distinct	O
mechanisms	O
mediate	O
discrimination	O
/	O
learning	O
and	O
memory	O
.	O

This	O
is	O
furthermore	O
consistent	O
with	O
a	O
prominent	O
role	O
of	O
cortical	O
areas	O
or	O
hippocampus	O
in	O
olfactory	O
memory	O
,	O
although	O
GluR	O
-	O
B	O
levels	O
in	O
the	O
olfactory	O
bulb	O
were	O
also	O
weakly	O
correlated	O
with	O
memory	O
performance	O
.	O

Transgenic	O
expression	O
of	O
GFPGluR	O
-	O
B	O
in	O
piriform	O
cortex	O
and	O
hippocampus	O
indeed	O
rescued	O
memory	O
to	O
an	O
extent	O
strikingly	O
consistent	O
with	O
the	O
transgenic	O
protein	O
levels	O
(	O
approximately	O
10	O
%	O
of	O
wild	O
-	O
type	O
GluR	O
-	O
B	O
)	O
,	O
confirming	O
the	O
reliability	O
of	O
the	O
correlation	O
analysis	O
and	O
the	O
sensitivity	O
of	O
the	O
behavioral	O
assay	O
.	O

In	O
general	O
,	O
the	O
hippocampus	O
is	O
thought	O
to	O
be	O
involved	O
in	O
only	O
those	O
olfactory	O
memory	O
tasks	O
that	O
involve	O
temporal	O
sequence	O
analysis	O
or	O
require	O
other	O
higher	O
cognitive	O
features	O
[	O
2	O
,	O
13	O
,	O
72	O
-	O
74	O
]	O
.	O

In	O
particular	O
,	O
extensive	O
lesions	O
to	O
the	O
hippocampal	O
formation	O
in	O
rats	O
do	O
not	O
interfere	O
with	O
long	O
-	O
term	O
olfactory	O
memory	O
in	O
go	O
/	O
no	O
-	O
go	O
successive	O
olfactory	O
discrimination	O
tasks	O
[	O
72	O
]	O
,	O
such	O
as	O
the	O
one	O
described	O
.	O

This	O
leaves	O
piriform	O
cortex	O
as	O
the	O
most	O
prominent	O
candidate	O
for	O
the	O
locus	O
of	O
the	O
olfactory	O
memory	O
deficit	O
described	O
,	O
consistent	O
with	O
the	O
prevalent	O
view	O
of	O
piriform	O
cortex	O
as	O
an	O
associational	O
memory	O
structure	O
[	O
75	O
]	O
and	O
learning	O
-	O
associated	O
changes	O
in	O
piriform	O
cortex	O
[	O
7	O
,	O
20	O
-	O
23	O
]	O
.	O

Potential	O
Mechanisms	O
of	O
Specific	O
Olfactory	O
Memory	O
Impairment	O

What	O
could	O
be	O
the	O
cellular	O
basis	O
of	O
the	O
long	O
-	O
term	O
memory	O
deficit	O
brought	O
about	O
by	O
lack	O
of	O
GluR	O
-	O
B	O
-	O
containing	O
AMPARs	O
?	O

For	O
complete	O
GluR	O
-	O
B	O
knockouts	O
,	O
increased	O
long	O
-	O
term	O
plasticity	O
(	O
LTP	O
)	O
was	O
reported	O
in	O
hippocampal	O
field	O
recordings	O
[	O
51	O
]	O
.	O

In	O
addition	O
,	O
in	O
hippocampal	O
and	O
amygdala	O
pathways	O
lacking	O
GluR	O
-	O
B	O
,	O
an	O
AMPAR	O
-	O
dependent	O
,	O
N	O
-	O
methyl	O
-	O
D	O
-	O
aspartate	O
(	O
NMDA	O
)	O
receptor	O
-	O
independent	O
form	O
of	O
LTP	O
can	O
be	O
readily	O
induced	O
[	O
51	O
,	O
52	O
]	O
.	O

Mechanistically	O
,	O
this	O
is	O
likely	O
to	O
be	O
due	O
to	O
Ca2	O
+	O
influx	O
through	O
GluR	O
-	O
B	O
-	O
less	O
AMPA	O
channels	O
leading	O
to	O
non	O
-	O
hebbian	O
forms	O
of	O
plasticity	O
.	O

However	O
,	O
hebbian	O
dependence	O
on	O
simultaneous	O
pre	O
-	O
and	O
postsynaptic	O
activity	O
is	O
often	O
a	O
critical	O
feature	O
for	O
memory	O
storage	O
(	O
reviewed	O
in	O
e	O
.	O
g	O
.	O
[	O
76	O
]	O
)	O
;	O
hence	O
,	O
a	O
non	O
-	O
hebbian	O
form	O
of	O
plasticity	O
should	O
result	O
in	O
impaired	O
memorization	O
.	O

Surprisingly	O
,	O
in	O
GluR	O
-	O
B	O
Delta	O
FB	O
mice	O
no	O
LTP	O
changes	O
could	O
be	O
observed	O
in	O
field	O
measurements	O
in	O
the	O
hippocampus	O
,	O
nor	O
could	O
NMDA	O
-	O
independent	O
LTP	O
be	O
induced	O
in	O
hippocampal	O
synapses	S-GO
between	O
Schaffer	O
collaterals	O
and	O
CA1	O
pyramidal	O
cells	O
in	O
presence	O
of	O
the	O
NMDA	O
antagonist	O
APV	O
(	O
K	O
.	O
Jensen	O
,	O
O	O
.	O
Hvalby	O
,	O
personal	O
communication	O
)	O
.	O

However	O
,	O
in	O
other	O
brain	O
areas	O
that	O
are	O
potentially	O
important	O
for	O
the	O
processing	O
of	O
olfactory	O
information	O
,	O
such	O
as	O
piriform	O
cortex	O
or	O
olfactory	O
bulb	O
,	O
LTP	O
measurements	O
have	O
not	O
yet	O
been	O
performed	O
;	O
synapses	S-GO
of	O
these	O
pathways	O
may	O
be	O
regulated	O
differently	O
than	O
hippocampal	O
CA3	O
/	O
CA1	O
synapses	S-GO
.	O

Additionally	O
,	O
by	O
changing	O
the	O
Ca2	O
+	O
permeability	O
of	O
AMPARs	O
,	O
Ca2	O
+	O
signaling	O
via	O
AMPA	O
and	O
colocalized	O
NMDA	O
channels	O
might	O
be	O
disturbed	O
,	O
thereby	O
impairing	O
memory	O
formation	O
.	O

Other	O
forms	O
of	O
plasticity	O
[	O
77	O
,	O
78	O
]	O
induced	O
by	O
Ca2	O
+	O
-	O
permeable	O
AMPARs	O
might	O
play	O
a	O
prevalent	O
role	O
in	O
olfactory	O
memory	O
.	O

Alternatively	O
,	O
long	O
-	O
term	O
stabilization	O
might	O
involve	O
GluR	O
-	O
B	O
phosphorylation	O
similar	O
to	O
cerebellar	O
long	O
-	O
term	O
depression	O
[	O
79	O
]	O
and	O
thus	O
be	O
selectively	O
impaired	O
by	O
GluR	O
-	O
B	O
depletion	O
.	O

Physiological	O
experiments	O
to	O
assess	O
these	O
hypotheses	O
will	O
ideally	O
make	O
use	O
of	O
even	O
more	O
restricted	O
genetic	O
modifications	O
with	O
completely	O
undisturbed	O
input	O
structures	O
.	O

One	O
possibility	O
would	O
be	O
Cre	O
-	O
mediated	O
GluR	O
-	O
B	O
depletion	O
and	O
GluR	O
-	O
B	O
(	O
Q	O
)	O
expression	O
in	O
piriform	O
cortex	O
as	O
suggested	O
above	O
.	O

Correlating	O
Quantitative	O
Behavior	O
and	O
Mosaic	O
Gene	O
Expression	O
for	O
Dissecting	O
Phenotypes	O

A	O
critical	O
step	O
in	O
discerning	O
the	O
discrimination	O
and	O
learning	O
phenotypes	O
from	O
the	O
memory	O
phenotype	O
was	O
the	O
observation	O
of	O
increased	O
variability	O
in	O
the	O
memory	O
of	O
the	O
GluR	O
-	O
B	O
knockout	O
animals	O
and	O
,	O
subsequently	O
,	O
the	O
individual	O
analyses	O
of	O
protein	O
expression	O
levels	O
.	O

We	O
made	O
use	O
of	O
the	O
epigenetic	O
variability	O
in	O
GluR	O
-	O
B	O
excision	O
that	O
could	O
be	O
correlated	O
to	O
the	O
variability	O
in	O
memory	O
but	O
showed	O
no	O
correlation	O
to	O
variability	O
in	O
discrimination	O
.	O

The	O
analysis	O
of	O
quantitative	O
trait	O
loci	O
(	O
for	O
review	O
,	O
see	O
[	O
80	O
]	O
)	O
,	O
or	O
classically	O
correlating	O
different	O
behavioral	O
phenotypes	O
within	O
a	O
truly	O
wild	O
-	O
type	O
population	O
[	O
81	O
-	O
84	O
]	O
,	O
also	O
attempts	O
to	O
find	O
common	O
or	O
distinct	O
genetic	O
origins	O
of	O
different	O
behavioral	O
traits	O
.	O

These	O
attempts	O
undoubtedly	O
contribute	O
significantly	O
to	O
unraveling	O
the	O
molecular	O
basis	O
of	O
behavior	O
.	O

Due	O
to	O
subtle	O
and	O
multigenic	O
differences	O
between	O
different	O
strains	O
of	O
rodents	O
or	O
different	O
individuals	O
in	O
a	O
wild	O
-	O
type	O
population	O
,	O
however	O
,	O
they	O
suffer	O
from	O
a	O
rather	O
low	O
"	O
signal	O
-	O
to	O
-	O
noise	O
"	O
ratio	O
.	O

Differences	O
in	O
individual	O
genes	O
are	O
rather	O
small	O
compared	O
with	O
the	O
vast	O
number	O
of	O
genes	O
involved	O
.	O

As	O
a	O
result	O
,	O
purely	O
correlating	O
behavioral	O
traits	O
within	O
a	O
wild	O
-	O
type	O
population	O
usually	O
remains	O
rather	O
descriptive	O
,	O
whereas	O
quantitative	O
trait	O
loci	O
analysis	O
is	O
capable	O
of	O
revealing	O
multigenic	O
basis	O
of	O
behavioral	O
traits	O
but	O
usually	O
lacks	O
the	O
power	O
to	O
identify	O
the	O
individual	O
genes	O
themselves	O
.	O

Herein	O
,	O
we	O
described	O
a	O
way	O
to	O
enhance	O
the	O
signal	O
-	O
to	O
-	O
noise	O
ratio	O
by	O
making	O
use	O
of	O
the	O
mosaic	O
expression	O
often	O
associated	O
with	O
transgenic	O
approaches	O
:	O
combining	O
the	O
advantages	O
of	O
"	O
classical	O
"	O
genetic	O
manipulation	O
--	O
namely	O
,	O
that	O
the	O
target	O
of	O
the	O
manipulation	O
is	O
well	O
defined	O
--	O
with	O
the	O
possibility	O
to	O
analyze	O
variability	O
,	O
might	O
also	O
in	O
future	O
provide	O
novel	O
ways	O
to	O
define	O
molecular	O
and	O
cellular	O
correlates	O
of	O
complex	O
behavioral	O
traits	O
.	O

In	O
this	O
study	O
,	O
we	O
combined	O
genetically	O
induced	O
manipulation	O
of	O
the	O
AMPAR	O
composition	O
with	O
quantitative	O
behavioral	O
and	O
molecular	O
analyses	O
.	O

We	O
could	O
thus	O
provide	O
evidence	O
for	O
opposing	O
roles	O
of	O
specific	O
GluR	O
-	O
B	O
manipulation	O
and	O
increased	O
Ca2	O
+	O
influx	O
via	O
AMPARs	O
in	O
olfactory	O
discrimination	O
/	O
learning	O
,	O
and	O
memory	O
,	O
potentially	O
in	O
the	O
olfactory	O
bulb	O
and	O
piriform	O
cortex	O
,	O
respectively	O
.	O

To	O
achieve	O
this	O
,	O
we	O
made	O
use	O
of	O
the	O
epigenetic	O
variability	O
in	O
the	O
extent	O
of	O
GluR	O
-	O
B	O
ablation	O
,	O
which	O
correlated	O
with	O
the	O
variability	O
in	O
odor	O
memory	O
,	O
but	O
not	O
in	O
discrimination	O
and	O
learning	O
;	O
this	O
finding	O
was	O
subsequently	O
confirmed	O
in	O
GluR	O
-	O
B	O
rescue	O
mice	O
with	O
piriform	O
cortex	O
-	O
specific	O
transgenic	O
expression	O
of	O
GluR	O
-	O
B	O
.	O

Extending	O
these	O
principles	O
of	O
combining	O
quantitative	O
behavioral	O
analyses	O
with	O
minimal	O
and	O
dosed	O
genetic	O
interference	O
,	O
together	O
with	O
further	O
physiological	O
analyses	O
,	O
will	O
ultimately	O
pinpoint	O
the	O
neural	O
circuitries	O
underlying	O
related	O
,	O
but	O
distinct	O
,	O
behavioral	O
traits	O
in	O
olfactory	O
and	O
other	O
systems	O
.	O

Materials	O
and	O
Methods	O

Mouse	O
lines	O

The	O
R26R	O
line	O
[	O
85	O
]	O
was	O
employed	O
as	O
Cre	O
indicator	O
.	O

GluR	O
-	O
B	O
Delta	O
ECS	O
:	O
FB	O
mice	O
were	O
of	O
mixed	O
C57Bl	O
/	O
6	O
and	O
NMRI	O
genetic	O
background	O
and	O
generated	O
from	O
TgCre4	O
(	O
"	O
Camkcre4	O
"	O
in	O
[	O
59	O
]	O
)	O
and	O
GluR	O
-	O
B	O
+	O
/	O
neo	O
[	O
60	O
]	O
mice	O
.	O

GluR	O
-	O
B	O
+	O
/	O
neo	O
mice	O
carry	O
a	O
wild	O
-	O
type	O
GluR	O
-	O
B	O
allele	O
and	O
a	O
gene	O
-	O
targeted	O
GluR	O
-	O
B	O
allele	O
in	O
which	O
the	O
intron	O
11	O
sequence	O
critical	O
for	O
Q	O
/	O
R	O
site	O
editing	O
is	O
replaced	O
by	O
a	O
TK	O
-	O
neo	O
gene	O
flanked	O
by	O
loxP	O
sites	O
(	O
"	O
floxed	O
"	O
)	O
.	O

GluR	O
-	O
B2lox	O
mice	O
[	O
86	O
]	O
carry	O
gene	O
-	O
targeted	O
GluR	O
-	O
B	O
alleles	O
in	O
which	O
exon	O
11	O
is	O
floxed	O
.	O

GluR	O
-	O
B	O
Delta	O
FB	O
mice	O
were	O
of	O
C57Bl	O
/	O
6	O
genetic	O
background	O
and	O
generated	O
from	O
TgCre4	O
and	O
GluR	O
-	O
B2lox	O
mice	O
.	O

TgCN12	O
-	O
itTA	O
mice	O
were	O
generated	O
as	O
described	O
for	O
TgCN10	O
-	O
itTA	O
mice	O
(	O
see	O
Materials	O
and	O
Methods	O
in	O
[	O
58	O
]	O
)	O
,	O
and	O
represent	O
another	O
founder	O
line	O
obtained	O
from	O
the	O
same	O
pronucleus	S-GO
injection	O
,	O
with	O
more	O
widespread	O
forebrain	O
expression	O
.	O

For	O
exogeneous	O
expression	O
of	O
GFPGluR	O
-	O
B	O
,	O
the	O
mouse	O
line	O
TgOCN1	O
was	O
generated	O
:	O
an	O
AseI	O
fragment	O
of	O
plasmid	O
pnlacZ	O
/	O
GFPGluR	O
-	O
B	O
was	O
injected	O
into	O
the	O
pronucleus	S-GO
of	O
oocytes	O
obtained	O
from	O
DBA1	O
/	O
C57Bl	O
/	O
6	O
F1	O
hybrids	O
.	O

Positive	O
founders	O
were	O
backcrossed	O
into	O
C57Bl	O
/	O
6	O
for	O
further	O
analysis	O
.	O

Plasmid	O
pnlacZ	O
/	O
GFPGluR	O
-	O
B	O
was	O
constructed	O
from	O
pnlacZ	O
/	O
GFPGluR	O
-	O
A	O
[	O
87	O
]	O
by	O
replacing	O
GluR	O
-	O
A	O
cDNA	O
with	O
the	O
rat	O
cDNA	O
for	O
GluR	O
-	O
B	O
.	O

Transgenic	O
GFPGluR	O
-	O
B	O
protein	O
levels	O
were	O
measured	O
in	O
hippocampus	O
of	O
TgOCN1	O
mice	O
also	O
carrying	O
a	O
transgene	O
for	O
forebrain	O
-	O
specific	O
homogeneous	O
tTA	O
expression	O
[	O
88	O
]	O
.	O

Experimental	O
groups	O

Mice	O
heterozygous	O
for	O
TgCre4	O
and	O
heterozygous	O
for	O
the	O
TK	O
-	O
neo	O
cassette	O
in	O
the	O
GluR	O
-	O
B	O
allele	O
(	O
GluR	O
-	O
B	O
Delta	O
ECS	O
:	O
FB	O
)	O
or	O
homozygous	O
for	O
the	O
floxed	O
GluR	O
-	O
B	O
(	O
GluR	O
-	O
B	O
Delta	O
FB	O
)	O
were	O
used	O
in	O
the	O
experiments	O
.	O

The	O
"	O
rescue	O
"	O
mice	O
(	O
GluR	O
-	O
BRescue	O
)	O
were	O
positive	O
for	O
TgCre4	O
,	O
homozygous	O
for	O
the	O
floxed	O
GluR	O
-	O
B	O
gene	O
,	O
and	O
positive	O
for	O
the	O
tet	O
-	O
sensitive	O
responder	O
transgene	O
TgOCN1	O
and	O
for	O
the	O
itTA	O
expressing	O
activator	O
transgene	O
TgCN12	O
-	O
itTA	O
.	O

Control	O
groups	O

Littermate	O
controls	O
were	O
used	O
in	O
all	O
experiments	O
.	O

GluR	O
-	O
B	O
+	O
/	O
+	O
mice	O
were	O
used	O
as	O
controls	O
in	O
the	O
task	O
described	O
in	O
Figure	O
1	O
.	O

GluR	O
-	O
B	O
+	O
/	O
2lox	O
and	O
GluR	O
-	O
B2lox	O
/	O
2lox	O
(	O
both	O
negative	O
for	O
TgCre4	O
)	O
mice	O
were	O
used	O
as	O
controls	O
in	O
experiments	O
described	O
in	O
Figures	O
2	O
,	O
4	O
,	O
and	O
6	O
.	O

For	O
the	O
GluR	O
-	O
BRescue	O
experiments	O
(	O
Figure	O
6	O
)	O
,	O
controls	O
positive	O
for	O
either	O
TgCN12	O
-	O
itTA	O
or	O
TgOCN1	O
in	O
a	O
GluR	O
-	O
B	O
+	O
/	O
2lox	O
and	O
GluR	O
-	O
B2lox	O
/	O
2lox	O
(	O
both	O
negative	O
for	O
TgCre4	O
)	O
background	O
were	O
used	O
.	O

Genotyping	O

Mice	O
were	O
selected	O
by	O
PCR	O
of	O
mouse	O
-	O
tail	O
DNA	O
with	O
specific	O
primers	O
as	O
described	O
below	O
.	O

Indicated	O
are	O
the	O
sequences	O
and	O
the	O
approximate	O
length	O
of	O
the	O
amplified	O
DNA	O
fragments	O
.	O

TgCre4	O
:	O
rspCre1	O
(	O
5	O
'	O
-	O
ACCAGGTTCGTTCACTCATGG	O
-	O
3	O
'	O
)	O
and	O
rspCre2	O
(	O
5	O
'	O
-	O
AGGCTAAGTGCCTTCTCTACAC	O
-	O
3	O
'	O
)	O
,	O
200	O
basepairs	O
(	O
bp	O
)	O
.	O

GluR	O
-	O
Bneo	O
:	O
MH60	O
(	O
5	O
'	O
-	O
CACTCACAGCAATGAAGCAGGAC	O
-	O
3	O
'	O
)	O
,	O
MH53a	O
(	O
5	O
'	O
-	O
GAATGTTGATCATGTGTTTCCCTG	O
-	O
3	O
'	O
)	O
,	O
and	O
MH117	O
(	O
5	O
'	O
-	O
GTTCGAATTCGCCAATGACAAGACG	O
-	O
3	O
'	O
)	O
,	O
wild	O
-	O
type	O
:	O
500	O
bp	O
and	O
mutant	O
:	O
400	O
bp	O
.	O

GluR	O
-	O
B2lox	O
:	O
VM12	O
(	O
5	O
'	O
-	O
GCGTAAGCCTGTGAAATACCTG	O
-	O
3	O
'	O
)	O
and	O
VM10	O
(	O
5	O
'	O
-	O
GTTGTCTAACAAGTTGTTGACC	O
-	O
3	O
'	O
)	O
,	O
wild	O
-	O
type	O
:	O
250	O
bp	O
and	O
mutant	O
:	O
350	O
bp	O
.	O

TgOCN1	O
:	O
VM4	O
(	O
5	O
'	O
-	O
CTCCCAGACAACCATTACCTGTCC	O
-	O
3	O
'	O
)	O
and	O
GluR	O
-	O
B882BST	O
(	O
5	O
'	O
-	O
CGAAGTATACTTAATTGTCGCTGTGTG	O
-	O
3	O
'	O
)	O
,	O
600	O
bp	O
.	O

TgCN12	O
-	O
itTA	O
:	O
htTA1	O
(	O
5	O
'	O
-	O
AGAGCAAAGTCATCAACTCTG	O
-	O
3	O
'	O
)	O
and	O
htTA2	O
(	O
5	O
'	O
-	O
GTGAGAGCCAGACTCACATTTCA	O
-	O
3	O
'	O
)	O
,	O
1	O
,	O
000	O
bp	O
.	O

Southern	O
blot	O
analysis	O

Genomic	O
DNA	O
from	O
mouse	O
-	O
tail	O
/	O
liver	O
was	O
digested	O
with	O
restriction	O
enzyme	O
BglII	O
(	O
NEB	O
)	O
,	O
and	O
the	O
Southern	O
blot	O
was	O
done	O
with	O
a	O
320	O
-	O
bp	O
probe	O
(	O
"	O
integ	O
"	O
)	O
obtained	O
by	O
PCR	O
detecting	O
the	O
alpha	O
CaMKII	O
promoter	O
.	O

Histochemistry	O

Histochemistry	O
was	O
performed	O
as	O
described	O
previously	O
[	O
89	O
]	O
,	O
with	O
the	O
following	O
exceptions	O
:	O
Coronal	O
70	O
-	O
to	O
100	O
-	O
mu	O
m	O
vibratome	O
slices	O
were	O
used	O
for	O
immunohistochemistry	O
with	O
GluR	O
-	O
B	O
(	O
1	O
:	O
60	O
,	O
polyclonal	O
;	O
Chemicon	O
,	O
Temecula	O
,	O
California	O
,	O
United	O
States	O
)	O
,	O
GFP	O
(	O
1	O
:	O
8	O
,	O
000	O
,	O
polyclonal	O
;	O
MobiTech	O
,	O
G	O
o	O
ttingen	O
,	O
Germany	O
)	O
,	O
and	O
Cre	O
(	O
1	O
:	O
8	O
,	O
000	O
,	O
polyclonal	O
;	O
BAbCO	O
,	O
Berkeley	O
,	O
California	O
,	O
United	O
States	O
)	O
primary	O
antibodies	S-GO
,	O
and	O
FITC	O
-	O
coupled	O
(	O
1	O
:	O
200	O
;	O
Dianova	O
,	O
Hamburg	O
,	O
Germany	O
)	O
and	O
peroxidase	O
-	O
coupled	O
(	O
1	O
:	O
600	O
;	O
Vector	O
,	O
Burlingame	O
,	O
California	O
,	O
United	O
States	O
)	O
secondary	O
goat	O
anti	O
-	O
rabbit	O
antibodies	S-GO
.	O

The	O
main	O
olfactory	O
epithelium	O
was	O
obtained	O
via	O
cryostat	O
sectioning	O
,	O
and	O
immunohistochemistry	O
was	O
performed	O
(	O
primary	O
antibody	S-GO
Cre	O
,	O
1	O
:	O
5	O
,	O
000	O
,	O
polyclonal	O
;	O
BAbCO	O
)	O
.	O

X	O
-	O
gal	O
staining	O
was	O
performed	O
as	O
described	O
[	O
89	O
]	O
.	O

Immunoblot	O
analysis	O

Mouse	O
brains	O
were	O
removed	O
,	O
and	O
the	O
hippocampus	O
,	O
olfactory	O
bulb	O
,	O
and	O
remaining	O
forebrain	O
areas	O
were	O
isolated	O
.	O

Total	O
protein	O
was	O
prepared	O
,	O
and	O
immunoblots	O
were	O
performed	O
as	O
described	O
[	O
87	O
]	O
.	O

Antibodies	S-GO
used	O
were	O
against	O
GluR	O
-	O
B	O
(	O
1	O
:	O
800	O
,	O
monoclonal	O
;	O
Chemicon	O
)	O
,	O
beta	O
-	O
actin	O
(	O
1	O
:	O
40	O
,	O
000	O
,	O
monoclonal	O
;	O
Sigma	O
,	O
St	O
.	O
Louis	O
,	O
Missouri	O
,	O
United	O
States	O
)	O
as	O
an	O
internal	O
standard	O
,	O
and	O
secondary	O
goat	O
anti	O
-	O
rabbit	O
and	O
goat	O
anti	O
-	O
mouse	O
antibodies	S-GO
(	O
Vector	O
,	O
1	O
:	O
15	O
,	O
000	O
)	O
.	O

Immunoreactivity	O
was	O
detected	O
with	O
ECLplus	O
(	O
Amersham	O
,	O
Little	O
Chalfont	O
,	O
United	O
Kingdom	O
)	O
,	O
and	O
immunoblots	O
were	O
scanned	O
and	O
quantitatively	O
analyzed	O
with	O
ImageJ	O
.	O

Behavioral	O
analysis	O
:	O
Subjects	O

All	O
mice	O
were	O
four	O
to	O
six	O
weeks	O
old	O
at	O
the	O
beginning	O
of	O
the	O
experiments	O
.	O

Subjects	O
were	O
maintained	O
on	O
a	O
12	O
-	O
h	O
light	O
-	O
dark	O
cycle	O
in	O
isolated	O
cages	O
in	O
a	O
temperature	O
and	O
humidity	O
-	O
controlled	O
animal	O
facility	O
.	O

All	O
behavioral	O
training	O
was	O
conducted	O
during	O
daytime	O
.	O

During	O
the	O
training	O
period	O
,	O
animals	O
were	O
kept	O
on	O
free	O
food	O
but	O
on	O
a	O
water	O
-	O
restriction	O
schedule	O
designed	O
to	O
keep	O
them	O
at	O
>	O
85	O
%	O
of	O
their	O
free	O
food	O
body	O
weight	O
.	O

Continuous	O
water	O
restriction	O
was	O
never	O
longer	O
than	O
12	O
h	O
.	O

All	O
animal	O
care	O
and	O
procedures	O
were	O
in	O
accordance	O
with	O
the	O
animal	O
ethics	O
guidelines	O
of	O
the	O
Max	O
-	O
Planck	O
Society	O
.	O

Apparatus	O

All	O
olfactory	O
discrimination	O
experiments	O
were	O
performed	O
using	O
three	O
modified	O
eight	O
-	O
channel	O
olfactometers	O
(	O
[	O
61	O
]	O
,	O
Knosys	O
,	O
Bethesda	O
,	O
Maryland	O
,	O
United	O
States	O
of	O
America	O
)	O
operated	O
by	O
custom	O
-	O
written	O
software	O
in	O
Igor	O
(	O
Wave	O
Metrics	O
,	O
Lake	O
Oswego	O
,	O
Oregon	O
,	O
United	O
States	O
of	O
America	O
)	O
on	O
Pentium	O
I	O
,	O
II	O
,	O
and	O
III	O
PCs	O
running	O
Microsoft	O
Windows	O
98	O
.	O

Great	O
care	O
was	O
taken	O
to	O
counterbalance	O
groups	O
between	O
setups	O
.	O

In	O
brief	O
,	O
animals	O
were	O
presented	O
with	O
odor	O
from	O
one	O
out	O
of	O
eight	O
possible	O
odor	O
channels	O
and	O
rewarded	O
with	O
a	O
2	O
-	O
to	O
4	O
-	O
mu	O
l	O
drop	O
of	O
water	O
in	O
a	O
combined	O
odor	O
/	O
reward	O
port	O
(	O
Figure	O
1B	O
)	O
,	O
ensuring	O
tight	O
association	O
of	O
the	O
water	O
-	O
reward	O
with	O
a	O
presented	O
odorant	O
.	O

Head	O
insertion	O
into	O
the	O
port	O
was	O
monitored	O
by	O
an	O
IR	O
beam	O
and	O
photodiode	O
(	O
Figure	O
1B	O
)	O
.	O

Odors	O
used	O
were	O
n	O
-	O
amyl	O
acetate	O
,	O
ethyl	O
butyrate	O
,	O
pelargonic	O
acid	O
,	O
valeric	O
acid	O
,	O
and	O
binary	O
mixtures	O
of	O
cineol	O
and	O
eugenol	O
.	O

If	O
not	O
otherwise	O
noted	O
,	O
odors	O
were	O
diluted	O
to	O
1	O
%	O
in	O
mineral	O
oil	O
(	O
Fluka	O
Chemie	O
,	O
Steinheim	O
,	O
Germany	O
)	O
and	O
further	O
diluted	O
by	O
airflow	O
to	O
a	O
final	O
concentration	O
of	O
approximately	O
0	O
.	O
15	O
%	O
.	O

All	O
dilutions	O
in	O
the	O
text	O
refer	O
to	O
the	O
dilution	O
in	O
mineral	O
oil	O
.	O

All	O
chemicals	O
were	O
obtained	O
from	O
Fluka	O
Chemie	O
.	O

Task	O
habituation	O
training	O

Beginning	O
1	O
-	O
3	O
d	O
after	O
the	O
start	O
of	O
the	O
water	O
restriction	O
schedule	O
,	O
animals	O
were	O
trained	O
using	O
standard	O
operant	O
-	O
conditioning	O
procedures	O
[	O
3	O
]	O
.	O

In	O
a	O
first	O
pretraining	O
step	O
,	O
each	O
lick	O
at	O
the	O
water	O
delivery	O
tube	O
was	O
rewarded	O
.	O

After	O
20	O
licks	O
,	O
a	O
second	O
stage	O
was	O
entered	O
in	O
which	O
head	O
insertion	O
initiated	O
a	O
2	O
-	O
s	O
"	O
odor	O
"	O
presentation	O
during	O
which	O
a	O
lick	O
was	O
rewarded	O
.	O

The	O
"	O
odorant	O
"	O
used	O
in	O
the	O
pretraining	O
was	O
the	O
carrier	O
medium	O
mineral	O
oil	O
.	O

All	O
animals	O
learned	O
this	O
task	O
within	O
one	O
day	O
(	O
2	O
-	O
3	O
sessions	O
30	O
min	O
each	O
)	O
.	O

Structure	O
of	O
an	O
individual	O
trial	O

The	O
mouse	O
initiates	O
each	O
trial	O
by	O
breaking	O
a	O
light	O
barrier	O
at	O
the	O
opening	O
of	O
the	O
sampling	O
port	O
(	O
see	O
also	O
[	O
3	O
]	O
)	O
.	O

This	O
opens	O
one	O
of	O
eight	O
odor	O
valves	O
,	O
and	O
a	O
diversion	O
valve	O
that	O
diverts	O
all	O
air	O
flow	O
away	O
from	O
the	O
animal	O
for	O
typically	O
500	O
ms	O
.	O

After	O
the	O
release	O
of	O
the	O
diversion	O
valve	O
,	O
the	O
odor	O
is	O
accessible	O
to	O
the	O
animal	O
for	O
2	O
,	O
000	O
ms	O
.	O

If	O
it	O
continuously	O
licks	O
at	O
the	O
lick	O
port	O
during	O
this	O
time	O
(	O
once	O
in	O
at	O
least	O
three	O
out	O
of	O
four	O
500	O
-	O
ms	O
bins	O
)	O
,	O
it	O
can	O
receive	O
a	O
2	O
-	O
to	O
4	O
-	O
mu	O
l	O
water	O
reward	O
after	O
the	O
end	O
of	O
the	O
2	O
,	O
000	O
-	O
ms	O
period	O
.	O

If	O
the	O
animal	O
does	O
not	O
continuously	O
lick	O
,	O
or	O
if	O
the	O
presented	O
odor	O
was	O
a	O
designated	O
nonrewarded	O
odor	O
,	O
neither	O
a	O
reward	O
is	O
given	O
nor	O
any	O
sort	O
of	O
punishment	O
,	O
to	O
minimize	O
stress	O
for	O
the	O
animal	O
.	O

Trials	O
are	O
counted	O
as	O
correct	O
if	O
the	O
animal	O
licks	O
continuously	O
upon	O
presentation	O
of	O
a	O
rewarded	O
odor	O
or	O
does	O
not	O
lick	O
continuously	O
with	O
a	O
nonrewarded	O
odor	O
.	O

A	O
second	O
trial	O
cannot	O
be	O
initiated	O
unless	O
an	O
intertrial	O
interval	O
of	O
at	O
least	O
5	O
s	O
has	O
passed	O
.	O

This	O
interval	O
is	O
sufficiently	O
long	O
so	O
that	O
animals	O
typically	O
retract	O
quickly	O
after	O
the	O
end	O
of	O
the	O
trial	O
.	O

Odors	O
are	O
presented	O
in	O
a	O
pseudo	O
-	O
randomized	O
scheme	O
(	O
no	O
more	O
than	O
two	O
successive	O
presentations	O
of	O
the	O
same	O
odor	O
,	O
equal	O
numbers	O
within	O
each	O
20	O
-	O
trial	O
block	O
)	O
.	O

No	O
intrinsic	O
preference	O
toward	O
any	O
of	O
the	O
odors	O
was	O
observed	O
but	O
controlled	O
for	O
by	O
counterbalancing	O
.	O

A	O
total	O
of	O
100	O
-	O
300	O
trials	O
were	O
performed	O
each	O
day	O
,	O
separated	O
into	O
30	O
-	O
to	O
40	O
-	O
min	O
stretches	O
to	O
ensure	O
maximal	O
motivation	O
despite	O
the	O
mild	O
water	O
restriction	O
scheme	O
.	O

Additionally	O
,	O
motivation	O
was	O
controlled	O
by	O
monitoring	O
intertrial	O
intervals	O
and	O
the	O
response	O
frequency	O
[	O
3	O
]	O
.	O

Measurement	O
of	O
performance	O

The	O
simplest	O
measure	O
of	O
performance	O
is	O
the	O
fraction	O
of	O
trials	O
in	O
which	O
the	O
animal	O
responds	O
correctly	O
--	O
that	O
is	O
,	O
responds	O
with	O
licking	O
to	O
the	O
presentation	O
of	O
the	O
S	O
+	O
odor	O
and	O
does	O
not	O
lick	O
with	O
presentation	O
of	O
the	O
S	O
-	O
odor	O
.	O

It	O
was	O
shown	O
previously	O
,	O
however	O
,	O
that	O
the	O
detailed	O
sampling	O
pattern	O
is	O
a	O
more	O
sensitive	O
measure	O
of	O
discrimination	O
performance	O
[	O
3	O
]	O
.	O

To	O
avoid	O
long	O
(	O
>	O
3	O
-	O
week	O
)	O
training	O
periods	O
,	O
we	O
chose	O
not	O
to	O
measure	O
discrimination	O
times	O
[	O
3	O
]	O
but	O
to	O
analyze	O
the	O
average	O
sampling	O
behavior	O
in	O
total	O
.	O

Upon	O
presentation	O
of	O
a	O
rewarded	O
odor	O
,	O
the	O
animal	O
usually	O
continuously	O
breaks	O
the	O
beam	O
,	O
whereas	O
upon	O
presentation	O
of	O
an	O
unrewarded	O
odor	O
the	O
head	O
is	O
quickly	O
retracted	O
.	O

The	O
difference	O
in	O
response	O
to	O
the	O
rewarded	O
and	O
unrewarded	O
odor	O
is	O
approximately	O
sigmoidal	O
(	O
Figures	O
1D	O
,	O
1E	O
,	O
and	O
2D	O
)	O
and	O
yields	O
a	O
sensitive	O
measure	O
of	O
the	O
discrimination	O
performance	O
.	O

From	O
this	O
difference	O
or	O
from	O
a	O
sigmoidal	O
fit	O
to	O
the	O
difference	O
(	O
Figure	O
1E	O
)	O
,	O
several	O
measures	O
of	O
discrimination	O
can	O
be	O
determined	O
:	O
the	O
average	O
difference	O
,	O
peak	O
,	O
or	O
maximum	O
,	O
time	O
of	O
half	O
maximum	O
,	O
and	O
slope	O
of	O
the	O
fitted	O
sigmoid	O
.	O

Whereas	O
for	O
small	O
trial	O
numbers	O
(	O
<	O
200	O
)	O
the	O
slope	O
often	O
is	O
not	O
well	O
constrained	O
,	O
any	O
of	O
the	O
other	O
parameters	O
yielded	O
essentially	O
the	O
same	O
results	O
.	O

The	O
discrimination	O
index	O
plotted	O
in	O
Figures	O
1F	O
,	O
2C	O
,	O
4D	O
,	O
and	O
6C	O
refers	O
to	O
the	O
fitted	O
maximum	O
,	O
generally	O
ranging	O
from	O
zero	O
to	O
one	O
,	O
one	O
indicating	O
the	O
best	O
discrimination	O
.	O

Identical	O
results	O
were	O
obtained	O
with	O
other	O
measures	O
of	O
discrimination	O
,	O
such	O
as	O
the	O
average	O
sampling	O
difference	O
.	O

Structure	O
of	O
training	O

After	O
habituation	O
,	O
mice	O
were	O
trained	O
to	O
discriminate	O
1	O
%	O
amylacetate	O
from	O
1	O
%	O
ethylbutyrate	O
for	O
500	O
trials	O
.	O

During	O
the	O
last	O
100	O
trials	O
,	O
the	O
S	O
+	O
odor	O
was	O
rewarded	O
in	O
only	O
50	O
%	O
of	O
the	O
cases	O
to	O
increase	O
the	O
resistance	O
to	O
extinction	O
of	O
the	O
acquired	O
memory	O
.	O

These	O
trials	O
were	O
excluded	O
for	O
the	O
statistical	O
analysis	O
of	O
the	O
learning	O
curves	O
.	O

Inclusion	O
did	O
not	O
alter	O
the	O
result	O
of	O
the	O
ANOVA	O
;	O
however	O
,	O
linear	O
fitting	O
of	O
the	O
learning	O
curve	O
was	O
not	O
appropriate	O
anymore	O
as	O
partial	O
saturation	O
of	O
learning	O
performance	O
had	O
already	O
occurred	O
.	O

Subsequently	O
,	O
animals	O
were	O
trained	O
for	O
500	O
trials	O
on	O
the	O
"	O
difficult	O
"	O
discrimination	O
task	O
[	O
3	O
]	O
between	O
the	O
binary	O
mixtures	O
0	O
.	O
6	O
%	O
eugenol	O
/	O
0	O
.	O
4	O
%	O
cineol	O
and	O
0	O
.	O
4	O
%	O
eugenol	O
/	O
0	O
.	O
6	O
%	O
cineol	O
.	O

To	O
allow	O
comparison	O
,	O
the	O
last	O
100	O
trials	O
were	O
altered	O
as	O
for	O
the	O
"	O
simple	O
"	O
discrimination	O
task	O
above	O
.	O

After	O
two	O
days	O
of	O
rest	O
,	O
animals	O
were	O
finally	O
trained	O
on	O
the	O
"	O
simple	O
"	O
discrimination	O
task	O
between	O
1	O
%	O
pelargonic	O
acid	O
and	O
1	O
%	O
valeric	O
acid	O
for	O
another	O
600	O
trials	O
.	O

In	O
all	O
experiments	O
,	O
counterbalancing	O
between	O
both	O
odors	O
and	O
setups	O
was	O
ensured	O
within	O
and	O
between	O
genetic	O
groups	O
,	O
or	O
results	O
were	O
compared	O
with	O
counterbalanced	O
subgroups	O
,	O
which	O
in	O
every	O
case	O
yielded	O
identical	O
results	O
.	O

During	O
the	O
entire	O
course	O
of	O
the	O
experiment	O
,	O
the	O
person	O
handling	O
the	O
animals	O
and	O
operating	O
the	O
olfactometers	O
was	O
blind	O
to	O
the	O
genotype	O
of	O
the	O
mice	O
.	O

Memory	O
measurement	O

To	O
assess	O
memory	O
,	O
after	O
280	O
trials	O
of	O
training	O
to	O
discriminate	O
between	O
pelargonic	O
acid	O
and	O
valeric	O
acid	O
,	O
memory	O
trials	O
were	O
interleaved	O
for	O
120	O
trials	O
;	O
that	O
is	O
,	O
within	O
each	O
block	O
of	O
20	O
trials	O
two	O
unrewarded	O
amylacetate	O
and	O
two	O
unrewarded	O
ethylbutyrate	O
trials	O
were	O
included	O
.	O

Memory	O
scores	O
are	O
given	O
as	O
the	O
fraction	O
of	O
those	O
unrewarded	O
trials	O
that	O
were	O
responded	O
to	O
"	O
correctly	O
"	O
(	O
licking	O
response	O
to	O
the	O
odor	O
that	O
was	O
rewarded	O
in	O
the	O
initial	O
training	O
session	O
[	O
S	O
+	O
]	O
,	O
no	O
response	O
to	O
the	O
odor	O
that	O
was	O
not	O
rewarded	O
initially	O
[	O
S	O
-	O
]	O
)	O
.	O

Due	O
to	O
the	O
epileptic	O
phenotype	O
and	O
the	O
slightly	O
increased	O
mortality	O
[	O
58	O
]	O
,	O
GluRB	O
Delta	O
ECS	O
:	O
FB	O
mice	O
were	O
trained	O
only	O
for	O
the	O
initial	O
period	O
of	O
400	O
trials	O
.	O

Statistics	O

Learning	O
curves	O
for	O
both	O
correct	O
performance	O
(	O
"	O
percentage	O
correct	O
"	O
)	O
and	O
the	O
discrimination	O
performance	O
were	O
analyzed	O
by	O
repeated	O
measure	O
ANOVA	O
.	O

Additionally	O
,	O
learning	O
curves	O
were	O
assessed	O
by	O
linearly	O
fitting	O
of	O
trend	O
lines	O
to	O
the	O
data	O
with	O
fixed	O
offsets	O
,	O
leaving	O
the	O
slope	O
as	O
the	O
only	O
variable	O
.	O

In	O
general	O
,	O
binning	O
was	O
100	O
trials	O
per	O
block	O
.	O

To	O
allow	O
for	O
the	O
investigation	O
of	O
group	O
/	O
block	O
interactions	O
,	O
the	O
repeated	O
measure	O
ANOVA	O
binning	O
was	O
reduced	O
to	O
20	O
trials	O
per	O
block	O
.	O

To	O
compare	O
memory	O
performance	O
in	O
the	O
GluR	O
-	O
BRescue	O
(	O
n	O
=	O
8	O
)	O
and	O
GluR	O
-	O
B	O
Delta	O
FB	O
(	O
n	O
=	O
22	O
)	O
mice	O
,	O
due	O
to	O
the	O
high	O
variability	O
,	O
a	O
bootstrap	O
approach	O
was	O
employed	O
.	O

Subpopulations	O
of	O
eight	O
animals	O
were	O
selected	O
from	O
the	O
population	O
of	O
22	O
GluR	O
-	O
B	O
Delta	O
FB	O
mice	O
,	O
and	O
mean	O
memory	O
was	O
determined	O
.	O

In	O
only	O
343	O
out	O
of	O
20	O
,	O
000	O
subpopulations	O
,	O
mean	O
memory	O
exceeded	O
the	O
mean	O
GluR	O
-	O
BRescue	O
memory	O
of	O
74	O
.	O
99	O
%	O
,	O
resulting	O
in	O
a	O
p	O
value	O
of	O
p	O
=	O
343	O
/	O
20	O
,	O
000	O
=	O
0	O
.	O
017	O
.	O

Supporting	O
Information	O

Figure	O
S1	O

Forebrain	O
-	O
Specific	O
Gene	O
Manipulation	O

(	O
A	O
)	O
Schematic	O
diagrams	O
depicting	O
Cre	O
under	O
the	O
alpha	O
CaMKII	O
promoter	O
control	O
[	O
59	O
]	O
and	O
Cre	O
-	O
dependent	O
expression	O
of	O
beta	O
-	O
galactosidase	O
(	O
LacZ	O
)	O
by	O
the	O
R26R	O
indicator	O
mouse	O
[	O
85	O
]	O
.	O

(	O
B	O
)	O
Coronal	O
forebrain	O
sections	O
(	O
left	O
)	O
and	O
sagittal	O
brainstem	O
/	O
cerebellum	O
sections	O
of	O
mice	O
at	O
P42	O
positive	O
for	O
TgCre4	O
and	O
R26R	O
Cre	O
-	O
indicator	O
.	O

Cre	O
expression	O
visualized	O
by	O
enzymatic	O
beta	O
-	O
galactosidase	O
activity	O
(	O
blue	O
,	O
X	O
-	O
gal	O
,	O
counterstain	O
by	O
eosin	O
)	O
of	O
R26R	O
and	O
by	O
anti	O
-	O
Cre	O
immunostainings	O
(	O
brown	O
,	O
DAB	O
[	O
diaminobenzadine	O
]	O
)	O
was	O
restricted	O
to	O
forebrain	O
regions	O
.	O

Scale	O
bars	O
:	O
1	O
mm	O
.	O

A	O
,	O
amygdala	O
;	O
Ce	O
,	O
Cerebellum	O
;	O
Cx	O
,	O
cortex	O
;	O
H	O
,	O
hippocampus	O
;	O
Me	O
,	O
medulla	O
oblongata	O
.	O

(	O
C	O
)	O
Olfactory	O
bulb	O
sections	O
of	O
the	O
same	O
mouse	O
to	O
visualize	O
Cre	O
expression	O
by	O
Cre	O
immunoreactivity	O
(	O
left	O
,	O
DAB	O
)	O
and	O
by	O
enzymatic	O
beta	O
-	O
galactosidase	O
activity	O
(	O
right	O
,	O
X	O
-	O
gal	O
,	O
counterstain	O
by	O
eosin	O
)	O
in	O
granule	O
cells	O
(	O
GC	O
)	O
and	O
mitral	O
cells	O
(	O
MC	O
)	O
as	O
indicated	O
by	O
arrows	O
.	O

Scale	O
bars	O
:	O
400	O
mu	O
m	O
(	O
upper	O
panel	O
)	O
,	O
50	O
mu	O
m	O
(	O
lower	O
panel	O
)	O
.	O

(	O
3	O
.	O
4	O
MB	O
TIF	O
)	O
.	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Figure	O
S2	O

Performance	O
of	O
GluR	O
-	O
B	O
Delta	O
FB	O
(	O
n	O
=	O
10	O
)	O
and	O
Littermate	O
Control	O
(	O
n	O
=	O
10	O
)	O
Mice	O
in	O
a	O
Spatial	O
Reference	O
Task	O
on	O
the	O
Elevated	O
Y	O
-	O
Maze	O

Details	O
of	O
the	O
methodology	O
are	O
described	O
in	O
[	O
90	O
]	O
.	O

*	O
indicates	O
p	O
<	O
0	O
.	O
05	O
.	O

(	O
126	O
KB	O
TIF	O
)	O
.	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Figure	O
S3	O

Memory	O
Deficit	O
Is	O
Not	O
Due	O
to	O
Increased	O
Extinction	O

(	O
A	O
)	O
Memory	O
performance	O
as	O
a	O
function	O
of	O
time	O
for	O
the	O
experiment	O
described	O
in	O
Figure	O
2E	O
(	O
nine	O
GluR	O
-	O
B	O
Delta	O
FB	O
and	O
nine	O
GluR	O
-	O
B2lox	O
control	O
animals	O
)	O
.	O

Only	O
four	O
unrewarded	O
"	O
memory	O
+	O
"	O
trials	O
are	O
binned	O
for	O
each	O
data	O
point	O
.	O

Memory	O
of	O
GluR	O
-	O
B	O
Delta	O
FB	O
animals	O
was	O
significantly	O
reduced	O
(	O
F	O
(	O
1	O
,	O
33	O
)	O
=	O
17	O
;	O
p	O
<	O
0	O
.	O
001	O
)	O
.	O

Whereas	O
a	O
weak	O
overall	O
time	O
effect	O
could	O
be	O
observed	O
(	O
F	O
(	O
2	O
,	O
66	O
)	O
=	O
3	O
.	O
6	O
;	O
p	O
=	O
0	O
.	O
03	O
)	O
,	O
there	O
was	O
no	O
genotype	O
-	O
time	O
interaction	O
effect	O
(	O
F	O
(	O
2	O
,	O
66	O
)	O
=	O
0	O
.	O
67	O
;	O
p	O
=	O
0	O
.	O
5	O
)	O
,	O
indicating	O
that	O
there	O
is	O
no	O
differential	O
effect	O
of	O
putative	O
extinction	O
on	O
memory	O
performance	O
.	O

*	O
indicates	O
p	O
-	O
values	O
for	O
a	O
Mann	O
-	O
Whitney	O
U	O
test	O
(	O
*	O
<	O
0	O
.	O
05	O
,	O
*	O
*	O
<	O
0	O
.	O
01	O
)	O
.	O

(	O
B	O
)	O
After	O
the	O
memory	O
experiments	O
from	O
Figure	O
6A	O
,	O
the	O
last	O
set	O
of	O
animals	O
(	O
eight	O
GluR	O
-	O
BRescue	O
,	O
four	O
GluR	O
-	O
B	O
Delta	O
FB	O
,	O
and	O
three	O
controls	O
)	O
was	O
further	O
trained	O
on	O
AA	O
versus	O
EB	O
for	O
900	O
trials	O
one	O
week	O
after	O
the	O
memory	O
experiment	O
.	O

Subsequently	O
,	O
training	O
continued	O
on	O
AA	O
/	O
EB	O
mixtures	O
for	O
1	O
,	O
200	O
trials	O
.	O

Finally	O
,	O
the	O
animals	O
were	O
retrained	O
on	O
AA	O
and	O
EB	O
for	O
100	O
trials	O
.	O

Relearning	O
performance	O
during	O
the	O
last	O
retraining	O
task	O
is	O
highly	O
correlated	O
to	O
the	O
original	O
memory	O
performance	O
(	O
R2	O
=	O
0	O
.	O
46	O
,	O
p	O
=	O
0	O
.	O
006	O
,	O
n	O
=	O
15	O
)	O
.	O

(	O
264	O
KB	O
TIF	O
)	O
.	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Figure	O
S4	O

Absence	O
of	O
Cre	O
Expression	O
in	O
the	O
Main	O
Olfactory	O
Epithelium	O
of	O
TgCre4	O
Mice	O

(	O
A	O
)	O
Overview	O
of	O
the	O
main	O
olfactory	O
epithelium	O
.	O

(	O
B	O
)	O
Higher	O
magnification	O
of	O
(	O
A	O
)	O
showing	O
all	O
cells	O
with	O
propidium	O
iodide	O
(	O
red	O
)	O
and	O
absence	O
of	O
Cre	O
-	O
positive	O
cells	O
(	O
green	O
,	O
anti	O
-	O
Cre	O
)	O
.	O

(	O
C	O
)	O
Positive	O
control	O
showing	O
granule	O
cells	O
of	O
the	O
dentate	O
gyrus	O
stained	O
for	O
nuclear	S-GO
Cre	O
(	O
green	O
)	O
from	O
the	O
same	O
mouse	O
.	O

(	O
3	O
.	O
7	O
MB	O
TIF	O
)	O
.	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Acknowledgements	O

The	O
authors	O
want	O
to	O
thank	O
Troy	O
Margrie	O
and	O
Bert	O
Sakmann	O
for	O
support	O
,	O
encouragement	O
,	O
and	O
discussion	O
;	O
Onyeka	O
Nobuka	O
for	O
help	O
with	O
the	O
construct	O
OCN	O
;	O
Mark	O
Mayford	O
for	O
the	O
alpha	O
CaMKII	O
promoter	O
;	O
Bettina	O
Suchanek	O
for	O
the	O
NR2C	O
silencer	O
;	O
Annette	O
Herold	O
,	O
Juliana	O
Kling	O
,	O
and	O
Christiane	O
Zacher	O
for	O
experimental	O
and	O
technical	O
supports	O
;	O
Nixon	O
Abraham	O
for	O
assistance	O
with	O
some	O
behavioral	O
experiments	O
;	O
and	O
David	O
Bannerman	O
,	O
Thomas	O
Kuner	O
,	O
and	O
Pavel	O
Osten	O
for	O
critically	O
reading	O
early	O
versions	O
of	O
the	O
manuscript	O
.	O

This	O
work	O
was	O
supported	O
by	O
a	O
Deutsche	O
Forschungsgemeinschaft	O
grant	O
(	O
SFB	O
636	O
)	O
to	O
RS	O
,	O
the	O
Heidelberger	O
Akademie	O
der	O
Wissenschaften	O
,	O
the	O
Boeringer	O
Ingelheim	O
Fonds	O
,	O
and	O
the	O
Leopoldina	O
Akademie	O
der	O
Wissenschaften	O
to	O
ATS	O
,	O
the	O
BMBF	O
,	O
and	O
the	O
MPG	O
.	O

Competing	O
interests	O
.	O

The	O
authors	O
have	O
declared	O
that	O
no	O
competing	O
interests	O
exist	O
.	O

Abbreviations	O

AMPA	O
-	O
alpha	O
-	O
amino	O
-	O
3	O
-	O
hydroxy	O
-	O
5	O
-	O
methyl	O
-	O
4	O
-	O
isoxazolepropionate	O

AMPAR	O
-	O
alpha	O
-	O
amino	O
-	O
3	O
-	O
hydroxy	O
-	O
5	O
-	O
methyl	O
-	O
4	O
-	O
isoxazolepropionate	O
receptor	O

bp	O
-	O
basepair	O

GFP	O
-	O
green	O
fluorescent	O
protein	O

LTP	O
-	O
long	O
-	O
term	O
plasticity	O

NMDA	O
-	O
N	O
-	O
methyl	O
-	O
D	O
-	O
aspartate	O

Q	O
-	O
glutamine	O

R	O
-	O
arginine	O

Figures	O
and	O
Tables	O

Figure	O
1	O

Odor	O
Learning	O
and	O
Discrimination	O
Is	O
Enhanced	O
in	O
GluR	O
-	O
B	O
Delta	O
ECS	O
:	O
FB	O
Mice	O

(	O
A	O
)	O
Schematic	O
diagram	O
depicting	O
Cre	O
-	O
mediated	O
activation	O
of	O
GluR	O
-	O
B	O
(	O
Q	O
)	O
by	O
removing	O
the	O
loxP	O
-	O
flanked	O
TK	O
-	O
neo	O
(	O
TK	O
-	O
neo	O
pA	O
,	O
GluR	O
-	O
Bneo	O
)	O
element	O
in	O
intron	O
11	O
,	O
which	O
is	O
acting	O
as	O
a	O
suppressor	O
in	O
expression	O
from	O
the	O
Q	O
/	O
R	O
site	O
editing	O
deficient	O
GluR	O
-	O
Bneo	O
allele	O
.	O

Exon	O
10	O
and	O
11	O
encode	O
membrane	O
-	O
spanning	O
segments	O
1	O
,	O
2	O
,	O
and	O
3	O
(	O
M1	O
,	O
2	O
,	O
3	O
)	O
of	O
the	O
GluR	O
-	O
B	O
subunit	O
.	O

The	O
intronic	O
element	O
necessary	O
for	O
editing	O
the	O
Q	O
/	O
R	O
site	O
is	O
shown	O
for	O
the	O
wild	O
-	O
type	O
allele	O
(	O
+	O
)	O
.	O

(	O
B	O
)	O
Scheme	O
of	O
an	O
individual	O
trial	O
.	O

Breaking	O
a	O
light	O
barrier	O
,	O
the	O
mouse	O
initiates	O
a	O
trial	O
.	O

An	O
odor	O
is	O
presented	O
,	O
and	O
(	O
depending	O
on	O
the	O
odor	O
denotation	O
and	O
the	O
mouse	O
'	O
s	O
response	O
)	O
the	O
mouse	O
is	O
rewarded	O
or	O
retracts	O
its	O
head	O
.	O

A	O
small	O
(	O
2	O
-	O
to	O
4	O
-	O
mu	O
l	O
)	O
water	O
reward	O
is	O
given	O
at	O
the	O
end	O
of	O
an	O
S	O
+	O
odor	O
if	O
the	O
mouse	O
continuously	O
licks	O
at	O
the	O
delivery	O
tube	O
during	O
the	O
2	O
-	O
s	O
trial	O
.	O

A	O
trial	O
is	O
counted	O
as	O
correct	O
if	O
the	O
mouse	O
licks	O
continuously	O
upon	O
presentation	O
of	O
a	O
rewarded	O
(	O
S	O
+	O
)	O
odor	O
or	O
does	O
not	O
lick	O
continuously	O
with	O
a	O
nonrewarded	O
(	O
S	O
-	O
)	O
odor	O
[	O
3	O
]	O
.	O

(	O
C	O
)	O
Twelve	O
experimentally	O
na	O
i	O
ve	O
animals	O
(	O
six	O
GluR	O
-	O
B	O
Delta	O
ECS	O
:	O
FB	O
[	O
orange	O
]	O
and	O
six	O
GluR	O
-	O
B	O
+	O
/	O
+	O
littermate	O
controls	O
[	O
black	O
]	O
)	O
were	O
trained	O
on	O
1	O
%	O
AA	O
versus	O
1	O
%	O
EB	O
for	O
two	O
tasks	O
of	O
200	O
trials	O
each	O
.	O

Both	O
groups	O
acquired	O
the	O
task	O
(	O
>	O
70	O
%	O
correct	O
)	O
;	O
however	O
,	O
the	O
GluR	O
-	O
B	O
Delta	O
ECS	O
:	O
FB	O
were	O
both	O
quicker	O
,	O
and	O
performed	O
better	O
overall	O
,	O
than	O
the	O
littermate	O
controls	O
(	O
group	O
effect	O
:	O
F	O
(	O
1	O
,	O
10	O
)	O
=	O
10	O
.	O
2	O
;	O
p	O
<	O
0	O
.	O
01	O
)	O
.	O

AA	O
,	O
amylacetate	O
;	O
EB	O
,	O
ethylbutyrate	O
.	O

(	O
D	O
)	O
Average	O
head	O
position	O
for	O
one	O
mouse	O
and	O
50	O
presentations	O
of	O
the	O
S	O
+	O
(	O
green	O
)	O
and	O
50	O
presentations	O
of	O
the	O
S	O
-	O
(	O
red	O
)	O
odor	O
.	O

"	O
1	O
"	O
indicates	O
the	O
breaking	O
of	O
the	O
light	O
beam	O
(	O
head	O
in	O
the	O
sampling	O
port	O
[	O
3	O
]	O
)	O
.	O

Note	O
the	O
rapid	O
head	O
retraction	O
for	O
the	O
S	O
-	O
odor	O
.	O

(	O
E	O
)	O
Difference	O
of	O
the	O
average	O
head	O
positions	O
from	O
(	O
D	O
)	O
for	O
S	O
+	O
and	O
S	O
-	O
odors	O
.	O

Blue	O
line	O
indicates	O
sigmoidal	O
fit	O
.	O

"	O
Discrimination	O
index	O
"	O
refers	O
to	O
the	O
maximum	O
of	O
the	O
fitted	O
sigmoid	O
.	O

(	O
F	O
)	O
As	O
(	O
C	O
)	O
but	O
depicting	O
the	O
discrimination	O
index	O
as	O
a	O
function	O
of	O
trial	O
number	O
(	O
group	O
effect	O
:	O
F	O
(	O
1	O
,	O
10	O
)	O
=	O
1	O
.	O
7	O
;	O
p	O
<	O
0	O
.	O
01	O
)	O
.	O

Figure	O
2	O

Odor	O
Learning	O
and	O
Discrimination	O
Is	O
Enhanced	O
,	O
but	O
Odor	O
Memory	O
Is	O
Reduced	O
in	O
GluR	O
-	O
B	O
Delta	O
FB	O
Mice	O

(	O
A	O
)	O
Schematic	O
diagram	O
depicting	O
Cre	O
-	O
mediated	O
ablation	O
of	O
loxP	O
-	O
flanked	O
exon	O
11	O
of	O
the	O
GluR	O
-	O
B	O
alleles	O
.	O

(	O
B	O
and	O
C	O
)	O
Nine	O
GluR	O
-	O
B	O
Delta	O
FB	O
(	O
red	O
)	O
and	O
nine	O
GluRB2lox	O
littermate	O
controls	O
(	O
black	O
)	O
were	O
trained	O
for	O
successive	O
odor	O
discrimination	O
tasks	O
on	O
1	O
%	O
AA	O
versus	O
1	O
%	O
EB	O
(	O
400	O
trials	O
)	O
,	O
0	O
.	O
4	O
%	O
Cin	O
/	O
0	O
.	O
6	O
%	O
Eu	O
versus	O
0	O
.	O
6	O
%	O
Cin	O
/	O
0	O
.	O
4	O
%	O
Eu	O
(	O
400	O
trials	O
)	O
and	O
1	O
%	O
Pel	O
versus	O
1	O
%	O
Val	O
.	O

GluR	O
-	O
B	O
Delta	O
FB	O
mice	O
showed	O
increased	O
learning	O
/	O
discrimination	O
compared	O
with	O
controls	O
,	O
both	O
using	O
the	O
performance	O
as	O
measured	O
by	O
percentage	O
of	O
correct	O
trials	O
(	O
[	O
B	O
]	O
;	O
group	O
effect	O
:	O
F1	O
,	O
16	O
=	O
6	O
.	O
55	O
,	O
p	O
<	O
0	O
.	O
05	O
)	O
or	O
the	O
discrimination	O
index	O
(	O
C	O
)	O
,	O
that	O
is	O
the	O
maximal	O
difference	O
of	O
the	O
sampling	O
pattern	O
(	O
see	O
Materials	O
and	O
Methods	O
and	O
Figure	O
1D	O
-	O
1F	O
;	O
F1	O
,	O
16	O
=	O
29	O
.	O
5	O
,	O
p	O
<	O
10	O
-	O
4	O
)	O
.	O

(	O
D	O
)	O
Sampling	O
difference	O
for	O
the	O
last	O
100	O
trials	O
of	O
the	O
mixture	O
discrimination	O
task	O
(	O
indicated	O
with	O
a	O
black	O
arrow	O
in	O
[	O
C	O
]	O
)	O
for	O
all	O
18	O
individual	O
mice	O
.	O

Note	O
that	O
the	O
GluR	O
-	O
B	O
Delta	O
FB	O
mice	O
show	O
a	O
consistently	O
larger	O
sampling	O
difference	O
.	O

(	O
E	O
)	O
Olfactory	O
memory	O
performance	O
for	O
nine	O
littermate	O
controls	O
(	O
black	O
)	O
and	O
nine	O
GluR	O
-	O
B	O
Delta	O
FB	O
(	O
red	O
)	O
mice	O
.	O

Olfactory	O
memory	O
was	O
tested	O
at	O
the	O
time	O
indicated	O
by	O
the	O
black	O
bar	O
in	O
(	O
C	O
)	O
by	O
interleaving	O
the	O
Pel	O
and	O
Val	O
trials	O
with	O
unrewarded	O
AA	O
and	O
EB	O
trials	O
.	O

AA	O
,	O
amylacetate	O
;	O
Cin	O
,	O
cineol	O
;	O
EB	O
,	O
ethylbutyrate	O
;	O
Eu	O
,	O
eugenol	O
;	O
Pel	O
,	O
pelargonic	O
acid	O
;	O
Val	O
,	O
valeric	O
acid	O
.	O

Figure	O
3	O

Variability	O
of	O
Cre	O
Expression	O
of	O
Mouse	O
Line	O
TgCre4	O

(	O
A	O
)	O
Variable	O
Cre	O
expression	O
in	O
forebrains	O
of	O
three	O
different	O
mice	O
positive	O
for	O
TgCre4	O
and	O
R26R	O
Cre	O
indicator	O
(	O
see	O
Figure	O
S1	O
)	O
at	O
postnatal	O
day	O
12	O
pictured	O
by	O
the	O
Cre	O
-	O
dependent	O
beta	O
-	O
galactosidase	O
activity	O
(	O
blue	O
,	O
X	O
-	O
gal	O
,	O
counterstain	O
by	O
eosin	O
)	O
in	O
coronal	O
brain	O
slices	O
.	O

Scale	O
bar	O
:	O
1	O
.	O
25	O
mm	O
.	O

(	O
B	O
)	O
Southern	O
blot	O
analysis	O
of	O
BglII	O
-	O
digested	O
genomic	O
mouse	O
DNA	O
of	O
four	O
TgCre4	O
mice	O
that	O
differed	O
in	O
the	O
Cre	O
expression	O
pattern	O
.	O

Southern	O
probe	O
detects	O
the	O
wild	O
-	O
type	O
(	O
4	O
.	O
5	O
kbp	O
)	O
and	O
the	O
transgenic	O
(	O
7	O
,	O
5	O
,	O
3	O
,	O
and	O
2	O
kbp	O
)	O
alleles	O
.	O

Figure	O
4	O

Olfactory	O
Memory	O
but	O
not	O
Odor	O
Learning	O
/	O
Discrimination	O
Is	O
Correlated	O
with	O
Residual	O
GluR	O
-	O
B	O
Levels	O
in	O
Hippocampus	O
and	O
Forebrain	O
of	O
GluR	O
-	O
B	O
Delta	O
FB	O
Mice	O

(	O
A	O
)	O
The	O
olfactory	O
memory	O
performance	O
for	O
18	O
GluR	O
-	O
B	O
Delta	O
FB	O
(	O
red	O
)	O
and	O
11	O
littermate	O
control	O
(	O
black	O
)	O
mice	O
is	O
given	O
as	O
mean	O
(	O
thick	O
lines	O
+/-	O
SEM	O
)	O
and	O
as	O
individual	O
performance	O
in	O
open	O
circles	O
and	O
triangles	O
.	O

Arrows	O
with	O
numbers	O
(	O
#	O
)	O
indicate	O
those	O
mice	O
used	O
in	O
experiments	O
(	O
B	O
-	O
C	O
)	O
.	O

Data	O
were	O
combined	O
from	O
Figure	O
2	O
(	O
open	O
symbols	O
)	O
and	O
an	O
additional	O
experiment	O
with	O
nine	O
GluR	O
-	O
B	O
Delta	O
FB	O
and	O
two	O
littermate	O
controls	O
(	O
shaded	O
symbols	O
)	O
.	O

(	O
B	O
and	O
C	O
)	O
Residual	O
GluR	O
-	O
B	O
levels	O
as	O
detected	O
by	O
anti	O
-	O
GluR	O
-	O
B	O
immunofluorescence	O
in	O
hippocampus	O
,	O
amygdala	O
,	O
piriform	O
cortex	O
,	O
and	O
olfactory	O
bulb	O
of	O
one	O
control	O
(	O
#	O
1	O
)	O
and	O
two	O
GluR	O
-	O
B	O
Delta	O
FB	O
(	O
#	O
2	O
and	O
#	O
3	O
)	O
coronal	O
mouse	O
brain	O
sections	O
(	O
B	O
)	O
and	O
by	O
immunoblot	O
analysis	O
from	O
hippocampal	O
(	O
Hip	O
)	O
,	O
cortical	O
forebrain	O
(	O
FB	O
)	O
,	O
and	O
olfactory	O
bulb	O
(	O
OB	O
)	O
protein	O
extracts	O
of	O
control	O
(	O
#	O
4	O
)	O
and	O
GluR	O
-	O
B	O
Delta	O
FB	O
mice	O
(	O
#	O
5	O
,	O
#	O
6	O
,	O
#	O
7	O
,	O
and	O
#	O
8	O
)	O
probed	O
with	O
antibodies	S-GO
detecting	O
GluR	O
-	O
B	O
and	O
beta	O
-	O
actin	O
as	O
an	O
internal	O
loading	O
control	O
(	O
C	O
)	O
.	O

Scale	O
bars	O
:	O
200	O
mu	O
m	O
(	O
first	O
panel	O
)	O
,	O
100	O
mu	O
m	O
(	O
other	O
panels	O
)	O
.	O

(	O
D	O
)	O
From	O
ten	O
GluR	O
-	O
B	O
Delta	O
FB	O
mice	O
,	O
the	O
individual	O
odor	O
learning	O
/	O
discrimination	O
and	O
olfactory	O
memory	O
performance	O
was	O
determined	O
together	O
with	O
the	O
relative	O
GluR	O
-	O
B	O
levels	O
in	O
immunoblots	O
of	O
hippocampal	O
,	O
forebrain	O
,	O
and	O
olfactory	O
bulb	O
protein	O
extracts	O
.	O

Memory	O
performance	O
(	O
top	O
panels	O
)	O
and	O
discrimination	O
capability	O
(	O
bottom	O
panels	O
;	O
discrimination	O
index	O
is	O
measured	O
for	O
the	O
last	O
100	O
trials	O
of	O
the	O
mixture	O
discrimination	O
task	O
as	O
indicated	O
by	O
the	O
arrow	O
in	O
Figure	O
2C	O
)	O
were	O
plotted	O
against	O
GluR	O
-	O
B	O
levels	O
.	O

Memory	O
was	O
tightly	O
correlated	O
to	O
GluR	O
-	O
B	O
protein	O
level	O
in	O
hippocampus	O
(	O
R2	O
=	O
0	O
.	O
72	O
;	O
p	O
<	O
0	O
.	O
003	O
)	O
and	O
cortical	O
forebrain	O
(	O
R2	O
=	O
0	O
.	O
62	O
;	O
p	O
<	O
0	O
.	O
006	O
)	O
and	O
only	O
weakly	O
in	O
the	O
olfactory	O
bulb	O
(	O
R2	O
=	O
0	O
.	O
48	O
;	O
p	O
=	O
0	O
.	O
03	O
)	O
.	O

No	O
measure	O
of	O
learning	O
/	O
discrimination	O
(	O
discrimination	O
index	O
for	O
last	O
100	O
mixture	O
trials	O
[	O
D	O
]	O
,	O
slopes	O
of	O
trend	O
lines	O
,	O
average	O
discrimination	O
index	O
,	O
average	O
sampling	O
pattern	O
differences	O
,	O
correct	O
performance	O
,	O
etc	O
.	O
[	O
not	O
shown	O
]	O
)	O
displayed	O
any	O
correlation	O
(	O
R2	O
<	O
0	O
.	O
3	O
)	O
.	O

Figure	O
5	O

Specific	O
Hippocampus	O
and	O
Piriform	O
Cortex	O
Expression	O
of	O
Transgenic	O
GFPGluR	O
-	O
B	O

(	O
A	O
)	O
Schematic	O
diagrams	O
depicting	O
forebrain	O
-	O
specific	O
GluR	O
-	O
B	O
deletion	O
as	O
in	O
Figure	O
2A	O
and	O
itTA	O
-	O
dependent	O
expression	O
of	O
GFPGluR	O
-	O
B	O
and	O
nuclear	S-GO
-	O
localized	O
beta	O
-	O
galactosidase	O
(	O
nLacZ	O
)	O
in	O
GluR	O
-	O
B	O
Delta	O
FB	O
mice	O
(	O
termed	O
GluR	O
-	O
BRescue	O
)	O
.	O

GFPGluR	O
-	O
B	O
and	O
nLacZ	O
are	O
both	O
encoded	O
by	O
TgOCN1	O
,	O
and	O
itTA	O
is	O
controlled	O
by	O
a	O
fusion	O
of	O
the	O
NR2C	O
silencer	O
element	O
[	O
91	O
]	O
and	O
the	O
alpha	O
CaMKII	O
promoter	O
(	O
termed	O
TgCN12	O
-	O
itTA	O
[	O
92	O
]	O
)	O
.	O

(	O
B	O
)	O
In	O
coronal	O
brain	O
sections	O
of	O
mice	O
positive	O
for	O
both	O
transgenes	O
(	O
TgCN12	O
-	O
itTA	O
and	O
TgOCN1	O
)	O
beta	O
-	O
galactosidase	O
activity	O
(	O
blue	O
,	O
X	O
-	O
gal	O
,	O
counterstain	O
by	O
eosin	O
)	O
is	O
restricted	O
to	O
hippocampal	O
neurons	O
in	O
CA1	O
,	O
DG	O
,	O
and	O
neurons	O
in	O
the	O
piriform	O
cortex	O
.	O

The	O
same	O
neurons	O
show	O
GFPGluR	O
-	O
B	O
expression	O
when	O
analyzed	O
in	O
immunohistochemical	O
sections	O
with	O
an	O
antibody	S-GO
against	O
GFP	O
.	O

Scale	O
bars	O
:	O
500	O
mu	O
m	O
.	O

(	O
C	O
)	O
Immunoblot	O
detecting	O
endogenous	O
GluR	O
-	O
B	O
and	O
transgenic	O
GFPGluR	O
-	O
B	O
in	O
the	O
hippocampus	O
of	O
three	O
different	O
mice	O
(	O
#	O
1	O
,	O
#	O
2	O
,	O
#	O
3	O
)	O
.	O

(	O
D	O
)	O
Relative	O
quantification	O
from	O
(	O
C	O
)	O
of	O
transgenic	O
GFPGluR	O
-	O
B	O
compared	O
with	O
endogenous	O
GluR	O
-	O
B	O
in	O
the	O
hippocampus	O
.	O

Figure	O
6	O

GluR	O
-	O
B	O
Expression	O
in	O
Hippocampus	O
and	O
Forebrain	O
Partially	O
Rescues	O
the	O
Memory	O
Deficit	O
of	O
GluR	O
-	O
B	O
Delta	O
FB	O
Mice	O

(	O
A	O
)	O
Olfactory	O
memory	O
experiments	O
as	O
in	O
Figure	O
2	O
were	O
performed	O
with	O
GluR	O
-	O
BRescue	O
.	O

Individual	O
mice	O
are	O
indicated	O
:	O
control	O
GluR	O
-	O
B2lox	O
with	O
black	O
circles	O
,	O
GluR	O
-	O
B	O
Delta	O
FB	O
with	O
red	O
triangles	O
,	O
GluR	O
-	O
BRescue	O
with	O
green	O
squares	O
.	O

Data	O
were	O
combined	O
from	O
Figure	O
3	O
and	O
4	O
(	O
open	O
symbols	O
)	O
and	O
an	O
additional	O
experiment	O
with	O
four	O
GluR	O
-	O
B	O
Delta	O
FB	O
,	O
three	O
littermate	O
controls	O
,	O
and	O
eight	O
GluR	O
-	O
BRescue	O
(	O
shaded	O
symbols	O
)	O
.	O

(	O
B	O
)	O
Cumulative	O
histogram	O
of	O
the	O
memory	O
performance	O
.	O

Memory	O
performance	O
is	O
indicated	O
as	O
a	O
stepped	O
line	O
.	O

The	O
sigmoidal	O
fit	O
is	O
indicated	O
as	O
a	O
continuous	O
line	O
.	O

The	O
predicted	O
rescue	O
on	O
the	O
basis	O
of	O
the	O
extent	O
of	O
transgenic	O
GFPGluR	O
-	O
B	O
expression	O
(	O
Figure	O
5D	O
)	O
and	O
the	O
correlation	O
between	O
memory	O
and	O
GluR	O
-	O
B	O
levels	O
in	O
piriform	O
cortex	O
(	O
9	O
.	O
1	O
+/-	O
2	O
.	O
5	O
%	O
increase	O
in	O
memory	O
for	O
10	O
%	O
increase	O
in	O
protein	O
,	O
Figure	O
4D	O
)	O
is	O
shown	O
in	O
blue	O
.	O

Note	O
that	O
the	O
predicted	O
rescue	O
is	O
in	O
perfect	O
numerical	O
correspondence	O
to	O
the	O
memory	O
performance	O
of	O
GluR	O
-	O
BRescue	O
mice	O
.	O

(	O
C	O
)	O
The	O
discrimination	O
index	O
was	O
calculated	O
as	O
in	O
Figures	O
1E	O
,	O
2C	O
,	O
and	O
4D	O
(	O
last	O
100	O
trials	O
of	O
the	O
mixture	O
discrimination	O
task	O
)	O
for	O
GluRBRescue	O
(	O
n	O
=	O
8	O
)	O
,	O
GluR	O
-	O
B	O
Delta	O
FB	O
(	O
n	O
=	O
22	O
)	O
,	O
and	O
control	O
(	O
n	O
=	O
14	O
)	O
animals	O
.	O

Footnotes	O

Author	O
contributions	O
.	O

DRS	O
and	O
ATS	O
conceived	O
and	O
designed	O
most	O
of	O
the	O
experiments	O
.	O

The	O
manuscript	O
was	O
written	O
by	O
DRS	O
,	O
PHS	O
,	O
RS	O
,	O
and	O
ATS	O
.	O

Mouse	O
lines	O
were	O
conceived	O
and	O
designed	O
by	O
DRS	O
,	O
PHS	O
,	O
RS	O
(	O
GluR	O
-	O
B	O
Delta	O
FB	O
,	O
GluR	O
-	O
B	O
Delta	O
ECS	O
:	O
FB	O
)	O
;	O
DRS	O
,	O
PHS	O
,	O
RS	O
,	O
ATS	O
(	O
GluR	O
-	O
BRescue	O
)	O
;	O
JK	O
,	O
PHS	O
,	O
RS	O
(	O
TgCN12	O
-	O
itTA	O
)	O
;	O
and	O
VM	O
,	O
PHS	O
,	O
RS	O
(	O
GluR	O
-	O
B2lox	O
,	O
TgOCN1	O
)	O
.	O

Olfactory	O
behavioral	O
experiments	O
were	O
done	O
by	O
TB	O
and	O
ATS	O
;	O
AM	O
performed	O
the	O
GFPGluR	O
-	O
B	O
Western	O
blots	O
;	O
immunohistochemical	O
experiments	O
and	O
other	O
Western	O
blots	O
as	O
well	O
as	O
the	O
nonolfactory	O
behavioral	O
experiments	O
were	O
performed	O
by	O
DRS	O
.	O

currency	O
Current	O
address	O
:	O
Department	O
of	O
Physiology	O
,	O
University	O
College	O
London	O
,	O
London	O
,	O
United	O
Kingdom	O

Citation	O
:	O
Shimshek	O
DR	O
,	O
Bus	O
T	O
,	O
Kim	O
J	O
,	O
Mihaljevic	O
A	O
,	O
Mack	O
V	O
,	O
et	O
al	O
.	O

(	O
2005	O
)	O
Enhanced	O
odor	O
discrimination	O
and	O
impaired	O
olfactory	O
memory	O
by	O
spatially	O
controlled	O
switch	O
of	O
AMPA	O
receptors	O
.	O

PLoS	O
Biol	O
3	O
(	O
11	O
)	O
:	O
e354	O
.	O

Two	O
major	O
branches	O
of	O
anti	O
-	O
cadmium	O
defense	O
in	O
the	O
mouse	O
:	O
MTF	O
-	O
1	O
/	O
metallothioneins	O
and	O
glutathione	O

Abstract	O

Metal	O
-	O
responsive	O
transcription	O
factor	O
1	O
(	O
MTF	O
-	O
1	O
)	O
regulates	O
expression	O
of	O
its	O
target	O
genes	O
in	O
response	O
to	O
various	O
stress	O
conditions	O
,	O
notably	O
heavy	O
metal	O
load	O
,	O
via	O
binding	O
to	O
metal	O
response	O
elements	O
(	O
MREs	O
)	O
in	O
the	O
respective	O
enhancer	O
/	O
promoter	O
regions	O
.	O

Furthermore	O
,	O
it	O
serves	O
a	O
vital	O
function	O
in	O
embryonic	O
liver	O
development	O
.	O

However	O
,	O
targeted	O
deletion	O
of	O
Mtf1	O
in	O
the	O
liver	O
after	O
birth	O
is	O
no	O
longer	O
lethal	O
.	O

For	O
this	O
study	O
,	O
Mtf1	O
conditional	O
knockout	O
mice	O
and	O
control	O
littermates	O
were	O
both	O
mock	O
-	O
or	O
cadmium	O
-	O
treated	O
and	O
liver	O
-	O
specific	O
transcription	O
was	O
analyzed	O
.	O

Besides	O
the	O
well	O
-	O
characterized	O
metallothionein	O
genes	O
,	O
several	O
new	O
MTF	O
-	O
1	O
target	O
genes	O
with	O
MRE	O
motifs	O
in	O
the	O
promoter	O
region	O
emerged	O
.	O

MTF	O
-	O
1	O
is	O
required	O
for	O
the	O
basal	O
expression	O
of	O
selenoprotein	O
W	O
,	O
muscle	O
1	O
gene	O
(	O
Sepw1	O
)	O
that	O
encodes	O
a	O
glutathione	O
-	O
binding	O
and	O
putative	O
antioxidant	O
protein	O
,	O
supporting	O
a	O
role	O
of	O
MTF	O
-	O
1	O
in	O
the	O
oxidative	O
stress	O
response	O
.	O

Furthermore	O
,	O
MTF	O
-	O
1	O
mediates	O
the	O
cadmium	O
-	O
induced	O
expression	O
of	O
N	O
-	O
myc	O
downstream	O
regulated	O
gene	O
1	O
(	O
Ndrg1	O
)	O
,	O
which	O
is	O
induced	O
by	O
several	O
stress	O
conditions	O
and	O
is	O
overexpressed	O
in	O
many	O
cancers	O
.	O

MTF	O
-	O
1	O
is	O
also	O
involved	O
in	O
the	O
cadmium	O
response	O
of	O
cysteine	O
-	O
and	O
glycine	O
-	O
rich	O
protein	O
1	O
gene	O
(	O
Csrp1	O
)	O
,	O
which	O
is	O
implicated	O
in	O
cytoskeletal	S-GO
organization	O
.	O

In	O
contrast	O
,	O
MTF	O
-	O
1	O
represses	O
the	O
basal	O
expression	O
of	O
Slc39a10	O
,	O
a	O
putative	O
zinc	O
transporter	O
.	O

In	O
a	O
pathway	O
independent	O
of	O
MTF	O
-	O
1	O
,	O
cadmium	O
also	O
induced	O
the	O
transcription	O
of	O
genes	O
involved	O
in	O
the	O
synthesis	O
and	O
regeneration	O
of	O
glutathione	O
,	O
a	O
cadmium	O
-	O
binding	O
antioxidant	O
.	O

These	O
data	O
provide	O
strong	O
evidence	O
for	O
two	O
major	O
branches	O
of	O
cellular	O
anti	O
-	O
cadmium	O
defense	O
,	O
one	O
via	O
MTF	O
-	O
1	O
and	O
its	O
target	O
genes	O
,	O
notably	O
metallothioneins	O
,	O
the	O
other	O
via	O
glutathione	O
,	O
with	O
an	O
apparent	O
overlap	O
in	O
selenoprotein	O
W	O
.	O

INTRODUCTION	O

All	O
organisms	O
have	O
evolved	O
mechanisms	O
to	O
cope	O
with	O
a	O
variety	O
of	O
stress	O
situations	O
.	O

One	O
type	O
of	O
stress	O
response	O
is	O
triggered	O
by	O
heavy	O
metals	O
,	O
such	O
as	O
zinc	O
,	O
copper	O
and	O
cadmium	O
(	O
for	O
convenience	O
,	O
the	O
terms	O
zinc	O
,	O
copper	O
and	O
cadmium	O
are	O
also	O
used	O
here	O
to	O
denote	O
Zn2	O
+	O
,	O
Cu2	O
+	O
and	O
Cd2	O
+	O
,	O
respectively	O
)	O
.	O

Metallothioneins	O
(	O
MTs	O
)	O
,	O
small	O
,	O
cysteine	O
-	O
rich	O
proteins	O
,	O
play	O
an	O
important	O
role	O
in	O
metal	O
homeostasis	O
and	O
detoxification	O
due	O
to	O
their	O
ability	O
to	O
bind	O
different	O
heavy	O
metal	O
ions	O
(	O
1	O
-	O
3	O
)	O
.	O

In	O
the	O
mouse	O
,	O
there	O
are	O
four	O
metallothionein	O
genes	O
,	O
designated	O
as	O
Mt1	O
to	O
Mt4	O
.	O

Basal	O
,	O
as	O
well	O
as	O
heavy	O
metal	O
-	O
induced	O
,	O
expression	O
of	O
Mt1	O
and	O
Mt2	O
is	O
mediated	O
by	O
metal	O
-	O
responsive	O
transcription	O
factor	O
1	O
(	O
MTF	O
-	O
1	O
)	O
(	O
4	O
-	O
7	O
)	O
.	O

This	O
zinc	O
finger	O
protein	O
recognizes	O
short	O
cis	O
-	O
acting	O
DNA	O
sequences	O
,	O
termed	O
metal	O
response	O
elements	O
(	O
MREs	O
;	O
core	O
consensus	O
sequence	O
TGCRCNC	O
)	O
,	O
which	O
are	O
present	O
in	O
the	O
promoters	O
of	O
target	O
genes	O
(	O
8	O
,	O
9	O
)	O
.	O

MTF	O
-	O
1	O
is	O
conserved	O
in	O
evolution	O
,	O
and	O
homologs	O
have	O
been	O
characterized	O
in	O
the	O
mouse	O
(	O
10	O
)	O
,	O
humans	O
(	O
11	O
)	O
,	O
Drosophila	O
(	O
12	O
-	O
14	O
)	O
and	O
fish	O
(	O
15	O
,	O
16	O
)	O
.	O

The	O
role	O
of	O
MTF	O
-	O
1	O
has	O
been	O
studied	O
most	O
extensively	O
in	O
the	O
mouse	O
.	O

Besides	O
coping	O
with	O
heavy	O
metal	O
load	O
,	O
MTF	O
-	O
1	O
can	O
also	O
mediate	O
the	O
induction	O
of	O
Mt	O
genes	O
in	O
response	O
to	O
other	O
stress	O
situations	O
,	O
such	O
as	O
oxidative	O
stress	O
(	O
5	O
,	O
17	O
)	O
and	O
hypoxia	O
(	O
18	O
)	O
.	O

In	O
addition	O
,	O
it	O
is	O
required	O
for	O
the	O
metalloregulation	O
of	O
Znt1	O
,	O
encoding	O
the	O
major	O
plasma	B-GO
membrane	E-GO
-	O
localized	O
zinc	O
efflux	O
transporter	O
(	O
19	O
)	O
,	O
the	O
hypoxic	O
/	O
anoxic	O
induction	O
of	O
the	O
gene	O
for	O
placental	O
growth	O
factor	O
(	O
Plgf	O
)	O
,	O
an	O
angiogenic	O
protein	O
of	O
the	O
vascular	O
endothelial	O
growth	O
factor	O
(	O
VEGF	O
)	O
family	O
(	O
20	O
)	O
,	O
and	O
has	O
recently	O
been	O
invoked	O
in	O
tumor	O
development	O
(	O
21	O
,	O
22	O
)	O
.	O

Furthermore	O
,	O
MTF	O
-	O
1	O
has	O
an	O
essential	O
function	O
during	O
embryogenesis	O
:	O
targeted	O
disruption	O
of	O
Mtf1	O
results	O
in	O
embryonic	O
lethality	O
around	O
14	O
days	O
post	O
coitum	O
due	O
to	O
hepatocyte	O
necrosis	O
(	O
23	O
)	O
.	O

In	O
contrast	O
,	O
mice	O
with	O
null	O
mutations	O
for	O
the	O
stress	O
-	O
inducible	O
metallothionein	O
genes	O
(	O
Mt1	O
and	O
Mt2	O
)	O
are	O
viable	O
,	O
though	O
sensitive	O
to	O
cadmium	O
(	O
24	O
,	O
25	O
)	O
,	O
indicating	O
that	O
additional	O
important	O
MTF	O
-	O
1	O
target	O
genes	O
are	O
involved	O
in	O
the	O
lethal	O
phenotype	O
.	O

With	O
the	O
Cre	O
-	O
loxP	O
conditional	O
knockout	O
technique	O
,	O
it	O
is	O
possible	O
to	O
circumvent	O
the	O
embryonic	O
lethal	O
phenotype	O
of	O
conventional	O
Mtf1	O
knockout	O
mice	O
.	O

Previous	O
experiments	O
with	O
this	O
technique	O
revealed	O
that	O
deletion	O
of	O
Mtf1	O
from	O
the	O
liver	O
after	O
birth	O
is	O
no	O
longer	O
lethal	O
under	O
non	O
-	O
stress	O
conditions	O
(	O
26	O
)	O
.	O

For	O
this	O
study	O
,	O
an	O
inducible	O
,	O
liver	O
-	O
specific	O
Mtf1	O
knockout	O
mouse	O
line	O
was	O
generated	O
to	O
perform	O
a	O
search	O
for	O
MTF	O
-	O
1	O
target	O
genes	O
and	O
cadmium	O
-	O
inducible	O
genes	O
in	O
the	O
adult	O
liver	O
.	O

A	O
number	O
of	O
target	O
gene	O
candidates	O
emerged	O
upon	O
a	O
transcriptome	O
analysis	O
of	O
mock	O
-	O
and	O
cadmium	O
-	O
treated	O
Mtf1	O
conditional	O
knockout	O
mice	O
and	O
control	O
littermates	O
and	O
several	O
of	O
these	O
were	O
confirmed	O
by	O
semiquantitative	O
RT	O
-	O
PCR	O
.	O

Besides	O
the	O
stress	O
-	O
inducible	O
metallothionein	O
genes	O
that	O
were	O
already	O
known	O
as	O
target	O
genes	O
of	O
MTF	O
-	O
1	O
,	O
we	O
find	O
that	O
MTF	O
-	O
1	O
is	O
important	O
for	O
basal	O
liver	O
expression	O
of	O
the	O
gene	O
for	O
selenoprotein	O
W	O
,	O
muscle	O
1	O
(	O
Sepw1	O
)	O
as	O
well	O
as	O
for	O
cadmium	O
-	O
induced	O
expression	O
of	O
N	O
-	O
myc	O
downstream	O
regulated	O
gene	O
1	O
(	O
Ndrg1	O
)	O
and	O
the	O
gene	O
encoding	O
cysteine	O
-	O
and	O
glycine	O
-	O
rich	O
protein	O
1	O
(	O
Csrp1	O
)	O
.	O

In	O
addition	O
,	O
MTF	O
-	O
1	O
appears	O
to	O
repress	O
the	O
expression	O
of	O
solute	O
carrier	O
family	O
39	O
,	O
member	O
10	O
gene	O
(	O
Slc39a10	O
)	O
,	O
which	O
encodes	O
a	O
putative	O
metal	O
ion	O
transporter	O
.	O

In	O
an	O
MTF	O
-	O
1	O
-	O
independent	O
transcriptome	O
response	O
,	O
several	O
genes	O
involved	O
in	O
glutathione	O
metabolism	O
are	O
induced	O
.	O

Further	O
studies	O
confirmed	O
a	O
dual	O
anti	O
-	O
cadmium	O
defense	O
,	O
one	O
via	O
glutathione	O
and	O
another	O
one	O
via	O
MTF	O
-	O
1	O
and	O
its	O
target	O
genes	O
,	O
including	O
metallothioneins	O
.	O

MATERIALS	O
AND	O
METHODS	O

Generation	O
of	O
Mtf1	O
conditional	O
knockout	O
mice	O
and	O
liver	O
-	O
specific	O
deletion	O

Mtf1	O
conditional	O
knockout	O
mice	O
were	O
generated	O
in	O
collaboration	O
with	O
Dr	O
Michael	O
Leviten	O
(	O
San	O
Carlos	O
,	O
CA	O
)	O
.	O

Two	O
genomic	O
clones	O
containing	O
exons	O
3	O
to	O
6	O
of	O
Mtf1	O
were	O
used	O
to	O
construct	O
a	O
gene	O
targeting	O
vector	O
for	O
homologous	O
recombination	O
(	O
Supplementary	O
Data	O
)	O
.	O

A	O
neomycin	O
resistance	O
cassette	O
(	O
PGK	O
-	O
neo	O
)	O
flanked	O
by	O
two	O
loxP	O
sites	O
was	O
cloned	O
into	O
the	O
SacI	O
site	O
5	O
'	O
of	O
exon	O
3	O
of	O
Mtf1	O
,	O
the	O
third	O
loxP	O
site	O
was	O
cloned	O
into	O
the	O
ScaI	O
site	O
3	O
'	O
of	O
exon	O
4	O
.	O

A	O
thymidine	O
kinase	O
(	O
TK	O
)	O
cassette	O
was	O
inserted	O
in	O
the	O
HpaI	O
site	O
3	O
'	O
of	O
exon	O
6	O
.	O

129	O
ES	O
cells	O
were	O
electroporated	O
with	O
the	O
linearized	O
targeting	O
vector	O
,	O
selected	O
in	O
the	O
presence	O
of	O
G418	O
and	O
FIAU	O
,	O
and	O
screened	O
for	O
correct	O
integration	O
events	O
by	O
PCR	O
and	O
Southern	O
blot	O
analysis	O
.	O

Transient	O
expression	O
of	O
Cre	O
recombinase	O
led	O
to	O
removal	O
of	O
the	O
PGK	O
-	O
neo	O
cassette	O
,	O
and	O
mice	O
carrying	O
the	O
modified	O
Mtf1loxP	O
allele	O
were	O
generated	O
by	O
injection	O
of	O
positive	O
clones	O
into	O
C57Bl	O
/	O
6	O
blastocysts	O
and	O
subsequent	O
crosses	O
.	O

Homozygous	O
conditional	O
knockout	O
animals	O
(	O
Mtf1loxP	O
/	O
loxP	O
)	O
were	O
crossed	O
with	O
the	O
Cre	O
recombinase	O
transgenic	O
line	O
Mx	O
-	O
cre	O
(	O
a	O
gift	O
from	O
Prof	O
.	O
Michel	O
Aguet	O
)	O
to	O
obtain	O
an	O
inducible	O
,	O
liver	O
-	O
specific	O
Mtf1	O
knockout	O
line	O
.	O

The	O
mice	O
were	O
genotyped	O
by	O
PCR	O
using	O
the	O
following	O
primers	O
(	O
Microsynth	O
)	O
:	O
Cre	O
recombinase	O
:	O
5	O
'	O
-	O
CTATCCAGCAACATTTGGGCCAGC	O
-	O
3	O
'	O
;	O
5	O
'	O
-	O
CCAGGTTACGGATATAGTTCATGAC	O
-	O
3	O
'	O
,	O
Mtf1loxP	O
or	O
wild	O
-	O
type	O
allele	O
:	O
5	O
'	O
-	O
CACACCCAGTTTGTGTATGTCTTC	O
-	O
3	O
'	O
;	O
5	O
'	O
-	O
CAGTCACAAGCAAATTACCAAACACTGCC	O
-	O
3	O
'	O
.	O

Animal	O
treatment	O

At	O
8	O
weeks	O
of	O
age	O
,	O
male	O
Mtf1loxP	O
/	O
loxP	O
mice	O
harboring	O
the	O
Mx	O
-	O
cre	O
transgene	O
(	O
Mtf1loxP	O
/	O
loxP	O
Mx	O
-	O
cre	O
,	O
abbr	O
.	O
:	O
Mtf1Mx	O
-	O
cre	O
)	O
and	O
control	O
littermates	O
without	O
transgene	O
(	O
Mtf1loxP	O
/	O
loxP	O
,	O
abbr	O
.	O
:	O
Mtf1loxP	O
)	O
received	O
four	O
intraperitoneal	O
injections	O
each	O
of	O
300	O
micro	O
g	O
synthetic	O
double	O
-	O
stranded	O
RNA	O
polyinosinic	O
-	O
polycytidylic	O
acid	O
[	O
pI	O
-	O
pC	O
;	O
Sigma	O
;	O
in	O
a	O
volume	O
of	O
60	O
micro	O
l	O
phosphate	O
-	O
buffered	O
saline	O
(	O
PBS	O
)	O
]	O
at	O
3	O
day	O
intervals	O
.	O

Only	O
in	O
the	O
case	O
of	O
DNA	O
-	O
binding	O
studies	O
with	O
MRE	O
sequences	O
from	O
MTF	O
-	O
1	O
target	O
gene	O
candidates	O
,	O
the	O
control	O
mice	O
received	O
no	O
pI	O
-	O
pC	O
injections	O
.	O

For	O
experiments	O
with	O
metal	O
treatment	O
,	O
mice	O
received	O
2	O
days	O
after	O
the	O
last	O
pI	O
-	O
pC	O
treatment	O
a	O
subcutaneous	O
(	O
s	O
.	O
c	O
.	O
)	O
injection	O
of	O
either	O
20	O
micro	O
mol	O
/	O
kg	O
body	O
weight	O
CdSO4	O
(	O
2	O
mM	O
CdSO4	O
in	O
H2O	O
;	O
cadmium	O
treatment	O
)	O
or	O
10	O
ml	O
/	O
kg	O
body	O
weight	O
H2O	O
(	O
mock	O
treatment	O
)	O
6	O
h	O
before	O
sacrificing	O
them	O
.	O

Microarray	O
analysis	O
and	O
data	O
processing	O

Total	O
RNA	O
was	O
isolated	O
from	O
liver	O
tissue	O
of	O
pI	O
-	O
pC	O
-	O
induced	O
,	O
mock	O
-	O
or	O
cadmium	O
-	O
treated	O
Mtf1Mx	O
-	O
cre	O
and	O
Mtf1loxP	O
mice	O
(	O
n	O
=	O
3	O
per	O
genotype	O
and	O
respective	O
treatment	O
;	O
all	O
male	O
)	O
essentially	O
as	O
described	O
by	O
Chomczynski	O
and	O
Sacchi	O
(	O
27	O
)	O
.	O

Gene	O
expression	O
analysis	O
was	O
performed	O
in	O
the	O
Functional	O
Genomics	O
Center	O
Zurich	O
using	O
GeneChip	O
(R)	O
Mouse	O
Genome	O
430	O
2	O
.	O
0	O
Arrays	O
(	O
Affymetrix	O
)	O
according	O
to	O
the	O
manufacturer	O
'	O
s	O
instructions	O
and	O
the	O
following	O
reagents	O
and	O
conditions	O
.	O

cDNA	O
was	O
synthesized	O
with	O
SuperScript	O
(TM)	O
Double	O
-	O
Stranded	O
cDNA	O
Synthesis	O
Kit	O
(	O
Invitrogen	O
)	O
,	O
using	O
15	O
micro	O
g	O
total	O
RNA	O
.	O

In	O
vitro	O
transcription	O
was	O
performed	O
with	O
BioArray	O
(TM)	O
High	O
Yield	O
(TM)	O
RNA	O
Transcript	O
Labeling	O
Kit	O
(	O
Enzo	O
)	O
and	O
3	O
.	O
5	O
to	O
6	O
micro	O
g	O
of	O
each	O
cDNA	O
.	O

Clean	O
-	O
up	O
of	O
both	O
cDNA	O
and	O
cRNA	O
samples	O
was	O
done	O
using	O
GeneChip	O
(R)	O
Sample	O
Clean	O
-	O
up	O
Module	O
(	O
Affymetrix	O
)	O
.	O

For	O
the	O
automated	O
washing	O
and	O
staining	O
in	O
the	O
Affymetrix	O
fluidics	O
station	O
450	O
,	O
the	O
protocol	O
EukGE	O
-	O
Ws2v4	O
_	O
450	O
was	O
used	O
.	O

The	O
probe	O
arrays	O
were	O
scanned	O
with	O
the	O
Affymetrix	O
GS	O
3000	O
scanner	O
.	O

Raw	O
data	O
are	O
available	O
at	O
ArrayExpress	O
(	O
,	O
accession	O
number	O
E	O
-	O
MEXP	O
-	O
438	O
)	O
.	O

Data	O
analysis	O
was	O
performed	O
with	O
GeneSpring	O
6	O
.	O
1	O
software	O
(	O
Silicon	O
Genetics	O
)	O
,	O
applying	O
a	O
significance	O
level	O
P	O
<=	O
0	O
.	O
05	O
.	O

Furthermore	O
,	O
multiple	O
testing	O
correction	O
was	O
used	O
in	O
addition	O
to	O
obtain	O
cadmium	O
-	O
responsive	O
,	O
MTF	O
-	O
1	O
-	O
independent	O
genes	O
.	O

Genes	O
were	O
considered	O
to	O
be	O
differentially	O
expressed	O
if	O
there	O
was	O
at	O
least	O
a	O
2	O
-	O
fold	O
difference	O
in	O
expression	O
levels	O
of	O
the	O
compared	O
experimental	O
groups	O
(	O
genotype	O
and	O
respective	O
treatment	O
)	O
.	O

The	O
result	O
was	O
considered	O
reliable	O
if	O
signal	O
values	O
for	O
the	O
respective	O
gene	O
were	O
scored	O
'	O
present	O
'	O
at	O
least	O
for	O
all	O
mice	O
in	O
one	O
experimental	O
group	O
or	O
for	O
two	O
mice	O
in	O
each	O
of	O
two	O
groups	O
.	O

To	O
screen	O
for	O
the	O
presence	O
of	O
the	O
MRE	O
core	O
consensus	O
sequence	O
TGCRCNC	O
in	O
the	O
promoter	O
region	O
,	O
the	O
upstream	O
sequences	O
of	O
the	O
respective	O
genes	O
were	O
obtained	O
from	O
the	O
University	O
of	O
California	O
Santa	O
Cruz	O
(	O
UCSC	O
)	O
Genome	O
Browser	O
Database	O
(	O
;	O
October	O
/	O
November	O
2004	O
)	O
(	O
28	O
)	O
.	O

RT	O
-	O
PCR	O

All	O
RT	O
-	O
PCRs	O
were	O
performed	O
with	O
QIAGEN	O
(R)	O
OneStep	O
RT	O
-	O
PCR	O
Kit	O
(	O
QIAGEN	O
)	O
according	O
to	O
the	O
manufacturer	O
'	O
s	O
instructions	O
,	O
using	O
150	O
-	O
200	O
ng	O
DNase	O
I	O
-	O
digested	O
total	O
RNA	O
(	O
RNA	O
isolation	O
see	O
microarray	O
analysis	O
)	O
.	O

The	O
reactions	O
were	O
carried	O
out	O
using	O
the	O
following	O
primers	O
:	O
Csrp1	O
:	O
5	O
'	O
-	O
TTCCGATGTGCCAAGTGTGGC	O
-	O
3	O
'	O
;	O
5	O
'	O
-	O
AGTAGAGAGTGGACATTCAGC	O
-	O
3	O
'	O
,	O
hypoxanthin	O
-	O
guanin	O
-	O
phosphoribosyltransferase	O
(	O
Hprt	O
)	O
:	O
5	O
'	O
-	O
GCTGGTGAAAAGGACCTCTCG	O
-	O
3	O
'	O
;	O
5	O
'	O
-	O
CCACAGGACTAGGACACCTGC	O
-	O
3	O
'	O
,	O
Mtf1	O
:	O
5	O
'	O
-	O
GTGACTTTTGAGACTGTACTGAGTG	O
-	O
3	O
'	O
;	O
5	O
'	O
-	O
CATGCCAAGAAACATTGAAGGTG	O
-	O
3	O
'	O
,	O
Ndrg1	O
:	O
5	O
'	O
-	O
AGATACACAACAACGTGGAGG	O
-	O
3	O
'	O
;	O
5	O
'	O
-	O
TGTGCGAGCGGCTTCGGGGGC	O
-	O
3	O
'	O
,	O
Sepw1	O
:	O
5	O
'	O
-	O
TAGAGGCAGGGTCCTGAAAGC	O
-	O
3	O
'	O
;	O
5	O
'	O
-	O
ACACCTGGAAACATGGCTGCC	O
-	O
3	O
'	O
,	O
Slc39a10	O
:	O
5	O
'	O
-	O
GCTGTGGCTGGTAGTAAAAGC	O
-	O
3	O
'	O
;	O
5	O
'	O
-	O
GTGGCATGGGATGTAAACAGC	O
-	O
3	O
'	O
.	O

S1	O
nuclease	O
mapping	O
of	O
transcripts	O
(	O
S1	O
analysis	O
)	O

S1	O
analysis	O
was	O
performed	O
as	O
previously	O
described	O
(	O
29	O
)	O
,	O
using	O
100	O
micro	O
g	O
DNase	O
I	O
-	O
digested	O
total	O
RNA	O
(	O
RNA	O
isolation	O
see	O
microarray	O
analysis	O
)	O
.	O

The	O
gels	O
were	O
developed	O
using	O
PhosphorImager	O
(	O
Molecular	O
Dynamics	O
)	O
.	O

S1	O
analysis	O
was	O
done	O
with	O
the	O
following	O
32P	O
-	O
labeled	O
oligonucleotides	O
:	O
Hprt	O
S1	O
:	O
5	O
'	O
-	O
TCTTCAGTCTGATAAAATCTACAGTCATAGGAATGGATCTATCACTATTTCTATTCAGTGATTACATTAAAG	O
-	O
3	O
'	O
,	O
Sepw1	O
S1	O
:	O
5	O
'	O
-	O
TTCAACCGGGAACACCTGGAAACATGGCTGCCTGTCTTCTTGAAGTCTTGAGGTGGAAAGGGAAAGCAAAGCAGGAGGGTTTTCCCACCC	O
-	O
3	O
'	O
.	O

Electrophoretic	O
mobility	O
shift	O
assay	O
(	O
EMSA	O
)	O

Protein	O
was	O
extracted	O
from	O
liver	O
tissue	O
with	O
T	O
-	O
PER	O
(TM)	O
Tissue	O
Protein	O
Extraction	O
Reagent	O
(	O
Pierce	O
)	O
according	O
to	O
the	O
manufacturer	O
'	O
s	O
instructions	O
,	O
using	O
a	O
1	O
:	O
10	O
ratio	O
of	O
mouse	O
tissue	O
(	O
mg	O
)	O
to	O
T	O
-	O
PER	O
reagent	O
(	O
micro	O
l	O
)	O
.	O

EMSA	O
was	O
essentially	O
performed	O
as	O
previously	O
described	O
(	O
10	O
)	O
.	O

All	O
binding	O
reactions	O
were	O
carried	O
out	O
by	O
incubating	O
2	O
-	O
5	O
fmol	O
32P	O
-	O
end	O
-	O
labeled	O
double	O
-	O
stranded	O
oligonucleotides	O
with	O
100	O
to	O
130	O
micro	O
g	O
liver	O
protein	O
extract	O
.	O

For	O
competition	O
experiments	O
,	O
5	O
pmol	O
of	O
unlabeled	O
competitor	O
oligonucleotide	O
was	O
added	O
to	O
the	O
binding	O
reaction	O
before	O
addition	O
of	O
the	O
extract	O
.	O

All	O
EMSA	O
gels	O
were	O
developed	O
using	O
PhosphorImager	O
(	O
Molecular	O
Dynamics	O
)	O
.	O

The	O
following	O
oligonucleotides	O
were	O
annealed	O
and	O
used	O
for	O
the	O
reactions	O
:	O
Csrp1	O
MRE1	O
:	O
5	O
'	O
-	O
GGAAACAAAACGGCGCGCACTCCGGCGC	O
-	O
3	O
'	O
;	O
5	O
'	O
-	O
GGCTGCGC	O
CGGAGTGCGCGCCGTTTTGT	O
-	O
3	O
'	O
,	O
Csrp1	O
MRE2	O
:	O
5	O
'	O
-	O
TGTTGTGGTGCAGTGTGCAAAGCCTAC	O
-	O
3	O
'	O
;	O
5	O
'	O
-	O
ACCAGTAGGCTTTGCACACTGCACCAC	O
-	O
3	O
'	O
,	O
Csrp1	O
MRE3	O
:	O
5	O
'	O
-	O
GAGATCGCCATAGGGTGCAAAGAGAAG	O
-	O
3	O
'	O
;	O
5	O
'	O
-	O
GTGACTTCTCTTTGCACCCTATGGCGA	O
-	O
3	O
'	O
,	O
Csrp1	O
MRE4	O
:	O
5	O
'	O
-	O
TGTCTTATTCTGGAGTGCAAGTTAGTC	O
-	O
3	O
'	O
;	O
5	O
'	O
-	O
AGGGGACTAACTTGCACTCCAGAATAA	O
-	O
3	O
'	O
,	O
Gal4	O
:	O
5	O
'	O
-	O
TCCGGAGGACTGTCCTCCGG	O
-	O
3	O
'	O
;	O
5	O
'	O
-	O
GCCGGAGGACAGTCCTCCGG	O
-	O
3	O
'	O
,	O
MREd	O
[	O
MRE	O
derived	O
from	O
mouse	O
Mt1	O
promoter	O
(	O
10	O
)	O
]	O
:	O
5	O
'	O
-	O
CGAGGGAGCTCTGCACTCCGCCCGAAAAGTG	O
-	O
3	O
'	O
;	O
5	O
'	O
-	O
TCGACACTTTTCGGGCGGAGTGCAGAGCTCCCTCGAGCT	O
-	O
3	O
'	O
,	O
MRE	O
-	O
s	O
[	O
synthetic	O
MRE	O
consensus	O
sequence	O
(	O
10	O
)	O
]	O
:	O
5	O
'	O
-	O
CGAGGGAGCTCTGCACACGGCCCGAAAAGTG	O
-	O
3	O
'	O
;	O
5	O
'	O
-	O
TCGACACTTTTCGGGCCGTGTGCAGAGCTCCCTCGAGCT	O
-	O
3	O
'	O
,	O
Ndrg1	O
MRE1	O
:	O
5	O
'	O
-	O
CAGCCCAGGCAGGGTGCAGCACGAG	O
-	O
3	O
'	O
;	O
5	O
'	O
-	O
CCGCCTCGTGCTGCACCCTGCCTGG	O
-	O
3	O
'	O
,	O
Ndrg1	O
MRE2	O
:	O
5	O
'	O
-	O
CACACGTTCGCTGCACACGCCGCGG	O
-	O
3	O
'	O
;	O
5	O
'	O
-	O
GGGACCGCGGCGTGTGCAGCGAACG	O
-	O
3	O
'	O
,	O
Ndrg1	O
MRE3	O
,	O
4	O
:	O
5	O
'	O
-	O
GGAGTCCTTATGCACACGCGCACGAGCGCGCACGGGCAC	O
-	O
3	O
'	O
;	O
5	O
'	O
-	O
TGGTGTGCCCGTGCGCGCTCGTGCGCGTGTGCATAAGGAC	O
-	O
3	O
'	O
,	O
Sepw1	O
MRE1	O
:	O
5	O
'	O
-	O
GAGGCAGTCGGCTGTGCGCACGGCCCCACGCTC	O
-	O
3	O
'	O
;	O
5	O
'	O
-	O
CTCTGAGCGTGGGGCCGTGCGCACAGCCGACTGC	O
-	O
3	O
'	O
,	O
Sepw1	O
MRE2	O
:	O
5	O
'	O
-	O
ATGGTTTTGGGGGTGCGCAGGGGGTCTG	O
-	O
3	O
'	O
;	O
5	O
'	O
-	O
CGACAGACCCCCTGCGCACCCCCAAAAC	O
-	O
3	O
'	O
,	O
Slc39a10	O
MRE1	O
:	O
5	O
'	O
-	O
GAATACACGACTGGGTGCAGCCGGGGTTTGG	O
-	O
3	O
'	O
;	O
5	O
'	O
-	O
GGTACCAAACCCCGGCTGCACCCAGTCGTGTA	O
-	O
3	O
'	O
,	O
Slc39a10	O
MRE2	O
:	O
5	O
'	O
-	O
GCGGAGAGGAGATGCACACGGCACTCG	O
-	O
3	O
'	O
;	O
5	O
'	O
-	O
CACTCGAGTGCCGTGTGCATCTCCTCT	O
-	O
3	O
'	O
,	O
Specificity	O
protein	O
1	O
(	O
Sp1	O
)	O
binding	O
sequence	O
(	O
10	O
)	O
:	O
5	O
'	O
-	O
CGAGGCCCCGCCCAG	O
-	O
3	O
'	O
;	O
5	O
'	O
-	O
TCGACTGGGCGGGGCCTCGAGct	O
-	O
3	O
'	O
.	O

Cell	O
culture	O

Primary	O
embryonic	O
fibroblasts	O
were	O
isolated	O
from	O
a	O
12	O
.	O
5	O
day	O
old	O
Mtf1loxP	O
mouse	O
embryo	O
and	O
grown	O
in	O
DMEM	O
supplemented	O
with	O
10	O
%	O
fetal	O
bovine	O
serum	O
(	O
ICN	O
)	O
,	O
100	O
U	O
/	O
ml	O
penicillin	O
-	O
streptomycin	O
(	O
Gibco	O
BRL	O
)	O
and	O
2	O
mM	O
l	O
-	O
glutamine	O
(	O
Gibco	O
BRL	O
)	O
.	O

100	O
mm	O
plates	O
with	O
primary	O
cells	O
were	O
transfected	O
with	O
10	O
micro	O
g	O
of	O
an	O
expression	O
plasmid	O
coding	O
for	O
simian	O
virus	O
40	O
(	O
SV40	O
)	O
large	O
T	O
antigen	O
driven	O
by	O
the	O
cytomegalovirus	O
(	O
CMV	O
)	O
promoter	O
,	O
using	O
lipofectamine	O
(TM)	O
reagent	O
(	O
Invitrogen	O
)	O
according	O
to	O
the	O
manufacturer	O
'	O
s	O
instructions	O
.	O

Cell	O
foci	O
were	O
isolated	O
and	O
the	O
immortalized	O
mouse	O
embryonic	O
fibroblast	O
cell	O
line	O
ckoC	O
was	O
derived	O
from	O
one	O
of	O
them	O
.	O

The	O
Mtf1loxP	O
genotype	O
of	O
this	O
line	O
as	O
well	O
as	O
the	O
genomic	O
integration	O
of	O
the	O
T	O
antigen	O
were	O
confirmed	O
by	O
PCR	O
.	O

100	O
mm	O
plates	O
with	O
these	O
cells	O
were	O
further	O
transfected	O
by	O
the	O
calcium	O
phosphate	O
method	O
(	O
30	O
)	O
with	O
19	O
.	O
6	O
micro	O
g	O
of	O
an	O
expression	O
plasmid	O
for	O
Cre	O
recombinase	O
driven	O
by	O
the	O
CMV	O
promoter	O
and	O
0	O
.	O
4	O
micro	O
g	O
of	O
an	O
expression	O
plasmid	O
for	O
the	O
neomycin	O
resistance	O
gene	O
under	O
the	O
control	O
of	O
the	O
TK	O
promoter	O
.	O

Stably	O
transfected	O
cells	O
were	O
selected	O
in	O
the	O
presence	O
of	O
0	O
.	O
4	O
micro	O
g	O
/	O
micro	O
l	O
G418	O
(	O
Calbiochem	O
)	O
,	O
isolated	O
clones	O
of	O
resistant	O
cells	O
were	O
harvested	O
and	O
grown	O
independently	O
,	O
and	O
the	O
expression	O
of	O
Cre	O
recombinase	O
and	O
excision	O
of	O
exons	O
3	O
and	O
4	O
of	O
Mtf1	O
were	O
analyzed	O
by	O
RT	O
-	O
PCR	O
.	O

The	O
cell	O
lines	O
delC19	O
,	O
delC21	O
and	O
delC23	O
with	O
a	O
deletion	O
of	O
Mtf1	O
were	O
chosen	O
for	O
further	O
experiments	O
.	O

Cytotoxicity	O
assay	O

Samples	O
of	O
1	O
x	O
104	O
cells	O
/	O
well	O
were	O
plated	O
in	O
96	O
-	O
well	O
tissue	O
culture	O
plates	O
and	O
allowed	O
to	O
adhere	O
for	O
24	O
h	O
.	O

The	O
cells	O
were	O
then	O
pre	O
-	O
incubated	O
for	O
24	O
h	O
in	O
medium	O
containing	O
0	O
,	O
5	O
,	O
10	O
,	O
25	O
or	O
50	O
micro	O
M	O
l	O
-	O
buthionine	O
-	O
[	O
S	O
,	O
R	O
]	O
-	O
sulfoximine	O
(	O
BSO	O
)	O
(	O
Sigma	O
)	O
,	O
a	O
drug	O
that	O
inhibits	O
glutathione	O
synthesis	O
(	O
31	O
)	O
.	O

Later	O
,	O
cells	O
were	O
exposed	O
to	O
0	O
,	O
5	O
,	O
10	O
or	O
20	O
micro	O
M	O
CdCl2	O
in	O
the	O
specified	O
pre	O
-	O
incubation	O
medium	O
for	O
an	O
additional	O
24	O
h	O
.	O

Cytotoxicity	O
was	O
determined	O
by	O
the	O
MTT	O
(	O
3	O
-	O
[	O
4	O
,	O
5	O
-	O
dimethylthiazol	O
-	O
2	O
-	O
yl	O
]	O
-	O
2	O
,	O
5	O
-	O
diphenyl	O
tetrazolium	O
bromid	O
)	O
-	O
based	O
Cell	O
Proliferation	O
Kit	O
I	O
(	O
Roche	O
)	O
according	O
to	O
the	O
manufacturer	O
'	O
s	O
instructions	O
.	O

RESULTS	O

Generation	O
of	O
an	O
inducible	O
,	O
liver	O
-	O
specific	O
Mtf1	O
knockout	O
mouse	O
line	O

Using	O
a	O
homologous	O
recombination	O
strategy	O
,	O
mice	O
were	O
obtained	O
with	O
a	O
modified	O
Mtf1	O
allele	O
Mtf1loxP	O
where	O
exons	O
3	O
and	O
4	O
,	O
encoding	O
four	O
of	O
the	O
six	O
zinc	O
fingers	O
of	O
the	O
DNA	O
-	O
binding	O
domain	O
,	O
are	O
flanked	O
by	O
loxP	O
sites	O
(	O
Figure	O
1a	O
)	O
.	O

Mice	O
homozygous	O
for	O
the	O
Mtf1loxP	O
allele	O
were	O
further	O
crossed	O
with	O
animals	O
of	O
the	O
Cre	O
recombinase	O
transgenic	O
line	O
Mx	O
-	O
cre	O
.	O

Cre	O
recombinase	O
is	O
expressed	O
in	O
this	O
line	O
under	O
the	O
control	O
of	O
the	O
mouse	O
Mx1	O
gene	O
promoter	O
,	O
which	O
is	O
inducible	O
by	O
administration	O
of	O
interferon	O
alpha	O
or	O
beta	O
,	O
or	O
synthetic	O
double	O
-	O
stranded	O
RNA	O
pI	O
-	O
pC	O
(	O
32	O
)	O
.	O

Cre	O
-	O
mediated	O
deletion	O
was	O
reported	O
to	O
be	O
complete	O
in	O
the	O
liver	O
,	O
while	O
varying	O
in	O
other	O
tissues	O
,	O
ranging	O
from	O
94	O
%	O
in	O
spleen	O
to	O
8	O
%	O
in	O
brain	O
(	O
32	O
)	O
.	O

After	O
Cre	O
-	O
mediated	O
deletion	O
of	O
exons	O
3	O
and	O
4	O
,	O
which	O
results	O
in	O
a	O
frameshift	O
and	O
premature	O
translation	O
stop	O
,	O
no	O
functional	O
MTF	O
-	O
1	O
protein	O
can	O
be	O
produced	O
.	O

For	O
induction	O
of	O
Cre	O
recombinase	O
,	O
Mtf1	O
conditional	O
knockout	O
mice	O
harboring	O
the	O
Mx	O
-	O
cre	O
transgene	O
(	O
Mtf1Mx	O
-	O
cre	O
)	O
received	O
four	O
intraperitoneal	O
pI	O
-	O
pC	O
injections	O
at	O
3	O
day	O
intervals	O
(	O
pI	O
-	O
pC	O
induction	O
)	O
;	O
control	O
littermates	O
without	O
transgene	O
(	O
Mtf1loxP	O
)	O
received	O
similar	O
injections	O
.	O

Using	O
RT	O
-	O
PCRs	O
(	O
Figure	O
1b	O
)	O
,	O
a	O
shortened	O
product	O
was	O
obtained	O
with	O
RNA	O
from	O
Mtf1Mx	O
-	O
cre	O
livers	O
,	O
indicating	O
a	O
successful	O
excision	O
of	O
exons	O
3	O
and	O
4	O
of	O
Mtf1	O
in	O
these	O
animals	O
.	O

On	O
close	O
examination	O
,	O
a	O
very	O
faint	O
band	O
similar	O
in	O
size	O
to	O
full	O
-	O
length	O
signal	O
was	O
also	O
observed	O
in	O
those	O
mice	O
,	O
probably	O
due	O
to	O
a	O
low	O
amount	O
of	O
residual	O
full	O
-	O
length	O
Mtf1	O
mRNA	O
.	O

The	O
level	O
of	O
functional	O
MTF	O
-	O
1	O
protein	O
was	O
examined	O
by	O
EMSA	O
(	O
Figure	O
1c	O
)	O
:	O
MTF	O
-	O
1	O
protein	B-GO
-	I-GO
DNA	I-GO
complex	E-GO
was	O
detectable	O
with	O
liver	O
protein	O
extract	O
from	O
an	O
Mtf1loxP	O
control	O
mouse	O
,	O
but	O
no	O
functional	O
MRE	O
-	O
binding	O
protein	O
was	O
observed	O
with	O
an	O
Mtf1Mx	O
-	O
cre	O
sample	O
.	O

Thus	O
,	O
deletion	O
of	O
exons	O
3	O
and	O
4	O
of	O
Mtf1	O
in	O
the	O
liver	O
of	O
Mtf1Mx	O
-	O
cre	O
mice	O
was	O
virtually	O
complete	O
.	O

All	O
examined	O
liver	O
-	O
specific	O
knockout	O
mice	O
were	O
viable	O
under	O
laboratory	O
conditions	O
and	O
appeared	O
normal	O
.	O

MTF	O
-	O
1	O
target	O
gene	O
search	O

For	O
the	O
identification	O
of	O
MTF	O
-	O
1	O
target	O
genes	O
,	O
we	O
compared	O
the	O
liver	O
transcript	O
profiles	O
of	O
mice	O
with	O
and	O
without	O
functional	O
Mtf1	O
gene	O
that	O
had	O
been	O
mock	O
-	O
treated	O
or	O
exposed	O
to	O
cadmium	O
(	O
n	O
=	O
3	O
per	O
genotype	O
and	O
respective	O
treatment	O
)	O
.	O

In	O
a	O
first	O
screen	O
,	O
the	O
transcripts	O
were	O
analyzed	O
with	O
a	O
differential	O
display	O
-	O
based	O
method	O
,	O
called	O
amplification	O
of	O
double	O
-	O
stranded	O
cDNA	O
end	O
restriction	O
fragments	O
(	O
ADDER	O
)	O
(	O
33	O
)	O
.	O

Thereby	O
an	O
overwhelming	O
number	O
of	O
signals	O
was	O
obtained	O
for	O
the	O
two	O
stress	O
-	O
inducible	O
metallothioneins	O
(	O
Mt1	O
and	O
Mt2	O
)	O
,	O
due	O
to	O
the	O
abundance	O
of	O
their	O
transcripts	O
both	O
in	O
mock	O
-	O
treated	O
and	O
especially	O
in	O
cadmium	O
-	O
treated	O
livers	O
that	O
harbored	O
a	O
functional	O
MTF	O
-	O
1	O
gene	O
(	O
data	O
not	O
shown	O
)	O
.	O

This	O
result	O
confirmed	O
the	O
importance	O
of	O
MTF	O
-	O
1	O
for	O
both	O
basal	O
and	O
metal	O
-	O
induced	O
expression	O
of	O
metallothionein	O
genes	O
.	O

In	O
a	O
second	O
approach	O
,	O
the	O
gene	O
expression	O
profile	O
in	O
livers	O
of	O
the	O
above	O
mentioned	O
mice	O
was	O
compared	O
by	O
Affymetrix	O
GeneChip	O
(R)	O
Mouse	O
Genome	O
430	O
2	O
.	O
0	O
Arrays	O
(	O
Table	O
1	O
)	O
.	O

When	O
analyzing	O
the	O
probe	O
array	O
data	O
of	O
livers	O
from	O
mock	O
-	O
treated	O
Mtf1Mx	O
-	O
cre	O
and	O
Mtf1loxP	O
mice	O
,	O
an	O
at	O
least	O
2	O
-	O
fold	O
,	O
reliable	O
downregulation	O
of	O
expression	O
was	O
detected	O
in	O
Mtf1Mx	O
-	O
cre	O
livers	O
for	O
13	O
Affymetrix	O
GeneChip	O
(R)	O
probe	O
sets	O
corresponding	O
to	O
11	O
characterized	O
genes	O
(	O
Table	O
1	O
,	O
a	O
)	O
.	O

Seven	O
of	O
these	O
genes	O
contain	O
one	O
or	O
more	O
MRE	O
core	O
consensus	O
sequence	O
TGCRCNC	O
within	O
a	O
segment	O
of	O
1000	O
bp	O
upstream	O
of	O
the	O
transcription	O
start	O
.	O

For	O
26	O
probe	O
sets	O
corresponding	O
to	O
24	O
different	O
characterized	O
genes	O
,	O
a	O
2	O
-	O
fold	O
or	O
higher	O
,	O
reliable	O
upregulation	O
was	O
detected	O
in	O
Mtf1Mx	O
-	O
cre	O
livers	O
(	O
Table	O
1	O
,	O
b	O
)	O
;	O
17	O
of	O
these	O
24	O
genes	O
contain	O
MRE	O
core	O
consensus	O
sequences	O
in	O
the	O
upstream	O
region	O
.	O

The	O
data	O
set	O
for	O
livers	O
of	O
cadmium	O
-	O
treated	O
Mtf1Mx	O
-	O
cre	O
and	O
Mtf1loxP	O
mice	O
revealed	O
an	O
at	O
least	O
2	O
-	O
fold	O
,	O
reliable	O
downregulation	O
in	O
Mtf1Mx	O
-	O
cre	O
livers	O
for	O
21	O
probe	O
sets	O
corresponding	O
to	O
16	O
different	O
characterized	O
genes	O
(	O
Table	O
1	O
,	O
c	O
)	O
;	O
10	O
of	O
these	O
contain	O
MRE	O
core	O
consensus	O
sequences	O
in	O
their	O
upstream	O
region	O
.	O

For	O
9	O
probe	O
sets	O
corresponding	O
to	O
9	O
different	O
characterized	O
genes	O
,	O
an	O
at	O
least	O
2	O
-	O
fold	O
,	O
reliable	O
upregulation	O
was	O
detected	O
(	O
Table	O
1	O
,	O
d	O
)	O
;	O
five	O
of	O
them	O
contain	O
MRE	O
motifs	O
.	O

In	O
addition	O
to	O
characterized	O
genes	O
,	O
ESTs	O
and	O
RIKEN	O
cDNA	O
sequences	O
were	O
also	O
found	O
in	O
the	O
comparison	O
of	O
Mtf1Mx	O
-	O
cre	O
and	O
Mtf1loxP	O
livers	O
to	O
be	O
differentially	O
expressed	O
(	O
Supplementary	O
Table	O
1	O
)	O
.	O

Downregulation	O
of	O
Mt1	O
and	O
Mt2	O
was	O
detected	O
in	O
Mtf1Mx	O
-	O
cre	O
livers	O
for	O
both	O
conditions	O
(	O
though	O
the	O
level	O
of	O
significance	O
for	O
the	O
downregulation	O
of	O
Mt1	O
in	O
mock	O
-	O
treated	O
animals	O
was	O
above	O
0	O
.	O
05	O
;	O
data	O
not	O
shown	O
)	O
.	O

For	O
all	O
MTF	O
-	O
1	O
target	O
genes	O
characterized	O
so	O
far	O
,	O
such	O
as	O
Mt1	O
,	O
Mt2	O
and	O
Znt1	O
,	O
MTF	O
-	O
1	O
exerts	O
its	O
transcriptional	O
activation	O
activity	O
via	O
standard	O
MRE	O
sequences	O
located	O
proximal	O
to	O
the	O
transcription	O
start	O
(	O
4	O
,	O
5	O
,	O
8	O
,	O
18	O
,	O
19	O
)	O
.	O

Even	O
a	O
specific	O
search	O
for	O
MTF	O
-	O
1	O
binding	O
sites	O
by	O
selection	O
from	O
a	O
pool	O
of	O
double	O
-	O
stranded	O
oligonucleotides	O
with	O
random	O
sequences	O
yielded	O
no	O
new	O
binding	O
motif	O
for	O
MTF	O
-	O
1	O
in	O
addition	O
to	O
the	O
known	O
MREs	O
(	O
34	O
)	O
.	O

Thus	O
,	O
an	O
MRE	O
sequence	O
is	O
to	O
date	O
the	O
only	O
indication	O
for	O
a	O
direct	O
MTF	O
-	O
1	O
target	O
gene	O
,	O
and	O
four	O
MRE	O
-	O
containing	O
target	O
gene	O
candidates	O
were	O
further	O
analyzed	O
.	O

Basal	O
expression	O
of	O
Sepw1	O
depends	O
on	O
MTF	O
-	O
1	O

Sepw1	O
was	O
found	O
in	O
microarray	O
analysis	O
to	O
be	O
significantly	O
downregulated	O
in	O
livers	O
from	O
cadmium	O
-	O
and	O
mock	O
-	O
treated	O
Mtf1Mx	O
-	O
cre	O
mice	O
(	O
Table	O
1	O
,	O
a	O
and	O
c	O
)	O
.	O

SEPW1	O
is	O
a	O
selenocysteine	O
-	O
containing	O
protein	O
that	O
binds	O
glutathione	O
(	O
35	O
)	O
and	O
is	O
thought	O
to	O
act	O
as	O
an	O
antioxidant	O
in	O
vivo	O
(	O
36	O
)	O
.	O

Sepw1	O
expression	O
in	O
livers	O
of	O
pI	O
-	O
pC	O
-	O
induced	O
,	O
mock	O
-	O
or	O
cadmium	O
-	O
treated	O
Mtf1Mx	O
-	O
cre	O
and	O
Mtf1loxP	O
mice	O
was	O
further	O
analyzed	O
by	O
semiquantitative	O
RT	O
-	O
PCRs	O
and	O
S1	O
analysis	O
(	O
Figure	O
2a	O
and	O
b	O
)	O
.	O

In	O
accordance	O
with	O
microarray	O
data	O
a	O
slight	O
,	O
if	O
any	O
,	O
upregulation	O
of	O
Sepw1	O
transcription	O
was	O
observed	O
in	O
livers	O
from	O
Mtf1loxP	O
mice	O
upon	O
cadmium	O
treatment	O
.	O

The	O
basal	O
level	O
was	O
reduced	O
in	O
livers	O
from	O
mock	O
-	O
and	O
cadmium	O
-	O
treated	O
Mtf1Mx	O
-	O
cre	O
mice	O
,	O
indicating	O
that	O
MTF	O
-	O
1	O
is	O
important	O
for	O
the	O
basal	O
expression	O
of	O
Sepw1	O
.	O

Three	O
MRE	O
core	O
consensus	O
sequences	O
were	O
found	O
in	O
the	O
region	O
upstream	O
of	O
the	O
mouse	O
Sepw1	O
transcription	O
start	O
(	O
Figure	O
2c	O
)	O
.	O

Two	O
of	O
them	O
in	O
opposite	O
orientation	O
overlap	O
almost	O
completely	O
proximal	O
to	O
the	O
transcription	O
start	O
(	O
MRE1	O
,	O
-	O
40	O
bp	O
)	O
,	O
the	O
third	O
one	O
is	O
located	O
further	O
upstream	O
(	O
MRE2	O
,	O
-	O
527	O
bp	O
)	O
.	O

Specific	O
binding	O
of	O
MTF	O
-	O
1	O
to	O
Sepw1	O
MRE1	O
but	O
not	O
MRE2	O
oligonucleotide	O
was	O
observed	O
in	O
EMSA	O
with	O
liver	O
protein	O
extract	O
from	O
an	O
Mtf1loxP	O
control	O
mouse	O
(	O
Figure	O
2d	O
)	O
.	O

As	O
a	O
control	O
,	O
no	O
binding	O
to	O
MRE1	O
was	O
detected	O
with	O
extract	O
from	O
a	O
pI	O
-	O
pC	O
-	O
induced	O
Mtf1Mx	O
-	O
cre	O
mouse	O
,	O
confirming	O
that	O
the	O
bandshift	O
was	O
indeed	O
dependent	O
on	O
the	O
presence	O
of	O
MTF	O
-	O
1	O
.	O

Cadmium	O
response	O
of	O
Ndrg1	O
depends	O
on	O
MTF	O
-	O
1	O

Ndrg1	O
was	O
significantly	O
downregulated	O
in	O
microarrays	O
of	O
liver	O
transcripts	O
from	O
cadmium	O
-	O
treated	O
Mtf1Mx	O
-	O
cre	O
mice	O
compared	O
to	O
similarly	O
treated	O
Mtf1loxP	O
control	O
mice	O
(	O
Table	O
1	O
,	O
c	O
)	O
.	O

Ndrg1	O
probably	O
has	O
some	O
role	O
in	O
stress	O
response	O
since	O
various	O
stimuli	O
,	O
including	O
hypoxia	O
and	O
nickel	O
compounds	O
,	O
activate	O
expression	O
of	O
rodent	O
Ndrg1	O
and	O
/	O
or	O
its	O
human	O
ortholog	O
(	O
37	O
-	O
40	O
)	O
.	O

The	O
Ndrg1	O
microarray	O
results	O
were	O
confirmed	O
with	O
semiquantitative	O
RT	O
-	O
PCRs	O
(	O
Figure	O
3a	O
)	O
:	O
for	O
Mtf1loxP	O
control	O
livers	O
,	O
a	O
clear	O
increase	O
of	O
Ndrg1	O
expression	O
was	O
observed	O
after	O
cadmium	O
exposure	O
;	O
in	O
livers	O
from	O
Mtf1Mx	O
-	O
cre	O
mice	O
,	O
this	O
cadmium	O
response	O
was	O
not	O
detectable	O
,	O
while	O
basal	O
expression	O
was	O
similar	O
to	O
controls	O
.	O

This	O
indicates	O
that	O
cadmium	O
-	O
induced	O
expression	O
of	O
Ndrg1	O
depends	O
on	O
MTF	O
-	O
1	O
.	O

Five	O
MRE	O
core	O
consensus	O
sequences	O
are	O
located	O
upstream	O
of	O
the	O
mouse	O
Ndrg1	O
transcription	O
start	O
(	O
Figure	O
3b	O
)	O
.	O

Four	O
of	O
them	O
are	O
clustered	O
(	O
MRE1	O
to	O
MRE4	O
,	O
-	O
138	O
to	O
-	O
332	O
bp	O
)	O
,	O
the	O
fifth	O
one	O
is	O
located	O
farther	O
upstream	O
(	O
MRE5	O
,	O
-	O
883	O
bp	O
)	O
.	O

EMSA	O
was	O
performed	O
to	O
test	O
whether	O
MTF	O
-	O
1	O
is	O
interacting	O
with	O
some	O
or	O
all	O
of	O
the	O
four	O
proximal	O
MRE	O
sequences	O
(	O
Figure	O
3c	O
)	O
.	O

Separate	O
oligonucleotides	O
were	O
tested	O
for	O
MRE1	O
and	O
MRE2	O
,	O
whereas	O
one	O
oligonucleotide	O
spanning	O
both	O
sequences	O
was	O
used	O
for	O
MRE3	O
and	O
MRE4	O
(	O
MRE3	O
,	O
4	O
)	O
.	O

No	O
complex	S-GO
was	O
seen	O
with	O
MRE1	O
,	O
but	O
specific	O
MTF	O
-	O
1	O
complexes	S-GO
were	O
observed	O
for	O
both	O
the	O
MRE2	O
and	O
MRE3	O
,	O
4	O
oligonucleotides	O
with	O
liver	O
protein	O
extract	O
from	O
an	O
Mtf1loxP	O
mouse	O
.	O

As	O
expected	O
,	O
no	O
bandshift	O
was	O
observed	O
with	O
protein	O
extract	O
from	O
a	O
mouse	O
lacking	O
MTF	O
-	O
1	O
(	O
Mtf1Mx	O
-	O
cre	O
)	O
.	O

Cadmium	O
response	O
of	O
Csrp1	O
depends	O
on	O
MTF	O
-	O
1	O

Csrp1	O
was	O
found	O
in	O
microarray	O
analyses	O
to	O
be	O
significantly	O
downregulated	O
in	O
cadmium	O
-	O
treated	O
Mtf1Mx	O
-	O
cre	O
mice	O
compared	O
to	O
Mtf1loxP	O
mice	O
(	O
Table	O
1	O
,	O
c	O
)	O
.	O

CSRP1	O
is	O
a	O
member	O
of	O
the	O
evolutionary	O
conserved	O
CRP	O
family	O
of	O
proteins	O
that	O
have	O
been	O
implicated	O
in	O
myogenesis	O
and	O
cytoskeletal	S-GO
remodeling	O
(	O
41	O
,	O
42	O
)	O
.	O

Semiquantitative	O
RT	O
-	O
PCRs	O
confirmed	O
the	O
microarray	O
results	O
,	O
namely	O
,	O
that	O
Csrp1	O
expression	O
is	O
elevated	O
in	O
Mtf1loxP	O
livers	O
upon	O
cadmium	O
exposure	O
(	O
Figure	O
4a	O
)	O
.	O

In	O
contrast	O
,	O
no	O
cadmium	O
response	O
was	O
detectable	O
in	O
livers	O
from	O
Mtf1Mx	O
-	O
cre	O
mice	O
,	O
suggesting	O
that	O
MTF	O
-	O
1	O
is	O
required	O
for	O
cadmium	O
induction	O
of	O
Csrp1	O
.	O

Three	O
MRE	O
core	O
consensus	O
sequences	O
were	O
found	O
upstream	O
of	O
the	O
Csrp1	O
transcription	O
start	O
(	O
MRE2	O
to	O
MRE4	O
,	O
-	O
56	O
to	O
-	O
366	O
bp	O
)	O
,	O
one	O
was	O
found	O
immediately	O
downstream	O
(	O
MRE1	O
,	O
+	O
7	O
bp	O
;	O
Figure	O
4b	O
)	O
.	O

Specific	O
binding	O
of	O
MTF	O
-	O
1	O
was	O
observed	O
with	O
EMSA	O
for	O
MRE2	O
oligonucleotide	O
and	O
protein	O
extract	O
from	O
an	O
Mtf1loxP	O
liver	O
,	O
but	O
not	O
an	O
Mtf1Mx	O
-	O
cre	O
liver	O
extract	O
lacking	O
MTF	O
-	O
1	O
,	O
confirming	O
the	O
participation	O
of	O
MTF	O
-	O
1	O
in	O
the	O
complex	S-GO
(	O
Figure	O
4c	O
)	O
.	O

MTF	O
-	O
1	O
inhibits	O
expression	O
of	O
Slc39a10	O

Slc39a10	O
was	O
detected	O
in	O
microarray	O
analysis	O
to	O
be	O
significantly	O
upregulated	O
in	O
livers	O
from	O
both	O
mock	O
-	O
and	O
cadmium	O
-	O
treated	O
Mtf1Mx	O
-	O
cre	O
mice	O
compared	O
to	O
control	O
animals	O
(	O
Table	O
1	O
,	O
b	O
and	O
d	O
)	O
.	O

SLC39	O
proteins	O
are	O
members	O
of	O
the	O
Zrt	O
-	O
and	O
Irt	O
-	O
like	O
protein	O
(	O
ZIP	O
)	O
family	O
of	O
metal	O
ion	O
transporters	O
that	O
transport	O
,	O
with	O
no	O
known	O
exception	O
,	O
metal	O
ion	O
substrates	O
across	O
cellular	B-GO
membranes	E-GO
into	O
the	O
cytoplasm	S-GO
(	O
43	O
,	O
44	O
)	O
.	O

In	O
accordance	O
with	O
microarray	O
data	O
,	O
semiquantitative	O
RT	O
-	O
PCRs	O
showed	O
a	O
downregulation	O
of	O
Slc39a10	O
expression	O
in	O
livers	O
of	O
Mtf1loxP	O
mice	O
upon	O
cadmium	O
exposure	O
.	O

In	O
samples	O
from	O
Mtf1Mx	O
-	O
cre	O
mice	O
,	O
the	O
basal	O
expression	O
was	O
significantly	O
increased	O
;	O
cadmium	O
treatment	O
still	O
resulted	O
in	O
a	O
decrease	O
of	O
Slc39a10	O
expression	O
(	O
Figure	O
5a	O
)	O
.	O

It	O
cannot	O
be	O
judged	O
by	O
this	O
experiment	O
whether	O
the	O
degree	O
of	O
cadmium	O
-	O
induced	O
reduction	O
of	O
Slc39a10	O
transcription	O
was	O
identical	O
for	O
Mtf1Mx	O
-	O
cre	O
and	O
Mtf1loxP	O
mice	O
or	O
lower	O
in	O
the	O
absence	O
of	O
MTF	O
-	O
1	O
.	O

In	O
microarray	O
analysis	O
,	O
the	O
degree	O
of	O
the	O
downregulation	O
was	O
either	O
comparable	O
to	O
the	O
one	O
in	O
control	O
livers	O
or	O
lower	O
,	O
depending	O
on	O
the	O
considered	O
Affymetrix	O
GeneChip	O
(R)	O
probe	O
set	O
(	O
data	O
not	O
shown	O
)	O
.	O

The	O
results	O
indicate	O
that	O
MTF	O
-	O
1	O
is	O
involved	O
in	O
repression	O
of	O
the	O
basal	O
expression	O
of	O
Slc39a10	O
.	O

It	O
might	O
also	O
participate	O
in	O
the	O
cadmium	O
response	O
of	O
this	O
gene	O
,	O
but	O
it	O
is	O
apparently	O
not	O
exclusively	O
responsible	O
.	O

One	O
MRE	O
core	O
consensus	O
sequence	O
was	O
found	O
just	O
upstream	O
of	O
the	O
mouse	O
Slc39a10	O
transcription	O
start	O
(	O
MRE1	O
,	O
-	O
21	O
bp	O
)	O
,	O
another	O
one	O
directly	O
downstream	O
(	O
MRE2	O
,	O
+	O
17	O
bp	O
;	O
Figure	O
5b	O
)	O
.	O

Specific	O
binding	O
of	O
MTF	O
-	O
1	O
was	O
observed	O
in	O
EMSA	O
analysis	O
for	O
MRE2	O
with	O
liver	O
protein	O
extract	O
from	O
an	O
Mtf1loxP	O
but	O
not	O
from	O
an	O
Mtf1Mx	O
-	O
cre	O
mouse	O
,	O
while	O
no	O
binding	O
was	O
detected	O
with	O
MRE1	O
(	O
Figure	O
5c	O
)	O
.	O

Cadmium	O
-	O
responsive	O
,	O
MTF	O
-	O
1	O
-	O
independent	O
genes	O

Finally	O
,	O
we	O
also	O
identified	O
a	O
number	O
of	O
cadmium	O
-	O
responsive	O
genes	O
that	O
were	O
independent	O
of	O
MTF	O
-	O
1	O
presence	O
,	O
by	O
comparing	O
the	O
probe	O
array	O
data	O
of	O
all	O
cadmium	O
-	O
treated	O
mice	O
with	O
the	O
data	O
of	O
all	O
mock	O
-	O
treated	O
mice	O
,	O
irrespective	O
of	O
the	O
genotype	O
(	O
Table	O
2	O
)	O
.	O

An	O
at	O
least	O
2	O
-	O
fold	O
,	O
reliable	O
upregulation	O
was	O
observed	O
after	O
cadmium	O
exposure	O
for	O
31	O
probe	O
sets	O
corresponding	O
to	O
21	O
different	O
characterized	O
genes	O
(	O
Table	O
2	O
,	O
a	O
)	O
.	O

For	O
2	O
probe	O
sets	O
corresponding	O
to	O
2	O
characterized	O
genes	O
,	O
an	O
at	O
least	O
2	O
-	O
fold	O
downregulation	O
was	O
detected	O
(	O
Table	O
2	O
,	O
b	O
)	O
.	O

Several	O
genes	O
involved	O
in	O
the	O
metabolism	O
of	O
the	O
antioxidant	O
glutathione	O
were	O
found	O
to	O
be	O
upregulated	O
by	O
cadmium	O
exposure	O
,	O
namely	O
the	O
genes	O
encoding	O
the	O
catalytic	O
subunit	O
of	O
glutamate	O
-	O
cysteine	O
ligase	O
(	O
Gclc	O
)	O
that	O
is	O
the	O
rate	O
limiting	O
enzyme	O
in	O
de	O
novo	O
synthesis	O
of	O
glutathione	O
(	O
45	O
)	O
;	O
glutathione	O
reductase	O
1	O
(	O
Gsr	O
)	O
,	O
the	O
reducing	O
enzyme	O
for	O
oxidized	O
glutathione	O
(	O
45	O
)	O
;	O
and	O
glutathione	O
-	O
S	O
-	O
transferase	O
,	O
mu	O
4	O
(	O
Gstm4	O
)	O
,	O
which	O
is	O
a	O
member	O
of	O
the	O
glutathione	O
-	O
S	O
-	O
transferase	O
supergene	O
family	O
of	O
detoxification	O
enzymes	O
(	O
45	O
)	O
.	O

In	O
all	O
of	O
these	O
cases	O
,	O
induction	O
was	O
confirmed	O
by	O
semiquantitative	O
RT	O
-	O
PCRs	O
(	O
data	O
not	O
shown	O
)	O
.	O

Gclc	O
,	O
also	O
referred	O
to	O
as	O
heavy	O
chain	O
subunit	O
of	O
gamma	O
-	O
glutamylcysteine	O
synthetase	O
(	O
Ggcs	O
-	O
hc	O
)	O
,	O
had	O
been	O
discussed	O
previously	O
as	O
a	O
target	O
gene	O
of	O
MTF	O
-	O
1	O
(	O
6	O
)	O
.	O

Our	O
expression	O
data	O
indicate	O
that	O
Gclc	O
is	O
induced	O
by	O
cadmium	O
but	O
,	O
at	O
least	O
in	O
the	O
adult	O
mouse	O
liver	O
,	O
not	O
dependent	O
on	O
MTF	O
-	O
1	O
.	O

To	O
analyze	O
the	O
role	O
of	O
the	O
glutathione	O
system	O
in	O
the	O
cellular	O
cadmium	O
response	O
,	O
mouse	O
embryonic	O
fibroblasts	O
with	O
and	O
without	O
functional	O
Mtf1	O
were	O
treated	O
with	O
cadmium	O
in	O
combination	O
with	O
BSO	O
,	O
a	O
specific	O
inhibitor	O
of	O
glutamate	O
-	O
cysteine	O
ligase	O
(	O
31	O
)	O
,	O
and	O
cell	O
viability	O
was	O
assessed	O
by	O
a	O
colorimetric	O
assay	O
based	O
on	O
the	O
tetrazolium	O
salt	O
MTT	O
(	O
Figure	O
6	O
)	O
.	O

Increasing	O
concentrations	O
of	O
BSO	O
or	O
cadmium	O
alone	O
were	O
to	O
some	O
extent	O
cytotoxic	O
for	O
the	O
examined	O
cell	O
lines	O
.	O

Treatment	O
with	O
both	O
BSO	O
and	O
cadmium	O
resulted	O
in	O
an	O
enhanced	O
lethality	O
particularly	O
for	O
the	O
cells	O
without	O
functional	O
Mtf1	O
,	O
indicating	O
that	O
a	O
depletion	O
of	O
glutathione	O
together	O
with	O
a	O
lack	O
of	O
Mtf1	O
impair	O
an	O
efficient	O
anti	O
-	O
cadmium	O
defense	O
.	O

Thus	O
,	O
adequate	O
glutathione	O
supply	O
as	O
well	O
as	O
MTF	O
-	O
1	O
and	O
its	O
target	O
genes	O
are	O
essential	O
for	O
the	O
survival	O
of	O
the	O
cell	O
under	O
cadmium	O
stress	O
.	O

Besides	O
genes	O
related	O
to	O
the	O
glutathione	O
pathway	O
,	O
several	O
other	O
stress	O
-	O
related	O
genes	O
were	O
upregulated	O
upon	O
cadmium	O
exposure	O
,	O
including	O
genes	O
for	O
thioredoxin	O
reductase	O
1	O
(	O
Txnrd1	O
)	O
,	O
one	O
of	O
the	O
reducing	O
enzymes	O
of	O
the	O
antioxidant	O
thioredoxin	O
(	O
46	O
)	O
;	O
KDEL	O
endoplasmic	O
reticulum	O
protein	O
retention	O
receptor	O
2	O
(	O
Kdelr2	O
)	O
participating	O
in	O
ER	S-GO
stress	O
response	O
(	O
47	O
)	O
;	O
and	O
the	O
anti	O
-	O
apoptotic	O
Bcl2	O
-	O
associated	O
athanogene	O
3	O
(	O
Bag3	O
)	O
involved	O
in	O
stress	O
-	O
induced	O
apoptosis	O
(	O
48	O
)	O
.	O

DISCUSSION	O

In	O
this	O
study	O
,	O
a	O
virtually	O
complete	O
deletion	O
of	O
Mtf1	O
in	O
the	O
liver	O
of	O
adult	O
,	O
pI	O
-	O
pC	O
-	O
induced	O
Mtf1Mx	O
-	O
cre	O
mice	O
did	O
not	O
detectably	O
affect	O
the	O
phenotype	O
of	O
the	O
respective	O
mice	O
under	O
non	O
-	O
stress	O
conditions	O
,	O
confirming	O
that	O
MTF	O
-	O
1	O
is	O
dispensable	O
in	O
the	O
adult	O
liver	O
(	O
26	O
)	O
,	O
in	O
contrast	O
to	O
its	O
essential	O
role	O
in	O
embryonic	O
liver	O
development	O
(	O
23	O
)	O
.	O

The	O
comparison	O
of	O
gene	O
expression	O
in	O
livers	O
of	O
mock	O
-	O
or	O
cadmium	O
-	O
treated	O
Mtf1Mx	O
-	O
cre	O
and	O
Mtf1loxP	O
mice	O
revealed	O
several	O
MTF	O
-	O
1	O
target	O
gene	O
candidates	O
.	O

Transcripts	O
of	O
the	O
two	O
stress	O
-	O
responsive	O
metallothionein	O
genes	O
Mt1	O
and	O
Mt2	O
were	O
severely	O
reduced	O
,	O
in	O
support	O
of	O
a	O
crucial	O
role	O
of	O
MTF	O
-	O
1	O
for	O
both	O
basal	O
and	O
metal	O
-	O
induced	O
expression	O
of	O
metallothioneins	O
(	O
4	O
,	O
6	O
)	O
.	O

One	O
of	O
the	O
newly	O
found	O
target	O
genes	O
is	O
Sepw1	O
.	O

The	O
exact	O
molecular	O
function	O
of	O
SEPW1	O
protein	O
is	O
unknown	O
to	O
date	O
,	O
but	O
a	O
role	O
as	O
antioxidant	O
has	O
been	O
proposed	O
due	O
to	O
its	O
ability	O
to	O
bind	O
glutathione	O
(	O
35	O
)	O
.	O

In	O
accordance	O
with	O
this	O
,	O
ectopic	O
expression	O
of	O
mouse	O
Sepw1	O
renders	O
cells	O
resistant	O
to	O
hydrogen	O
peroxide	O
,	O
and	O
this	O
resistance	O
is	O
dependent	O
on	O
it	O
binding	O
glutathione	O
(	O
36	O
)	O
.	O

Furthermore	O
,	O
Amantana	O
et	O
al	O
.	O

(	O
49	O
)	O
showed	O
that	O
expression	O
of	O
a	O
reporter	O
gene	O
fused	O
to	O
a	O
rat	O
Sepw1	O
promoter	O
fragment	O
can	O
be	O
induced	O
in	O
rat	O
glial	O
cells	O
by	O
copper	O
and	O
zinc	O
,	O
but	O
not	O
cadmium	O
.	O

This	O
response	O
was	O
dependent	O
on	O
an	O
overlapping	O
-	O
inverted	O
MRE	O
sequence	O
located	O
proximal	O
to	O
the	O
rat	O
Sepw1	O
transcription	O
start	O
(	O
49	O
)	O
,	O
even	O
though	O
initial	O
studies	O
failed	O
to	O
demonstrate	O
MTF	O
-	O
1	O
binding	O
to	O
that	O
sequence	O
(	O
50	O
)	O
.	O

Our	O
expression	O
and	O
DNA	O
-	O
binding	O
studies	O
strongly	O
suggest	O
that	O
MTF	O
-	O
1	O
is	O
important	O
for	O
the	O
basal	O
expression	O
of	O
mouse	O
Sepw1	O
by	O
binding	O
to	O
the	O
corresponding	O
overlapping	O
-	O
inverted	O
MRE	O
sequence	O
.	O

Ndrg1	O
,	O
another	O
interesting	O
MTF	O
-	O
1	O
target	O
gene	O
was	O
named	O
N	O
-	O
myc	O
downstream	O
regulated	O
gene	O
1	O
following	O
the	O
discovery	O
that	O
the	O
transcription	O
factor	O
N	O
-	O
myc	O
represses	O
the	O
expression	O
of	O
mouse	O
Ndrg1	O
(	O
51	O
)	O
.	O

Transcription	O
of	O
Ndrg1	O
and	O
/	O
or	O
its	O
human	O
ortholog	O
is	O
induced	O
by	O
different	O
physiological	O
and	O
cell	O
stress	O
conditions	O
,	O
such	O
as	O
androgens	O
,	O
nickel	O
compounds	O
,	O
DNA	O
damage	O
and	O
hypoxia	O
(	O
37	O
-	O
40	O
,	O
52	O
,	O
53	O
)	O
.	O

In	O
addition	O
,	O
the	O
protein	O
is	O
overexpressed	O
in	O
human	O
cancers	O
of	O
many	O
tissues	O
,	O
such	O
as	O
lung	O
,	O
liver	O
,	O
brain	O
,	O
breast	O
,	O
kidney	O
and	O
skin	O
(	O
40	O
)	O
.	O

Although	O
Ndrg1	O
and	O
especially	O
its	O
human	O
ortholog	O
have	O
been	O
quite	O
intensely	O
studied	O
,	O
its	O
function	O
remains	O
unclear	O
;	O
however	O
,	O
the	O
induction	O
by	O
stimuli	O
like	O
nickel	O
and	O
hypoxia	O
suggests	O
an	O
involvement	O
in	O
the	O
cell	O
stress	O
response	O
.	O

Such	O
a	O
role	O
is	O
strongly	O
endorsed	O
by	O
our	O
finding	O
that	O
Ndrg1	O
gene	O
expression	O
is	O
also	O
induced	O
by	O
cadmium	O
,	O
and	O
that	O
MTF	O
-	O
1	O
plays	O
a	O
crucial	O
role	O
in	O
this	O
induction	O
.	O

In	O
the	O
case	O
of	O
Csrp1	O
,	O
expression	O
analyses	O
and	O
DNA	O
-	O
binding	O
studies	O
indicate	O
that	O
MTF	O
-	O
1	O
is	O
required	O
for	O
cadmium	O
induction	O
by	O
binding	O
to	O
an	O
MRE	O
upstream	O
of	O
the	O
transcription	O
start	O
.	O

Studies	O
with	O
human	O
,	O
avian	O
and	O
chicken	O
CSRP1	O
have	O
shown	O
that	O
this	O
protein	O
is	O
localized	O
at	O
adhesion	B-GO
plaques	E-GO
and	O
in	O
association	O
with	O
filamentous	B-GO
actin	E-GO
,	O
and	O
interacts	O
with	O
the	O
adhesion	B-GO
plaque	E-GO
protein	O
zyxin	O
,	O
as	O
well	O
as	O
the	O
actin	O
-	O
cross	O
-	O
linking	O
protein	O
alpha	O
-	O
actinin	O
(	O
54	O
-	O
57	O
)	O
.	O

The	O
ability	O
to	O
bind	O
these	O
partners	O
suggests	O
a	O
role	O
in	O
cytoskeletal	S-GO
organization	O
(	O
58	O
)	O
.	O

Exposure	O
of	O
cultured	O
cells	O
to	O
cadmium	O
causes	O
a	O
decrease	O
in	O
,	O
and	O
destruction	O
of	O
,	O
cellular	O
contact	O
proteins	O
and	O
the	O
actin	B-GO
cytoskeleton	E-GO
(	O
59	O
)	O
.	O

In	O
the	O
proximal	O
tubule	O
cells	O
of	O
the	O
rat	O
kidney	O
,	O
a	O
partial	O
loss	O
of	O
actin	O
and	O
the	O
actin	O
-	O
bundling	O
protein	O
villin	O
is	O
observed	O
upon	O
cadmium	O
treatment	O
,	O
as	O
well	O
as	O
the	O
derangement	O
and	O
depolymerization	O
of	O
microtubules	S-GO
(	O
60	O
)	O
.	O

Assuming	O
that	O
CSRP1	O
is	O
important	O
for	O
the	O
organization	O
of	O
cytoskeletal	B-GO
elements	E-GO
in	O
the	O
mouse	O
,	O
its	O
upregulation	O
by	O
cadmium	O
might	O
protect	O
the	O
organism	O
from	O
damage	O
of	O
the	O
cytoskeleton	S-GO
.	O

Such	O
a	O
mechanism	O
would	O
expand	O
the	O
role	O
of	O
MTF	O
-	O
1	O
in	O
stress	O
response	O
.	O

Our	O
expression	O
studies	O
also	O
suggest	O
that	O
MTF	O
-	O
1	O
represses	O
basal	O
transcription	O
of	O
Slc39a10	O
,	O
in	O
contrast	O
to	O
its	O
role	O
as	O
activator	O
for	O
the	O
expression	O
of	O
other	O
target	O
genes	O
like	O
Mt1	O
,	O
Mt2	O
,	O
and	O
Znt1	O
(	O
4	O
,	O
19	O
)	O
.	O

SLC39A10	O
is	O
one	O
of	O
14	O
mouse	O
SLC39	O
members	O
,	O
which	O
belong	O
to	O
the	O
ZIP	O
family	O
of	O
metal	O
ion	O
transporters	O
(	O
43	O
,	O
44	O
)	O
.	O

All	O
members	O
of	O
the	O
ZIP	O
family	O
characterized	O
so	O
far	O
increase	O
intracellular	S-GO
cytoplasmic	S-GO
metal	O
ion	O
concentrations	O
by	O
promoting	O
extracellular	S-GO
and	O
vesicular	S-GO
ion	O
transport	O
into	O
the	O
cytoplasm	S-GO
.	O

ZIP	O
proteins	O
have	O
been	O
reported	O
to	O
be	O
transporters	O
of	O
zinc	O
,	O
iron	O
,	O
manganese	O
and	O
/	O
or	O
cadmium	O
(	O
44	O
,	O
61	O
-	O
63	O
)	O
.	O

Although	O
SLC39A10	O
is	O
largely	O
uncharacterized	O
(	O
44	O
)	O
,	O
it	O
is	O
referred	O
to	O
in	O
several	O
databases	O
as	O
putative	O
zinc	O
transporter	O
.	O

It	O
has	O
been	O
previously	O
shown	O
that	O
MTF	O
-	O
1	O
is	O
important	O
for	O
both	O
basal	O
expression	O
and	O
metal	O
induction	O
of	O
the	O
mouse	O
Znt1	O
gene	O
(	O
19	O
)	O
.	O

ZnT	O
proteins	O
represent	O
a	O
different	O
family	O
of	O
transporters	O
that	O
reduce	O
intracellular	S-GO
cytoplasmic	S-GO
zinc	O
by	O
promoting	O
zinc	O
efflux	O
from	O
cells	O
or	O
into	O
intracellular	S-GO
vesicles	S-GO
.	O

Thus	O
,	O
members	O
of	O
the	O
ZnT	O
and	O
ZIP	O
family	O
with	O
zinc	O
as	O
predominant	O
substrate	O
have	O
opposite	O
roles	O
in	O
cellular	O
zinc	O
homeostasis	O
(	O
43	O
)	O
.	O

Assuming	O
that	O
SLC39A10	O
is	O
indeed	O
a	O
zinc	O
transporter	O
,	O
MTF	O
-	O
1	O
would	O
control	O
expression	O
of	O
two	O
zinc	O
transporters	O
with	O
antagonistic	O
functions	O
,	O
namely	O
,	O
Znt1	O
and	O
Slc39a10	O
.	O

Specific	O
binding	O
of	O
MTF	O
-	O
1	O
was	O
observed	O
for	O
an	O
MRE	O
located	O
just	O
downstream	O
of	O
the	O
Slc39a10	O
transcription	O
start	O
.	O

In	O
a	O
simple	O
model	O
,	O
such	O
a	O
binding	O
could	O
interfere	O
with	O
the	O
accessibility	O
of	O
the	O
transcriptional	O
start	O
site	O
for	O
RNA	B-GO
polymerase	I-GO
II	E-GO
and	O
/	O
or	O
general	O
transcription	O
factors	O
,	O
thus	O
preventing	O
transcription	O
initiation	O
of	O
the	O
gene	O
.	O

Indeed	O
,	O
such	O
a	O
mechanism	O
has	O
been	O
described	O
in	O
yeast	O
for	O
the	O
zinc	O
-	O
responsive	O
activator	O
protein	O
1	O
(	O
Zap1	O
)	O
and	O
its	O
target	O
gene	O
,	O
zinc	O
-	O
regulated	O
transporter	O
2	O
(	O
ZRT2	O
)	O
(	O
64	O
)	O
.	O

However	O
,	O
the	O
inhibition	O
of	O
Slc39a10	O
expression	O
by	O
MTF	O
-	O
1	O
may	O
well	O
be	O
more	O
complex	O
than	O
a	O
competition	O
for	O
promoter	O
binding	O
.	O

Independent	O
of	O
MTF	O
-	O
1	O
,	O
cadmium	O
treatment	O
also	O
leads	O
to	O
downregulation	O
of	O
Slc39a10	O
transcripts	O
,	O
suggesting	O
that	O
some	O
other	O
factor	O
is	O
mediating	O
this	O
response	O
.	O

A	O
previous	O
target	O
gene	O
search	O
for	O
MTF	O
-	O
1	O
with	O
mouse	O
embryos	O
of	O
conventional	O
Mtf1	O
knockout	O
phenotype	O
revealed	O
,	O
besides	O
metallothionein	O
genes	O
,	O
the	O
multifunctional	O
alpha	O
-	O
fetoprotein	O
(	O
Afp	O
)	O
and	O
the	O
liver	O
-	O
enriched	O
transcription	O
factor	O
CCAAT	O
/	O
enhancer	O
binding	O
protein	O
alpha	O
(	O
Cebpa	O
)	O
as	O
prime	O
candidates	O
(	O
65	O
)	O
.	O

After	O
an	O
early	O
onset	O
during	O
hepatogenesis	O
,	O
Afp	O
expression	O
is	O
repressed	O
postnatally	O
and	O
replaced	O
by	O
albumin	O
(	O
66	O
)	O
.	O

Thus	O
,	O
our	O
adult	O
Mtf1Mx	O
-	O
cre	O
mice	O
lacking	O
MTF	O
-	O
1	O
were	O
not	O
suitable	O
to	O
analyze	O
Afp	O
expression	O
.	O

Cebpa	O
is	O
expressed	O
in	O
the	O
adult	O
liver	O
as	O
well	O
as	O
in	O
other	O
tissues	O
(	O
67	O
)	O
,	O
but	O
the	O
present	O
microarray	O
data	O
revealed	O
no	O
significant	O
expression	O
differences	O
in	O
livers	O
from	O
adult	O
Mtf1loxP	O
and	O
Mtf1Mx	O
-	O
cre	O
mice	O
(	O
data	O
not	O
shown	O
)	O
.	O

Therefore	O
,	O
MTF	O
-	O
1	O
may	O
affect	O
Cebpa	O
expression	O
only	O
during	O
embryonal	O
development	O
,	O
perhaps	O
in	O
combination	O
with	O
as	O
yet	O
unidentified	O
factors	O
.	O

The	O
present	O
study	O
confirms	O
and	O
extends	O
the	O
role	O
of	O
MTF	O
-	O
1	O
as	O
an	O
important	O
stress	O
response	O
regulator	O
.	O

We	O
have	O
identified	O
and	O
preliminarily	O
characterized	O
four	O
target	O
genes	O
of	O
MTF	O
-	O
1	O
in	O
the	O
adult	O
mouse	O
liver	O
:	O
in	O
the	O
case	O
of	O
Sepw1	O
,	O
MTF	O
-	O
1	O
is	O
required	O
to	O
maintain	O
basal	O
expression	O
,	O
supporting	O
a	O
role	O
of	O
mouse	O
MTF	O
-	O
1	O
in	O
oxidative	O
stress	O
response	O
.	O

In	O
addition	O
,	O
MTF	O
-	O
1	O
contributes	O
to	O
the	O
cadmium	O
-	O
induced	O
expression	O
of	O
Ndrg1	O
and	O
Csrp1	O
.	O

Furthermore	O
,	O
MTF	O
-	O
1	O
helps	O
to	O
repress	O
the	O
basal	O
expression	O
of	O
Slc39a10	O
,	O
in	O
contrast	O
to	O
its	O
role	O
as	O
transcriptional	O
activator	O
for	O
genes	O
like	O
Mt1	O
,	O
Mt2	O
or	O
Znt1	O
.	O

Thus	O
the	O
same	O
transcription	O
factor	O
apparently	O
serves	O
as	O
an	O
activator	O
or	O
repressor	O
,	O
depending	O
on	O
the	O
target	O
gene	O
.	O

The	O
comparison	O
of	O
liver	O
gene	O
expression	O
of	O
cadmium	O
-	O
and	O
mock	O
-	O
treated	O
mice	O
also	O
revealed	O
a	O
number	O
of	O
genes	O
that	O
were	O
responsive	O
to	O
cadmium	O
exposure	O
,	O
independent	O
of	O
the	O
presence	O
or	O
absence	O
of	O
MTF	O
-	O
1	O
.	O

Evidence	O
suggests	O
that	O
the	O
production	O
of	O
reactive	O
oxygen	O
species	O
is	O
a	O
major	O
effect	O
of	O
acute	O
cadmium	O
toxicity	O
(	O
68	O
,	O
69	O
)	O
,	O
and	O
exposure	O
of	O
cultured	O
cells	O
or	O
animals	O
to	O
cadmium	O
is	O
associated	O
with	O
depletion	O
of	O
reduced	O
glutathione	O
,	O
lipid	O
peroxidation	O
and	O
DNA	O
damage	O
(	O
70	O
-	O
73	O
)	O
.	O

Oxidative	O
stress	O
and	O
the	O
subsequent	O
restoration	O
of	O
cellular	O
homeostasis	O
have	O
been	O
shown	O
to	O
induce	O
the	O
expression	O
of	O
genes	O
encoding	O
acute	O
-	O
phase	O
proteins	O
and	O
antioxidant	O
enzymes	O
(	O
74	O
)	O
.	O

In	O
mammals	O
,	O
cadmium	O
tends	O
to	O
accumulate	O
in	O
the	O
kidney	O
and	O
liver	O
as	O
a	O
cadmium	O
-	O
metallothionein	O
complex	O
that	O
has	O
an	O
extremely	O
slow	O
turnover	O
(	O
75	O
,	O
76	O
)	O
.	O

Furthermore	O
,	O
metallothioneins	O
provide	O
protection	O
against	O
oxidative	O
stress	O
(	O
1	O
,	O
17	O
)	O
.	O

In	O
addition	O
to	O
metallothioneins	O
,	O
glutathione	O
was	O
postulated	O
as	O
a	O
first	O
line	O
of	O
defense	O
against	O
cadmium	O
toxicity	O
(	O
77	O
)	O
.	O

Glutathione	O
efficiently	O
complexes	O
cadmium	O
(	O
78	O
)	O
and	O
scavenges	O
free	O
radicals	O
and	O
other	O
reactive	O
oxygen	O
species	O
directly	O
,	O
and	O
indirectly	O
via	O
enzymatic	O
reactions	O
(	O
45	O
)	O
.	O

In	O
such	O
reactions	O
,	O
glutathione	O
is	O
oxidized	O
and	O
has	O
to	O
be	O
regenerated	O
by	O
glutathione	O
reductase	O
.	O

Also	O
,	O
glutathione	O
-	O
S	O
-	O
transferases	O
mediate	O
the	O
conjugation	O
of	O
various	O
electrophiles	O
to	O
glutathione	O
.	O

The	O
observed	O
cadmium	O
-	O
induced	O
upregulation	O
of	O
Gclc	O
,	O
Gsr	O
and	O
Gstm4	O
supports	O
the	O
importance	O
of	O
glutathione	O
in	O
the	O
cellular	O
cadmium	O
response	O
.	O

The	O
enhanced	O
sensitivity	O
to	O
cadmium	O
toxicity	O
that	O
we	O
found	O
for	O
mouse	O
embryonic	O
fibroblasts	O
upon	O
a	O
combination	O
of	O
Mtf1	O
deletion	O
and	O
depletion	O
of	O
glutathione	O
further	O
corroborates	O
the	O
importance	O
of	O
MTF	O
-	O
1	O
and	O
its	O
target	O
genes	O
as	O
well	O
as	O
reduced	O
glutathione	O
for	O
an	O
efficient	O
anti	O
-	O
cadmium	O
defense	O
.	O

Our	O
data	O
provide	O
strong	O
evidence	O
for	O
at	O
least	O
two	O
branches	O
of	O
cellular	O
anti	O
-	O
cadmium	O
defense	O
,	O
one	O
via	O
MTF	O
-	O
1	O
and	O
its	O
target	O
genes	O
,	O
notably	O
metallothioneins	O
,	O
the	O
other	O
via	O
glutathione	O
,	O
with	O
an	O
apparent	O
overlap	O
in	O
Sepw1	O
.	O

SUPPLEMENTARY	O
DATA	O

Supplementary	O
data	O
are	O
available	O
at	O
NAR	O
online	O
.	O

Supplementary	O
Material	O

[	O
Supplementary	O
Material	O
]	O

Acknowledgements	O

We	O
are	O
indebted	O
to	O
the	O
Functional	O
Genomics	O
Center	O
Zurich	O
(	O
Zurich	O
,	O
CH	O
)	O
for	O
financial	O
as	O
well	O
as	O
technical	O
support	O
(	O
thanks	O
especially	O
to	O
Andrea	O
Patrignani	O
,	O
Dr	O
Ulrich	O
Wagner	O
,	O
and	O
Dr	O
Hubert	O
Rehrauer	O
for	O
their	O
assistance	O
in	O
data	O
generation	O
and	O
evaluation	O
)	O
,	O
and	O
to	O
Dr	O
Michael	O
Leviten	O
(	O
San	O
Carlos	O
,	O
CA	O
)	O
for	O
the	O
help	O
in	O
generating	O
Mtf1	O
conditional	O
knockout	O
mice	O
.	O

We	O
also	O
thank	O
Prof	O
.	O

Ueli	O
Schibler	O
(	O
Geneva	O
,	O
CH	O
)	O
for	O
his	O
advice	O
on	O
the	O
ADDER	O
technique	O
,	O
Prof	O
.	O

Michel	O
Aguet	O
(	O
Epalinges	O
-	O
Lausanne	O
,	O
CH	O
)	O
for	O
the	O
gift	O
of	O
Mx	O
-	O
Cre	O
mice	O
,	O
Dr	O
George	O
Hausmann	O
and	O
Dr	O
Michael	O
Fetchko	O
for	O
critical	O
reading	O
of	O
the	O
manuscript	O
,	O
and	O
Fritz	O
Ochsenbein	O
for	O
preparing	O
the	O
figures	O
.	O

Funding	O
to	O
pay	O
the	O
Open	O
Access	O
publication	O
charges	O
for	O
this	O
article	O
was	O
provided	O
by	O
the	O
Kanton	O
Zurich	O
.	O

Conflict	O
of	O
interest	O
statement	O
.	O

None	O
declared	O
.	O

Figures	O
and	O
Tables	O

Figure	O
1	O

Deletion	O
of	O
Mtf1	O
in	O
adult	O
mouse	O
liver	O
.	O

(	O
a	O
)	O
Generation	O
of	O
Mtf1	O
conditional	O
knockout	O
mice	O
.	O

The	O
targeted	O
allele	O
was	O
obtained	O
by	O
homologous	O
recombination	O
of	O
wild	O
-	O
type	O
(	O
wt	O
)	O
allele	O
and	O
targeting	O
vector	O
in	O
ES	O
cells	O
.	O

Removal	O
of	O
the	O
neomycin	O
cassette	O
(	O
NEO	O
)	O
by	O
Cre	O
recombinase	O
led	O
to	O
the	O
conditional	O
knockout	O
allele	O
Mtf1loxP	O
.	O

Conditional	O
Cre	O
-	O
mediated	O
deletion	O
of	O
exons	O
3	O
and	O
4	O
(	O
Mtf1	O
Delta	O
)	O
results	O
in	O
loss	O
of	O
function	O
via	O
loss	O
of	O
an	O
essential	O
part	O
of	O
the	O
DNA	O
-	O
binding	O
domain	O
and	O
the	O
generation	O
of	O
a	O
new	O
stop	O
codon	O
right	O
after	O
exon	O
2	O
.	O

Exons	O
3	O
to	O
7	O
of	O
Mtf1	O
are	O
indicated	O
by	O
grey	O
boxes	O
,	O
loxP	O
sites	O
by	O
black	O
triangles	O
.	O

TK	O
,	O
thymidine	O
kinase	O
cassette	O
.	O

Restriction	O
enzymes	O
:	O
San	O
,	O
SanDI	O
;	O
B	O
,	O
BbvCI	O
;	O
S	O
,	O
SrfI	O
;	O
H	O
,	O
HpaI	O
.	O

The	O
HpaI	O
site	O
indicated	O
by	O
the	O
crossed	O
H	O
was	O
lost	O
during	O
the	O
cloning	O
procedure	O
for	O
the	O
targeting	O
vector	O
.	O

(	O
b	O
)	O
RT	O
-	O
PCRs	O
with	O
total	O
liver	O
RNA	O
from	O
pI	O
-	O
pC	O
-	O
induced	O
male	O
Mtf1Mx	O
-	O
cre	O
or	O
Mtf1loxP	O
mice	O
.	O

The	O
used	O
primer	O
pair	O
results	O
in	O
products	O
of	O
589	O
bp	O
and	O
218	O
bp	O
with	O
full	O
-	O
length	O
mRNA	O
and	O
mRNA	O
without	O
exons	O
3	O
and	O
4	O
,	O
respectively	O
.	O

(	O
c	O
)	O
EMSA	O
with	O
liver	O
protein	O
extract	O
of	O
a	O
pI	O
-	O
pC	O
-	O
induced	O
male	O
Mtf1Mx	O
-	O
cre	O
or	O
Mtf1loxP	O
mouse	O
.	O

MTF	O
-	O
1	O
protein	B-GO
-	I-GO
DNA	I-GO
complex	E-GO
formation	O
was	O
tested	O
with	O
32P	O
-	O
labeled	O
MRE	O
consensus	O
oligonucleotide	O
MRE	O
-	O
s	O
.	O

Specificity	O
of	O
binding	O
was	O
verified	O
with	O
excess	O
of	O
unlabeled	O
competitor	O
MREd	O
or	O
unrelated	O
Gal4	O
oligonucleotide	O
;	O
Sp1	O
bandshifts	O
with	O
32P	O
-	O
labeled	O
Sp1	O
consensus	O
oligonucleotide	O
were	O
included	O
as	O
a	O
loading	O
control	O
.	O

Figure	O
2	O

Sepw1	O
basal	O
expression	O
depends	O
on	O
MTF	O
-	O
1	O
.	O

(	O
a	O
)	O
Semiquantitative	O
RT	O
-	O
PCRs	O
for	O
Sepw1	O
mRNA	O
using	O
total	O
liver	O
RNA	O
from	O
pI	O
-	O
pC	O
-	O
induced	O
male	O
Mtf1Mx	O
-	O
cre	O
or	O
Mtf1loxP	O
mice	O
.	O

The	O
animals	O
had	O
obtained	O
either	O
mock	O
s	O
.	O
c	O
.	O
injections	O
(	O
-	O
Cd	O
)	O
or	O
s	O
.	O
c	O
.	O
injections	O
with	O
20	O
micro	O
mol	O
/	O
kg	O
body	O
weight	O
CdSO4	O
(	O
+	O
Cd	O
)	O
6	O
h	O
before	O
sacrificing	O
them	O
.	O

RT	O
-	O
PCRs	O
for	O
Hprt	O
mRNA	O
were	O
used	O
as	O
internal	O
control	O
to	O
adjust	O
the	O
amount	O
of	O
total	O
RNA	O
used	O
.	O

(	O
b	O
)	O
S1	O
analysis	O
for	O
Sepw1	O
mRNA	O
with	O
RNA	O
described	O
in	O
(	O
a	O
)	O
,	O
using	O
a	O
32P	O
-	O
labeled	O
Sepw1	O
S1	O
probe	O
.	O

A	O
32P	O
-	O
labeled	O
S1	O
probe	O
for	O
Hprt	O
mRNA	O
was	O
used	O
to	O
adjust	O
the	O
amount	O
of	O
RNA	O
used	O
.	O

(	O
c	O
)	O
MRE	O
core	O
consensus	O
sequences	O
TGCRCNC	O
(	O
bold	O
letters	O
)	O
and	O
flanking	O
sequences	O
found	O
in	O
a	O
region	O
of	O
1000	O
bp	O
upstream	O
from	O
Sepw1	O
transcription	O
start	O
;	O
the	O
position	O
of	O
each	O
core	O
sequence	O
is	O
indicated	O
.	O

(	O
d	O
)	O
EMSA	O
with	O
liver	O
protein	O
extracts	O
of	O
a	O
male	O
Mtf1loxP	O
or	O
a	O
pI	O
-	O
pC	O
-	O
induced	O
,	O
male	O
Mtf1Mx	O
-	O
cre	O
mouse	O
,	O
both	O
mock	O
-	O
treated	O
.	O

MTF	O
-	O
1	O
protein	B-GO
-	I-GO
DNA	I-GO
complex	E-GO
formation	O
was	O
tested	O
with	O
32P	O
-	O
labeled	O
Sepw1	O
MRE1	O
or	O
MRE2	O
oligonucleotide	O
,	O
respectively	O
.	O

Specificity	O
of	O
binding	O
was	O
verified	O
with	O
excess	O
of	O
unlabeled	O
competitor	O
MREd	O
or	O
unrelated	O
Gal4	O
oligonucleotide	O
.	O

32P	O
-	O
labeled	O
MRE	O
-	O
s	O
was	O
included	O
to	O
indicate	O
the	O
position	O
of	O
an	O
MTF	O
-	O
1	O
-	O
DNA	O
complex	S-GO
;	O
bandshifts	O
for	O
the	O
common	O
transcription	O
factor	O
Sp1	O
with	O
32P	O
-	O
labeled	O
Sp1	O
consensus	O
oligonucleotide	O
were	O
obtained	O
as	O
protein	O
loading	O
control	O
.	O

Figure	O
3	O

Cadmium	O
response	O
of	O
Ndrg1	O
depends	O
on	O
MTF	O
-	O
1	O
.	O

(	O
a	O
)	O
Semiquantitative	O
RT	O
-	O
PCRs	O
for	O
Ndrg1	O
mRNA	O
using	O
total	O
liver	O
RNA	O
from	O
pI	O
-	O
pC	O
-	O
induced	O
male	O
Mtf1Mx	O
-	O
cre	O
or	O
Mtf1loxP	O
mice	O
.	O

The	O
animals	O
had	O
obtained	O
either	O
mock	O
s	O
.	O
c	O
.	O
injections	O
(	O
-	O
Cd	O
)	O
or	O
s	O
.	O
c	O
.	O
injections	O
with	O
20	O
micro	O
mol	O
/	O
kg	O
body	O
weight	O
CdSO4	O
(	O
+	O
Cd	O
)	O
6	O
h	O
before	O
sacrificing	O
them	O
.	O

RT	O
-	O
PCRs	O
for	O
Hprt	O
mRNA	O
were	O
used	O
as	O
internal	O
control	O
to	O
adjust	O
the	O
amount	O
of	O
total	O
RNA	O
used	O
.	O

(	O
b	O
)	O
MRE	O
core	O
consensus	O
sequences	O
TGCRCNC	O
(	O
bold	O
letters	O
)	O
and	O
flanking	O
sequences	O
found	O
in	O
a	O
region	O
of	O
1000	O
bp	O
upstream	O
from	O
Ndrg1	O
transcription	O
start	O
;	O
the	O
position	O
of	O
each	O
core	O
sequence	O
is	O
indicated	O
.	O

(	O
c	O
)	O
EMSA	O
with	O
liver	O
protein	O
extracts	O
of	O
a	O
male	O
Mtf1loxP	O
or	O
a	O
pI	O
-	O
pC	O
-	O
induced	O
,	O
male	O
Mtf1Mx	O
-	O
cre	O
mouse	O
,	O
both	O
mock	O
-	O
treated	O
.	O

MTF	O
-	O
1	O
protein	B-GO
-	I-GO
DNA	I-GO
complex	E-GO
formation	O
was	O
tested	O
with	O
32P	O
-	O
labeled	O
Ndrg1	O
MRE1	O
or	O
MRE2	O
oligonucleotide	O
,	O
or	O
a	O
32P	O
-	O
labeled	O
oligonucleotide	O
including	O
both	O
MRE3	O
and	O
MRE4	O
(	O
MRE3	O
,	O
4	O
)	O
.	O

Specificity	O
of	O
binding	O
was	O
verified	O
with	O
excess	O
of	O
unlabeled	O
competitor	O
MREd	O
or	O
unrelated	O
Gal4	O
oligonucleotide	O
.	O

32P	O
-	O
labeled	O
MRE	O
-	O
s	O
was	O
included	O
to	O
indicate	O
the	O
position	O
of	O
an	O
MTF	O
-	O
1	O
-	O
DNA	O
complex	S-GO
;	O
Sp1	O
bandshifts	O
with	O
32P	O
-	O
labeled	O
Sp1	O
consensus	O
oligonucleotide	O
were	O
obtained	O
as	O
protein	O
loading	O
control	O
.	O

Figure	O
4	O

Cadmium	O
response	O
of	O
Csrp1	O
depends	O
on	O
MTF	O
-	O
1	O
.	O

(	O
a	O
)	O
Semiquantitative	O
RT	O
-	O
PCRs	O
for	O
Csrp1	O
mRNA	O
using	O
total	O
liver	O
RNA	O
from	O
pI	O
-	O
pC	O
-	O
induced	O
male	O
Mtf1Mx	O
-	O
cre	O
or	O
Mtf1loxP	O
mice	O
.	O

The	O
animals	O
had	O
obtained	O
either	O
mock	O
s	O
.	O
c	O
.	O
injections	O
(	O
-	O
Cd	O
)	O
or	O
s	O
.	O
c	O
.	O
injections	O
with	O
20	O
micro	O
mol	O
/	O
kg	O
body	O
weight	O
CdSO4	O
(	O
+	O
Cd	O
)	O
6	O
h	O
before	O
sacrificing	O
them	O
.	O

RT	O
-	O
PCRs	O
for	O
Hprt	O
mRNA	O
were	O
used	O
as	O
internal	O
control	O
to	O
adjust	O
the	O
amount	O
of	O
total	O
RNA	O
used	O
.	O

(	O
b	O
)	O
MRE	O
core	O
consensus	O
sequences	O
TGCRCNC	O
(	O
bold	O
letters	O
)	O
and	O
flanking	O
sequences	O
found	O
in	O
a	O
region	O
of	O
1000	O
bp	O
upstream	O
from	O
Csrp1	O
transcription	O
start	O
;	O
the	O
position	O
of	O
each	O
core	O
sequence	O
is	O
indicated	O
.	O

(	O
c	O
)	O
EMSA	O
with	O
liver	O
protein	O
extracts	O
of	O
a	O
male	O
Mtf1loxP	O
or	O
a	O
pI	O
-	O
pC	O
-	O
induced	O
,	O
male	O
Mtf1Mx	O
-	O
cre	O
mouse	O
,	O
both	O
mock	O
-	O
treated	O
.	O

MTF	O
-	O
1	O
protein	B-GO
-	I-GO
DNA	I-GO
complex	E-GO
formation	O
was	O
tested	O
with	O
32P	O
-	O
labeled	O
Csrp1	O
MRE1	O
,	O
MRE2	O
,	O
MRE3	O
or	O
MRE4	O
oligonucleotide	O
,	O
respectively	O
.	O

Specificity	O
of	O
binding	O
was	O
verified	O
with	O
excess	O
of	O
unlabeled	O
competitor	O
MREd	O
or	O
unrelated	O
Gal4	O
oligonucleotide	O
.	O

32P	O
-	O
labeled	O
MRE	O
-	O
s	O
was	O
included	O
to	O
indicate	O
the	O
position	O
of	O
an	O
MTF	O
-	O
1	O
-	O
DNA	O
complex	S-GO
;	O
Sp1	O
bandshifts	O
with	O
32P	O
-	O
labeled	O
Sp1	O
consensus	O
oligonucleotide	O
were	O
obtained	O
as	O
protein	O
loading	O
control	O
.	O

Figure	O
5	O

MTF	O
-	O
1	O
represses	O
basal	O
expression	O
of	O
Slc39a10	O
.	O

(	O
a	O
)	O
Semiquantitative	O
RT	O
-	O
PCRs	O
for	O
Slc39a10	O
mRNA	O
using	O
total	O
liver	O
RNA	O
from	O
pI	O
-	O
pC	O
-	O
induced	O
male	O
Mtf1Mx	O
-	O
cre	O
or	O
Mtf1loxP	O
mice	O
.	O

The	O
animals	O
had	O
obtained	O
either	O
mock	O
s	O
.	O
c	O
.	O
injections	O
(	O
-	O
Cd	O
)	O
or	O
s	O
.	O
c	O
.	O
injections	O
with	O
20	O
micro	O
mol	O
/	O
kg	O
body	O
weight	O
CdSO4	O
(	O
+	O
Cd	O
)	O
6	O
h	O
before	O
sacrificing	O
them	O
.	O

RT	O
-	O
PCRs	O
for	O
Hprt	O
mRNA	O
were	O
used	O
as	O
internal	O
control	O
to	O
adjust	O
the	O
amount	O
of	O
total	O
RNA	O
used	O
.	O

(	O
b	O
)	O
MRE	O
core	O
consensus	O
sequences	O
TGCRCNC	O
(	O
bold	O
letters	O
)	O
and	O
flanking	O
sequences	O
found	O
in	O
a	O
region	O
of	O
1000	O
bp	O
upstream	O
from	O
Slc39a10	O
transcription	O
start	O
;	O
the	O
position	O
of	O
each	O
core	O
sequence	O
is	O
indicated	O
.	O

(	O
c	O
)	O
EMSA	O
with	O
liver	O
protein	O
extracts	O
of	O
a	O
male	O
Mtf1loxP	O
or	O
a	O
pI	O
-	O
pC	O
-	O
induced	O
,	O
male	O
Mtf1Mx	O
-	O
cre	O
mouse	O
,	O
both	O
mock	O
-	O
treated	O
.	O

MTF	O
-	O
1	O
protein	B-GO
-	I-GO
DNA	I-GO
complex	E-GO
formation	O
was	O
tested	O
with	O
32P	O
-	O
labeled	O
Slc39a10	O
MRE1	O
or	O
MRE2	O
oligonucleotide	O
,	O
respectively	O
.	O

Specificity	O
of	O
binding	O
was	O
verified	O
with	O
excess	O
of	O
unlabeled	O
competitor	O
MREd	O
or	O
unrelated	O
Gal4	O
oligonucleotide	O
.	O

32P	O
-	O
labeled	O
MRE	O
-	O
s	O
was	O
included	O
to	O
indicate	O
the	O
position	O
of	O
an	O
MTF	O
-	O
1	O
-	O
DNA	O
complex	S-GO
;	O
Sp1	O
bandshifts	O
with	O
32P	O
-	O
labeled	O
Sp1	O
consensus	O
oligonucleotide	O
were	O
obtained	O
as	O
protein	O
loading	O
control	O
.	O

Figure	O
6	O

Cells	O
with	O
reduced	O
glutathione	O
level	O
that	O
also	O
lack	O
MTF	O
-	O
1	O
are	O
hypersensitive	O
to	O
cadmium	O
.	O

The	O
viability	O
of	O
cells	O
was	O
assessed	O
with	O
the	O
so	O
-	O
called	O
MTT	O
assay	O
.	O

Mouse	O
embryonic	O
fibroblasts	O
with	O
(	O
ckoC	O
)	O
and	O
without	O
(	O
delC19	O
,	O
delC21	O
and	O
delC23	O
)	O
functional	O
Mtf1	O
were	O
compared	O
.	O

Cells	O
were	O
pre	O
-	O
incubated	O
in	O
medium	O
containing	O
0	O
,	O
5	O
,	O
10	O
,	O
25	O
or	O
50	O
micro	O
M	O
BSO	O
for	O
24	O
h	O
and	O
further	O
exposed	O
to	O
0	O
,	O
5	O
,	O
10	O
or	O
20	O
micro	O
M	O
CdCl2	O
(	O
Cd	O
)	O
in	O
the	O
specified	O
pre	O
-	O
incubation	O
medium	O
for	O
an	O
additional	O
24	O
h	O
.	O

Results	O
are	O
expressed	O
as	O
mean	O
values	O
+/-	O
SD	O
(	O
n	O
=	O
3	O
)	O
normalized	O
to	O
the	O
respective	O
value	O
of	O
untreated	O
cells	O
.	O

Table	O
1	O

Comparison	O
of	O
liver	O
gene	O
expression	O
for	O
pI	O
-	O
pC	O
-	O
induced	O
Mtf1Mx	O
-	O
cre	O
and	O
Mtf1loxP	O
mice	O
(	O
up	O
-	O
or	O
downregulation	O
at	O
least	O
2	O
-	O
fold	O
,	O
P	O
<=	O
0	O
.	O
05	O
)	O

The	O
animals	O
had	O
obtained	O
either	O
mock	O
s	O
.	O
c	O
.	O
injections	O
(	O
-	O
Cd	O
)	O
or	O
s	O
.	O
c	O
.	O
injections	O
with	O
20	O
micro	O
mol	O
/	O
kg	O
body	O
weight	O
CdSO4	O
(	O
+	O
Cd	O
)	O
6	O
h	O
before	O
sacrificing	O
them	O
.	O

The	O
expression	O
values	O
for	O
each	O
gene	O
are	O
given	O
as	O
mean	O
value	O
of	O
three	O
animals	O
per	O
group	O
,	O
normalized	O
to	O
the	O
mean	O
value	O
of	O
group	O
Mtf1loxP	O
-	O
Cd	O
(	O
relative	O
activity	O
)	O
.	O

Grey	O
shading	O
indicates	O
the	O
two	O
groups	O
of	O
animals	O
compared	O
,	O
relative	O
activities	O
for	O
the	O
other	O
two	O
groups	O
are	O
shown	O
for	O
a	O
complete	O
overview	O
.	O

The	O
number	O
of	O
MRE	O
core	O
consensus	O
sequences	O
TGCRCNC	O
in	O
a	O
region	O
of	O
1000	O
bp	O
upstream	O
from	O
the	O
annotated	O
transcription	O
start	O
is	O
indicated	O
.	O

aOnly	O
incomplete	O
region	O
up	O
to	O
-	O
1000	O
bp	O
from	O
transcription	O
start	O
is	O
available	O
in	O
database	O
.	O

bMean	O
values	O
of	O
two	O
independent	O
Affymetrix	O
probe	O
sets	O
.	O

cMean	O
value	O
of	O
four	O
independent	O
Affymetrix	O
probe	O
sets	O
.	O

Table	O
2	O

Comparison	O
of	O
liver	O
gene	O
expression	O
for	O
cadmium	O
-	O
and	O
mock	O
-	O
treated	O
mice	O
(	O
up	O
-	O
or	O
downregulation	O
at	O
least	O
2	O
-	O
fold	O
,	O
P	O
<=	O
0	O
.	O
05	O
)	O

The	O
animals	O
had	O
obtained	O
either	O
mock	O
s	O
.	O
c	O
.	O
injections	O
(	O
-	O
Cd	O
)	O
or	O
s	O
.	O
c	O
.	O
injections	O
with	O
20	O
micro	O
mol	O
/	O
kg	O
body	O
weight	O
CdSO4	O
(	O
+	O
Cd	O
)	O
6	O
h	O
before	O
sacrificing	O
them	O
.	O

The	O
expression	O
values	O
for	O
each	O
gene	O
are	O
given	O
as	O
mean	O
value	O
of	O
three	O
animals	O
per	O
group	O
,	O
normalized	O
to	O
the	O
mean	O
value	O
of	O
group	O
Mtf1loxP	O
-	O
Cd	O
(	O
relative	O
activity	O
)	O
.	O

aMean	O
values	O
of	O
three	O
independent	O
Affymetrix	O
probe	O
sets	O
.	O

bMean	O
value	O
of	O
six	O
independent	O
Affymetrix	O
probe	O
sets	O
.	O

cMean	O
value	O
of	O
two	O
independent	O
Affymetrix	O
probe	O
sets	O
.	O

CEBPG	O
transcription	O
factor	O
correlates	O
with	O
antioxidant	O
and	O
DNA	O
repair	O
genes	O
in	O
normal	O
bronchial	O
epithelial	O
cells	O
but	O
not	O
in	O
individuals	O
with	O
bronchogenic	O
carcinoma	O

Abstract	O

Background	O

Cigarette	O
smoking	O
is	O
the	O
primary	O
cause	O
of	O
bronchogenic	O
carcinoma	O
(	O
BC	O
)	O
,	O
yet	O
only	O
10	O
-	O
15	O
%	O
of	O
heavy	O
smokers	O
develop	O
BC	O
and	O
it	O
is	O
likely	O
that	O
this	O
variation	O
in	O
risk	O
is	O
,	O
in	O
part	O
,	O
genetically	O
determined	O
.	O

We	O
previously	O
reported	O
a	O
set	O
of	O
antioxidant	O
genes	O
for	O
which	O
transcript	O
abundance	O
was	O
lower	O
in	O
normal	O
bronchial	O
epithelial	O
cells	O
(	O
NBEC	O
)	O
of	O
BC	O
individuals	O
compared	O
to	O
non	O
-	O
BC	O
individuals	O
.	O

In	O
unpublished	O
studies	O
of	O
the	O
same	O
NBEC	O
samples	O
,	O
transcript	O
abundance	O
values	O
for	O
several	O
DNA	O
repair	O
genes	O
were	O
correlated	O
with	O
these	O
antioxidant	O
genes	O
.	O

From	O
these	O
data	O
,	O
we	O
hypothesized	O
that	O
antioxidant	O
and	O
DNA	O
repair	O
genes	O
are	O
co	O
-	O
regulated	O
by	O
one	O
or	O
more	O
transcription	O
factors	O
and	O
that	O
inter	O
-	O
individual	O
variation	O
in	O
expression	O
and	O
/	O
or	O
function	O
of	O
one	O
or	O
more	O
of	O
these	O
transcription	O
factors	O
is	O
responsible	O
for	O
inter	O
-	O
individual	O
variation	O
in	O
risk	O
for	O
BC	O
.	O

Methods	O

The	O
putative	O
transcription	O
factor	O
recognition	O
sites	O
common	O
to	O
six	O
of	O
the	O
antioxidant	O
genes	O
were	O
identified	O
through	O
in	O
silico	O
DNA	O
sequence	O
analysis	O
.	O

The	O
transcript	O
abundance	O
values	O
of	O
these	O
transcription	O
factors	O
(	O
n	O
=	O
6	O
)	O
and	O
an	O
expanded	O
group	O
of	O
antioxidant	O
and	O
DNA	O
repair	O
genes	O
(	O
n	O
=	O
16	O
)	O
were	O
measured	O
simultaneously	O
by	O
quantitative	O
PCR	O
in	O
NBEC	O
of	O
24	O
non	O
-	O
BC	O
and	O
25	O
BC	O
individuals	O
.	O

Results	O

CEBPG	O
transcription	O
factor	O
was	O
significantly	O
(	O
p	O
<	O
0	O
.	O
01	O
)	O
correlated	O
with	O
eight	O
of	O
the	O
antioxidant	O
or	O
DNA	O
repair	O
genes	O
in	O
non	O
-	O
BC	O
individuals	O
but	O
not	O
in	O
BC	O
individuals	O
.	O

In	O
BC	O
individuals	O
the	O
correlation	O
with	O
CEBPG	O
was	O
significantly	O
(	O
p	O
<	O
0	O
.	O
01	O
)	O
lower	O
than	O
that	O
of	O
non	O
-	O
BC	O
individuals	O
for	O
four	O
of	O
the	O
genes	O
(	O
XRCC1	O
,	O
ERCC5	O
,	O
GSTP1	O
,	O
and	O
SOD1	O
)	O
and	O
the	O
difference	O
was	O
nearly	O
significant	O
for	O
GPX1	O
.	O

The	O
only	O
other	O
transcription	O
factor	O
correlated	O
with	O
any	O
of	O
these	O
five	O
target	O
genes	O
in	O
non	O
-	O
BC	O
individuals	O
was	O
E2F1	O
.	O

E2F1	O
was	O
correlated	O
with	O
GSTP1	O
among	O
non	O
-	O
BC	O
individuals	O
,	O
but	O
in	O
contrast	O
to	O
CEBPG	O
,	O
there	O
was	O
no	O
significant	O
difference	O
in	O
this	O
correlation	O
in	O
non	O
-	O
BC	O
individuals	O
compared	O
to	O
BC	O
individuals	O
.	O

Conclusion	O

We	O
conclude	O
that	O
CEBPG	O
is	O
the	O
transcription	O
factor	O
primarily	O
responsible	O
for	O
regulating	O
transcription	O
of	O
key	O
antioxidant	O
and	O
DNA	O
repair	O
genes	O
in	O
non	O
-	O
BC	O
individuals	O
.	O

Further	O
,	O
we	O
conclude	O
that	O
the	O
heavy	O
smokers	O
selected	O
for	O
development	O
of	O
BC	O
are	O
those	O
who	O
have	O
sub	O
-	O
optimal	O
regulation	O
of	O
antioxidant	O
and	O
DNA	O
repair	O
genes	O
by	O
CEBPG	O
.	O

Background	O

BC	O
is	O
currently	O
the	O
leading	O
cause	O
of	O
cancer	O
-	O
related	O
death	O
in	O
the	O
United	O
States	O
,	O
causing	O
28	O
%	O
of	O
all	O
cancer	O
deaths	O
[	O
1	O
]	O
.	O

Although	O
cigarette	O
smoking	O
is	O
the	O
primary	O
risk	O
factor	O
,	O
only	O
10	O
-	O
15	O
%	O
of	O
heavy	O
smokers	O
(	O
greater	O
than	O
20	O
pack	O
years	O
)	O
develop	O
BC	O
[	O
1	O
-	O
3	O
]	O
.	O

Antioxidant	O
and	O
DNA	O
repair	O
enzymes	O
that	O
provide	O
protection	O
from	O
the	O
effects	O
of	O
cigarette	O
smoke	O
are	O
expressed	O
in	O
the	O
progenitor	O
cells	O
for	O
BC	O
,	O
normal	O
bronchial	O
epithelial	O
cells	O
(	O
NBEC	O
)	O
[	O
1	O
]	O
.	O

Inherited	O
inter	O
-	O
individual	O
variation	O
in	O
the	O
function	O
of	O
these	O
genes	O
plays	O
a	O
role	O
in	O
determining	O
risk	O
for	O
BC	O
[	O
4	O
-	O
6	O
]	O
.	O

Antioxidant	O
enzymes	O
protect	O
NBEC	O
from	O
reactive	O
oxygen	O
species	O
produced	O
by	O
interaction	O
with	O
and	O
metabolism	O
of	O
xenobiotics	O
such	O
as	O
pollution	O
and	O
cigarette	O
smoke	O
[	O
4	O
-	O
7	O
]	O
as	O
well	O
as	O
those	O
produced	O
by	O
normal	O
cellular	O
metabolism	O
.	O

Reactive	O
oxygen	O
species	O
cause	O
many	O
damaging	O
reactions	O
including	O
denaturation	O
of	O
proteins	O
,	O
cross	O
-	O
linking	O
of	O
lipids	O
and	O
proteins	O
and	O
modification	O
of	O
nucleic	O
acid	O
bases	O
,	O
which	O
can	O
lead	O
to	O
cancer	O
[	O
7	O
]	O
.	O

DNA	O
repair	O
enzymes	O
repair	O
the	O
frequent	O
damage	O
to	O
DNA	O
caused	O
by	O
oxidant	O
stress	O
as	O
well	O
as	O
other	O
stresses	O
,	O
including	O
bulky	O
adducts	O
derived	O
from	O
carcinogens	O
in	O
cigarette	O
smoke	O
[	O
8	O
]	O
.	O

We	O
previously	O
reported	O
that	O
an	O
interactive	O
transcript	O
abundance	O
index	O
comprising	O
antioxidant	O
genes	O
was	O
lower	O
in	O
NBEC	O
of	O
BC	O
individuals	O
compared	O
to	O
non	O
-	O
BC	O
individuals	O
,	O
suggesting	O
that	O
BC	O
individuals	O
are	O
selected	O
on	O
the	O
basis	O
of	O
poor	O
antioxidant	O
protection	O
[	O
9	O
]	O
.	O

In	O
that	O
study	O
,	O
there	O
was	O
a	O
tendency	O
towards	O
correlation	O
in	O
transcript	O
abundance	O
between	O
several	O
pairs	O
of	O
antioxidant	O
or	O
DNA	O
repair	O
genes	O
in	O
non	O
-	O
BC	O
individuals	O
,	O
but	O
not	O
in	O
BC	O
individuals	O
.	O

Gene	O
pairs	O
included	O
in	O
that	O
observation	O
were	O
GSTP1	O
/	O
GPX1	O
,	O
CAT	O
/	O
GPX3	O
,	O
and	O
GPX3	O
/	O
SOD1	O
.	O

Correlation	O
is	O
one	O
typical	O
characteristic	O
of	O
co	O
-	O
regulated	O
genes	O
.	O

Another	O
is	O
shared	O
transcription	O
factor	O
recognition	O
sites	O
in	O
the	O
regulatory	O
regions	O
of	O
those	O
genes	O
[	O
10	O
]	O
.	O

Based	O
on	O
the	O
above	O
findings	O
,	O
it	O
was	O
hypothesized	O
first	O
,	O
that	O
there	O
is	O
inter	O
-	O
individual	O
variation	O
in	O
regulation	O
of	O
key	O
antioxidant	O
and	O
DNA	O
repair	O
genes	O
by	O
one	O
or	O
more	O
transcription	O
factors	O
and	O
second	O
,	O
that	O
individuals	O
with	O
sub	O
-	O
optimal	O
regulation	O
are	O
selected	O
for	O
development	O
of	O
BC	O
if	O
they	O
smoke	O
cigarettes	O
.	O

To	O
test	O
these	O
hypotheses	O
,	O
transcription	O
factor	O
recognition	O
sites	O
common	O
to	O
the	O
regulatory	O
regions	O
of	O
the	O
above	O
correlated	O
gene	O
pairs	O
were	O
identified	O
through	O
in	O
silico	O
DNA	O
sequence	O
analysis	O
,	O
and	O
their	O
transcript	O
abundance	O
measured	O
simultaneously	O
with	O
an	O
expanded	O
group	O
of	O
ten	O
antioxidant	O
and	O
six	O
DNA	O
repair	O
genes	O
.	O

Methods	O

NBEC	O
sample	O
procurement	O

Brush	O
biopsy	O
samples	O
of	O
normal	O
bronchial	O
epithelium	O
were	O
obtained	O
for	O
research	O
studies	O
at	O
the	O
time	O
of	O
diagnostic	O
bronchoscopy	O
according	O
to	O
previously	O
described	O
methods	O
[	O
9	O
,	O
11	O
]	O
.	O

Normal	O
bronchial	O
epithelium	O
in	O
the	O
lung	O
not	O
involved	O
with	O
cancer	O
was	O
brushed	O
prior	O
to	O
biopsy	O
of	O
the	O
suspected	O
cancerous	O
area	O
.	O

Samples	O
were	O
collected	O
in	O
a	O
manner	O
satisfying	O
all	O
requirements	O
of	O
the	O
Institutional	O
Review	O
Board	O
for	O
the	O
Medical	O
University	O
of	O
Ohio	O
.	O

Each	O
BC	O
diagnosis	O
and	O
subtype	O
identification	O
was	O
determined	O
by	O
histopathological	O
examination	O
in	O
the	O
Department	O
of	O
Pathology	O
at	O
the	O
Medical	O
University	O
of	O
Ohio	O
.	O

NBEC	O
samples	O
from	O
a	O
total	O
of	O
49	O
individuals	O
,	O
including	O
24	O
non	O
-	O
BC	O
individuals	O
and	O
25	O
BC	O
individuals	O
,	O
were	O
evaluated	O
in	O
this	O
study	O
.	O

The	O
biographical	O
characteristics	O
of	O
these	O
individuals	O
are	O
presented	O
in	O
Table	O
1	O
.	O

Transcript	O
abundance	O
measurement	O

Total	O
RNA	O
samples	O
extracted	O
from	O
NBEC	O
were	O
reverse	O
transcribed	O
using	O
M	O
-	O
MLV	O
reverse	O
transcriptase	O
and	O
oligo	O
dT	O
primers	O
as	O
previously	O
described	O
[	O
9	O
,	O
11	O
]	O
.	O

Standardized	O
RT	O
(	O
StaRT	O
)	O
-	O
PCR	O
was	O
used	O
for	O
transcript	O
abundance	O
measurement	O
in	O
these	O
studies	O
.	O

With	O
StaRT	O
-	O
PCR	O
,	O
an	O
internal	O
standard	O
for	O
each	O
gene	O
within	O
a	O
standardized	O
mixture	O
of	O
internal	O
standards	O
(	O
SMIS	O
)	O
is	O
included	O
in	O
each	O
PCR	O
reaction	O
.	O

After	O
amplification	O
,	O
products	O
were	O
electrophoresed	O
on	O
an	O
Agilent	O
2100	O
Bioanalyzer	O
using	O
DNA	O
Chips	O
with	O
DNA	O
1000	O
Kit	O
reagents	O
for	O
visualization	O
according	O
to	O
the	O
manufacturer	O
'	O
s	O
protocol	O
(	O
Agilent	O
Technologies	O
Deutschland	O
GmbH	O
,	O
Waldbronn	O
,	O
Germany	O
)	O
.	O

The	O
StaRT	O
-	O
PCR	O
technology	O
is	O
licensed	O
to	O
Gene	O
Express	O
,	O
Inc	O
.	O

(	O
Toledo	O
,	O
OH	O
)	O
.	O

Many	O
of	O
the	O
reagents	O
are	O
available	O
commercially	O
and	O
were	O
obtained	O
through	O
Gene	O
Express	O
,	O
Inc	O
.	O
for	O
this	O
study	O
.	O

StaRT	O
-	O
PCR	O
reagents	O
for	O
each	O
of	O
the	O
measured	O
genes	O
that	O
were	O
not	O
commercially	O
available	O
,	O
including	O
primers	O
and	O
SMIS	O
,	O
were	O
prepared	O
according	O
to	O
previously	O
described	O
methods	O
[	O
11	O
,	O
12	O
]	O
.	O

Sequence	O
information	O
for	O
the	O
primers	O
is	O
provided	O
in	O
Table	O
2	O
.	O

Including	O
an	O
internal	O
standard	O
within	O
a	O
SMIS	O
in	O
each	O
measurement	O
controls	O
for	O
all	O
known	O
sources	O
of	O
variation	O
during	O
PCR	O
,	O
including	O
inhibitors	O
in	O
samples	O
,	O
and	O
generates	O
virtually	O
-	O
multiplexed	O
transcript	O
abundance	O
data	O
that	O
are	O
directly	O
comparable	O
across	O
multiple	O
experiments	O
and	O
institutions	O
[	O
13	O
]	O
.	O

The	O
performance	O
characteristics	O
of	O
StaRT	O
-	O
PCR	O
are	O
superior	O
to	O
other	O
forms	O
of	O
commercially	O
available	O
quantitative	O
PCR	O
technology	O
in	O
the	O
areas	O
critical	O
to	O
this	O
study	O
.	O

With	O
respect	O
to	O
these	O
studies	O
,	O
the	O
key	O
property	O
of	O
a	O
quantitative	O
PCR	O
method	O
is	O
not	O
whether	O
the	O
PCR	O
products	O
are	O
measured	O
kinetically	O
or	O
at	O
endpoint	O
,	O
but	O
rather	O
whether	O
there	O
are	O
internal	O
standards	O
in	O
each	O
measurement	O
or	O
not	O
.	O

The	O
overall	O
performance	O
characteristics	O
of	O
StaRT	O
-	O
PCR	O
,	O
including	O
extensive	O
validation	O
of	O
the	O
method	O
in	O
independent	O
laboratories	O
have	O
been	O
presented	O
in	O
several	O
recent	O
articles	O
and	O
chapters	O
[	O
13	O
-	O
15	O
]	O
.	O

With	O
respect	O
to	O
the	O
genes	O
measured	O
in	O
this	O
study	O
,	O
for	O
each	O
gene	O
the	O
StaRT	O
-	O
PCR	O
reagents	O
had	O
lower	O
detection	O
threshold	O
of	O
less	O
than	O
10	O
molecules	O
,	O
linear	O
dynamic	O
range	O
of	O
more	O
than	O
six	O
orders	O
of	O
magnitude	O
(	O
less	O
than	O
10	O
to	O
over	O
107	O
molecules	O
)	O
,	O
and	O
signal	O
-	O
to	O
-	O
analyte	O
response	O
of	O
100	O
%	O
.	O

In	O
addition	O
,	O
the	O
presence	O
of	O
an	O
internal	O
standard	O
controls	O
for	O
inter	O
-	O
sample	O
variation	O
in	O
presence	O
of	O
PCR	O
inhibitors	O
(	O
which	O
often	O
are	O
gene	O
-	O
specific	O
)	O
and	O
ensures	O
no	O
false	O
negatives	O
(	O
if	O
the	O
PCR	O
fails	O
the	O
internal	O
standard	O
PCR	O
product	O
is	O
not	O
observed	O
and	O
there	O
are	O
no	O
data	O
to	O
report	O
)	O
.	O

False	O
positives	O
are	O
eliminated	O
through	O
use	O
of	O
a	O
control	O
PCR	O
reaction	O
with	O
no	O
cDNA	O
in	O
it	O
.	O

Statistical	O
analysis	O

More	O
than	O
6	O
,	O
000	O
transcript	O
abundance	O
measurements	O
were	O
conducted	O
in	O
multiple	O
experiments	O
over	O
two	O
years	O
to	O
assess	O
the	O
six	O
transcription	O
factors	O
and	O
sixteen	O
antioxidant	O
and	O
DNA	O
repair	O
genes	O
in	O
NBEC	O
samples	O
from	O
49	O
individuals	O
(	O
24	O
non	O
-	O
BC	O
individuals	O
and	O
25	O
BC	O
individuals	O
)	O
.	O

Correlation	O
of	O
each	O
of	O
the	O
six	O
transcription	O
factors	O
with	O
each	O
of	O
the	O
antioxidant	O
or	O
DNA	O
repair	O
genes	O
was	O
determined	O
by	O
Pearson	O
'	O
s	O
correlation	O
following	O
logarithmic	O
transformation	O
.	O

The	O
transformation	O
was	O
necessary	O
due	O
to	O
the	O
wide	O
biological	O
variation	O
in	O
expression	O
of	O
each	O
gene	O
among	O
the	O
individuals	O
.	O

Significance	O
level	O
was	O
defined	O
as	O
p	O
<	O
0	O
.	O
01	O
following	O
Bonferroni	O
adjustment	O
for	O
multiple	O
comparison	O
,	O
specifically	O
comparison	O
of	O
each	O
of	O
six	O
transcription	O
factors	O
to	O
each	O
of	O
the	O
antioxidant	O
or	O
DNA	O
repair	O
genes	O
.	O

Comparison	O
for	O
significant	O
differences	O
between	O
pairs	O
of	O
correlation	O
coefficients	O
was	O
done	O
by	O
Fisher	O
'	O
s	O
Z	O
-	O
transformation	O
test	O
[	O
16	O
]	O
.	O

Analysis	O
of	O
the	O
relationship	O
between	O
virtually	O
-	O
multiplexed	O
transcript	O
abundance	O
data	O
for	O
each	O
gene	O
with	O
age	O
was	O
assessed	O
by	O
Pearson	O
'	O
s	O
correlation	O
,	O
with	O
gender	O
by	O
t	O
-	O
test	O
,	O
and	O
with	O
smoking	O
history	O
by	O
ANOVA	O
followed	O
by	O
Duncan	O
'	O
s	O
test	O
.	O

Transcription	O
factor	O
recognition	O
site	O
analysis	O

The	O
El	O
Dorado	O
(	O
Build	O
35	O
)	O
program	O
from	O
the	O
Genomatix	O
software	O
package	O
was	O
used	O
to	O
locate	O
the	O
correlated	O
genes	O
within	O
the	O
genome	O
and	O
define	O
1101	O
base	O
pairs	O
of	O
the	O
promoter	O
regions	O
(	O
1000	O
base	O
pairs	O
upstream	O
of	O
and	O
100	O
base	O
pairs	O
into	O
the	O
transcription	O
start	O
site	O
)	O
for	O
each	O
gene	O
(	O
Genomatix	O
Software	O
GmbH	O
,	O
Munich	O
,	O
Germany	O
,	O
[	O
17	O
]	O
)	O
.	O

The	O
1101	O
base	O
pair	O
sequences	O
obtained	O
from	O
the	O
El	O
Dorado	O
program	O
then	O
were	O
used	O
as	O
the	O
target	O
sequences	O
for	O
putative	O
transcription	O
factor	O
recognition	O
site	O
identification	O
using	O
the	O
MatInspector	O
Version	O
4	O
.	O
2	O
program	O
,	O
which	O
yielded	O
sites	O
for	O
11	O
transcription	O
factors	O
(	O
Genomatix	O
Software	O
GmbH	O
,	O
Munich	O
,	O
Germany	O
,	O
[	O
17	O
]	O
)	O
.	O

The	O
parameters	O
used	O
were	O
the	O
standard	O
(	O
0	O
.	O
75	O
)	O
core	O
similarity	O
and	O
the	O
optimized	O
matrix	O
similarity	O
[	O
18	O
]	O
.	O

StaRT	O
-	O
PCR	O
reagents	O
were	O
optimized	O
for	O
ten	O
of	O
these	O
transcription	O
factors	O
,	O
including	O
CEBPB	O
,	O
CEBPE	O
,	O
CEBPG	O
,	O
E2F1	O
,	O
E2F3	O
,	O
E2F4	O
,	O
E2F5	O
,	O
E2F6	O
,	O
EVI1	O
,	O
and	O
PAX5	O
.	O

Four	O
transcription	O
factors	O
were	O
expressed	O
at	O
low	O
and	O
invariant	O
levels	O
among	O
multiple	O
NBEC	O
samples	O
and	O
were	O
therefore	O
excluded	O
from	O
the	O
study	O
.	O

The	O
remaining	O
six	O
,	O
CEBPB	O
,	O
CEBPG	O
,	O
E2F1	O
,	O
E2F3	O
,	O
E2F6	O
,	O
and	O
EVI	O
,	O
were	O
evaluated	O
for	O
correlation	O
with	O
an	O
expanded	O
group	O
of	O
ten	O
antioxidant	O
and	O
six	O
DNA	O
repair	O
genes	O
.	O

Results	O

Virtually	O
-	O
multiplexed	O
transcript	O
abundance	O
data	O
were	O
obtained	O
for	O
each	O
gene	O
in	O
each	O
of	O
the	O
49	O
samples	O
,	O
except	O
for	O
E2F1	O
measurement	O
in	O
sample	O
147	O
(	O
Table	O
3	O
)	O
.	O

A	O
gene	O
-	O
specific	O
inhibitor	O
in	O
sample	O
147	O
prevented	O
amplification	O
of	O
E2F1	O
.	O

Neither	O
the	O
internal	O
standard	O
,	O
nor	O
the	O
native	O
cDNA	O
PCR	O
product	O
was	O
observed	O
.	O

The	O
presence	O
of	O
gene	O
-	O
specific	O
PCR	O
inhibition	O
was	O
observable	O
in	O
some	O
other	O
samples	O
as	O
reduction	O
in	O
peak	O
heights	O
in	O
internal	O
standard	O
PCR	O
products	O
relative	O
to	O
that	O
expected	O
for	O
the	O
number	O
of	O
internal	O
standard	O
molecules	O
present	O
at	O
the	O
beginning	O
of	O
the	O
PCR	O
reaction	O
.	O

However	O
,	O
in	O
each	O
such	O
case	O
,	O
the	O
PCR	O
amplification	O
was	O
efficient	O
enough	O
to	O
enable	O
quantification	O
.	O

Bivariate	O
analysis	O

In	O
non	O
-	O
BC	O
individuals	O
there	O
was	O
significant	O
(	O
p	O
<	O
0	O
.	O
01	O
)	O
correlation	O
between	O
CEBPG	O
and	O
eight	O
of	O
the	O
16	O
antioxidant	O
or	O
DNA	O
repair	O
genes	O
,	O
specifically	O
XRCC1	O
,	O
ERCC5	O
,	O
GSTP1	O
,	O
SOD1	O
,	O
GPX1	O
,	O
ERCC1	O
,	O
CAT	O
and	O
ERCC2	O
(	O
Table	O
4	O
)	O
.	O

In	O
contrast	O
,	O
in	O
BC	O
individuals	O
samples	O
CEBPG	O
was	O
not	O
correlated	O
with	O
any	O
of	O
the	O
antioxidant	O
or	O
DNA	O
repair	O
genes	O
.	O

These	O
relationships	O
were	O
not	O
observed	O
with	O
any	O
of	O
the	O
other	O
transcription	O
factors	O
studied	O
.	O

For	O
XRCC1	O
,	O
ERCC5	O
,	O
GSTP1	O
,	O
and	O
SOD1	O
the	O
correlation	O
with	O
CEBPG	O
was	O
significantly	O
lower	O
in	O
BC	O
individuals	O
compared	O
to	O
non	O
-	O
BC	O
individuals	O
and	O
the	O
difference	O
was	O
nearly	O
significant	O
for	O
GPX1	O
(	O
Fig	O
.	O
1b	O
)	O
.	O

Scatter	O
plots	O
of	O
the	O
relationship	O
between	O
CEBPG	O
and	O
XRCC1	O
in	O
non	O
-	O
BC	O
individuals	O
or	O
BC	O
individuals	O
(	O
Fig	O
.	O
2a	O
,	O
b	O
)	O
are	O
representative	O
of	O
the	O
other	O
four	O
genes	O
.	O

Neither	O
CEBPG	O
,	O
nor	O
XRCC1	O
,	O
ERCC5	O
,	O
GSTP1	O
,	O
SOD1	O
or	O
GPX1	O
was	O
significantly	O
correlated	O
with	O
age	O
,	O
gender	O
,	O
or	O
smoking	O
history	O
in	O
non	O
-	O
BC	O
individuals	O
,	O
BC	O
individuals	O
,	O
or	O
the	O
combined	O
group	O
.	O

In	O
non	O
-	O
BC	O
individuals	O
,	O
based	O
on	O
the	O
r2	O
values	O
from	O
Pearson	O
'	O
s	O
correlation	O
analysis	O
,	O
CEBPG	O
accounts	O
for	O
much	O
of	O
the	O
variance	O
in	O
expression	O
of	O
XRCC1	O
(	O
69	O
%	O
)	O
,	O
ERCC5	O
(	O
62	O
%	O
)	O
,	O
GSTP1	O
(	O
55	O
%	O
)	O
,	O
SOD1	O
(	O
44	O
%	O
)	O
,	O
and	O
GPX1	O
(	O
52	O
%	O
)	O
.	O

E2F1	O
accounts	O
for	O
some	O
of	O
the	O
remaining	O
variance	O
.	O

For	O
example	O
,	O
when	O
samples	O
from	O
all	O
49	O
non	O
-	O
BC	O
individuals	O
and	O
BC	O
individuals	O
were	O
assessed	O
as	O
a	O
single	O
group	O
,	O
E2F1	O
was	O
significantly	O
correlated	O
with	O
ERCC5	O
,	O
GSTP1	O
and	O
SOD1	O
(	O
Table	O
4	O
)	O
.	O

Further	O
,	O
in	O
non	O
-	O
BC	O
individuals	O
,	O
E2F1	O
was	O
correlated	O
with	O
GSTP1	O
(	O
Fig	O
.	O
1c	O
)	O
and	O
the	O
correlation	O
was	O
lower	O
in	O
BC	O
individuals	O
.	O

However	O
,	O
the	O
difference	O
in	O
correlation	O
between	O
non	O
-	O
BC	O
individuals	O
and	O
BC	O
individuals	O
was	O
not	O
significant	O
.	O

None	O
of	O
the	O
other	O
transcription	O
factors	O
were	O
correlated	O
with	O
XRCC1	O
,	O
ERCC5	O
,	O
GSTP1	O
,	O
SOD1	O
,	O
or	O
GPX1	O
(	O
Fig	O
.	O
1a	O
,	O
d	O
,	O
e	O
,	O
f	O
)	O
.	O

Comparison	O
of	O
gene	O
expression	O
with	O
demographic	O
characteristics	O

E2F1	O
and	O
GSTZ1	O
each	O
were	O
positively	O
correlated	O
with	O
age	O
.	O

GSTM1	O
-	O
5	O
was	O
the	O
only	O
gene	O
with	O
a	O
difference	O
in	O
expression	O
by	O
gender	O
.	O

There	O
was	O
a	O
difference	O
in	O
ERCC2	O
expression	O
between	O
former	O
and	O
never	O
smokers	O
.	O

Discussion	O

In	O
this	O
study	O
,	O
we	O
tested	O
two	O
hypotheses	O
.	O

First	O
,	O
that	O
there	O
is	O
inter	O
-	O
individual	O
variation	O
in	O
regulation	O
of	O
key	O
antioxidant	O
and	O
DNA	O
repair	O
genes	O
by	O
one	O
or	O
more	O
transcription	O
factors	O
.	O

Second	O
,	O
that	O
individuals	O
with	O
sub	O
-	O
optimal	O
regulation	O
are	O
selected	O
for	O
development	O
of	O
BC	O
if	O
they	O
smoke	O
cigarettes	O
.	O

These	O
hypotheses	O
are	O
supported	O
by	O
the	O
findings	O
that	O
a	O
)	O
there	O
was	O
large	O
inter	O
-	O
individual	O
variation	O
in	O
transcript	O
levels	O
of	O
CEBPG	O
and	O
each	O
of	O
the	O
target	O
genes	O
and	O
in	O
non	O
-	O
BC	O
individuals	O
,	O
b	O
)	O
CEBPG	O
transcript	O
abundance	O
values	O
were	O
significantly	O
correlated	O
by	O
bivariate	O
analysis	O
with	O
the	O
transcript	O
abundance	O
values	O
of	O
four	O
key	O
antioxidant	O
and	O
DNA	O
repair	O
genes	O
in	O
non	O
-	O
BC	O
individuals	O
,	O
and	O
c	O
)	O
that	O
there	O
was	O
no	O
correlation	O
between	O
CEBPG	O
and	O
these	O
genes	O
in	O
BC	O
individuals	O
.	O

These	O
results	O
support	O
the	O
hypothesis	O
that	O
each	O
of	O
the	O
antioxidant	O
or	O
DNA	O
repair	O
genes	O
correlated	O
with	O
CEBPG	O
in	O
non	O
-	O
BC	O
individuals	O
is	O
regulated	O
by	O
CEBPG	O
.	O

This	O
is	O
supported	O
by	O
the	O
specificity	O
of	O
the	O
CEBPG	O
correlation	O
.	O

That	O
is	O
,	O
there	O
was	O
lack	O
of	O
correlation	O
between	O
any	O
of	O
the	O
other	O
five	O
transcription	O
factors	O
assessed	O
and	O
these	O
target	O
genes	O
.	O

Of	O
particular	O
note	O
is	O
the	O
lack	O
of	O
correlation	O
of	O
the	O
target	O
genes	O
with	O
CEBPB	O
,	O
which	O
binds	O
to	O
the	O
same	O
recognition	O
site	O
as	O
CEBPG	O
,	O
and	O
shares	O
its	O
recognition	O
site	O
within	O
each	O
of	O
the	O
antioxidant	O
or	O
DNA	O
repair	O
genes	O
.	O

However	O
,	O
there	O
are	O
alternative	O
explanations	O
for	O
the	O
observed	O
correlation	O
of	O
CEBPG	O
with	O
antioxidant	O
and	O
DNA	O
repair	O
genes	O
in	O
non	O
-	O
BC	O
individuals	O
.	O

One	O
possibility	O
is	O
that	O
CEBPG	O
and	O
each	O
of	O
the	O
correlated	O
antioxidant	O
or	O
DNA	O
repair	O
genes	O
is	O
regulated	O
by	O
a	O
transcription	O
factor	O
that	O
is	O
as	O
yet	O
undiscovered	O
,	O
and	O
/	O
or	O
has	O
a	O
recognition	O
site	O
that	O
is	O
not	O
yet	O
known	O
and	O
was	O
not	O
in	O
the	O
Genomatix	O
software	O
database	O
.	O

There	O
also	O
is	O
more	O
than	O
one	O
possible	O
explanation	O
for	O
the	O
observed	O
lack	O
of	O
correlation	O
between	O
CEBPG	O
and	O
antioxidant	O
or	O
DNA	O
repair	O
genes	O
in	O
BC	O
individuals	O
.	O

For	O
example	O
,	O
the	O
non	O
-	O
BC	O
individual	O
and	O
BC	O
individual	O
groups	O
are	O
not	O
perfectly	O
matched	O
with	O
respect	O
to	O
age	O
,	O
gender	O
or	O
smoking	O
history	O
(	O
Table	O
1	O
)	O
and	O
each	O
of	O
these	O
factors	O
could	O
contribute	O
to	O
the	O
observed	O
difference	O
in	O
correlation	O
between	O
groups	O
.	O

However	O
,	O
the	O
lack	O
of	O
association	O
of	O
transcript	O
abundance	O
level	O
for	O
CEBPG	O
,	O
XRCC1	O
,	O
ERCC5	O
,	O
GSTP1	O
,	O
SOD1	O
,	O
or	O
GPX1	O
with	O
age	O
,	O
gender	O
or	O
smoking	O
history	O
argues	O
against	O
such	O
an	O
explanation	O
.	O

One	O
way	O
to	O
examine	O
this	O
possibility	O
is	O
through	O
additional	O
,	O
larger	O
,	O
more	O
closely	O
matched	O
studies	O
.	O

Another	O
possible	O
explanation	O
is	O
that	O
any	O
differences	O
in	O
NBEC	O
from	O
BC	O
individuals	O
compared	O
to	O
non	O
-	O
BC	O
individuals	O
resulted	O
from	O
development	O
of	O
BC	O
,	O
instead	O
of	O
being	O
a	O
hereditary	O
cause	O
of	O
increased	O
risk	O
for	O
cancer	O
.	O

The	O
best	O
way	O
to	O
determine	O
this	O
will	O
be	O
to	O
conduct	O
a	O
prospective	O
study	O
.	O

In	O
such	O
a	O
study	O
,	O
individuals	O
matched	O
for	O
smoking	O
history	O
will	O
be	O
monitored	O
for	O
development	O
of	O
BC	O
over	O
time	O
.	O

The	O
correlation	O
of	O
transcript	O
abundance	O
values	O
for	O
CEBPG	O
relative	O
to	O
transcript	O
abundance	O
values	O
for	O
each	O
of	O
the	O
antioxidant	O
or	O
DNA	O
repair	O
genes	O
will	O
be	O
assessed	O
.	O

It	O
is	O
expected	O
that	O
the	O
greatest	O
incidence	O
of	O
BC	O
will	O
be	O
among	O
the	O
heaviest	O
smokers	O
.	O

Among	O
the	O
matched	O
heaviest	O
smokers	O
,	O
it	O
is	O
expected	O
that	O
CEBPG	O
will	O
be	O
significantly	O
correlated	O
with	O
each	O
of	O
the	O
antioxidant	O
or	O
DNA	O
repair	O
genes	O
among	O
the	O
non	O
-	O
BC	O
individuals	O
but	O
not	O
correlated	O
in	O
BC	O
individuals	O
.	O

Thus	O
,	O
there	O
are	O
multiple	O
possible	O
explanations	O
for	O
the	O
observed	O
findings	O
.	O

However	O
,	O
based	O
on	O
the	O
preponderance	O
of	O
data	O
thus	O
far	O
available	O
,	O
we	O
conclude	O
that	O
CEBPG	O
is	O
responsible	O
for	O
optimal	O
transcriptional	O
regulation	O
of	O
key	O
antioxidant	O
or	O
DNA	O
repair	O
genes	O
in	O
NBEC	O
and	O
that	O
there	O
is	O
inter	O
-	O
individual	O
variation	O
in	O
the	O
regulation	O
of	O
each	O
of	O
these	O
genes	O
by	O
CEBPG	O
.	O

If	O
this	O
conclusion	O
is	O
correct	O
,	O
the	O
individuals	O
at	O
greatest	O
risk	O
for	O
BC	O
will	O
be	O
those	O
with	O
the	O
most	O
extreme	O
smoking	O
history	O
combined	O
with	O
sub	O
-	O
optimal	O
regulation	O
of	O
the	O
largest	O
number	O
of	O
antioxidant	O
and	O
DNA	O
repair	O
genes	O
.	O

This	O
,	O
in	O
turn	O
,	O
leads	O
to	O
increased	O
representation	O
among	O
BC	O
individuals	O
of	O
individuals	O
with	O
lack	O
of	O
correlation	O
between	O
CEBPG	O
and	O
each	O
of	O
the	O
affected	O
antioxidant	O
and	O
/	O
or	O
DNA	O
repair	O
genes	O
.	O

CEBPG	O
is	O
a	O
truncated	O
CEBP	O
transcription	O
factor	O
[	O
19	O
]	O
and	O
possesses	O
the	O
sequences	O
necessary	O
for	O
DNA	O
binding	O
and	O
heterodimer	O
formation	O
,	O
but	O
lacks	O
the	O
sequences	O
necessary	O
for	O
transactivation	O
[	O
20	O
]	O
.	O

CEBPG	O
forms	O
heterodimers	O
with	O
other	O
CEBP	O
family	O
members	O
and	O
in	O
other	O
tissues	O
this	O
leads	O
to	O
increased	O
[	O
21	O
]	O
or	O
decreased	O
[	O
20	O
]	O
transcription	O
of	O
the	O
regulated	O
gene	O
.	O

CEBPG	O
is	O
known	O
to	O
have	O
stimulatory	O
effect	O
on	O
the	O
IL	O
-	O
6	O
and	O
IL	O
-	O
8	O
promoters	O
in	O
B	O
cell	O
lines	O
[	O
21	O
]	O
,	O
and	O
can	O
also	O
act	O
as	O
a	O
dominant	O
negative	O
regulator	O
of	O
CEBPA	O
and	O
CEBPB	O
in	O
fibroblast	O
and	O
B	O
cell	O
lines	O
[	O
20	O
]	O
.	O

The	O
data	O
from	O
CEBPG	O
knockout	O
mice	O
support	O
a	O
role	O
for	O
CEBPG	O
in	O
protecting	O
lungs	O
from	O
oxidant	O
damage	O
.	O

CEBPG	O
-	O
/	O
-	O
knockout	O
mice	O
are	O
healthy	O
at	O
birth	O
but	O
begin	O
to	O
die	O
within	O
24	O
hours	O
,	O
and	O
histological	O
examination	O
reveals	O
emphysematous	O
lungs	O
[	O
22	O
]	O
.	O

In	O
humans	O
,	O
risk	O
for	O
emphysema	O
is	O
associated	O
with	O
antioxidant	O
capacity	O
[	O
23	O
]	O
,	O
and	O
there	O
is	O
a	O
strong	O
correlation	O
between	O
risk	O
for	O
emphysema	O
and	O
risk	O
for	O
BC	O
.	O

However	O
,	O
it	O
will	O
be	O
important	O
to	O
obtain	O
direct	O
experimental	O
evidence	O
in	O
NBECs	O
for	O
the	O
role	O
of	O
CEBPG	O
in	O
regulating	O
the	O
antioxidant	O
and	O
DNA	O
repair	O
genes	O
included	O
in	O
this	O
study	O
.	O

Correlation	O
between	O
CEBPG	O
and	O
target	O
gene	O
transcript	O
levels	O
may	O
not	O
be	O
associated	O
with	O
correlation	O
at	O
the	O
protein	O
level	O
.	O

In	O
this	O
study	O
,	O
E2F1	O
correlation	O
with	O
DNA	O
repair	O
and	O
antioxidant	O
genes	O
was	O
less	O
than	O
the	O
correlation	O
observed	O
with	O
CEBPG	O
,	O
and	O
the	O
E2F1	O
correlation	O
was	O
observed	O
in	O
both	O
non	O
-	O
BC	O
individuals	O
as	O
well	O
as	O
BC	O
individuals	O
.	O

The	O
maintained	O
correlation	O
of	O
E2F1	O
with	O
DNA	O
repair	O
and	O
antioxidant	O
genes	O
in	O
BC	O
individuals	O
suggests	O
that	O
this	O
function	O
is	O
more	O
tightly	O
controlled	O
in	O
the	O
population	O
and	O
does	O
not	O
play	O
a	O
role	O
in	O
determination	O
of	O
risk	O
for	O
BC	O
.	O

E2F1	O
has	O
previously	O
been	O
reported	O
to	O
regulate	O
transcription	O
of	O
DNA	O
repair	O
enzyme	O
genes	O
in	O
other	O
cell	O
types	O
,	O
including	O
primary	O
human	O
fibroblasts	O
and	O
mouse	O
epidermal	O
cells	O
[	O
24	O
,	O
25	O
]	O
.	O

Clearly	O
this	O
would	O
have	O
survival	O
value	O
since	O
DNA	O
repair	O
gene	O
up	O
-	O
regulation	O
in	O
response	O
to	O
E2F1	O
provides	O
additional	O
DNA	O
repair	O
when	O
the	O
DNA	O
is	O
replicating	O
and	O
is	O
particularly	O
vulnerable	O
to	O
damage	O
.	O

Epidemiologic	O
assessment	O
of	O
the	O
correlation	O
between	O
a	O
particular	O
variation	O
in	O
DNA	O
sequence	O
,	O
or	O
polymorphism	O
,	O
and	O
risk	O
for	O
BC	O
has	O
been	O
a	O
dominant	O
paradigm	O
for	O
many	O
years	O
.	O

Thus	O
far	O
,	O
these	O
efforts	O
have	O
met	O
with	O
scant	O
success	O
[	O
26	O
]	O
.	O

A	O
common	O
limitation	O
in	O
design	O
of	O
such	O
studies	O
is	O
that	O
they	O
involve	O
assessment	O
of	O
a	O
single	O
polymorphism	O
or	O
occasionally	O
,	O
a	O
few	O
polymorphisms	O
.	O

Further	O
,	O
although	O
the	O
polymorphism	O
assessed	O
typically	O
resides	O
within	O
a	O
gene	O
known	O
to	O
protect	O
bronchial	O
epithelium	O
from	O
carcinogens	O
,	O
oxidants	O
,	O
or	O
DNA	O
damage	O
,	O
the	O
selection	O
of	O
the	O
particular	O
polymorphism	O
for	O
study	O
is	O
largely	O
empiric	O
,	O
and	O
not	O
based	O
on	O
known	O
functional	O
properties	O
.	O

These	O
are	O
problems	O
because	O
multiple	O
infrequent	O
polymorphisms	O
at	O
different	O
sites	O
may	O
all	O
contribute	O
to	O
risk	O
and	O
unless	O
the	O
key	O
polymorphisms	O
can	O
be	O
identified	O
through	O
a	O
functional	O
test	O
,	O
a	O
statistically	O
valid	O
assessment	O
would	O
require	O
much	O
larger	O
study	O
populations	O
[	O
27	O
]	O
.	O

The	O
findings	O
of	O
this	O
study	O
support	O
a	O
novel	O
approach	O
to	O
identifying	O
clinically	O
useful	O
biomarkers	O
.	O

According	O
to	O
the	O
paradigm	O
used	O
in	O
this	O
study	O
,	O
a	O
)	O
a	O
normal	O
phenotype	O
results	O
from	O
regulated	O
transcription	O
of	O
a	O
group	O
of	O
genes	O
by	O
one	O
or	O
more	O
transcription	O
factors	O
,	O
b	O
)	O
the	O
corresponding	O
risk	O
-	O
conferring	O
or	O
disease	O
phenotype	O
results	O
from	O
sub	O
-	O
optimal	O
interaction	O
among	O
those	O
same	O
genes	O
,	O
and	O
c	O
)	O
each	O
phenotype	O
is	O
identifiable	O
and	O
distinguishable	O
through	O
virtually	O
-	O
multiplexed	O
transcript	O
abundance	O
analysis	O
.	O

The	O
data	O
presented	O
here	O
support	O
the	O
utility	O
of	O
this	O
paradigm	O
in	O
identifying	O
genes	O
associated	O
with	O
risk	O
for	O
BC	O
.	O

The	O
next	O
step	O
will	O
be	O
to	O
identify	O
polymorphisms	O
that	O
affect	O
regulation	O
of	O
XRCC1	O
,	O
ERCC5	O
,	O
GSTP1	O
,	O
SOD1	O
,	O
and	O
GPX1	O
by	O
CEBPG	O
.	O

Such	O
polymorphisms	O
should	O
yield	O
biomarkers	O
suitable	O
for	O
more	O
readily	O
accessible	O
samples	O
,	O
such	O
as	O
peripheral	O
blood	O
or	O
buccal	O
smears	O
.	O

A	O
biomarker	O
combining	O
polymorphisms	O
that	O
affect	O
regulation	O
with	O
those	O
that	O
affect	O
function	O
of	O
antioxidant	O
and	O
DNA	O
repair	O
genes	O
is	O
likely	O
to	O
be	O
the	O
most	O
accurate	O
for	O
identifying	O
individuals	O
at	O
risk	O
for	O
BC	O
.	O

Biomarkers	O
that	O
accurately	O
identify	O
individuals	O
at	O
risk	O
for	O
BC	O
will	O
improve	O
efficacy	O
of	O
chemoprevention	O
and	O
early	O
detection	O
clinical	O
trials	O
.	O

The	O
observed	O
inter	O
-	O
sample	O
variation	O
in	O
the	O
presence	O
of	O
gene	O
-	O
specific	O
inhibitors	O
of	O
PCR	O
provides	O
evidence	O
supporting	O
the	O
need	O
for	O
inclusion	O
of	O
an	O
internal	O
standard	O
in	O
each	O
quantitative	O
PCR	O
transcript	O
abundance	O
measurement	O
.	O

Including	O
such	O
internal	O
standards	O
in	O
the	O
form	O
of	O
standardized	O
mixtures	O
of	O
internal	O
standards	O
improves	O
the	O
reproducibility	O
of	O
transcript	O
abundance	O
measurement	O
and	O
enables	O
development	O
of	O
a	O
standardized	O
database	O
comprising	O
virtually	O
-	O
multiplexed	O
transcript	O
abundance	O
data	O
.	O

Virtually	O
-	O
multiplexed	O
transcript	O
abundance	O
data	O
are	O
highly	O
suited	O
to	O
identification	O
of	O
genes	O
that	O
have	O
correlated	O
transcript	O
abundance	O
values	O
.	O

Correlation	O
at	O
the	O
transcript	O
abundance	O
level	O
is	O
an	O
important	O
property	O
of	O
genes	O
that	O
are	O
co	O
-	O
regulated	O
at	O
the	O
transcription	O
level	O
.	O

Conclusion	O

We	O
conclude	O
that	O
in	O
non	O
-	O
BC	O
individuals	O
,	O
CEBPG	O
regulates	O
transcription	O
of	O
key	O
antioxidant	O
or	O
DNA	O
repair	O
genes	O
in	O
NBEC	O
and	O
that	O
in	O
smokers	O
who	O
develop	O
BC	O
,	O
CEBPG	O
regulation	O
is	O
sub	O
-	O
optimal	O
for	O
a	O
sufficient	O
number	O
of	O
antioxidant	O
and	O
/	O
or	O
DNA	O
repair	O
genes	O
to	O
cause	O
increased	O
risk	O
.	O

Competing	O
interests	O

JCW	O
and	O
ELC	O
each	O
have	O
significant	O
equity	O
interest	O
in	O
Gene	O
Express	O
,	O
Inc	O
.	O
,	O
which	O
produces	O
and	O
markets	O
StaRT	O
-	O
PCR	O
(TM)	O
reagents	O
used	O
in	O
this	O
study	O
.	O

Authors	O
'	O
contributions	O

DNM	O
participated	O
in	O
the	O
design	O
of	O
the	O
study	O
,	O
performed	O
the	O
TF	O
identification	O
,	O
carried	O
out	O
TA	O
measurements	O
,	O
coordinated	O
and	O
participated	O
in	O
the	O
statistical	O
analysis	O
and	O
drafted	O
the	O
manuscript	O
.	O

ELC	O
contributed	O
the	O
preliminary	O
data	O
,	O
participated	O
in	O
the	O
design	O
of	O
the	O
study	O
and	O
carried	O
out	O
TA	O
measurements	O
.	O

SAK	O
performed	O
the	O
statistical	O
analysis	O
for	O
interpretation	O
of	O
data	O
.	O

DAH	O
and	O
YY	O
consented	O
patients	O
and	O
obtained	O
the	O
primary	O
samples	O
necessary	O
for	O
the	O
study	O
according	O
to	O
IRB	O
regulations	O
.	O

JCW	O
conceived	O
of	O
the	O
study	O
,	O
participated	O
in	O
its	O
design	O
and	O
coordination	O
,	O
and	O
helped	O
to	O
draft	O
the	O
manuscript	O
.	O

All	O
authors	O
read	O
and	O
approved	O
the	O
final	O
manuscript	O
.	O

Pre	O
-	O
publication	O
history	O

The	O
pre	O
-	O
publication	O
history	O
for	O
this	O
paper	O
can	O
be	O
accessed	O
here	O
:	O

Acknowledgements	O

These	O
studies	O
and	O
manuscript	O
preparation	O
were	O
supported	O
by	O
grants	O
from	O
the	O
National	O
Cancer	O
Institute	O
(	O
NCI	O
)	O
,	O
including	O
CA85147	O
and	O
CA	O
95806	O
,	O
and	O
the	O
George	O
Isaac	O
Cancer	O
Research	O
Fund	O
.	O

StaRT	O
-	O
PCR	O
reagents	O
for	O
measurement	O
of	O
some	O
of	O
the	O
genes	O
were	O
provided	O
at	O
no	O
cost	O
by	O
Gene	O
Express	O
,	O
Inc	O
.	O

Neither	O
the	O
NCI	O
nor	O
Gene	O
Express	O
,	O
Inc	O
.	O
had	O
any	O
role	O
in	O
study	O
design	O
,	O
collection	O
,	O
analysis	O
,	O
or	O
interpretation	O
of	O
data	O
,	O
writing	O
of	O
the	O
manuscript	O
,	O
or	O
in	O
the	O
decision	O
to	O
submit	O
the	O
manuscript	O
for	O
publication	O
.	O

Figures	O
and	O
Tables	O

Figure	O
1	O

Correlation	O
of	O
each	O
transcription	O
factor	O
with	O
XRCC1	O
,	O
ERCC5	O
,	O
GSTP1	O
,	O
SOD1	O
,	O
or	O
GPX1	O
.	O

(	O
a	O
-	O
f	O
)	O
Each	O
panel	O
presents	O
the	O
correlation	O
coefficients	O
(	O
r	O
values	O
)	O
for	O
one	O
transcription	O
factor	O
in	O
relation	O
to	O
each	O
of	O
the	O
five	O
genes	O
:	O
(	O
a	O
)	O
CEBPB	O
,	O
(	O
b	O
)	O
CEBPG	O
,	O
(	O
c	O
)	O
E2F1	O
,	O
(	O
d	O
)	O
E2F3	O
,	O
(	O
e	O
)	O
E2F6	O
,	O
(	O
f	O
)	O
EVI1	O
.	O

The	O
p	O
value	O
for	O
each	O
significant	O
correlation	O
is	O
provided	O
above	O
the	O
bar	O
.	O

For	O
CEBPG	O
,	O
presented	O
in	O
panel	O
b	O
,	O
the	O
difference	O
in	O
r	O
value	O
between	O
non	O
-	O
BC	O
individuals	O
and	O
BC	O
individuals	O
was	O
significant	O
or	O
nearly	O
significant	O
for	O
each	O
correlated	O
gene	O
,	O
and	O
the	O
p	O
value	O
for	O
each	O
comparison	O
is	O
provided	O
below	O
the	O
corresponding	O
pair	O
of	O
bars	O
.	O

Figure	O
2	O

Scatter	O
plot	O
representation	O
of	O
bivariate	O
correlation	O
of	O
CEBPG	O
with	O
XRCC1	O
.	O

(	O
a	O
,	O
b	O
)	O
CEBPG	O
/	O
XRCC1	O
data	O
from	O
Figure	O
1b	O
presented	O
as	O
scatter	O
plots	O
:	O
(	O
a	O
)	O
non	O
-	O
BC	O
individuals	O
,	O
(	O
b	O
)	O
BC	O
individuals	O
.	O

Table	O
1	O

Demographic	O
data	O
of	O
patients	O
from	O
whom	O
the	O
NBEC	O
samples	O
were	O
obtained	O
.	O

1Pack	O
years	O
;	O
2Non	O
-	O
bronchogenic	O
carcinoma	O
individual	O
;	O
3White	O
;	O
4African	O
-	O
American	O
;	O
5Non	O
-	O
smoker	O
;	O
6Not	O
available	O
;	O
7Hispanic	O
;	O
8Bronchogenic	O
carcinoma	O
individual	O
;	O
9Non	O
-	O
small	O
cell	O
lung	O
cancer	O
;	O
10Squamous	O
carcinoma	O
;	O
11Small	O
cell	O
lung	O
cancer	O
;	O
12Carcinoma	O
-	O
in	O
-	O
situ	O
;	O
13Adenocarcinoma	O
;	O
14Bronchogenic	O
Cancer	O
,	O
histology	O
not	O
specified	O
;	O
15Poorly	O
differentiated	O
carcinoma	O
.	O

Table	O
2	O

Sequence	O
for	O
each	O
primer	O
used	O
for	O
StaRT	O
-	O
PCR	O
virtually	O
-	O
multiplexed	O
transcript	O
abundance	O
measurement	O
or	O
for	O
internal	O
standard	O
preparation	O
(	O
CT	O
)	O
[	O
15	O
]	O
.	O

Table	O
3	O

Virtually	O
-	O
multiplexed	O
transcript	O
abundance	O
data	O
.	O

Virtually	O
-	O
multiplexed	O
transcript	O
abundance	O
data	O
for	O
each	O
gene	O
(	O
in	O
the	O
form	O
of	O
molecules	O
/	O
106	O
beta	O
-	O
actin	O
molecules	O
)	O
from	O
all	O
experiments	O
were	O
included	O
in	O
the	O
same	O
Standardized	O
Expression	O
Database	O
(	O
SED	O
)	O
.	O

These	O
data	O
are	O
now	O
directly	O
comparable	O
to	O
previously	O
published	O
virtually	O
-	O
multiplexed	O
transcript	O
abundance	O
data	O
from	O
this	O
laboratory	O
[	O
15	O
]	O
,	O
or	O
to	O
Virtually	O
-	O
multiplexed	O
transcript	O
abundance	O
data	O
collected	O
by	O
others	O
who	O
use	O
the	O
NCI	O
-	O
funded	O
(	O
R24	O
CA	O
95806	O
)	O
Standardized	O
Expression	O
Measurement	O
(	O
SEM	O
)	O
Center	O
.	O

The	O
data	O
presented	O
here	O
represent	O
more	O
than	O
6	O
,	O
000	O
Virtually	O
-	O
multiplexed	O
transcript	O
abundance	O
measurements	O
conducted	O
in	O
multiple	O
experiments	O
.	O

The	O
sixteen	O
antioxidant	O
or	O
DNA	O
repair	O
genes	O
and	O
each	O
of	O
the	O
six	O
transcription	O
factors	O
except	O
for	O
E2F1	O
were	O
measured	O
in	O
each	O
NBEC	O
sample	O
from	O
49	O
individuals	O
(	O
24	O
non	O
-	O
BC	O
individuals	O
and	O
25	O
BC	O
individuals	O
)	O
.	O

1ND	O
,	O
Not	O
detectable	O
(	O
When	O
60	O
molecules	O
of	O
Competitive	O
Template	O
(	O
CT	O
)	O
were	O
added	O
to	O
the	O
reaction	O
,	O
CT	O
was	O
detected	O
but	O
native	O
template	O
was	O
not	O
.	O
)	O

2NA	O
,	O
Not	O
available	O
.	O

E2F1	O
was	O
measured	O
in	O
all	O
of	O
the	O
samples	O
except	O
for	O
one	O
BC	O
individual	O
(	O
24	O
non	O
-	O
BC	O
individuals	O
and	O
24	O
BC	O
individuals	O
)	O
.	O

Table	O
4	O

Bivariate	O
analysis	O
of	O
virtually	O
-	O
multiplexed	O
transcript	O
abundance	O
data	O
values	O
for	O
each	O
antioxidant	O
or	O
DNA	O
repair	O
gene	O
versus	O
each	O
transcription	O
factor	O
.	O

The	O
correlation	O
of	O
logarithmically	O
transformed	O
virtually	O
-	O
multiplexed	O
transcript	O
abundance	O
data	O
(	O
Table	O
3	O
)	O
from	O
each	O
of	O
the	O
six	O
transcription	O
factors	O
with	O
each	O
of	O
the	O
sixteen	O
antioxidant	O
or	O
DNA	O
repair	O
genes	O
was	O
determined	O
.	O

The	O
transformation	O
was	O
necessary	O
due	O
to	O
the	O
wide	O
range	O
of	O
expression	O
of	O
each	O
gene	O
among	O
the	O
samples	O
.	O

The	O
correlation	O
coefficient	O
(	O
r	O
value	O
)	O
and	O
level	O
of	O
significance	O
(	O
p	O
value	O
)	O
for	O
each	O
correlation	O
are	O
presented	O
.	O

Significance	O
(	O
p	O
<	O
0	O
.	O
01	O
)	O
was	O
determined	O
using	O
a	O
two	O
-	O
tailed	O
test	O
following	O
Bonferroni	O
adjustment	O
for	O
six	O
multiple	O
comparisons	O
(	O
comparison	O
of	O
each	O
of	O
six	O
transcription	O
factors	O
to	O
each	O
of	O
the	O
antioxidant	O
or	O
DNA	O
repair	O
genes	O
)	O
.	O

*	O
values	O
for	O
E2F1	O
obtained	O
in	O
all	O
but	O
one	O
BC	O
individuals	O
.	O

Persistent	O
Amyloidosis	O
following	O
Suppression	O
of	O
A	O
beta	O
Production	O
in	O
a	O
Transgenic	O
Model	O
of	O
Alzheimer	O
Disease	O

Abstract	O

Background	O

The	O
proteases	O
(	O
secretases	O
)	O
that	O
cleave	O
amyloid	O
-	O
beta	O
(	O
A	O
beta	O
)	O
peptide	O
from	O
the	O
amyloid	O
precursor	O
protein	O
(	O
APP	O
)	O
have	O
been	O
the	O
focus	O
of	O
considerable	O
investigation	O
in	O
the	O
development	O
of	O
treatments	O
for	O
Alzheimer	O
disease	O
.	O

The	O
prediction	O
has	O
been	O
that	O
reducing	O
A	O
beta	O
production	O
in	O
the	O
brain	O
,	O
even	O
after	O
the	O
onset	O
of	O
clinical	O
symptoms	O
and	O
the	O
development	O
of	O
associated	O
pathology	O
,	O
will	O
facilitate	O
the	O
repair	O
of	O
damaged	O
tissue	O
and	O
removal	O
of	O
amyloid	O
lesions	O
.	O

However	O
,	O
no	O
long	O
-	O
term	O
studies	O
using	O
animal	O
models	O
of	O
amyloid	O
pathology	O
have	O
yet	O
been	O
performed	O
to	O
test	O
this	O
hypothesis	O
.	O

Methods	O
and	O
Findings	O

We	O
have	O
generated	O
a	O
transgenic	O
mouse	O
model	O
that	O
genetically	O
mimics	O
the	O
arrest	O
of	O
A	O
beta	O
production	O
expected	O
from	O
treatment	O
with	O
secretase	O
inhibitors	O
.	O

These	O
mice	O
overexpress	O
mutant	O
APP	O
from	O
a	O
vector	O
that	O
can	O
be	O
regulated	O
by	O
doxycycline	O
.	O

Under	O
normal	O
conditions	O
,	O
high	O
-	O
level	O
expression	O
of	O
APP	O
quickly	O
induces	O
fulminant	O
amyloid	O
pathology	O
.	O

We	O
show	O
that	O
doxycycline	O
administration	O
inhibits	O
transgenic	O
APP	O
expression	O
by	O
greater	O
than	O
95	O
%	O
and	O
reduces	O
A	O
beta	O
production	O
to	O
levels	O
found	O
in	O
nontransgenic	O
mice	O
.	O

Suppression	O
of	O
transgenic	O
A	O
beta	O
synthesis	O
in	O
this	O
model	O
abruptly	O
halts	O
the	O
progression	O
of	O
amyloid	O
pathology	O
.	O

However	O
,	O
formation	O
and	O
disaggregation	O
of	O
amyloid	O
deposits	O
appear	O
to	O
be	O
in	O
disequilibrium	O
as	O
the	O
plaques	O
require	O
far	O
longer	O
to	O
disperse	O
than	O
to	O
assemble	O
.	O

Mice	O
in	O
which	O
APP	O
synthesis	O
was	O
suppressed	O
for	O
as	O
long	O
as	O
6	O
mo	O
after	O
the	O
formation	O
of	O
A	O
beta	O
deposits	O
retain	O
a	O
considerable	O
amyloid	O
load	O
,	O
with	O
little	O
sign	O
of	O
active	O
clearance	O
.	O

Conclusion	O

This	O
study	O
demonstrates	O
that	O
amyloid	O
lesions	O
in	O
transgenic	O
mice	O
are	O
highly	O
stable	O
structures	O
in	O
vivo	O
that	O
are	O
slow	O
to	O
disaggregate	O
.	O

Our	O
findings	O
suggest	O
that	O
arresting	O
A	O
beta	O
production	O
in	O
patients	O
with	O
Alzheimer	O
disease	O
should	O
halt	O
the	O
progression	O
of	O
pathology	O
,	O
but	O
that	O
early	O
treatment	O
may	O
be	O
imperative	O
,	O
as	O
it	O
appears	O
that	O
amyloid	O
deposits	O
,	O
once	O
formed	O
,	O
will	O
require	O
additional	O
intervention	O
to	O
clear	O
.	O

Introduction	O

Over	O
a	O
decade	O
ago	O
the	O
amyloid	O
cascade	O
hypothesis	O
predicted	O
that	O
increased	O
levels	O
of	O
amyloid	O
-	O
beta	O
(	O
A	O
beta	O
)	O
peptide	O
lead	O
to	O
secondary	O
pathologies	O
that	O
ultimately	O
culminate	O
in	O
the	O
onset	O
of	O
Alzheimer	O
disease	O
(	O
AD	O
)	O
[	O
1	O
]	O
.	O

Early	O
support	O
for	O
this	O
hypothesis	O
came	O
from	O
genetic	O
studies	O
linking	O
early	O
-	O
onset	O
AD	O
to	O
mutations	O
in	O
the	O
amyloid	O
precursor	O
protein	O
(	O
APP	O
)	O
,	O
from	O
which	O
A	O
beta	O
is	O
derived	O
,	O
and	O
presenilins	O
1	O
and	O
2	O
,	O
which	O
are	O
interchangeable	O
components	O
of	O
a	O
endoprotease	O
complex	S-GO
that	O
releases	O
A	O
beta	O
from	O
APP	O
(	O
for	O
review	O
see	O
[	O
2	O
,	O
3	O
]	O
)	O
.	O

If	O
,	O
as	O
predicted	O
,	O
overproduction	O
of	O
A	O
beta	O
initiates	O
the	O
cascade	O
of	O
events	O
leading	O
to	O
disease	O
,	O
then	O
therapeutic	O
strategies	O
that	O
lower	O
A	O
beta	O
levels	O
should	O
either	O
arrest	O
or	O
reverse	O
the	O
progression	O
from	O
peptide	O
to	O
dementia	O
.	O

Early	O
evidence	O
from	O
clinical	O
trials	O
of	O
antibody	S-GO
-	O
mediated	O
clearance	O
,	O
one	O
of	O
the	O
first	O
A	O
beta	O
-	O
lowering	O
approaches	O
tested	O
in	O
humans	O
,	O
suggested	O
that	O
treatments	O
designed	O
to	O
reduce	O
amyloid	O
burden	O
may	O
indeed	O
be	O
beneficial	O
.	O

Although	O
the	O
trials	O
were	O
halted	O
because	O
of	O
adverse	O
effects	O
in	O
a	O
subset	O
of	O
volunteers	O
[	O
4	O
,	O
5	O
]	O
,	O
further	O
analysis	O
of	O
several	O
patients	O
found	O
evidence	O
that	O
amyloid	O
pathology	O
,	O
and	O
to	O
a	O
lesser	O
degree	O
cognitive	O
function	O
,	O
was	O
improved	O
in	O
proportion	O
to	O
the	O
patient	O
'	O
s	O
titer	O
of	O
A	O
beta	O
-	O
specific	O
antibody	S-GO
[	O
6	O
,	O
7	O
]	O
.	O

While	O
this	O
approach	O
is	O
promising	O
,	O
constant	O
exposure	O
to	O
antibodies	S-GO
that	O
recognize	O
an	O
epitope	O
highly	O
enriched	O
in	O
the	O
brain	O
may	O
have	O
unexpected	O
side	O
effects	O
that	O
will	O
limit	O
its	O
long	O
-	O
term	O
use	O
.	O

An	O
alternative	O
approach	O
that	O
is	O
being	O
actively	O
pursued	O
for	O
future	O
treatment	O
of	O
AD	O
seeks	O
to	O
lower	O
A	O
beta	O
levels	O
by	O
limiting	O
its	O
production	O
from	O
the	O
precursor	O
protein	O
APP	O
.	O

Peptide	O
A	O
beta	O
is	O
released	O
from	O
APP	O
by	O
the	O
action	O
of	O
two	O
enzymes	O
,	O
the	O
beta	O
-	O
APP	O
cleaving	O
enzyme	O
1	O
(	O
BACE1	O
)	O
and	O
gamma	O
-	O
secretase	O
,	O
which	O
cleave	O
the	O
holoprotein	O
at	O
the	O
N	O
-	O
and	O
C	O
-	O
termini	O
of	O
A	O
beta	O
,	O
respectively	O
.	O

Several	O
inhibitors	O
of	O
gamma	O
-	O
secretase	O
have	O
already	O
been	O
produced	O
[	O
8	O
,	O
9	O
]	O
,	O
and	O
small	O
molecule	O
inhibitors	O
of	O
beta	O
-	O
APP	O
cleaving	O
enzyme	O
1	O
are	O
currently	O
being	O
developed	O
[	O
10	O
,	O
11	O
]	O
.	O

The	O
long	O
-	O
term	O
effectiveness	O
of	O
this	O
approach	O
in	O
either	O
humans	O
or	O
model	O
systems	O
,	O
however	O
,	O
has	O
not	O
been	O
reported	O
.	O

Although	O
loss	O
of	O
beta	O
-	O
APP	O
cleaving	O
enzyme	O
1	O
function	O
can	O
prevent	O
the	O
development	O
of	O
plaques	O
in	O
transgenic	O
mouse	O
models	O
for	O
AD	O
(	O
F	O
.	O
Laird	O
,	O
H	O
.	O
Cai	O
,	O
P	O
.	O
C	O
.	O
Wong	O
,	O
personal	O
communication	O
)	O
,	O
it	O
is	O
not	O
known	O
whether	O
the	O
brain	O
can	O
clear	O
pre	O
-	O
existing	O
amyloid	O
deposits	O
once	O
production	O
of	O
A	O
beta	O
has	O
been	O
suppressed	O
.	O

Clearly	O
,	O
the	O
amyloid	O
-	O
lowering	O
approach	O
should	O
be	O
rigorously	O
examined	O
in	O
animal	O
models	O
before	O
these	O
reagents	O
are	O
tested	O
in	O
patients	O
.	O

However	O
,	O
the	O
chemical	O
secretase	O
inhibitors	O
most	O
likely	O
to	O
reach	O
human	O
trials	O
are	O
still	O
in	O
development	O
.	O

Therefore	O
,	O
we	O
developed	O
a	O
mouse	O
model	O
of	O
Alzheimer	O
-	O
type	O
amyloid	O
that	O
expresses	O
a	O
controllable	O
APP	O
transgene	O
.	O

This	O
system	O
,	O
commonly	O
known	O
as	O
the	O
tet	O
-	O
off	O
system	O
,	O
can	O
be	O
regulated	O
by	O
analogs	O
of	O
tetracycline	O
administered	O
in	O
food	O
or	O
water	O
[	O
12	O
,	O
13	O
]	O
.	O

The	O
strong	O
expression	O
levels	O
produced	O
with	O
the	O
tet	O
-	O
off	O
vectors	O
,	O
combined	O
with	O
the	O
ability	O
to	O
reduce	O
this	O
expression	O
by	O
several	O
orders	O
of	O
magnitude	O
with	O
tetracycline	O
[	O
14	O
]	O
,	O
allowed	O
for	O
a	O
stringent	O
test	O
of	O
how	O
a	O
highly	O
effective	O
pharmaceutical	O
inhibitor	O
of	O
A	O
beta	O
production	O
would	O
impact	O
the	O
progression	O
of	O
amyloid	O
pathology	O
and	O
whether	O
reversal	O
of	O
these	O
lesions	O
might	O
be	O
possible	O
following	O
such	O
treatment	O
.	O

Methods	O

Transgene	O
Construction	O

We	O
created	O
a	O
tetracycline	O
-	O
responsive	O
chimeric	O
mouse	O
/	O
human	O
APP695Swedish	O
/	O
Indiana	O
(	O
swe	O
/	O
ind	O
)	O
vector	O
by	O
replacing	O
the	O
promoter	O
region	O
of	O
the	O
moPrP	O
.	O
XhoI	O
vector	O
(	O
also	O
known	O
as	O
pPrPpE1	O
/	O
E2	O
,	O
3sal	O
[	O
15	O
]	O
)	O
with	O
the	O
tetracycline	O
-	O
responsive	O
promoter	O
of	O
pTetSplice	O
(	O
Life	O
Technologies	O
,	O
Rockville	O
,	O
Maryland	O
,	O
United	O
States	O
)	O
,	O
and	O
then	O
ligating	O
mouse	O
APP	O
with	O
a	O
humanized	O
A	O
beta	O
domain	O
(	O
mo	O
/	O
huAPP695	O
)	O
cDNA	O
into	O
the	O
new	O
vector	O
.	O

We	O
began	O
by	O
cloning	O
the	O
tetracycline	O
-	O
responsive	O
promoter	O
(	O
bp	O
6	O
-	O
481	O
)	O
from	O
pTetSplice	O
by	O
PCR	O
using	O
primers	O
that	O
added	O
external	O
BamHI	O
and	O
NotI	O
sites	O
to	O
the	O
5	O
'	O
end	O
and	O
a	O
BamHI	O
site	O
to	O
the	O
3	O
'	O
end	O
,	O
while	O
destroying	O
XhoI	O
and	O
BamHI	O
sites	O
within	O
the	O
promoter	O
(	O
forward	O
:	O
GCC	O
GGA	O
TCC	O
GCG	O
GCC	O
GCC	O
GTC	O
GAG	O
TTT	O
ACC	O
ACT	O
CCC	O
TAT	O
C	O
;	O
reverse	O
:	O
GCC	O
GGA	O
TCC	O
ACT	O
CTA	O
GAA	O
GAT	O
CCC	O
CGG	O
GTA	O
CCG	O
)	O
.	O

We	O
then	O
isolated	O
the	O
moPrP	O
.	O
XhoI	O
intron	O
by	O
amplification	O
with	O
primers	O
that	O
added	O
an	O
external	O
BamHI	O
site	O
to	O
the	O
5	O
'	O
end	O
of	O
exon	O
1	O
and	O
ran	O
through	O
the	O
Asp718	O
site	O
of	O
exon	O
2	O
(	O
forward	O
:	O
GCC	O
GGA	O
TCC	O
GAT	O
CAG	O
CAG	O
ACC	O
GAT	O
TCT	O
GG	O
;	O
reverse	O
:	O
GCC	O
GGT	O
ACC	O
ACT	O
AGG	O
AAG	O
GCA	O
GAA	O
TGC	O
)	O
.	O

This	O
2	O
-	O
kb	O
intron	O
fragment	O
was	O
cloned	O
into	O
a	O
TA	O
cloning	O
vector	O
(	O
Invitrogen	O
,	O
Carlsbad	O
,	O
California	O
,	O
United	O
States	O
)	O
,	O
then	O
excised	O
by	O
Asp718	O
digestion	O
and	O
ligated	O
to	O
the	O
6	O
.	O
8	O
-	O
kb	O
Asp718	O
fragment	O
of	O
moPrP	O
.	O
XhoI	O
containing	O
exon	O
2	O
,	O
exon	O
3	O
,	O
the	O
3	O
'	O
UTR	O
,	O
and	O
pBluescript	O
to	O
generate	O
an	O
intermediate	O
vector	O
with	O
all	O
three	O
exons	O
and	O
a	O
central	O
intron	O
but	O
no	O
promoter	O
.	O

This	O
vector	O
was	O
then	O
opened	O
at	O
the	O
BamHI	O
site	O
introduced	O
by	O
the	O
intron	O
cloning	O
primer	O
,	O
and	O
ligated	O
to	O
the	O
0	O
.	O
5	O
-	O
kb	O
BamHI	O
-	O
cut	O
tetracycline	O
promoter	O
fragment	O
.	O

This	O
ligation	O
generated	O
a	O
9	O
.	O
3	O
-	O
kb	O
vector	O
encoding	O
the	O
tetracycline	O
promoter	O
from	O
pTetSplice	O
with	O
two	O
exons	O
,	O
one	O
intron	O
,	O
and	O
the	O
original	O
3	O
'	O
UTR	O
of	O
the	O
moPrP	O
.	O
XhoI	O
vector	O
,	O
all	O
carried	O
in	O
the	O
pBluescript	O
cloning	O
vector	O
.	O

We	O
incorporated	O
the	O
Swedish	O
(	O
KM570	O
/	O
571NL	O
)	O
and	O
Indiana	O
(	O
V617F	O
)	O
mutations	O
into	O
the	O
mo	O
/	O
huAPP695	O
cDNA	O
(	O
in	O
BS	O
-	O
KS	O
)	O
by	O
PCR	O
using	O
a	O
four	O
-	O
primer	O
strategy	O
:	O
first	O
,	O
two	O
partially	O
overlapping	O
products	O
were	O
generated	O
in	O
separate	O
reactions	O
using	O
primers	O
that	O
encode	O
the	O
desired	O
mutations	O
(	O
Swedish	O
forward	O
:	O
GGA	O
GAT	O
CTC	O
TGA	O
AGT	O
GAA	O
TCT	O
GGA	O
TGC	O
AGA	O
ATT	O
CCG	O
/	O
Indiana	O
reverse	O
:	O
GGG	O
TGA	O
TGA	O
AAA	O
TCA	O
CGG	O
TTG	O
C	O
;	O
Indiana	O
forward	O
:	O
CAA	O
CCG	O
TGA	O
TTT	O
TCA	O
TCA	O
CCC	O
TGG	O
/	O
M13	O
reverse	O
)	O
.	O

The	O
two	O
PCR	O
products	O
were	O
ligated	O
,	O
digested	O
with	O
BglII	O
and	O
ApaI	O
and	O
cloned	O
back	O
into	O
the	O
original	O
mo	O
/	O
huAPP695	O
-	O
BS	O
-	O
KS	O
vector	O
.	O

Finally	O
,	O
the	O
new	O
APP695swe	O
/	O
ind	O
was	O
subcloned	O
into	O
the	O
XhoI	O
site	O
of	O
the	O
moPrP	O
-	O
tetP	O
vector	O
from	O
above	O
to	O
complete	O
the	O
construct	O
.	O

Pronuclear	S-GO
Injection	O
,	O
Screening	O
of	O
Founders	O
,	O
and	O
Maintenance	O
of	O
the	O
Lines	O

The	O
moPrP	O
-	O
tetP	O
-	O
mo	O
/	O
huAPP695swe	O
/	O
ind	O
vector	O
was	O
linearized	O
and	O
the	O
pBluescript	O
domain	O
excised	O
by	O
digestion	O
with	O
NotI	O
.	O

The	O
purified	O
vector	O
was	O
injected	O
into	O
the	O
pronucleus	S-GO
of	O
fertilized	O
eggs	O
from	O
C57BL	O
/	O
6J	O
x	O
C3HeJ	O
F1	O
matings	O
.	O

Founder	O
animals	O
were	O
screened	O
for	O
the	O
presence	O
of	O
the	O
transgene	O
by	O
three	O
-	O
way	O
PCR	O
using	O
the	O
S36	O
and	O
PrP	O
-	O
S	O
/	O
PrP	O
-	O
AS	O
primers	O
described	O
below	O
.	O

Transgene	O
-	O
positive	O
founders	O
were	O
bred	O
to	O
animals	O
expressing	O
the	O
tetracycline	O
transactivator	O
(	O
tTA	O
)	O
under	O
control	O
of	O
the	O
calcium	O
-	O
calmodulin	O
kinase	O
II	O
alpha	O
(	O
CaMKII	O
alpha	O
)	O
promoter	O
obtained	O
from	O
Jackson	O
Laboratory	O
[	O
16	O
]	O
(	O
Bar	O
Harbor	O
,	O
Maine	O
,	O
United	O
States	O
;	O
stock	O
#	O
3010	O
;	O
B6	O
;	O
CBA	O
-	O
TgN	O
[	O
Camk2a	O
-	O
tTA	O
]	O
1Mmay	O
)	O
.	O

The	O
colony	O
was	O
thereafter	O
maintained	O
by	O
crossing	O
single	O
transgenic	O
tTA	O
and	O
APP	O
offspring	O
for	O
each	O
of	O
the	O
four	O
APP	O
lines	O
.	O

All	O
mice	O
were	O
provided	O
fresh	O
food	O
and	O
water	O
ad	O
libitum	O
.	O

Animal	O
protocols	O
were	O
approved	O
by	O
both	O
the	O
Johns	O
Hopkins	O
University	O
and	O
the	O
California	O
Institute	O
of	O
Technology	O
Institutional	O
Animal	O
Care	O
and	O
Use	O
Committees	O
.	O

Doxycycline	O
Administration	O

Doxycycline	O
(	O
dox	O
)	O
was	O
administered	O
through	O
commercially	O
available	O
dox	O
-	O
containing	O
chow	O
(	O
BioServ	O
,	O
Frenchtown	O
,	O
New	O
Jersey	O
,	O
United	O
States	O
)	O
.	O

The	O
chow	O
contained	O
200	O
mg	O
/	O
kg	O
of	O
antibiotic	O
;	O
based	O
on	O
estimated	O
consumption	O
of	O
5	O
g	O
per	O
mouse	O
per	O
day	O
,	O
the	O
expected	O
dose	O
to	O
each	O
animal	O
was	O
1	O
mg	O
dox	O
per	O
day	O
.	O

The	O
average	O
25	O
-	O
g	O
animal	O
therefore	O
received	O
40	O
mu	O
g	O
of	O
dox	O
per	O
gram	O
body	O
weight	O
per	O
day	O
.	O

Chow	O
was	O
changed	O
1	O
-	O
2	O
times	O
per	O
week	O
to	O
prevent	O
breakdown	O
of	O
the	O
antibiotic	O
.	O

Genotyping	O

Offspring	O
were	O
genotyped	O
for	O
the	O
presence	O
of	O
each	O
transgene	O
by	O
PCR	O
amplification	O
of	O
genomic	O
DNA	O
extracted	O
from	O
a	O
5	O
-	O
mm	O
tail	O
biopsy	O
.	O

Tails	O
were	O
heated	O
to	O
95	O
degrees	O
C	O
for	O
45	O
min	O
in	O
250	O
mu	O
l	O
of	O
50	O
mM	O
NaOH	O
,	O
vortexed	O
,	O
then	O
neutralized	O
with	O
an	O
equal	O
volume	O
of	O
0	O
.	O
5	O
M	O
Tris	O
-	O
HCl	O
(	O
pH	O
5	O
.	O
5	O
)	O
.	O

Debris	O
was	O
sedimented	O
by	O
centrifugation	O
,	O
and	O
3	O
mu	O
l	O
of	O
supernatant	O
was	O
used	O
for	O
amplification	O
.	O

Genotyping	O
for	O
APP	O
and	O
tTA	O
transgenes	O
was	O
performed	O
in	O
the	O
same	O
PCR	O
reaction	O
,	O
using	O
five	O
separate	O
primers	O
.	O

APP	O
was	O
amplified	O
using	O
forward	O
primer	O
S36	O
located	O
in	O
the	O
3	O
'	O
end	O
of	O
the	O
APP	O
cDNA	O
(	O
CCG	O
AGA	O
TCT	O
CTG	O
AAG	O
TGA	O
AGA	O
TGG	O
ATG	O
)	O
and	O
reverse	O
primer	O
PrP	O
-	O
AS	O
-	O
J	O
located	O
in	O
the	O
3	O
'	O
UTR	O
of	O
the	O
vector	O
(	O
CCA	O
AGC	O
CTA	O
GAC	O
CAC	O
GAG	O
AAT	O
GC	O
)	O
.	O

The	O
tTA	O
transgene	O
was	O
detected	O
using	O
a	O
primer	O
set	O
that	O
amplified	O
across	O
its	O
two	O
subdomains	O
with	O
tet	O
forward	O
located	O
within	O
the	O
Tn10	O
tetracycline	O
repressor	O
(	O
CGC	O
TGT	O
GGG	O
GCA	O
TTT	O
TAC	O
TTT	O
AG	O
)	O
and	O
tet	O
reverse	O
within	O
the	O
HSV1	O
VP16	O
(	O
CAT	O
GTC	O
CAG	O
ATC	O
GAA	O
ATC	O
GTC	O
)	O
.	O

All	O
reactions	O
,	O
whether	O
transgene	O
-	O
positive	O
or	O
not	O
,	O
amplified	O
a	O
segment	O
of	O
the	O
endogenous	O
prion	O
protein	O
gene	O
as	O
a	O
control	O
for	O
DNA	O
quality	O
using	O
a	O
forward	O
primer	O
,	O
PrP	O
-	O
S	O
-	O
J	O
,	O
specific	O
to	O
the	O
mouse	O
PrP	O
open	O
reading	O
frame	O
(	O
GGG	O
ACT	O
ATG	O
TGG	O
ACT	O
GAT	O
GTC	O
GG	O
)	O
and	O
a	O
reverse	O
primer	O
,	O
PrP	O
-	O
AS	O
-	O
J	O
,	O
shared	O
by	O
the	O
3	O
'	O
UTR	O
of	O
the	O
endogenous	O
PrP	O
gene	O
and	O
the	O
transgene	O
vector	O
.	O

Amplification	O
reactions	O
were	O
run	O
for	O
37	O
cycles	O
at	O
94	O
degrees	O
C	O
for	O
30	O
s	O
,	O
64	O
degrees	O
C	O
for	O
1	O
min	O
,	O
and	O
72	O
degrees	O
C	O
for	O
1	O
min	O
.	O

All	O
samples	O
,	O
transgenic	O
and	O
wild	O
-	O
type	O
,	O
gave	O
a	O
750	O
-	O
bp	O
product	O
from	O
the	O
endogenous	O
PrP	O
gene	O
.	O

The	O
APP	O
transgene	O
yielded	O
an	O
additional	O
band	O
at	O
400	O
bp	O
;	O
the	O
tTA	O
product	O
fell	O
in	O
between	O
at	O
480	O
bp	O
.	O

Immunoblotting	O
/	O
Quantitation	O

Frozen	O
cortical	O
or	O
whole	O
forebrain	O
tissue	O
was	O
homogenized	O
by	O
sonication	O
in	O
five	O
volumes	O
of	O
phosphate	O
-	O
buffered	O
saline	O
(	O
PBS	O
)	O
with	O
5	O
mM	O
EDTA	O
and	O
protease	O
inhibitors	O
(	O
Mammalian	O
cell	O
cocktail	O
,	O
Sigma	O
,	O
St	O
.	O
Louis	O
,	O
Missouri	O
,	O
United	O
States	O
)	O
,	O
using	O
a	O
probe	O
sonicator	O
set	O
to	O
50	O
%	O
output	O
(	O
TEKMAR	O
,	O
Cincinnati	O
,	O
Ohio	O
,	O
United	O
States	O
)	O
.	O

After	O
dilution	O
with	O
an	O
equal	O
volume	O
of	O
PBS	O
/	O
EDTA	O
/	O
protease	O
inhibitor	O
,	O
the	O
samples	O
were	O
centrifuged	O
briefly	O
and	O
the	O
supernatant	O
used	O
for	O
analysis	O
.	O

Fifty	O
micrograms	O
(	O
6E10	O
and	O
CT15	O
)	O
or	O
5	O
mu	O
g	O
(	O
22C11	O
)	O
of	O
brain	O
homogenate	O
was	O
loaded	O
per	O
lane	O
onto	O
7	O
.	O
5	O
%	O
,	O
10	O
%	O
-	O
20	O
%	O
,	O
or	O
4	O
%	O
-	O
20	O
%	O
Tris	O
-	O
HCl	O
PAGE	O
gels	O
(	O
Bio	O
-	O
Rad	O
Laboratories	O
,	O
Hercules	O
,	O
California	O
,	O
United	O
States	O
)	O
and	O
electrophoresed	O
for	O
several	O
hours	O
in	O
1	O
x	O
Tris	O
-	O
glycine	O
-	O
sodium	O
dodecyl	O
sulfate	O
(	O
1	O
x	O
TG	O
-	O
SDS	O
)	O
buffer	O
(	O
6E10	O
and	O
22C11	O
;	O
Amresco	O
,	O
Solon	O
,	O
Ohio	O
,	O
United	O
States	O
)	O
or	O
1	O
x	O
Tris	O
-	O
tricine	O
-	O
SDS	O
buffer	O
(	O
CT15	O
;	O
Invitrogen	O
,	O
Carlsbad	O
,	O
California	O
,	O
United	O
States	O
)	O
.	O

Proteins	O
were	O
transferred	O
overnight	O
to	O
0	O
.	O
45	O
-	O
mu	O
m	O
Optitran	O
nitrocellulose	O
(	O
Schleicher	O
and	O
Schuell	O
,	O
Keene	O
,	O
New	O
Hampshire	O
,	O
United	O
States	O
)	O
in	O
1	O
x	O
TG	O
buffer	O
(	O
Amresco	O
)	O
.	O

Blots	O
were	O
blocked	O
in	O
PBS	O
containing	O
5	O
%	O
nonfat	O
dry	O
milk	O
powder	O
,	O
and	O
incubated	O
for	O
3	O
h	O
at	O
room	O
temperature	O
in	O
blocking	O
solution	O
with	O
one	O
of	O
the	O
following	O
antibodies	S-GO
:	O
mouse	O
monoclonal	O
22C11	O
(	O
kind	O
gift	O
of	O
Konrad	O
Beyreuther	O
and	O
Andreas	O
Weidemann	O
;	O
[	O
17	O
]	O
)	O
diluted	O
1	O
:	O
1	O
,	O
000	O
,	O
mouse	O
monoclonal	O
6E10	O
(	O
Signet	O
Laboratories	O
,	O
Dedham	O
,	O
Massachusetts	O
,	O
United	O
States	O
)	O
diluted	O
1	O
:	O
2	O
,	O
500	O
,	O
rabbit	O
polyclonal	O
anti	O
-	O
superoxide	O
dismutase	O
1	O
(	O
m	O
/	O
hSOD1	O
)	O
[	O
18	O
]	O
diluted	O
1	O
:	O
2	O
,	O
500	O
to	O
1	O
:	O
4	O
,	O
000	O
,	O
or	O
rabbit	O
polyclonal	O
CT15	O
(	O
kind	O
gift	O
of	O
Ed	O
Koo	O
;	O
[	O
19	O
]	O
)	O
diluted	O
1	O
:	O
1	O
,	O
000	O
.	O

Subsequently	O
,	O
the	O
blots	O
were	O
washed	O
with	O
PBS	O
containing	O
0	O
.	O
1	O
%	O
Tween	O
-	O
20	O
,	O
and	O
then	O
incubated	O
with	O
either	O
goat	O
anti	O
-	O
mouse	O
-	O
or	O
goat	O
anti	O
-	O
rabbit	O
-	O
HRP	O
conjugated	O
secondary	O
antibody	S-GO
diluted	O
1	O
:	O
1	O
,	O
000	O
in	O
blocking	O
solution	O
.	O

After	O
several	O
additional	O
rinses	O
in	O
PBS	O
with	O
0	O
.	O
1	O
%	O
Tween	O
-	O
20	O
,	O
blots	O
were	O
developed	O
with	O
enhanced	O
chemiluminescence	O
reagent	O
and	O
imaged	O
with	O
the	O
Bio	O
-	O
Rad	O
Molecular	O
Imager	O
FX	O
system	O
.	O

Staining	O
intensity	O
within	O
each	O
lane	O
was	O
quantified	O
using	O
the	O
Quantity	O
One	O
image	O
analysis	O
software	O
(	O
Molecular	O
Imager	O
FX	O
,	O
Bio	O
-	O
Rad	O
Laboratories	O
)	O
.	O

Background	O
was	O
calculated	O
from	O
across	O
the	O
image	O
and	O
subtracted	O
from	O
the	O
entire	O
file	O
.	O

The	O
signal	O
intensity	O
for	O
each	O
band	O
(	O
corrected	O
signal	O
intensity	O
x	O
pixel	O
number	O
)	O
was	O
then	O
calculated	O
using	O
the	O
Volume	O
report	O
tool	O
.	O

Slot	O
Blot	O
mRNA	O
Analysis	O

Five	O
micrograms	O
per	O
sample	O
of	O
total	O
RNA	O
extracted	O
from	O
fresh	O
-	O
frozen	O
brain	O
,	O
liver	O
,	O
kidney	O
,	O
heart	O
,	O
lung	O
,	O
spleen	O
,	O
and	O
skeletal	O
muscle	O
was	O
vacuum	O
-	O
filtered	O
through	O
0	O
.	O
45	O
-	O
mu	O
m	O
Optitran	O
nitrocellulose	O
.	O

After	O
several	O
washes	O
through	O
the	O
manifold	O
with	O
10	O
x	O
SSC	O
,	O
blots	O
were	O
UV	O
-	O
cross	O
-	O
linked	O
and	O
probed	O
with	O
a	O
radiolabeled	O
~	O
350	O
-	O
bp	O
BglII	O
-	O
XhoI	O
cDNA	O
fragment	O
of	O
mo	O
/	O
huAPP695	O
cDNA	O
.	O

After	O
hybridizing	O
overnight	O
at	O
65	O
degrees	O
C	O
in	O
1	O
%	O
BSA	O
/	O
1	O
mM	O
EDTA	O
/	O
0	O
.	O
5	O
M	O
sodium	O
phosphate	O
buffer	O
(	O
pH	O
7	O
.	O
2	O
)	O
/	O
7	O
%	O
SDS	O
[	O
20	O
]	O
,	O
the	O
blots	O
were	O
washed	O
twice	O
at	O
65	O
degrees	O
C	O
for	O
30	O
min	O
each	O
in	O
0	O
.	O
1	O
%	O
BSA	O
/	O
1	O
mM	O
EDTA	O
/	O
40	O
mM	O
sodium	O
phosphate	O
buffer	O
(	O
pH	O
7	O
.	O
2	O
)	O
/	O
5	O
%	O
SDS	O
before	O
two	O
final	O
30	O
-	O
min	O
washes	O
at	O
65	O
degrees	O
C	O
with	O
1	O
mM	O
EDTA	O
/	O
40	O
mM	O
sodium	O
phosphate	O
buffer	O
(	O
pH	O
7	O
.	O
2	O
)	O
/	O
1	O
%	O
SDS	O
.	O

Blots	O
were	O
wrapped	O
wet	O
and	O
exposed	O
to	O
phosphorscreens	O
overnight	O
at	O
room	O
temperature	O
.	O

Amyloid	O
Histology	O

Mice	O
were	O
euthanized	O
by	O
ether	O
inhalation	O
and	O
brains	O
removed	O
for	O
immersion	O
fixation	O
in	O
4	O
%	O
paraformaldehyde	O
/	O
1	O
x	O
PBS	O
.	O

After	O
48	O
h	O
in	O
fixative	O
at	O
4	O
degrees	O
C	O
,	O
brains	O
were	O
transferred	O
to	O
PBS	O
,	O
dehydrated	O
in	O
alcohols	O
,	O
treated	O
with	O
cedarwood	O
oil	O
and	O
methylsalicylate	O
,	O
and	O
embedded	O
in	O
paraffin	O
for	O
sectioning	O
.	O

Hirano	O
silver	O
stain	O

Silver	O
impregnation	O
histology	O
was	O
performed	O
on	O
10	O
-	O
mu	O
m	O
paraffin	O
-	O
embedded	O
sections	O
by	O
Hirano	O
'	O
s	O
modification	O
of	O
the	O
Bielschowsky	O
method	O
[	O
21	O
]	O
.	O

Briefly	O
,	O
sections	O
were	O
deparaffinized	O
through	O
xylene	O
and	O
alcohols	O
into	O
tap	O
water	O
before	O
being	O
placed	O
into	O
fresh	O
20	O
%	O
silver	O
nitrate	O
solution	O
for	O
20	O
min	O
.	O

After	O
being	O
washed	O
thoroughly	O
with	O
distilled	O
water	O
,	O
slides	O
were	O
immersed	O
in	O
20	O
%	O
silver	O
nitrate	O
solution	O
titrated	O
with	O
fresh	O
ammonium	O
hydroxide	O
.	O

After	O
20	O
min	O
,	O
slides	O
were	O
washed	O
with	O
ammonia	O
water	O
before	O
being	O
individually	O
developed	O
with	O
100	O
mu	O
l	O
of	O
developer	O
(	O
20	O
ml	O
of	O
37	O
%	O
formaldehyde	O
,	O
100	O
ml	O
of	O
distilled	O
water	O
,	O
50	O
mu	O
l	O
of	O
concentrated	O
nitric	O
acid	O
,	O
and	O
0	O
.	O
5	O
g	O
of	O
citric	O
acid	O
)	O
added	O
to	O
50	O
ml	O
of	O
titrated	O
silver	O
nitrate	O
solution	O
.	O

Slides	O
were	O
then	O
rinsed	O
in	O
tap	O
water	O
,	O
fixed	O
in	O
5	O
%	O
sodium	O
thiosulfate	O
,	O
and	O
dehydrated	O
through	O
alcohols	O
and	O
xylene	O
.	O

Thioflavin	O
-	O
S	O
staining	O

Following	O
deparaffinization	O
of	O
sections	O
through	O
xylene	O
and	O
alcohols	O
,	O
amyloid	O
impregnation	O
with	O
thioflavin	O
-	O
S	O
was	O
performed	O
according	O
to	O
the	O
Guntern	O
modification	O
of	O
the	O
standard	O
protocol	O
.	O

Slides	O
holding	O
10	O
-	O
mu	O
m	O
paraffin	O
sections	O
were	O
washed	O
twice	O
in	O
distilled	O
water	O
,	O
then	O
immersed	O
for	O
5	O
min	O
in	O
a	O
0	O
.	O
25	O
%	O
potassium	O
permanganate	O
solution	O
,	O
followed	O
by	O
5	O
min	O
in	O
a	O
1	O
%	O
potassium	O
metabisulfate	O
/	O
1	O
%	O
oxalic	O
acid	O
solution	O
.	O

After	O
this	O
preparation	O
,	O
slides	O
were	O
placed	O
into	O
a	O
filtered	O
aqueous	O
0	O
.	O
02	O
%	O
thioflavin	O
-	O
S	O
solution	O
(	O
Chroma	O
-	O
Gesellschaft	O
Schmid	O
,	O
Kongen	O
,	O
Germany	O
)	O
for	O
8	O
min	O
.	O

Excess	O
stain	O
was	O
removed	O
by	O
two	O
brief	O
rinses	O
in	O
80	O
%	O
ethanol	O
,	O
then	O
two	O
in	O
distilled	O
water	O
,	O
after	O
which	O
slides	O
were	O
finished	O
in	O
aqueous	O
mounting	O
medium	O
for	O
florescence	O
photomicrography	O
.	O

Ubiquitin	O
,	O
glial	O
fibrillary	O
acidic	O
protein	O
,	O
and	O
A	O
beta	O
immunohistochemistry	O

Prior	O
to	O
immunostaining	O
,	O
slides	O
were	O
deparaffinized	O
by	O
oven	O
heating	O
followed	O
by	O
immersion	O
in	O
xylene	O
.	O

After	O
rehydration	O
through	O
graded	O
alcohols	O
into	O
tap	O
water	O
,	O
endogenous	O
peroxidase	O
activity	O
was	O
quenched	O
by	O
incubation	O
with	O
3	O
%	O
hydrogen	O
peroxide	O
in	O
methanol	O
.	O

Slides	O
were	O
microwaved	O
for	O
5	O
-	O
7	O
min	O
in	O
water	O
,	O
cooled	O
for	O
5	O
min	O
,	O
then	O
washed	O
in	O
TBS	O
.	O

Nonspecific	O
staining	O
was	O
blocked	O
for	O
1	O
h	O
with	O
3	O
%	O
normal	O
goat	O
serum	O
and	O
0	O
.	O
1	O
%	O
Triton	O
-	O
X	O
100	O
in	O
TBS	O
.	O

Slides	O
were	O
then	O
placed	O
into	O
primary	O
antibody	S-GO
(	O
rabbit	O
anti	O
-	O
A	O
beta	O
peptide	O
polyclonal	O
antibody	S-GO
,	O
Zymed	O
Laboratories	O
,	O
South	O
San	O
Francisco	O
,	O
California	O
,	O
United	O
States	O
;	O
rabbit	O
anti	O
-	O
ubiquitin	O
and	O
rabbit	O
anti	O
-	O
glial	O
fibrillary	O
acidic	O
protein	O
(	O
GFAP	O
)	O
polyclonal	O
antibodies	S-GO
,	O
Dako	O
,	O
Carpinteria	O
,	O
California	O
,	O
United	O
States	O
)	O
diluted	O
1	O
:	O
500	O
in	O
TBS	O
with	O
2	O
%	O
normal	O
goat	O
serum	O
and	O
incubated	O
overnight	O
at	O
room	O
temperature	O
.	O

After	O
being	O
washed	O
of	O
excess	O
primary	O
antibody	S-GO
with	O
several	O
changes	O
of	O
TBS	O
,	O
slides	O
were	O
incubated	O
with	O
either	O
the	O
Vectastain	O
Elite	O
anti	O
-	O
rabbit	O
secondary	O
system	O
(	O
anti	O
-	O
A	O
beta	O
;	O
Vector	O
Laboratories	O
,	O
Burlingame	O
,	O
California	O
,	O
United	O
States	O
)	O
or	O
peroxidase	O
/	O
anti	O
-	O
peroxidase	O
reagents	O
(	O
anti	O
-	O
ubitquitin	O
and	O
anti	O
-	O
GFAP	O
;	O
Sternberger	O
Monoclonals	O
,	O
Lutherville	O
,	O
Maryland	O
,	O
United	O
States	O
)	O
according	O
to	O
the	O
manufacturers	O
'	O
directions	O
.	O

Antibody	S-GO
binding	O
was	O
visualized	O
with	O
diaminobenzidene	O
,	O
and	O
sections	O
were	O
counterstained	O
with	O
hematoxylin	O
.	O

Filter	O
Trap	O
Assay	O

An	O
aliquot	O
of	O
each	O
cortical	O
homogenate	O
used	O
for	O
Western	O
blotting	O
above	O
was	O
partially	O
solubilized	O
by	O
the	O
addition	O
of	O
SDS	O
to	O
a	O
final	O
concentration	O
of	O
1	O
%	O
.	O

Serial	O
1	O
:	O
2	O
dilutions	O
were	O
made	O
with	O
1	O
x	O
PBS	O
/	O
1	O
%	O
SDS	O
,	O
and	O
100	O
mu	O
l	O
of	O
each	O
dilution	O
was	O
then	O
vacuum	O
-	O
filtered	O
through	O
a	O
pre	O
-	O
wet	O
0	O
.	O
22	O
-	O
mu	O
m	O
cellulose	O
acetate	O
membrane	O
(	O
Schleicher	O
and	O
Schuell	O
)	O
[	O
22	O
]	O
.	O

Each	O
well	O
was	O
washed	O
several	O
times	O
with	O
PBS	O
,	O
after	O
which	O
blots	O
were	O
incubated	O
overnight	O
with	O
polyclonal	O
anti	O
-	O
A	O
beta	O
antibody	S-GO
(	O
Zymed	O
Laboratories	O
)	O
diluted	O
1	O
:	O
600	O
in	O
a	O
blocking	O
solution	O
of	O
1	O
x	O
TBS	O
/	O
5	O
%	O
nonfat	O
dry	O
milk	O
powder	O
.	O

After	O
washing	O
the	O
blots	O
three	O
times	O
for	O
10	O
min	O
each	O
in	O
1	O
x	O
TBS	O
/	O
0	O
.	O
1	O
%	O
Tween	O
-	O
20	O
,	O
the	O
membrane	O
was	O
incubated	O
for	O
1	O
h	O
with	O
HRP	O
-	O
conjugated	O
protein	O
A	O
(	O
Sigma	O
)	O
diluted	O
1	O
:	O
5	O
,	O
000	O
in	O
blocking	O
solution	O
.	O

The	O
membranes	O
were	O
again	O
washed	O
three	O
times	O
with	O
1	O
x	O
TBS	O
/	O
0	O
.	O
1	O
%	O
Tween	O
-	O
20	O
,	O
before	O
antibody	S-GO
binding	O
was	O
detected	O
with	O
enhanced	O
chemiluminescence	O
(	O
PerkinElmer	O
,	O
Boston	O
,	O
Massachusetts	O
,	O
United	O
States	O
)	O
.	O

Digital	O
images	O
of	O
each	O
blot	O
were	O
captured	O
with	O
a	O
Molecular	O
Imager	O
FX	O
gel	O
documentation	O
system	O
,	O
and	O
the	O
intensity	O
of	O
A	O
beta	O
staining	O
was	O
quantified	O
using	O
Quantity	O
One	O
image	O
analysis	O
software	O
.	O

A	O
beta	O
ELISA	O

An	O
aliquot	O
of	O
cortical	O
homogenate	O
generated	O
for	O
Western	O
analysis	O
described	O
above	O
was	O
subjected	O
to	O
a	O
three	O
-	O
step	O
sequential	O
extraction	O
using	O
PBS	O
,	O
2	O
%	O
SDS	O
,	O
and	O
70	O
%	O
formic	O
acid	O
(	O
FA	O
)	O
.	O

At	O
each	O
step	O
,	O
the	O
sample	O
was	O
sonicated	O
in	O
appropriate	O
buffer	O
and	O
centrifuged	O
at	O
100	O
,	O
000g	O
for	O
30	O
min	O
(	O
1	O
-	O
to	O
1	O
.	O
5	O
-	O
mo	O
samples	O
)	O
or	O
60	O
min	O
(	O
6	O
-	O
to	O
12	O
-	O
mo	O
samples	O
)	O
at	O
4	O
degrees	O
C	O
as	O
previously	O
described	O
[	O
23	O
-	O
25	O
]	O
.	O

The	O
supernatant	O
was	O
removed	O
for	O
analysis	O
,	O
and	O
the	O
pellet	O
was	O
sonicated	O
in	O
the	O
next	O
solution	O
in	O
sequence	O
.	O

The	O
2	O
%	O
SDS	O
extracts	O
were	O
diluted	O
in	O
EC	O
buffer	O
,	O
and	O
the	O
FA	O
extracts	O
neutralized	O
with	O
1M	O
Tris	O
-	O
phosphate	O
buffer	O
(	O
pH	O
11	O
)	O
then	O
diluted	O
with	O
EC	O
buffer	O
prior	O
to	O
testing	O
.	O

Human	O
A	O
beta	O
was	O
measured	O
in	O
each	O
fraction	O
using	O
BAN50	O
for	O
capture	O
(	O
epitope	O
A	O
beta	O
1	O
-	O
16	O
)	O
and	O
BA27	O
and	O
BC05	O
for	O
detection	O
(	O
A	O
beta	O
40	O
and	O
A	O
beta	O
42	O
,	O
respectively	O
)	O
(	O
Takeda	O
Chemical	O
Industries	O
,	O
Osaka	O
,	O
Japan	O
)	O
.	O

Total	O
A	O
beta	O
(	O
mouse	O
+	O
human	O
;	O
1	O
-	O
to	O
1	O
.	O
5	O
-	O
mo	O
samples	O
only	O
)	O
was	O
measured	O
in	O
each	O
fraction	O
using	O
BNT77	O
for	O
capture	O
(	O
epitope	O
A	O
beta	O
11	O
-	O
28	O
)	O
and	O
BA27	O
and	O
BC05	O
for	O
detection	O
.	O

All	O
values	O
were	O
calculated	O
as	O
picomoles	O
per	O
gram	O
based	O
on	O
the	O
initial	O
weight	O
of	O
cortical	O
tissue	O
.	O

Activity	O
Monitoring	O

Daily	O
basal	O
activity	O
was	O
studied	O
in	O
28	O
CaMKII	O
alpha	O
-	O
tTA	O
x	O
tet	O
-	O
APPswe	O
/	O
ind	O
line	O
107	O
mice	O
between	O
4	O
and	O
5	O
mo	O
of	O
age	O
.	O

Animals	O
were	O
separated	O
into	O
individual	O
cages	O
immediately	O
before	O
the	O
start	O
of	O
each	O
experiment	O
(	O
n	O
=	O
3	O
-	O
6	O
per	O
genotype	O
untreated	O
,	O
2	O
-	O
5	O
per	O
genotype	O
dox	O
-	O
reared	O
)	O
.	O

The	O
cages	O
were	O
placed	O
inside	O
activity	O
-	O
monitoring	O
frames	O
designed	O
to	O
count	O
every	O
time	O
the	O
animal	O
passed	O
through	O
one	O
of	O
three	O
photobeams	O
spanning	O
the	O
width	O
of	O
the	O
cage	O
(	O
San	O
Diego	O
Instruments	O
,	O
San	O
Diego	O
,	O
California	O
,	O
United	O
States	O
)	O
.	O

Experiments	O
were	O
started	O
midway	O
through	O
the	O
light	O
phase	O
of	O
the	O
day	O
,	O
and	O
data	O
were	O
collected	O
in	O
1	O
-	O
h	O
bins	O
for	O
the	O
following	O
48	O
h	O
.	O

Testing	O
rooms	O
were	O
maintained	O
on	O
the	O
same	O
13	O
:	O
11	O
h	O
day	O
:	O
night	O
cycle	O
as	O
the	O
main	O
animal	O
housing	O
areas	O
and	O
were	O
closed	O
to	O
entry	O
during	O
the	O
experiment	O
.	O

Statistical	O
Analyses	O

Statistical	O
analyses	O
of	O
protein	O
expression	O
,	O
ELISA	O
data	O
,	O
and	O
filter	O
trap	O
assays	O
were	O
performed	O
by	O
ANOVA	O
with	O
Tukey	O
'	O
s	O
honest	O
significant	O
difference	O
post	O
-	O
hoc	O
test	O
applied	O
to	O
significant	O
main	O
effects	O
or	O
interactions	O
(	O
Statistica	O
6	O
.	O
0	O
,	O
StatSoft	O
,	O
Tulsa	O
,	O
Oklahoma	O
,	O
United	O
States	O
)	O
.	O

In	O
cases	O
of	O
positively	O
skewed	O
data	O
distribution	O
,	O
log10	O
(	O
x	O
+	O
0	O
.	O
5	O
)	O
transformation	O
was	O
applied	O
to	O
the	O
raw	O
data	O
before	O
submitting	O
them	O
to	O
ANOVA	O
.	O

Results	O

We	O
used	O
the	O
tet	O
-	O
off	O
transgene	O
system	O
to	O
express	O
a	O
double	O
mutant	O
version	O
of	O
chimeric	O
mo	O
/	O
huAPP695	O
(	O
swe	O
/	O
ind	O
KM570	O
,	O
571NL	O
,	O
and	O
V617F	O
)	O
from	O
a	O
tetracycline	O
-	O
responsive	O
promoter	O
[	O
12	O
,	O
13	O
]	O
.	O

Transgenic	O
APP	O
expression	O
was	O
activated	O
by	O
crossing	O
the	O
APPswe	O
/	O
ind	O
mice	O
to	O
animals	O
producing	O
tTA	O
under	O
control	O
of	O
the	O
CaMKII	O
alpha	O
promoter	O
[	O
16	O
]	O
.	O

After	O
initial	O
screening	O
of	O
founders	O
,	O
we	O
identified	O
four	O
lines	O
of	O
tet	O
-	O
APPswe	O
/	O
ind	O
mice	O
that	O
produced	O
very	O
high	O
levels	O
of	O
transgene	O
product	O
in	O
offspring	O
coexpressing	O
tTA	O
(	O
Figures	O
1	O
and	O
Figure	O
S1	O
)	O
.	O

Compared	O
to	O
a	O
standard	O
APP	O
transgenic	O
line	O
used	O
for	O
previous	O
amyloid	O
studies	O
by	O
our	O
laboratory	O
(	O
line	O
C3	O
-	O
3	O
;	O
[	O
15	O
,	O
26	O
,	O
27	O
]	O
)	O
,	O
we	O
estimated	O
that	O
the	O
four	O
controllable	O
lines	O
produce	O
transgenic	O
APP	O
protein	O
at	O
10	O
-	O
to	O
30	O
-	O
fold	O
over	O
endogenous	O
levels	O
(	O
Figure	O
S1	O
)	O
.	O

This	O
estimate	O
was	O
confirmed	O
by	O
direct	O
comparison	O
of	O
APP	O
levels	O
in	O
nontransgenic	O
and	O
tet	O
-	O
off	O
APP	O
mice	O
using	O
an	O
antibody	S-GO
that	O
recognizes	O
both	O
endogenous	O
APP	O
(	O
and	O
amyloid	O
precursor	O
-	O
like	O
protein	O
2	O
)	O
and	O
the	O
transgenic	O
protein	O
(	O
monoclonal	O
antibody	S-GO
22C11	O
;	O
Figure	O
1D	O
)	O
.	O

Importantly	O
,	O
all	O
four	O
new	O
lines	O
of	O
tet	O
-	O
off	O
APP	O
mice	O
showed	O
nearly	O
complete	O
suppression	O
of	O
the	O
transgene	O
following	O
dox	O
treatment	O
(	O
Figures	O
1	O
and	O
Figure	O
S1	O
)	O
.	O

We	O
focused	O
on	O
one	O
of	O
the	O
four	O
lines	O
,	O
line	O
107	O
,	O
to	O
examine	O
in	O
more	O
detail	O
the	O
time	O
dependence	O
and	O
extent	O
of	O
transgene	O
suppression	O
following	O
either	O
acute	O
or	O
chronic	O
treatment	O
with	O
dox	O
.	O

Two	O
dox	O
-	O
treated	O
groups	O
were	O
compared	O
to	O
two	O
untreated	O
groups	O
:	O
one	O
group	O
of	O
mice	O
was	O
born	O
and	O
raised	O
on	O
dox	O
,	O
a	O
second	O
group	O
was	O
treated	O
with	O
dox	O
for	O
2	O
wk	O
starting	O
at	O
1	O
mo	O
of	O
age	O
(	O
4	O
wk	O
+	O
2	O
wk	O
dox	O
)	O
;	O
two	O
untreated	O
groups	O
kept	O
on	O
normal	O
chow	O
were	O
harvested	O
at	O
either	O
4	O
or	O
6	O
wk	O
of	O
age	O
.	O

Animals	O
born	O
and	O
raised	O
on	O
dox	O
harbored	O
no	O
transgenic	O
APP	O
(	O
Figure	O
1A	O
)	O
.	O

Following	O
as	O
little	O
as	O
2	O
wk	O
of	O
dox	O
treatment	O
,	O
transgenic	O
APP	O
expression	O
was	O
reduced	O
by	O
more	O
than	O
95	O
%	O
compared	O
to	O
pre	O
-	O
dox	O
levels	O
.	O

The	O
residual	O
expression	O
remaining	O
in	O
acutely	O
treated	O
mice	O
represents	O
less	O
than	O
4	O
%	O
of	O
the	O
transgenic	O
protein	O
produced	O
in	O
the	O
absence	O
of	O
dox	O
(	O
Figure	O
1C	O
)	O
,	O
and	O
likely	O
results	O
from	O
slight	O
leakage	O
at	O
the	O
level	O
of	O
transcription	O
(	O
data	O
not	O
shown	O
)	O
.	O

Importantly	O
,	O
the	O
total	O
amount	O
of	O
APP	O
(	O
endogenous	O
plus	O
transgenic	O
)	O
and	O
related	O
APLPs	O
in	O
both	O
acute	O
and	O
chronically	O
treated	O
animals	O
was	O
statistically	O
indistinguishable	O
from	O
that	O
in	O
nontransgenic	O
mice	O
(	O
Figure	O
1D	O
;	O
statistical	O
analyses	O
for	O
experiments	O
throughout	O
the	O
study	O
are	O
presented	O
in	O
the	O
accompanying	O
figure	O
legends	O
)	O
.	O

To	O
ensure	O
that	O
A	O
beta	O
production	O
was	O
suppressed	O
in	O
concert	O
with	O
the	O
dox	O
-	O
mediated	O
inhibition	O
of	O
its	O
precursor	O
APPswe	O
/	O
ind	O
,	O
we	O
measured	O
A	O
beta	O
40	O
and	O
A	O
beta	O
42	O
levels	O
by	O
ELISA	O
in	O
forebrain	O
homogenates	O
from	O
young	O
tet	O
-	O
off	O
animals	O
.	O

At	O
1	O
mo	O
of	O
age	O
,	O
the	O
mice	O
lacked	O
visible	O
amyloid	O
aggregates	O
that	O
might	O
act	O
as	O
an	O
intractable	O
reservoir	O
of	O
peptide	O
remaining	O
in	O
the	O
brain	O
after	O
the	O
transgene	O
had	O
been	O
suppressed	O
.	O

To	O
further	O
ensure	O
we	O
could	O
detect	O
any	O
such	O
insoluble	O
aggregates	O
that	O
might	O
bias	O
our	O
measure	O
of	O
changes	O
in	O
peptide	O
synthesis	O
,	O
we	O
performed	O
a	O
sequential	O
three	O
-	O
step	O
extraction	O
with	O
PBS	O
,	O
2	O
%	O
SDS	O
,	O
and	O
70	O
%	O
FA	O
that	O
would	O
separate	O
peptides	O
by	O
solubility	O
.	O

We	O
compared	O
the	O
levels	O
of	O
human	O
transgene	O
-	O
derived	O
A	O
beta	O
40	O
and	O
A	O
beta	O
42	O
in	O
untreated	O
mice	O
at	O
4	O
and	O
6	O
wk	O
of	O
age	O
to	O
animals	O
that	O
had	O
either	O
been	O
born	O
and	O
raised	O
on	O
dox	O
or	O
that	O
had	O
been	O
left	O
untreated	O
for	O
4	O
wk	O
and	O
then	O
placed	O
on	O
dox	O
chow	O
for	O
2	O
wk	O
prior	O
to	O
harvest	O
(	O
the	O
same	O
groups	O
described	O
above	O
for	O
immunoblot	O
analysis	O
of	O
APPswe	O
/	O
ind	O
levels	O
,	O
line	O
107	O
)	O
.	O

Consistent	O
with	O
the	O
reduction	O
in	O
full	O
-	O
length	O
APPswe	O
/	O
ind	O
synthesis	O
shown	O
by	O
immunoblot	O
(	O
see	O
Figure	O
1	O
)	O
,	O
we	O
found	O
that	O
transgene	O
-	O
derived	O
A	O
beta	O
levels	O
were	O
completely	O
suppressed	O
in	O
animals	O
born	O
and	O
raised	O
on	O
dox	O
,	O
and	O
were	O
sharply	O
reduced	O
following	O
acute	O
(	O
2	O
wk	O
)	O
antibiotic	O
treatment	O
.	O

Compared	O
to	O
the	O
levels	O
in	O
untreated	O
4	O
-	O
wk	O
-	O
old	O
mice	O
,	O
PBS	O
-	O
soluble	O
A	O
beta	O
42	O
dropped	O
by	O
95	O
.	O
2	O
%	O
following	O
2	O
wk	O
of	O
dox	O
treatment	O
and	O
by	O
99	O
.	O
2	O
%	O
with	O
chronic	O
treatment	O
(	O
Figure	O
2A	O
)	O
.	O

Similarly	O
,	O
SDS	O
-	O
soluble	O
A	O
beta	O
42	O
decreased	O
by	O
75	O
.	O
2	O
%	O
and	O
94	O
.	O
8	O
%	O
following	O
2	O
-	O
wk	O
or	O
lifelong	O
dox	O
treatment	O
(	O
Figure	O
2B	O
)	O
.	O

Only	O
the	O
FA	O
fraction	S-GO
revealed	O
a	O
small	O
dox	O
-	O
resistant	O
pool	O
of	O
peptide	O
in	O
acutely	O
treated	O
animals	O
that	O
we	O
believe	O
represents	O
stable	O
predeposit	O
aggregates	O
that	O
have	O
already	O
accumulated	O
by	O
4	O
wk	O
of	O
age	O
when	O
treatment	O
was	O
begun	O
(	O
Figure	O
2C	O
)	O
.	O

Indeed	O
,	O
animals	O
that	O
were	O
born	O
and	O
raised	O
on	O
dox	O
did	O
not	O
harbor	O
this	O
reservoir	O
of	O
treatment	O
-	O
resistant	O
peptide	O
,	O
with	O
96	O
.	O
3	O
%	O
less	O
A	O
beta	O
42	O
than	O
untreated	O
4	O
-	O
wk	O
-	O
old	O
mice	O
.	O

Measurement	O
of	O
total	O
A	O
beta	O
in	O
chronically	O
treated	O
mice	O
,	O
including	O
endogenous	O
and	O
transgene	O
-	O
derived	O
peptide	O
,	O
demonstrated	O
that	O
A	O
beta	O
levels	O
in	O
tet	O
-	O
off	O
APP	O
mice	O
were	O
reduced	O
to	O
the	O
level	O
of	O
endogenous	O
peptide	O
found	O
in	O
nontransgenic	O
animals	O
(	O
Figure	O
2D	O
)	O
.	O

Taken	O
together	O
with	O
the	O
immunoblotting	O
data	O
for	O
full	O
-	O
length	O
APPswe	O
/	O
ind	O
,	O
the	O
ELISA	O
measurements	O
indicate	O
that	O
dox	O
-	O
mediated	O
suppression	O
of	O
transgenic	O
APPswe	O
/	O
ind	O
synthesis	O
leads	O
to	O
parallel	O
reduction	O
of	O
A	O
beta	O
levels	O
.	O

The	O
ELISA	O
data	O
also	O
confirmed	O
that	O
incorporation	O
of	O
the	O
Swedish	O
and	O
Indiana	O
mutations	O
led	O
to	O
high	O
levels	O
of	O
A	O
beta	O
42	O
,	O
which	O
we	O
predicted	O
would	O
induce	O
rapid	O
plaque	O
formation	O
in	O
untreated	O
animals	O
.	O

Histological	O
characterization	O
of	O
double	O
transgenic	O
(	O
CaMKII	O
alpha	O
-	O
tTA	O
x	O
tet	O
-	O
APPswe	O
/	O
ind	O
)	O
mice	O
revealed	O
early	O
-	O
onset	O
amyloid	O
formation	O
in	O
all	O
four	O
new	O
lines	O
.	O

Amyloid	O
plaques	O
were	O
seen	O
in	O
mice	O
as	O
young	O
as	O
8	O
wk	O
of	O
age	O
(	O
data	O
not	O
shown	O
)	O
.	O

Plaques	O
were	O
limited	O
to	O
the	O
forebrain	O
,	O
including	O
the	O
cortex	O
,	O
hippocampus	O
,	O
olfactory	O
bulb	O
,	O
and	O
striatum	O
,	O
where	O
the	O
CaMKII	O
alpha	O
promoter	O
is	O
known	O
to	O
be	O
most	O
active	O
[	O
16	O
,	O
28	O
]	O
(	O
Figure	O
S2	O
)	O
.	O

By	O
6	O
mo	O
of	O
age	O
,	O
amyloid	O
burden	O
became	O
severe	O
,	O
covering	O
large	O
areas	O
of	O
the	O
cortex	O
and	O
hippocampus	O
(	O
Figure	O
S3	O
)	O
.	O

No	O
lesions	O
were	O
seen	O
in	O
the	O
cerebellum	O
or	O
brain	O
stem	O
even	O
at	O
late	O
ages	O
,	O
consistent	O
with	O
CaMKII	O
alpha	O
-	O
controlled	O
transgene	O
expression	O
.	O

Unlike	O
what	O
is	O
thought	O
to	O
occur	O
in	O
the	O
human	O
disease	O
,	O
the	O
first	O
visible	O
plaques	O
in	O
the	O
tet	O
-	O
off	O
APP	O
mice	O
are	O
fibrillar	O
-	O
cored	O
deposits	O
.	O

We	O
have	O
noted	O
the	O
same	O
early	O
appearance	O
of	O
cored	O
deposits	O
in	O
other	O
lines	O
of	O
APP	O
transgenic	O
mice	O
that	O
harbor	O
the	O
Swedish	O
mutation	O
[	O
27	O
]	O
.	O

Diffuse	O
plaques	O
were	O
apparent	O
in	O
6	O
-	O
mo	O
-	O
old	O
tTA	O
/	O
APP	O
mice	O
,	O
and	O
became	O
relatively	O
abundant	O
by	O
9	O
mo	O
of	O
age	O
.	O

At	O
older	O
ages	O
(	O
9	O
-	O
12	O
mo	O
)	O
amyloid	O
deposits	O
were	O
visible	O
in	O
the	O
thalamus	O
,	O
which	O
has	O
also	O
been	O
observed	O
in	O
mice	O
expressing	O
mutant	O
APP	O
via	O
the	O
Thy	O
-	O
1	O
promoter	O
.	O

The	O
presence	O
of	O
amyloid	O
pathology	O
in	O
this	O
region	O
has	O
been	O
attributed	O
to	O
axonal	S-GO
transport	O
of	O
APP	O
/	O
A	O
beta	O
to	O
the	O
terminals	B-GO
of	I-GO
cortical	I-GO
neurons	E-GO
in	O
the	O
thalamus	O
[	O
29	O
]	O
.	O

Most	O
importantly	O
,	O
only	O
double	O
transgenic	O
mice	O
,	O
expressing	O
both	O
the	O
tTA	O
and	O
APP	O
transgenes	O
,	O
developed	O
amyloid	O
lesions	O
.	O

Single	O
transgenic	O
mice	O
up	O
to	O
15	O
mo	O
of	O
age	O
showed	O
no	O
sign	O
of	O
pathology	O
(	O
Figure	O
S3	O
)	O
.	O

Similarly	O
,	O
amyloid	O
pathology	O
can	O
be	O
completely	O
prevented	O
in	O
double	O
transgenic	O
animals	O
born	O
and	O
raised	O
on	O
dox	O
.	O

Animals	O
from	O
our	O
highest	O
expressing	O
line	O
(	O
line	O
885	O
)	O
maintained	O
on	O
dox	O
for	O
up	O
to	O
1	O
y	O
harbored	O
no	O
amyloid	O
pathology	O
(	O
data	O
not	O
shown	O
)	O
,	O
indicating	O
that	O
residual	O
leakage	O
of	O
transgene	O
expression	O
in	O
the	O
presence	O
of	O
dox	O
does	O
not	O
provide	O
sufficient	O
A	O
beta	O
peptide	O
to	O
induce	O
amyloid	O
formation	O
even	O
over	O
long	O
periods	O
.	O

To	O
mimic	O
therapeutic	O
intervention	O
with	O
inhibitors	O
of	O
A	O
beta	O
production	O
,	O
we	O
raised	O
a	O
group	O
of	O
25	O
double	O
transgenic	O
mice	O
(	O
CaMKII	O
alpha	O
-	O
tTA	O
x	O
APP	O
line	O
107	O
)	O
on	O
normal	O
food	O
until	O
6	O
mo	O
of	O
age	O
,	O
when	O
we	O
knew	O
amyloid	O
formation	O
was	O
already	O
well	O
underway	O
in	O
the	O
brain	O
.	O

At	O
6	O
mo	O
,	O
half	O
of	O
the	O
animals	O
were	O
switched	O
from	O
normal	O
chow	O
to	O
food	O
containing	O
dox	O
at	O
200	O
mg	O
/	O
kg	O
until	O
they	O
were	O
sacrificed	O
at	O
9	O
or	O
12	O
mo	O
of	O
age	O
.	O

The	O
remaining	O
control	O
animals	O
were	O
kept	O
on	O
standard	O
chow	O
(	O
untreated	O
)	O
.	O

In	O
all	O
,	O
four	O
cohorts	O
were	O
created	O
:	O
6	O
mo	O
untreated	O
(	O
n	O
=	O
7	O
)	O
,	O
9	O
mo	O
untreated	O
(	O
n	O
=	O
5	O
)	O
,	O
6	O
mo	O
+	O
3	O
mo	O
treated	O
(	O
n	O
=	O
8	O
)	O
,	O
and	O
6	O
mo	O
+	O
6	O
mo	O
treated	O
(	O
n	O
=	O
5	O
)	O
.	O

Full	O
suppression	O
(	O
>	O
95	O
%	O
)	O
of	O
transgenic	O
APPswe	O
/	O
ind	O
levels	O
in	O
the	O
dox	O
-	O
treated	O
animals	O
was	O
confirmed	O
by	O
immunoblot	O
(	O
Figure	O
3	O
)	O
.	O

To	O
ensure	O
that	O
the	O
transgene	O
could	O
be	O
suppressed	O
as	O
rapidly	O
in	O
6	O
-	O
mo	O
-	O
old	O
mice	O
with	O
fulminant	O
pathology	O
as	O
it	O
can	O
in	O
young	O
,	O
predeposit	O
animals	O
,	O
we	O
treated	O
an	O
additional	O
set	O
of	O
6	O
-	O
mo	O
-	O
old	O
animals	O
with	O
dox	O
for	O
1	O
wk	O
prior	O
to	O
harvest	O
.	O

Importantly	O
,	O
both	O
APPswe	O
/	O
ind	O
and	O
APP	O
-	O
C	O
-	O
terminal	O
fragment	O
levels	O
were	O
fully	O
suppressed	O
after	O
only	O
1	O
wk	O
of	O
treatment	O
,	O
indicating	O
that	O
the	O
in	O
vivo	O
half	O
-	O
life	O
of	O
APPswe	O
/	O
ind	O
and	O
its	O
processed	O
C	O
-	O
terminal	O
fragments	O
are	O
relatively	O
short	O
(	O
Figure	O
3D	O
)	O
.	O

Tissue	O
sections	O
from	O
each	O
animal	O
in	O
the	O
four	O
treatment	O
groups	O
were	O
stained	O
for	O
amyloid	O
pathology	O
by	O
Hirano	O
silver	O
,	O
Campbell	O
-	O
Switzer	O
silver	O
,	O
thioflavin	O
-	O
S	O
,	O
and	O
A	O
beta	O
immunohistochemistry	O
.	O

As	O
expected	O
,	O
the	O
6	O
mo	O
untreated	O
cohort	O
displayed	O
moderate	O
amyloid	O
pathology	O
,	O
and	O
the	O
9	O
mo	O
untreated	O
cohort	O
progressed	O
to	O
a	O
severe	O
amyloid	O
burden	O
.	O

In	O
contrast	O
,	O
the	O
extent	O
of	O
amyloid	O
pathology	O
in	O
mice	O
from	O
the	O
6	O
mo	O
+	O
3	O
mo	O
treated	O
or	O
6	O
mo	O
+	O
6	O
mo	O
treated	O
cohorts	O
closely	O
resembled	O
that	O
of	O
the	O
6	O
mo	O
untreated	O
cohort	O
,	O
despite	O
the	O
significant	O
age	O
difference	O
between	O
the	O
treated	O
and	O
untreated	O
groups	O
(	O
Figures	O
4	O
and	O
Figure	O
S3	O
)	O
.	O

Well	O
-	O
formed	O
plaques	O
remained	O
in	O
the	O
treated	O
animals	O
after	O
6	O
mo	O
of	O
transgene	O
suppression	O
,	O
even	O
though	O
as	O
much	O
time	O
was	O
given	O
to	O
clear	O
the	O
lesions	O
as	O
they	O
had	O
taken	O
to	O
form	O
.	O

Moreover	O
,	O
both	O
types	O
of	O
amyloid	O
,	O
diffuse	O
and	O
fibrillar	O
,	O
remained	O
intact	O
throughout	O
treatment	O
.	O

Using	O
the	O
Campbell	O
-	O
Switzer	O
silver	O
stain	O
to	O
distinguish	O
different	O
forms	O
of	O
amyloid	O
,	O
we	O
found	O
diffuse	O
plaques	O
were	O
as	O
persistent	O
as	O
cored	O
deposits	O
(	O
Figure	O
S4	O
)	O
.	O

It	O
was	O
nevertheless	O
clear	O
that	O
dox	O
-	O
induced	O
suppression	O
of	O
transgenic	O
APP	O
had	O
completely	O
halted	O
the	O
progression	O
of	O
pathology	O
.	O

To	O
confirm	O
that	O
the	O
arrest	O
of	O
plaques	O
without	O
any	O
sign	O
of	O
clearance	O
was	O
not	O
unique	O
to	O
the	O
line	O
107	O
mice	O
,	O
we	O
repeated	O
the	O
dox	O
-	O
suppression	O
experiment	O
in	O
a	O
second	O
line	O
of	O
tet	O
-	O
off	O
APP	O
mice	O
(	O
CaMKII	O
alpha	O
-	O
tTA	O
x	O
tet	O
-	O
APPswe	O
/	O
ind	O
line	O
18	O
;	O
n	O
=	O
22	O
)	O
.	O

Again	O
,	O
long	O
-	O
term	O
dox	O
treatment	O
was	O
begun	O
at	O
6	O
mo	O
of	O
age	O
,	O
and	O
mice	O
were	O
harvested	O
after	O
3	O
mo	O
of	O
transgene	O
suppression	O
(	O
6	O
mo	O
untreated	O
,	O
n	O
=	O
8	O
;	O
9	O
mo	O
untreated	O
,	O
n	O
=	O
6	O
;	O
6	O
mo	O
+	O
3	O
mo	O
treated	O
,	O
n	O
=	O
8	O
)	O
.	O

Immunoblotting	O
for	O
APP	O
confirmed	O
full	O
transgene	O
suppression	O
in	O
the	O
treated	O
animals	O
(	O
Figure	O
S5	O
)	O
.	O

As	O
in	O
the	O
line	O
107	O
mice	O
described	O
above	O
,	O
amyloid	O
burden	O
worsened	O
substantially	O
in	O
the	O
untreated	O
mice	O
between	O
6	O
and	O
9	O
mo	O
of	O
age	O
.	O

Suppression	O
of	O
transgene	O
expression	O
abruptly	O
arrested	O
progression	O
of	O
pathology	O
(	O
Figure	O
S6	O
)	O
,	O
but	O
again	O
without	O
any	O
sign	O
of	O
reduction	O
.	O

Both	O
silver	O
-	O
and	O
thioflavin	O
-	O
S	O
-	O
positive	O
plaques	O
could	O
still	O
be	O
found	O
in	O
each	O
of	O
the	O
dox	O
-	O
treated	O
animals	O
.	O

We	O
biochemically	O
measured	O
the	O
amount	O
of	O
aggregated	O
A	O
beta	O
in	O
the	O
brains	O
of	O
our	O
mice	O
before	O
and	O
after	O
transgene	O
suppression	O
using	O
filter	O
trap	O
analysis	O
of	O
cortical	O
tissue	O
from	O
each	O
animal	O
.	O

In	O
this	O
assay	O
,	O
serial	O
dilutions	O
of	O
protein	O
homogenate	O
are	O
passed	O
through	O
a	O
cellulose	O
acetate	O
filter	O
;	O
particles	O
larger	O
than	O
the	O
pore	O
size	O
of	O
the	O
filter	O
become	O
trapped	O
in	O
the	O
membrane	O
and	O
are	O
revealed	O
by	O
immunoblotting	O
[	O
22	O
]	O
.	O

Consistent	O
with	O
our	O
visual	O
analysis	O
of	O
the	O
histological	O
sections	O
,	O
line	O
107	O
tTA	O
/	O
APP	O
mice	O
treated	O
with	O
dox	O
for	O
3	O
or	O
6	O
mo	O
had	O
the	O
same	O
amount	O
of	O
aggregated	O
A	O
beta	O
as	O
when	O
they	O
started	O
treatment	O
at	O
6	O
mo	O
of	O
age	O
(	O
Figure	O
4A	O
and	O
4B	O
)	O
.	O

In	O
contrast	O
,	O
untreated	O
9	O
-	O
mo	O
-	O
old	O
mice	O
had	O
almost	O
twice	O
as	O
much	O
aggregated	O
A	O
beta	O
as	O
either	O
of	O
the	O
treated	O
groups	O
.	O

Filter	O
trap	O
analysis	O
of	O
line	O
18	O
tTA	O
/	O
APP	O
mice	O
yielded	O
similar	O
results	O
:	O
the	O
increase	O
in	O
aggregated	O
A	O
beta	O
observed	O
in	O
untreated	O
animals	O
between	O
6	O
and	O
9	O
mo	O
of	O
age	O
was	O
completely	O
arrested	O
by	O
transgene	O
suppression	O
(	O
Figure	O
S5C	O
and	O
S5D	O
)	O
.	O

We	O
next	O
used	O
ELISA	O
to	O
measure	O
total	O
A	O
beta	O
in	O
the	O
brains	O
of	O
each	O
group	O
to	O
determine	O
whether	O
any	O
change	O
in	O
the	O
amount	O
or	O
solubility	O
of	O
peptide	O
occurred	O
while	O
APPswe	O
/	O
ind	O
expression	O
was	O
suppressed	O
.	O

Cortical	O
homogenates	O
were	O
sequentially	O
extracted	O
to	O
separate	O
peptide	O
into	O
PBS	O
-	O
,	O
SDS	O
-	O
,	O
and	O
FA	O
-	O
soluble	O
fractions	S-GO
,	O
then	O
transgene	O
-	O
derived	O
A	O
beta	O
40	O
and	O
A	O
beta	O
42	O
were	O
measured	O
by	O
human	O
-	O
specific	O
ELISA	O
[	O
23	O
]	O
.	O

In	O
all	O
animals	O
harboring	O
amyloid	O
deposits	O
,	O
we	O
found	O
that	O
the	O
vast	O
majority	O
of	O
A	O
beta	O
(	O
>	O
99	O
%	O
)	O
was	O
extracted	O
into	O
the	O
SDS	O
and	O
FA	O
fractions	S-GO
(	O
Figure	O
5A	O
and	O
5B	O
)	O
.	O

Consistent	O
with	O
the	O
filter	O
trap	O
results	O
presented	O
above	O
,	O
there	O
were	O
no	O
significant	O
differences	O
in	O
SDS	O
-	O
or	O
FA	O
-	O
soluble	O
A	O
beta	O
between	O
the	O
6	O
mo	O
untreated	O
cohort	O
and	O
either	O
the	O
6	O
mo	O
+	O
3	O
mo	O
treated	O
or	O
6	O
mo	O
+	O
6	O
mo	O
treated	O
cohorts	O
.	O

However	O
,	O
brains	O
of	O
both	O
6	O
mo	O
+	O
3	O
mo	O
and	O
6	O
mo	O
+	O
6	O
mo	O
treated	O
cohorts	O
contained	O
roughly	O
twice	O
as	O
much	O
PBS	O
-	O
soluble	O
A	O
beta	O
40	O
as	O
untreated	O
6	O
-	O
mo	O
-	O
old	O
mice	O
(	O
Figure	O
5C	O
)	O
.	O

Levels	O
of	O
A	O
beta	O
42	O
showed	O
a	O
similar	O
trend	O
,	O
but	O
did	O
not	O
reach	O
statistical	O
significance	O
.	O

In	O
fact	O
,	O
levels	O
of	O
PBS	O
-	O
soluble	O
A	O
beta	O
40	O
and	O
A	O
beta	O
42	O
in	O
the	O
6	O
mo	O
+	O
3	O
mo	O
and	O
6	O
mo	O
+	O
6	O
mo	O
treated	O
cohorts	O
were	O
most	O
similar	O
to	O
that	O
of	O
the	O
9	O
mo	O
untreated	O
cohort	O
,	O
suggesting	O
that	O
age	O
,	O
as	O
opposed	O
to	O
synthetic	O
rate	O
(	O
which	O
would	O
be	O
negligible	O
in	O
the	O
treated	O
animals	O
)	O
,	O
may	O
determine	O
the	O
fraction	O
of	O
PBS	O
-	O
soluble	O
A	O
beta	O
in	O
these	O
animals	O
.	O

We	O
also	O
assessed	O
neuritic	O
and	O
glial	O
pathology	O
surrounding	O
the	O
plaques	O
to	O
determine	O
whether	O
there	O
were	O
any	O
changes	O
in	O
nearby	O
tissue	O
following	O
long	O
-	O
term	O
transgene	O
suppression	O
.	O

Both	O
Hirano	O
silver	O
stain	O
and	O
ubiquitin	O
immunostaining	O
showed	O
neuritic	O
pathology	O
in	O
all	O
treatment	O
groups	O
(	O
Figure	O
6	O
)	O
.	O

Similarly	O
,	O
activated	O
astrocytes	O
immunostained	O
for	O
GFAP	O
were	O
found	O
near	O
plaques	O
in	O
all	O
animals	O
(	O
Figure	O
6	O
)	O
.	O

Neuritic	O
and	O
glial	O
pathology	O
were	O
more	O
severe	O
in	O
the	O
older	O
untreated	O
mice	O
.	O

In	O
contrast	O
,	O
transgene	O
suppression	O
prevented	O
the	O
growth	O
of	O
individual	O
deposits	O
apparent	O
in	O
untreated	O
mice	O
,	O
and	O
limited	O
the	O
surrounding	O
pathology	O
to	O
what	O
was	O
already	O
present	O
when	O
treatment	O
began	O
.	O

An	O
obvious	O
question	O
we	O
sought	O
to	O
address	O
was	O
whether	O
the	O
deposition	O
of	O
A	O
beta	O
diminished	O
cognitive	O
ability	O
in	O
untreated	O
mice	O
,	O
and	O
what	O
might	O
happen	O
to	O
cognition	O
when	O
the	O
process	O
was	O
interrupted	O
.	O

Unfortunately	O
,	O
efforts	O
to	O
characterize	O
cognitive	O
behavior	O
were	O
compromised	O
by	O
severe	O
hyperactivity	O
in	O
untreated	O
double	O
transgenic	O
mice	O
.	O

The	O
tTA	O
/	O
APP	O
animals	O
were	O
often	O
seen	O
running	O
in	O
circles	O
around	O
the	O
perimeter	O
of	O
their	O
cages	O
,	O
and	O
a	O
similar	O
swimming	O
pattern	O
was	O
noted	O
when	O
the	O
mice	O
were	O
tested	O
in	O
the	O
Morris	O
water	O
maze	O
.	O

In	O
the	O
radial	O
water	O
maze	O
,	O
repetitive	O
swim	O
patterns	O
were	O
noted	O
with	O
no	O
evidence	O
of	O
choice	O
-	O
motivated	O
actions	O
.	O

Other	O
studies	O
have	O
dealt	O
with	O
similar	O
problems	O
by	O
excluding	O
animals	O
that	O
do	O
not	O
show	O
adequate	O
attention	O
to	O
the	O
task	O
,	O
retaining	O
only	O
those	O
mice	O
that	O
meet	O
certain	O
performance	O
criteria	O
[	O
30	O
]	O
.	O

In	O
our	O
case	O
,	O
the	O
penetrance	O
of	O
hyperactivity	O
was	O
close	O
to	O
100	O
%	O
,	O
leaving	O
us	O
with	O
no	O
testable	O
animals	O
.	O

This	O
phenotype	O
has	O
not	O
affected	O
previous	O
lines	O
of	O
APPswe	O
mice	O
we	O
have	O
produced	O
,	O
such	O
as	O
lines	O
E1	O
-	O
2	O
or	O
C3	O
-	O
3	O
,	O
that	O
express	O
lower	O
levels	O
of	O
transgenic	O
protein	O
.	O

Indeed	O
,	O
in	O
past	O
studies	O
where	O
hyperactivity	O
was	O
not	O
a	O
factor	O
,	O
we	O
established	O
a	O
clear	O
relationship	O
between	O
amyloid	O
load	O
and	O
cognitive	O
ability	O
[	O
31	O
]	O
.	O

However	O
,	O
in	O
the	O
current	O
study	O
,	O
we	O
feel	O
that	O
although	O
the	O
poor	O
performance	O
of	O
the	O
tTA	O
/	O
APP	O
mice	O
in	O
the	O
maze	O
tests	O
could	O
technically	O
be	O
scored	O
as	O
cognitive	O
impairment	O
,	O
the	O
animals	O
'	O
severe	O
hyperactivity	O
made	O
interpretation	O
of	O
the	O
cognitive	O
tasks	O
impossible	O
.	O

In	O
order	O
to	O
understand	O
the	O
nature	O
and	O
extent	O
of	O
hyperactivity	O
in	O
the	O
tTA	O
/	O
APP	O
mice	O
,	O
we	O
quantified	O
daily	O
activity	O
levels	O
in	O
double	O
transgenic	O
animals	O
along	O
with	O
their	O
single	O
transgenic	O
and	O
nontransgenic	O
siblings	O
using	O
four	O
-	O
beam	O
frames	O
designed	O
to	O
monitor	O
ambulation	O
within	O
an	O
enclosed	O
cage	O
.	O

As	O
shown	O
in	O
Figure	O
7	O
,	O
the	O
double	O
transgenic	O
mice	O
were	O
up	O
to	O
10	O
-	O
fold	O
more	O
active	O
during	O
the	O
dark	O
phase	O
of	O
the	O
day	O
-	O
night	O
cycle	O
than	O
any	O
of	O
the	O
control	O
groups	O
.	O

Activity	O
levels	O
appeared	O
to	O
follow	O
a	O
relatively	O
normal	O
diurnal	O
cycle	O
,	O
decreasing	O
substantially	O
during	O
the	O
daylight	O
hours	O
.	O

However	O
,	O
even	O
during	O
the	O
light	O
phase	O
,	O
the	O
tTA	O
/	O
APP	O
mice	O
remained	O
many	O
-	O
fold	O
more	O
active	O
than	O
normal	O
controls	O
.	O

This	O
behavior	O
was	O
partially	O
,	O
but	O
not	O
consistently	O
,	O
reversed	O
by	O
1	O
mo	O
of	O
transgene	O
suppression	O
beginning	O
at	O
4	O
-	O
5	O
mo	O
of	O
age	O
(	O
data	O
not	O
shown	O
)	O
.	O

In	O
contrast	O
,	O
hyperactivity	O
was	O
completely	O
abolished	O
by	O
rearing	O
tTA	O
/	O
APP	O
mice	O
on	O
dox	O
.	O

Animals	O
born	O
and	O
raised	O
on	O
dox	O
showed	O
activity	O
levels	O
similar	O
to	O
the	O
untreated	O
controls	O
(	O
Figure	O
7C	O
)	O
.	O

Intriguingly	O
,	O
all	O
of	O
the	O
dox	O
-	O
reared	O
animals	O
,	O
both	O
transgenic	O
and	O
wild	O
-	O
type	O
,	O
showed	O
altered	O
circadian	O
rhythms	O
with	O
far	O
less	O
distinction	O
between	O
their	O
day	O
-	O
and	O
nighttime	O
activity	O
levels	O
.	O

Discussion	O

We	O
present	O
a	O
new	O
mouse	O
model	O
for	O
AD	O
that	O
was	O
designed	O
to	O
test	O
the	O
consequences	O
of	O
inhibiting	O
A	O
beta	O
production	O
after	O
the	O
onset	O
of	O
amyloid	O
pathology	O
.	O

New	O
lines	O
of	O
transgenic	O
mice	O
were	O
developed	O
for	O
this	O
study	O
that	O
express	O
high	O
levels	O
of	O
APPswe	O
/	O
ind	O
under	O
the	O
control	O
of	O
a	O
tetracycline	O
-	O
responsive	O
promoter	O
.	O

We	O
demonstrate	O
that	O
treatment	O
with	O
dox	O
suppresses	O
steady	O
-	O
state	O
levels	O
of	O
both	O
APPswe	O
/	O
ind	O
and	O
its	O
C	O
-	O
terminal	O
fragments	O
,	O
indicating	O
that	O
the	O
mutant	O
proteins	O
have	O
a	O
relatively	O
short	O
half	O
-	O
life	O
in	O
vivo	O
.	O

Transgenic	O
expression	O
of	O
APPswe	O
/	O
ind	O
and	O
consequent	O
overproduction	O
of	O
A	O
beta	O
42	O
cause	O
early	O
-	O
onset	O
amyloid	O
deposition	O
in	O
untreated	O
mice	O
,	O
in	O
which	O
deposits	O
appear	O
as	O
early	O
as	O
2	O
mo	O
of	O
age	O
.	O

Amyloid	O
burden	O
worsens	O
significantly	O
with	O
age	O
,	O
and	O
by	O
9	O
mo	O
,	O
the	O
hippocampus	O
and	O
cortex	O
of	O
untreated	O
mice	O
are	O
largely	O
filled	O
with	O
aggregated	O
peptide	O
.	O

We	O
find	O
that	O
suppression	O
of	O
transgenic	O
APP	O
by	O
more	O
than	O
95	O
%	O
abruptly	O
halts	O
the	O
progression	O
of	O
amyloid	O
pathology	O
.	O

Importantly	O
,	O
this	O
outcome	O
occurs	O
in	O
animals	O
already	O
harboring	O
considerable	O
amyloid	O
pathology	O
,	O
a	O
situation	O
similar	O
to	O
what	O
might	O
be	O
expected	O
in	O
patients	O
to	O
be	O
treated	O
with	O
secretase	O
inhibitors	O
.	O

Somewhat	O
unexpectedly	O
,	O
we	O
observe	O
no	O
appreciable	O
clearance	O
of	O
deposited	O
amyloid	O
even	O
following	O
periods	O
of	O
transgene	O
suppression	O
equal	O
to	O
the	O
time	O
taken	O
for	O
plaques	O
to	O
form	O
.	O

This	O
latter	O
finding	O
indicates	O
that	O
compared	O
to	O
other	O
disease	O
-	O
associated	O
protein	O
aggregates	O
such	O
as	O
mutant	O
huntingtin	O
,	O
which	O
clear	O
in	O
less	O
than	O
3	O
mo	O
[	O
32	O
]	O
,	O
the	O
disaggregation	O
of	O
extracellular	S-GO
amyloid	O
is	O
relatively	O
slow	O
.	O

Notably	O
,	O
pharmaceutical	O
gamma	O
-	O
secretase	O
inhibitors	O
published	O
to	O
date	O
show	O
less	O
strict	O
regulation	O
of	O
A	O
beta	O
production	O
following	O
chronic	O
administration	O
than	O
we	O
have	O
attained	O
here	O
.	O

Two	O
independent	O
compounds	O
tested	O
in	O
Tg2576	O
[	O
33	O
]	O
and	O
TgCRND8	O
[	O
34	O
]	O
transgenic	O
mice	O
show	O
no	O
more	O
than	O
85	O
%	O
suppression	O
of	O
A	O
beta	O
40	O
levels	O
,	O
and	O
where	O
measured	O
,	O
even	O
less	O
suppression	O
of	O
A	O
beta	O
42	O
(	O
approximately	O
60	O
%	O
)	O
[	O
35	O
,	O
36	O
]	O
.	O

Thus	O
,	O
even	O
after	O
accounting	O
for	O
the	O
much	O
higher	O
APP	O
expression	O
levels	O
in	O
our	O
mice	O
than	O
in	O
the	O
Tg2576	O
and	O
TgCRND8	O
lines	O
,	O
we	O
have	O
achieved	O
better	O
absolute	O
suppression	O
of	O
A	O
beta	O
production	O
with	O
the	O
tet	O
-	O
off	O
system	O
than	O
is	O
currently	O
possible	O
with	O
published	O
gamma	O
-	O
secretase	O
inhibitors	O
.	O

Since	O
even	O
the	O
most	O
advanced	O
future	O
pharmaceutical	O
agents	O
are	O
unlikely	O
to	O
attain	O
more	O
complete	O
control	O
of	O
A	O
beta	O
production	O
than	O
achieved	O
here	O
,	O
this	O
system	O
provides	O
a	O
salient	O
test	O
of	O
therapeutic	O
intervention	O
with	O
A	O
beta	O
-	O
lowering	O
compounds	O
.	O

Although	O
the	O
progression	O
of	O
amyloid	O
deposition	O
was	O
sharply	O
arrested	O
by	O
this	O
approach	O
,	O
we	O
found	O
that	O
a	O
substantial	O
amyloid	O
burden	O
remained	O
even	O
after	O
long	O
periods	O
of	O
transgene	O
suppression	O
.	O

We	O
examined	O
a	O
small	O
number	O
of	O
animals	O
after	O
12	O
mo	O
of	O
dox	O
treatment	O
(	O
beginning	O
at	O
6	O
mo	O
of	O
age	O
)	O
,	O
and	O
found	O
that	O
amyloid	O
deposits	O
were	O
still	O
relatively	O
abundant	O
.	O

Longer	O
-	O
term	O
treatments	O
are	O
now	O
in	O
progress	O
.	O

At	O
the	O
latest	O
treatment	O
interval	O
analyzed	O
by	O
ELISA	O
,	O
animals	O
administered	O
dox	O
for	O
6	O
mo	O
showed	O
elevated	O
levels	O
of	O
PBS	O
-	O
soluble	O
A	O
beta	O
(	O
see	O
Figure	O
5	O
)	O
that	O
could	O
be	O
interpreted	O
as	O
an	O
indication	O
that	O
the	O
plaques	O
are	O
slowly	O
releasing	O
peptide	O
(	O
or	O
oligomeric	O
A	O
beta	O
)	O
into	O
the	O
soluble	O
pool	O
and	O
might	O
eventually	O
dissolve	O
.	O

Whether	O
inhibiting	O
A	O
beta	O
production	O
longer	O
than	O
6	O
(	O
or	O
12	O
)	O
mo	O
may	O
ultimately	O
result	O
in	O
clearance	O
of	O
amyloid	O
is	O
under	O
investigation	O
;	O
unfortunately	O
,	O
the	O
life	O
span	O
of	O
the	O
model	O
eventually	O
limits	O
this	O
experiment	O
.	O

Therapeutics	O
used	O
in	O
humans	O
will	O
have	O
considerably	O
more	O
time	O
to	O
act	O
than	O
is	O
possible	O
within	O
the	O
life	O
span	O
of	O
rodent	O
models	O
.	O

Long	O
-	O
term	O
treatments	O
would	O
certainly	O
be	O
possible	O
and	O
could	O
be	O
a	O
key	O
to	O
effective	O
therapy	O
.	O

Overall	O
,	O
however	O
,	O
we	O
interpret	O
our	O
findings	O
as	O
evidence	O
that	O
AD	O
therapies	O
that	O
significantly	O
lower	O
the	O
production	O
of	O
A	O
beta	O
(	O
by	O
either	O
inhibiting	O
secretase	O
activity	O
or	O
inhibiting	O
APP	O
expression	O
)	O
may	O
not	O
quickly	O
reverse	O
preexisting	O
pathology	O
,	O
but	O
should	O
effectively	O
halt	O
further	O
deposition	O
of	O
amyloid	O
.	O

In	O
interpreting	O
our	O
study	O
,	O
it	O
should	O
be	O
remembered	O
that	O
the	O
earliest	O
plaques	O
to	O
appear	O
in	O
these	O
mice	O
,	O
like	O
other	O
APP	O
transgenics	O
harboring	O
the	O
Swedish	O
mutation	O
[	O
27	O
]	O
,	O
are	O
predominantly	O
fibrillar	O
deposits	O
,	O
which	O
may	O
be	O
less	O
tractable	O
than	O
the	O
diffuse	O
aggregates	O
thought	O
to	O
come	O
first	O
in	O
the	O
course	O
of	O
the	O
human	O
disease	O
.	O

However	O
,	O
our	O
data	O
suggest	O
that	O
once	O
diffuse	O
deposits	O
are	O
formed	O
in	O
these	O
mice	O
,	O
they	O
are	O
no	O
more	O
easily	O
cleared	O
in	O
our	O
system	O
than	O
cored	O
plaques	O
(	O
see	O
Figure	O
S4	O
)	O
.	O

An	O
additional	O
consideration	O
we	O
recognize	O
is	O
that	O
a	O
small	O
amount	O
of	O
transgene	O
expression	O
continues	O
in	O
the	O
presence	O
of	O
dox	O
and	O
that	O
endogenous	O
mouse	O
A	O
beta	O
continues	O
to	O
be	O
produced	O
.	O

It	O
is	O
possible	O
that	O
the	O
combined	O
low	O
levels	O
of	O
endogenous	O
mouse	O
A	O
beta	O
and	O
nonsuppressed	O
human	O
peptide	O
are	O
sufficient	O
to	O
maintain	O
existing	O
deposits	O
.	O

However	O
,	O
these	O
low	O
levels	O
of	O
peptide	O
are	O
not	O
sufficient	O
to	O
induce	O
new	O
amyloid	O
formation	O
,	O
as	O
CaMKII	O
alpha	O
-	O
tTA	O
x	O
tetAPPswe	O
/	O
ind	O
mice	O
raised	O
on	O
dox	O
for	O
up	O
to	O
a	O
year	O
do	O
not	O
develop	O
amyloid	O
lesions	O
(	O
data	O
not	O
shown	O
)	O
.	O

It	O
is	O
also	O
clear	O
that	O
in	O
this	O
genetic	O
system	O
,	O
we	O
have	O
raised	O
the	O
production	O
of	O
A	O
beta	O
to	O
levels	O
not	O
found	O
in	O
humans	O
to	O
accelerate	O
pathology	O
into	O
an	O
experimentally	O
feasible	O
time	O
frame	O
.	O

This	O
system	O
allowed	O
us	O
to	O
create	O
an	O
approximately	O
20	O
-	O
fold	O
differential	O
between	O
APP	O
/	O
A	O
beta	O
synthetic	O
rates	O
before	O
and	O
after	O
treatment	O
,	O
yet	O
the	O
in	O
vivo	O
equilibrium	O
between	O
aggregated	O
and	O
disaggregated	O
states	O
of	O
A	O
beta	O
still	O
favored	O
the	O
maintenance	O
of	O
amyloid	O
deposits	O
.	O

In	O
our	O
opinion	O
,	O
it	O
seems	O
unlikely	O
that	O
amyloid	O
deposits	O
in	O
human	O
brain	O
would	O
be	O
inherently	O
any	O
less	O
stable	O
than	O
those	O
formed	O
in	O
mouse	O
brain	O
.	O

However	O
,	O
the	O
human	O
brain	O
may	O
harbor	O
clearance	O
mechanisms	O
not	O
shared	O
by	O
mice	O
that	O
would	O
allow	O
more	O
efficient	O
removal	O
of	O
preexisting	O
amyloid	O
.	O

One	O
potential	O
mechanism	O
by	O
which	O
amyloid	O
may	O
be	O
more	O
efficiently	O
removed	O
in	O
the	O
human	O
disease	O
than	O
in	O
the	O
mouse	O
models	O
is	O
through	O
microglial	O
phagocytosis	O
.	O

Resident	O
microglia	O
in	O
transgenic	O
mouse	O
models	O
localize	O
to	O
tissue	O
surrounding	O
plaques	O
but	O
show	O
little	O
evidence	O
of	O
amyloid	O
engulfment	O
[	O
37	O
-	O
40	O
]	O
.	O

In	O
contrast	O
,	O
microglia	O
surrounding	O
amyloid	O
plaques	O
in	O
human	O
brain	O
show	O
a	O
much	O
higher	O
state	O
of	O
activation	O
with	O
greater	O
expression	O
of	O
complement	O
receptor	O
[	O
40	O
]	O
.	O

Thus	O
,	O
the	O
role	O
of	O
microglia	O
in	O
amyloid	O
metabolism	O
is	O
minor	O
in	O
transgenic	O
models	O
compared	O
to	O
the	O
human	O
condition	O
.	O

Somewhat	O
paradoxically	O
,	O
several	O
studies	O
further	O
demonstrate	O
that	O
treatment	O
with	O
anti	O
-	O
inflammatory	O
drugs	O
to	O
reduce	O
microglial	O
activation	O
actually	O
lowers	O
amyloid	O
load	O
in	O
APP	O
transgenic	O
mice	O
,	O
suggesting	O
a	O
role	O
for	O
mouse	O
microglia	O
in	O
the	O
formation	O
and	O
maintenance	O
of	O
amyloid	O
aggregates	O
[	O
41	O
-	O
43	O
]	O
.	O

However	O
,	O
this	O
outcome	O
may	O
be	O
alternatively	O
explained	O
by	O
direct	O
effects	O
of	O
many	O
anti	O
-	O
inflammatory	O
drugs	O
on	O
gamma	O
-	O
secretase	O
cleavage	O
[	O
44	O
-	O
47	O
]	O
.	O

Nonetheless	O
,	O
the	O
role	O
of	O
microglia	O
in	O
both	O
the	O
human	O
condition	O
and	O
the	O
mouse	O
models	O
is	O
poorly	O
understood	O
,	O
and	O
differences	O
in	O
microglial	O
reactivity	O
between	O
the	O
two	O
could	O
lead	O
to	O
significantly	O
faster	O
amyloid	O
clearance	O
in	O
the	O
brains	O
of	O
patients	O
with	O
AD	O
than	O
we	O
observe	O
in	O
the	O
tet	O
-	O
off	O
APP	O
mice	O
.	O

Given	O
the	O
relatively	O
minor	O
role	O
played	O
by	O
microglia	O
in	O
other	O
mouse	O
models	O
of	O
amyloidosis	O
,	O
we	O
think	O
it	O
unlikely	O
that	O
these	O
cells	O
have	O
influenced	O
the	O
rate	O
of	O
amyloid	O
clearance	O
in	O
the	O
tet	O
-	O
off	O
APP	O
mice	O
.	O

Even	O
so	O
,	O
we	O
considered	O
the	O
possibility	O
that	O
chronic	O
dox	O
treatment	O
may	O
have	O
altered	O
the	O
activation	O
state	O
of	O
microglia	O
in	O
our	O
treated	O
mice	O
.	O

Dox	O
is	O
structurally	O
similar	O
to	O
minocycline	O
,	O
a	O
reported	O
anti	O
-	O
inflammatory	O
drug	O
and	O
inhibitor	O
of	O
microglial	O
activation	O
[	O
48	O
]	O
.	O

However	O
,	O
if	O
dox	O
does	O
have	O
anti	O
-	O
inflammatory	O
activity	O
,	O
then	O
,	O
based	O
on	O
previous	O
studies	O
with	O
other	O
anti	O
-	O
inflammatories	O
,	O
we	O
would	O
have	O
expected	O
to	O
find	O
less	O
amyloid	O
in	O
the	O
dox	O
-	O
treated	O
animals	O
.	O

Clearly	O
,	O
that	O
was	O
not	O
the	O
case	O
.	O

While	O
it	O
is	O
possible	O
that	O
dox	O
acts	O
in	O
some	O
other	O
way	O
to	O
slow	O
amyloid	O
clearance	O
,	O
data	O
from	O
multiple	O
studies	O
demonstrate	O
that	O
microglial	O
responses	O
are	O
normally	O
weak	O
in	O
the	O
mouse	O
AD	O
models	O
[	O
37	O
-	O
40	O
]	O
,	O
and	O
thus	O
it	O
is	O
doubtful	O
that	O
dox	O
-	O
mediated	O
microglial	O
inhibition	O
affected	O
the	O
outcome	O
of	O
our	O
study	O
.	O

The	O
persistence	O
and	O
stability	O
of	O
amyloid	O
deposits	O
in	O
our	O
system	O
is	O
unexpected	O
given	O
the	O
speed	O
with	O
which	O
A	O
beta	O
aggregates	O
are	O
cleared	O
in	O
other	O
mouse	O
models	O
of	O
therapeutic	O
intervention	O
.	O

Anti	O
-	O
A	O
beta	O
antibodies	S-GO
injected	O
directly	O
into	O
the	O
brain	O
have	O
been	O
shown	O
to	O
eliminate	O
amyloid	O
deposits	O
in	O
as	O
little	O
as	O
1	O
wk	O
after	O
treatment	O
[	O
49	O
-	O
51	O
]	O
.	O

Peripheral	O
antibody	S-GO
injection	O
decreases	O
amyloid	O
load	O
more	O
broadly	O
,	O
and	O
although	O
it	O
does	O
not	O
appear	O
to	O
act	O
as	O
quickly	O
as	O
local	O
injection	O
,	O
can	O
significantly	O
reduce	O
amyloid	O
load	O
within	O
2	O
mo	O
of	O
initial	O
treatment	O
[	O
52	O
,	O
53	O
]	O
.	O

More	O
recently	O
,	O
an	O
alternative	O
approach	O
has	O
shown	O
that	O
lentiviral	O
transfer	O
of	O
neprilysin	O
can	O
also	O
reduce	O
the	O
number	O
of	O
aggregates	O
in	O
the	O
area	O
of	O
the	O
injection	O
site	O
[	O
54	O
]	O
.	O

Careful	O
study	O
of	O
the	O
mechanism	O
behind	O
several	O
of	O
the	O
antibody	S-GO
-	O
mediated	O
therapies	O
has	O
suggested	O
that	O
activated	O
microglia	O
play	O
an	O
important	O
role	O
in	O
the	O
removal	O
of	O
fibrillar	O
plaques	O
after	O
immunization	O
[	O
50	O
,	O
52	O
,	O
55	O
]	O
.	O

However	O
,	O
it	O
has	O
been	O
noted	O
that	O
deletion	O
of	O
the	O
Fc	O
receptor	O
(	O
the	O
primary	O
receptor	O
for	O
microglial	O
opsinization	O
of	O
antibody	S-GO
-	O
antigen	O
complexes	S-GO
)	O
in	O
APP	O
transgenic	O
mouse	O
models	O
has	O
no	O
impact	O
on	O
the	O
effectiveness	O
of	O
antibody	S-GO
-	O
mediated	O
therapy	O
[	O
56	O
,	O
57	O
]	O
.	O

It	O
is	O
,	O
nevertheless	O
,	O
possible	O
that	O
lack	O
of	O
microglia	O
activation	O
is	O
the	O
major	O
difference	O
between	O
the	O
slow	O
clearance	O
described	O
here	O
,	O
where	O
no	O
perturbation	O
of	O
the	O
immune	O
system	O
is	O
expected	O
,	O
and	O
the	O
rapid	O
clearance	O
described	O
in	O
studies	O
involving	O
antibody	S-GO
or	O
viral	O
injection	O
.	O

In	O
isolation	O
,	O
mild	O
activation	O
of	O
microglia	O
by	O
injection	O
damage	O
or	O
opsinization	O
may	O
not	O
be	O
adequate	O
to	O
induce	O
substantial	O
phagocytosis	O
,	O
but	O
when	O
combined	O
with	O
an	O
A	O
beta	O
-	O
lowering	O
agent	O
,	O
such	O
as	O
neprilysin	O
or	O
A	O
beta	O
-	O
targeted	O
antibodies	S-GO
,	O
the	O
two	O
may	O
work	O
in	O
concert	O
to	O
clear	O
peptide	O
deposits	O
.	O

Consistent	O
with	O
this	O
hypothesis	O
,	O
strong	O
activation	O
of	O
microglia	O
through	O
transgenic	O
expression	O
of	O
TGF	O
beta	O
[	O
58	O
]	O
or	O
central	O
injection	O
of	O
lipopolysaccharide	O
[	O
59	O
,	O
60	O
]	O
can	O
by	O
itself	O
substantially	O
reduce	O
plaque	O
burden	O
in	O
APP	O
transgenic	O
mice	O
.	O

But	O
in	O
the	O
case	O
of	O
acute	O
antibody	S-GO
-	O
and	O
/	O
or	O
injury	O
-	O
mediated	O
activation	O
,	O
once	O
the	O
inflammation	O
has	O
passed	O
,	O
and	O
the	O
antibody	S-GO
and	O
bound	O
peptide	O
have	O
been	O
cleared	O
and	O
degraded	O
,	O
the	O
remaining	O
A	O
beta	O
quickly	O
reaggregates	O
and	O
amyloid	O
pathology	O
is	O
reestablished	O
[	O
49	O
]	O
.	O

This	O
finding	O
reinforces	O
the	O
notion	O
that	O
without	O
continued	O
stimulation	O
,	O
microglia	O
in	O
mouse	O
models	O
do	O
not	O
maintain	O
the	O
same	O
level	O
of	O
sustained	O
activation	O
that	O
may	O
occur	O
in	O
humans	O
.	O

SantaCruz	O
et	O
al	O
.	O
recently	O
published	O
a	O
study	O
of	O
mice	O
that	O
express	O
P301L	O
human	O
tau	O
via	O
a	O
similar	O
vector	O
system	O
[	O
61	O
]	O
.	O

As	O
in	O
our	O
tet	O
-	O
off	O
APP	O
mice	O
,	O
SantaCruz	O
et	O
al	O
.	O
found	O
that	O
tau	O
neurofibrillary	O
tangles	O
,	O
like	O
amyloid	O
plaques	O
,	O
are	O
not	O
cleared	O
efficiently	O
following	O
transgene	O
suppression	O
.	O

The	O
lack	O
of	O
clearance	O
in	O
both	O
models	O
of	O
AD	O
pathology	O
comes	O
as	O
a	O
stark	O
contrast	O
to	O
the	O
rapid	O
removal	O
of	O
protein	O
aggregates	O
found	O
in	O
similar	O
tet	O
-	O
off	O
mouse	O
models	O
of	O
Huntington	O
[	O
32	O
]	O
and	O
prion	O
disease	O
[	O
62	O
]	O
.	O

In	O
these	O
cases	O
,	O
disrupting	O
the	O
input	O
of	O
new	O
monomer	O
to	O
the	O
system	O
via	O
dox	O
-	O
mediated	O
transgene	O
suppression	O
led	O
to	O
relatively	O
rapid	O
clearance	O
of	O
protein	O
aggregates	O
.	O

By	O
contrast	O
,	O
our	O
study	O
and	O
that	O
of	O
SantaCruz	O
et	O
al	O
.	O
suggest	O
that	O
protein	O
aggregates	O
in	O
AD	O
may	O
be	O
more	O
tenacious	O
than	O
in	O
other	O
neurodegenerative	O
disorders	O
.	O

Perhaps	O
once	O
aggregated	O
,	O
A	O
beta	O
and	O
tau	O
are	O
either	O
inherently	O
more	O
stable	O
than	O
other	O
protein	O
aggregates	O
or	O
more	O
resistant	O
to	O
intra	O
-	O
and	O
extracellular	S-GO
clearance	O
mechanisms	O
.	O

One	O
question	O
we	O
were	O
not	O
able	O
to	O
address	O
in	O
this	O
study	O
is	O
whether	O
abrogating	O
synthesis	O
of	O
new	O
A	O
beta	O
halts	O
the	O
progression	O
of	O
cognitive	O
decline	O
.	O

Studies	O
from	O
the	O
tet	O
-	O
off	O
tau	O
mice	O
suggest	O
that	O
protein	O
clearance	O
may	O
in	O
fact	O
not	O
be	O
required	O
for	O
cognitive	O
improvement	O
following	O
transgene	O
suppression	O
[	O
61	O
]	O
.	O

At	O
present	O
,	O
because	O
of	O
unexpected	O
noncognitive	O
behavioral	O
abnormalities	O
,	O
it	O
is	O
not	O
clear	O
whether	O
the	O
tet	O
-	O
off	O
APP	O
mice	O
can	O
be	O
used	O
to	O
address	O
the	O
same	O
question	O
in	O
the	O
context	O
of	O
amyloid	O
pathology	O
.	O

Both	O
lines	O
of	O
tTA	O
/	O
APP	O
mice	O
we	O
studied	O
here	O
display	O
extreme	O
hyperactivity	O
visible	O
as	O
cage	O
circling	O
and	O
quantified	O
by	O
activity	O
monitoring	O
(	O
see	O
Figure	O
7	O
)	O
.	O

Many	O
of	O
the	O
double	O
transgenic	O
mice	O
showed	O
similar	O
circular	O
patterns	O
of	O
swimming	O
near	O
the	O
edge	O
of	O
the	O
tank	O
when	O
tested	O
in	O
the	O
Morris	O
water	O
maze	O
.	O

Expression	O
of	O
this	O
phenotype	O
makes	O
standard	O
tests	O
of	O
learning	O
and	O
memory	O
uninterpretable	O
.	O

Hyperactivity	O
nonspecifically	O
inhibits	O
choice	O
-	O
driven	O
changes	O
in	O
movement	O
,	O
the	O
key	O
element	O
behind	O
all	O
cognitive	O
behavioral	O
paradigms	O
.	O

We	O
are	O
currently	O
working	O
to	O
determine	O
whether	O
hyperactivity	O
correlates	O
with	O
expression	O
of	O
the	O
APPswe	O
/	O
ind	O
holoprotein	O
or	O
its	O
proteolytic	O
derivatives	O
.	O

Preliminary	O
studies	O
suggest	O
that	O
hyperactivity	O
does	O
not	O
appear	O
quickly	O
when	O
dox	O
-	O
reared	O
mice	O
are	O
shifted	O
to	O
nonmedicated	O
diets	O
(	O
J	O
.	O
L	O
.	O
J	O
.	O
,	O
unpublished	O
data	O
)	O
.	O

These	O
data	O
may	O
indicate	O
that	O
the	O
neuroactive	O
culprit	O
is	O
not	O
immediately	O
present	O
after	O
transgenic	O
APP	O
synthesis	O
is	O
initiated	O
,	O
but	O
requires	O
additional	O
time	O
to	O
develop	O
.	O

Alternatively	O
,	O
hyperactivity	O
may	O
be	O
caused	O
by	O
neuronal	O
alterations	O
due	O
to	O
transgene	O
expression	O
during	O
early	O
postnatal	O
development	O
.	O

Further	O
experiments	O
are	O
needed	O
to	O
distinguish	O
between	O
these	O
possibilities	O
.	O

In	O
summary	O
,	O
we	O
demonstrate	O
that	O
abrogating	O
A	O
beta	O
production	O
halts	O
the	O
progression	O
of	O
pathologic	O
changes	O
in	O
a	O
transgenic	O
mouse	O
model	O
of	O
Alzheimer	O
-	O
type	O
amyloidosis	O
.	O

However	O
,	O
despite	O
dramatic	O
reductions	O
in	O
A	O
beta	O
synthesis	O
,	O
neuritic	O
plaques	O
are	O
stable	O
structures	O
in	O
vivo	O
that	O
do	O
not	O
quickly	O
disaggregate	O
.	O

It	O
is	O
possible	O
that	O
a	O
combination	O
of	O
therapies	O
to	O
limit	O
A	O
beta	O
production	O
,	O
increase	O
A	O
beta	O
degradation	O
,	O
and	O
enhance	O
phagocytosis	O
of	O
deposited	O
amyloid	O
may	O
be	O
required	O
to	O
reverse	O
damage	O
associated	O
with	O
AD	O
.	O

However	O
,	O
if	O
started	O
early	O
enough	O
in	O
the	O
course	O
of	O
disease	O
,	O
secretase	O
inhibitors	O
alone	O
could	O
provide	O
substantial	O
benefit	O
in	O
slowing	O
pathogenic	O
processes	O
linked	O
to	O
amyloid	O
deposition	O
.	O

Even	O
at	O
later	O
stages	O
in	O
the	O
disease	O
,	O
the	O
presence	O
of	O
substantial	O
microglial	O
activation	O
in	O
human	O
AD	O
[	O
40	O
]	O
suggests	O
that	O
simply	O
slowing	O
the	O
formation	O
of	O
new	O
amyloid	O
deposits	O
may	O
allow	O
ongoing	O
phagocytosis	O
to	O
diminish	O
preexisting	O
lesions	O
.	O

However	O
,	O
the	O
development	O
of	O
safe	O
and	O
effective	O
secretase	O
inhibitors	O
will	O
ultimately	O
be	O
required	O
to	O
determine	O
whether	O
the	O
human	O
brain	O
has	O
the	O
capacity	O
to	O
repair	O
amyloid	O
-	O
associated	O
damage	O
of	O
AD	O
once	O
the	O
progression	O
of	O
pathology	O
is	O
arrested	O
.	O

Supporting	O
Information	O

Figure	O
S1	O

Transgenic	O
APP	O
Expression	O
and	O
Suppression	O
by	O
Dox	O
in	O
the	O
Four	O
New	O
Tet	O
-	O
Off	O
APP	O
Lines	O

Western	O
blotting	O
with	O
human	O
-	O
specific	O
antibody	S-GO
6E10	O
reveals	O
transgene	O
-	O
derived	O
full	O
-	O
length	O
APP	O
in	O
cortical	O
homogenates	O
from	O
untreated	O
animals	O
(	O
left	O
lanes	O
of	O
each	O
panel	O
)	O
.	O

The	O
new	O
lines	O
produce	O
exceptionally	O
high	O
levels	O
of	O
transgene	O
expression	O
;	O
an	O
equal	O
amount	O
of	O
brain	O
homogenate	O
from	O
a	O
standard	O
transgenic	O
APP	O
line	O
is	O
shown	O
for	O
comparison	O
(	O
extreme	O
left	O
lane	O
,	O
Standard	O
Tg	O
line	O
C3	O
-	O
3	O
;	O
[	O
15	O
,	O
63	O
]	O
)	O
.	O

After	O
1	O
mo	O
of	O
dox	O
treatment	O
,	O
transgenic	O
protein	O
in	O
all	O
four	O
new	O
tet	O
-	O
off	O
APP	O
lines	O
is	O
reduced	O
to	O
residual	O
levels	O
(	O
+	O
dox	O
;	O
right	O
lanes	O
of	O
each	O
panel	O
)	O
.	O

(	O
474	O
KB	O
TIF	O
)	O
.	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Figure	O
S2	O

Transgenic	O
APP	O
mRNA	O
Is	O
Brain	O
-	O
Specific	O

A	O
slot	O
blot	O
of	O
mRNA	O
harvested	O
from	O
various	O
tissues	O
in	O
three	O
of	O
the	O
four	O
new	O
tet	O
-	O
off	O
APP	O
lines	O
and	O
a	O
nontransgenic	O
control	O
was	O
used	O
to	O
examine	O
transgenic	O
mRNA	O
expression	O
.	O

Hybridization	O
is	O
seen	O
only	O
in	O
the	O
brain	O
;	O
no	O
signal	O
above	O
background	O
is	O
seen	O
in	O
any	O
other	O
tissue	O
.	O

(	O
781	O
KB	O
PSD	O
)	O
.	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Figure	O
S3	O

Amyloid	O
Pathology	O
in	O
the	O
Cortex	O
Reiterates	O
That	O
in	O
the	O
Hippocampus	O

Amyloid	O
histology	O
was	O
performed	O
on	O
sections	O
from	O
line	O
107	O
double	O
transgenic	O
mice	O
by	O
Hirano	O
silver	O
stain	O
(	O
top	O
row	O
)	O
,	O
thioflavin	O
-	O
S	O
(	O
middle	O
row	O
)	O
,	O
and	O
A	O
beta	O
immunohistochemistry	O
(	O
bottom	O
row	O
)	O
to	O
examine	O
the	O
persistence	O
of	O
pathology	O
following	O
transgene	O
suppression	O
.	O

As	O
in	O
the	O
hippocampus	O
(	O
see	O
Figure	O
4	O
and	O
text	O
)	O
,	O
the	O
progression	O
of	O
amyloid	O
pathology	O
in	O
the	O
cortex	O
worsens	O
substantially	O
between	O
6	O
and	O
9	O
mo	O
of	O
age	O
in	O
untreated	O
mice	O
.	O

This	O
progression	O
is	O
completely	O
prevented	O
by	O
suppression	O
of	O
the	O
transgene	O
with	O
dox	O
.	O

For	O
comparison	O
,	O
normal	O
neurohistology	O
is	O
shown	O
in	O
an	O
age	O
-	O
matched	O
single	O
transgenic	O
(	O
tTA	O
only	O
)	O
animal	O
.	O

No	O
amyloid	O
pathology	O
has	O
been	O
detected	O
in	O
either	O
APP	O
or	O
tTA	O
single	O
transgenic	O
animals	O
up	O
to	O
15	O
mo	O
of	O
age	O
.	O

(	O
4	O
.	O
8	O
MB	O
PSD	O
)	O
.	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Figure	O
S4	O

Diffuse	O
Deposits	O
Do	O
Not	O
Disperse	O
During	O
A	O
beta	O
Suppression	O

Campbell	O
-	O
Switzer	O
silver	O
stain	O
was	O
used	O
to	O
differentiate	O
cored	O
(	O
brown	O
)	O
from	O
diffuse	O
(	O
black	O
)	O
deposits	O
in	O
line	O
107	O
tTA	O
/	O
APP	O
mice	O
.	O

This	O
stain	O
demonstrates	O
that	O
both	O
types	O
of	O
deposit	O
persist	O
throughout	O
long	O
periods	O
of	O
transgene	O
suppression	O
.	O

The	O
lower	O
panels	O
,	O
showing	O
low	O
-	O
power	O
images	O
(	O
10	O
x	O
)	O
of	O
frontal	O
cortex	O
from	O
each	O
condition	O
,	O
reveal	O
little	O
change	O
in	O
the	O
extent	O
of	O
diffuse	O
amyloid	O
following	O
up	O
to	O
6	O
mo	O
of	O
A	O
beta	O
suppression	O
.	O

High	O
-	O
power	O
images	O
(	O
40	O
x	O
)	O
in	O
the	O
upper	O
panels	O
show	O
that	O
the	O
diffuse	O
halo	O
surrounding	O
individual	O
cored	O
deposits	O
remains	O
relatively	O
unchanged	O
in	O
treated	O
mice	O
.	O

Untreated	O
tTA	O
single	O
transgenic	O
animals	O
are	O
shown	O
as	O
a	O
negative	O
control	O
.	O

Protocol	O
for	O
the	O
Campbell	O
-	O
Switzer	O
Alzheimer	O
'	O
s	O
Method	O
was	O
kindly	O
shared	O
by	O
Robert	O
Switzer	O
,	O
III	O
(	O
NeuroScience	O
Associates	O
,	O
Knoxville	O
,	O
Tennessee	O
,	O
United	O
States	O
)	O
,	O
and	O
can	O
be	O
downloaded	O
at	O
http	O
:	O
/	O
/	O
www	O
.	O
nsalabs	O
.	O
com	O
/	O
Documents	O
/	O
publications	O
/	O
campbell	O
-	O
switzer	O
_	O
protocol	O
.	O
htm	O
[	O
64	O
,	O
65	O
]	O
.	O

(	O
923	O
KB	O
JPG	O
)	O
.	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Figure	O
S5	O

Chronic	O
Transgene	O
Suppression	O
and	O
Arrest	O
of	O
A	O
beta	O
Aggregate	O
Formation	O
in	O
an	O
Independent	O
Line	O
of	O
Tet	O
-	O
Off	O
APP	O
Mice	O
(	O
CaMKII	O
alpha	O
-	O
tTA	O
x	O
tet	O
-	O
APPswe	O
/	O
ind	O
Line	O
18	O
)	O

(	O
A	O
)	O
The	O
experiment	O
presented	O
in	O
the	O
text	O
for	O
line	O
107	O
tet	O
-	O
off	O
APP	O
was	O
repeated	O
with	O
a	O
second	O
tet	O
-	O
off	O
APP	O
line	O
(	O
line	O
18	O
)	O
to	O
control	O
for	O
integration	O
site	O
artifacts	O
.	O

Cortical	O
homogenates	O
from	O
untreated	O
control	O
and	O
dox	O
-	O
treated	O
double	O
transgenic	O
mice	O
were	O
immunoblotted	O
for	O
full	O
-	O
length	O
APP	O
with	O
the	O
human	O
-	O
specific	O
antibody	S-GO
6E10	O
to	O
confirm	O
transgene	O
suppression	O
at	O
the	O
time	O
of	O
harvest	O
.	O

Immunostaining	O
for	O
endogenous	O
superoxide	O
dismutase	O
(	O
SOD1	O
)	O
was	O
included	O
as	O
a	O
loading	O
control	O
.	O

(	O
B	O
)	O
Quantitation	O
of	O
signal	O
intensity	O
from	O
the	O
Western	O
blot	O
in	O
(	O
A	O
)	O
shows	O
transgenic	O
APP	O
levels	O
in	O
line	O
18	O
are	O
suppressed	O
by	O
more	O
than	O
98	O
%	O
following	O
3	O
mo	O
of	O
dox	O
treatment	O
(	O
significant	O
effect	O
of	O
group	O
ANOVA	O
F2	O
,	O
8	O
=	O
1559	O
.	O
7	O
,	O
p	O
<	O
0	O
.	O
001	O
)	O
.	O

This	O
level	O
of	O
suppression	O
was	O
equal	O
to	O
or	O
better	O
than	O
that	O
attained	O
in	O
line	O
107	O
(	O
see	O
Figure	O
3B	O
)	O
.	O

(	O
C	O
)	O
Serial	O
dilution	O
filter	O
trap	O
assay	O
was	O
used	O
to	O
quantify	O
aggregated	O
A	O
beta	O
in	O
cortical	O
homogenates	O
.	O

(	O
D	O
)	O
Quantitation	O
of	O
signal	O
intensity	O
in	O
the	O
linear	O
range	O
of	O
the	O
dilution	O
series	O
shown	O
in	O
(	O
C	O
)	O
.	O

Consistent	O
with	O
the	O
amyloid	O
histology	O
shown	O
in	O
Figure	O
S5	O
,	O
aggregate	O
formation	O
was	O
significantly	O
increased	O
between	O
6	O
and	O
9	O
mo	O
of	O
age	O
in	O
untreated	O
mice	O
(	O
significant	O
effect	O
of	O
group	O
ANOVA	O
F2	O
,	O
18	O
=	O
12	O
.	O
14	O
,	O
p	O
<	O
0	O
.	O
001	O
)	O
.	O

Aggregate	O
formation	O
was	O
completely	O
arrested	O
by	O
transgene	O
suppression	O
,	O
and	O
is	O
identical	O
in	O
9	O
-	O
mo	O
-	O
old	O
mice	O
treated	O
with	O
dox	O
for	O
3	O
mo	O
as	O
in	O
untreated	O
animals	O
harvested	O
when	O
treatment	O
began	O
(	O
p	O
>	O
0	O
.	O
5	O
,	O
Tukey	O
post	O
-	O
hoc	O
test	O
)	O
.	O

*	O
,	O
p	O
<	O
0	O
.	O
05	O
;	O
*	O
*	O
,	O
p	O
<	O
0	O
.	O
005	O
;	O
*	O
*	O
*	O
,	O
p	O
<	O
0	O
.	O
001	O
versus	O
9	O
-	O
mo	O
-	O
old	O
untreated	O
mice	O
,	O
Tukey	O
post	O
-	O
hoc	O
test	O
.	O

(	O
962	O
KB	O
TIF	O
)	O
.	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Figure	O
S6	O

Arrest	O
of	O
Amyloid	O
Progression	O
by	O
Chronic	O
Transgene	O
Suppression	O
in	O
Line	O
18	O
Tet	O
-	O
Off	O
APP	O
Mice	O

Amyloid	O
histology	O
in	O
cortical	O
(	O
first	O
and	O
third	O
rows	O
)	O
and	O
hippocampal	O
(	O
second	O
and	O
fourth	O
rows	O
)	O
sections	O
from	O
untreated	O
tTA	O
/	O
APP	O
mice	O
shows	O
a	O
dramatic	O
progression	O
of	O
pathology	O
between	O
6	O
and	O
9	O
mo	O
of	O
age	O
.	O

Suppression	O
of	O
transgenic	O
APP	O
expression	O
arrests	O
this	O
progression	O
,	O
although	O
without	O
any	O
sign	O
of	O
plaque	O
clearance	O
(	O
6	O
mo	O
+	O
3	O
mo	O
dox	O
)	O
.	O

Hirano	O
silver	O
stain	O
(	O
top	O
panels	O
)	O
;	O
thioflavin	O
-	O
S	O
(	O
bottom	O
panels	O
)	O
.	O

(	O
5	O
.	O
8	O
MB	O
PSD	O
)	O
.	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Patient	O
Summary	O

Background	O

Patients	O
with	O
Alzheimer	O
disease	O
(	O
AD	O
)	O
have	O
elevated	O
levels	O
of	O
a	O
small	O
protein	O
called	O
amyloid	O
-	O
beta	O
peptide	O
that	O
sticks	O
together	O
to	O
form	O
what	O
are	O
known	O
as	O
amyloid	O
plaques	O
in	O
their	O
brains	O
.	O

This	O
peptide	O
is	O
normally	O
made	O
at	O
low	O
levels	O
in	O
healthy	O
individuals	O
,	O
and	O
is	O
made	O
when	O
a	O
larger	O
protein	O
called	O
amyloid	O
precursor	O
protein	O
(	O
APP	O
)	O
is	O
cut	O
down	O
in	O
size	O
.	O

New	O
treatments	O
are	O
now	O
being	O
developed	O
that	O
will	O
decrease	O
the	O
amount	O
of	O
A	O
beta	O
produced	O
from	O
APP	O
.	O

However	O
,	O
it	O
is	O
not	O
clear	O
whether	O
lowering	O
the	O
production	O
of	O
A	O
beta	O
will	O
allow	O
the	O
brain	O
to	O
heal	O
itself	O
by	O
clearing	O
the	O
amyloid	O
plaques	O
.	O

The	O
answer	O
to	O
this	O
question	O
may	O
be	O
important	O
for	O
deciding	O
when	O
A	O
beta	O
-	O
lowering	O
drugs	O
should	O
be	O
started	O
,	O
and	O
may	O
also	O
determine	O
how	O
effective	O
they	O
are	O
in	O
reversing	O
the	O
mental	O
symptoms	O
of	O
AD	O
.	O

What	O
Did	O
the	O
Researchers	O
Do	O
and	O
Find	O
?	O

Because	O
new	O
drugs	O
designed	O
to	O
lower	O
A	O
beta	O
levels	O
are	O
still	O
in	O
development	O
,	O
they	O
are	O
not	O
available	O
for	O
testing	O
in	O
animal	O
models	O
of	O
the	O
disease	O
.	O

Instead	O
,	O
basic	O
questions	O
about	O
the	O
effectiveness	O
of	O
this	O
type	O
of	O
treatment	O
must	O
be	O
answered	O
using	O
systems	O
that	O
mimic	O
how	O
the	O
drugs	O
work	O
.	O

To	O
do	O
this	O
,	O
the	O
authors	O
created	O
mice	O
that	O
produce	O
too	O
much	O
APP	O
and	O
that	O
develop	O
the	O
same	O
amyloid	O
lesions	O
as	O
do	O
human	O
patients	O
with	O
AD	O
.	O

Unlike	O
normal	O
mice	O
,	O
these	O
mice	O
also	O
carried	O
a	O
"	O
switch	O
"	O
gene	O
that	O
allowed	O
the	O
researchers	O
to	O
turn	O
off	O
APP	O
by	O
feeding	O
the	O
mice	O
special	O
food	O
.	O

Turning	O
off	O
APP	O
in	O
these	O
mice	O
had	O
the	O
same	O
effect	O
as	O
treating	O
them	O
with	O
A	O
beta	O
-	O
lowering	O
drugs	O
,	O
and	O
so	O
the	O
researchers	O
were	O
able	O
to	O
ask	O
what	O
happened	O
to	O
the	O
amyloid	O
plaques	O
after	O
A	O
beta	O
production	O
was	O
shut	O
down	O
.	O

They	O
showed	O
that	O
lowering	O
A	O
beta	O
production	O
prevents	O
the	O
amyloid	O
lesions	O
from	O
getting	O
worse	O
as	O
the	O
disease	O
progresses	O
.	O

This	O
means	O
that	O
treatment	O
with	O
A	O
beta	O
-	O
lowering	O
drugs	O
may	O
be	O
able	O
to	O
stop	O
the	O
disease	O
from	O
filling	O
the	O
brain	O
with	O
plaques	O
.	O

However	O
,	O
the	O
researchers	O
also	O
found	O
that	O
the	O
amyloid	O
lesions	O
that	O
had	O
formed	O
before	O
treatment	O
was	O
started	O
remained	O
intact	O
throughout	O
the	O
experiment	O
.	O

What	O
Do	O
These	O
Findings	O
Mean	O
?	O

These	O
results	O
indicate	O
that	O
treatments	O
designed	O
to	O
lower	O
the	O
production	O
of	O
A	O
beta	O
may	O
be	O
an	O
important	O
part	O
of	O
future	O
AD	O
treatment	O
,	O
as	O
this	O
approach	O
seems	O
to	O
prevents	O
additional	O
amyloid	O
plaques	O
from	O
forming	O
in	O
the	O
mouse	O
brain	O
.	O

However	O
,	O
by	O
itself	O
,	O
this	O
strategy	O
may	O
not	O
be	O
able	O
to	O
rid	O
the	O
brain	O
of	O
plaques	O
that	O
have	O
already	O
formed	O
in	O
the	O
brain	O
before	O
treatment	O
is	O
started	O
.	O

The	O
findings	O
suggest	O
that	O
early	O
treatment	O
may	O
be	O
important	O
for	O
this	O
approach	O
to	O
succeed	O
.	O

Where	O
Can	O
I	O
Get	O
More	O
Information	O
Online	O
?	O

MedlinePlus	O
has	O
several	O
Web	O
pages	O
of	O
information	O
on	O
Alzheimer	O
disease	O
:	O

http	O
:	O
/	O
/	O
www	O
.	O
nlm	O
.	O
nih	O
.	O
gov	O
/	O
medlineplus	O
/	O
alzheimersdisease	O
.	O
html	O

The	O
ADEAR	O
Center	O
of	O
the	O
US	O
Government	O
'	O
s	O
National	O
Institute	O
on	O
Aging	O
also	O
has	O
information	O
on	O
Alzheimer	O
disease	O
:	O

http	O
:	O
/	O
/	O
www	O
.	O
alzheimers	O
.	O
org	O
/	O

The	O
Alzheimer	O
'	O
s	O
Association	O
Web	O
site	O
contains	O
information	O
on	O
both	O
caregiving	O
and	O
research	O
:	O

http	O
:	O
/	O
/	O
www	O
.	O
alz	O
.	O
org	O

Acknowledgements	O

We	O
thank	O
Patrick	O
Tremblay	O
for	O
helpful	O
advice	O
on	O
the	O
tet	O
system	O
at	O
a	O
critical	O
time	O
in	O
the	O
project	O
,	O
and	O
Mark	O
Mayford	O
for	O
sharing	O
the	O
CaMKII	O
alpha	O
-	O
tTA	O
mice	O
through	O
Jackson	O
Laboratory	O
.	O

We	O
also	O
thank	O
Fraser	O
Moss	O
for	O
saving	O
several	O
immunoblots	O
with	O
last	O
-	O
minute	O
shipments	O
,	O
Andy	O
Groves	O
for	O
many	O
thoughtful	O
discussions	O
,	O
Neil	O
Segil	O
for	O
generously	O
sharing	O
his	O
laboratory	O
and	O
equipment	O
,	O
Beth	O
Olson	O
,	O
Natasha	O
Bouey	O
,	O
and	O
Yolanda	O
Jackson	O
for	O
outstanding	O
animal	O
care	O
,	O
Debbie	O
Swing	O
for	O
expert	O
microinjection	O
,	O
and	O
Dave	O
Fromholt	O
for	O
genotyping	O
and	O
dissection	O
.	O

We	O
gratefully	O
acknowledge	O
Takeda	O
Chemical	O
Industries	O
for	O
providing	O
antibodies	S-GO
BAN50	O
,	O
BA27	O
,	O
and	O
BC05	O
,	O
Konrad	O
Beyreuther	O
and	O
Andreas	O
Weidemann	O
for	O
providing	O
22C11	O
antibody	S-GO
,	O
and	O
Ed	O
Koo	O
for	O
sharing	O
CT15	O
antibody	S-GO
.	O

This	O
work	O
was	O
supported	O
by	O
grants	O
from	O
the	O
Johns	O
Hopkins	O
Alzheimer	O
'	O
s	O
Disease	O
Research	O
Center	O
(	O
JLJ	O
)	O
,	O
the	O
National	O
Alliance	O
for	O
Research	O
on	O
Schizophrenia	O
and	O
Depression	O
(	O
Young	O
Investigator	O
Award	O
[	O
JLJ	O
]	O
)	O
,	O
the	O
Rose	O
Hills	O
Foundation	O
(	O
JLJ	O
)	O
,	O
the	O
Alzheimer	O
'	O
s	O
Association	O
(	O
Zenith	O
Award	O
[	O
DRB	O
]	O
)	O
,	O
the	O
National	O
Institute	O
of	O
Aging	O
(	O
K01	O
AG26144	O
-	O
01	O
[	O
JLJ	O
]	O
,	O
P50	O
AGO5146	O
-	O
20	O
[	O
DRB	O
]	O
,	O
R01	O
AG006656	O
-	O
16	O
[	O
SGY	O
]	O
,	O
and	O
P01	O
AG015453	O
[	O
SGY	O
]	O
)	O
,	O
the	O
National	O
Institute	O
of	O
Neurologic	O
Disease	O
and	O
Stoke	O
(	O
R01	O
NS	O
047225	O
[	O
DRB	O
]	O
)	O
,	O
and	O
the	O
National	O
Cancer	O
Institute	O
(	O
NAJ	O
and	O
NGC	O
)	O
.	O

The	O
funding	O
agencies	O
generously	O
provided	O
for	O
research	O
supplies	O
,	O
animal	O
care	O
,	O
and	O
salary	O
support	O
;	O
the	O
funders	O
of	O
this	O
work	O
had	O
no	O
role	O
in	O
study	O
design	O
,	O
data	O
collection	O
and	O
analysis	O
,	O
decision	O
to	O
publish	O
,	O
or	O
preparation	O
of	O
the	O
manuscript	O
.	O

Abbreviations	O

A	O
beta	O
-	O
amyloid	O
-	O
beta	O

AD	O
-	O
Alzheimer	O
disease	O

APLP	O
-	O
amyloid	O
precursor	O
-	O
like	O
protein	O

APP	O
-	O
amyloid	O
precursor	O
protein	O

CaMKII	O
alpha	O
-	O
calcium	O
-	O
calmodulin	O
kinase	O
II	O
alpha	O

dox	O
-	O
doxycycline	O

FA	O
-	O
formic	O
acid	O

GFAP	O
-	O
glial	O
fibrillary	O
acidic	O
protein	O

mo	O
/	O
huAPP695	O
-	O
mouse	O
APP	O
with	O
a	O
humanized	O
A	O
beta	O
domain	O

PBS	O
-	O
phosphate	O
-	O
buffered	O
saline	O

SDS	O
-	O
sodium	O
dodecyl	O
sulfate	O

swe	O
/	O
ind	O
-	O
Swedish	O
/	O
Indiana	O

tTA	O
-	O
tetracycline	O
transactivator	O

Figures	O
and	O
Tables	O

Figure	O
1	O

Control	O
of	O
Transgenic	O
APP	O
Expression	O
by	O
Dox	O

(	O
A	O
)	O
Western	O
blotting	O
for	O
transgenic	O
APP	O
using	O
the	O
human	O
-	O
specific	O
6E10	O
antibody	S-GO
shows	O
expression	O
of	O
full	O
-	O
length	O
protein	O
in	O
forebrain	O
tissue	O
from	O
young	O
predeposit	O
double	O
transgenic	O
animals	O
(	O
line	O
107	O
)	O
and	O
its	O
suppression	O
following	O
dox	O
treatment	O
.	O

Untreated	O
animals	O
show	O
high	O
levels	O
of	O
transgene	O
expression	O
;	O
protein	O
levels	O
drop	O
dramatically	O
in	O
animals	O
acutely	O
treated	O
with	O
dox	O
for	O
2	O
wk	O
.	O

A	O
faint	O
,	O
but	O
detectable	O
band	O
of	O
full	O
-	O
length	O
protein	O
remains	O
in	O
acutely	O
treated	O
animals	O
that	O
can	O
be	O
eliminated	O
in	O
mice	O
born	O
and	O
raised	O
on	O
dox	O
.	O

(	O
B	O
)	O
Immunoblotting	O
with	O
the	O
N	O
-	O
terminal	O
antibody	S-GO
22C11	O
to	O
detect	O
both	O
transgenic	O
and	O
endogenous	O
protein	O
shows	O
that	O
dox	O
treatment	O
reduces	O
APP	O
/	O
APLP	O
to	O
levels	O
found	O
in	O
nontransgenic	O
mice	O
.	O

(	O
C	O
)	O
Measurement	O
of	O
signal	O
intensity	O
from	O
the	O
Western	O
blot	O
in	O
(	O
A	O
)	O
shows	O
transgenic	O
APP	O
levels	O
are	O
decreased	O
more	O
than	O
95	O
%	O
by	O
dox	O
in	O
both	O
acutely	O
and	O
chronically	O
treated	O
animals	O
(	O
97	O
.	O
2	O
%	O
for	O
4	O
wk	O
+	O
2	O
wk	O
dox	O
,	O
98	O
.	O
0	O
%	O
for	O
reared	O
on	O
dox	O
versus	O
4	O
wk	O
untreated	O
;	O
ANOVA	O
effect	O
of	O
treatment	O
group	O
F4	O
,	O
15	O
=	O
85	O
.	O
55	O
,	O
p	O
<	O
0	O
.	O
001	O
)	O
.	O

APP	O
levels	O
in	O
4	O
wk	O
+	O
2	O
wk	O
dox	O
,	O
reared	O
on	O
dox	O
,	O
and	O
nontransgenic	O
(	O
NTg	O
)	O
were	O
not	O
significantly	O
different	O
(	O
p	O
>	O
0	O
.	O
9	O
,	O
Tukey	O
post	O
-	O
hoc	O
test	O
)	O
.	O

(	O
D	O
)	O
Measurement	O
of	O
signal	O
intensity	O
from	O
the	O
Western	O
blot	O
in	O
(	O
B	O
)	O
shows	O
total	O
APP	O
/	O
APLP	O
levels	O
in	O
dox	O
-	O
treated	O
tTA	O
/	O
APP	O
mice	O
are	O
significantly	O
lower	O
than	O
in	O
4	O
-	O
wk	O
-	O
old	O
untreated	O
mice	O
(	O
ANOVA	O
effect	O
of	O
treatment	O
group	O
F4	O
,	O
15	O
=	O
84	O
.	O
41	O
,	O
p	O
<	O
0	O
.	O
001	O
)	O
and	O
indistinguishable	O
from	O
those	O
of	O
nontransgenic	O
animals	O
(	O
p	O
>	O
0	O
.	O
9	O
,	O
Tukey	O
post	O
-	O
hoc	O
test	O
)	O
.	O

*	O
,	O
p	O
<	O
0	O
.	O
001	O
versus	O
untreated	O
4	O
-	O
wk	O
-	O
old	O
mice	O
,	O
Tukey	O
post	O
-	O
hoc	O
test	O
applied	O
to	O
significant	O
effect	O
of	O
group	O
ANOVA	O
.	O

Figure	O
2	O

A	O
beta	O
Levels	O
Are	O
Dramatically	O
Reduced	O
by	O
Transgene	O
Suppression	O

Cortical	O
homogenates	O
from	O
young	O
,	O
predeposit	O
tTA	O
/	O
APP	O
mice	O
used	O
for	O
Western	O
blot	O
in	O
Figure	O
1	O
(	O
line	O
107	O
)	O
were	O
fractionated	O
by	O
sequential	O
multi	O
-	O
step	O
extraction	O
with	O
PBS	O
,	O
2	O
%	O
SDS	O
,	O
and	O
70	O
%	O
FA	O
followed	O
by	O
human	O
-	O
specific	O
A	O
beta	O
ELISA	O
to	O
measure	O
transgene	O
-	O
derived	O
peptide	O
in	O
each	O
fraction	S-GO
.	O

A	O
beta	O
40	O
is	O
shown	O
in	O
white	O
,	O
A	O
beta	O
42	O
in	O
black	O
.	O

(	O
A	O
)	O
PBS	O
-	O
soluble	O
A	O
beta	O
levels	O
are	O
substantially	O
reduced	O
by	O
both	O
acute	O
and	O
chronic	O
dox	O
treatment	O
(	O
ANOVA	O
,	O
effect	O
of	O
treatment	O
group	O
F4	O
,	O
24	O
=	O
137	O
.	O
10	O
and	O
386	O
.	O
01	O
,	O
p	O
<	O
0	O
.	O
001	O
,	O
for	O
A	O
beta	O
40	O
and	O
A	O
beta	O
42	O
,	O
respectively	O
)	O
.	O

A	O
beta	O
levels	O
in	O
treated	O
animals	O
are	O
indistinguishable	O
from	O
nontransgenic	O
(	O
NTg	O
)	O
animals	O
(	O
p	O
>	O
0	O
.	O
3	O
,	O
Tukey	O
post	O
-	O
hoc	O
test	O
)	O
.	O

(	O
B	O
)	O
In	O
the	O
young	O
animals	O
tested	O
here	O
prior	O
to	O
the	O
formation	O
of	O
visible	O
amyloid	O
deposits	O
,	O
most	O
A	O
beta	O
is	O
extracted	O
into	O
the	O
SDS	O
fraction	S-GO
(	O
84	O
%	O
and	O
76	O
%	O
of	O
all	O
transgene	O
-	O
derived	O
A	O
beta	O
40	O
and	O
A	O
beta	O
42	O
,	O
respectively	O
)	O
.	O

As	O
in	O
the	O
PBS	O
-	O
soluble	O
fraction	S-GO
,	O
A	O
beta	O
levels	O
in	O
the	O
SDS	O
fraction	S-GO
are	O
significantly	O
lowered	O
by	O
dox	O
treatment	O
compared	O
to	O
untreated	O
animals	O
(	O
ANOVA	O
effect	O
of	O
group	O
F4	O
,	O
24	O
=	O
197	O
.	O
57	O
and	O
163	O
.	O
48	O
,	O
p	O
<	O
0	O
.	O
001	O
,	O
for	O
A	O
beta	O
40	O
and	O
A	O
beta	O
42	O
,	O
respectively	O
)	O
.	O

Acutely	O
treated	O
animals	O
retained	O
a	O
small	O
(	O
although	O
significant	O
)	O
amount	O
of	O
residual	O
peptide	O
(	O
p	O
<	O
0	O
.	O
001	O
compared	O
to	O
nontransgeinc	O
,	O
Tukey	O
post	O
-	O
hoc	O
test	O
)	O
,	O
whereas	O
A	O
beta	O
levels	O
in	O
mice	O
born	O
and	O
raised	O
on	O
dox	O
were	O
reduced	O
to	O
levels	O
indistinguishable	O
from	O
nontransgenic	O
(	O
p	O
>	O
0	O
.	O
8	O
,	O
Tukey	O
post	O
-	O
hoc	O
test	O
)	O
.	O

(	O
C	O
)	O
The	O
FA	O
-	O
soluble	O
fraction	S-GO
already	O
contains	O
a	O
small	O
but	O
significant	O
pool	O
of	O
aggregated	O
A	O
beta	O
42	O
in	O
untreated	O
animals	O
by	O
4	O
wk	O
of	O
age	O
(	O
p	O
<	O
0	O
.	O
05	O
versus	O
nontransgenic	O
;	O
Tukey	O
post	O
-	O
hoc	O
test	O
applied	O
to	O
significant	O
effect	O
of	O
group	O
ANOVA	O
F4	O
,	O
24	O
=	O
17	O
.	O
11	O
,	O
p	O
<	O
0	O
.	O
001	O
)	O
.	O

By	O
6	O
wk	O
of	O
age	O
,	O
the	O
amount	O
of	O
A	O
beta	O
in	O
the	O
FA	O
fraction	S-GO
is	O
increased	O
significantly	O
preceding	O
the	O
appearance	O
of	O
visible	O
deposits	O
2	O
wk	O
later	O
.	O

The	O
FA	O
pool	O
is	O
the	O
only	O
peptide	O
fraction	S-GO
not	O
lowered	O
by	O
acute	O
dox	O
treatment	O
(	O
4	O
wk	O
untreated	O
=	O
4	O
wk	O
+	O
2	O
wk	O
dox	O
,	O
p	O
>	O
0	O
.	O
9	O
,	O
Tukey	O
post	O
-	O
hoc	O
test	O
)	O
,	O
consistent	O
with	O
poor	O
turnover	O
of	O
aggregated	O
A	O
beta	O
species	O
.	O

(	O
D	O
)	O
Measurements	O
of	O
total	O
A	O
beta	O
,	O
including	O
both	O
endogenous	O
and	O
transgene	O
-	O
derived	O
peptides	O
,	O
show	O
that	O
animals	O
born	O
and	O
raised	O
on	O
dox	O
harbor	O
A	O
beta	O
levels	O
identical	O
to	O
nontransgenic	O
animals	O
(	O
p	O
>	O
0	O
.	O
9	O
,	O
Tukey	O
post	O
-	O
hoc	O
test	O
,	O
effect	O
of	O
group	O
ANOVA	O
F4	O
,	O
24	O
=	O
39	O
.	O
13	O
and	O
35	O
.	O
29	O
,	O
p	O
<	O
0	O
.	O
001	O
,	O
for	O
A	O
beta	O
40	O
and	O
A	O
beta	O
42	O
,	O
respectively	O
)	O
.	O

Whereas	O
chronic	O
transgene	O
suppression	O
fully	O
prevents	O
synthesis	O
of	O
both	O
peptides	O
,	O
acute	O
dox	O
treatment	O
fully	O
suppresses	O
A	O
beta	O
40	O
levels	O
(	O
p	O
>	O
0	O
.	O
8	O
,	O
Tukey	O
post	O
-	O
hoc	O
test	O
)	O
,	O
but	O
leaves	O
a	O
small	O
amount	O
of	O
nonsuppressed	O
A	O
beta	O
42	O
.	O

The	O
residual	O
A	O
beta	O
42	O
observed	O
in	O
acutely	O
treated	O
young	O
animals	O
derives	O
from	O
uncleared	O
aggregates	O
extracted	O
in	O
the	O
SDS	O
and	O
FA	O
fractions	S-GO
.	O

*	O
,	O
p	O
<	O
0	O
.	O
05	O
;	O
*	O
*	O
,	O
p	O
<	O
0	O
.	O
005	O
;	O
*	O
*	O
*	O
,	O
p	O
<	O
0	O
.	O
001	O
versus	O
4	O
-	O
wk	O
-	O
old	O
untreated	O
mice	O
,	O
Tukey	O
post	O
-	O
hoc	O
applied	O
to	O
significant	O
effect	O
of	O
group	O
ANOVA	O
.	O

Figure	O
3	O

Robust	O
Transgene	O
Suppression	O
in	O
Older	O
Mice	O
with	O
Preexisting	O
Amyloid	O
Pathology	O

(	O
A	O
)	O
Cortical	O
homogenates	O
from	O
6	O
-	O
to	O
12	O
-	O
mo	O
-	O
old	O
animals	O
used	O
for	O
pathology	O
studies	O
described	O
below	O
(	O
line	O
107	O
)	O
were	O
immunoblotted	O
with	O
human	O
-	O
specific	O
antibody	S-GO
6E10	O
to	O
examine	O
transgene	O
suppression	O
following	O
3	O
or	O
6	O
mo	O
of	O
dox	O
treatment	O
.	O

The	O
blot	O
was	O
co	O
-	O
immunostained	O
for	O
endogenous	O
superoxide	O
dismutase	O
1	O
(	O
SOD1	O
)	O
as	O
a	O
control	O
for	O
loading	O
.	O

(	O
B	O
)	O
Quantitation	O
of	O
signal	O
intensity	O
from	O
the	O
Western	O
blot	O
shown	O
in	O
(	O
A	O
)	O
.	O

Transgenic	O
APP	O
levels	O
are	O
significantly	O
suppressed	O
following	O
3	O
or	O
6	O
mo	O
of	O
dox	O
treatment	O
(	O
96	O
.	O
9	O
%	O
and	O
97	O
.	O
6	O
%	O
,	O
respectively	O
)	O
.	O

*	O
,	O
p	O
<	O
0	O
.	O
001	O
compared	O
to	O
6	O
-	O
mo	O
-	O
old	O
untreated	O
animals	O
,	O
Tukey	O
post	O
-	O
hoc	O
test	O
applied	O
to	O
significant	O
effect	O
of	O
group	O
ANOVA	O
F3	O
,	O
12	O
=	O
107	O
.	O
22	O
,	O
p	O
<	O
0	O
.	O
001	O
.	O

These	O
data	O
demonstrate	O
that	O
strong	O
transgene	O
suppression	O
is	O
attained	O
both	O
before	O
and	O
after	O
the	O
onset	O
of	O
amyloid	O
pathology	O
(	O
see	O
Figure	O
1	O
for	O
predeposit	O
experiments	O
)	O
.	O

(	O
C	O
)	O
Experimental	O
design	O
.	O

To	O
examine	O
the	O
effects	O
of	O
chronic	O
A	O
beta	O
suppression	O
on	O
amyloid	O
pathology	O
after	O
the	O
onset	O
of	O
deposition	O
,	O
we	O
compared	O
untreated	O
controls	O
harvested	O
at	O
6	O
and	O
9	O
mo	O
of	O
age	O
to	O
animals	O
placed	O
on	O
dox	O
at	O
6	O
mo	O
of	O
age	O
and	O
harvested	O
after	O
3	O
or	O
6	O
mo	O
of	O
treatment	O
.	O

(	O
D	O
)	O
Dox	O
treatment	O
leads	O
to	O
rapid	O
transgene	O
suppression	O
even	O
in	O
6	O
-	O
mo	O
-	O
old	O
tTA	O
/	O
APP	O
mice	O
.	O

Immunostaining	O
with	O
6E10	O
shows	O
APPswe	O
/	O
ind	O
levels	O
are	O
dramatically	O
reduced	O
in	O
6	O
-	O
mo	O
-	O
old	O
mice	O
treated	O
for	O
1	O
wk	O
with	O
dox	O
(	O
upper	O
panel	O
)	O
.	O

A	O
separate	O
blot	O
was	O
immunostained	O
for	O
APP	O
C	O
-	O
terminal	O
fragments	O
with	O
CT15	O
antibody	S-GO
to	O
show	O
that	O
the	O
precursors	O
to	O
A	O
beta	O
cleavage	O
are	O
decreased	O
in	O
parallel	O
with	O
the	O
full	O
-	O
length	O
protein	O
(	O
middle	O
panel	O
)	O
.	O

Costaining	O
for	O
superoxide	O
dismutase	O
1	O
was	O
used	O
as	O
an	O
internal	O
control	O
for	O
loading	O
(	O
lower	O
panel	O
,	O
taken	O
from	O
bottom	O
half	O
of	O
6E10	O
blot	O
)	O
.	O

Figure	O
4	O

Suppression	O
of	O
Transgenic	O
APP	O
Arrests	O
Progression	O
of	O
Amyloid	O
Pathology	O

(	O
A	O
)	O
Aggregated	O
A	O
beta	O
was	O
quantified	O
in	O
cortical	O
tissue	O
from	O
dox	O
-	O
treated	O
and	O
control	O
tTA	O
/	O
APP	O
mice	O
(	O
line	O
107	O
)	O
using	O
a	O
filter	O
trap	O
assay	O
.	O

Serial	O
dilutions	O
of	O
protein	O
homogenate	O
were	O
passed	O
through	O
a	O
cellulose	O
acetate	O
filter	O
;	O
protein	O
aggregates	O
larger	O
than	O
the	O
pore	O
size	O
were	O
trapped	O
and	O
immunostained	O
for	O
A	O
beta	O
.	O

(	O
B	O
)	O
Quantitation	O
of	O
signal	O
intensity	O
in	O
the	O
linear	O
range	O
of	O
each	O
filter	O
trap	O
dilution	O
series	O
(	O
arrow	O
in	O
[	O
A	O
]	O
)	O
was	O
used	O
to	O
compare	O
aggregate	O
load	O
across	O
treatment	O
groups	O
.	O

Aggregated	O
A	O
beta	O
increased	O
significantly	O
between	O
6	O
and	O
9	O
mo	O
of	O
age	O
in	O
untreated	O
mice	O
(	O
significant	O
effect	O
of	O
group	O
ANOVA	O
F3	O
,	O
18	O
=	O
7	O
.	O
85	O
,	O
p	O
<	O
0	O
.	O
002	O
)	O
.	O

This	O
progression	O
of	O
pathology	O
was	O
completely	O
prevented	O
by	O
transgene	O
suppression	O
.	O

The	O
amount	O
of	O
aggregated	O
A	O
beta	O
was	O
identical	O
in	O
untreated	O
mice	O
at	O
6	O
mo	O
of	O
age	O
to	O
that	O
in	O
9	O
-	O
or	O
12	O
-	O
mo	O
-	O
old	O
animals	O
treated	O
with	O
dox	O
(	O
p	O
>	O
0	O
.	O
9	O
,	O
Tukey	O
post	O
-	O
hoc	O
test	O
)	O
.	O

Single	O
transgenic	O
tTA	O
samples	O
were	O
included	O
as	O
negative	O
controls	O
and	O
showed	O
no	O
signal	O
above	O
background	O
.	O

*	O
,	O
p	O
<	O
0	O
.	O
01	O
;	O
*	O
*	O
,	O
p	O
<	O
0	O
.	O
005	O
versus	O
9	O
-	O
mo	O
-	O
old	O
untreated	O
mice	O
,	O
Tukey	O
post	O
-	O
hoc	O
test	O
;	O
*	O
*	O
*	O
,	O
p	O
<	O
0	O
.	O
001	O
versus	O
9	O
-	O
mo	O
-	O
old	O
untreated	O
mice	O
,	O
Student	O
'	O
s	O
t	O
-	O
test	O
.	O

(	O
C	O
)	O
Amyloid	O
pathology	O
in	O
the	O
hippocampus	O
of	O
representative	O
mice	O
from	O
each	O
treatment	O
group	O
:	O
Hirano	O
silver	O
stain	O
(	O
top	O
row	O
)	O
,	O
thioflavin	O
-	O
S	O
(	O
middle	O
row	O
)	O
,	O
and	O
A	O
beta	O
immunohistochemistry	O
(	O
bottom	O
row	O
)	O
.	O

Amyloid	O
burden	O
increases	O
dramatically	O
between	O
6	O
and	O
9	O
mo	O
of	O
age	O
in	O
untreated	O
animals	O
,	O
but	O
remains	O
stable	O
in	O
transgene	O
-	O
suppressed	O
mice	O
over	O
the	O
same	O
period	O
(	O
6	O
mo	O
+	O
3	O
mo	O
dox	O
and	O
6	O
mo	O
+	O
6	O
mo	O
dox	O
)	O
.	O

Single	O
transgenic	O
animals	O
(	O
tTA	O
only	O
shown	O
here	O
)	O
show	O
no	O
sign	O
of	O
amyloid	O
pathology	O
at	O
any	O
age	O
tested	O
.	O

Figure	O
5	O

A	O
beta	O
ELISA	O
Confirms	O
Arrest	O
of	O
Progression	O
without	O
Clearance	O
of	O
Peptide	O
in	O
Mice	O
with	O
Preexisting	O
Aggregates	O

A	O
beta	O
levels	O
in	O
untreated	O
6	O
-	O
and	O
9	O
-	O
mo	O
-	O
old	O
tTA	O
/	O
APP	O
line	O
107	O
mice	O
(	O
shown	O
in	O
Figure	O
4	O
)	O
were	O
compared	O
to	O
those	O
in	O
9	O
-	O
and	O
12	O
-	O
mo	O
-	O
old	O
animals	O
treated	O
with	O
dox	O
from	O
the	O
age	O
of	O
6	O
mo	O
.	O

Single	O
transgenic	O
APP	O
samples	O
were	O
included	O
as	O
negative	O
controls	O
.	O

Cortical	O
homogenates	O
were	O
fractionated	O
by	O
sequential	O
multi	O
-	O
step	O
extraction	O
with	O
PBS	O
,	O
2	O
%	O
SDS	O
,	O
and	O
70	O
%	O
FA	O
followed	O
by	O
human	O
-	O
specific	O
A	O
beta	O
ELISA	O
to	O
measure	O
transgene	O
-	O
derived	O
peptide	O
in	O
each	O
fraction	S-GO
.	O

A	O
beta	O
40	O
is	O
shown	O
in	O
white	O
,	O
A	O
beta	O
42	O
in	O
black	O
.	O

(	O
A	O
and	O
B	O
)	O
Most	O
A	O
beta	O
in	O
the	O
brains	O
of	O
plaque	O
-	O
bearing	O
mice	O
is	O
extracted	O
into	O
the	O
FA	O
and	O
SDS	O
fractions	S-GO
.	O

Consistent	O
with	O
amyloid	O
burden	O
(	O
Figures	O
4	O
and	O
Figure	O
S3	O
)	O
,	O
SDS	O
-	O
and	O
FA	O
-	O
extracted	O
A	O
beta	O
levels	O
in	O
untreated	O
9	O
-	O
mo	O
-	O
old	O
mice	O
were	O
significantly	O
higher	O
than	O
in	O
untreated	O
6	O
-	O
mo	O
-	O
old	O
mice	O
(	O
Tukey	O
post	O
-	O
hoc	O
test	O
applied	O
to	O
significant	O
effect	O
of	O
group	O
ANOVA	O
for	O
SDS	O
and	O
FA	O
fractions	S-GO
F3	O
,	O
18	O
=	O
4	O
.	O
72	O
-	O
12	O
.	O
92	O
,	O
p	O
<	O
0	O
.	O
02	O
)	O
.	O

In	O
contrast	O
,	O
3	O
or	O
6	O
mo	O
of	O
transgene	O
suppression	O
held	O
A	O
beta	O
at	O
levels	O
equivalent	O
to	O
those	O
harbored	O
when	O
treatment	O
was	O
started	O
(	O
p	O
>	O
0	O
.	O
2	O
compared	O
to	O
6	O
mo	O
untreated	O
mice	O
,	O
Tukey	O
post	O
-	O
hoc	O
test	O
)	O
.	O

*	O
,	O
p	O
<	O
0	O
.	O
05	O
;	O
*	O
*	O
,	O
p	O
<	O
0	O
.	O
005	O
;	O
*	O
*	O
*	O
,	O
p	O
<	O
0	O
.	O
001	O
versus	O
9	O
-	O
mo	O
-	O
old	O
untreated	O
mice	O
,	O
Tukey	O
post	O
-	O
hoc	O
test	O
.	O

Significance	O
for	O
APP	O
versus	O
9	O
-	O
mo	O
-	O
old	O
untreated	O
mice	O
is	O
based	O
on	O
Student	O
'	O
s	O
t	O
-	O
test	O
.	O

(	O
C	O
)	O
The	O
PBS	O
fraction	S-GO
represents	O
less	O
than	O
0	O
.	O
1	O
%	O
of	O
total	O
A	O
beta	O
(	O
note	O
the	O
change	O
in	O
y	O
-	O
axis	O
from	O
[	O
A	O
]	O
and	O
[	O
B	O
]	O
)	O
,	O
but	O
only	O
here	O
do	O
A	O
beta	O
levels	O
in	O
the	O
dox	O
-	O
treated	O
mice	O
differ	O
from	O
those	O
in	O
younger	O
untreated	O
mice	O
.	O

Although	O
both	O
peptides	O
appear	O
elevated	O
in	O
the	O
treated	O
groups	O
compared	O
to	O
the	O
untreated	O
6	O
-	O
mo	O
-	O
old	O
mice	O
,	O
only	O
A	O
beta	O
40	O
reaches	O
statistical	O
significance	O
(	O
p	O
<	O
0	O
.	O
05	O
,	O
Tukey	O
post	O
-	O
hoc	O
test	O
applied	O
to	O
significant	O
effect	O
of	O
group	O
ANOVA	O
for	O
A	O
beta	O
40	O
F3	O
,	O
18	O
=	O
4	O
.	O
60	O
,	O
p	O
<	O
0	O
.	O
02	O
)	O
.	O

A	O
similar	O
trend	O
was	O
seen	O
for	O
A	O
beta	O
42	O
,	O
where	O
ANOVA	O
yielded	O
a	O
significant	O
effect	O
of	O
group	O
for	O
PBS	O
-	O
soluble	O
A	O
beta	O
42	O
(	O
F3	O
,	O
18	O
=	O
3	O
.	O
75	O
,	O
p	O
<	O
0	O
.	O
03	O
)	O
,	O
however	O
this	O
was	O
due	O
only	O
to	O
differences	O
between	O
the	O
untreated	O
6	O
-	O
and	O
9	O
-	O
mo	O
-	O
old	O
groups	O
.	O

*	O
,	O
p	O
<	O
0	O
.	O
05	O
versus	O
6	O
-	O
mo	O
-	O
old	O
untreated	O
mice	O
,	O
Tukey	O
post	O
-	O
hoc	O
test	O
;	O
*	O
*	O
*	O
,	O
p	O
<	O
0	O
.	O
001	O
versus	O
6	O
-	O
mo	O
-	O
old	O
untreated	O
mice	O
,	O
Student	O
'	O
s	O
t	O
-	O
test	O
.	O

Figure	O
6	O

Neuritic	O
and	O
Glial	O
Pathology	O
Are	O
Unchanged	O
following	O
Transgene	O
Suppression	O

Dystrophic	O
neurites	O
and	O
activated	O
astrocytes	O
surround	O
most	O
compact	O
plaques	O
in	O
tet	O
-	O
off	O
APP	O
mice	O
(	O
line	O
107	O
)	O
.	O

Dark	O
-	O
stained	O
,	O
ubiquitin	O
-	O
filled	O
neurites	O
and	O
reactive	O
astrocytes	O
form	O
a	O
halo	O
around	O
cored	O
,	O
fibrillar	O
deposits	O
by	O
6	O
mo	O
of	O
age	O
that	O
worsens	O
with	O
time	O
in	O
untreated	O
mice	O
.	O

Both	O
plaque	O
-	O
associated	O
pathologies	O
are	O
arrested	O
,	O
although	O
not	O
reversed	O
,	O
by	O
transgene	O
suppression	O
.	O

Hirano	O
silver	O
stain	O
(	O
top	O
row	O
)	O
;	O
GFAP	O
immunohistochemistry	O
(	O
middle	O
row	O
)	O
;	O
ubiquitin	O
immunohistochemistry	O
(	O
bottom	O
row	O
)	O
.	O

Figure	O
7	O

Transgene	O
Suppression	O
Attenuates	O
Hyperactivity	O
in	O
tTA	O
/	O
APP	O
Mice	O

(	O
A	O
)	O
A	O
48	O
-	O
h	O
measure	O
of	O
ambulation	O
records	O
extreme	O
hyperactivity	O
in	O
untreated	O
double	O
transgenic	O
mice	O
compared	O
to	O
single	O
transgenic	O
and	O
nontransgenic	O
controls	O
(	O
line	O
107	O
)	O
.	O

This	O
phenotype	O
is	O
completely	O
eliminated	O
by	O
rearing	O
the	O
double	O
transgenic	O
mice	O
on	O
dox	O
.	O

(	O
B	O
)	O
The	O
same	O
data	O
shown	O
in	O
(	O
A	O
)	O
are	O
replotted	O
to	O
magnify	O
data	O
from	O
untreated	O
control	O
and	O
dox	O
-	O
treated	O
groups	O
.	O

(	O
C	O
and	O
D	O
)	O
Activity	O
levels	O
in	O
the	O
combined	O
control	O
groups	O
of	O
(	O
A	O
)	O
and	O
(	O
B	O
)	O
are	O
here	O
separated	O
by	O
genotype	O
.	O

None	O
of	O
the	O
single	O
transgenic	O
or	O
nontransgenic	O
control	O
groups	O
display	O
the	O
hyperactivity	O
present	O
in	O
untreated	O
tTA	O
/	O
APP	O
animals	O
.	O

Again	O
,	O
note	O
the	O
y	O
-	O
axes	O
have	O
been	O
enlarged	O
for	O
detail	O
compared	O
to	O
(	O
A	O
)	O
.	O

Footnotes	O

Citation	O
:	O
Jankowsky	O
JL	O
,	O
Slunt	O
HH	O
,	O
Gonzales	O
V	O
,	O
Savonenko	O
AV	O
,	O
Wen	O
JC	O
,	O
et	O
al	O
.	O

(	O
2005	O
)	O
Persistent	O
amyloidosis	O
following	O
suppression	O
of	O
A	O
beta	O
production	O
in	O
a	O
transgenic	O
model	O
of	O
Alzheimer	O
disease	O
.	O

PLoS	O
Med	O
2	O
(	O
12	O
)	O
:	O
e355	O
.	O

Genetic	O
and	O
Genomic	O
Analysis	O
of	O
a	O
Fat	O
Mass	O
Trait	O
with	O
Complex	O
Inheritance	O
Reveals	O
Marked	O
Sex	O
Specificity	O

Abstract	O

The	O
integration	O
of	O
expression	O
profiling	O
with	O
linkage	O
analysis	O
has	O
increasingly	O
been	O
used	O
to	O
identify	O
genes	O
underlying	O
complex	O
phenotypes	O
.	O

The	O
effects	O
of	O
gender	O
on	O
the	O
regulation	O
of	O
many	O
physiological	O
traits	O
are	O
well	O
documented	O
;	O
however	O
,	O
"	O
genetical	O
genomic	O
"	O
analyses	O
have	O
not	O
yet	O
addressed	O
the	O
degree	O
to	O
which	O
their	O
conclusions	O
are	O
affected	O
by	O
sex	O
.	O

We	O
constructed	O
and	O
densely	O
genotyped	O
a	O
large	O
F2	O
intercross	O
derived	O
from	O
the	O
inbred	O
mouse	O
strains	O
C57BL	O
/	O
6J	O
and	O
C3H	O
/	O
HeJ	O
on	O
an	O
apolipoprotein	O
E	O
null	O
(	O
ApoE	O
-	O
/	O
-	O
)	O
background	O
.	O

This	O
BXH	O
.	O
ApoE	O
-	O
/	O
-	O
population	O
recapitulates	O
several	O
"	O
metabolic	O
syndrome	O
"	O
phenotypes	O
.	O

The	O
cross	O
consists	O
of	O
334	O
animals	O
of	O
both	O
sexes	O
,	O
allowing	O
us	O
to	O
specifically	O
test	O
for	O
the	O
dependence	O
of	O
linkage	O
on	O
sex	O
.	O

We	O
detected	O
several	O
thousand	O
liver	O
gene	O
expression	O
quantitative	O
trait	O
loci	O
,	O
a	O
significant	O
proportion	O
of	O
which	O
are	O
sex	O
-	O
biased	O
.	O

We	O
used	O
these	O
analyses	O
to	O
dissect	O
the	O
genetics	O
of	O
gonadal	O
fat	O
mass	O
,	O
a	O
complex	O
trait	O
with	O
sex	O
-	O
specific	O
regulation	O
.	O

We	O
present	O
evidence	O
for	O
a	O
remarkably	O
high	O
degree	O
of	O
sex	O
-	O
dependence	O
on	O
both	O
the	O
cis	O
and	O
trans	O
regulation	O
of	O
gene	O
expression	O
.	O

We	O
demonstrate	O
how	O
these	O
analyses	O
can	O
be	O
applied	O
to	O
the	O
study	O
of	O
the	O
genetics	O
underlying	O
gonadal	O
fat	O
mass	O
,	O
a	O
complex	O
trait	O
showing	O
significantly	O
female	O
-	O
biased	O
heritability	O
.	O

These	O
data	O
have	O
implications	O
on	O
the	O
potential	O
effects	O
of	O
sex	O
on	O
the	O
genetic	O
regulation	O
of	O
other	O
complex	O
traits	O
.	O

Synopsis	O

Although	O
their	O
genomes	O
are	O
nearly	O
identical	O
,	O
the	O
males	O
and	O
females	O
of	O
a	O
species	O
exhibit	O
striking	O
differences	O
in	O
many	O
traits	O
,	O
including	O
complex	O
traits	O
such	O
as	O
obesity	O
.	O

This	O
study	O
combines	O
genetic	O
and	O
genomic	O
tools	O
to	O
identify	O
in	O
parallel	O
quantitative	O
trait	O
loci	O
(	O
QTLs	O
)	O
for	O
a	O
measure	O
of	O
gonadal	O
fat	O
mass	O
and	O
for	O
expression	O
of	O
transcripts	O
in	O
the	O
liver	O
.	O

The	O
results	O
are	O
used	O
to	O
explore	O
the	O
relationship	O
between	O
genetic	O
variation	O
,	O
sexual	O
differentiation	O
,	O
and	O
obesity	O
in	O
the	O
mouse	O
model	O
.	O

Using	O
over	O
300	O
intercross	O
progeny	O
of	O
two	O
inbred	O
mouse	O
strains	O
,	O
five	O
loci	O
in	O
the	O
genome	O
were	O
found	O
to	O
be	O
highly	O
correlated	O
with	O
abdominal	O
fat	O
mass	O
.	O

Four	O
of	O
the	O
five	O
loci	O
exhibited	O
opposite	O
effects	O
on	O
obesity	O
in	O
the	O
two	O
sexes	O
,	O
a	O
phenomenon	O
known	O
as	O
sexual	O
antagonism	O
.	O

To	O
identify	O
candidate	O
genes	O
that	O
may	O
be	O
involved	O
in	O
obesity	O
through	O
their	O
expression	O
in	O
the	O
liver	O
,	O
global	O
gene	O
expression	O
analysis	O
was	O
employed	O
using	O
microarrays	O
.	O

Many	O
of	O
these	O
expression	O
QTLs	O
also	O
show	O
sex	O
-	O
specific	O
effects	O
on	O
transcription	O
.	O

A	O
hotspot	O
for	O
trans	O
-	O
acting	O
QTLs	O
regulating	O
the	O
expression	O
of	O
transcripts	O
whose	O
abundance	O
is	O
correlated	O
with	O
gonadal	O
fat	O
mass	O
was	O
identified	O
on	O
Chromosome	S-GO
19	O
.	O

This	O
region	O
of	O
the	O
genome	O
colocalizes	O
with	O
a	O
clinical	O
QTL	O
for	O
gonadal	O
fat	O
mass	O
,	O
suggesting	O
that	O
it	O
harbors	O
a	O
good	O
candidate	O
gene	O
for	O
obesity	O
.	O

Introduction	O

Females	O
and	O
males	O
share	O
nearly	O
identical	O
genetic	O
information	O
,	O
but	O
vary	O
widely	O
with	O
respect	O
to	O
disease	O
susceptibility	O
[	O
1	O
,	O
2	O
]	O
.	O

Apart	O
from	O
the	O
obvious	O
gender	O
-	O
specific	O
diseases	O
such	O
as	O
cervical	O
or	O
prostate	O
cancer	O
,	O
sex	O
influences	O
susceptibility	O
to	O
nearly	O
all	O
highly	O
prevalent	O
diseases	O
that	O
affect	O
both	O
women	O
and	O
men	O
,	O
including	O
atherosclerosis	O
and	O
diabetes	O
and	O
their	O
precursor	O
conditions	O
of	O
hyperlipidemia	O
,	O
obesity	O
,	O
and	O
insulin	O
resistance	O
.	O

These	O
are	O
multifactorial	O
in	O
their	O
pathogenesis	O
,	O
encompassing	O
environmental	O
and	O
behavioral	O
aspects	O
,	O
as	O
well	O
as	O
significant	O
genetic	O
determination	O
,	O
on	O
which	O
these	O
other	O
factors	O
interact	O
.	O

The	O
genetic	O
component	O
is	O
multigenic	O
,	O
with	O
the	O
heritability	O
embedded	O
in	O
the	O
genetic	O
variation	O
intrinsic	O
to	O
our	O
population	O
.	O

Although	O
the	O
sex	O
differences	O
in	O
disease	O
susceptibility	O
are	O
recognized	O
,	O
the	O
interplay	O
between	O
sex	O
and	O
gene	O
expression	O
that	O
is	O
at	O
the	O
basis	O
of	O
these	O
differences	O
is	O
not	O
well	O
understood	O
.	O

Females	O
and	O
males	O
inherit	O
(	O
on	O
average	O
)	O
the	O
same	O
genes	O
that	O
may	O
be	O
risk	O
factors	O
,	O
but	O
their	O
expression	O
and	O
effect	O
on	O
disease	O
risk	O
varies	O
significantly	O
.	O

An	O
understanding	O
and	O
recognition	O
of	O
the	O
significance	O
of	O
specific	O
disease	O
-	O
associated	O
polymorphisms	O
/	O
mutations	O
in	O
the	O
context	O
of	O
sex	O
is	O
therefore	O
of	O
critical	O
clinical	O
importance	O
.	O

We	O
have	O
utilized	O
the	O
mouse	O
as	O
a	O
model	O
system	O
to	O
study	O
the	O
genetics	O
of	O
metabolic	O
and	O
vascular	O
diseases	O
[	O
3	O
-	O
5	O
]	O
.	O

Rather	O
than	O
focus	O
initially	O
on	O
natural	O
or	O
induced	O
mutants	O
of	O
single	O
genes	O
,	O
we	O
utilize	O
the	O
complex	O
endogenous	O
genetic	O
variation	O
between	O
strains	O
in	O
genetic	O
crosses	O
to	O
identify	O
causative	O
genetic	O
loci	O
and	O
ultimately	O
the	O
underlying	O
variations	O
responsible	O
for	O
trait	O
differences	O
[	O
6	O
]	O
.	O

This	O
design	O
more	O
closely	O
reflects	O
the	O
situation	O
faced	O
when	O
studying	O
human	O
populations	O
.	O

The	O
genetic	O
composition	O
of	O
each	O
individual	O
mouse	O
is	O
restricted	O
to	O
that	O
of	O
the	O
two	O
parental	O
strains	O
and	O
is	O
defined	O
at	O
every	O
locus	O
across	O
the	O
genome	O
.	O

The	O
application	O
of	O
quantitative	O
trait	O
locus	O
(	O
QTL	O
)	O
analysis	O
allows	O
the	O
identification	O
of	O
those	O
chromosomal	O
regions	O
that	O
contain	O
a	O
genetic	O
variation	O
that	O
influences	O
trait	O
expression	O
(	O
for	O
a	O
comprehensive	O
review	O
on	O
QTLs	O
see	O
[	O
7	O
]	O
)	O
.	O

We	O
[	O
5	O
,	O
8	O
]	O
,	O
and	O
others	O
[	O
9	O
-	O
17	O
]	O
,	O
have	O
recently	O
extended	O
the	O
power	O
of	O
this	O
approach	O
by	O
incorporating	O
genome	O
-	O
wide	O
gene	O
expression	O
array	O
analysis	O
,	O
which	O
allows	O
us	O
to	O
model	O
the	O
"	O
genetics	O
of	O
gene	O
expression	O
"	O
using	O
similar	O
methods	O
.	O

An	O
immediate	O
extension	O
of	O
this	O
approach	O
is	O
toward	O
dissecting	O
the	O
genetic	O
regulation	O
of	O
complex	O
phenotypes	O
,	O
which	O
would	O
greatly	O
improve	O
the	O
progression	O
from	O
candidate	O
locus	O
to	O
candidate	O
gene	O
.	O

Here	O
we	O
report	O
the	O
application	O
of	O
this	O
integrated	O
approach	O
to	O
study	O
the	O
significance	O
of	O
sex	O
on	O
the	O
genetic	O
determinants	O
of	O
obesity	O
and	O
the	O
associated	O
regulation	O
of	O
liver	O
gene	O
expression	O
in	O
an	O
F2	O
intercross	O
derived	O
from	O
the	O
inbred	O
strains	O
C57BL	O
/	O
6J	O
(	O
B6	O
)	O
and	O
C3H	O
/	O
HeJ	O
(	O
C3H	O
)	O
on	O
an	O
apolipoprotein	O
E	O
null	O
(	O
ApoE	O
-	O
/	O
-	O
)	O
background	O
.	O

The	O
BXH	O
.	O
ApoE	O
-	O
/	O
-	O
population	O
was	O
designed	O
to	O
recapitulate	O
several	O
of	O
the	O
phenotypes	O
associated	O
with	O
the	O
so	O
-	O
called	O
metabolic	O
syndrome	O
.	O

The	O
cross	O
consists	O
of	O
334	O
animals	O
of	O
both	O
sexes	O
,	O
allowing	O
us	O
to	O
specifically	O
test	O
for	O
the	O
dependence	O
of	O
QTLs	O
on	O
sex	O
.	O

We	O
detected	O
several	O
thousand	O
gene	O
expression	O
QTLs	O
(	O
eQTLs	O
)	O
,	O
a	O
significant	O
proportion	O
of	O
which	O
were	O
sex	O
-	O
biased	O
.	O

We	O
used	O
these	O
analyses	O
to	O
dissect	O
the	O
genetic	O
regulation	O
of	O
the	O
gonadal	O
fat	O
mass	O
trait	O
and	O
to	O
identify	O
genes	O
associated	O
with	O
the	O
trait	O
.	O

Results	O

QTLs	O
Associated	O
with	O
Gonadal	O
Fat	O
Mass	O

Characteristics	O
of	O
the	O
B6	O
.	O
ApoE	O
-	O
/	O
-	O
and	O
C3H	O
.	O
ApoE	O
-	O
/	O
-	O
parents	O
and	O
the	O
F2	O
BXH	O
.	O
ApoE	O
-	O
/	O
-	O
generation	O
on	O
a	O
Western	O
diet	O
are	O
summarized	O
in	O
Table	O
1	O
.	O

Gonadal	O
fat	O
mass	O
differed	O
significantly	O
between	O
the	O
sexes	O
in	O
F2	O
(	O
p	O
<	O
10	O
-	O
4	O
)	O
and	O
in	O
the	O
parental	O
C3H	O
.	O
ApoE	O
-	O
/	O
-	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
,	O
but	O
not	O
in	O
B6	O
.	O
ApoE	O
-	O
/	O
-	O
mice	O
.	O

Gonadal	O
fat	O
mass	O
was	O
the	O
fat	O
pad	O
collection	O
that	O
represented	O
the	O
most	O
animals	O
and	O
the	O
most	O
accurate	O
collections	O
and	O
was	O
thus	O
chosen	O
for	O
further	O
analysis	O
.	O

Broad	O
sense	O
heritability	O
(	O
h2	O
)	O
calculated	O
as	O
(	O
sigma	O
2Total	O
-	O
sigma	O
2Parental	O
)	O
/	O
sigma	O
2Total	O
for	O
the	O
gonadal	O
fat	O
mass	O
trait	O
was	O
54	O
%	O
for	O
females	O
and	O
36	O
%	O
for	O
males	O
,	O
which	O
is	O
in	O
close	O
agreement	O
with	O
previous	O
reports	O
[	O
18	O
,	O
19	O
]	O
and	O
demonstrates	O
significant	O
heritability	O
of	O
gonadal	O
fat	O
mass	O
.	O

A	O
total	O
of	O
334	O
F2	O
mice	O
were	O
genotyped	O
at	O
an	O
average	O
1	O
.	O
5	O
cM	O
density	O
using	O
1	O
,	O
032	O
single	O
nucleotide	O
polymorphisms	O
(	O
SNPs	O
)	O
spanning	O
all	O
19	O
autosomes	S-GO
.	O

QTL	O
analysis	O
for	O
several	O
clinical	O
traits	O
(	O
clinical	O
QTLs	O
[	O
cQTLs	O
]	O
)	O
,	O
including	O
the	O
unadjusted	O
raw	O
values	O
for	O
gonadal	O
fat	O
mass	O
,	O
was	O
performed	O
using	O
a	O
single	O
marker	O
regression	O
approach	O
(	O
justified	O
by	O
the	O
high	O
-	O
density	O
of	O
markers	O
,	O
making	O
interval	O
mapping	O
unnecessary	O
)	O
.	O

In	O
order	O
to	O
test	O
specifically	O
for	O
sex	O
effects	O
of	O
linkage	O
,	O
we	O
included	O
additive	O
,	O
dominant	O
,	O
sex	O
,	O
sex	O
-	O
additive	O
,	O
and	O
sex	O
-	O
dominant	O
parameters	O
in	O
our	O
calculations	O
(	O
see	O
Materials	O
and	O
Methods	O
)	O
.	O

A	O
stepwise	O
regression	O
procedure	O
was	O
used	O
to	O
determine	O
whether	O
the	O
addition	O
of	O
the	O
final	O
two	O
terms	O
significantly	O
improved	O
the	O
linear	O
regression	O
model	O
,	O
conditional	O
on	O
realizing	O
a	O
significant	O
additive	O
QTL	O
effect	O
.	O

We	O
performed	O
permutation	O
analyses	O
over	O
all	O
gene	O
expression	O
traits	O
,	O
estimating	O
false	O
discovery	O
rates	O
(	O
FDRs	O
)	O
at	O
different	O
logarithm	O
of	O
odds	O
(	O
LOD	O
)	O
score	O
thresholds	O
and	O
assessing	O
the	O
overall	O
rate	O
of	O
QTL	O
detection	O
.	O

From	O
these	O
analyses	O
we	O
constructed	O
receiver	O
operating	O
characteristic	O
(	O
ROC	O
)	O
-	O
like	O
curves	O
to	O
demonstrate	O
that	O
our	O
straightforward	O
method	O
has	O
significantly	O
increased	O
power	O
to	O
detect	O
QTLs	O
compared	O
to	O
QTL	O
mapping	O
methods	O
that	O
do	O
not	O
incorporate	O
sex	O
and	O
genotype	O
-	O
sex	O
interactions	O
(	O
Figure	O
S1	O
)	O
.	O

It	O
is	O
clear	O
from	O
the	O
ROC	O
curves	O
that	O
the	O
sex	O
and	O
sex	O
-	O
interaction	O
terms	O
add	O
significantly	O
to	O
the	O
detection	O
of	O
QTL	O
for	O
the	O
gene	O
expression	O
traits	O
.	O

Using	O
previously	O
described	O
conventions	O
[	O
20	O
]	O
,	O
QTL	O
models	O
without	O
the	O
final	O
two	O
interaction	O
terms	O
(	O
sex	O
*	O
add	O
and	O
sex	O
*	O
dom	O
)	O
have	O
a	O
suggestive	O
threshold	O
of	O
3	O
.	O
0	O
(	O
p	O
<	O
1	O
x	O
10	O
-	O
3	O
)	O
and	O
a	O
significant	O
threshold	O
of	O
4	O
.	O
3	O
(	O
p	O
<	O
5	O
x	O
10	O
-	O
5	O
,	O
genome	O
-	O
wide	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O

QTL	O
models	O
incorporating	O
only	O
the	O
sex	O
*	O
add	O
interaction	O
term	O
in	O
addition	O
to	O
the	O
additive	O
terms	O
have	O
one	O
extra	O
degree	O
of	O
freedom	O
that	O
leads	O
to	O
a	O
corresponding	O
increase	O
in	O
the	O
LOD	O
score	O
thresholds	O
to	O
3	O
.	O
5	O
(	O
suggestive	O
)	O
and	O
4	O
.	O
9	O
(	O
significant	O
)	O
for	O
the	O
0	O
.	O
001	O
and	O
0	O
.	O
00005	O
p	O
-	O
value	O
thresholds	O
,	O
respectively	O
.	O

QTL	O
models	O
incorporating	O
both	O
sex	O
*	O
add	O
and	O
sex	O
*	O
dom	O
interaction	O
terms	O
possess	O
two	O
extra	O
degrees	O
of	O
freedom	O
,	O
with	O
a	O
corresponding	O
increase	O
in	O
LOD	O
score	O
thresholds	O
to	O
4	O
.	O
0	O
(	O
suggestive	O
)	O
and	O
5	O
.	O
4	O
(	O
significant	O
)	O
for	O
the	O
0	O
.	O
001	O
and	O
0	O
.	O
00005	O
p	O
-	O
value	O
thresholds	O
,	O
respectively	O
.	O

One	O
suggestive	O
(	O
Chromosome	S-GO
1	O
)	O
and	O
four	O
significant	O
(	O
Chromosomes	S-GO
3	O
,	O
5	O
,	O
11	O
,	O
and	O
19	O
)	O
cQTLs	O
for	O
the	O
gonadal	O
fat	O
mass	O
trait	O
were	O
identified	O
(	O
Figure	O
1A	O
;	O
Table	O
2	O
)	O
.	O

Four	O
out	O
of	O
the	O
five	O
cQTLs	O
showed	O
statistically	O
significant	O
better	O
fits	O
with	O
the	O
full	O
model	O
incorporating	O
the	O
interaction	O
terms	O
sex	O
*	O
add	O
and	O
sex	O
*	O
dom	O
,	O
compared	O
to	O
the	O
model	O
including	O
only	O
the	O
additive	O
terms	O
.	O

Interestingly	O
,	O
the	O
cQTL	O
over	O
Chromosome	S-GO
11	O
did	O
not	O
improve	O
,	O
suggesting	O
that	O
the	O
additional	O
terms	O
did	O
not	O
contribute	O
to	O
improved	O
detection	O
of	O
this	O
locus	O
.	O

Table	O
2	O
summarizes	O
the	O
position	O
and	O
LOD	O
score	O
of	O
maximal	O
linkage	O
for	O
each	O
cQTL	O
.	O

While	O
the	O
focus	O
of	O
this	O
study	O
was	O
the	O
gonadal	O
fat	O
mass	O
trait	O
,	O
it	O
is	O
noted	O
that	O
a	O
genome	O
scan	O
for	O
the	O
adiposity	O
trait	O
resulted	O
in	O
cQTLs	O
at	O
the	O
same	O
locations	O
,	O
with	O
very	O
similar	O
LOD	O
scores	O
and	O
sex	O
dependence	O
(	O
unpublished	O
data	O
)	O
.	O

Results	O
from	O
the	O
various	O
regression	O
models	O
used	O
to	O
determine	O
linkage	O
for	O
the	O
Chromosome	S-GO
5	O
cQTL	O
are	O
depicted	O
in	O
Figure	O
1B	O
.	O

Analysis	O
of	O
all	O
animals	O
with	O
and	O
without	O
sex	O
as	O
a	O
covariate	O
failed	O
to	O
demonstrate	O
evidence	O
of	O
linkage	O
on	O
Chromosome	S-GO
5	O
.	O

When	O
females	O
were	O
analyzed	O
alone	O
,	O
a	O
suggestive	O
LOD	O
score	O
of	O
3	O
.	O
7	O
was	O
realized	O
(	O
p	O
=	O
2	O
x	O
10	O
-	O
4	O
)	O
;	O
males	O
analyzed	O
alone	O
did	O
not	O
demonstrate	O
evidence	O
for	O
linkage	O
.	O

However	O
,	O
using	O
all	O
334	O
animals	O
and	O
adding	O
the	O
interaction	O
terms	O
to	O
the	O
QTL	O
model	O
significantly	O
improved	O
sensitivity	O
,	O
and	O
a	O
cQTL	O
with	O
a	O
maximum	O
LOD	O
of	O
7	O
.	O
56	O
(	O
p	O
=	O
1	O
.	O
7	O
x	O
10	O
-	O
6	O
)	O
was	O
realized	O
.	O

Given	O
the	O
improved	O
detection	O
of	O
four	O
of	O
the	O
five	O
cQTLs	O
when	O
sex	O
-	O
additive	O
and	O
sex	O
-	O
dominant	O
interaction	O
terms	O
were	O
considered	O
,	O
we	O
hypothesized	O
that	O
the	O
main	O
genotype	O
effect	O
of	O
these	O
cQTLs	O
on	O
the	O
gonadal	O
fat	O
mass	O
trait	O
would	O
differ	O
between	O
the	O
sexes	O
(	O
Figure	O
2	O
)	O
.	O

Indeed	O
,	O
cQTLs	O
located	O
on	O
Chromosomes	S-GO
1	O
,	O
3	O
,	O
and	O
5	O
showed	O
opposing	O
effects	O
on	O
fat	O
mass	O
,	O
or	O
sex	O
antagonism	O
.	O

The	O
effect	O
of	O
the	O
cQTL	O
on	O
Chromosome	S-GO
11	O
was	O
in	O
the	O
same	O
direction	O
in	O
both	O
males	O
and	O
females	O
,	O
but	O
was	O
sex	O
-	O
biased	O
toward	O
a	O
larger	O
effect	O
in	O
females	O
(	O
R2	O
=	O
0	O
.	O
091	O
in	O
females	O
versus	O
R2	O
=	O
0	O
.	O
046	O
in	O
males	O
)	O
,	O
confirming	O
the	O
minimal	O
sex	O
specificity	O
of	O
this	O
cQTL	O
.	O

The	O
cQTL	O
on	O
Chromosome	S-GO
19	O
showed	O
a	O
sex	O
-	O
specific	O
effect	O
in	O
females	O
,	O
with	O
no	O
effect	O
in	O
males	O
.	O

Overall	O
,	O
all	O
five	O
cQTLs	O
for	O
gonadal	O
fat	O
mass	O
were	O
biased	O
toward	O
a	O
larger	O
effect	O
in	O
females	O
.	O

Assuming	O
purely	O
additive	O
effects	O
of	O
each	O
genotype	O
,	O
these	O
cQTLs	O
account	O
for	O
approximately	O
42	O
%	O
of	O
the	O
variation	O
in	O
female	O
F2	O
mice	O
and	O
13	O
%	O
in	O
males	O
,	O
consistent	O
with	O
the	O
narrow	O
sense	O
heritability	O
estimates	O
for	O
this	O
trait	O
and	O
again	O
demonstrating	O
significant	O
differences	O
in	O
the	O
regulation	O
and	O
heritability	O
of	O
the	O
gonadal	O
fat	O
trait	O
between	O
the	O
sexes	O
.	O

Liver	O
eQTLs	O

Livers	O
from	O
312	O
F2	O
animals	O
(	O
156	O
female	O
,	O
156	O
male	O
)	O
were	O
profiled	O
using	O
oligonucleotide	O
microarrays	O
manufactured	O
by	O
Agilent	O
Technologies	O
(	O
Palo	O
Alto	O
,	O
California	O
,	O
United	O
States	O
)	O
,	O
which	O
included	O
probes	O
for	O
23	O
,	O
574	O
mouse	O
transcripts	O
.	O

Individual	O
transcript	O
intensities	O
were	O
corrected	O
for	O
experimental	O
variation	O
and	O
normalized	O
and	O
are	O
reported	O
as	O
the	O
mean	O
log10	O
ratio	O
(	O
mlratio	O
)	O
of	O
an	O
individual	O
experiment	O
relative	O
to	O
a	O
pool	O
composed	O
of	O
150	O
mice	O
randomly	O
selected	O
from	O
the	O
F2	O
population	O
[	O
21	O
]	O
.	O

Each	O
measurement	O
was	O
fitted	O
to	O
an	O
error	O
model	O
and	O
assigned	O
a	O
significance	O
measurement	O
(	O
type	O
I	O
error	O
)	O
.	O

A	O
heat	O
map	O
of	O
the	O
2	O
,	O
320	O
transcripts	O
most	O
differentially	O
expressed	O
(	O
p	O
<	O
0	O
.	O
05	O
in	O
10	O
%	O
or	O
more	O
of	O
animals	O
)	O
relative	O
to	O
the	O
pool	O
is	O
depicted	O
in	O
Figure	O
3	O
.	O

This	O
selection	O
of	O
genes	O
was	O
not	O
biased	O
on	O
a	O
priori	O
known	O
differential	O
expression	O
between	O
the	O
sexes	O
,	O
linkage	O
,	O
or	O
correlation	O
with	O
a	O
clinical	O
phenotype	O
.	O

This	O
is	O
noteworthy	O
because	O
hierarchical	O
clustering	O
of	O
these	O
transcripts	O
against	O
the	O
312	O
F2	O
mice	O
shows	O
an	O
almost	O
perfect	O
clustering	O
into	O
male	O
and	O
female	O
subgroups	O
,	O
emphasizing	O
striking	O
effects	O
of	O
sex	O
on	O
liver	O
gene	O
expression	O
levels	O
and	O
suggesting	O
that	O
sex	O
is	O
controlling	O
more	O
variance	O
in	O
these	O
transcripts	O
'	O
expression	O
than	O
any	O
other	O
parameter	O
.	O

The	O
expression	O
values	O
of	O
the	O
23	O
,	O
574	O
transcripts	O
were	O
treated	O
as	O
quantitative	O
traits	O
and	O
fitted	O
to	O
the	O
same	O
linear	O
regression	O
models	O
used	O
to	O
compute	O
LOD	O
scores	O
for	O
clinical	O
traits	O
(	O
eQTLs	O
)	O
.	O

The	O
FDR	O
at	O
each	O
threshold	O
was	O
determined	O
by	O
permuting	O
the	O
data	O
100	O
times	O
and	O
taking	O
the	O
mean	O
number	O
of	O
QTLs	O
detected	O
over	O
all	O
of	O
the	O
permuted	O
datasets	O
at	O
a	O
given	O
threshold	O
,	O
and	O
dividing	O
this	O
count	O
by	O
the	O
number	O
of	O
QTLs	O
detected	O
at	O
the	O
same	O
threshold	O
in	O
the	O
observed	O
data	O
.	O

At	O
the	O
threshold	O
for	O
significant	O
linkage	O
(	O
p	O
<	O
5	O
x	O
10	O
-	O
5	O
,	O
genome	O
-	O
wide	O
p	O
<	O
0	O
.	O
05	O
,	O
based	O
on	O
a	O
single	O
trait	O
)	O
,	O
the	O
FDR	O
was	O
estimated	O
at	O
3	O
.	O
4	O
%	O
for	O
the	O
standard	O
QTL	O
model	O
not	O
accounting	O
for	O
any	O
sex	O
terms	O
,	O
3	O
.	O
1	O
%	O
for	O
the	O
QTL	O
model	O
accounting	O
for	O
additive	O
sex	O
effects	O
,	O
and	O
3	O
.	O
2	O
%	O
for	O
the	O
QTL	O
model	O
accounting	O
for	O
additive	O
sex	O
effects	O
and	O
allowing	O
for	O
the	O
sex	O
interaction	O
terms	O
to	O
enter	O
the	O
model	O
.	O

A	O
list	O
of	O
all	O
detected	O
suggestive	O
(	O
p	O
<	O
1	O
x	O
10	O
-	O
3	O
)	O
and	O
significant	O
eQTLs	O
(	O
p	O
<	O
5	O
x	O
10	O
-	O
5	O
)	O
detected	O
in	O
the	O
BXH	O
.	O
ApoE	O
-	O
/	O
-	O
intercross	O
is	O
provided	O
in	O
Table	O
S1	O
.	O

Characteristics	O
of	O
the	O
eQTLs	O
at	O
different	O
significance	O
levels	O
are	O
summarized	O
in	O
Table	O
3	O
and	O
shown	O
graphically	O
in	O
Figure	O
4	O
.	O

We	O
detected	O
6	O
,	O
676	O
eQTLs	O
representing	O
4	O
,	O
998	O
transcripts	O
at	O
the	O
5	O
x	O
10	O
-	O
5	O
significant	O
level	O
.	O

Of	O
these	O
,	O
2	O
,	O
118	O
eQTLs	O
were	O
located	O
within	O
20	O
Mb	O
(	O
roughly	O
10	O
cM	O
)	O
of	O
the	O
corresponding	O
gene	O
,	O
likely	O
representing	O
eQTLs	O
regulated	O
by	O
cis	O
-	O
acting	O
variation	O
within	O
the	O
gene	O
itself	O
.	O

Of	O
the	O
6	O
,	O
676	O
significant	O
eQTLs	O
,	O
1	O
,	O
166	O
(	O
17	O
%	O
)	O
demonstrated	O
a	O
sex	O
bias	O
and	O
were	O
subsequently	O
significantly	O
improved	O
with	O
the	O
addition	O
of	O
the	O
sex	O
-	O
additive	O
and	O
sex	O
-	O
dominant	O
terms	O
.	O

The	O
distribution	O
of	O
all	O
6	O
,	O
676	O
significant	O
eQTLs	O
(	O
p	O
<	O
5	O
x	O
10	O
-	O
5	O
)	O
across	O
the	O
genome	O
in	O
2	O
cM	O
bins	O
is	O
shown	O
in	O
Figure	O
4A	O
.	O

Evidence	O
for	O
eQTL	O
hotspots	O
is	O
clear	O
on	O
Chromosomes	S-GO
1	O
,	O
2	O
,	O
4	O
,	O
5	O
,	O
6	O
,	O
and	O
7	O
where	O
significant	O
fractions	O
of	O
the	O
6	O
,	O
676	O
eQTLs	O
colocalize	O
within	O
2	O
cM	O
regions	O
on	O
each	O
chromosome	O
.	O

Approximately	O
67	O
%	O
of	O
eQTLs	O
at	O
this	O
threshold	O
are	O
trans	O
,	O
and	O
these	O
eQTL	O
hotspots	O
consist	O
primarily	O
of	O
trans	O
-	O
acting	O
effects	O
on	O
transcriptional	O
variation	O
.	O

Distribution	O
of	O
the	O
1	O
,	O
166	O
eQTLs	O
with	O
significant	O
sex	O
effects	O
,	O
of	O
which	O
852	O
(	O
73	O
%	O
)	O
are	O
trans	O
,	O
showed	O
enrichment	O
on	O
Chromosome	S-GO
5	O
at	O
approximately	O
49	O
cM	O
(	O
Figure	O
4B	O
)	O
as	O
assessed	O
using	O
the	O
Fisher	O
exact	O
test	O
(	O
p	O
=	O
8	O
.	O
7	O
x	O
10	O
-	O
25	O
after	O
Bonferroni	O
correction	O
)	O
.	O

At	O
this	O
locus	O
there	O
were	O
250	O
eQTLs	O
,	O
140	O
of	O
which	O
exhibited	O
genotype	O
-	O
sex	O
interactions	O
.	O

At	O
increasing	O
thresholds	O
for	O
linkage	O
,	O
a	O
higher	O
fraction	O
of	O
detected	O
eQTLs	O
were	O
cis	O
-	O
acting	O
(	O
Figure	O
4C	O
)	O
.	O

The	O
increased	O
proportion	O
of	O
cis	O
-	O
eQTLs	O
with	O
increasing	O
LOD	O
score	O
thresholds	O
has	O
been	O
reported	O
before	O
[	O
5	O
,	O
15	O
]	O
and	O
confirms	O
what	O
is	O
likely	O
to	O
be	O
our	O
increased	O
power	O
to	O
detect	O
first	O
-	O
order	O
cis	O
-	O
acting	O
variations	O
affecting	O
transcription	O
.	O

The	O
proportion	O
of	O
eQTLs	O
with	O
significant	O
sex	O
effects	O
remained	O
relatively	O
constant	O
at	O
all	O
thresholds	O
(	O
Figure	O
4C	O
)	O
.	O

Furthermore	O
,	O
the	O
majority	O
of	O
these	O
sex	O
-	O
specific	O
eQTLs	O
(	O
73	O
%	O
)	O
are	O
acting	O
in	O
trans	O
on	O
a	O
given	O
gene	O
'	O
s	O
expression	O
(	O
Figure	O
4D	O
)	O
,	O
and	O
similar	O
proportions	O
of	O
sex	O
-	O
specific	O
eQTLs	O
(	O
26	O
%	O
)	O
are	O
cis	O
compared	O
to	O
the	O
proportion	O
of	O
all	O
liver	O
cis	O
-	O
eQTLs	O
(	O
32	O
%	O
)	O
.	O

These	O
data	O
demonstrate	O
the	O
profound	O
effects	O
of	O
sex	O
on	O
the	O
genetic	O
regulation	O
of	O
gene	O
expression	O
.	O

Cis	O
-	O
eQTLs	O
Are	O
Candidate	O
Genes	O
for	O
the	O
Gonadal	O
Fat	O
Mass	O
Trait	O

Given	O
the	O
marked	O
effects	O
of	O
sex	O
on	O
liver	O
gene	O
expression	O
and	O
the	O
genetic	O
regulation	O
of	O
gonadal	O
fat	O
mass	O
,	O
we	O
reasoned	O
that	O
cis	O
-	O
eQTLs	O
with	O
significant	O
"	O
sex	O
-	O
additive	O
"	O
and	O
"	O
sex	O
-	O
dominant	O
"	O
interactions	O
would	O
be	O
potential	O
candidate	O
genes	O
for	O
our	O
trait	O
.	O

Of	O
the	O
2	O
,	O
118	O
significant	O
cis	O
-	O
eQTLs	O
,	O
304	O
(	O
14	O
%	O
)	O
were	O
improved	O
by	O
the	O
sex	O
-	O
interaction	O
terms	O
.	O

Cis	O
-	O
eQTLs	O
overlapping	O
the	O
confidence	O
interval	O
for	O
the	O
fat	O
mass	O
cQTL	O
are	O
candidate	O
genes	O
for	O
the	O
trait	O
.	O

Those	O
genes	O
with	O
significant	O
sex	O
interactions	O
receive	O
increased	O
consideration	O
as	O
potential	O
candidates	O
(	O
Tables	O
4	O
and	O
5	O
)	O
.	O

Thousands	O
of	O
Genes	O
Show	O
a	O
Sex	O
-	O
Specific	O
Correlation	O
with	O
Gonadal	O
Fat	O
Mass	O

For	O
each	O
of	O
the	O
23	O
,	O
574	O
oligonucleotides	O
represented	O
on	O
the	O
array	O
,	O
we	O
computed	O
a	O
linear	O
regression	O
analysis	O
to	O
test	O
for	O
association	O
between	O
the	O
trait	O
"	O
gonadal	O
fat	O
mass	O
"	O
and	O
each	O
transcript	O
abundance	O
measure	O
,	O
incorporating	O
the	O
terms	O
"	O
gene	O
,	O
"	O
"	O
sex	O
,	O
"	O
and	O
"	O
gene	O
-	O
by	O
-	O
sex	O
,	O
"	O
where	O
the	O
"	O
gene	O
-	O
by	O
-	O
sex	O
"	O
parameter	O
tests	O
for	O
sex	O
-	O
specific	O
correlation	O
between	O
a	O
gene	O
and	O
the	O
trait	O
.	O

As	O
before	O
,	O
a	O
stepwise	O
regression	O
procedure	O
was	O
used	O
to	O
determine	O
if	O
the	O
addition	O
of	O
the	O
interaction	O
term	O
significantly	O
improved	O
the	O
model	O
fit	O
(	O
see	O
Materials	O
and	O
Methods	O
)	O
.	O

Multiple	O
testing	O
was	O
addressed	O
by	O
controlling	O
for	O
the	O
FDR	O
.	O

Distribution	O
of	O
the	O
p	O
-	O
values	O
obtained	O
from	O
these	O
23	O
,	O
574	O
correlations	O
is	O
shown	O
in	O
Figure	O
5A	O
.	O

At	O
FDR	O
=	O
0	O
.	O
01	O
,	O
4	O
,	O
613	O
genes	O
were	O
significantly	O
correlated	O
with	O
gonadal	O
fat	O
mass	O
.	O

Of	O
these	O
genes	O
,	O
4	O
,	O
524	O
(	O
98	O
%	O
)	O
showed	O
significant	O
"	O
gene	O
-	O
by	O
-	O
sex	O
"	O
effects	O
,	O
supporting	O
the	O
high	O
degree	O
of	O
sex	O
specificity	O
in	O
the	O
genetic	O
regulation	O
of	O
this	O
trait	O
.	O

A	O
complete	O
list	O
of	O
all	O
genes	O
correlated	O
with	O
gonadal	O
fat	O
mass	O
is	O
provided	O
in	O
Table	O
S2	O
.	O

Of	O
the	O
4	O
,	O
613	O
genes	O
correlated	O
with	O
gonadal	O
fat	O
mass	O
,	O
1	O
,	O
130	O
generate	O
1	O
,	O
478	O
significant	O
eQTLs	O
(	O
Figure	O
5B	O
)	O
.	O

The	O
colocalization	O
of	O
eQTLs	O
for	O
these	O
correlated	O
genes	O
with	O
the	O
cQTL	O
for	O
the	O
fat	O
mass	O
trait	O
provides	O
useful	O
implications	O
for	O
the	O
possible	O
role	O
of	O
these	O
genes	O
.	O

Whether	O
the	O
eQTLs	O
are	O
cis	O
or	O
trans	O
determines	O
what	O
that	O
role	O
may	O
be	O
.	O

Genes	O
that	O
show	O
significant	O
correlation	O
with	O
the	O
gonadal	O
fat	O
mass	O
trait	O
and	O
that	O
have	O
cis	O
-	O
eQTLs	O
coincident	O
with	O
the	O
fat	O
mass	O
cQTLs	O
are	O
potential	O
candidate	O
genes	O
for	O
the	O
trait	O
(	O
i	O
.	O
e	O
.	O
,	O
they	O
may	O
contain	O
a	O
genetic	O
variation	O
in	O
that	O
gene	O
that	O
is	O
the	O
cause	O
of	O
the	O
trait	O
cQTL	O
)	O
.	O

Table	O
5	O
summarizes	O
the	O
genes	O
that	O
possess	O
these	O
properties	O
for	O
each	O
cQTL	O
,	O
increasing	O
evidence	O
for	O
these	O
genes	O
as	O
potential	O
candidates	O
.	O

As	O
addressed	O
below	O
,	O
given	O
the	O
complex	O
multiorgan	O
regulation	O
of	O
adipose	O
tissue	O
mass	O
,	O
it	O
is	O
unlikely	O
that	O
the	O
genetic	O
regulation	O
of	O
all	O
five	O
loci	O
resides	O
in	O
the	O
liver	O
.	O

However	O
,	O
some	O
may	O
involve	O
the	O
liver	O
,	O
and	O
even	O
for	O
those	O
that	O
do	O
not	O
,	O
the	O
liver	O
transcriptional	O
variation	O
may	O
reflect	O
that	O
of	O
the	O
relevant	O
tissue	O
.	O

Genes	O
that	O
show	O
significant	O
correlation	O
with	O
gonadal	O
fat	O
mass	O
and	O
have	O
trans	O
-	O
eQTLs	O
coincident	O
with	O
the	O
fat	O
mass	O
cQTL	O
cannot	O
be	O
candidates	O
directly	O
responsible	O
for	O
the	O
trait	O
,	O
as	O
they	O
are	O
physically	O
located	O
elsewhere	O
in	O
the	O
genome	O
.	O

However	O
,	O
they	O
are	O
potentially	O
involved	O
in	O
the	O
pathway	O
(	O
s	O
)	O
leading	O
from	O
the	O
causative	O
gene	O
to	O
the	O
expression	O
of	O
the	O
fat	O
mass	O
trait	O
(	O
i	O
.	O
e	O
.	O
,	O
their	O
transcription	O
is	O
closely	O
regulated	O
by	O
the	O
causative	O
gene	O
at	O
the	O
locus	O
)	O
.	O

All	O
of	O
the	O
five	O
fat	O
mass	O
cQTLs	O
have	O
colocalizing	O
trans	O
-	O
eQTLs	O
for	O
correlated	O
genes	O
.	O

However	O
,	O
for	O
a	O
trait	O
such	O
as	O
fat	O
mass	O
that	O
is	O
regulated	O
by	O
multiple	O
tissues	O
and	O
organs	O
,	O
it	O
is	O
unlikely	O
that	O
all	O
five	O
fat	O
mass	O
cQTLs	O
are	O
primarily	O
driven	O
by	O
liver	O
gene	O
expression	O
.	O

As	O
an	O
approach	O
to	O
this	O
problem	O
,	O
we	O
hypothesized	O
that	O
those	O
cQTLs	O
that	O
are	O
most	O
closely	O
associated	O
with	O
liver	O
gene	O
expression	O
would	O
show	O
an	O
overrepresentation	O
of	O
colocalized	O
eQTL	O
for	O
correlated	O
genes	O
,	O
while	O
those	O
loci	O
primarily	O
controlled	O
by	O
other	O
tissues	O
would	O
not	O
have	O
shown	O
this	O
pattern	O
.	O

To	O
assess	O
this	O
,	O
we	O
first	O
determined	O
the	O
distribution	O
of	O
these	O
1	O
,	O
478	O
eQTLs	O
across	O
the	O
genome	O
in	O
2	O
-	O
cM	O
bins	O
as	O
shown	O
in	O
Figure	O
5C	O
.	O

In	O
order	O
to	O
see	O
if	O
there	O
exist	O
any	O
hotspots	O
for	O
these	O
eQTLs	O
,	O
we	O
tested	O
eQTLs	O
with	O
p	O
<	O
0	O
.	O
001	O
for	O
enrichment	O
along	O
the	O
genome	O
in	O
overlapping	O
2	O
-	O
cM	O
bins	O
against	O
the	O
distribution	O
of	O
all	O
liver	O
eQTLs	O
(	O
Figure	O
4A	O
)	O
using	O
a	O
Fisher	O
exact	O
test	O
.	O

Figure	O
5D	O
shows	O
the	O
significance	O
of	O
enrichment	O
reported	O
as	O
-	O
log10	O
of	O
the	O
enrichment	O
p	O
-	O
value	O
across	O
the	O
genome	O
.	O

One	O
locus	O
on	O
Chromosome	O
19	O
was	O
significantly	O
enriched	O
for	O
eQTLs	O
of	O
transcripts	O
correlated	O
with	O
the	O
gonadal	O
fat	O
mass	O
trait	O
.	O

As	O
anticipated	O
,	O
there	O
was	O
an	O
overlap	O
of	O
a	O
correlated	O
eQTL	O
hotspot	O
and	O
a	O
fat	O
mass	O
cQTL	O
,	O
specifically	O
Chromosome	S-GO
19	O
at	O
40	O
cM	O
.	O

This	O
suggests	O
that	O
the	O
genetic	O
regulation	O
of	O
fat	O
mass	O
for	O
the	O
Chromosome	O
19	O
locus	O
is	O
more	O
closely	O
tied	O
to	O
liver	O
gene	O
expression	O
than	O
are	O
the	O
other	O
four	O
fat	O
mass	O
cQTLs	O
.	O

The	O
effect	O
of	O
the	O
trans	O
-	O
eQTLs	O
at	O
the	O
Chromosome	O
19	O
locus	O
on	O
gene	O
expression	O
is	O
summarized	O
in	O
Figure	O
6	O
.	O

Twenty	O
-	O
nine	O
trans	O
-	O
eQTLs	O
colocalize	O
to	O
Chromosome	S-GO
9	O
at	O
40	O
cM	O
,	O
suggesting	O
that	O
29	O
genes	O
correlated	O
with	O
gonadal	O
fat	O
mass	O
are	O
regulated	O
in	O
trans	O
by	O
a	O
polymorphism	O
at	O
this	O
position	O
.	O

The	O
proportion	O
of	O
gene	O
expression	O
levels	O
controlled	O
by	O
this	O
locus	O
(	O
approximated	O
as	O
the	O
coefficients	O
of	O
determination	O
R2	O
)	O
differs	O
between	O
males	O
and	O
females	O
for	O
the	O
majority	O
of	O
the	O
transcripts	O
(	O
as	O
in	O
Figure	O
6A	O
)	O
,	O
and	O
for	O
Chromosome	S-GO
19	O
(	O
Figure	O
6B	O
)	O
,	O
females	O
demonstrated	O
greater	O
genetic	O
regulation	O
of	O
gene	O
expression	O
than	O
males	O
.	O

This	O
substantial	O
female	O
bias	O
is	O
significantly	O
higher	O
than	O
would	O
be	O
expected	O
to	O
arise	O
by	O
chance	O
for	O
the	O
Chromosome	O
19	O
locus	O
(	O
p	O
<	O
0	O
.	O
001	O
by	O
chi	O
2	O
)	O
.	O

This	O
locus	O
corresponds	O
to	O
one	O
of	O
the	O
four	O
sex	O
-	O
biased	O
cQTLs	O
for	O
gonadal	O
fat	O
mass	O
reported	O
in	O
this	O
study	O
,	O
and	O
the	O
significant	O
sex	O
specificity	O
of	O
both	O
the	O
cis	O
and	O
trans	O
genetic	O
regulation	O
of	O
liver	O
genes	O
correlated	O
with	O
fat	O
mass	O
supports	O
the	O
functional	O
significance	O
of	O
this	O
locus	O
in	O
this	O
organ	O
.	O

Discussion	O

In	O
this	O
study	O
,	O
we	O
described	O
a	O
large	O
,	O
densely	O
mapped	O
,	O
segregating	O
F2	O
mouse	O
population	O
designed	O
to	O
study	O
the	O
genetic	O
regulation	O
of	O
several	O
traits	O
associated	O
with	O
the	O
so	O
-	O
called	O
metabolic	O
syndrome	O
.	O

Several	O
groups	O
,	O
including	O
ours	O
,	O
have	O
reported	O
the	O
advantage	O
of	O
combining	O
traditional	O
genetics	O
with	O
genome	O
-	O
wide	O
gene	O
expression	O
analysis	O
for	O
the	O
dissection	O
of	O
complex	O
traits	O
.	O

This	O
study	O
improved	O
on	O
past	O
models	O
by	O
including	O
over	O
300	O
animals	O
(	O
three	O
times	O
the	O
size	O
of	O
previous	O
studies	O
)	O
of	O
both	O
sexes	O
,	O
allowing	O
for	O
the	O
incorporation	O
of	O
sex	O
-	O
specific	O
effects	O
on	O
underlying	O
genetic	O
regulation	O
.	O

Significant	O
Sex	O
Bias	O
in	O
the	O
Regulation	O
of	O
Both	O
Complex	O
Traits	O
and	O
Gene	O
Expression	O

Given	O
the	O
known	O
dichotomy	O
between	O
females	O
and	O
males	O
in	O
the	O
susceptibility	O
and	O
control	O
of	O
obesity	O
,	O
this	O
study	O
was	O
designed	O
to	O
sufficiently	O
power	O
the	O
detection	O
of	O
significant	O
QTLs	O
for	O
this	O
and	O
other	O
traits	O
with	O
sex	O
-	O
dependent	O
effects	O
.	O

Note	O
,	O
however	O
,	O
that	O
these	O
effects	O
can	O
extend	O
to	O
traits	O
without	O
overall	O
mean	O
differences	O
between	O
the	O
sexes	O
.	O

Previous	O
studies	O
have	O
described	O
the	O
advantages	O
of	O
performing	O
QTL	O
analysis	O
both	O
with	O
and	O
without	O
sex	O
as	O
an	O
interactive	O
covariate	O
[	O
22	O
-	O
25	O
]	O
.	O

Analyzing	O
the	O
sexes	O
separately	O
is	O
suboptimal	O
since	O
it	O
reduces	O
sample	O
size	O
in	O
both	O
groups	O
,	O
thus	O
reducing	O
power	O
to	O
detect	O
main	O
QTL	O
effects	O
,	O
as	O
demonstrated	O
by	O
our	O
genome	O
scan	O
of	O
Chromosome	S-GO
5	O
(	O
Figure	O
1B	O
)	O
.	O

Furthermore	O
,	O
separate	O
analyses	O
would	O
not	O
allow	O
for	O
the	O
detection	O
of	O
QTLs	O
that	O
have	O
opposing	O
,	O
or	O
sex	O
-	O
antagonistic	O
,	O
effects	O
in	O
females	O
and	O
males	O
and	O
would	O
hinder	O
the	O
detection	O
of	O
QTLs	O
specific	O
to	O
one	O
sex	O
.	O

Accordingly	O
,	O
we	O
detected	O
five	O
cQTLs	O
for	O
the	O
gonadal	O
fat	O
mass	O
trait	O
on	O
Chromosomes	S-GO
1	O
,	O
3	O
,	O
5	O
,	O
11	O
,	O
and	O
19	O
.	O

The	O
detection	O
of	O
all	O
five	O
cQTLs	O
was	O
"	O
driven	O
"	O
by	O
the	O
larger	O
effect	O
in	O
females	O
,	O
with	O
significant	O
improvement	O
by	O
the	O
incorporation	O
of	O
sex	O
*	O
additive	O
and	O
sex	O
*	O
dominant	O
parameters	O
.	O

QTLs	O
associated	O
with	O
obesity	O
,	O
gonadal	O
fat	O
,	O
and	O
abdominal	O
fat	O
have	O
been	O
reported	O
before	O
overlapping	O
with	O
cQTLs	O
on	O
Chromosomes	S-GO
1	O
[	O
26	O
-	O
28	O
]	O
,	O
5	O
[	O
26	O
,	O
29	O
]	O
,	O
and	O
11	O
[	O
19	O
,	O
29	O
]	O
reported	O
here	O
,	O
whereas	O
the	O
cQTL	O
on	O
Chromosome	S-GO
3	O
represents	O
a	O
novel	O
QTL	O
for	O
this	O
trait	O
.	O

The	O
Chromosome	S-GO
19	O
cQTL	O
for	O
fat	O
mass	O
was	O
recently	O
reported	O
by	O
us	O
[	O
5	O
]	O
in	O
the	O
BXD	O
intercross	O
F2	O
progeny	O
from	O
the	O
strains	O
B6	O
and	O
DBA	O
(	O
which	O
shares	O
the	O
same	O
haplotype	O
at	O
this	O
region	O
as	O
the	O
C3H	O
strain	O
used	O
in	O
this	O
study	O
)	O
.	O

Interestingly	O
,	O
significant	O
heritability	O
and	O
genetic	O
regulation	O
was	O
seen	O
in	O
this	O
F2	O
population	O
despite	O
the	O
hyperlipidemic	O
,	O
proinflammatory	O
ApoE	O
-	O
/	O
-	O
background	O
and	O
the	O
high	O
-	O
fat	O
Western	O
diet	O
.	O

This	O
background	O
possesses	O
several	O
advantages	O
,	O
such	O
as	O
allowing	O
the	O
modeling	O
of	O
human	O
-	O
like	O
disease	O
states	O
.	O

The	O
predominantly	O
female	O
-	O
driven	O
effects	O
of	O
the	O
five	O
cQTLs	O
likely	O
reflect	O
the	O
significant	O
effect	O
of	O
differential	O
gonadal	O
hormone	O
secretions	O
on	O
the	O
genetic	O
regulation	O
of	O
this	O
complex	O
trait	O
.	O

The	O
identification	O
of	O
genes	O
underlying	O
cQTLs	O
remains	O
a	O
challenge	O
.	O

The	O
widespread	O
availability	O
of	O
genome	O
-	O
wide	O
expression	O
analysis	O
has	O
begun	O
to	O
address	O
this	O
by	O
providing	O
a	O
snapshot	O
of	O
transcription	O
in	O
relevant	O
organs	O
and	O
thus	O
providing	O
initial	O
information	O
for	O
which	O
genes	O
can	O
differentiate	O
a	O
given	O
trait	O
.	O

Furthermore	O
,	O
by	O
treating	O
transcript	O
levels	O
as	O
quantitative	O
traits	O
,	O
we	O
can	O
map	O
the	O
genetic	O
regulation	O
underlying	O
differential	O
gene	O
expression	O
(	O
eQTLs	O
)	O
.	O

Those	O
eQTLs	O
that	O
have	O
cis	O
-	O
acting	O
variations	O
affecting	O
their	O
transcription	O
are	O
potential	O
candidate	O
genes	O
for	O
the	O
trait	O
.	O

At	O
a	O
single	O
trait	O
,	O
genome	O
-	O
wide	O
significance	O
level	O
of	O
0	O
.	O
05	O
,	O
we	O
detected	O
6	O
,	O
676	O
eQTLs	O
representing	O
4	O
,	O
998	O
genes	O
,	O
of	O
which	O
2	O
,	O
118	O
were	O
cis	O
-	O
acting	O
.	O

At	O
increased	O
thresholds	O
,	O
the	O
proportion	O
of	O
cis	O
-	O
eQTLs	O
increased	O
,	O
which	O
is	O
in	O
good	O
agreement	O
with	O
previous	O
studies	O
[	O
5	O
,	O
15	O
]	O
and	O
likely	O
reflects	O
the	O
increased	O
power	O
to	O
detect	O
cis	O
-	O
acting	O
variations	O
affecting	O
transcription	O
.	O

Of	O
all	O
6	O
,	O
676	O
significant	O
eQTLs	O
,	O
1	O
,	O
166	O
possessed	O
significant	O
sex	O
interactions	O
.	O

Of	O
these	O
,	O
304	O
were	O
cis	O
and	O
852	O
were	O
trans	O
,	O
suggesting	O
that	O
only	O
a	O
minority	O
of	O
the	O
sex	O
-	O
specific	O
effects	O
on	O
the	O
regulation	O
of	O
gene	O
expression	O
occur	O
through	O
polymorphisms	O
within	O
the	O
gene	O
itself	O
.	O

Rather	O
,	O
underlying	O
genetic	O
regulation	O
of	O
most	O
transcripts	O
is	O
the	O
result	O
of	O
interactions	O
between	O
trans	O
loci	O
and	O
sex	O
-	O
specific	O
factors	O
(	O
e	O
.	O
g	O
.	O
,	O
hormones	O
)	O
.	O

As	O
with	O
cQTLs	O
,	O
sex	O
bias	O
in	O
the	O
predominantly	O
trans	O
genetic	O
regulation	O
of	O
gene	O
expression	O
is	O
likely	O
secondary	O
to	O
different	O
sex	O
hormone	O
profiles	O
.	O

Recently	O
,	O
using	O
a	O
similar	O
dataset	O
,	O
our	O
group	O
demonstrated	O
that	O
significant	O
cis	O
-	O
eQTLs	O
(	O
p	O
<	O
5	O
x	O
10	O
-	O
5	O
)	O
largely	O
represent	O
true	O
positives	O
[	O
30	O
]	O
and	O
are	O
enriched	O
for	O
highly	O
polymorphic	O
regions	O
over	O
the	O
mouse	O
genome	O
.	O

The	O
cis	O
-	O
eQTLs	O
presented	O
in	O
Table	O
5	O
overlap	O
with	O
one	O
of	O
the	O
gonadal	O
fat	O
mass	O
cQTLs	O
and	O
should	O
be	O
considered	O
potential	O
candidates	O
.	O

Given	O
the	O
sex	O
effects	O
in	O
the	O
gonadal	O
fat	O
mass	O
cQTLs	O
,	O
we	O
reasoned	O
that	O
the	O
cis	O
-	O
eQTLs	O
with	O
significant	O
sex	O
*	O
additive	O
and	O
sex	O
*	O
dominant	O
effects	O
should	O
receive	O
priority	O
consideration	O
.	O

The	O
use	O
of	O
eQTLs	O
to	O
dissect	O
cQTLs	O
is	O
a	O
method	O
still	O
in	O
its	O
infancy	O
,	O
with	O
uncertain	O
efficacy	O
and	O
applicability	O
.	O

Nevertheless	O
,	O
application	O
of	O
this	O
analysis	O
to	O
this	O
dataset	O
provides	O
some	O
tantalizingly	O
attractive	O
candidate	O
genes	O
.	O

One	O
shortcoming	O
of	O
this	O
approach	O
,	O
however	O
,	O
is	O
that	O
candidate	O
genes	O
are	O
limited	O
to	O
those	O
whose	O
transcript	O
expression	O
levels	O
vary	O
in	O
association	O
with	O
a	O
nearby	O
polymorphism	O
that	O
differs	O
between	O
the	O
parental	O
strains	O
--	O
in	O
other	O
words	O
,	O
genes	O
with	O
significant	O
and	O
detectable	O
cis	O
-	O
eQTLs	O
.	O

However	O
,	O
it	O
is	O
not	O
strictly	O
necessary	O
for	O
candidate	O
genes	O
to	O
have	O
evidence	O
of	O
such	O
linkage	O
:	O
polymorphisms	O
underlying	O
a	O
trait	O
cQTL	O
can	O
affect	O
gene	O
function	O
or	O
posttranslational	O
modifications	O
.	O

Nevertheless	O
,	O
several	O
phenotypes	O
are	O
known	O
to	O
be	O
regulated	O
,	O
at	O
least	O
partly	O
,	O
at	O
the	O
level	O
of	O
transcription	O
or	O
mRNA	O
stability	O
,	O
which	O
is	O
exactly	O
what	O
our	O
methods	O
are	O
designed	O
to	O
detect	O
.	O

A	O
separate	O
problem	O
is	O
that	O
organ	O
-	O
specific	O
gene	O
expression	O
differences	O
may	O
preclude	O
one	O
from	O
detecting	O
the	O
relevant	O
causative	O
gene	O
if	O
the	O
tissue	O
arrayed	O
is	O
not	O
the	O
tissue	O
where	O
the	O
control	O
is	O
exerted	O
.	O

This	O
is	O
particularly	O
relevant	O
for	O
a	O
trait	O
such	O
as	O
adipose	O
tissue	O
mass	O
,	O
which	O
is	O
controlled	O
by	O
multiple	O
tissues	O
.	O

We	O
propose	O
that	O
analysis	O
of	O
correlated	O
genes	O
can	O
provide	O
guidance	O
as	O
discussed	O
below	O
.	O

Genes	O
Correlated	O
with	O
Gonadal	O
Fat	O
Mass	O
Illustrate	O
Tissue	O
-	O
Specific	O
Regulation	O
of	O
the	O
Trait	O

In	O
an	O
effort	O
to	O
identify	O
genes	O
associated	O
with	O
the	O
fat	O
mass	O
trait	O
,	O
but	O
not	O
necessarily	O
candidate	O
genes	O
underlying	O
the	O
trait	O
cQTLs	O
,	O
we	O
fitted	O
linear	O
models	O
to	O
assess	O
the	O
degree	O
of	O
association	O
between	O
transcripts	O
and	O
gonadal	O
fat	O
mass	O
.	O

As	O
with	O
QTLs	O
,	O
sex	O
-	O
specific	O
correlations	O
were	O
modeled	O
.	O

At	O
an	O
FDR	O
of	O
1	O
%	O
,	O
4	O
,	O
613	O
genes	O
were	O
found	O
to	O
be	O
significantly	O
correlated	O
with	O
gonadal	O
fat	O
mass	O
,	O
of	O
which	O
4	O
,	O
254	O
(	O
98	O
%	O
)	O
showed	O
sex	O
-	O
biased	O
correlation	O
.	O

As	O
indicated	O
in	O
Tables	O
4	O
and	O
5	O
,	O
several	O
genes	O
with	O
detectable	O
cis	O
-	O
eQTLs	O
are	O
also	O
significantly	O
correlated	O
with	O
the	O
trait	O
and	O
are	O
even	O
further	O
prioritized	O
as	O
candidate	O
genes	O
.	O

Thus	O
far	O
,	O
studies	O
that	O
have	O
examined	O
the	O
"	O
genetics	O
of	O
gene	O
expression	O
"	O
are	O
in	O
good	O
agreement	O
regarding	O
the	O
increased	O
power	O
to	O
detect	O
cis	O
-	O
eQTLs	O
relative	O
to	O
trans	O
[	O
5	O
,	O
9	O
,	O
15	O
,	O
16	O
,	O
31	O
]	O
.	O

It	O
is	O
unclear	O
at	O
this	O
time	O
,	O
however	O
,	O
what	O
exactly	O
is	O
the	O
significance	O
of	O
trans	O
-	O
eQTLs	O
and	O
the	O
nature	O
of	O
the	O
underlying	O
polymorphisms	O
associated	O
with	O
them	O
.	O

Furthermore	O
,	O
the	O
eQTL	O
hotspots	O
reported	O
in	O
this	O
and	O
previous	O
studies	O
[	O
5	O
,	O
9	O
,	O
10	O
]	O
largely	O
represent	O
trans	O
-	O
eQTLs	O
.	O

This	O
localization	O
suggests	O
some	O
functional	O
significance	O
to	O
these	O
regions	O
.	O

Of	O
the	O
4	O
,	O
613	O
genes	O
correlated	O
with	O
gonadal	O
fat	O
mass	O
,	O
1	O
,	O
130	O
generate	O
1	O
,	O
478	O
significant	O
eQTLs	O
,	O
of	O
which	O
1	O
,	O
023	O
(	O
69	O
%	O
)	O
are	O
trans	O
-	O
acting	O
.	O

These	O
eQTLs	O
are	O
significantly	O
enriched	O
at	O
one	O
locus	O
(	O
Chromosome	S-GO
19	O
)	O
.	O

Interestingly	O
,	O
this	O
hotspot	O
was	O
coincident	O
with	O
a	O
cQTL	O
associated	O
with	O
fat	O
mass	O
reported	O
in	O
this	O
study	O
.	O

Since	O
these	O
transcripts	O
represent	O
those	O
significantly	O
correlated	O
with	O
gonadal	O
fat	O
mass	O
,	O
the	O
localization	O
of	O
their	O
eQTLs	O
to	O
these	O
regions	O
strongly	O
supports	O
the	O
notion	O
that	O
the	O
genes	O
with	O
trans	O
-	O
eQTLs	O
represent	O
downstream	O
targets	O
of	O
candidate	O
regulatory	O
genes	O
located	O
at	O
the	O
position	O
of	O
significant	O
linkage	O
.	O

This	O
means	O
that	O
the	O
genes	O
may	O
be	O
causal	O
but	O
downstream	O
of	O
the	O
gene	O
responsible	O
for	O
the	O
cQTLs	O
,	O
or	O
they	O
may	O
be	O
reacting	O
to	O
the	O
increased	O
gonadal	O
fat	O
mass	O
and	O
associated	O
metabolic	O
changes	O
.	O

These	O
data	O
also	O
suggest	O
that	O
identifying	O
such	O
loci	O
that	O
show	O
overrepresentation	O
of	O
highly	O
correlated	O
genes	O
is	O
a	O
means	O
to	O
identify	O
which	O
of	O
the	O
trait	O
cQTLs	O
are	O
more	O
likely	O
controlled	O
by	O
the	O
tissue	O
arrayed	O
.	O

As	O
expected	O
,	O
the	O
Chromosome	O
19	O
locus	O
was	O
enriched	O
for	O
trans	O
-	O
eQTLs	O
with	O
substantially	O
greater	O
effects	O
in	O
females	O
.	O

Functional	O
and	O
promoter	O
analysis	O
of	O
genes	O
with	O
a	O
common	O
trans	O
-	O
eQTL	O
may	O
prove	O
enlightening	O
.	O

Furthermore	O
,	O
gene	O
expression	O
network	O
construction	O
and	O
analysis	O
may	O
be	O
improved	O
by	O
the	O
incorporation	O
of	O
experimentally	O
demonstrated	O
cis	O
versus	O
trans	O
regulation	O
.	O

Conclusion	O

The	O
integration	O
of	O
traditional	O
genetics	O
with	O
genome	O
-	O
wide	O
expression	O
analysis	O
was	O
first	O
proposed	O
by	O
Jansen	O
and	O
Nap	O
4	O
y	O
ago	O
[	O
32	O
]	O
.	O

Advances	O
in	O
genomic	O
technology	O
and	O
bioinformatic	O
resources	O
since	O
then	O
have	O
vastly	O
improved	O
the	O
applicability	O
of	O
these	O
methods	O
to	O
the	O
dissection	O
of	O
complex	O
traits	O
.	O

Taking	O
into	O
account	O
sex	O
-	O
specific	O
effects	O
will	O
similarly	O
improve	O
the	O
sensitivity	O
to	O
detect	O
underlying	O
genetic	O
regulation	O
,	O
especially	O
for	O
phenotypes	O
known	O
to	O
be	O
affected	O
by	O
sex	O
.	O

Furthermore	O
,	O
network	O
analyses	O
are	O
increasingly	O
being	O
applied	O
to	O
complex	O
phenotypes	O
[	O
11	O
,	O
33	O
]	O
.	O

Regardless	O
of	O
which	O
variables	O
are	O
used	O
in	O
the	O
construction	O
of	O
these	O
networks	O
,	O
whether	O
they	O
measure	O
gene	O
expression	O
or	O
protein	O
interactions	O
,	O
accounting	O
for	O
sex	O
specificity	O
,	O
hormonal	O
status	O
,	O
or	O
construction	O
of	O
different	O
networks	O
for	O
females	O
and	O
males	O
would	O
likely	O
more	O
accurately	O
represent	O
the	O
complexity	O
associated	O
with	O
these	O
phenotypes	O
.	O

We	O
reported	O
here	O
on	O
the	O
initial	O
genetic	O
and	O
genomic	O
analysis	O
of	O
an	O
F2	O
intercross	O
population	O
designed	O
to	O
recapitulate	O
several	O
traits	O
associated	O
with	O
human	O
metabolic	O
syndrome	O
.	O

Using	O
334	O
mice	O
of	O
both	O
sexes	O
genotyped	O
at	O
high	O
density	O
,	O
this	O
is	O
the	O
largest	O
study	O
of	O
its	O
kind	O
to	O
date	O
designed	O
,	O
and	O
it	O
is	O
strongly	O
powered	O
to	O
detect	O
subtle	O
effects	O
of	O
genetic	O
regulation	O
and	O
sex	O
specificity	O
.	O

We	O
identified	O
five	O
cQTLs	O
for	O
the	O
gonadal	O
fat	O
mass	O
trait	O
,	O
all	O
with	O
greater	O
effects	O
in	O
females	O
.	O

We	O
also	O
detected	O
several	O
thousand	O
significant	O
liver	O
eQTLs	O
,	O
a	O
significant	O
fraction	O
of	O
which	O
are	O
sex	O
-	O
biased	O
,	O
demonstrating	O
how	O
meaningful	O
effects	O
of	O
sex	O
on	O
gene	O
expression	O
extend	O
beyond	O
overall	O
mean	O
differences	O
.	O

We	O
demonstrated	O
the	O
application	O
of	O
linkage	O
and	O
correlation	O
methods	O
to	O
identify	O
candidate	O
genes	O
.	O

Finally	O
,	O
we	O
showed	O
that	O
localization	O
of	O
a	O
subset	O
of	O
liver	O
genes	O
linked	O
in	O
trans	O
to	O
a	O
cQTL	O
region	O
can	O
identify	O
relative	O
tissue	O
contributions	O
to	O
the	O
genetic	O
regulation	O
of	O
a	O
complex	O
trait	O
.	O

We	O
anticipate	O
that	O
the	O
application	O
of	O
these	O
and	O
similar	O
methods	O
would	O
significantly	O
improve	O
the	O
elucidation	O
of	O
the	O
genetic	O
regulation	O
underlying	O
complex	O
phenotypes	O
.	O

Materials	O
and	O
Methods	O

Animals	O
and	O
tissue	O
collection	O
.	O

C57BL	O
/	O
6J	O
ApoE	O
-	O
/	O
-	O
(	O
B6	O
.	O
ApoE	O
-	O
/	O
-	O
)	O
were	O
purchased	O
from	O
Jackson	O
Laboratory	O
(	O
Bar	O
Harbor	O
,	O
Maine	O
,	O
United	O
States	O
)	O
.	O

C3H	O
/	O
HeJ	O
ApoE	O
-	O
/	O
-	O
(	O
C3H	O
.	O
ApoE	O
-	O
/	O
-	O
)	O
were	O
generated	O
by	O
backcrossing	O
B6	O
.	O
ApoE	O
-	O
/	O
-	O
to	O
C3H	O
for	O
ten	O
generations	O
.	O

F1	O
mice	O
were	O
generated	O
from	O
reciprocal	O
intercrossing	O
between	O
B6	O
.	O
ApoE	O
-	O
/	O
-	O
and	O
C3H	O
.	O
ApoE	O
-	O
/	O
-	O
,	O
and	O
F2	O
mice	O
were	O
subsequently	O
bred	O
by	O
intercrossing	O
F1	O
mice	O
.	O

A	O
total	O
of	O
334	O
mice	O
(	O
169	O
female	O
,	O
165	O
male	O
)	O
were	O
produced	O
.	O

All	O
mice	O
were	O
fed	O
Purina	O
Chow	O
containing	O
4	O
%	O
fat	O
until	O
8	O
wk	O
of	O
age	O
and	O
then	O
transferred	O
to	O
a	O
"	O
Western	O
"	O
diet	O
containing	O
42	O
%	O
fat	O
and	O
0	O
.	O
15	O
%	O
cholesterol	O
for	O
16	O
wk	O
.	O

Mice	O
were	O
sacrificed	O
at	O
24	O
wk	O
of	O
age	O
.	O

At	O
death	O
,	O
livers	O
were	O
immediately	O
collected	O
and	O
flash	O
-	O
frozen	O
in	O
liquid	O
N2	O
,	O
and	O
gonadal	O
fat	O
pads	O
were	O
extracted	O
and	O
weighed	O
.	O

RNA	O
sample	O
preparation	O
,	O
microarray	O
hybridization	O
,	O
and	O
expression	O
analysis	O
.	O

RNA	O
preparation	O
and	O
array	O
hybridizations	O
were	O
performed	O
at	O
Rosetta	O
Inpharmatics	O
(	O
Seattle	O
,	O
Washington	O
,	O
United	O
States	O
)	O
.	O

The	O
custom	O
ink	O
-	O
jet	O
microarrays	O
used	O
in	O
this	O
study	O
(	O
Agilent	O
Technologies	O
,	O
previously	O
described	O
[	O
21	O
,	O
34	O
]	O
)	O
contain	O
2	O
,	O
186	O
control	O
probes	O
and	O
23	O
,	O
574	O
noncontrol	O
oligonucleotides	O
extracted	O
from	O
mouse	O
UniGene	O
clusters	O
and	O
combined	O
with	O
RefSeq	O
sequences	O
and	O
RIKEN	O
full	O
-	O
length	O
clones	O
.	O

Mouse	O
livers	O
were	O
homogenized	O
and	O
total	O
RNA	O
extracted	O
using	O
TRIzol	O
reagent	O
(	O
Invitrogen	O
,	O
Carlsbad	O
,	O
California	O
,	O
United	O
States	O
)	O
according	O
to	O
manufacturer	O
'	O
s	O
protocol	O
.	O

Three	O
micrograms	O
of	O
total	O
RNA	O
was	O
reverse	O
transcribed	O
and	O
labeled	O
with	O
either	O
Cy3	O
or	O
Cy5	O
fluorochrome	O
.	O

Purified	O
Cy3	O
or	O
Cy5	O
complementary	O
RNA	O
was	O
hybridized	O
to	O
at	O
least	O
two	O
microarray	O
slides	O
with	O
fluor	O
reversal	O
for	O
24	O
h	O
in	O
a	O
hybridization	O
chamber	O
,	O
washed	O
,	O
and	O
scanned	O
using	O
a	O
laser	O
confocal	O
scanner	O
.	O

Arrays	O
were	O
quantified	O
on	O
the	O
basis	O
of	O
spot	O
intensity	O
relative	O
to	O
background	O
,	O
adjusted	O
for	O
experimental	O
variation	O
between	O
arrays	O
using	O
average	O
intensity	O
over	O
multiple	O
channels	O
,	O
and	O
fitted	O
to	O
an	O
error	O
model	O
to	O
determine	O
significance	O
(	O
type	O
I	O
error	O
)	O
.	O

Gene	O
expression	O
is	O
reported	O
as	O
the	O
mlratio	O
relative	O
to	O
the	O
pool	O
derived	O
from	O
150	O
mice	O
randomly	O
selected	O
from	O
the	O
F2	O
population	O
.	O

For	O
subsequent	O
analyses	O
,	O
mlratio	O
data	O
are	O
assumed	O
to	O
be	O
normally	O
distributed	O
,	O
a	O
valid	O
assumption	O
as	O
previously	O
demonstrated	O
[	O
21	O
,	O
30	O
]	O
.	O

The	O
error	O
model	O
used	O
to	O
assess	O
whether	O
a	O
given	O
gene	O
is	O
significantly	O
differentially	O
expressed	O
in	O
a	O
single	O
sample	O
relative	O
to	O
a	O
pool	O
comprised	O
of	O
a	O
randomly	O
selected	O
subset	O
of	O
150	O
samples	O
has	O
been	O
extensively	O
described	O
and	O
tested	O
in	O
a	O
number	O
of	O
publications	O
[	O
35	O
,	O
36	O
]	O
.	O

Genotyping	O
and	O
linkage	O
statistics	O
.	O

Genomic	O
DNA	O
was	O
isolated	O
from	O
kidney	O
by	O
phenol	O
-	O
chloroform	O
extraction	O
.	O

An	O
examination	O
of	O
existing	O
databases	O
identified	O
over	O
1	O
,	O
300	O
SNPs	O
that	O
showed	O
variation	O
between	O
the	O
B6	O
and	O
C3H	O
strains	O
,	O
and	O
a	O
complete	O
linkage	O
map	O
for	O
all	O
19	O
autosomes	S-GO
was	O
constructed	O
using	O
1	O
,	O
032	O
of	O
these	O
SNPs	O
at	O
an	O
average	O
density	O
of	O
1	O
.	O
5	O
cM	O
.	O

Genotyping	O
was	O
conducted	O
by	O
ParAllele	O
(	O
South	O
San	O
Francisco	O
,	O
California	O
,	O
United	O
States	O
)	O
using	O
the	O
molecular	O
-	O
inversion	O
probe	O
(	O
MIB	O
)	O
multiplex	O
technique	O
[	O
37	O
]	O
.	O

Testing	O
for	O
linkage	O
of	O
both	O
clinical	O
traits	O
and	O
gene	O
expression	O
(	O
using	O
mlratio	O
)	O
was	O
conducted	O
using	O
a	O
linear	O
model	O
.	O

Consider	O
a	O
phenotype	O
denoted	O
by	O
y	O
.	O

The	O
linear	O
model	O
that	O
relates	O
variation	O
in	O
y	O
to	O
QTLs	O
and	O
other	O
covariates	O
(	O
e	O
.	O
g	O
.	O
,	O
sex	O
)	O
is	O
given	O
by	O
the	O
general	O
form	O

where	O
mu	O
is	O
the	O
trait	O
mean	O
,	O
X	O
'	O
a	O
vector	O
of	O
covariates	O
,	O
beta	O
being	O
the	O
associated	O
vector	O
of	O
regression	O
coefficients	O
,	O
and	O
e	O
the	O
residual	O
error	O
.	O

Linkage	O
was	O
computed	O
for	O
over	O
20	O
clinical	O
traits	O
as	O
well	O
as	O
23	O
,	O
574	O
liver	O
transcripts	O
.	O

Standard	O
genome	O
scans	O
calculate	O
linkage	O
by	O
comparing	O
the	O
linear	O
model	O

to	O
the	O
null	O
model	O

where	O
beta	O
1	O
and	O
beta	O
2	O
are	O
the	O
regression	O
coefficients	O
of	O
the	O
additive	O
and	O
dominant	O
parameters	O
,	O
respectively	O
.	O

The	O
LOD	O
score	O
represents	O
the	O
difference	O
in	O
the	O
log10	O
of	O
the	O
likelihood	O
of	O
the	O
above	O
two	O
equations	O
,	O
where	O
the	O
individual	O
model	O
likelihoods	O
are	O
maximized	O
with	O
respect	O
to	O
the	O
model	O
parameters	O
,	O
given	O
the	O
marker	O
genotype	O
and	O
phenotype	O
data	O
.	O

If	O
a	O
trait	O
y	O
differs	O
on	O
average	O
between	O
the	O
two	O
sexes	O
but	O
the	O
QTL	O
has	O
the	O
same	O
effect	O
in	O
both	O
males	O
and	O
females	O
,	O
we	O
can	O
model	O
this	O
interaction	O
by	O
including	O
sex	O
as	O
an	O
additive	O
covariate	O
in	O
the	O
above	O
models	O
,	O
resulting	O
in	O
the	O
new	O
model	O

which	O
is	O
then	O
compared	O
to	O
the	O
null	O
model	O

where	O
beta	O
3	O
is	O
the	O
regression	O
coefficient	O
of	O
the	O
sex	O
parameter	O
.	O

The	O
effect	O
of	O
a	O
QTL	O
may	O
be	O
dependent	O
on	O
the	O
state	O
of	O
a	O
covariate	O
;	O
for	O
instance	O
,	O
a	O
QTL	O
may	O
have	O
an	O
effect	O
specific	O
to	O
one	O
sex	O
,	O
or	O
may	O
have	O
opposite	O
effects	O
in	O
the	O
two	O
sexes	O
.	O

This	O
interaction	O
can	O
be	O
modeled	O
using	O
a	O
full	O
model	O
,	O
which	O
accounts	O
for	O
all	O
additive	O
covariates	O
,	O
as	O
well	O
as	O
interactions	O
between	O
the	O
covariates	O
:	O

which	O
is	O
compared	O
to	O
the	O
above	O
null	O
model	O
(	O
Equation	O
5	O
)	O
.	O

The	O
full	O
model	O
(	O
Equation	O
6	O
)	O
allows	O
us	O
to	O
model	O
all	O
heritable	O
and	O
sex	O
-	O
specific	O
interactions	O
in	O
a	O
single	O
equation	O
and	O
maximally	O
powers	O
us	O
to	O
detect	O
significant	O
QTLs	O
when	O
the	O
sex	O
and	O
sex	O
-	O
interaction	O
terms	O
are	O
significant	O
,	O
given	O
all	O
334	O
animals	O
are	O
included	O
in	O
the	O
analysis	O
.	O

Furthermore	O
,	O
using	O
the	O
full	O
model	O
obviates	O
the	O
need	O
for	O
modeling	O
QTLs	O
in	O
one	O
sex	O
only	O
,	O
a	O
procedure	O
that	O
could	O
decrease	O
our	O
power	O
by	O
halving	O
the	O
sample	O
size	O
,	O
rendering	O
it	O
impossible	O
to	O
detect	O
interactions	O
between	O
QTLs	O
and	O
sex	O
.	O

However	O
,	O
because	O
the	O
full	O
model	O
contains	O
two	O
more	O
parameters	O
than	O
the	O
model	O
that	O
treats	O
sex	O
as	O
an	O
additive	O
covariate	O
(	O
Equation	O
4	O
)	O
,	O
the	O
LOD	O
score	O
threshold	O
for	O
significant	O
linkage	O
is	O
higher	O
(	O
using	O
the	O
convention	O
of	O
Lander	O
and	O
Kruglyak	O
[	O
20	O
]	O
)	O
,	O
with	O
QTL	O
-	O
specific	O
significance	O
levels	O
of	O
2	O
x	O
10	O
-	O
3	O
and	O
5	O
x	O
10	O
-	O
5	O
equivalent	O
to	O
LOD	O
scores	O
of	O
4	O
.	O
0	O
(	O
suggestive	O
linkage	O
)	O
and	O
5	O
.	O
4	O
(	O
significant	O
linkage	O
,	O
equivalent	O
to	O
genome	O
-	O
wide	O
p	O
<	O
0	O
.	O
05	O
)	O
,	O
respectively	O
.	O

As	O
a	O
result	O
,	O
if	O
there	O
are	O
no	O
significant	O
sex	O
-	O
additive	O
or	O
sex	O
-	O
dominant	O
interactions	O
,	O
the	O
full	O
model	O
will	O
actually	O
reduce	O
power	O
to	O
detect	O
linkage	O
.	O

To	O
minimize	O
the	O
loss	O
in	O
power	O
of	O
fitting	O
the	O
full	O
model	O
when	O
the	O
sex	O
-	O
interaction	O
terms	O
are	O
not	O
significant	O
,	O
we	O
employed	O
a	O
model	O
selection	O
procedure	O
that	O
introduces	O
sex	O
-	O
interaction	O
terms	O
only	O
if	O
they	O
add	O
significantly	O
to	O
the	O
overall	O
QTL	O
model	O
.	O

The	O
model	O
selection	O
procedure	O
makes	O
use	O
of	O
forward	O
stepwise	O
regression	O
techniques	O
to	O
determine	O
whether	O
it	O
is	O
beneficial	O
to	O
include	O
the	O
sex	O
-	O
interaction	O
terms	O
,	O
conditional	O
on	O
realizing	O
a	O
significant	O
additive	O
effect	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
.	O

That	O
is	O
,	O
the	O
data	O
are	O
fitted	O
to	O
Equation	O
4	O
for	O
a	O
given	O
marker	O
,	O
and	O
if	O
the	O
add	O
term	O
is	O
significant	O
at	O
the	O
0	O
.	O
001	O
significance	O
level	O
,	O
then	O
we	O
attempt	O
to	O
add	O
the	O
sex	O
*	O
add	O
term	O
into	O
the	O
model	O
.	O

The	O
sex	O
*	O
add	O
term	O
is	O
retained	O
in	O
the	O
model	O
if	O
the	O
Bayesian	O
information	O
criterion	O
(	O
BIC	O
)	O
for	O
this	O
model	O
is	O
smaller	O
than	O
the	O
BIC	O
for	O
Equation	O
4	O
.	O

If	O
sex	O
*	O
add	O
is	O
included	O
in	O
the	O
model	O
as	O
a	O
result	O
of	O
this	O
procedure	O
,	O
then	O
we	O
again	O
use	O
BIC	O
to	O
consider	O
including	O
the	O
sex	O
*	O
dom	O
term	O
in	O
the	O
model	O
.	O

To	O
determine	O
which	O
of	O
the	O
four	O
models	O
(	O
Equations	O
2	O
,	O
4	O
,	O
6	O
,	O
and	O
the	O
model	O
selection	O
)	O
is	O
optimal	O
,	O
we	O
empirically	O
estimated	O
the	O
FDR	O
for	O
each	O
model	O
over	O
a	O
set	O
of	O
3	O
,	O
000	O
genes	O
randomly	O
selected	O
from	O
the	O
set	O
of	O
all	O
genes	O
detected	O
as	O
expressed	O
in	O
the	O
liver	O
samples	O
.	O

For	O
each	O
gene	O
and	O
for	O
each	O
marker	O
we	O
fitted	O
each	O
of	O
the	O
four	O
models	O
to	O
the	O
data	O
.	O

We	O
performed	O
this	O
same	O
analysis	O
on	O
ten	O
separate	O
permutation	O
sets	O
in	O
which	O
each	O
of	O
the	O
3	O
,	O
000	O
gene	O
expression	O
trait	O
vectors	O
was	O
permuted	O
such	O
that	O
the	O
correlation	O
structure	O
among	O
the	O
genes	O
was	O
preserved	O
.	O

The	O
FDR	O
for	O
a	O
given	O
LOD	O
score	O
threshold	O
was	O
then	O
computed	O
as	O
the	O
ratio	O
of	O
the	O
mean	O
number	O
of	O
QTL	O
detected	O
in	O
the	O
permuted	O
datasets	O
(	O
the	O
mean	O
taken	O
over	O
the	O
ten	O
permuted	O
datasets	O
)	O
and	O
the	O
total	O
number	O
of	O
QTL	O
detected	O
in	O
the	O
observed	O
3	O
,	O
000	O
-	O
gene	O
dataset	O
.	O

We	O
then	O
generated	O
ROC	O
-	O
like	O
curves	O
by	O
varying	O
the	O
LOD	O
score	O
threshold	O
,	O
resulting	O
in	O
a	O
range	O
of	O
FDRs	O
(	O
from	O
0	O
%	O
to	O
more	O
than	O
50	O
%	O
)	O
.	O

To	O
simplify	O
this	O
type	O
of	O
summary	O
,	O
we	O
considered	O
no	O
more	O
than	O
one	O
QTL	O
per	O
chromosome	S-GO
per	O
gene	O
expression	O
trait	O
by	O
considering	O
only	O
the	O
QTL	O
with	O
the	O
max	O
LOD	O
score	O
on	O
each	O
chromosome	S-GO
for	O
each	O
trait	O
.	O

The	O
ROC	O
curves	O
for	O
each	O
of	O
the	O
four	O
models	O
are	O
shown	O
in	O
Figure	O
S1	O
,	O
with	O
the	O
black	O
curve	O
corresponding	O
to	O
Equation	O
2	O
,	O
the	O
blue	O
curve	O
corresponding	O
to	O
Equation	O
4	O
,	O
the	O
red	O
curve	O
corresponding	O
to	O
Equation	O
6	O
,	O
and	O
the	O
green	O
curve	O
corresponding	O
to	O
the	O
model	O
selection	O
procedure	O
.	O

It	O
is	O
clear	O
from	O
the	O
ROC	O
curves	O
that	O
the	O
sex	O
and	O
sex	O
-	O
interaction	O
terms	O
are	O
significant	O
in	O
the	O
gene	O
expression	O
dataset	O
.	O

For	O
example	O
,	O
at	O
an	O
FDR	O
of	O
5	O
%	O
we	O
note	O
that	O
800	O
QTLs	O
were	O
detected	O
in	O
the	O
set	O
of	O
3	O
,	O
000	O
genes	O
for	O
model	O
1	O
,	O
while	O
968	O
(	O
21	O
%	O
increase	O
)	O
and	O
1	O
,	O
159	O
(	O
45	O
%	O
increase	O
)	O
QTLs	O
were	O
detected	O
for	O
Equations	O
4	O
and	O
6	O
,	O
respectively	O
.	O

These	O
results	O
demonstrate	O
significantly	O
increased	O
power	O
to	O
detect	O
QTLs	O
when	O
sex	O
is	O
taken	O
into	O
account	O
.	O

We	O
further	O
note	O
that	O
the	O
stepwise	O
selection	O
procedure	O
captures	O
more	O
information	O
than	O
Equation	O
4	O
,	O
indicating	O
a	O
significant	O
interaction	O
signature	O
in	O
this	O
dataset	O
and	O
also	O
demonstrating	O
that	O
this	O
simple	O
statistical	O
procedure	O
is	O
capable	O
of	O
identifying	O
significant	O
interaction	O
events	O
even	O
at	O
conservative	O
FDR	O
thresholds	O
.	O

Finally	O
,	O
it	O
is	O
of	O
particular	O
note	O
that	O
Equation	O
4	O
performed	O
better	O
than	O
Equation	O
6	O
,	O
the	O
model	O
that	O
incorporated	O
the	O
interaction	O
terms	O
at	O
all	O
times	O
.	O

That	O
is	O
,	O
despite	O
there	O
being	O
a	O
significant	O
interaction	O
signature	O
,	O
the	O
signature	O
was	O
not	O
large	O
enough	O
to	O
justify	O
including	O
interaction	O
terms	O
for	O
every	O
expression	O
trait	O
and	O
at	O
every	O
marker	O
tested	O
.	O

This	O
fact	O
motivated	O
the	O
need	O
to	O
employ	O
the	O
forward	O
regression	O
procedure	O
,	O
and	O
these	O
results	O
further	O
motivate	O
the	O
need	O
to	O
explore	O
sex	O
effects	O
by	O
employing	O
even	O
more	O
sophisticated	O
QTL	O
detection	O
methods	O
,	O
such	O
as	O
that	O
recently	O
described	O
by	O
Yi	O
et	O
al	O
.	O

[	O
38	O
]	O
.	O

Additional	O
statistics	O
.	O

For	O
each	O
23	O
,	O
574	O
oligonucleotides	O
represented	O
on	O
the	O
array	O
,	O
we	O
computed	O
a	O
linear	O
regression	O
analysis	O
to	O
test	O
for	O
a	O
correlation	O
between	O
the	O
trait	O
"	O
gonadal	O
fat	O
mass	O
"	O
and	O
each	O
transcript	O
.	O

Similar	O
to	O
our	O
method	O
of	O
calculating	O
linkage	O
,	O
we	O
employed	O
a	O
stepwise	O
linear	O
regression	O
procedure	O
using	O
equations	O
of	O
the	O
form	O

or	O

compared	O
to	O
the	O
null	O
model	O

where	O
beta	O
0	O
is	O
the	O
intercept	O
,	O
and	O
beta	O
1	O
,	O
beta	O
2	O
,	O
and	O
beta	O
3	O
represent	O
the	O
regression	O
coefficients	O
of	O
their	O
respective	O
terms	O
.	O

As	O
before	O
,	O
the	O
parameter	O
"	O
sex	O
*	O
gene	O
"	O
is	O
only	O
retained	O
if	O
it	O
significantly	O
improves	O
the	O
fit	O
of	O
the	O
model	O
.	O

The	O
p	O
-	O
value	O
threshold	O
for	O
significant	O
correlation	O
is	O
calculated	O
by	O
an	O
F	O
test	O
,	O
which	O
compares	O
the	O
appropriate	O
model	O
(	O
Equation	O
7	O
or	O
8	O
)	O
to	O
the	O
null	O
model	O
(	O
Equation	O
9	O
)	O
.	O

As	O
before	O
,	O
multiple	O
testing	O
was	O
addressed	O
with	O
use	O
of	O
the	O
FDR	O
,	O
ranking	O
the	O
p	O
-	O
values	O
obtained	O
from	O
the	O
above	O
F	O
tests	O
and	O
setting	O
alpha	O
=	O
0	O
.	O
01	O
.	O

Genes	O
correlated	O
with	O
the	O
gonadal	O
fat	O
mass	O
trait	O
generated	O
several	O
significant	O
eQTLs	O
.	O

In	O
order	O
to	O
determine	O
if	O
eQTLs	O
generated	O
by	O
these	O
genes	O
were	O
enriched	O
in	O
any	O
locus	O
or	O
if	O
they	O
were	O
distributed	O
randomly	O
,	O
we	O
compared	O
the	O
distribution	O
of	O
these	O
eQTLs	O
against	O
the	O
distribution	O
of	O
all	O
liver	O
eQTLs	O
in	O
overlapping	O
6	O
-	O
cM	O
bins	O
across	O
the	O
genome	O
using	O
the	O
Fisher	O
exact	O
test	O
.	O

This	O
test	O
is	O
based	O
on	O
exact	O
probabilities	O
from	O
a	O
specific	O
distribution	O
(	O
hypergeometric	O
distribution	O
)	O
.	O

p	O
-	O
Values	O
obtained	O
from	O
this	O
test	O
were	O
corrected	O
for	O
multiple	O
comparisons	O
using	O
a	O
simple	O
Bonferonni	O
correction	O
(	O
given	O
that	O
we	O
performed	O
772	O
tests	O
across	O
the	O
genome	O
,	O
0	O
.	O
05	O
/	O
772	O
)	O
.	O

Loci	O
with	O
p	O
<	O
6	O
.	O
5	O
x	O
10	O
-	O
5	O
by	O
Fisher	O
exact	O
test	O
were	O
considered	O
significantly	O
enriched	O
for	O
eQTLs	O
correlated	O
with	O
gonadal	O
fat	O
mass	O
.	O

Supporting	O
Information	O

Figure	O
S1	O

ROC	O
Curves	O
for	O
Each	O
of	O
the	O
Four	O
Models	O

(	O
21	O
KB	O
DOC	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Table	O
S1	O

Suggestive	O
and	O
Significant	O
eQTLs	O

(	O
3	O
.	O
7	O
MB	O
XLS	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Table	O
S2	O

Transcripts	O
Significantly	O
Correlated	O
with	O
Gonadal	O
Fat	O
Mass	O

(	O
716	O
KB	O
XLS	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Acknowledgements	O

The	O
authors	O
wish	O
to	O
thank	O
Steve	O
Horvath	O
,	O
Desmond	O
Smith	O
,	O
Xia	O
Yang	O
,	O
Sudheer	O
Doss	O
,	O
Anatole	O
Ghazalpour	O
,	O
Pek	O
Lum	O
,	O
and	O
John	O
Lamb	O
for	O
valuable	O
discussions	O
and	O
insights	O
.	O

We	O
thank	O
Leslie	O
Ingram	O
-	O
Drake	O
for	O
work	O
on	O
data	O
preparation	O
.	O

Initial	O
work	O
on	O
construction	O
of	O
the	O
BXH	O
.	O
ApoE	O
-	O
/	O
-	O
cross	O
was	O
done	O
by	O
Weibin	O
Shi	O
.	O

Abbreviations	O

ApoE	O
-	O
/	O
-	O
-	O
apolipoprotein	O
E	O
null	O

cQTL	O
-	O
clinical	O
QTL	O

eQTL	O
-	O
gene	O
expression	O
QTL	O

FDR	O
-	O
false	O
discovery	O
rate	O

LOD	O
-	O
logarithm	O
of	O
odds	O

mlratio	O
-	O
mean	O
log10	O
ratio	O

QTL	O
-	O
quantitative	O
trait	O
locus	O

ROC	O
-	O
receiver	O
operating	O
characteristic	O

SNP	O
-	O
single	O
nucleotide	O
polymorphism	O

Figures	O
and	O
Tables	O

Figure	O
1	O

Genome	O
Scan	O
for	O
Gonadal	O
Fat	O
Mass	O

(	O
A	O
)	O
Animals	O
were	O
genotyped	O
at	O
an	O
average	O
1	O
.	O
5	O
cM	O
density	O
using	O
1	O
,	O
032	O
SNPs	O
polymorphic	O
between	O
the	O
parental	O
strains	O
.	O

LOD	O
scores	O
computed	O
using	O
sex	O
as	O
an	O
additive	O
covariate	O
(	O
black	O
)	O
failed	O
to	O
detect	O
significant	O
linkage	O
.	O

A	O
genome	O
scan	O
accounting	O
for	O
interactions	O
between	O
sex	O
and	O
QTL	O
(	O
red	O
)	O
showed	O
evidence	O
for	O
suggestive	O
linkage	O
on	O
Chromosome	S-GO
1	O
and	O
significant	O
linkage	O
on	O
Chromosomes	S-GO
3	O
,	O
5	O
,	O
11	O
,	O
and	O
19	O
.	O

Dashed	O
and	O
solid	O
lines	O
are	O
thresholds	O
for	O
suggestive	O
(	O
p	O
<	O
1	O
x	O
10	O
-	O
3	O
)	O
and	O
significant	O
linkage	O
(	O
p	O
<	O
5	O
x	O
10	O
-	O
5	O
)	O
,	O
respectively	O
.	O

(	O
B	O
)	O
Genome	O
scans	O
for	O
gonadal	O
fat	O
mass	O
using	O
different	O
models	O
over	O
mouse	O
Chromosome	S-GO
5	O
.	O

Scans	O
for	O
fat	O
mass	O
using	O
all	O
animals	O
with	O
(	O
black	O
)	O
and	O
without	O
(	O
green	O
)	O
sex	O
as	O
an	O
additive	O
covariate	O
failed	O
to	O
detect	O
significant	O
linkage	O
.	O

Females	O
analyzed	O
alone	O
(	O
magenta	O
)	O
showed	O
evidence	O
for	O
suggestive	O
linkage	O
(	O
p	O
<	O
2	O
x	O
10	O
-	O
4	O
)	O
.	O

When	O
both	O
sexes	O
were	O
analyzed	O
to	O
account	O
for	O
sex	O
effects	O
(	O
red	O
)	O
,	O
a	O
significant	O
QTL	O
was	O
realized	O
(	O
p	O
<	O
10	O
-	O
6	O
)	O
.	O

For	O
clarity	O
,	O
only	O
the	O
model	O
incorporating	O
both	O
the	O
"	O
sex	O
*	O
add	O
"	O
and	O
"	O
sex	O
*	O
dom	O
"	O
terms	O
is	O
shown	O
in	O
red	O
,	O
although	O
additional	O
models	O
incorporating	O
the	O
terms	O
separately	O
were	O
also	O
computed	O
.	O

Figure	O
2	O

Effect	O
of	O
Genotype	O
on	O
Fat	O
Mass	O

Homozygous	O
B6	O
(	O
BB	O
)	O
,	O
C3H	O
(	O
CC	O
)	O
,	O
or	O
heterozygous	O
(	O
BC	O
)	O
genotype	O
at	O
all	O
five	O
QTL	O
positions	O
,	O
separated	O
by	O
sex	O
,	O
are	O
shown	O
.	O

The	O
underlying	O
genotypic	O
effects	O
of	O
the	O
QTLs	O
on	O
fat	O
mass	O
differ	O
between	O
the	O
sexes	O
.	O

Coefficients	O
of	O
determination	O
(	O
R2	O
)	O
are	O
shown	O
along	O
with	O
associated	O
ANOVAs	O
*	O
p	O
<	O
0	O
.	O
05	O
,	O
*	O
*	O
p	O
<	O
0	O
.	O
01	O
,	O
*	O
*	O
*	O
p	O
<	O
0	O
.	O
001	O
.	O

Figure	O
3	O

Heat	O
Map	O
of	O
Liver	O
Gene	O
Expression	O

Over	O
2	O
,	O
300	O
of	O
the	O
most	O
differentially	O
expressed	O
genes	O
in	O
liver	O
hierarchically	O
clustered	O
by	O
animals	O
(	O
x	O
-	O
axis	O
)	O
against	O
transcript	O
levels	O
(	O
y	O
-	O
axis	O
)	O
.	O

Expression	O
is	O
reported	O
as	O
mlratio	O
of	O
individual	O
experiment	O
against	O
a	O
common	O
pool	O
.	O

Red	O
is	O
over	O
-	O
and	O
green	O
underrepresented	O
relative	O
to	O
pool	O
.	O

Figure	O
4	O

Properties	O
of	O
All	O
Liver	O
eQTLs	O

(	O
A	O
)	O
Distribution	O
of	O
all	O
significant	O
liver	O
eQTLs	O
across	O
the	O
genome	O
in	O
2	O
-	O
cM	O
bins	O
.	O

A	O
total	O
of	O
6	O
,	O
676	O
significant	O
eQTLs	O
were	O
realized	O
,	O
representing	O
4	O
,	O
998	O
liver	O
transcripts	O
.	O

Hotspots	O
of	O
nonrandom	O
eQTL	O
colocalization	O
are	O
clearly	O
evident	O
.	O

(	O
B	O
)	O
Distribution	O
of	O
eQTLs	O
with	O
significant	O
sex	O
-	O
specific	O
effects	O
.	O

A	O
total	O
of	O
1	O
,	O
166	O
eQTLs	O
representing	O
1	O
,	O
044	O
transcripts	O
show	O
an	O
eQTL	O
hotspot	O
on	O
Chromosome	S-GO
5	O
.	O

(	O
C	O
)	O
Properties	O
of	O
eQTLs	O
at	O
increasing	O
significance	O
levels	O
.	O

As	O
the	O
threshold	O
for	O
significant	O
linkage	O
increases	O
(	O
p	O
-	O
value	O
decreases	O
,	O
or	O
LOD	O
score	O
increases	O
)	O
,	O
the	O
proportion	O
of	O
cis	O
-	O
eQTLs	O
(	O
black	O
)	O
increases	O
.	O

The	O
fraction	O
of	O
all	O
eQTLs	O
with	O
sex	O
effects	O
(	O
red	O
)	O
and	O
cis	O
-	O
eQTLs	O
with	O
sex	O
effects	O
(	O
blue	O
)	O
remains	O
relatively	O
constant	O
at	O
increasing	O
thresholds	O
.	O

The	O
dashed	O
line	O
indicates	O
the	O
genome	O
-	O
wide	O
significance	O
threshold	O
(	O
p	O
<	O
5	O
x	O
10	O
-	O
5	O
;	O
genome	O
-	O
wide	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O

(	O
D	O
)	O
Properties	O
of	O
sex	O
-	O
specific	O
eQTLs	O
at	O
increasing	O
significance	O
levels	O
.	O

For	O
eQTLs	O
with	O
significant	O
sex	O
effects	O
,	O
as	O
with	O
all	O
eQTLs	O
,	O
the	O
proportion	O
of	O
cis	O
-	O
eQTLs	O
(	O
black	O
)	O
increases	O
and	O
trans	O
(	O
blue	O
)	O
decreases	O
as	O
the	O
threshold	O
for	O
significance	O
increases	O
.	O

At	O
the	O
genome	O
-	O
wide	O
threshold	O
for	O
significance	O
(	O
dashed	O
line	O
)	O
,	O
over	O
70	O
%	O
of	O
eQTLs	O
with	O
significant	O
sex	O
effects	O
are	O
trans	O
.	O

Figure	O
5	O

Properties	O
of	O
Transcripts	O
Significantly	O
Correlated	O
with	O
Gonadal	O
Fat	O
Mass	O

(	O
A	O
)	O
Distribution	O
of	O
p	O
-	O
values	O
for	O
trait	O
-	O
gene	O
correlations	O
between	O
transcripts	O
and	O
gonadal	O
fat	O
mass	O
.	O

At	O
FDR	O
=	O
0	O
.	O
01	O
,	O
4	O
,	O
613	O
transcripts	O
are	O
significantly	O
correlated	O
with	O
the	O
trait	O
.	O

(	O
B	O
)	O
Number	O
of	O
eQTLs	O
generated	O
by	O
the	O
4	O
,	O
613	O
genes	O
significantly	O
correlated	O
with	O
gonadal	O
fat	O
mass	O
.	O

Of	O
these	O
,	O
1	O
,	O
130	O
genes	O
possessed	O
at	O
least	O
one	O
significant	O
eQTL	O
.	O

(	O
C	O
)	O
Distribution	O
of	O
1	O
,	O
478	O
eQTLs	O
significantly	O
correlated	O
with	O
gonadal	O
fat	O
mass	O
across	O
the	O
genome	O
in	O
2	O
-	O
cM	O
bins	O
.	O

(	O
D	O
)	O
Identification	O
of	O
genomic	O
regions	O
enriched	O
for	O
eQTLs	O
correlated	O
with	O
gonadal	O
fat	O
mass	O
.	O

The	O
x	O
-	O
axis	O
represents	O
genome	O
position	O
in	O
2	O
-	O
cM	O
bins	O
,	O
and	O
the	O
y	O
-	O
axis	O
represents	O
the	O
-	O
log10	O
Fisher	O
exact	O
test	O
p	O
-	O
value	O
for	O
enrichment	O
of	O
eQTLs	O
in	O
overlapping	O
6	O
-	O
cM	O
bins	O
.	O

The	O
dashed	O
line	O
corresponds	O
to	O
p	O
=	O
0	O
.	O
05	O
after	O
correction	O
for	O
multiple	O
comparisons	O
.	O

One	O
significantly	O
enriched	O
region	O
on	O
Chromosome	O
19	O
is	O
shown	O
.	O

The	O
Chromosome	S-GO
19	O
(	O
40	O
-	O
cM	O
)	O
hotspot	O
is	O
coincident	O
with	O
a	O
cQTL	O
for	O
gonadal	O
fat	O
mass	O
and	O
is	O
highlighted	O
in	O
red	O
.	O

Figure	O
6	O

The	O
Effects	O
of	O
Sex	O
on	O
Trans	O
-	O
eQTL	O
Correlated	O
with	O
Gonadal	O
Fat	O
Mass	O

(	O
A	O
)	O
Example	O
of	O
the	O
effect	O
of	O
genotype	O
at	O
a	O
trans	O
locus	O
on	O
gene	O
expression	O
.	O

Presence	O
of	O
homozygous	O
B6	O
(	O
BB	O
)	O
,	O
C3H	O
(	O
CC	O
)	O
,	O
or	O
heterozygous	O
(	O
BC	O
)	O
genotype	O
at	O
a	O
trans	O
locus	O
affects	O
transcript	O
MMT00016118	O
levels	O
(	O
reported	O
as	O
mlratio	O
)	O
in	O
a	O
sex	O
-	O
specific	O
manner	O
,	O
with	O
effects	O
detectable	O
only	O
in	O
females	O
.	O

Coefficients	O
of	O
determination	O
(	O
R2	O
,	O
or	O
proportion	O
variance	O
explained	O
)	O
are	O
shown	O
along	O
with	O
associated	O
ANOVA	O
p	O
-	O
values	O
.	O

Several	O
trans	O
-	O
eQTLs	O
correlated	O
with	O
gonadal	O
fat	O
mass	O
localize	O
to	O
regions	O
overlapping	O
with	O
cQTLs	O
for	O
this	O
trait	O
,	O
specifically	O
,	O
to	O
Chromosome	S-GO
19	O
,	O
40	O
cM	O
.	O

(	O
B	O
)	O
For	O
Chromosome	S-GO
19	O
,	O
the	O
vast	O
majority	O
of	O
these	O
correlated	O
trans	O
-	O
eQTLs	O
are	O
biased	O
toward	O
larger	O
effects	O
on	O
gene	O
expression	O
in	O
females	O
(	O
red	O
lines	O
)	O
.	O

The	O
effect	O
of	O
any	O
given	O
trans	O
-	O
eQTL	O
is	O
approximated	O
as	O
R2	O
determined	O
in	O
a	O
manner	O
similar	O
to	O
that	O
depicted	O
in	O
(	O
A	O
)	O
.	O

Table	O
1	O

Characteristics	O
of	O
the	O
BXH	O
.	O
ApoE	O
-	O
/	O
-	O
Cross	O

Table	O
2	O

cQTLs	O
for	O
Gonadal	O
Fat	O
Mass	O

Table	O
3	O

Characteristics	O
of	O
Liver	O
eQTLs	O

Table	O
4	O

Properties	O
of	O
Genes	O
Coincident	O
with	O
the	O
Gonadal	O
Fat	O
Mass	O
cQTL	O

Table	O
5	O

Transcripts	O
Coincident	O
with	O
cQTLs	O
with	O
Significant	O
Sex	O
Effects	O
and	O
Correlated	O
with	O
Gonadal	O
Fat	O
Mass	O
Are	O
Strong	O
Candidate	O
Genes	O
for	O
the	O
Trait	O

Footnotes	O

Author	O
contributions	O
.	O

SW	O
,	O
TAD	O
,	O
and	O
AJL	O
conceived	O
and	O
designed	O
the	O
experiments	O
.	O

SW	O
,	O
NY	O
,	O
and	O
EES	O
performed	O
the	O
experiments	O
.	O

SW	O
,	O
NY	O
,	O
HW	O
,	O
and	O
TAD	O
analyzed	O
the	O
data	O
.	O

EES	O
and	O
HW	O
contributed	O
reagents	O
/	O
materials	O
/	O
analysis	O
tools	O
.	O

HW	O
designed	O
script	O
and	O
code	O
to	O
analyze	O
data	O
.	O

SW	O
,	O
NY	O
,	O
EES	O
,	O
TAD	O
,	O
and	O
AJL	O
wrote	O
the	O
paper	O
.	O

Funding	O
.	O

Work	O
was	O
supported	O
in	O
part	O
by	O
National	O
Institutes	O
of	O
Health	O
grants	O
HL	O
-	O
30568	O
and	O
HL	O
-	O
28481	O
to	O
AJL	O
,	O
Public	O
Health	O
Services	O
Training	O
Grant	O
HD07228	O
-	O
24	O
to	O
SW	O
,	O
the	O
Iris	O
Cantor	O
-	O
UCLA	O
Women	O
'	O
s	O
Health	O
Center	O
,	O
UCLA	O
National	O
Center	O
for	O
Excellence	O
in	O
Women	O
'	O
s	O
Health	O
Grant	O
to	O
TAD	O
,	O
and	O
by	O
an	O
American	O
Heart	O
Association	O
Medical	O
Student	O
Research	O
Grant	O
to	O
NY	O
.	O

Competing	O
interests	O
.	O

The	O
authors	O
have	O
declared	O
that	O
no	O
competing	O
interests	O
exist	O
.	O

Citation	O
:	O
Wang	O
S	O
,	O
Yehya	O
N	O
,	O
Schadt	O
EE	O
,	O
Wang	O
H	O
,	O
Drake	O
TA	O
,	O
et	O
al	O
.	O

(	O
2006	O
)	O
Genetic	O
and	O
genomic	O
analysis	O
of	O
a	O
fat	O
mass	O
trait	O
with	O
complex	O
inheritance	O
reveals	O
marked	O
sex	O
specificity	O
.	O

PLoS	O
Genet	O
2	O
(	O
2	O
)	O
:	O
e15	O
.	O

Identification	O
and	O
targeted	O
disruption	O
of	O
the	O
mouse	O
gene	O
encoding	O
ESG1	O
(	O
PH34	O
/	O
ECAT2	O
/	O
DPPA5	O
)	O

Abstract	O

Background	O

Embryonic	O
stem	O
cell	O
-	O
specific	O
gene	O
(	O
ESG	O
)	O
1	O
,	O
which	O
encodes	O
a	O
KH	O
-	O
domain	O
containing	O
protein	O
,	O
is	O
specifically	O
expressed	O
in	O
early	O
embryos	O
,	O
germ	O
cells	O
,	O
and	O
embryonic	O
stem	O
(	O
ES	O
)	O
cells	O
.	O

Previous	O
studies	O
identified	O
genomic	O
clones	O
containing	O
the	O
mouse	O
ESG1	O
gene	O
and	O
five	O
pseudogenes	O
.	O

However	O
,	O
their	O
chromosomal	O
localizations	O
or	O
physiological	O
functions	O
have	O
not	O
been	O
determined	O
.	O

Results	O

A	O
Blast	O
search	O
of	O
mouse	O
genomic	O
databases	O
failed	O
to	O
locate	O
the	O
ESG1	O
gene	O
.	O

We	O
identified	O
several	O
bacterial	O
artificial	O
clones	O
containing	O
the	O
mouse	O
ESG1	O
gene	O
and	O
an	O
additional	O
ESG1	O
-	O
like	O
sequence	O
with	O
a	O
similar	O
gene	O
structure	O
from	O
chromosome	S-GO
9	O
.	O

The	O
ESG1	O
-	O
like	O
sequence	O
contained	O
a	O
multiple	O
critical	O
mutations	O
,	O
indicating	O
that	O
it	O
was	O
a	O
duplicated	O
pseudogene	O
.	O

The	O
5	O
'	O
flanking	O
region	O
of	O
the	O
ESG1	O
gene	O
,	O
but	O
not	O
that	O
of	O
the	O
pseudogene	O
,	O
exhibited	O
strong	O
enhancer	O
and	O
promoter	O
activity	O
in	O
undifferentiated	O
ES	O
cells	O
by	O
luciferase	O
reporter	O
assay	O
.	O

To	O
study	O
the	O
physiological	O
functions	O
of	O
the	O
ESG1	O
gene	O
,	O
we	O
replaced	O
this	O
sequence	O
in	O
ES	O
cells	O
with	O
a	O
beta	O
-	O
geo	O
cassette	O
by	O
homologous	O
recombination	O
.	O

Despite	O
specific	O
expression	O
in	O
early	O
embryos	O
and	O
germ	O
cells	O
,	O
ESG1	O
-	O
/	O
-	O
mice	O
developed	O
normally	O
and	O
were	O
fertile	O
.	O

We	O
also	O
generated	O
ESG1	O
-	O
/	O
-	O
ES	O
cells	O
both	O
by	O
a	O
second	O
independent	O
homologous	O
recombination	O
and	O
directly	O
from	O
blastocysts	O
derived	O
from	O
heterozygous	O
intercrosses	O
.	O

Northern	O
blot	O
and	O
western	O
blot	O
analyses	O
confirmed	O
the	O
absence	O
of	O
ESG1	O
in	O
these	O
cells	O
.	O

These	O
ES	O
cells	O
demonstrated	O
normal	O
morphology	O
,	O
proliferation	O
,	O
and	O
differentiation	O
.	O

Conclusion	O

The	O
mouse	O
ESG1	O
gene	O
,	O
together	O
with	O
a	O
duplicated	O
pseudogene	O
,	O
is	O
located	O
on	O
chromosome	S-GO
9	O
.	O

Despite	O
its	O
specific	O
expression	O
in	O
pluripotent	O
cells	O
and	O
germ	O
cells	O
,	O
ESG1	O
is	O
dispensable	O
for	O
self	O
-	O
renewal	O
of	O
ES	O
cells	O
and	O
establishment	O
of	O
germcells	O
.	O

Background	O

Embryonic	O
stem	O
(	O
ES	O
)	O
cells	O
were	O
first	O
derived	O
from	O
the	O
blastocysts	O
of	O
mice	O
in	O
1981	O
[	O
1	O
,	O
2	O
]	O
and	O
humans	O
in	O
1998	O
[	O
3	O
]	O
.	O

ES	O
cells	O
have	O
two	O
important	O
properties	O
:	O
theability	O
to	O
maintain	O
pluripotency	O
,	O
which	O
is	O
the	O
ability	O
to	O
differentiate	O
into	O
a	O
wide	O
variety	O
of	O
cells	O
,	O
and	O
rapid	O
proliferation	O
.	O

These	O
characteristics	O
make	O
mouse	O
ES	O
cells	O
an	O
essential	O
component	O
of	O
gene	O
targeting	O
technology	O
.	O

These	O
qualitiesalso	O
make	O
human	O
ES	O
cells	O
attractive	O
sources	O
for	O
cell	O
transplantation	O
therapy	O
to	O
treat	O
various	O
diseases	O
,	O
including	O
spinal	O
cord	O
injuries	O
and	O
juvenile	O
diabetes	O
.	O

The	O
molecular	O
mechanisms	O
underlying	O
the	O
pluripotency	O
and	O
rapid	O
proliferation	O
of	O
ES	O
cells	O
are	O
currently	O
a	O
major	O
focus	O
of	O
the	O
field	O
of	O
stem	O
cell	O
biology	O
[	O
4	O
-	O
6	O
]	O
.	O

To	O
identify	O
molecules	O
essential	O
in	O
ES	O
cells	O
for	O
these	O
properties	O
,	O
several	O
groups	O
have	O
utilized	O
transcriptome	O
analyses	O
to	O
identify	O
genes	O
specifically	O
expressed	O
in	O
ES	O
cells	O
and	O
early	O
embryos	O
.	O

These	O
analyses	O
,	O
including	O
DNA	O
microarray	O
analyses	O
[	O
7	O
]	O
and	O
expressed	O
sequence	O
tag	O
analyses	O
[	O
8	O
-	O
12	O
]	O
,	O
identified	O
several	O
common	O
transcripts	O
,	O
including	O
ESG1	O
that	O
was	O
also	O
designated	O
dppa5	O
or	O
ECAT2	O
.	O

ESG1	O
was	O
originally	O
identified	O
as	O
a	O
transcript	O
Ph34	O
that	O
was	O
down	O
-	O
regulated	O
by	O
retinoic	O
acid	O
in	O
embryonic	O
carcinoma	O
cells	O
[	O
13	O
]	O
.	O

The	O
expression	O
of	O
this	O
gene	O
was	O
confined	O
in	O
mice	O
to	O
early	O
embryos	O
and	O
germ	O
cells	O
[	O
14	O
]	O
.	O

It	O
is	O
also	O
expressed	O
in	O
pluripotent	O
cells	O
,	O
including	O
ES	O
cells	O
,	O
embryonic	O
germ	O
cells	O
,	O
and	O
multipotent	O
germline	O
stem	O
cells	O
[	O
15	O
]	O
.	O

ESG1	O
encodes	O
a	O
polypeptide	O
of	O
118	O
amino	O
acids	O
that	O
contains	O
a	O
single	O
KH	O
domain	O
,	O
which	O
is	O
an	O
RNA	O
-	O
binding	O
domain	O
[	O
16	O
]	O
.	O

It	O
remains	O
unclear	O
,	O
however	O
,	O
if	O
ESG1	O
functions	O
as	O
an	O
RNA	O
-	O
binding	O
protein	O
or	O
the	O
roles	O
it	O
plays	O
in	O
ES	O
cells	O
and	O
mice	O
.	O

Previous	O
genomic	O
library	O
screening	O
by	O
identified	O
genomic	O
clones	O
containing	O
the	O
mouse	O
ESG1	O
gene	O
and	O
seven	O
pseudogenes	O
[	O
17	O
]	O
.	O

Two	O
of	O
these	O
pseudogenes	O
exhibit	O
a	O
similar	O
exon	O
-	O
intron	O
structure	O
as	O
the	O
ESG1	O
gene	O
,	O
indicating	O
their	O
generation	O
by	O
gene	O
duplication	O
.	O

The	O
five	O
remaining	O
pseudogenes	O
did	O
not	O
contain	O
any	O
introns	O
,	O
indicating	O
that	O
these	O
were	O
generated	O
by	O
retrotransposition	O
of	O
ESG1	O
transcripts	O
.	O

The	O
chromosomal	O
localizations	O
of	O
the	O
mouse	O
ESG1	O
gene	O
and	O
pseudogenes	O
,	O
however	O
,	O
have	O
not	O
been	O
reported	O
.	O

In	O
this	O
study	O
,	O
we	O
determined	O
the	O
structure	O
of	O
the	O
mouse	O
gene	O
encoding	O
this	O
protein	O
and	O
related	O
pseudogenes	O
.	O

We	O
also	O
performed	O
gene	O
targeting	O
to	O
determine	O
the	O
physiological	O
function	O
of	O
ESG1	O
.	O

Results	O
and	O
discussion	O

Chromosomal	O
localization	O
and	O
structures	O
of	O
mouse	O
ESG1	O
gene	O
and	O
psedogenes	O

To	O
determine	O
the	O
chromosomal	O
localizations	O
of	O
the	O
mouse	O
ESG1	O
gene	O
and	O
pseudogenes	O
,	O
we	O
performed	O
a	O
Blast	O
analysis	O
of	O
the	O
mouse	O
genomic	O
database	O
with	O
the	O
ESG1	O
cDNA	O
sequence	O
as	O
a	O
query	O
.	O

We	O
identified	O
several	O
putative	O
pseudogenes	O
without	O
introns	O
on	O
chromosomes	S-GO
1	O
,	O
5	O
,	O
11	O
,	O
12	O
,	O
14	O
,	O
16	O
,	O
17	O
,	O
and	O
X	O
(	O
Figure	O
1	O
)	O
.	O

In	O
addition	O
,	O
two	O
intron	O
-	O
less	O
pseudogenes	O
were	O
identified	O
in	O
DNA	O
fragments	O
for	O
which	O
the	O
chromosomal	O
localization	O
remained	O
unmapped	O
.	O

While	O
these	O
pseudodgenes	O
have	O
significant	O
homology	O
to	O
ESG1	O
cDNA	O
,	O
they	O
could	O
not	O
produce	O
functional	O
proteins	O
,	O
because	O
of	O
critical	O
mutations	O
.	O

This	O
result	O
suggests	O
that	O
there	O
are	O
a	O
larger	O
number	O
of	O
intron	O
-	O
less	O
pseudogenes	O
than	O
previously	O
anticipated	O
.	O

Existence	O
of	O
multiple	O
retropseudogenes	O
is	O
a	O
hallmark	O
of	O
pluripotent	O
cell	O
-	O
specific	O
genes	O
[	O
18	O
]	O
.	O

Figure	O
1	O

ESG1pseudogenes	O
identified	O
by	O
a	O
Blast	O
search	O
of	O
mouse	O
genomic	O
databases	O
.	O

Substitution	O
mutations	O
are	O
indicated	O
by	O
black	O
lines	O
.	O

Intron	O
-	O
like	O
gap	O
sequences	O
are	O
indicated	O
with	O
triangles	O
.	O

Chromosomal	O
localizations	O
are	O
shown	O
on	O
the	O
right	O
.	O

On	O
chromosome	S-GO
9	O
,	O
we	O
identified	O
a	O
DNA	O
fragment	O
similar	O
to	O
the	O
ESG1	O
gene	O
that	O
included	O
two	O
putative	O
introns	O
.	O

These	O
putative	O
first	O
and	O
second	O
exons	O
,	O
however	O
,	O
contained	O
(	O
4	O
)	O
multiple	O
mutations	O
of	O
the	O
ESG1	O
cDNA	O
sequence	O
.	O

The	O
putative	O
third	O
exon	O
was	O
identical	O
to	O
that	O
of	O
the	O
previously	O
reported	O
ESG1	O
gene	O
.	O

Also	O
on	O
chromosome	S-GO
9	O
,	O
we	O
identified	O
another	O
DNA	O
fragment	O
that	O
was	O
similar	O
,	O
but	O
not	O
identical	O
,	O
to	O
the	O
third	O
exon	O
of	O
the	O
ESG1	O
gene	O
.	O

These	O
findings	O
suggest	O
that	O
these	O
ESG1	O
-	O
like	O
sequences	O
on	O
chromosome	O
9	O
have	O
not	O
been	O
correctly	O
assembled	O
.	O

To	O
obtain	O
DNA	O
fragments	O
containing	O
the	O
ESG1	O
gene	O
,	O
we	O
screened	O
the	O
bacterial	O
artificial	O
chromosome	O
(	O
BAC	O
)	O
DNA	O
pool	O
by	O
PCR	O
using	O
primer	O
pairs	O
that	O
would	O
only	O
amplify	O
the	O
real	O
gene	O
,	O
not	O
the	O
pseudogenes	O
.	O

We	O
obtained	O
two	O
independent	O
,	O
but	O
overlapping	O
BAC	O
clones	O
.	O

Southern	O
blot	O
analyses	O
and	O
sequencing	O
demonstrated	O
that	O
these	O
clones	O
contained	O
a	O
sequence	O
exhibiting	O
complete	O
identity	O
with	O
ESG1	O
cDNA	O
that	O
was	O
interrupted	O
by	O
two	O
putative	O
introns	O
(	O
Figure	O
2A	O
)	O
.	O

The	O
two	O
intron	O
sequences	O
begin	O
with	O
GT	O
and	O
terminate	O
with	O
AG	O
,	O
fulfilling	O
the	O
GT	O
-	O
AG	O
rule	O
of	O
exon	O
-	O
intron	O
junctions	O
[	O
19	O
]	O
.	O

The	O
5	O
'	O
flanking	O
region	O
of	O
this	O
DNA	O
fragment	O
exhibited	O
strong	O
promoter	O
/	O
enhancer	O
activity	O
by	O
luciferase	O
reporter	O
assays	O
in	O
undifferentiated	O
ES	O
cells	O
,	O
but	O
not	O
in	O
somatic	O
cells	O
(	O
Figure	O
3	O
)	O
.	O

The	O
same	O
fragment	O
showed	O
much	O
weaker	O
activity	O
after	O
induction	O
of	O
differentiation	O
by	O
retinoic	O
acid	O
.	O

We	O
concluded	O
that	O
this	O
sequence	O
is	O
the	O
ESG1	O
gene	O
.	O

Figure	O
2	O

BAC	O
clones	O
containing	O
the	O
ESG1	O
gene	O
and	O
a	O
duplication	O
pseudogene	O
(	O
PS	O
)	O
.	O

A	O
)	O
Localization	O
of	O
the	O
gene	O
and	O
PS	O
on	O
chromosome	S-GO
9	O
.	O

B	O
)	O
Sequence	O
comparison	O
of	O
the	O
gene	O
and	O
PS	O
revealed	O
that	O
these	O
are	O
homologous	O
from	O
eight	O
base	O
pairs	O
upstream	O
of	O
the	O
first	O
exon	O
to	O
675	O
bp	O
downstream	O
of	O
the	O
third	O
exon	O
.	O

Substitution	O
mutations	O
are	O
indicated	O
by	O
black	O
lines	O
.	O

The	O
insertion	O
is	O
indicated	O
by	O
an	O
open	O
triangle	O
.	O

Figure	O
3	O

Promoter	O
/	O
enhancer	O
activity	O
of	O
the	O
ESG1	O
gene	O
and	O
pseudogene	O
.	O

DNA	O
fragments	O
of	O
~	O
6	O
kbp	O
isolated	O
from	O
the	O
5	O
'	O
flanking	O
regions	O
of	O
the	O
gene	O
and	O
PS	O
were	O
transferred	O
into	O
luciferase	O
reporter	O
plasmids	O
.	O

We	O
introduced	O
the	O
reporter	O
genes	O
into	O
undifferentiated	O
ES	O
cells	O
(	O
open	O
columns	O
)	O
,	O
retinoic	O
acid	O
-	O
treated	O
ES	O
cells	O
(	O
grey	O
columns	O
)	O
,	O
and	O
NIH3T3	O
cells	O
(	O
closed	O
columns	O
)	O
.	O

Data	O
represent	O
the	O
averages	O
and	O
standard	O
deviations	O
of	O
three	O
independent	O
experiments	O
.	O

We	O
also	O
found	O
that	O
the	O
two	O
BAC	O
clones	O
contained	O
another	O
ESG1	O
-	O
like	O
sequence	O
(	O
Figure	O
2A	O
)	O
.	O

The	O
two	O
sequences	O
,	O
separated	O
by	O
a	O
68	O
kbp	O
intergenic	O
sequence	O
,	O
were	O
oriented	O
in	O
opposite	O
directions	O
.	O

The	O
ESG1	O
-	O
like	O
sequence	O
exhibited	O
greater	O
than	O
95	O
%	O
identity	O
to	O
the	O
exons	O
and	O
introns	O
of	O
the	O
ESG1	O
gene	O
.	O

This	O
sequence	O
,	O
however	O
,	O
contained	O
critical	O
nucleotide	O
substitutions	O
in	O
all	O
of	O
the	O
exons	O
and	O
one	O
nucleotide	O
insertion	O
in	O
exon	O
2	O
(	O
Figure	O
2B	O
)	O
.	O

Although	O
675	O
base	O
pairs	O
of	O
the	O
3	O
'	O
flanking	O
regions	O
were	O
conserved	O
between	O
the	O
ESG1	O
gene	O
and	O
the	O
pseudogene	O
,	O
only	O
five	O
base	O
pairs	O
of	O
the	O
5	O
'	O
flanking	O
region	O
were	O
identical	O
.	O

This	O
5	O
'	O
flanking	O
region	O
(	O
~	O
6	O
kbp	O
)	O
did	O
not	O
possess	O
any	O
promoter	O
/	O
enhancer	O
activity	O
in	O
luciferase	O
reporter	O
assays	O
(	O
Figure	O
3	O
)	O
.	O

It	O
is	O
thus	O
unlikely	O
that	O
this	O
sequence	O
is	O
transcribed	O
or	O
translated	O
into	O
a	O
functional	O
protein	O
.	O

This	O
sequence	O
likely	O
represents	O
a	O
duplication	O
pseudogene	O
.	O

Bierbaum	O
previously	O
reported	O
the	O
existence	O
of	O
two	O
pseudogenes	O
with	O
similar	O
exon	O
-	O
intron	O
organization	O
as	O
the	O
ESG1	O
gene	O
[	O
17	O
]	O
.	O

We	O
could	O
not	O
determine	O
which	O
of	O
these	O
two	O
pseudogenes	O
corresponds	O
to	O
the	O
one	O
we	O
identified	O
or	O
the	O
location	O
of	O
the	O
remaining	O
pseudogene	O
.	O

Targeted	O
disruption	O
of	O
the	O
mouse	O
ESG1	O
gene	O

To	O
study	O
the	O
function	O
of	O
ESG1	O
,	O
we	O
deleted	O
the	O
gene	O
by	O
homologous	O
recombination	O
in	O
mouse	O
ES	O
cells	O
.	O

We	O
replaced	O
the	O
three	O
exons	O
with	O
either	O
a	O
fusion	O
of	O
the	O
neomycin	O
-	O
resistance	O
and	O
beta	O
-	O
galactosidase	O
genes	O
(	O
beta	O
-	O
geo	O
)	O
or	O
the	O
hygromycin	O
resistant	O
gene	O
(	O
HygR	O
)	O
using	O
two	O
targeting	O
vectors	O
(	O
Figure	O
4A	O
)	O
introduced	O
into	O
RF8	O
ES	O
cells	O
by	O
electroporation	O
.	O

We	O
obtained	O
eight	O
ES	O
cell	O
clones	O
with	O
correct	O
homologous	O
recombination	O
of	O
the	O
beta	O
-	O
geo	O
targeting	O
vector	O
,	O
which	O
was	O
confirmed	O
by	O
Southern	O
blot	O
analysis	O
(	O
Figure	O
4B	O
)	O
.	O

We	O
obtained	O
only	O
one	O
clone	O
with	O
correct	O
homologous	O
recombination	O
of	O
the	O
HygR	O
targeting	O
vector	O
.	O

Figure	O
4	O

Targeted	O
disruption	O
of	O
the	O
mouse	O
ESG1	O
gene	O
.	O

A	O
)	O
Targeting	O
strategy	O
.	O

Homologous	O
regions	O
are	O
indicated	O
by	O
thick	O
lines	O
.	O

Recognition	O
sites	O
of	O
PstI	O
(	O
P	O
)	O
and	O
SpeI	O
(	O
S	O
)	O
,	O
which	O
were	O
used	O
for	O
Southern	O
blot	O
analyses	O
,	O
are	O
shown	O
.	O

The	O
gene	O
encoding	O
diphtheria	O
toxin	O
A	O
(	O
DTA	O
)	O
was	O
inserted	O
at	O
the	O
3	O
'	O
end	O
of	O
the	O
targeting	O
vectors	O
to	O
facilitate	O
negative	O
selection	O
.	O

B	O
)	O
Southern	O
blot	O
analyses	O
confirming	O
homologous	O
recombination	O
.	O

WT	O
,	O
wild	O
-	O
type	O
ES	O
cells	O
;	O
beta	O
,	O
beta	O
-	O
geo	O
+	O
/	O
-	O
ES	O
cells	O
;	O
H	O
,	O
HygR	O
+	O
/	O
-	O
ES	O
cells	O
;	O
-	O
/	O
-	O
,	O
ESG1	O
-	O
null	O
ES	O
cells	O
.	O

Numbers	O
indicate	O
clone	O
numbers	O
.	O

C	O
)	O
Northern	O
blot	O
(	O
upper	O
)	O
and	O
western	O
blot	O
(	O
lower	O
)	O
analyses	O
of	O
wild	O
-	O
type	O
ES	O
cells	O
(	O
WT	O
)	O
,	O
ESG1	O
-	O
null	O
ES	O
cells	O
(	O
-	O
/	O
-	O
,	O
three	O
clones	O
)	O
and	O
heterozygous	O
ES	O
cells	O
(	O
+	O
/	O
-	O
)	O
.	O

Northern	O
blot	O
was	O
performed	O
as	O
previously	O
described	O
[	O
20	O
]	O
.	O

To	O
confirm	O
the	O
loading	O
of	O
equal	O
amounts	O
of	O
RNA	O
,	O
ethidium	O
bromide	O
staining	O
of	O
ribosomal	O
RNA	O
is	O
also	O
shown	O
(	O
middle	O
)	O
.	O

To	O
obtain	O
homozygous	O
mutant	O
ES	O
cells	O
,	O
we	O
introduced	O
the	O
beta	O
-	O
geo	O
vector	O
into	O
HygR	O
heterozygous	O
ES	O
cells	O
.	O

Of	O
105	O
G418	O
-	O
resistant	O
colonies	O
tested	O
,	O
49	O
were	O
homozygous	O
for	O
ESG1	O
deletion	O
.	O

Northern	O
blot	O
and	O
western	O
blot	O
analyses	O
confirmed	O
the	O
absence	O
of	O
ESG1	O
in	O
these	O
cells	O
(	O
Figure	O
4C	O
)	O
.	O

In	O
29	O
clones	O
,	O
the	O
beta	O
-	O
geo	O
vector	O
had	O
replaced	O
the	O
HygR	O
vector	O
,	O
such	O
that	O
the	O
cells	O
remained	O
heterozygous	O
.	O

In	O
the	O
remaining	O
27	O
clones	O
,	O
the	O
beta	O
-	O
geo	O
vector	O
was	O
integrated	O
at	O
non	O
-	O
homologous	O
sites	O
.	O

ESG1	O
-	O
/	O
-	O
ES	O
cells	O
exhibited	O
normal	O
morphology	O
(	O
Figure	O
5A	O
)	O
.	O

These	O
cells	O
also	O
proliferated	O
at	O
a	O
speed	O
comparable	O
to	O
that	O
of	O
the	O
control	O
(	O
heterozygous	O
and	O
wild	O
-	O
type	O
)	O
cells	O
(	O
Figure	O
5B	O
)	O
.	O

ESG1	O
-	O
/	O
-	O
cells	O
differentiated	O
normally	O
after	O
the	O
removal	O
of	O
leukemia	O
inhibitory	O
factor	O
(	O
Figure	O
5B	O
)	O
or	O
retinoic	O
acid	O
treatment	O
(	O
not	O
shown	O
)	O
.	O

When	O
transplanted	O
into	O
hind	O
flanks	O
of	O
nude	O
mice	O
,	O
these	O
cells	O
produced	O
teratomas	O
,	O
tumors	O
containing	O
components	O
of	O
all	O
three	O
germ	O
layers	O
(	O
Figure	O
5C	O
)	O
.	O

These	O
results	O
indicate	O
that	O
ESG1	O
is	O
dispensable	O
for	O
the	O
self	O
-	O
renewal	O
properties	O
and	O
pluripotency	O
of	O
ES	O
cells	O
.	O

Figure	O
5	O

Analyses	O
of	O
ESG1	O
-	O
null	O
ES	O
cells	O
.	O

A	O
)	O
The	O
morphology	O
of	O
ESG1	O
-	O
null	O
ES	O
cell	O
colonies	O
grown	O
on	O
STO	O
feeder	O
cells	O
.	O

B	O
)	O
Growth	O
curve	O
of	O
wild	O
-	O
type	O
(	O
WT	O
)	O
,	O
ESG1	O
-	O
null	O
(	O
-	O
/	O
-	O
)	O
and	O
heterozygous	O
(	O
+	O
/	O
-	O
)	O
ES	O
cells	O
.	O

Each	O
clone	O
(	O
1	O
x	O
104	O
cells	O
/	O
well	O
)	O
was	O
plated	O
in	O
24	O
-	O
well	O
plates	O
.	O

Cell	O
numbers	O
were	O
determined	O
with	O
a	O
Coulter	O
counter	O
at	O
2	O
,	O
4	O
,	O
and	O
6	O
days	O
.	O

Data	O
of	O
+	O
/	O
-	O
and	O
-	O
/	O
-	O
cells	O
are	O
shown	O
as	O
averages	O
and	O
standard	O
deviations	O
of	O
three	O
independent	O
clones	O
.	O

C	O
)	O
A	O
section	O
of	O
teratoma	O
derived	O
from	O
ESG1	O
-	O
null	O
ES	O
cells	O
(	O
hematoxylin	O
&	O
eosin	O
staining	O
)	O
.	O

We	O
examined	O
the	O
gene	O
expression	O
profiles	O
of	O
ESG1	O
-	O
/	O
-	O
ES	O
cells	O
using	O
oligonucleotide	O
-	O
based	O
DNA	O
microarrays	O
representing	O
~	O
20	O
,	O
000	O
genes	O
.	O

In	O
comparison	O
to	O
control	O
ES	O
cells	O
,	O
ESG1	O
was	O
identified	O
as	O
the	O
gene	O
reduced	O
to	O
the	O
greatest	O
extent	O
in	O
ESG1	O
-	O
/	O
-	O
ES	O
cells	O
(	O
Figure	O
6A	O
)	O
.	O

The	O
expression	O
of	O
ES	O
cell	O
marker	O
genes	O
,	O
such	O
as	O
Nanog	O
and	O
Oct3	O
/	O
4	O
,	O
was	O
normal	O
in	O
ESG1	O
-	O
/	O
-	O
ES	O
cells	O
.	O

We	O
confirmed	O
normal	O
Oct3	O
/	O
4	O
expression	O
at	O
protein	O
levels	O
by	O
Western	O
blot	O
(	O
Figure	O
6B	O
)	O
.	O

The	O
overall	O
gene	O
expression	O
profiles	O
were	O
similar	O
between	O
control	O
ES	O
cells	O
and	O
ESG1	O
-	O
/	O
-	O
ES	O
cells	O
.	O

Several	O
genes	O
exhibited	O
a	O
greater	O
than	O
two	O
-	O
fold	O
reduction	O
in	O
ESG1	O
-	O
/	O
-	O
cells	O
,	O
including	O
Krt1	O
-	O
8	O
,	O
Pem	O
,	O
Ctgf	O
,	O
Ptgs2	O
,	O
Igf2	O
and	O
Inhba	O
.	O

These	O
genes	O
might	O
be	O
regulated	O
directly	O
or	O
indirectly	O
by	O
ESG1	O
.	O

Since	O
ESG1	O
contains	O
a	O
KH	O
-	O
type	O
RNA	O
-	O
binding	O
domain	O
,	O
it	O
may	O
stabilize	O
mRNA	O
of	O
these	O
genes	O
.	O

Further	O
studied	O
are	O
required	O
to	O
clarify	O
this	O
possibility	O
.	O

Figure	O
6	O

Gene	O
expression	O
analyses	O
of	O
ESG1	O
-	O
null	O
ES	O
cells	O
.	O

A	O
)	O
DNA	O
microarray	O
analyses	O
.	O

Total	O
RNA	O
from	O
wild	O
-	O
type	O
ES	O
cells	O
and	O
ESG1	O
-	O
null	O
ES	O
cells	O
were	O
labeled	O
with	O
Cy3	O
and	O
Cy5	O
,	O
respectively	O
.	O

Samples	O
were	O
hybridized	O
to	O
Agilent	O
Mouse	O
Developmental	O
Microarrays	O
.	O

The	O
averages	O
of	O
two	O
independent	O
clones	O
are	O
shown	O
.	O

B	O
)	O
Western	O
blot	O
analyses	O
.	O

Cell	O
lysates	O
from	O
ESG1	O
+	O
/	O
-	O
and	O
ESG1	O
-	O
/	O
-	O
cells	O
were	O
examined	O
for	O
expression	O
of	O
ESG1	O
,	O
Oct3	O
/	O
4	O
and	O
CDK4	O
with	O
immunoblotting	O
.	O

To	O
generate	O
ESG1	O
-	O
knockout	O
mice	O
,	O
we	O
injected	O
beta	O
-	O
geo	O
-	O
ESG1	O
+	O
/	O
-	O
ES	O
cell	O
clones	O
into	O
the	O
blastocysts	O
of	O
C57BL6	O
mice	O
.	O

We	O
obtained	O
germline	O
transmission	O
from	O
three	O
clones	O
.	O

We	O
obtained	O
ESG1	O
-	O
/	O
-	O
mice	O
at	O
the	O
Mendelian	O
ratios	O
(	O
36	O
wild	O
-	O
type	O
,	O
69	O
ESG1	O
+	O
/	O
-	O
,	O
and	O
45	O
ESG1	O
-	O
/	O
-	O
)	O
from	O
intercrosses	O
of	O
ESG1	O
+	O
/	O
-	O
mice	O
.	O

These	O
animals	O
exhibited	O
normal	O
development	O
,	O
gross	O
appearance	O
,	O
and	O
fertility	O
(	O
not	O
shown	O
)	O
.	O

Histological	O
examination	O
of	O
testis	O
and	O
ovary	O
could	O
not	O
identify	O
any	O
abnormalities	O
(	O
not	O
shown	O
)	O
.	O

These	O
data	O
demonstrated	O
that	O
ESG1	O
is	O
dispensable	O
for	O
both	O
mouse	O
development	O
and	O
germ	O
cell	O
formation	O
.	O

We	O
also	O
generated	O
ES	O
cells	O
from	O
blastocysts	O
obtained	O
by	O
intercrosses	O
of	O
ESG1	O
+	O
/	O
-	O
males	O
and	O
ESG1	O
-	O
/	O
-	O
females	O
.	O

Of	O
the	O
eight	O
ES	O
cell	O
lines	O
established	O
,	O
two	O
clones	O
were	O
ESG1	O
-	O
/	O
-	O
.	O

These	O
ESG1	O
-	O
null	O
ES	O
cells	O
demonstrated	O
normal	O
morphology	O
,	O
proliferation	O
,	O
and	O
differentiation	O
(	O
not	O
shown	O
)	O
,	O
confirming	O
that	O
ESG1	O
is	O
dispensable	O
in	O
ES	O
cells	O
.	O

Conclusion	O

To	O
analyze	O
the	O
physiological	O
roles	O
of	O
ESG1	O
,	O
we	O
identified	O
the	O
mouse	O
gene	O
on	O
chromosome	S-GO
9	O
and	O
deleted	O
it	O
by	O
homologous	O
recombination	O
in	O
ES	O
cells	O
.	O

Despite	O
specific	O
expression	O
in	O
early	O
embryos	O
,	O
germ	O
cells	O
,	O
and	O
pluripotent	O
cells	O
,	O
our	O
data	O
demonstrated	O
that	O
ESG1	O
is	O
dispensable	O
for	O
mouse	O
development	O
,	O
germ	O
cell	O
formation	O
,	O
and	O
ES	O
cell	O
self	O
-	O
renewal	O
.	O

Methods	O

Identification	O
and	O
analyses	O
of	O
BAC	O
clones	O
containing	O
the	O
mouse	O
ESG1	O
gene	O

To	O
identify	O
bacterial	O
artificial	O
chromosome	O
(	O
BAC	O
)	O
clones	O
containing	O
mouse	O
ESG1	O
gene	O
,	O
we	O
performed	O
PCR	O
-	O
based	O
screening	O
of	O
mouse	O
BAC	O
library	O
DNA	O
pools	O
(	O
Research	O
Genetics	O
)	O
using	O
the	O
pH34	O
-	O
u38	O
(	O
5	O
'	O
-	O
GAAGTCTGGTTCCTTGGCAGG	O
-	O
3	O
'	O
)	O
and	O
pH34	O
-	O
L394	O
(	O
5	O
'	O
-	O
ACTCGATACACTGGCCTAGC	O
-	O
3	O
'	O
)	O
primers	O
.	O

Following	O
restriction	O
enzyme	O
digestion	O
,	O
we	O
performed	O
Southern	O
blot	O
analyses	O
of	O
BAC	O
clones	O
as	O
described	O
[	O
20	O
]	O
using	O
the	O
pH34	O
-	O
U258	O
(	O
5	O
'	O
-	O
CTCGAGTGTACAGTCAAGTGGTTGCTGGGA	O
-	O
3	O
'	O
)	O
,	O
pH34	O
-	O
U65	O
(	O
5	O
'	O
-	O
GTGACCCTCGTGACCCGTAA	O
-	O
3	O
'	O
)	O
,	O
pH34	O
-	O
intron1L	O
(	O
5	O
'	O
-	O
CTGCGTGAGAGAAACACCAAACAGGC	O
-	O
3	O
'	O
)	O
,	O
pH34	O
-	O
L545	O
(	O
5	O
'	O
-	O
TGTGAATGGGAAGGTTACCACTCT	O
-	O
3	O
'	O
)	O
and	O
pH34	O
-	O
SCL1	O
(	O
5	O
'	O
-	O
GCCCTCTTCTGGTTTGTCTCGAAAT	O
-	O
3	O
'	O
)	O
probes	O
.	O

Hybridization	O
with	O
these	O
probes	O
revealed	O
bands	O
containing	O
either	O
the	O
ESG1	O
gene	O
or	O
pseudogenes	O
.	O

To	O
sequence	O
the	O
region	O
containing	O
the	O
mouse	O
ESG1	O
gene	O
and	O
the	O
3	O
'	O
flanking	O
region	O
,	O
we	O
subcloned	O
a	O
~	O
15	O
kbp	O
XhoI	O
-	O
SalI	O
fragment	O
into	O
the	O
pZERO	O
-	O
2	O
vector	O
(	O
Invitrogen	O
)	O
.	O

HindIII	O
-	O
or	O
EcoRI	O
-	O
digested	O
fragments	O
of	O
this	O
vector	O
were	O
then	O
cloned	O
into	O
pBluescript	O
KS	O
(	O
-	O
)	O
for	O
sequencing	O
.	O

To	O
sequence	O
the	O
ESG1	O
pseudogene	O
and	O
the	O
3	O
'	O
flanking	O
region	O
,	O
an	O
8	O
kbp	O
NotI	O
/	O
XhoI	O
fragment	O
was	O
cloned	O
into	O
pBluescript	O
KS	O
(	O
-	O
)	O
.	O

BamHI	O
-	O
or	O
PstI	O
-	O
fragments	O
of	O
this	O
vector	O
were	O
also	O
cloned	O
into	O
pBluescript	O
KS	O
(	O
-	O
)	O
.	O

To	O
identify	O
the	O
sequence	O
containing	O
the	O
5	O
'	O
flanking	O
regions	O
of	O
the	O
ESG1	O
gene	O
and	O
the	O
related	O
pseudogenes	O
,	O
we	O
used	O
a	O
TOPO	O
walker	O
kit	O
(	O
Invitrogen	O
)	O
with	O
the	O
pH34	O
-	O
T2L	O
(	O
5	O
'	O
-	O
ACTAGTCGCAGCAGGGATCCAGGAATATCT	O
-	O
3	O
'	O
)	O
and	O
pH34	O
-	O
L394	O
primers	O
.	O

The	O
resulting	O
sequence	O
was	O
cloned	O
into	O
pCR2	O
.	O
1	O
(	O
Invitrogen	O
)	O
.	O

We	O
obtained	O
a	O
~	O
6	O
kbp	O
band	O
from	O
the	O
NsiI	O
-	O
digensted	O
library	O
;	O
XbaI	O
-	O
,	O
SpeI	O
-	O
,	O
EcoRI	O
-	O
,	O
and	O
PstI	O
-	O
digested	O
fragments	O
of	O
this	O
band	O
were	O
cloned	O
into	O
pBluescript	O
KS	O
(	O
-	O
)	O
for	O
sequencing	O
.	O

This	O
fragment	O
contained	O
the	O
5	O
'	O
flanking	O
region	O
of	O
the	O
ESG1	O
gene	O
.	O

A	O
~	O
3	O
kbp	O
fragment	O
,	O
obtained	O
from	O
the	O
SacI	O
-	O
digested	O
library	O
,	O
was	O
cloned	O
into	O
pCR2	O
.	O
1	O
for	O
sequencing	O
.	O

This	O
fragment	O
was	O
contained	O
the	O
5	O
'	O
region	O
flanking	O
the	O
pseudogene	O
.	O

Construction	O
of	O
ESG1	O
targeting	O
vectors	O

We	O
replaced	O
all	O
of	O
the	O
ESG1	O
exons	O
with	O
two	O
targeting	O
vectors	O
containing	O
either	O
an	O
IRES	O
-	O
beta	O
-	O
geo	O
cassette	O
[	O
21	O
]	O
or	O
an	O
IRES	O
-	O
HygR	O
cassette	O
by	O
promoter	O
trap	O
selection	O
.	O

We	O
amplified	O
the	O
5	O
'	O
arm	O
(	O
1	O
.	O
8	O
kbp	O
)	O
using	O
KOD	O
plus	O
(	O
TOYOBO	O
)	O
with	O
the	O
pH34	O
-	O
targetpair5	O
-	O
U	O
(	O
5	O
'	O
-	O
CCGCGGAAAGTCAAGAGATTGGGTGG	O
-	O
3	O
'	O
)	O
and	O
pH34	O
-	O
targetpair5	O
-	O
L	O
(	O
5	O
'	O
-	O
GCGGCCGCCTTTACGGGTCACGAGGGTCAC	O
-	O
3	O
'	O
)	O
primers	O
.	O

The	O
3	O
'	O
arm	O
(	O
5	O
.	O
8	O
kbp	O
)	O
was	O
amplified	O
using	O
the	O
pH34	O
-	O
targetpair3	O
-	O
U	O
(	O
5	O
'	O
-	O
TGTGGCCAGTGTTTGGTTCTGGCGGG	O
-	O
3	O
'	O
)	O
and	O
pH34	O
-	O
targetpair3	O
-	O
L	O
(	O
5	O
'	O
-	O
CTCGAGGACTCGCCATTCTAGCCAAG	O
-	O
3	O
'	O
)	O
primers	O
.	O

The	O
IRES	O
beta	O
-	O
geo	O
or	O
IRES	O
HygR	O
cassettes	O
were	O
ligated	O
in	O
between	O
the	O
two	O
PCR	O
fragments	O
.	O

The	O
diphtheria	O
toxin	O
A	O
cassette	O
was	O
placed	O
downstream	O
of	O
the	O
3	O
'	O
arm	O
.	O

After	O
linearization	O
with	O
SacII	O
,	O
these	O
targeting	O
vectors	O
were	O
electroporated	O
into	O
2	O
.	O
0	O
x	O
107	O
RF8	O
ES	O
cells	O
[	O
22	O
]	O
using	O
a	O
Gene	O
pulser	O
(	O
BIORAD	O
)	O
.	O

Transfected	O
cells	O
were	O
selected	O
with	O
250	O
mu	O
g	O
/	O
mL	O
G418	O
or	O
100	O
mu	O
g	O
/	O
mL	O
hygromycin	O
B	O
,	O
respectively	O
.	O

Genomic	O
DNA	O
from	O
G418	O
-	O
or	O
hygromycin	O
B	O
-	O
resistant	O
colonies	O
was	O
screened	O
for	O
homologous	O
recombination	O
by	O
Southern	O
blotting	O
.	O

Southern	O
blot	O
screening	O
for	O
homologous	O
recombination	O

ES	O
cells	O
genomic	O
DNA	O
was	O
extracted	O
with	O
PUREGENE	O
(TM)	O
Cell	O
Lysis	O
Solution	O
(	O
Gentra	O
systems	O
)	O
.	O

For	O
5	O
'	O
Southern	O
blot	O
analysis	O
,	O
genomic	O
DNA	O
was	O
first	O
digested	O
with	O
PstI	O
,	O
then	O
separated	O
on	O
an	O
0	O
.	O
8	O
%	O
agarose	O
gel	O
and	O
transferred	O
to	O
a	O
nylon	O
membrane	O
as	O
described	O
[	O
20	O
]	O
.	O

A	O
560	O
bp	O
5	O
'	O
probe	O
was	O
amplified	O
using	O
the	O
ESG1S5	O
(	O
5	O
'	O
-	O
GATGGTGGTGGTGACTCAGAG	O
-	O
3	O
'	O
)	O
and	O
ESG1AS5	O
as	O
(	O
5	O
'	O
-	O
CCTCCATTGCCTCTATATCAG	O
-	O
3	O
'	O
)	O
primers	O
.	O

The	O
probe	O
specifically	O
labeled	O
an	O
18	O
kbp	O
band	O
from	O
the	O
wild	O
-	O
type	O
locus	O
,	O
a	O
15	O
kbp	O
band	O
from	O
the	O
beta	O
-	O
geo	O
locus	O
,	O
and	O
a	O
12	O
kbp	O
band	O
from	O
the	O
HygR	O
locus	O
.	O

Genomic	O
DNA	O
was	O
also	O
digested	O
with	O
SpeI	O
for	O
3	O
'	O
Southern	O
blot	O
analysis	O
.	O

A	O
1	O
,	O
010	O
bp	O
3	O
'	O
probe	O
was	O
amplified	O
with	O
the	O
pH34U	O
-	O
8000	O
(	O
5	O
'	O
-	O
CCAACCAGCCAGAGTTTCAGTTAT	O
-	O
3	O
'	O
)	O
and	O
pH34L	O
-	O
9000	O
(	O
5	O
'	O
-	O
GATAAGCTGCTGCCAAAAGACAAG	O
-	O
3	O
'	O
)	O
primers	O
.	O

The	O
probe	O
hybridized	O
to	O
an	O
11	O
.	O
5	O
kbp	O
band	O
from	O
the	O
wild	O
-	O
type	O
locus	O
,	O
a	O
12	O
.	O
5	O
kbp	O
band	O
from	O
the	O
beta	O
-	O
geo	O
locus	O
,	O
and	O
a	O
9	O
.	O
5	O
kbp	O
band	O
from	O
the	O
HygR	O
locus	O
.	O

Generation	O
of	O
anti	O
-	O
ESG1	O
polyclonal	O
antibodies	S-GO

The	O
coding	O
sequence	O
of	O
Esg1	O
was	O
amplified	O
by	O
PCR	O
with	O
the	O
pH34	O
-	O
gw	O
-	O
s	O
(	O
5	O
'	O
-	O
AAAAAGCAGGCTGGATGATGGTGACCCTCGTGA	O
-	O
3	O
'	O
)	O
and	O
pH34	O
-	O
gw	O
-	O
as	O
(	O
5	O
'	O
-	O
AGAAAGCTGGGTCTGCATCCAGGTCGGAGACA	O
-	O
3	O
'	O
)	O
primers	O
.	O

To	O
construct	O
pDONR	O
-	O
pH34	O
,	O
the	O
resulting	O
PCR	O
product	O
was	O
subcloned	O
into	O
pDONR201	O
(	O
Invitrogen	O
)	O
.	O

pDONR	O
-	O
pH34	O
was	O
interacted	O
with	O
pDEST17	O
(	O
Invitrogen	O
)	O
by	O
LR	O
recombination	O
.	O

After	O
introduction	O
of	O
the	O
resulting	O
expression	O
vector	O
pDEST17	O
-	O
pH34	O
into	O
BL21	O
-	O
AI	O
E	O
.	O
coli	O
(	O
Invitrogen	O
)	O
,	O
recombinant	O
protein	O
production	O
was	O
induced	O
according	O
to	O
the	O
manufacture	O
'	O
s	O
protocol	O
.	O

Histidine	O
-	O
tagged	O
ESG1	O
was	O
purified	O
using	O
Ni	O
-	O
nitrilotriacetic	O
acid	O
agarose	O
(	O
Qiagen	O
)	O
under	O
denaturing	O
conditions	O
in	O
the	O
presence	O
of	O
8	O
M	O
urea	O
.	O

After	O
dialysis	O
against	O
6	O
M	O
urea	O
,	O
the	O
recombinant	O
proteins	O
were	O
injected	O
into	O
New	O
Zealand	O
White	O
rabbits	O
to	O
generate	O
anti	O
-	O
ESG1	O
polyclonal	O
antibodies	S-GO
.	O

Western	O
blot	O

After	O
preparation	O
of	O
ES	O
cell	O
extracts	O
with	O
M	O
-	O
Per	O
(	O
Pierce	O
)	O
,	O
cellular	O
proteins	O
were	O
separated	O
on	O
sodium	O
dodecyl	O
sulfate	O
(	O
SDS	O
)	O
-	O
14	O
%	O
polyacrylamide	O
gels	O
and	O
transferred	O
to	O
nitrocellulose	O
membranes	O
(	O
Millipore	O
)	O
.	O

Membranes	O
were	O
incubated	O
with	O
anti	O
-	O
ESG1	O
(	O
1	O
/	O
500	O
dilution	O
)	O
,	O
anti	O
-	O
Oct3	O
/	O
4	O
(	O
1	O
/	O
500	O
;	O
Santa	O
Cruz	O
Biotechnology	O
)	O
,	O
anti	O
-	O
CDK4	O
(	O
1	O
/	O
200	O
;	O
Santa	O
Cruz	O
Biotechnology	O
)	O
,	O
and	O
anti	O
-	O
GFP	O
(	O
1	O
/	O
1000	O
;	O
MBL	O
)	O
primary	O
antibodies	S-GO
.	O

Horseradish	O
peroxidase	O
-	O
conjugated	O
anti	O
-	O
rabbit	O
and	O
anti	O
-	O
mouse	O
immunoglobulins	S-GO
(	O
1	O
/	O
5000	O
;	O
Cell	O
Signaling	O
)	O
were	O
used	O
to	O
detect	O
antibody	S-GO
binding	O
.	O

We	O
visualized	O
bound	O
antibody	S-GO
with	O
an	O
ECL	O
Western	O
Blotting	O
Detection	O
System	O
(	O
Amersham	O
)	O
.	O

Derivation	O
of	O
ESG1	O
-	O
deficient	O
ES	O
cells	O
from	O
blastocysts	O

Esg1	O
+	O
/	O
-	O
or	O
ESG1	O
-	O
/	O
-	O
mutant	O
female	O
mice	O
were	O
injected	O
with	O
Tamoxifen	O
(	O
10	O
mu	O
g	O
)	O
and	O
Depo	O
-	O
provera	O
(	O
1	O
mg	O
)	O
subcutaneously	O
on	O
the	O
third	O
day	O
of	O
pregnancy	O
.	O

Four	O
days	O
later	O
,	O
embryos	O
in	O
diapause	O
were	O
flushed	O
out	O
of	O
the	O
uterus	O
and	O
cultured	O
on	O
STO	O
feeder	O
cells	O
in	O
four	O
-	O
well	O
plates	O
in	O
Dulbecco	O
'	O
s	O
Modified	O
Eagle	O
Medium	O
(	O
DMEM	O
)	O
supplemented	O
with	O
20	O
%	O
Fetal	O
Bovine	O
Serum	O
(	O
Hyclone	O
)	O
,	O
0	O
.	O
1	O
mM	O
Non	O
-	O
Essential	O
Amino	O
Acids	O
(	O
Invitrogen	O
)	O
,	O
2	O
mM	O
L	O
-	O
glutamine	O
(	O
Invitrogen	O
)	O
,	O
50	O
U	O
/	O
ml	O
Penicillin	O
-	O
Streptomysin	O
(	O
Invitrogen	O
)	O
,	O
and	O
0	O
.	O
11	O
mM	O
2	O
-	O
mercaptoethanol	O
(	O
Invitrogen	O
)	O
.	O

After	O
six	O
days	O
,	O
the	O
central	O
mass	O
of	O
each	O
explant	O
was	O
harvested	O
,	O
rinsed	O
in	O
PBS	O
,	O
and	O
placed	O
in	O
a	O
drop	O
of	O
trypsin	O
for	O
a	O
few	O
minutes	O
.	O

The	O
cell	O
mass	O
was	O
collected	O
with	O
a	O
finely	O
drawn	O
-	O
out	O
Pasteur	O
pipette	O
preloaded	O
with	O
medium	O
,	O
ensuring	O
minimal	O
carryover	O
of	O
the	O
trypsin	O
.	O

The	O
cells	O
were	O
gently	O
transfered	O
into	O
a	O
fresh	O
well	O
with	O
20	O
%	O
FBS	O
-	O
containing	O
medium	O
.	O

The	O
resulting	O
primary	O
ES	O
cell	O
colonies	O
were	O
individually	O
passaged	O
into	O
wells	O
of	O
four	O
-	O
well	O
plates	O
containing	O
STO	O
feeder	O
cell	O
layers	O
.	O

Thereafter	O
,	O
cells	O
were	O
expanded	O
by	O
trypsinization	O
of	O
the	O
entire	O
culture	O
.	O

Microarrays	O

Total	O
RNA	O
from	O
wild	O
-	O
type	O
ES	O
cells	O
and	O
ESG1	O
-	O
/	O
-	O
ES	O
cells	O
was	O
labeled	O
with	O
Cy3	O
and	O
Cy5	O
,	O
respectively	O
.	O

The	O
samples	O
were	O
hybridized	O
to	O
a	O
Mouse	O
Development	O
Microarray	O
(	O
Algilent	O
)	O
according	O
to	O
the	O
manufacturer	O
'	O
s	O
protocol	O
.	O

Arrays	O
were	O
scanned	O
with	O
a	O
G2565BA	O
Microarray	O
Scanner	O
System	O
(	O
Agilent	O
)	O
.	O

Hybridization	O
was	O
repeated	O
with	O
two	O
independent	O
clones	O
.	O

Data	O
were	O
analyzed	O
with	O
GeneSprings	O
software	O
(	O
Silico	O
Genetics	O
)	O
.	O

Authors	O
'	O
contributions	O

HA	O
carried	O
out	O
the	O
phenotypic	O
studies	O
of	O
ESG1	O
knockout	O
mice	O
.	O

KI	O
determined	O
the	O
chromosomal	O
localizations	O
of	O
the	O
ESG1	O
gene	O
and	O
pseudogenes	O
and	O
constructed	O
the	O
targeting	O
vector	O
.	O

TI	O
carried	O
out	O
mouse	O
embryo	O
manipulation	O
.	O

MM	O
and	O
MN	O
carried	O
out	O
ES	O
cell	O
culture	O
.	O

SY	O
conceived	O
of	O
the	O
study	O
,	O
and	O
participated	O
in	O
its	O
design	O
and	O
coordination	O
and	O
helped	O
to	O
draft	O
the	O
manuscript	O
.	O

All	O
authors	O
read	O
and	O
approved	O
the	O
final	O
manuscript	O
.	O

Acknowledgements	O

We	O
thank	O
Chihiro	O
Takigawa	O
,	O
Junko	O
Iida	O
,	O
Masako	O
Shirasaka	O
,	O
Yumi	O
Ohuchi	O
,	O
and	O
Megumi	O
Narita	O
for	O
their	O
technical	O
and	O
administrative	O
assistance	O
.	O

We	O
are	O
grateful	O
to	O
Drs	O
.	O

Minoru	O
Ko	O
and	O
Azim	O
Surani	O
for	O
sharing	O
helpful	O
data	O
prior	O
to	O
publication	O
,	O
Dr	O
.	O
Hitoshi	O
Niwa	O
for	O
generously	O
providing	O
various	O
vectors	O
,	O
and	O
Dr	O
.	O
Robert	O
Farese	O
Jr	O
.	O
for	O
his	O
kind	O
gift	O
of	O
the	O
RF8	O
ES	O
cells	O
.	O

This	O
work	O
was	O
supported	O
in	O
part	O
by	O
research	O
grants	O
from	O
the	O
Ministry	O
of	O
Education	O
,	O
Culture	O
,	O
Sports	O
,	O
Science	O
,	O
and	O
Technology	O
of	O
Japan	O
,	O
the	O
Uehara	O
Memorial	O
Foundation	O
,	O
the	O
Naito	O
Foundation	O
,	O
the	O
Sumitomo	O
Research	O
Foundation	O
,	O
the	O
Mitsubishi	O
Foundation	O
.	O

S	O
.	O
Y	O
.	O
was	O
supported	O
by	O
a	O
Toray	O
Science	O
and	O
Technology	O
Grant	O
(	O
to	O
S	O
.	O
Y	O
.	O
)	O
.	O

This	O
work	O
was	O
also	O
supported	O
in	O
part	O
by	O
a	O
Grant	O
-	O
in	O
-	O
Aid	O
for	O
21st	O
Century	O
COE	O
(	O
Center	O
of	O
Excellence	O
)	O
Research	O
from	O
the	O
Ministry	O
of	O
Education	O
,	O
Culture	O
,	O
Sports	O
,	O
Science	O
,	O
and	O
Technology	O
.	O

Identification	O
of	O
collagen	O
-	O
induced	O
arthritis	O
loci	O
in	O
aged	O
multiparous	O
female	O
mice	O

Abstract	O

Collagen	O
-	O
induced	O
arthritis	O
in	O
mice	O
is	O
one	O
of	O
the	O
most	O
commonly	O
used	O
autoimmune	O
experimental	O
models	O
,	O
with	O
many	O
similarities	O
to	O
rheumatoid	O
arthritis	O
.	O

Since	O
collagen	O
-	O
induced	O
arthritis	O
is	O
a	O
complex	O
polygenic	O
disease	O
there	O
is	O
a	O
need	O
for	O
identification	O
of	O
several	O
major	O
disease	O
-	O
controlling	O
genes	O
.	O

Because	O
rheumatoid	O
arthritis	O
particularly	O
affects	O
aged	O
women	O
,	O
we	O
have	O
in	O
the	O
present	O
study	O
identified	O
new	O
genetic	O
regions	O
critical	O
for	O
collagen	O
-	O
induced	O
arthritis	O
by	O
studying	O
aged	O
female	O
mice	O
of	O
a	O
cross	O
between	O
NFR	O
/	O
N	O
and	O
B10	O
.	O
Q	O
(	O
H	O
-	O
2q	O
haplotype	O
)	O
.	O

The	O
mice	O
in	O
the	O
present	O
study	O
had	O
different	O
reproductive	O
histories	O
,	O
which	O
did	O
not	O
significantly	O
affect	O
the	O
onset	O
,	O
incidence	O
or	O
severity	O
of	O
the	O
disease	O
.	O

A	O
total	O
of	O
200	O
female	O
mice	O
were	O
used	O
in	O
a	O
total	O
genome	O
-	O
wide	O
screening	O
with	O
125	O
microsatellite	O
markers	O
.	O

We	O
found	O
one	O
new	O
significant	O
quantitative	O
trait	O
locus	O
affecting	O
the	O
arthritis	O
incidence	O
,	O
severity	O
and	O
day	O
of	O
onset	O
on	O
chromosome	S-GO
11	O
(	O
denoted	O
Cia40	O
)	O
,	O
which	O
colocalizes	O
with	O
a	O
locus	O
controlling	O
pregnancy	O
failure	O
.	O

Furthermore	O
,	O
a	O
quantitative	O
trait	O
locus	O
of	O
suggestive	O
significance	O
associated	O
with	O
the	O
incidence	O
,	O
severity	O
and	O
day	O
of	O
onset	O
was	O
identified	O
on	O
chromosome	S-GO
1	O
.	O

Finally	O
,	O
a	O
suggestively	O
significant	O
quantitative	O
trait	O
locus	O
associated	O
with	O
collagen	O
type	O
II	O
antibody	S-GO
titers	O
was	O
identified	O
on	O
chromosome	S-GO
13	O
.	O

This	O
study	O
indicates	O
that	O
several	O
gene	O
loci	O
control	O
arthritis	O
in	O
aged	O
multiparous	O
females	O
,	O
and	O
that	O
at	O
least	O
one	O
of	O
these	O
loci	O
coincides	O
with	O
pregnancy	O
failure	O
.	O

Introduction	O

The	O
similarities	O
between	O
rheumatoid	O
arthritis	O
(	O
RA	O
)	O
in	O
man	O
and	O
collagen	O
-	O
induced	O
arthritis	O
(	O
CIA	O
)	O
in	O
mice	O
are	O
well	O
established	O
,	O
although	O
differences	O
in	O
the	O
disease	O
pattern	O
exist	O
[	O
1	O
-	O
3	O
]	O
.	O

Characteristic	O
of	O
RA	O
is	O
the	O
fact	O
that	O
women	O
of	O
reproductive	O
age	O
are	O
more	O
susceptible	O
to	O
the	O
disease	O
than	O
men	O
[	O
4	O
]	O
.	O

It	O
has	O
also	O
been	O
reported	O
that	O
75	O
%	O
of	O
female	O
patients	O
(	O
23	O
out	O
of	O
31	O
females	O
)	O
with	O
RA	O
exhibit	O
clinical	O
remission	O
during	O
the	O
course	O
of	O
pregnancy	O
[	O
5	O
]	O
.	O

On	O
the	O
other	O
hand	O
,	O
it	O
has	O
been	O
suggested	O
that	O
the	O
onset	O
of	O
RA	O
is	O
postponed	O
by	O
parity	O
.	O

The	O
risk	O
of	O
onset	O
is	O
reduced	O
during	O
pregnancy	O
,	O
while	O
in	O
the	O
first	O
year	O
postpartum	O
the	O
chance	O
of	O
onset	O
is	O
increased	O
[	O
6	O
,	O
7	O
]	O
.	O

The	O
results	O
of	O
a	O
recent	O
study	O
of	O
RA	O
in	O
women	O
,	O
however	O
,	O
indicate	O
that	O
pregnancy	O
history	O
does	O
not	O
increase	O
the	O
incidence	O
of	O
the	O
disease	O
later	O
in	O
life	O
[	O
8	O
]	O
.	O

Adequate	O
animal	O
models	O
are	O
useful	O
tools	O
for	O
the	O
identification	O
of	O
genes	O
involved	O
in	O
complex	O
human	O
diseases	O
.	O

CIA	O
in	O
mice	O
shares	O
both	O
immunological	O
and	O
pathological	O
characteristics	O
with	O
human	O
RA	O
and	O
is	O
one	O
of	O
the	O
most	O
used	O
models	O
for	O
the	O
identification	O
of	O
genes	O
and	O
mechanisms	O
involved	O
in	O
arthritis	O
.	O

The	O
incidence	O
of	O
CIA	O
is	O
sex	O
dependent	O
,	O
like	O
the	O
incidence	O
in	O
RA	O
,	O
although	O
different	O
species	O
and	O
different	O
variants	O
of	O
the	O
disease	O
could	O
lead	O
to	O
both	O
male	O
and	O
female	O
predominance	O
.	O

Male	O
mice	O
are	O
more	O
often	O
affected	O
than	O
females	O
.	O

Gender	O
differences	O
in	O
CIA	O
susceptibility	O
are	O
dependent	O
on	O
many	O
factors	O
,	O
including	O
genetic	O
,	O
hormonal	O
and	O
behavioral	O
influences	O
[	O
9	O
]	O
.	O

However	O
,	O
isolated	O
factors	O
are	O
remarkably	O
consistent	O
between	O
RA	O
and	O
the	O
different	O
animal	O
models	O
[	O
3	O
,	O
9	O
]	O
.	O

Pregnancy	O
in	O
mice	O
,	O
like	O
pregnancy	O
in	O
women	O
,	O
normally	O
causes	O
remission	O
of	O
arthritis	O
[	O
5	O
,	O
10	O
]	O
,	O
while	O
exacerbation	O
often	O
occurs	O
postpartum	O
[	O
7	O
,	O
10	O
,	O
11	O
]	O
.	O

Pregnancy	O
-	O
induced	O
remission	O
of	O
CIA	O
in	O
mice	O
appears	O
to	O
be	O
caused	O
by	O
the	O
increase	O
in	O
estrogen	O
levels	O
,	O
while	O
the	O
postpartum	O
exacerbation	O
can	O
be	O
explained	O
by	O
the	O
dramatic	O
drop	O
in	O
estrogen	O
[	O
10	O
]	O
,	O
possibly	O
together	O
with	O
increased	O
prolactin	O
levels	O
[	O
11	O
]	O
.	O

To	O
what	O
extent	O
the	O
pregnancy	O
history	O
(	O
parity	O
)	O
affects	O
the	O
incidence	O
of	O
CIA	O
later	O
in	O
life	O
has	O
,	O
to	O
our	O
knowledge	O
,	O
not	O
previously	O
been	O
studied	O
.	O

Importantly	O
,	O
RA	O
occurs	O
predominantly	O
in	O
women	O
,	O
many	O
of	O
which	O
have	O
had	O
several	O
children	O
,	O
and	O
it	O
is	O
therefore	O
appropriate	O
to	O
also	O
mimic	O
this	O
situation	O
using	O
animal	O
models	O
.	O

In	O
the	O
present	O
paper	O
we	O
have	O
analyzed	O
female	O
mice	O
that	O
previously	O
had	O
undergone	O
a	O
reproductive	O
study	O
(	O
Liljander	O
M	O
,	O
S	O
a	O
llstr	O
o	O
m	O
MA	O
,	O
Andersson	O
S	O
,	O
Wernhoff	O
P	O
,	O
Andersson	O
A	O
,	O
Holmdahl	O
R	O
,	O
Mattsson	O
R	O
,	O
unpublished	O
data	O
)	O
.	O

A	O
total	O
of	O
200	O
female	O
mice	O
(	O
ten	O
months	O
of	O
age	O
)	O
of	O
the	O
N2	O
backcross	O
between	O
NFR	O
/	O
N	O
and	O
C57BL	O
/	O
B10	O
.	O
Q	O
(	O
B10	O
.	O
Q	O
)	O
were	O
used	O
to	O
analyze	O
the	O
genetic	O
control	O
of	O
CIA	O
in	O
aged	O
females	O
with	O
a	O
multiparous	O
history	O
.	O

Materials	O
and	O
methods	O

Mice	O

Inbred	O
NFR	O
/	O
N	O
mice	O
were	O
originally	O
obtained	O
from	O
the	O
National	O
Institute	O
of	O
Health	O
(	O
Bethesda	O
,	O
MD	O
,	O
USA	O
)	O
and	O
the	O
B10	O
.	O
Q	O
mice	O
were	O
originally	O
bought	O
from	O
The	O
Jackson	O
Laboratory	O
(	O
Bar	O
Harbor	O
,	O
ME	O
,	O
USA	O
)	O
.	O

(	O
B10Q	O
x	O
NFR	O
/	O
N	O
)	O
F1	O
hybrids	O
and	O
(	O
B10	O
.	O
Q	O
x	O
NFR	O
/	O
N	O
)	O
x	O
B10	O
.	O
Q	O
N2	O
mice	O
were	O
bred	O
in	O
individual	O
ventilated	O
cages	O
in	O
the	O
BMC	O
Barrier	O
animal	O
facility	O
and	O
at	O
the	O
animal	O
house	O
of	O
the	O
Department	O
of	O
Pathology	O
,	O
Lund	O
University	O
,	O
Sweden	O
.	O

The	O
animals	O
were	O
fed	O
ad	O
libitum	O
with	O
standard	O
rodent	O
chow	O
(	O
LAB	O
FOR	O
R36	O
,	O
irradiated	O
breeding	O
food	O
for	O
rats	O
and	O
mice	O
;	O
Lactamin	O
AB	O
,	O
Stockholm	O
,	O
Sweden	O
)	O
and	O
water	O
in	O
a	O
photoperiod	O
of	O
12	O
hours	O
:	O
12	O
hours	O
light	O
:	O
dark	O
.	O

The	O
mice	O
used	O
in	O
the	O
present	O
study	O
had	O
clean	O
health	O
monitoring	O
protocols	O
according	O
to	O
the	O
Federation	O
of	O
European	O
Laboratory	O
Animal	O
Sciences	O
Association	O
recommendations	O
.	O

Ethical	O
permissions	O
were	O
M125	O
-	O
04	O
(	O
embryo	O
transfer	O
)	O
and	O
M290	O
-	O
03	O
(	O
reproduction	O
and	O
arthritis	O
)	O
.	O

Experimental	O
design	O

A	O
total	O
of	O
200	O
female	O
mice	O
(	O
approximately	O
ten	O
months	O
old	O
)	O
of	O
N2	O
backcross	O
(	O
B10	O
.	O
Q	O
x	O
NFR	O
/	O
N	O
)	O
x	O
B10	O
.	O
Q	O
were	O
used	O
.	O

The	O
mice	O
had	O
earlier	O
undergone	O
a	O
reproductive	O
study	O
where	O
each	O
animal	O
had	O
four	O
mating	O
opportunities	O
.	O

First	O
,	O
the	O
female	O
mice	O
were	O
allowed	O
to	O
mate	O
twice	O
with	O
B10	O
.	O
RIII	O
males	O
(	O
allogeneic	O
mating	O
by	O
means	O
of	O
MHC	S-GO
(	O
major	B-GO
histocompatibility	I-GO
complex	E-GO
)	O
and	O
finally	O
to	O
mate	O
twice	O
with	O
B10	O
.	O
Q	O
males	O
(	O
syngeneic	O
mating	O
by	O
means	O
of	O
MHC	S-GO
)	O
.	O

After	O
four	O
possible	O
pregnancies	O
CIA	O
was	O
induced	O
to	O
the	O
female	O
mice	O
.	O

Induction	O
and	O
evaluation	O
of	O
CIA	O

To	O
induce	O
CIA	O
,	O
the	O
mice	O
were	O
immunized	O
subcutaneously	O
at	O
the	O
base	O
of	O
the	O
tail	O
with	O
100	O
mu	O
g	O
rat	O
collagen	O
type	O
II	O
(	O
CII	O
)	O
emulsified	O
in	O
0	O
.	O
1	O
M	O
acetic	O
acid	O
combined	O
with	O
an	O
equal	O
amount	O
of	O
complete	O
Freud	O
'	O
s	O
adjuvant	O
(	O
Difco	O
Laboratories	O
,	O
Detroit	O
,	O
MI	O
,	O
USA	O
)	O
.	O

A	O
booster	O
injection	O
containing	O
50	O
mu	O
g	O
CII	O
emulsified	O
in	O
0	O
.	O
1	O
M	O
acetic	O
acid	O
combined	O
with	O
an	O
equal	O
amount	O
of	O
Freud	O
'	O
s	O
incomplete	O
adjuvant	O
(	O
Difco	O
Laboratories	O
)	O
was	O
given	O
after	O
30	O
days	O
.	O

The	O
clinical	O
scoring	O
of	O
arthritis	O
commenced	O
25	O
days	O
after	O
the	O
first	O
immunization	O
.	O

Animals	O
were	O
examined	O
for	O
clinical	O
signs	O
of	O
CIA	O
three	O
times	O
per	O
week	O
and	O
were	O
graded	O
on	O
a	O
12	O
-	O
point	O
scale	O
.	O

The	O
arthritis	O
index	O
was	O
assigned	O
to	O
each	O
mouse	O
using	O
the	O
following	O
criteria	O
:	O
0	O
=	O
no	O
visible	O
sign	O
of	O
arthritis	O
,	O
1	O
=	O
redness	O
and	O
swelling	O
in	O
a	O
single	O
joint	O
,	O
2	O
=	O
inflammation	O
in	O
multiple	O
joints	O
,	O
and	O
3	O
=	O
severe	O
inflammation	O
in	O
the	O
entire	O
paw	O
and	O
/	O
or	O
anklebone	O
.	O

Each	O
paw	O
was	O
given	O
the	O
scores	O
0	O
-	O
3	O
,	O
with	O
the	O
index	O
being	O
the	O
sum	O
of	O
all	O
four	O
paws	O
.	O

The	O
severity	O
trait	O
is	O
the	O
maximum	O
score	O
observed	O
in	O
each	O
individual	O
female	O
.	O

The	O
onset	O
is	O
the	O
number	O
of	O
days	O
calculated	O
from	O
the	O
first	O
immunization	O
to	O
the	O
first	O
clinical	O
signs	O
of	O
arthritis	O
excluding	O
unaffected	O
animals	O
.	O

Microsatellite	O
genotyping	O
and	O
linkage	O
analysis	O

Tail	O
biopsies	O
were	O
collected	O
from	O
all	O
N2	O
females	O
and	O
the	O
F0	O
generation	O
.	O

DNA	O
was	O
isolated	O
according	O
to	O
a	O
previously	O
described	O
protocol	O
[	O
12	O
]	O
.	O

After	O
screening	O
of	O
parental	O
DNA	O
with	O
approximately	O
450	O
mouse	O
fluorescence	O
-	O
labeled	O
microsatellite	O
markers	O
(	O
INTERACTIVA	O
,	O
Ulm	O
,	O
Germany	O
)	O
,	O
125	O
informative	O
markers	O
were	O
selected	O
covering	O
the	O
genome	O
.	O

Two	O
hundred	O
and	O
thirty	O
-	O
seven	O
N2	O
mice	O
were	O
genotyped	O
with	O
markers	O
covering	O
all	O
chromosomes	S-GO
except	O
for	O
the	O
Y	B-GO
chromosome	E-GO
.	O

PCR	O
amplification	O
for	O
the	O
markers	O
was	O
performed	O
in	O
a	O
final	O
volume	O
of	O
10	O
mu	O
l	O
in	O
a	O
96	O
-	O
well	O
V	O
-	O
bottom	O
microtiter	O
plate	O
using	O
20	O
ng	O
DNA	O
,	O
10	O
mM	O
KCl	O
,	O
20	O
mM	O
Tris	O
-	O
HCl	O
,	O
10	O
mM	O
(	O
NH4	O
)	O
2SO4	O
,	O
2	O
mM	O
MgCl2	O
,	O
0	O
.	O
1	O
%	O
Triton	O
X	O
-	O
100	O
,	O
pH	O
8	O
.	O
8	O
(	O
New	O
England	O
BioLabs	O
Inc	O
.	O
,	O
Ipswich	O
,	O
MA	O
,	O
USA	O
)	O
,	O
3	O
mu	O
M	O
(	O
10	O
pmol	O
)	O
each	O
primer	O
,	O
2	O
mM	O
dNTPs	O
(	O
Advanced	O
Biotechnologies	O
,	O
Epsom	O
,	O
Surrey	O
,	O
UK	O
)	O
and	O
0	O
.	O
25	O
U	O
Taq	O
DNA	O
Polymerase	O
(	O
New	O
England	O
BioLabs	O
Inc	O
.	O
)	O
.	O

The	O
following	O
program	O
was	O
used	O
to	O
amplify	O
the	O
DNA	O
:	O
denaturation	O
at	O
95	O
degrees	O
C	O
for	O
3	O
minutes	O
,	O
annealing	O
at	O
56	O
degrees	O
C	O
for	O
45	O
seconds	O
,	O
polymerization	O
at	O
72	O
degrees	O
C	O
for	O
1	O
minute	O
,	O
30	O
cycles	O
of	O
95	O
degrees	O
C	O
for	O
30	O
seconds	O
,	O
56	O
degrees	O
C	O
for	O
45	O
seconds	O
and	O
72	O
degrees	O
C	O
for	O
1	O
minute	O
,	O
and	O
a	O
final	O
extension	O
step	O
of	O
7	O
minutes	O
at	O
72	O
degrees	O
C	O
.	O

The	O
PCR	O
products	O
were	O
analyzed	O
on	O
a	O
MegaBACE	O
(TM)	O
1000	O
(	O
Amersham	O
Pharmacia	O
Biotech	O
Inc	O
Piscataway	O
,	O
NJ	O
,	O
USA	O
)	O
according	O
to	O
the	O
manufacturer	O
'	O
s	O
protocol	O
.	O

Data	O
were	O
analyzed	O
with	O
Genetic	O
Profiler	O
1	O
.	O
1	O
(	O
Amersham	O
Pharmacia	O
Biotech	O
Inc	O
)	O
.	O

Map	O
Manager	O
QTXb20	O
free	O
software	O
[	O
13	O
]	O
was	O
used	O
to	O
perform	O
linkage	O
analysis	O
and	O
the	O
permutation	O
test	O
.	O

Ninety	O
percent	O
of	O
the	O
mouse	O
genome	O
was	O
within	O
a	O
20	O
cM	O
intermarker	O
distance	O
.	O

The	O
marker	O
map	O
was	O
generated	O
using	O
the	O
Kosambis	O
map	O
function	O
and	O
1	O
,	O
000	O
permutations	O
were	O
performed	O
for	O
every	O
phenotype	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
.	O

The	O
permutation	O
tests	O
were	O
carried	O
out	O
to	O
establish	O
empirical	O
significance	O
thresholds	O
for	O
the	O
interactions	O
.	O

A	O
threshold	O
equal	O
to	O
or	O
above	O
the	O
37th	O
percentile	O
(	O
P	O
=	O
0	O
.	O
63	O
)	O
was	O
considered	O
suggestively	O
significant	O
,	O
and	O
the	O
level	O
for	O
the	O
significant	O
threshold	O
was	O
set	O
to	O
the	O
95th	O
percentile	O
(	O
P	O
=	O
0	O
.	O
05	O
)	O
.	O

Interval	O
mapping	O
was	O
made	O
with	O
a	O
2	O
cM	O
increase	O
under	O
the	O
additive	O
regression	O
model	O
in	O
order	O
to	O
calculate	O
the	O
test	O
statistics	O
.	O

Enzyme	O
-	O
linked	O
immunosorbent	O
assay	O

The	O
adult	O
female	O
mice	O
were	O
sacrificed	O
at	O
15	O
months	O
of	O
age	O
and	O
sera	O
were	O
collected	O
.	O

Anti	O
-	O
CII	O
antibody	S-GO
titers	O
in	O
sera	O
were	O
analyzed	O
by	O
a	O
sandwich	O
ELISA	O
technique	O
[	O
14	O
]	O
.	O

In	O
brief	O
,	O
CII	O
(	O
10	O
mu	O
g	O
/	O
ml	O
)	O
was	O
coupled	O
to	O
immunosorbent	O
plates	O
overnight	O
at	O
4	O
degrees	O
C	O
.	O

Bovine	O
serum	O
albumin	O
(	O
Sigma	O
Chemical	O
St	O
Louis	O
,	O
MO	O
,	O
USA	O
)	O
was	O
used	O
for	O
blocking	O
,	O
and	O
thereafter	O
different	O
dilutions	O
of	O
control	O
sera	O
(	O
purified	O
mouse	O
anti	O
-	O
CII	O
antibodies	S-GO
)	O
,	O
test	O
sera	O
,	O
and	O
positive	O
and	O
negative	O
controls	O
were	O
added	O
.	O

The	O
presence	O
of	O
CII	O
-	O
specific	O
IgG	S-GO
was	O
visualized	O
by	O
means	O
of	O
peroxidase	O
-	O
conjugated	O
goat	O
antimouse	O
IgG	S-GO
.	O

Statistical	O
analysis	O

Statistical	O
comparison	O
between	O
the	O
different	O
experimental	O
groups	O
was	O
performed	O
using	O
the	O
Mann	O
-	O
Whitney	O
U	O
test	O
or	O
Student	O
'	O
s	O
unpaired	O
t	O
test	O
.	O

Results	O

NFR	O
/	O
N	O
female	O
mice	O
show	O
delayed	O
onset	O
and	O
lower	O
incidence	O
of	O
CIA	O
compared	O
with	O
B10	O
.	O
Q	O
females	O

The	O
onset	O
of	O
the	O
disease	O
was	O
significantly	O
delayed	O
in	O
NFR	O
/	O
N	O
mice	O
,	O
which	O
resulted	O
in	O
lower	O
incidence	O
in	O
the	O
initial	O
phase	O
of	O
the	O
disease	O
(	O
Table	O
1	O
and	O
Figure	O
1	O
)	O
.	O

The	O
appearance	O
of	O
the	O
arthritis	O
was	O
slightly	O
different	O
between	O
the	O
two	O
strains	O
,	O
NFR	O
/	O
N	O
mice	O
showing	O
a	O
higher	O
frequency	O
of	O
swelling	O
of	O
the	O
entire	O
paw	O
than	O
B10	O
.	O
Q	O
mice	O
.	O

Later	O
in	O
the	O
disease	O
course	O
the	O
differences	O
in	O
CIA	O
frequency	O
and	O
severity	O
between	O
the	O
strains	O
were	O
less	O
obvious	O
.	O

However	O
,	O
the	O
anti	O
-	O
CII	O
titers	O
100	O
days	O
after	O
primary	O
immunization	O
(	O
and	O
70	O
days	O
after	O
the	O
booster	O
)	O
differed	O
significantly	O
between	O
NFR	O
/	O
N	O
and	O
B10	O
.	O
Q	O
female	O
mice	O
(	O
see	O
Table	O
1	O
)	O
.	O

Pregnancy	O
history	O
does	O
not	O
significantly	O
affect	O
incidence	O
or	O
severity	O
of	O
CIA	O
in	O
female	O
mice	O
of	O
mixed	O
genetic	O
background	O

Table	O
2	O
presents	O
the	O
results	O
of	O
arthritic	O
incidence	O
,	O
arthritis	O
onset	O
and	O
maximum	O
arthritic	O
score	O
for	O
the	O
female	O
mice	O
of	O
the	O
N2	O
generation	O
,	O
(	O
NFR	O
/	O
N	O
x	O
B10	O
.	O
Q	O
)	O
x	O
B10	O
.	O
Q	O
,	O
grouped	O
according	O
to	O
the	O
number	O
of	O
pregnancies	O
they	O
had	O
experienced	O
prior	O
to	O
immunization	O
with	O
CII	O
.	O

There	O
was	O
no	O
significant	O
difference	O
in	O
the	O
incidence	O
or	O
severity	O
of	O
arthritis	O
depending	O
on	O
the	O
number	O
of	O
pregnancies	O
that	O
had	O
been	O
passed	O
prior	O
to	O
the	O
induction	O
of	O
the	O
disease	O
.	O

We	O
observed	O
a	O
trend	O
towards	O
lower	O
severity	O
in	O
multiparous	O
mice	O
compared	O
with	O
mice	O
with	O
a	O
history	O
of	O
zero	O
to	O
two	O
pregnancies	O
.	O

The	O
onset	O
of	O
diseases	O
,	O
however	O
,	O
was	O
earlier	O
in	O
mice	O
that	O
had	O
passed	O
more	O
than	O
one	O
pregnancy	O
.	O

There	O
was	O
no	O
difference	O
in	O
the	O
development	O
of	O
the	O
disease	O
between	O
female	O
mice	O
that	O
have	O
only	O
been	O
pregnant	O
with	O
MHC	S-GO
mismatched	O
males	O
(	O
B10	O
.	O
RIII	O
)	O
and	O
female	O
mice	O
that	O
only	O
have	O
been	O
pregnant	O
with	O
MHC	S-GO
matched	O
males	O
(	O
B10	O
.	O
Q	O
)	O
.	O

New	O
loci	O
associated	O
with	O
CIA	O
in	O
identified	O
old	O
female	O
mice	O

The	O
genetic	O
linkage	O
analysis	O
revealed	O
one	O
significant	O
quantitative	O
trait	O
locus	O
(	O
QTL	O
)	O
located	O
at	O
64	O
-	O
70	O
cM	O
on	O
chromosome	S-GO
11	O
(	O
Table	O
3	O
and	O
Figure	O
2	O
)	O
.	O

This	O
locus	O
(	O
denoted	O
Cia40	O
)	O
gave	O
significant	O
LOD	O
scores	O
for	O
the	O
traits	O
incidence	O
(	O
LOD	O
=	O
4	O
.	O
1	O
)	O
and	O
'	O
day	O
of	O
onset	O
'	O
(	O
LOD	O
=	O
4	O
.	O
0	O
)	O
,	O
and	O
a	O
suggestive	O
LOD	O
score	O
for	O
the	O
trait	O
'	O
arthritis	O
score	O
'	O
(	O
LOD	O
=	O
3	O
.	O
3	O
)	O
.	O

Another	O
QTL	O
of	O
suggestive	O
significance	O
for	O
the	O
incidence	O
of	O
disease	O
was	O
identified	O
around	O
27	O
cM	O
on	O
chromosome	S-GO
1	O
(	O
Figure	O
2	O
)	O
.	O

Finally	O
,	O
a	O
suggestive	O
QTL	O
for	O
the	O
trait	O
anti	O
-	O
CII	O
antibody	S-GO
titer	O
was	O
identified	O
on	O
chromosome	S-GO
13	O
(	O
Figure	O
2	O
)	O
.	O

Discussion	O

Although	O
carrying	O
the	O
same	O
CIA	O
-	O
susceptible	O
MHC	S-GO
region	O
,	O
the	O
NFR	O
/	O
N	O
and	O
B10	O
.	O
Q	O
mice	O
are	O
different	O
in	O
several	O
respects	O
.	O

The	O
NFR	O
/	O
N	O
mouse	O
,	O
which	O
is	O
an	O
inbred	O
NMRI	O
mouse	O
of	O
the	O
H	O
-	O
2q	O
haplotype	O
,	O
is	O
larger	O
in	O
size	O
than	O
the	O
B10	O
.	O
Q	O
mouse	O
and	O
is	O
also	O
known	O
for	O
its	O
extraordinarily	O
good	O
breeding	O
properties	O
.	O

The	O
mice	O
used	O
in	O
the	O
present	O
study	O
,	O
(	O
NFR	O
/	O
N	O
x	O
B10	O
.	O
Q	O
)	O
x	O
B10	O
.	O
Q	O
females	O
,	O
first	O
underwent	O
a	O
genetic	O
study	O
of	O
reproduction	O
,	O
in	O
which	O
a	O
number	O
of	O
loci	O
associated	O
with	O
breeding	O
performance	O
were	O
identified	O
(	O
Liljander	O
M	O
,	O
S	O
a	O
llstr	O
o	O
m	O
MA	O
,	O
Andersson	O
S	O
,	O
Wernhoff	O
P	O
,	O
Andersson	O
A	O
,	O
Holmdahl	O
R	O
,	O
Mattsson	O
R	O
;	O
unpublished	O
data	O
)	O
.	O

Since	O
the	O
parental	O
strains	O
differ	O
in	O
susceptibility	O
to	O
CIA	O
,	O
in	O
spite	O
of	O
both	O
having	O
the	O
MHC	O
class	O
II	O
A	O
beta	O
genes	O
[	O
15	O
]	O
,	O
we	O
wanted	O
to	O
test	O
the	O
susceptibility	O
to	O
inflammatory	O
disease	O
in	O
mice	O
from	O
this	O
cross	O
.	O

In	O
fact	O
,	O
this	O
situation	O
gave	O
an	O
opportunity	O
to	O
study	O
the	O
genetic	O
control	O
of	O
arthritis	O
in	O
aged	O
multiparous	O
females	O
,	O
a	O
common	O
situation	O
in	O
human	O
RA	O
.	O

This	O
susceptibility	O
was	O
important	O
to	O
investigate	O
for	O
various	O
reasons	O
.	O

The	O
fact	O
that	O
the	O
mice	O
differed	O
in	O
their	O
reproductive	O
history	O
made	O
it	O
possible	O
to	O
analyze	O
whether	O
this	O
would	O
significantly	O
affect	O
the	O
incidence	O
or	O
severity	O
of	O
CIA	O
.	O

Second	O
,	O
almost	O
all	O
the	O
linkage	O
analyses	O
performed	O
for	O
detection	O
of	O
CIA	O
-	O
associated	O
loci	O
in	O
mice	O
have	O
been	O
carried	O
out	O
with	O
male	O
mice	O
.	O

Another	O
reason	O
is	O
that	O
the	O
use	O
of	O
old	O
multiparous	O
mice	O
mimicked	O
the	O
RA	O
situation	O
(	O
older	O
women	O
is	O
the	O
major	O
risk	O
group	O
)	O
.	O

Finally	O
,	O
the	O
NFR	O
/	O
N	O
strain	O
had	O
not	O
previously	O
been	O
used	O
in	O
linkage	O
analyses	O
for	O
detection	O
of	O
CIA	O
-	O
associated	O
loci	O
,	O
which	O
opened	O
(	O
up	O
)	O
the	O
possibility	O
of	O
detecting	O
new	O
polymorphic	O
genes	O
of	O
importance	O
in	O
this	O
disease	O
.	O

The	O
first	O
conclusion	O
from	O
the	O
present	O
paper	O
is	O
that	O
multiparity	O
does	O
not	O
negatively	O
influence	O
the	O
incidence	O
or	O
severity	O
of	O
CIA	O
induced	O
later	O
in	O
life	O
(	O
Table	O
2	O
)	O
.	O

This	O
is	O
in	O
agreement	O
with	O
results	O
from	O
a	O
recent	O
study	O
of	O
RA	O
in	O
women	O
,	O
which	O
similarly	O
indicates	O
that	O
previous	O
experience	O
of	O
pregnancy	O
does	O
not	O
negatively	O
affect	O
the	O
incidence	O
or	O
severity	O
of	O
RA	O
later	O
in	O
life	O
[	O
8	O
]	O
.	O

It	O
is	O
worth	O
noting	O
that	O
the	O
situation	O
is	O
quite	O
different	O
if	O
pregnancy	O
is	O
entered	O
during	O
ongoing	O
arthritis	O
.	O

This	O
will	O
normally	O
lead	O
to	O
a	O
temporary	O
remission	O
of	O
the	O
disease	O
in	O
both	O
mice	O
and	O
humans	O
,	O
followed	O
by	O
an	O
exacerbation	O
phase	O
after	O
delivery	O
[	O
7	O
,	O
10	O
,	O
11	O
]	O
.	O

The	O
second	O
conclusion	O
from	O
this	O
study	O
is	O
that	O
loci	O
of	O
possible	O
importance	O
for	O
CIA	O
have	O
been	O
detected	O
,	O
two	O
associated	O
with	O
arthritis	O
susceptibility	O
(	O
chromosomes	S-GO
1	O
and	O
11	O
)	O
and	O
one	O
associated	O
with	O
anti	O
-	O
CII	O
titers	O
(	O
chromosome	S-GO
13	O
)	O
.	O

Some	O
arthritis	O
loci	O
have	O
previously	O
been	O
identified	O
on	O
chromosome	S-GO
1	O
:	O
Cia15	O
at	O
8	O
cM	O
[	O
16	O
]	O
,	O
Cia20	O
at	O
44	O
cM	O
[	O
16	O
]	O
and	O
Cia9	O
at	O
92	O
cM	O
[	O
17	O
]	O
.	O

However	O
,	O
none	O
of	O
these	O
loci	O
appears	O
to	O
be	O
close	O
to	O
the	O
locus	O
found	O
on	O
chromosome	S-GO
1	O
in	O
the	O
present	O
study	O
.	O

The	O
newly	O
identified	O
Cia40	O
locus	O
includes	O
the	O
Ctla4	O
(	O
CD152	O
)	O
gene	O
,	O
which	O
is	O
a	O
strong	O
candidate	O
associated	O
with	O
spontaneous	O
diabetes	O
identified	O
in	O
crosses	O
between	O
C57Bl	O
and	O
nonobese	O
diabetic	O
strains	O
[	O
18	O
]	O
.	O

Analyses	O
of	O
CIA	O
in	O
crosses	O
of	O
the	O
same	O
backgrounds	O
,	O
however	O
,	O
did	O
not	O
identify	O
a	O
linkage	O
to	O
this	O
locus	O
,	O
suggesting	O
that	O
the	O
polymorphism	O
underlying	O
Cia40	O
differs	O
from	O
the	O
genes	O
associated	O
with	O
diabetes	O
[	O
18	O
]	O
.	O

Interestingly	O
,	O
Bauer	O
and	O
colleagues	O
previously	O
identified	O
a	O
locus	O
(	O
Cia28	O
)	O
associated	O
with	O
anti	O
-	O
CII	O
antibody	S-GO
production	O
at	O
53	O
cM	O
on	O
chromosome	S-GO
13	O
[	O
19	O
]	O
,	O
which	O
is	O
approximately	O
at	O
the	O
same	O
position	O
as	O
where	O
we	O
find	O
the	O
linkage	O
for	O
this	O
trait	O
in	O
the	O
present	O
study	O
.	O

It	O
is	O
therefore	O
most	O
likely	O
that	O
the	O
QTL	O
we	O
have	O
identified	O
on	O
chromosome	S-GO
13	O
is	O
the	O
same	O
as	O
Cia28	O
.	O

Since	O
the	O
possible	O
new	O
locus	O
of	O
potential	O
interest	O
on	O
chromosome	S-GO
1	O
was	O
of	O
suggestive	O
significance	O
,	O
and	O
since	O
the	O
locus	O
identified	O
on	O
chromosome	S-GO
13	O
probably	O
is	O
Cia28	O
,	O
we	O
are	O
now	O
paying	O
special	O
attention	O
to	O
the	O
significant	O
QTL	O
for	O
CIA	O
incidence	O
detected	O
at	O
60	O
-	O
70	O
cM	O
on	O
chromosome	S-GO
11	O
(	O
denoted	O
Cia40	O
)	O
.	O

No	O
other	O
CIA	O
genes	O
have	O
previously	O
been	O
typed	O
in	O
this	O
region	O
,	O
but	O
the	O
central	O
part	O
of	O
chromosome	O
11	O
is	O
known	O
to	O
contain	O
a	O
number	O
of	O
inflammation	O
loci	O
,	O
such	O
as	O
Eae22	O
,	O
Eae6b	O
,	O
Eae23	O
and	O
Eae7	O
[	O
20	O
-	O
22	O
]	O
.	O

One	O
QTL	O
for	O
proteoglycan	O
-	O
induced	O
arthritis	O
,	O
which	O
was	O
female	O
specific	O
for	O
disease	O
onset	O
,	O
have	O
also	O
been	O
found	O
on	O
chromosome	S-GO
11	O
.	O

Although	O
this	O
locus	O
(	O
Pgia28	O
)	O
is	O
not	O
located	O
in	O
the	O
vicinity	O
of	O
Cia40	O
,	O
it	O
is	O
worth	O
noting	O
[	O
23	O
]	O
.	O

The	O
mouse	O
chromosome	S-GO
11	O
contains	O
several	O
genes	O
that	O
are	O
highly	O
conserved	O
with	O
human	O
chromosome	S-GO
17	O
.	O

Linkages	O
for	O
human	O
RA	O
have	O
been	O
found	O
in	O
this	O
particular	O
region	O
[	O
24	O
]	O
.	O

Another	O
interesting	O
locus	O
is	O
Cia5	O
on	O
the	O
homolog	O
rat	O
chromosome	S-GO
10	O
,	O
which	O
regulates	O
the	O
severity	O
of	O
CIA	O
and	O
pristane	O
-	O
induced	O
arthritis	O
[	O
25	O
]	O
.	O

Interestingly	O
,	O
from	O
studies	O
with	O
the	O
same	O
cross	O
,	O
we	O
have	O
previously	O
detected	O
a	O
significant	O
QTL	O
denoted	O
Pregq2	O
for	O
the	O
trait	O
'	O
pregnancy	O
frequency	O
'	O
in	O
the	O
very	O
same	O
region	O
as	O
Cia40	O
(	O
peak	O
at	O
64	O
-	O
70	O
cM	O
on	O
chromosome	S-GO
11	O
)	O
(	O
Liljander	O
M	O
,	O
S	O
a	O
llstr	O
o	O
m	O
MA	O
,	O
Andersson	O
S	O
,	O
Wernhoff	O
P	O
,	O
Andersson	O
A	O
,	O
Holmdahl	O
R	O
,	O
Mattsson	O
R	O
,	O
unpublished	O
data	O
)	O
.	O

This	O
means	O
that	O
this	O
region	O
contains	O
genes	O
affecting	O
the	O
CIA	O
incidence	O
in	O
multiparous	O
mice	O
in	O
addition	O
to	O
the	O
rate	O
of	O
successful	O
deliveries	O
in	O
female	O
mice	O
.	O

The	O
'	O
pregnancy	O
rate	O
'	O
in	O
mice	O
is	O
defined	O
as	O
successful	O
pregnancies	O
per	O
detected	O
vaginal	O
plug	O
,	O
a	O
phenotype	O
associated	O
with	O
early	O
pregnancy	O
failure	O
,	O
which	O
in	O
turn	O
possibly	O
could	O
have	O
an	O
inflammatory	O
cause	O
.	O

We	O
cannot	O
exclude	O
that	O
the	O
same	O
gene	O
(	O
s	O
)	O
are	O
affecting	O
both	O
these	O
traits	O
.	O

Conclusion	O

Our	O
results	O
show	O
that	O
multiparity	O
does	O
not	O
negatively	O
influence	O
the	O
incidence	O
or	O
severity	O
of	O
CIA	O
induced	O
later	O
in	O
life	O
.	O

Furthermore	O
,	O
two	O
new	O
loci	O
linked	O
to	O
CIA	O
susceptibility	O
were	O
detected	O
on	O
chromosome	S-GO
11	O
(	O
Cia40	O
)	O
and	O
on	O
chromosome	S-GO
1	O
.	O

We	O
detected	O
on	O
chromosome	S-GO
13	O
a	O
locus	O
associated	O
with	O
anti	O
-	O
CII	O
titers	O
,	O
which	O
probably	O
is	O
the	O
same	O
as	O
the	O
recently	O
reported	O
Cia28	O
[	O
19	O
]	O
.	O

Abbreviations	O

CIA	O
=	O
collagen	O
-	O
induced	O
arthritis	O
;	O
CII	O
=	O
collagen	O
type	O
II	O
;	O
LOD	O
=	O
logarithm	O
of	O
the	O
odds	O
;	O
MHC	S-GO
=	O
major	B-GO
histocompatibility	I-GO
complex	E-GO
;	O
PCR	O
=	O
polymerase	O
chain	O
reaction	O
;	O
QTL	O
=	O
quantitative	O
trait	O
locus	O
;	O
RA	O
=	O
rheumatoid	O
arthritis	O
.	O

Competing	O
interests	O

The	O
authors	O
declare	O
that	O
they	O
have	O
no	O
competing	O
interest	O
.	O

Authors	O
'	O
contributions	O

ML	O
is	O
responsible	O
for	O
genotyping	O
,	O
phenotyping	O
,	O
analyses	O
and	O
,	O
together	O
with	O
RM	O
,	O
for	O
interpretation	O
and	O
for	O
writing	O
the	O
manuscript	O
.	O

M	O
-	O
AS	O
and	O
SA	O
have	O
contributed	O
to	O
collection	O
of	O
phenotype	O
data	O
.	O

RM	O
,	O
A	O
A	O
,	O
RH	O
and	O
ML	O
designed	O
the	O
study	O
.	O

All	O
authors	O
read	O
and	O
approved	O
the	O
final	O
manuscript	O
.	O

Acknowledgements	O

This	O
study	O
was	O
supported	O
by	O
O	O
sterlund	O
'	O
s	O
fund	O
,	O
Crafoord	O
'	O
s	O
fund	O
,	O
the	O
Gustav	O
V	O
80	O
Year	O
Foundation	O
,	O
the	O
Royal	O
Physiographic	O
Society	O
in	O
Lund	O
and	O
by	O
Swegene	O
.	O

Figures	O
and	O
Tables	O

Figure	O
1	O

The	O
accumulated	O
incidence	O
of	O
arthritis	O
in	O
the	O
parental	O
strains	O
(	O
NFR	O
/	O
N	O
and	O
B10	O
.	O
Q	O
)	O
of	O
female	O
mice	O
.	O

Figure	O
2	O

Chromosomal	O
locations	O
of	O
the	O
quantitative	O
trait	O
loci	O
(	O
QTL	O
)	O
for	O
collagen	O
-	O
induced	O
arthritis	O
incidence	O
on	O
chromosomes	S-GO
1	O
and	O
11	O
.	O

QTL	O
for	O
collagen	O
type	O
II	O
(	O
CII	O
)	O
antibody	S-GO
titers	O
are	O
illustrated	O
on	O
chromosome	S-GO
13	O
.	O

*	O
Suggestive	O
level	O
threshold	O
(	O
P	O
=	O
0	O
.	O
63	O
)	O
according	O
to	O
the	O
permutation	O
test	O
(	O
n	O
=	O
1	O
,	O
000	O
)	O
.	O

*	O
*	O
Significance	O
level	O
threshold	O
(	O
P	O
=	O
0	O
.	O
05	O
)	O
according	O
to	O
the	O
permutation	O
test	O
(	O
n	O
=	O
1	O
,	O
000	O
)	O
.	O

Table	O
1	O

Severity	O
of	O
arthritis	O
and	O
anti	O
-	O
collagen	O
type	O
II	O
(	O
anti	O
-	O
CII	O
)	O
titers	O
in	O
(	O
NFR	O
/	O
N	O
x	O
B10	O
.	O
Q	O
)	O
x	O
B10	O
.	O
Q	O
female	O
mice	O
and	O
parental	O
strains	O

aMedian	O
value	O
on	O
the	O
days	O
of	O
onset	O
when	O
calculated	O
in	O
all	O
arthritic	O
mice	O
in	O
the	O
group	O
on	O
day	O
100	O
(	O
maximum	O
-	O
minimum	O
values	O
in	O
the	O
series	O
)	O
.	O

bMean	O
+/-	O
standard	O
error	O
of	O
the	O
maximum	O
score	O
from	O
all	O
arthritic	O
mice	O
in	O
the	O
respective	O
group	O
.	O

cSignificantly	O
higher	O
than	O
in	O
B10	O
.	O
Q	O
mice	O
(	O
P	O
=	O
0	O
.	O
02	O
in	O
Student	O
'	O
s	O
unpaired	O
t	O
test	O
)	O
.	O

Table	O
2	O

Incidence	O
,	O
onset	O
and	O
maximum	O
score	O
in	O
(	O
NFR	O
/	O
N	O
x	O
B10	O
.	O
Q	O
)	O
x	O
B10	O
.	O
Q	O
female	O
mice	O

aMedian	O
value	O
on	O
the	O
days	O
of	O
onset	O
when	O
calculated	O
in	O
all	O
arthritic	O
mice	O
in	O
the	O
group	O
(	O
maximum	O
-	O
minimum	O
values	O
in	O
the	O
series	O
)	O
.	O

bMean	O
(	O
+/-	O
standard	O
error	O
)	O
of	O
the	O
maximum	O
score	O
from	O
all	O
arthritic	O
mice	O
in	O
the	O
respective	O
group	O
on	O
day	O
100	O
.	O

Table	O
3	O

Distribution	O
of	O
genotypes	O
between	O
affected	O
and	O
unaffected	O
N2	O
mice	O
at	O
different	O
loci	O
linked	O
to	O
clinical	O
phenotypes	O
of	O
collagen	O
-	O
induced	O
arthritis	O

*	O
Suggestive	O
significance	O
,	O
*	O
*	O
significant	O
.	O

Cloning	O
and	O
characterization	O
of	O
mr	O
-	O
s	O
,	O
a	O
novel	O
SAM	O
domain	O
protein	O
,	O
predominantly	O
expressed	O
in	O
retinal	O
photoreceptor	O
cells	O

Abstract	O

Background	O

Sterile	O
alpha	O
motif	O
(	O
SAM	O
)	O
domains	O
are	O
~	O
70	O
residues	O
long	O
and	O
have	O
been	O
reported	O
as	O
common	O
protein	O
-	O
protein	O
interaction	O
modules	O
.	O

This	O
domain	O
is	O
found	O
in	O
a	O
large	O
number	O
of	O
proteins	O
,	O
including	O
Polycomb	O
group	O
(	O
PcG	O
)	O
proteins	O
and	O
ETS	O
family	O
transcription	O
factors	O
.	O

In	O
this	O
work	O
,	O
we	O
report	O
the	O
cloning	O
and	O
functional	O
characterization	O
of	O
a	O
novel	O
SAM	O
domain	O
-	O
containing	O
protein	O
,	O
which	O
is	O
predominantly	O
expressed	O
in	O
retinal	O
photoreceptors	O
and	O
the	O
pineal	O
gland	O
and	O
is	O
designated	O
mouse	O
mr	O
-	O
s	O
(	O
major	O
retinal	O
SAM	O
domain	O
protein	O
)	O
.	O

Results	O

mr	O
-	O
s	O
is	O
evolutionarily	O
conserved	O
from	O
zebrafish	O
through	O
human	O
,	O
organisms	O
through	O
which	O
the	O
mechanism	O
of	O
photoreceptor	O
development	O
is	O
also	O
highly	O
conserved	O
.	O

Phylogenetic	O
analysis	O
suggests	O
that	O
the	O
SAM	O
domain	O
of	O
mr	O
-	O
s	O
is	O
most	O
closely	O
related	O
to	O
a	O
mouse	O
polyhomeotic	O
(	O
ph	O
)	O
ortholog	O
,	O
Mph1	O
/	O
Rae28	O
,	O
which	O
is	O
known	O
as	O
an	O
epigenetic	O
molecule	O
involved	O
in	O
chromatin	S-GO
modifications	O
.	O

These	O
findings	O
provide	O
the	O
possibility	O
that	O
mr	O
-	O
s	O
may	O
play	O
a	O
critical	O
role	O
by	O
regulating	O
gene	O
expression	O
in	O
photoreceptor	O
development	O
.	O

mr	O
-	O
s	O
is	O
preferentially	O
expressed	O
in	O
the	O
photoreceptors	O
at	O
postnatal	O
day	O
3	O
-	O
6	O
(	O
P3	O
-	O
6	O
)	O
,	O
when	O
photoreceptors	O
undergo	O
terminal	O
differentiation	O
,	O
and	O
in	O
the	O
adult	O
pineal	O
gland	O
.	O

Transcription	O
of	O
mr	O
-	O
s	O
is	O
directly	O
regulated	O
by	O
the	O
cone	O
-	O
rod	O
homeodomain	O
protein	O
Crx	O
.	O

Immunoprecipitation	O
assay	O
showed	O
that	O
the	O
mr	O
-	O
s	O
protein	O
self	O
-	O
associates	O
mainly	O
through	O
the	O
SAM	O
domain	O
-	O
containing	O
region	O
as	O
well	O
as	O
ph	O
.	O

The	O
mr	O
-	O
s	O
protein	O
localizes	O
mainly	O
in	O
the	O
nucleus	S-GO
,	O
when	O
mr	O
-	O
s	O
is	O
overexpressed	O
in	O
HEK293T	O
cells	O
.	O

Moreover	O
,	O
in	O
the	O
luciferase	O
assays	O
,	O
we	O
found	O
that	O
mr	O
-	O
s	O
protein	O
fused	O
to	O
GAL4	O
DNA	O
-	O
binding	O
domain	O
functions	O
as	O
a	O
transcriptional	O
repressor	O
.	O

We	O
revealed	O
that	O
the	O
repression	O
activity	O
of	O
mr	O
-	O
s	O
is	O
not	O
due	O
to	O
a	O
homophilic	O
interaction	O
through	O
its	O
SAM	O
domain	O
but	O
to	O
the	O
C	O
-	O
terminal	O
region	O
.	O

Conclusion	O

We	O
identified	O
a	O
novel	O
gene	O
,	O
mr	O
-	O
s	O
,	O
which	O
is	O
predominantly	O
expressed	O
in	O
retinal	O
photoreceptors	O
and	O
pineal	O
gland	O
.	O

Based	O
on	O
its	O
expression	O
pattern	O
and	O
biochemical	O
analysis	O
,	O
we	O
predict	O
that	O
mr	O
-	O
s	O
may	O
function	O
as	O
a	O
transcriptional	O
repressor	O
in	O
photoreceptor	O
cells	O
and	O
in	O
pinealocytes	O
of	O
the	O
pineal	O
gland	O
.	O

Background	O

In	O
the	O
development	O
of	O
the	O
mammalian	O
retina	O
,	O
a	O
diverse	O
range	O
of	O
cell	O
types	O
is	O
generated	O
from	O
a	O
pool	O
of	O
multipotent	O
retinal	O
progenitor	O
cells	O
.	O

Among	O
these	O
cell	O
types	O
,	O
photoreceptors	O
account	O
for	O
over	O
70	O
%	O
of	O
all	O
cells	O
in	O
the	O
retina	O
.	O

In	O
vertebrates	O
,	O
there	O
are	O
two	O
classes	O
of	O
photoreceptors	O
,	O
rods	O
and	O
cones	O
.	O

Rods	O
are	O
sensors	O
of	O
dim	O
light	O
,	O
while	O
cones	O
function	O
in	O
bright	O
light	O
and	O
are	O
responsible	O
for	O
color	O
vision	O
.	O

Phototransduction	O
,	O
a	O
series	O
of	O
signal	O
amplifications	O
detecting	O
a	O
single	O
photon	O
of	O
light	O
,	O
is	O
initiated	O
by	O
the	O
capture	O
of	O
light	O
with	O
11	O
-	O
cis	O
-	O
retinal	O
,	O
a	O
chromophore	O
bound	O
by	O
the	O
opsin	O
proteins	O
:	O
rhodopsin	O
in	O
rods	O
and	O
cone	O
opsins	O
in	O
cones	O
.	O

The	O
proteins	O
that	O
carry	O
out	O
phototransduction	O
are	O
located	O
in	O
an	O
elaborate	O
and	O
highly	O
specialized	O
membranous	S-GO
structure	O
,	O
the	O
outer	B-GO
segment	E-GO
.	O

The	O
outer	B-GO
segment	E-GO
appears	O
to	O
be	O
relatively	O
fragile	O
,	O
degenerating	O
in	O
response	O
to	O
many	O
environmental	O
and	O
/	O
or	O
genetic	O
perturbations	O
.	O

In	O
the	O
rodent	O
retina	O
,	O
the	O
production	O
of	O
specific	O
cell	O
types	O
during	O
development	O
progresses	O
in	O
a	O
general	O
order	O
[	O
1	O
,	O
2	O
]	O
.	O

Rod	O
photoreceptor	O
generation	O
peaks	O
around	O
the	O
time	O
of	O
birth	O
.	O

Cone	O
photoreceptors	O
,	O
ganglion	O
cells	O
,	O
horizontal	O
cells	O
and	O
amacrine	O
cells	O
are	O
generated	O
earlier	O
,	O
while	O
M	O
u	O
ller	O
glia	O
and	O
bipolar	O
cells	O
are	O
generated	O
later	O
.	O

This	O
production	O
of	O
different	O
cell	O
types	O
at	O
different	O
times	O
appears	O
to	O
derive	O
from	O
differences	O
in	O
the	O
intrinsic	O
properties	O
of	O
progenitor	O
cells	O
involved	O
in	O
the	O
transcription	O
or	O
chromatin	S-GO
modification	O
.	O

Recent	O
studies	O
identified	O
several	O
important	O
transcription	O
factors	O
of	O
photoreceptor	O
development	O
[	O
3	O
-	O
7	O
]	O
.	O

Two	O
Otx	O
family	O
homeobox	O
genes	O
,	O
Otx2	O
and	O
Crx	O
,	O
play	O
essential	O
roles	O
in	O
early	O
cell	O
fate	O
determination	O
and	O
terminal	O
differentiation	O
of	O
photoreceptors	O
[	O
3	O
,	O
8	O
,	O
9	O
]	O
.	O

In	O
the	O
absence	O
of	O
Otx2	O
function	O
,	O
differentiating	O
photoreceptor	O
cells	O
are	O
converted	O
to	O
amacrine	O
-	O
like	O
neurons	O
[	O
9	O
]	O
.	O

Crx	O
,	O
a	O
downstream	O
target	O
of	O
Otx2	O
,	O
controls	O
the	O
transcription	O
of	O
various	O
photoreceptor	O
cell	O
-	O
specific	O
genes	O
and	O
is	O
essential	O
for	O
the	O
formation	O
of	O
outer	B-GO
segments	E-GO
,	O
synaptic	S-GO
terminals	S-GO
,	O
and	O
phototransduction	O
pathways	O
[	O
8	O
,	O
10	O
]	O
.	O

Crx	O
transcripts	O
begin	O
to	O
be	O
expressed	O
in	O
developing	O
photoreceptors	O
at	O
embryonic	O
day	O
12	O
.	O
5	O
(	O
E12	O
.	O
5	O
)	O
in	O
the	O
mouse	O
and	O
a	O
strong	O
upregulation	O
of	O
Crx	O
transcription	O
is	O
apparent	O
across	O
the	O
differentiating	O
photoreceptors	O
at	O
postnatal	O
day	O
6	O
(	O
P6	O
)	O
.	O

Photoreceptor	O
cells	O
in	O
the	O
Crx	O
knockout	O
(	O
KO	O
)	O
mice	O
exhibit	O
a	O
dramatic	O
reduction	O
of	O
many	O
photoreceptor	O
molecules	O
including	O
visual	O
pigments	O
and	O
develop	O
neither	O
photoreceptor	B-GO
outer	I-GO
segments	E-GO
nor	O
a	O
synaptic	S-GO
terminus	S-GO
[	O
8	O
,	O
10	O
]	O
.	O

In	O
addition	O
,	O
mutations	O
of	O
human	O
CRX	O
have	O
been	O
demonstrated	O
to	O
be	O
associated	O
with	O
three	O
types	O
of	O
photoreceptor	O
diseases	O
:	O
autosomal	S-GO
dominant	O
cone	O
-	O
rod	O
dystrophy	O
2	O
,	O
autosomal	S-GO
dominant	O
-	O
type	O
retinitis	O
pigmentosa	O
,	O
and	O
Leber	O
'	O
s	O
congenital	O
amaurosis	O
(	O
LCA	O
)	O
[	O
11	O
-	O
14	O
]	O
.	O

While	O
Otx2	O
and	O
Crx	O
control	O
general	O
photoreceptor	O
development	O
,	O
three	O
other	O
transcription	O
factors	O
,	O
TR	O
beta	O
2	O
,	O
Nrl	O
,	O
and	O
Nr2e3	O
regulate	O
the	O
specification	O
of	O
photoreceptor	O
cell	O
types	O
[	O
4	O
,	O
5	O
,	O
7	O
]	O
.	O

SAM	O
domains	O
(	O
also	O
known	O
as	O
Pointed	O
,	O
HLH	O
,	O
or	O
SPM	O
domains	O
)	O
are	O
~	O
70	O
residues	O
long	O
and	O
have	O
been	O
reported	O
as	O
common	O
protein	O
-	O
protein	O
interaction	O
modules	O
[	O
15	O
-	O
17	O
]	O
.	O

This	O
domain	O
is	O
found	O
in	O
a	O
large	O
number	O
of	O
proteins	O
,	O
including	O
Polycomb	O
group	O
(	O
PcG	O
)	O
proteins	O
[	O
18	O
]	O
,	O
serine	O
threonine	O
kinases	O
[	O
19	O
]	O
,	O
Eph	O
family	O
receptor	O
tyrosine	O
kinases	O
[	O
20	O
]	O
,	O
the	O
p73	O
tumor	O
suppressor	O
[	O
21	O
]	O
,	O
the	O
RNA	O
-	O
binding	O
protein	O
Smaug	O
[	O
22	O
]	O
,	O
diacylglycerol	O
kinases	O
[	O
23	O
,	O
24	O
]	O
,	O
yeast	O
mating	O
type	O
signaling	O
proteins	O
[	O
19	O
,	O
25	O
]	O
and	O
ETS	O
family	O
transcription	O
factors	O
[	O
26	O
,	O
27	O
]	O
.	O

The	O
PcG	O
proteins	O
are	O
transcriptional	O
repressors	O
that	O
maintain	O
gene	O
silencing	O
during	O
development	O
[	O
28	O
-	O
30	O
]	O
.	O

In	O
mammals	O
,	O
PcG	O
proteins	O
are	O
also	O
implicated	O
in	O
Hox	O
gene	O
regulation	O
.	O

Their	O
biological	O
activity	O
lies	O
in	O
stable	O
silencing	O
of	O
specific	O
sets	O
of	O
genes	O
through	O
chromatin	S-GO
modifications	O
.	O

A	O
member	O
of	O
polycomb	B-GO
repressive	I-GO
complex	I-GO
1	E-GO
(	O
PRC1	S-GO
)	O
,	O
ph	O
,	O
contains	O
a	O
SAM	O
domain	O
at	O
the	O
C	O
-	O
terminal	O
,	O
and	O
PRC1	B-GO
complex	E-GO
is	O
known	O
to	O
form	O
helical	O
,	O
head	O
-	O
to	O
-	O
tail	O
polymers	O
through	O
its	O
SAM	O
domain	O
[	O
31	O
]	O
.	O

These	O
polymeric	O
structures	O
mediate	O
the	O
formation	O
of	O
a	O
higher	O
order	O
chromatin	B-GO
structure	E-GO
and	O
possibly	O
stabilize	O
the	O
repressed	O
state	O
of	O
Hox	O
genes	O
.	O

In	O
this	O
study	O
,	O
we	O
identified	O
a	O
novel	O
gene	O
,	O
mr	O
-	O
s	O
,	O
which	O
encodes	O
a	O
SAM	O
domain	O
-	O
containing	O
protein	O
.	O

The	O
SAM	O
domain	O
of	O
mr	O
-	O
s	O
is	O
most	O
closely	O
related	O
to	O
that	O
of	O
ph	O
mouse	O
ortholog	O
,	O
MPH1	O
/	O
Rae28	O
.	O

mr	O
-	O
s	O
is	O
predominantly	O
expressed	O
in	O
retinal	O
photoreceptors	O
when	O
they	O
undergo	O
terminal	O
differentiation	O
,	O
and	O
adult	O
pineal	O
gland	O
.	O

The	O
expression	O
of	O
mr	O
-	O
s	O
is	O
directly	O
regulated	O
by	O
Crx	O
.	O

Moreover	O
,	O
mr	O
-	O
s	O
is	O
localized	O
in	O
the	O
nucleus	S-GO
and	O
can	O
self	O
-	O
associate	O
through	O
its	O
SAM	O
domain	O
-	O
containing	O
region	O
.	O

We	O
also	O
found	O
that	O
mr	O
-	O
s	O
protein	O
fused	O
to	O
GAL4	O
DNA	O
-	O
binding	O
domain	O
functions	O
as	O
a	O
transcriptional	O
repressor	O
.	O

These	O
findings	O
suggest	O
that	O
mr	O
-	O
s	O
functions	O
as	O
a	O
member	O
of	O
a	O
transcriptional	B-GO
repressor	I-GO
complex	E-GO
in	O
retinal	O
photoreceptor	O
development	O
.	O

Results	O

Cloning	O
of	O
mouse	O
mr	O
-	O
s	O

In	O
order	O
to	O
identify	O
novel	O
mouse	O
genes	O
preferentially	O
expressed	O
in	O
the	O
developing	O
retina	O
,	O
we	O
screened	O
the	O
National	O
Institute	O
for	O
Biotechnology	O
Information	O
(	O
NCBI	O
)	O
database	O
,	O
UniGene	O
,	O
using	O
Digital	O
Differential	O
Display	O
(	O
DDD	O
)	O
and	O
found	O
EST	O
fragments	O
which	O
are	O
frequently	O
present	O
in	O
mouse	O
retinal	O
cDNA	O
libraries	O
.	O

We	O
found	O
that	O
one	O
clone	O
in	O
these	O
cDNAs	O
encodes	O
a	O
protein	O
containing	O
a	O
SAM	O
domain	O
related	O
to	O
that	O
of	O
polyhomeotic	O
protein	O
.	O

A	O
PCR	O
fragment	O
corresponding	O
to	O
this	O
mouse	O
clone	O
was	O
used	O
to	O
screen	O
a	O
mouse	O
P0	O
-	O
P3	O
retinal	O
cDNA	O
library	O
to	O
obtain	O
a	O
full	O
-	O
length	O
cDNA	O
clone	O
.	O

Sequence	O
analysis	O
showed	O
that	O
this	O
cDNA	O
was	O
a	O
novel	O
gene	O
encoding	O
a	O
SAM	O
domain	O
-	O
containing	O
protein	O
.	O

We	O
referred	O
to	O
this	O
protein	O
as	O
mr	O
-	O
s	O
(	O
major	O
retinal	O
SAM	O
domain	O
protein	O
)	O
.	O

As	O
shown	O
in	O
Fig	O
.	O

1A	O
,	O
a	O
translation	O
initiation	O
codon	O
is	O
present	O
in	O
the	O
same	O
open	O
reading	O
frame	O
as	O
the	O
SAM	O
domain	O
.	O

This	O
initiation	O
site	O
shows	O
similarity	O
to	O
the	O
consensus	O
sequence	O
proposed	O
by	O
Kozak	O
[	O
32	O
]	O
including	O
the	O
presence	O
of	O
the	O
highly	O
conserved	O
purine	O
at	O
position	O
-	O
3	O
.	O

The	O
stop	O
codon	O
of	O
the	O
predicted	O
mr	O
-	O
s	O
protein	O
is	O
also	O
indicated	O
in	O
Fig	O
.	O

1A	O
.	O

The	O
amino	O
acid	O
sequence	O
of	O
the	O
SAM	O
domain	O
of	O
mr	O
-	O
s	O
protein	O
(	O
Fig	O
.	O
1A	O
,	O
boxed	O
sequence	O
)	O
exhibits	O
homology	O
with	O
SAM	O
domains	O
of	O
EphB2	O
,	O
EphA4	O
,	O
MPH1	O
,	O
TEL	O
and	O
Smaug	O
(	O
Fig	O
.	O
1B	O
)	O
.	O

By	O
phylogenetic	O
analysis	O
,	O
the	O
SAM	O
domain	O
of	O
mr	O
-	O
s	O
is	O
most	O
closely	O
related	O
to	O
that	O
of	O
Mph1	O
/	O
Rae28	O
,	O
a	O
mouse	O
homolog	O
of	O
ph	O
(	O
Fig	O
.	O
1C	O
)	O
.	O

Mouse	O
mr	O
-	O
s	O
protein	O
is	O
conserved	O
in	O
rat	O
,	O
human	O
,	O
chick	O
and	O
zebrafish	O
,	O
which	O
display	O
91	O
%	O
,	O
70	O
%	O
,	O
36	O
%	O
and	O
26	O
%	O
identity	O
with	O
mouse	O
mr	O
-	O
s	O
,	O
respectively	O
(	O
Fig	O
.	O
1D	O
)	O
.	O

The	O
SAM	O
domains	O
of	O
rat	O
,	O
human	O
,	O
chick	O
and	O
zebrafish	O
mr	O
-	O
s	O
protein	O
are	O
highly	O
conserved	O
and	O
display	O
96	O
%	O
,	O
90	O
%	O
,	O
76	O
%	O
and	O
72	O
%	O
identity	O
with	O
the	O
SAM	O
domain	O
of	O
mouse	O
mr	O
-	O
s	O
protein	O
.	O

The	O
chromosomal	O
localizations	O
of	O
mouse	O
and	O
human	O
mr	O
-	O
s	O
genes	O
were	O
determined	O
by	O
searching	O
the	O
mouse	O
and	O
human	O
genome	O
databases	O
(	O
NCBI	O
)	O
,	O
respectively	O
.	O

Mouse	O
mr	O
-	O
s	O
is	O
mapped	O
to	O
chromosome	S-GO
4E2	O
,	O
and	O
human	O
MR	O
-	O
S	O
is	O
mapped	O
to	O
chromosome	S-GO
1p36	O
.	O
33	O
.	O

LCA	O
is	O
the	O
most	O
common	O
cause	O
of	O
inherited	O
childhood	O
blindness	O
.	O

Human	O
MR	O
-	O
S	O
maps	O
in	O
the	O
vicinity	O
region	O
of	O
the	O
LCA9	O
,	O
recently	O
identified	O
as	O
a	O
new	O
locus	O
for	O
LCA	O
[	O
33	O
]	O
.	O

Figure	O
1	O

mr	O
-	O
s	O
nucleotide	O
and	O
amino	O
acid	O
sequences	O
.	O

(	O
A	O
)	O
mr	O
-	O
s	O
nucleotide	O
and	O
amino	O
acids	O
sequences	O
.	O

Boxed	O
amino	O
acids	O
are	O
the	O
SAM	O
domain	O
sequence	O
and	O
the	O
dashed	O
box	O
indicates	O
a	O
putative	O
nuclear	S-GO
localization	O
signal	O
.	O

The	O
underline	O
indicates	O
a	O
putative	O
polyadenylation	O
termination	O
signal	O
.	O

(	O
B	O
)	O
Alignment	O
of	O
SAM	O
domain	O
sequences	O
for	O
SAM	O
domain	O
-	O
containing	O
proteins	O
.	O

The	O
five	O
alpha	O
helices	O
are	O
marked	O
H1	O
-	O
H5	O
.	O

Conserved	O
amino	O
acid	O
residues	O
are	O
shown	O
with	O
a	O
dark	O
shadow	O
and	O
functionally	O
similar	O
residues	O
are	O
shown	O
with	O
a	O
light	O
shadow	O
.	O

The	O
sites	O
that	O
were	O
targeted	O
for	O
mutagenesis	O
are	O
indicated	O
by	O
arrows	O
.	O

(	O
C	O
)	O
Phylogenetic	O
tree	O
of	O
SAM	O
domain	O
-	O
containing	O
proteins	O
.	O

Amino	O
acid	O
sequences	O
were	O
analyzed	O
by	O
the	O
neighbor	O
-	O
joining	O
method	O
in	O
MacVector	O
7	O
.	O
2	O
.	O

Branch	O
lengths	O
reflect	O
the	O
mean	O
number	O
of	O
substitutions	O
per	O
site	O
.	O

(	O
D	O
)	O
Schematic	O
comparison	O
of	O
the	O
amino	O
acid	O
sequences	O
for	O
mouse	O
,	O
rat	O
,	O
human	O
,	O
chick	O
and	O
zebrafish	O
mr	O
-	O
s	O
proteins	O
.	O

The	O
percent	O
similarity	O
of	O
the	O
SAM	O
domains	O
and	O
other	O
regions	O
to	O
the	O
corresponding	O
regions	O
of	O
the	O
mouse	O
protein	O
is	O
shown	O
.	O

Overall	O
sequence	O
similarity	O
with	O
the	O
mouse	O
protein	O
is	O
shown	O
on	O
the	O
right	O
.	O

Expression	O
of	O
mr	O
-	O
s	O
in	O
the	O
developing	O
retina	O
and	O
the	O
pineal	O
gland	O

To	O
investigate	O
mr	O
-	O
s	O
expression	O
,	O
we	O
first	O
performed	O
whole	O
mount	O
in	O
situ	O
hybridization	O
in	O
mouse	O
embryos	O
.	O

No	O
hybridization	O
signal	O
was	O
detected	O
at	O
E9	O
.	O
5	O
,	O
E10	O
.	O
5	O
and	O
E11	O
.	O
5	O
with	O
an	O
mr	O
-	O
s	O
probe	O
(	O
data	O
not	O
shown	O
)	O
.	O

We	O
then	O
investigated	O
the	O
expression	O
of	O
the	O
mr	O
-	O
s	O
gene	O
in	O
the	O
developing	O
retina	O
by	O
section	O
in	O
situ	O
hybridization	O
(	O
Fig	O
.	O
1A	O
-	O
G	O
)	O
.	O

No	O
significant	O
signal	O
was	O
detected	O
in	O
the	O
developing	O
retina	O
at	O
E13	O
(	O
Fig	O
.	O
2A	O
)	O
.	O

A	O
weak	O
signal	O
was	O
initially	O
detected	O
in	O
the	O
outer	O
aspect	O
of	O
the	O
neuroblastic	O
layer	O
(	O
NBL	O
)	O
,	O
a	O
presumptive	O
photoreceptor	O
layer	O
at	O
E18	O
(	O
Fig	O
.	O
2B	O
,	O
arrow	O
)	O
.	O

At	O
P3	O
,	O
an	O
mr	O
-	O
s	O
transcript	O
was	O
clearly	O
detected	O
in	O
the	O
developing	O
photoreceptor	O
layer	O
(	O
Fig	O
.	O
2E	O
)	O
.	O

At	O
P6	O
,	O
mr	O
-	O
s	O
showed	O
peak	O
expression	O
in	O
the	O
photoreceptor	O
layer	O
(	O
Fig	O
.	O
2F	O
)	O
.	O

This	O
pattern	O
correlates	O
with	O
the	O
rapid	O
increase	O
in	O
cells	O
expressing	O
rhodopsin	O
and	O
other	O
phototransduction	O
genes	O
between	O
P6	O
-	O
P8	O
[	O
34	O
-	O
37	O
]	O
.	O

At	O
P9	O
,	O
the	O
intensity	O
of	O
the	O
mr	O
-	O
s	O
signal	O
was	O
significantly	O
reduced	O
but	O
was	O
localized	O
to	O
the	O
outer	O
nuclear	O
layer	O
(	O
ONL	O
)	O
(	O
data	O
not	O
shown	O
)	O
.	O

Faint	O
expression	O
of	O
mr	O
-	O
s	O
mRNA	O
was	O
observed	O
in	O
mature	O
photoreceptors	O
in	O
the	O
adult	O
retina	O
(	O
Fig	O
.	O
2G	O
)	O
.	O

Figure	O
2	O

mr	O
-	O
s	O
expression	O
in	O
developing	O
mouse	O
retina	O
and	O
pineal	O
gland	O
.	O

(	O
A	O
-	O
G	O
)	O
mr	O
-	O
s	O
expression	O
during	O
development	O
of	O
the	O
mouse	O
retina	O
.	O

The	O
in	O
situ	O
hybridization	O
signal	O
of	O
mr	O
-	O
s	O
was	O
not	O
detected	O
at	O
E13	O
(	O
A	O
)	O
.	O

The	O
signal	O
(	O
arrow	O
)	O
was	O
first	O
detected	O
in	O
the	O
outer	O
aspect	O
of	O
NBL	O
at	O
E18	O
(	O
B	O
)	O
.	O

A	O
strong	O
mr	O
-	O
s	O
signal	O
was	O
detected	O
in	O
outer	O
layer	O
of	O
the	O
retina	O
at	O
P3	O
-	O
P6	O
,	O
and	O
then	O
the	O
signal	O
decreased	O
in	O
the	O
adult	O
retina	O
(	O
E	O
-	O
G	O
)	O
.	O

Control	O
with	O
the	O
sense	O
probe	O
in	O
E18	O
retina	O
is	O
shown	O
(	O
C	O
)	O
.	O

Scale	O
bar	O
,	O
100	O
mu	O
m	O
.	O

(	O
H	O
)	O
Northern	O
blot	O
analysis	O
of	O
mr	O
-	O
s	O
expression	O
in	O
adult	O
mouse	O
organs	O
.	O

The	O
arrow	O
corresponds	O
to	O
2	O
.	O
2kb	O
mr	O
-	O
s	O
transcript	O
.	O

(	O
I	O
)	O
RT	O
-	O
PCR	O
analysis	O
of	O
total	O
RNAs	O
extracted	O
from	O
E13	O
whole	O
embryo	O
,	O
P0	O
whole	O
body	O
(	O
except	O
for	O
the	O
eye	O
)	O
,	O
P7	O
retina	O
,	O
P7	O
pineal	O
gland	O
,	O
P7	O
brain	O
,	O
P7	O
liver	O
,	O
adult	O
retina	O
,	O
adult	O
pineal	O
gland	O
,	O
adult	O
brain	O
and	O
adult	O
liver	O
,	O
respectively	O
.	O

RPE	O
,	O
retinal	O
pigment	O
epithelium	O
;	O
NR	O
,	O
neural	O
retina	O
;	O
NBL	O
,	O
neuroblastic	O
layer	O
;	O
GCL	O
,	O
ganglion	O
cell	O
layer	O
;	O
ONL	O
,	O
outer	O
nuclear	O
layer	O
;	O
INL	O
,	O
inner	O
nuclear	O
layer	O
.	O

To	O
determine	O
the	O
tissue	O
specificity	O
of	O
mr	O
-	O
s	O
expression	O
,	O
the	O
expression	O
of	O
the	O
mr	O
-	O
s	O
gene	O
in	O
various	O
adult	O
tissues	O
was	O
examined	O
by	O
Northern	O
hybridization	O
(	O
Fig	O
.	O
2H	O
)	O
.	O

As	O
a	O
control	O
,	O
P7	O
retinal	O
RNA	O
was	O
used	O
.	O

Four	O
bands	O
corresponding	O
to	O
7	O
.	O
2	O
-	O
kb	O
,	O
4	O
.	O
0	O
-	O
kb	O
,	O
2	O
.	O
5	O
-	O
kb	O
and	O
2	O
.	O
2	O
-	O
kb	O
were	O
detected	O
in	O
P7	O
retina	O
.	O

The	O
2	O
.	O
2	O
-	O
kb	O
band	O
corresponds	O
to	O
the	O
cDNA	O
characterized	O
in	O
this	O
study	O
.	O

The	O
larger	O
bands	O
,	O
possibly	O
alternative	O
spliced	O
transcripts	O
,	O
have	O
not	O
yet	O
been	O
characterized	O
.	O

The	O
mr	O
-	O
s	O
probe	O
did	O
not	O
detect	O
a	O
band	O
in	O
the	O
adult	O
tissues	O
examined	O
,	O
indicating	O
that	O
these	O
tissues	O
do	O
not	O
express	O
mr	O
-	O
s	O
at	O
a	O
level	O
comparable	O
to	O
that	O
of	O
the	O
developing	O
retina	O
.	O

Previous	O
reports	O
revealed	O
that	O
many	O
photoreceptor	O
-	O
specific	O
genes	O
are	O
also	O
expressed	O
in	O
the	O
pineal	O
gland	O
[	O
38	O
]	O
.	O

We	O
examined	O
the	O
expression	O
of	O
mr	O
-	O
s	O
transcripts	O
in	O
the	O
whole	O
embryo	O
,	O
whole	O
body	O
,	O
retina	O
,	O
pineal	O
gland	O
,	O
brain	O
,	O
liver	O
and	O
other	O
organs	O
at	O
various	O
stages	O
by	O
RT	O
-	O
PCR	O
(	O
Fig	O
.	O
2I	O
and	O
data	O
not	O
shown	O
)	O
.	O

We	O
amplified	O
PCR	O
fragments	O
of	O
292	O
bp	O
and	O
452	O
bp	O
with	O
primer	O
pairs	O
for	O
genes	O
encoding	O
mouse	O
mr	O
-	O
s	O
and	O
G3PDH	O
,	O
respectively	O
.	O

In	O
E13	O
whole	O
embryo	O
and	O
P0	O
whole	O
body	O
(	O
except	O
for	O
the	O
eye	O
)	O
,	O
no	O
mr	O
-	O
s	O
signal	O
was	O
detected	O
.	O

As	O
expected	O
,	O
we	O
observed	O
that	O
mr	O
-	O
s	O
is	O
expressed	O
in	O
the	O
P7	O
and	O
adult	O
pineal	O
gland	O
.	O

In	O
the	O
P7	O
and	O
adult	O
brain	O
,	O
liver	O
and	O
several	O
other	O
organs	O
,	O
the	O
RT	O
-	O
PCR	O
amplified	O
band	O
of	O
mr	O
-	O
s	O
was	O
not	O
detected	O
(	O
Fig	O
.	O
2I	O
and	O
data	O
not	O
shown	O
)	O
.	O

Our	O
data	O
showed	O
that	O
mr	O
-	O
s	O
is	O
predominantly	O
expressed	O
in	O
developing	O
photoreceptors	O
and	O
the	O
pineal	O
gland	O
.	O

Regulation	O
of	O
mr	O
-	O
s	O
transcription	O
by	O
Crx	O
homeodomain	O
protein	O

Transcription	O
factors	O
Otx2	O
and	O
Crx	O
are	O
known	O
to	O
be	O
key	O
regulators	O
of	O
retinal	O
photoreceptor	O
development	O
[	O
3	O
,	O
8	O
,	O
9	O
]	O
.	O

Although	O
both	O
Otx2	O
and	O
Crx	O
are	O
expressed	O
in	O
developing	O
photoreceptor	O
cells	O
in	O
the	O
embryonic	O
retina	O
,	O
only	O
Crx	O
is	O
highly	O
expressed	O
in	O
the	O
postnatal	O
photoreceptors	O
,	O
suggesting	O
that	O
mr	O
-	O
s	O
may	O
be	O
regulated	O
by	O
Crx	O
.	O

To	O
test	O
whether	O
Crx	O
regulates	O
mr	O
-	O
s	O
transcription	O
,	O
we	O
performed	O
in	O
situ	O
hybridization	O
of	O
mr	O
-	O
s	O
mRNA	O
on	O
wild	O
-	O
type	O
and	O
Crx	O
KO	O
P5	O
retinas	O
(	O
Fig	O
.	O
3A	O
,	O
B	O
)	O
.	O

In	O
the	O
Crx	O
KO	O
retina	O
,	O
the	O
mr	O
-	O
s	O
transcript	O
was	O
dramatically	O
reduced	O
(	O
Fig	O
.	O
3B	O
)	O
.	O

This	O
indicates	O
that	O
Crx	O
is	O
essential	O
for	O
transactivation	O
of	O
mr	O
-	O
s	O
.	O

Moreover	O
,	O
to	O
test	O
whether	O
the	O
transcription	O
of	O
mr	O
-	O
s	O
is	O
also	O
regulated	O
by	O
Crx	O
in	O
the	O
pineal	O
gland	O
,	O
RT	O
-	O
PCR	O
analysis	O
was	O
used	O
to	O
compare	O
transcriptional	O
levels	O
of	O
mr	O
-	O
s	O
in	O
P28	O
wild	O
-	O
type	O
and	O
Crx	O
KO	O
pineal	O
gland	O
(	O
Fig	O
.	O
3C	O
)	O
.	O

The	O
results	O
revealed	O
that	O
mr	O
-	O
s	O
transcription	O
was	O
significantly	O
downregulated	O
in	O
the	O
Crx	O
KO	O
pineal	O
gland	O
.	O

Taken	O
together	O
,	O
these	O
data	O
indicate	O
that	O
mr	O
-	O
s	O
transcription	O
is	O
regulated	O
by	O
Crx	O
in	O
the	O
developing	O
photoreceptors	O
and	O
pineal	O
gland	O
.	O

Figure	O
3	O

The	O
transcription	O
of	O
mr	O
-	O
s	O
is	O
regulated	O
by	O
Crx	O
.	O

(	O
A	O
,	O
B	O
)	O
In	O
situ	O
hybridization	O
using	O
a	O
probe	O
for	O
mouse	O
mr	O
-	O
s	O
was	O
performed	O
on	O
the	O
wild	O
-	O
type	O
(	O
A	O
)	O
and	O
Crx	O
KO	O
retinas	O
(	O
B	O
)	O
at	O
P5	O
.	O

mr	O
-	O
s	O
expression	O
was	O
drastically	O
reduced	O
in	O
the	O
Crx	O
KO	O
retina	O
(	O
B	O
)	O
.	O

Scale	O
bar	O
,	O
100	O
mu	O
m	O
.	O

(	O
C	O
)	O
RT	O
-	O
PCR	O
analysis	O
of	O
total	O
RNAs	O
extracted	O
from	O
the	O
pineal	O
glands	O
of	O
P5	O
wild	O
-	O
type	O
and	O
Crx	O
KO	O
mouse	O
.	O

The	O
upper	O
and	O
lower	O
lanes	O
show	O
PCR	O
products	O
amplified	O
by	O
the	O
primer	O
pairs	O
specific	O
for	O
mr	O
-	O
s	O
and	O
G3PDH	O
cDNAs	O
,	O
respectively	O
.	O

Water	O
was	O
used	O
for	O
control	O
RT	O
-	O
PCR	O
reaction	O
.	O

(	O
D	O
-	O
F	O
)	O
Crx	O
transactivates	O
mr	O
-	O
s	O
transcription	O
.	O

Reporter	O
plasmids	O
for	O
the	O
luciferase	O
assay	O
are	O
shown	O
.	O

Blue	O
boxes	O
represent	O
Crx	O
binding	O
sites	O
(	O
D	O
)	O
.	O

Relative	O
activity	O
of	O
the	O
luciferase	O
is	O
indicated	O
when	O
Pro1	O
.	O
2k	O
was	O
co	O
-	O
transfected	O
with	O
Crx	O
,	O
Otx2	O
,	O
Nrl	O
,	O
and	O
Crx	O
+	O
Nrl	O
,	O
respectively	O
(	O
E	O
)	O
.	O

Fold	O
activation	O
is	O
indicated	O
when	O
Pro1	O
.	O
2k	O
,	O
mut1259	O
,	O
mut198	O
,	O
mut72	O
and	O
mut	O
all	O
were	O
co	O
-	O
transfected	O
with	O
the	O
Crx	O
expression	O
vector	O
(	O
Crx	O
+	O
)	O
or	O
the	O
empty	O
vector	O
(	O
Crx	O
-	O
)	O
into	O
HEK293T	O
cells	O
(	O
F	O
)	O
.	O

Error	O
bars	O
represent	O
standard	O
error	O
of	O
mean	O
.	O

To	O
further	O
examine	O
whether	O
Crx	O
regulates	O
mr	O
-	O
s	O
transcription	O
directly	O
or	O
not	O
,	O
we	O
next	O
performed	O
a	O
luciferase	O
assay	O
using	O
the	O
1	O
.	O
2	O
-	O
kb	O
proximal	O
promoter	O
region	O
of	O
mr	O
-	O
s	O
fused	O
to	O
a	O
luciferase	O
gene	O
as	O
a	O
luciferase	O
reporter	O
(	O
Fig	O
.	O
3D	O
,	O
Pro1	O
.	O
2k	O
)	O
and	O
the	O
Crx	O
,	O
Otx2	O
,	O
Nrl	O
expression	O
vectors	O
,	O
respectively	O
.	O

This	O
1	O
.	O
2	O
-	O
kb	O
region	O
of	O
the	O
mr	O
-	O
s	O
upstream	O
sequence	O
contains	O
three	O
Crx	O
binding	O
consensus	O
sequences	O
.	O

As	O
shown	O
in	O
Fig	O
.	O

3E	O
,	O
the	O
luciferase	O
activity	O
was	O
significantly	O
upregulated	O
when	O
the	O
Crx	O
or	O
Otx2	O
expression	O
vector	O
was	O
co	O
-	O
introduced	O
with	O
Pro1	O
.	O
2k	O
into	O
HEK293T	O
cells	O
,	O
while	O
the	O
luciferase	O
activity	O
was	O
not	O
altered	O
when	O
the	O
Nrl	O
expression	O
vector	O
was	O
co	O
-	O
introduced	O
.	O

A	O
previous	O
report	O
suggested	O
that	O
the	O
transcriptional	O
activity	O
of	O
Crx	O
is	O
augmented	O
with	O
Nrl	O
when	O
the	O
rhodopsin	O
promoter	O
was	O
used	O
as	O
a	O
reporter	O
gene	O
[	O
6	O
]	O
.	O

On	O
the	O
other	O
hand	O
,	O
our	O
present	O
data	O
showed	O
that	O
the	O
luciferase	O
gene	O
expression	O
was	O
not	O
upregulated	O
when	O
both	O
Crx	O
and	O
Nrl	O
expression	O
vectors	O
were	O
co	O
-	O
introduced	O
with	O
Pro1	O
.	O
2k	O
compared	O
to	O
the	O
activity	O
when	O
the	O
Crx	O
only	O
expression	O
vector	O
was	O
introduced	O
.	O

This	O
may	O
be	O
due	O
to	O
cell	O
type	O
differences	O
because	O
a	O
cell	O
type	O
of	O
retinal	O
/	O
pineal	O
origin	O
was	O
not	O
used	O
in	O
our	O
luciferase	O
assay	O
.	O

In	O
addition	O
,	O
our	O
present	O
data	O
showed	O
that	O
Otx2	O
,	O
which	O
is	O
reported	O
to	O
have	O
the	O
same	O
binding	O
consensus	O
as	O
Crx	O
,	O
also	O
transactivated	O
mr	O
-	O
s	O
expression	O
.	O

As	O
shown	O
in	O
Fig	O
.	O

2A	O
-	O
F	O
,	O
the	O
expression	O
pattern	O
of	O
mr	O
-	O
s	O
correlates	O
with	O
that	O
of	O
Crx	O
.	O

In	O
contrast	O
,	O
the	O
transcripts	O
of	O
Otx2	O
are	O
mainly	O
detected	O
in	O
the	O
photoreceptor	O
layer	O
at	O
embryonic	O
stages	O
.	O

Therefore	O
,	O
we	O
concluded	O
that	O
mr	O
-	O
s	O
transcription	O
is	O
directly	O
regulated	O
mainly	O
by	O
Crx	O
.	O

We	O
also	O
constructed	O
reporter	O
vectors	O
in	O
which	O
mutations	O
were	O
introduced	O
at	O
the	O
three	O
Crx	O
binding	O
sites	O
(	O
Fig	O
.	O
3D	O
,	O
mut1259	O
,	O
mut198	O
,	O
mut72	O
,	O
mut	O
all	O
)	O
.	O

Then	O
the	O
Crx	O
expression	O
vector	O
was	O
co	O
-	O
introduced	O
with	O
mut1259	O
,	O
mut198	O
,	O
mut72	O
and	O
mut	O
all	O
,	O
respectively	O
(	O
Fig	O
.	O
3F	O
)	O
.	O

The	O
transactivaton	O
activity	O
by	O
Crx	O
was	O
clearly	O
reduced	O
when	O
mut198	O
or	O
mut72	O
was	O
co	O
-	O
introduced	O
.	O

On	O
the	O
other	O
hand	O
,	O
when	O
mut1259	O
was	O
co	O
-	O
transfected	O
,	O
the	O
transactivation	O
activity	O
by	O
Crx	O
was	O
not	O
altered	O
.	O

These	O
results	O
suggest	O
that	O
the	O
Crx	O
binding	O
sites	O
72	O
-	O
bp	O
and	O
198	O
-	O
bp	O
upstream	O
from	O
the	O
transcription	O
initiation	O
site	O
are	O
crucial	O
for	O
the	O
direct	O
regulation	O
of	O
mr	O
-	O
s	O
transcription	O
by	O
Crx	O
.	O

Self	O
-	O
association	O
of	O
mr	O
-	O
s	O
protein	O

SAM	O
domains	O
are	O
known	O
to	O
function	O
as	O
protein	O
-	O
protein	O
interaction	O
modules	O
[	O
15	O
-	O
17	O
]	O
.	O

Although	O
SAM	O
domains	O
can	O
bind	O
to	O
various	O
non	O
-	O
SAM	O
domain	O
-	O
containing	O
proteins	O
,	O
many	O
homo	O
-	O
SAM	O
and	O
hetero	O
-	O
SAM	O
domain	O
interactions	O
have	O
been	O
reported	O
.	O

To	O
investigate	O
whether	O
the	O
SAM	O
domain	O
of	O
the	O
mr	O
-	O
s	O
protein	O
can	O
also	O
function	O
as	O
a	O
protein	O
-	O
protein	O
interaction	O
module	O
,	O
we	O
performed	O
yeast	O
two	O
-	O
hybrid	O
screening	O
using	O
full	O
-	O
length	O
mr	O
-	O
s	O
protein	O
as	O
the	O
bait	O
.	O

Using	O
this	O
bait	O
,	O
we	O
screened	O
the	O
transcriptional	O
activator	O
fusion	O
protein	O
library	O
in	O
which	O
mouse	O
P0	O
-	O
P3	O
retinal	O
cDNAs	O
were	O
fused	O
to	O
the	O
GAL4	O
activation	O
domain	O
.	O

The	O
most	O
frequent	O
positive	O
clones	O
(	O
5	O
out	O
of	O
28	O
)	O
were	O
cDNA	O
fragments	O
containing	O
the	O
SAM	O
domain	O
of	O
mr	O
-	O
s	O
(	O
Fig	O
.	O
4A	O
)	O
.	O

This	O
result	O
strongly	O
suggests	O
that	O
mr	O
-	O
s	O
protein	O
self	O
-	O
associates	O
through	O
SAM	O
domain	O
-	O
containing	O
regions	O
.	O

We	O
then	O
directly	O
tested	O
this	O
self	O
-	O
association	O
of	O
mr	O
-	O
s	O
protein	O
in	O
yeast	O
.	O

We	O
fused	O
full	O
-	O
length	O
or	O
truncated	O
portions	O
of	O
the	O
mr	O
-	O
s	O
protein	O
to	O
the	O
DNA	O
-	O
binding	O
domain	O
of	O
the	O
yeast	O
transcription	O
factor	O
GAL4	O
to	O
make	O
bait	O
constructs	O
.	O

We	O
fused	O
full	O
-	O
length	O
or	O
truncated	O
portions	O
of	O
the	O
mr	O
-	O
s	O
protein	O
to	O
the	O
GAL4	O
transcriptional	O
activation	O
domain	O
to	O
make	O
prey	O
constructs	O
(	O
Fig	O
.	O
4B	O
)	O
.	O

These	O
constructs	O
were	O
transformed	O
into	O
yeast	O
that	O
contain	O
a	O
transgene	O
with	O
GAL4	O
binding	O
sites	O
upstream	O
of	O
the	O
lacZ	O
gene	O
.	O

We	O
found	O
that	O
the	O
full	O
-	O
length	O
mr	O
-	O
s	O
bait	O
construct	O
induced	O
lacZ	O
expression	O
with	O
the	O
full	O
-	O
length	O
mr	O
-	O
s	O
prey	O
construct	O
(	O
Fig	O
.	O
4B	O
,	O
full	O
x	O
full	O
)	O
.	O

The	O
N	O
-	O
terminus	O
400	O
amino	O
acid	O
(	O
aa	O
)	O
stretch	O
of	O
mr	O
-	O
s	O
,	O
which	O
does	O
not	O
contain	O
a	O
SAM	O
domain	O
,	O
does	O
weakly	O
activate	O
transcription	O
of	O
lacZ	O
(	O
Fig	O
.	O
4B	O
,	O
full	O
x	O
N	O
)	O
.	O

The	O
N	O
-	O
terminus	O
400	O
aa	O
stretch	O
of	O
mr	O
-	O
s	O
was	O
able	O
to	O
induce	O
transcription	O
of	O
lacZ	O
weakly	O
with	O
the	O
same	O
N	O
-	O
terminus	O
400	O
aa	O
stretch	O
of	O
mr	O
-	O
s	O
(	O
Fig	O
.	O
4B	O
,	O
N	O
x	O
N	O
)	O
.	O

Although	O
the	O
N	O
-	O
terminus	O
400	O
aa	O
mr	O
-	O
s	O
protein	O
weakly	O
activates	O
lacZ	O
transcription	O
with	O
the	O
same	O
N	O
-	O
terminus	O
portion	O
,	O
a	O
much	O
stronger	O
activation	O
of	O
lacZ	O
expression	O
was	O
observed	O
with	O
a	O
C	O
-	O
terminus	O
portion	O
encoding	O
the	O
391	O
-	O
542	O
aa	O
stretch	O
of	O
mr	O
-	O
s	O
(	O
Fig	O
.	O
4B	O
,	O
full	O
x	O
C	O
,	O
C	O
x	O
C	O
)	O
.	O

Our	O
GAL4	O
assay	O
indicated	O
that	O
the	O
signal	O
when	O
the	O
full	O
-	O
length	O
mr	O
-	O
s	O
was	O
present	O
in	O
both	O
the	O
bait	O
and	O
prey	O
contexts	O
was	O
weaker	O
than	O
when	O
isolated	O
SAM	O
domains	O
were	O
used	O
.	O

This	O
may	O
simply	O
reflect	O
the	O
tendency	O
for	O
the	O
small	O
fusion	O
proteins	O
to	O
enter	O
the	O
yeast	O
nucleus	S-GO
and	O
occupy	O
GAL4	O
binding	O
sites	O
.	O

Alternatively	O
,	O
the	O
SAM	O
domain	O
may	O
be	O
less	O
accessible	O
for	O
interaction	O
in	O
the	O
full	O
-	O
length	O
protein	O
context	O
as	O
previously	O
reported	O
[	O
39	O
]	O
.	O

Figure	O
4	O

Summary	O
of	O
yeast	O
two	O
-	O
hybrid	O
screening	O
and	O
GAL4	O
assay	O
.	O

(	O
A	O
)	O
Full	O
-	O
length	O
mr	O
-	O
s	O
as	O
a	O
bait	O
used	O
in	O
the	O
yeast	O
two	O
-	O
hybrid	O
screening	O
and	O
positive	O
clones	O
are	O
indicated	O
.	O

Note	O
that	O
all	O
of	O
five	O
mr	O
-	O
s	O
clones	O
identified	O
in	O
the	O
screening	O
contain	O
SAM	O
domains	O
.	O

(	O
B	O
)	O
Schematic	O
diagram	O
of	O
the	O
mr	O
-	O
s	O
fusion	O
proteins	O
used	O
in	O
the	O
yeast	O
GAL4	O
assay	O
.	O

Black	O
boxes	O
represent	O
the	O
position	O
of	O
SAM	O
domains	O
.	O

Relative	O
levels	O
of	O
LacZ	O
expression	O
are	O
shown	O
on	O
the	O
right	O
,	O
respectively	O
.	O

Note	O
;	O
+	O
+	O
indicates	O
an	O
intense	O
blue	O
signal	O
visible	O
after	O
12hr	O
of	O
incubation	O
at	O
37	O
degrees	O
C	O
,	O
+	O
indicates	O
a	O
blue	O
signal	O
visible	O
after	O
24hr	O
of	O
incubation	O
.	O

BD	O
,	O
binding	O
domain	O
;	O
AD	O
,	O
activation	O
domain	O
;	O
full	O
,	O
full	O
-	O
length	O
mr	O
-	O
s	O
;	O
N	O
,	O
N	O
-	O
terminal	O
portion	O
of	O
mr	O
-	O
s	O
(	O
amino	O
acids	O
1	O
to	O
400	O
)	O
;	O
C	O
,	O
C	O
-	O
terminal	O
portion	O
of	O
mr	O
-	O
s	O
(	O
amino	O
acids	O
391	O
to	O
542	O
)	O
.	O

To	O
confirm	O
self	O
-	O
association	O
of	O
the	O
mr	O
-	O
s	O
protein	O
in	O
mammalian	O
cells	O
,	O
we	O
next	O
performed	O
co	O
-	O
immunoprecipitation	O
studies	O
in	O
HEK293T	O
cells	O
by	O
co	O
-	O
transfection	O
of	O
HA	O
-	O
tagged	O
full	O
-	O
length	O
/	O
truncated	O
mr	O
-	O
s	O
and	O
Flag	O
-	O
tagged	O
full	O
-	O
length	O
/	O
truncated	O
mr	O
-	O
s	O
(	O
Fig	O
.	O
5A	O
)	O
.	O

As	O
a	O
negative	O
control	O
,	O
we	O
constructed	O
Flag	O
-	O
tagged	O
Sonic	O
hedgehog	O
(	O
Shh	O
)	O
(	O
lane	O
2	O
and	O
7	O
)	O
.	O

In	O
accordance	O
with	O
the	O
result	O
of	O
the	O
yeast	O
two	O
-	O
hybrid	O
GAL4	O
assay	O
,	O
HA	O
-	O
tagged	O
full	O
-	O
length	O
mr	O
-	O
s	O
(	O
full	O
-	O
HA	O
)	O
was	O
co	O
-	O
immunoprecipitated	O
with	O
Flag	O
-	O
tagged	O
full	O
-	O
length	O
mr	O
-	O
s	O
(	O
Flag	O
-	O
mrs	O
)	O
and	O
the	O
Flag	O
-	O
tagged	O
C	O
-	O
terminus	O
portion	O
containing	O
the	O
SAM	O
domain	O
(	O
Flag	O
-	O
SAM	O
)	O
,	O
respectively	O
(	O
Fig	O
5B	O
,	O
lane3	O
and	O
lane5	O
)	O
.	O

We	O
also	O
found	O
a	O
weak	O
co	O
-	O
immunoprecipitation	O
band	O
in	O
co	O
-	O
transfection	O
of	O
full	O
-	O
HA	O
and	O
Flag	O
-	O
tagged	O
N	O
-	O
terminus	O
portion	O
of	O
mr	O
-	O
s	O
(	O
Flag	O
-	O
Delta	O
SAM	O
,	O
Fig	O
.	O
5B	O
,	O
lane	O
4	O
)	O
.	O

When	O
Delta	O
SAM	O
-	O
HA	O
and	O
Flag	O
-	O
tagged	O
deletion	O
mutants	O
were	O
co	O
-	O
transfected	O
,	O
Delta	O
SAM	O
-	O
HA	O
was	O
co	O
-	O
immunoprecipitated	O
with	O
Flag	O
-	O
mrs	O
and	O
Flag	O
-	O
Delta	O
SAM	O
(	O
Fig	O
.	O
5B	O
,	O
lane	O
8	O
and	O
lane	O
9	O
)	O
,	O
while	O
Delta	O
SAM	O
-	O
HA	O
was	O
not	O
co	O
-	O
immunoprecipitated	O
with	O
Flag	O
-	O
SAM	O
(	O
Fig	O
.	O
5B	O
,	O
lane	O
10	O
)	O
.	O

Figure	O
5	O

The	O
mr	O
-	O
s	O
protein	O
can	O
self	O
-	O
associate	O
in	O
mammalian	O
cells	O
.	O

(	O
A	O
)	O
Schematic	O
drawing	O
of	O
the	O
constructs	O
used	O
for	O
immunoprecipitation	O
assay	O
.	O

HA	O
-	O
tagged	O
or	O
Flag	O
-	O
tagged	O
full	O
-	O
length	O
(	O
amino	O
acids	O
1	O
to	O
542	O
)	O
,	O
Delta	O
SAM	O
(	O
amino	O
acids	O
1	O
to	O
400	O
)	O
and	O
SAM	O
(	O
amino	O
acids	O
401	O
to	O
542	O
)	O
regions	O
were	O
inserted	O
into	O
pcDNA3	O
vector	O
,	O
respectively	O
.	O

(	O
B	O
)	O
The	O
constructs	O
indicated	O
above	O
were	O
transfected	O
into	O
HEK293T	O
cells	O
.	O

Each	O
lane	O
was	O
co	O
-	O
immunoprecipitated	O
by	O
anti	O
-	O
Flag	O
antibody	S-GO
and	O
detected	O
by	O
anti	O
-	O
HA	O
antibody	S-GO
.	O

Input	O
protein	O
lysates	O
are	O
shown	O
in	O
the	O
lower	O
panels	O
.	O

(	O
C	O
)	O
Flag	O
-	O
tagged	O
two	O
site	O
-	O
directed	O
mr	O
-	O
s	O
mutants	O
,	O
Flag	O
-	O
W404A	O
and	O
Flag	O
-	O
G453A	O
were	O
generated	O
and	O
co	O
-	O
transfected	O
with	O
full	O
-	O
HA	O
.	O

Each	O
lane	O
was	O
co	O
-	O
immunoprecipitated	O
by	O
anti	O
-	O
HA	O
antibody	S-GO
and	O
detected	O
by	O
anti	O
-	O
Flag	O
antibody	S-GO
.	O

To	O
investigate	O
whether	O
the	O
mr	O
-	O
s	O
protein	O
self	O
-	O
associates	O
mainly	O
through	O
the	O
SAM	O
domain	O
,	O
two	O
site	O
-	O
directed	O
mutations	O
were	O
generated	O
in	O
the	O
SAM	O
domain	O
of	O
mr	O
-	O
s	O
(	O
Fig	O
.	O
1B	O
,	O
arrows	O
)	O
.	O

These	O
mutations	O
alter	O
residues	O
that	O
are	O
conserved	O
in	O
the	O
SAM	O
domain	O
of	O
ph	O
and	O
previous	O
report	O
indicates	O
that	O
these	O
mutations	O
of	O
ph	O
-	O
SAM	O
cause	O
significant	O
reduction	O
in	O
binding	O
activity	O
to	O
the	O
other	O
SAM	O
domain	O
-	O
containing	O
protein	O
,	O
Sex	O
comb	O
on	O
midleg	O
(	O
Scm	O
)	O
(	O
41	O
)	O
.	O

Based	O
on	O
this	O
result	O
,	O
we	O
introduced	O
two	O
types	O
of	O
site	O
-	O
directed	O
mutations	O
,	O
which	O
correspond	O
to	O
the	O
mutations	O
introduced	O
in	O
ph	O
protein	O
,	O
into	O
Flag	O
-	O
tagged	O
full	O
-	O
length	O
mr	O
-	O
s	O
(	O
Flag	O
-	O
W404A	O
and	O
Flag	O
-	O
G453A	O
)	O
.	O

We	O
found	O
that	O
Flag	O
-	O
W404A	O
binding	O
activity	O
was	O
significantly	O
reduced	O
and	O
Flag	O
-	O
G453A	O
binding	O
activity	O
was	O
also	O
slightly	O
reduced	O
compared	O
to	O
Flag	O
-	O
mrs	O
(	O
Fig	O
.	O
5C	O
)	O
.	O

These	O
results	O
,	O
together	O
with	O
yeast	O
two	O
-	O
hybrid	O
GAL4	O
assay	O
,	O
indicate	O
that	O
the	O
mr	O
-	O
s	O
protein	O
self	O
-	O
associates	O
strongly	O
through	O
its	O
SAM	O
domain	O
and	O
weakly	O
through	O
the	O
N	O
-	O
terminus	O
portion	O
lacking	O
SAM	O
domain	O
.	O

The	O
subcellular	O
localization	O
of	O
mr	O
-	O
s	O
protein	O
in	O
mammalian	O
cells	O

The	O
putative	O
nuclear	S-GO
localization	O
signal	O
at	O
the	O
N	O
-	O
terminus	O
of	O
the	O
mr	O
-	O
s	O
protein	O
(	O
Fig	O
.	O
1A	O
,	O
dashed	O
box	O
)	O
suggests	O
that	O
the	O
mr	O
-	O
s	O
protein	O
localizes	O
in	O
the	O
nucleus	S-GO
.	O

To	O
determine	O
the	O
subcellular	O
localization	O
of	O
mr	O
-	O
s	O
in	O
mammalian	O
cells	O
,	O
we	O
introduced	O
an	O
HA	O
-	O
tagged	O
full	O
-	O
length	O
mr	O
-	O
s	O
plasmid	O
into	O
HEK293T	O
cells	O
.	O

Confocal	O
microscopy	O
showed	O
that	O
the	O
mr	O
-	O
s	O
protein	O
localized	O
mainly	O
in	O
the	O
nucleus	S-GO
of	O
HEK293T	O
cells	O
(	O
Fig	O
.	O
6A	O
,	O
B	O
)	O
.	O

To	O
confirm	O
the	O
precise	O
localization	O
of	O
the	O
mr	O
-	O
s	O
protein	O
,	O
full	O
-	O
length	O
mr	O
-	O
s	O
was	O
co	O
-	O
immunostained	O
with	O
DAPI	O
(	O
Fig	O
.	O
6C	O
-	O
E	O
)	O
.	O

These	O
data	O
showed	O
that	O
the	O
mr	O
-	O
s	O
protein	O
localizes	O
preferentially	O
to	O
the	O
nucleus	S-GO
in	O
mammalian	O
cells	O
,	O
supporting	O
the	O
idea	O
that	O
the	O
mr	O
-	O
s	O
protein	O
is	O
involved	O
in	O
transcriptional	O
regulation	O
as	O
are	O
ph	O
and	O
/	O
or	O
TEL	O
.	O

Figure	O
6	O

Subcellular	O
localization	O
of	O
mr	O
-	O
s	O
in	O
mammalian	O
cells	O
.	O

(	O
A	O
,	O
B	O
)	O
HA	O
-	O
tagged	O
full	O
-	O
length	O
mr	O
-	O
s	O
was	O
transfected	O
into	O
HEK293T	O
(	O
B	O
)	O
and	O
detected	O
by	O
anti	O
-	O
HA	O
antibody	S-GO
(	O
A	O
)	O
.	O

Scale	O
bar	O
,	O
20	O
mu	O
m	O
.	O

(	O
C	O
-	O
E	O
)	O
HEK293T	O
cells	O
immunostained	O
with	O
anti	O
-	O
HA	O
antibody	S-GO
(	O
C	O
)	O
,	O
DAPI	O
(	O
D	O
)	O
,	O
and	O
merged	O
image	O
(	O
E	O
)	O
.	O

Scale	O
bar	O
,	O
50	O
mu	O
m	O
.	O

The	O
GAL4	O
-	O
mr	O
-	O
s	O
fusion	O
protein	O
functions	O
as	O
transcriptional	O
repressor	O

A	O
member	O
of	O
PcG	O
proteins	O
,	O
ph	O
,	O
does	O
not	O
contain	O
an	O
obvious	O
sequence	O
-	O
specific	O
DNA	O
binding	O
motif	O
(	O
16	O
)	O
.	O

Ph	O
functions	O
as	O
a	O
transcriptional	O
repressor	O
through	O
its	O
polymerization	O
and	O
protein	O
-	O
protein	O
interaction	O
with	O
other	O
sequence	O
-	O
specific	O
transcriptional	O
repressors	O
,	O
which	O
can	O
form	O
a	O
higher	O
order	O
chromatin	B-GO
structure	E-GO
.	O

The	O
mr	O
-	O
s	O
protein	O
also	O
does	O
not	O
have	O
an	O
obvious	O
DNA	O
-	O
binding	O
domain	O
.	O

To	O
characterize	O
the	O
biochemical	O
activity	O
of	O
mr	O
-	O
s	O
,	O
we	O
next	O
performed	O
a	O
luciferase	O
assay	O
.	O

We	O
generated	O
effector	O
plasmids	O
,	O
which	O
express	O
various	O
deletion	O
constructs	O
of	O
mr	O
-	O
s	O
fused	O
to	O
the	O
GAL4	O
DNA	O
-	O
binding	O
domain	O
(	O
Fig	O
.	O
7A	O
)	O
.	O

We	O
first	O
confirmed	O
that	O
full	O
-	O
length	O
mr	O
-	O
s	O
fused	O
to	O
GAL4	O
DNA	O
binding	O
domain	O
(	O
DBD	O
-	O
mrs	O
)	O
had	O
no	O
effect	O
on	O
the	O
pGL3	O
promoter	O
plasmid	O
lacking	O
GAL4	O
binding	O
sites	O
(	O
data	O
not	O
shown	O
)	O
.	O

When	O
the	O
5xGAL4	O
-	O
pGL3	O
reporter	O
plasmid	O
was	O
co	O
-	O
transfected	O
,	O
DBD	O
-	O
mrs	O
repressed	O
luciferase	O
activity	O
by	O
about	O
90	O
%	O
in	O
a	O
dose	O
-	O
dependent	O
manner	O
(	O
Fig	O
.	O
7B	O
)	O
.	O

As	O
a	O
control	O
,	O
GAL4	O
DNA	O
-	O
binding	O
domain	O
(	O
DBD	O
)	O
had	O
no	O
significant	O
effect	O
on	O
the	O
5xGAL4	O
-	O
pGL3	O
reporter	O
plasmid	O
.	O

In	O
addition	O
,	O
we	O
confirmed	O
that	O
full	O
-	O
length	O
mr	O
-	O
s	O
without	O
GAL4	O
DBD	O
had	O
no	O
effect	O
on	O
the	O
same	O
reporter	O
plasmid	O
(	O
data	O
not	O
shown	O
)	O
.	O

We	O
next	O
analyzed	O
deletion	O
constructs	O
in	O
which	O
the	O
N	O
-	O
terminus	O
400	O
aa	O
stretch	O
of	O
mr	O
-	O
s	O
(	O
amino	O
acids	O
1	O
to	O
400	O
)	O
or	O
the	O
C	O
-	O
terminus	O
portion	O
(	O
amino	O
acids	O
391	O
to	O
542	O
)	O
were	O
fused	O
to	O
the	O
GAL4	O
DBD	O
(	O
Fig	O
.	O
7A	O
,	O
DBD	O
-	O
N	O
,	O
DBD	O
-	O
C	O
)	O
.	O

While	O
DBD	O
-	O
N	O
had	O
no	O
repressive	O
effect	O
on	O
this	O
reporter	O
activity	O
,	O
DBD	O
-	O
C	O
repressed	O
luciferase	O
gene	O
expression	O
by	O
about	O
65	O
%	O
.	O

This	O
result	O
suggested	O
to	O
us	O
the	O
possibility	O
that	O
DBD	O
-	O
mrs	O
exerts	O
transcriptional	O
repressive	O
activity	O
via	O
self	O
-	O
association	O
through	O
its	O
SAM	O
domain	O
.	O

To	O
investigate	O
whether	O
the	O
homophilic	O
association	O
of	O
mr	O
-	O
s	O
is	O
required	O
for	O
transcriptional	O
repression	O
,	O
two	O
site	O
-	O
directed	O
mutants	O
,	O
DBD	O
-	O
W404A	O
and	O
DBD	O
-	O
G453A	O
,	O
either	O
of	O
which	O
may	O
reduce	O
self	O
-	O
binding	O
ability	O
,	O
were	O
analyzed	O
(	O
Fig	O
.	O
7C	O
)	O
.	O

Compared	O
to	O
DBD	O
-	O
mrs	O
,	O
DBD	O
-	O
W404A	O
and	O
DBD	O
-	O
G453A	O
had	O
repression	O
activity	O
of	O
72	O
%	O
and	O
87	O
%	O
,	O
respectively	O
.	O

While	O
the	O
ability	O
of	O
mr	O
-	O
s	O
self	O
-	O
association	O
partially	O
correlates	O
with	O
transcriptional	O
repressive	O
activity	O
,	O
these	O
mutants	O
do	O
not	O
compromise	O
the	O
ability	O
to	O
repress	O
transcription	O
critically	O
.	O

To	O
determine	O
the	O
regions	O
of	O
mr	O
-	O
s	O
involved	O
in	O
transcriptional	O
repression	O
more	O
precisely	O
,	O
the	O
C	O
-	O
terminus	O
portion	O
was	O
divided	O
into	O
two	O
regions	O
and	O
each	O
was	O
fused	O
to	O
the	O
GAL4	O
DBD	O
(	O
Fig	O
.	O
7A	O
,	O
DBD	O
-	O
tail	O
,	O
DBD	O
-	O
SAM	O
)	O
.	O

As	O
a	O
consequence	O
,	O
DBD	O
-	O
SAM	O
(	O
amino	O
acids	O
384	O
to	O
462	O
)	O
did	O
not	O
have	O
a	O
repressive	O
effect	O
on	O
the	O
5xGAL4	O
-	O
pGL3	O
reporter	O
plasmid	O
.	O

On	O
the	O
other	O
hand	O
,	O
luciferase	O
activity	O
was	O
repressed	O
by	O
55	O
%	O
when	O
DBD	O
-	O
tail	O
(	O
amino	O
acids	O
459	O
to	O
542	O
)	O
was	O
co	O
-	O
transfected	O
with	O
this	O
reporter	O
plasmid	O
(	O
Fig	O
.	O
7D	O
)	O
.	O

To	O
assess	O
the	O
transcriptional	O
repressive	O
activity	O
of	O
mr	O
-	O
s	O
in	O
cells	O
of	O
retinal	O
origin	O
,	O
we	O
performed	O
similar	O
experiments	O
using	O
human	O
Y79	O
retinoblastoma	O
cells	O
.	O

The	O
results	O
indicated	O
that	O
DBD	O
-	O
mrs	O
also	O
reduced	O
luciferase	O
activity	O
significantly	O
in	O
Y79	O
retinoblastoma	O
cells	O
(	O
Fig	O
.	O
7E	O
)	O
.	O

However	O
,	O
luciferase	O
activity	O
was	O
repressed	O
by	O
about	O
30	O
%	O
in	O
Y79	O
cells	O
,	O
while	O
it	O
was	O
repressed	O
by	O
90	O
%	O
in	O
HEK293T	O
cells	O
.	O

This	O
might	O
be	O
due	O
to	O
the	O
difference	O
in	O
transfection	O
efficiency	O
between	O
these	O
cell	O
lines	O
.	O

Another	O
possibility	O
is	O
that	O
intracellular	B-GO
environment	E-GO
in	O
Y79	O
cells	O
,	O
a	O
retinoblastoma	O
cell	O
line	O
,	O
is	O
insufficient	O
for	O
recapitulating	O
developing	O
photoreceptors	O
.	O

In	O
this	O
study	O
,	O
we	O
did	O
not	O
address	O
the	O
question	O
whether	O
or	O
not	O
our	O
in	O
vitro	O
data	O
reflect	O
native	O
mr	O
-	O
s	O
transcriptional	O
repression	O
in	O
vivo	O
.	O

However	O
,	O
these	O
in	O
vitro	O
experiments	O
using	O
HEK293T	O
and	O
Y79	O
cells	O
strongly	O
support	O
our	O
hypothesis	O
that	O
mr	O
-	O
s	O
functions	O
as	O
a	O
transcriptional	O
repressor	O
in	O
developing	O
photoreceptors	O
.	O

Our	O
results	O
suggested	O
that	O
the	O
C	O
-	O
terminal	O
region	O
of	O
mr	O
-	O
s	O
(	O
amino	O
acids	O
463	O
to	O
542	O
)	O
is	O
required	O
for	O
transcriptional	O
repression	O
of	O
mr	O
-	O
s	O
and	O
the	O
SAM	O
domain	O
appears	O
to	O
be	O
dispensable	O
for	O
this	O
repressive	O
activity	O
.	O

This	O
C	O
-	O
terminal	O
region	O
of	O
mouse	O
mr	O
-	O
s	O
is	O
highly	O
conserved	O
among	O
species	O
(	O
Fig	O
.	O
7F	O
)	O
.	O

The	O
sequence	O
identity	O
of	O
the	O
region	O
was	O
93	O
%	O
,	O
73	O
%	O
,	O
41	O
%	O
and	O
40	O
%	O
for	O
rat	O
,	O
human	O
,	O
chick	O
and	O
zebrafish	O
,	O
respectively	O
(	O
Fig	O
.	O
1D	O
)	O
.	O

This	O
strongly	O
suggests	O
that	O
the	O
C	O
-	O
terminal	O
region	O
of	O
mouse	O
mr	O
-	O
s	O
functions	O
as	O
a	O
transcriptional	O
repressive	O
domain	O
in	O
photoreceptor	O
development	O
.	O

However	O
,	O
this	O
region	O
does	O
not	O
contain	O
characteristic	O
amino	O
acid	O
motifs	O
and	O
the	O
mechanism	O
through	O
which	O
the	O
region	O
achieves	O
and	O
/	O
or	O
maintains	O
gene	O
repression	O
remains	O
to	O
be	O
clarified	O
in	O
the	O
future	O
.	O

Figure	O
7	O

mr	O
-	O
s	O
fused	O
to	O
GAL4	O
DNA	O
binding	O
domain	O
functions	O
as	O
a	O
transcriptional	O
repressor	O
in	O
HEK293T	O
cells	O
.	O

(	O
A	O
)	O
Schematic	O
drawing	O
of	O
the	O
constructs	O
used	O
for	O
the	O
luciferase	O
assay	O
.	O

5xGAL4	O
-	O
pGL3	O
reporter	O
plasmid	O
was	O
co	O
-	O
transfected	O
into	O
HEK293T	O
cells	O
with	O
effector	O
plasmids	O
expressing	O
various	O
deletion	O
mutants	O
fused	O
to	O
GAL4	O
-	O
DBD	O
.	O

(	O
B	O
)	O
Various	O
amounts	O
of	O
DBD	O
,	O
DBD	O
-	O
mrs	O
,	O
DBD	O
-	O
N	O
or	O
DBD	O
-	O
C	O
plasmids	O
were	O
transfected	O
with	O
0	O
.	O
1	O
mu	O
g	O
of	O
5xGAL4	O
-	O
pGL3	O
reporter	O
plasmid	O
.	O

The	O
reporter	O
activity	O
in	O
the	O
presence	O
of	O
the	O
pcDNA3	O
vector	O
(	O
pcDNA3	O
)	O
was	O
designated	O
as	O
1	O
.	O

Error	O
bars	O
represent	O
standard	O
error	O
of	O
mean	O
.	O

(	O
C	O
)	O
DBD	O
-	O
W404A	O
and	O
DBD	O
-	O
G453A	O
were	O
co	O
-	O
transfected	O
into	O
HEK293T	O
cells	O
with	O
5xGAL4	O
-	O
pGL3	O
reporter	O
plasmid	O
.	O

Fold	O
repression	O
was	O
calculated	O
as	O
the	O
fold	O
decrease	O
in	O
luciferase	O
activity	O
compared	O
with	O
DBD	O
-	O
mrs	O
.	O

Error	O
bars	O
represent	O
standard	O
deviation	O
.	O

(	O
D	O
)	O
Various	O
amounts	O
of	O
DBD	O
-	O
tail	O
or	O
DBD	O
-	O
SAM	O
were	O
transfected	O
with	O
5xGAL4	O
-	O
pGL3	O
reporter	O
plasmid	O
.	O

Error	O
bars	O
represent	O
standard	O
error	O
of	O
mean	O
.	O

(	O
E	O
)	O
pcDNA3	O
or	O
DBD	O
-	O
mrs	O
(	O
5	O
mu	O
g	O
)	O
was	O
co	O
-	O
transfected	O
into	O
Y79	O
retinoblastoma	O
cells	O
with	O
0	O
.	O
5	O
mu	O
g	O
of	O
5xGAL4	O
-	O
pGL3	O
reporter	O
plasmid	O
.	O

The	O
reporter	O
activity	O
in	O
the	O
presence	O
of	O
pcDNA3	O
was	O
designated	O
as	O
1	O
.	O

Error	O
bars	O
represent	O
standard	O
deviation	O
.	O

Asterisk	O
marks	O
statistically	O
significant	O
difference	O
(	O
Student	O
'	O
s	O
t	O
test	O
:	O
p	O
<	O
0	O
.	O
03	O
)	O
.	O

(	O
F	O
)	O
Alignment	O
of	O
the	O
C	O
-	O
terminal	O
regions	O
for	O
mouse	O
,	O
rat	O
,	O
human	O
,	O
chick	O
and	O
zebrafish	O
mr	O
-	O
s	O
proteins	O
.	O

Conserved	O
amino	O
acid	O
residues	O
are	O
shown	O
with	O
a	O
dark	O
shadow	O
.	O

Taken	O
together	O
,	O
our	O
findings	O
suggest	O
that	O
DBD	O
-	O
mrs	O
functions	O
as	O
a	O
transcriptional	O
repressor	O
and	O
that	O
the	O
repression	O
activity	O
of	O
mr	O
-	O
s	O
is	O
not	O
due	O
to	O
a	O
homophilic	O
interaction	O
through	O
its	O
SAM	O
domain	O
but	O
to	O
the	O
C	O
-	O
terminal	O
region	O
(	O
amino	O
acids	O
463	O
to	O
542	O
)	O
.	O

Discussion	O

In	O
the	O
present	O
study	O
,	O
we	O
identified	O
a	O
novel	O
gene	O
,	O
mr	O
-	O
s	O
,	O
which	O
is	O
predominantly	O
expressed	O
in	O
retinal	O
photoreceptors	O
and	O
the	O
pineal	O
gland	O
.	O

The	O
peak	O
of	O
mr	O
-	O
s	O
expression	O
in	O
the	O
developing	O
retina	O
is	O
around	O
P6	O
.	O

This	O
expression	O
pattern	O
correlates	O
with	O
the	O
rapid	O
increase	O
of	O
Crx	O
,	O
rhodopsin	O
and	O
other	O
photoreceptor	O
genes	O
around	O
P6	O
-	O
P8	O
.	O

Around	O
P6	O
,	O
the	O
outer	O
plexiform	O
layer	O
becomes	O
visible	O
and	O
the	O
outer	O
layer	O
of	O
retina	O
separates	O
into	O
two	O
layers	O
,	O
ONL	O
and	O
INL	O
.	O

At	O
the	O
same	O
time	O
,	O
photoreceptors	O
begin	O
to	O
undergo	O
terminal	O
differentiation	O
,	O
forming	O
the	O
outer	B-GO
segment	E-GO
.	O

We	O
therefore	O
hypothesized	O
that	O
mr	O
-	O
s	O
is	O
a	O
key	O
molecule	O
in	O
the	O
late	O
development	O
of	O
photoreceptors	O
.	O

We	O
previously	O
reported	O
that	O
Otx2	O
and	O
Crx	O
have	O
a	O
critical	O
role	O
in	O
photoreceptor	O
development	O
and	O
that	O
Otx2	O
directly	O
regulates	O
Crx	O
transcription	O
[	O
3	O
,	O
9	O
]	O
.	O

In	O
situ	O
hybridization	O
and	O
RT	O
-	O
PCR	O
showed	O
significant	O
reduction	O
of	O
mr	O
-	O
s	O
signal	O
in	O
the	O
Crx	O
KO	O
retina	O
and	O
pineal	O
gland	O
.	O

Furthermore	O
,	O
the	O
luciferase	O
assay	O
demonstrated	O
that	O
Otx2	O
and	O
Crx	O
may	O
directly	O
upregulate	O
the	O
transcription	O
of	O
mr	O
-	O
s	O
in	O
mammalian	O
cells	O
.	O

In	O
retinal	O
photoreceptor	O
cells	O
,	O
the	O
Otx2	O
transcripts	O
are	O
not	O
highly	O
expressed	O
at	O
P6	O
-	O
P9	O
,	O
while	O
the	O
Crx	O
transcripts	O
are	O
strongly	O
detected	O
around	O
P6	O
.	O

Therefore	O
,	O
our	O
results	O
strongly	O
suggest	O
that	O
mr	O
-	O
s	O
transcription	O
is	O
directly	O
regulated	O
by	O
Crx	O
.	O

In	O
the	O
present	O
study	O
,	O
Nrl	O
,	O
a	O
photoreceptor	O
-	O
specific	O
transcription	O
factor	O
that	O
is	O
highly	O
expressed	O
in	O
photoreceptors	O
at	O
the	O
postnatal	O
stage	O
,	O
did	O
not	O
affect	O
the	O
transcription	O
of	O
mr	O
-	O
s	O
.	O

This	O
finding	O
is	O
actually	O
consistent	O
with	O
the	O
analysis	O
of	O
the	O
Nrl	O
KO	O
mouse	O
which	O
was	O
recently	O
reported	O
[	O
40	O
]	O
.	O

The	O
expression	O
profiles	O
of	O
wild	O
-	O
type	O
and	O
Nrl	O
KO	O
retinas	O
at	O
P2	O
,	O
P10	O
and	O
2	O
months	O
were	O
analyzed	O
and	O
mr	O
-	O
s	O
was	O
not	O
included	O
in	O
161	O
differentially	O
expressed	O
genes	O
in	O
the	O
Nrl	O
KO	O
retina	O
.	O

Previous	O
reports	O
suggested	O
that	O
the	O
SAM	O
domain	O
is	O
a	O
protein	O
-	O
protein	O
interaction	O
module	O
.	O

The	O
SAM	O
domain	O
of	O
the	O
mr	O
-	O
s	O
protein	O
is	O
closely	O
related	O
to	O
that	O
of	O
ph	O
and	O
TEL	O
,	O
whose	O
SAM	O
domains	O
can	O
form	O
a	O
helical	O
,	O
head	O
-	O
to	O
-	O
tail	O
polymeric	O
structure	O
and	O
mediate	O
the	O
formation	O
of	O
a	O
higher	O
order	O
chromatin	S-GO
structure	O
.	O

To	O
characterize	O
the	O
biochemical	O
function	O
of	O
mr	O
-	O
s	O
,	O
we	O
performed	O
yeast	O
two	O
-	O
hybrid	O
screening	O
using	O
full	O
-	O
length	O
mr	O
-	O
s	O
as	O
the	O
bait	O
.	O

As	O
a	O
result	O
,	O
the	O
most	O
frequent	O
positive	O
clones	O
(	O
5	O
/	O
28	O
)	O
in	O
the	O
screening	O
were	O
the	O
cDNA	O
fragments	O
containing	O
the	O
SAM	O
domain	O
of	O
mr	O
-	O
s	O
.	O

This	O
strongly	O
suggests	O
that	O
mr	O
-	O
s	O
self	O
-	O
associates	O
through	O
its	O
SAM	O
domain	O
.	O

An	O
immunoprecipitation	O
assay	O
,	O
using	O
two	O
site	O
-	O
directed	O
mutants	O
of	O
the	O
SAM	O
domain	O
of	O
mr	O
-	O
s	O
,	O
demonstrated	O
that	O
the	O
mr	O
-	O
s	O
protein	O
can	O
self	O
-	O
associate	O
through	O
its	O
SAM	O
domain	O
in	O
mammalian	O
cells	O
.	O

While	O
we	O
did	O
not	O
address	O
the	O
question	O
whether	O
the	O
SAM	O
domain	O
of	O
mr	O
-	O
s	O
forms	O
a	O
polymeric	O
structure	O
in	O
the	O
present	O
study	O
,	O
the	O
phylogenetic	O
analysis	O
of	O
SAM	O
domain	O
of	O
mr	O
-	O
s	O
and	O
other	O
SAM	O
domain	O
-	O
containing	O
molecules	O
suggests	O
that	O
mr	O
-	O
s	O
can	O
form	O
head	O
-	O
to	O
-	O
tail	O
polymer	O
and	O
mediate	O
gene	O
silencing	O
by	O
spreading	O
repressive	B-GO
complexes	E-GO
along	O
the	O
chromatin	S-GO
similar	O
to	O
ph	O
and	O
/	O
or	O
TEL	O
.	O

Although	O
our	O
results	O
in	O
the	O
immunoprecipitation	O
assay	O
demonstrated	O
that	O
the	O
N	O
-	O
terminal	O
constructs	O
lacking	O
a	O
SAM	O
domain	O
still	O
interact	O
with	O
each	O
other	O
,	O
these	O
results	O
do	O
not	O
fit	O
into	O
the	O
head	O
-	O
to	O
-	O
tail	O
polymer	O
model	O
.	O

We	O
cannot	O
exclude	O
the	O
possibility	O
that	O
the	O
resulting	O
protein	O
-	O
protein	O
interaction	O
of	O
mr	O
-	O
s	O
is	O
an	O
artifact	O
of	O
the	O
overexpression	O
conditions	O
.	O

The	O
issue	O
of	O
whether	O
or	O
not	O
mr	O
-	O
s	O
forms	O
a	O
polymer	O
awaits	O
future	O
analysis	O
.	O

A	O
previous	O
report	O
indicated	O
that	O
TEL	O
contains	O
a	O
sequence	O
-	O
specific	O
DNA	O
binding	O
domain	O
,	O
namely	O
the	O
ETS	O
domain	O
,	O
and	O
binds	O
to	O
specific	O
sites	O
via	O
its	O
ETS	O
domain	O
[	O
41	O
]	O
.	O

TEL	O
could	O
serve	O
to	O
nucleate	O
a	O
polymer	O
,	O
which	O
would	O
spread	O
by	O
oligomerization	O
of	O
the	O
SAM	O
domain	O
.	O

In	O
contrast	O
to	O
TEL	O
,	O
ph	O
does	O
not	O
contain	O
an	O
obvious	O
sequence	O
-	O
specific	O
DNA	O
binding	O
motif	O
(	O
16	O
)	O
.	O

Therefore	O
,	O
its	O
initial	O
binding	O
to	O
the	O
template	O
may	O
require	O
protein	O
-	O
protein	O
interactions	O
with	O
other	O
sequence	O
-	O
specific	O
transcriptional	O
repressors	O
.	O

The	O
segmentation	O
gene	O
-	O
encoding	O
transcriptional	O
repressors	O
such	O
as	O
Hunchback	O
have	O
a	O
role	O
in	O
recruiting	O
SAM	O
domain	O
-	O
containing	O
PcG	O
proteins	O
,	O
which	O
can	O
spread	O
along	O
the	O
template	O
via	O
polymerization	O
[	O
42	O
]	O
.	O

Since	O
mr	O
-	O
s	O
does	O
not	O
contain	O
obvious	O
DNA	O
binding	O
motifs	O
,	O
we	O
suppose	O
that	O
there	O
is	O
a	O
sequence	O
-	O
specific	O
transcription	O
factor	O
(	O
s	O
)	O
which	O
interacts	O
with	O
mr	O
-	O
s	O
.	O

However	O
,	O
we	O
did	O
not	O
find	O
any	O
transcription	O
factors	O
in	O
the	O
present	O
yeast	O
two	O
-	O
hybrid	O
screening	O
.	O

We	O
also	O
found	O
that	O
full	O
-	O
length	O
mr	O
-	O
s	O
fused	O
to	O
the	O
GAL4	O
DNA	O
binding	O
domain	O
(	O
DBD	O
-	O
mrs	O
)	O
functions	O
as	O
a	O
transcriptional	O
repressor	O
.	O

This	O
may	O
support	O
the	O
idea	O
that	O
mr	O
-	O
s	O
is	O
involved	O
in	O
repressive	B-GO
complexes	E-GO
similar	O
to	O
other	O
SAM	O
domain	O
-	O
containing	O
proteins	O
.	O

Our	O
results	O
,	O
however	O
,	O
showed	O
that	O
the	O
self	O
-	O
association	O
of	O
mr	O
-	O
s	O
through	O
its	O
SAM	O
domain	O
is	O
not	O
essential	O
for	O
the	O
transcriptional	O
repressive	O
activity	O
.	O

Polymerization	O
of	O
the	O
SAM	O
domain	O
has	O
been	O
previously	O
reported	O
to	O
be	O
essential	O
for	O
the	O
repressive	O
functions	O
of	O
ph	O
and	O
TEL	O
[	O
43	O
,	O
44	O
]	O
.	O

On	O
the	O
other	O
hand	O
,	O
human	O
lethal	O
(	O
3	O
)	O
malignant	O
brain	O
tumor	O
(	O
H	O
-	O
L	O
(	O
3	O
)	O
MBT	O
)	O
protein	O
,	O
which	O
also	O
contains	O
a	O
SAM	O
domain	O
at	O
the	O
C	O
-	O
terminus	O
,	O
was	O
reported	O
as	O
a	O
transcriptional	O
repressor	O
and	O
the	O
repressor	O
activity	O
of	O
H	O
-	O
L	O
(	O
3	O
)	O
MBT	O
required	O
mainly	O
the	O
presence	O
of	O
the	O
MBT	O
repeats	O
but	O
not	O
the	O
SAM	O
domain	O
[	O
45	O
]	O
.	O

To	O
determine	O
the	O
transcriptional	O
repressor	O
region	O
of	O
the	O
mr	O
-	O
s	O
protein	O
,	O
we	O
performed	O
a	O
luciferase	O
assay	O
using	O
site	O
-	O
directed	O
mutants	O
(	O
DBD	O
-	O
W404A	O
and	O
DBD	O
-	O
G453A	O
)	O
.	O

The	O
result	O
showed	O
that	O
the	O
reduced	O
binding	O
ability	O
of	O
self	O
-	O
association	O
partially	O
compromises	O
the	O
transcriptional	O
repressive	O
activity	O
of	O
mr	O
-	O
s	O
(	O
Fig	O
.	O
7D	O
)	O
.	O

However	O
,	O
the	O
repressive	O
effect	O
was	O
more	O
significant	O
when	O
DBD	O
-	O
tail	O
,	O
which	O
does	O
not	O
contain	O
SAM	O
domain	O
,	O
was	O
co	O
-	O
introduced	O
with	O
the	O
5xGAL4	O
-	O
pGL3	O
reporter	O
plasmid	O
.	O

Therefore	O
,	O
we	O
conclude	O
that	O
a	O
region	O
from	O
amino	O
acids	O
463	O
to	O
542	O
is	O
mainly	O
responsible	O
for	O
the	O
repressor	O
activity	O
in	O
the	O
case	O
of	O
mr	O
-	O
s	O
.	O

Evolutionary	O
conservation	O
of	O
the	O
C	O
-	O
terminal	O
80	O
aa	O
region	O
of	O
mr	O
-	O
s	O
from	O
zebrafish	O
through	O
human	O
may	O
underlie	O
the	O
functional	O
importance	O
of	O
this	O
region	O
.	O

Two	O
distinct	O
multiprotein	O
PcG	B-GO
complexes	E-GO
,	O
PRC1	S-GO
and	O
PRC2	O
,	O
have	O
been	O
identified	O
.	O

PRC2	O
is	O
involved	O
in	O
the	O
initiation	O
of	O
silencing	O
and	O
contains	O
histone	O
deacetylases	O
(	O
HDACs	O
)	O
and	O
histone	O
methyltransferases	O
,	O
which	O
can	O
methylate	O
histone	O
H3	O
lysine	O
9	O
and	O
27	O
,	O
marks	O
of	O
silenced	O
chromatin	S-GO
.	O

PRC1	S-GO
,	O
including	O
ph	O
,	O
recognizes	O
the	O
histone	O
H3	O
lysine	O
27	O
mark	O
set	O
by	O
PRC2	O
and	O
maintains	O
a	O
stable	O
state	O
of	O
gene	O
repression	O
in	O
which	O
PRC1	S-GO
blocks	O
chromatin	S-GO
remodeling	O
by	O
the	O
trithorax	O
group	O
-	O
related	O
SWI	B-GO
-	I-GO
SNF	I-GO
complex	E-GO
[	O
46	O
,	O
47	O
]	O
.	O

Therefore	O
,	O
the	O
mechanism	O
of	O
repression	O
by	O
PRC2	O
is	O
thought	O
to	O
be	O
HDAC	O
-	O
dependent	O
while	O
the	O
mechanism	O
of	O
repression	O
by	O
PRC1	S-GO
appears	O
to	O
be	O
HDAC	O
-	O
independent	O
.	O

Our	O
luciferase	O
assay	O
also	O
showed	O
that	O
transcriptional	O
repression	O
of	O
DBD	O
-	O
mrs	O
was	O
not	O
affected	O
by	O
the	O
addition	O
of	O
various	O
concentrations	O
of	O
trichostatin	O
A	O
,	O
a	O
potent	O
HDAC	O
inhibitor	O
(	O
data	O
not	O
shown	O
)	O
.	O

Therefore	O
,	O
we	O
speculate	O
that	O
the	O
mechanism	O
of	O
repression	O
of	O
mr	O
-	O
s	O
may	O
be	O
HDAC	O
-	O
independent	O
and	O
more	O
similar	O
to	O
that	O
of	O
PRC1	B-GO
complex	E-GO
.	O

In	O
the	O
present	O
study	O
,	O
the	O
biochemical	O
experiments	O
demonstrate	O
that	O
the	O
mr	O
-	O
s	O
protein	O
functions	O
as	O
a	O
transcriptional	O
repressor	O
and	O
possibly	O
down	O
-	O
regulates	O
the	O
spatial	O
and	O
temporal	O
expression	O
of	O
the	O
target	O
genes	O
during	O
retinal	O
photoreceptor	O
development	O
.	O

Our	O
data	O
also	O
revealed	O
that	O
the	O
repressive	O
activity	O
of	O
mr	O
-	O
s	O
is	O
mainly	O
due	O
to	O
the	O
C	O
-	O
terminal	O
region	O
(	O
amino	O
acids	O
463	O
to	O
542	O
)	O
.	O

However	O
,	O
downstream	O
targets	O
of	O
mr	O
-	O
s	O
still	O
remain	O
unclear	O
.	O

In	O
situ	O
hybridization	O
showed	O
that	O
the	O
peak	O
of	O
mr	O
-	O
s	O
expression	O
is	O
around	O
P6	O
,	O
when	O
retinal	O
photoreceptors	O
undergo	O
terminal	O
differentiation	O
.	O

We	O
hypothesize	O
that	O
the	O
target	O
genes	O
of	O
mr	O
-	O
s	O
might	O
be	O
non	O
-	O
photoreceptor	O
genes	O
.	O

In	O
this	O
case	O
,	O
mr	O
-	O
s	O
may	O
suppress	O
the	O
expression	O
of	O
non	O
-	O
photoreceptor	O
genes	O
in	O
rod	O
and	O
cone	O
photoreceptors	O
.	O

There	O
may	O
be	O
another	O
possibility	O
that	O
mr	O
-	O
s	O
is	O
involved	O
in	O
cell	O
fate	O
determination	O
of	O
rod	O
photoreceptors	O
versus	O
cone	O
photoreceptors	O
.	O

While	O
cone	O
photoreceptors	O
are	O
born	O
during	O
the	O
early	O
embryonic	O
stages	O
of	O
mouse	O
retinogenesis	O
,	O
rod	O
photoreceptors	O
are	O
born	O
primarily	O
in	O
the	O
late	O
embryonic	O
and	O
early	O
postnatal	O
period	O
[	O
48	O
]	O
.	O

The	O
expression	O
pattern	O
of	O
mr	O
-	O
s	O
may	O
suggest	O
that	O
mr	O
-	O
s	O
is	O
expressed	O
in	O
rod	O
photoreceptors	O
but	O
not	O
in	O
cone	O
photoreceptors	O
as	O
well	O
as	O
Nr2e3	O
,	O
which	O
is	O
known	O
as	O
a	O
transcriptional	O
repressor	O
and	O
is	O
thought	O
to	O
down	O
-	O
regulate	O
cone	O
photoreceptor	O
-	O
specific	O
genes	O
.	O

To	O
clarify	O
the	O
biological	O
function	O
of	O
mr	O
-	O
s	O
,	O
analysis	O
of	O
mice	O
with	O
targeted	O
disruptions	O
of	O
mr	O
-	O
s	O
will	O
be	O
very	O
important	O
.	O

Conclusion	O

Here	O
we	O
identified	O
mouse	O
mr	O
-	O
s	O
,	O
which	O
is	O
predominantly	O
expressed	O
in	O
retinal	O
photoreceptors	O
and	O
the	O
pineal	O
gland	O
.	O

mr	O
-	O
s	O
is	O
evolutionarily	O
conserved	O
from	O
zebrafish	O
through	O
to	O
human	O
,	O
suggesting	O
a	O
significant	O
role	O
of	O
mr	O
-	O
s	O
in	O
photoreceptor	O
development	O
.	O

Our	O
present	O
data	O
suggest	O
that	O
mr	O
-	O
s	O
protein	O
localizes	O
in	O
the	O
nucleus	S-GO
and	O
can	O
self	O
-	O
associated	O
mainly	O
through	O
the	O
SAM	O
domain	O
.	O

Moreover	O
,	O
mr	O
-	O
s	O
protein	O
fused	O
to	O
GAL4	O
DBD	O
functions	O
as	O
a	O
transcriptional	O
repressor	O
.	O

The	O
repressive	O
activity	O
of	O
mr	O
-	O
s	O
is	O
due	O
to	O
its	O
C	O
-	O
terminal	O
region	O
(	O
amino	O
acid	O
463	O
to	O
542	O
)	O
.	O

Taken	O
together	O
,	O
mr	O
-	O
s	O
is	O
a	O
novel	O
repressor	O
molecule	O
possibly	O
involved	O
in	O
the	O
development	O
of	O
retinal	O
photoreceptors	O
and	O
pineal	O
gland	O
.	O

Methods	O

Isolation	O
of	O
mouse	O
mr	O
-	O
s	O
cDNA	O

We	O
used	O
the	O
bioinformatics	O
method	O
Digital	O
Differential	O
Display	O
(	O
NCBI	O
,	O
UniGene	O
)	O
to	O
screen	O
novel	O
mouse	O
genes	O
expressed	O
preferentially	O
in	O
the	O
retina	O
.	O

Some	O
of	O
the	O
clusters	O
in	O
the	O
UniGene	O
database	O
were	O
mainly	O
from	O
mouse	O
retinal	O
cDNAs	O
.	O

One	O
clone	O
in	O
these	O
clusters	O
(	O
#	O
Mm	O
.	O
246385	O
)	O
has	O
a	O
weak	O
homology	O
with	O
the	O
polyhomeotic	O
family	O
genes	O
.	O

A	O
735	O
-	O
bp	O
cDNA	O
fragment	O
of	O
this	O
clone	O
,	O
encoding	O
amino	O
acids	O
140	O
-	O
384	O
was	O
amplified	O
by	O
RT	O
-	O
PCR	O
from	O
mouse	O
P0	O
retinal	O
cDNA	O
.	O

This	O
fragment	O
was	O
used	O
as	O
the	O
probe	O
for	O
library	O
screening	O
,	O
in	O
situ	O
hybridization	O
and	O
Northern	O
hybridization	O
.	O

A	O
mouse	O
P0	O
-	O
P3	O
retinal	O
cDNA	O
library	O
was	O
screened	O
using	O
this	O
mouse	O
cDNA	O
fragment	O
.	O

Positive	O
bacteriophage	O
clones	O
were	O
isolated	O
and	O
the	O
full	O
-	O
length	O
mr	O
-	O
s	O
fragment	O
was	O
inserted	O
into	O
pBluescriptII	O
(	O
Stratagene	O
)	O
.	O

DNA	O
sequencing	O
was	O
performed	O
on	O
both	O
strands	O
by	O
the	O
cycle	O
sequencing	O
method	O
.	O

The	O
nucleotide	O
sequence	O
for	O
mr	O
-	O
s	O
gene	O
has	O
been	O
deposited	O
in	O
the	O
GenBank	O
database	O
under	O
GenBank	O
Accession	O
Number	O
#	O
AY458844	O
.	O

In	O
situ	O
hybridization	O

The	O
735	O
-	O
bp	O
cDNA	O
fragment	O
of	O
mr	O
-	O
s	O
amplified	O
by	O
RT	O
-	O
PCR	O
was	O
used	O
as	O
a	O
probe	O
for	O
in	O
situ	O
hybridization	O
.	O

In	O
situ	O
hybridization	O
was	O
performed	O
as	O
described	O
previously	O
[	O
49	O
]	O
.	O

Cell	O
culture	O
and	O
transfection	O

HEK293T	O
cells	O
were	O
maintained	O
at	O
37	O
degrees	O
C	O
in	O
Dulbecco	O
'	O
s	O
modified	O
Eagle	O
'	O
s	O
medium	O
(	O
DMEM	O
)	O
supplemented	O
with	O
10	O
%	O
fetal	O
bovine	O
serum	O
(	O
Sigma	O
)	O
,	O
100	O
IU	O
/	O
ml	O
penicillin	O
and	O
100	O
mu	O
g	O
/	O
ml	O
streptomycin	O
.	O

Transient	O
transfection	O
of	O
HEK293T	O
cells	O
was	O
carried	O
out	O
using	O
calcium	O
phosphate	O
method	O
or	O
Fugene6	O
transfection	O
reagent	O
(	O
Roche	O
)	O
.	O

Y79	O
retinoblastoma	O
cells	O
were	O
maintained	O
in	O
Iscove	O
'	O
s	O
modified	O
Dulbecco	O
'	O
s	O
medium	O
with	O
4	O
mM	O
L	O
-	O
glutamine	O
adjusted	O
to	O
contain	O
1	O
.	O
5	O
g	O
/	O
L	O
sodium	O
bicarbonate	O
,	O
20	O
%	O
FBS	O
.	O

Transient	O
transfection	O
was	O
carried	O
out	O
using	O
TransIt	O
LT1	O
(	O
Mirus	O
)	O
.	O

Northern	O
-	O
blot	O
analysis	O

RNA	O
was	O
extracted	O
from	O
the	O
tissues	O
of	O
adult	O
mice	O
using	O
Trizol	O
(	O
Invitrogen	O
)	O
.	O

A	O
5	O
mu	O
g	O
of	O
total	O
RNA	O
was	O
electrophoresed	O
in	O
a	O
1	O
.	O
0	O
%	O
agarose	O
-	O
formaldehyde	O
gel	O
and	O
transferred	O
to	O
a	O
nylon	O
membrane	O
(	O
Zeta	O
-	O
Probe	O
GT	O
,	O
Bio	O
-	O
Rad	O
)	O
.	O

The	O
735	O
-	O
bp	O
cDNA	O
fragment	O
encoding	O
the	O
SAM	O
domain	O
of	O
mr	O
-	O
s	O
was	O
used	O
as	O
a	O
probe	O
for	O
hybridization	O
.	O

Hybridization	O
was	O
performed	O
according	O
to	O
the	O
manufacturer	O
'	O
s	O
protocol	O
.	O

Washes	O
with	O
increasing	O
stringency	O
were	O
performed	O
,	O
the	O
last	O
being	O
at	O
50	O
degrees	O
C	O
in	O
0	O
.	O
1	O
x	O
standard	O
saline	O
citrate	O
/	O
0	O
.	O
1	O
%	O
sodium	O
dodecyl	O
sulfate	O
(	O
SDS	O
)	O
.	O

RT	O
-	O
PCR	O
analysis	O

Total	O
RNA	O
was	O
isolated	O
from	O
each	O
tissue	O
using	O
Trizol	O
.	O

A	O
1	O
mu	O
g	O
of	O
total	O
RNA	O
was	O
reverse	O
transcribed	O
using	O
SuperscriptII	O
(	O
Invitrogen	O
)	O
.	O

RT	O
-	O
PCR	O
primers	O
,	O
which	O
span	O
introns	O
,	O
for	O
detection	O
of	O
mr	O
-	O
s	O
cDNA	O
were	O
5	O
'	O
-	O
TGTCCAGCCCAGCCAACCCAAGGAGACGACA	O
-	O
3	O
'	O
and	O
5	O
'	O
-	O
TGTGGTCTCCTCATCAGTGAAGA	O
-	O
3	O
'	O
.	O

Product	O
size	O
was	O
292	O
bp	O
(	O
positions	O
965	O
-	O
1256	O
of	O
Genbank	O
Accession	O
Number	O
#	O
AY458844	O
)	O
.	O

Primer	O
pairs	O
for	O
mouse	O
G3PDH	O
were	O
5	O
'	O
-	O
ACCACAGTCCATGCCATCAC	O
-	O
3	O
'	O
and	O
5	O
'	O
-	O
TCCACCACCCTGTTGCTGTA	O
-	O
3	O
'	O
which	O
amplified	O
a	O
452	O
-	O
bp	O
product	O
(	O
positions	O
587	O
-	O
1038	O
of	O
Genbank	O
Accession	O
Number	O
#	O
BC85275	O
)	O
.	O

Yeast	O
two	O
-	O
hybrid	O
screening	O
and	O
GAL4	O
assay	O

We	O
carried	O
out	O
yeast	O
two	O
-	O
hybrid	O
experiments	O
using	O
the	O
MATCHMAKER	O
GAL4	O
two	O
-	O
hybrid	O
system	O
3	O
(	O
BD	O
Bioscience	O
)	O
as	O
recommended	O
by	O
the	O
manufacturer	O
.	O

We	O
cloned	O
the	O
full	O
-	O
length	O
mr	O
-	O
s	O
into	O
the	O
pGBKT7	O
vector	O
and	O
used	O
it	O
to	O
screen	O
a	O
library	O
of	O
mouse	O
P0	O
-	O
P3	O
retinal	O
cDNAs	O
in	O
the	O
pGADT7	O
vector	O
.	O

Transformants	O
that	O
conferred	O
growth	O
were	O
picked	O
,	O
isolated	O
and	O
re	O
-	O
introduced	O
with	O
the	O
bait	O
into	O
AH109	O
to	O
confirm	O
interaction	O
.	O

Plasmid	O
DNA	O
was	O
isolated	O
from	O
yeast	O
using	O
RPM	O
Yeast	O
Plasmid	O
Isolation	O
Kit	O
(	O
Qbiogene	O
)	O
.	O

In	O
order	O
to	O
confirm	O
the	O
protein	O
interactions	O
,	O
single	O
colonies	O
were	O
picked	O
and	O
grown	O
individually	O
in	O
synthetic	O
complete	O
media	O
lacking	O
leucine	O
,	O
tryptophan	O
and	O
containing	O
X	O
-	O
gal	O
.	O

After	O
4	O
-	O
5	O
days	O
,	O
X	O
-	O
gal	O
positive	O
clones	O
were	O
selected	O
and	O
analyzed	O
.	O

To	O
test	O
self	O
-	O
interaction	O
of	O
mr	O
-	O
s	O
,	O
we	O
subcloned	O
the	O
full	O
-	O
length	O
,	O
N	O
-	O
terminus	O
(	O
amino	O
acids	O
1	O
-	O
400	O
)	O
and	O
C	O
-	O
terminus	O
(	O
amino	O
acids	O
391	O
-	O
542	O
)	O
of	O
mr	O
-	O
s	O
into	O
pGBKT7	O
and	O
pGADT7	O
vectors	O
.	O

We	O
assessed	O
interactions	O
by	O
scoring	O
blue	O
color	O
on	O
plates	O
of	O
medium	O
containing	O
X	O
-	O
gal	O
.	O

Immunoprecipitation	O
assay	O

For	O
immunoprecipitation	O
assay	O
,	O
4	O
x	O
hemagglutinin	O
(	O
HA	O
)	O
or	O
3	O
x	O
Flag	O
tagged	O
cDNA	O
fragment	O
encoding	O
full	O
-	O
length	O
mr	O
-	O
s	O
(	O
full	O
-	O
HA	O
and	O
Flag	O
-	O
mrs	O
)	O
,	O
a	O
cDNA	O
fragment	O
encoding	O
amino	O
acids	O
1	O
-	O
400	O
(	O
Delta	O
SAM	O
-	O
HA	O
and	O
Flag	O
-	O
Delta	O
SAM	O
)	O
,	O
and	O
a	O
cDNA	O
fragment	O
encoding	O
amino	O
acids	O
400	O
-	O
542	O
(	O
Flag	O
-	O
SAM	O
)	O
were	O
subcloned	O
into	O
the	O
pcDNA3	O
(	O
Invitrogen	O
)	O
expression	O
vector	O
.	O

We	O
also	O
constructed	O
two	O
site	O
-	O
directed	O
mutants	O
,	O
Flag	O
-	O
W404A	O
and	O
Flag	O
-	O
G453A	O
,	O
using	O
PCR	O
.	O

Each	O
of	O
these	O
mutations	O
was	O
also	O
introduced	O
into	O
Flag	O
-	O
mr	O
-	O
s	O
.	O

We	O
transfected	O
HEK293T	O
cells	O
with	O
5	O
mu	O
g	O
of	O
plasmid	O
DNA	O
per	O
6	O
cm	O
dish	O
by	O
calcium	O
phosphate	O
method	O
.	O

Approximately	O
48	O
hr	O
after	O
transfection	O
,	O
cells	O
were	O
harvested	O
in	O
immunoprecipitation	O
buffer	O
(	O
50	O
mM	O
Tris	O
-	O
HCl	O
[	O
pH	O
7	O
.	O
5	O
]	O
,	O
1	O
mM	O
EDTA	O
,	O
2	O
mM	O
MgCl2	O
,	O
150	O
mM	O
NaCl	O
,	O
1	O
mM	O
phenylmethylsulfonyl	O
fluoride	O
[	O
Wako	O
]	O
,	O
1	O
%	O
Nonidet	O
P	O
-	O
40	O
,	O
10	O
%	O
glycerol	O
)	O
in	O
the	O
presence	O
of	O
protease	O
inhibitor	O
cocktail	O
tablets	O
(	O
Roche	O
)	O
.	O

For	O
each	O
reaction	O
,	O
1	O
mg	O
of	O
cell	O
lysate	O
was	O
mixed	O
with	O
0	O
.	O
5	O
mu	O
g	O
of	O
anti	O
-	O
Flag	O
antibody	S-GO
(	O
SIGMA	O
,	O
F3165	O
)	O
and	O
15	O
mu	O
l	O
of	O
protein	O
G	O
-	O
Sepharose	O
(	O
Amersham	O
)	O
on	O
a	O
rotating	O
wheel	O
at	O
4	O
degrees	O
C	O
for	O
2	O
hrs	O
.	O

Protein	O
concentration	O
was	O
determined	O
by	O
the	O
BCA	O
protein	O
assay	O
system	O
(	O
Pierce	O
)	O
.	O

The	O
beads	O
were	O
then	O
washed	O
three	O
times	O
with	O
immunoprecipitation	O
buffer	O
and	O
followed	O
by	O
three	O
times	O
with	O
wash	O
buffer	O
(	O
50	O
mM	O
Tris	O
-	O
HCl	O
[	O
pH	O
7	O
.	O
5	O
]	O
,	O
150	O
mM	O
NaCl	O
,	O
20	O
mM	O
MgCl2	O
)	O
.	O

Proteins	O
were	O
then	O
boiled	O
for	O
5	O
min	O
in	O
SDS	O
sample	O
buffer	O
(	O
1	O
%	O
SDS	O
,	O
1	O
mM	O
Tris	O
[	O
pH	O
6	O
.	O
8	O
]	O
,	O
40	O
mM	O
DTT	O
,	O
4	O
%	O
glycerol	O
,	O
0	O
.	O
01	O
%	O
pyronine	O
Y	O
)	O
.	O

The	O
supernatants	O
were	O
fractionated	O
by	O
sodium	O
dodecyl	O
sulfate	O
-	O
polyacrylamide	O
gel	O
electrophoresis	O
(	O
SDS	O
-	O
PAGE	O
)	O
and	O
transferred	O
to	O
the	O
nitrocellulose	O
membrane	O
(	O
Trans	O
-	O
Blot	O
Transfer	O
Medium	O
,	O
Bio	O
-	O
Rad	O
)	O
.	O

Western	O
blotting	O
was	O
performed	O
with	O
rabbit	O
polyclonal	O
anti	O
-	O
HA	O
antibody	S-GO
(	O
Santa	O
Cruz	O
,	O
#	O
sc	O
-	O
805	O
)	O
.	O

Signals	O
were	O
detected	O
with	O
horseradish	O
peroxidase	O
-	O
conjugated	O
goat	O
anti	O
-	O
rabbit	O
IgG	O
and	O
ECL	O
plus	O
Western	O
Blotting	O
Detection	O
System	O
(	O
Amersham	O
)	O
.	O

Subcellular	O
localization	O
analysis	O

We	O
transfected	O
the	O
plasmid	O
encoding	O
HA	O
-	O
tagged	O
full	O
-	O
length	O
mr	O
-	O
s	O
into	O
HEK293T	O
cells	O
,	O
seeded	O
cells	O
on	O
coverslips	O
coated	O
with	O
collagen	O
48	O
hr	O
after	O
transfection	O
,	O
fixed	O
with	O
4	O
%	O
paraformaldehyde	O
in	O
phosphate	O
-	O
buffered	O
saline	O
(	O
PBS	O
)	O
at	O
room	O
temperature	O
for	O
20	O
min	O
,	O
and	O
washed	O
with	O
PBS	O
.	O

Then	O
we	O
permeabilized	O
cells	O
in	O
PBS	O
containing	O
0	O
.	O
1	O
%	O
Triton	O
X	O
-	O
100	O
for	O
15	O
min	O
,	O
washed	O
again	O
with	O
PBS	O
,	O
and	O
incubated	O
in	O
PBS	O
containing	O
0	O
.	O
1	O
%	O
bovine	O
serum	O
albumin	O
(	O
BSA	O
)	O
for	O
30	O
min	O
at	O
room	O
temperature	O
.	O

We	O
incubated	O
cells	O
with	O
anti	O
-	O
HA	O
antibody	S-GO
overnight	O
at	O
4	O
degrees	O
C	O
(	O
1	O
:	O
200	O
in	O
PBS	O
containing	O
0	O
.	O
2	O
%	O
BSA	O
)	O
.	O

The	O
following	O
day	O
,	O
we	O
washed	O
cells	O
three	O
times	O
with	O
PBS	O
and	O
incubated	O
with	O
a	O
Cy3	O
-	O
conjugated	O
goat	O
IgG	O
against	O
rabbit	O
IgG	O
(	O
1	O
:	O
400	O
in	O
PBS	O
,	O
Jackson	O
ImmunoReseach	O
Laboratories	O
)	O
for	O
30	O
min	O
.	O

We	O
rinsed	O
cells	O
three	O
times	O
with	O
PBS	O
,	O
followed	O
by	O
observation	O
using	O
a	O
confocal	O
microscope	O
FV300	O
(	O
Olympus	O
)	O
equipped	O
with	O
a	O
60	O
x	O
objective	O
lens	O
.	O

Luciferase	O
assay	O

For	O
transcriptional	O
analysis	O
of	O
the	O
1	O
.	O
2	O
-	O
kb	O
promoter	O
region	O
of	O
mr	O
-	O
s	O
,	O
we	O
constructed	O
a	O
reporter	O
plasmid	O
(	O
pro1	O
.	O
2k	O
)	O
by	O
subcloning	O
a	O
1	O
.	O
2	O
-	O
kb	O
upstream	O
genomic	O
fragment	O
of	O
mr	O
-	O
s	O
gene	O
into	O
a	O
pGL3	O
luciferase	O
reporter	O
plasmid	O
(	O
Promega	O
)	O
.	O

The	O
expression	O
vectors	O
were	O
constructed	O
by	O
subcloning	O
full	O
-	O
length	O
Crx	O
,	O
Otx2	O
,	O
Nrl	O
genes	O
into	O
a	O
pMIK	O
expression	O
vector	O
(	O
a	O
gift	O
from	O
Dr	O
.	O
K	O
.	O
Maruyama	O
)	O
,	O
respectively	O
.	O

For	O
the	O
"	O
mut1259	O
"	O
vector	O
,	O
the	O
Crx	O
binding	O
site	O
at	O
the	O
-	O
1259	O
bp	O
position	O
was	O
mutated	O
by	O
replacing	O
GGATTA	O
with	O
AGATCT	O
.	O

For	O
the	O
"	O
mut198	O
"	O
vector	O
,	O
the	O
Crx	O
binding	O
site	O
at	O
the	O
-	O
198	O
bp	O
position	O
was	O
mutated	O
by	O
replacing	O
TAATCC	O
with	O
GAATTC	O
.	O

For	O
the	O
"	O
mut72	O
"	O
vector	O
,	O
the	O
Crx	O
binding	O
site	O
at	O
the	O
-	O
72	O
bp	O
position	O
was	O
mutated	O
by	O
replacing	O
GGATTA	O
with	O
GAATTC	O
.	O

For	O
the	O
"	O
mut	O
all	O
"	O
vector	O
,	O
all	O
of	O
three	O
Crx	O
binding	O
sites	O
were	O
mutated	O
.	O

5xGAL4	O
-	O
pGL3	O
Control	O
reporter	O
plasmid	O
,	O
which	O
contains	O
five	O
copies	O
of	O
the	O
GAL4	O
DNA	O
recognition	O
sequence	O
positioned	O
immediately	O
upstream	O
of	O
SV40	O
minimal	O
promoter	O
,	O
was	O
kindly	O
gifted	O
from	O
Dr	O
.	O
T	O
.	O

Noguchi	O
and	O
used	O
for	O
analysis	O
of	O
the	O
transcriptional	O
activity	O
of	O
mr	O
-	O
s	O
[	O
50	O
]	O
.	O

To	O
generate	O
effector	O
plasmids	O
,	O
various	O
deletion	O
fragments	O
were	O
produced	O
by	O
PCR	O
reaction	O
and	O
subcloned	O
into	O
pGBKT7	O
vector	O
,	O
respectively	O
.	O

These	O
fragments	O
were	O
digested	O
with	O
the	O
sequence	O
,	O
which	O
encodes	O
GAL4	O
DNA	O
binding	O
domain	O
,	O
and	O
inserted	O
into	O
pcDNA3	O
.	O

We	O
transfected	O
0	O
.	O
1	O
mu	O
g	O
of	O
reporter	O
plasmid	O
DNA	O
and	O
2	O
mu	O
g	O
of	O
the	O
expression	O
vector	O
DNA	O
per	O
6	O
cm	O
dish	O
into	O
HEK293T	O
cells	O
using	O
Fugene6	O
transfection	O
reagent	O
.	O

We	O
analyzed	O
luciferase	O
activity	O
48	O
hr	O
after	O
transfection	O
.	O

List	O
of	O
abbreviations	O

Crx	O
,	O
cone	O
-	O
rod	O
homeobox	O
;	O
Otx2	O
,	O
orthodenticle	O
-	O
related	O
homeobox	O
2	O
;	O
TR	O
beta	O
2	O
,	O
thyroid	O
hormone	O
receptor	O
beta	O
2	O
;	O
Nrl	O
,	O
neural	O
retina	O
leucine	O
zipper	O
;	O
Nr2e3	O
,	O
nuclear	O
receptor	O
subfamily	O
2	O
group	O
E	O
member	O
3	O
;	O
EST	O
,	O
expressed	O
sequence	O
tag	O
;	O
EphB2	O
,	O
ephrin	O
receptor	O
B2	O
;	O
EphA4	O
,	O
ephrin	O
receptor	O
A4	O
;	O
TEL	O
,	O
translocation	O
ETS	O
leukemia	O
.	O

Authors	O
'	O
contributions	O

TI	O
and	O
KT	O
performed	O
most	O
of	O
the	O
experiments	O
,	O
interpreted	O
the	O
data	O
and	O
wrote	O
the	O
first	O
draft	O
of	O
the	O
manuscript	O
.	O

AF	O
prepared	O
retinal	O
tissues	O
and	O
their	O
sections	O
of	O
wild	O
-	O
type	O
and	O
Crx	O
mutant	O
mice	O
.	O

CK	O
performed	O
luciferase	O
assay	O
using	O
Y79	O
retinoblastoma	O
cells	O
.	O

YT	O
,	O
MA	O
and	O
TF	O
have	O
made	O
substantial	O
contributions	O
to	O
conception	O
and	O
design	O
of	O
the	O
experiments	O
and	O
drafting	O
of	O
the	O
manuscript	O
.	O

All	O
authors	O
read	O
and	O
approved	O
the	O
final	O
manuscript	O
.	O

Acknowledgements	O

We	O
thank	O
T	O
.	O

Noguchi	O
for	O
5xGAL4	O
-	O
pGL3	O
reporter	O
plasmid	O
;	O
A	O
.	O

Nishida	O
for	O
discussion	O
and	O
critical	O
reading	O
of	O
the	O
manuscript	O
;	O
A	O
.	O

Yoshimura	O
for	O
advice	O
on	O
confocal	O
microscopy	O
;	O
A	O
.	O

Tani	O
,	O
Y	O
.	O

Kambara	O
,	O
M	O
.	O

Murai	O
,	O
Y	O
.	O

Hirao	O
and	O
H	O
.	O

Yoshii	O
for	O
technical	O
assistance	O
.	O

This	O
work	O
was	O
supported	O
by	O
Precursory	O
Research	O
for	O
Embryonic	O
Science	O
and	O
Technology	O
(	O
PRESTO	O
)	O
,	O
Dynamics	O
of	O
Development	O
Systems	O
Molecular	O
Brain	O
Science	O
,	O
Grant	O
-	O
in	O
Aid	O
for	O
Scientific	O
Research	O
(	O
B	O
)	O
,	O
Senri	O
Life	O
Science	O
Foundation	O
,	O
and	O
Uehara	O
Foundation	O
.	O

Rescue	O
of	O
Progeria	O
in	O
Trichothiodystrophy	O
by	O
Homozygous	O
Lethal	O
Xpd	O
Alleles	O

Abstract	O

Although	O
compound	O
heterozygosity	O
,	O
or	O
the	O
presence	O
of	O
two	O
different	O
mutant	O
alleles	O
of	O
the	O
same	O
gene	O
,	O
is	O
common	O
in	O
human	O
recessive	O
disease	O
,	O
its	O
potential	O
to	O
impact	O
disease	O
outcome	O
has	O
not	O
been	O
well	O
documented	O
.	O

This	O
is	O
most	O
likely	O
because	O
of	O
the	O
inherent	O
difficulty	O
in	O
distinguishing	O
specific	O
biallelic	O
effects	O
from	O
differences	O
in	O
environment	O
or	O
genetic	O
background	O
.	O

We	O
addressed	O
the	O
potential	O
of	O
different	O
recessive	O
alleles	O
to	O
contribute	O
to	O
the	O
enigmatic	O
pleiotropy	O
associated	O
with	O
XPD	O
recessive	O
disorders	O
in	O
compound	O
heterozygous	O
mouse	O
models	O
.	O

Alterations	O
in	O
this	O
essential	O
helicase	O
,	O
with	O
functions	O
in	O
both	O
DNA	O
repair	O
and	O
basal	O
transcription	O
,	O
result	O
in	O
diverse	O
pathologies	O
ranging	O
from	O
elevated	O
UV	O
sensitivity	O
and	O
cancer	O
predisposition	O
to	O
accelerated	O
segmental	O
progeria	O
.	O

We	O
report	O
a	O
variety	O
of	O
biallelic	O
effects	O
on	O
organismal	O
phenotype	O
attributable	O
to	O
combinations	O
of	O
recessive	O
Xpd	O
alleles	O
,	O
including	O
the	O
following	O
:	O
(	O
i	O
)	O
the	O
ability	O
of	O
homozygous	O
lethal	O
Xpd	O
alleles	O
to	O
ameliorate	O
a	O
variety	O
of	O
disease	O
symptoms	O
when	O
their	O
essential	O
basal	O
transcription	O
function	O
is	O
supplied	O
by	O
a	O
different	O
disease	O
-	O
causing	O
allele	O
,	O
(	O
ii	O
)	O
differential	O
developmental	O
and	O
tissue	O
-	O
specific	O
functions	O
of	O
distinct	O
Xpd	O
allele	O
products	O
,	O
and	O
(	O
iii	O
)	O
interallelic	O
complementation	O
,	O
a	O
phenomenon	O
rarely	O
reported	O
at	O
clinically	O
relevant	O
loci	O
in	O
mammals	O
.	O

Our	O
data	O
suggest	O
a	O
re	O
-	O
evaluation	O
of	O
the	O
contribution	O
of	O
"	O
null	O
"	O
alleles	O
to	O
XPD	O
disorders	O
and	O
highlight	O
the	O
potential	O
of	O
combinations	O
of	O
recessive	O
alleles	O
to	O
affect	O
both	O
normal	O
and	O
pathological	O
phenotypic	O
plasticity	O
in	O
mammals	O
.	O

Introduction	O

Interallelic	O
complementation	O
is	O
defined	O
as	O
the	O
ability	O
of	O
two	O
differentially	O
mutated	O
alleles	O
to	O
function	O
better	O
together	O
than	O
either	O
can	O
on	O
its	O
own	O
.	O

Despite	O
its	O
near	O
universality	O
in	O
lower	O
organisms	O
[	O
1	O
]	O
,	O
its	O
potential	O
to	O
contribute	O
to	O
clinical	O
heterogeneity	O
in	O
human	O
disease	O
is	O
seldom	O
considered	O
.	O

Evidence	O
of	O
interallelic	O
complementation	O
at	O
clinically	O
relevant	O
loci	O
is	O
limited	O
to	O
biochemical	O
and	O
cell	O
-	O
based	O
studies	O
of	O
a	O
handful	O
of	O
metabolic	O
disorders	O
with	O
defects	O
in	O
enzymes	O
including	O
propinyl	O
-	O
CoA	O
carboxylase	O
[	O
2	O
]	O
,	O
argininosuccinate	O
lyase	O
[	O
3	O
]	O
,	O
galactose	O
-	O
1	O
-	O
phosphate	O
uridylyltransferase	O
[	O
4	O
]	O
,	O
and	O
methylmalonyl	O
CoA	O
mutase	O
[	O
5	O
]	O
.	O

Compound	O
heterozygotes	O
are	O
individuals	O
carrying	O
two	O
different	O
mutant	O
alleles	O
of	O
the	O
same	O
gene	O
.	O

In	O
the	O
absence	O
of	O
a	O
dominant	O
(	O
wild	O
-	O
type	O
[	O
wt	O
]	O
)	O
allele	O
,	O
genetic	O
interactions	O
between	O
recessive	O
alleles	O
(	O
referred	O
to	O
here	O
as	O
"	O
biallelic	O
"	O
effects	O
)	O
could	O
result	O
in	O
different	O
phenotypic	O
outcomes	O
including	O
interallelic	O
complementation	O
.	O

Although	O
amelioration	O
of	O
disease	O
symptoms	O
by	O
interallelic	O
complementation	O
would	O
create	O
an	O
ascertainment	O
bias	O
in	O
the	O
clinic	O
,	O
the	O
lack	O
of	O
evidence	O
concerning	O
interallelic	O
complementation	O
or	O
other	O
biallelic	O
effects	O
in	O
human	O
disease	O
is	O
likely	O
caused	O
by	O
the	O
difficulty	O
in	O
distinguishing	O
such	O
effects	O
from	O
environment	O
and	O
genetic	O
background	O
.	O

XPD	O
encodes	O
one	O
of	O
the	O
two	O
helicase	O
components	O
of	O
basal	B-GO
transcription	I-GO
/	I-GO
DNA	I-GO
repair	I-GO
factor	I-GO
IIH	E-GO
(	O
TFIIH	S-GO
)	O
,	O
a	O
ten	O
-	O
subunit	O
,	O
multifunctional	O
complex	S-GO
that	O
is	O
essential	O
for	O
multiple	O
processes	O
,	O
including	O
basal	O
transcription	O
initiation	O
and	O
DNA	O
damage	O
repair	O
via	O
the	O
nucleotide	O
excision	O
repair	O
(	O
NER	O
)	O
pathway	O
[	O
6	O
,	O
7	O
]	O
.	O

Alterations	O
in	O
XPD	O
resulting	O
in	O
defective	O
TFIIH	S-GO
function	O
are	O
associated	O
with	O
UV	O
-	O
sensitive	O
,	O
multisystem	O
disorders	O
including	O
xeroderma	O
pigmentosum	O
(	O
XP	O
)	O
,	O
XP	O
combined	O
with	O
Cockayne	O
syndrome	O
(	O
CS	O
)	O
,	O
and	O
trichothiodystrophy	O
(	O
TTD	O
)	O
[	O
8	O
-	O
10	O
]	O
.	O

XP	O
is	O
marked	O
by	O
sun	O
-	O
induced	O
pigmentation	O
anomalies	O
and	O
a	O
greater	O
than	O
1	O
,	O
000	O
-	O
fold	O
elevation	O
in	O
skin	O
cancer	O
risk	O
.	O

Severe	O
cases	O
can	O
also	O
present	O
with	O
growth	O
retardation	O
and	O
primary	O
neurodegeneration	O
[	O
11	O
]	O
.	O

CS	O
and	O
TTD	O
,	O
on	O
the	O
other	O
hand	O
,	O
are	O
segmental	O
progeroid	O
disorders	O
characterised	O
by	O
progressive	O
post	O
-	O
natal	O
growth	O
failure	O
and	O
primary	O
demyelination	O
resulting	O
in	O
severe	O
neurodysfunction	O
,	O
but	O
without	O
a	O
clear	O
cancer	O
predisposition	O
[	O
12	O
-	O
15	O
]	O
.	O

Patients	O
with	O
TTD	O
additionally	O
display	O
hallmark	O
sulphur	O
-	O
deficient	O
brittle	O
hair	O
and	O
nails	O
and	O
scaling	O
skin	O
[	O
13	O
]	O
,	O
resulting	O
from	O
a	O
basal	O
transcription	O
defect	O
in	O
specific	O
cell	O
types	O
[	O
16	O
,	O
17	O
]	O
.	O

A	O
related	O
disorder	O
with	O
the	O
cancer	O
predisposition	O
of	O
XP	O
combined	O
with	O
the	O
neurodevelopmental	O
complications	O
of	O
CS	O
(	O
XPCS	O
)	O
,	O
although	O
rare	O
,	O
has	O
also	O
been	O
described	O
[	O
18	O
]	O
.	O

Many	O
XPD	O
mutations	O
are	O
associated	O
with	O
an	O
exclusive	O
disease	O
phenotype	O
(	O
e	O
.	O
g	O
.	O
,	O
XPDR722W	O
with	O
TTD	O
and	O
XPDR683W	O
with	O
XP	O
)	O
and	O
are	O
thus	O
viewed	O
as	O
causative	O
of	O
the	O
corresponding	O
syndromes	O
.	O

Alleles	O
not	O
associated	O
exclusively	O
with	O
one	O
disorder	O
are	O
considered	O
"	O
likely	O
null	O
"	O
alleles	O
[	O
19	O
,	O
20	O
]	O
.	O

Some	O
of	O
these	O
alleles	O
fail	O
to	O
support	O
viability	O
in	O
a	O
haploid	O
Schizosaccharomyces	O
pombe	O
yeast	O
strain	O
with	O
a	O
null	O
mutation	O
in	O
the	O
XPD	O
homologue	O
rad15	O
and	O
are	O
thus	O
considered	O
devoid	O
of	O
significant	O
biological	O
activity	O
[	O
19	O
]	O
.	O

This	O
classification	O
of	O
alleles	O
as	O
either	O
causative	O
or	O
null	O
currently	O
defines	O
what	O
we	O
refer	O
to	O
as	O
a	O
"	O
monoallelic	O
"	O
paradigm	O
of	O
XPD	O
disease	O
.	O

However	O
,	O
the	O
identification	O
in	O
recent	O
years	O
of	O
XP	O
complementation	O
group	O
D	O
patients	O
with	O
atypical	O
disease	O
presentation	O
,	O
including	O
symptoms	O
of	O
both	O
XP	O
and	O
TTD	O
[	O
8	O
]	O
,	O
casts	O
doubt	O
on	O
the	O
ability	O
of	O
such	O
a	O
monoallelic	O
paradigm	O
to	O
explain	O
clinical	O
heterogeneity	O
in	O
compound	O
heterozygotes	O
.	O

Previously	O
,	O
we	O
generated	O
a	O
TTD	O
mouse	O
model	O
(	O
XPDR722W	O
)	O
that	O
phenocopies	O
the	O
human	O
syndrome	O
[	O
15	O
,	O
21	O
]	O
.	O

Here	O
we	O
report	O
the	O
generation	O
of	O
additional	O
mutant	O
Xpd	O
alleles	O
that	O
fail	O
to	O
support	O
viability	O
on	O
their	O
own	O
but	O
nevertheless	O
ameliorate	O
TTD	O
-	O
associated	O
premature	O
segmental	O
ageing	O
,	O
cutaneous	O
features	O
,	O
cellular	O
DNA	O
repair	O
capacity	O
,	O
and	O
UV	O
survival	O
when	O
present	O
in	O
a	O
compound	O
heterozygote	O
state	O
.	O

Results	O

Generation	O
of	O
Xpd	O
Compound	O
Heterozygotes	O

We	O
generated	O
an	O
Xpd	O
knock	O
-	O
in	O
allele	O
with	O
a	O
point	O
mutation	O
encoding	O
a	O
single	O
amino	O
acid	O
change	O
(	O
XPDG602D	O
)	O
found	O
in	O
the	O
XPCS	O
patient	O
XPCS2	O
(	O
Figure	O
1A	O
-	O
1C	O
)	O
.	O

mRNA	O
expression	O
from	O
the	O
targeted	O
allele	O
could	O
be	O
detected	O
in	O
embryonic	O
stem	O
cells	O
by	O
RT	O
-	O
PCR	O
(	O
Figure	O
1D	O
)	O
,	O
although	O
expression	O
was	O
reduced	O
approximately	O
5	O
-	O
fold	O
relative	O
to	O
wt	O
mRNA	O
transcript	O
levels	O
as	O
determined	O
by	O
Northern	O
blotting	O
of	O
RNA	O
from	O
the	O
testis	O
of	O
heterozygous	O
animals	O
(	O
Figure	O
1E	O
)	O
.	O

Because	O
patient	O
XPCS2	O
was	O
a	O
hemizygote	O
with	O
mutant	O
XPD	O
protein	O
(	O
XPDG602D	O
)	O
expressed	O
from	O
a	O
single	O
allele	O
,	O
the	O
corresponding	O
mutation	O
was	O
expected	O
to	O
be	O
viable	O
in	O
the	O
homozygous	O
state	O
.	O

However	O
,	O
homozygous	O
mutant	O
mice	O
were	O
not	O
observed	O
,	O
neither	O
amongst	O
live	O
births	O
nor	O
embryonic	O
day	O
13	O
.	O
5	O
(	O
E13	O
.	O
5	O
)	O
or	O
E3	O
.	O
5	O
embryos	O
(	O
Table	O
1	O
)	O
.	O

The	O
corresponding	O
hypomorphic	O
,	O
mutant	O
allele	O
was	O
thus	O
designated	O
as	O
homozygous	O
lethal	O
(	O
+	O
XPCS	O
)	O
.	O

Homozygous	O
lethality	O
of	O
the	O
XPCS	O
allele	O
is	O
likely	O
due	O
to	O
reduced	O
levels	O
of	O
expression	O
of	O
this	O
essential	O
protein	O
as	O
a	O
result	O
of	O
gene	O
targeting	O
(	O
Figure	O
1A	O
)	O
rather	O
than	O
to	O
the	O
mutation	O
itself	O
.	O

Xpd	O
ablation	O
(	O
XpdKO	O
/	O
KO	O
)	O
is	O
similarly	O
incompatible	O
with	O
life	O
beyond	O
the	O
earliest	O
stages	O
of	O
embryogenesis	O
[	O
22	O
]	O
.	O

Consistent	O
with	O
this	O
interpretation	O
,	O
a	O
different	O
targeted	O
Xpd	O
mutation	O
encoding	O
XPDR683W	O
,	O
which	O
is	O
associated	O
with	O
XP	O
in	O
the	O
homozygous	O
state	O
in	O
humans	O
,	O
was	O
similarly	O
underexpressed	O
and	O
lethal	O
in	O
the	O
homozygous	O
state	O
(	O
designated	O
as	O
+	O
XP	O
allele	O
)	O
(	O
Figure	O
1A	O
-	O
1C	O
;	O
Table	O
1	O
;	O
unpublished	O
data	O
)	O
.	O

Also	O
,	O
a	O
different	O
targeting	O
approach	O
leading	O
to	O
the	O
use	O
of	O
the	O
native	O
3	O
'	O
UTR	O
and	O
removal	O
of	O
the	O
neo	O
gene	O
resulted	O
in	O
normalisation	O
of	O
XpdXPCS	O
mRNA	O
levels	O
and	O
viable	O
homozygous	O
XpdXPCS	O
/	O
XPCS	O
(	O
XPDG602D	O
/	O
G602D	O
)	O
animals	O
[	O
23	O
]	O
.	O

Figure	O
1	O

Targeting	O
of	O
the	O
Mouse	O
Xpd	O
Gene	O

(	O
A	O
)	O
Schematic	O
representation	O
of	O
the	O
genomic	O
structure	O
and	O
partial	O
restriction	O
map	O
of	O
the	O
wt	O
and	O
targeted	O
mouse	O
Xpd	O
loci	O
.	O

For	O
the	O
wt	O
Xpd	O
allele	O
,	O
shaded	O
boxes	O
represent	O
coding	O
regions	O
of	O
exons	O
12	O
and	O
19	O
-	O
23	O
;	O
the	O
3	O
'	O
UTR	O
is	O
represented	O
by	O
an	O
open	O
box	O
.	O

TGA	O
indicates	O
the	O
translational	O
stop	O
codon	O
;	O
PolyA	O
indicates	O
the	O
polyadenylation	O
signal	O
.	O

For	O
the	O
XpdTTD	O
targeted	O
allele	O
,	O
the	O
194	O
-	O
base	O
pair	O
(	O
bp	O
)	O
human	O
XPD	O
cDNA	O
fragment	O
fused	O
to	O
exon	O
22	O
is	O
indicated	O
as	O
a	O
striped	O
box	O
including	O
the	O
TTD	O
(	O
R722W	O
)	O
mutation	O
indicated	O
by	O
a	O
vertical	O
arrow	O
.	O

Chicken	O
beta	O
-	O
globin	O
exons	O
2	O
and	O
3	O
including	O
the	O
3	O
'	O
UTR	O
are	O
indicated	O
as	O
black	O
boxes	O
with	O
corresponding	O
Roman	O
numerals	O
followed	O
by	O
the	O
beta	O
-	O
globin	O
polyadenylation	O
signal	O
(	O
PolyA	O
*	O
)	O
.	O

For	O
the	O
Xpd	O
+	O
XP	O
and	O
Xpd	O
+	O
XPCS	O
targeted	O
alleles	O
,	O
vertical	O
arrows	O
indicate	O
XPCS	O
(	O
G602D	O
-	O
encoding	O
)	O
and	O
XP	O
(	O
R683W	O
-	O
encoding	O
)	O
mutations	O
in	O
exons	O
19	O
and	O
22	O
,	O
respectively	O
.	O

The	O
unique	O
3	O
'	O
probe	O
located	O
outside	O
the	O
targeting	O
construct	O
is	O
marked	O
by	O
a	O
thick	O
black	O
line	O
.	O

Restriction	O
sites	O
:	O
B	O
,	O
BamHI	O
;	O
C	O
,	O
ClaI	O
;	O
E	O
,	O
EcoRI	O
;	O
H	O
,	O
HindIII	O
;	O
Hp	O
,	O
HpaI	O
;	O
Sf	O
,	O
SfiI	O
.	O

(	O
B	O
)	O
Southern	O
blot	O
analysis	O
of	O
EcoRI	O
-	O
digested	O
genomic	O
DNA	O
from	O
wt	O
,	O
Xpd	O
+	O
XPCS	O
/	O
wt	O
,	O
and	O
Xpd	O
+	O
XP	O
/	O
wt	O
recombinant	O
embryonic	O
stem	O
cell	O
clones	O
hybridised	O
with	O
the	O
3	O
'	O
probe	O
depicted	O
in	O
(	O
A	O
)	O
.	O

The	O
wt	O
allele	O
yields	O
a	O
6	O
.	O
5	O
-	O
kilobase	O
(	O
kb	O
)	O
fragment	O
,	O
whereas	O
both	O
targeted	O
Xpd	O
+	O
XP	O
and	O
Xpd	O
+	O
XPCS	O
alleles	O
yield	O
a	O
5	O
.	O
1	O
-	O
kb	O
fragment	O
.	O

(	O
C	O
)	O
Genotyping	O
of	O
wt	O
and	O
targeted	O
alleles	O
by	O
PCR	O
using	O
primers	O
F2	O
,	O
R1	O
,	O
and	O
mR	O
as	O
indicated	O
in	O
(	O
A	O
)	O
yields	O
fragments	O
of	O
399	O
bp	O
and	O
468	O
bp	O
,	O
respectively	O
.	O

(	O
D	O
)	O
RT	O
-	O
PCR	O
detection	O
of	O
mRNA	O
expression	O
originating	O
from	O
the	O
targeted	O
+	O
XP	O
and	O
+	O
XPCS	O
alleles	O
in	O
embryonic	O
stem	O
cell	O
clones	O
using	O
primers	O
F1	O
(	O
hybridising	O
outside	O
the	O
targeting	O
construct	O
)	O
and	O
mR	O
as	O
indicated	O
in	O
(	O
A	O
)	O
results	O
in	O
a	O
1	O
,	O
416	O
-	O
bp	O
fragment	O
.	O

(	O
E	O
)	O
Northern	O
blot	O
analysis	O
of	O
total	O
RNA	O
isolated	O
from	O
testis	O
of	O
homozygous	O
wt	O
and	O
XpdTTD	O
/	O
TTD	O
,	O
heterozygous	O
Xpd	O
+	O
XPCS	O
/	O
wt	O
and	O
XpdTTD	O
/	O
wt	O
,	O
and	O
compound	O
heterozygous	O
Xpd	O
+	O
XPCS	O
/	O
TTD	O
mice	O
as	O
indicated	O
.	O

Hybridisation	O
with	O
a	O
1	O
.	O
4	O
-	O
kb	O
mouse	O
Xpd	O
cDNA	O
probe	O
detects	O
mRNAs	O
of	O
4	O
,	O
3	O
.	O
3	O
,	O
and	O
2	O
.	O
7	O
kb	O
from	O
wt	O
,	O
Xpd	O
+	O
XPCS	O
,	O
and	O
XpdTTD	O
alleles	O
,	O
respectively	O
.	O

An	O
ethidium	O
bromide	O
(	O
EtBr	O
)	O
-	O
stained	O
gel	O
showing	O
the	O
amount	O
of	O
total	O
RNA	O
loaded	O
is	O
shown	O
below	O
.	O

Table	O
1	O

Frequency	O
of	O
Xpd	O
+	O
XP	O
/	O
+	O
XP	O
,	O
Xpd	O
+	O
XPCS	O
/	O
+	O
XPCS	O
,	O
and	O
Compound	O
Heterozygous	O
Xpd	O
+	O
XP	O
/	O
+	O
XPCS	O
Embryos	O
and	O
Offspring	O

"	O
Null	O
"	O
Allele	O
Can	O
Alleviate	O
Developmental	O
Delay	O
,	O
Skin	O
,	O
and	O
Hair	O
Features	O
of	O
TTD	O

To	O
test	O
the	O
potential	O
of	O
a	O
homozygous	O
lethal	O
"	O
null	O
"	O
allele	O
to	O
nevertheless	O
contribute	O
to	O
organismal	O
phenotype	O
,	O
we	O
combined	O
an	O
Xpd	O
+	O
XPCS	O
allele	O
with	O
a	O
viable	O
XpdTTD	O
allele	O
by	O
crossing	O
the	O
corresponding	O
heterozygous	O
animals	O
.	O

Similar	O
to	O
hemizygous	O
TTD	O
mice	O
carrying	O
one	O
true	O
Xpd	O
knockout	O
allele	O
(	O
XpdTTD	O
/	O
KO	O
)	O
,	O
compound	O
heterozygous	O
XpdTTD	O
/	O
+	O
XPCS	O
mice	O
were	O
born	O
at	O
the	O
expected	O
Mendelian	O
frequencies	O
.	O

Expression	O
from	O
the	O
Xpd	O
+	O
XPCS	O
allele	O
was	O
also	O
reduced	O
in	O
the	O
testis	O
of	O
compound	O
heterozygous	O
animals	O
,	O
whereas	O
expression	O
from	O
the	O
XpdTTD	O
allele	O
was	O
increased	O
relative	O
to	O
wt	O
by	O
~	O
5	O
-	O
fold	O
(	O
Figure	O
1E	O
)	O
.	O

Because	O
of	O
a	O
lack	O
of	O
available	O
antibodies	S-GO
and	O
the	O
inability	O
to	O
distinguish	O
amongst	O
various	O
mutant	O
forms	O
of	O
XPD	O
differing	O
only	O
by	O
single	O
amino	O
acid	O
substitutions	O
,	O
we	O
were	O
unable	O
to	O
ascertain	O
the	O
relative	O
amount	O
of	O
XPD	O
protein	O
from	O
the	O
different	O
alleles	O
.	O

Despite	O
reduced	O
levels	O
of	O
mRNA	O
expression	O
,	O
the	O
homozygous	O
lethal	O
Xpd	O
+	O
XPCS	O
allele	O
ameliorated	O
multiple	O
XpdTTD	O
-	O
associated	O
disease	O
symptoms	O
in	O
compound	O
heterozygous	O
XpdTTD	O
/	O
+	O
XPCS	O
animals	O
including	O
the	O
hallmark	O
brittle	O
hair	O
and	O
cutaneous	O
features	O
fully	O
penetrant	O
in	O
homo	O
-	O
and	O
hemizygous	O
TTD	O
mice	O
(	O
Figure	O
2A	O
-	O
2C	O
)	O
.	O

In	O
marked	O
contrast	O
to	O
XpdTTD	O
/	O
TTD	O
(	O
and	O
XpdTTD	O
/	O
KO	O
)	O
mice	O
,	O
which	O
display	O
complete	O
hair	O
loss	O
in	O
the	O
first	O
hair	O
cycle	O
and	O
partial	O
hair	O
loss	O
in	O
subsequent	O
cycles	O
throughout	O
their	O
lives	O
[	O
21	O
]	O
,	O
compound	O
heterozygous	O
XpdTTD	O
/	O
+	O
XPCS	O
mice	O
displayed	O
some	O
hair	O
loss	O
only	O
during	O
the	O
first	O
hair	O
cycle	O
and	O
only	O
locally	O
at	O
the	O
back	O
(	O
Figure	O
2A	O
)	O
.	O

Scanning	O
electron	O
microscope	O
analysis	O
of	O
XpdTTD	O
/	O
+	O
XPCS	O
hair	O
revealed	O
an	O
almost	O
normal	O
appearance	O
,	O
with	O
TTD	O
-	O
like	O
features	O
such	O
as	O
broken	O
hairs	O
found	O
only	O
at	O
very	O
low	O
frequency	O
(	O
unpublished	O
data	O
)	O
.	O

Amino	O
acid	O
analysis	O
confirmed	O
that	O
cysteine	O
levels	O
in	O
the	O
hair	O
of	O
the	O
XpdTTD	O
/	O
+	O
XPCS	O
mice	O
were	O
significantly	O
higher	O
than	O
in	O
XpdTTD	O
/	O
TTD	O
animals	O
,	O
but	O
remained	O
below	O
the	O
wt	O
level	O
(	O
Figure	O
2C	O
)	O
.	O

TTD	O
hemizygotes	O
(	O
XpdTTD	O
/	O
KO	O
)	O
do	O
not	O
display	O
significant	O
differences	O
in	O
cutaneous	O
features	O
and	O
longevity	O
relative	O
to	O
homozygous	O
XpdTTD	O
/	O
TTD	O
mice	O
[	O
21	O
]	O
.	O

Figure	O
2	O

Partial	O
Rescue	O
of	O
TTD	O
Cutaneous	O
,	O
Blood	O
,	O
and	O
Developmental	O
Phenotypes	O
in	O
Compound	O
Heterozygous	O
XpdTTD	O
/	O
+	O
XPCS	O
Mice	O

(	O
A	O
)	O
Photographs	O
of	O
5	O
-	O
mo	O
-	O
old	O
homozygous	O
XpdTTD	O
/	O
TTD	O
,	O
compound	O
heterozygous	O
XpdTTD	O
/	O
+	O
XPCS	O
,	O
and	O
wt	O
mice	O
.	O

Insets	O
:	O
images	O
of	O
first	O
-	O
round	O
hair	O
loss	O
.	O

(	O
B	O
)	O
Histological	O
analysis	O
of	O
the	O
skin	O
of	O
XpdTTD	O
/	O
TTD	O
,	O
XpdTTD	O
/	O
+	O
XPCS	O
,	O
and	O
wt	O
mice	O
.	O

TTD	O
-	O
associated	O
acanthosis	O
(	O
thicker	O
epidermis	O
,	O
indicated	O
by	O
solid	O
vertical	O
line	O
)	O
,	O
pronounced	O
granular	O
layer	O
(	O
indicated	O
by	O
arrows	O
)	O
,	O
and	O
sebacious	O
gland	O
hyperplasia	O
(	O
indicated	O
by	O
dotted	O
vertical	O
line	O
)	O
were	O
absent	O
in	O
the	O
epidermis	O
of	O
XpdTTD	O
/	O
+	O
XPCS	O
and	O
wt	O
mice	O
.	O

Magnification	O
400	O
x	O
.	O

(	O
C	O
)	O
Cysteine	O
content	O
of	O
hair	O
from	O
wt	O
,	O
XpdTTD	O
/	O
TTD	O
,	O
and	O
XpdTTD	O
/	O
+	O
XPCS	O
mice	O
.	O

The	O
p	O
-	O
value	O
indicates	O
significant	O
differences	O
between	O
mutants	O
and	O
wt	O
,	O
as	O
well	O
as	O
between	O
XpdTTD	O
/	O
TTD	O
and	O
XpdTTD	O
/	O
+	O
XPCS	O
mice	O
.	O

Error	O
bars	O
indicate	O
standard	O
error	O
of	O
the	O
mean	O
(	O
SEM	O
)	O
.	O

(	O
D	O
)	O
Hematocrit	O
values	O
from	O
blood	O
of	O
XpdTTD	O
/	O
TTD	O
and	O
XpdTTD	O
/	O
+	O
XPCS	O
mice	O
.	O

The	O
p	O
-	O
values	O
indicate	O
the	O
significance	O
of	O
the	O
difference	O
relative	O
to	O
wt	O
.	O

Error	O
bars	O
indicate	O
SEM	O
.	O

(	O
E	O
)	O
Body	O
weights	O
of	O
developing	O
XpdTTD	O
/	O
TTD	O
and	O
XpdTTD	O
/	O
+	O
XPCS	O
mice	O
after	O
weaning	O
plotted	O
as	O
a	O
percentage	O
of	O
the	O
weight	O
of	O
age	O
-	O
matched	O
control	O
wt	O
and	O
heterozygote	O
(	O
hz	O
)	O
littermates	O
(	O
set	O
at	O
100	O
%	O
)	O
.	O

Error	O
bars	O
indicate	O
SEM	O
.	O

Other	O
prominent	O
TTD	O
features	O
in	O
the	O
epidermis	O
,	O
including	O
acanthosis	O
(	O
thickening	O
of	O
the	O
layer	O
of	O
the	O
nucleated	S-GO
cells	O
)	O
,	O
hyperkeratosis	O
(	O
prominent	O
thickening	O
of	O
the	O
cornified	O
layer	O
)	O
,	O
and	O
pronounced	O
granular	O
layer	O
and	O
sebacious	O
gland	O
hyperplasia	O
(	O
causing	O
greasy	O
appearance	O
of	O
the	O
hair	O
)	O
,	O
were	O
absent	O
in	O
the	O
skin	O
of	O
XpdTTD	O
/	O
+	O
XPCS	O
mice	O
,	O
as	O
established	O
by	O
blind	O
microscopic	O
examination	O
of	O
skin	O
sections	O
(	O
Figure	O
2B	O
)	O
.	O

Furthermore	O
,	O
anaemia	O
and	O
developmental	O
delay	O
present	O
in	O
patients	O
with	O
TTD	O
[	O
24	O
]	O
and	O
in	O
XpdTTD	O
/	O
TTD	O
mice	O
[	O
15	O
]	O
were	O
both	O
partially	O
rescued	O
in	O
compound	O
heterozygous	O
XpdTTD	O
/	O
+	O
XPCS	O
mice	O
(	O
Figure	O
2D	O
and	O
2E	O
)	O
.	O

Rescue	O
of	O
Progeroid	O
Features	O
in	O
TTD	O
Mice	O
by	O
Homozygous	O
Lethal	O
Xpd	O
Alleles	O

Because	O
patients	O
with	O
TTD	O
,	O
XPCS	O
,	O
and	O
CS	O
(	O
but	O
not	O
XP	O
)	O
and	O
the	O
corresponding	O
mouse	O
models	O
share	O
similar	O
accelerated	O
progeroid	O
symptoms	O
[	O
12	O
,	O
13	O
,	O
15	O
,	O
23	O
]	O
,	O
we	O
next	O
addressed	O
ageing	O
-	O
related	O
parameters	O
in	O
compound	O
heterozygous	O
mice	O
(	O
Figure	O
3	O
)	O
.	O

Whereas	O
XpdTTD	O
/	O
TTD	O
animals	O
show	O
reduced	O
bone	O
mineral	O
density	O
as	O
an	O
indication	O
of	O
the	O
early	O
onset	O
of	O
osteoporosis	O
before	O
~	O
14	O
mo	O
of	O
age	O
[	O
15	O
]	O
,	O
tail	O
vertebrae	O
from	O
compound	O
heterozygous	O
XpdTTD	O
/	O
+	O
XPCS	O
mice	O
were	O
comparable	O
to	O
wt	O
even	O
at	O
20	O
mo	O
of	O
age	O
(	O
Figure	O
3B	O
and	O
3C	O
)	O
.	O

Furthermore	O
,	O
whereas	O
XpdTTD	O
/	O
TTD	O
mice	O
developed	O
kyphosis	O
earlier	O
than	O
wt	O
animals	O
(	O
onset	O
~	O
3	O
mo	O
versus	O
12	O
-	O
20	O
mo	O
)	O
,	O
compound	O
heterozygous	O
XpdTTD	O
/	O
+	O
XPCS	O
mice	O
did	O
not	O
(	O
Figure	O
3B	O
)	O
.	O

Overall	O
appearance	O
and	O
body	O
weight	O
curves	O
revealed	O
that	O
TTD	O
-	O
associated	O
age	O
-	O
related	O
premature	O
cachexia	O
and	O
lack	O
of	O
general	O
fitness	O
were	O
fully	O
rescued	O
in	O
compound	O
heterozygous	O
XpdTTD	O
/	O
+	O
XPCS	O
mice	O
(	O
Figure	O
3A	O
and	O
3D	O
)	O
.	O

Finally	O
,	O
the	O
life	O
span	O
of	O
compound	O
heterozygotes	O
was	O
extended	O
relative	O
to	O
XpdTTD	O
/	O
TTD	O
mice	O
(	O
Table	O
2	O
)	O
.	O

Figure	O
3	O

Rescue	O
of	O
TTD	O
-	O
Associated	O
Segmental	O
Progeroid	O
Features	O
in	O
Compound	O
Heterozygous	O
Xpd	O
TTD	O
/	O
+	O
XPCS	O
Mice	O

(	O
A	O
)	O
Photographs	O
of	O
20	O
-	O
mo	O
-	O
old	O
wt	O
,	O
compound	O
heterozygous	O
XpdTTD	O
/	O
+	O
XPCS	O
,	O
and	O
homozygous	O
XpdTTD	O
/	O
TTD	O
mice	O
.	O

Note	O
the	O
extreme	O
cachexia	O
(	O
lack	O
of	O
subcutaneous	O
fat	O
)	O
in	O
the	O
XpdTTD	O
/	O
TTD	O
mouse	O
and	O
the	O
absence	O
of	O
this	O
phenotype	O
in	O
wt	O
and	O
XpdTTD	O
/	O
+	O
XPCS	O
mice	O
.	O

(	O
B	O
)	O
Radiographs	O
of	O
20	O
-	O
mo	O
-	O
old	O
male	O
wt	O
,	O
XpdTTD	O
/	O
+	O
XPCS	O
,	O
and	O
XpdTTD	O
/	O
TTD	O
mice	O
.	O

Ageing	O
XpdTTD	O
/	O
TTD	O
mice	O
develop	O
kyphosis	O
(	O
curvature	O
of	O
the	O
spinal	O
column	O
)	O
and	O
reduction	O
of	O
bone	O
mineral	O
density	O
as	O
shown	O
in	O
the	O
6	O
-	O
8	O
segment	O
of	O
the	O
tail	O
vertebrae	O
counted	O
from	O
the	O
pelvis	O
(	O
see	O
close	O
-	O
up	O
at	O
right	O
)	O
.	O

Note	O
the	O
absence	O
of	O
these	O
features	O
in	O
the	O
XpdTTD	O
/	O
+	O
XPCS	O
mouse	O
.	O

(	O
C	O
)	O
Quantification	O
of	O
relative	O
bone	O
mineral	O
density	O
of	O
tail	O
vertebrae	O
from	O
20	O
-	O
mo	O
-	O
old	O
male	O
wt	O
(	O
n	O
=	O
3	O
)	O
,	O
XpdTTD	O
/	O
+	O
XPCS	O
(	O
n	O
=	O
4	O
)	O
,	O
and	O
XpdTTD	O
/	O
TTD	O
(	O
n	O
=	O
3	O
)	O
mice	O
.	O

The	O
p	O
-	O
values	O
indicate	O
the	O
significance	O
of	O
the	O
difference	O
relative	O
to	O
XpdTTD	O
/	O
TTD	O
.	O

Error	O
bars	O
indicate	O
SEM	O
.	O

(	O
D	O
)	O
Body	O
weight	O
curves	O
as	O
a	O
function	O
of	O
time	O
.	O

Note	O
that	O
the	O
age	O
-	O
dependent	O
cachexia	O
observed	O
in	O
XpdTTD	O
/	O
TTD	O
mice	O
was	O
rescued	O
in	O
both	O
male	O
and	O
female	O
XpdTTD	O
/	O
+	O
XPCS	O
mice	O
.	O

Significant	O
differences	O
between	O
wt	O
and	O
XpdTTD	O
/	O
TTD	O
but	O
not	O
between	O
wt	O
and	O
XpdTTD	O
/	O
+	O
XPCS	O
mice	O
were	O
observed	O
at	O
9	O
and	O
18	O
mo	O
of	O
age	O
as	O
indicated	O
by	O
asterisks	O
.	O

Error	O
bars	O
indicate	O
SEM	O
.	O

Table	O
2	O

Pleiotropic	O
Xpd	O
Biallelic	O
Effects	O
in	O
Mice	O
and	O
Cells	O

To	O
determine	O
whether	O
the	O
homozygous	O
lethal	O
Xpd	O
+	O
XPCS	O
allele	O
was	O
unique	O
in	O
its	O
ability	O
to	O
ameliorate	O
symptoms	O
associated	O
with	O
the	O
XpdTTD	O
allele	O
,	O
we	O
generated	O
compound	O
heterozygous	O
XpdTTD	O
/	O
+	O
XP	O
mice	O
by	O
crossing	O
the	O
corresponding	O
heterozygous	O
animals	O
.	O

Similar	O
to	O
the	O
Xpd	O
+	O
XPCS	O
allele	O
,	O
the	O
homozygous	O
lethal	O
Xpd	O
+	O
XP	O
allele	O
rescued	O
cutaneous	O
symptoms	O
including	O
hair	O
loss	O
(	O
except	O
locally	O
during	O
the	O
first	O
round	O
;	O
unpublished	O
data	O
)	O
,	O
reduced	O
cysteine	O
content	O
(	O
cysteine	O
index	O
9	O
.	O
3	O
+/-	O
0	O
.	O
9	O
standard	O
deviation	O
[	O
87	O
%	O
of	O
wt	O
]	O
,	O
p	O
=	O
0	O
.	O
01	O
versus	O
TTD	O
)	O
,	O
ageing	O
-	O
associated	O
premature	O
cachexia	O
(	O
males	O
and	O
females	O
were	O
36	O
.	O
1	O
+/-	O
6	O
.	O
4	O
g	O
[	O
93	O
%	O
of	O
wt	O
]	O
and	O
39	O
.	O
2	O
+/-	O
3	O
.	O
2	O
g	O
[	O
116	O
%	O
of	O
wt	O
]	O
,	O
respectively	O
)	O
,	O
and	O
reduced	O
life	O
span	O
(	O
Table	O
2	O
)	O
.	O

Taken	O
together	O
,	O
these	O
data	O
indicate	O
that	O
two	O
independent	O
alleles	O
,	O
which	O
on	O
their	O
own	O
are	O
unable	O
to	O
support	O
viability	O
(	O
Table	O
1	O
)	O
,	O
were	O
nonetheless	O
able	O
to	O
ameliorate	O
TTD	O
-	O
associated	O
phenotypes	O
in	O
vivo	O
(	O
Table	O
2	O
)	O
.	O

Molecular	O
Mechanisms	O
of	O
Biallelic	O
Effects	O

We	O
next	O
turned	O
to	O
UV	O
-	O
based	O
cellular	O
assays	O
including	O
unscheduled	O
DNA	O
synthesis	O
after	O
UV	O
irradiation	O
(	O
UV	O
-	O
UDS	O
)	O
,	O
recovery	O
of	O
RNA	O
synthesis	O
after	O
UV	O
irradiation	O
(	O
UV	O
-	O
RRS	O
)	O
,	O
and	O
UV	O
survival	O
,	O
which	O
report	O
on	O
the	O
NER	O
subpathways	O
(	O
global	O
genome	O
NER	O
and	O
transcription	O
-	O
coupled	O
NER	O
)	O
and	O
total	O
NER	O
,	O
respectively	O
.	O

In	O
none	O
of	O
these	O
assays	O
was	O
the	O
response	O
to	O
UV	O
improved	O
in	O
compound	O
heterozygotes	O
relative	O
to	O
TTD	O
homozygotes	O
(	O
Figure	O
4A	O
-	O
4C	O
)	O
.	O

However	O
,	O
unlike	O
the	O
in	O
vivo	O
TTD	O
phenotypes	O
described	O
above	O
,	O
in	O
which	O
XpdTTD	O
/	O
TTD	O
and	O
XpdTTD	O
/	O
KO	O
animals	O
were	O
indistinguishable	O
,	O
XpdTTD	O
dosage	O
effects	O
were	O
observed	O
in	O
UV	O
survival	O
,	O
UV	O
-	O
UDS	O
,	O
and	O
UV	O
-	O
RRS	O
,	O
indicating	O
that	O
cellular	O
parameters	O
as	O
measured	O
in	O
fibroblasts	O
here	O
do	O
not	O
always	O
correlate	O
with	O
the	O
phenotype	O
at	O
the	O
level	O
of	O
the	O
intact	O
organism	O
.	O

XpdTTD	O
/	O
KO	O
hemizygous	O
cells	O
were	O
thus	O
used	O
as	O
the	O
baseline	O
on	O
which	O
to	O
compare	O
the	O
activity	O
of	O
compound	O
heterozygous	O
cells	O
.	O

Relative	O
to	O
XpdTTD	O
/	O
KO	O
hemizygote	O
cells	O
,	O
UV	O
survival	O
was	O
improved	O
by	O
the	O
homozygous	O
lethal	O
Xpd	O
+	O
XPCS	O
allele	O
in	O
XpdTTD	O
/	O
+	O
XPCS	O
compound	O
heterozygous	O
cells	O
and	O
to	O
a	O
lesser	O
degree	O
by	O
the	O
Xpd	O
+	O
XP	O
allele	O
(	O
Figure	O
4A	O
)	O
.	O

Because	O
of	O
embryonic	O
and	O
cellular	O
lethality	O
,	O
we	O
were	O
unable	O
to	O
test	O
UV	O
survival	O
associated	O
exclusively	O
with	O
the	O
Xpd	O
+	O
XPCS	O
or	O
Xpd	O
+	O
XP	O
alleles	O
.	O

However	O
,	O
homozygous	O
XPDXP	O
(	O
XPDR683W	O
)	O
and	O
hemizygous	O
XPDXPCS	O
(	O
XPDG602D	O
)	O
human	O
cells	O
are	O
known	O
to	O
be	O
highly	O
sensitive	O
to	O
UV	O
[	O
19	O
,	O
25	O
]	O
,	O
as	O
are	O
cells	O
from	O
a	O
homozygous	O
viable	O
XpdXPCS	O
/	O
XPCS	O
(	O
XPDG602D	O
/	O
G602D	O
)	O
mouse	O
model	O
(	O
Figure	O
4A	O
,	O
dotted	O
line	O
)	O
[	O
23	O
]	O
.	O

Thus	O
,	O
the	O
survival	O
of	O
XpdTTD	O
/	O
+	O
XPCS	O
(	O
and	O
XpdTTD	O
/	O
+	O
XP	O
)	O
cells	O
likely	O
represents	O
a	O
level	O
of	O
UV	O
resistance	O
that	O
neither	O
mutant	O
allele	O
can	O
impart	O
on	O
its	O
own	O
(	O
Table	O
2	O
)	O
.	O

Significant	O
effects	O
of	O
compound	O
heterozygosity	O
on	O
NER	O
subpathways	O
relative	O
to	O
XpdTTD	O
/	O
KO	O
cells	O
were	O
observed	O
in	O
XpdTTD	O
/	O
+	O
XP	O
cells	O
but	O
only	O
for	O
UV	O
-	O
UDS	O
activity	O
.	O

Finally	O
,	O
none	O
of	O
the	O
mutant	O
TFIIH	S-GO
combinations	O
(	O
carrying	O
alterations	O
associated	O
with	O
TTD	O
[	O
XPDR722W	O
]	O
,	O
XPCS	O
[	O
XPDG602D	O
]	O
,	O
or	O
XP	O
[	O
XPDR683W	O
]	O
)	O
exhibited	O
synergism	O
in	O
an	O
in	O
vitro	O
NER	O
reaction	O
reconstituted	O
with	O
different	O
mutant	O
TFIIH	B-GO
complexes	E-GO
(	O
Figure	O
4D	O
)	O
.	O

Taken	O
together	O
,	O
these	O
data	O
are	O
consistent	O
with	O
interallelic	O
complementation	O
of	O
UV	O
sensitivity	O
in	O
cells	O
but	O
underscore	O
the	O
lack	O
of	O
any	O
correlation	O
between	O
UV	O
-	O
related	O
repair	O
characteristics	O
and	O
TTD	O
progeroid	O
phenotypes	O
in	O
animal	O
models	O
.	O

Figure	O
4	O

TFIIH	S-GO
Functions	O
and	O
Mechanisms	O
of	O
XPD	O
-	O
Associated	O
Disease	O
Pleiotropy	O

(	O
A	O
)	O
Cellular	O
survival	O
after	O
UV	O
irradiation	O
.	O

Rescue	O
of	O
hemizygous	O
XpdTTD	O
/	O
KO	O
survival	O
by	O
Xpd	O
+	O
XPCS	O
and	O
Xpd	O
+	O
XP	O
alleles	O
is	O
illustrated	O
by	O
arrows	O
marked	O
A	O
and	O
B	O
,	O
respectively	O
.	O

UV	O
survival	O
of	O
homozygous	O
XpdXPCS	O
/	O
XPCS	O
cells	O
(	O
asterisk	O
)	O
from	O
the	O
normally	O
expressed	O
viable	O
allele	O
(	O
XpdXPCS	O
)	O
is	O
depicted	O
by	O
a	O
dotted	O
line	O
.	O

Survival	O
curves	O
represent	O
an	O
average	O
of	O
four	O
independent	O
experiments	O
;	O
1	O
-	O
2	O
cell	O
lines	O
per	O
genotype	O
were	O
included	O
in	O
each	O
experiment	O
.	O

Error	O
bars	O
indicate	O
SEM	O
between	O
experiments	O
.	O

(	O
B	O
)	O
UV	O
-	O
UDS	O
,	O
a	O
measure	O
of	O
global	O
genome	O
repair	O
.	O

Number	O
of	O
experiments	O
:	O
n	O
=	O
15	O
(	O
XpdTTD	O
/	O
TTD	O
)	O
,	O
n	O
=	O
6	O
(	O
XpdTTD	O
/	O
KO	O
)	O
,	O
n	O
=	O
4	O
(	O
XpdTTD	O
/	O
+	O
XPCS	O
)	O
,	O
n	O
=	O
2	O
(	O
XpdTTD	O
/	O
+	O
XP	O
)	O
;	O
1	O
-	O
2	O
cell	O
lines	O
per	O
genotype	O
were	O
included	O
in	O
each	O
experiment	O
.	O

The	O
asterisk	O
indicates	O
significant	O
difference	O
with	O
XpdTTD	O
/	O
TTD	O
;	O
crosses	O
indicate	O
significant	O
differences	O
with	O
XpdTTD	O
/	O
KO	O
.	O

(	O
C	O
)	O
UV	O
-	O
RRS	O
,	O
a	O
measure	O
of	O
transcription	O
-	O
coupled	O
repair	O
of	O
UV	O
-	O
induced	O
lesions	O
.	O

Number	O
of	O
experiments	O
:	O
n	O
=	O
7	O
(	O
XpdTTD	O
/	O
TTD	O
)	O
,	O
n	O
=	O
2	O
(	O
XpdTTD	O
/	O
KO	O
)	O
,	O
n	O
=	O
4	O
(	O
XpdTTD	O
/	O
+	O
XPCS	O
)	O
,	O
n	O
=	O
2	O
(	O
XpdTTD	O
/	O
+	O
XP	O
)	O
;	O
1	O
-	O
2	O
cell	O
lines	O
per	O
genotype	O
were	O
included	O
in	O
each	O
experiment	O
.	O

(	O
D	O
)	O
Incision	O
/	O
excision	O
activity	O
of	O
combinations	O
of	O
altered	O
TFIIH	B-GO
complexes	E-GO
in	O
a	O
reconstituted	O
NER	O
reaction	O
.	O

Equal	O
amounts	O
of	O
single	O
or	O
mixed	O
populations	O
of	O
recombinant	O
TFIIHs	S-GO
(	O
containing	O
XPD	O
,	O
XPB	O
,	O
p62	O
,	O
p52	O
,	O
His	O
-	O
p44	O
,	O
Flag	O
-	O
p34	O
,	O
cdk7	O
,	O
cyclin	O
H	O
,	O
Mat1	O
,	O
and	O
p8	O
)	O
were	O
mixed	O
with	O
recombinant	O
XPG	O
,	O
XPF	O
/	O
ERCC1	O
,	O
XPC	O
/	O
hHR23B	O
,	O
RPA	O
,	O
and	O
a	O
radiolabelled	O
synthetic	O
NER	O
substrate	O
.	O

The	O
excision	O
products	O
(	O
26	O
-	O
34	O
nucleotides	O
in	O
length	O
)	O
were	O
visualised	O
at	O
nucleotide	O
resolution	O
on	O
a	O
denaturing	O
polyacrylamide	O
gel	O
as	O
indicated	O
.	O

Note	O
the	O
weak	O
activity	O
corresponding	O
to	O
each	O
single	O
and	O
combined	O
TFIIH	B-GO
complex	E-GO
(	O
lanes	O
3	O
-	O
8	O
)	O
relative	O
to	O
the	O
wt	O
(	O
lane	O
1	O
)	O
and	O
negative	O
controls	O
(	O
lane	O
2	O
)	O
.	O

(	O
E	O
)	O
Xpd	O
dose	O
-	O
dependent	O
reduction	O
of	O
TFIIH	S-GO
in	O
homozygous	O
XpdTTD	O
/	O
TTD	O
,	O
hemizygous	O
XpdTTD	O
/	O
KO	O
,	O
and	O
compound	O
heterozygous	O
XpdTTD	O
/	O
+	O
XPCS	O
and	O
XpdTTD	O
/	O
+	O
XP	O
cells	O
by	O
comparative	O
immunofluorescence	O
of	O
the	O
p62	O
subunit	O
of	O
TFIIH	O
.	O

Roman	O
numerals	O
represent	O
different	O
microscopic	O
slides	O
and	O
Arabic	O
numerals	O
different	O
cell	O
lines	O
labelled	O
as	O
follows	O
:	O
(	O
I	O
)	O
wt	O
cells	O
(	O
1	O
)	O
labelled	O
with	O
2	O
-	O
mu	O
m	O
beads	O
,	O
XpdTTD	O
/	O
TTD	O
cells	O
(	O
2	O
)	O
with	O
0	O
.	O
79	O
-	O
mu	O
m	O
beads	O
,	O
and	O
XpdTTD	O
/	O
KO	O
cells	O
(	O
3	O
)	O
with	O
no	O
beads	O
;	O
(	O
II	O
)	O
wt	O
cells	O
(	O
1	O
)	O
labelled	O
with	O
0	O
.	O
79	O
-	O
mu	O
m	O
beads	O
and	O
XpdTTD	O
/	O
+	O
XPCS	O
cells	O
(	O
4	O
)	O
with	O
no	O
beads	O
;	O
and	O
(	O
III	O
)	O
wt	O
cells	O
(	O
1	O
)	O
labelled	O
with	O
0	O
.	O
79	O
-	O
mu	O
m	O
beads	O
and	O
XpdTTD	O
/	O
+	O
XP	O
cells	O
(	O
5	O
)	O
with	O
no	O
beads	O
.	O

(	O
F	O
)	O
Quantification	O
of	O
immunofluorescent	O
signal	O
from	O
at	O
least	O
50	O
nuclei	S-GO
per	O
cell	O
line	O
and	O
2	O
-	O
6	O
experiments	O
per	O
genotype	O
.	O

Bars	O
representing	O
cells	O
analysed	O
on	O
the	O
same	O
microscopic	O
slide	O
are	O
depicted	O
side	O
by	O
side	O
,	O
with	O
wt	O
set	O
at	O
100	O
%	O
.	O

The	O
p	O
-	O
value	O
indicates	O
minimum	O
significant	O
difference	O
between	O
wt	O
and	O
the	O
indicated	O
cell	O
lines	O
analysed	O
on	O
the	O
same	O
microscopic	O
slide	O
within	O
one	O
experiment	O
.	O

Next	O
we	O
asked	O
whether	O
the	O
Xpd	O
+	O
XPCS	O
and	O
Xpd	O
+	O
XP	O
alleles	O
,	O
despite	O
decreased	O
mRNA	O
levels	O
,	O
ameliorated	O
TTD	O
symptoms	O
by	O
increasing	O
overall	O
TFIIH	S-GO
levels	O
in	O
compound	O
heterozygous	O
XpdTTD	O
/	O
+	O
XPCS	O
and	O
XpdTTD	O
/	O
+	O
XP	O
cells	O
.	O

Previously	O
,	O
using	O
comparative	O
immunohistochemistry	O
,	O
we	O
and	O
others	O
have	O
shown	O
an	O
up	O
to	O
70	O
%	O
reduction	O
of	O
TFIIH	S-GO
levels	O
in	O
primary	O
fibroblasts	O
from	O
patients	O
with	O
TTD	O
compared	O
with	O
wt	O
controls	O
due	O
to	O
reduced	O
stability	O
[	O
16	O
,	O
17	O
]	O
.	O

Despite	O
overexpression	O
of	O
mRNA	O
from	O
the	O
XpdTTD	O
allele	O
relative	O
to	O
the	O
wt	O
allele	O
(	O
Figure	O
1E	O
)	O
,	O
TFIIH	S-GO
protein	O
levels	O
were	O
reduced	O
by	O
50	O
%	O
in	O
primary	O
mouse	O
XpdTTD	O
/	O
TTD	O
fibroblasts	O
(	O
Figure	O
4E	O
and	O
4F	O
)	O
,	O
thereby	O
mimicking	O
the	O
situation	O
in	O
human	O
patients	O
with	O
TTD	O
.	O

In	O
accordance	O
with	O
the	O
gene	O
dosage	O
,	O
a	O
further	O
reduction	O
of	O
up	O
to	O
70	O
%	O
of	O
the	O
wt	O
level	O
was	O
observed	O
in	O
hemizygous	O
XpdTTD	O
/	O
KO	O
cells	O
.	O

Consistent	O
with	O
low	O
mRNA	O
expression	O
levels	O
,	O
neither	O
the	O
Xpd	O
+	O
XPCS	O
nor	O
the	O
Xpd	O
+	O
XP	O
allele	O
was	O
able	O
to	O
restore	O
TFIIH	S-GO
abundance	O
to	O
wt	O
levels	O
in	O
XpdTTD	O
compound	O
heterozygote	O
cells	O
(	O
Figure	O
4E	O
and	O
4F	O
)	O
.	O

Thus	O
,	O
the	O
improved	O
UV	O
survival	O
observed	O
in	O
compound	O
heterozygote	O
cells	O
(	O
Figure	O
4A	O
)	O
and	O
likely	O
the	O
rescue	O
of	O
TTD	O
progeroid	O
symptoms	O
(	O
Figure	O
3	O
)	O
were	O
not	O
due	O
to	O
normalisation	O
of	O
TFIIH	S-GO
levels	O
,	O
suggesting	O
a	O
qualitative	O
rather	O
than	O
a	O
quantitative	O
effect	O
on	O
these	O
phenotypes	O
in	O
vivo	O
.	O

In	O
contrast	O
,	O
the	O
level	O
of	O
XPCS	O
mRNA	O
expression	O
did	O
affect	O
the	O
ability	O
of	O
the	O
encoded	O
protein	O
(	O
XPDG602D	O
)	O
to	O
restore	O
the	O
TTD	O
hair	O
phenotype	O
to	O
normal	O
.	O

Notably	O
,	O
XpdTTD	O
/	O
+	O
XPCS	O
animals	O
had	O
a	O
partial	O
TTD	O
hair	O
phenotype	O
,	O
correlating	O
with	O
low	O
levels	O
of	O
Xpd	O
+	O
XPCS	O
expression	O
,	O
whereas	O
XpdTTD	O
/	O
XPCS	O
animals	O
had	O
wt	O
hair	O
,	O
correlating	O
with	O
normal	O
expression	O
levels	O
from	O
the	O
viable	O
XpdXPCS	O
allele	O
(	O
Table	O
2	O
and	O
unpublished	O
data	O
)	O
.	O

Thus	O
,	O
the	O
range	O
of	O
expression	O
levels	O
from	O
these	O
two	O
mutant	O
alleles	O
affected	O
their	O
ability	O
to	O
complement	O
some	O
phenotypes	O
(	O
hair	O
)	O
.	O

An	O
overview	O
of	O
the	O
functional	O
relationships	O
between	O
Xpd	O
alleles	O
,	O
phenotypes	O
,	O
and	O
the	O
presumed	O
underlying	O
TFIIH	S-GO
function	O
in	O
mice	O
and	O
cells	O
is	O
presented	O
in	O
Table	O
2	O
.	O

Discussion	O

Dissection	O
of	O
Biallelic	O
Effects	O
from	O
other	O
Determinants	O
of	O
Phenotype	O

Although	O
phenotypic	O
consequences	O
,	O
referred	O
to	O
here	O
as	O
biallelic	O
effects	O
,	O
resulting	O
from	O
two	O
different	O
mutant	O
alleles	O
in	O
compound	O
heterozygote	O
patients	O
have	O
been	O
postulated	O
,	O
such	O
effects	O
have	O
historically	O
been	O
difficult	O
to	O
distinguish	O
from	O
the	O
influence	O
of	O
environment	O
and	O
genetic	O
background	O
.	O

We	O
used	O
a	O
genetically	O
defined	O
mammalian	O
model	O
system	O
under	O
controlled	O
environmental	O
conditions	O
to	O
reveal	O
phenotypic	O
effects	O
attributable	O
specifically	O
to	O
combinations	O
of	O
differentially	O
mutated	O
Xpd	O
alleles	O
.	O

The	O
observed	O
biallelic	O
effects	O
were	O
of	O
three	O
general	O
types	O
.	O

In	O
the	O
first	O
,	O
the	O
allele	O
associated	O
in	O
a	O
homozygous	O
state	O
with	O
a	O
phenotype	O
closer	O
to	O
wt	O
singularly	O
determined	O
the	O
phenotypic	O
outcome	O
,	O
a	O
phenomenon	O
widely	O
known	O
in	O
human	O
recessive	O
disease	O
.	O

Because	O
these	O
Xpd	O
alleles	O
functioned	O
at	O
or	O
near	O
wt	O
levels	O
with	O
respect	O
to	O
a	O
particular	O
function	O
,	O
we	O
call	O
these	O
effects	O
"	O
dominant	O
"	O
.	O

Such	O
alleles	O
can	O
also	O
be	O
referred	O
to	O
as	O
"	O
separation	O
of	O
function	O
"	O
alleles	O
,	O
because	O
they	O
allow	O
dissection	O
of	O
the	O
roles	O
of	O
multifunctional	O
proteins	O
in	O
specific	O
phenotypes	O
.	O

Secondly	O
,	O
highlighting	O
the	O
potential	O
relevance	O
of	O
current	O
findings	O
to	O
all	O
diploid	O
organisms	O
including	O
humans	O
was	O
the	O
observation	O
that	O
in	O
one	O
compound	O
heterozygous	O
animal	O
,	O
the	O
Xpd	O
allelic	O
relationship	O
could	O
shift	O
from	O
Adominant	O
|	O
arecessive	O
to	O
Arecessive	O
|	O
adominant	O
with	O
respect	O
to	O
different	O
phenotypes	O
in	O
a	O
time	O
-	O
dependent	O
and	O
tissue	O
-	O
specific	O
manner	O
(	O
see	O
below	O
and	O
Table	O
2	O
)	O
.	O

In	O
the	O
third	O
type	O
of	O
biallelic	O
effect	O
,	O
known	O
as	O
interallelic	O
complementation	O
,	O
two	O
mutant	O
alleles	O
produced	O
a	O
phenotype	O
closer	O
to	O
wt	O
than	O
either	O
could	O
alone	O
in	O
a	O
homo	O
-	O
or	O
hemizygous	O
state	O
.	O

As	O
summarised	O
in	O
Table	O
2	O
,	O
examples	O
of	O
all	O
types	O
of	O
biallelic	O
effects	O
were	O
observed	O
in	O
a	O
variety	O
of	O
Xpd	O
-	O
associated	O
phenotypes	O
,	O
ranging	O
from	O
brittle	O
hair	O
to	O
segmental	O
progeria	O
.	O

TFIIH	S-GO
in	O
Transcription	O
and	O
Repair	O
:	O
Mechanisms	O
of	O
XPD	O
Disease	O
Pleiotropy	O

We	O
observed	O
differences	O
in	O
the	O
ability	O
of	O
XpdTTD	O
versus	O
homozygous	O
lethal	O
Xpd	O
+	O
XPCS	O
and	O
Xpd	O
+	O
XP	O
alleles	O
to	O
function	O
in	O
two	O
transcription	O
-	O
related	O
phenotypes	O
separated	O
in	O
the	O
organism	O
by	O
both	O
time	O
and	O
space	O
:	O
embryonic	O
lethality	O
and	O
terminal	O
differentiation	O
of	O
enucleating	O
skin	O
and	O
blood	O
cells	O
.	O

The	O
preblastocyst	O
-	O
stage	O
homozygous	O
lethality	O
shared	O
by	O
the	O
XpdKO	O
,	O
Xpd	O
+	O
XPCS	O
,	O
and	O
Xpd	O
+	O
XP	O
alleles	O
most	O
likely	O
reflects	O
a	O
defect	O
in	O
basal	O
transcription	O
that	O
is	O
incompatible	O
with	O
life	O
.	O

In	O
XpdTTD	O
/	O
+	O
XPCS	O
and	O
XpdTTD	O
/	O
+	O
XP	O
compound	O
heterozygous	O
mice	O
,	O
embryonic	O
lethality	O
was	O
fully	O
rescued	O
by	O
the	O
XpdTTD	O
allele	O
.	O

Because	O
embryonic	O
lethality	O
was	O
also	O
fully	O
rescued	O
in	O
XpdTTD	O
/	O
KO	O
hemizygous	O
mice	O
,	O
the	O
XpdTTD	O
allele	O
can	O
be	O
considered	O
as	O
wt	O
and	O
thus	O
dominant	O
to	O
each	O
of	O
the	O
homozygous	O
lethal	O
alleles	O
(	O
XpdKO	O
,	O
Xpd	O
+	O
XPCS	O
,	O
and	O
Xpd	O
+	O
XP	O
)	O
with	O
respect	O
to	O
this	O
particular	O
phenotype	O
(	O
Table	O
2	O
)	O
.	O

TTD	O
-	O
specific	O
cutaneous	O
and	O
anaemic	O
features	O
,	O
on	O
the	O
other	O
hand	O
,	O
are	O
thought	O
to	O
result	O
from	O
a	O
specific	O
kind	O
of	O
transcriptional	O
insufficiency	O
caused	O
by	O
depletion	O
of	O
unstable	O
TFIIH	S-GO
during	O
the	O
terminal	O
differentiation	O
of	O
skin	O
,	O
hair	O
-	O
shaft	O
,	O
and	O
blood	O
cells	O
[	O
16	O
,	O
24	O
]	O
.	O

In	O
compound	O
heterozygous	O
mice	O
,	O
both	O
homozygous	O
lethal	O
Xpd	O
+	O
XPCS	O
and	O
Xpd	O
+	O
XP	O
alleles	O
were	O
able	O
to	O
alleviate	O
XpdTTD	O
-	O
specific	O
cutaneous	O
and	O
anaemic	O
features	O
and	O
can	O
thus	O
be	O
defined	O
as	O
dominant	O
over	O
the	O
XpdTTD	O
allele	O
with	O
respect	O
to	O
these	O
phenotypes	O
.	O

We	O
conclude	O
that	O
the	O
defects	O
leading	O
to	O
embryonic	O
lethality	O
and	O
aberrant	O
terminal	O
differentiation	O
of	O
the	O
skin	O
,	O
hair	O
,	O
and	O
blood	O
represent	O
two	O
qualitatively	O
and	O
/	O
or	O
quantitatively	O
different	O
transcriptional	O
deficiencies	O
.	O

During	O
early	O
embryonic	O
development	O
,	O
XpdTTD	O
is	O
dominant	O
over	O
the	O
Xpd	O
+	O
XPCS	O
and	O
Xpd	O
+	O
XP	O
alleles	O
,	O
whereas	O
later	O
in	O
the	O
ontogenesis	O
of	O
skin	O
,	O
hair	O
-	O
shaft	O
,	O
and	O
blood	O
cells	O
,	O
the	O
situation	O
is	O
reversed	O
.	O

In	O
its	O
role	O
in	O
the	O
repair	O
of	O
UV	O
photolesions	O
,	O
the	O
Xpd	O
+	O
XPCS	O
allele	O
imparted	O
a	O
clear	O
UV	O
survival	O
benefit	O
over	O
a	O
single	O
XpdTTD	O
allele	O
or	O
two	O
XpdXPCS	O
alleles	O
independent	O
of	O
expression	O
levels	O
,	O
which	O
is	O
consistent	O
with	O
interallelic	O
complementation	O
.	O

However	O
,	O
the	O
observation	O
that	O
no	O
other	O
cellular	O
or	O
biochemical	O
UV	O
-	O
related	O
parameters	O
were	O
improved	O
in	O
XpdTTD	O
/	O
+	O
XPCS	O
argues	O
against	O
complementation	O
of	O
this	O
repair	O
activity	O
in	O
the	O
rescue	O
of	O
TTD	O
progeroid	O
symptoms	O
in	O
vivo	O
.	O

Interallelic	O
Complementation	O
and	O
XPD	O
Function	O

What	O
does	O
interallelic	O
complementation	O
tell	O
us	O
about	O
the	O
mechanism	O
of	O
XPD	O
function	O
?	O

Interallelic	O
complementation	O
is	O
most	O
often	O
observed	O
in	O
multimeric	O
proteins	O
with	O
multiple	O
functional	O
domains	O
.	O

Unfortunately	O
,	O
the	O
structure	O
-	O
function	O
relationship	O
between	O
disease	O
-	O
causing	O
mutations	O
and	O
XPD	O
functional	O
domains	O
,	O
including	O
detailed	O
structural	O
information	O
on	O
XPD	O
or	O
even	O
its	O
stoichiometry	O
within	O
TFIIH	S-GO
,	O
remains	O
unknown	O
.	O

However	O
,	O
based	O
on	O
the	O
ability	O
of	O
cell	O
extracts	O
that	O
are	O
defective	O
in	O
two	O
different	O
TFIIH	S-GO
components	O
(	O
XPD	O
and	O
XPB	O
)	O
to	O
complement	O
NER	O
activity	O
in	O
vitro	O
[	O
26	O
]	O
,	O
it	O
is	O
likely	O
that	O
TFIIH	S-GO
(	O
or	O
its	O
components	O
)	O
can	O
either	O
multimerise	O
or	O
exchange	O
at	O
least	O
during	O
the	O
NER	O
reaction	O
.	O

Furthermore	O
,	O
XPD	O
is	O
known	O
to	O
be	O
a	O
"	O
loosely	O
bound	O
"	O
subunit	O
of	O
TFIIH	S-GO
[	O
27	O
]	O
.	O

We	O
thus	O
envisage	O
the	O
molecular	O
mechanism	O
of	O
interallelic	O
complementation	O
to	O
involve	O
the	O
exchange	O
of	O
XPD	O
molecules	O
within	O
the	O
TFIIH	B-GO
complex	E-GO
or	O
turnover	O
of	O
TFIIH	B-GO
complexes	E-GO
containing	O
different	O
XPD	O
molecules	O
at	O
the	O
site	O
of	O
DNA	O
damage	O
during	O
the	O
course	O
of	O
the	O
global	O
genome	O
as	O
well	O
as	O
transcription	O
-	O
coupled	O
repair	O
of	O
either	O
UV	O
-	O
induced	O
or	O
endogenous	O
DNA	O
damage	O
.	O

A	O
Biallelic	O
Paradigm	O
for	O
XPD	O
Disorders	O

Recently	O
,	O
proteins	O
originating	O
from	O
presumed	O
null	O
alleles	O
were	O
biochemically	O
characterised	O
as	O
inactive	O
in	O
basal	O
transcription	O
[	O
27	O
]	O
,	O
providing	O
an	O
explanation	O
as	O
to	O
why	O
these	O
alleles	O
failed	O
to	O
rescue	O
lethality	O
in	O
haploid	O
S	O
.	O
pombe	O
with	O
a	O
null	O
mutation	O
in	O
the	O
XPD	O
homologue	O
rad15	O
[	O
19	O
]	O
.	O

Our	O
data	O
suggest	O
that	O
certain	O
presumed	O
null	O
alleles	O
,	O
although	O
unable	O
on	O
their	O
own	O
to	O
support	O
basal	O
transcription	O
,	O
may	O
in	O
fact	O
have	O
a	O
substantial	O
impact	O
on	O
disease	O
outcome	O
in	O
compound	O
heterozygous	O
humans	O
,	O
as	O
they	O
do	O
in	O
mouse	O
models	O
.	O

Clinical	O
evidence	O
in	O
support	O
of	O
this	O
hypothesis	O
comes	O
from	O
a	O
number	O
of	O
XP	O
complementation	O
group	O
D	O
patients	O
that	O
do	O
not	O
fit	O
within	O
the	O
framework	O
of	O
the	O
current	O
monoallelic	O
paradigm	O
of	O
XPD	O
disorders	O
(	O
Figure	O
5	O
)	O
.	O

In	O
contrast	O
to	O
two	O
hemizygous	O
XPDXPCS	O
patients	O
carrying	O
the	O
XPDG47R	O
-	O
or	O
XPDR666W	O
-	O
encoding	O
alleles	O
who	O
died	O
of	O
the	O
disease	O
before	O
2	O
y	O
of	O
age	O
,	O
two	O
compound	O
heterozygous	O
XPDXPCS	O
patients	O
carrying	O
the	O
same	O
XPDG47R	O
-	O
or	O
XPDR666W	O
-	O
encoding	O
alleles	O
in	O
addition	O
to	O
the	O
presumed	O
null	O
XPDL461V	O
+	O
del716	O
-	O
730	O
both	O
had	O
considerably	O
milder	O
disease	O
symptoms	O
and	O
survived	O
more	O
than	O
ten	O
times	O
longer	O
(	O
A	O
.	O
Lehmann	O
,	O
personal	O
communication	O
)	O
(	O
Figure	O
5	O
)	O
.	O

Compound	O
heterozygosity	O
is	O
also	O
associated	O
with	O
the	O
recently	O
reported	O
combination	O
XP	O
and	O
TTD	O
(	O
XPTTD	O
)	O
syndrome	O
[	O
8	O
]	O
.	O

Similar	O
to	O
the	O
XpdTTD	O
/	O
+	O
XPCS	O
and	O
XpdTTD	O
/	O
+	O
XP	O
mice	O
described	O
here	O
,	O
both	O
patients	O
with	O
XPTTD	O
described	O
so	O
far	O
had	O
intermediate	O
hair	O
cysteine	O
values	O
.	O

Furthermore	O
,	O
XPTTD	O
patient	O
XP38BR	O
carried	O
a	O
"	O
causative	O
"	O
TTD	O
mutation	O
in	O
one	O
allele	O
and	O
a	O
novel	O
point	O
mutation	O
encoding	O
XPDL485P	O
in	O
the	O
other	O
.	O

Although	O
the	O
XPDL485P	O
-	O
encoding	O
allele	O
fails	O
to	O
complement	O
viability	O
in	O
the	O
haploid	O
S	O
.	O
pombe	O
rad15	O
deletion	O
strain	O
and	O
is	O
thus	O
interpretable	O
as	O
a	O
null	O
allele	O
[	O
8	O
]	O
,	O
we	O
nonetheless	O
suggest	O
that	O
the	O
combined	O
XPTTD	O
phenotype	O
in	O
this	O
patient	O
involves	O
phenotypic	O
contributions	O
from	O
both	O
alleles	O
.	O

Taken	O
together	O
,	O
these	O
data	O
suggest	O
a	O
shift	O
to	O
a	O
biallelic	O
paradigm	O
for	O
compound	O
heterozygous	O
patients	O
in	O
XP	O
complementation	O
group	O
D	O
.	O

Figure	O
5	O

Genotype	O
-	O
Phenotype	O
Relationships	O
in	O
XPD	O
Disorders	O

According	O
to	O
the	O
current	O
monoallelic	O
hypothesis	O
,	O
phenotype	O
is	O
determined	O
solely	O
by	O
the	O
causative	O
allele	O
product	O
.	O

If	O
a	O
second	O
,	O
different	O
allele	O
is	O
present	O
,	O
it	O
is	O
considered	O
a	O
functional	O
null	O
.	O

There	O
is	O
a	O
lack	O
of	O
any	O
correlation	O
between	O
the	O
site	O
of	O
the	O
XPD	O
mutation	O
and	O
the	O
resulting	O
disorder	O
.	O

We	O
propose	O
a	O
biallelic	O
hypothesis	O
for	O
compound	O
heterozygotes	O
in	O
which	O
both	O
alleles	O
can	O
contribute	O
to	O
the	O
phenotype	O
.	O

Examples	O
of	O
compound	O
heterozygous	O
patients	O
in	O
which	O
a	O
second	O
,	O
presumed	O
null	O
allele	O
is	O
likely	O
to	O
contribute	O
to	O
disease	O
outcome	O
are	O
provided	O
above	O
in	O
comparison	O
to	O
corresponding	O
homo	O
-	O
or	O
hemizygous	O
patients	O
with	O
the	O
same	O
causative	O
allele	O
.	O

Numbers	O
in	O
the	O
schematic	O
of	O
the	O
protein	O
indicate	O
the	O
helicase	O
domains	O
.	O

Potential	O
of	O
Combined	O
Recessive	O
Alleles	O
to	O
Affect	O
Phenotypic	O
Diversity	O
in	O
Mammals	O

In	O
humans	O
,	O
the	O
clinical	O
relevance	O
of	O
biallelic	O
effects	O
such	O
as	O
interallelic	O
complementation	O
remains	O
unknown	O
.	O

Although	O
interallelic	O
complementation	O
between	O
two	O
endogenous	O
mutant	O
alleles	O
has	O
been	O
described	O
in	O
cells	O
from	O
a	O
compound	O
heterozygous	O
patient	O
with	O
methylmalonic	O
acidaemia	O
,	O
no	O
observable	O
effects	O
on	O
disease	O
outcome	O
were	O
noted	O
in	O
the	O
patient	O
[	O
28	O
]	O
.	O

Thus	O
,	O
to	O
the	O
best	O
of	O
our	O
knowledge	O
,	O
the	O
amelioration	O
of	O
progeroid	O
features	O
observed	O
here	O
is	O
the	O
first	O
in	O
vivo	O
demonstration	O
in	O
compound	O
heterozygous	O
animals	O
of	O
interallelic	O
complementation	O
relevant	O
to	O
a	O
human	O
disease	O
.	O

Keeping	O
in	O
mind	O
that	O
the	O
~	O
1	O
,	O
200	O
alleles	O
known	O
to	O
exist	O
for	O
the	O
CTRF	O
gene	O
implicated	O
in	O
the	O
common	O
autosomal	S-GO
recessive	O
disorder	O
cystic	O
fibrosis	O
alone	O
[	O
29	O
]	O
can	O
theoretically	O
result	O
in	O
~	O
700	O
,	O
000	O
different	O
allelic	O
combinations	O
,	O
the	O
potential	O
number	O
of	O
allelic	O
combinations	O
of	O
different	O
recessive	O
mutations	O
and	O
single	O
nucleotide	O
polymorphisms	O
genome	O
-	O
wide	O
is	O
currently	O
incalculable	O
.	O

We	O
suggest	O
biallelic	O
effects	O
as	O
a	O
previously	O
underestimated	O
yet	O
important	O
variable	O
in	O
considering	O
genotype	O
-	O
phenotype	O
relationships	O
from	O
autosomal	S-GO
recessive	O
disease	O
to	O
normal	O
phenotypic	O
diversity	O
in	O
mammals	O
.	O

Extension	O
of	O
the	O
above	O
concept	O
implies	O
that	O
recessive	O
mutations	O
can	O
enter	O
evolutionary	O
selection	O
in	O
F1	O
provided	O
that	O
the	O
second	O
allele	O
carries	O
a	O
different	O
recessive	O
alteration	O
.	O

Finally	O
,	O
our	O
data	O
highlight	O
the	O
potential	O
of	O
clinically	O
relevant	O
alleles	O
previously	O
designated	O
as	O
null	O
,	O
with	O
little	O
or	O
no	O
detectable	O
expression	O
or	O
activity	O
,	O
to	O
nonetheless	O
contribute	O
to	O
phenotype	O
.	O

Materials	O
and	O
Methods	O

Derivation	O
and	O
analysis	O
of	O
mutant	O
mice	O
.	O

Generation	O
of	O
XpdTTD	O
(	O
XPDR722W	O
)	O
and	O
XpdTTD	O
/	O
KO	O
mice	O
has	O
been	O
described	O
previously	O
[	O
21	O
,	O
22	O
]	O
.	O

A	O
detailed	O
description	O
of	O
the	O
generation	O
of	O
targeting	O
constructs	O
for	O
Xpd	O
+	O
XPCS	O
and	O
Xpd	O
+	O
XP	O
alleles	O
carrying	O
mutations	O
encoding	O
the	O
G602D	O
and	O
R683W	O
alterations	O
will	O
be	O
provided	O
upon	O
request	O
.	O

Chimeric	O
mice	O
and	O
mouse	O
embryonic	O
fibroblasts	O
were	O
generated	O
according	O
to	O
standard	O
procedures	O
.	O

Haematoxylin	O
and	O
eosin	O
staining	O
was	O
performed	O
according	O
to	O
standard	O
procedures	O
.	O

Amino	O
acid	O
analysis	O
was	O
conducted	O
as	O
described	O
in	O
[	O
21	O
]	O
.	O

Blood	O
values	O
were	O
analysed	O
using	O
Animal	O
Blood	O
Counter	O
Vet	O
(	O
ABX	O
Diagnostix	O
,	O
Montpellier	O
,	O
France	O
)	O
.	O

Radiographs	O
were	O
taken	O
,	O
and	O
relative	O
bone	O
mineral	O
density	O
was	O
calculated	O
as	O
described	O
in	O
[	O
15	O
]	O
.	O

Mice	O
used	O
in	O
this	O
study	O
were	O
in	O
a	O
129Ola	O
/	O
C57BL6	O
mixed	O
background	O
unless	O
noted	O
differently	O
.	O

All	O
experiments	O
involving	O
mice	O
were	O
judged	O
and	O
approved	O
by	O
the	O
national	O
committee	O
for	O
genetic	O
identification	O
of	O
organisms	O
and	O
the	O
animal	O
ethical	O
committee	O
,	O
and	O
were	O
conducted	O
according	O
to	O
national	O
and	O
international	O
guidelines	O
.	O

UV	O
sensitivity	O
,	O
UV	O
-	O
UDS	O
,	O
UV	O
-	O
RRS	O
,	O
and	O
TFIIH	S-GO
incision	O
/	O
excision	O
activity	O
.	O

UV	O
survival	O
,	O
UV	O
-	O
UDS	O
,	O
and	O
UV	O
-	O
RRS	O
assays	O
were	O
performed	O
as	O
described	O
previously	O
[	O
21	O
,	O
30	O
]	O
.	O

For	O
UV	O
-	O
RRS	O
,	O
average	O
values	O
from	O
the	O
representative	O
experiment	O
containing	O
two	O
wt	O
,	O
three	O
XpdTTD	O
/	O
TTD	O
,	O
two	O
XpdTTD	O
/	O
XPCS	O
,	O
and	O
one	O
XpdTTD	O
/	O
XP	O
cell	O
line	O
are	O
presented	O
.	O

The	O
~	O
48	O
%	O
UV	O
-	O
UDS	O
value	O
presented	O
in	O
this	O
study	O
for	O
XpdTTD	O
/	O
TTD	O
cells	O
differs	O
from	O
our	O
previously	O
published	O
data	O
of	O
25	O
%	O
UV	O
-	O
UDS	O
[	O
21	O
]	O
,	O
possibly	O
because	O
of	O
the	O
high	O
variability	O
intrinsic	O
to	O
the	O
assay	O
or	O
routine	O
variations	O
in	O
the	O
cell	O
culture	O
conditions	O
.	O

For	O
the	O
incision	O
/	O
excision	O
activity	O
assay	O
,	O
recombinant	O
TFIIH	S-GO
was	O
prepared	O
and	O
assayed	O
as	O
described	O
previously	O
[	O
27	O
]	O
.	O

Comparative	O
immunofluorescence	O
.	O

Latex	O
bead	O
labelling	O
and	O
comparative	O
immunofluorescence	O
analysis	O
of	O
the	O
p62	O
subunit	O
of	O
the	O
TFIIH	O
was	O
performed	O
as	O
described	O
previously	O
[	O
16	O
,	O
17	O
]	O
using	O
primary	O
mouse	O
embryonic	O
fibroblasts	O
at	O
passages	O
2	O
-	O
5	O
.	O

Two	O
or	O
more	O
cell	O
lines	O
per	O
genotype	O
(	O
except	O
for	O
the	O
XpdTTD	O
/	O
+	O
XP	O
cells	O
,	O
in	O
which	O
only	O
one	O
cell	O
line	O
was	O
used	O
in	O
repeated	O
experiments	O
)	O
were	O
used	O
,	O
and	O
experiments	O
were	O
repeated	O
2	O
-	O
6	O
times	O
per	O
genotype	O
.	O

Acknowledgements	O

We	O
are	O
very	O
grateful	O
to	O
Steven	O
Bergink	O
,	O
Koos	O
Jaspers	O
,	O
and	O
Bjorn	O
Schumacher	O
for	O
thoughtful	O
discussions	O
and	O
critical	O
reading	O
of	O
the	O
manuscript	O
and	O
to	O
Ruud	O
Koppenol	O
and	O
Tom	O
de	O
Vries	O
for	O
photography	O
.	O

Author	O
contributions	O
.	O

JOA	O
,	O
JJ	O
,	O
JHJH	O
,	O
GTJvdH	O
,	O
and	O
JRM	O
conceived	O
and	O
designed	O
the	O
experiments	O
.	O

JOA	O
,	O
JJ	O
,	O
JdW	O
,	O
FC	O
,	O
DH	O
,	O
MvdV	O
,	O
WT	O
,	O
JH	O
,	O
WJvL	O
,	O
and	O
JRM	O
performed	O
the	O
experiments	O
.	O

JOA	O
,	O
JJ	O
,	O
JdW	O
,	O
FC	O
,	O
DH	O
,	O
MvdV	O
,	O
JH	O
,	O
HBT	O
,	O
WJvL	O
,	O
JME	O
,	O
JHJH	O
,	O
and	O
JRM	O
analyzed	O
the	O
data	O
.	O

JdB	O
and	O
GTJvdH	O
contributed	O
reagents	O
/	O
materials	O
/	O
analysis	O
tools	O
.	O

JOA	O
,	O
JHJH	O
,	O
and	O
JRM	O
wrote	O
the	O
paper	O
.	O

Funding	O
.	O

This	O
research	O
was	O
supported	O
by	O
the	O
Netherlands	O
Organization	O
for	O
Scientific	O
Research	O
(	O
NWO	O
)	O
through	O
the	O
foundation	O
of	O
the	O
Research	O
Institute	O
for	O
Diseases	O
of	O
the	O
Elderly	O
,	O
as	O
well	O
as	O
grants	O
from	O
the	O
National	O
Institutes	O
of	O
Health	O
(	O
1PO1	O
AG17242	O
-	O
02	O
)	O
,	O
National	O
Institute	O
of	O
Environmental	O
Health	O
Sciences	O
(	O
1UO1	O
ES011044	O
)	O
,	O
European	O
Commission	O
(	O
QRTL	O
-	O
1999	O
-	O
02002	O
)	O
,	O
and	O
the	O
Dutch	O
Cancer	O
Society	O
(	O
EUR	O
99	O
-	O
2004	O
)	O
.	O

JRM	O
was	O
a	O
fellow	O
of	O
the	O
Damon	O
Runyon	O
Cancer	O
Research	O
Fund	O
(	O
DRG	O
1677	O
)	O
.	O

Abbreviations	O

bp	O
-	O
base	O
pair	O

CS	O
-	O
Cockayne	O
syndrome	O

E	O
[	O
number	O
]	O
-	O
embryonic	O
day	O
[	O
number	O
]	O

kb	O
-	O
kilobase	O

NER	O
-	O
nucleotide	O
excision	O
repair	O

SEM	O
-	O
standard	O
error	O
of	O
the	O
mean	O

TFIIH	S-GO
-	O
basal	B-GO
transcription	I-GO
/	I-GO
DNA	I-GO
repair	I-GO
factor	I-GO
IIH	E-GO

TTD	O
-	O
trichothiodystrophy	O

UV	O
-	O
RRS	O
-	O
recovery	O
of	O
RNA	O
synthesis	O
after	O
ultraviolet	O
irradiation	O

UV	O
-	O
UDS	O
-	O
unscheduled	O
DNA	O
synthesis	O
after	O
ultraviolet	O
irradiation	O

wt	O
-	O
wild	O
-	O
type	O

XP	O
-	O
xeroderma	O
pigmentosum	O

XPCS	O
-	O
xeroderma	O
pigmentosum	O
combined	O
with	O
Cockayne	O
syndrome	O

XPTTD	O
-	O
combination	O
xeroderma	O
pigmentosum	O
and	O
trichothiodystrophy	O

Footnotes	O

Competing	O
interests	O
.	O

The	O
authors	O
have	O
declared	O
that	O
no	O
competing	O
interests	O
exist	O
.	O

currency	O
a	O
Current	O
address	O
:	O
Institute	O
of	O
Biotechnology	O
,	O
University	O
of	O
Helsinki	O
,	O
Helsinki	O
,	O
Finland	O

currency	O
b	O
Current	O
address	O
:	O
Department	O
of	O
Molecular	O
and	O
Cell	O
Biology	O
,	O
University	O
of	O
California	O
Berkeley	O
,	O
Berkeley	O
,	O
California	O
,	O
United	O
States	O
of	O
America	O

currency	O
c	O
Current	O
address	O
:	O
Institute	O
for	O
Biomedical	O
Technology	O
,	O
University	O
of	O
Twente	O
,	O
Bilthoven	O
,	O
Netherlands	O

Genetic	O
background	O
determines	O
response	O
to	O
hemostasis	O
and	O
thrombosis	O

Abstract	O

Background	O

Thrombosis	O
is	O
the	O
fatal	O
and	O
disabling	O
consequence	O
of	O
cardiovascular	O
diseases	O
,	O
the	O
leading	O
cause	O
of	O
mortality	O
and	O
morbidity	O
in	O
Western	O
countries	O
.	O

Two	O
inbred	O
mouse	O
strains	O
,	O
C57BL	O
/	O
6J	O
and	O
A	O
/	O
J	O
,	O
have	O
marked	O
differences	O
in	O
susceptibility	O
to	O
obesity	O
,	O
atherosclerosis	O
,	O
and	O
vessel	O
remodeling	O
.	O

However	O
,	O
it	O
is	O
unclear	O
how	O
these	O
diverse	O
genetic	O
backgrounds	O
influence	O
pathways	O
known	O
to	O
regulate	O
thrombosis	O
and	O
hemostasis	O
.	O

The	O
objective	O
of	O
this	O
study	O
was	O
to	O
evaluate	O
thrombosis	O
and	O
hemostasis	O
in	O
these	O
two	O
inbred	O
strains	O
and	O
determine	O
the	O
phenotypic	O
response	O
of	O
A	O
/	O
J	O
chromosomes	S-GO
in	O
the	O
C57BL	O
/	O
6J	O
background	O
.	O

Methods	O

A	O
/	O
J	O
and	O
C57Bl	O
/	O
6J	O
mice	O
were	O
evaluated	O
for	O
differences	O
in	O
thrombosis	O
and	O
hemostasis	O
.	O

A	O
thrombus	O
was	O
induced	O
in	O
the	O
carotid	O
artery	O
by	O
application	O
of	O
the	O
exposed	O
carotid	O
to	O
ferric	O
chloride	O
and	O
blood	O
flow	O
measured	O
until	O
the	O
vessel	O
occluded	O
.	O

Bleeding	O
and	O
rebleeding	O
times	O
,	O
as	O
surrogate	O
markers	O
for	O
thrombosis	O
and	O
hemostasis	O
,	O
were	O
determined	O
after	O
clipping	O
the	O
tail	O
and	O
placing	O
in	O
warm	O
saline	O
.	O

Twenty	O
-	O
one	O
chromosome	S-GO
substitution	O
strains	O
,	O
A	O
/	O
J	O
chromosomes	S-GO
in	O
a	O
C57BL	O
/	O
6J	O
background	O
,	O
were	O
screened	O
for	O
response	O
to	O
the	O
tail	O
bleeding	O
assay	O
.	O

Results	O

Thrombus	O
occlusion	O
time	O
was	O
markedly	O
decreased	O
in	O
the	O
A	O
/	O
J	O
mice	O
compared	O
to	O
C57BL	O
/	O
6J	O
mice	O
.	O

Tail	O
bleeding	O
time	O
was	O
similar	O
in	O
the	O
two	O
strains	O
,	O
but	O
rebleeding	O
time	O
was	O
markedly	O
increased	O
in	O
the	O
A	O
/	O
J	O
mice	O
compared	O
to	O
C57BL	O
/	O
6J	O
mice	O
.	O

Coagulation	O
times	O
and	O
tail	O
morphology	O
were	O
similar	O
,	O
but	O
tail	O
collagen	S-GO
content	O
was	O
higher	O
in	O
A	O
/	O
J	O
than	O
C57BL	O
/	O
6J	O
mice	O
.	O

Three	O
chromosome	S-GO
substitution	O
strains	O
,	O
B6	O
-	O
Chr5A	O
/	O
J	O
,	O
B6	O
-	O
Chr11A	O
/	O
J	O
,	O
and	O
B6	O
-	O
Chr17A	O
/	O
J	O
,	O
were	O
identified	O
with	O
increased	O
rebleeding	O
time	O
,	O
a	O
phenotype	O
similar	O
to	O
A	O
/	O
J	O
mice	O
.	O

Mice	O
heterosomic	O
for	O
chromosomes	S-GO
5	O
or	O
17	O
had	O
rebleeding	O
times	O
similar	O
to	O
C57BL	O
/	O
6J	O
mice	O
,	O
but	O
when	O
these	O
two	O
chromosome	S-GO
substitution	O
strains	O
,	O
B6	O
-	O
Chr5A	O
/	O
J	O
and	O
B6	O
-	O
Chr17A	O
/	O
J	O
,	O
were	O
crossed	O
,	O
the	O
A	O
/	O
J	O
phenotype	O
was	O
restored	O
in	O
these	O
doubly	O
heterosomic	O
progeny	O
.	O

Conclusion	O

These	O
results	O
indicate	O
that	O
susceptibility	O
to	O
arterial	O
thrombosis	O
and	O
haemostasis	O
is	O
remarkably	O
different	O
in	O
C57BL	O
/	O
and	O
A	O
/	O
J	O
mice	O
.	O

Three	O
A	O
/	O
J	O
chromosome	S-GO
substitution	O
strains	O
were	O
identified	O
that	O
expressed	O
a	O
phenotype	O
similar	O
to	O
A	O
/	O
J	O
for	O
rebleeding	O
,	O
the	O
C57Bl	O
/	O
6J	O
background	O
could	O
modify	O
the	O
A	O
/	O
J	O
phenotype	O
,	O
and	O
the	O
combination	O
of	O
two	O
A	O
/	O
J	O
QTL	O
could	O
restore	O
the	O
phenotype	O
.	O

The	O
diverse	O
genetic	O
backgrounds	O
and	O
differences	O
in	O
response	O
to	O
vascular	O
injury	O
induced	O
thrombosis	O
and	O
the	O
tail	O
bleeding	O
assay	O
,	O
suggest	O
the	O
potential	O
for	O
identifying	O
novel	O
genetic	O
determinants	O
of	O
thrombotic	O
risk	O
.	O

Background	O

Family	O
history	O
[	O
1	O
]	O
is	O
the	O
strongest	O
risk	O
factor	O
for	O
cardiovascular	O
diseases	O
(	O
CVD	O
)	O
.	O

While	O
a	O
number	O
of	O
genetic	O
mutations	O
have	O
been	O
identified	O
,	O
these	O
account	O
for	O
only	O
a	O
small	O
percentage	O
of	O
the	O
CVD	O
in	O
human	O
populations	O
.	O

Thrombus	O
formation	O
on	O
fissured	O
atherosclerotic	O
plaques	O
is	O
the	O
precipitating	O
event	O
in	O
the	O
transition	O
from	O
a	O
stable	O
or	O
subclinical	O
atherosclerotic	O
disease	O
and	O
leads	O
to	O
acute	O
myocardial	O
infarction	O
,	O
ischemic	O
stroke	O
or	O
peripheral	O
arterial	O
occlusion	O
.	O

Arterial	O
and	O
venous	O
thrombosis	O
are	O
complex	O
responses	O
and	O
are	O
influenced	O
by	O
multiple	O
genetic	O
and	O
environmental	O
factors	O
[	O
2	O
-	O
5	O
]	O
.	O

Polymorphisms	O
and	O
mutations	O
in	O
coagulation	O
factors	O
,	O
fibrinolytic	O
factors	O
,	O
platelet	O
surface	O
receptors	O
,	O
methylenetetrahydrofalate	O
reductase	O
,	O
endothelial	O
nitric	O
oxide	O
synthase	O
,	O
and	O
antioxidant	O
enzymes	O
have	O
been	O
implicated	O
as	O
genetic	O
determinants	O
of	O
susceptibility	O
to	O
thrombosis	O
[	O
6	O
,	O
7	O
]	O
.	O

Great	O
strides	O
have	O
been	O
made	O
in	O
the	O
diagnosis	O
and	O
treatment	O
of	O
thrombosis	O
in	O
the	O
last	O
decade	O
.	O

However	O
,	O
strategies	O
to	O
prevent	O
thrombosis	O
have	O
lagged	O
far	O
behind	O
due	O
,	O
in	O
part	O
,	O
to	O
the	O
contribution	O
of	O
multiple	O
,	O
and	O
as	O
yet	O
undefined	O
,	O
genetic	O
factors	O
that	O
lead	O
to	O
thrombotic	O
risk	O
.	O

Moreover	O
,	O
it	O
remains	O
unclear	O
how	O
genetic	O
background	O
influences	O
the	O
function	O
of	O
molecules	O
and	O
pathways	O
known	O
to	O
regulate	O
thrombus	O
formation	O
and	O
lysis	O
and	O
,	O
thereby	O
,	O
contributes	O
to	O
the	O
risk	O
of	O
thrombotic	O
disease	O
.	O

Many	O
of	O
the	O
available	O
inbred	O
mouse	O
strains	O
,	O
such	O
as	O
C57BL	O
/	O
6J	O
(	O
B6	O
)	O
and	O
A	O
/	O
J	O
,	O
have	O
been	O
classified	O
as	O
resistant	O
or	O
susceptible	O
to	O
particular	O
complex	O
diseases	O
(	O
Table	O
1	O
)	O
.	O

These	O
two	O
strains	O
have	O
diverse	O
responses	O
to	O
diet	O
-	O
induced	O
obesity	O
[	O
8	O
]	O
(	O
B6	O
susceptible	O
;	O
A	O
/	O
J	O
resistant	O
)	O
,	O
diet	O
-	O
induced	O
atherosclerosis	O
(	O
B6	O
susceptible	O
;	O
A	O
/	O
J	O
resistant	O
)	O
[	O
9	O
]	O
,	O
arterial	O
ligation	O
-	O
induced	O
neointimal	O
hyperplasia	O
(	O
B6	O
resistant	O
;	O
A	O
/	O
J	O
resistant	O
)	O
,	O
and	O
ligation	O
induced	O
vessel	O
remodeling	O
(	O
B6	O
resistant	O
;	O
A	O
/	O
J	O
susceptible	O
)	O
[	O
10	O
]	O
.	O

These	O
conditions	O
are	O
predisposing	O
to	O
thrombosis	O
per	O
se	O
,	O
but	O
these	O
mice	O
have	O
not	O
been	O
systematically	O
evaluated	O
for	O
thrombosis	O
.	O

Clot	O
formation	O
and	O
lysis	O
,	O
which	O
ultimately	O
determine	O
thrombosis	O
,	O
requires	O
platelet	O
aggregation	O
,	O
coagulation	O
,	O
and	O
fibrinolytic	O
functions	O
.	O

Interactions	O
among	O
these	O
pathways	O
may	O
occur	O
and	O
additional	O
factors	O
may	O
modulate	O
these	O
processes	O
.	O

Identification	O
of	O
novel	O
modulators	O
and	O
factors	O
of	O
these	O
pathways	O
can	O
be	O
identified	O
by	O
associating	O
the	O
phenotype	O
with	O
a	O
location	O
(	O
s	O
)	O
on	O
a	O
specific	O
chromosome	O
,	O
a	O
quantitative	O
trait	O
locus	O
(	O
QTL	O
)	O
.	O

Table	O
1	O

Identification	O
of	O
mice	O
susceptible	O
or	O
resistant	O
to	O
obesity	O
,	O
atherosclerosis	O
,	O
and	O
vascular	O
injury	O

R	O
:	O
resistant	O
;	O
S	O
:	O
susceptible	O
.	O

Reference	O
provided	O
by	O
number	O
in	O
parenthesis	O
.	O

Lepob	O
,	O
Plg	O
-	O
/	O
-	O
,	O
and	O
PAI	O
-	O
F1	O
-	O
/	O
-	O
mice	O
were	O
in	O
a	O
B6	O
background	O
.	O

A	O
panel	O
of	O
chromosome	S-GO
substitution	O
strains	O
(	O
CSS	O
)	O
was	O
generated	O
[	O
11	O
]	O
by	O
a	O
"	O
marker	O
-	O
assisted	O
"	O
breeding	O
program	O
where	O
the	O
progeny	O
of	O
a	O
B6	O
x	O
A	O
/	O
J	O
cross	O
were	O
successively	O
backcrossed	O
to	O
the	O
B6	O
mice	O
.	O

Genetic	O
markers	O
were	O
used	O
to	O
identify	O
homozygosity	O
in	O
the	O
background	O
(	O
B6	O
)	O
and	O
the	O
individual	O
A	O
/	O
J	O
chromosome	S-GO
.	O

These	O
strains	O
have	O
one	O
chromosome	S-GO
from	O
A	O
/	O
J	O
mice	O
in	O
a	O
B6	O
background	O
.	O

This	O
allows	O
the	O
identification	O
of	O
a	O
trait	O
in	O
one	O
or	O
more	O
CSS	O
and	O
implies	O
that	O
at	O
least	O
one	O
QTL	O
resides	O
on	O
this	O
chromosome	S-GO
.	O

Use	O
of	O
this	O
panel	O
requires	O
fewer	O
mice	O
to	O
determine	O
the	O
QTL	O
than	O
does	O
a	O
genome	O
-	O
wide	O
scan	O
.	O

Another	O
advantage	O
is	O
the	O
ability	O
for	O
detection	O
of	O
QTL	O
in	O
the	O
presence	O
of	O
other	O
QTL	O
.	O

In	O
addition	O
,	O
initial	O
screens	O
with	O
the	O
CSS	O
simplify	O
the	O
fine	O
-	O
mapping	O
of	O
QTL	O
.	O

Several	O
studies	O
of	O
this	O
CSS	O
panel	O
,	O
B6	O
Chr1	O
-	O
19	O
,	O
X	O
,	O
YA	O
/	O
J	O
,	O
have	O
been	O
reported	O
for	O
behavior	O
[	O
12	O
]	O
,	O
weight	O
gain	O
[	O
13	O
]	O
,	O
sterols	O
[	O
13	O
]	O
,	O
and	O
plasma	O
amino	O
acids	O
levels	O
[	O
13	O
,	O
14	O
]	O
,	O
and	O
have	O
identified	O
many	O
more	O
QTL	O
than	O
studies	O
of	O
the	O
same	O
traits	O
using	O
a	O
genome	O
-	O
wide	O
scan	O
.	O

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
evaluate	O
the	O
two	O
inbred	O
strains	O
of	O
mice	O
for	O
prothrombotic	O
risk	O
,	O
utilizing	O
a	O
ferric	O
chloride	O
vascular	O
injury	O
model	O
,	O
tail	O
bleeding	O
assay	O
,	O
and	O
measures	O
of	O
coagulation	O
and	O
fibrinolysis	O
.	O

The	O
results	O
of	O
this	O
study	O
indicate	O
that	O
the	O
two	O
inbred	O
strains	O
,	O
B6	O
and	O
A	O
/	O
J	O
mice	O
,	O
have	O
diverse	O
prothrombotic	O
phenotypes	O
,	O
unrelated	O
to	O
coagulation	O
or	O
platelet	O
aggregation	O
.	O

In	O
addition	O
,	O
in	O
the	O
CSS	O
,	O
expression	O
of	O
the	O
A	O
/	O
J	O
phenotypes	O
,	O
rebleeding	O
time	O
and	O
arterial	O
occlusion	O
,	O
was	O
modified	O
in	O
the	O
B6	O
background	O
,	O
and	O
suggested	O
that	O
interactions	O
occurred	O
among	O
the	O
A	O
/	O
J	O
QTL	O
.	O

Thus	O
,	O
it	O
should	O
be	O
possible	O
to	O
identify	O
independent	O
genetic	O
determinants	O
of	O
susceptibility	O
to	O
pathological	O
haemostasis	O
and	O
thrombosis	O
.	O

Methods	O

Mice	O

The	O
inbred	O
strains	O
,	O
B6	O
(	O
#	O
000664	O
)	O
,	O
Lepob	O
(	O
#	O
000632	O
)	O
,	O
A	O
/	O
J	O
(	O
#	O
000646	O
)	O
and	O
gene	O
-	O
targeted	O
plasminogen	O
(	O
Plg	O
)	O
activator	O
inhibitor	O
deficient	O
mice	O
(	O
PAI	O
-	O
1	O
-	O
/	O
-	O
)	O
(	O
#	O
002507	O
)	O
[	O
15	O
]	O
mice	O
in	O
a	O
B6	O
background	O
were	O
obtained	O
from	O
Jackson	O
Laboratory	O
(	O
Bar	O
Harbor	O
,	O
Maine	O
)	O
at	O
6	O
wks	O
-	O
of	O
-	O
age	O
.	O

The	O
Plg	O
-	O
/	O
-	O
mice	O
were	O
generated	O
as	O
previously	O
described	O
[	O
16	O
]	O
and	O
maintained	O
in	O
the	O
B6	O
background	O
,	O
generated	O
by	O
crossing	O
mice	O
from	O
the	O
original	O
mixed	O
(	O
B6	O
:	O
129	O
)	O
background	O
for	O
eight	O
generations	O
with	O
B6	O
mice	O
.	O

The	O
Plg	O
-	O
/	O
-	O
mice	O
do	O
not	O
reproduce	O
well	O
and	O
Plg	O
heterozygous	O
pairs	O
were	O
used	O
for	O
breeding	O
.	O

Genotypes	O
(	O
Plg	O
+	O
/	O
+	O
,	O
Plg	O
+	O
/	O
-	O
,	O
Plg	O
-	O
/	O
-	O
)	O
of	O
the	O
offspring	O
were	O
determined	O
by	O
a	O
PCR	O
assay	O
at	O
3	O
-	O
4	O
weeks	O
-	O
of	O
-	O
age	O
from	O
an	O
ear	O
punch	O
[	O
17	O
]	O
.	O

Breeding	O
pairs	O
of	O
the	O
CSS	O
mice	O
were	O
transferred	O
from	O
Dr	O
.	O
Nadeau	O
'	O
s	O
laboratory	O
.	O

All	O
mice	O
were	O
housed	O
and	O
bred	O
in	O
the	O
Biological	O
Resource	O
Unit	O
at	O
the	O
Cleveland	O
Clinic	O
Foundation	O
(	O
CCF	O
)	O
.	O

Mice	O
were	O
housed	O
in	O
sterilized	O
isolator	O
cages	O
,	O
maintained	O
on	O
a	O
14	O
hr	O
light	O
/	O
10	O
hr	O
dark	O
cycle	O
,	O
and	O
were	O
provided	O
sterilized	O
food	O
and	O
water	O
ad	O
libitum	O
.	O

Mice	O
were	O
fed	O
a	O
standard	O
autoclavable	O
laboratory	O
diet	O
consisting	O
of	O
:	O
23	O
%	O
protein	O
,	O
4	O
.	O
5	O
%	O
fat	O
,	O
6	O
%	O
fiber	O
,	O
(	O
Purina	O
,	O
St	O
.	O
Louis	O
,	O
MO	O
)	O
,	O
and	O
tested	O
between	O
7	O
and	O
9	O
wks	O
-	O
of	O
-	O
age	O
.	O

All	O
animal	O
experiments	O
were	O
performed	O
in	O
accordance	O
with	O
a	O
protocol	O
approved	O
by	O
the	O
Institutional	O
Animal	O
Care	O
and	O
Research	O
Advisory	O
Committee	O
at	O
CCF	O
.	O

Vascular	O
injury	O

To	O
induce	O
thrombosis	O
formation	O
in	O
the	O
carotid	O
artery	O
,	O
a	O
ferric	O
chloride	O
(	O
FeCl3	O
)	O
model	O
of	O
vessel	O
injury	O
[	O
18	O
,	O
19	O
]	O
was	O
employed	O
.	O

Mice	O
were	O
anesthetized	O
with	O
ketamine	O
/	O
xylazine	O
(	O
80	O
mg	O
/	O
kg	O
,	O
5	O
mg	O
/	O
kg	O
)	O
,	O
a	O
midline	O
cervical	O
incision	O
was	O
made	O
and	O
the	O
left	O
common	O
carotid	O
artery	O
isolated	O
by	O
blunt	O
dissection	O
.	O

The	O
flow	O
probe	O
(	O
Transonic	O
Systems	O
,	O
model	O
0	O
.	O
5PSB	O
)	O
was	O
placed	O
under	O
the	O
artery	O
and	O
when	O
a	O
stable	O
baseline	O
was	O
reached	O
,	O
a	O
0	O
.	O
5	O
x	O
2	O
mm	O
strip	O
of	O
filter	O
paper	O
saturated	O
with	O
10	O
%	O
FeCl3	O
solution	O
was	O
applied	O
to	O
the	O
surface	O
of	O
the	O
carotid	O
artery	O
for	O
3	O
min	O
.	O

Occlusion	O
time	O
was	O
determined	O
from	O
the	O
addition	O
of	O
the	O
FeCl3	O
solution	O
to	O
the	O
occlusion	O
of	O
the	O
artery	O
(	O
minimum	O
blood	O
flow	O
)	O
.	O

The	O
flow	O
probe	O
was	O
in	O
place	O
from	O
the	O
establishment	O
of	O
the	O
baseline	O
until	O
several	O
min	O
after	O
the	O
stable	O
occlusion	O
had	O
been	O
reached	O
or	O
stopped	O
at	O
30	O
min	O
if	O
it	O
had	O
not	O
occluded	O
.	O

Blood	O
flow	O
was	O
recorded	O
every	O
10	O
sec	O
(	O
Transonic	O
Systems	O
,	O
model	O
TS420	O
)	O
.	O

There	O
was	O
no	O
difference	O
in	O
body	O
weight	O
among	O
the	O
mice	O
that	O
were	O
tested	O
in	O
the	O
vascular	O
injury	O
model	O
.	O

Bleeding	O
and	O
rebleeding	O
assay	O

For	O
the	O
tail	O
bleeding	O
assay	O
,	O
mice	O
were	O
anesthetized	O
with	O
ketamine	O
/	O
xylazine	O
(	O
80	O
mg	O
/	O
kg	O
,	O
5	O
mg	O
/	O
kg	O
)	O
,	O
the	O
tail	O
prewarmed	O
for	O
5	O
min	O
in	O
10	O
mL	O
of	O
saline	O
at	O
37	O
degrees	O
C	O
in	O
a	O
water	O
bath	O
.	O

The	O
tail	O
was	O
lifted	O
from	O
the	O
saline	O
and	O
a	O
5	O
mm	O
tail	O
segment	O
amputated	O
and	O
immediately	O
returned	O
to	O
the	O
saline	O
.	O

Bleeding	O
time	O
was	O
measured	O
as	O
the	O
time	O
between	O
the	O
start	O
of	O
bleeding	O
to	O
cessation	O
of	O
bleeding	O
.	O

With	O
the	O
tail	O
remaining	O
in	O
the	O
same	O
saline	O
solution	O
,	O
the	O
rebleeding	O
time	O
was	O
measured	O
from	O
the	O
time	O
between	O
bleeding	O
cessation	O
and	O
the	O
start	O
of	O
the	O
second	O
bleeding	O
.	O

Coagulation	O
,	O
Plg	O
,	O
alpha	O
2	O
-	O
antiplasmin	O
,	O
fibrinogen	S-GO
,	O
fibrinolytic	O
and	O
PAI	O
-	O
1	O
assays	O

Mice	O
were	O
anesthetized	O
with	O
Isoflurane	O
(	O
Abbott	O
)	O
,	O
bled	O
from	O
the	O
orbital	O
sinus	O
into	O
uncoated	O
capillary	O
tubes	O
,	O
and	O
a	O
drop	O
of	O
blood	O
immediately	O
placed	O
on	O
a	O
reagent	O
strip	O
(	O
Synbiotics	O
)	O
for	O
prothrombin	O
time	O
(	O
PT	O
)	O
or	O
activated	O
partial	O
thromboplastin	O
time	O
(	O
aPTT	O
)	O
determinations	O
and	O
inserted	O
into	O
the	O
precalibrated	O
Coagulation	O
Analyzer	O
(	O
SCA2000	O
,	O
Synbiotics	O
)	O
.	O

PAI	O
-	O
1	O
activity	O
was	O
determined	O
according	O
to	O
the	O
method	O
of	O
Chandler	O
et	O
al	O
[	O
20	O
]	O
.	O

PAI	O
-	O
1	O
antigen	O
concentration	O
was	O
determined	O
by	O
ELISA	O
[	O
21	O
]	O
using	O
sheep	O
-	O
anti	O
mouse	O
PAI	O
-	O
1	O
(	O
American	O
Diagnostica	O
)	O
as	O
the	O
capture	O
antibody	S-GO
and	O
mouse	O
PAI	O
-	O
1	O
(	O
American	O
Diagnostica	O
)	O
as	O
the	O
standard	O
(	O
0	O
-	O
3	O
.	O
5	O
ng	O
/	O
mL	O
)	O
.	O

Plg	O
was	O
determined	O
with	O
a	O
chromogenic	O
assay	O
[	O
22	O
]	O
and	O
the	O
fibrinolytic	O
activity	O
determined	O
by	O
fibrin	O
degradation	O
[	O
23	O
]	O
.	O

For	O
the	O
negative	O
controls	O
in	O
these	O
assays	O
,	O
plasma	O
from	O
PAI	O
-	O
1	O
or	O
Plg	O
deficient	O
mice	O
was	O
used	O
.	O

Functionally	O
active	O
mouse	O
alpha	O
2	O
-	O
antiplasmin	O
was	O
determined	O
with	O
a	O
plasmin	O
capture	O
assay	O
and	O
detection	O
with	O
a	O
mouse	O
antibody	S-GO
(	O
Molecular	O
Innovations	O
,	O
Southfield	O
,	O
MI	O
)	O
,	O
and	O
fibrinogen	S-GO
with	O
an	O
ELISA	O
assay	O
with	O
antibodies	S-GO
that	O
recognize	O
mouse	O
fibrinogen	S-GO
(	O
Hyphen	O
BioMed	O
,	O
France	O
)	O
.	O

Histochemical	O
and	O
immunohistochemistry	O
analysis	O

The	O
frozen	O
tails	O
or	O
injured	O
carotids	O
in	O
OCT	O
were	O
sectioned	O
at	O
5	O
mu	O
m	O
thickness	O
and	O
stained	O
with	O
Masson	O
'	O
s	O
Trichrome	O
(	O
HT	O
15	O
,	O
Sigma	O
Diagnostics	O
)	O
.	O

For	O
quantitative	O
analysis	O
of	O
collagen	S-GO
area	O
in	O
the	O
tail	O
sections	O
,	O
four	O
sections	O
from	O
2	O
-	O
3	O
sites	O
were	O
measured	O
using	O
computer	O
assisted	O
image	O
analysis	O
(	O
Image	O
-	O
Pro	O
Plus	O
,	O
Cybernetics	O
)	O
.	O

For	O
the	O
area	O
determination	O
of	O
the	O
injured	O
carotid	O
lumen	O
,	O
3	O
-	O
4	O
sections	O
from	O
different	O
sites	O
approximately	O
100	O
mu	O
m	O
apart	O
were	O
analyzed	O
and	O
averaged	O
for	O
each	O
mouse	O
.	O

Statistics	O

Data	O
are	O
presented	O
as	O
mean	O
+/-	O
SEM	O
.	O

The	O
statistical	O
analysis	O
for	O
comparisons	O
between	O
A	O
/	O
J	O
and	O
B6	O
mice	O
and	O
between	O
wild	O
-	O
type	O
(	O
WT	O
)	O
and	O
Plg	O
-	O
/	O
-	O
littermates	O
was	O
compared	O
with	O
a	O
two	O
-	O
tailed	O
t	O
-	O
test	O
.	O

Differences	O
among	O
B6	O
,	O
Lepob	O
,	O
PAI	O
-	O
1	O
-	O
/	O
-	O
mice	O
were	O
determined	O
by	O
a	O
one	O
-	O
way	O
ANOVA	O
and	O
a	O
Newman	O
-	O
Keuls	O
post	O
-	O
test	O
.	O

A	O
value	O
of	O
P	O
<	O
0	O
.	O
05	O
was	O
considered	O
significant	O
.	O

The	O
statistical	O
analysis	O
for	O
comparisons	O
between	O
B6	O
mice	O
and	O
CSS	O
were	O
determined	O
with	O
two	O
-	O
tail	O
t	O
-	O
tests	O
and	O
the	O
level	O
of	O
the	O
significant	O
P	O
-	O
values	O
(	O
see	O
figure	O
legends	O
)	O
determined	O
with	O
a	O
Bonferroni	O
correction	O
to	O
account	O
for	O
multihypothesis	O
testing	O
[	O
13	O
]	O
.	O

Results	O

Marked	O
differences	O
in	O
arterial	O
thrombus	O
formation	O
in	O
B6	O
and	O
A	O
/	O
J	O
mice	O

The	O
FeCl3	O
cartoid	O
artery	O
injury	O
model	O
[	O
24	O
]	O
,	O
a	O
well	O
-	O
characterized	O
arterial	O
thrombosis	O
model	O
,	O
was	O
used	O
to	O
induce	O
an	O
occlusive	O
thrombus	O
in	O
the	O
B6	O
and	O
A	O
/	O
J	O
mouse	O
strains	O
under	O
investigation	O
.	O

A	O
marked	O
difference	O
in	O
arterial	O
thrombus	O
occlusion	O
time	O
was	O
found	O
between	O
the	O
B6	O
and	O
the	O
A	O
/	O
J	O
mice	O
(	O
Figure	O
1A	O
)	O
.	O

The	O
occlusion	O
time	O
in	O
the	O
A	O
/	O
J	O
mice	O
was	O
2	O
-	O
fold	O
less	O
than	O
for	O
the	O
B6	O
mice	O
.	O

A	O
5	O
%	O
dose	O
of	O
FeCl3	O
was	O
tested	O
in	O
the	O
A	O
/	O
J	O
and	O
B6	O
mice	O
and	O
the	O
occlusion	O
time	O
was	O
lower	O
in	O
the	O
A	O
/	O
J	O
than	O
the	O
B6	O
mice	O
,	O
the	O
same	O
results	O
as	O
with	O
the	O
10	O
%	O
dose	O
.	O

The	O
occlusion	O
time	O
(	O
min	O
for	O
both	O
B6	O
(	O
15	O
+/-	O
3	O
,	O
n	O
=	O
3	O
)	O
and	O
A	O
/	O
J	O
(	O
8	O
+/-	O
1	O
,	O
n	O
=	O
3	O
)	O
at	O
5	O
%	O
were	O
longer	O
than	O
at	O
10	O
%	O
for	O
B6	O
(	O
10	O
+/-	O
1	O
,	O
n	O
=	O
17	O
and	O
A	O
/	O
J	O
(	O
5	O
+/-	O
2	O
,	O
n	O
=	O
14	O
)	O
.	O

The	O
curves	O
of	O
blood	O
flow	O
after	O
FeCl3	O
application	O
indicated	O
a	O
pattern	O
with	O
a	O
gradual	O
decrease	O
before	O
occlusion	O
for	O
the	O
B6	O
mice	O
(	O
Figure	O
1B	O
)	O
,	O
but	O
for	O
the	O
A	O
/	O
J	O
mice	O
the	O
blood	O
flow	O
decreased	O
abruptly	O
to	O
zero	O
(	O
Figure	O
1C	O
)	O
,	O
demonstrating	O
a	O
marked	O
difference	O
from	O
the	O
B6	O
strain	O
.	O

The	O
mean	O
occlusion	O
times	O
were	O
significantly	O
different	O
between	O
the	O
two	O
strains	O
(	O
Figure	O
1A	O
)	O
.	O

The	O
size	O
of	O
the	O
carotids	O
in	O
the	O
two	O
strains	O
was	O
noticeably	O
different	O
.	O

The	O
area	O
(	O
mm2	O
)	O
of	O
the	O
lumen	O
(	O
0	O
.	O
066	O
+/-	O
0	O
.	O
007	O
,	O
n	O
=	O
6	O
)	O
was	O
significantly	O
less	O
in	O
the	O
A	O
/	O
J	O
mice	O
than	O
for	O
B6	O
mice	O
(	O
0	O
.	O
128	O
+/-	O
0	O
.	O
007	O
,	O
n	O
=	O
6	O
)	O
.	O

However	O
,	O
the	O
ratio	O
of	O
the	O
thrombus	O
to	O
lumen	O
was	O
similar	O
for	O
A	O
/	O
J	O
(	O
0	O
.	O
63	O
+/-	O
0	O
.	O
03	O
)	O
compared	O
to	O
B6	O
mice	O
(	O
0	O
.	O
67	O
+/-	O
0	O
.	O
09	O
)	O
.	O

Calculated	O
sheer	O
stress	O
rates	O
[	O
25	O
]	O
were	O
14	O
%	O
less	O
in	O
the	O
A	O
/	O
J	O
mice	O
when	O
compared	O
to	O
B6	O
mice	O
.	O

Figure	O
1	O

Arterial	O
occlusion	O
time	O
in	O
B6	O
and	O
A	O
/	O
J	O
mice	O
.	O

Panels	O
A	O
and	O
B	O
are	O
representative	O
occlusion	O
curves	O
from	O
each	O
genotype	O
.	O

Red	O
arrows	O
indicate	O
duration	O
of	O
ferric	O
chloride	O
application	O
to	O
the	O
carotid	O
.	O

Panel	O
A	O
:	O
B6	O
mice	O
,	O
Panel	O
B	O
:	O
A	O
/	O
J	O
mice	O
.	O

Panel	O
C	O
:	O
Arterial	O
occlusion	O
time	O
,	O
mean	O
+/-	O
SEM	O
of	O
14	O
-	O
17	O
mice	O
per	O
genotype	O
.	O

Symbol	O
indicates	O
a	O
significant	O
difference	O
(	O
*	O
*	O
P	O
<	O
0	O
.	O
01	O
)	O
between	O
B6	O
mice	O
determined	O
with	O
a	O
t	O
-	O
test	O
.	O

Marked	O
differences	O
in	O
rebleeding	O
time	O
in	O
B6	O
and	O
A	O
/	O
J	O
mice	O

The	O
bleeding	O
time	O
,	O
an	O
indicator	O
of	O
hemostatic	O
activity	O
,	O
was	O
determined	O
after	O
prewarming	O
the	O
tail	O
,	O
clipping	O
a	O
5	O
mm	O
segment	O
,	O
placing	O
the	O
tail	O
in	O
warm	O
saline	O
and	O
measuring	O
the	O
time	O
for	O
the	O
bleeding	O
to	O
stop	O
.	O

We	O
found	O
this	O
procedure	O
was	O
consistent	O
and	O
reproducible	O
in	O
different	O
mouse	O
strains	O
and	O
was	O
not	O
gender	O
dependent	O
.	O

Bleeding	O
time	O
was	O
not	O
different	O
in	O
A	O
/	O
J	O
mice	O
compared	O
to	O
B6	O
mice	O
(	O
Figure	O
2A	O
)	O
.	O

In	O
order	O
to	O
determine	O
if	O
specific	O
pathways	O
were	O
altered	O
in	O
the	O
B6	O
and	O
A	O
/	O
J	O
strains	O
,	O
mice	O
with	O
known	O
alterations	O
in	O
hemostasis	O
,	O
Lepob	O
mice	O
,	O
or	O
thrombosis	O
,	O
Plg	O
-	O
/	O
-	O
and	O
PAI	O
-	O
/	O
-	O
mice	O
,	O
were	O
also	O
tested	O
.	O

The	O
Lepob	O
mice	O
have	O
impaired	O
platelet	O
aggregation	O
[	O
26	O
]	O
and	O
were	O
evaluated	O
as	O
a	O
reference	O
for	O
platelet	O
function	O
.	O

In	O
the	O
Lepob	O
mice	O
(	O
Figure	O
2A	O
)	O
there	O
was	O
nearly	O
a	O
10	O
-	O
fold	O
increase	O
in	O
bleeding	O
time	O
compared	O
to	O
B6	O
mice	O
.	O

Bleeding	O
time	O
was	O
also	O
significantly	O
(	O
P	O
=	O
0	O
.	O
0001	O
)	O
increased	O
by	O
66	O
%	O
in	O
the	O
Plg	O
-	O
/	O
-	O
mice	O
compared	O
to	O
WT	O
mice	O
littermates	O
.	O

Bleeding	O
time	O
was	O
not	O
different	O
in	O
PAI	O
-	O
1	O
-	O
/	O
-	O
mice	O
compared	O
to	O
B6	O
mice	O
.	O

In	O
contrast	O
to	O
the	O
Lepob	O
mice	O
with	O
a	O
platelet	O
defect	O
and	O
10	O
-	O
fold	O
increase	O
in	O
bleeding	O
time	O
,	O
there	O
was	O
no	O
difference	O
in	O
the	O
bleeding	O
time	O
between	O
B6	O
and	O
A	O
/	O
J	O
mice	O
and	O
suggested	O
platelet	O
aggregation	O
is	O
not	O
altered	O
in	O
these	O
two	O
strains	O
.	O

Figure	O
2	O

Bleeding	O
and	O
rebleeding	O
time	O
in	O
B6	O
,	O
A	O
/	O
J	O
,	O
Lepob	O
,	O
Plg	O
-	O
/	O
-	O
and	O
PAI	O
-	O
1	O
-	O
/	O
-	O
mice	O
.	O

Panel	O
A	O
,	O
B	O
:	O
Bleeding	O
time	O
(	O
seconds	O
)	O
and	O
Panel	O
C	O
,	O
D	O
:	O
Rebleeding	O
time	O
(	O
seconds	O
)	O
.	O

To	O
determine	O
statistical	O
differences	O
,	O
values	O
from	O
B6	O
and	O
A	O
/	O
J	O
and	O
from	O
WT	O
and	O
Plg	O
-	O
/	O
-	O
littermates	O
were	O
compared	O
with	O
a	O
t	O
-	O
test	O
,	O
and	O
values	O
from	O
B6	O
,	O
PAI	O
-	O
1	O
-	O
/	O
-	O
and	O
Lepob	O
were	O
compared	O
by	O
a	O
one	O
-	O
way	O
ANOVA	O
and	O
a	O
Newman	O
-	O
Keuls	O
post	O
-	O
test	O
.	O

Symbols	O
indicate	O
a	O
significant	O
difference	O
(	O
*	O
P	O
<	O
0	O
.	O
05	O
,	O
*	O
*	O
P	O
<	O
0	O
.	O
01	O
,	O
*	O
*	O
*	O
P	O
<	O
0	O
.	O
001	O
)	O
between	O
B6	O
or	O
WT	O
mice	O
.	O

Values	O
are	O
the	O
mean	O
+/-	O
SEM	O
of	O
10	O
-	O
34	O
mice	O
per	O
genotype	O
.	O

Rebleeding	O
time	O
,	O
an	O
indicator	O
of	O
thrombus	O
stability	O
,	O
was	O
measured	O
as	O
the	O
time	O
between	O
the	O
cessation	O
of	O
bleeding	O
and	O
the	O
start	O
of	O
the	O
second	O
bleeding	O
(	O
Figure	O
2B	O
)	O
.	O

Rebleeding	O
times	O
were	O
significantly	O
higher	O
in	O
A	O
/	O
J	O
(	O
2	O
.	O
6	O
-	O
fold	O
,	O
P	O
<	O
0	O
.	O
001	O
)	O
mice	O
than	O
the	O
B6	O
mice	O
.	O

In	O
contrast	O
,	O
the	O
rebleeding	O
time	O
was	O
nearly	O
8	O
.	O
5	O
-	O
fold	O
less	O
in	O
the	O
Lepob	O
mice	O
than	O
the	O
B6	O
mice	O
.	O

To	O
determine	O
how	O
alterations	O
in	O
the	O
fibrinolytic	O
system	O
may	O
affect	O
rebleeding	O
time	O
,	O
Plg	O
-	O
/	O
-	O
and	O
PAI	O
-	O
1	O
-	O
/	O
-	O
mice	O
were	O
also	O
tested	O
(	O
Figure	O
2B	O
)	O
.	O

Rebleeding	O
time	O
was	O
not	O
different	O
in	O
Plg	O
-	O
/	O
-	O
mice	O
compared	O
to	O
WT	O
littermates	O
,	O
but	O
PAI	O
-	O
1	O
-	O
/	O
-	O
mice	O
had	O
a	O
significantly	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
reduced	O
rebleeding	O
time	O
,	O
which	O
was	O
1	O
.	O
8	O
-	O
fold	O
lower	O
than	O
for	O
the	O
B6	O
mice	O
.	O

Although	O
a	O
Plg	O
deficiency	O
did	O
not	O
result	O
in	O
a	O
prolonged	O
rebleeding	O
time	O
as	O
anticipated	O
,	O
a	O
PAI	O
-	O
1	O
deficiency	O
resulted	O
in	O
a	O
shortened	O
time	O
.	O

The	O
markedly	O
increased	O
rebleeding	O
time	O
in	O
the	O
A	O
/	O
J	O
may	O
suggest	O
differences	O
in	O
the	O
regulation	O
of	O
the	O
Plg	O
network	O
.	O

No	O
difference	O
in	O
blood	O
coagulation	O
between	O
B6	O
and	O
A	O
/	O
J	O
mice	O

To	O
determine	O
if	O
differences	O
in	O
coagulation	O
were	O
contributing	O
factors	O
to	O
the	O
bleeding	O
and	O
rebleeding	O
results	O
,	O
prothrombin	O
time	O
(	O
PT	O
)	O
and	O
activated	O
partial	O
thromboplastin	O
time	O
(	O
aPTT	O
)	O
were	O
measured	O
.	O

PT	O
is	O
a	O
measurement	O
of	O
the	O
extrinsic	O
coagulation	O
pathway	O
(	O
activation	O
of	O
Factor	O
VII	O
by	O
tissue	O
factor	O
)	O
while	O
aPTT	O
is	O
a	O
measurement	O
of	O
the	O
intrinsic	O
pathway	O
(	O
activation	O
of	O
Factors	O
XII	O
,	O
XI	O
,	O
IX	O
and	O
VIII	O
)	O
.	O

The	O
products	O
of	O
both	O
pathways	O
activate	O
Factor	O
X	O
,	O
which	O
initiates	O
the	O
common	O
pathway	O
leading	O
to	O
thrombin	O
generation	O
and	O
fibrin	O
clot	O
formation	O
.	O

PT	O
and	O
aPTT	O
were	O
measured	O
in	O
the	O
B6	O
and	O
A	O
/	O
J	O
mice	O
and	O
values	O
were	O
not	O
different	O
between	O
the	O
two	O
mouse	O
strains	O
(	O
Table	O
2	O
)	O
.	O

These	O
results	O
suggest	O
that	O
the	O
coagulation	O
pathway	O
is	O
not	O
different	O
in	O
the	O
two	O
inbred	O
strains	O
.	O

Table	O
2	O

Coagulation	O
and	O
Plasminogen	O
System	O
Parameters	O
in	O
B6	O
and	O
A	O
/	O
J	O
inbred	O
mouse	O
strains	O

Values	O
are	O
the	O
mean	O
+/-	O
SEM	O
.	O

*	O
P	O
<	O
0	O
.	O
05	O
,	O
*	O
*	O
P	O
<	O
0	O
.	O
01	O
.	O

n	O
=	O
5	O
-	O
8	O
.	O

Plg	O
and	O
PAI	O
-	O
1	O
higher	O
in	O
A	O
/	O
J	O
than	O
B6	O
mice	O

Plg	O
concentration	O
was	O
34	O
%	O
higher	O
in	O
the	O
A	O
/	O
J	O
mice	O
than	O
in	O
B6	O
mice	O
.	O

In	O
addition	O
,	O
fibrinolytic	O
activity	O
,	O
PAI	O
-	O
1	O
activity	O
,	O
and	O
alpha	O
2	O
-	O
anitplasmin	O
were	O
also	O
increased	O
in	O
the	O
A	O
/	O
J	O
mice	O
when	O
compared	O
to	O
the	O
B6	O
mice	O
(	O
Table	O
2	O
)	O
.	O

The	O
functional	O
consequences	O
of	O
these	O
differences	O
are	O
not	O
clear	O
,	O
since	O
fibrinogen	S-GO
is	O
also	O
higher	O
in	O
the	O
A	O
/	O
J	O
mice	O
.	O

To	O
determine	O
whether	O
there	O
were	O
protein	O
structure	O
changes	O
of	O
Plg	O
from	O
the	O
A	O
/	O
J	O
mice	O
,	O
plasma	O
from	O
the	O
B6	O
and	O
the	O
A	O
/	O
J	O
mice	O
were	O
subjected	O
to	O
electrophoresis	O
under	O
reduced	O
,	O
non	O
-	O
reduced	O
,	O
and	O
non	O
-	O
denaturing	O
conditions	O
.	O

No	O
difference	O
in	O
migration	O
for	O
immunostained	O
Plg	O
under	O
these	O
conditions	O
was	O
observed	O
(	O
data	O
not	O
shown	O
)	O
.	O

The	O
density	O
of	O
the	O
Western	O
blot	O
from	O
SDS	O
-	O
PAGE	O
under	O
reducing	O
conditions	O
of	O
plasma	O
of	O
varying	O
volumes	O
from	O
B6	O
and	O
A	O
/	O
J	O
mice	O
was	O
compared	O
and	O
the	O
density	O
of	O
the	O
bands	O
was	O
56	O
%	O
higher	O
in	O
the	O
A	O
/	O
J	O
than	O
the	O
B6	O
mice	O
(	O
six	O
individual	O
mice	O
were	O
tested	O
on	O
at	O
least	O
two	O
occasions	O
)	O
from	O
the	O
same	O
amount	O
of	O
plasma	O
(	O
Fig	O
.	O
1B	O
)	O
.	O

Thus	O
,	O
the	O
concentration	O
of	O
Plg	O
in	O
plasma	O
from	O
the	O
A	O
/	O
J	O
mice	O
was	O
higher	O
than	O
plasma	O
from	O
the	O
B6	O
mice	O
as	O
determined	O
by	O
two	O
methods	O
and	O
no	O
difference	O
in	O
migration	O
after	O
electrophoresis	O
was	O
observed	O
,	O
suggesting	O
no	O
marked	O
changes	O
in	O
the	O
structure	O
of	O
Plg	O
in	O
the	O
two	O
mouse	O
strains	O
.	O

Tail	O
morphology	O
in	O
B6	O
and	O
A	O
/	O
J	O

The	O
tails	O
of	O
the	O
mice	O
were	O
examined	O
for	O
differences	O
that	O
might	O
account	O
for	O
the	O
variations	O
in	O
the	O
bleeding	O
and	O
rebleeding	O
values	O
.	O

Sections	O
of	O
the	O
tail	O
from	O
the	O
B6	O
and	O
A	O
/	O
J	O
mice	O
were	O
stained	O
with	O
Hematoxylin	O
/	O
Eosin	O
or	O
Masson	O
'	O
s	O
Trichrome	O
and	O
representative	O
sections	O
are	O
shown	O
in	O
Figure	O
3	O
.	O

No	O
obvious	O
qualitative	O
differences	O
were	O
observed	O
in	O
hair	O
follicles	O
,	O
sebaceous	O
glands	O
,	O
or	O
center	O
bone	O
/	O
cartilage	O
in	O
Hematoxylin	O
/	O
Eosin	O
(	O
Figure	O
3A	O
)	O
stained	O
sections	O
.	O

Sections	O
of	O
the	O
tails	O
were	O
stained	O
with	O
Masson	O
'	O
s	O
Trichrome	O
(	O
Figure	O
3B	O
)	O
that	O
detects	O
collagen	S-GO
,	O
the	O
major	O
platelet	O
adhesive	O
substratum	O
for	O
initiation	O
of	O
thrombus	O
formation	O
.	O

Collagen	S-GO
content	O
(	O
%	O
tail	O
area	O
)	O
was	O
quantified	O
(	O
Figure	O
3C	O
)	O
from	O
3	O
-	O
4	O
sections	O
from	O
2	O
-	O
3	O
areas	O
/	O
mouse	O
.	O

The	O
amount	O
of	O
collagen	S-GO
was	O
greater	O
in	O
the	O
A	O
/	O
J	O
than	O
the	O
B6	O
mice	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
.	O

Collagen	S-GO
in	O
vessels	O
in	O
adipose	O
tissue	O
in	O
the	O
A	O
/	O
J	O
mice	O
is	O
also	O
increased	O
compared	O
to	O
the	O
B6	O
mice	O
(	O
data	O
not	O
shown	O
)	O
.	O

Figure	O
3	O

Tail	O
morphology	O
and	O
collagen	S-GO
.	O

Tails	O
were	O
excised	O
,	O
embedded	O
in	O
OCT	O
,	O
sectioned	O
,	O
and	O
stained	O
with	O
Hematoxylin	O
/	O
Eosin	O
or	O
Masson	O
'	O
s	O
Trichrome	O
.	O

Panel	O
A	O
:	O
Representative	O
sections	O
stained	O
with	O
hematoxylin	O
and	O
eosin	O
from	O
B6	O
and	O
A	O
/	O
J	O
mice	O
.	O

Panel	O
B	O
:	O
Representative	O
sections	O
stained	O
with	O
Masson	O
'	O
s	O
Trichrome	O
from	O
B6	O
and	O
A	O
/	O
J	O
mice	O
.	O

The	O
blue	O
color	O
identifies	O
the	O
collagen	S-GO
.	O

Panel	O
C	O
:	O
The	O
percentage	O
of	O
the	O
collagen	S-GO
area	O
(	O
excluding	O
center	O
bone	O
/	O
cartilage	O
)	O
of	O
the	O
total	O
tail	O
area	O
of	O
each	O
section	O
was	O
determined	O
in	O
3	O
-	O
4	O
sections	O
at	O
2	O
-	O
3	O
sites	O
for	O
each	O
tail	O
and	O
averaged	O
for	O
each	O
mouse	O
.	O

Values	O
are	O
the	O
mean	O
+/-	O
SEM	O
of	O
4	O
-	O
8	O
mice	O
per	O
genotype	O
.	O

Symbol	O
indicates	O
a	O
significant	O
difference	O
(	O
*	O
P	O
<	O
0	O
.	O
05	O
)	O
between	O
B6	O
mice	O
determined	O
by	O
t	O
-	O
test	O
.	O

Tail	O
bleeding	O
assay	O
identifies	O
three	O
chromosomes	S-GO
with	O
QTL	O
for	O
rebleeding	O
in	O
CSS	O

Using	O
the	O
tail	O
bleeding	O
/	O
rebleeding	O
assay	O
as	O
a	O
surrogate	O
marker	O
for	O
hemostasis	O
and	O
thrombosis	O
,	O
the	O
CSS	O
were	O
screened	O
.	O

The	O
bleeding	O
times	O
(	O
Figure	O
4A	O
)	O
for	O
the	O
B6	O
and	O
the	O
A	O
/	O
J	O
mice	O
were	O
not	O
different	O
,	O
but	O
6six	O
of	O
the	O
strains	O
,	O
B6	O
-	O
Chr5	O
,	O
6	O
,	O
8	O
,	O
14	O
,	O
15	O
,	O
and	O
YA	O
/	O
J	O
,	O
had	O
lower	O
(	O
P	O
<	O
0	O
.	O
002	O
)	O
bleeding	O
times	O
(	O
49	O
-	O
79	O
seconds	O
)	O
compared	O
to	O
the	O
value	O
for	O
the	O
B6	O
mice	O
(	O
121	O
sec	O
)	O
.	O

The	O
rebleeding	O
time	O
(	O
Figure	O
4B	O
)	O
,	O
determined	O
as	O
the	O
time	O
between	O
bleeding	O
cessation	O
and	O
initiation	O
of	O
the	O
second	O
bleeding	O
,	O
was	O
markedly	O
increased	O
in	O
the	O
A	O
/	O
J	O
mice	O
compared	O
to	O
the	O
B6	O
mice	O
and	O
two	O
strains	O
,	O
B6	O
-	O
Chr11A	O
/	O
J	O
(	O
CSS	O
-	O
11	O
)	O
and	O
B6	O
-	O
Chr17A	O
/	O
J	O
(	O
CSS	O
-	O
17	O
)	O
,	O
had	O
significantly	O
(	O
P	O
<	O
0	O
.	O
002	O
)	O
longer	O
rebleeding	O
times	O
compared	O
to	O
the	O
B6	O
mice	O
that	O
were	O
similar	O
to	O
values	O
from	O
the	O
A	O
/	O
J	O
mice	O
.	O

Another	O
strain	O
,	O
B6	O
-	O
Chr5A	O
/	O
J	O
(	O
CSS	O
-	O
5	O
)	O
,	O
approached	O
significance	O
at	O
P	O
<	O
0	O
.	O
008	O
.	O

The	O
rebleeding	O
time	O
was	O
stopped	O
at	O
600	O
sec	O
,	O
and	O
the	O
percentage	O
of	O
mice	O
with	O
this	O
value	O
determined	O
for	O
the	O
three	O
strains	O
:	O
CSS	O
-	O
5	O
-	O
60	O
%	O
,	O
CSS	O
-	O
11	O
-	O
60	O
%	O
and	O
CSS	O
-	O
A17	O
-	O
46	O
%	O
.	O

The	O
percentage	O
of	O
B6	O
mice	O
with	O
a	O
rebleeding	O
time	O
of	O
600	O
sec	O
was	O
7	O
%	O
and	O
for	O
the	O
A	O
/	O
J	O
mice	O
the	O
percentage	O
was	O
85	O
%	O
.	O

Figure	O
4	O

Bleeding	O
and	O
rebleeding	O
time	O
in	O
the	O
CSS	O
.	O

Panel	O
A	O
:	O
Bleeding	O
Time	O
(	O
seconds	O
)	O
.	O

Panel	O
B	O
:	O
Rebleeding	O
Time	O
(	O
seconds	O
)	O
.	O

Bars	O
are	O
the	O
mean	O
+/-	O
SEM	O
of	O
7	O
-	O
28	O
mice	O
.	O

Statistical	O
differences	O
between	O
B6	O
mice	O
and	O
CSS	O
were	O
determined	O
with	O
a	O
t	O
-	O
test	O
,	O
and	O
a	O
Bonferroni	O
correction	O
was	O
made	O
to	O
determine	O
significance	O
value	O
(	O
P	O
<	O
0	O
.	O
002	O
)	O
.	O

Symbols	O
indicate	O
a	O
significant	O
difference	O
between	O
B6	O
values	O
.	O

*	O
P	O
<	O
0	O
.	O
002	O
.	O

Rebleeding	O
time	O
in	O
the	O
parent	O
strains	O
and	O
CSS	O
were	O
compared	O
to	O
values	O
from	O
the	O
progeny	O
of	O
mice	O
that	O
were	O
crossed	O
with	O
B6	O
mice	O
to	O
produce	O
heterosomic	O
mice	O
for	O
the	O
CSS	O
-	O
5	O
,	O
(	O
B6xCSS	O
-	O
5	O
)	O
F1	O
and	O
CSS	O
-	O
17	O
(	O
B6xCSS	O
-	O
17	O
)	O
F1	O
strains	O
(	O
Figure	O
5	O
)	O
.	O

The	O
rebleeding	O
values	O
for	O
CSS	O
-	O
5F1	O
and	O
CSS	O
-	O
17F1	O
mice	O
were	O
similar	O
to	O
the	O
B6	O
rather	O
than	O
the	O
A	O
/	O
J	O
mice	O
,	O
suggesting	O
the	O
A	O
/	O
J	O
trait	O
is	O
recessive	O
.	O

Bleeding	O
and	O
rebleeding	O
in	O
the	O
progeny	O
of	O
the	O
cross	O
,	O
B6	O
-	O
Chr5A	O
/	O
J	O
x	O
B6	O
-	O
Chr17A	O
/	O
J	O
(	O
CSS	O
-	O
5	O
x	O
CSS	O
-	O
17	O
)	O
resulted	O
in	O
the	O
recovery	O
of	O
the	O
A	O
/	O
J	O
phenotype	O
in	O
the	O
progeny	O
of	O
these	O
double	O
heterosomic	O
strains	O
.	O

Thus	O
,	O
despite	O
the	O
heterosomic	O
chromosomes	S-GO
of	O
5	O
and	O
17	O
in	O
the	O
progeny	O
of	O
the	O
CSS	O
-	O
5	O
x	O
CSS	O
-	O
17	O
,	O
the	O
phenotype	O
was	O
now	O
similar	O
to	O
A	O
/	O
J	O
.	O

This	O
suggested	O
that	O
traits	O
on	O
the	O
A	O
/	O
J	O
chromosomes	S-GO
were	O
interacting	O
to	O
produce	O
the	O
phenotype	O
.	O

Figure	O
5	O

Bleeding	O
and	O
rebleeding	O
time	O
in	O
the	O
CSS	O
backcrosses	O
.	O

Panel	O
A	O
:	O
Bleeding	O
Time	O
(	O
seconds	O
)	O
and	O
Panel	O
B	O
:	O
Rebleeding	O
Time	O
(	O
seconds	O
)	O
were	O
tested	O
in	O
heterosomic	O
mice	O
,	O
(	O
B6xCSS	O
-	O
5	O
)	O
F1	O
(	O
5F1	O
)	O
and	O
(	O
B6xCSS	O
-	O
17	O
)	O
F1	O
(	O
17F1	O
)	O
and	O
doubly	O
heterosomic	O
mice	O
for	O
chromosomes	S-GO
5	O
and	O
17	O
(	O
5	O
x	O
17	O
)	O
.	O

Bars	O
are	O
the	O
mean	O
+/-	O
SEM	O
of	O
5	O
-	O
28	O
mice	O
.	O

Statistical	O
differences	O
between	O
B6	O
mice	O
and	O
the	O
CSS	O
were	O
determined	O
with	O
a	O
t	O
-	O
test	O
,	O
and	O
a	O
Bonferroni	O
correction	O
was	O
made	O
to	O
determine	O
significance	O
value	O
(	O
P	O
<	O
0	O
.	O
01	O
)	O
.	O

Symbols	O
indicate	O
a	O
significant	O
difference	O
between	O
B6	O
values	O
.	O

*	O
P	O
<	O
0	O
.	O
01	O
.	O

Interactions	O
of	O
CSS	O
for	O
PAI	O
-	O
1	O
antigen	O
and	O
activity	O

Components	O
of	O
the	O
Plg	O
system	O
reside	O
on	O
chromosomes	S-GO
CSS	O
-	O
5	O
(	O
PAI	O
-	O
1	O
)	O
,	O
CSS	O
-	O
11	O
(	O
alpha	O
2	O
-	O
antiplasmin	O
)	O
,	O
and	O
CSS	O
-	O
17	O
(	O
Plg	O
)	O
.	O

As	O
reported	O
in	O
Table	O
2	O
,	O
the	O
A	O
/	O
J	O
mice	O
had	O
increased	O
Plg	O
antigen	O
,	O
fibrinolytic	O
activity	O
,	O
alpha	O
2	O
-	O
antiplasmin	O
,	O
PAI	O
-	O
1	O
activity	O
and	O
fibrinogen	S-GO
when	O
compared	O
to	O
B6	O
mice	O
.	O

In	O
CSS	O
-	O
17	O
mice	O
,	O
the	O
Plg	O
antigen	O
was	O
also	O
significantly	O
(	O
P	O
=	O
0	O
.	O
015	O
)	O
increased	O
(	O
152	O
+/-	O
6	O
,	O
n	O
=	O
12	O
)	O
when	O
compared	O
to	O
the	O
B6	O
mice	O
,	O
but	O
for	O
CSS	O
-	O
5	O
and	O
CSS	O
-	O
5	O
x	O
17	O
,	O
the	O
Plg	O
antigen	O
was	O
similar	O
to	O
values	O
for	O
the	O
B6	O
mice	O
.	O

Fibrinolytic	O
activity	O
was	O
not	O
different	O
in	O
the	O
CSS	O
-	O
5	O
or	O
CSS	O
-	O
17	O
strains	O
compared	O
to	O
the	O
B6	O
mice	O
.	O

alpha	O
2	O
-	O
antiplasmin	O
was	O
significantly	O
(	O
P	O
=	O
<	O
0	O
.	O
01	O
)	O
reduced	O
in	O
CSS	O
-	O
5	O
mice	O
(	O
142	O
+/-	O
4	O
mu	O
g	O
/	O
mL	O
,	O
n	O
=	O
5	O
)	O
,	O
significantly	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
higher	O
in	O
the	O
CSS	O
-	O
11	O
(	O
201	O
+/-	O
6	O
,	O
n	O
=	O
8	O
)	O
,	O
but	O
not	O
different	O
in	O
CSS	O
-	O
17	O
or	O
CSS	O
-	O
5	O
x	O
17	O
mice	O
compared	O
to	O
the	O
B6	O
mice	O
.	O

PAI	O
-	O
1	O
antigen	O
and	O
activity	O
were	O
determined	O
in	O
the	O
CSS	O
with	O
increased	O
rebleeding	O
times	O
,	O
CSS	O
-	O
5	O
,	O
CSS	O
-	O
11	O
,	O
and	O
CSS	O
-	O
17	O
(	O
Figure	O
6	O
)	O
,	O
the	O
heterosomic	O
,	O
CSS	O
-	O
5F1	O
,	O
CSS	O
-	O
17F1	O
,	O
and	O
double	O
hetersomic	O
,	O
CSS	O
-	O
5	O
x	O
17	O
.	O

CSS	O
-	O
5	O
,	O
CSS	O
-	O
17	O
,	O
CSS	O
-	O
5F1	O
,	O
and	O
CSS	O
-	O
17F1	O
generally	O
had	O
reduced	O
PAI	O
-	O
1	O
antigen	O
when	O
compared	O
to	O
B6	O
mice	O
.	O

The	O
reduced	O
PAI	O
-	O
1	O
antigen	O
was	O
a	O
dominant	O
trait	O
due	O
to	O
the	O
fact	O
that	O
the	O
values	O
were	O
similar	O
in	O
the	O
homosomic	O
and	O
heterosomic	O
CSS	O
-	O
5	O
and	O
CSS	O
-	O
17	O
.	O

The	O
CSS	O
-	O
5	O
x	O
CSS	O
-	O
17	O
double	O
heterosomic	O
strains	O
had	O
values	O
similar	O
to	O
the	O
B6	O
and	O
A	O
/	O
J	O
parent	O
strains	O
.	O

PAI	O
-	O
1	O
activity	O
was	O
significantly	O
reduced	O
in	O
the	O
CSS	O
-	O
5	O
and	O
CSS	O
-	O
17F1	O
mice	O
,	O
but	O
again	O
in	O
the	O
CSS	O
-	O
5	O
x	O
CSS	O
-	O
17	O
strain	O
the	O
value	O
for	O
PAI	O
-	O
1	O
activity	O
was	O
restored	O
to	O
the	O
value	O
of	O
the	O
B6	O
and	O
A	O
/	O
J	O
parent	O
strains	O
.	O

The	O
PAI	O
-	O
1	O
antigen	O
(	O
5	O
.	O
4	O
ng	O
/	O
mL	O
+/-	O
0	O
.	O
5	O
,	O
n	O
=	O
7	O
)	O
and	O
activity	O
(	O
170	O
U	O
/	O
mL	O
+/-	O
20	O
,	O
n	O
=	O
6	O
)	O
in	O
the	O
CSS	O
-	O
11	O
mice	O
was	O
not	O
different	O
than	O
for	O
B6	O
mice	O
.	O

Figure	O
6	O

PAI	O
-	O
1	O
in	O
the	O
CSS	O
backcrosses	O
.	O

Panel	O
A	O
:	O
Plasma	O
PAI	O
-	O
1	O
antigen	O
(	O
ng	O
/	O
mL	O
)	O
and	O
Panel	O
B	O
:	O
Plasma	O
PAI	O
-	O
1	O
activity	O
(	O
U	O
/	O
mL	O
)	O
were	O
tested	O
in	O
heterosomic	O
mice	O
,	O
(	O
B6xCSS	O
-	O
5	O
)	O
F1	O
(	O
5F1	O
)	O
and	O
(	O
B6xCSS	O
-	O
17	O
)	O
F1	O
(	O
17F1	O
)	O
and	O
doubly	O
heterosomic	O
mice	O
for	O
chromosomes	S-GO
5	O
and	O
17	O
(	O
5	O
x	O
17	O
)	O
.	O

Bars	O
are	O
the	O
mean	O
+/-	O
SEM	O
of	O
5	O
-	O
18	O
mice	O
.	O

Statistical	O
differences	O
between	O
B6	O
mice	O
and	O
CSS	O
were	O
determined	O
with	O
a	O
t	O
-	O
test	O
,	O
and	O
a	O
Bonferroni	O
correction	O
was	O
made	O
to	O
determine	O
significance	O
value	O
(	O
P	O
<	O
0	O
.	O
01	O
)	O
.	O

Symbols	O
indicate	O
a	O
significant	O
difference	O
between	O
B6	O
values	O
.	O

*	O
P	O
<	O
0	O
.	O
01	O
.	O

Interactions	O
of	O
CSS	O
for	O
arterial	O
thrombus	O
formation	O

The	O
tail	O
bleeding	O
assay	O
was	O
rapid	O
and	O
facilitated	O
the	O
screening	O
of	O
the	O
21	O
CSS	O
strains	O
,	O
and	O
subsequently	O
the	O
identified	O
strains	O
were	O
tested	O
for	O
arterial	O
occlusion	O
after	O
the	O
FeCl3	O
injury	O
(	O
Figure	O
7	O
)	O
.	O

The	O
CSS	O
-	O
5	O
and	O
CSS	O
-	O
17	O
had	O
occlusion	O
times	O
similar	O
to	O
the	O
B6	O
mice	O
,	O
but	O
the	O
doubly	O
heterosomic	O
CSS	O
-	O
5	O
x	O
CSS	O
-	O
17	O
progeny	O
had	O
occlusion	O
times	O
higher	O
than	O
either	O
the	O
B6	O
mice	O
or	O
the	O
heterosomic	O
CSS	O
-	O
5F1	O
and	O
CSS	O
-	O
17F1	O
or	O
the	O
A	O
/	O
J	O
strains	O
.	O

In	O
double	O
heterosomic	O
CSS	O
-	O
5	O
x	O
CSS	O
-	O
17	O
mice	O
,	O
only	O
one	O
or	O
three	O
mice	O
tested	O
had	O
occluded	O
by	O
30	O
min	O
;	O
the	O
other	O
two	O
mice	O
did	O
not	O
occlude	O
by	O
30	O
min	O
.	O

While	O
only	O
a	O
small	O
number	O
of	O
CSS	O
mice	O
have	O
been	O
tested	O
for	O
the	O
arterial	O
occlusion	O
,	O
the	O
results	O
suggest	O
that	O
interaction	O
of	O
the	O
genes	O
on	O
chromosome	S-GO
5	O
and	O
17	O
also	O
determines	O
arterial	O
occlusion	O
time	O
.	O

Figure	O
7	O

Arterial	O
occlusion	O
time	O
in	O
the	O
CSS	O
backcrosses	O
.	O

Occlusion	O
time	O
was	O
determined	O
in	O
heterosomic	O
mice	O
,	O
(	O
B6xCSS	O
-	O
5	O
)	O
F1	O
(	O
5F1	O
)	O
and	O
(	O
B6xCSS	O
-	O
17	O
)	O
F1	O
(	O
17F1	O
)	O
,	O
and	O
doubly	O
heterosomic	O
mice	O
for	O
chromosomes	S-GO
5	O
and	O
17	O
(	O
5	O
x	O
17	O
)	O
.	O

Bars	O
are	O
the	O
mean	O
+/-	O
SEM	O
of	O
5	O
-	O
18	O
mice	O
.	O

Statistical	O
differences	O
between	O
B6	O
mice	O
and	O
CSS	O
were	O
determined	O
with	O
a	O
t	O
-	O
test	O
,	O
and	O
a	O
Bonferroni	O
correction	O
was	O
made	O
to	O
determine	O
significance	O
value	O
(	O
P	O
<	O
0	O
.	O
02	O
)	O
.	O

Symbols	O
indicate	O
a	O
significant	O
difference	O
between	O
B6	O
values	O
.	O

*	O
P	O
<	O
0	O
.	O
0001	O
.	O

Discussion	O

In	O
this	O
study	O
,	O
thrombotic	O
risk	O
was	O
systematically	O
assessed	O
in	O
two	O
inbred	O
strains	O
of	O
mice	O
that	O
have	O
marked	O
differences	O
in	O
susceptibility	O
to	O
diet	O
-	O
induced	O
obesity	O
,	O
diet	O
-	O
induced	O
atherosclerosis	O
,	O
and	O
ligation	O
-	O
induced	O
neointimal	O
hyperplasia	O
and	O
vessel	O
remodeling	O
.	O

Arterial	O
occlusion	O
time	O
,	O
tail	O
bleeding	O
and	O
rebleeding	O
time	O
were	O
evaluated	O
as	O
potential	O
predictors	O
of	O
thrombotic	O
response	O
.	O

Assessments	O
of	O
the	O
two	O
inbred	O
strains	O
were	O
compared	O
to	O
values	O
from	O
gene	O
targeted	O
mice	O
of	O
the	O
Plg	O
network	O
with	O
altered	O
fibrinolytic	O
responses	O
,	O
as	O
well	O
as	O
in	O
leptin	O
deficient	O
mice	O
with	O
a	O
reduced	O
platelet	O
function	O
.	O

Marked	O
differences	O
were	O
found	O
in	O
the	O
thrombotic	O
response	O
among	O
the	O
two	O
inbred	O
strains	O
,	O
B6	O
and	O
A	O
/	O
J	O
,	O
and	O
the	O
observed	O
differences	O
were	O
not	O
correlated	O
with	O
change	O
in	O
coagulation	O
or	O
platelet	O
function	O
.	O

Screening	O
the	O
CSS	O
identified	O
three	O
chromosomes	S-GO
that	O
harbored	O
genes	O
which	O
contributed	O
to	O
the	O
A	O
/	O
J	O
phenotype	O
of	O
increased	O
rebleeding	O
time	O
.	O

Mice	O
homosomic	O
for	O
these	O
chromosomes	S-GO
or	O
doubly	O
heterosomic	O
for	O
two	O
of	O
the	O
chromosomes	S-GO
,	O
5	O
and	O
17	O
,	O
were	O
required	O
to	O
express	O
the	O
A	O
/	O
J	O
phenotype	O
,	O
elevated	O
rebleeding	O
time	O
.	O

PAI	O
-	O
1	O
antigen	O
and	O
activity	O
were	O
decreased	O
in	O
both	O
CSS	O
-	O
5	O
and	O
CSS	O
-	O
17	O
and	O
the	O
heterosomic	O
mice	O
,	O
CSS	O
-	O
5F1	O
and	O
CSS	O
-	O
17F1	O
,	O
but	O
not	O
in	O
the	O
CSS	O
-	O
11	O
strain	O
.	O

Values	O
were	O
restored	O
in	O
the	O
doubly	O
heterosomic	O
for	O
two	O
of	O
chromosomes	S-GO
,	O
5	O
and	O
17	O
.	O

Arterial	O
occlusion	O
time	O
was	O
similar	O
to	O
B6	O
in	O
the	O
CSS	O
-	O
5	O
and	O
CSS	O
-	O
17	O
homozygous	O
strains	O
,	O
but	O
increased	O
in	O
doubly	O
heterosomic	O
for	O
two	O
of	O
chromosomes	S-GO
,	O
5	O
and	O
17	O
.	O

The	O
FeCl3	O
-	O
induced	O
model	O
of	O
vascular	O
injury	O
and	O
thrombosis	O
in	O
mice	O
is	O
now	O
widely	O
used	O
to	O
evaluate	O
genetic	O
and	O
pharmacological	O
interventions	O
[	O
24	O
]	O
.	O

The	O
two	O
inbred	O
strains	O
had	O
marked	O
differences	O
in	O
the	O
time	O
for	O
occlusion	O
of	O
the	O
carotid	O
artery	O
after	O
FeCl3	O
injury	O
.	O

After	O
FeCl3	O
treatment	O
,	O
thrombus	O
formation	O
and	O
occlusion	O
was	O
remarkably	O
shortened	O
in	O
the	O
A	O
/	O
J	O
mice	O
compared	O
to	O
the	O
B6	O
mice	O
.	O

These	O
results	O
have	O
not	O
previously	O
been	O
reported	O
.	O

A	O
recent	O
study	O
[	O
25	O
]	O
of	O
sheer	O
stress	O
in	O
rats	O
,	O
found	O
that	O
the	O
magnitude	O
of	O
changes	O
in	O
sheer	O
stress	O
with	O
increased	O
blood	O
flow	O
varied	O
with	O
the	O
different	O
strains	O
.	O

Further	O
investigation	O
,	O
beyond	O
the	O
scope	O
of	O
this	O
study	O
would	O
be	O
necessary	O
to	O
determine	O
the	O
contribution	O
in	O
the	O
differences	O
in	O
size	O
and	O
sheer	O
stress	O
of	O
the	O
carotids	O
to	O
arterial	O
occlusion	O
rates	O
in	O
the	O
B6	O
and	O
A	O
/	O
J	O
mice	O
.	O

In	O
preliminary	O
studies	O
,	O
we	O
have	O
noted	O
differences	O
in	O
the	O
composition	O
of	O
the	O
thrombus	O
in	O
B6	O
and	O
A	O
/	O
J	O
mice	O
.	O

The	O
pattern	O
of	O
blood	O
flow	O
cessation	O
for	O
the	O
two	O
inbred	O
strains	O
was	O
different	O
than	O
for	O
the	O
Lepob	O
mice	O
[	O
26	O
]	O
with	O
impaired	O
platelet	O
function	O
,	O
and	O
coagulation	O
time	O
was	O
similar	O
in	O
the	O
two	O
strains	O
.	O

In	O
the	O
mice	O
with	O
deficiencies	O
of	O
the	O
Plg	O
network	O
[	O
27	O
]	O
,	O
thrombus	O
formation	O
time	O
was	O
reduced	O
in	O
the	O
Plg	O
-	O
/	O
-	O
mice	O
,	O
but	O
increased	O
in	O
the	O
PAI	O
-	O
/	O
-	O
mice	O
,	O
suggesting	O
that	O
alterations	O
in	O
plasmin	O
activity	O
that	O
affect	O
the	O
rate	O
of	O
clot	O
lysis	O
,	O
can	O
modulate	O
the	O
events	O
leading	O
to	O
occlusive	O
thrombus	O
formation	O
.	O

The	O
tail	O
-	O
bleeding	O
assay	O
has	O
been	O
used	O
extensively	O
in	O
mice	O
to	O
assess	O
the	O
impact	O
of	O
deficiencies	O
and	O
over	O
expression	O
of	O
platelet	O
and	O
coagulation	O
proteins	O
in	O
mice	O
.	O

Sweeny	O
et	O
al	O
[	O
28	O
]	O
screened	O
25	O
strains	O
of	O
mice	O
and	O
found	O
only	O
the	O
RIIS	O
/	O
J	O
mice	O
to	O
have	O
increased	O
bleeding	O
time	O
due	O
to	O
reduced	O
von	O
Willebrand	O
antigen	O
.	O

Broze	O
et	O
al	O
[	O
29	O
]	O
evaluated	O
mice	O
with	O
gene	O
deletions	O
of	O
the	O
coagulation	O
pathway	O
and	O
found	O
that	O
while	O
bleeding	O
time	O
was	O
not	O
increased	O
,	O
rebleeding	O
persisted	O
despite	O
electrocautery	O
of	O
the	O
tail	O
in	O
FVIII	O
and	O
FIX	O
deficient	O
mice	O
.	O

This	O
observation	O
raised	O
the	O
possibility	O
that	O
rebleeding	O
time	O
may	O
be	O
a	O
sensitive	O
reporter	O
of	O
genetic	O
influences	O
on	O
thrombus	O
formation	O
and	O
stability	O
.	O

Mice	O
that	O
are	O
deficient	O
in	O
factors	O
required	O
for	O
normal	O
platelet	O
function	O
,	O
platelet	O
glycoprotein	O
Ib	O
[	O
30	O
]	O
,	O
and	O
protease	O
-	O
activated	O
receptor	O
-	O
4	O
,	O
[	O
31	O
]	O
have	O
increased	O
tail	O
bleeding	O
time	O
.	O

The	O
leptin	O
deficiency	O
with	O
reduced	O
platelet	O
aggregation	O
clearly	O
shows	O
a	O
marked	O
increase	O
in	O
bleeding	O
time	O
and	O
the	O
increased	O
bleeding	O
time	O
in	O
Plg	O
-	O
/	O
-	O
and	O
uPA	O
-	O
/	O
-	O
mice	O
suggests	O
that	O
Plg	O
and	O
uPA	O
may	O
exert	O
an	O
influence	O
on	O
platelet	O
response	O
to	O
promote	O
normal	O
thrombus	O
formation	O
.	O

Overall	O
,	O
the	O
marked	O
increase	O
in	O
rebleeding	O
times	O
observed	O
in	O
certain	O
mouse	O
strains	O
suggests	O
genetic	O
factors	O
other	O
than	O
coagulation	O
may	O
play	O
a	O
role	O
in	O
the	O
stability	O
of	O
a	O
thrombus	O
.	O

In	O
the	O
tail	O
bleeding	O
assay	O
,	O
A	O
/	O
J	O
mice	O
did	O
not	O
have	O
changes	O
in	O
bleeding	O
time	O
,	O
but	O
rebleeding	O
time	O
was	O
higher	O
compared	O
to	O
B6	O
mice	O
.	O

In	O
our	O
study	O
,	O
Plg	O
-	O
/	O
-	O
mice	O
had	O
increased	O
bleeding	O
time	O
,	O
PAI	O
-	O
1	O
-	O
/	O
-	O
had	O
decreased	O
rebleeding	O
time	O
,	O
and	O
uPA	O
-	O
/	O
-	O
mice	O
had	O
an	O
increased	O
bleeding	O
time	O
similar	O
to	O
the	O
Plg	O
-	O
/	O
-	O
mice	O
(	O
J	O
.	O
Hoover	O
-	O
Plow	O
,	O
A	O
.	O
Shchurin	O
,	O
and	O
E	O
.	O
Hart	O
,	O
unpublished	O
results	O
)	O
.	O

Increased	O
bleeding	O
or	O
rebleeding	O
times	O
have	O
not	O
been	O
reported	O
in	O
any	O
of	O
the	O
Plg	O
network	O
targeted	O
mice	O
.	O

Matsuno	O
et	O
al	O
[	O
32	O
]	O
reported	O
no	O
difference	O
in	O
bleeding	O
time	O
for	O
tPA	O
-	O
/	O
-	O
,	O
uPA	O
-	O
/	O
-	O
,	O
PAI	O
-	O
1	O
-	O
/	O
-	O
mice	O
compared	O
to	O
WT	O
mice	O
,	O
and	O
the	O
assay	O
was	O
similar	O
,	O
but	O
the	O
tail	O
clip	O
segment	O
was	O
considerably	O
shorter	O
and	O
bleeding	O
times	O
reduced	O
compared	O
to	O
the	O
times	O
reported	O
in	O
our	O
study	O
.	O

Bleeding	O
time	O
has	O
not	O
been	O
previously	O
reported	O
for	O
Plg	O
-	O
/	O
-	O
mice	O
.	O

We	O
have	O
found	O
similar	O
values	O
for	O
Plg	O
-	O
/	O
-	O
mice	O
in	O
a	O
50	O
%	O
B6	O
:	O
50	O
%	O
129	O
background	O
(	O
J	O
.	O
Hoover	O
-	O
Plow	O
,	O
A	O
.	O
Shchurin	O
,	O
and	O
E	O
.	O
Hart	O
,	O
unpublished	O
results	O
)	O
.	O

The	O
results	O
of	O
this	O
study	O
suggest	O
that	O
not	O
only	O
is	O
bleeding	O
time	O
genetically	O
determined	O
by	O
background	O
,	O
but	O
also	O
that	O
tail	O
rebleeding	O
time	O
is	O
genetically	O
determined	O
.	O

While	O
blood	O
pressure	O
could	O
conceivably	O
be	O
higher	O
in	O
mice	O
with	O
elevated	O
tail	O
bleeding	O
time	O
,	O
several	O
studies	O
suggest	O
that	O
this	O
is	O
not	O
the	O
case	O
.	O

Studies	O
of	O
A	O
/	O
J	O
[	O
33	O
-	O
36	O
]	O
mice	O
have	O
reported	O
either	O
decreased	O
blood	O
pressure	O
or	O
no	O
difference	O
compared	O
to	O
the	O
B6	O
mice	O
.	O

Blood	O
pressure	O
was	O
measured	O
in	O
the	O
Plg	O
-	O
/	O
-	O
mice	O
(	O
D	O
.	O
Hellard	O
,	O
J	O
.	O
Hoover	O
-	O
Plow	O
,	O
and	O
E	O
.	O
Plow	O
,	O
unpublished	O
results	O
)	O
,	O
and	O
these	O
mice	O
have	O
reduced	O
blood	O
pressure	O
when	O
compared	O
to	O
WT	O
littermates	O
,	O
and	O
uPA	O
-	O
/	O
-	O
[	O
37	O
]	O
and	O
Lepob	O
[	O
38	O
,	O
39	O
]	O
mice	O
also	O
have	O
reduced	O
blood	O
pressure	O
,	O
but	O
there	O
is	O
no	O
correspondence	O
between	O
blood	O
pressure	O
and	O
tail	O
bleeding	O
or	O
rebleeding	O
times	O
.	O

Morphometric	O
analysis	O
of	O
the	O
tail	O
indicated	O
a	O
difference	O
in	O
the	O
collagen	S-GO
content	O
of	O
the	O
tail	O
in	O
the	O
A	O
/	O
J	O
mice	O
.	O

Differences	O
in	O
the	O
structure	O
and	O
/	O
or	O
metabolism	O
of	O
collagen	S-GO
or	O
extracellular	B-GO
matrix	E-GO
proteins	O
may	O
contribute	O
to	O
the	O
increased	O
rebleeding	O
and	O
reduced	O
occlusion	O
time	O
in	O
the	O
A	O
/	O
J	O
mice	O
and	O
warrant	O
further	O
investigation	O
.	O

The	O
genes	O
for	O
Plg	O
,	O
PAI	O
-	O
1	O
,	O
and	O
alpha	O
2	O
-	O
antiplasmin	O
reside	O
on	O
the	O
three	O
chromosomes	S-GO
identified	O
for	O
QTL	O
for	O
rebleeding	O
time	O
and	O
may	O
or	O
may	O
not	O
be	O
coincidental	O
to	O
the	O
observed	O
phenotypes	O
found	O
in	O
the	O
A	O
/	O
J	O
mice	O
and	O
CSS	O
.	O

It	O
is	O
not	O
likely	O
that	O
merely	O
the	O
concentration	O
of	O
these	O
components	O
explains	O
the	O
increased	O
rebleeding	O
time	O
and	O
reduced	O
arterial	O
occlusion	O
time	O
in	O
the	O
A	O
/	O
J	O
mice	O
.	O

When	O
compared	O
to	O
the	O
B6	O
mice	O
,	O
the	O
A	O
/	O
J	O
mice	O
and	O
the	O
three	O
strains	O
with	O
elevated	O
rebleeding	O
time	O
had	O
variable	O
Plg	O
,	O
PAI	O
-	O
1	O
,	O
and	O
alpha	O
2	O
-	O
antiplasmin	O
.	O

Two	O
allelic	O
forms	O
of	O
the	O
mouse	O
Plg	O
gene	O
have	O
been	O
reported	O
for	O
B6	O
and	O
A	O
/	O
J	O
mice	O
[	O
40	O
]	O
.	O

Plg	O
concentration	O
was	O
increased	O
in	O
A	O
/	O
J	O
mice	O
compared	O
to	O
B6	O
mice	O
.	O

Although	O
we	O
did	O
not	O
detect	O
differences	O
in	O
Plg	O
structure	O
,	O
this	O
would	O
not	O
exclude	O
possible	O
functional	O
differences	O
.	O

A	O
congenic	O
strain	O
(	O
specific	O
for	O
a	O
homosomic	O
region	O
from	O
A	O
/	O
J	O
and	O
the	O
remaining	O
Chr	S-GO
and	O
background	O
is	O
from	O
B6	O
mice	O
)	O
of	O
A	O
/	O
J	O
chromosome	S-GO
17	O
that	O
includes	O
the	O
Plg	O
gene	O
was	O
tested	O
in	O
the	O
bleeding	O
assay	O
.	O

Values	O
for	O
bleeding	O
and	O
rebleeding	O
in	O
this	O
congenic	O
strain	O
were	O
similar	O
to	O
values	O
from	O
B6	O
mice	O
,	O
indicating	O
that	O
the	O
QTL	O
is	O
not	O
Plg	O
.	O

There	O
are	O
genes	O
for	O
other	O
proteases	O
and	O
matrix	O
proteins	O
that	O
reside	O
on	O
chromosome	S-GO
17	O
in	O
addition	O
to	O
unknown	O
genes	O
.	O

DNA	O
base	O
pair	O
sequence	O
data	O
for	O
the	O
PAI	O
-	O
1	O
gene	O
or	O
the	O
alpha	O
2	O
-	O
antiplasmin	O
gene	O
in	O
B6	O
and	O
A	O
/	O
J	O
mice	O
have	O
reported	O
no	O
differences	O
[	O
51	O
]	O
,	O
but	O
regulatory	O
genes	O
upstream	O
of	O
the	O
coding	O
region	O
may	O
be	O
important	O
.	O

Our	O
results	O
suggest	O
that	O
novel	O
or	O
unknown	O
genes	O
may	O
interact	O
with	O
the	O
Plg	O
system	O
components	O
to	O
modify	O
their	O
function	O
.	O

In	O
summary	O
,	O
this	O
study	O
reports	O
marked	O
differences	O
in	O
two	O
inbred	O
strains	O
of	O
mice	O
,	O
B6	O
and	O
A	O
/	O
J	O
,	O
in	O
arterial	O
thrombosis	O
formation	O
in	O
a	O
FeCl3	O
vascular	O
injury	O
model	O
,	O
rebleeding	O
time	O
in	O
a	O
tail	O
bleeding	O
assay	O
,	O
plasminogen	O
function	O
,	O
and	O
tissue	O
and	O
vessel	O
collagen	S-GO
deposition	O
.	O

Three	O
chromosomes	S-GO
from	O
A	O
/	O
J	O
mice	O
were	O
identified	O
that	O
had	O
QTL	O
for	O
rebleeding	O
time	O
.	O

The	O
genes	O
may	O
interact	O
with	O
components	O
in	O
the	O
Plg	O
network	O
and	O
modulate	O
arterial	O
occlusion	O
time	O
.	O

Conclusion	O

The	O
marked	O
independent	O
differences	O
demonstrated	O
in	O
the	O
B6	O
and	O
A	O
/	O
J	O
mice	O
can	O
be	O
exploited	O
to	O
identify	O
genetic	O
determinants	O
of	O
thrombosis	O
and	O
haemostasis	O
.	O

Our	O
results	O
of	O
the	O
CSS	O
screening	O
suggest	O
that	O
novel	O
or	O
unknown	O
genes	O
can	O
be	O
used	O
to	O
identify	O
the	O
genes	O
responsible	O
for	O
the	O
traits	O
related	O
to	O
arterial	O
thrombosis	O
,	O
tail	O
bleeding	O
/	O
rebleeding	O
and	O
vessel	O
extracellular	B-GO
matrix	E-GO
.	O

Identification	O
of	O
differences	O
in	O
the	O
parent	O
strains	O
,	O
such	O
as	O
those	O
described	O
in	O
this	O
study	O
,	O
and	O
screening	O
of	O
the	O
CSS	O
is	O
a	O
first	O
-	O
step	O
in	O
the	O
discovery	O
of	O
new	O
genetic	O
determinants	O
of	O
thrombotic	O
risk	O
.	O

Abbreviations	O

B6	O
=	O
C57BL	O
/	O
6J	O

CSS	O
=	O
chromosome	S-GO
substitution	O
strains	O

CSS	O
-	O
#	O
=	O
B6	O
-	O
Chr	O
#	O
A	O
/	O
J	O

CSS	O
-	O
#	O
F1	O
=	O
(	O
B6	O
x	O
CSS	O
-	O
#	O
)	O
F1	O

WT	O
=	O
wild	O
-	O
type	O

-	O
/	O
-	O
=	O
deficient	O

Plg	O
=	O
plasminogen	O

PAI	O
-	O
1	O
=	O
plasminogen	O
activator	O
inhibitor	O
-	O
1	O

tPA	O
=	O
tissue	O
plasminogen	O
activator	O

uPA	O
=	O
urokinase	O
plasminogen	O
activator	O

SEM	O
=	O
standard	O
error	O
of	O
the	O
mean	O

QTL	O
=	O
quantitative	O
trait	O
locus	O

Competing	O
interests	O

The	O
author	O
(	O
s	O
)	O
declare	O
that	O
they	O
have	O
no	O
competing	O
interests	O
.	O

Authors	O
'	O
contributions	O

JHP	O
conceived	O
and	O
designed	O
the	O
study	O
,	O
coordinated	O
the	O
experiments	O
and	O
drafted	O
the	O
manuscript	O
.	O

AS	O
developed	O
and	O
performed	O
the	O
tail	O
bleeding	O
assay	O
and	O
participated	O
in	O
drafting	O
the	O
manuscript	O
.	O

EH	O
carried	O
out	O
the	O
vascular	O
injury	O
model	O
and	O
analyses	O
and	O
the	O
tail	O
bleeding	O
assay	O
,	O
participated	O
in	O
the	O
tail	O
collagen	S-GO
analyses	O
,	O
and	O
coordination	O
of	O
the	O
mouse	O
breeding	O
.	O

JS	O
participated	O
in	O
the	O
analysis	O
of	O
the	O
vascular	O
injury	O
model	O
results	O
and	O
collagen	S-GO
analyses	O
.	O

JHN	O
and	O
AHE	O
provided	O
the	O
CSS	O
breeding	O
pairs	O
,	O
JHN	O
participated	O
in	O
discussions	O
of	O
the	O
results	O
,	O
and	O
JBS	O
and	O
JHN	O
developed	O
the	O
CSS	O
.	O

All	O
the	O
authors	O
have	O
read	O
and	O
approved	O
the	O
final	O
manuscript	O
.	O

Pre	O
-	O
publication	O
history	O

The	O
pre	O
-	O
publication	O
history	O
for	O
this	O
paper	O
can	O
be	O
accessed	O
here	O
:	O

Acknowledgements	O

The	O
authors	O
thank	O
Dr	O
.	O
A	O
.	O

Vasanji	O
,	O
Shiyang	O
Wang	O
,	O
and	O
Jenna	O
Saraniti	O
for	O
assistance	O
with	O
image	O
analyses	O
,	O
David	O
Hellard	O
for	O
performing	O
the	O
blood	O
pressure	O
measurements	O
,	O
Dr	O
.	O
Y	O
.	O
Shchurina	O
for	O
the	O
plasminogen	O
analyses	O
,	O
Drs	O
.	O

Lindsey	O
Burrage	O
and	O
Jonathan	O
Smith	O
for	O
helpful	O
discussions	O
,	O
and	O
Robin	O
Lewis	O
for	O
assistance	O
with	O
manuscript	O
preparation	O
.	O

This	O
study	O
was	O
supported	O
by	O
grants	O
from	O
NIH	O
,	O
HL17964	O
,	O
HL65204	O
,	O
HL078701	O
(	O
JHP	O
)	O
,	O
T32	O
HL07914	O
(	O
AS	O
)	O
,	O
and	O
RR12305	O
(	O
JHN	O
)	O
.	O

CAF	B-GO
-	I-GO
1	E-GO
Is	O
Essential	O
for	O
Heterochromatin	S-GO
Organization	O
in	O
Pluripotent	O
Embryonic	O
Cells	O

Abstract	O

During	O
mammalian	O
development	O
,	O
chromatin	S-GO
dynamics	O
and	O
epigenetic	O
marking	O
are	O
important	O
for	O
genome	O
reprogramming	O
.	O

Recent	O
data	O
suggest	O
an	O
important	O
role	O
for	O
the	O
chromatin	S-GO
assembly	O
machinery	O
in	O
this	O
process	O
.	O

To	O
analyze	O
the	O
role	O
of	O
chromatin	B-GO
assembly	I-GO
factor	I-GO
1	E-GO
(	O
CAF	B-GO
-	I-GO
1	E-GO
)	O
during	O
pre	O
-	O
implantation	O
development	O
,	O
we	O
generated	O
a	O
mouse	O
line	O
carrying	O
a	O
targeted	O
mutation	O
in	O
the	O
gene	O
encoding	O
its	O
large	O
subunit	O
,	O
p150CAF	O
-	O
1	O
.	O

Loss	O
of	O
p150CAF	O
-	O
1	O
in	O
homozygous	O
mutants	O
leads	O
to	O
developmental	O
arrest	O
at	O
the	O
16	O
-	O
cell	O
stage	O
.	O

Absence	O
of	O
p150CAF	O
-	O
1	O
in	O
these	O
embryos	O
results	O
in	O
severe	O
alterations	O
in	O
the	O
nuclear	S-GO
organization	O
of	O
constitutive	O
heterochromatin	S-GO
.	O

We	O
provide	O
evidence	O
that	O
in	O
wild	O
-	O
type	O
embryos	O
,	O
heterochromatin	B-GO
domains	E-GO
are	O
extensively	O
reorganized	O
between	O
the	O
two	O
-	O
cell	O
and	O
blastocyst	O
stages	O
.	O

In	O
p150CAF	O
-	O
1	O
mutant	O
16	O
-	O
cell	O
stage	O
embryos	O
,	O
the	O
altered	O
organization	O
of	O
heterochromatin	S-GO
displays	O
similarities	O
to	O
the	O
structure	O
of	O
heterochromatin	S-GO
in	O
two	O
-	O
to	O
four	O
-	O
cell	O
stage	O
wild	O
-	O
type	O
embryos	O
,	O
suggesting	O
that	O
CAF	B-GO
-	I-GO
1	E-GO
is	O
required	O
for	O
the	O
maturation	O
of	O
heterochromatin	S-GO
during	O
preimplantation	O
development	O
.	O

In	O
embryonic	O
stem	O
cells	O
,	O
depletion	O
of	O
p150CAF	O
-	O
1	O
using	O
RNA	O
interference	O
results	O
in	O
the	O
mislocalization	O
,	O
loss	O
of	O
clustering	O
,	O
and	O
decondensation	O
of	O
pericentric	B-GO
heterochromatin	I-GO
domains	E-GO
.	O

Furthermore	O
,	O
loss	O
of	O
CAF	B-GO
-	I-GO
1	E-GO
in	O
these	O
cells	O
results	O
in	O
the	O
alteration	O
of	O
epigenetic	O
histone	O
methylation	O
marks	O
at	O
the	O
level	O
of	O
pericentric	B-GO
heterochromatin	E-GO
.	O

These	O
alterations	O
of	O
heterochromatin	S-GO
are	O
not	O
found	O
in	O
p150CAF	O
-	O
1	O
-	O
depleted	O
mouse	O
embryonic	O
fibroblasts	O
,	O
which	O
are	O
cells	O
that	O
are	O
already	O
lineage	O
committed	O
,	O
suggesting	O
that	O
CAF	B-GO
-	I-GO
1	E-GO
is	O
specifically	O
required	O
for	O
heterochromatin	S-GO
organization	O
in	O
pluripotent	O
embryonic	O
cells	O
.	O

Our	O
findings	O
underline	O
the	O
role	O
of	O
the	O
chromatin	S-GO
assembly	O
machinery	O
in	O
controlling	O
the	O
spatial	O
organization	O
and	O
epigenetic	O
marking	O
of	O
the	O
genome	O
in	O
early	O
embryos	O
and	O
embryonic	O
stem	O
cells	O
.	O

Synopsis	O

Chromatin	S-GO
is	O
the	O
support	O
of	O
our	O
genetic	O
information	O
.	O

It	O
is	O
composed	O
of	O
numerous	O
repeated	O
units	O
called	O
nucleosomes	S-GO
,	O
in	O
which	O
DNA	O
wraps	O
around	O
a	O
core	O
of	O
histone	O
proteins	O
.	O

Modifications	O
in	O
the	O
composition	O
and	O
biochemical	O
properties	O
of	O
nucleosomes	S-GO
play	O
major	O
roles	O
in	O
the	O
regulation	O
of	O
genome	O
function	O
.	O

Such	O
modifications	O
are	O
termed	O
"	O
epigenetic	O
"	O
when	O
they	O
are	O
inherited	O
across	O
cell	O
divisions	O
and	O
confer	O
new	O
information	O
to	O
chromatin	S-GO
,	O
in	O
addition	O
to	O
the	O
genetic	O
information	O
provided	O
by	O
DNA	O
.	O

It	O
is	O
usually	O
believed	O
that	O
during	O
genome	O
replication	O
,	O
the	O
basic	O
chromatin	S-GO
assembly	O
machinery	O
builds	O
up	O
"	O
na	O
i	O
ve	O
"	O
nucleosomes	S-GO
,	O
and	O
,	O
in	O
a	O
subsequent	O
step	O
,	O
nucleosomes	S-GO
are	O
selectively	O
modified	O
by	O
a	O
series	O
of	O
enzymes	O
to	O
acquire	O
epigenetic	O
information	O
.	O

Here	O
,	O
the	O
authors	O
studied	O
the	O
role	O
of	O
a	O
basic	O
chromatin	S-GO
assembly	O
factor	O
(	O
CAF	B-GO
-	I-GO
1	E-GO
)	O
in	O
mouse	O
embryonic	O
stem	O
cells	O
and	O
early	O
embryos	O
.	O

Surprisingly	O
,	O
they	O
show	O
that	O
CAF	B-GO
-	I-GO
1	E-GO
confers	O
epigenetic	O
information	O
to	O
specific	O
genomic	O
regions	O
.	O

In	O
addition	O
,	O
this	O
study	O
revealed	O
that	O
CAF	B-GO
-	I-GO
1	E-GO
is	O
required	O
for	O
the	O
proper	O
spatial	O
organization	O
of	O
chromosomes	B-GO
in	I-GO
the	I-GO
nucleus	E-GO
.	O

This	O
new	O
knowledge	O
may	O
contribute	O
to	O
better	O
understanding	O
the	O
role	O
of	O
chromatin	S-GO
in	O
the	O
maintenance	O
of	O
embryonic	O
stem	O
cell	O
identity	O
and	O
plasticity	O
.	O

Introduction	O

During	O
mouse	O
pre	O
-	O
implantation	O
development	O
,	O
the	O
genome	O
undergoes	O
a	O
series	O
of	O
major	O
epigenetic	O
changes	O
required	O
for	O
embryonic	O
gene	O
expression	O
,	O
the	O
maintenance	O
of	O
totipotency	O
,	O
and	O
the	O
first	O
differentiation	O
events	O
[	O
1	O
,	O
2	O
]	O
.	O

While	O
many	O
studies	O
have	O
established	O
the	O
importance	O
of	O
DNA	O
methylation	O
in	O
epigenetic	O
reprogramming	O
,	O
recent	O
data	O
point	O
to	O
a	O
crucial	O
role	O
of	O
chromatin	S-GO
in	O
this	O
process	O
[	O
3	O
-	O
5	O
]	O
.	O

Yet	O
we	O
know	O
very	O
little	O
about	O
the	O
role	O
of	O
histone	O
modifying	O
enzymes	O
,	O
chromatin	S-GO
remodeling	O
factors	O
,	O
and	O
histone	O
chaperones	O
during	O
pre	O
-	O
implantation	O
development	O
,	O
or	O
in	O
stem	O
cells	O
derived	O
from	O
early	O
embryos	O
[	O
6	O
]	O
.	O

A	O
subset	O
of	O
identified	O
histone	O
chaperones	O
and	O
chromatin	B-GO
remodeling	I-GO
complexes	E-GO
can	O
collaborate	O
to	O
promote	O
nucleosome	S-GO
assembly	O
in	O
vitro	O
and	O
are	O
therefore	O
in	O
a	O
strategic	O
position	O
to	O
control	O
chromatin	S-GO
assembly	O
and	O
maturation	O
during	O
development	O
[	O
7	O
,	O
8	O
]	O
.	O

Among	O
histone	O
chaperones	O
,	O
chromatin	B-GO
assembly	I-GO
factor	I-GO
1	E-GO
(	O
CAF	B-GO
-	I-GO
1	E-GO
)	O
is	O
a	O
three	O
-	O
subunit	O
(	O
p150	O
,	O
p60	O
,	O
and	O
p48	O
)	O
complex	S-GO
which	O
promotes	O
histone	O
H3	O
and	O
H4	O
deposition	O
onto	O
newly	O
synthesized	O
DNA	O
during	O
replication	O
or	O
DNA	O
repair	O
[	O
9	O
,	O
10	O
]	O
.	O

Specifically	O
,	O
CAF	B-GO
-	I-GO
1	E-GO
deposits	O
the	O
histone	O
H3	O
variant	O
H3	O
.	O
1	O
into	O
chromatin	S-GO
,	O
in	O
a	O
pathway	O
coupled	O
to	O
DNA	O
synthesis	O
,	O
whereas	O
a	O
second	O
histone	O
chaperone	O
,	O
HIRA	O
,	O
is	O
involved	O
in	O
the	O
deposition	O
of	O
the	O
H3	O
.	O
3	O
variant	O
in	O
a	O
DNA	O
synthesis	O
independent	O
pathway	O
[	O
11	O
,	O
12	O
]	O
.	O

In	O
addition	O
to	O
this	O
specific	O
chromatin	S-GO
assembly	O
activity	O
,	O
CAF	B-GO
-	I-GO
1	E-GO
interacts	O
with	O
several	O
proteins	O
present	O
in	O
heterochromatin	S-GO
,	O
including	O
heterochromatin	S-GO
protein	O
1	O
(	O
HP1	O
)	O
and	O
MBD1	O
,	O
a	O
methyl	O
-	O
CpG	O
binding	O
domain	O
protein	O
that	O
recruits	O
histone	O
deacetylase	O
and	O
repressive	O
histone	O
methyltransferase	O
activities	O
[	O
13	O
-	O
15	O
]	O
.	O

Furthermore	O
,	O
p150CAF	O
-	O
1	O
is	O
required	O
to	O
ensure	O
a	O
replication	O
-	O
specific	O
pool	O
of	O
HP1	O
molecules	O
at	O
replication	O
sites	O
in	O
pericentric	B-GO
heterochromatin	E-GO
during	O
mid	O
-	O
late	O
S	O
phase	O
[	O
16	O
]	O
.	O

Taken	O
together	O
,	O
these	O
data	O
suggest	O
roles	O
for	O
CAF	B-GO
-	I-GO
1	E-GO
in	O
the	O
formation	O
of	O
heterochromatin	S-GO
and	O
in	O
the	O
heritability	O
of	O
epigenetic	O
traits	O
.	O

While	O
the	O
function	O
of	O
this	O
evolutionary	O
conserved	O
histone	O
chaperone	O
has	O
been	O
studied	O
extensively	O
biochemically	O
,	O
we	O
still	O
lack	O
information	O
concerning	O
its	O
importance	O
during	O
early	O
development	O
in	O
mammals	O
and	O
in	O
pluripotent	O
cells	O
such	O
as	O
embryonic	O
stem	O
(	O
ES	O
)	O
cells	O
.	O

Here	O
,	O
we	O
have	O
analyzed	O
the	O
importance	O
of	O
CAF	B-GO
-	I-GO
1	E-GO
during	O
early	O
mouse	O
development	O
by	O
genetic	O
ablation	O
and	O
in	O
ES	O
cells	O
by	O
depletion	O
using	O
RNA	O
interference	O
(	O
RNAi	O
)	O
.	O

We	O
show	O
that	O
CAF	B-GO
-	I-GO
1	E-GO
is	O
essential	O
for	O
viability	O
in	O
early	O
mouse	O
embryos	O
and	O
ES	O
cells	O
.	O

We	O
provide	O
evidence	O
that	O
CAF	B-GO
-	I-GO
1	E-GO
is	O
required	O
for	O
the	O
spatial	O
organization	O
and	O
epigenetic	O
marking	O
of	O
heterochromatin	B-GO
domains	E-GO
in	O
pluripotent	O
embryonic	O
cells	O
.	O

Results	O

We	O
used	O
gene	O
targeting	O
in	O
ES	O
cells	O
to	O
delete	O
exon	O
3	O
in	O
the	O
Chaf1a	O
gene	O
,	O
which	O
encodes	O
p150CAF	O
-	O
1	O
(	O
Figure	O
1A	O
)	O
.	O

Chaf1a	O
+	O
/	O
-	O
mice	O
were	O
born	O
at	O
a	O
Mendelian	O
frequency	O
,	O
were	O
of	O
normal	O
size	O
and	O
weight	O
,	O
displayed	O
no	O
obvious	O
abnormalities	O
,	O
and	O
were	O
fertile	O
.	O

Crossing	O
heterozygous	O
mice	O
failed	O
to	O
generate	O
viable	O
newborn	O
Chaf1a	O
-	O
/	O
-	O
mice	O
.	O

Furthermore	O
,	O
no	O
homozygous	O
Chaf1a	O
-	O
/	O
-	O
embryos	O
were	O
detected	O
at	O
any	O
of	O
the	O
post	O
-	O
implantation	O
stages	O
.	O

However	O
,	O
we	O
could	O
detect	O
Chaf1a	O
-	O
/	O
-	O
embryos	O
at	O
embryonic	O
day	O
4	O
(	O
E4	O
)	O
using	O
a	O
PCR	O
strategy	O
(	O
Figure	O
1B	O
)	O
.	O

They	O
represent	O
only	O
10	O
%	O
of	O
E4	O
embryos	O
obtained	O
from	O
Chaf1a	O
+	O
/	O
-	O
mice	O
intercrosses	O
,	O
suggesting	O
that	O
more	O
than	O
half	O
of	O
the	O
homozygous	O
mutant	O
embryos	O
had	O
degenerated	O
before	O
this	O
stage	O
.	O

Moreover	O
,	O
mutant	O
embryos	O
contained	O
only	O
eight	O
to	O
16	O
cells	O
at	O
the	O
E4	O
stage	O
,	O
instead	O
of	O
32	O
cells	O
observed	O
for	O
wild	O
-	O
type	O
or	O
heterozygous	O
blastocysts	O
(	O
Figure	O
1C	O
and	O
1D	O
)	O
.	O

Further	O
analysis	O
by	O
light	O
microscopy	O
using	O
immunofluorescence	O
(	O
IF	O
)	O
allowed	O
us	O
to	O
compare	O
wild	O
-	O
type	O
and	O
p150CAF	O
-	O
1	O
-	O
depleted	O
embryos	O
.	O

A	O
loss	O
of	O
p150CAF	O
-	O
1	O
staining	O
could	O
not	O
be	O
detected	O
before	O
the	O
eight	O
-	O
cell	O
stage	O
(	O
unpublished	O
data	O
)	O
suggesting	O
that	O
maternally	O
contributed	O
protein	O
is	O
present	O
in	O
the	O
embryo	O
up	O
to	O
the	O
four	O
-	O
cell	O
stage	O
.	O

Thus	O
,	O
depletion	O
of	O
p150CAF	O
-	O
1	O
protein	O
from	O
this	O
stage	O
allows	O
a	O
maximum	O
of	O
two	O
additional	O
cell	O
divisions	O
before	O
developmental	O
arrest	O
.	O

Strikingly	O
,	O
we	O
found	O
that	O
the	O
nuclear	S-GO
organization	O
of	O
heterochromatin	S-GO
appeared	O
abnormal	O
in	O
the	O
nuclei	S-GO
of	O
Chaf1a	O
-	O
/	O
-	O
embryos	O
.	O

Pericentric	B-GO
heterochromatin	E-GO
,	O
the	O
major	O
component	O
of	O
constitutive	O
heterochromatin	S-GO
,	O
can	O
easily	O
be	O
visualized	O
in	O
interphase	O
nuclei	S-GO
by	O
the	O
fluorochrome	O
DAPI	O
and	O
by	O
immunostaining	O
with	O
HP1	O
alpha	O
[	O
16	O
,	O
17	O
-	O
19	O
]	O
.	O

In	O
wild	O
-	O
type	O
blastocysts	O
and	O
in	O
mouse	O
somatic	O
cells	O
,	O
pericentric	B-GO
heterochromatin	I-GO
domains	E-GO
cluster	O
together	O
and	O
form	O
higher	O
-	O
order	O
chromatin	B-GO
structures	E-GO
called	O
chromocenters	S-GO
[	O
20	O
]	O
,	O
which	O
are	O
visualized	O
as	O
DAPI	O
-	O
dense	O
foci	O
(	O
Figure	O
1C	O
)	O
.	O

These	O
structures	O
were	O
not	O
detected	O
in	O
Chaf1a	O
-	O
/	O
-	O
embryos	O
(	O
Figure	O
1D	O
)	O
.	O

Since	O
chromatin	S-GO
architecture	O
and	O
higher	O
-	O
order	O
structures	O
are	O
important	O
for	O
genome	O
function	O
[	O
21	O
]	O
,	O
we	O
decided	O
to	O
characterize	O
this	O
phenotype	O
in	O
more	O
detail	O
.	O

For	O
this	O
purpose	O
,	O
we	O
examined	O
the	O
status	O
of	O
heterochromatin	S-GO
organization	O
between	O
the	O
two	O
-	O
cell	O
and	O
blastocyst	O
stages	O
.	O

In	O
two	O
-	O
cell	O
stage	O
wild	O
-	O
type	O
embryos	O
,	O
DAPI	O
staining	O
is	O
diffuse	O
and	O
fibrillar	O
,	O
with	O
regions	O
of	O
higher	O
density	O
around	O
the	O
nucleolar	B-GO
precursor	I-GO
bodies	E-GO
(	O
Figure	O
1E	O
)	O
.	O

Heterochromatin	B-GO
domains	E-GO
are	O
progressively	O
assembled	O
into	O
DAPI	O
-	O
dense	O
foci	O
between	O
the	O
four	O
-	O
cell	O
and	O
32	O
-	O
cell	O
blastocyst	O
stages	O
(	O
Figure	O
1F	O
)	O
.	O

Localization	O
of	O
HP1	O
alpha	O
confirmed	O
that	O
the	O
structures	O
visualized	O
by	O
DAPI	O
staining	O
correspond	O
to	O
constitutive	O
heterochromatin	S-GO
(	O
Figure	O
1E	O
)	O
.	O

Thus	O
,	O
the	O
nuclear	S-GO
organization	O
of	O
heterochromatin	S-GO
is	O
dramatically	O
modified	O
during	O
pre	O
-	O
implantation	O
development	O
,	O
between	O
the	O
two	O
-	O
cell	O
and	O
blastocyst	O
stages	O
.	O

In	O
Chaf1a	O
-	O
/	O
-	O
E4	O
embryos	O
,	O
which	O
are	O
arrested	O
between	O
the	O
eight	O
-	O
and	O
16	O
-	O
cell	O
stage	O
,	O
DAPI	O
-	O
dense	O
foci	O
were	O
barely	O
detectable	O
(	O
Figure	O
1D	O
)	O
.	O

Instead	O
,	O
DAPI	O
staining	O
was	O
diffuse	O
within	O
the	O
nucleus	S-GO
,	O
with	O
regions	O
of	O
higher	O
density	O
around	O
the	O
nucleoli	S-GO
and	O
at	O
the	O
periphery	O
of	O
the	O
nuclei	S-GO
(	O
Figure	O
1D	O
)	O
.	O

Localization	O
of	O
HP1	O
alpha	O
showed	O
a	O
diffuse	O
pattern	O
similar	O
to	O
the	O
DAPI	O
,	O
with	O
some	O
enrichment	O
at	O
the	O
nuclear	S-GO
periphery	O
,	O
and	O
around	O
the	O
nucleoli	S-GO
(	O
Figure	O
1D	O
)	O
.	O

This	O
abnormal	O
organization	O
of	O
heterochromatin	S-GO
in	O
Chaf1a	O
-	O
/	O
-	O
embryos	O
is	O
reminiscent	O
of	O
the	O
heterochromatin	S-GO
organization	O
found	O
in	O
two	O
-	O
to	O
four	O
-	O
cell	O
stage	O
wild	O
-	O
type	O
embryos	O
(	O
compare	O
Figure	O
1D	O
and	O
1F	O
)	O
.	O

These	O
data	O
evidence	O
a	O
key	O
role	O
for	O
p150CAF	O
-	O
1	O
during	O
pre	O
-	O
implantation	O
development	O
,	O
and	O
reveal	O
that	O
this	O
protein	O
is	O
required	O
for	O
the	O
proper	O
3	O
-	O
D	O
organization	O
of	O
heterochromatin	B-GO
within	I-GO
embryonic	I-GO
cell	I-GO
nuclei	E-GO
.	O

Next	O
,	O
we	O
wondered	O
whether	O
a	O
similar	O
requirement	O
for	O
CAF	B-GO
-	I-GO
1	E-GO
could	O
also	O
be	O
observed	O
in	O
ES	O
cells	O
,	O
which	O
are	O
derived	O
from	O
the	O
blastocyst	O
inner	O
cell	O
mass	O
.	O

Given	O
the	O
early	O
developmental	O
arrest	O
observed	O
in	O
Chaf1a	O
-	O
/	O
-	O
embryos	O
,	O
such	O
cells	O
could	O
not	O
be	O
derived	O
directly	O
from	O
null	O
embryos	O
,	O
and	O
we	O
thus	O
used	O
an	O
RNAi	O
strategy	O
(	O
Figure	O
2A	O
)	O
.	O

p150CAF	O
-	O
1	O
knockdown	O
in	O
ES	O
cells	O
was	O
quantified	O
by	O
Western	O
blot	O
analysis	O
and	O
IF	O
.	O

(	O
Figure	O
S1	O
)	O
.	O

p150CAF	O
-	O
1	O
RNAi	O
-	O
depleted	O
ES	O
cells	O
displayed	O
a	O
phenotype	O
very	O
similar	O
to	O
the	O
cells	O
of	O
Chaf1a	O
-	O
/	O
-	O
E4	O
mice	O
.	O

DAPI	O
-	O
dense	O
foci	O
were	O
lost	O
,	O
and	O
we	O
observed	O
diffuse	O
HP1	O
alpha	O
and	O
DAPI	O
staining	O
around	O
the	O
nucleoli	S-GO
and	O
at	O
the	O
periphery	O
of	O
the	O
nucleus	S-GO
(	O
Figure	O
2B	O
)	O
.	O

This	O
result	O
indicates	O
that	O
p150CAF	O
-	O
1	O
is	O
essential	O
for	O
nuclear	S-GO
organization	O
of	O
heterochromatin	S-GO
in	O
ES	O
cells	O
in	O
a	O
similar	O
way	O
to	O
early	O
pre	O
-	O
implantation	O
embryos	O
.	O

Surprisingly	O
,	O
we	O
did	O
not	O
observe	O
this	O
severe	O
alteration	O
in	O
heterochromatin	S-GO
organization	O
in	O
primary	O
mouse	O
embryonic	O
fibroblasts	O
(	O
MEFs	O
)	O
following	O
p150CAF	O
-	O
1	O
depletion	O
by	O
RNAi	O
.	O

p150CAF	O
-	O
1	O
depletion	O
in	O
MEFs	O
resulted	O
in	O
a	O
strong	O
inhibition	O
of	O
cell	O
proliferation	O
(	O
unpublished	O
data	O
)	O
,	O
but	O
did	O
not	O
alter	O
the	O
clustering	O
of	O
heterochromatin	B-GO
domains	E-GO
(	O
Figures	O
2C	O
and	O
S2	O
)	O
.	O

Similarly	O
,	O
p150CAF	O
-	O
1	O
depletion	O
in	O
3T3	O
cells	O
did	O
not	O
affect	O
heterochromatin	S-GO
organization	O
[	O
16	O
]	O
.	O

These	O
observations	O
reveal	O
a	O
specific	O
function	O
for	O
CAF	B-GO
-	I-GO
1	E-GO
in	O
the	O
early	O
embryo	O
and	O
ES	O
cells	O
.	O

We	O
also	O
wondered	O
whether	O
loss	O
of	O
p150CAF	O
-	O
1	O
in	O
ES	O
cells	O
specifically	O
affects	O
the	O
heterochromatin	S-GO
nuclear	B-GO
subcompartment	E-GO
,	O
or	O
whether	O
it	O
might	O
result	O
in	O
a	O
more	O
global	O
loss	O
of	O
nuclear	S-GO
organization	O
and	O
architecture	O
.	O

We	O
used	O
a	O
specific	O
antibody	S-GO
against	O
the	O
promyelocytic	O
leukemia	O
(	O
PML	O
)	O
protein	O
to	O
study	O
the	O
fate	O
of	O
the	O
PML	B-GO
nuclear	I-GO
bodies	E-GO
,	O
which	O
are	O
well	O
-	O
characterized	O
subnuclear	B-GO
structures	E-GO
[	O
22	O
]	O
.	O

We	O
could	O
not	O
detect	O
any	O
significant	O
difference	O
in	O
the	O
distribution	O
and	O
aspect	O
of	O
PML	B-GO
nuclear	I-GO
bodies	E-GO
between	O
control	O
and	O
p150CAF	O
-	O
1	O
-	O
depleted	O
ES	O
cells	O
(	O
Figure	O
2D	O
)	O
.	O

These	O
data	O
show	O
that	O
nuclear	S-GO
architecture	O
is	O
not	O
globally	O
altered	O
following	O
CAF	B-GO
-	I-GO
1	E-GO
loss	O
-	O
of	O
-	O
function	O
.	O

In	O
addition	O
,	O
Western	O
blot	O
analysis	O
revealed	O
that	O
CAF	B-GO
-	I-GO
1	E-GO
depletion	O
did	O
not	O
result	O
in	O
altered	O
levels	O
of	O
chromatin	S-GO
architectural	O
proteins	O
such	O
as	O
histone	O
H3	O
and	O
HP1	O
alpha	O
(	O
Figure	O
S1	O
)	O
.	O

Thus	O
,	O
CAF	B-GO
-	I-GO
1	E-GO
is	O
specifically	O
required	O
in	O
early	O
embryos	O
and	O
in	O
ES	O
cells	O
for	O
the	O
proper	O
organization	O
of	O
the	O
heterochromatin	S-GO
subnuclear	B-GO
compartment	E-GO
.	O

Previous	O
studies	O
performed	O
in	O
mammalian	O
cell	O
lines	O
showed	O
that	O
CAF	B-GO
-	I-GO
1	E-GO
activity	O
is	O
required	O
for	O
S	O
phase	O
progression	O
[	O
16	O
,	O
23	O
,	O
24	O
]	O
.	O

We	O
show	O
here	O
that	O
3	O
d	O
after	O
transfection	O
of	O
the	O
RNAi	O
vector	O
,	O
p150CAF	O
-	O
1	O
-	O
depleted	O
cells	O
(	O
identified	O
by	O
a	O
complete	O
absence	O
of	O
CAF	B-GO
-	I-GO
1	E-GO
IF	O
signal	O
)	O
appear	O
still	O
active	O
for	O
replication	O
,	O
as	O
revealed	O
by	O
incorporation	O
of	O
the	O
thymidine	O
analog	O
bromodeoxyuridine	O
(	O
BrdU	O
)	O
(	O
Figure	O
3A	O
)	O
,	O
the	O
PCNA	O
(	O
proliferating	O
cell	O
nuclear	O
antigen	O
)	O
pattern	O
(	O
Figure	O
3B	O
)	O
,	O
and	O
flow	O
cytometry	O
analysis	O
(	O
Figure	O
3C	O
)	O
.	O

Hence	O
,	O
in	O
these	O
cells	O
,	O
DNA	O
replication	O
persists	O
despite	O
the	O
drastic	O
changes	O
in	O
heterochromatin	S-GO
organization	O
.	O

However	O
,	O
24	O
h	O
later	O
,	O
ES	O
cells	O
cease	O
to	O
proliferate	O
and	O
die	O
,	O
revealing	O
that	O
p150CAF	O
-	O
1	O
is	O
required	O
for	O
an	O
essential	O
cellular	O
process	O
,	O
as	O
in	O
embryos	O
.	O

Altogether	O
,	O
our	O
data	O
demonstrate	O
that	O
loss	O
of	O
p150CAF	O
-	O
1	O
function	O
in	O
ES	O
cells	O
and	O
early	O
embryos	O
alters	O
first	O
the	O
organization	O
of	O
heterochromatin	B-GO
in	I-GO
the	I-GO
nucleus	E-GO
and	O
,	O
in	O
a	O
subsequent	O
step	O
,	O
cell	O
cycle	O
and	O
viability	O
.	O

In	O
order	O
to	O
better	O
characterize	O
the	O
defects	O
in	O
heterochromatin	S-GO
organization	O
,	O
we	O
performed	O
two	O
-	O
color	O
DNA	O
fluorescence	O
in	O
situ	O
hybridization	O
(	O
FISH	O
)	O
experiments	O
to	O
reveal	O
the	O
spatial	O
distribution	O
of	O
pericentric	B-GO
and	I-GO
centric	I-GO
chromosomal	I-GO
regions	E-GO
,	O
which	O
in	O
mouse	O
are	O
mainly	O
composed	O
of	O
large	O
blocks	O
of	O
major	O
and	O
minor	O
satellite	O
repeats	O
,	O
respectively	O
[	O
20	O
]	O
.	O

Pericentric	B-GO
domains	I-GO
from	I-GO
different	I-GO
chromosomes	E-GO
form	O
clusters	O
,	O
which	O
are	O
revealed	O
by	O
FISH	O
as	O
large	O
spots	O
that	O
coincide	O
with	O
DAPI	O
-	O
dense	O
foci	O
in	O
the	O
interphase	O
nucleus	S-GO
(	O
Figure	O
4A	O
)	O
.	O

At	O
the	O
periphery	O
of	O
each	O
pericentric	B-GO
domain	E-GO
,	O
centric	O
regions	O
form	O
individual	O
entities	O
(	O
Figure	O
4A	O
)	O
.	O

In	O
p150CAF	O
-	O
1	O
RNAi	O
-	O
depleted	O
cells	O
,	O
we	O
observed	O
a	O
disruption	O
of	O
pericentric	B-GO
heterochromatin	E-GO
clusters	O
that	O
coincides	O
with	O
the	O
disappearance	O
of	O
DAPI	O
-	O
dense	O
foci	O
(	O
Figure	O
4B	O
)	O
.	O

Individual	O
pericentric	B-GO
domains	I-GO
from	I-GO
single	I-GO
chromosomes	E-GO
are	O
now	O
found	O
either	O
isolated	O
or	O
aggregated	O
in	O
a	O
pattern	O
less	O
dense	O
than	O
the	O
regular	O
clusters	O
observed	O
in	O
control	O
cells	O
(	O
Figure	O
4B	O
)	O
.	O

Such	O
aggregates	O
,	O
which	O
are	O
often	O
found	O
at	O
the	O
nuclear	S-GO
periphery	O
,	O
are	O
also	O
revealed	O
by	O
DAPI	O
staining	O
as	O
a	O
typical	O
signature	O
of	O
p150CAF	O
-	O
1	O
loss	O
-	O
of	O
-	O
function	O
.	O

Quantification	O
of	O
fluorescence	O
along	O
a	O
line	O
randomly	O
drawn	O
across	O
the	O
nucleus	S-GO
revealed	O
lower	O
fluorescence	O
intensity	O
and	O
a	O
broader	O
distribution	O
of	O
DAPI	O
and	O
major	O
satellite	O
hybridization	O
signals	O
in	O
p150CAF	O
-	O
1	O
-	O
depleted	O
cells	O
(	O
Figure	O
4C	O
and	O
4D	O
)	O
,	O
indicating	O
decondensation	O
of	O
pericentric	B-GO
heterochromatin	I-GO
domains	E-GO
.	O

In	O
contrast	O
,	O
centric	O
domains	O
showed	O
an	O
intensity	O
and	O
shape	O
similar	O
to	O
control	O
cells	O
,	O
suggesting	O
that	O
they	O
remain	O
unaffected	O
by	O
p150CAF	O
-	O
1	O
depletion	O
(	O
Figure	O
4C	O
and	O
4D	O
)	O
.	O

In	O
conclusion	O
,	O
these	O
results	O
show	O
that	O
p150CAF	O
-	O
1	O
is	O
required	O
for	O
the	O
proper	O
condensation	O
and	O
clustering	O
of	O
pericentric	B-GO
heterochromatin	I-GO
domains	E-GO
.	O

Given	O
the	O
known	O
role	O
of	O
CAF	B-GO
-	I-GO
1	E-GO
in	O
the	O
deposition	O
of	O
histone	O
H3	O
.	O
1	O
and	O
H4	O
associated	O
with	O
DNA	O
synthesis	O
[	O
11	O
,	O
12	O
]	O
,	O
we	O
wondered	O
whether	O
this	O
defect	O
in	O
higher	O
-	O
order	O
chromatin	S-GO
organization	O
could	O
reflect	O
an	O
aberrant	O
nucleosomal	S-GO
organization	O
.	O

Using	O
DNase	O
I	O
and	O
micrococcal	O
nuclease	O
(	O
MNase	O
)	O
assays	O
,	O
we	O
could	O
not	O
observe	O
any	O
significant	O
difference	O
between	O
control	O
and	O
p150CAF	O
-	O
1	O
-	O
depleted	O
ES	O
cells	O
at	O
the	O
level	O
of	O
bulk	O
genome	O
chromatin	S-GO
or	O
at	O
pericentric	S-GO
repeats	O
(	O
Figure	O
5	O
)	O
.	O

In	O
a	O
second	O
series	O
of	O
experiments	O
,	O
we	O
compared	O
the	O
association	O
of	O
histone	O
H3	O
with	O
chromatin	B-GO
in	I-GO
nuclei	E-GO
isolated	O
from	O
cells	O
transfected	O
with	O
control	O
and	O
p150CAF	O
-	O
1	O
RNAi	O
plasmid	O
vectors	O
.	O

Nuclei	S-GO
were	O
incubated	O
in	O
buffers	O
with	O
different	O
salt	O
concentrations	O
ranging	O
from	O
100	O
mM	O
NaCl	O
to	O
1	O
M	O
NaCl	O
.	O

In	O
all	O
conditions	O
,	O
the	O
amount	O
of	O
histone	O
H3	O
remaining	O
associated	O
with	O
chromatin	S-GO
was	O
indistinguishable	O
in	O
control	O
and	O
p150CAF	O
-	O
1	O
-	O
depleted	O
ES	O
cells	O
(	O
unpublished	O
data	O
)	O
.	O

Therefore	O
,	O
the	O
loss	O
of	O
clustering	O
and	O
decondensation	O
of	O
pericentric	B-GO
heterochromatin	E-GO
are	O
unlikely	O
to	O
be	O
the	O
consequence	O
of	O
severe	O
defects	O
in	O
nucleosomal	S-GO
organization	O
.	O

Our	O
findings	O
showed	O
that	O
the	O
nuclear	S-GO
localization	O
of	O
HP1	O
alpha	O
is	O
severely	O
altered	O
in	O
Chaf1a	O
-	O
/	O
-	O
embryos	O
and	O
p150CAF	O
-	O
1	O
-	O
depleted	O
ES	O
cells	O
.	O

We	O
therefore	O
examined	O
the	O
status	O
of	O
other	O
epigenetic	O
marks	O
previously	O
shown	O
to	O
characterize	O
pericentric	B-GO
heterochromatin	E-GO
.	O

We	O
first	O
tested	O
DNA	O
CpG	O
methylation	O
[	O
25	O
]	O
at	O
major	O
satellite	O
repeats	O
and	O
found	O
no	O
significant	O
difference	O
between	O
control	O
and	O
p150CAF	O
-	O
1	O
-	O
depleted	O
cells	O
(	O
Figure	O
6	O
)	O
.	O

As	O
the	O
LTM7	O
ES	O
cell	O
line	O
that	O
we	O
used	O
in	O
our	O
RNAi	O
experiments	O
is	O
a	O
female	O
(	O
XX	O
)	O
cell	O
line	O
,	O
DNA	O
methylation	O
is	O
globally	O
reduced	O
in	O
these	O
cells	O
[	O
26	O
]	O
.	O

To	O
rule	O
out	O
the	O
possibility	O
that	O
hypomethylation	O
of	O
pericentric	S-GO
repeats	O
might	O
contribute	O
to	O
the	O
destabilization	O
of	O
heterochromatin	B-GO
domains	E-GO
in	O
p150CAF	O
-	O
1	O
-	O
depleted	O
ES	O
cells	O
,	O
we	O
tested	O
our	O
RNAi	O
plasmid	O
vector	O
in	O
a	O
XY	O
ES	O
cell	O
line	O
,	O
and	O
confirmed	O
that	O
loss	O
of	O
p150CAF	O
-	O
1	O
leads	O
to	O
disruption	O
of	O
heterochromatin	S-GO
organization	O
independently	O
of	O
the	O
degree	O
of	O
DNA	O
methylation	O
at	O
pericentric	S-GO
repeats	O
(	O
unpublished	O
data	O
)	O
.	O

We	O
next	O
analyzed	O
specific	O
histone	O
modifications	O
[	O
27	O
]	O
in	O
chromatin	S-GO
immunoprecipitation	O
(	O
ChIP	O
)	O
experiments	O
using	O
native	O
chromatin	S-GO
[	O
28	O
]	O
.	O

We	O
found	O
that	O
pericentric	B-GO
DNA	E-GO
was	O
immunoprecipitated	O
with	O
a	O
2	O
-	O
fold	O
lower	O
efficiency	O
with	O
H4K20me3	O
[	O
29	O
,	O
30	O
]	O
antibodies	S-GO
following	O
p150CAF	O
-	O
1	O
depletion	O
(	O
Figure	O
7A	O
and	O
7B	O
)	O
.	O

Immunoprecipitation	O
of	O
minor	O
satellite	O
repeats	O
in	O
the	O
same	O
experiment	O
was	O
less	O
affected	O
(	O
Figure	O
7B	O
)	O
,	O
showing	O
that	O
loss	O
of	O
p150CAF	O
-	O
1	O
function	O
mainly	O
affects	O
H4K20me3	O
at	O
pericentric	B-GO
heterochromatin	E-GO
.	O

Moreover	O
,	O
no	O
significant	O
difference	O
in	O
immunoprecipitation	O
efficiency	O
was	O
detected	O
at	O
intracisternal	O
A	O
particle	O
(	O
IAP	O
)	O
elements	O
(	O
Figure	O
7B	O
)	O
,	O
which	O
are	O
noncentromeric	O
repeated	O
DNA	O
elements	O
also	O
enriched	O
in	O
H4K20me3	O
[	O
31	O
]	O
.	O

This	O
result	O
shows	O
that	O
p150CAF	O
-	O
1	O
contributes	O
to	O
normal	O
levels	O
of	O
H4K20me3	O
at	O
pericentric	B-GO
heterochromatin	E-GO
,	O
but	O
not	O
necessarily	O
at	O
other	O
loci	O
.	O

The	O
H3K9me3	O
mark	O
[	O
32	O
]	O
was	O
also	O
significantly	O
reduced	O
in	O
p150CAF	O
-	O
1	O
-	O
depleted	O
cells	O
,	O
though	O
to	O
a	O
lesser	O
extent	O
than	O
H4K20me3	O
(	O
Figure	O
7A	O
and	O
7B	O
)	O
.	O

In	O
wild	O
-	O
type	O
cells	O
,	O
most	O
of	O
H4K20me3	O
and	O
H3K9me3	O
signals	O
are	O
present	O
at	O
the	O
level	O
of	O
DAPI	O
-	O
dense	O
domains	O
when	O
visualized	O
by	O
IF	O
[	O
29	O
]	O
(	O
Figures	O
7C	O
and	O
7D	O
)	O
.	O

H3K9me3	O
was	O
severely	O
perturbed	O
in	O
p150CAF	O
-	O
1	O
-	O
depleted	O
cells	O
,	O
displaying	O
a	O
diffuse	O
pattern	O
similar	O
to	O
HP1	O
alpha	O
(	O
Figure	O
7C	O
)	O
.	O

The	O
H4K20me3	O
pattern	O
was	O
even	O
more	O
severely	O
altered	O
,	O
showing	O
both	O
a	O
loss	O
of	O
the	O
typical	O
dots	O
revealed	O
in	O
control	O
cells	O
and	O
a	O
reduction	O
in	O
signal	O
intensity	O
(	O
Figure	O
7D	O
)	O
.	O

Consistent	O
with	O
our	O
ChIP	O
experiments	O
,	O
residual	O
H4K20me3	O
epitopes	O
were	O
detected	O
at	O
the	O
level	O
of	O
relocated	O
DAPI	O
-	O
dense	O
material	O
.	O

Altogether	O
,	O
our	O
results	O
show	O
that	O
depletion	O
of	O
CAF	B-GO
-	I-GO
1	E-GO
in	O
ES	O
cells	O
leads	O
to	O
a	O
simultaneous	O
disruption	O
of	O
heterochromatin	S-GO
3	O
-	O
D	O
organization	O
and	O
an	O
alteration	O
in	O
epigenetic	O
marking	O
.	O

Discussion	O

Here	O
,	O
we	O
provide	O
evidence	O
that	O
p150CAF	O
-	O
1	O
has	O
a	O
crucial	O
function	O
during	O
mouse	O
early	O
embryogenesis	O
and	O
in	O
ES	O
cells	O
.	O

Previous	O
studies	O
showed	O
that	O
CAF	B-GO
-	I-GO
1	E-GO
is	O
essential	O
for	O
the	O
progression	O
of	O
DNA	O
replication	O
in	O
vertebrates	O
.	O

In	O
Xenopus	O
laevis	O
,	O
p150CAF	O
-	O
1	O
function	O
is	O
required	O
for	O
the	O
rapid	O
cell	O
divisions	O
that	O
occur	O
during	O
early	O
development	O
[	O
33	O
]	O
.	O

Similarly	O
,	O
CAF	B-GO
-	I-GO
1	E-GO
is	O
essential	O
in	O
mammalian	O
cell	O
lines	O
for	O
the	O
progression	O
of	O
DNA	O
replication	O
[	O
16	O
,	O
23	O
,	O
24	O
,	O
34	O
]	O
.	O

Our	O
findings	O
reveal	O
a	O
role	O
for	O
CAF	B-GO
-	I-GO
1	E-GO
in	O
the	O
nuclear	S-GO
organization	O
of	O
heterochromatin	B-GO
domains	E-GO
during	O
early	O
development	O
and	O
in	O
ES	O
cells	O
.	O

We	O
show	O
that	O
in	O
p150CAF	O
-	O
1	O
-	O
depleted	O
ES	O
cells	O
,	O
while	O
DNA	O
replication	O
initially	O
persists	O
without	O
significant	O
perturbation	O
in	O
nucleosomal	S-GO
organization	O
,	O
severe	O
heterochromatin	S-GO
organization	O
defects	O
can	O
be	O
observed	O
.	O

Loss	O
of	O
p150CAF	O
-	O
1	O
did	O
not	O
affect	O
PML	B-GO
bodies	E-GO
in	O
ES	O
cell	O
nuclei	S-GO
,	O
showing	O
that	O
nuclear	S-GO
architecture	O
is	O
not	O
generally	O
altered	O
.	O

Ultimately	O
,	O
p150CAF	O
-	O
1	O
depletion	O
results	O
in	O
the	O
arrest	O
of	O
ES	O
cell	O
division	O
and	O
cell	O
death	O
.	O

Given	O
the	O
major	O
defects	O
observed	O
in	O
heterochromatin	S-GO
organization	O
,	O
it	O
is	O
tempting	O
to	O
speculate	O
that	O
these	O
defects	O
cause	O
the	O
developmental	O
arrest	O
in	O
the	O
embryos	O
and	O
death	O
in	O
ES	O
cells	O
.	O

The	O
role	O
of	O
CAF	B-GO
-	I-GO
1	E-GO
in	O
the	O
nuclear	S-GO
organization	O
of	O
heterochromatin	S-GO
includes	O
spatial	O
localization	O
,	O
condensation	O
,	O
and	O
clustering	O
of	O
pericentric	B-GO
domains	E-GO
.	O

This	O
important	O
function	O
of	O
CAF	B-GO
-	I-GO
1	E-GO
was	O
not	O
revealed	O
in	O
primary	O
MEFs	O
,	O
3T3	O
cells	O
,	O
or	O
human	O
cell	O
lines	O
,	O
suggesting	O
that	O
it	O
is	O
specific	O
of	O
pluripotent	O
embryonic	O
cells	O
.	O

Alternatively	O
,	O
early	O
embryos	O
and	O
ES	O
cells	O
,	O
whose	O
genome	O
is	O
more	O
plastic	O
than	O
somatic	O
cells	O
,	O
might	O
represent	O
a	O
particularly	O
sensitive	O
context	O
in	O
which	O
the	O
importance	O
of	O
CAF	B-GO
-	I-GO
1	E-GO
in	O
heterochromatin	S-GO
organization	O
is	O
exacerbated	O
.	O

In	O
ES	O
cells	O
,	O
major	O
architectural	O
chromatin	S-GO
proteins	O
are	O
hyperdynamic	O
and	O
bind	O
relatively	O
loosely	O
to	O
chromatin	S-GO
[	O
35	O
]	O
.	O

In	O
this	O
cellular	O
context	O
,	O
our	O
findings	O
show	O
that	O
proper	O
heterochromatin	S-GO
nuclear	S-GO
architecture	O
relies	O
on	O
CAF	B-GO
-	I-GO
1	E-GO
function	O
.	O

In	O
contrast	O
,	O
in	O
undifferentiated	O
cells	O
that	O
are	O
already	O
lineage	O
committed	O
(	O
such	O
as	O
MEFs	O
)	O
genome	O
architecture	O
might	O
be	O
more	O
stable	O
than	O
in	O
ES	O
cells	O
and	O
thus	O
cannot	O
be	O
disrupted	O
by	O
CAF	B-GO
-	I-GO
1	E-GO
depletion	O
.	O

This	O
important	O
function	O
of	O
CAF	B-GO
-	I-GO
1	E-GO
in	O
pluripotent	O
embryonic	O
cells	O
could	O
be	O
partially	O
conserved	O
during	O
evolution	O
.	O

Indeed	O
,	O
in	O
Arabidopsis	O
thaliana	O
,	O
in	O
which	O
CAF	B-GO
-	I-GO
1	E-GO
is	O
not	O
essential	O
for	O
viability	O
[	O
36	O
]	O
,	O
loss	O
of	O
CAF	B-GO
-	I-GO
1	E-GO
is	O
associated	O
with	O
a	O
mild	O
alteration	O
in	O
chromocenter	S-GO
size	O
[	O
37	O
]	O
.	O

This	O
phenotype	O
is	O
somehow	O
reminiscent	O
of	O
loss	O
of	O
CAF	B-GO
-	I-GO
1	E-GO
-	O
mediated	O
defects	O
in	O
heterochromatin	S-GO
organization	O
in	O
early	O
mouse	O
embryos	O
.	O

In	O
mouse	O
ES	O
cells	O
,	O
we	O
show	O
that	O
CAF	B-GO
-	I-GO
1	E-GO
is	O
also	O
required	O
for	O
regular	O
levels	O
of	O
H4K20me3	O
at	O
pericentric	S-GO
repeats	O
,	O
but	O
not	O
at	O
IAP	O
elements	O
,	O
which	O
are	O
repeated	O
sequences	O
spread	O
all	O
over	O
the	O
mouse	O
genome	O
.	O

These	O
data	O
suggest	O
that	O
proper	O
nuclear	S-GO
organization	O
and	O
epigenetic	O
marking	O
of	O
pericentric	B-GO
heterochromatin	E-GO
are	O
coupled	O
in	O
ES	O
cells	O
.	O

Alternatively	O
,	O
3	O
-	O
D	O
organization	O
of	O
heterochromatin	S-GO
and	O
epigenetic	O
marking	O
might	O
represent	O
two	O
independent	O
functions	O
of	O
CAF	B-GO
-	I-GO
1	E-GO
.	O

The	O
variable	O
requirement	O
for	O
CAF	B-GO
-	I-GO
1	E-GO
across	O
species	O
might	O
reflect	O
the	O
acquisition	O
of	O
new	O
properties	O
affecting	O
the	O
function	O
of	O
histone	O
H3	O
variants	O
during	O
evolution	O
of	O
eukaryotes	O
.	O

CAF	B-GO
-	I-GO
1	E-GO
is	O
essential	O
in	O
mammals	O
but	O
dispensable	O
in	O
Saccharomyces	O
cerevisiae	O
[	O
38	O
]	O
.	O

Interestingly	O
,	O
the	O
budding	O
yeast	O
genome	O
does	O
not	O
contain	O
heterochromatin	B-GO
regions	E-GO
equivalent	O
to	O
those	O
of	O
higher	O
eukaryotes	O
,	O
and	O
several	O
hallmark	O
features	O
of	O
heterochromatin	S-GO
such	O
as	O
di	O
-	O
and	O
trimethylation	O
at	O
H3K9	O
,	O
H3K27	O
,	O
and	O
H4K20	O
are	O
not	O
observed	O
in	O
the	O
silent	O
chromatin	S-GO
of	O
S	O
.	O
cerevisiae	O
.	O

In	O
mammals	O
,	O
H3K9	O
dimethylation	O
is	O
predominantly	O
associated	O
with	O
H3	O
.	O
1	O
,	O
but	O
not	O
with	O
H3	O
.	O
3	O
,	O
which	O
carries	O
modifications	O
typically	O
found	O
in	O
transcribed	O
chromatin	B-GO
regions	E-GO
[	O
39	O
]	O
.	O

Outside	O
of	O
the	O
centromeric	O
H3	O
variant	O
,	O
S	O
.	O
cerevisiae	O
possesses	O
only	O
H3	O
.	O
3	O
,	O
which	O
is	O
expressed	O
and	O
incorporated	O
into	O
chromatin	S-GO
in	O
a	O
replication	O
-	O
independent	O
fashion	O
in	O
higher	O
eukaryotes	O
[	O
12	O
]	O
.	O

These	O
data	O
suggest	O
a	O
specific	O
role	O
for	O
H3	O
.	O
1	O
in	O
heterochromatin	B-GO
regions	E-GO
.	O

We	O
show	O
here	O
that	O
CAF	B-GO
-	I-GO
1	E-GO
,	O
which	O
is	O
a	O
H3	O
.	O
1	O
replication	O
-	O
dependent	O
loading	O
complex	S-GO
[	O
11	O
]	O
,	O
is	O
specifically	O
required	O
for	O
the	O
nuclear	S-GO
organization	O
of	O
pericentric	B-GO
heterochromatin	E-GO
in	O
embryos	O
and	O
ES	O
cells	O
.	O

One	O
possibility	O
would	O
be	O
a	O
scenario	O
in	O
which	O
incorporation	O
of	O
H3	O
.	O
1	O
into	O
chromatin	S-GO
is	O
required	O
for	O
the	O
proper	O
nuclear	S-GO
organization	O
of	O
constitutive	O
heterochromatin	S-GO
in	O
an	O
embryonic	O
context	O
.	O

While	O
this	O
has	O
to	O
be	O
addressed	O
experimentally	O
,	O
it	O
is	O
worthwhile	O
to	O
mention	O
an	O
alternate	O
possible	O
mechanism	O
that	O
might	O
explain	O
the	O
disruption	O
of	O
heterochromatin	B-GO
domains	E-GO
in	O
p150CAF	O
-	O
1	O
null	O
embryos	O
and	O
ES	O
cells	O
.	O

CAF	B-GO
-	I-GO
1	E-GO
could	O
be	O
required	O
for	O
the	O
loading	O
,	O
into	O
heterochromatin	S-GO
,	O
of	O
an	O
interacting	O
partner	O
required	O
for	O
the	O
clustering	O
of	O
pericentric	B-GO
domains	E-GO
.	O

Following	O
one	O
or	O
two	O
rounds	O
of	O
DNA	O
replication	O
in	O
the	O
absence	O
of	O
p150CAF	O
-	O
1	O
,	O
heterochromatin	S-GO
would	O
become	O
deprived	O
of	O
this	O
molecule	O
,	O
which	O
would	O
cause	O
the	O
disruption	O
of	O
its	O
3	O
-	O
D	O
organization	O
.	O

A	O
potential	O
candidate	O
is	O
the	O
HP1	O
protein	O
,	O
which	O
interacts	O
with	O
CAF	B-GO
-	I-GO
1	E-GO
[	O
13	O
,	O
16	O
]	O
.	O

In	O
agreement	O
with	O
a	O
recent	O
report	O
[	O
40	O
]	O
,	O
our	O
analysis	O
of	O
heterochromatin	S-GO
in	O
pre	O
-	O
implantation	O
embryos	O
has	O
revealed	O
drastic	O
changes	O
in	O
nuclear	S-GO
organization	O
between	O
the	O
two	O
-	O
cell	O
and	O
blastocyst	O
stages	O
.	O

Cloning	O
experiments	O
in	O
mouse	O
revealed	O
that	O
the	O
nuclear	S-GO
organization	O
of	O
heterochromatin	B-GO
in	I-GO
ES	I-GO
cell	I-GO
nuclei	E-GO
was	O
quickly	O
reverted	O
into	O
the	O
one	O
-	O
cell	O
stage	O
-	O
specific	O
form	O
after	O
nuclear	S-GO
transfer	O
[	O
40	O
]	O
.	O

Hence	O
,	O
remodeling	O
of	O
heterochromatin	S-GO
3	O
-	O
D	O
organization	O
parallels	O
nuclear	S-GO
reprogramming	O
toward	O
an	O
early	O
embryonic	O
status	O
in	O
cloned	O
embryos	O
.	O

This	O
drastic	O
reorganization	O
of	O
heterochromatin	S-GO
organization	O
is	O
similar	O
to	O
that	O
observed	O
in	O
p150CAF	O
-	O
1	O
-	O
depleted	O
ES	O
cells	O
,	O
and	O
in	O
developmentally	O
arrested	O
16	O
-	O
cell	O
stage	O
Chaf1a	O
-	O
/	O
-	O
embryos	O
.	O

These	O
data	O
show	O
that	O
CAF	B-GO
-	I-GO
1	E-GO
is	O
involved	O
in	O
setting	O
up	O
proper	O
heterochromatin	S-GO
architecture	O
during	O
the	O
first	O
cell	O
divisions	O
of	O
embryonic	O
life	O
.	O

Given	O
the	O
importance	O
of	O
nuclear	S-GO
organization	O
in	O
the	O
control	O
of	O
gene	O
expression	O
[	O
21	O
,	O
41	O
]	O
,	O
this	O
finding	O
suggests	O
that	O
CAF	B-GO
-	I-GO
1	E-GO
contributes	O
to	O
the	O
coordinated	O
programs	O
of	O
gene	O
expression	O
during	O
early	O
embryogenesis	O
.	O

Our	O
findings	O
open	O
new	O
perspectives	O
in	O
the	O
understanding	O
of	O
chromatin	S-GO
dynamics	O
during	O
early	O
development	O
and	O
in	O
pluripotent	O
embryonic	O
cells	O
.	O

While	O
most	O
studies	O
focused	O
on	O
the	O
role	O
of	O
DNA	O
methylation	O
and	O
histone	O
modifying	O
enzymes	O
[	O
3	O
]	O
,	O
our	O
data	O
point	O
to	O
the	O
importance	O
of	O
the	O
chromatin	S-GO
assembly	O
machinery	O
.	O

We	O
show	O
that	O
in	O
addition	O
to	O
assembling	O
nucleosomes	S-GO
,	O
CAF	B-GO
-	I-GO
1	E-GO
provides	O
spatial	O
and	O
epigenetic	O
information	O
to	O
heterochromatin	B-GO
domains	E-GO
in	O
early	O
embryos	O
and	O
ES	O
cells	O
.	O

Materials	O
and	O
Methods	O

Generation	O
of	O
Chaf1a	O
mutant	O
mice	O
and	O
embryos	O
.	O

Using	O
PCR	O
,	O
we	O
amplified	O
two	O
genomic	O
fragments	O
(	O
about	O
3	O
kb	O
each	O
)	O
flanking	O
Chaf1a	O
exon	O
3	O
.	O

These	O
DNA	O
fragments	O
were	O
assembled	O
by	O
conventional	O
cloning	O
with	O
the	O
neomycin	O
and	O
DT	O
(	O
diphtheria	O
toxin	O
)	O
cassettes	O
,	O
as	O
described	O
in	O
Figure	O
1A	O
.	O

The	O
construct	O
was	O
transfected	O
in	O
ES	O
cells	O
by	O
electroporation	O
.	O

We	O
identified	O
recombinant	O
ES	O
cells	O
carrying	O
the	O
mutant	O
Chaf1atm1Ger	O
(	O
abbreviated	O
Chaf1a	O
-	O
in	O
the	O
manuscript	O
)	O
allele	O
by	O
Southern	O
blot	O
(	O
Figure	O
1A	O
)	O
.	O

We	O
derived	O
Chaf1a	O
+	O
/	O
-	O
mice	O
by	O
injecting	O
recombined	O
ES	O
cells	O
into	O
C57BL	O
/	O
6N	O
blastocysts	O
.	O

E4	O
embryos	O
obtained	O
from	O
the	O
intercross	O
of	O
Chaf1a	O
+	O
/	O
-	O
mice	O
were	O
genotyped	O
by	O
nested	O
-	O
PCR	O
amplification	O
.	O

Embryos	O
were	O
collected	O
in	O
a	O
PCR	O
reaction	O
mix	O
containing	O
oligonucleotide	O
primers	O
1	O
,	O
2	O
,	O
and	O
3	O
(	O
Figure	O
1A	O
)	O
that	O
amplify	O
the	O
wild	O
-	O
type	O
and	O
mutant	O
alleles	O
.	O

After	O
30	O
cycles	O
of	O
amplification	O
,	O
1	O
mu	O
l	O
of	O
each	O
PCR	O
reaction	O
was	O
used	O
in	O
a	O
second	O
round	O
of	O
PCR	O
amplification	O
with	O
a	O
new	O
set	O
of	O
oligonucleotide	O
primers	O
.	O

After	O
30	O
cycles	O
of	O
amplification	O
,	O
PCR	O
reactions	O
were	O
run	O
onto	O
an	O
agarose	O
gel	O
,	O
which	O
revealed	O
the	O
presence	O
of	O
the	O
wild	O
-	O
type	O
(	O
150	O
bp	O
)	O
and	O
recombinant	O
(	O
200	O
bp	O
)	O
alleles	O
.	O

P150CAF	O
-	O
1	O
depletion	O
by	O
RNAi	O
.	O

The	O
RNAi	O
plasmid	O
vector	O
that	O
we	O
used	O
in	O
this	O
study	O
contains	O
the	O
mouse	O
H1	O
promoter	O
and	O
a	O
puromycin	O
selection	O
gene	O
(	O
SB	O
and	O
MG	O
,	O
unpublished	O
data	O
)	O
.	O

We	O
characterized	O
in	O
detail	O
the	O
properties	O
of	O
this	O
new	O
vector	O
using	O
a	O
GFP	O
target	O
gene	O
and	O
FACS	O
:	O
Extinction	O
of	O
target	O
genes	O
in	O
ES	O
cells	O
is	O
highly	O
efficient	O
in	O
70	O
%	O
of	O
the	O
cells	O
,	O
of	O
intermediate	O
efficiency	O
in	O
15	O
%	O
,	O
and	O
inefficient	O
in	O
the	O
remaining	O
15	O
%	O
of	O
cells	O
analysis	O
.	O

The	O
sequence	O
of	O
p150CAF	O
-	O
1	O
siRNA	O
(	O
short	O
interfering	O
RNA	O
)	O
duplex	O
[	O
16	O
]	O
was	O
cloned	O
into	O
this	O
plasmid	O
.	O

The	O
control	O
vector	O
expressed	O
a	O
siRNA	O
that	O
targets	O
GFP	O
RNA	O
degradation	O
.	O

ES	O
cells	O
were	O
transfected	O
by	O
electroporation	O
with	O
the	O
RNA	O
plasmid	O
vector	O
,	O
seeded	O
onto	O
gelatin	O
-	O
coated	O
slides	O
,	O
and	O
cultured	O
for	O
24	O
h	O
in	O
the	O
absence	O
of	O
selection	O
.	O

Puromycin	O
(	O
2	O
mu	O
g	O
/	O
ml	O
)	O
was	O
added	O
to	O
the	O
culture	O
medium	O
and	O
cells	O
were	O
cultured	O
for	O
an	O
additional	O
48	O
-	O
h	O
period	O
.	O

Using	O
the	O
p150CAF	O
-	O
1	O
RNAi	O
vector	O
,	O
IF	O
microscopy	O
quantification	O
reveals	O
a	O
complete	O
CAF	B-GO
-	I-GO
1	E-GO
depletion	O
in	O
most	O
cells	O
(	O
Figure	O
S1B	O
)	O
.	O

Western	O
blot	O
analysis	O
(	O
Figure	O
S1A	O
)	O
reveals	O
residual	O
p150CAF	O
-	O
1	O
expression	O
,	O
as	O
expected	O
from	O
the	O
15	O
%	O
of	O
cells	O
that	O
do	O
not	O
inhibit	O
the	O
target	O
gene	O
.	O

MEFs	O
(	O
passage	O
3	O
,	O
90	O
%	O
confluence	O
)	O
were	O
transfected	O
during	O
4	O
h	O
with	O
the	O
RNAi	O
plasmid	O
vector	O
using	O
Lipofectamine	O
2000	O
(	O
Invitrogene	O
,	O
Carlsbad	O
,	O
California	O
,	O
United	O
States	O
)	O
according	O
to	O
manufacturer	O
'	O
s	O
conditions	O
.	O

Cells	O
were	O
trypsinized	O
,	O
plated	O
at	O
1	O
/	O
3	O
dilution	O
,	O
and	O
cultured	O
for	O
48	O
h	O
in	O
the	O
presence	O
of	O
puromycin	O
.	O

Cell	O
lines	O
.	O

AT	O
-	O
1	O
ES	O
cells	O
[	O
42	O
]	O
(	O
a	O
gift	O
of	O
M	O
.	O
Vernet	O
)	O
were	O
used	O
for	O
gene	O
targeting	O
.	O

LTM7	O
ES	O
cells	O
were	O
used	O
in	O
all	O
RNAi	O
experiments	O
.	O

We	O
derived	O
this	O
cell	O
line	O
from	O
(	O
C57BL	O
/	O
6	O
x	O
129	O
)	O
F1	O
females	O
bred	O
with	O
C3H	O
/	O
HeJ	O
males	O
.	O

LTM7	O
are	O
XX	O
ES	O
cells	O
,	O
competent	O
for	O
germ	O
line	O
transmission	O
.	O

Primary	O
MEFs	O
were	O
derived	O
from	O
E13	O
embryos	O
as	O
described	O
in	O
[	O
43	O
]	O
.	O

Immunofluorescence	O
.	O

Cells	O
were	O
fixed	O
for	O
20	O
min	O
in	O
PBS	O
with	O
4	O
%	O
paraformaldehyde	O
,	O
and	O
immunodetection	O
was	O
performed	O
as	O
previously	O
described	O
[	O
44	O
]	O
.	O

E4	O
embryos	O
were	O
collected	O
and	O
treated	O
with	O
tyrode	O
acid	O
to	O
remove	O
the	O
zona	O
pellucida	O
,	O
deposited	O
onto	O
microscope	O
slides	O
,	O
and	O
processed	O
for	O
immunostaining	O
as	O
described	O
for	O
ES	O
cells	O
.	O

Antibodies	S-GO
anti	O
-	O
HP1	O
alpha	O
(	O
2HP1H5	O
,	O
Euromedex	O
,	O
France	O
)	O
,	O
anti	O
-	O
H4K20me3	O
(	O
Abcam	O
,	O
Cambridge	O
,	O
United	O
Kingdom	O
)	O
,	O
anti	O
-	O
BrdU	O
(	O
DakoCytomation	O
,	O
Glostrup	O
,	O
Denmark	O
)	O
,	O
anti	O
-	O
PCNA	O
(	O
DakoCytomation	O
)	O
,	O
and	O
anti	O
-	O
PML	O
(	O
Upstate	O
Biotechnology	O
,	O
Lake	O
Placid	O
,	O
New	O
York	O
,	O
United	O
States	O
)	O
were	O
all	O
used	O
at	O
1	O
/	O
1000	O
dilution	O
.	O

Antibodies	S-GO
anti	O
-	O
mouse	O
p150CAF1	O
[	O
16	O
]	O
and	O
anti	O
-	O
H3K9me3	O
(	O
Upstate	O
Biotechnology	O
)	O
were	O
used	O
at	O
1	O
/	O
250	O
and	O
1	O
/	O
500	O
,	O
respectively	O
.	O

All	O
secondary	O
antibodies	S-GO
were	O
purchased	O
from	O
Molecular	O
Probes	O
(	O
Sunnyvale	O
,	O
California	O
,	O
United	O
States	O
)	O
.	O

Western	O
blot	O
analysis	O
.	O

Cells	O
were	O
lysed	O
in	O
Laemli	O
buffer	O
and	O
run	O
onto	O
a	O
4	O
%	O
-	O
12	O
%	O
SDS	O
PAGE	O
gradient	O
gel	O
.	O

We	O
used	O
antibodies	S-GO
against	O
p150CAF	O
-	O
1	O
(	O
[	O
16	O
]	O
;	O
dilution	O
1	O
/	O
500	O
)	O
,	O
HP1	O
alpha	O
(	O
2G9	O
,	O
Euromedex	O
;	O
1	O
/	O
500	O
)	O
,	O
Histone	O
H3	O
(	O
Abcam	O
;	O
1	O
/	O
500	O
)	O
,	O
H3K9me3	O
(	O
Upstate	O
;	O
1	O
/	O
500	O
)	O
and	O
beta	O
-	O
actin	O
(	O
Upstate	O
;	O
1	O
/	O
40	O
000	O
)	O
.	O

DNA	O
FISH	O
.	O

Probes	O
were	O
described	O
previously	O
[	O
20	O
]	O
.	O

Biotin	O
-	O
16	O
-	O
dUTP	O
or	O
Digoxigenin	O
-	O
11	O
-	O
dUTP	O
(	O
Roche	O
,	O
Basel	O
,	O
Switzerland	O
)	O
labeled	O
probes	O
were	O
generated	O
by	O
nick	O
translation	O
(	O
Roche	O
)	O
and	O
FISH	O
performed	O
as	O
described	O
[	O
20	O
]	O
.	O

Image	O
acquisition	O
was	O
performed	O
with	O
the	O
Deltavision	O
RT	O
microscope	O
(	O
100	O
x	O
,	O
1	O
.	O
4	O
NA	O
objective	O
)	O
,	O
images	O
were	O
deconvoluted	O
,	O
and	O
fluorescence	O
profiles	O
measured	O
along	O
an	O
arbitrary	O
line	O
using	O
SoftWorx	O
.	O

Nuclei	S-GO
preparation	O
,	O
nuclease	O
digestion	O
,	O
and	O
biochemical	O
analysis	O
of	O
chromatin	S-GO
.	O

ES	O
cells	O
were	O
incubated	O
on	O
ice	O
for	O
10	O
min	O
in	O
buffer	O
1	O
(	O
15	O
mM	O
Tris	O
-	O
HCl	O
[	O
pH	O
7	O
.	O
5	O
]	O
,	O
0	O
.	O
3	O
M	O
sucrose	O
,	O
60	O
mM	O
KCl	O
,	O
15	O
mM	O
NaCl	O
,	O
5	O
mM	O
MgCl2	O
,	O
0	O
.	O
1	O
mM	O
EGTA	O
)	O
with	O
0	O
.	O
15	O
%	O
IGEPAL	O
(	O
Sigma	O
,	O
St	O
.	O
Louis	O
,	O
Missouri	O
,	O
United	O
States	O
)	O
.	O

Nuclei	S-GO
were	O
purified	O
by	O
centrifugation	O
(	O
10	O
,	O
000	O
x	O
g	O
for	O
30	O
min	O
,	O
at	O
4	O
degrees	O
C	O
)	O
on	O
sucrose	O
cushions	O
(	O
buffer	O
1	O
with	O
1	O
.	O
2	O
M	O
sucrose	O
)	O
and	O
resuspended	O
in	O
nuclease	O
buffer	O
(	O
50	O
mM	O
Tris	O
-	O
HCl	O
[	O
pH	O
7	O
.	O
5	O
]	O
,	O
20	O
mM	O
NaCl	O
,	O
0	O
.	O
32	O
M	O
sucrose	O
,	O
4	O
mM	O
MgCl2	O
,	O
1	O
mM	O
CaCl2	O
)	O
.	O

About	O
2	O
.	O
106	O
nuclei	S-GO
were	O
incubated	O
with	O
increasing	O
quantities	O
of	O
MNase	O
(	O
0	O
.	O
04	O
-	O
1	O
.	O
6	O
units	O
)	O
or	O
DNase	O
I	O
(	O
0	O
.	O
25	O
-	O
16	O
units	O
)	O
.	O

Digestion	O
time	O
at	O
37	O
degrees	O
C	O
was	O
10	O
min	O
for	O
MNase	O
and	O
2	O
min	O
for	O
DNase	O
I	O
.	O

Digestions	O
were	O
stopped	O
by	O
adding	O
SDS	O
to	O
1	O
%	O
and	O
EDTA	O
to	O
50	O
mM	O
.	O

DNAs	O
were	O
prepared	O
by	O
proteinase	O
K	O
digestion	O
followed	O
by	O
phenol	O
-	O
chloroform	O
extraction	O
and	O
isopropanol	O
precipitation	O
.	O

To	O
test	O
the	O
association	O
of	O
histone	O
H3	O
with	O
chromatin	S-GO
in	O
control	O
and	O
p150	O
-	O
depleted	O
cells	O
,	O
isolated	O
nuclei	S-GO
were	O
incubated	O
on	O
ice	O
for	O
30	O
min	O
in	O
buffer	O
2	O
(	O
50	O
mM	O
Hepes	O
[	O
pH7	O
.	O
9	O
]	O
,	O
20	O
%	O
Glycerol	O
,	O
3	O
mM	O
MgCl2	O
,	O
0	O
.	O
1	O
%	O
IGEPAL	O
,	O
0	O
.	O
5	O
mM	O
DTT	O
,	O
0	O
.	O
5	O
mM	O
PMSF	O
)	O
supplemented	O
with	O
either	O
0	O
.	O
1	O
M	O
,	O
0	O
.	O
3	O
M	O
,	O
0	O
.	O
45	O
M	O
,	O
0	O
.	O
7	O
M	O
,	O
or	O
1	O
M	O
NaCl	O
.	O

After	O
centrifugation	O
at	O
15	O
,	O
000	O
g	O
,	O
pellets	O
and	O
supernants	O
were	O
analyzed	O
by	O
Western	O
blot	O
using	O
a	O
histone	O
H3	O
antibody	S-GO
(	O
Abcam	O
)	O
.	O

ChIP	O
.	O

We	O
prepared	O
native	O
chromatin	S-GO
fragments	O
of	O
two	O
to	O
six	O
nucleosomes	S-GO
in	O
length	O
as	O
described	O
[	O
28	O
]	O
.	O

5	O
mu	O
g	O
of	O
chromatin	S-GO
were	O
incubated	O
overnight	O
with	O
10	O
mu	O
l	O
of	O
commercial	O
antibodies	S-GO
.	O

After	O
incubation	O
with	O
protein	O
-	O
G	O
sepharose	O
and	O
three	O
washes	O
,	O
immunoprecipitated	O
DNA	O
was	O
purified	O
,	O
sized	O
onto	O
an	O
agarose	O
gel	O
,	O
and	O
analyzed	O
by	O
Southern	O
blot	O
.	O

Hybridization	O
signals	O
were	O
quantified	O
using	O
an	O
Instant	O
Imager	O
(	O
PerkinElmer	O
,	O
Wellesley	O
,	O
California	O
,	O
United	O
States	O
)	O
.	O

Antibodies	S-GO
specific	O
for	O
H4K20me3	O
were	O
purchased	O
from	O
Abcam	O
.	O

Antibodies	S-GO
for	O
H3K9me3	O
were	O
purchased	O
from	O
both	O
Abcam	O
and	O
Upstate	O
Biotechnology	O
and	O
gave	O
similar	O
results	O
.	O

For	O
Southern	O
blot	O
analysis	O
,	O
we	O
used	O
a	O
240	O
-	O
bp	O
EcoRI	O
/	O
BamHI	O
fragment	O
from	O
pSAT	O
(	O
major	O
satellite	O
probe	O
)	O
[	O
45	O
-	O
47	O
]	O
and	O
a	O
360	O
-	O
bp	O
EcoRI	O
/	O
HindIII	O
fragment	O
from	O
R198	O
,	O
corresponding	O
to	O
three	O
copies	O
of	O
the	O
120	O
-	O
bp	O
minor	O
satellite	O
repeat	O
[	O
49	O
]	O
.	O

Probes	O
used	O
in	O
FISH	O
experiments	O
were	O
described	O
in	O
[	O
46	O
-	O
48	O
]	O
.	O

The	O
probe	O
for	O
IAP	O
elements	O
was	O
described	O
in	O
[	O
50	O
]	O
.	O

Supporting	O
Information	O

Figure	O
S1	O

Analysis	O
of	O
p150CAF	O
-	O
1	O
Depletion	O
by	O
RNAi	O
with	O
Western	O
Blot	O
and	O
IF	O

(	O
A	O
)	O
Western	O
blot	O
analysis	O
of	O
ES	O
cells	O
transfected	O
with	O
control	O
(	O
cont	O
)	O
or	O
p150CAF	O
-	O
1	O
(	O
p150	O
)	O
RNAi	O
plasmid	O
vectors	O
.	O

beta	O
-	O
actin	O
was	O
used	O
as	O
a	O
loading	O
control	O
.	O

Amount	O
of	O
cells	O
used	O
in	O
each	O
lane	O
is	O
indicated	O
.	O

p150CAF	O
-	O
1	O
knockdown	O
does	O
not	O
significantly	O
affect	O
HP1	O
alpha	O
,	O
histone	O
H3	O
,	O
or	O
H3K9me3	O
levels	O
.	O

(	O
B	O
)	O
IF	O
analysis	O
.	O

ES	O
cells	O
transfected	O
with	O
control	O
(	O
cont	O
)	O
or	O
p150CAF	O
-	O
1	O
(	O
p150	O
)	O
siRNA	O
vector	O
were	O
immunostained	O
with	O
p150CAF	O
-	O
1	O
antibody	S-GO
(	O
green	O
)	O
and	O
DAPI	O
(	O
blue	O
)	O
.	O

Scale	O
bar	O
=	O
5	O
mu	O
m	O
.	O

Fluorescence	O
was	O
quantified	O
along	O
a	O
line	O
drawn	O
across	O
the	O
nucleus	S-GO
and	O
data	O
were	O
plotted	O
,	O
revealing	O
efficient	O
p150CAF	O
-	O
1	O
depletion	O
by	O
RNAi	O
.	O

The	O
apparent	O
difference	O
in	O
the	O
efficiency	O
of	O
CAF	B-GO
-	I-GO
1	E-GO
knockdown	O
revealed	O
by	O
Western	O
blot	O
and	O
IF	O
likely	O
reflects	O
the	O
observation	O
that	O
the	O
RNAi	O
plasmid	O
vector	O
used	O
in	O
this	O
study	O
is	O
efficient	O
in	O
85	O
%	O
of	O
the	O
transfected	O
ES	O
cell	O
population	O
,	O
whereas	O
15	O
%	O
of	O
cells	O
display	O
no	O
inhibition	O
of	O
the	O
target	O
gene	O
(	O
see	O
Materials	O
and	O
Methods	O
)	O
.	O

(	O
1	O
.	O
3	O
MB	O
TIF	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Figure	O
S2	O

CAF	B-GO
-	I-GO
1	E-GO
-	O
Depleted	O
Embryonic	O
Fibroblasts	O
Active	O
for	O
DNA	O
Replication	O
Do	O
Not	O
Display	O
an	O
Altered	O
Heterochromatin	S-GO
Nuclear	S-GO
Architecture	O

Immunodetection	O
of	O
p150CAF	O
-	O
1	O
(	O
green	O
)	O
and	O
BrdU	O
(	O
red	O
)	O
in	O
MEFs	O
transfected	O
with	O
control	O
(	O
cont	O
)	O
or	O
p150CAF	O
-	O
1	O
RNAi	O
vectors	O
.	O

MEFs	O
were	O
pulse	O
-	O
labeled	O
for	O
1	O
h	O
with	O
BrdU	O
prior	O
to	O
fixation	O
and	O
IF	O
analysis	O
.	O

The	O
p150	O
+	O
BrdU	O
image	O
shows	O
the	O
merge	O
between	O
p150CAF	O
-	O
1	O
and	O
BrdU	O
fluorescence	O
.	O

DAPI	O
staining	O
is	O
shown	O
in	O
the	O
right	O
-	O
hand	O
panel	O
.	O

The	O
cytoplasmic	S-GO
CAF	B-GO
-	I-GO
1	E-GO
IF	O
pattern	O
is	O
non	O
-	O
specific	O
.	O

(	O
343	O
KB	O
TIF	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Acknowledgements	O

We	O
thank	O
E	O
.	O

Heard	O
and	O
S	O
.	O

Khochbin	O
for	O
critical	O
reading	O
and	O
suggestions	O
;	O
S	O
.	O

Jounier	O
and	O
H	O
.	O

Humbertclaude	O
for	O
cell	O
culture	O
;	O
J	O
.	O

Mitja	O
,	O
S	O
.	O

Thessier	O
,	O
and	O
J	O
.	O

C	O
.	O

Robillard	O
for	O
animal	O
care	O
;	O
M	O
.	O

Vernet	O
for	O
AT	O
-	O
1	O
cells	O
;	O
K	O
.	O

Nacerddine	O
for	O
the	O
PML	O
antibody	S-GO
;	O
N	O
.	O

Gilbert	O
and	O
T	O
.	O

Bestor	O
for	O
probes	O
;	O
G	O
.	O

Hamard	O
for	O
advice	O
on	O
blastocyst	O
injection	O
;	O
P	O
.	O

Le	O
Baccon	O
for	O
help	O
on	O
image	O
analysis	O
;	O
and	O
C	O
.	O

Mann	O
,	O
A	O
.	O

Sentenac	O
,	O
and	O
E	O
.	O

Moustacchi	O
for	O
their	O
support	O
.	O

Abbreviations	O

BrdU	O
-	O
bromodeoxyuridine	O

CAF	B-GO
-	I-GO
1	E-GO
-	O
chromatin	B-GO
assembly	I-GO
factor	I-GO
1	E-GO

ChIP	O
-	O
chromatin	S-GO
immunoprecipitation	O

E4	O
-	O
embryonic	O
day	O
4	O

ES	O
-	O
embryonic	O
stem	O

FISH	O
-	O
fluorescence	O
in	O
situ	O
hybridization	O

IAP	O
-	O
intracisternal	O
A	O
particle	O

IF	O
-	O
immunofluorescence	O

MEF	O
-	O
mouse	O
embryonic	O
fibroblast	O

PCNA	O
-	O
proliferating	O
cell	O
nuclear	O
antigen	O

PML	O
-	O
promyelocytic	O
leukemia	O

RNAi	O
-	O
RNA	O
interference	O

siRNA	O
-	O
short	O
interfering	O
RNA	O

Figures	O
and	O
Tables	O

Figure	O
1	O

Loss	O
of	O
p150CAF	O
-	O
1	O
Function	O
Leads	O
to	O
Early	O
Developmental	O
Arrest	O
and	O
Alteration	O
of	O
Heterochromatin	S-GO
Organization	O

(	O
A	O
)	O
Generation	O
of	O
Chaf1a	O
+	O
/	O
-	O
mice	O
by	O
homologous	O
recombination	O
in	O
ES	O
cells	O
.	O

(	O
Top	O
)	O
Scheme	O
of	O
the	O
p150CAF1	O
protein	O
indicating	O
the	O
interacting	O
domains	O
(	O
ID	O
)	O
for	O
HP1	O
and	O
p60CAF	O
-	O
1	O
,	O
and	O
the	O
acidic	O
domain	O
(	O
AD	O
)	O
.	O

(	O
Middle	O
)	O
Structure	O
of	O
the	O
murine	O
Chaf1a	O
gene	O
.	O

Blocks	O
and	O
lines	O
represent	O
exons	O
and	O
introns	O
,	O
respectively	O
.	O

A	O
star	O
indicates	O
the	O
translation	O
initiation	O
site	O
.	O

Below	O
is	O
shown	O
the	O
Chaf1a	O
targeting	O
vector	O
,	O
which	O
includes	O
genomic	O
DNA	O
homology	O
regions	O
(	O
5	O
HR	O
and	O
3	O
HR	O
)	O
,	O
the	O
diphtheria	O
toxin	O
(	O
DT	O
)	O
,	O
and	O
neomycin	O
selection	O
genes	O
.	O

Recombined	O
(	O
Rec	O
)	O
ES	O
cells	O
and	O
mice	O
were	O
identified	O
by	O
Southern	O
blot	O
using	O
ScaI	O
(	O
S	O
)	O
and	O
the	O
indicated	O
probe	O
.	O

(	O
B	O
)	O
Breeding	O
strategy	O
used	O
for	O
the	O
production	O
of	O
E4	O
Chaf1a	O
-	O
/	O
-	O
embryos	O
.	O

Genotyping	O
was	O
performed	O
by	O
PCR	O
using	O
the	O
three	O
oligonucleotide	O
primers	O
indicated	O
in	O
(	O
A	O
)	O
(	O
1	O
,	O
2	O
,	O
and	O
3	O
)	O
.	O

An	O
example	O
of	O
the	O
result	O
of	O
a	O
genotyping	O
experiment	O
is	O
shown	O
.	O

(	O
C	O
)	O
Immunodetection	O
of	O
p150CAF	O
-	O
1	O
(	O
green	O
)	O
and	O
HP1	O
alpha	O
(	O
red	O
)	O
in	O
E4	O
embryos	O
derived	O
from	O
Chaf1a	O
+	O
/	O
-	O
intercrosses	O
.	O

Because	O
Chaf1a	O
+	O
/	O
+	O
and	O
Chaf1a	O
+	O
/	O
-	O
embryos	O
both	O
stain	O
positively	O
for	O
the	O
presence	O
of	O
p150CAF	O
-	O
1	O
,	O
they	O
are	O
both	O
designated	O
as	O
wild	O
-	O
type	O
.	O

p150CAF	O
-	O
1	O
expression	O
,	O
which	O
indicates	O
ongoing	O
S	O
phase	O
,	O
can	O
be	O
detected	O
in	O
most	O
cells	O
within	O
the	O
wild	O
-	O
type	O
blastocyst	O
(	O
upper	O
panel	O
)	O
.	O

The	O
lower	O
panel	O
shows	O
a	O
12	O
-	O
cell	O
embryo	O
labeling	O
negatively	O
for	O
p150CAF	O
-	O
1	O
.	O

Only	O
nonspecific	O
background	O
labeling	O
can	O
be	O
observed	O
.	O

In	O
each	O
panel	O
,	O
the	O
right	O
-	O
hand	O
image	O
shows	O
the	O
merge	O
between	O
the	O
HP1	O
alpha	O
fluorescence	O
and	O
DAPI	O
-	O
stained	O
DNA	O
in	O
blue	O
.	O

Pink	O
color	O
indicates	O
the	O
association	O
of	O
HP1	O
with	O
DAPI	O
-	O
dense	O
material	O
.	O

The	O
bottom	O
of	O
each	O
panel	O
shows	O
the	O
magnification	O
of	O
a	O
nucleus	S-GO
selected	O
from	O
the	O
above	O
embryo	O
(	O
white	O
square	O
)	O
.	O

The	O
arrowhead	O
indicates	O
the	O
typical	O
heterochromatin	B-GO
foci	E-GO
revealed	O
by	O
DAPI	O
and	O
HP1	O
alpha	O
staining	O
in	O
wild	O
-	O
type	O
embryos	O
.	O

These	O
foci	O
are	O
not	O
visible	O
in	O
Chaf1a	O
-	O
/	O
-	O
embryos	O
.	O

DAPI	O
and	O
HP1	O
alpha	O
staining	O
are	O
diffuse	O
within	O
the	O
nucleus	S-GO
of	O
p150CAF	O
-	O
1	O
-	O
depleted	O
embryos	O
,	O
with	O
enrichment	O
at	O
the	O
nuclear	S-GO
periphery	O
,	O
revealing	O
abnormal	O
heterochromatin	S-GO
organization	O
.	O

Scale	O
bars	O
represent	O
10	O
mu	O
m	O
.	O

(	O
E	O
)	O
Wild	O
-	O
type	O
embryos	O
isolated	O
at	O
embryonic	O
day	O
2	O
(	O
E2	O
,	O
two	O
cells	O
)	O
,	O
E2	O
.	O
5	O
(	O
four	O
cells	O
)	O
,	O
E3	O
(	O
eight	O
cells	O
)	O
,	O
E3	O
.	O
5	O
(	O
16	O
cells	O
)	O
,	O
and	O
E4	O
(	O
32	O
cells	O
)	O
are	O
shown	O
.	O

Heterochromatin	S-GO
was	O
monitored	O
by	O
DAPI	O
staining	O
(	O
upper	O
panel	O
)	O
and	O
HP1	O
immunolabeling	O
(	O
in	O
red	O
,	O
lower	O
panel	O
)	O
.	O

(	O
F	O
)	O
Magnification	O
of	O
a	O
nucleus	S-GO
(	O
DAPI	O
-	O
stained	O
)	O
representative	O
of	O
each	O
stage	O
.	O

The	O
right	O
-	O
hand	O
panel	O
shows	O
the	O
nucleus	S-GO
of	O
an	O
ES	O
cell	O
.	O

Scale	O
bar	O
represents	O
10	O
mu	O
m	O
.	O

Figure	O
2	O

Depletion	O
of	O
p150CAF	O
-	O
1	O
in	O
ES	O
Cells	O
Results	O
in	O
a	O
Severe	O
Alteration	O
of	O
Heterochromatin	S-GO
Organization	O

(	O
A	O
)	O
Strategy	O
used	O
to	O
deplete	O
p150CAF	O
-	O
1	O
by	O
RNAi	O
in	O
ES	O
cells	O
.	O

The	O
siRNA	O
expression	O
vector	O
includes	O
a	O
puromycin	O
selection	O
cassette	O
(	O
Puro	O
)	O
,	O
the	O
mouse	O
H1	O
promoter	O
,	O
and	O
the	O
siRNA	O
encoding	O
sequence	O
.	O

ES	O
cells	O
were	O
kept	O
under	O
puromycin	O
selection	O
during	O
48	O
h	O
following	O
transfection	O
.	O

(	O
B	O
)	O
Abnormal	O
heterochromatin	S-GO
organization	O
in	O
p150CAF	O
-	O
1	O
-	O
depleted	O
ES	O
cells	O
.	O

Immunodetection	O
of	O
p150CAF	O
-	O
1	O
(	O
green	O
)	O
and	O
HP1	O
alpha	O
(	O
red	O
)	O
in	O
ES	O
cells	O
transfected	O
with	O
control	O
(	O
cont	O
)	O
and	O
p150CAF	O
-	O
1	O
siRNA	O
.	O

siRNA	O
expression	O
results	O
in	O
efficient	O
p150CAF	O
-	O
1	O
depletion	O
.	O

The	O
right	O
-	O
hand	O
image	O
shows	O
the	O
merge	O
between	O
HP1	O
alpha	O
fluorescence	O
and	O
DAPI	O
-	O
stained	O
DNA	O
in	O
blue	O
.	O

Scale	O
bar	O
=	O
10	O
mu	O
m	O
.	O

(	O
C	O
)	O
Heterochromatin	S-GO
organization	O
is	O
not	O
altered	O
in	O
p150CAF	O
-	O
1	O
-	O
depleted	O
MEFs	O
.	O

Immunodetection	O
of	O
p150CAF	O
-	O
1	O
(	O
green	O
)	O
and	O
HP1	O
alpha	O
(	O
red	O
)	O
in	O
MEFs	O
transfected	O
with	O
control	O
(	O
cont	O
)	O
or	O
p150CAF	O
-	O
1	O
siRNA	O
.	O

The	O
right	O
-	O
hand	O
image	O
shows	O
the	O
merge	O
between	O
HP1	O
alpha	O
fluorescence	O
and	O
DAPI	O
-	O
stained	O
DNA	O
in	O
blue	O
.	O

(	O
D	O
)	O
PML	B-GO
bodies	E-GO
are	O
not	O
altered	O
in	O
p150CAF	O
-	O
1	O
-	O
depleted	O
ES	O
cells	O
.	O

Immunodetection	O
of	O
PML	O
(	O
red	O
)	O
in	O
ES	O
cells	O
transfected	O
with	O
control	O
(	O
cont	O
)	O
or	O
p150CAF	O
-	O
1	O
siRNA	O
.	O

The	O
right	O
-	O
hand	O
image	O
shows	O
the	O
merge	O
between	O
PML	O
fluorescence	O
and	O
DAPI	O
-	O
stained	O
DNA	O
in	O
blue	O
.	O

Figure	O
3	O

p150CAF	O
-	O
1	O
Depletion	O
and	O
Loss	O
of	O
Heterochromatin	S-GO
Organization	O
Are	O
Compatible	O
with	O
Active	O
DNA	O
Replication	O
in	O
ES	O
Cells	O

(	O
A	O
)	O
ES	O
cells	O
were	O
transfected	O
with	O
p150CAF	O
-	O
1	O
or	O
control	O
siRNA	O
vectors	O
.	O

After	O
3	O
d	O
under	O
puromycin	O
selection	O
,	O
cells	O
were	O
pulse	O
-	O
labeled	O
for	O
10	O
min	O
with	O
BrdU	O
and	O
immediately	O
analyzed	O
by	O
IF	O
.	O

No	O
significant	O
difference	O
in	O
BrdU	O
incorporation	O
could	O
be	O
detected	O
between	O
control	O
and	O
p150CAF	O
-	O
1	O
-	O
depleted	O
cells	O
.	O

The	O
right	O
-	O
hand	O
image	O
shows	O
the	O
merge	O
between	O
the	O
p150CAF	O
-	O
1	O
and	O
BrdU	O
fluorescence	O
.	O

Scale	O
bar	O
=	O
10	O
mu	O
m	O
.	O

(	O
B	O
)	O
Immunodetection	O
of	O
PCNA	O
(	O
red	O
)	O
revealed	O
no	O
significant	O
difference	O
in	O
the	O
formation	O
of	O
replication	O
foci	O
between	O
control	O
and	O
p150CAF	O
-	O
1	O
-	O
depleted	O
ES	O
cells	O
.	O

Immunodetection	O
of	O
p150CAF	O
-	O
1	O
is	O
shown	O
in	O
green	O
and	O
the	O
merging	O
of	O
p150CAF	O
-	O
1	O
and	O
PCNA	O
appears	O
in	O
yellow	O
.	O

(	O
C	O
)	O
Flow	O
cytometry	O
analysis	O
showed	O
a	O
similar	O
cell	O
-	O
cycle	O
profile	O
for	O
control	O
and	O
p150CAF	O
-	O
1	O
-	O
depleted	O
ES	O
cells	O
.	O

Results	O
are	O
presented	O
as	O
the	O
percentage	O
of	O
cells	O
in	O
each	O
phase	O
of	O
the	O
cell	O
cycle	O
(	O
G1	O
,	O
S	O
,	O
G2	O
/	O
M	O
)	O
,	O
as	O
defined	O
by	O
BrdU	O
incorporation	O
and	O
DNA	O
content	O
.	O

Data	O
presented	O
are	O
the	O
mean	O
of	O
three	O
independent	O
experiments	O
;	O
error	O
bars	O
indicate	O
the	O
standard	O
deviation	O
.	O

All	O
experiments	O
were	O
performed	O
3	O
d	O
after	O
transfection	O
of	O
the	O
siRNA	O
vectors	O
.	O

Figure	O
4	O

Depletion	O
of	O
p150CAF	O
-	O
1	O
Leads	O
to	O
Loss	O
of	O
Clustering	O
,	O
Altered	O
Localization	O
,	O
and	O
Decondensation	O
of	O
Pericentric	B-GO
Heterochromatin	I-GO
Domains	E-GO

Distribution	O
of	O
pericentric	B-GO
(	I-GO
red	I-GO
)	I-GO
and	I-GO
centric	I-GO
(	I-GO
green	I-GO
)	I-GO
domains	E-GO
was	O
analyzed	O
in	O
the	O
interphase	O
nuclei	S-GO
of	O
mouse	O
ES	O
cells	O
by	O
DNA	O
FISH	O
,	O
using	O
major	O
satellite	O
(	O
pSAT	O
)	O
[	O
47	O
]	O
and	O
minor	O
satellite	O
(	O
pMR150	O
)	O
[	O
48	O
]	O
DNA	O
probes	O
,	O
respectively	O
.	O

(	O
A	O
)	O
In	O
ES	O
cells	O
expressing	O
control	O
(	O
cont	O
)	O
siRNA	O
,	O
pericentric	B-GO
regions	I-GO
from	I-GO
several	I-GO
chromosomes	E-GO
associate	O
in	O
clusters	O
(	O
red	O
)	O
.	O

These	O
chromocenters	S-GO
form	O
foci	O
as	O
revealed	O
by	O
DAPI	O
staining	O
(	O
left	O
-	O
hand	O
image	O
)	O
,	O
while	O
centric	O
regions	O
(	O
green	O
)	O
remain	O
independent	O
entities	O
at	O
the	O
periphery	O
of	O
these	O
domains	O
.	O

The	O
right	O
-	O
hand	O
image	O
shows	O
the	O
merge	O
between	O
the	O
pericentric	S-GO
and	O
centric	O
FISH	O
signals	O
.	O

(	O
B	O
)	O
The	O
organization	O
of	O
pericentric	B-GO
domains	E-GO
was	O
altered	O
in	O
cells	O
expressing	O
p150CAF	O
-	O
1	O
siRNA	O
.	O

Instead	O
of	O
forming	O
well	O
-	O
defined	O
chromocenters	S-GO
,	O
pericentric	B-GO
domains	E-GO
were	O
found	O
either	O
isolated	O
or	O
associated	O
in	O
heterogeneous	O
aggregates	O
of	O
various	O
sizes	O
,	O
often	O
at	O
the	O
nuclear	S-GO
periphery	O
.	O

Scale	O
bar	O
=	O
10	O
mu	O
m	O
.	O

(	O
C	O
)	O
Control	O
ES	O
cells	O
.	O

Fluorescence	O
was	O
quantified	O
along	O
a	O
line	O
randomly	O
drawn	O
across	O
the	O
nucleus	S-GO
in	O
the	O
merged	O
image	O
and	O
data	O
were	O
plotted	O
.	O

One	O
can	O
distinguish	O
clear	O
peaks	O
corresponding	O
to	O
chromocenters	S-GO
(	O
red	O
)	O
and	O
the	O
condensed	O
minor	O
satellites	O
(	O
green	O
)	O
.	O

(	O
D	O
)	O
ES	O
cells	O
expressing	O
p150CAF	O
-	O
1	O
siRNA	O
.	O

p150CAF	O
-	O
1	O
depletion	O
led	O
to	O
a	O
lower	O
fluorescence	O
intensity	O
and	O
a	O
broader	O
distribution	O
of	O
signals	O
corresponding	O
to	O
DAPI	O
(	O
blue	O
)	O
and	O
major	O
satellite	O
hybridization	O
(	O
red	O
,	O
plot	O
)	O
while	O
the	O
organization	O
of	O
the	O
minor	O
satellites	O
remained	O
unaffected	O
.	O

Insets	O
in	O
the	O
right	O
-	O
hand	O
images	O
show	O
a	O
typical	O
chromocenter	S-GO
in	O
control	O
cells	O
(	O
C	O
)	O
and	O
a	O
disrupted	O
chromocenter	S-GO
in	O
p150CAF	O
-	O
1	O
-	O
depleted	O
cells	O
(	O
D	O
)	O
.	O

Figure	O
5	O

Nucleosomal	S-GO
Organization	O
Is	O
Not	O
Altered	O
in	O
p150CAF	O
-	O
1	O
-	O
Depleted	O
ES	O
Cells	O

Nuclei	O
were	O
prepared	O
from	O
ES	O
cells	O
transfected	O
with	O
control	O
or	O
p150CAF	O
-	O
1	O
siRNA	O
vector	O
.	O

Nuclei	S-GO
were	O
digested	O
with	O
increasing	O
amounts	O
of	O
DNase	O
I	O
or	O
MNase	O
.	O

(	O
A	O
)	O
After	O
digestion	O
with	O
the	O
indicated	O
nucleases	O
,	O
total	O
DNA	O
was	O
prepared	O
and	O
run	O
onto	O
an	O
agarose	O
gel	O
which	O
was	O
stained	O
with	O
ethidium	O
bromide	O
to	O
reveal	O
bulk	O
genomic	O
DNA	O
.	O

(	O
B	O
)	O
The	O
DNA	O
was	O
blotted	O
onto	O
a	O
nylon	O
membrane	O
,	O
which	O
was	O
then	O
hybridized	O
with	O
the	O
alpha	O
-	O
32P	O
-	O
labeled	O
pSAT	O
major	O
satellite	O
repeat	O
probe	O
[	O
47	O
]	O
.	O

Figure	O
6	O

DNA	O
CpG	O
Methylation	O
at	O
Pericentric	B-GO
Heterochromatin	E-GO
Is	O
Not	O
Altered	O
in	O
p150CAF	O
-	O
1	O
-	O
Depleted	O
ES	O
Cells	O

Total	O
DNA	O
was	O
isolated	O
from	O
cells	O
transfected	O
with	O
a	O
control	O
or	O
the	O
p150CAF	O
-	O
1	O
siRNA	O
vector	O
and	O
digested	O
with	O
MaeII	O
,	O
whose	O
recognition	O
sequence	O
is	O
present	O
in	O
major	O
satellite	O
repeats	O
.	O

Digested	O
DNA	O
was	O
run	O
onto	O
an	O
agarose	O
gel	O
and	O
analyzed	O
by	O
Southern	O
blotting	O
using	O
the	O
pSAT	O
major	O
satellite	O
probe	O
[	O
47	O
]	O
.	O

Figure	O
7	O

Alteration	O
of	O
Epigenetic	O
Marking	O
at	O
Pericentric	B-GO
Heterochromatin	E-GO
in	O
p150CAF	O
-	O
1	O
-	O
Depleted	O
Cells	O

(	O
A	O
)	O
p150CAF	O
-	O
1	O
depletion	O
leads	O
to	O
reduced	O
H4K20me3	O
and	O
H3K9me3	O
at	O
pericentric	B-GO
heterochromatin	E-GO
.	O

Enrichment	O
of	O
histone	O
marks	O
at	O
major	O
satellite	O
repeats	O
was	O
determined	O
by	O
ChIP	O
from	O
control	O
(	O
cont	O
)	O
and	O
p150CAF	O
-	O
1	O
(	O
p150	O
)	O
siRNA	O
-	O
expressing	O
ES	O
cells	O
.	O

DNA	O
prepared	O
from	O
the	O
input	O
and	O
the	O
antibody	S-GO
-	O
bound	O
fraction	S-GO
were	O
run	O
onto	O
an	O
agarose	O
gel	O
and	O
analyzed	O
by	O
Southern	O
blot	O
with	O
the	O
pSAT	O
major	O
satellite	O
repeat	O
probe	O
[	O
47	O
]	O
.	O

(	O
B	O
)	O
Hybridization	O
signals	O
were	O
quantified	O
using	O
an	O
Instant	O
Imager	O
.	O

After	O
autoradiography	O
,	O
the	O
membrane	O
was	O
stripped	O
and	O
rehybridized	O
with	O
a	O
minor	O
satellite	O
probe	O
[	O
49	O
]	O
.	O

After	O
quantification	O
,	O
the	O
membrane	O
was	O
stripped	O
and	O
rehybridized	O
with	O
an	O
IAP	O
LTR	O
probe	O
[	O
50	O
]	O
.	O

Results	O
are	O
presented	O
as	O
the	O
amount	O
of	O
DNA	O
immunoprecipitated	O
from	O
p150CAF	O
-	O
1	O
-	O
depleted	O
ES	O
cells	O
divided	O
by	O
the	O
DNA	O
obtained	O
from	O
control	O
cells	O
.	O

The	O
figure	O
shows	O
the	O
mean	O
value	O
and	O
standard	O
deviation	O
of	O
three	O
independent	O
ChIP	O
experiments	O
.	O

(	O
C	O
and	O
D	O
)	O
H3K9me3	O
and	O
H4K20me3	O
fluorescence	O
patterns	O
are	O
severely	O
altered	O
in	O
p150CAF	O
-	O
1	O
-	O
depleted	O
ES	O
cells	O
.	O

Immunodetection	O
of	O
H3K9me3	O
(	O
C	O
,	O
green	O
)	O
,	O
H4K20me3	O
(	O
D	O
,	O
green	O
)	O
,	O
and	O
HP1	O
alpha	O
(	O
red	O
)	O
in	O
control	O
and	O
p150CAF	O
-	O
1	O
siRNA	O
-	O
expressing	O
ES	O
cells	O
.	O

Merging	O
of	O
HP1	O
alpha	O
with	O
H3K9me3	O
(	O
C	O
)	O
and	O
H4K20me3	O
(	O
D	O
)	O
is	O
shown	O
in	O
yellow	O
.	O

Scale	O
bars	O
represent	O
10	O
mu	O
m	O
.	O

Footnotes	O

currency	O
Current	O
address	O
:	O
Unit	O
e	O
de	O
G	O
e	O
n	O
e	O
tique	O
Fonctionnelle	O
de	O
la	O
Souris	O
,	O
Centre	O
National	O
de	O
la	O
Recherche	O
Scientifique	O
URA	O
2578	O
,	O
Institut	O
Pasteur	O
,	O
Paris	O
,	O
France	O

Competing	O
interests	O
.	O

The	O
authors	O
have	O
declared	O
that	O
no	O
competing	O
interests	O
exist	O
.	O

A	O
previous	O
version	O
of	O
this	O
article	O
appeared	O
as	O
an	O
Early	O
Online	O
Release	O
on	O
September	O
11	O
,	O
2006	O
(	O
doi	O
:	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pgen	O
.	O
0020181	O
.	O
eor	O
)	O
.	O

Author	O
contributions	O
.	O

MH	O
,	O
SB	O
,	O
AVP	O
,	O
JPQ	O
,	O
GA	O
,	O
and	O
MG	O
conceived	O
and	O
designed	O
the	O
experiments	O
.	O

MH	O
,	O
SB	O
,	O
AVP	O
,	O
and	O
PH	O
performed	O
the	O
experiments	O
.	O

MH	O
,	O
SB	O
,	O
AVP	O
,	O
and	O
JPQ	O
analyzed	O
the	O
data	O
.	O

MG	O
wrote	O
the	O
paper	O
.	O

Funding	O
.	O

This	O
study	O
was	O
funded	O
by	O
grants	O
from	O
the	O
Association	O
Pour	O
la	O
Recherche	O
Sur	O
le	O
Cancer	O
and	O
the	O
Fondation	O
Pour	O
la	O
Recherche	O
Medicale	O
to	O
MG	O
,	O
and	O
grants	O
from	O
a	O
Collaborative	O
Programme	O
Curie	O
Institute	O
/	O
Commissariat	O
a	O
l	O
'	O
Energie	O
Atomique	O
to	O
MG	O
and	O
GA	O
.	O

GA	O
'	O
s	O
team	O
is	O
labelized	O
by	O
la	O
Ligue	O
Contre	O
le	O
Cancer	O
,	O
and	O
part	O
of	O
the	O
Epigenome	O
Network	O
.	O

AVP	O
has	O
been	O
supported	O
by	O
the	O
Curie	O
Institute	O
and	O
the	O
Fondation	O
Franco	O
Norv	O
e	O
gienne	O
;	O
MH	O
by	O
the	O
CEA	O
,	O
the	O
Curie	O
Institute	O
,	O
and	O
the	O
Canceropole	O
IdF	O
.	O

Rb	O
-	O
Mediated	O
Neuronal	O
Differentiation	O
through	O
Cell	O
-	O
Cycle	O
-	O
Independent	O
Regulation	O
of	O
E2f3a	O

Abstract	O

It	O
has	O
long	O
been	O
known	O
that	O
loss	O
of	O
the	O
retinoblastoma	O
protein	O
(	O
Rb	O
)	O
perturbs	O
neural	O
differentiation	O
,	O
but	O
the	O
underlying	O
mechanism	O
has	O
never	O
been	O
solved	O
.	O

Rb	O
absence	O
impairs	O
cell	O
cycle	O
exit	O
and	O
triggers	O
death	O
of	O
some	O
neurons	O
,	O
so	O
differentiation	O
defects	O
may	O
well	O
be	O
indirect	O
.	O

Indeed	O
,	O
we	O
show	O
that	O
abnormalities	O
in	O
both	O
differentiation	O
and	O
light	O
-	O
evoked	O
electrophysiological	O
responses	O
in	O
Rb	O
-	O
deficient	O
retinal	O
cells	O
are	O
rescued	O
when	O
ectopic	O
division	O
and	O
apoptosis	O
are	O
blocked	O
specifically	O
by	O
deleting	O
E2f	O
transcription	O
factor	O
(	O
E2f	O
)	O
1	O
.	O

However	O
,	O
comprehensive	O
cell	O
-	O
type	O
analysis	O
of	O
the	O
rescued	O
double	O
-	O
null	O
retina	O
exposed	O
cell	O
-	O
cycle	O
-	O
independent	O
differentiation	O
defects	O
specifically	O
in	O
starburst	O
amacrine	O
cells	O
(	O
SACs	O
)	O
,	O
cholinergic	O
interneurons	O
critical	O
in	O
direction	O
selectivity	O
and	O
developmentally	O
important	O
rhythmic	O
bursts	O
.	O

Typically	O
,	O
Rb	O
is	O
thought	O
to	O
block	O
division	O
by	O
repressing	O
E2fs	O
,	O
but	O
to	O
promote	O
differentiation	O
by	O
potentiating	O
tissue	O
-	O
specific	O
factors	O
.	O

Remarkably	O
,	O
however	O
,	O
Rb	O
promotes	O
SAC	O
differentiation	O
by	O
inhibiting	O
E2f3	O
activity	O
.	O

Two	O
E2f3	O
isoforms	O
exist	O
,	O
and	O
we	O
find	O
both	O
in	O
the	O
developing	O
retina	O
,	O
although	O
intriguingly	O
they	O
show	O
distinct	O
subcellular	O
distribution	O
.	O

E2f3b	O
is	O
thought	O
to	O
mediate	O
Rb	O
function	O
in	O
quiescent	O
cells	O
.	O

However	O
,	O
in	O
what	O
is	O
to	O
our	O
knowledge	O
the	O
first	O
work	O
to	O
dissect	O
E2f	O
isoform	O
function	O
in	O
vivo	O
we	O
show	O
that	O
Rb	O
promotes	O
SAC	O
differentiation	O
through	O
E2f3a	O
.	O

These	O
data	O
reveal	O
a	O
mechanism	O
through	O
which	O
Rb	O
regulates	O
neural	O
differentiation	O
directly	O
,	O
and	O
,	O
unexpectedly	O
,	O
it	O
involves	O
inhibition	O
of	O
E2f3a	O
,	O
not	O
potentiation	O
of	O
tissue	O
-	O
specific	O
factors	O
.	O

Author	O
Summary	O

The	O
retinoblastoma	O
protein	O
(	O
Rb	O
)	O
,	O
an	O
important	O
tumor	O
suppressor	O
,	O
blocks	O
division	O
and	O
death	O
by	O
inhibiting	O
the	O
E2f	O
transcription	O
factor	O
family	O
.	O

In	O
contrast	O
,	O
Rb	O
is	O
thought	O
to	O
promote	O
differentiation	O
by	O
potentiating	O
tissue	O
-	O
specific	O
transcription	O
factors	O
,	O
although	O
differentiation	O
defects	O
in	O
Rb	O
null	O
cells	O
could	O
be	O
an	O
indirect	O
consequence	O
of	O
E2f	O
-	O
driven	O
division	O
and	O
death	O
.	O

Here	O
,	O
we	O
resolve	O
different	O
mechanisms	O
by	O
which	O
Rb	O
controls	O
division	O
,	O
death	O
,	O
and	O
differentiation	O
in	O
the	O
retina	O
.	O

Removing	O
E2f1	O
rescues	O
aberrant	O
division	O
of	O
differentiating	O
Rb	O
-	O
deficient	O
retinal	O
neurons	O
,	O
as	O
well	O
as	O
death	O
in	O
cells	O
prone	O
to	O
apoptosis	O
,	O
and	O
restores	O
both	O
normal	O
differentiation	O
and	O
function	O
of	O
major	O
cell	O
types	O
,	O
such	O
as	O
photoreceptors	O
.	O

However	O
,	O
Rb	O
-	O
deficient	O
starburst	O
amacrine	O
neurons	O
differentiate	O
abnormally	O
even	O
when	O
E2f1	O
is	O
removed	O
,	O
providing	O
an	O
unequivocal	O
example	O
of	O
a	O
direct	O
role	O
for	O
Rb	O
in	O
neuronal	O
differentiation	O
.	O

Rather	O
than	O
potentiating	O
a	O
cell	O
-	O
specific	O
factor	O
,	O
Rb	O
promotes	O
starburst	O
cell	O
differentiation	O
by	O
inhibiting	O
another	O
E2f	O
,	O
E2f3a	O
.	O

This	O
cell	O
-	O
cycle	O
-	O
independent	O
activity	O
broadens	O
the	O
importance	O
of	O
the	O
Rb	O
-	O
E2f	O
pathway	O
,	O
and	O
suggests	O
we	O
should	O
reassess	O
its	O
role	O
in	O
the	O
differentiation	O
of	O
other	O
cell	O
types	O
.	O

Introduction	O

The	O
simplicity	O
of	O
the	O
retina	O
makes	O
it	O
an	O
ideal	O
tissue	O
to	O
study	O
neurogenesis	O
.	O

Its	O
development	O
proceeds	O
through	O
three	O
overlapping	O
steps	O
starting	O
with	O
retinal	O
progenitor	O
cell	O
(	O
RPC	O
)	O
proliferation	O
,	O
followed	O
by	O
birth	O
of	O
post	O
-	O
mitotic	O
retinal	O
transition	O
cells	O
(	O
RTCs	O
,	O
also	O
referred	O
to	O
as	O
precursors	O
)	O
,	O
and	O
ending	O
with	O
terminal	O
differentiation	O
of	O
seven	O
major	O
cell	O
types	O
(	O
Figure	O
1A	O
)	O
[	O
1	O
]	O
.	O

RPCs	O
are	O
multipotent	O
and	O
exit	O
the	O
cell	O
cycle	O
to	O
generate	O
different	O
RTCs	O
at	O
specific	O
time	O
periods	O
in	O
development	O
[	O
1	O
]	O
.	O

This	O
process	O
of	O
RTC	O
"	O
birth	O
"	O
requires	O
coupling	O
of	O
differentiation	O
and	O
cell	O
cycle	O
exit	O
.	O

Once	O
born	O
,	O
post	O
-	O
mitotic	O
RTCs	O
migrate	O
and	O
form	O
different	O
retinal	O
layers	O
.	O

Rods	O
and	O
cones	O
make	O
up	O
the	O
outer	O
nuclear	O
layer	O
(	O
ONL	O
)	O
;	O
horizontal	O
,	O
bipolar	O
,	O
and	O
amacrine	O
cells	O
,	O
as	O
well	O
as	O
M	O
u	O
ller	O
glia	O
cell	O
bodies	O
,	O
reside	O
in	O
the	O
inner	O
nuclear	O
layer	O
(	O
INL	O
)	O
;	O
and	O
ganglion	O
and	O
displaced	O
amacrine	O
cells	O
form	O
the	O
ganglion	O
cell	O
layer	O
(	O
GCL	O
)	O
(	O
Figure	O
1A	O
)	O
.	O

The	O
outer	O
plexiform	O
layer	O
(	O
OPL	O
)	O
and	O
inner	O
plexiform	O
layer	O
(	O
IPL	O
)	O
house	O
synaptic	B-GO
connections	E-GO
separating	O
the	O
ONL	O
/	O
INL	O
and	O
INL	O
/	O
GCL	O
,	O
respectively	O
.	O

Figure	O
1	O

E2f1	O
,	O
but	O
Not	O
E2f2	O
or	O
E2f3	O
,	O
Loss	O
Rescues	O
Ectopic	O
Division	O
and	O
Cell	O
Death	O
in	O
the	O
Rb	O
KO	O
Retina	O

(	O
A	O
)	O
Retinal	O
development	O
.	O

At	O
E11	O
the	O
retina	O
is	O
a	O
NBL	O
of	O
dividing	O
RPCs	O
(	O
white	O
circle	O
,	O
green	O
nuclei	S-GO
)	O
.	O

RPC	O
cell	B-GO
bodies	E-GO
oscillate	O
along	O
processes	S-GO
as	O
they	O
progress	O
through	O
the	O
cell	O
cycle	O
.	O

By	O
P0	O
the	O
NBL	O
contains	O
both	O
RPCs	O
and	O
post	O
-	O
mitotic	O
RTCs	O
(	O
coloured	O
circles	O
,	O
red	O
nuclei	S-GO
)	O
and	O
is	O
separated	O
from	O
the	O
GCL	O
by	O
the	O
IPL	O
.	O

By	O
P8	O
there	O
are	O
no	O
RPCs	O
,	O
fewer	O
RTCs	O
,	O
an	O
OPL	O
,	O
and	O
more	O
differentiated	O
rods	O
(	O
r	O
)	O
and	O
cones	O
(	O
c	O
)	O
in	O
the	O
ONL	O
;	O
horizontal	O
(	O
h	O
)	O
,	O
bipolar	O
(	O
b	O
)	O
,	O
M	O
u	O
ller	O
(	O
m	O
)	O
,	O
and	O
amacrine	O
(	O
a	O
)	O
cells	O
in	O
the	O
INL	O
;	O
and	O
ganglion	O
(	O
g	O
)	O
and	O
displaced	O
amacrine	O
cells	O
in	O
the	O
GCL	O
.	O

Development	O
is	O
complete	O
by	O
~	O
P18	O
.	O

(	O
B	O
)	O
Rb	O
is	O
thought	O
to	O
regulate	O
cell	O
cycle	O
and	O
apoptosis	O
by	O
repressing	O
E2fs	O
,	O
but	O
to	O
promote	O
differentiation	O
by	O
potentiating	O
tissue	O
-	O
specific	O
transcription	O
factors	O
.	O

However	O
,	O
Rb	O
loss	O
could	O
also	O
perturb	O
differentiation	O
through	O
the	O
indirect	O
effects	O
of	O
abnormal	O
division	O
or	O
death	O
,	O
and	O
/	O
or	O
through	O
direct	O
regulation	O
of	O
differentiation	O
genes	O
by	O
E2fs	O
.	O

(	O
C	O
and	O
D	O
)	O
Horizontal	O
retinal	O
sections	O
of	O
the	O
indicated	O
genotypes	O
and	O
ages	O
were	O
stained	O
for	O
nuclei	S-GO
(	O
DAPI	O
,	O
blue	O
)	O
,	O
and	O
(	O
C	O
)	O
S	O
-	O
phase	O
(	O
anti	O
-	O
BrdU	O
,	O
red	O
)	O
or	O
(	O
D	O
)	O
apoptosis	O
(	O
TUNEL	O
,	O
red	O
)	O
.	O

Scale	O
bars	O
are	O
50	O
mu	O
m	O
.	O

(	O
E	O
-	O
G	O
)	O
Quantification	O
of	O
(	O
E	O
)	O
all	O
BrdU	O
+	O
cells	O
,	O
(	O
F	O
)	O
ectopic	O
BrdU	O
+	O
cells	O
in	O
GCL	O
at	O
P0	O
,	O
and	O
(	O
G	O
)	O
total	O
TUNEL	O
+	O
cells	O
.	O

(	O
H	O
)	O
Real	O
-	O
time	O
RT	O
-	O
PCR	O
analysis	O
of	O
E2fs	O
and	O
E2f	O
target	O
genes	O
in	O
P8	O
retinas	O
of	O
the	O
indicated	O
genotypes	O
.	O

Error	O
bars	O
represent	O
SD	O
of	O
measurements	O
from	O
three	O
animals	O
,	O
and	O
asterisks	O
indicate	O
a	O
significant	O
difference	O
between	O
the	O
WT	O
and	O
indicated	O
genotypes	O
(	O
*	O
,	O
p	O
<	O
0	O
.	O
05	O
;	O
*	O
*	O
;	O
p	O
<	O
0	O
.	O
01	O
;	O
ANOVA	O
and	O
Tukey	O
HSD	O
test	O
for	O
[	O
E	O
-	O
G	O
]	O
and	O
Fisher	O
test	O
for	O
[	O
H	O
]	O
)	O
.	O

The	O
retinoblastoma	O
protein	O
(	O
Rb	O
)	O
is	O
critical	O
for	O
cell	O
cycle	O
exit	O
during	O
retinal	O
transition	O
cell	O
birth	O
.	O

Rb	O
knockout	O
(	O
KO	O
)	O
RTCs	O
continue	O
to	O
proliferate	O
inappropriately	O
and	O
some	O
(	O
rod	O
,	O
ganglion	O
,	O
and	O
bipolar	O
cells	O
)	O
die	O
by	O
apoptosis	O
[	O
2	O
,	O
3	O
]	O
.	O

Rb	O
controls	O
the	O
cell	O
cycle	O
by	O
binding	O
and	O
inhibiting	O
E2f	O
transcription	O
factors	O
(	O
E2fs	O
)	O
(	O
Figure	O
1B	O
)	O
,	O
first	O
defined	O
as	O
transcription	O
factors	O
that	O
bind	O
adenoviral	O
E2	O
regulatory	O
elements	O
and	O
subsequently	O
shown	O
to	O
be	O
critical	O
cell	O
cycle	O
regulators	O
[	O
4	O
,	O
5	O
]	O
.	O

E2fs	O
bind	O
to	O
DNA	O
as	O
heterodimers	O
with	O
proteins	O
of	O
the	O
related	O
Tfdp	O
family	O
.	O

E2f1	O
,	O
E2f2	O
,	O
and	O
E2f3a	O
are	O
"	O
activating	O
E2fs	O
"	O
that	O
are	O
required	O
for	O
fibroblast	O
division	O
.	O

They	O
are	O
strong	O
transcriptional	O
activators	O
that	O
can	O
drive	O
G0	O
fibroblasts	O
into	O
cycle	O
,	O
and	O
are	O
inhibited	O
when	O
bound	O
to	O
Rb	O
[	O
4	O
,	O
5	O
]	O
.	O

Ectopic	O
division	O
in	O
Rb	O
KO	O
embryos	O
can	O
be	O
rescued	O
to	O
various	O
extents	O
in	O
different	O
tissues	O
by	O
knocking	O
out	O
E2f1	O
,	O
E2f2	O
,	O
or	O
E2f3	O
[	O
6	O
-	O
9	O
]	O
,	O
but	O
which	O
member	O
(	O
s	O
)	O
drive	O
division	O
in	O
Rb	O
KO	O
RTCs	O
is	O
unknown	O
.	O

Other	O
members	O
of	O
the	O
family	O
,	O
such	O
as	O
E2f4	O
and	O
E2f5	O
,	O
are	O
known	O
as	O
"	O
repressive	O
E2fs	O
"	O
because	O
they	O
are	O
weak	O
activators	O
and	O
appear	O
to	O
be	O
primarily	O
involved	O
in	O
gene	O
silencing	O
in	O
quiescent	O
or	O
differentiated	O
cells	O
.	O

Activating	O
E2fs	O
may	O
also	O
promote	O
apoptosis	O
in	O
the	O
Rb	O
KO	O
retina	O
(	O
Figure	O
1B	O
)	O
.	O

Originally	O
,	O
E2f1	O
was	O
considered	O
the	O
primary	O
pro	O
-	O
apoptotic	O
member	O
of	O
the	O
family	O
[	O
10	O
]	O
.	O

However	O
,	O
this	O
view	O
was	O
reevaluated	O
when	O
it	O
was	O
shown	O
that	O
either	O
E2f1	O
or	O
E2f3	O
deletion	O
rescues	O
apoptosis	O
in	O
the	O
developing	O
central	O
nervous	O
system	O
(	O
CNS	O
)	O
of	O
Rb	O
KO	O
embryos	O
[	O
6	O
,	O
11	O
]	O
.	O

Subsequently	O
,	O
CNS	O
apoptosis	O
was	O
shown	O
to	O
be	O
an	O
indirect	O
result	O
of	O
placental	O
defects	O
and	O
probable	O
hypoxia	O
[	O
12	O
-	O
14	O
]	O
.	O

Indeed	O
,	O
E2f3	O
-	O
induced	O
apoptosis	O
in	O
fibroblasts	O
has	O
recently	O
been	O
shown	O
to	O
require	O
E2f1	O
[	O
15	O
]	O
.	O

Thus	O
,	O
it	O
is	O
controversial	O
whether	O
E2f3	O
is	O
required	O
for	O
apoptosis	O
of	O
any	O
Rb	O
KO	O
cell	O
type	O
.	O

Determining	O
which	O
activating	O
E2fs	O
promote	O
death	O
in	O
distinct	O
Rb	O
KO	O
tissues	O
requires	O
conditional	O
rather	O
than	O
germ	O
line	O
models	O
of	O
Rb	O
deletion	O
to	O
avoid	O
secondary	O
indirect	O
effects	O
(	O
such	O
as	O
hypoxia	O
)	O
.	O

E2f	O
family	O
diversity	O
is	O
expanded	O
by	O
E2f3	O
isoforms	O
.	O

Alternative	O
promoters	O
generate	O
two	O
forms	O
(	O
a	O
and	O
b	O
)	O
that	O
are	O
identical	O
except	O
for	O
distinct	O
first	O
exons	O
[	O
16	O
]	O
.	O

E2f3a	O
is	O
a	O
strong	O
activator	O
,	O
and	O
,	O
like	O
other	O
activating	O
E2fs	O
,	O
its	O
expression	O
is	O
induced	O
when	O
quiescent	O
cells	O
are	O
stimulated	O
to	O
divide	O
[	O
16	O
]	O
.	O

E2f3b	O
,	O
like	O
repressive	O
E2fs	O
,	O
is	O
present	O
in	O
both	O
quiescent	O
and	O
dividing	O
cells	O
,	O
and	O
in	O
quiescent	O
fibroblasts	O
it	O
associates	O
primarily	O
with	O
Rb	O
,	O
suggesting	O
that	O
it	O
mediates	O
repression	O
[	O
16	O
-	O
18	O
]	O
.	O

Indeed	O
,	O
silencing	O
the	O
Cdkn2d	O
(	O
p19Arf	O
)	O
locus	O
in	O
unstressed	O
cells	O
relies	O
on	O
E2f3b	O
[	O
19	O
]	O
.	O

Other	O
E2fs	O
may	O
also	O
exist	O
in	O
isoforms	O
since	O
at	O
least	O
two	O
mRNA	O
species	O
have	O
been	O
detected	O
for	O
E2f1	O
and	O
E2f2	O
[	O
16	O
]	O
.	O

The	O
roles	O
of	O
E2f	O
isoforms	O
in	O
vivo	O
are	O
unknown	O
.	O

E2fs	O
are	O
also	O
regulated	O
by	O
subcellular	O
localization	O
.	O

Although	O
this	O
feature	O
has	O
been	O
best	O
characterized	O
for	O
repressive	O
E2fs	O
[	O
20	O
-	O
22	O
]	O
,	O
it	O
also	O
affects	O
activating	O
E2fs	O
[	O
23	O
-	O
25	O
]	O
.	O

The	O
distribution	O
of	O
E2f	O
isoforms	O
has	O
never	O
been	O
assessed	O
.	O

It	O
has	O
been	O
known	O
for	O
many	O
years	O
that	O
Rb	O
loss	O
perturbs	O
neuronal	O
differentiation	O
[	O
26	O
-	O
29	O
]	O
.	O

However	O
,	O
prior	O
work	O
could	O
not	O
exclude	O
the	O
possibility	O
that	O
differentiation	O
defects	O
are	O
simply	O
an	O
indirect	O
consequence	O
of	O
abnormal	O
division	O
and	O
death	O
.	O

If	O
Rb	O
does	O
regulate	O
differentiation	O
directly	O
it	O
is	O
unclear	O
whether	O
it	O
does	O
so	O
in	O
all	O
or	O
a	O
subset	O
of	O
neurons	O
.	O

Moreover	O
,	O
the	O
mechanism	O
has	O
never	O
been	O
solved	O
.	O

In	O
other	O
cell	O
types	O
where	O
Rb	O
may	O
promote	O
differentiation	O
directly	O
,	O
such	O
as	O
muscle	O
and	O
bone	O
,	O
it	O
seems	O
to	O
do	O
so	O
through	O
E2f	O
-	O
independent	O
means	O
by	O
potentiating	O
tissue	O
-	O
specific	O
transcription	O
factors	O
(	O
Figure	O
1B	O
)	O
[	O
30	O
-	O
33	O
]	O
.	O

In	O
the	O
retina	O
,	O
others	O
have	O
noted	O
abnormally	O
shaped	O
Rb	O
KO	O
rods	O
and	O
have	O
suggested	O
Rb	O
may	O
directly	O
promote	O
their	O
morphogenesis	O
by	O
activating	O
retina	O
-	O
specific	O
factors	O
[	O
29	O
]	O
.	O

However	O
,	O
differentiation	O
defects	O
in	O
any	O
Rb	O
KO	O
neuron	O
could	O
be	O
an	O
indirect	O
effect	O
of	O
ectopic	O
division	O
and	O
/	O
or	O
apoptosis	O
(	O
Figure	O
1B	O
)	O
.	O

Thus	O
,	O
it	O
is	O
critical	O
to	O
study	O
differentiation	O
of	O
Rb	O
KO	O
cells	O
in	O
the	O
absence	O
of	O
ectopic	O
proliferation	O
and	O
death	O
.	O

Here	O
,	O
we	O
establish	O
that	O
Rb	O
suppresses	O
RTC	O
division	O
and	O
death	O
by	O
inhibiting	O
E2f1	O
,	O
not	O
E2f2	O
or	O
E2f3	O
.	O

When	O
these	O
defects	O
were	O
rescued	O
,	O
most	O
retinal	O
neurons	O
,	O
including	O
rods	O
,	O
survived	O
,	O
differentiated	O
,	O
and	O
functioned	O
normally	O
.	O

Thus	O
,	O
unexpectedly	O
,	O
retina	O
-	O
specific	O
differentiation	O
factors	O
function	O
independently	O
of	O
Rb	O
.	O

However	O
,	O
comprehensive	O
assessment	O
of	O
the	O
Rb	O
/	O
E2f1	O
double	O
-	O
null	O
rescued	O
retina	O
revealed	O
a	O
differentiation	O
defect	O
in	O
cholinergic	O
starburst	O
amacrine	O
cells	O
(	O
SACs	O
)	O
.	O

Recent	O
breakthroughs	O
have	O
revealed	O
that	O
these	O
interneurons	O
are	O
critical	O
for	O
direction	O
selectivity	O
and	O
developmentally	O
important	O
rhythmic	O
bursts	O
[	O
34	O
-	O
36	O
]	O
.	O

However	O
,	O
their	O
differentiation	O
is	O
poorly	O
understood	O
.	O

Contrary	O
to	O
the	O
prevailing	O
view	O
that	O
Rb	O
promotes	O
differentiation	O
through	O
E2f	O
-	O
independent	O
tissue	O
-	O
specific	O
transcription	O
factors	O
,	O
we	O
show	O
that	O
Rb	O
facilitates	O
SAC	O
development	O
through	O
E2f3	O
.	O

Defects	O
in	O
Rb	O
null	O
SACs	O
correlated	O
with	O
specific	O
E2f3	O
expression	O
in	O
these	O
cells	O
,	O
and	O
E2f3	O
expression	O
was	O
absent	O
in	O
neurons	O
that	O
differentiated	O
without	O
Rb	O
.	O

E2f3	O
is	O
also	O
present	O
in	O
a	O
specific	O
subset	O
of	O
other	O
CNS	O
neurons	O
,	O
implying	O
that	O
this	O
may	O
be	O
a	O
general	O
mechanism	O
by	O
which	O
Rb	O
facilitates	O
neurogenesis	O
.	O

To	O
define	O
the	O
mechanism	O
in	O
even	O
more	O
detail	O
,	O
we	O
determined	O
which	O
E2f3	O
isoform	O
Rb	O
targets	O
to	O
control	O
SAC	O
differentiation	O
.	O

E2f3b	O
mediates	O
Rb	O
function	O
in	O
quiescent	O
fibroblasts	O
[	O
19	O
]	O
,	O
yet	O
no	O
prior	O
studies	O
to	O
our	O
knowledge	O
have	O
dissected	O
E2f3a	O
or	O
E2f3b	O
functions	O
in	O
vivo	O
.	O

Using	O
an	O
isoform	O
-	O
specific	O
null	O
mouse	O
we	O
show	O
that	O
Rb	O
drives	O
SAC	O
differentiation	O
through	O
E2f3a	O
.	O

Thus	O
,	O
independent	O
of	O
E2f1	O
-	O
mediated	O
effects	O
on	O
division	O
and	O
death	O
,	O
Rb	O
does	O
regulate	O
neuronal	O
differentiation	O
,	O
but	O
only	O
in	O
specific	O
neurons	O
and	O
,	O
unexpectedly	O
,	O
through	O
E2f3a	O
,	O
not	O
tissue	O
-	O
specific	O
differentiation	O
factors	O
.	O

Results	O

Rb	O
Regulates	O
Division	O
and	O
Death	O
through	O
E2f1	O

We	O
used	O
the	O
alpha	O
-	O
Cre	O
transgene	O
to	O
delete	O
floxed	O
Rb	O
exon	O
19	O
at	O
embryonic	O
day	O
(	O
E	O
)	O
10	O
in	O
peripheral	O
retina	O
[	O
2	O
]	O
.	O

RbloxP	O
/	O
loxP	O
;	O
alpha	O
-	O
Cre	O
mice	O
were	O
bred	O
with	O
strains	O
lacking	O
E2f1	O
or	O
E2f2	O
in	O
the	O
germ	O
line	O
,	O
or	O
a	O
strain	O
carrying	O
a	O
floxed	O
E2f3	O
allele	O
[	O
5	O
]	O
.	O

RbloxP	O
/	O
loxP	O
;	O
E2f1	O
+	O
/	O
-	O
and	O
RbloxP	O
/	O
loxP	O
;	O
E2f1	O
+	O
/	O
-	O
;	O
alpha	O
-	O
Cre	O
mice	O
were	O
bred	O
to	O
produce	O
RbloxP	O
/	O
loxP	O
;	O
E2f1	O
-	O
/	O
-	O
;	O
alpha	O
-	O
Cre	O
mice	O
at	O
a	O
frequency	O
of	O
1	O
/	O
8	O
and	O
littermate	O
controls	O
at	O
the	O
same	O
or	O
higher	O
(	O
1	O
/	O
4	O
)	O
frequency	O
.	O

For	O
simplicity	O
we	O
will	O
refer	O
to	O
the	O
RbloxP	O
/	O
loxP	O
;	O
E2f1	O
-	O
/	O
-	O
;	O
alpha	O
-	O
Cre	O
peripheral	O
retina	O
as	O
the	O
Rb	O
/	O
E2f1	O
double	O
knockout	O
(	O
DKO	O
)	O
retina	O
.	O

Similar	O
strategies	O
were	O
employed	O
in	O
the	O
case	O
of	O
E2f2	O
or	O
E2f3	O
.	O

Cre	O
-	O
mediated	O
excision	O
of	O
Rb	O
and	O
E2f3	O
alleles	O
in	O
the	O
retina	O
was	O
confirmed	O
by	O
PCR	O
as	O
described	O
previously	O
[	O
2	O
,	O
5	O
]	O
.	O

To	O
measure	O
ectopic	O
cell	O
division	O
,	O
mice	O
were	O
pulse	O
-	O
labelled	O
with	O
bromodeoxyuridine	O
(	O
BrdU	O
)	O
2	O
h	O
before	O
sacrifice	O
and	O
the	O
peripheral	O
retina	O
analyzed	O
for	O
BrdU	O
incorporation	O
by	O
immunofluorescence	O
.	O

As	O
reported	O
before	O
[	O
2	O
,	O
3	O
]	O
,	O
Rb	O
KO	O
retinas	O
exhibited	O
both	O
spatial	O
and	O
temporal	O
ectopic	O
DNA	O
synthesis	O
(	O
Figures	O
1C	O
and	O
S1A	O
)	O
.	O

This	O
is	O
easily	O
detected	O
at	O
E14	O
,	O
E16	O
,	O
and	O
postnatal	O
day	O
(	O
P	O
)	O
0	O
in	O
the	O
inner	O
retina	O
where	O
abnormal	O
BrdU	O
+	O
ganglion	O
and	O
amacrine	O
RTCs	O
are	O
located	O
,	O
or	O
on	O
the	O
outermost	O
region	O
of	O
the	O
P0	O
retina	O
,	O
where	O
BrdU	O
+	O
photoreceptor	O
RTCs	O
reside	O
(	O
Figures	O
S1A	O
and	O
S2	O
,	O
arrows	O
)	O
[	O
2	O
]	O
.	O

Ectopic	O
RTC	O
division	O
in	O
Rb	O
KO	O
retinas	O
is	O
even	O
more	O
obvious	O
at	O
P8	O
or	O
P18	O
,	O
when	O
division	O
is	O
completed	O
in	O
wild	O
-	O
type	O
(	O
WT	O
)	O
retina	O
(	O
Figures	O
1C	O
and	O
S1A	O
)	O
.	O

Strikingly	O
,	O
the	O
ectopically	O
positioned	O
S	O
-	O
phase	O
cells	O
at	O
E14	O
,	O
E16	O
,	O
and	O
P0	O
and	O
all	O
the	O
abnormal	O
division	O
at	O
P8	O
and	O
P18	O
were	O
completely	O
suppressed	O
in	O
the	O
Rb	O
/	O
E2f1	O
DKO	O
retina	O
(	O
Figures	O
1C	O
,	O
1E	O
,	O
1F	O
,	O
S1A	O
,	O
and	O
S2	O
)	O
.	O

In	O
contrast	O
,	O
deletion	O
of	O
E2f2	O
or	O
E2f3	O
had	O
no	O
effect	O
at	O
any	O
stage	O
of	O
development	O
.	O

Analysis	O
of	O
mitotic	O
cells	O
with	O
anti	O
-	O
phosphohistone	O
3	O
(	O
PH3	O
)	O
-	O
specific	O
antibodies	S-GO
confirmed	O
that	O
loss	O
of	O
E2f1	O
,	O
but	O
not	O
E2f2	O
or	O
E2f3	O
,	O
suppressed	O
ectopic	O
division	O
(	O
Figure	O
S3	O
)	O
.	O

Deleting	O
one	O
E2f1	O
allele	O
partially	O
suppressed	O
ectopic	O
S	O
-	O
phase	O
and	O
mitosis	O
in	O
Rb	O
KO	O
RTCs	O
(	O
Figures	O
1C	O
,	O
1E	O
,	O
1F	O
,	O
S1A	O
,	O
S2	O
,	O
and	O
S3	O
)	O
,	O
suggesting	O
that	O
E2f1	O
drives	O
ectopic	O
division	O
in	O
Rb	O
KO	O
RTCs	O
in	O
a	O
dose	O
-	O
dependent	O
fashion	O
.	O

These	O
data	O
contrast	O
with	O
previous	O
findings	O
in	O
the	O
lens	O
and	O
CNS	O
of	O
Rb	O
KO	O
embryos	O
,	O
where	O
deletion	O
of	O
any	O
activating	O
E2f	O
suppresses	O
ectopic	O
division	O
to	O
some	O
extent	O
[	O
6	O
-	O
9	O
]	O
.	O

Loss	O
of	O
Rb	O
in	O
the	O
retina	O
results	O
in	O
considerable	O
RTC	O
apoptosis	O
,	O
eliminating	O
most	O
bipolar	O
and	O
ganglion	O
cells	O
as	O
well	O
as	O
many	O
rods	O
(	O
Figure	O
2A	O
-	O
2D	O
)	O
[	O
2	O
,	O
3	O
]	O
.	O

The	O
loss	O
of	O
Rb	O
KO	O
rods	O
is	O
evident	O
from	O
the	O
thinner	O
ONL	O
,	O
and	O
the	O
death	O
of	O
these	O
cells	O
as	O
well	O
as	O
bipolar	O
and	O
ganglion	O
neurons	O
can	O
be	O
detected	O
directly	O
by	O
double	O
labelling	O
for	O
apoptotic	O
and	O
cell	O
-	O
type	O
-	O
specific	O
markers	O
[	O
2	O
]	O
(	O
M	O
.	O
P	O
.	O
and	O
R	O
.	O
B	O
.	O
,	O
unpublished	O
data	O
)	O
.	O

Loss	O
of	O
peripheral	O
Rb	O
KO	O
ganglion	O
cells	O
is	O
also	O
evident	O
from	O
thinning	O
of	O
the	O
optic	O
nerve	O
(	O
D	O
.	O
C	O
.	O
and	O
R	O
.	O
B	O
.	O
,	O
unpublished	O
data	O
)	O
.	O

Deleting	O
E2f1	O
,	O
but	O
not	O
E2f2	O
or	O
E2f3	O
,	O
blocked	O
this	O
ectopic	O
cell	O
death	O
in	O
a	O
dose	O
-	O
dependent	O
fashion	O
(	O
Figures	O
1D	O
,	O
1G	O
,	O
and	O
S1B	O
)	O
.	O

Figure	O
2	O

E2f1	O
Deletion	O
Rescues	O
Ganglion	O
,	O
Rod	O
,	O
and	O
Bipolar	O
Cells	O
in	O
the	O
Rb	O
KO	O
Retina	O

(	O
A	O
)	O
Horizontal	O
retinal	O
sections	O
from	O
mice	O
of	O
the	O
indicated	O
ages	O
and	O
genotypes	O
were	O
stained	O
for	O
nuclei	S-GO
(	O
DAPI	O
,	O
blue	O
)	O
and	O
markers	O
that	O
detect	O
ganglion	O
cells	O
(	O
Pou4f2	O
,	O
red	O
)	O
,	O
rods	O
and	O
cones	O
(	O
Sag	O
[	O
rod	O
arrestin	O
]	O
,	O
green	O
)	O
,	O
and	O
rod	O
bipolar	O
cells	O
(	O
Prkca	O
,	O
green	O
,	O
and	O
Cabp5	O
,	O
red	O
)	O
.	O

Scale	O
bars	O
are	O
50	O
mu	O
m	O
.	O

(	O
B	O
)	O
Quantification	O
of	O
Pou4f2	O
+	O
ganglion	O
cells	O
.	O

(	O
C	O
)	O
Quantification	O
of	O
Prkca	O
+	O
and	O
Cabp5	O
+	O
bipolar	O
cells	O
.	O

(	O
D	O
)	O
Thickness	O
of	O
the	O
ONL	O
,	O
which	O
represents	O
the	O
number	O
of	O
rods	O
.	O

Error	O
bars	O
represent	O
SD	O
of	O
measurements	O
from	O
three	O
animals	O
,	O
and	O
asterisks	O
indicate	O
a	O
significant	O
difference	O
between	O
retinas	O
of	O
WT	O
and	O
the	O
indicated	O
genotypes	O
,	O
unless	O
indicated	O
otherwise	O
by	O
connecting	O
lines	O
(	O
*	O
,	O
p	O
<	O
0	O
.	O
05	O
;	O
*	O
*	O
;	O
p	O
<	O
0	O
.	O
01	O
;	O
ANOVA	O
and	O
Tukey	O
HSD	O
test	O
)	O
.	O

(	O
E	O
and	O
F	O
)	O
ERGs	O
were	O
recorded	O
from	O
the	O
indicated	O
genotypes	O
under	O
dark	O
-	O
adapted	O
(	O
scotopic	O
)	O
conditions	O
,	O
and	O
(	O
E	O
)	O
intensity	O
series	O
and	O
(	O
F	O
)	O
b	O
-	O
wave	O
amplitudes	O
as	O
a	O
function	O
of	O
the	O
logarithm	O
of	O
the	O
flash	O
intensity	O
were	O
determined	O
.	O

(	O
F	O
)	O
Further	O
illustrates	O
that	O
the	O
relative	O
influence	O
of	O
the	O
mutations	O
on	O
the	O
photoreceptors	O
(	O
indicated	O
by	O
the	O
saturated	O
a	O
-	O
wave	O
amplitude	O
,	O
right	O
graph	O
)	O
was	O
not	O
substantially	O
different	O
from	O
their	O
effect	O
on	O
the	O
b	O
-	O
wave	O
response	O
(	O
dominated	O
by	O
the	O
bipolars	O
,	O
left	O
graph	O
)	O
at	O
the	O
same	O
intensity	O
of	O
10	O
cd	O
.	O
s	O
/	O
m2	O
.	O

To	O
investigate	O
the	O
molecular	O
mechanism	O
that	O
underlies	O
the	O
unique	O
role	O
of	O
E2f1	O
,	O
we	O
assessed	O
the	O
expression	O
of	O
known	O
E2f	O
targets	O
as	O
well	O
as	O
other	O
genes	O
that	O
regulate	O
the	O
cell	O
cycle	O
and	O
apoptosis	O
.	O

Numerous	O
positive	O
and	O
negative	O
cell	O
cycle	O
and	O
apoptotic	O
regulators	O
were	O
up	O
-	O
regulated	O
in	O
the	O
Rb	O
KO	O
retina	O
(	O
Figure	O
1H	O
)	O
.	O

Among	O
the	O
E2f	O
family	O
,	O
E2f1	O
,	O
E2f2	O
,	O
E2f3a	O
,	O
and	O
E2f7	O
were	O
induced	O
following	O
Rb	O
loss	O
,	O
but	O
E2f3b	O
,	O
E2f4	O
,	O
and	O
E2f5	O
were	O
unaffected	O
.	O

Consistent	O
with	O
the	O
BrdU	O
and	O
terminal	O
dUTP	O
nick	O
-	O
end	O
labelling	O
(	O
TUNEL	O
)	O
analyses	O
,	O
E2f1	O
deletion	O
specifically	O
reversed	O
all	O
these	O
molecular	O
defects	O
,	O
but	O
E2f3	O
deletion	O
had	O
no	O
effect	O
(	O
Figure	O
1H	O
)	O
.	O

Normal	O
Differentiation	O
in	O
the	O
Rb	O
/	O
E2f1	O
DKO	O
Retina	O

Because	O
E2f1	O
deletion	O
blocks	O
abnormal	O
division	O
and	O
death	O
in	O
the	O
Rb	O
KO	O
retina	O
,	O
the	O
Rb	O
/	O
E2f1	O
DKO	O
retina	O
provided	O
a	O
unique	O
opportunity	O
to	O
evaluate	O
whether	O
Rb	O
controls	O
differentiation	O
independent	O
of	O
cell	O
cycle	O
effects	O
.	O

The	O
Rb	O
/	O
E2f1	O
DKO	O
retina	O
had	O
many	O
Sag	O
+	O
(	O
S	O
-	O
antigen	O
/	O
rod	O
arrestin	O
)	O
photoreceptors	O
,	O
Pou4f2	O
+	O
(	O
Brn3b	O
)	O
ganglion	O
cells	O
,	O
and	O
numerous	O
Prkca	O
+	O
/	O
Cabp5	O
+	O
bipolar	O
neurons	O
(	O
Figure	O
2A	O
-	O
2D	O
)	O
.	O

In	O
contrast	O
,	O
there	O
was	O
no	O
such	O
rescue	O
of	O
cell	O
types	O
in	O
Rb	O
/	O
E2f2	O
or	O
Rb	O
/	O
E2f3	O
DKO	O
retinas	O
(	O
Figure	O
S4	O
)	O
.	O

Analysis	O
with	O
general	O
neuronal	O
markers	O
Mtap2	O
(	O
MAP2	O
)	O
and	O
Snap25	O
,	O
as	O
well	O
as	O
other	O
markers	O
expressed	O
in	O
bipolar	O
cells	O
(	O
Chx10	O
,	O
Rcvrn	O
,	O
Vsx1	O
,	O
Tacr3	O
,	O
and	O
Atp2b1	O
)	O
and	O
rod	O
photoreceptors	O
(	O
Rho	O
and	O
Rcvrn	O
)	O
confirmed	O
rescue	O
of	O
the	O
Rb	O
/	O
E2f1	O
DKO	O
retina	O
(	O
Table	O
S1	O
)	O
.	O

Moreover	O
,	O
neurons	O
exhibited	O
the	O
same	O
complex	O
morphology	O
as	O
in	O
WT	O
retina	O
.	O

Bipolar	O
cell	O
bodies	O
were	O
located	O
in	O
the	O
INL	O
and	O
had	O
ascending	O
and	O
descending	O
processes	S-GO
ending	O
in	O
the	O
OPL	O
and	O
IPL	O
,	O
respectively	O
(	O
Figure	O
2A	O
)	O
.	O

In	O
addition	O
,	O
the	O
Rb	O
/	O
E2f1	O
DKO	O
retina	O
had	O
a	O
healthy	O
appearing	O
ONL	O
consisting	O
of	O
morphologically	O
normal	O
rods	O
with	O
descending	O
processes	S-GO
ending	O
in	O
the	O
OPL	O
and	O
ascending	O
processes	S-GO
that	O
terminated	O
in	O
inner	B-GO
and	I-GO
outer	I-GO
segments	E-GO
(	O
Figure	O
2A	O
)	O
.	O

It	O
was	O
suggested	O
that	O
Rb	O
might	O
regulate	O
photoreceptor	O
differentiation	O
,	O
possibly	O
through	O
rod	O
-	O
specific	O
transcription	O
factors	O
(	O
Figure	O
1B	O
)	O
[	O
29	O
]	O
.	O

However	O
,	O
if	O
Rb	O
does	O
regulate	O
photoreceptor	O
differentiation	O
,	O
it	O
does	O
so	O
by	O
inhibiting	O
E2f1	O
,	O
not	O
by	O
potentiating	O
rod	O
differentiation	O
factors	O
,	O
such	O
as	O
Otx2	O
,	O
Crx	O
,	O
or	O
Nrl	O
.	O

It	O
is	O
impossible	O
to	O
tell	O
whether	O
E2f1	O
perturbs	O
differentiation	O
directly	O
,	O
by	O
affecting	O
the	O
expression	O
of	O
genes	O
that	O
modulate	O
maturation	O
,	O
and	O
/	O
or	O
indirectly	O
through	O
its	O
effects	O
on	O
proliferation	O
and	O
survival	O
(	O
Figure	O
1B	O
)	O
.	O

As	O
with	O
ectopic	O
division	O
and	O
apoptosis	O
(	O
Figure	O
1C	O
and	O
1D	O
)	O
,	O
the	O
rescue	O
of	O
Rb	O
KO	O
retinal	O
bipolar	O
,	O
ganglion	O
,	O
and	O
rod	O
cells	O
was	O
dependent	O
on	O
E2f1	O
dose	O
(	O
Figure	O
2A	O
-	O
2D	O
)	O
.	O

Separate	O
from	O
its	O
role	O
in	O
driving	O
ectopic	O
division	O
of	O
Rb	O
KO	O
RTCs	O
,	O
E2f1	O
also	O
promotes	O
normal	O
RPC	O
division	O
since	O
in	O
its	O
absence	O
RPC	O
proliferation	O
drops	O
~	O
2	O
-	O
fold	O
(	O
D	O
.	O
C	O
.	O
and	O
R	O
.	O
B	O
.	O
,	O
unpublished	O
data	O
)	O
.	O

This	O
modest	O
reduction	O
of	O
RPC	O
numbers	O
in	O
the	O
absence	O
of	O
E2f1	O
accounts	O
for	O
the	O
slight	O
reduction	O
in	O
the	O
number	O
of	O
ganglion	O
cells	O
at	O
P0	O
,	O
in	O
the	O
number	O
of	O
bipolar	O
cells	O
at	O
P18	O
or	O
P30	O
,	O
and	O
in	O
the	O
thickness	O
of	O
the	O
ONL	O
at	O
P18	O
or	O
P30	O
in	O
the	O
E2f1	O
KO	O
and	O
Rb	O
/	O
E2f1	O
DKO	O
retina	O
(	O
Figure	O
2B	O
-	O
2D	O
)	O
.	O

The	O
morphology	O
of	O
E2f1	O
KO	O
neurons	O
was	O
WT	O
(	O
Figure	O
2A	O
)	O
.	O

Despite	O
a	O
slight	O
drop	O
in	O
absolute	O
cell	O
numbers	O
,	O
the	O
proportion	O
of	O
Rb	O
/	O
E2f1	O
DKO	O
and	O
E2f1	O
KO	O
bipolar	O
cells	O
was	O
the	O
same	O
as	O
WT	O
(	O
data	O
not	O
shown	O
)	O
.	O

Slightly	O
reduced	O
cell	O
numbers	O
were	O
not	O
due	O
to	O
residual	O
RTC	O
death	O
since	O
we	O
have	O
not	O
observed	O
ectopic	O
apoptosis	O
at	O
any	O
embryonic	O
or	O
postnatal	O
stage	O
in	O
the	O
developing	O
Rb	O
/	O
E2f1	O
DKO	O
retina	O
(	O
Figures	O
1D	O
,	O
1G	O
,	O
and	O
S2	O
)	O
.	O

Moreover	O
,	O
deleting	O
Ccnd1	O
,	O
which	O
acts	O
upstream	O
of	O
Rb	O
proteins	O
,	O
also	O
reduces	O
RPC	O
number	O
,	O
but	O
does	O
not	O
suppress	O
any	O
defect	O
in	O
the	O
Rb	O
KO	O
retina	O
(	O
D	O
.	O
C	O
.	O
and	O
R	O
.	O
B	O
.	O
,	O
unpublished	O
data	O
)	O
.	O

Thus	O
,	O
slightly	O
reduced	O
RPC	O
division	O
and	O
dramatic	O
rescue	O
of	O
severe	O
defects	O
in	O
Rb	O
KO	O
RTCs	O
are	O
distinct	O
effects	O
stemming	O
from	O
the	O
deletion	O
of	O
E2f1	O
.	O

Normal	O
Function	O
of	O
the	O
Rb	O
/	O
E2f1	O
DKO	O
Retina	O

The	O
discovery	O
that	O
E2f1	O
loss	O
rescues	O
even	O
the	O
morphology	O
of	O
Rb	O
KO	O
neurons	O
is	O
surprising	O
because	O
Rb	O
is	O
thought	O
to	O
regulate	O
differentiation	O
primarily	O
through	O
E2f	O
-	O
independent	O
pathways	O
[	O
30	O
-	O
33	O
]	O
.	O

However	O
,	O
normal	O
morphology	O
may	O
not	O
equate	O
to	O
completely	O
normal	O
differentiation	O
.	O

Thus	O
,	O
we	O
compared	O
the	O
electroretinograms	O
(	O
ERGs	O
)	O
of	O
adult	O
WT	O
(	O
alpha	O
-	O
Cre	O
)	O
,	O
E2f1	O
-	O
/	O
-	O
,	O
alpha	O
-	O
Cre	O
;	O
RbloxP	O
/	O
loxP	O
,	O
and	O
alpha	O
-	O
Cre	O
;	O
RbloxP	O
/	O
loxP	O
;	O
E2f1	O
-	O
/	O
-	O
mice	O
.	O

ERGs	O
functionally	O
assess	O
visual	O
signalling	O
in	O
the	O
mammalian	O
retina	O
from	O
photoreceptors	O
to	O
amacrine	O
cells	O
(	O
but	O
usually	O
not	O
gangion	O
cells	O
)	O
,	O
and	O
are	O
dominated	O
by	O
rod	O
and	O
cone	O
bipolar	O
cells	O
.	O

Typically	O
,	O
an	O
ERG	O
signal	O
begins	O
with	O
a	O
negative	O
deflection	O
initiated	O
by	O
the	O
photoreceptors	O
(	O
the	O
a	O
-	O
wave	O
)	O
,	O
which	O
is	O
terminated	O
by	O
a	O
large	O
positive	O
deflection	O
due	O
to	O
the	O
activation	O
of	O
ON	O
bipolar	O
cells	O
(	O
the	O
b	O
-	O
wave	O
)	O
.	O

Responses	O
to	O
dim	O
light	O
in	O
dark	O
-	O
adapted	O
(	O
scotopic	O
)	O
conditions	O
specifically	O
assess	O
the	O
rod	O
system	O
,	O
and	O
were	O
defective	O
in	O
the	O
Rb	O
KO	O
retina	O
(	O
Figure	O
2E	O
)	O
.	O

The	O
substantial	O
reduction	O
of	O
both	O
a	O
-	O
and	O
b	O
-	O
waves	O
is	O
consistent	O
with	O
rod	O
and	O
bipolar	O
cell	O
apoptosis	O
[	O
2	O
]	O
.	O

The	O
sensitivity	O
of	O
the	O
residual	O
response	O
appeared	O
unchanged	O
,	O
suggesting	O
it	O
arose	O
from	O
the	O
Cre	O
-	O
negative	O
portions	O
of	O
the	O
retina	O
.	O

Responses	O
were	O
about	O
the	O
same	O
in	O
the	O
WT	O
and	O
E2f1	O
KO	O
retina	O
,	O
and	O
,	O
most	O
importantly	O
,	O
also	O
the	O
Rb	O
/	O
E2f1	O
DKO	O
response	O
median	O
lay	O
at	O
the	O
lower	O
end	O
of	O
the	O
normal	O
range	O
for	O
most	O
intensities	O
(	O
Figure	O
2F	O
)	O
.	O

Thus	O
,	O
E2f1	O
deletion	O
almost	O
completely	O
rescued	O
the	O
rod	O
system	O
in	O
the	O
Rb	O
KO	O
retina	O
.	O

Light	O
-	O
adapted	O
(	O
photopic	O
)	O
recordings	O
to	O
specifically	O
assess	O
the	O
cone	O
system	O
yielded	O
comparable	O
results	O
.	O

Cones	O
represent	O
only	O
3	O
%	O
of	O
photoreceptors	O
and	O
,	O
unlike	O
rods	O
,	O
develop	O
without	O
Rb	O
,	O
but	O
they	O
require	O
rods	O
for	O
survival	O
,	O
and	O
in	O
the	O
Rb	O
KO	O
retina	O
,	O
they	O
have	O
abnormal	O
morphology	O
and	O
their	O
synaptic	S-GO
targets	O
,	O
bipolar	O
cells	O
,	O
are	O
much	O
depleted	O
[	O
2	O
]	O
.	O

The	O
photopic	O
response	O
,	O
a	O
product	O
of	O
cone	O
and	O
mainly	O
bipolar	O
activity	O
,	O
was	O
much	O
reduced	O
by	O
Rb	O
loss	O
,	O
but	O
was	O
rescued	O
considerably	O
in	O
the	O
Rb	O
/	O
E2f1	O
DKO	O
retina	O
(	O
Figure	O
S5	O
)	O
.	O

Again	O
,	O
the	O
median	O
amplitude	O
lay	O
at	O
the	O
lower	O
end	O
of	O
the	O
E2f1	O
KO	O
range	O
.	O

The	O
photopic	O
response	O
in	O
E2f1	O
KO	O
mice	O
was	O
slightly	O
reduced	O
relative	O
to	O
WT	O
(	O
Figure	O
S5B	O
)	O
,	O
possibly	O
because	O
E2f1	O
is	O
required	O
for	O
maximal	O
expansion	O
of	O
embryonic	O
RPCs	O
,	O
and	O
the	O
E2f1	O
KO	O
retina	O
has	O
,	O
as	O
noted	O
earlier	O
,	O
slightly	O
fewer	O
cells	O
than	O
the	O
WT	O
retina	O
,	O
although	O
cell	O
type	O
proportions	O
are	O
unaffected	O
(	O
D	O
.	O
C	O
.	O
and	O
R	O
.	O
B	O
.	O
,	O
unpublished	O
data	O
)	O
.	O

Thus	O
,	O
marginally	O
subnormal	O
photopic	O
responses	O
in	O
the	O
Rb	O
/	O
E2f1	O
DKO	O
retina	O
can	O
be	O
attributed	O
to	O
both	O
a	O
reduction	O
of	O
cone	O
numbers	O
in	O
E2f1	O
KO	O
mice	O
alone	O
,	O
and	O
a	O
"	O
genuine	O
"	O
slight	O
reduction	O
in	O
cone	O
function	O
attributable	O
to	O
Rb	O
loss	O
relative	O
to	O
WT	O
.	O

This	O
slight	O
effect	O
may	O
relate	O
to	O
a	O
true	O
differentiation	O
defect	O
in	O
a	O
subset	O
of	O
amacrine	O
cells	O
discussed	O
below	O
.	O

This	O
discussion	O
should	O
not	O
obscure	O
the	O
major	O
outcome	O
that	O
E2f1	O
deletion	O
recovers	O
most	O
of	O
the	O
ERG	O
response	O
.	O

Thus	O
,	O
E2f1	O
deletion	O
not	O
only	O
rescues	O
morphology	O
but	O
also	O
both	O
rod	O
and	O
cone	O
system	O
function	O
in	O
the	O
Rb	O
KO	O
retina	O
.	O

Abnormal	O
SAC	O
Differentiation	O
Independent	O
of	O
Cell	O
Cycle	O
and	O
Survival	O
Defects	O

ERGs	O
primarily	O
assess	O
photoreceptor	O
and	O
bipolar	O
cell	O
function	O
,	O
but	O
may	O
miss	O
differentiation	O
defects	O
in	O
other	O
cells	O
.	O

To	O
test	O
for	O
subtle	O
differences	O
we	O
stained	O
the	O
Rb	O
/	O
E2f1	O
DKO	O
retina	O
with	O
43	O
markers	O
(	O
Table	O
S1	O
)	O
.	O

Thirty	O
-	O
two	O
proteins	O
displayed	O
identical	O
patterns	O
in	O
WT	O
,	O
E2f1	O
KO	O
,	O
and	O
Rb	O
/	O
E2f1	O
DKO	O
retina	O
(	O
Table	O
S1	O
)	O
.	O

The	O
other	O
11	O
markers	O
revealed	O
a	O
cell	O
-	O
cycle	O
-	O
and	O
apoptosis	O
-	O
independent	O
differentiation	O
defect	O
in	O
SACs	O
.	O

We	O
first	O
studied	O
Calb2	O
(	O
calretinin	O
)	O
,	O
which	O
marks	O
a	O
subset	O
of	O
amacrine	O
and	O
ganglion	O
cell	O
bodies	O
as	O
well	O
as	O
three	O
tracks	O
corresponding	O
to	O
their	O
processes	S-GO
in	O
the	O
IPL	O
(	O
Figure	O
3A	O
)	O
.	O

Normal	O
Calb2	O
staining	O
was	O
seen	O
in	O
the	O
E2f1	O
KO	O
IPL	O
(	O
data	O
not	O
shown	O
)	O
.	O

However	O
,	O
only	O
one	O
Calb2	O
+	O
track	O
was	O
evident	O
in	O
the	O
Rb	O
KO	O
IPL	O
,	O
and	O
this	O
defect	O
was	O
not	O
rescued	O
in	O
the	O
Rb	O
/	O
E2f1	O
DKO	O
retina	O
(	O
Figure	O
3A	O
)	O
.	O

We	O
quantified	O
Calb2	O
+	O
cell	B-GO
bodies	E-GO
in	O
the	O
Rb	O
KO	O
INL	O
(	O
corresponding	O
to	O
amacrine	O
cell	O
staining	O
only	O
)	O
and	O
observed	O
a	O
reduction	O
from	O
P8	O
onwards	O
(	O
Figures	O
3C	O
and	O
S6	O
)	O
.	O

Figure	O
3	O

Differentiation	O
Defects	O
in	O
Rb	O
KO	O
SACs	O

(	O
A	O
)	O
P18	O
horizontal	O
sections	O
of	O
WT	O
,	O
Rb	O
KO	O
,	O
and	O
Rb	O
/	O
E2f1	O
DKO	O
retina	O
were	O
stained	O
for	O
nuclei	S-GO
(	O
DAPI	O
,	O
blue	O
)	O
,	O
Calb2	O
(	O
green	O
)	O
,	O
and	O
Slc18a3	O
(	O
red	O
)	O
.	O

(	O
B	O
)	O
Confocal	O
images	O
of	O
P30	O
horizontal	O
sections	O
of	O
WT	O
and	O
Rb	O
KO	O
retina	O
were	O
stained	O
for	O
nuclei	S-GO
(	O
DAPI	O
,	O
blue	O
)	O
,	O
Chat	O
and	O
Slc18a3	O
(	O
both	O
red	O
)	O
,	O
and	O
Camk2a	O
(	O
green	O
)	O
.	O

In	O
the	O
Rb	O
KO	O
section	O
,	O
the	O
red	O
stain	O
is	O
Chat	O
only	O
,	O
as	O
Slc18a3	O
is	O
missing	O
(	O
see	O
[	O
A	O
]	O
)	O
.	O

(	O
C	O
)	O
Quantification	O
of	O
dense	O
Calb2	O
+	O
cell	B-GO
bodies	E-GO
in	O
the	O
INL	O
,	O
total	O
Slc18a3	O
+	O
cell	B-GO
bodies	E-GO
,	O
and	O
Camk2a	O
+	O
cell	B-GO
bodies	E-GO
in	O
the	O
INL	O
.	O

Error	O
bars	O
represent	O
SD	O
of	O
measurements	O
from	O
three	O
animals	O
,	O
and	O
asterisks	O
indicate	O
significant	O
differences	O
between	O
retinas	O
of	O
WT	O
and	O
the	O
indicated	O
genotypes	O
(	O
*	O
,	O
p	O
<	O
0	O
.	O
05	O
;	O
*	O
*	O
;	O
p	O
<	O
0	O
.	O
01	O
;	O
ANOVA	O
and	O
Tukey	O
HSD	O
test	O
)	O
.	O

Scale	O
bars	O
are	O
50	O
mu	O
m	O
in	O
(	O
A	O
)	O
and	O
20	O
mu	O
m	O
in	O
(	O
B	O
)	O
.	O

Of	O
the	O
three	O
Calb2	O
+	O
tracks	O
in	O
the	O
IPL	O
,	O
the	O
two	O
outer	O
tracks	O
are	O
from	O
SACs	O
,	O
named	O
after	O
their	O
extensive	O
dendritic	B-GO
-	I-GO
tree	E-GO
-	O
like	O
morphology	O
[	O
37	O
]	O
.	O

SACs	O
are	O
cholinergic	O
,	O
represent	O
~	O
5	O
.	O
2	O
%	O
of	O
amacrine	O
neurons	O
[	O
38	O
]	O
,	O
and	O
are	O
critical	O
for	O
both	O
direction	O
selectivity	O
[	O
34	O
,	O
35	O
]	O
and	O
spontaneous	O
rhythmic	O
activity	O
that	O
occurs	O
during	O
normal	O
retinal	O
development	O
[	O
36	O
]	O
.	O

SACs	O
in	O
the	O
INL	O
synapse	S-GO
in	O
the	O
OFF	O
layer	O
of	O
the	O
IPL	O
that	O
responds	O
to	O
decreasing	O
light	O
,	O
while	O
displaced	O
SACs	O
in	O
the	O
GCL	O
have	O
processes	S-GO
that	O
synapse	O
in	O
the	O
nearby	O
ON	O
layer	O
of	O
the	O
IPL	O
that	O
responds	O
to	O
increasing	O
light	O
(	O
reviewed	O
in	O
[	O
39	O
]	O
)	O
.	O

Mature	O
SAC	O
processes	S-GO
stain	O
specifically	O
for	O
Slc18a3	O
(	O
vesicular	O
acetyl	O
choline	O
transporter	O
,	O
VAChT	O
)	O
[	O
37	O
]	O
,	O
and	O
,	O
significantly	O
,	O
this	O
marker	O
was	O
absent	O
in	O
the	O
peripheral	O
Rb	O
KO	O
or	O
Rb	O
/	O
E2f1	O
DKO	O
P18	O
retina	O
(	O
Figures	O
3A	O
and	O
S7B	O
)	O
.	O

Chat	O
,	O
expressed	O
from	O
the	O
same	O
locus	O
,	O
is	O
also	O
SAC	O
specific	O
,	O
but	O
marks	O
both	O
cell	B-GO
bodies	E-GO
and	O
processes	S-GO
of	O
mature	O
SACs	O
[	O
37	O
]	O
.	O

Chat	O
was	O
seen	O
in	O
fewer	O
cells	O
in	O
the	O
mature	O
Rb	O
KO	O
retina	O
,	O
and	O
was	O
present	O
in	O
the	O
soma	S-GO
but	O
absent	O
from	O
processes	S-GO
(	O
Figure	O
3B	O
)	O
.	O

We	O
obtained	O
similar	O
results	O
for	O
Sv2c	O
,	O
a	O
synaptic	B-GO
vesicle	E-GO
protein	O
found	O
in	O
SACs	O
[	O
40	O
]	O
;	O
Kcnc1b	O
and	O
Kcnc2	O
,	O
potassium	O
channels	O
expressed	O
on	O
SAC	O
soma	S-GO
and	O
dendrites	S-GO
as	O
well	O
as	O
a	O
very	O
small	O
number	O
of	O
ganglion	O
cells	O
[	O
41	O
]	O
;	O
gamma	O
-	O
aminobutyric	O
acid	O
(	O
GABA	O
)	O
,	O
an	O
inhibitory	O
neurotransmitter	O
present	O
in	O
about	O
half	O
of	O
amacrine	O
cells	O
including	O
SACs	O
,	O
as	O
well	O
as	O
horizontal	O
and	O
some	O
bipolar	O
neurons	O
[	O
37	O
]	O
;	O
and	O
Calb1	O
(	O
calbindin	O
)	O
,	O
which	O
is	O
expressed	O
in	O
many	O
amacrine	O
cells	O
and	O
labels	O
SAC	O
process	S-GO
faintly	O
(	O
Figure	O
S7A	O
and	O
S7B	O
;	O
Table	O
S1	O
;	O
and	O
data	O
not	O
shown	O
)	O
.	O

Finally	O
,	O
we	O
also	O
examined	O
the	O
effect	O
of	O
Rb	O
deletion	O
on	O
SAC	O
differentiation	O
using	O
a	O
Chx10	O
-	O
Cre	O
transgene	O
that	O
is	O
expressed	O
in	O
a	O
mosaic	O
pattern	O
across	O
the	O
retina	O
,	O
generating	O
patches	O
of	O
Cre	O
-	O
expressing	O
cells	O
[	O
42	O
]	O
.	O

Consistent	O
with	O
the	O
mosaic	O
deletion	O
pattern	O
,	O
we	O
observed	O
markedly	O
reduced	O
Chat	O
/	O
Slc18a3	O
staining	O
in	O
the	O
IPL	O
of	O
Chx10	O
-	O
Cre	O
;	O
RbloxP	O
/	O
loxP	O
retina	O
compared	O
to	O
WT	O
(	O
Figure	O
S7C	O
)	O
.	O

Together	O
,	O
these	O
results	O
suggest	O
a	O
role	O
for	O
Rb	O
in	O
SAC	O
differentiation	O
.	O

The	O
above	O
findings	O
could	O
indicate	O
a	O
defect	O
in	O
SAC	O
specification	O
,	O
SAC	O
survival	O
,	O
or	O
the	O
levels	O
and	O
/	O
or	O
transport	O
of	O
the	O
markers	O
described	O
above	O
.	O

Camk2a	O
marks	O
both	O
SACs	O
and	O
ganglion	O
cells	O
[	O
37	O
]	O
,	O
but	O
because	O
ganglion	O
cells	O
are	O
eliminated	O
in	O
the	O
Rb	O
KO	O
retina	O
,	O
Camk2a	O
is	O
a	O
specific	O
SAC	O
marker	O
in	O
this	O
context	O
.	O

Importantly	O
,	O
Camk2a	O
+	O
tracks	O
and	O
dendrites	S-GO
were	O
present	O
in	O
both	O
the	O
WT	O
and	O
Rb	O
KO	O
retina	O
(	O
Figure	O
3B	O
)	O
,	O
and	O
the	O
number	O
of	O
Camk2a	O
+	O
soma	S-GO
was	O
similar	O
in	O
WT	O
and	O
Rb	O
KO	O
retina	O
at	O
P30	O
and	O
beyond	O
,	O
although	O
fewer	O
cells	O
stained	O
in	O
Rb	O
KO	O
retina	O
at	O
P18	O
,	O
suggesting	O
a	O
delay	O
in	O
its	O
appearance	O
(	O
Figures	O
3C	O
and	O
S6B	O
)	O
.	O

Thus	O
,	O
Rb	O
is	O
not	O
required	O
for	O
SAC	O
survival	O
or	O
for	O
process	S-GO
outgrowth	O
,	O
but	O
rather	O
it	O
seems	O
to	O
regulate	O
the	O
expression	O
and	O
/	O
or	O
stability	O
of	O
Calb2	O
,	O
Calb1	O
,	O
Chat	O
,	O
Slc18a3	O
,	O
Sv2c	O
,	O
Kcnc1b	O
,	O
Kcnc2	O
,	O
and	O
GABA	O
in	O
SACs	O
,	O
but	O
leaves	O
Camk2a	O
expression	O
virtually	O
unaffected	O
.	O

The	O
presence	O
of	O
Chat	O
in	O
some	O
cell	B-GO
bodies	E-GO
but	O
never	O
in	O
processes	S-GO
(	O
Figure	O
3B	O
)	O
also	O
suggests	O
a	O
transport	O
defect	O
.	O

The	O
developmental	O
pattern	O
of	O
Slc18a3	O
expression	O
also	O
supported	O
this	O
notion	O
.	O

In	O
mature	O
WT	O
SACs	O
Slc18a3	O
is	O
only	O
in	O
processes	S-GO
,	O
but	O
in	O
early	O
postnatal	O
SACs	O
,	O
it	O
is	O
found	O
in	O
the	O
cell	B-GO
body	E-GO
,	O
and	O
moves	O
into	O
emerging	O
processes	S-GO
at	O
approximately	O
P4	O
-	O
P6	O
.	O

As	O
noted	O
above	O
,	O
Slc18a3	O
was	O
absent	O
at	O
P18	O
in	O
the	O
Rb	O
KO	O
retina	O
(	O
Figure	O
3A	O
)	O
;	O
at	O
P4	O
or	O
P5	O
it	O
was	O
in	O
cell	B-GO
bodies	E-GO
,	O
yet	O
was	O
rarely	O
present	O
in	O
Rb	O
KO	O
processes	S-GO
(	O
Figures	O
4A	O
and	O
S6	O
)	O
.	O

Slc18a3	O
became	O
virtually	O
undetectable	O
in	O
Rb	O
KO	O
SACs	O
by	O
P8	O
(	O
Figures	O
3C	O
and	O
S6C	O
)	O
.	O

These	O
data	O
suggest	O
that	O
Rb	O
affects	O
both	O
the	O
synthesis	O
/	O
stability	O
and	O
transport	O
of	O
SAC	O
markers	O
.	O

Figure	O
4	O

E2f3	O
Loss	O
Rescues	O
Differentiation	O
of	O
Rb	O
KO	O
SACs	O

(	O
A	O
)	O
Horizontal	O
retinal	O
sections	O
of	O
the	O
indicated	O
ages	O
and	O
genotypes	O
were	O
stained	O
for	O
nuclei	S-GO
(	O
DAPI	O
,	O
blue	O
)	O
,	O
mitosis	O
marker	O
PH3	O
(	O
green	O
)	O
,	O
and	O
Slc18a3	O
(	O
red	O
)	O
,	O
which	O
marks	O
SAC	O
soma	S-GO
at	O
early	O
stages	O
and	O
processes	S-GO
from	O
~	O
P5	O
onwards	O
.	O

Arrows	O
show	O
mitotic	O
PH3	O
+	O
nuclei	S-GO
in	O
Rb	O
KO	O
,	O
Rb	O
/	O
E2f2	O
DKO	O
,	O
and	O
Rb	O
/	O
E2f3	O
DKO	O
retinas	O
.	O

E2f1	O
loss	O
rescues	O
the	O
ectopic	O
mitosis	O
and	O
cell	O
death	O
defects	O
,	O
but	O
not	O
the	O
SAC	O
defect	O
.	O

E2f2	O
loss	O
has	O
no	O
effect	O
.	O

E2f3	O
loss	O
does	O
not	O
rescue	O
the	O
ectopic	O
mitosis	O
and	O
cell	O
loss	O
defects	O
,	O
but	O
rescues	O
the	O
SAC	O
defect	O
.	O

Inactivating	O
E2f1	O
and	O
E2f3	O
together	O
rescues	O
the	O
ectopic	O
mitosis	O
,	O
cell	O
death	O
,	O
and	O
SAC	O
defects	O
.	O

(	O
B	O
)	O
The	O
fraction	O
of	O
Camk2a	O
+	O
cells	O
that	O
are	O
Chat	O
+	O
and	O
Slc18a3	O
+	O
in	O
the	O
P30	O
retina	O
.	O

(	O
C	O
)	O
Horizontal	O
P5	O
retinal	O
sections	O
were	O
stained	O
for	O
nuclei	S-GO
(	O
DAPI	O
,	O
blue	O
)	O
,	O
Slc18a3	O
(	O
green	O
)	O
,	O
and	O
Isl1	O
(	O
red	O
)	O
.	O

Arrows	O
show	O
double	O
-	O
labelled	O
Isl1	O
+	O
/	O
Slc18a3	O
+	O
cells	O
in	O
the	O
inner	O
INL	O
.	O

(	O
D	O
)	O
Horizontal	O
P0	O
retinal	O
sections	O
of	O
the	O
indicated	O
genotypes	O
were	O
stained	O
for	O
nuclei	S-GO
(	O
DAPI	O
,	O
blue	O
)	O
,	O
cell	O
division	O
marker	O
Mki67	O
(	O
green	O
)	O
,	O
and	O
Isl1	O
(	O
red	O
)	O
.	O

Arrows	O
show	O
double	O
-	O
labelled	O
dividing	O
SACs	O
.	O

(	O
E	O
)	O
The	O
fraction	O
of	O
Isl1	O
+	O
cells	O
in	O
the	O
inner	O
NBL	O
(	O
INBL	O
)	O
of	O
P0	O
retinas	O
that	O
are	O
dividing	O
(	O
Mki67	O
+	O
)	O
.	O

Error	O
bars	O
represent	O
SD	O
of	O
measurements	O
from	O
three	O
animals	O
,	O
and	O
asterisks	O
indicate	O
significant	O
differences	O
between	O
retinas	O
of	O
WT	O
and	O
the	O
indicated	O
genotypes	O
(	O
*	O
,	O
p	O
<	O
0	O
.	O
05	O
;	O
*	O
*	O
;	O
p	O
<	O
0	O
.	O
01	O
;	O
ANOVA	O
and	O
Tukey	O
HSD	O
test	O
)	O
.	O

Scale	O
bars	O
in	O
(	O
A	O
)	O
,	O
(	O
C	O
)	O
,	O
and	O
(	O
D	O
)	O
are	O
50	O
mu	O
m	O
.	O

Rb	O
Regulates	O
SAC	O
Differentiation	O
through	O
E2f3	O

Rb	O
binds	O
more	O
than	O
100	O
proteins	O
[	O
43	O
]	O
and	O
in	O
some	O
non	O
-	O
neuronal	O
cells	O
,	O
such	O
as	O
skeletal	O
muscle	O
,	O
adipocytes	O
,	O
and	O
bone	O
,	O
Rb	O
is	O
thought	O
to	O
bind	O
and	O
potentiate	O
tissue	O
-	O
specific	O
transcription	O
factors	O
that	O
promote	O
differentiation	O
[	O
31	O
-	O
33	O
]	O
.	O

Thus	O
,	O
we	O
expected	O
that	O
Rb	O
might	O
interact	O
with	O
retina	O
-	O
specific	O
factors	O
to	O
facilitate	O
SAC	O
differentiation	O
.	O

A	O
direct	O
role	O
for	O
E2f	O
in	O
mediating	O
Rb	O
-	O
dependent	O
differentiation	O
defects	O
(	O
independent	O
of	O
cell	O
cycle	O
or	O
death	O
defects	O
)	O
has	O
to	O
our	O
knowledge	O
not	O
been	O
described	O
,	O
but	O
because	O
E2f	O
can	O
regulate	O
some	O
differentiation	O
genes	O
[	O
44	O
-	O
48	O
]	O
,	O
we	O
first	O
tested	O
whether	O
E2f2	O
or	O
E2f3	O
might	O
perturb	O
Rb	O
KO	O
SAC	O
maturation	O
.	O

At	O
multiple	O
time	O
points	O
,	O
E2f1	O
deletion	O
suppressed	O
ectopic	O
mitosis	O
(	O
PH3	O
+	O
cells	O
)	O
,	O
but	O
did	O
not	O
reverse	O
the	O
SAC	O
defect	O
,	O
and	O
E2f2	O
deletion	O
had	O
no	O
effect	O
on	O
either	O
defect	O
(	O
Figure	O
4A	O
)	O
.	O

Remarkably	O
,	O
although	O
E2f3	O
deletion	O
did	O
not	O
reverse	O
ectopic	O
mitosis	O
,	O
it	O
rescued	O
Calb2	O
,	O
Slc18a3	O
,	O
Chat	O
,	O
GABA	O
,	O
Kcnc1b	O
,	O
Kcnc2	O
,	O
and	O
Sv2c	O
staining	O
at	O
multiple	O
times	O
(	O
Figure	O
4A	O
and	O
data	O
not	O
shown	O
)	O
.	O

Rb	O
/	O
E2f3	O
DKO	O
SAC	O
tracks	O
were	O
slightly	O
more	O
disordered	O
than	O
in	O
WT	O
retina	O
,	O
most	O
likely	O
because	O
of	O
the	O
absence	O
of	O
synaptic	S-GO
partner	O
cells	O
,	O
which	O
are	O
killed	O
by	O
E2f1	O
.	O

Indeed	O
,	O
this	O
minor	O
defect	O
was	O
rescued	O
in	O
the	O
Rb	O
/	O
E2f1	O
/	O
E2f3	O
triple	O
knockout	O
retina	O
,	O
where	O
bipolar	O
and	O
ganglion	O
cell	O
death	O
was	O
rescued	O
and	O
SAC	O
differentiation	O
was	O
restored	O
(	O
Figure	O
4A	O
)	O
.	O

E2f3	O
deletion	O
alone	O
did	O
not	O
affect	O
SAC	O
differentiation	O
(	O
Figure	O
4A	O
)	O
;	O
thus	O
,	O
it	O
is	O
unleashed	O
E2f3	O
activity	O
that	O
is	O
detrimental	O
,	O
and	O
the	O
critical	O
role	O
for	O
Rb	O
is	O
to	O
inhibit	O
E2f3	O
.	O

We	O
quantified	O
the	O
fraction	O
of	O
Camk2a	O
+	O
SACs	O
in	O
different	O
genotypes	O
and	O
found	O
that	O
60	O
%	O
of	O
WT	O
P30	O
Camk2a	O
+	O
cells	O
expressed	O
Chat	O
and	O
Slc18a3	O
,	O
which	O
dropped	O
to	O
only	O
5	O
.	O
6	O
%	O
in	O
the	O
Rb	O
KO	O
retina	O
,	O
and	O
remained	O
low	O
at	O
3	O
.	O
7	O
%	O
in	O
the	O
Rb	O
/	O
E2f1	O
DKO	O
retina	O
,	O
but	O
rose	O
to	O
91	O
%	O
in	O
the	O
Rb	O
/	O
E2f3	O
DKO	O
retina	O
(	O
Figure	O
4B	O
)	O
.	O

The	O
latter	O
fraction	O
is	O
higher	O
than	O
WT	O
because	O
ganglion	O
cells	O
,	O
which	O
normally	O
make	O
up	O
~	O
40	O
%	O
of	O
Camk2a	O
+	O
cells	O
,	O
are	O
killed	O
by	O
apoptosis	O
.	O

To	O
quantify	O
the	O
effect	O
of	O
different	O
E2fs	O
on	O
ectopic	O
division	O
specifically	O
in	O
SACs	O
,	O
we	O
exploited	O
Isl1	O
(	O
Islet1	O
)	O
.	O

This	O
marker	O
is	O
expressed	O
in	O
both	O
SACs	O
and	O
ganglion	O
cells	O
,	O
thus	O
Isl1	O
+	O
cells	O
in	O
the	O
INL	O
are	O
exclusively	O
SACs	O
[	O
49	O
]	O
.	O

We	O
found	O
that	O
98	O
.	O
2	O
%	O
+/-	O
1	O
.	O
8	O
%	O
of	O
Isl1	O
+	O
cells	O
in	O
the	O
forming	O
inner	O
INL	O
at	O
P5	O
were	O
also	O
Slc18a3	O
+	O
,	O
confirming	O
that	O
Isl1	O
is	O
an	O
excellent	O
SAC	O
marker	O
(	O
Figure	O
4C	O
)	O
.	O

Moreover	O
,	O
Isl1	O
,	O
unlike	O
Slc18a3	O
,	O
is	O
nuclear	S-GO
,	O
which	O
facilitates	O
scoring	O
of	O
Isl1	O
+	O
/	O
Mki67	O
+	O
cells	O
.	O

It	O
is	O
also	O
expressed	O
earlier	O
than	O
Slc18a3	O
,	O
permitting	O
analysis	O
of	O
SACs	O
soon	O
after	O
their	O
birth	O
at	O
~	O
E15	O
;	O
thus	O
,	O
we	O
could	O
study	O
retina	O
at	O
P0	O
,	O
a	O
time	O
when	O
ectopic	O
division	O
is	O
high	O
in	O
the	O
inner	O
retina	O
and	O
prior	O
to	O
Rb	O
-	O
independent	O
cell	O
cycle	O
exit	O
associated	O
with	O
terminal	O
differentiation	O
[	O
2	O
]	O
.	O

At	O
P0	O
,	O
no	O
WT	O
Isl1	O
+	O
cells	O
in	O
the	O
inner	O
neuroblastic	O
layer	O
(	O
NBL	O
)	O
(	O
which	O
is	O
the	O
future	O
INL	O
)	O
were	O
dividing	O
,	O
but	O
57	O
+/-	O
14	O
Isl1	O
+	O
/	O
Mki67	O
+	O
cells	O
were	O
detected	O
in	O
the	O
Rb	O
KO	O
inner	O
NBL	O
(	O
Figure	O
4D	O
)	O
.	O

Indeed	O
,	O
about	O
one	O
-	O
third	O
of	O
all	O
Isl1	O
+	O
cells	O
in	O
the	O
entire	O
inner	O
NBL	O
were	O
dividing	O
in	O
the	O
Rb	O
KO	O
retina	O
,	O
or	O
~	O
50	O
%	O
in	O
the	O
periphery	O
where	O
Cre	O
is	O
expressed	O
(	O
Figure	O
4E	O
and	O
data	O
not	O
shown	O
)	O
.	O

This	O
defect	O
was	O
suppressed	O
in	O
the	O
Rb	O
/	O
E2f1	O
DKO	O
retina	O
,	O
where	O
we	O
detected	O
only	O
1	O
+/-	O
1	O
dividing	O
SAC	O
,	O
but	O
not	O
the	O
Rb	O
/	O
E2f3	O
DKO	O
retina	O
,	O
where	O
there	O
were	O
53	O
+/-	O
8	O
dividing	O
SACs	O
(	O
Figure	O
4D	O
and	O
4E	O
)	O
.	O

We	O
observed	O
similar	O
effects	O
at	O
P0	O
with	O
Calb2	O
,	O
which	O
marks	O
newborn	O
SACs	O
and	O
other	O
amacrine	O
cells	O
(	O
data	O
not	O
shown	O
)	O
.	O

Thus	O
,	O
in	O
Rb	O
KO	O
SACs	O
,	O
E2f1	O
deletion	O
suppresses	O
ectopic	O
division	O
but	O
not	O
aberrant	O
differentiation	O
,	O
whereas	O
E2f3	O
deletion	O
suppresses	O
aberrant	O
differentiation	O
but	O
not	O
ectopic	O
division	O
.	O

Specific	O
Expression	O
of	O
E2f3	O
in	O
SACs	O
and	O
Other	O
Subsets	O
of	O
CNS	O
Neurons	O

The	O
unique	O
effect	O
of	O
E2f3	O
in	O
disrupting	O
the	O
differentiation	O
of	O
SACs	O
but	O
not	O
other	O
retinal	O
neurons	O
might	O
be	O
due	O
to	O
cell	O
-	O
type	O
-	O
specific	O
expression	O
or	O
cell	O
-	O
type	O
-	O
specific	O
activity	O
of	O
E2f3	O
.	O

Determining	O
between	O
these	O
two	O
possibilities	O
is	O
not	O
easy	O
,	O
as	O
E2f	O
immunostaining	O
in	O
mouse	O
tissues	O
is	O
problematic	O
.	O

We	O
did	O
not	O
solve	O
this	O
issue	O
for	O
E2f1	O
or	O
E2f2	O
,	O
but	O
used	O
a	O
modified	O
protocol	O
[	O
50	O
]	O
to	O
successfully	O
track	O
E2f3	O
expression	O
(	O
Figure	O
5	O
)	O
.	O

At	O
P0	O
,	O
E2f3	O
was	O
detected	O
in	O
RPCs	O
,	O
consistent	O
with	O
a	O
putative	O
role	O
in	O
normal	O
proliferation	O
(	O
Figure	O
5A	O
)	O
.	O

The	O
signal	O
was	O
specific	O
as	O
it	O
was	O
absent	O
in	O
the	O
E2f3	O
KO	O
peripheral	O
retina	O
(	O
Figure	O
5A	O
)	O
.	O

As	O
the	O
retina	O
differentiated	O
and	O
RPC	O
division	O
diminished	O
,	O
the	O
number	O
of	O
E2f3	O
+	O
cells	O
also	O
dropped	O
,	O
and	O
by	O
P8	O
,	O
when	O
division	O
is	O
virtually	O
over	O
,	O
only	O
a	O
subset	O
of	O
post	O
-	O
mitotic	O
cells	O
in	O
the	O
inner	O
retina	O
expressed	O
E2f3	O
(	O
Figure	O
5A	O
)	O
.	O

By	O
P18	O
,	O
E2f3	O
was	O
also	O
detected	O
in	O
two	O
tracks	O
in	O
the	O
IPL	O
(	O
Figure	O
5A	O
and	O
5B	O
)	O
,	O
reminiscent	O
of	O
SAC	O
markers	O
such	O
as	O
Chat	O
and	O
Slc18a3	O
(	O
c	O
.	O
f	O
.	O
Figures	O
3	O
and	O
4	O
)	O
.	O

This	O
cytoplasmic	S-GO
E2f3	O
staining	O
was	O
also	O
specific	O
,	O
as	O
it	O
was	O
absent	O
in	O
the	O
E2f3	O
KO	O
peripheral	O
retina	O
of	O
alpha	O
-	O
Cre	O
;	O
E2f3loxP	O
/	O
loxP	O
mice	O
(	O
Figure	O
5A	O
)	O
.	O

Indeed	O
,	O
double	O
labelling	O
with	O
E2f3	O
(	O
red	O
)	O
and	O
Chat	O
plus	O
Slc18a3	O
(	O
green	O
)	O
confirmed	O
that	O
E2f3	O
is	O
present	O
in	O
both	O
SAC	O
soma	S-GO
and	O
dendrites	S-GO
(	O
Figure	O
5B	O
)	O
.	O

Rb	O
protein	O
was	O
also	O
detected	O
in	O
the	O
inner	O
retina	O
(	O
Figure	O
5A	O
)	O
,	O
and	O
showed	O
a	O
similar	O
distribution	O
as	O
E2f3	O
in	O
SACs	O
(	O
Figure	O
5B	O
)	O
,	O
and	O
was	O
also	O
present	O
in	O
mature	O
ganglion	O
cells	O
and	O
M	O
u	O
ller	O
cells	O
as	O
reported	O
[	O
51	O
]	O
.	O

Rb	O
staining	O
in	O
SAC	O
processes	S-GO
was	O
specific	O
as	O
it	O
was	O
absent	O
in	O
the	O
peripheral	O
retina	O
of	O
alpha	O
Cre	O
;	O
RbloxP	O
/	O
loxP	O
mice	O
(	O
Figure	O
5A	O
)	O
.	O

These	O
data	O
suggest	O
that	O
Rb	O
and	O
E2f3	O
colocalize	O
in	O
SACs	O
and	O
that	O
E2f3	O
triggers	O
defects	O
in	O
SAC	O
differentiation	O
because	O
it	O
is	O
specifically	O
expressed	O
in	O
these	O
retinal	O
neurons	O
.	O

Figure	O
5	O

E2f3	O
and	O
Rb	O
Expression	O
in	O
SACs	O

(	O
A	O
)	O
Left	O
panels	O
:	O
horizontal	O
P0	O
,	O
P8	O
,	O
and	O
P18	O
retinal	O
sections	O
of	O
the	O
indicated	O
genotypes	O
were	O
stained	O
for	O
E2f3	O
(	O
red	O
)	O
and	O
DAPI	O
(	O
blue	O
)	O
.	O

The	O
arrow	O
indicates	O
the	O
junction	O
between	O
the	O
E2f3	O
null	O
peripheral	O
and	O
WT	O
central	O
P0	O
retina	O
.	O

Note	O
the	O
absence	O
of	O
E2f3	O
protein	O
in	O
the	O
peripheral	O
E2f3	O
KO	O
RPCs	O
at	O
P0	O
and	O
in	O
peripheral	O
inner	O
retinal	O
neurons	O
at	O
P18	O
.	O

Far	O
right	O
panel	O
:	O
P18	O
retinal	O
sections	O
of	O
the	O
indicated	O
genotypes	O
were	O
stained	O
for	O
Rb	O
(	O
red	O
)	O
and	O
DAPI	O
(	O
blue	O
)	O
.	O

Note	O
the	O
absence	O
of	O
Rb	O
protein	O
in	O
the	O
peripheral	O
Rb	O
KO	O
inner	O
retinal	O
neurons	O
.	O

(	O
B	O
)	O
WT	O
P18	O
retinal	O
sections	O
were	O
stained	O
for	O
nuclei	S-GO
(	O
DAPI	O
,	O
blue	O
)	O
,	O
E2f3	O
(	O
red	O
)	O
or	O
Rb	O
(	O
red	O
)	O
,	O
and	O
Chat	O
plus	O
Slc18a3	O
(	O
green	O
)	O
.	O

Arrows	O
indicate	O
double	O
-	O
labelled	O
soma	S-GO
.	O

Note	O
that	O
the	O
IPL	O
processes	S-GO
are	O
also	O
double	O
-	O
labelled	O
.	O

Scale	O
bars	O
are	O
50	O
mu	O
m	O
.	O

We	O
also	O
found	O
that	O
E2f3	O
is	O
present	O
in	O
a	O
specific	O
subset	O
of	O
mature	O
neurons	O
in	O
various	O
brain	O
regions	O
(	O
data	O
not	O
shown	O
)	O
.	O

For	O
example	O
,	O
in	O
the	O
P20	O
amygdala	O
,	O
E2f3	O
colocalized	O
with	O
the	O
general	O
neuronal	O
markers	O
Mtap2	O
and	O
Mecp2	O
[	O
52	O
]	O
,	O
but	O
not	O
with	O
Calb2	O
,	O
which	O
marks	O
a	O
subset	O
of	O
neurons	O
,	O
or	O
with	O
the	O
glial	O
marker	O
Gfap	O
(	O
data	O
not	O
shown	O
)	O
.	O

Unlike	O
in	O
retinal	O
SACs	O
,	O
E2f3	O
was	O
not	O
coexpressed	O
in	O
Chat	O
+	O
or	O
Slc18a3	O
+	O
cholinergic	O
neurons	O
located	O
in	O
various	O
regions	O
of	O
the	O
brain	O
and	O
spinal	O
cord	O
(	O
data	O
not	O
shown	O
)	O
.	O

In	O
agreement	O
,	O
we	O
could	O
not	O
detect	O
defects	O
in	O
cholinergic	O
Rb	O
KO	O
neurons	O
in	O
the	O
developing	O
forebrain	O
,	O
but	O
other	O
Rb	O
KO	O
neurons	O
in	O
this	O
region	O
showed	O
differentiation	O
defects	O
that	O
were	O
rescued	O
by	O
deleting	O
E2f3	O
[	O
53	O
]	O
.	O

Together	O
,	O
these	O
results	O
suggest	O
that	O
the	O
common	O
mechanism	O
by	O
which	O
Rb	O
promotes	O
neural	O
differentiation	O
is	O
through	O
E2f3	O
inhibition	O
.	O

Distinct	O
Localization	O
of	O
E2f3	O
Isoforms	O

As	O
noted	O
above	O
,	O
E2f3	O
and	O
Rb	O
staining	O
in	O
SACs	O
was	O
both	O
nuclear	S-GO
and	O
cytoplasmic	S-GO
(	O
Figure	O
5A	O
and	O
5B	O
)	O
.	O

The	O
antibody	S-GO
that	O
worked	O
in	O
immunostaining	O
recognizes	O
a	O
C	O
-	O
terminal	O
region	O
and	O
thus	O
,	O
does	O
not	O
distinguish	O
a	O
/	O
b	O
isoforms	O
.	O

To	O
our	O
knowledge	O
,	O
the	O
subcellular	O
location	O
of	O
E2f3	O
isoforms	O
has	O
not	O
been	O
determined	O
in	O
any	O
cell	O
type	O
.	O

To	O
verify	O
the	O
dual	O
locations	O
of	O
E2f3	O
and	O
to	O
determine	O
which	O
isoforms	O
were	O
present	O
in	O
retina	O
,	O
we	O
analyzed	O
nuclear	S-GO
and	O
cytoplasmic	S-GO
fractions	S-GO
by	O
Western	O
blot	O
at	O
different	O
times	O
during	O
development	O
.	O

Analysis	O
with	O
the	O
pan	O
-	O
E2f3	O
antibody	S-GO
(	O
sc	O
-	O
878	O
,	O
Santa	O
Cruz	O
Biotechnology	O
)	O
detected	O
a	O
55	O
-	O
kD	O
E2f3a	O
species	O
and	O
a	O
40	O
-	O
kD	O
E2f3b	O
polypeptide	O
(	O
Figure	O
6	O
)	O
.	O

To	O
confirm	O
that	O
the	O
upper	O
species	O
in	O
our	O
retinal	O
lysates	O
was	O
E2f3a	O
,	O
we	O
exploited	O
novel	O
mice	O
that	O
lack	O
E2f3	O
exon	O
1a	O
and	O
thus	O
express	O
E2f3b	O
exclusively	O
(	O
R	O
.	O
O	O
.	O
and	O
G	O
.	O
L	O
.	O
,	O
unpublished	O
data	O
)	O
.	O

The	O
genotyping	O
strategy	O
is	O
discussed	O
in	O
detail	O
later	O
and	O
is	O
outlined	O
in	O
Figure	O
7A	O
.	O

Western	O
analysis	O
confirmed	O
that	O
the	O
upper	O
band	O
was	O
absent	O
in	O
E2f3a	O
-	O
/	O
-	O
mice	O
(	O
Figures	O
6	O
and	O
S8	O
)	O
.	O

Consistent	O
with	O
the	O
drop	O
in	O
E2f3	O
-	O
expressing	O
cells	O
during	O
WT	O
retinal	O
maturation	O
(	O
Figure	O
5A	O
)	O
,	O
the	O
total	O
amount	O
of	O
E2f3a	O
was	O
less	O
at	O
P18	O
compared	O
to	O
P0	O
(	O
Figure	O
6	O
)	O
.	O

E2f3b	O
was	O
present	O
in	O
similar	O
amounts	O
at	O
both	O
time	O
points	O
.	O

At	O
P0	O
and	O
P18	O
,	O
E2f3a	O
was	O
present	O
in	O
both	O
nuclear	S-GO
and	O
cytoplasmic	S-GO
fractions	S-GO
,	O
but	O
in	O
marked	O
contrast	O
,	O
E2f3b	O
was	O
exclusively	O
nuclear	S-GO
at	O
both	O
times	O
(	O
Figure	O
6	O
)	O
.	O

Two	O
closely	O
migrating	O
E2f3a	O
bands	O
were	O
detected	O
,	O
more	O
clearly	O
evident	O
at	O
P18	O
,	O
of	O
which	O
the	O
faster	O
migrating	O
species	O
was	O
dominant	O
in	O
nuclear	S-GO
and	O
the	O
slower	O
species	O
was	O
dominant	O
in	O
cytoplasm	S-GO
(	O
Figure	O
6	O
)	O
.	O

The	O
identity	O
of	O
both	O
as	O
E2f3a	O
species	O
was	O
confirmed	O
by	O
their	O
absence	O
in	O
the	O
P18	O
E2f3a	O
KO	O
retina	O
(	O
Figure	O
S8	O
)	O
.	O

Analysis	O
of	O
Pou4f2	O
,	O
a	O
nuclear	S-GO
transcription	O
factor	O
expressed	O
in	O
ganglion	O
cells	O
,	O
showed	O
that	O
nuclear	S-GO
proteins	O
had	O
not	O
contaminated	O
the	O
cytoplasmic	S-GO
fraction	S-GO
,	O
and	O
analysis	O
of	O
Slc18a3	O
,	O
a	O
cytoplasmic	S-GO
SAC	O
marker	O
,	O
confirmed	O
that	O
the	O
reverse	O
had	O
also	O
not	O
occurred	O
(	O
Figure	O
6	O
)	O
.	O

These	O
data	O
show	O
,	O
to	O
our	O
knowledge	O
for	O
the	O
first	O
time	O
,	O
that	O
E2f3a	O
and	O
E2f3b	O
exhibit	O
distinct	O
patterns	O
of	O
subcellular	O
distribution	O
,	O
and	O
raise	O
the	O
possibility	O
that	O
E2f3a	O
localization	O
may	O
be	O
regulated	O
by	O
as	O
yet	O
unknown	O
post	O
-	O
translational	O
modifications	O
.	O

Figure	O
6	O

Subcellular	O
Distribution	O
of	O
E2f3	O
Isoforms	O
and	O
Other	O
Cell	O
Cycle	O
Proteins	O
in	O
the	O
Developing	O
Retina	O

Nuclear	O
and	O
cytoplasmic	S-GO
extracts	O
from	O
an	O
equivalent	O
number	O
of	O
retinal	O
cells	O
from	O
mice	O
of	O
the	O
indicated	O
genotypes	O
and	O
ages	O
were	O
analyzed	O
by	O
Western	O
blotting	O
to	O
detect	O
the	O
indicated	O
proteins	O
.	O

Lysate	O
from	O
E2f3a	O
-	O
/	O
-	O
mice	O
was	O
used	O
as	O
a	O
control	O
to	O
confirm	O
the	O
location	O
of	O
E2f3a	O
protein	O
.	O

C	S-GO
,	O
cytoplasmic	S-GO
extracts	O
;	O
N	S-GO
,	O
nuclear	S-GO
extracts	O
.	O

Figure	O
7	O

The	O
E2f3a	O
Isoform	O
Drives	O
the	O
Differentiation	O
Defect	O
in	O
Rb	O
KO	O
SACs	O

(	O
A	O
)	O
Schematic	O
diagrams	O
of	O
the	O
mouse	O
WT	O
,	O
E2f3a	O
-	O
/	O
-	O
,	O
and	O
the	O
Cre	O
-	O
recombined	O
floxed	O
E2f3	O
loci	O
(	O
indicated	O
here	O
as	O
E2f3	O
-	O
/	O
-	O
for	O
simplicity	O
)	O
.	O

E2f3a	O
-	O
/	O
-	O
mice	O
lack	O
most	O
of	O
E2f3	O
exon	O
1a	O
and	O
part	O
of	O
intron	O
1a	O
(	O
red	O
dotted	O
box	O
)	O
.	O

Arrows	O
indicate	O
PCR	O
primers	O
.	O

Genotyping	O
of	O
an	O
E2f3a	O
+	O
/	O
-	O
mouse	O
is	O
shown	O
on	O
the	O
right	O
.	O

(	O
B	O
)	O
RT	O
-	O
PCR	O
detection	O
of	O
E2f3a	O
and	O
E2f3b	O
mRNA	O
in	O
the	O
retina	O
.	O

The	O
sequences	O
of	O
primers	O
are	O
1aF	O
(	O
5	O
'	O
-	O
GCCTCTACACCACGCCACAAG	O
-	O
3	O
'	O
)	O
,	O
1bF	O
(	O
5	O
'	O
-	O
CGGAAATGCCCTTACAGC	O
-	O
3	O
'	O
)	O
,	O
and	O
4R	O
(	O
5	O
'	O
-	O
CTCAGTCACTTCTTTGGACAG	O
-	O
3	O
'	O
)	O
.	O

WT	O
retina	O
expresses	O
both	O
E2f3a	O
and	O
E2f3b	O
mRNA	O
.	O

As	O
expected	O
,	O
E2f3a	O
-	O
/	O
-	O
retina	O
lacks	O
E2f3a	O
mRNA	O
and	O
still	O
expresses	O
E2f3b	O
mRNA	O
.	O

E2f3	O
-	O
/	O
-	O
retina	O
lacks	O
full	O
-	O
length	O
E2f3a	O
and	O
E2f3b	O
mRNAs	O
,	O
and	O
instead	O
expresses	O
a	O
truncated	O
mRNA	O
lacking	O
exon	O
3	O
.	O

(	O
C	O
)	O
Real	O
-	O
time	O
RT	O
-	O
PCR	O
analysis	O
of	O
E2f	O
genes	O
in	O
P8	O
retinas	O
of	O
the	O
indicated	O
genotypes	O
.	O

Error	O
bars	O
represent	O
SD	O
of	O
measurements	O
from	O
three	O
animals	O
,	O
and	O
asterisks	O
indicate	O
a	O
significant	O
difference	O
between	O
WT	O
and	O
the	O
indicated	O
genotypes	O
(	O
*	O
,	O
p	O
<	O
0	O
.	O
05	O
;	O
*	O
*	O
;	O
p	O
<	O
0	O
.	O
01	O
;	O
ANOVA	O
and	O
Tukey	O
HSD	O
test	O
)	O
.	O

(	O
D	O
)	O
Rescue	O
of	O
Rb	O
KO	O
SACs	O
by	O
E2f3a	O
deletion	O
.	O

Horizontal	O
retinal	O
sections	O
of	O
the	O
indicated	O
genotypes	O
and	O
ages	O
were	O
stained	O
for	O
nuclei	S-GO
(	O
DAPI	O
,	O
blue	O
)	O
,	O
M	O
-	O
phase	O
(	O
PH3	O
,	O
green	O
)	O
,	O
and	O
the	O
SAC	O
marker	O
Slc18a3	O
(	O
red	O
)	O
.	O

E2f3a	O
deletion	O
does	O
not	O
suppress	O
ectopic	O
division	O
,	O
but	O
rescues	O
the	O
SAC	O
defect	O
.	O

Scale	O
bars	O
are	O
50	O
mu	O
m	O
.	O

M	O
,	O
molecular	O
size	O
marker	O
.	O

We	O
also	O
examined	O
the	O
distribution	O
of	O
other	O
cell	O
cycle	O
regulators	O
during	O
retinal	O
development	O
.	O

Like	O
E2f3a	O
,	O
Rb	O
was	O
present	O
in	O
both	O
the	O
WT	O
cytoplasm	S-GO
and	O
nucleus	S-GO
at	O
P0	O
,	O
but	O
at	O
P18	O
,	O
when	O
the	O
levels	O
of	O
Rb	O
had	O
increased	O
,	O
it	O
was	O
primarily	O
nuclear	S-GO
(	O
Figure	O
6	O
)	O
.	O

A	O
very	O
faint	O
cytoplasmic	S-GO
Rb	O
signal	O
was	O
evident	O
at	O
P18	O
,	O
which	O
is	O
consistent	O
with	O
Rb	O
staining	O
of	O
SAC	O
processes	S-GO
(	O
Figure	O
5B	O
)	O
,	O
and	O
with	O
the	O
very	O
small	O
proportion	O
of	O
SACs	O
in	O
the	O
retina	O
[	O
38	O
]	O
.	O

E2f1	O
was	O
also	O
detected	O
in	O
both	O
nuclear	S-GO
and	O
cytoplasmic	S-GO
fractions	S-GO
,	O
although	O
unlike	O
E2f3a	O
it	O
was	O
predominantly	O
nuclear	S-GO
both	O
at	O
P0	O
and	O
P18	O
(	O
Figure	O
6	O
)	O
.	O

The	O
E2f	O
dimerization	O
partner	O
,	O
Tfdp1	O
,	O
which	O
lacks	O
a	O
nuclear	S-GO
localization	O
signal	O
[	O
54	O
]	O
,	O
was	O
primarily	O
cytoplasmic	S-GO
at	O
both	O
P0	O
and	O
P18	O
,	O
and	O
the	O
Cdk	O
inhibitors	O
Cdkn1a	O
and	O
Cdkn1b	O
showed	O
a	O
similar	O
pattern	O
of	O
distribution	O
(	O
Figure	O
6	O
)	O
.	O

Thus	O
,	O
among	O
the	O
cell	O
cycle	O
regulators	O
we	O
examined	O
,	O
most	O
showed	O
bivalent	O
distribution	O
,	O
and	O
E2f3b	O
was	O
unusual	O
in	O
its	O
solely	O
nuclear	S-GO
compartmentalization	O
.	O

Rb	O
Regulates	O
SAC	O
Differentiation	O
through	O
E2f3a	O

To	O
test	O
which	O
E2f3	O
isoform	O
is	O
responsible	O
for	O
aberrant	O
Rb	O
KO	O
SAC	O
differentiation	O
we	O
exploited	O
E2f3a	O
-	O
/	O
-	O
mice	O
(	O
Figure	O
7A	O
)	O
.	O

The	O
genotyping	O
strategy	O
outlined	O
in	O
Figure	O
7A	O
was	O
used	O
to	O
distinguish	O
the	O
E2f3a	O
,	O
WT	O
,	O
and	O
null	O
alleles	O
.	O

Reverse	O
transcriptase	O
PCR	O
(	O
RT	O
-	O
PCR	O
)	O
confirmed	O
the	O
presence	O
of	O
both	O
E2f3a	O
and	O
E2f3b	O
RNA	O
species	O
in	O
the	O
developing	O
WT	O
retina	O
,	O
and	O
the	O
specific	O
absence	O
of	O
E2f3a	O
RNA	O
in	O
the	O
E2f3a	O
-	O
/	O
-	O
retina	O
(	O
Figure	O
7B	O
)	O
.	O

E2f3a	O
protein	O
was	O
absent	O
in	O
E2f3a	O
-	O
/	O
-	O
retinal	O
lysate	O
(	O
Figures	O
6	O
and	O
S8	O
)	O
.	O

Importantly	O
,	O
the	O
levels	O
of	O
E2f3b	O
message	O
were	O
similar	O
in	O
the	O
Rb	O
KO	O
and	O
Rb	O
/	O
E2f3a	O
DKO	O
retina	O
,	O
ruling	O
out	O
the	O
possibility	O
that	O
any	O
effects	O
of	O
E2f3a	O
deletion	O
we	O
might	O
observe	O
were	O
due	O
to	O
down	O
-	O
regulation	O
of	O
E2f3b	O
(	O
Figure	O
7C	O
)	O
.	O

Also	O
,	O
the	O
levels	O
of	O
other	O
E2fs	O
were	O
the	O
same	O
in	O
the	O
Rb	O
KO	O
,	O
Rb	O
/	O
E2f3	O
DKO	O
,	O
and	O
Rb	O
/	O
E2f3a	O
DKO	O
retina	O
,	O
ruling	O
out	O
any	O
cross	O
-	O
regulatory	O
effects	O
(	O
Figure	O
7C	O
)	O
[	O
55	O
]	O
.	O

E2f3a	O
can	O
trigger	O
cell	O
cycle	O
induction	O
,	O
but	O
because	O
SAC	O
defects	O
are	O
not	O
linked	O
to	O
cell	O
cycle	O
perturbation	O
(	O
Figures	O
3A	O
and	O
4	O
)	O
,	O
and	O
in	O
view	O
of	O
the	O
predominant	O
association	O
between	O
E2f3b	O
and	O
Rb	O
in	O
quiescent	O
cells	O
[	O
16	O
,	O
19	O
]	O
,	O
we	O
suspected	O
that	O
E2f3b	O
may	O
perturb	O
differentiation	O
in	O
Rb	O
KO	O
SACs	O
.	O

Unexpectedly	O
,	O
however	O
,	O
E2f3a	O
deletion	O
suppressed	O
the	O
Rb	O
KO	O
SAC	O
defect	O
(	O
Figure	O
7D	O
)	O
.	O

Thus	O
,	O
separate	O
from	O
its	O
role	O
in	O
cell	O
cycle	O
control	O
,	O
Rb	O
regulation	O
of	O
E2f3a	O
is	O
critical	O
to	O
ensure	O
proper	O
neuronal	O
differentiation	O
.	O

Discussion	O

Rb	O
Controls	O
Retinal	O
Cell	O
Division	O
and	O
Death	O
through	O
E2f1	O

Work	O
in	O
the	O
early	O
1990s	O
showed	O
that	O
Rb	O
loss	O
triggers	O
defects	O
in	O
neuronal	O
cell	O
cycle	O
exit	O
,	O
survival	O
,	O
and	O
differentiation	O
[	O
26	O
-	O
28	O
]	O
.	O

Much	O
of	O
the	O
death	O
is	O
an	O
indirect	O
consequence	O
of	O
probable	O
hypoxia	O
linked	O
to	O
placental	O
defects	O
[	O
12	O
-	O
14	O
]	O
.	O

However	O
,	O
targeted	O
KO	O
and	O
chimeric	O
studies	O
reveal	O
that	O
Rb	O
autonomously	O
promotes	O
cell	O
cycle	O
exit	O
in	O
newborn	O
neurons	O
,	O
and	O
is	O
required	O
for	O
survival	O
of	O
a	O
subset	O
of	O
neurons	O
,	O
particularly	O
in	O
the	O
retina	O
[	O
2	O
,	O
3	O
,	O
13	O
,	O
14	O
,	O
56	O
-	O
59	O
]	O
.	O

However	O
,	O
whether	O
Rb	O
also	O
regulates	O
differentiation	O
is	O
obscured	O
by	O
potentially	O
indirect	O
effects	O
of	O
ectopic	O
division	O
and	O
death	O
.	O

Moreover	O
,	O
a	O
mechanism	O
though	O
which	O
Rb	O
may	O
regulate	O
neuronal	O
maturation	O
has	O
not	O
been	O
elucidated	O
.	O

Here	O
,	O
deleting	O
E2f1	O
specifically	O
rescued	O
ectopic	O
division	O
and	O
death	O
in	O
the	O
Rb	O
KO	O
retina	O
.	O

Importantly	O
,	O
major	O
Rb	O
/	O
E2f1	O
DKO	O
neurons	O
differentiated	O
normally	O
,	O
and	O
ERGs	O
revealed	O
the	O
rescue	O
of	O
rod	O
-	O
and	O
cone	O
-	O
mediated	O
function	O
,	O
implicating	O
a	O
regular	O
signal	O
flow	O
from	O
photoreceptors	O
to	O
bipolar	O
and	O
amacrine	O
cells	O
.	O

Division	O
and	O
death	O
genes	O
were	O
induced	O
in	O
Rb	O
KO	O
cells	O
,	O
and	O
deleting	O
E2f1	O
,	O
but	O
not	O
E2f2	O
or	O
E2f3	O
,	O
reversed	O
these	O
molecular	O
events	O
.	O

E2f1	O
may	O
also	O
regulate	O
differentiation	O
targets	O
,	O
but	O
whether	O
this	O
contributes	O
to	O
defects	O
in	O
retinal	O
cell	O
maturation	O
is	O
impossible	O
to	O
separate	O
from	O
potentially	O
indirect	O
consequences	O
of	O
deregulated	O
division	O
and	O
death	O
.	O

In	O
any	O
case	O
,	O
it	O
is	O
clear	O
that	O
in	O
most	O
retinal	O
cells	O
,	O
including	O
photoreceptors	O
[	O
29	O
]	O
,	O
transcription	O
factors	O
that	O
promote	O
differentiation	O
function	O
independently	O
of	O
Rb	O
.	O

We	O
have	O
also	O
found	O
that	O
E2f1	O
deletion	O
rescues	O
cell	O
-	O
autonomous	O
ectopic	O
division	O
,	O
death	O
,	O
and	O
differentiation	O
defects	O
in	O
sporadic	O
Rb	O
KO	O
clones	O
generated	O
using	O
a	O
Cre	O
retrovirus	O
vector	O
(	O
M	O
.	O
P	O
.	O
and	O
R	O
.	O
B	O
.	O
,	O
unpublished	O
data	O
)	O
.	O

These	O
data	O
are	O
consistent	O
with	O
the	O
observation	O
that	O
E2f1	O
overexpression	O
in	O
newborn	O
photoreceptors	O
drives	O
ectopic	O
division	O
and	O
apoptosis	O
[	O
60	O
]	O
,	O
and	O
add	O
to	O
the	O
growing	O
evidence	O
indicating	O
that	O
E2f1	O
is	O
the	O
major	O
,	O
and	O
perhaps	O
only	O
,	O
member	O
of	O
the	O
three	O
activating	O
E2fs	O
required	O
to	O
induce	O
apoptosis	O
in	O
Rb	O
KO	O
cells	O
[	O
10	O
,	O
15	O
]	O
.	O

Thus	O
,	O
deregulated	O
E2f1	O
activity	O
in	O
the	O
retina	O
,	O
whether	O
resulting	O
from	O
the	O
inactivation	O
of	O
Rb	O
or	O
from	O
overexpression	O
,	O
promotes	O
unscheduled	O
cell	O
division	O
and	O
triggers	O
apoptosis	O
in	O
susceptible	O
RTCs	O
.	O

E2f1	O
,	O
rather	O
than	O
other	O
E2fs	O
,	O
may	O
be	O
a	O
potential	O
target	O
for	O
novel	O
therapeutics	O
to	O
prevent	O
retinoblastoma	O
in	O
RB1	O
+	O
/	O
-	O
humans	O
.	O

Our	O
ERG	O
studies	O
revealed	O
rescue	O
of	O
the	O
Rb	O
KO	O
rod	O
-	O
bipolar	O
system	O
,	O
and	O
almost	O
complete	O
restoration	O
of	O
the	O
cone	O
-	O
bipolar	O
system	O
following	O
E2f1	O
deletion	O
.	O

There	O
was	O
a	O
slightly	O
lower	O
response	O
in	O
the	O
Rb	O
/	O
E2f1	O
DKO	O
retina	O
relative	O
to	O
the	O
E2f1	O
KO	O
control	O
retina	O
.	O

This	O
difference	O
might	O
reflect	O
a	O
role	O
for	O
Rb	O
in	O
the	O
development	O
of	O
cones	O
,	O
bipolar	O
cells	O
,	O
or	O
other	O
cells	O
that	O
may	O
contribute	O
to	O
the	O
photopic	O
ERG	O
,	O
including	O
potentially	O
SACs	O
,	O
which	O
do	O
have	O
a	O
serious	O
defect	O
in	O
the	O
Rb	O
/	O
E2f1	O
DKO	O
retina	O
.	O

Rb	O
Controls	O
SAC	O
Differentiation	O
through	O
E2f3a	O

Comprehensive	O
marker	O
analysis	O
revealed	O
that	O
,	O
in	O
striking	O
contrast	O
to	O
other	O
retinal	O
neurons	O
,	O
E2f1	O
deletion	O
did	O
not	O
suppress	O
defects	O
in	O
Rb	O
KO	O
cholinergic	O
SACs	O
.	O

Instead	O
,	O
we	O
observed	O
E2f1	O
-	O
independent	O
defects	O
in	O
the	O
synthesis	O
and	O
transport	O
of	O
a	O
large	O
cohort	O
of	O
SAC	O
proteins	O
.	O

These	O
data	O
expand	O
insight	O
into	O
the	O
development	O
of	O
these	O
important	O
interneurons	O
,	O
but	O
more	O
critically	O
,	O
provide	O
to	O
our	O
knowledge	O
the	O
first	O
unambiguous	O
evidence	O
that	O
Rb	O
regulates	O
neurogenesis	O
beyond	O
terminal	O
mitosis	O
.	O

Rb	O
binds	O
more	O
than	O
100	O
factors	O
[	O
43	O
]	O
,	O
and	O
in	O
several	O
non	O
-	O
neuronal	O
cells	O
,	O
such	O
as	O
skeletal	O
muscle	O
,	O
adipocytes	O
,	O
and	O
bone	O
,	O
it	O
binds	O
and	O
potentiates	O
tissue	O
-	O
specific	O
transcription	O
factors	O
that	O
promote	O
differentiation	O
[	O
31	O
-	O
33	O
]	O
.	O

The	O
idea	O
that	O
Rb	O
promotes	O
muscle	O
differentiation	O
by	O
potentiating	O
Myod1	O
activity	O
was	O
contested	O
[	O
61	O
]	O
,	O
and	O
other	O
mechanisms	O
proposed	O
[	O
62	O
,	O
63	O
]	O
,	O
but	O
not	O
involving	O
E2f	O
repression	O
.	O

Strikingly	O
,	O
however	O
,	O
we	O
discovered	O
that	O
Rb	O
promotes	O
SAC	O
differentiation	O
through	O
E2f3	O
(	O
Figure	O
8	O
)	O
.	O

Figure	O
8	O

Rb	O
Regulates	O
Distinct	O
Processes	O
through	O
E2f1	O
and	O
E2f3a	O

Red	O
text	O
and	O
arrows	O
indicate	O
Rb	O
-	O
dependent	O
events	O
.	O

Black	O
text	O
and	O
arrows	O
indicate	O
events	O
for	O
which	O
there	O
is	O
no	O
direct	O
evidence	O
of	O
Rb	O
involvement	O
.	O

Rb	O
does	O
not	O
appear	O
to	O
temper	O
RPC	O
expansion	O
and	O
is	O
not	O
required	O
for	O
differentiation	O
of	O
RPCs	O
into	O
RTCs	O
,	O
but	O
is	O
essential	O
to	O
couple	O
RTC	O
birth	O
to	O
terminal	O
mitosis	O
,	O
thus	O
locking	O
them	O
out	O
of	O
cycle	O
.	O

Rb	O
performs	O
this	O
function	O
by	O
inhibiting	O
E2f1	O
.	O

Rb	O
is	O
also	O
required	O
for	O
SAC	O
differentiation	O
,	O
and	O
in	O
this	O
case	O
,	O
acts	O
by	O
inhibiting	O
E2f3a	O
.	O

There	O
is	O
no	O
direct	O
evidence	O
that	O
Rb	O
is	O
required	O
for	O
terminal	O
differentiation	O
of	O
other	O
cell	O
types	O
.	O

Colour	O
codes	O
and	O
abbreviations	O
as	O
in	O
Figure	O
1A	O
.	O

Rb	O
regulation	O
of	O
SAC	O
differentiation	O
through	O
E2f3	O
was	O
independent	O
of	O
its	O
role	O
in	O
controlling	O
division	O
or	O
death	O
:	O
E2f3	O
deletion	O
rescued	O
Rb	O
KO	O
SAC	O
defects	O
but	O
did	O
not	O
suppress	O
aberrant	O
proliferation	O
or	O
death	O
,	O
whereas	O
E2f1	O
deletion	O
reversed	O
abnormal	O
proliferation	O
and	O
death	O
but	O
did	O
not	O
rescue	O
SAC	O
differentiation	O
.	O

Double	O
labelling	O
confirmed	O
that	O
E2f1	O
but	O
not	O
E2f3	O
deletion	O
reversed	O
Rb	O
KO	O
SAC	O
division	O
.	O

Moreover	O
,	O
deleting	O
E2f1	O
,	O
but	O
not	O
E2f3	O
,	O
reversed	O
deregulated	O
expression	O
of	O
cell	O
cycle	O
and	O
apoptotic	O
genes	O
in	O
the	O
Rb	O
KO	O
retina	O
.	O

E2f3	O
is	O
expressed	O
in	O
a	O
subset	O
of	O
CNS	O
neurons	O
(	O
this	O
work	O
)	O
and	O
drives	O
specific	O
cell	O
-	O
cycle	O
-	O
independent	O
defects	O
in	O
Rb	O
KO	O
forebrain	O
neurons	O
[	O
53	O
]	O
.	O

Thus	O
,	O
E2f3	O
inhibition	O
is	O
the	O
first	O
,	O
and	O
may	O
be	O
the	O
only	O
,	O
mechanism	O
by	O
which	O
Rb	O
participates	O
directly	O
in	O
neuronal	O
differentiation	O
.	O

To	O
further	O
dissect	O
the	O
mechanism	O
of	O
action	O
of	O
Rb	O
in	O
SACs	O
we	O
determined	O
the	O
E2f3	O
isoform	O
it	O
targets	O
to	O
promote	O
differentiation	O
.	O

E2f3b	O
was	O
the	O
primary	O
candidate	O
,	O
since	O
Rb	O
and	O
E2f3b	O
collaborate	O
to	O
repress	O
targets	O
in	O
quiescent	O
cells	O
in	O
vitro	O
[	O
19	O
]	O
.	O

However	O
,	O
in	O
the	O
first	O
work	O
to	O
our	O
knowledge	O
to	O
examine	O
the	O
function	O
of	O
any	O
E2f	O
protein	O
isoform	O
in	O
vivo	O
,	O
we	O
made	O
the	O
surprising	O
observation	O
that	O
Rb	O
regulates	O
SAC	O
differentiation	O
through	O
E2f3a	O
(	O
Figure	O
8	O
)	O
.	O

Formally	O
,	O
we	O
cannot	O
exclude	O
the	O
possibility	O
that	O
deleting	O
E2f3b	O
might	O
also	O
rescue	O
SAC	O
differentiation	O
,	O
but	O
definitive	O
proof	O
will	O
require	O
analysis	O
of	O
E2f3b	O
null	O
mice	O
.	O

Nevertheless	O
,	O
our	O
data	O
prove	O
that	O
Rb	O
definitely	O
regulates	O
SAC	O
differentiation	O
through	O
the	O
activating	O
E2f3	O
isoform	O
.	O

Distinct	O
E2f3a	O
and	O
E2f3b	O
Localization	O

The	O
subcellular	O
location	O
of	O
E2f	O
isoforms	O
has	O
not	O
to	O
our	O
knowledge	O
been	O
addressed	O
before	O
.	O

E2f3a	O
and	O
E2f3b	O
share	O
110	O
C	O
-	O
terminal	O
amino	O
acids	O
that	O
encode	O
the	O
NLS	O
,	O
DNA	O
-	O
binding	O
,	O
marked	O
box	O
,	O
transactivation	O
,	O
and	O
Rb	O
-	O
binding	O
domains	O
[	O
16	O
]	O
,	O
yet	O
they	O
exhibit	O
different	O
subcellular	O
distribution	O
in	O
developing	O
retinal	O
cells	O
.	O

E2f3a	O
is	O
both	O
nuclear	S-GO
and	O
cytoplasmic	S-GO
,	O
but	O
E2f3b	O
is	O
always	O
nuclear	S-GO
.	O

The	O
unique	O
121	O
-	O
and	O
six	O
-	O
residue	O
N	O
-	O
termini	O
of	O
E2f3a	O
and	O
E2f3b	O
,	O
respectively	O
,	O
likely	O
mediate	O
this	O
difference	O
.	O

This	O
region	O
in	O
E2f1	O
,	O
E2f2	O
,	O
and	O
E2f3a	O
binds	O
Ccna2	O
,	O
establishing	O
a	O
negative	O
regulatory	O
loop	O
that	O
deactivates	O
E2fs	O
in	O
mid	O
-	O
late	O
S	O
-	O
phase	O
[	O
64	O
,	O
65	O
]	O
.	O

However	O
,	O
even	O
E2f3b	O
,	O
which	O
lacks	O
this	O
domain	O
,	O
binds	O
and	O
is	O
regulated	O
by	O
Ccna2	O
[	O
18	O
]	O
,	O
so	O
the	O
domain	O
difference	O
may	O
not	O
explain	O
the	O
unique	O
distributions	O
we	O
observed	O
.	O

Rb	O
family	O
and	O
Tfdp	O
proteins	O
can	O
also	O
determine	O
E2f	O
localization	O
[	O
20	O
-	O
22	O
]	O
,	O
and	O
we	O
found	O
that	O
a	O
portion	O
of	O
both	O
Rb	O
and	O
Tfdp1	O
proteins	O
are	O
cytoplasmic	S-GO
in	O
retinal	O
cells	O
.	O

Indeed	O
,	O
immunostaining	O
revealed	O
that	O
Rb	O
and	O
E2f3	O
colocalize	O
to	O
SAC	O
processes	S-GO
.	O

The	O
nuclear	S-GO
localization	O
of	O
E2f3b	O
contrasts	O
with	O
that	O
of	O
other	O
repressive	O
E2fs	O
in	O
differentiating	O
muscle	O
,	O
where	O
E2f5	O
switches	O
from	O
the	O
nucleus	S-GO
to	O
cytoplasm	S-GO
,	O
while	O
E2f4	O
remains	O
in	O
both	O
compartments	O
[	O
23	O
]	O
.	O

The	O
distinct	O
compartmentalization	O
of	O
E2f3a	O
and	O
E2f3b	O
in	O
the	O
retina	O
suggests	O
temporally	O
and	O
functionally	O
distinct	O
activities	O
.	O

Rb	O
distribution	O
matches	O
that	O
of	O
E2f3a	O
,	O
consistent	O
with	O
its	O
critical	O
role	O
in	O
supporting	O
SAC	O
differentiation	O
through	O
E2f3a	O
.	O

Ectopic	O
Division	O
and	O
Differentiation	O

Rb	O
is	O
critical	O
to	O
ensure	O
that	O
many	O
types	O
of	O
terminally	O
differentiating	O
cells	O
leave	O
the	O
cell	O
cycle	O
(	O
e	O
.	O
g	O
.	O
,	O
neurons	O
,	O
gut	O
and	O
skin	O
epithelia	O
,	O
muscle	O
,	O
and	O
lens	O
fibres	O
)	O
(	O
reviewed	O
in	O
[	O
66	O
]	O
)	O
.	O

Early	O
overexpression	O
studies	O
in	O
vitro	O
suggested	O
Rb	O
might	O
temper	O
expansion	O
of	O
cycling	O
cells	O
,	O
but	O
KO	O
studies	O
in	O
vivo	O
indicate	O
that	O
its	O
major	O
role	O
is	O
to	O
block	O
division	O
in	O
terminally	O
differentiating	O
cells	O
.	O

In	O
its	O
absence	O
,	O
many	O
(	O
but	O
clearly	O
not	O
all	O
)	O
aspects	O
of	O
differentiation	O
go	O
ahead	O
relatively	O
unperturbed	O
.	O

In	O
the	O
retina	O
,	O
differentiating	O
transition	O
cells	O
are	O
born	O
in	O
the	O
absence	O
of	O
Rb	O
,	O
migrate	O
to	O
the	O
correct	O
layer	O
,	O
and	O
express	O
appropriate	O
markers	O
(	O
[	O
2	O
]	O
and	O
this	O
work	O
)	O
.	O

In	O
brain	O
,	O
Rb	O
KO	O
neurons	O
migrate	O
away	O
from	O
the	O
ventricular	O
zone	O
and	O
switch	O
on	O
Tubb3	O
(	O
beta	O
III	O
-	O
tubulin	O
)	O
,	O
but	O
continue	O
to	O
incorporate	O
BrdU	O
[	O
13	O
]	O
,	O
and	O
in	O
gut	O
epithelia	O
,	O
differentiated	O
enterocytes	O
migrate	O
up	O
the	O
villi	O
and	O
activate	O
expression	O
of	O
serotonin	O
,	O
yet	O
continue	O
to	O
incorporate	O
BrdU	O
[	O
67	O
]	O
.	O

In	O
the	O
case	O
of	O
SACs	O
,	O
the	O
differentiation	O
defects	O
we	O
observed	O
(	O
e	O
.	O
g	O
.	O
,	O
loss	O
of	O
Slc18a3	O
and	O
Chat	O
)	O
were	O
not	O
due	O
to	O
aberrant	O
division	O
,	O
but	O
it	O
is	O
possible	O
there	O
are	O
other	O
problems	O
with	O
these	O
cells	O
that	O
are	O
caused	O
by	O
ectopic	O
division	O
.	O

Nevertheless	O
,	O
it	O
is	O
clear	O
that	O
many	O
aspects	O
of	O
differentiation	O
in	O
multiple	O
cell	O
types	O
are	O
compatible	O
with	O
ectopic	O
division	O
.	O

However	O
,	O
division	O
of	O
terminally	O
differentiating	O
cells	O
is	O
dangerous	O
,	O
since	O
it	O
may	O
facilitate	O
transformation	O
,	O
as	O
is	O
the	O
case	O
in	O
retinoblastoma	O
(	O
reviewed	O
in	O
[	O
66	O
]	O
)	O
.	O

How	O
Does	O
E2f3a	O
Perturb	O
SAC	O
Differentiation	O
?	O

E2f3a	O
could	O
disrupt	O
SAC	O
differentiation	O
through	O
its	O
well	O
known	O
role	O
as	O
a	O
transcriptional	O
activator	O
,	O
or	O
,	O
in	O
view	O
of	O
the	O
discovery	O
that	O
it	O
is	O
partially	O
cytoplasmic	S-GO
,	O
E2f3a	O
may	O
affect	O
processes	O
other	O
than	O
gene	O
regulation	O
.	O

Both	O
scenarios	O
are	O
feasible	O
since	O
E2fs	O
regulate	O
differentiation	O
genes	O
[	O
44	O
-	O
48	O
]	O
,	O
and	O
cell	O
cycle	O
regulators	O
,	O
such	O
as	O
Cdkn1b	O
,	O
have	O
cytoplasmic	S-GO
activities	O
that	O
influence	O
differentiation	O
[	O
68	O
,	O
69	O
]	O
.	O

Many	O
transcription	O
factors	O
shuttle	O
between	O
nucleus	S-GO
and	O
cytoplasm	S-GO
during	O
neurogenesis	O
(	O
e	O
.	O
g	O
.	O
,	O
[	O
70	O
]	O
and	O
references	O
therein	O
)	O
.	O

It	O
may	O
be	O
difficult	O
to	O
identify	O
E2f3a	O
-	O
specific	O
target	O
genes	O
or	O
cytoplasmic	S-GO
proteins	O
in	O
SACs	O
since	O
these	O
neurons	O
are	O
a	O
small	O
proportion	O
(	O
<	O
1	O
%	O
)	O
of	O
the	O
total	O
retina	O
and	O
only	O
~	O
5	O
.	O
2	O
%	O
of	O
amacrine	O
neurons	O
[	O
38	O
]	O
.	O

Do	O
E2fs	O
Mediate	O
All	O
Rb	O
Functions	O
?	O

Others	O
have	O
suggested	O
that	O
Rb	O
promotes	O
differentiation	O
in	O
non	O
-	O
neuronal	O
cells	O
through	O
E2f	O
-	O
independent	O
means	O
[	O
31	O
-	O
33	O
]	O
.	O

However	O
,	O
these	O
studies	O
did	O
not	O
assess	O
whether	O
these	O
cell	O
types	O
differentiate	O
normally	O
if	O
Rb	O
is	O
deleted	O
along	O
with	O
one	O
or	O
more	O
E2f	O
family	O
members	O
.	O

One	O
study	O
reported	O
that	O
Rb	O
mutants	O
that	O
do	O
not	O
bind	O
E2f	O
still	O
induce	O
differentiation	O
[	O
30	O
]	O
.	O

However	O
,	O
the	O
binding	O
assays	O
were	O
performed	O
in	O
solution	O
,	O
and	O
we	O
have	O
found	O
that	O
several	O
of	O
these	O
mutants	O
do	O
bind	O
E2f	O
,	O
albeit	O
weakly	O
,	O
on	O
chromatin	S-GO
(	O
T	O
.	O
Yu	O
and	O
R	O
.	O
B	O
.	O
,	O
unpublished	O
data	O
)	O
.	O

It	O
is	O
possible	O
that	O
Rb	O
-	O
mediated	O
potentiation	O
of	O
tissue	O
-	O
specific	O
transcription	O
factors	O
may	O
,	O
at	O
least	O
in	O
some	O
cases	O
,	O
be	O
a	O
redundant	O
activity	O
,	O
and	O
that	O
the	O
only	O
critical	O
Rb	O
function	O
is	O
to	O
inhibit	O
E2f	O
.	O

Our	O
study	O
is	O
the	O
first	O
to	O
our	O
knowledge	O
to	O
assess	O
comprehensively	O
whether	O
Rb	O
KO	O
cells	O
can	O
differentiate	O
in	O
the	O
absence	O
of	O
different	O
E2fs	O
.	O

In	O
light	O
of	O
our	O
findings	O
,	O
it	O
will	O
be	O
important	O
to	O
reassess	O
differentiation	O
defects	O
in	O
other	O
Rb	O
KO	O
tissues	O
in	O
the	O
absence	O
of	O
individual	O
and	O
combined	O
activating	O
E2f	O
family	O
members	O
.	O

Materials	O
and	O
Methods	O

Mouse	O
strains	O
and	O
genotyping	O
.	O

Mice	O
were	O
treated	O
according	O
to	O
institutional	O
and	O
national	O
guidelines	O
.	O

alpha	O
-	O
Cre	O
mice	O
(	O
P	O
.	O
Gruss	O
)	O
,	O
Chx10	O
-	O
Cre	O
mice	O
(	O
C	O
.	O
Cepko	O
)	O
,	O
RbloxP	O
/	O
loxP	O
mice	O
(	O
A	O
.	O
Berns	O
)	O
,	O
E2f1	O
-	O
/	O
-	O
mice	O
,	O
E2f2	O
-	O
/	O
-	O
mice	O
,	O
E2f3loxP	O
/	O
loxP	O
mice	O
,	O
and	O
E2f3a	O
-	O
/	O
-	O
mice	O
were	O
maintained	O
on	O
a	O
mixed	O
(	O
NMRI	O
x	O
C57	O
/	O
Bl	O
x	O
FVB	O
/	O
N	O
x	O
129sv	O
)	O
background	O
.	O

A	O
detailed	O
description	O
of	O
E2f3a	O
-	O
/	O
-	O
mice	O
will	O
be	O
published	O
elsewhere	O
.	O

Mice	O
of	O
different	O
genotypes	O
were	O
compared	O
within	O
the	O
same	O
litter	O
and	O
across	O
a	O
minimum	O
of	O
three	O
litters	O
.	O

We	O
have	O
not	O
noted	O
any	O
phenotypic	O
differences	O
in	O
separate	O
litters	O
.	O

Genotyping	O
was	O
performed	O
as	O
before	O
[	O
2	O
,	O
5	O
]	O
,	O
and	O
the	O
primers	O
used	O
for	O
genotyping	O
E2f3a	O
-	O
/	O
-	O
mice	O
were	O
E2f3a	O
KL	O
(	O
5	O
'	O
-	O
CTCCAGACCCCCGATTATTT	O
-	O
3	O
'	O
)	O
,	O
E2f3a	O
KR1	O
(	O
5	O
'	O
-	O
TCCAGTGCACTACTCCCTCC	O
-	O
3	O
'	O
)	O
,	O
and	O
E2f3a	O
KM	O
(	O
5	O
'	O
-	O
GCTAGCAGTGCCCTTTTGTC	O
-	O
3	O
'	O
)	O
.	O

Histology	O
,	O
immunofluorescence	O
,	O
and	O
measurements	O
.	O

Eyeballs	O
were	O
fixed	O
in	O
4	O
%	O
paraformaldehyde	O
for	O
1	O
h	O
at	O
4	O
degrees	O
C	O
,	O
embedded	O
in	O
OCT	O
(	O
TissueTek	O
4583	O
,	O
Sakura	O
,	O
http	O
:	O
/	O
/	O
www	O
.	O
sakuraeu	O
.	O
com	O
)	O
,	O
frozen	O
on	O
dry	O
ice	O
,	O
and	O
cut	O
into	O
12	O
-	O
mu	O
m	O
sections	O
on	O
Superfrost	O
plus	O
slides	O
(	O
VWR	O
,	O
http	O
:	O
/	O
/	O
www	O
.	O
vwr	O
.	O
com	O
)	O
.	O

For	O
S	O
-	O
phase	O
analysis	O
,	O
BrdU	O
(	O
100	O
mu	O
g	O
/	O
g	O
of	O
body	O
weight	O
)	O
was	O
injected	O
intraperitoneally	O
2	O
h	O
prior	O
to	O
sacrifice	O
.	O

BrdU	O
+	O
cells	O
were	O
detected	O
using	O
a	O
biotin	O
-	O
conjugated	O
sheep	O
polyclonal	O
antibody	S-GO
(	O
1	O
:	O
500	O
,	O
Maine	O
Biotechnology	O
Services	O
,	O
http	O
:	O
/	O
/	O
www	O
.	O
mainebiotechnology	O
.	O
com	O
)	O
.	O

All	O
other	O
antibodies	S-GO
are	O
described	O
in	O
Table	O
S1	O
.	O

For	O
E2f3	O
,	O
Mki67	O
,	O
and	O
Rb	O
staining	O
,	O
antigen	O
retrieval	O
was	O
performed	O
by	O
boiling	O
sections	O
in	O
citric	O
acid	O
solution	O
for	O
15	O
min	O
according	O
to	O
Ino	O
[	O
50	O
]	O
,	O
except	O
on	O
frozen	O
sections	O
.	O

TUNEL	O
was	O
performed	O
as	O
described	O
[	O
13	O
]	O
.	O

Briefly	O
,	O
sections	O
were	O
incubated	O
for	O
1	O
h	O
at	O
37	O
degrees	O
C	O
with	O
75	O
mu	O
l	O
of	O
mixture	O
solution	O
consisting	O
of	O
0	O
.	O
5	O
mu	O
l	O
of	O
terminal	O
deoxynucleotide	O
transferase	O
,	O
1	O
mu	O
l	O
of	O
biotin	O
-	O
16	O
-	O
dUTP	O
,	O
7	O
.	O
5	O
mu	O
l	O
of	O
CoCl2	O
,	O
15	O
mu	O
l	O
of	O
5	O
x	O
terminal	O
deoxynucleotide	O
transferase	O
buffer	O
,	O
and	O
51	O
mu	O
l	O
of	O
distilled	O
water	O
.	O

After	O
three	O
washes	O
in	O
4	O
x	O
SSC	O
buffer	O
,	O
sections	O
were	O
incubated	O
with	O
Alexa	O
488	O
-	O
or	O
Alexa	O
568	O
-	O
streptavidin	O
(	O
1	O
:	O
1	O
,	O
000	O
;	O
Molecular	O
Probes	O
,	O
http	O
:	O
/	O
/	O
probes	O
.	O
invitrogen	O
.	O
com	O
)	O
for	O
1	O
h	O
at	O
room	O
temperature	O
.	O

Primary	O
antibodies	S-GO
or	O
labelled	O
cells	O
were	O
visualized	O
using	O
donkey	O
anti	O
-	O
mouse	O
Alexa	O
488	O
or	O
Alexa	O
568	O
,	O
donkey	O
anti	O
-	O
rabbit	O
Alexa	O
488	O
or	O
Alexa	O
568	O
,	O
donkey	O
anti	O
-	O
goat	O
Alexa	O
488	O
or	O
Alexa	O
568	O
,	O
and	O
streptavidin	O
Alexa	O
488	O
or	O
Alexa	O
568	O
(	O
1	O
:	O
1	O
,	O
000	O
;	O
Molecular	O
Probes	O
)	O
.	O

Nuclei	S-GO
were	O
counter	O
-	O
stained	O
with	O
4	O
,	O
6	O
-	O
diamidino	O
-	O
2	O
-	O
phenyindole	O
(	O
DAPI	O
;	O
Sigma	O
,	O
http	O
:	O
/	O
/	O
www	O
.	O
sigmaaldrich	O
.	O
com	O
)	O
.	O

Labelled	O
cells	O
were	O
visualized	O
using	O
a	O
Zeiss	O
(	O
http	O
:	O
/	O
/	O
www	O
.	O
zeiss	O
.	O
com	O
)	O
Axioplan	O
-	O
2	O
microscope	O
with	O
Plan	O
Neofluar	O
objectives	O
and	O
images	O
captured	O
with	O
a	O
Zeiss	O
AxionCam	O
camera	O
.	O

For	O
double	O
-	O
labelled	O
samples	O
,	O
confocal	O
images	O
were	O
obtained	O
with	O
a	O
Zeiss	O
LSM	O
5	O
.	O
0	O
laser	O
scanning	O
microscope	O
.	O

The	O
retina	O
was	O
separated	O
into	O
three	O
bins	O
by	O
dividing	O
the	O
ventricular	O
edge	O
of	O
the	O
retina	O
into	O
equal	O
parts	O
and	O
extending	O
a	O
line	O
to	O
the	O
vitreal	O
edge	O
[	O
2	O
]	O
.	O

Bin	O
1	O
contains	O
only	O
cells	O
that	O
expressed	O
Cre	O
as	O
progenitors	O
;	O
bin	O
3	O
is	O
at	O
central	O
retina	O
and	O
contains	O
cells	O
derived	O
from	O
progenitors	O
that	O
did	O
not	O
express	O
Cre	O
.	O

For	O
cell	O
counts	O
or	O
thickness	O
measurement	O
we	O
used	O
a	O
region	O
0	O
-	O
100	O
mu	O
m	O
peripheral	O
to	O
the	O
boundary	O
separating	O
bins	O
1	O
and	O
2	O
.	O

Measurements	O
were	O
performed	O
on	O
an	O
Axioplan	O
-	O
2	O
microscope	O
using	O
Axiovison	O
software	O
.	O

Quantification	O
of	O
S	O
-	O
phase	O
,	O
M	O
-	O
phase	O
,	O
and	O
apoptotic	O
cells	O
was	O
performed	O
on	O
horizontal	O
sections	O
that	O
included	O
the	O
optic	O
nerve	O
.	O

Quantification	O
of	O
differentiated	O
cell	O
types	O
was	O
performed	O
using	O
horizontal	O
sections	O
at	O
equal	O
distances	O
from	O
the	O
optic	O
nerve	O
.	O

A	O
minimum	O
of	O
three	O
sections	O
per	O
eye	O
and	O
three	O
eyes	O
from	O
different	O
litters	O
were	O
counted	O
.	O

RNA	O
extraction	O
,	O
reverse	O
transcription	O
,	O
and	O
PCR	O
.	O

Total	O
RNA	O
was	O
isolated	O
from	O
dissected	O
peripheral	O
retina	O
using	O
TRIzol	O
reagent	O
(	O
Invitrogen	O
,	O
http	O
:	O
/	O
/	O
www	O
.	O
invitrogen	O
.	O
com	O
)	O
followed	O
by	O
digestion	O
with	O
RNase	O
-	O
free	O
DNase	O
(	O
DNA	O
-	O
free	O
,	O
Ambion	O
,	O
http	O
:	O
/	O
/	O
www	O
.	O
ambion	O
.	O
com	O
)	O
to	O
remove	O
DNA	O
contamination	O
.	O

First	O
-	O
strand	O
cDNA	O
was	O
synthesized	O
from	O
0	O
.	O
2	O
-	O
0	O
.	O
5	O
mu	O
g	O
of	O
total	O
RNA	O
using	O
the	O
SuperScript	O
II	O
first	O
-	O
strand	O
synthesis	O
system	O
(	O
Invitrogen	O
)	O
.	O

PCR	O
primers	O
are	O
listed	O
in	O
Table	O
S2	O
.	O

Real	O
-	O
time	O
quantitative	O
PCR	O
was	O
performed	O
using	O
an	O
Applied	O
Biosystems	O
(	O
http	O
:	O
/	O
/	O
appliedbiosystems	O
.	O
com	O
)	O
PRISM	O
7900HT	O
.	O

Tests	O
were	O
run	O
in	O
duplicate	O
on	O
three	O
separate	O
biological	O
samples	O
with	O
SYBR	O
Green	O
PCR	O
Master	O
Mix	O
(	O
Applied	O
Biosystems	O
)	O
exactly	O
as	O
we	O
described	O
previously	O
[	O
71	O
]	O
.	O

Briefly	O
,	O
master	O
stocks	O
were	O
prepared	O
such	O
that	O
each	O
10	O
-	O
mu	O
l	O
reaction	O
contained	O
5	O
mu	O
l	O
of	O
SYBR	O
Green	O
PCR	O
Master	O
Mix	O
,	O
0	O
.	O
1	O
mu	O
l	O
of	O
each	O
forward	O
and	O
reverse	O
primer	O
(	O
stock	O
50	O
mu	O
M	O
)	O
,	O
0	O
.	O
8	O
mu	O
l	O
of	O
blue	O
H2O	O
(	O
0	O
.	O
73	O
%	O
Blue	O
Food	O
Colour	O
;	O
McCormick	O
,	O
http	O
:	O
/	O
/	O
www	O
.	O
mccormick	O
.	O
com	O
)	O
,	O
2	O
mu	O
l	O
of	O
diluted	O
cDNA	O
template	O
,	O
and	O
2	O
mu	O
l	O
of	O
yellow	O
H2O	O
(	O
0	O
.	O
73	O
%	O
Yellow	O
Food	O
Colour	O
)	O
.	O

PCR	O
consisted	O
of	O
40	O
cycles	O
of	O
denaturation	O
at	O
95	O
degrees	O
C	O
for	O
15	O
s	O
and	O
annealing	O
and	O
extension	O
at	O
55	O
degrees	O
C	O
for	O
30	O
s	O
.	O

An	O
additional	O
cycle	O
(	O
95	O
degrees	O
C	O
,	O
15	O
s	O
,	O
60	O
degrees	O
C	O
)	O
generated	O
a	O
dissociation	O
curve	O
to	O
confirm	O
a	O
single	O
product	O
.	O

The	O
cycle	O
quantity	O
required	O
to	O
reach	O
a	O
threshold	O
in	O
the	O
linear	O
range	O
was	O
determined	O
and	O
compared	O
to	O
a	O
standard	O
curve	O
for	O
each	O
primer	O
set	O
generated	O
by	O
five	O
3	O
-	O
fold	O
dilutions	O
of	O
genomic	O
DNA	O
or	O
cDNA	O
samples	O
of	O
known	O
concentration	O
.	O

Values	O
obtained	O
for	O
test	O
RNAs	O
were	O
normalized	O
to	O
Hprt1	O
mRNA	O
levels	O
.	O

Western	O
blots	O
.	O

Mouse	O
retinas	O
were	O
homogenized	O
by	O
passing	O
them	O
through	O
a	O
30	O
-	O
gauge	O
BD	O
9	O
http	O
:	O
/	O
/	O
www	O
.	O
bd	O
.	O
com	O
)	O
needle	O
5	O
-	O
10	O
times	O
in	O
1	O
x	O
PBS	O
solution	O
.	O

Nuclear	S-GO
and	O
cytoplasmic	S-GO
proteins	O
were	O
extracted	O
using	O
the	O
NE	O
-	O
PER	O
Nuclear	S-GO
and	O
Cytoplasmic	S-GO
Extraction	O
Kit	O
(	O
Product	O
#	O
78833	O
,	O
Pierce	O
Biotechnology	O
,	O
http	O
:	O
/	O
/	O
www	O
.	O
piercenet	O
.	O
com	O
)	O
.	O

Proteins	O
were	O
separated	O
by	O
10	O
%	O
SDS	O
-	O
PAGE	O
and	O
transferred	O
to	O
nitrocellulose	O
.	O

After	O
blocking	O
overnight	O
at	O
4	O
degrees	O
C	O
in	O
5	O
%	O
skim	O
milk	O
,	O
membranes	O
were	O
incubated	O
in	O
the	O
primary	O
antibody	S-GO
for	O
2	O
h	O
at	O
room	O
temperature	O
.	O

After	O
three	O
10	O
-	O
min	O
washes	O
in	O
TPBS	O
(	O
100	O
mM	O
Na2HPO4	O
,	O
100	O
mM	O
NaH2PO4	O
,	O
0	O
.	O
5	O
N	O
NaCl	O
,	O
0	O
.	O
1	O
%	O
Tween	O
-	O
20	O
)	O
,	O
membranes	O
were	O
incubated	O
for	O
30	O
min	O
at	O
room	O
temperature	O
in	O
the	O
secondary	O
horseradish	O
peroxidase	O
-	O
conjugated	O
antibody	S-GO
(	O
Jackson	O
ImmunoResearch	O
Laboratories	O
,	O
http	O
:	O
/	O
/	O
www	O
.	O
jacksonimmuno	O
.	O
com	O
)	O
.	O

Blots	O
were	O
developed	O
using	O
the	O
ECL	O
-	O
Plus	O
chemiluminescent	O
detection	O
system	O
(	O
Amersham	O
Pharmacia	O
Biotech	O
,	O
http	O
:	O
/	O
/	O
www	O
.	O
pharmacia	O
.	O
ca	O
)	O
,	O
according	O
to	O
the	O
manufacturer	O
'	O
s	O
instructions	O
.	O

The	O
following	O
primary	O
antibodies	S-GO
were	O
used	O
:	O
E2f	O
-	O
1	O
(	O
SC	O
-	O
193	O
)	O
,	O
E2f	O
-	O
3	O
(	O
SC	O
-	O
878	O
)	O
,	O
Cdkn1a	O
(	O
p21	O
,	O
SC	O
-	O
471	O
)	O
,	O
Cdkn1b	O
(	O
p27	O
,	O
SC	O
-	O
528	O
)	O
,	O
Pou4f2	O
(	O
Brn3b	O
,	O
SC	O
-	O
6062	O
)	O
,	O
and	O
Tfdp1	O
(	O
Dp1	O
,	O
SC	O
-	O
610	O
)	O
from	O
Santa	O
Cruz	O
Biotechnology	O
(	O
http	O
:	O
/	O
/	O
www	O
.	O
scbt	O
.	O
com	O
)	O
,	O
pRB	O
(	O
554136	O
)	O
from	O
BD	O
Science	O
-	O
Pharmingen	O
(	O
http	O
:	O
/	O
/	O
www	O
.	O
bdbiosciences	O
.	O
com	O
)	O
,	O
and	O
Slc18a3	O
(	O
VAChT	O
,	O
G448A	O
)	O
from	O
Promega	O
(	O
http	O
:	O
/	O
/	O
www	O
.	O
promega	O
.	O
com	O
)	O
.	O

Electroretinography	O
.	O

ERGs	O
were	O
recorded	O
from	O
dark	O
-	O
adapted	O
mice	O
as	O
described	O
[	O
72	O
]	O
.	O

Briefly	O
,	O
mice	O
were	O
dark	O
-	O
adapted	O
overnight	O
and	O
anaesthetized	O
by	O
subcutaneous	O
injection	O
of	O
ketamine	O
(	O
66	O
.	O
7	O
mg	O
/	O
kg	O
body	O
weight	O
)	O
and	O
xylazine	O
(	O
11	O
.	O
7	O
mg	O
/	O
kg	O
body	O
weight	O
)	O
.	O

The	O
pupils	O
were	O
dilated	O
and	O
single	O
-	O
flash	O
ERG	O
recordings	O
were	O
obtained	O
under	O
dark	O
-	O
adapted	O
(	O
scotopic	O
)	O
and	O
light	O
-	O
adapted	O
(	O
photopic	O
)	O
conditions	O
.	O

Light	O
adaptation	O
was	O
accomplished	O
with	O
a	O
background	O
illumination	O
of	O
30	O
candela	O
(	O
cd	O
)	O
per	O
square	O
meter	O
starting	O
10	O
min	O
before	O
recording	O
.	O

Single	O
white	O
-	O
flash	O
stimulation	O
ranged	O
from	O
10	O
-	O
4	O
to	O
25	O
cd	O
.	O
s	O
/	O
m2	O
,	O
divided	O
into	O
ten	O
steps	O
of	O
0	O
.	O
5	O
and	O
1	O
log	O
cd	O
.	O
s	O
/	O
m2	O
.	O

Ten	O
responses	O
were	O
averaged	O
with	O
an	O
inter	O
-	O
stimulus	O
interval	O
of	O
either	O
5	O
s	O
(	O
for	O
10	O
-	O
4	O
,	O
10	O
-	O
3	O
,	O
10	O
-	O
2	O
,	O
3	O
x	O
10	O
-	O
2	O
,	O
10	O
-	O
1	O
,	O
and	O
3	O
x	O
10	O
-	O
1	O
cd	O
.	O
s	O
/	O
m2	O
)	O
or	O
17	O
s	O
(	O
for	O
1	O
,	O
3	O
,	O
10	O
,	O
and	O
25	O
cd	O
.	O
s	O
/	O
m2	O
)	O
.	O

Band	O
-	O
pass	O
filter	O
cut	O
-	O
off	O
frequencies	O
were	O
0	O
.	O
1	O
and	O
3	O
,	O
000	O
Hz	O
.	O

Statistics	O
.	O

Different	O
genotypes	O
were	O
evaluated	O
using	O
analysis	O
of	O
variance	O
(	O
ANOVA	O
)	O
followed	O
by	O
the	O
Tukey	O
honestly	O
significant	O
difference	O
(	O
HSD	O
)	O
test	O
or	O
Fisher	O
test	O
(	O
XLSTAT	O
program	O
,	O
http	O
:	O
/	O
/	O
www	O
.	O
xlstat	O
.	O
com	O
)	O
.	O

Supporting	O
Information	O

Figure	O
S1	O

Deleting	O
E2f1	O
,	O
but	O
Not	O
E2f2	O
or	O
E2f3	O
,	O
Rescues	O
Ectopic	O
Division	O
and	O
Cell	O
Death	O
in	O
P0	O
and	O
P18	O
Rb	O
KO	O
Retina	O

Horizontal	O
sections	O
of	O
the	O
indicated	O
genotypes	O
and	O
ages	O
were	O
stained	O
for	O
nuclei	S-GO
(	O
DAPI	O
,	O
blue	O
)	O
,	O
and	O
(	O
A	O
)	O
S	O
-	O
phase	O
(	O
anti	O
-	O
BrdU	O
,	O
red	O
)	O
or	O
(	O
B	O
)	O
apoptosis	O
(	O
TUNEL	O
,	O
red	O
)	O
.	O

In	O
Rb	O
-	O
/	O
-	O
retinas	O
,	O
BrdU	O
+	O
cells	O
extend	O
beyond	O
the	O
normal	O
boundaries	O
at	O
P0	O
(	O
arrows	O
)	O
,	O
and	O
ectopic	O
DNA	O
synthesis	O
continues	O
in	O
multiple	O
layers	O
at	O
later	O
stages	O
.	O

Scale	O
bar	O
is	O
50	O
mu	O
m	O
.	O

The	O
NBL	O
is	O
where	O
dividing	O
RPCs	O
are	O
located	O
.	O

(	O
815	O
KB	O
PDF	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Figure	O
S2	O

Deleting	O
E2f1	O
Rescues	O
Ectopic	O
Division	O
and	O
Apoptosis	O
in	O
the	O
Embryonic	O
Rb	O
KO	O
Retina	O

Horizontal	O
sections	O
of	O
the	O
indicated	O
genotypes	O
and	O
ages	O
(	O
E14	O
and	O
E16	O
,	O
the	O
period	O
during	O
which	O
SACs	O
are	O
born	O
)	O
were	O
stained	O
for	O
nuclei	S-GO
(	O
DAPI	O
,	O
blue	O
)	O
,	O
and	O
either	O
S	O
-	O
phase	O
(	O
upper	O
two	O
panels	O
,	O
anti	O
-	O
BrdU	O
,	O
red	O
)	O
or	O
apoptosis	O
(	O
lower	O
two	O
panels	O
,	O
TUNEL	O
,	O
red	O
)	O
.	O

In	O
Rb	O
-	O
/	O
-	O
retinas	O
,	O
BrdU	O
+	O
and	O
TUNEL	O
+	O
cells	O
can	O
be	O
seen	O
in	O
the	O
inner	O
retina	O
(	O
arrows	O
)	O
.	O

Inactivation	O
of	O
E2f1	O
rescued	O
these	O
defects	O
.	O

Scale	O
bar	O
is	O
50	O
mu	O
m	O
.	O

The	O
NBL	O
is	O
where	O
dividing	O
RPCs	O
are	O
located	O
.	O

(	O
754	O
KB	O
PDF	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Figure	O
S3	O

Deleting	O
E2f1	O
,	O
but	O
Not	O
E2f2	O
or	O
E2f3	O
,	O
Rescues	O
Ectopic	O
Mitosis	O
in	O
the	O
Rb	O
KO	O
Retina	O

(	O
A	O
)	O
Horizontal	O
retinal	O
sections	O
of	O
the	O
indicated	O
genotypes	O
and	O
ages	O
were	O
stained	O
for	O
nuclei	S-GO
(	O
DAPI	O
,	O
blue	O
)	O
and	O
M	O
-	O
phase	O
(	O
anti	O
-	O
PH3	O
,	O
red	O
)	O
.	O

Scale	O
bar	O
is	O
50	O
mu	O
m	O
.	O

(	O
B	O
)	O
Quantification	O
of	O
all	O
PH3	O
+	O
cells	O
.	O

(	O
C	O
)	O
Quantification	O
of	O
ectopic	O
PH3	O
+	O
cells	O
.	O

Error	O
bars	O
represent	O
standard	O
deviation	O
(	O
SD	O
)	O
,	O
and	O
asterisks	O
indicate	O
significant	O
difference	O
between	O
retina	O
of	O
WT	O
and	O
indicated	O
genotypes	O
(	O
*	O
,	O
p	O
<	O
0	O
.	O
05	O
;	O
*	O
*	O
,	O
p	O
<	O
0	O
.	O
01	O
;	O
ANOVA	O
and	O
Tukey	O
HSD	O
test	O
)	O
.	O

(	O
628	O
KB	O
PDF	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Figure	O
S4	O

Deleting	O
E2f2	O
or	O
E2f3	O
Does	O
Not	O
Rescue	O
Ganglion	O
,	O
Rod	O
,	O
or	O
Bipolar	O
Cell	O
Death	O
in	O
the	O
Rb	O
KO	O
Retina	O

(	O
A	O
)	O
Horizontal	O
retinal	O
sections	O
from	O
mice	O
of	O
the	O
indicated	O
ages	O
and	O
genotypes	O
were	O
stained	O
for	O
nuclei	S-GO
(	O
DAPI	O
,	O
blue	O
)	O
and	O
markers	O
that	O
detect	O
ganglion	O
cells	O
(	O
Pou4f2	O
,	O
red	O
)	O
,	O
rods	O
and	O
cones	O
(	O
Sag	O
[	O
rod	O
arrestin	O
]	O
,	O
green	O
)	O
,	O
and	O
rod	O
bipolar	O
cells	O
(	O
Prkca	O
,	O
green	O
)	O
.	O

Scale	O
bar	O
is	O
50	O
mu	O
m	O
.	O

(	O
B	O
)	O
Quantification	O
of	O
total	O
ganglion	O
(	O
Pou4f2	O
+	O
)	O
cells	O
.	O

(	O
C	O
)	O
Quantification	O
of	O
total	O
rod	O
bipolar	O
(	O
Prkca	O
+	O
)	O
cells	O
.	O

(	O
D	O
)	O
Thickness	O
of	O
the	O
ONL	O
,	O
which	O
represents	O
the	O
number	O
of	O
rods	O
.	O

Error	O
bars	O
represent	O
SD	O
,	O
and	O
asterisks	O
indicate	O
significant	O
difference	O
between	O
retina	O
of	O
WT	O
and	O
indicated	O
genotypes	O
(	O
*	O
*	O
,	O
p	O
<	O
0	O
.	O
01	O
;	O
ANOVA	O
and	O
Tukey	O
HSD	O
test	O
)	O
.	O

(	O
488	O
KB	O
PDF	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Figure	O
S5	O

E2f1	O
Deletion	O
Rescues	O
alpha	O
-	O
Cre	O
;	O
RbloxP	O
/	O
loxP	O
Retinal	O
Function	O

ERGs	O
were	O
recorded	O
from	O
the	O
indicated	O
genotypes	O
under	O
light	O
adapted	O
(	O
photopic	O
)	O
conditions	O
.	O

(	O
A	O
)	O
Intensity	O
series	O
.	O

(	O
B	O
)	O
The	O
b	O
-	O
wave	O
amplitudes	O
as	O
a	O
function	O
of	O
the	O
logarithm	O
of	O
the	O
flash	O
intensity	O
.	O

(	O
383	O
KB	O
PDF	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Figure	O
S6	O

Differentiation	O
Defects	O
in	O
Rb	O
KO	O
SACs	O

Horizontal	O
retinal	O
sections	O
of	O
indicated	O
genotypes	O
and	O
ages	O
were	O
stained	O
for	O
nuclei	S-GO
(	O
DAPI	O
,	O
blue	O
)	O
and	O
Calb2	O
(	O
[	O
A	O
]	O
,	O
red	O
;	O
only	O
densely	O
stained	O
cells	O
were	O
counted	O
for	O
Figure	O
3C	O
)	O
,	O
Camk2a	O
(	O
[	O
B	O
]	O
,	O
green	O
)	O
,	O
and	O
Slc18a3	O
(	O
[	O
C	O
]	O
,	O
red	O
)	O
.	O

Scale	O
bars	O
are	O
50	O
mu	O
m	O
.	O

(	O
564	O
KB	O
PDF	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Figure	O
S7	O

GABA	O
Neurotransmitter	O
in	O
the	O
Rb	O
KO	O
Retina	O
and	O
Abnormal	O
SACs	O
in	O
Chx10	O
-	O
Cre	O
;	O
RbloxP	O
/	O
loxP	O
Retina	O

Horizontal	O
sections	O
of	O
the	O
indicated	O
genotypes	O
and	O
ages	O
of	O
retina	O
were	O
stained	O
for	O
nuclei	S-GO
(	O
DAPI	O
,	O
blue	O
)	O
,	O
and	O
(	O
A	O
and	O
B	O
)	O
GABA	O
(	O
red	O
)	O
and	O
Slc18a3	O
(	O
green	O
)	O
or	O
(	O
C	O
)	O
Chat	O
and	O
Slc18a3	O
(	O
red	O
)	O
.	O

(	O
A	O
)	O
In	O
P18	O
WT	O
retina	O
,	O
GABA	O
labelled	O
four	O
IPL	O
tracks	O
,	O
of	O
which	O
the	O
two	O
inner	O
tracks	O
co	O
-	O
stained	O
with	O
Slc18a3	O
.	O

The	O
latter	O
tracks	O
disappeared	O
in	O
the	O
Rb	O
KO	O
retina	O
,	O
and	O
were	O
rescued	O
by	O
E2f3	O
KO	O
but	O
not	O
E2f1	O
KO	O
.	O

(	O
B	O
)	O
At	O
the	O
boundary	O
of	O
the	O
WT	O
(	O
central	O
)	O
and	O
Rb	O
KO	O
area	O
(	O
peripheral	O
retina	O
)	O
the	O
inner	O
GABA	O
+	O
SAC	O
tracks	O
can	O
be	O
seen	O
disappearing	O
towards	O
the	O
periphery	O
(	O
left	O
)	O
.	O

(	O
C	O
)	O
Slc18a3	O
staining	O
in	O
the	O
IPL	O
of	O
Chx10	O
-	O
Cre	O
;	O
RbloxP	O
/	O
loxP	O
retina	O
is	O
consistent	O
with	O
the	O
mosaic	O
pattern	O
of	O
Rb	O
inactivation	O
.	O

Scale	O
bars	O
are	O
50	O
mu	O
m	O
.	O

(	O
633	O
KB	O
PDF	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Figure	O
S8	O

Subcellular	O
Distribution	O
of	O
E2f3a	O
Isoform	O
in	O
the	O
Developing	O
Retina	O

Nuclear	S-GO
and	O
cytoplasmic	S-GO
extracts	O
from	O
an	O
equivalent	O
number	O
of	O
retinal	O
cells	O
from	O
mice	O
of	O
the	O
indicated	O
genotypes	O
and	O
ages	O
were	O
analyzed	O
by	O
Western	O
blotting	O
to	O
detect	O
the	O
E2f3a	O
protein	O
.	O

Lysates	O
from	O
E2f3a	O
-	O
/	O
-	O
mice	O
of	O
matched	O
ages	O
were	O
used	O
as	O
a	O
control	O
to	O
confirm	O
the	O
location	O
of	O
E2f3a	O
protein	O
.	O

C	S-GO
,	O
cytoplasmic	S-GO
extracts	O
;	O
N	S-GO
,	O
nuclear	S-GO
extracts	O
.	O

(	O
115	O
KB	O
PDF	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Table	O
S1	O

List	O
of	O
Antibodies	S-GO
and	O
Marker	O
Patterns	O
in	O
Rb	O
/	O
E2f1	O
DKO	O
SACs	O

(	O
97	O
KB	O
DOC	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Table	O
S2	O

Real	O
-	O
Time	O
RT	O
-	O
PCR	O
Primers	O

(	O
49	O
KB	O
DOC	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Accession	O
Numbers	O

The	O
GenBank	O
(	O
http	O
:	O
/	O
/	O
www	O
.	O
ncbi	O
.	O
nlm	O
.	O
nih	O
.	O
gov	O
/	O
genbank	O
)	O
accession	O
numbers	O
for	O
the	O
major	O
genes	O
and	O
gene	O
products	O
discussed	O
in	O
this	O
paper	O
are	O
Camk2a	O
(	O
NM	O
_	O
009792	O
)	O
,	O
Chat	O
(	O
NM	O
_	O
009891	O
)	O
,	O
E2f1	O
(	O
NM	O
_	O
007891	O
)	O
,	O
E2f2	O
(	O
NM	O
_	O
177733	O
)	O
,	O
E2f3	O
(	O
NM	O
_	O
010093	O
)	O
,	O
Rb	O
(	O
NM	O
_	O
009029	O
)	O
,	O
and	O
Slc18a3	O
(	O
NM	O
_	O
021712	O
)	O
.	O

Acknowledgements	O

We	O
thank	O
K	O
.	O

McClellan	O
and	O
R	O
.	O

Slack	O
for	O
sharing	O
unpublished	O
data	O
,	O
L	O
.	O

Galli	O
-	O
Resta	O
for	O
suggesting	O
Isl1	O
(	O
Islet1	O
)	O
as	O
an	O
early	O
SAC	O
marker	O
,	O
J	O
.	O

Eubanks	O
for	O
advice	O
on	O
immunostaining	O
,	O
A	O
.	O

Berns	O
,	O
C	O
.	O

Cepko	O
,	O
and	O
P	O
.	O

Gruss	O
for	O
mice	O
,	O
and	O
T	O
.	O

Edlund	O
,	O
F	O
.	O

Haeseleer	O
,	O
R	O
.	O

Janz	O
,	O
S	O
.	O

Sugita	O
,	O
P	O
.	O

A	O
.	O

Hargrave	O
,	O
C	O
.	O

M	O
.	O

Craft	O
,	O
X	O
.	O

Zhu	O
,	O
R	O
.	O

McInnes	O
,	O
R	O
.	O

L	O
.	O

Chow	O
,	O
and	O
J	O
.	O

Saari	O
for	O
antibodies	S-GO
.	O

Abbreviations	O

ANOVA	O
-	O
analysis	O
of	O
variance	O

BrdU	O
-	O
bromodeoxyuridine	O

cd	O
-	O
candela	O

CNS	O
-	O
central	O
nervous	O
system	O

DAPI	O
-	O
4	O
,	O
6	O
-	O
diamidino	O
-	O
2	O
-	O
phenyindole	O

DKO	O
-	O
double	O
knockout	O

E	O
[	O
number	O
]	O
-	O
embryonic	O
day	O
[	O
number	O
]	O

E2f	O
-	O
E2f	O
transcription	O
factor	O

ERG	O
-	O
electroretinogram	O

HSD	O
-	O
honestly	O
significant	O
difference	O

GABA	O
-	O
gamma	O
-	O
aminobutyric	O
acid	O

GCL	O
-	O
ganglion	O
cell	O
layer	O

INL	O
-	O
inner	O
nuclear	O
layer	O

IPL	O
-	O
inner	O
plexiform	O
layer	O

KO	O
-	O
knockout	O

NBL	O
-	O
neuroblastic	O
layer	O

ONL	O
-	O
outer	O
nuclear	O
layer	O

OPL	O
-	O
outer	O
plexiform	O
layer	O

P	O
[	O
number	O
]	O
-	O
postnatal	O
day	O
[	O
number	O
]	O

PH3	O
-	O
phosphohistone	O
3	O

Rb	O
-	O
retinoblastoma	O
protein	O

RPC	O
-	O
retinal	O
progenitor	O
cell	O

RTC	O
-	O
retinal	O
transition	O
cell	O

RT	O
-	O
PCR	O
-	O
reverse	O
transcriptase	O
PCR	O

SAC	O
-	O
starburst	O
amacrine	O
cell	O

SD	O
-	O
standard	O
deviation	O

TUNEL	O
-	O
terminal	O
dUTP	O
nick	O
-	O
end	O
labelling	O

WT	O
-	O
wild	O
-	O
type	O

Footnotes	O

Author	O
contributions	O
.	O

DC	O
and	O
RB	O
conceived	O
and	O
designed	O
the	O
experiments	O
.	O

DC	O
performed	O
most	O
of	O
the	O
experiments	O
.	O

RO	O
,	O
PW	O
,	O
and	O
GL	O
provided	O
the	O
E2f3	O
floxed	O
and	O
E2f3a	O
KO	O
mice	O
.	O

DC	O
and	O
RB	O
analyzed	O
the	O
data	O
.	O

MP	O
,	O
NT	O
,	O
and	O
MWS	O
performed	O
the	O
ERG	O
analysis	O
.	O

DC	O
and	O
RB	O
wrote	O
the	O
paper	O
.	O

Funding	O
.	O

This	O
work	O
was	O
supported	O
by	O
grants	O
from	O
the	O
Canadian	O
Institute	O
for	O
Health	O
Research	O
and	O
Foundation	O
Fighting	O
Blindness	O
Canada	O
to	O
RB	O
,	O
and	O
by	O
the	O
German	O
Research	O
Council	O
(	O
DFG	O
Se837	O
/	O
4	O
-	O
1	O
and	O
5	O
-	O
1	O
)	O
and	O
the	O
European	O
Union	O
(	O
IP	O
"	O
EVI	O
-	O
GenoRet	O
"	O
LSHG	O
-	O
CT	O
-	O
512036	O
)	O
to	O
MWS	O
.	O

Competing	O
interests	O
.	O

The	O
authors	O
have	O
declared	O
that	O
no	O
competing	O
interests	O
exist	O
.	O
